PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Hosokawa, M; Saito, M; Nakano, A; Iwashita, S; Ishizaka, A; Ueda, K; Iwakawa, S				Hosokawa, Mika; Saito, Mai; Nakano, Aiko; Iwashita, Sakura; Ishizaka, Ayano; Ueda, Kumiko; Iwakawa, Seigo			Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine	ONCOLOGY LETTERS			English	Article						colorectal cancer; decitabine; epigenetics; gemcitabine; resistance	DNA-METHYLTRANSFERASE INHIBITORS; MYELODYSPLASTIC SYNDROME; NUCLEOSIDE TRANSPORTERS; HYPOMETHYLATING AGENTS; DEOXYCYTIDINE KINASE; SOLID TUMORS; THERAPY; 5-AZACYTIDINE; AZACITIDINE; LINES	The aim of the present study was to determine the effects of long-term exposure of decitabine (DAC) to HCT116 colorectal cancer (CRC) cells on the acquisition of resistance to DAC as well as cross-resistance to anticancer drugs used for CRC or other epigenetic modifiers. In the present study, DAC-resistant HCI116 CRC cells were established through long-term treatment with increasing concentrations of DAC (10 to 540 nM); and the cross-resistance to other drugs was subsequently examined. DAC-resistant HCT116 cells were obtained following a 104-day treatment with DAC, including DAC-free intervals. The results demonstrated that the IC50 value of DAC was increased 100-fold in DAC-resistant HCI116 cells. Messenger (m)RNA expression of secreted frizzed-related protein 1 (SERPI), which is regulated by DNA ir-nethylation, was not detected in DAC-resistant cells; however STRP/ mRNA was present in HCIL16 cells treated with DAC for 52 days. DNA methyltransferase 1 (DNMT1) protein levels were slightly decreased until day 81 and then returned to control levels in DAC-resistant cells. Further experiments using DAC-resistant HCIL16 cells revealed that these cells exhibited cross-resistance to gemcitabine (Gem); however, cross-resistance was not observed for other DNIVIT inhibitors (azacitidine and zebularine), histone deacetylase inhibitors (trichostatin A, vorinostat and valproic acid) or anticancer drugs for CRC (5-fluorouracil, irinotecan and axaliplatin). Furthermore, the protein expression levels of cytidine deaminase (CDA) were increased, while those of deoxycytidine kinase (dCK) were decreased in [)AC-resistant NCI:116 cells; by contrast, the rriRNA expression levels for these proteins were not significantly altered. In conclusion, the results of the present study indicated that the long-term treatment of HCT116 cells with DAC led to the acquisition of resistance to both DAC and Gem. In addition, these results may be partly attributed to Changes in CDA and/or dCK, which are involved in metabolic pathways common to these two drugs.	[Hosokawa, Mika; Saito, Mai; Nakano, Aiko; Iwashita, Sakura; Ishizaka, Ayano; Ueda, Kumiko; Iwakawa, Seigo] Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Hosokawa, M (reprint author), Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	ikehatam@kobepharma-u.ac.jp					Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Sarkar S, 2013, INT J MOL SCI, V14, P21087, DOI 10.3390/ijms141021087; Mahfouz RZ, 2013, CLIN CANCER RES, V19, P938, DOI 10.1158/1078-0432.CCR-12-1722; Stordal B, 2007, CANCER TREAT REV, V33, P347, DOI 10.1016/j.ctrv.2007.01.009; Ueno H, 2007, BRIT J CANCER, V97, P145, DOI 10.1038/sj.bjc.6603860; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Ishikawa T, 2014, INT J CLIN ONCOL, V19, P10, DOI 10.1007/s10147-013-0651-5; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Arimany-Nardi C, 2014, BRIT J PHARMACOL, V171, P3868, DOI 10.1111/bph.12748; Cashen AF, 2008, CANCER CHEMOTH PHARM, V61, P759, DOI 10.1007/s00280-007-0531-7; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Qiu XN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012994; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Damia G, 2004, CELL CYCLE, V3, P46; Cowan LA, 2010, EPIGENOMICS-UK, V2, P71, DOI [10.2217/epi.09.44, 10.2217/EPI.09.44]; Damaraju VL, 2012, NUCLEOS NUCLEOT NUCL, V31, P236, DOI 10.1080/15257770.2011.652330; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dedes KJ, 2009, ANTI-CANCER DRUG, V20, P321, DOI 10.1097/CAD.0b013e3283262a32; Fedier A, 2007, INT J ONCOL, V31, P633; Flis S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092305; Hodge LS, 2011, DRUG METAB DISPOS, V39, P2013, DOI 10.1124/dmd.111.040790; Hummel-Eisenbeiss J, 2013, MOL PHARMACOL, V84, P438, DOI 10.1124/mol.113.086801; Ikehata M, 2014, BIOL PHARM BULL, V37, P67; Imesch P, 2009, INT J ONCOL, V35, P631, DOI 10.3892/ijo_00000375; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kakumoto M, 2002, BIOL PHARM BULL, V25, P1604, DOI 10.1248/bpb.25.1604; Kihslinger JE, 2007, LEUKEMIA LYMPHOMA, V48, P1676, DOI 10.1080/10428190701493910; Lyons John, 2003, Curr Opin Investig Drugs, V4, P1442; Marquez VE, 2005, ANN NY ACAD SCI, V1058, P246, DOI 10.1196/annals.1359.037; Ohmine K, 2012, PHARM RES-DORDR, V29, P2006, DOI 10.1007/s11095-012-0728-2; Panczyk M, 2014, WORLD J GASTROENTERO, V20, P9775, DOI 10.3748/wjg.v20.i29.9775; Kahramanogullari O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050176; Qin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023372; Robak T, 2011, EXPERT OPIN INV DRUG, V20, P343, DOI 10.1517/13543784.2011.554822; Sripayap P, 2014, EXP HEMATOL, V42, P294, DOI 10.1016/j.exphem.2013.12.004	40	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					761	767		10.3892/ol.2015.3253		7	Oncology	Oncology	CN8FX	WOS:000358676200032		
J	Gamoh, S; Akiyama, H; Tominaga, K; Nakajima, M; Kakudo, K; Tanaka, A; Shimizutani, K				Gamoh, Shoko; Akiyama, Hironori; Tominaga, Kazuya; Nakajima, Masahiro; Kakudo, Kenji; Tanaka, Akio; Shimizutani, Kimishige			Simultaneous occurrence of keratocystic odontogenic tumor and ameloblastoma in the mandible: A case report	ONCOLOGY LETTERS			English	Article						ameloblastoma; keratocystic odontogemc tumor; panoramic image; computed tomography image; simultaneous occurrence of odontogenic tumors	CELL CARCINOMA; FEATURES; PATIENT; CYST	Keratocystic odontogenic tumors (KCOTs) and amcloblastomas arc benign odontogenic tumors that primarily occur in the molar region of the inaudible. However, it is uncommon for these tumors to arise simultaneously in a patient's jaw. The present study reported the diagnostic process and features of a rare case of the simultaneous occurrence of KCOT and ameloblastoma in the mandible of a 45-year-old male. Image-based diagnosis was challenging due to several conditions, including the intactness of the teeth and bone cortex as well as the sizes and locations of the lesions. Based on radiographic evidence, the patient was initially misdiagnosed and underwent a biopsy for a radicular cyst and a simple hone cyst prior to the correct diagnoses of KCOT and ameloblastoma, respectively. In addition, the present study discussed the diagnostic process of the present case and reviewed previous literature regarding the simultaneous occurrence of benign tumors of the jaw.	[Gamoh, Shoko; Akiyama, Hironori; Shimizutani, Kimishige] Osaka Dent Univ, Dept Oral Radiol, Osaka 5400008, Japan; [Tominaga, Kazuya; Tanaka, Akio] Osaka Dent Univ, Dept Oral Pathol, Osaka 5400008, Japan; [Nakajima, Masahiro] Osaka Dent Univ, Dept Dent Disabil & Oral Hlth, Osaka 5400008, Japan; [Nakajima, Masahiro; Kakudo, Kenji] Osaka Dent Univ, Dept Oral & Maxillofacial Surg, Osaka 5400008, Japan	Gamoh, S (reprint author), Osaka Dent Univ, Dept Oral Radiol, Chuo Ku, 1-5-17 Otemae, Osaka 5400008, Japan.	shoko1105@gmail.com					GORLIN RJ, 1965, CANCER, V18, P89, DOI 10.1002/1097-0142(196501)18:1<89::AID-CNCR2820180114>3.0.CO;2-9; Philipsen HP, 2006, J ORAL PATHOL MED, V35, P525; SIAR CH, 1993, BRIT J ORAL MAX SURG, V31, P183, DOI 10.1016/0266-4356(93)90122-D; Antonoglou GN, 2014, J CRANIO MAXILL SURG, V42, pE364, DOI 10.1016/j.jcms.2014.03.020; Fregnani ER, 2006, J ORAL PATHOL MED, V35, P573, DOI 10.1111/j.1600-0714.2006.00445.x; Gamoh S, 2011, DENT RADIOLOGY, V51, P16; Gardner DG, 2005, PATHOLOGY GENETICS H, P296; Hisatomi M, 2000, DENTOMAXILLOFAC RAD, V29, P249, DOI 10.1038/sj.dmfr.4600531; McClary AC, 2015, EUR ARCH OTORHINOLAR; Nishimura T, 2000, J ORAL MAXIL SURG, V58, P1297, DOI 10.1053/joms.2000.16634; Philipsen HP, 2005, PATHOLOGY GENETICS H, P306; Shear M, 2007, CYSTS ORAL MAXILLOFA, P6; Shepard M, 2014, AUST DENT J, V59, P121, DOI 10.1111/adj.12137; Shimamoto H, 2011, ORAL SURG ORAL MED O, V112, P798, DOI 10.1016/j.tripleo.2011.06.025; Som PM, 2003, HEAD NECK IMAGING, V1, p[347, 354]	15	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					785	789		10.3892/ol.2015.3323		5	Oncology	Oncology	CN8FX	WOS:000358676200036		
J	Suzuki, T; Ishibashi, K; Yumoto, A; Nishio, K; Ogasawara, Y				Suzuki, Toshihiro; Ishibashi, Kenichi; Yumoto, Atsushi; Nishio, Kazuto; Ogasawara, Yuki			Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells	ONCOLOGY LETTERS			English	Article						cisplatin resistance; arsenic trioxicle; glutathione; adenosine triphosphate-binding cassette subfamily C transporter	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; MULTIDRUG-RESISTANCE; OVARIAN-CANCER; TRANSPORT; LINES; PUMP	Cisplatin is a commonly used drug in combination chemotherapy. However, various malignant tumors frequently acquire resistance to cisplatin. Arsenic trioxide (ATO) has been approved as a chemotherapeutic drug for the treatment of acute promyelocytic leukemia, and the combination of ATE) and cisplatin has been revealed to demonstrate synergistic effects in ovarian and small cell lung cancer cells. Thus, it was hypothesized that ATO may also be active against cisplatin-resistant non-small cell lung cancer (NSCLC) PC-9/CDDP and PC-114./CDDP cells. The present study also evaluated the effects of ATO on the cisplatin-sensitive NSCLC PC-9 and PC-14 cell lines. Notably, ATO demonstrated a markedly decreased IC in the cisplatin-resistant PC-9/CDDP and PC-14/CDDP cells compared with the IC in the cisplatiri-sensitive parental PC-9 and PC-14 cells. Additionally, it was found that arsenite accumulation in the PC-9 cell line was affected through the downregulation of GS -X pump systems. Although it is likely that cisplatin resistance in PC-9 cells does not depend on the GS-X pump systems, ATE) was effective against cisplatin-resistant NSCLC PC-9/CDDP and PC-14/CDDP cells in combination chemotherapy.	[Suzuki, Toshihiro; Ishibashi, Kenichi; Yumoto, Atsushi; Ogasawara, Yuki] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo 2048588, Japan; [Nishio, Kazuto] Kinki Univ, Dept Genome Biol, Osaka, Osaka 5898511, Japan	Suzuki, T (reprint author), Meiji Pharmaceut Univ, Dept Analyt Biochem, 2-522-1 Noshio, Tokyo 2048588, Japan.	tssuzuki@my-pharm.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [20790147, 22790173, 24590218]	This study was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research KAKENHI (grant nos., 20790147, 22790173 and 24590218).	Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879; Zheng CY, 2013, LUNG CANCER, V82, P222, DOI 10.1016/j.lungcan.2013.08.022; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Uemura M, 2012, METALLOMICS, V4, P686, DOI 10.1039/c2mt20026k; Suzuki T, 2001, CURR DRUG METAB, V2, P367, DOI 10.2174/1389200013338289; Zhang N, 2009, CANCER SCI, V100, P2459, DOI 10.1111/j.1349-7006.2009.01340.x; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Leslie EM, 2012, J INORG BIOCHEM, V108, P141, DOI 10.1016/j.jinorgbio.2011.11.009; Helm CW, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-2; HONG WS, 1988, INT J CANCER, V41, P462, DOI 10.1002/ijc.2910410325; Ishikawa T, 1996, J BIOL CHEM, V271, P14981; KUROKAWA H, 1995, BIOCHEM BIOPH RES CO, V216, P258, DOI 10.1006/bbrc.1995.2618; Mukai Y, 2002, J CHROMATOGR B, V767, P263, DOI 10.1016/S0378-4347(01)00554-0; Nakaoka T, 2014, CELL ONCOL DORDR, V37, P119; NAREDI P, 1995, J CLIN INVEST, V95, P1193, DOI 10.1172/JCI117768; Nishio Kazuto, 1999, Current Opinion in Oncology, V11, P109, DOI 10.1097/00001622-199903000-00006; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Rao Y, 2013, SCI CHINA LIFE SCI, V56, P495, DOI 10.1007/s11427-013-4487-z; Suzuki Toshihiro, 2007, J Toxicol Sci, V32, P321, DOI 10.2131/jts.32.321; Yoshikawa M, 2004, INT J CANCER, V110, P921	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					805	809		10.3892/ol.2015.3352		5	Oncology	Oncology	CN8FX	WOS:000358676200040		
J	Onishi, R; Noguchi, M; Kaida, H; Moriya, F; Chikui, K; Kurata, S; Kawahara, A; Kage, M; Ishibashi, M; Matsuoka, K				Onishi, Rei; Noguchi, Masanori; Kaida, Hayato; Moriya, Fukuko; Chikui, Katsuaki; Kurata, Seiji; Kawahara, Akihiko; Kage, Masayoshi; Ishibashi, Masatoshi; Matsuoka, Kei			Assessment of cell proliferation in renal cell carcinoma using dual-phase F-18-fluorodeoxyglucose PET/CT	ONCOLOGY LETTERS			English	Article						renal cell carcinoma; F-18-fluorodeoxyglucose; positron emission tomography/computed tomography; cell proliferation; Ki-67; minichromosome maintenance 2; topoisomerase II alpha	POSITRON-EMISSION-TOMOGRAPHY; BREAST-CANCER; LUNG-CANCER; GLUCOSE-TRANSPORTER-1 EXPRESSION; PROGNOSTIC-SIGNIFICANCE; RETENTION INDEX; F-18-FDG UPTAKE; HEXOKINASE-II; TUMOR; KI-67	The present study aimed to examine the association between F-18-fluorodeoxyglucose (F-18-FDG) uptake and cell proliferation markers; in addition, the correlation between F-18-FDG uptake and biological characteristic in patients with renal cell carcinoma (RCC) was investigated using dual-phase F-18-FDG-positron emission tomography/computed tomography (PET/CT). Dual-phase F-18-FDG PET/CT was performed on 31 RCC patients and the maximum standardized uptake values at 1 h (SUV1) and 2 h (SUV2) as well as the retention index (RI; %) in the primary tumors were calculated. Monoclonal antibodies for Ki-67, minichromosome maintenance 2 (MCM2) and topoisomerase II alpha (topo II alpha) were used to assess the expression levels of their respective proteins in excised tumor tissue using immunohistochemistry. The results demonstrated that RI and SUV2 in patients with Stage I/II + grade 1 (G1) RCC were significantly decreased compared with all patients with other stages/grades (RI, P=0.0065; SUV2, P=0.043); in addition, significantly increased uptake and RI were detected in patients with metastases compared with patients without metastases (SUV1, P=0.029; SUV2, P=0.0003; RI, P<0.001). All proliferation markers significantly correlated with RI (Ki-67, r=0.501, P=0.004; MCM2, r=0.359, P=0.047; topo II a, r=0.402, P=0.024), while SUV1 and SUV2 correlated with Ki-67 only. In conclusion, the results of the present study demonstrated that dual-phase F-18-FDG-PET/CT was more useful for predicting cell proliferation in RCC compared with single-phase imaging alone. However, follow-ups are required in order to determine whether dual-phase F-18-FDG-PET/CT provides independent prognostic information.	[Onishi, Rei; Noguchi, Masanori; Chikui, Katsuaki; Matsuoka, Kei] Kurume Univ, Dept Urol, Sch Med, Kurume, Fukuoka 8300011, Japan; [Noguchi, Masanori] Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Clin Res Div, Kurume, Fukuoka 8300011, Japan; [Kaida, Hayato; Kurata, Seiji; Ishibashi, Masatoshi] Kurume Univ, Sch Med, PET Ctr, Div Nucl Med, Kurume, Fukuoka 8300011, Japan; [Kaida, Hayato; Kurata, Seiji; Ishibashi, Masatoshi] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 8300011, Japan; [Moriya, Fukuko; Kawahara, Akihiko; Kage, Masayoshi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan	Noguchi, M (reprint author), Kurume Univ, Res Ctr Innovat Canc Therapy, Div Clin Res, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	noguchi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22591782]	The present study was supported, in part, by Grants-in-Aid (KAKENHI) of the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 22591782 to Professor Masanori Noguchi, Department Urology, Clinical Research Division, Research Center for Innovative Cancer therapy, Kurume University School of Medicine).	Albadine R, 2009, J UROLOGY, V182, P735, DOI 10.1016/j.juro.2009.03.078; Chang CC, 2012, CLIN NUCL MED, V37, pE189, DOI 10.1097/RLU.0b013e318251e16e; Nguyen XC, 2007, EUR J RADIOL, V62, P214, DOI 10.1016/j.ejrad.2006.12.008; Ozulker T, 2011, NUCL MED COMMUN, V32, P265, DOI 10.1097/MNM.0b013e3283442e3b; Kim BS, 2012, ANN NUCL MED, V26, P175, DOI 10.1007/s12149-011-0556-1; Ferda J, 2013, ANTICANCER RES, V33, P2665; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Aide N, 2003, EUR J NUCL MED MOL I, V30, P1236, DOI 10.1007/s00259-003-1211-4; Watanabe Y, 2013, INT J HEMATOL, V97, P43, DOI 10.1007/s12185-012-1225-4; Dekel Y, 2005, ONCOL REP, V14, P271; Noguchi M, 2007, PROSTATE, V67, P933, DOI 10.1002/pros.20572; Vicente AMG, 2012, CLIN NUCL MED, V37, P460, DOI 10.1097/RLU.0b013e31823926c9; Cheng G, 2013, EUR J NUCL MED MOL I, V40, P779, DOI 10.1007/s00259-013-2343-9; Ho CL, 2012, CLIN NUCL MED, V37, P1075, DOI 10.1097/RLU.0b013e318266cde2; Higashi T, 2002, J NUCL MED, V43, P173; Dooms C, 2009, J THORAC ONCOL, V4, P822, DOI 10.1097/JTO.0b013e3181a97df7; Zhao SJ, 2005, J NUCL MED, V46, P675; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Dudderidge TJ, 2005, CLIN CANCER RES, V11, P2510, DOI 10.1158/1078-0432.CCR-04-1776; Mitsudomi T, 2000, CLIN CANCER RES, V6, P4055; Kankuri M, 2006, ANTICANCER RES, V26, P3825; Wang HY, 2012, CANCER IMAGING, V12, P464, DOI 10.1102/1470-7330.2012.0042; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gianni L, 2009, J CLIN ONCOL, V27, P4798, DOI 10.1200/JCO.2008.21.4791; Groheux D, 2009, NUCL MED COMMUN, V30, P926, DOI 10.1097/MNM.0b013e32832ed3cf; Kumar R, 2010, NUCL MED COMMUN, V31, P844, DOI 10.1097/MNM.0b013e32833d6882; Lawrentschuk N, 2010, NAT REV UROL, V7, P258, DOI 10.1038/nrurol.2010.40; Minamimoto R, 2010, CLIN NUCL MED, V35, P918, DOI 10.1097/RLU.0b013e3181f9ddd9; Murakami S, 2010, EUR J RADIOL, V75, pE62, DOI 10.1016/j.ejrad.2009.11.020; Namura K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-667; Rodins K, 2002, CLIN CANCER RES, V8, P1075; Sobin LH, 2009, INT UNION CANC TNM C, V7th, P253; WAHL RL, 1991, J UROLOGY, V146, P1470; Waki A, 1998, NUCL MED BIOL, V25, P593, DOI 10.1016/S0969-8051(98)00038-9; Wong PK, 2014, ASIA OCEANIA J NUCL, V2, P3	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					822	828		10.3892/ol.2015.3372		7	Oncology	Oncology	CN8FX	WOS:000358676200043		
J	Nakamura, T; Matsumine, A; Matsubara, T; Asanuma, K; Uchida, A; Sudo, A				Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Uchida, Astumasa; Sudo, Akihiro			Clinical characteristics of patients with large and deep soft tissue sarcomas	ONCOLOGY LETTERS			English	Article						soft tissue sarcoma; wound complication; survival	WOUND-HEALING COMPLICATIONS; RESECTION; SURGERY; SURVIVAL; THERAPY	In the present study, the incidence of surgical wound complications in patients with large and deep high-grade soft tissue sarcoma (STS) was investigated. In addition, the disease-specific and event-free survival rates were examined in these patients. In total, 30 adult patients with primary high-grade deep STS with a size of 10 cm or greater were treated in the current study. Of the 30 patients, 16 (53%) developed a total of 19 wound complications. In addition, 10 cases of wound dehiscence, 5 cases of infections, 3 cases of hematomas and 1 case of lymphorrhea were reported, while 3 patients with postoperative infections underwent additional surgical treatment. Longer surgery duration was associated with wound complications (P=0.04). The disease-specific survival was 58.5% at 3 years and 46.1% at 5 years after treatment. Furthermore, local recurrence was detected in 13 patients and distant metastasis was identified in 17 patients as the first relapse. The 3- and 5-year event-free survival rates were 24.4 and 16.3%, respectively. In conclusion, patients with large and high-grade, deep STSs presented a high complication rate; therefore, careful wound care is required in these patients. Furthermore, it should be also taken into account that these patients have a greater risk of tumor-associated events and mortality.	[Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Uchida, Astumasa; Sudo, Akihiro] Mie Univ Hosp, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan	Nakamura, T (reprint author), Mie Univ Hosp, Dept Orthopaed Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	tomoki66@clin.medic.mie-u.ac.jp					Aded R, 2008, ANN NY ACAD SCI, V1138, P77; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Grimer RJ, 2006, ANN ROY COLL SURG, V88, P519, DOI 10.1308/003588406X130651; Geller DS, 2007, CLIN ORTHOP RELAT R, P182, DOI 10.1097/BLO.0b013e3180514c50; Nakamura T, 2011, J SURG ONCOL, V104, P771, DOI 10.1002/jso.22006; Pisters PWT, 1996, J CLIN ONCOL, V14, P1679; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; PEAT BG, 1994, PLAST RECONSTR SURG, V93, P980, DOI 10.1097/00006534-199404001-00012; Edge SB, 2010, AJCC CANC STAGING MA, P345; Kneisl JS, 2014, J SURG ONCOL, V110, P527, DOI 10.1002/jso.23685; Matsubara T, 2013, CLIN ORTHOP RELAT R, V471, P792, DOI 10.1007/s11999-012-2616-9; SADDEGH MK, 1993, CLIN ORTHOP RELAT R, P247; Schwartz A, 2013, CLIN ORTHOP RELAT R, V471, P3612, DOI 10.1007/s11999-013-3130-4	13	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					841	844		10.3892/ol.2015.3289		4	Oncology	Oncology	CN8FX	WOS:000358676200046		
J	Arai, H; Yamauchi, T; Uzui, K; Ueda, T				Arai, Hajime; Yamauchi, Takahiro; Uzui, Kanako; Ueda, Takanori			Leukemia cells are sensitized to temozolomide, carmustine and melphalan by the inhibition of O-6-methylguanine-DNA methyltransferase	ONCOLOGY LETTERS			English	Article						DNA repair; temozolomide; carmustine; melphalan; O-6-benzylguanine	CHRONIC LYMPHOCYTIC-LEUKEMIA; DNA MISMATCH REPAIR; NITROGEN MUSTARDS; MALIGNANT GLIOMA; ALKYLATING-AGENTS; DRUG-RESISTANCE; CROSS-LINKING; DAMAGE; TRIAL; 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA	The cytotoxicity of the monofunctional alkylator, temozolomide (TMZ), is known to be mediated by mismatch repair (MMR) triggered by O-6-alkylguanine. By contrast, the cytotoxicity of bifunctional alkylators, including carmustine (BCNU) and melphalan (MEL), depends on interstrand cross-links formed through O-6-alkylguanine, which is repaired by nucleotide excision repair and recombination. O-6-alkylguanine is removed by O-6-methylguanine-DNA methyltransferase (MGMT). The aim of the present study was to evaluate the cytotoxicity of TMZ, BCNU and MEL in two different leukemic cell lines (HL-60 and MOLT-4) in the context of DNA repair. The transcript levels of MGMT, ERCC1, hMLH1 and hMSH2 were determined using reverse transcription-quantitative polymerase chain reaction. In addition, the proliferation was measured using the trypan blue exclusion assay. Drug sensitivity was found to vary between the two cell lines. Treatment of the cells with TMZ, BCNU or MEL in combination with O-6-benzylguanine, an MGMT inhibitor, was demonstrated to sensitize the two cell lines to these agents. However, the extent of sensitization was not found to be correlated with the expression levels of MGMT transcripts. Furthermore, the drug sensitivity was also not associated with the transcript levels of ERCC1, hMLH1 and hMSH2. Thus, leukemic cells were sensitized to alkylating agents by the inhibition of MGMT.	[Arai, Hajime; Yamauchi, Takahiro; Uzui, Kanako; Ueda, Takanori] Univ Fukui, Dept Hematol & Oncol, Fac Med Sci, Fukui 9101193, Japan	Yamauchi, T (reprint author), Univ Fukui, Dept Hematol & Oncol, Fac Med Sci, 23 Shimoaizuki, Fukui 9101193, Japan.	tyamauch@u-fukui.ac.jp					Adams DM, 2008, PEDIATR BLOOD CANCER, V50, P549, DOI 10.1002/pbc.21362; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Fahrer J, 2013, CARCINOGENESIS, V34, P2435, DOI 10.1093/carcin/bgt275; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Fiumicino S, 2000, INT J CANCER, V85, P590, DOI 10.1002/(SICI)1097-0215(20000215)85:4<590::AID-IJC23>3.0.CO;2-O; Fink D, 1998, CLIN CANCER RES, V4, P1; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Chaney SG, 1996, J NATL CANCER I, V88, P1346, DOI 10.1093/jnci/88.19.1346; Quinn JA, 2009, J CLIN ONCOL, V27, P1262, DOI 10.1200/JCO.2008.18.8417; Stupp R, 2001, LANCET ONCOL, V2, P552, DOI 10.1016/S1470-2045(01)00489-2; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Loeber R, 2008, CHEM RES TOXICOL, V21, P787, DOI 10.1021/tx7004508; Panasci L, 2001, CLIN CANCER RES, V7, P454; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Mason WP, 2005, NAT CLIN PRACT NEURO, V1, P88, DOI 10.1038/ncpneuro0045; Aquilina G, 1998, CANCER RES, V58, P135; Balana C, 2003, CLIN CANCER RES, V9, P1461; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; GELEZIUNAS R, 1991, J NATL CANCER I, V83, P557, DOI 10.1093/jnci/83.8.557; Tew KD, 1996, CANC CHEMOTHERAPY BI, P297; Fan CH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.388; WIENCKE JK, 1995, MUTAT RES-REV GENET, V339, P91, DOI 10.1016/0165-1110(95)90005-5; Yamamoto S, 2007, INT J HEMATOL, V85, P108, DOI 10.1532/IJH97.06177; Yamauchi T, 2008, MOL PHARMACOL, V74, P82, DOI 10.1124/mol.107.041988	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					845	849		10.3892/ol.2015.3307		5	Oncology	Oncology	CN8FX	WOS:000358676200047		
J	Kurata, K; Onoda, N; Noda, S; Kashiwagi, S; Asano, Y; Kawajiri, H; Takashima, T; Tanaka, S; Ohsawa, M; Hirakawa, K				Kurata, Kento; Onoda, Naoyoshi; Noda, Satoru; Kashiwagi, Shinichiro; Asano, Yuka; Kawajiri, Hidemi; Takashima, Tsutomu; Tanaka, Sayaka; Ohsawa, Masahiko; Hirakawa, Kosei			Nestin expression as an independent indicator of poor prognosis for patients with anaplastic thyroid cancer	ONCOLOGY LETTERS			English	Article						nestin; anaplastic thyroid cancer; prognostic indicator; stem cell marker	TUMOR ANGIOGENESIS; TREATMENT OUTCOMES; PANCREATIC-CANCER; PROSTATE-CANCER; CARCINOMA; MIGRATION; INVASION; MARKER; TARGET; PROLIFERATION	The protein nestin, a neuronal stem cell marker, has been reported to indicate a poor prognosis in various tumours. Anaplastic thyroid cancer (ATC) is one of the most aggressive malignancies in humans, and its molecular background has not been identified. The present study evaluated the expression of nestin and its significance in ATC. Tissue samples from 23 patients with ATC were subjected to immunohistochemical staining and the staining intensity of nestin in the cytoplasm was evaluated. The expression of nestin in the tumour cytoplasm was confirmed in 6 of the 23 tissue samples (26.1%). Between the nestin-positive group (n=6) and the nestin-negative group (n=17), there were no significant differences in the clinicopathological factors of the patients. However, the nestin-positive group exhibited significantly worse prognoses than the nestin-negative group (median survival time, 86.5 vs. 306 days; P<0.01, log-rank test). The multivariate analysis indicated that nestin expression was a prognostic indicator for the ATC patients (hazard ratio, 5.59; 95% confidence interval, 1.63-19.50; P<0.01), which is independent of the known clinical indicators. Nestin expression has the potential to be an independent indicator of a poor prognosis for patients with ATC.	[Kurata, Kento; Onoda, Naoyoshi; Noda, Satoru; Kashiwagi, Shinichiro; Asano, Yuka; Kawajiri, Hidemi; Takashima, Tsutomu; Hirakawa, Kosei] Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka 5458585, Japan; [Tanaka, Sayaka; Ohsawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka 5458585, Japan	Onoda, N (reprint author), Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	nonoda@med.osaka-cu.ac.jp			JSPS KAKENHI [25461992]	The authors would like to thank Dr Tamami Morisaki (Department of Surgical Oncology, Osaka City University Graduate School of Medicine) for providing advice. The present study was supported in part by Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI; grant no. 25461992)	Narita K, 2014, INT J ONCOL, V44, P1118, DOI 10.3892/ijo.2014.2278; Matsuda Y, 2013, WORLD J GASTROENTERO, V19, P42, DOI 10.3748/wjg.v19.i1.42; Suman S, 2013, AGING-US, V5, P607; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; Sugitani I, 2001, WORLD J SURG, V25, P617; Teranishi N, 2007, INT J ONCOL, V30, P593; Sugitani I, 2012, WORLD J SURG, V36, P1247, DOI 10.1007/s00268-012-1437-z; Liu J, 2010, INT J CLIN EXP PATHO, V3, P755; Strojnik T, 2007, SURG NEUROL, V68, P133, DOI 10.1016/j.surneu.2006.10.050; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Akaishi J, 2011, THYROID, V21, P1183, DOI 10.1089/thy.2010.0332; Yau T, 2008, ANN SURG ONCOL, V15, P2500, DOI 10.1245/s10434-008-0005-0; Matsuda Y, 2011, CANCER BIOL THER, V11, P512, DOI 10.4161/cbt.11.5.14673; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; Brychtova S, 2007, J CUTAN PATHOL, V34, P370, DOI 10.1111/j.1600-0560.2006.00627.x; Chen ZG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085584; Ishiwata T, 2011, ONCOL REP, V26, P91, DOI 10.3892/or.2011.1267; Kasiwagi S, 2013, BRIT J SURG, V100, P490; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Maderna E, 2007, CANCER BIOL THER, V6, P1018; Onoda N, 2014, WORLD J SURG, V38, P688, DOI 10.1007/s00268-013-2409-7; Orita Y, 2011, SURGERY, V150, P1212, DOI 10.1016/j.surg.2011.09.005; Piras F, 2011, Eur J Histochem, V55, pe39, DOI 10.4081/ejh.2011.e39; Smallridge RC, 2010, CLIN ONCOL-UK, V22, P486, DOI 10.1016/j.clon.2010.03.013; Tennvall J, 2002, BRIT J CANCER, V86, P1848, DOI 10.1038/sj.bjc.6600361; Tsutsui K, 1995, NAIBUNPITSU GEKA, V12, P133; Yamahatsu K, 2012, INT J ONCOL, V40, P1345, DOI 10.3892/ijo.2012.1333	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					850	856		10.3892/ol.2015.3366		7	Oncology	Oncology	CN8FX	WOS:000358676200048		
J	Morita, S; Hiramatsu, M; Sugishita, M; Gyawali, B; Shibata, T; Shimokata, T; Urakawa, H; Mitsuma, A; Moritani, S; Kubota, T; Ichihara, S; Ando, Y				Morita, Sachi; Hiramatsu, Mariko; Sugishita, Mihoko; Gyawali, Bishal; Shibata, Takashi; Shimokata, Tomoya; Urakawa, Hiroshi; Mitsuma, Ayako; Moritani, Suzuko; Kubota, Toshinobu; Ichihara, Shu; Ando, Yuichi			Pazopanib monotherapy in a patient with a malignant granular cell tumor originating from the right orbit: A case report	ONCOLOGY LETTERS			English	Article						pazopanib; malignant granular cell tumor; orbit	SOFT-TISSUE SARCOMA	Granular cell tumors are uncommon, usually benign tumors of Schwann cell origin. The malignant variant is extremely rare, representing <2% of all granular cell tumors. Therefore, standard systemic chemotherapy for this disease does not exist. The present study reports the case of a 40-year-old female with a malignant granular cell tumor that originally arose in the right orbit and subsequently relapsed. The patient was started on pazopanib monotherapy following treatment with two investigational drugs, a smoothened inhibitor and then a phosphatidylinositol 3-kinase inhibitor, as part of a clinical trial. Although additional radiotherapy for local control was necessary, the lung metastases remained stable during the pazopanib monotherapy, which lasted for 7 months, following which a clinically stable disease state was determined. This case suggests that pazopanib can be a treatment option for the stabilization of disease progression in metastatic malignant granular cell tumor.	[Morita, Sachi; Sugishita, Mihoko; Gyawali, Bishal; Shibata, Takashi; Shimokata, Tomoya; Urakawa, Hiroshi; Mitsuma, Ayako; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi 4668560, Japan; [Hiramatsu, Mariko] Nagoya Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4660027, Japan; [Moritani, Suzuko; Ichihara, Shu] Natl Hosp Org Nagoya Med Ctr, Dept Pathol, Nagoya, Aichi 4600008, Japan; [Kubota, Toshinobu] Natl Hosp Org Nagoya Med Ctr, Dept Ophthalmol, Nagoya, Aichi 4600008, Japan	Morita, S (reprint author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	s-kamei@med.nagoya-u.ac.jp					Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Fanburg-Smith JC, 1998, AM J SURG PATHOL, V22, P779, DOI 10.1097/00000478-199807000-00001; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; FISHER ER, 1962, CANCER, V15, P936, DOI 10.1002/1097-0142(196209/10)15:5<936::AID-CNCR2820150509>3.0.CO;2-F; Argenyi ZB, 2006, WHO CLASSIFICATION T, P274; Conley AP, 2014, J CLIN ONCOL, V32, pE107, DOI 10.1200/JCO.2012.47.1078; Evaluation and Licensing Division Pharmaceutical and Food Safety Bureau Ministry of Health, 2012, REP DEL RES VOTR 200, P1; Fanburg-Smith JC, 2013, WHO CLASSIFICATION T, P190; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Kanat O, 2008, CLIN ONCOL-UK, V20, P93, DOI 10.1016/j.clon.2007.09.002; Peter S, 2012, TXB UNCOMMON CANC, P679	12	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					972	974		10.3892/ol.2015.3263		3	Oncology	Oncology	CN8FX	WOS:000358676200073		
J	Kawashima, H; Ogose, A; Hotta, T; Imai, C; Imamura, M; Endo, N				Kawashima, Hiroyuki; Ogose, Akira; Hotta, Tetsuo; Imai, Chihaya; Imamura, Masaharu; Endo, Naoto			Secondary osteosarcoma arising from osteochondroma following autologous stem cell transplantation with total-body irradiation for neuroblastoma: A case report	ONCOLOGY LETTERS			English	Article						osteosarcoma; osteochondroma; total-body irradiation; secondary malignancy	RADIATION-INDUCED OSTEOCHONDROMA; CHILDHOOD-CANCER SURVIVOR; SOLITARY OSTEOCHONDROMA; MALIGNANT NEOPLASMS; 2ND MALIGNANCIES; CHONDROSARCOMA; CHILDREN; CHEMOTHERAPY; RADIOTHERAPY; TUMOR	The present study reports the first case of malignant transformation to osteosarcoma arising from osteochondroma following childhood total-body irradiation (TBI). The association between TBI and later development of osteochondroma is well-known; however, malignant degeneration arising from radiation-induced osteochondroma is rare. The current study describes the case of a 17-year-old boy with osteosarcoma arising from osteochondroma of the left distal humerus, which developed following TBI. TBI was administered as part of a conditioning regimen received prior to autologous peripheral hematopoietic stem cell transplantation (HSCT) at the age of 6 years, following an initial diagnosis of neuroblastoma at the age of 5 years. The patient subsequently underwent preoperative chemotherapy followed by wide local excision and reconstruction with an extracorporeally irradiated autograft. Postoperative chemotherapy was administered, and the patient demonstrated no clinical or radiographic evidence of recurrence after 40 months of follow-up. To the best of our knowledge, this is only the second reported case of malignant degeneration of osteochondroma following childhood TBI, and the first reported case of transformation to osteosarcoma. The current case highlights the importance of close observation for secondary malignancies in this patient population.	[Kawashima, Hiroyuki; Ogose, Akira; Hotta, Tetsuo; Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Dept Regenerat & Transplant Med, Niigata 9518510, Japan; [Imai, Chihaya; Imamura, Masaharu] Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Div Pediat, Niigata 9518510, Japan	Kawashima, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Dept Regenerat & Transplant Med,Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	inskawa@med.niigata-u.ac.jp					GARRISON RC, 1982, CANCER, V49, P1890, DOI 10.1002/1097-0142(19820501)49:9<1890::AID-CNCR2820490923>3.0.CO;2-U; Paulino AC, 2005, PEDIATR HEMAT ONCOL, V22, P89, DOI 10.1080/08880010590896459; Friedman DL, 2010, J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Mariotto AB, 2009, CANCER EPIDEM BIOMAR, V18, P1033, DOI 10.1158/1055-9965.EPI-08-0988; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466; Bordigoni P, 2002, BONE MARROW TRANSPL, V29, P611, DOI 10.1038/sj/bmt/1703424; Bovee JVMG, 2002, J CLIN PATHOL, V55, P226; Bovee JVMG, 2013, WHO CLASSIFICATION T, P250; BRESLOW NE, 1995, J CLIN ONCOL, V13, P1851; Danner-Koptik KE, 2013, BONE MARROW TRANSPL, V48, P363, DOI 10.1038/bmt.2012.166; Engel EE, 2012, GENET MOL RES, V11, P448, DOI 10.4238/2012.March.1.1; Faraci M, 2005, INT J RADIAT ONCOL, V63, P1568, DOI 10.1016/j.ijrobp.2005.04.031; Faraci M, 2009, BIOL BLOOD MARROW TR, V15, P1271, DOI 10.1016/j.bbmt.2009.06.003; Goldsby Robert E, 2006, Paediatr Drugs, V8, P71, DOI 10.2165/00148581-200608020-00001; Lamovec J, 1999, ARCH PATHOL LAB MED, V123, P832; Mahboubi S, 1997, SKELETAL RADIOL, V26, P195; Marcovici PA, 2007, PEDIATR RADIOL, V37, P301, DOI 10.1007/s00247-006-0382-0; Meissner SA, 2006, CLIN IMAG, V30, P206, DOI 10.1016/j.clinimag.2005.12.026; Nagata S, 2013, SKELETAL RADIOL, V42, P1173, DOI 10.1007/s00256-013-1608-5; NOJIMA T, 1991, ACTA ORTHOP SCAND, V62, P290, DOI 10.3109/17453679108993613; Paulino AC, 2002, INT J RADIAT ONCOL, V52, P1025, DOI 10.1016/S0360-3016(01)02713-4; PEREZ CA, 1967, RADIOLOGY, V88, P750; PoustchiAmin M, 1996, PEDIATR RADIOL, V26, P155, DOI 10.1007/BF01372098; Staals EL, 2007, J BONE JOINT SURG AM, V89A, P987, DOI 10.2106/JBJS.F.00288; Suita S, 2000, J PEDIATR SURG, V35, P1737, DOI 10.1053/jpsu.2000.19236; Varan A, 2011, PEDIATR HEMAT ONCOL, V28, P345, DOI 10.3109/08880018.2011.553879	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					1026	1030		10.3892/ol.2015.3257		5	Oncology	Oncology	CN8FX	WOS:000358676200085		
J	Kobatake, K; Mita, K; Ohara, S; Kato, M				Kobatake, Kohei; Mita, Koji; Ohara, Shinya; Kato, Masao			Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer	ONCOLOGY LETTERS			English	Article						narrow band imaging; bladder cancer; transurethral resection	7 EORTC; CYSTOSCOPY; RECURRENCE; CARCINOMA	The aim of the present study was to compare the benefits of transurethral resection (TUR) under narrow band imaging (NBI-TUR) and TUR under conventional white light imaging (WLI-TUR) for non-muscle invasive bladder cancer (NMIBC). The study cohort consisted of 135 patients with NMIBC who were followed up for >= 1 year after TUR and who received no additional post-operative treatment. In the WLI-TUR group (n=78), systematic intravesical observation under WLI was followed by a multiple site biopsy (MSB), after which lesions detected as positive findings were resected completely under WLI. In the NBI-TUR group (n=57), similar observation under WLI was followed by systematic intravesical observation under NBI. Following MSB under NBI, TUR was performed for all lesions detected as positive findings under NBI. The sensitivity, specificity, positive-predictive value, negative-predictive value (NPV) and accuracy in the NBI-TUR group were calculated using results from the cystoscopical and pathological examinations of MSB samples under WLI and NBI. The tumor recurrence rate was analyzed in the two groups. Background factors did not differ significantly between the two groups, with the exception of the observation period (31.0 vs. 15.0 months; P<0.01). The procedure under NBI exhibited significantly higher sensitivity (95.0 vs. 70.0%; P<0.01) and NPV (97.1 vs. 86.8%; P<0.01) compared with the procedure under WLI. The 1-year recurrence rate in the NBI-TUR group was significantly lower than that in the WLI-TUR group (21.1 vs. 39.7%; P=0.016). In conclusion, the present study indicated that NBI-TUR is more advantageous than conventional WLI-TUR for patients with NMIBC.	[Kobatake, Kohei; Mita, Koji; Ohara, Shinya; Kato, Masao] Hiroshima City Asa Hosp, Dept Urol, Asakita Ku, Hiroshima 7310293, Japan	Mita, K (reprint author), Hiroshima City Asa Hosp, Dept Urol, Asakita Ku, 2-1-1 Kabe Minami, Hiroshima 7310293, Japan.	mita@plum.ocn.ne.jp					Bryan RT, 2008, BJU INT, V101, P702, DOI 10.1111/j.1464-410X.2007.07317.07471.x; Tatsugami K, 2010, J ENDOUROL, V24, P1807, DOI 10.1089/end.2010.0055; Brausi M, 2002, EUR UROL, V41, P523, DOI 10.1016/S0302-2838(02)00068-4; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315; Cauberg ECC, 2010, UROLOGY, V76, P658, DOI 10.1016/j.urology.2009.11.075; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Herr HW, 2008, BJU INT, V102, P1111, DOI 10.1111/j.1464-410X.2008.07846.x; Daniltchenko DI, 2005, J UROLOGY, V174, P2129, DOI 10.1097/01.ju.0000181814.73466.14; Naselli A, 2010, BJU INT, V105, P208, DOI 10.1111/j.1464-410X.2009.08701.x; Naselli A, 2012, EUR UROL, V61, P908, DOI 10.1016/j.eururo.2012.01.018; Hirata I, 2012, DIGESTION, V85, P74, DOI 10.1159/000334642; Brausi M, 2012, EUR UROL, V61, P914, DOI 10.1016/j.eururo.2012.02.023; Cauberg ECC, 2011, WORLD J UROL, V29, P503, DOI 10.1007/s00345-011-0659-2; Clinical Research Office of the Endourological society, GLOB RAND NBI BLADD; Schumacher MC, 2010, EUR UROL, V57, P293, DOI 10.1016/j.eururo.2009.10.030	16	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					1097	1102		10.3892/ol.2015.3280		6	Oncology	Oncology	CN8FX	WOS:000358676200098		
J	Tamura, T; Kurishima, K; Nakazawa, K; Ishikawa, H; Satoh, H; Hizawa, N				Tamura, Tomohiro; Kurishima, Koichi; Nakazawa, Kensuke; Ishikawa, Hiroichi; Satoh, Hiroaki; Hizawa, Nobuyuki			Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer	ONCOLOGY LETTERS			English	Article						non-small cell lung cancer; stable disease; disease control rate; survival	RANDOMIZED PHASE-III; ERLOTINIB MAINTENANCE THERAPY; VINORELBINE PLUS CISPLATIN; 1ST-LINE TREATMENT; CLINICAL BENEFIT; PEMETREXED PLUS; OPEN-LABEL; CARBOPLATIN; TRIAL; EGFR	The present study aimed to evaluate the similar survival benefits of a good response [complete response or partial response (CR/PR)] and stable disease (SD) to chemotherapy in non-small cell lung cancer (NSCLC) patients in clinical practice. All 322 patients who were treated between 1999 and 2012 with first-line platinum-based chemotherapy were retrospectively analyzed. Tumor responses were classified according to the response evaluation criteria for solid tumors. A total of 67 (20.8%) patients experienced CR/PR and 165 (51.2%) achieved SD. There was no difference in progression-free survival between the patients with CR/PR and those with SD (P=0.347). There was also no difference between the two groups with regard to overall survival time (P=0.878). In multivariate analysis, disease-control (more than SD) was one of the favorable prognostic factors. In clinical practice, a survival benefit would be provided not only for the patients who have good response, but also for those with SD.	[Tamura, Tomohiro; Nakazawa, Kensuke; Hizawa, Nobuyuki] Univ Tsukuba, Div Resp Med, Fac Med, Mito, Ibaraki 3100015, Japan; [Kurishima, Koichi; Ishikawa, Hiroichi] Tsukuba Med Ctr Hosp, Div Resp Med, Tsukuba, Ibaraki, Japan; [Satoh, Hiroaki] Univ Tsukuba, Div Resp Med, Mito Med Ctr, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Div Resp Med, Mito Med Ctr, 3-2-7 Miya Machi, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Coudert B, 2012, ANN ONCOL, V23, P388, DOI 10.1093/annonc/mdr125; Therasse P, 2002, EUR J CANCER, V38, P1817, DOI 10.1016/S0959-8049(02)00182-X; Kelly K, 2001, J CLIN ONCOL, V19, P3210; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Ramalingam S, 2008, ONCOLOGIST, V13, P5, DOI 10.1634/theoncologist.13-S1-5; Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Mandrekar SJ, 2014, J CLIN ONCOL, V32, P841, DOI 10.1200/JCO.2013.52.3019; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Ho C, 2014, J THORAC ONCOL, V9, P1180, DOI 10.1097/JTO.0000000000000225; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Perol M, 2012, J CLIN ONCOL, V30, P3516, DOI 10.1200/JCO.2011.39.9782; Little AG, 2007, LUNG CANCER, V57, P253, DOI 10.1016/j.lungcan.2007.03.012; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Barlesi F, 2014, ANN ONCOL, V25, P1044, DOI 10.1093/annonc/mdu098; Cesano A, 2000, INT J ONCOL, V17, P587; He LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-681; Lara PN, 2008, J CLIN ONCOL, V26, P463, DOI 10.1200/JCO.2007.13.0344; Lyman GH, 2015, ANN ONCOL; Travis WD, 1999, WHO INT HISTOLOGICAL, V3rd, P21; Uchino J, 2012, ASIAN PAC J CANCER P, V13, P4187, DOI 10.7314/APJCP.2012.13.8.4187; Yamamoto N, 2009, J THORAC ONCOL, V4, P697, DOI 10.1097/JTO.0b013e31819e7888	33	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					1135	1140		10.3892/ol.2015.3350		6	Oncology	Oncology	CN8FX	WOS:000358676200105		
J	Sasaki, T; Onishi, T				Sasaki, Takeshi; Onishi, Takehisa			Pretherapeutic Plasma Fibrinogen Level is an Independent Survival Predictor in Renal Cell Carcinoma	ONCOLOGY RESEARCH AND TREATMENT			English	Article						Renal cell carcinoma; Pretherapeutic plasma fibrinogen; Nephrectomy; Prognostic factor	PROGNOSTIC-FACTOR; SERUM FIBRINOGEN; EUROPEAN COHORT; POOR-PROGNOSIS; CANCER; METASTASIS; REPRESENTS; VARIABLES; RATIO	Background: Systematic inflammatory responses such as the elevated C-reactive protein, erythrocyte sedimentation rate and lymphocyte-monocyte ratio have been found to have significant prognostic value in renal cell carcinoma (RCC). The purpose of this study was to identify the impact of pretherapeutic plasma fibrinogen levels on survival for RCC patients. Patients and Methods: We retrospectively reviewed 126 RCC patients who were treated at our institution. The median follow-up period was 30.8 months. 116 patients underwent nephrectomy. Results: The 3-year overall survival rates in patients with non-metastatic or metastatic RCC were 91.9% and 14.3%, respectively (p < 0.001). Pretherapeutic plasma fibrinogen levels in the metastatic group were significantly higher than those in the non-metastatic group (p < 0.001). In the non-metastatic group, multivariate analysis revealed that the pathological T stage (p = 0.008), lactate dehydrogenase (p = 0.007) and fibrinogen (p = 0.036) were independent prognostic factors for survival. Overall survival rates in patients with low fibrinogen levels (< 399 mg/dl) were significantly higher than in those with high fibrinogen levels (>= 399 mg/dl). Conclusion: Pretherapeutic high plasma fibrinogen levels are associated with disease progression in patients with RCC of all stages. We propose that pretherapeutic plasma fibrinogen levels may become a useful biomarker, and could be helpful for decision making in the management of RCC. (C) 2015 S. Karger GmbH, Freiburg	[Sasaki, Takeshi; Onishi, Takehisa] Ise Red Cross Hosp, Dept Urol, Ise, Mie, Japan	Sasaki, T (reprint author), Mie Univ, Grad Sch Med, Dept Nephrourol Surg & Androl, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	t-sasaki@clin.medic.mie-u.ac.jp					Pichler M, 2013, BRIT J CANCER, V109, P1123, DOI 10.1038/bjc.2013.443; Yamashita H, 2009, WORLD J SURG, V33, P1298, DOI 10.1007/s00268-009-9992-7; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Tanaka N, 2013, BJU INT, V111, P857, DOI 10.1111/j.1464-410X.2012.11353.x; Sheng LM, 2013, INT J CANCER, V133, P2720, DOI 10.1002/ijc.28284; Son HJ, 2013, ANN SURG ONCOL, V20, P2908, DOI 10.1245/s10434-013-2968-8; Polterauer S, 2009, ONCOLOGIST, V14, P979, DOI 10.1634/theoncologist.2009-0079; Preston T, 1998, J NUTR, V128, P1355; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Sengupta S, 2006, CANCER, V106, P304, DOI 10.1002/cncr.21617; Lamb GWA, 2006, BRIT J CANCER, V94, P781, DOI 10.1038/sj.bjc.6603034; Lu K, 2011, HEPATO-GASTROENTEROL, V58, P1507, DOI 10.5754/hge11133; Takeuchi H, 2007, J GASTROEN HEPATOL, V22, P2222, DOI 10.1111/j.1440-1746.2006.04736.x; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Du J, 2013, INT J CLIN ONCOL, V18, P517, DOI 10.1007/s10147-012-0412-x; Sahni A, 2008, J THROMB HAEMOST, V6, P176; Sahni A, 2000, BLOOD, V96, P3772; Bensalah K, 2008, BJU INT, V102, P1376, DOI 10.1111/j.1464-410X.2008.07847.x; Erdem S, 2014, UROL ONCOL-SEMIN ORI, V32, P1031, DOI 10.1016/j.urolonc.2014.03.013; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hutterer GC, 2014, UROL ONCOL-SEMIN ORI, V32, P1041, DOI 10.1016/j.urolonc.2014.04.001; Iimura Y, 2009, J UROLOGY, V181, P1004, DOI 10.1016/j.juro.2008.10.156; Lee SE, 2006, BJU INT, V98, P1228, DOI 10.1111/j.1464-410X.2006.06437.x; Tsimafeyeu IV, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-30; Xiao B, 2011, CHINESE MED J-PEKING, V124, P1205, DOI 10.3760/cma.j.issn.0366-6999.2011.08.015; Yoshiaki S, 1973, JPN J UROL, V64, P195	28	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	2296-5270	2296-5262		ONCOL RES TREAT	Oncol. Res. Treat.	AUG	2015	38	7-8					374	378		10.1159/000435896		5	Oncology	Oncology	CO8US	WOS:000359448200006		
J	Jin, LH; Yamaguchi, K; Watanabe, M; Hira, S; Kondoh, E; Gelloz, B				Jin, Lianhua; Yamaguchi, Koji; Watanabe, Mitsuhiro; Hira, Shinichiro; Kondoh, Eiichi; Gelloz, Bernard			Polarization characteristics of scattered light from macroscopically rough surfaces	OPTICAL REVIEW			English	Article						Polarization; Scattering measurements; Rough surfaces; Stokes parameter; Facet model	BACKSCATTERING ENHANCEMENT	The polarization status of in-and out-of-plane scattered light from macroscopically rough surfaces was measured and expressed in a scattering coordinate system. In this coordinate system, the direction of the scattered light was decided by the transverse and longitudinal scattering angles, both of which are defined by using the incident ray and its section plane as the fundamental axis and plane. The polarization characteristics of scattering, which consist of patterns of polarization degrees and the Stokes of the scattered light in terms of transverse and longitudinal scattering angles, was presented and investigated. The Stokes patterns of scattered light exhibited independence from the transverse scattering angle. Furthermore, the ellipsometric parameters of samples, which were deduced from the polarization status of full scattering, showed the validity as well as limitations of the facet model for macroscopically rough surface.	[Jin, Lianhua; Yamaguchi, Koji; Watanabe, Mitsuhiro; Hira, Shinichiro; Kondoh, Eiichi] Univ Yamanashi, Grad Sch Med & Engn, Yamanashi 4008511, Japan; [Gelloz, Bernard] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648601, Japan	Jin, LH (reprint author), Univ Yamanashi, Grad Sch Med & Engn, Yamanashi 4008511, Japan.	lianhua@yamanashi.ac.jp					[Anonymous], 1991, ACM COMPUTER GRAPHIC, DOI 10.1145/127719.122738; MENDEZ ER, 1987, OPT COMMUN, V61, P91, DOI 10.1016/0030-4018(87)90225-2; Renhorn IGE, 2008, OPT EXPRESS, V16, P12892, DOI 10.1364/OE.16.012892; TORRANCE KE, 1967, J OPT SOC AM, V57, P1105, DOI 10.1364/JOSA.57.001105; BARRICK DE, 1968, IEEE T ANTENN PROPAG, VAP16, P449, DOI 10.1109/TAP.1968.1139220; Hyde IV W. W., 2009, OPT EXPRESS, V17, P22138, DOI DOI 10.1364/OE.17.022138; Jafolla J, 1999, P SOC PHOTO-OPT INS, V3699, P2, DOI 10.1117/12.352935; Jin L., 2011, P SPIE, V8160; Jin LH, 2010, OPT LETT, V35, P595, DOI 10.1364/OL.35.000595; Li H., 2005, P SOC PHOTO-OPT INS, V5878, DOI 10.1117/12.617637; Maxwell J. R., 1973, ALTR73303 AF ERIM; ODONNELL KA, 1987, J OPT SOC AM A, V4, P1194, DOI 10.1364/JOSAA.4.001194; Priest R. G., 2000, P 2000 M MIL SENS S, P169; Rhenhorn I. G., 2011, OPT EXPRESS, V19, P1027; SANT AJ, 1989, OPT LETT, V14, P1183, DOI 10.1364/OL.14.001183; Stankevich D, 2007, J QUANT SPECTROSC RA, V106, P509, DOI 10.1016/j.jqsrt.2007.01.030; Stover J. C., 1995, OPTICAL SCATTERING M; Jin LH, 2009, PROC SPIE, V7432, DOI 10.1117/12.828030; Tompkins H. G., 2006, USERS GUIDE ELLIPSOM; Tompkins H G, 2005, HDB ELLIPSOMETRY; VIDEEN G, 1992, J OPT SOC AM A, V9, P1111, DOI 10.1364/JOSAA.9.001111	21	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					511	520		10.1007/s10043-015-0117-2		10	Optics	Optics	CO1TO	WOS:000358938400002		
J	Sugawara, S; Harada, K; Sakai, D				Sugawara, Shiori; Harada, Kenji; Sakai, Daisuke			High-chroma visual cryptography using interference color of high-order retarder films	OPTICAL REVIEW			English	Article						Visual cryptography; Information security; Interference color; Retarder film	SPATIAL LIGHT MODULATORS; SECURING INFORMATION; IMAGE; ENCRYPTION; DISPLAY	Visual cryptography can be used as a method of sharing a secret image through several encrypted images. Conventional visual cryptography can display only monochrome images. We have developed a high-chroma color visual encryption technique using the interference color of high-order retarder films. The encrypted films are composed of a polarizing film and retarder films. The retarder films exhibit interference color when they are sandwiched between two polarizing films. We propose a stacking technique for displaying high-chroma interference color images. A prototype visual cryptography device using high-chroma interference color is developed.	[Sugawara, Shiori; Harada, Kenji; Sakai, Daisuke] Kitami Inst Technol, Dept Comp Sci, Kitami, Hokkaido 0908507, Japan	Sugawara, S (reprint author), Kitami Inst Technol, Dept Comp Sci, Kitami, Hokkaido 0908507, Japan.	m1452400056@std.kitami-it.ac.jp; haraken@cs.kitami-it.ac.jp					Javidi B, 2000, OPT LETT, V25, P28, DOI 10.1364/OL.25.000028; Hou YC, 2003, PATTERN RECOGN, V36, P1619, DOI 10.1016/S0031-3203(02)00258-3; Yamamoto H, 2004, OPT EXPRESS, V12, P1258, DOI 10.1364/OPEX.12.001258; KAFRI O, 1987, OPT LETT, V12, P377, DOI 10.1364/OL.12.000377; REFREGIER P, 1995, OPT LETT, V20, P767; Blundo C, 2000, INFORM PROCESS LETT, V75, P255, DOI 10.1016/S0020-0190(00)00108-3; Cheng CJ, 2004, OPT COMMUN, V237, P45, DOI 10.1016/j.optcom.2004.03.060; Cimato S, 2007, THEOR COMPUT SCI, V374, P261, DOI 10.1016/j.tcs.2007.01.006; Yamamoto H, 2003, OPT LETT, V28, P1564, DOI 10.1364/OL.28.001564; JAVIDI B, 1994, OPT ENG, V33, P1752, DOI 10.1117/12.170736; Commission Internationale de l'Eclairage, 1931, P 8 SESS CAMBR, P19; FUKUSHIMA S, 1991, IEEE PHOTONIC TECH L, V3, P1133, DOI 10.1109/68.118031; Harada K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.062501; Harada K., 2006, OYO BUTURI KYOIKU, V30, P25; Harada K., 2010, OYO BUTURI KYOIKU, V34, P35; Hayasaki Y, 2004, APPL OPTICS, V43, P1552, DOI 10.1364/AO.43.001552; Imagawa T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09LC02; Kato T., 2001, J GEOL SOC JPN, V107, P64; Koga H, 2001, IEICE T FUND ELECTR, VE84A, P262; Kowa H., 2011, P SOC PHOTO-OPT INS, P81340; Machizaud J, 2011, OPT EXPRESS, V19, P22709, DOI 10.1364/OE.19.022709; Matoba O, 2002, OPT LETT, V27, P321, DOI 10.1364/OL.27.000321; Shamir A., 1994, LECT NOTES COMPUTER; Sheng Yuan, 2009, Opt Express, V17, P3270; Shogenji R, 2014, OPT REV, V21, P237, DOI 10.1007/s10043-014-0034-9	25	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					544	552		10.1007/s10043-015-0095-4		9	Optics	Optics	CO1TO	WOS:000358938400007		
J	Sharif, GM; Quang, NT; Matsuura, M; Kishi, N				Sharif, Gazi Mohammad; Quang Nguyen-The; Matsuura, Motoharu; Kishi, Naoto			All-optical pulsewidth-tunable wavelength conversion of return-to-zero differential phase-shift keying signal	OPTICAL REVIEW			English	Article						RZ-DPSK; Wavelength conversion; Pulsewidth-tunable operation; Raman amplifier; Four-wave mixing (FWM)	RZ-DPSK SIGNAL; FIBER; TRANSMISSION; RECEIVERS; AMPLIFIER; SYSTEMS; PUMP; FWM	We demonstrate the wavelength conversion of return-to-zero differential phase-shift keying (RZ-DPSK) signal with the pulsewidth-tunable operation using a Raman amplifier (RA)-based ultrashort pulse compressor and a highly nonlinear fiber (HNLF)-based four-wave mixing (FWM) switch. The wavelength of the input RZ-DPSK signal is converted to new wavelengths owing to the FWM effect in HNLF. On the other hand, the pulsewidth of the wavelength-converted RZ-DPSK signal is tuned from 10 to 3 ps by using the ultrashort pulse source based on RA-based adiabatic soliton pulse compression. The bit error rate characteristics of the input RZ-DPSK and the wavelength-converted RZ-DPSK signals with different pulsewidths are measured and error-free operations are achieved in all cases. The optical spectra, autocorrelation traces, and clear and opening eye diagrams show high conversion performance with wide-range pulsewidth tunability.	[Sharif, Gazi Mohammad; Matsuura, Motoharu; Kishi, Naoto] Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan; [Quang Nguyen-The] Le Quy Don Tech Univ, Fac Radioelect, Hanoi, Vietnam	Sharif, GM (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan.	gazi.md.sharif@uec.ac.jp			JSPS KAKENHI [24360148]	This work was partly supported by JSPS KAKENHI Grant Number 24360148.	Agrawal G. P., 1995, NONLINEAR FIBER OPTI; Ramamurthy B, 1998, IEEE J SEL AREA COMM, V16, P1061, DOI 10.1109/49.725178; D'Ottavi A, 1998, IEEE PHOTONIC TECH L, V10, P952, DOI 10.1109/68.681281; HASEGAWA T, 1993, IEEE PHOTONIC TECH L, V5, P947, DOI 10.1109/68.238264; Kwok CH, 2006, IEEE J SEL TOP QUANT, V12, P451, DOI 10.1109/JSTQE.2006.872732; Yoo SJB, 1996, J LIGHTWAVE TECHNOL, V14, P955, DOI 10.1109/50.511595; Gnauck AH, 2005, J LIGHTWAVE TECHNOL, V23, P115, DOI 10.1109/JLT.2004.840357; Matsuura M, 2011, IEEE PHOTONIC TECH L, V23, P615, DOI 10.1109/LPT.2011.2119396; Andersen PA, 2005, IEEE PHOTONIC TECH L, V17, P1908, DOI 10.1109/LPT.2005.853275; Pu MH, 2011, IEEE PHOTONIC TECH L, V23, P1409, DOI 10.1109/LPT.2011.2162059; INOUE K, 1992, IEEE PHOTONIC TECH L, V4, P69, DOI 10.1109/68.124880; Astar W, 2007, IEEE PHOTONIC TECH L, V19, P1676, DOI 10.1109/LPT.2007.905052; Bogris A, 2003, J LIGHTWAVE TECHNOL, V21, P1892, DOI [10.1109/JLT.2003.814390, 10.1109/JTL.2003.814390]; Cai JX, 2005, J LIGHTWAVE TECHNOL, V23, P95, DOI 10.1109/JLT.2004.840041; ELREFAIE AF, 1991, IEEE PHOTONIC TECH L, V3, P71, DOI 10.1109/68.68052; Geng Y., 2006, MP5 LAS EEL SOC; Hu H, 2012, MICROW OPT TECHN LET, V54, P2172, DOI 10.1002/mop.27034; Li ZH, 2004, IEEE PHOTONIC TECH L, V16, P1685, DOI 10.1109/LPT.2004.828463; Lu GW, 2009, ELECTRON LETT, V45, P221, DOI 10.1049/el:20092990; Matsuura M, 2009, IEEE PHOTONIC TECH L, V21, P572, DOI 10.1109/LPT.2009.2014968; Nakazawa M., 2010, ULTRAHIGH SPEED OPTI; Nguyen-The Q., 2011, IEICE T ELECT C, V1160; Reeves-Hall PC, 2001, ELECTRON LETT, V37, P417, DOI 10.1049/el:20010303; Sano A, 1998, J LIGHTWAVE TECHNOL, V16, P977, DOI 10.1109/50.681453; TONGUZ OK, 1991, IEEE PHOTONIC TECH L, V3, P835, DOI 10.1109/68.84510; Yan L.-S., 2002, P 28 EUR C OPT COMM; Yu C, 2004, IEEE PHOTONIC TECH L, V16, P1906, DOI 10.1109/LPT.2004.831316	27	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					553	559		10.1007/s10043-015-0094-5		7	Optics	Optics	CO1TO	WOS:000358938400008		
J	Katsura, S; Mizokami, Y; Yaguchi, H				Katsura, Shigehito; Mizokami, Yoko; Yaguchi, Hirohisa			Perceived quality of wood images influenced by the skewness of image histogram	OPTICAL REVIEW			English	Article						Wood grain; Perceived quality; Skewness; Kurtosis; Histogram	LUMINANCE DISTRIBUTION; PERCEPTION; STATISTICS; FRESHNESS; MODEL	The shape of image luminance histograms is related to material perception. We investigated how the luminance histogram contributed to improvements in the perceived quality of wood images by examining various natural wood and adhesive vinyl sheets with printed wood grain. In the first experiment, we visually evaluated the perceived quality of wood samples. In addition, we measured the colorimetric parameters of the wood samples and calculated statistics of image luminance. The relationship between visual evaluation scores and image statistics suggested that skewness and kurtosis affected the perceived quality of wood. In the second experiment, we evaluated the perceived quality of wood images with altered luminance skewness and kurtosis using a paired comparison method. Our result suggests that wood images are more realistic if the skewness of the luminance histogram is slightly negative.	[Katsura, Shigehito; Mizokami, Yoko; Yaguchi, Hirohisa] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan; [Katsura, Shigehito] Kyushu Univ, Fac Design, Minami Ku, Fukuoka 8158540, Japan	Katsura, S (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, 1-33 Yayoicho, Chiba 2638522, Japan.	katsura.shigehito.997@m.kyushu-u.ac.jp			Japan Society for Promotion of Science [23135506]	This work was partially supported the Japan Society for Promotion of Science 23135506 (YM).	Arce-Lopera C, 2012, I-PERCEPTION, V3, P338, DOI 10.1068/i0471; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; Arce-Lopera C, 2013, FOOD QUAL PREFER, V27, P202, DOI 10.1016/j.foodqual.2012.03.005; Arce-Lopera C, 2013, SKIN RES TECHNOL, V19, pE273, DOI 10.1111/j.1600-0846.2012.00638.x; Fairchild M. D., 2005, COLOR APPEARANCE MOD, P26; GUTH SL, 1973, J OPT SOC AM, V63, P450, DOI 10.1364/JOSA.63.000450; Luo MR, 1998, COLOR RES APPL, V23, P138, DOI 10.1002/(SICI)1520-6378(199806)23:3<138::AID-COL5>3.3.CO;2-T; Nakamura M., 1995, Mokuzai Gakkaishi = Journal of the Japan Wood Research Society, V41, P301; Wada Y, 2010, APPETITE, V54, P363, DOI 10.1016/j.appet.2010.01.002; Woods R. E., 1992, DIGITAL IMAGE PROCES, P161	12	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					565	576		10.1007/s10043-015-0104-7		12	Optics	Optics	CO1TO	WOS:000358938400010		
J	Dake, F; Nakayama, S; Taki, Y				Dake, Fumihiro; Nakayama, Shigeru; Taki, Yusuke			Theoretical assessment of two-dimensional nonlinear structured illumination microscopy based on structured excitation and structured stimulated emission depletion	OPTICAL REVIEW			English	Article						Fluorescence microscopy; Nonlinear microscopy; Superresolution; Illumination design	STED MICROSCOPY; RESOLUTION; LIMIT	The performance of nonlinear structured illumination microscopy (NSIM), which has theoretically infinite optical resolution, largely depends on nonlinear phenomena. Unfortunately, nonlinear effects of excitation saturation and photoswitchable fluorophores suffer from photobleaching and slow switching time, respectively. In contrast, stimulated emission depletion (STED) is also a nonlinear phenomenon, having fast switching time and being potentially harmless. We propose NSIM based on STED, which has structured excitation light and structured STED light, and both structured illuminations have the same pitch and orientation in the sample plane. Theoretical analysis shows that two-structured illumination having the same grating vector can efficiently increase nonlinearity caused by the STED effect and improve optical resolution. We also found that nonlinearity depends on the phase difference between two-structured illumination made by excitation and STED light and that opposite phase is the most efficient to increase harmonic strength. The feasibility study shows that our method can theoretically achieve optical resolution of 1/7 of wavelength with commercially available laser over large field of view.	[Dake, Fumihiro; Nakayama, Shigeru; Taki, Yusuke] Nikon Inc, Res & Dev Sect, Core Technol Div, Sakae Ku, Yokohama, Kanagawa 2448533, Japan	Dake, F (reprint author), Nikon Inc, Res & Dev Sect, Core Technol Div, Sakae Ku, 471 Nagaodai Cho, Yokohama, Kanagawa 2448533, Japan.	Fumihiro.Dake@nikon.com					Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Fujita K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228105; Yang B, 2014, OPT EXPRESS, V22, P5581, DOI 10.1364/OE.22.005581; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Leutenegger M, 2010, OPT EXPRESS, V18, P26417, DOI 10.1364/OE.18.026417; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Bretschneider S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218103; Zhang H, 2011, OPT EXPRESS, V19, P24783, DOI 10.1364/OE.19.024783; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/nmeth.1324, 10.1038/NMETH.1324]; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Dyba M, 2003, APPL OPTICS, V42, P5123, DOI 10.1364/AO.42.005123; Heintzmann R, 2003, MICRON, V34, P283, DOI 10.1016/S0968-4328(03)00053-2; Hirvonen L., 2008, P SOC PHOTO-OPT INS, V6861; Kasper R, 2010, SMALL, V6, P1379, DOI 10.1002/smll.201000203; Rittweger E, 2007, CHEM PHYS LETT, V442, P483, DOI 10.1016/j.cplett.2007.06.017; So R. T. C., 2001, J OPT SOC AM A, V18, P2833	21	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					598	604		10.1007/s10043-015-0115-4		7	Optics	Optics	CO1TO	WOS:000358938400014		
J	Kijima, K; Abe, O; Shimizu, A; Nakamura, T; Kono, H; Hagihara, S; Torikai, E; Hori, H				Kijima, K.; Abe, O.; Shimizu, A.; Nakamura, T.; Kono, H.; Hagihara, S.; Torikai, E.; Hori, H.			Electro-optical field sensor using single total internal reflection in electro-optical crystals	OPTICAL REVIEW			English	Article						Electro-optical sensor; Evanescent light wave; Electro-optical crystals; Total internal reflection; Oblique incidence interferometer	LITHIUM-NIOBATE	A novel electro-optical radio frequency field sensor with simple structure and high sensitivity is realized using single total internal reflection in electro-optical crystals. Without employing any waveguide structures, the minimum detectable electric field strength of the total internal reflection electro-optical-sensor is estimated to 86.52 dB mu V/m (21.18 mV/m) at a resolution band width of 100 Hz for a short interaction length.	[Kijima, K.; Shimizu, A.; Nakamura, T.; Kono, H.; Hagihara, S.] Yamanashi Prefectural Ind Technol Ctr, Kofu, Yamanashi 4000055, Japan; [Abe, O.] Yamanashi Prefectural Fuji Ind Technol Ctr, Fujiyoshida, Yamanashi 4030004, Japan; [Kijima, K.; Torikai, E.; Hori, H.] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008511, Japan	Kijima, K (reprint author), Yamanashi Prefectural Ind Technol Ctr, 2094 Ohtsu Machi, Kofu, Yamanashi 4000055, Japan.	kijima-akj@pref.yamanashi.lg.jp					EDWARDS GJ, 1984, OPT QUANT ELECTRON, V16, P373, DOI 10.1007/BF00620081; BOEBEL D, 1991, OPT ENG, V30, P1910, DOI 10.1117/12.56025; Gardelein A, 2007, ELECTRON LETT, V43, P489, DOI 10.1049/el:20070257; Hidaka N., 2005, IEICE T ELECTRON, VE88-C, P98; Mushiake Y., 1949, J IEE JAPAN, V69, P87; Nishihara H., 1993, HIKARI SHUSEKI KAIRO, P113; Nishihara H., 1993, HIKARI SHUSEKI KAIRO, P120; Nishihara H., 1993, HIKARI SHUSEKI KAIRO, P116; Nishihara H., 1993, HIKARI SHUSEKI KAIRO, P111; Renard R. H., 1964, J OPT SOC AM, V54, P87; Tajima K., 2002, IEICE Transactions on Electronics, VE85-C; Takahashi T, 2001, SENSOR MATER, V13, P461; Toba Y., 2008, IEICE T ELECTRON, VJ91-C, P84; Tokano Y., 1994, 9426 IEICE EMCJ, P1; Wang WC, 2006, OPT ENG, V45, DOI 10.1117/1.2404611; WEIS RS, 1985, APPL PHYS A-MATER, V37, P191, DOI 10.1007/BF00614817; Wolf E., 1999, PRINCIPLE OPTICS, V7th, P52; Wolf E., 1999, PRINCIPLE OPTICS, V7th, P315; Yariv A., 2000, OPTICAL ELECT MODERN, P470	19	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					623	628		10.1007/s10043-015-0099-0		6	Optics	Optics	CO1TO	WOS:000358938400017		
J	Yamaguchi, T; Ucikawa, K				Yamaguchi, Tatsuo; Ucikawa, Keiji			Measurements of contrast sensitivity by an adaptive optics visual simulator	OPTICAL REVIEW			English	Article						Adaptive optics visual simulator; Contrast sensitivity; Liquid crystal phase modulator	HUMAN EYE; ABERRATIONS; MODULATOR; STIMULI	We developed an adaptive optics visual simulator (AOVS) to study the relationship between the contrast sensitivity and higher-order wavefront aberrations of human eyes. A desired synthetic aberration was virtually generated on a subject eye by the AOVS, and red laser light was used to measure the aberrations. The contrast sensitivity was measured in a psychophysical experiment using visual stimulus patterns provided by a large-contrast-range imaging system, which included two liquid crystal displays illuminated by red light emitting diodes from the backside. The diameter of the pupil was set to 4 mm by an artificial aperture, and the retinal illuminance of the stimulus image was controlled to 10 Td. Experiments conducted with four normal subjects revealed that their contrast sensitivity to a high-spatial-frequency vertical sinusoidal grating pattern was lower in the presence of a horizontal coma aberration than in the presence of a vertical coma or no aberrations (p < 0.02, Nagai method).	[Yamaguchi, Tatsuo; Ucikawa, Keiji] Tokyo Inst Technol, Dept Informat Proc, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yamaguchi, Tatsuo] Topcon Corp, Itabashi Ku, Tokyo 1748580, Japan	Yamaguchi, T (reprint author), Tokyo Inst Technol, Dept Informat Proc, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	t-yamaguchi@topcon.co.jp			Topcon Corporation, Japan	This research was supported by Topcon Corporation, Japan. The authors appreciate Professor Toshifumi Mihashi's helpful advice and thank Dr. Yoko Hirohara, Mr. Joji Ichimura and Ms. Akemi Miwa for their cooperation in collecting data.	Agostini T, 1996, PERCEPT PSYCHOPHYS, V58, P250, DOI 10.3758/BF03211878; [Anonymous], 2007, AM NAT STAND SAF US, P15; Peli Eli, 1993, Spatial Vision, V7, P1, DOI 10.1163/156856893X00018; Yoon GY, 2002, J OPT SOC AM A, V19, P266, DOI 10.1364/JOSAA.19.000266; Llorente L, 2003, OPTOMETRY VISION SCI, V80, P26, DOI 10.1097/00006324-200301000-00005; Liou SW, 2001, CURR EYE RES, V22, P81, DOI 10.1076/ceyr.22.2.81.5530; Artal P, 1996, VISION RES, V36, P3575, DOI 10.1016/0042-6989(96)00107-1; Barten P. G., 1999, CONTRAST SENSITIVITY; Bouman M. A., 1967, J OPT SOC AM, V57, P401; COLETTA NJ, 1995, J OPT SOC AM A, V12, P2244, DOI 10.1364/JOSAA.12.002244; Frederick K., 2010, PSYCHOPHYSICS PRACTI, P69; Fukuchi N, 2005, OPT REV, V12, P372, DOI 10.1007/s10043-005-0372-8; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Manzanera S, 2007, OPT EXPRESS, V15, P16177, DOI 10.1364/OE.15.016177; MOVSHON JA, 1988, J OPT SOC AM A, V5, P2166, DOI 10.1364/JOSAA.5.002166; Nagai T, 2011, SEEING PERCEIVING, V24, P91, DOI 10.1163/187847511X568180; Prieto PM, 2004, OPT EXPRESS, V12, P4059, DOI 10.1364/OPEX.12.004059; Rocha KM, 2007, J REFRACT SURG, V23, P953; Roddier F., 1999, ADAPTIVE OPTICS ASTR; Sabesan R, 2009, J VIS, V9, P1, DOI [DOI 10.1167/9.5.6, 10.1167/9.5.6]	20	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					629	636		10.1007/s10043-015-0100-y		8	Optics	Optics	CO1TO	WOS:000358938400018		
J	Tsuchiya, H; Miyauchi, K; Homma, T				Tsuchiya, Hitoshi; Miyauchi, Kou; Homma, Tetsuya			Fabrication process of thick fluorescent layer for flat panel displays using a new paste supply system	OPTICAL REVIEW			English	Article						Fluorescent layer; Fluorescent paste; Dispenser nozzle; Laser-based displacement gauge; Flat panel display	DROP-ON-DEMAND; TECHNOLOGY; SCREEN	A new paste and fabrication procedure for forming stable fluorescent layers on flat panel displays formation is discussed. We have characterized the uniformity and thickness of the fluorescent paste and, using simulations, have found that the optimum fabrication conditions are with a paste sectional area of 2050 mu m(2), a dispenser pressure of 0.5 MPa, a nozzle gap of 30 mu m, and nozzle inner diameter of 0.14 mm. In addition, a contact angle of 0 degrees is the optimum surface of the glass substrate, supporting a heat-treated black matrix. The finished layer has a uniform thickness of 13.9 +/- 1.1 mu m, and a thickness/width aspect ratio of 0.1. The new method can form uniform 8 +/- 1.5-mu m-thick fluorescent layers at each opening in the black matrix; it reduces contamination, and can be extended to large substrates.	[Tsuchiya, Hitoshi; Homma, Tetsuya] Shibaura Inst Technol, Postgrad Course Funct Control Syst, Koto Ku, Tokyo 1358548, Japan; [Tsuchiya, Hitoshi] Toshiba IT & Control Syst Corp, Inspect & Mechatron Syst Div, Shinjuku Ku, Tokyo 1600023, Japan; [Miyauchi, Kou] Toshiba Co Ltd, Corp Mfg Engn Ctr, Yokohama, Kanagawa 2350017, Japan	Tsuchiya, H (reprint author), Shibaura Inst Technol, Postgrad Course Funct Control Syst, Koto Ku, Tokyo 1358548, Japan.	hitoshi.tsuchiya@toshiba.co.jp			Toshiba Corporate Manufacturing Center	This work was supported by the Toshiba Corporate Manufacturing Center. The author is deeply grateful to Mr. Ryoichi Takahashi, Toshiba Corporate Manufacturing Center, for his helpful advice.	Adachi H., 2004, IEEJ T SENS MICROMAC, V124, P207, DOI 10.1541/ieejsmas.124.207; Erath D, 2010, SOL ENERG MAT SOL C, V94, P57, DOI 10.1016/j.solmat.2009.05.018; Lee TM, 2008, THIN SOLID FILMS, V516, P7875, DOI 10.1016/j.tsf.2008.05.044; Sabnis RW, 1999, DISPLAYS, V20, P119, DOI 10.1016/S0141-9382(99)00013-X; Shinoda T, 2006, IEEE T PLASMA SCI, V34, P279, DOI 10.1109/TPS.2006.872453; Wang JB, 2009, LAB CHIP, V9, P1831, DOI 10.1039/b901635j; Chinnov EA, 2012, HIGH TEMP+, V50, P98, DOI 10.1134/S0018151X12010038; Lee TM, 2010, THIN SOLID FILMS, V518, P3355, DOI 10.1016/j.tsf.2009.10.017; Pudas M, 2004, J EUR CERAM SOC, V24, P2943, DOI 10.1016/j.jeurceramsoc.2003.11.011; Cheong BHP, 2012, ANAL BIOCHEM, V422, P39, DOI 10.1016/j.ab.2011.12.034; Duqi E, 2011, SENSOR ACTUAT A-PHYS, V168, P320, DOI 10.1016/j.sna.2011.04.029; Fujikake H, 2013, J I IMAGE INF TELEV, V67, P152; Ishikawa J, 2002, J SURF SCI SOC JPN, V23, P2; Lee JH, 2008, SENSOR ACTUAT A-PHYS, V148, P454, DOI 10.1016/j.sna.2008.09.012; Lee JH, 2007, J MICROMECH MICROENG, V17, P258, DOI 10.1088/0960-1317/17/2/011; Li GG, 2014, CHEM SOC REV, V43, P7099, DOI 10.1039/c4cs00109e; Litborn E, 1998, ANAL CHEM, V70, P4847, DOI 10.1021/ac9801317; Mogi T, 2011, BIOSENS BIOELECTRON, V26, P1942, DOI 10.1016/j.bios.2010.07.015; Moon D, 2014, EXP THERM FLUID SCI, V53, P251, DOI 10.1016/j.expthermflusci.2013.12.016; Niwa A., 1990, Journal of the Institute of Television Engineers of Japan, V44; Osawa M., 2004, J I IMAGE INF TELEV, V58, P1064; Seki M., 1992, Journal of the Institute of Television Engineers of Japan, V46; Steinert CP, 2004, SENSOR ACTUAT A-PHYS, V116, P171, DOI 10.1016/j.sna.2004.04.007; Takahashi R., 1998, P JSPE SEM M, V2, P539; Todo I., 1994, T JPN SOC MECH ENG-C, V60, P3130; Uematsu C, 2004, J BIOSCI BIOENG, V97, P432, DOI 10.1016/S1389-1723(04)70233-9; Wong EY, 2008, ANAL BIOCHEM, V381, P101, DOI 10.1016/j.ab.2008.06.024; Yoshino M., 1997, J I IMAGE INF TELEV, V51, P419	28	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					647	653		10.1007/s10043-015-0106-5		7	Optics	Optics	CO1TO	WOS:000358938400020		
J	Mano, K; Tanigawa, S; Wada, K; Matsunaka, T; Horinaka, H				Mano, Kazune; Tanigawa, Shohei; Wada, Kenji; Matsunaka, Toshiyuki; Horinaka, Hiromichi			Basic study for diagnosing blood vessel plaque employing ultrasonic velocity-change imaging in combination with near-infrared illumination	OPTICAL REVIEW			English	Article						Ultrasonic velocity; Blood vessel plaque; Near-infrared light; Tissue characterization; Ultrasonic imaging	DISRUPTION	It is important to detect unstable blood vessel plaques at an early stage to prevent their detachment and subsequent myocardial or brain infarctions. The instability of such plaques depends on the size and distribution of the internal lipid core. We propose a method for identifying lipid domains by changes in the ultrasound propagation velocity after warming with a near-infrared laser. First, we demonstrate that the most effective warming of fatty tissue to induce ultrasonic velocity changes is with a 935-nm laser. Next, a compliant blood vessel phantom containing an internal lipid domain was constructed and attached to a pulsatile pump. Experiments showed that the lipid domain could be identified with ultrasonic velocity-change imaging even in the presence of flow pulsation. We submit that ultrasonic velocity-change imaging under optical illumination may be an effective technique for diagnosing the presence of blood vessel plaques.	[Mano, Kazune; Tanigawa, Shohei; Wada, Kenji; Matsunaka, Toshiyuki; Horinaka, Hiromichi] Osaka Prefecture Univ, Phys & Elect, Fac Engn, Sakai, Osaka 5998531, Japan	Mano, K (reprint author), Osaka Prefecture Univ, Phys & Elect, Fac Engn, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	mano@pe.osakafu-u.ac.jp			Nihon Kohden Corporation; program for SENTAN-JST	This research was supported by grants from Nihon Kohden Corporation and the program for SENTAN-JST (2012-2014).	CONWAY JM, 1984, AM J CLIN NUTR, V40, P1123; Farb A, 1996, CIRCULATION, V93, P1354; Kern R, 2004, STROKE, V35, P870, DOI 10.1161/01.STR.0000120728.72958.4A; BUJA LM, 1994, CIRCULATION, V89, P503; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; FALK E, 1995, CIRCULATION, V92, P657; Horinaka H., 2010, P IEEE INT ULTR S 20, P1416; Mano K., 2012, P S ULTR EL, P373	8	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	AUG	2015	22	4					654	658		10.1007/s10043-015-0097-2		5	Optics	Optics	CO1TO	WOS:000358938400021		
J	Burri, A; Ogata, S; Vehof, J; Williams, F				Burri, Andrea; Ogata, Soshiro; Vehof, Jelle; Williams, Frances			Chronic widespread pain: clinical comorbidities and psychological correlates	PAIN			English	Article						CWP; Chronic widespread pain; Genetics; Twins; Emotional regulation; Comorbidity	POPULATION; FIBROMYALGIA; EPIDEMIOLOGY; SINGLE; BIG-5; TWIN	Recent studies have provided consistent evidence for a genetic influence on chronic widespread pain (CWP). The aim of this study was to investigate (1) the etiological structure underlying CWP by examining the covariation between CWP and psychological comorbidities and psychoaffective correlates and (2) the decomposition of the covariation into genetic and environmental components. A total of 3266 female twins (mean age 56.6 years) were subject to multivariate analyses. Using validated questionnaires to classify twins as having CWP, the prevalence of CWP was 20.8%. In the multivariate analysis, the most suitable model was the common pathway model. This model revealed 2 underlying latent variables, one common to anxiety, emotional intelligence, and emotional instability (f1) and the other common to depression and CWP (f2), the latter being highly heritable (86%). Both latent variables (f1 and f2) shared an additive genetic and a nonshared environmental factor. In addition, a second additive genetic factor loading only on f2 was found. This study reveals the structure of genetic and environmental influences of CWP and its psychoaffective correlates. The results show that the clustering of CWP and depression is due to a common, highly heritable, underlying latent trait. In addition, we found evidence that CWP, anxiety, emotional instability, and emotional intelligence are influenced by different underlying latent traits sharing the same genetic and nonshared environmental factors. This is the first study to reveal the structure and relative importance of genetic and environmental influences on complex etiological mechanisms of CWP and its correlates.	[Burri, Andrea] Univ Zurich, Dept Psychol, CH-8050 Zurich, Switzerland; [Burri, Andrea; Vehof, Jelle; Williams, Frances] Kings Coll London, Dept Twin Res, London, England; [Ogata, Soshiro] Osaka Univ, Grad Sch Med, Dept Hlth Promot Sci, Suita, Osaka, Japan; [Vehof, Jelle] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Vehof, Jelle] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	Burri, A (reprint author), Univ Zurich, Dept Psychol, Binzmuehlestr 14 Box 9, CH-8050 Zurich, Switzerland.	a.burri@psychologie.uzh.ch			Swiss National Science Foundation; EU FP7 project Pain_OMICS; Pain Research Foundation; Arthritis Research UK; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership; King's College London	The authors have no conflicts of interest to declare. A. Burri reports an Ambizione personal career fellowship by the Swiss National Science Foundation. F. Williams is supported by the EU FP7 project Pain_OMICS and has grant support from the Pain Research Foundation and Arthritis Research UK. This work was supported by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Spector TD, 2006, TWIN RES HUM GENET, V9, P899; White KP, 1999, J RHEUMATOL, V26, P880; Malkin I, 2014, ANN HUM GENET, V78, P357, DOI 10.1111/ahg.12074; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Burri A, 2011, J SEX MED, V8, P2420, DOI 10.1111/j.1743-6109.2011.02341.x; Croft P, 2002, J MUSCULOSKELET PAIN, V10, P191; Bhui K, 1997, BRIT J HOSP MED, V58, P145; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Ogata S, 2014, J EPIDEMIOL, V24, P31, DOI 10.2188/jea.JE20130070; Aaron LA, 2003, BEST PRACT RES CL RH, V17, P563, DOI 10.1016/S1521-6942(03)00033-0; Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007; Kato K, 2006, ARTHRITIS RHEUM, V54, P1682, DOI 10.1002/art.21798; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Petrides KV, 2006, J APPL SOC PSYCHOL, V36, P552; Vehof J, 2014, PAIN, V155, P1562, DOI 10.1016/j.pain.2014.05.002; Williams FMK, 2010, RHEUMATOLOGY, V49, P1753, DOI 10.1093/rheumatology/keq170; Woods SA, 2005, EUR J PERSONALITY, V19, P373, DOI 10.1002/per.542; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kato K, 2006, ARCH GEN PSYCHIAT, V63, P1267, DOI 10.1001/archpsyc.63.11.1267; Bradley Laurence A, 2005, Curr Pain Headache Rep, V9, P79, DOI 10.1007/s11916-005-0042-3; Burn A, 2014, J SEX MED, V11, P2772; Burri A, 2015, TWIN RES HUM GENET, V2, P1; CEDERLOEF R, 1961, ACTA GENET STAT MED, V11, P338; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Loehlin JC, 1995, BEHAV GENET, V26, P19; Neale MC, PSYCHOMETRIKA; Neale MC, 1992, METHODOLOGY GENETIC; Nyman T, 2011, SPINE, V36, pE1469, DOI 10.1097/BRS.0b013e3181e2c878; Peterson R. A., 1992, ANXIETY SENSITIVITY; Peterson RA, 1999, ANXIETY SENSITIVITY, P66; Petrides K. V., 2004, TECHNICAL MANUAL TRA; Rijsdijk Frühling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Wade JB, 2000, PERSONALITY CHARACTE, P89, DOI 10.1037/10376-004; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	AUG	2015	156	8					1458	1464		10.1097/j.pain.0000000000000182		7	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CO0BQ	WOS:000358815500013		
J	Yoritaka, A; Kawajiri, S; Yamamoto, Y; Nakahara, T; Ando, M; Hashimoto, K; Nagase, M; Saito, Y; Hattori, N				Yoritaka, Asako; Kawajiri, Sumihiro; Yamamoto, Yorihiro; Nakahara, Toshiki; Ando, Maya; Hashimoto, Kazuhiko; Nagase, Midori; Saito, Yufuko; Hattori, Nobutaka			Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q(10) for Parkinson's disease	PARKINSONISM & RELATED DISORDERS			English	Article						Parkinson's disease; Reduced form of coenzyme Q10; Randomized controlled trial; Complex I; Oxidative stress	OXIDATIVE STRESS; COMPLEX-I; UBIQUINOL-10 SUPPLEMENTATION; REDOX STATUS; MITOCHONDRIA; DEFICIENCY; PLASMA; SAFETY; FLUID	Introduction: Mitochondrial complex I deficiencies have been found in post-mortem brains of patients with Parkinson's disease (PD). Coenzyme Q(10) (CoQ(10)) is the electron acceptor found in complexes I and II, and is a potent antioxidant. A recent trial of the oxidized form of CoQ(10) for PD failed to show benefits; however, the reduced form of CoQ(10) (ubiquinol-10) has shown better neuroprotective effects in animal models. Methods: Randomized, double-blind, placebo-controlled, parallel-group pilot trials were conducted to assess the efficacy of ubiquinol-10 in Japanese patients with PD. Participants were divided into two groups: PD experiencing wearing off (Group A), and early PD, without levodopa (with or without a dopamine agonist) (Group B). Participants took 300 mg of ubiquinol-10 or placebo per day for 48 weeks (Group A) or 96 weeks (Group B). Results: In Group A, total Unified Parkinson's Disease Rating Scale (UPDRS) scores decreased in the ubiquinol-10 group (n = 14; mean +/- SD [-4.2 +/- 8.2]), indicating improvement in symptoms. There was a statistically significant difference (p < 0.05) compared with the placebo group (n = 12; 2.9 +/- 8.9). In Group B, UPDRS increased in the ubiquinol-10 group (n = 14; 3.9 +/- 8.0), as well as in the placebo group (n = 8; 5.1 +/- 10.3). Conclusions: This is the first report showing that ubiquinol-10 may significantly improve PD with wearing off, as judged by total UPDRS scores, and that ubiquinol-10 is safe and well tolerated. (C) 2015 Elsevier Ltd. All rights reserved.	[Yoritaka, Asako; Kawajiri, Sumihiro; Nakahara, Toshiki; Ando, Maya; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138421, Japan; [Yoritaka, Asako] Juntendo Univ, Dept Neurol, Koshigaya Hosp, Tokyo 1138421, Japan; [Yamamoto, Yorihiro; Hashimoto, Kazuhiko; Nagase, Midori] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo, Japan; [Saito, Yufuko] Higashi Nagoya Natl Hosp, Dept Neurol, Nagoya, Aichi, Japan	Hattori, N (reprint author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nhattori@juntendo.ac.jp			JSPS KAKENHI [23591282]; Juntendo Institute of Mental Health	We thank KANEKA Co., Ltd. for supplying the ubiquinol-10 and placebo capsules. This work was supported by grants from JSPS KAKENHI (Grant Number 23591282), and grant from the Juntendo Institute of Mental Health. We thank Hideo Mori in the Department of Neurology, Juntendo University Koshigaya Hospital, and Masashi Takanashi in the Department of Neurology, Juntendo University School of Medicine for enrolling participants.	Olanow CW, 2004, ARCH NEUROL-CHICAGO, V61, P1563, DOI 10.1001/archneur.61.10.1563; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Stamelou M, 2008, MOVEMENT DISORD, V23, P942, DOI 10.1002/mds.22023; Miles MV, 2007, PEDIATR NEUROL, V37, P398, DOI 10.1016/j.pediatrneurol.2007.08.003; Sohmiya M, 2004, J NEUROL SCI, V223, P161, DOI 10.1016/j.jns.2004.05.007; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131; Kaufmann P, 2009, ANN NEUROL, V66, P235, DOI 10.1002/ana.21743; Yamashita S, 1997, ANAL BIOCHEM, V250, P66, DOI 10.1006/abio.1997.2187; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x; Hosoe K, 2007, REGUL TOXICOL PHARM, V47, P19, DOI 10.1016/j.yrtph.2006.07.001; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Shults CW, 1997, ANN NEUROL, V42, P261, DOI 10.1002/ana.410420221; Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X; Gotz ME, 2000, J NEURAL TRANSM, V107, P41, DOI 10.1007/s007020050003; HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Hyson HC, 2010, MOVEMENT DISORD, V25, P1924, DOI 10.1002/mds.22408; Isobe C, 2010, NEUROSCI LETT, V469, P159, DOI 10.1016/j.neulet.2009.11.065; Isobe C, 2007, J CLIN NEUROSCI, V14, P340, DOI 10.1016/j.jocn.2005.12.023; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Matsubara A, 2012, J CHROMATOGR A, V1250, P76, DOI 10.1016/j.chroma.2012.05.009; Miyamae T, 2013, REDOX REP, V18, P12, DOI 10.1179/1351000212Y.0000000036; Safarinejad MR, 2012, J UROLOGY, V188, P526, DOI 10.1016/j.juro.2012.03.131; Wada Hiroo, 2007, J Am Geriatr Soc, V55, P1141, DOI 10.1111/j.1532-5415.2007.01209.x	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	AUG	2015	21	8					911	916		10.1016/j.parkreldis.2015.05.022		6	Clinical Neurology	Neurosciences & Neurology	CO2FB	WOS:000358970400015		
J	Suzuki, J; Nakamura, T; Hirayama, M; Mizutani, Y; Okada, A; Ito, M; Watanabe, H; Sobue, G				Suzuki, Junichiro; Nakamura, Tomohiko; Hirayama, Masaaki; Mizutani, Yasuaki; Okada, Akinori; Ito, Mizuki; Watanabe, Hirohisa; Sobue, Gen			Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy	PARKINSONISM & RELATED DISORDERS			English	Article						Peripheral resistance; Impaired vasoconstrictor response; Orthostatic hypotension; Multiple system atrophy; Head-up tilt test	CHRONIC AUTONOMIC FAILURE; HEAD-UP TILT; PARKINSONS-DISEASE; BLOOD-PRESSURE; HYPOTENSION; MANAGEMENT; DYSFUNCTION; CEREBELLAR; DIAGNOSIS; IMPEDANCE	Background and purpose: Most patients with multiple system atrophy (MSA) develop autonomic dysfunction; however, orthostatic hypotension is not always present. Failure of the vasoconstrictor response is thought to be responsible for orthostatic hypotension, but the degree of impairment of this response in patients with MSA is unclear. We assessed autonomic function in patients with MSA by evaluating the vasoconstrictive response during a head-up tilt test and determining its relationship to orthostatic hypotension. As an additional examination, the efficacy of norepinephrine in treating orthostatic hypotension was also assessed. Methods: The study included 82 patients with MSA and 28 controls. Measures of total peripheral resistance were obtained during a head-up tilt test. Norepinephrine was administered to the patients lacking a vasoconstrictive response to evaluate its ability to treat orthostatic hypotension. Results: At a 60 tilt, orthostatic hypotension occurred in 47.6% of the patients and 0% of controls. Reduction in total peripheral resistance from baseline at a 60 degrees tilt was observed in 69.5% of the patients and 0% of controls. In patients with MSA, changes in systolic blood pressure from the baseline at a 60 tilt correlated positively with changes in the total peripheral resistance (r = 0.69, p < 0.0001). Norepinephrine prevented the reduction of total peripheral resistance and development of orthostatic hypotension. Conclusions: A large number of patients with MSA with and without orthostatic hypotension have an impaired peripheral vasoconstrictive response, suggesting a high frequency of cardiovascular dysautonomia with an associated risk of developing orthostatic hypotension. A norepinephrine infusion was effective for treating orthostatic hypotension. (C) 2015 Elsevier Ltd. All rights reserved.	[Suzuki, Junichiro; Nakamura, Tomohiko; Hirayama, Masaaki; Mizutani, Yasuaki; Okada, Akinori; Ito, Mizuki; Watanabe, Hirohisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Hirayama, Masaaki] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan	Sobue, G (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp			Ministry of Health, Labor and Welfare, Japan	This study was supported by Health and Labor Sciences Research grants for research on measures for intractable diseases and comprehensive research on Aging and Health of the Ministry of Health, Labor and Welfare, Japan.	Wenning GK, 2013, LANCET NEUROL, V12, P264, DOI 10.1016/S1474-4422(12)70327-7; Tang WHW, 2009, AM HEART J, V157, P402, DOI 10.1016/j.ahj.2008.10.016; Roncevic D, 2014, J NEURAL TRANSM, V121, P507, DOI 10.1007/s00702-013-1133-7; Smit AAJ, 1999, J PHYSIOL-LONDON, V519, P1, DOI 10.1111/j.1469-7793.1999.0001o.x; Ha AD, 2011, PARKINSONISM RELAT D, V17, P625, DOI 10.1016/j.parkreldis.2011.05.020; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; DAVIES B, 1982, J CLIN INVEST, V69, P779, DOI 10.1172/JCI110516; Metzler M, 2013, J NEUROL, V260, P2212, DOI 10.1007/s00415-012-6736-7; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Lewis SJ, 2012, NEUROBIOL DIS, V46, P130, DOI 10.1016/j.nbd.2011.12.053; Chandler MP, 2002, J NEUROL, V249, P542, DOI 10.1007/s004150200062; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; Freeman R, 2008, NEW ENGL J MED, V358, P615, DOI 10.1056/NEJMcp074189; Shannon JR, 2000, CIRCULATION, V101, P2710; Yabe I, 2006, J NEUROL SCI, V249, P115, DOI 10.1016/j.jns.2006.05.064; Niimi Y, 1999, CLIN AUTON RES, V9, P139, DOI 10.1007/BF02281627; Kaufmann H, 2014, NEUROLOGY, V83, P328, DOI 10.1212/WNL.0000000000000615; Gratze G, 1998, COMPUT BIOL MED, V28, P121, DOI 10.1016/S0010-4825(98)00005-5; OPPENHEIMER DR, 1980, J NEUROL SCI, V46, P393, DOI 10.1016/0022-510X(80)90064-7; Asahina M, 2005, J NEUROL, V252, P72, DOI 10.1007/s00415-005-0609-2; Biaggioni I, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0542-z; Buchheit M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00069; Cybulski G, 2012, CARDIOL J, V19, P550, DOI 10.5603/CJ.2012.0104; HAINSWORTH R, 1988, CLIN SCI, V74, P17; Kollensperger M, 2010, MOVEMENT DISORD, V25, P2604, DOI 10.1002/mds.23192; Nakamura T, 2014, PARKINSONISM RELAT D, V20, P409, DOI 10.1016/j.parkreldis.2014.01.003; Schmidt C, 2008, MOVEMENT DISORD, V23, P1766, DOI 10.1002/mds.22187; Wenning GK, 2012, CEREBELLUM, V11, P223, DOI 10.1007/s12311-011-0299-5; Yoshida M, 2007, NEUROPATHOLOGY, V27, P484, DOI 10.1111/j.1440-1789.2007.00841.x	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	AUG	2015	21	8					917	922		10.1016/j.parkreldis.2015.05.023		6	Clinical Neurology	Neurosciences & Neurology	CO2FB	WOS:000358970400016		
J	Kikuchi, K; Hamano, S; Higurashi, N; Matsuura, R; Suzuki, K; Tanaka, M; Minamitani, M				Kikuchi, Kenjiro; Hamano, Shin-ichiro; Higurashi, Norimichi; Matsuura, Ryuki; Suzuki, Kotoko; Tanaka, Manabu; Minamitani, Motoyuki			Difficulty of Early Diagnosis and Requirement of Long-Term Follow-Up in Benign Infantile Seizures	PEDIATRIC NEUROLOGY			English	Article						antiepileptic drugs; benign infantile seizures; epilepsy; gastroenteritis; nonconvulsive seizures	COMPLEX PARTIAL SEIZURES; PARTIAL EPILEPSY; MILD GASTROENTERITIS; VERTEX SPIKES; INFANCY; CONVULSIONS; CLASSIFICATION; TERMINOLOGY; SPECTRUM; WAVES	PURPOSE: We investigated whether benign infantile seizures can be diagnosed in the acute phase. METHODS: We retrospectively analyzed the medical records of 44 patients initially diagnosed with acute phase benign infantile seizures. All patients were followed for more than 12 months, and we reviewed patients' psychomotor development and presence or absence of seizure recurrence at the last visit. Patients were divided into the following three groups according to the final diagnosis: benign infantile seizures, benign infantile seizures associated with mild gastroenteritis, and non-benign infantile seizures. We defined benign infantile seizures associated with mild gastroenteritis and benign infantile seizures as those associated with normal psychomotor development and no seizure recurrence 3 months after onset of the first seizure, whereas non-benign infantile seizures were associated with delayed psychomotor development and/or seizure recurrence after 3 months of onset of the first seizure. We analyzed the clinical features in the acute phase and compared them between the groups. RESULTS: The median age of seizure onset was 7.6 months. A final diagnosis of benign infantile seizures associated with mild gastroenteritis was made in three patients. In the remaining 41 patients, the final diagnosis was benign infantile seizures in 30 (73.2%) and non-benign infantile seizures in 11(26.8%). In the non-benign infantile seizure group, intellectual disability was diagnosed in eight patients and seizure recurrence in six. There were no significant differences in clinical features between the groups in the acute phase, such as seizure type or seizure duration. CONCLUSION: About 30% of patients initially diagnosed as having benign infantile seizures did not experience a benign clinical course. Our findings suggest that clinical features in the acute phase are not helpful for predicting benign outcomes in benign infantile seizures and that only long-term follow-up can discriminate benign infantile seizures from non-benign infantile seizures.	[Kikuchi, Kenjiro; Hamano, Shin-ichiro; Tanaka, Manabu; Minamitani, Motoyuki] Saitama Childrens Med Ctr, Div Neurol, Saitama, Saitama 3398551, Japan; [Kikuchi, Kenjiro; Higurashi, Norimichi; Matsuura, Ryuki; Suzuki, Kotoko] Jikei Univ, Sch Med, Dept Pediat, Minato Ku, Tokyo, Japan	Kikuchi, K (reprint author), Saitama Childrens Med Ctr, Div Neurol, Iwatsuki Ku, 2100 Magome, Saitama, Saitama 3398551, Japan.	kikuchi.kenjirojikei@gmail.com					Oguni H, 2011, BRAIN DEV-JPN, V33, P207, DOI 10.1016/j.braindev.2010.10.024; Matsufuji H, 2005, BRAIN DEV-JPN, V27, P554, DOI 10.1016/j.braindev.2005.01.005; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Caraballo RH, 2003, EPILEPTIC DISORD, V5, P45; Dura-Trave T, 2011, EUR J NEUROL, V18, P273, DOI 10.1111/j.1468-1331.2010.03120.x; Okumura A, 2004, BRAIN DEV-JPN, V26, P164, DOI 10.1016/S038707604(03)00121-9; Engel J, 2006, EPILEPSIA, V47, P1558, DOI 10.1111/j.1528-1167.2006.00215.x; Uemura N, 2002, BRAIN DEV-JPN, V24, P745, DOI 10.1016/S0387-7604(02)00097-9; Okumura A, 2006, EPILEPSIA, V47, P181, DOI 10.1111/j.1528-1167.2006.00385.x; WATANABE K, 1987, PEDIATR NEUROL, V3, P208, DOI 10.1016/0887-8994(87)90018-X; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Capovilla G, 2000, BRAIN DEV-JPN, V22, P93, DOI 10.1016/S0387-7604(99)00120-5; Capovilla G, 1998, BRAIN DEV-JPN, V20, P105, DOI 10.1016/S0387-7604(98)00005-9; Capovilla G, 2006, BRAIN DEV-JPN, V28, P85, DOI 10.1016/j.braindev.2005.05.001; Caraballo RH, 2009, SEIZURE-EUR J EPILEP, V18, P686, DOI 10.1016/j.seizure.2009.09.006; Cusmai R, 2010, EPILEPTIC DISORD, V12, P255, DOI 10.1684/epd.2010.0340; Espeche A, 2010, EPILEPSY RES, V89, P96, DOI 10.1016/j.eplepsyres.2009.10.017; Fukuyama Y, 1963, SEISHIN IGAKU, V5, P211; Fukuyama Y, 2006, EPILEPSIES, V18, P8; Ichiyama Takashi, 2005, No To Hattatsu, V37, P493; Korff CM, 2006, PEDIATR NEUROL, V34, P253, DOI 10.1016/j.pediatrneurol.2005.08.005; Li TS, 2014, SEIZURE-EUR J EPILEP, V23, P16, DOI 10.1016/j.seizure.2013.09.003; Martin ET, 2010, PEDIATRICS, V126, pE1477, DOI 10.1542/peds.2010-1138; Morooka K., 1982, SHONIKA, V23, P131; Okumura A, 2006, EPILEPSY RES, V70, pS168, DOI 10.1016/j.eplepsyres.2005.11.019; Saadeldin IY, 2010, BRAIN DEV-JPN, V32, P378, DOI 10.1016/j.braindev.2009.04.014; Specchio N, 2006, EPILEPSY RES, V70, pS156, DOI 10.1016/j.eplepsyres.2006.01.018; Tanabe T, 2006, EPILEPSY RES, V70, pS185, DOI 10.1016/j.eplepsyres.2006.02.007; Verrotti A, 2011, EPILEPSY RES, V93, P107, DOI 10.1016/j.eplepsyres.2010.11.004; WATANABE K, 1990, J CLIN NEUROPHYSIOL, V7, P409, DOI 10.1097/00004691-199007000-00006; WATANABE K, 1993, EPILEPSIA, V34, P635, DOI 10.1111/j.1528-1157.1993.tb00440.x; Watanabe K, 2000, BRAIN DEV-JPN, V22, P296, DOI 10.1016/S0387-7604(00)00112-1; Youssef WF, 2011, PEDIATR EMERG CARE, V27, P1062, DOI 10.1097/PEC.0b013e31823b45b3	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	AUG	2015	53	2					157	162		10.1016/j.pediatrneurol.2015.03.025		6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CO7HH	WOS:000359329700009		
J	Guillen, U; Weiss, EM; Munson, D; Maton, P; Jefferies, A; Norman, M; Naulaers, G; Mendes, J; da Silva, LJ; Zoban, P; Hansen, TWR; Hallman, M; Delivoria-Papadopoulos, M; Hosono, S; Albersheim, SG; Williams, C; Boyle, E; Lui, K; Darlow, B; Kirpalani, H				Guillen, Ursula; Weiss, Elliott M.; Munson, David; Maton, Pierre; Jefferies, Ann; Norman, Mikael; Naulaers, Gunnar; Mendes, Joana; da Silva, Lincoln Justo; Zoban, Petr; Hansen, Thor W. R.; Hallman, Mikko; Delivoria-Papadopoulos, Maria; Hosono, Shigeharu; Albersheim, Susan G.; Williams, Constance; Boyle, Elaine; Lui, Kei; Darlow, Brian; Kirpalani, Haresh			Guidelines for the Management of Extremely Premature Deliveries: A Systematic Review	PEDIATRICS			English	Review							EXTREMELY PRETERM BIRTH; LOW-GESTATIONAL-AGE; INTERNATIONAL COMPARISONS; INFANT-MORTALITY; NEONATAL OUTCOMES; GRAY ZONE; RESUSCITATION; VIABILITY; CARE; BABIES	BACKGROUND AND OBJECTIVES: Available data on survival rates and outcomes of extremely low gestational age (GA) infants (22-25 weeks' gestation) display wide variation by country. Whether similar variation is found in statements by national professional bodies is unknown. The objectives were to perform a systematic review of management from scientific and professional organizations for delivery room care of extremely low GA infants. METHODS: We searched Embase, PubMed, and Google Scholar for management guidelines on perinatal care. Countries were included if rated by the United Nations Development Programme's Human Development Index as "very highly developed." The primary outcome was rating of recommendations from "comfort care" to "active care." Secondary outcomes were specifying country-specific survival and considering potential for 3 biases: limitations of GA assessment; bias from different definitions of stillbirths and live births; and bias from the use of different denominators to calculate survival. RESULTS: Of 47 highly developed countries, 34 guidelines from 23 countries and 4 international groups were identified. Of these, 3 did not state management recommendations. Of the remaining 31 guidelines, 21 (68%) supported comfort care at 22 weeks' gestation, and 20 (65%) supported active care at 25 weeks' gestation. Between 23 and 24 weeks' gestation, much greater variation was seen. Seventeen guidelines cited national survival rates. Few guidelines discussed potential biases: limitations in GA (n = 17); definition bias (n = 3); and denominator bias (n = 7). CONCLUSIONS: Although there is a wide variation in recommendations (especially between 23 and 24 weeks' GA), there is general agreement for comfort care at 22 weeks' GA and active care at 25 weeks' GA.	[Guillen, Ursula] Christiana Care Hlth Syst, Div Neonatol, Newark, DE 19713 USA; [Weiss, Elliott M.; Munson, David; Kirpalani, Haresh] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Maton, Pierre] CHC St Vincent, Rocourt, Belgium; [Jefferies, Ann] Univ Toronto, Mt Sinai Hosp, Dept Pediat, Toronto, ON M5G 1X5, Canada; [Norman, Mikael] Karolinska Hosp, Dept Neonatal Med, S-10401 Stockholm, Sweden; [Naulaers, Gunnar] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Mendes, Joana] Sao Francisco Xavier Hosp, Lisbon, Portugal; [da Silva, Lincoln Justo] Lisbon Med Sch, Dept Pediat, Lisbon, Portugal; [Hansen, Thor W. R.] Charles Univ Prague, Dept Neonatol, Prague, Czech Republic; [Hansen, Thor W. R.] Oslo Univ Hosp, Women & Childrens Div, Oslo, Norway; [Hansen, Thor W. R.] Univ Oslo, Fac Med, Oslo, Norway; [Hallman, Mikko] Oulu Univ Hosp, Dept Pediat, Oulu, Finland; [Hallman, Mikko] Univ Oulu, Oulu, Finland; [Delivoria-Papadopoulos, Maria] St Christophers Hosp Children, Div Neonatol, Philadelphia, PA 19133 USA; [Hosono, Shigeharu] Nihon Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Albersheim, Susan G.] Univ British Columbia, Div Neonatol, Vancouver, BC V5Z 1M9, Canada; [Williams, Constance] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Boyle, Elaine] Univ Leicester, Dept Pediat, Leicester, Leics, England; [Lui, Kei] Univ New S Wales, Dept Newborn Care, Sydney, NSW, Australia; [Darlow, Brian] Univ Otago, Dept Pediat, Christchurch, New Zealand	Guillen, U (reprint author), Christiana Care Hlth Syst, 4745 Ogletown Stanton Rd,MAP 1,Suite 217, Newark, DE 19713 USA.	ursula.guillen@gmail.com		Hallman, Mikko/0000-0002-8172-729X			American College of Obstetricians and Gynecologists, 2012, ACOG PRACT B, V38; Anderson NG, 2007, ULTRASOUND OBST GYN, V30, P173, DOI 10.1002/uog.4037; Janvier A, 2012, ACTA PAEDIATR, V101, P800, DOI 10.1111/j.1651-2227.2012.02695.x; Lui K, 2006, MED J AUSTRALIA, V185, P495; Batton DG, 2009, PEDIATRICS, V124, P422, DOI 10.1542/peds.2009-1060; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Seri I, 2008, J PERINATOL, V28, pS4, DOI 10.1038/jp.2008.42; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Jefferies AL, 2012, PAED CHILD HEALT-CAN, V17, P443; Smith PB, 2012, PEDIATRICS, V129, pE1508, DOI 10.1542/peds.2011-2216; Singh J, 2007, PEDIATRICS, V120, P519, DOI 10.1542/peds.2006-2966; Evans DJ, 2001, ARCH DIS CHILD, V84, pF79, DOI 10.1136/fn.84.2.F79; Wilkinson AR, 2009, ARCH DIS CHILD-FETAL, V94, pF2, DOI 10.1136/adc.2008.143321; Kramer MS, 2002, PAEDIATR PERINAT EP, V16, P16; Itabashi K, 2009, PEDIATRICS, V123, P445, DOI 10.1542/peds.2008-0763; Anthony S, 2001, PAEDIATR PERINAT EP, V15, P306, DOI 10.1046/j.1365-3016.2001.00355.x; Australian Resuscitation Council; New Zealand Resuscitation Council, 2011, EMERG MED AUSTRALAS, V23, P450; Batton DG, 2011, AM J PERINAT, V28, P299, DOI 10.1055/s-0030-1268714; Berger TM, 2011, SWISS MED WEEKLY, V141; Castro A, 2012, ARCH ARGENT PEDIATR, V110, P70, DOI [10.1590/S0325-00752012000100018, 10.5546/aap.2012.70]; Consiglio superiore di sanita. Ministero della salute, 2008, EM PAR RACC CUR ESTR; Doyle LW, 2010, J PEDIAT, V156, pe1; Dupont-Thibodeau A, 2014, SEMIN PERINATOL, V38, P31, DOI 10.1053/j.semperi.2013.07.006; El-Metwally D, 2000, J PEDIATR-US, V137, P616, DOI 10.1067/mpd.2000.109143; Serour GI, 2006, INT J GYNECOL OBSTET, V94, P169, DOI 10.1016/j.ijgo.2006.06.005; Gallagher K, 2014, ARCH DIS CHILD-FETAL, V99, pF245, DOI 10.1136/archdischild-2013-305191; Gemeinsame Empfehlung der; Deutschen Gesellschaft fur Gynakologie und Geburtshilfe; Deutschen Gesellschaft fur Kinderheilkunde und Jugendmedizin; Deutschen Gesellschaft fur Perinatale Medizin; Gesellschaft fur Neonatologie und Padiatrische Intensivmedizin, 2008, Z GEBURTSHILFE NEONA, V212, P109; Grupo de Reanimacion Cardiopulmonar de la Sociedad Espanola de Neonatologia, 2004, AN PEDIAT BARC, V60, P65; Guillen U, 2011, AM J OBSTET GYNECOL, V205; Guillen U, 2012, J PEDIATR-US, V160, P382, DOI 10.1016/j.jpeds.2011.08.070; International Liaison Committee on Resuscitation, 2006, PEDIATRICS, V117; Joseph KS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e746; Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P975, DOI 10.1016/j.ajog.2004.06.053; de Laat Monique W M, 2010, Ned Tijdschr Geneeskd, V154, pA2701; Marlow N, 2014, ACTA PAEDIATR, V103, P4, DOI 10.1111/apa.12518; Mendes J, 2012, PORTUGUESE CONSENSUS; Mercurio MR, 2009, SEMIN PERINATOL, V33, P354, DOI 10.1053/j.semperi.2009.07.002; Moriette G, 2010, ARCH PEDIATRIE, V17, P527, DOI 10.1016/j.arcped.2009.09.024; National Medical Ethics Committee, ETH GUID MED TREATM; Neonatal Subcommittee of the Irish Faculty of Paediatrics, 2006, STAT PER CAR THRESH; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Raju TNK, 2014, J PERINATOL, V34, P333, DOI 10.1038/jp.2014.70; Richmond S, 2010, RESUSCITATION, V81, P1389, DOI 10.1016/j.resuscitation.2010.08.018; Royal College of Obstetricians & Gynaecologists, 2014, PER MAN PREG WOM THR; Rutkowska M., 2011, MED WIEKU ROZWOJ 2, V15, P356; SACHS BP, 1995, OBSTET GYNECOL, V85, P941, DOI 10.1016/0029-7844(95)00056-W; Skupski DW, 2010, J PERINAT MED, V38, P579, DOI 10.1515/JPM.2010.098; Taipale P, 2001, OBSTET GYNECOL, V97, P189, DOI 10.1016/S0029-7844(00)01131-5; Tammela O, GUIDELINES RESUSCITA; Tamura M, NEONATAL CARDIOPULMO; The National Board of Health and Welfare, PER OMH VID EXTR UND; Tomlinson MW, 2010, AM J OBSTET GYNECOL, V202; United Nations Development Programme (UNDP), 2013, HUM DEV REP 2013 RIS; Verloove-Vanhorick SP, 2006, BJOG-INT J OBSTET GY, V113, P13, DOI 10.1111/j.1471-0528.2006.01119.x; Wilkinson D., 2013, PERINATAL CARE THRES	56	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2015	136	2					343	350		10.1542/peds.2015-0542		8	Pediatrics	Pediatrics	CN9SA	WOS:000358788100054		
J	Takeuchi, S; Yazaki, M; Yamada, S; Fukuyama, T; Inui, A; Iwasaki, Y; Ikeda, S				Takeuchi, Satsuki; Yazaki, Masahide; Yamada, Shinji; Fukuyama, Tetsuhiro; Inui, Akio; Iwasaki, Yasushi; Ikeda, Shu-ichi			An Adolescent Case of Citrin Deficiency With Severe Anorexia Mimicking Anorexia Nervosa	PEDIATRICS			English	Article							II CITRULLINEMIA; SODIUM PYRUVATE; ORAL GLUCOSE; ARGININE; GHRELIN; SIBLINGS; DISEASE; PATIENT; PROTEIN; NICCD	We report a 12-year-old female citrin-deficient patient presenting with severe anorexia and body weight loss, mimicking the restricting type of anorexia nervosa (AN). She showed normal development until age 10 years when she started to play volleyball at school. She then became gradually anorexic, and her growth was stunted. At age 12, she was admitted to hospital because of severe anorexia and thinness. She was first thought to have AN, and drip infusion of glucose solution and high-calorie drinks were given, but her condition deteriorated further. She had a history of neonatal hepatitis and was therefore suspected to have citrin deficiency (CD). Genetic analysis of SLC25A13 revealed that she was compound heterozygous for 851del4 and IVS16ins3kb, and a diagnosis of CD was made. A low-carbohydrate diet with oral intake of arginine and ursodeoxycholic acid was started, and her condition gradually improved. The clinical features in our patient were similar to those of AN, and therefore AN may also be an important clinical sign in adolescent patients with CD.	[Takeuchi, Satsuki; Yamada, Shinji; Iwasaki, Yasushi] Chu Shin Matsumoto Hosp, Matsumoto Med Ctr, Dept Pediat, Matsumoto, Nagano, Japan; [Yazaki, Masahide; Ikeda, Shu-ichi] Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano 3908621, Japan; [Yazaki, Masahide; Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 3908621, Japan; [Fukuyama, Tetsuhiro] Nagano Red Cross Hosp, Dept Pediat, Nagano, Japan; [Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan	Yazaki, M (reprint author), Shinshu Univ, Inst Biomed Sci, Matsumoto, Nagano 3908621, Japan.	mayazaki@shinshu-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Shinshu University Hospital	Supported in part by grant of citrin working group from the Ministry of Health, Labor and Welfare of Japan and grant-in-aid of the Promotion project of education, research, and medical care from Shinshu University Hospital.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Dimmock D, 2007, PEDIATRICS, V119, pE773, DOI 10.1542/peds.2006-1950; Harada T, 2008, BIOL PSYCHIAT, V63, P245, DOI 10.1016/j.biopsych.2007.04.005; Hayasaka K, 2012, JIMD REP, V2, P37, DOI 10.1007/8904_2011_42; Imamura Y, 2003, HEPATOL RES, V26, P68, DOI 10.1016/S1386-6346(02)00331-5; Kobayashi K, 1997, HEPATOLOGY, V25, P1160, DOI 10.1002/hep.510250519; Lee BH, 2010, J PEDIATR GASTR NUTR, V50, P682, DOI 10.1097/MPG.0b013e3181d67fbf; Mutoh K, 2008, J INHERIT METAB DIS, V31, pS343, DOI 10.1007/s10545-008-0914-x; Nagasaka H, 2009, MOL GENET METAB, V97, P21, DOI 10.1016/j.ymgme.2009.01.009; Nakamura M, 2011, J NUTR SCI VITAMINOL, V57, P239, DOI 10.3177/jnsv.57.239; Ohura T, 2007, J INHERIT METAB DIS, V30, P139, DOI 10.1007/s10545-007-0506-1; Okano Y, 2013, MOL GENET METAB, V109, P9, DOI 10.1016/j.ymgme.2013.01.020; Saheki T, 2008, J INHERIT METAB DIS, V31, P386, DOI 10.1007/s10545-008-0752-x; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Song YZ, 2011, INT J MOL MED, V28, P33, DOI 10.3892/ijmm.2011.653; Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2; Tanaka M, 2003, CLIN ENDOCRINOL, V59, P574, DOI 10.1046/j.1365-2265.2003.01886.x; Yazaki M, 2013, CLIN NEUROL NEUROSUR, V115, P1542, DOI 10.1016/j.clineuro.2012.12.027	21	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2015	136	2					E530	E534		10.1542/peds.2014-4172		5	Pediatrics	Pediatrics	CN9SA	WOS:000358788100031		
J	Pratt, N; Chan, EW; Choi, NK; Kimura, M; Kimura, T; Kubota, K; Lai, ECC; Man, KKC; Ooba, N; Park, BJ; Sato, T; Shin, JY; Wong, ICK; Yang, YHK; Roughead, EE				Pratt, Nicole; Chan, Esther W.; Choi, Nam-Kyong; Kimura, Michio; Kimura, Tomomi; Kubota, Kiyoshi; Lai, Edward Chia-Cheng; Man, Kenneth K. C.; Ooba, Nobuhiro; Park, Byung-Joo; Sato, Tsugumichi; Shin, Ju-Young; Wong, Ian C. K.; Yang, Yea-Huei Kao; Roughead, Elizabeth E.			Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries	PHARMACOEPIDEMIOLOGY AND DRUG SAFETY			English	Article						prescription symmetry analysis; pharmacovigilance; amiodarone; hyperthyroidism; pharmacoepidemiology	THYROID-DYSFUNCTION; AMIODARONE THERAPY	BackgroundPrescription sequence symmetry analysis (PSSA) is a signal detection method for adverse drug events. Its capacity to consistently detect adverse drug events across different settings has not been tested. We aimed to determine the consistency of PSSA results for detecting positive and negative control adverse drug events across different settings. MethodsUsing a distributed network model, we analyzed prescription dispensing data using PSSA in Australia, Hong Kong, Japan, Korea, and Taiwan. Positive control was amiodarone and thyroxine, as a marker of amiodarone-induced hypothyroidism, a known adverse event with a clear temporal relationship to amiodarone initiation. Negative controls were amiodarone and allopurinol, as a marker of amiodarone-induced gout and thyroxine and allopurinol, as a marker of thyroxine-induced gout. Gout is not recorded as an adverse event in product information for either medicine. Adjusted sequence ratios (ASR) were calculated for each country. Pooled estimates were obtained by using the generic inverse variance method. ResultsA positive association was identified between amiodarone and thyroxine in all settings with a pooled ASR 2.63 (95% confidence interval (CI) 1.47-4.72). Temporal analysis showed the effect occurred within the first few weeks of treatment. No significant associations were found for the negative controls in any setting; pooled ASR were 0.76 (95%CI 0.62-0.93) and 0.98 (95%CI 0.85-1.12) for amiodarone-allopurinol and thyroxine-allopurinol, respectively. ConclusionDespite different health settings, different populations, and different patterns of medicine utilization, PSSA gave consistent estimates across countries for a well-known positive association and two negative control adverse events. (c) 2015 The Authors Pharmacoepidemiology and Drug Safety Published by John Wiley & Sons Ltd.	[Pratt, Nicole; Roughead, Elizabeth E.] Univ S Australia, Sansom Inst Hlth Res, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia; [Chan, Esther W.; Man, Kenneth K. C.; Wong, Ian C. K.] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Pok Fu Lam, Hong Kong, Peoples R China; [Choi, Nam-Kyong] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea; [Kimura, Michio; Kimura, Tomomi] Hamamatsu Univ Sch Med, Dept Med Informat, Shizuoka, Japan; [Kubota, Kiyoshi; Ooba, Nobuhiro; Sato, Tsugumichi] Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan; [Lai, Edward Chia-Cheng; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Preventat Med, Seoul, South Korea; [Park, Byung-Joo; Shin, Ju-Young] Korea Inst Drug Safety & Risk Management, Seoul, South Korea	Roughead, EE (reprint author), Univ S Australia, Sansom Inst Hlth Res, Qual Use Med & Pharm Res Ctr, 101 Currie St, Adelaide, SA 5001, Australia.	libby.roughead@unisa.edu.au	Roughead, Libby/G-4431-2010; 	Roughead, Libby/0000-0002-6811-8991; Choi, Nam-Kyong/0000-0003-1153-9928			Bogazzi F, 2012, J ENDOCRINOL INVEST, V35, P340, DOI 10.3275/8298; Tsiropoulos I, 2009, PHARMACOEPIDEM DR S, V18, P483, DOI 10.1002/pds.1736; Vorperian VR, 1997, J AM COLL CARDIOL, V30, P791, DOI 10.1016/S0735-1097(97)00220-9; Hallas J, 1996, EPIDEMIOLOGY, V7, P478, DOI 10.1097/00001648-199609000-00004; Pratt N, 2013, PHARMACOEPIDEM DR S, V22, P915, DOI 10.1002/pds.3440; Andersen M, 2013, PHARMACOEPIDEM DR S, V22, P700, DOI 10.1002/pds.3439; Batcher EL, 2007, AM J MED, V120, P880, DOI 10.1016/j.amjmed.2007.04.022; Bouvy ML, 2002, PHARMACOEPIDEM DR S, V11, P601, DOI 10.1002/pds.735; Cohen-Lehman J, 2010, NAT REV ENDOCRINOL, V6, P34, DOI 10.1038/nrendo.2009.225; Higginss JPT, 2011, COCHRANE HDB SYSTEMA; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792; Rouleau F, 2001, ARCH MAL COEUR VAISS, V94, P39; TRIP MD, 1991, AM J MED, V91, P507, DOI 10.1016/0002-9343(91)90187-3; Wahab IA, 2013, PHARMACOEPIDEM DR S, V22, P496, DOI 10.1002/pds.3417	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-8569	1099-1557		PHARMACOEPIDEM DR S	Pharmacoepidemiol. Drug Saf.	AUG	2015	24	8					858	864		10.1002/pds.3780		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO3NI	WOS:000359064400009		
J	Chaki, S; Shimazaki, T; Nishiguchi, M; Funakoshi, T; Iijima, M; Ito, A; Kanuma, K; Sekiguchi, Y				Chaki, Shigeyuki; Shimazaki, Toshiharu; Nishiguchi, Mariko; Funakoshi, Takeo; Iijima, Michihiko; Ito, Akie; Kanuma, Kosuke; Sekiguchi, Yoshinori			Antidepressant/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Melanin-concentrating hormone receptor 1 antagonist; Antidepressant; Anxiolytic; TASP0382650; TASPO489838	ANXIOLYTIC-LIKE; MESSENGER-RNA; ANXIETY DISORDERS; ADRENAL AXIS; RAT-BRAIN; DEPRESSION; MICE; MCHR1; INVOLVEMENT; EXPRESSION	Melanin-concentrating hormone receptor 1 (MCH1 receptor) is known to be involved in the control of mood and stress, in addition to the regulation of feeding. Here, we report further evidence that the blockade of the MCH1 receptor exhibits antidepressant and anxiolytic-like effects in a variety of animal models using TASP0382650 and TASP0489838, newly synthesized MCH1 receptor antagonists, with different scaffolds. Both TASP0382650 and TASP0489838 exhibited high affinities for human MCH1 receptor with IC50 values of 7.13 and 3.80 nM, respectively. Both compounds showed potent antagonist activities at the MCH1 receptor, as assessed using MCH-increased [S-35]GTP gamma S binding to human Mall receptor and an MCH-induced [Ca2+](1) assay in rat MCH1 receptor expressing cells. In contrast neither TASP0382650 nor TASP0489838 showed an affinity for the MCH2 receptor, another MCH receptor subtype. The oral administration of TASP0382650 or TASP0489838 significantly reduced the immobility time during the forced swimming test in rats, and reduced hyperemotionality induced by an olfactory bulbectomy, both of which are indicative of an antidepressant-like potential. In the olfactory bulbectomy model, the antidepressant effect of TASP0382650 appeared following a single administration, suggesting a faster onset of action, compared with current medications. Moreover, both TASP0382650 and TASP0489838 exhibited anxiolytic effects in several animal models of anxiety. In contrast, both TASP0382650 and TASP0489838 did not affect spontaneous locomotor activity, motor function, spatial memory during the Morris water maze task, or the convulsion threshold to pentylenetetrazole. These findings provide additional evidence that the blockade of the MCH1 receptor exhibits antidepressant- and anxiolytic activities with no adverse effects in experimental animal models. (C) 2015 Elsevier Inc All rights reserved.	[Chaki, Shigeyuki; Shimazaki, Toshiharu; Nishiguchi, Mariko; Funakoshi, Takeo; Iijima, Michihiko; Ito, Akie; Kanuma, Kosuke; Sekiguchi, Yoshinori] Taisho Pharmaceut Co Ltd, Kita Ku, Saitama, Saitama 3319530, Japan	Chaki, S (reprint author), Taisho Pharmaceut Co Ltd, Pharmacol Labs, Pharmacol 1, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan.	s-chaki@so.taisho.co.jp					Binneman B, 2008, AM J PSYCHIAT, V165, P617, DOI 10.1176/appi.ajp.2008.07071199; David DJ, 2007, J PHARMACOL EXP THER, V321, P237, DOI 10.1124/jpet.106.109678; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.001; Cryan JF, 2005, PSYCHOPHARMACOLOGY, V182, P335, DOI 10.1007/s00213-005-0093-5; Roy M, 2007, BIOL PSYCHIAT, V61, P174, DOI 10.1016/j.biopsych.2006.03.076; Smith DG, 2006, NEUROPSYCHOPHARMACOL, V31, P1135, DOI 10.1038/sj.npp.1300913; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Slattery DA, 2007, PSYCHOPHARMACOLOGY, V190, P555, DOI 10.1007/s00213-006-0630-x; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Varas MM, 2003, PEPTIDES, V24, P1403, DOI 10.1016/j.peptides.2003.09.006; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Roy M, 2006, NEUROPSYCHOPHARMACOL, V31, P112, DOI 10.1038/sj.npp.1300805; Millan MJ, 2008, INT J NEUROPSYCHOPH, V11, P1105, DOI 10.1017/S1461145708008894; Keller M, 2006, BIOL PSYCHIAT, V59, P216, DOI 10.1016/j.biopsych.2005.07.013; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; Yoshimizu T, 2006, PSYCHOPHARMACOLOGY, V186, P587, DOI 10.1007/s00213-006-0390-7; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Saitoh A, 2007, PSYCHOPHARMACOLOGY, V191, P857, DOI 10.1007/s00213-007-0699-x; Shimazaki T, 2006, EUR J PHARMACOL, V543, P63, DOI 10.1016/j.ejphar.2006.06.032; Lagos P, 2011, BEHAV BRAIN RES, V218, P259, DOI 10.1016/j.bbr.2010.10.035; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; Griebel G, 2012, J CLIN PSYCHIAT, V73, P1403, DOI 10.4088/JCP.12m07804; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Iijima M, 2014, BRIT J PHARMACOL, V171, P3511, DOI 10.1111/bph.12699; Chaki S, 2005, J PHARMACOL EXP THER, V313, P831, DOI 10.1124/jpet.104.081711; Chaki S, 2004, EUR J PHARMACOL, V485, P145, DOI 10.1016/j.ejphar.2003.11.032; Chaki S, 2003, J PHARMACOL EXP THER, V304, P818, DOI 10.1124/jpet.102.044826; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fernandes C, 1999, BRAIN RES, V815, P431, DOI 10.1016/S0006-8993(98)01160-3; Gehlert DR, 2009, J PHARMACOL EXP THER, V329, P429, DOI 10.1124/jpet.108.143362; JEZOVA D, 1992, ENDOCRINOLOGY, V130, P1024, DOI 10.1210/en.130.2.1024; Kennedy AR, 2003, J NEUROENDOCRINOL, V15, P268, DOI 10.1046/j.1365-2826.2003.00997.x; Knigge KM, 1997, PEPTIDES, V18, P1095, DOI 10.1016/S0196-9781(97)00036-3; Monzon ME, 1999, PEPTIDES, V20, P1517, DOI 10.1016/S0196-9781(99)00164-3; Okuyama S, 1999, J PHARMACOL EXP THER, V289, P926; Parks GS, 2010, NEUROSCI LETT, V484, P104, DOI 10.1016/j.neulet.2010.08.018; Paxinos G., 1986, RAT BRAIN STEREOTAXI; Smith DG, 2009, BEHAV BRAIN RES, V197, P284, DOI 10.1016/j.bbr.2008.08.026; TRICKLEBANK MD, 1985, EUR J PHARMACOL, V117, P15, DOI 10.1016/0014-2999(85)90467-4	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	AUG	2015	135						154	168		10.1016/j.pbb.2015.05.018		15	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CN7QE	WOS:000358628300020		
J	Suzuki, D; Ichie, T; Hayashi, H; Sugiura, Y; Sugiyama, T				Suzuki, D.; Ichie, T.; Hayashi, H.; Sugiura, Y.; Sugiyama, T.			Gastrointestinal symptoms after the substitution of sevelamer hydrochloride with lanthanum carbonate in Japanese patients undergoing hemodialysis	PHARMAZIE			English	Article							CHRONIC KIDNEY-DISEASE; PHOSPHATE BINDER; BONE DISORDER; CALCIUM; HYPERPHOSPHATEMIA; MORTALITY; EFFICACY	Lanthanum carbonate has the same phosphorus depressant effect as the other phosphorus adsorbents, and is expected to decrease digestive symptom onset such as constipation in Japanese patients undergoing hemodialysis compared to sevelamar hydrochloride. In this study, we investigated the short- and long-term changes in digestive symptoms in these patients after substituting sevelamar hydrochloride with lanthanum carbonate. We studied 16 patients (4 men, 12 women) and evaluated their gastrointestinal symptoms before administration, at the time of administration, and 2, 4, 8, and 12 weeks after administration, using the Gastrointestinal Symptom Rating Scale. In addition, we conducted repeat evaluations 52 weeks after administration for the patients in whom lanthanum carbonate was administered continuously for 52 weeks. Fourteen (87.5 %) out of the 16 patients could tolerate continuous administration for 12 weeks. The constipation score was 3.21 +/- 1.74 before administration, 2.07 +/- 0.83 2 weeks after administration, 1.76 +/- 0.83 4 weeks after administration, 1.57 +/- 0.56 8 weeks after administration, and 11.41 +/- 0.48 12 weeks after administration. The scores improved significantly 4 weeks after administration (p < 0.05) and even 12 weeks after continuous administration. Among the 16 study patients, 9 patients (1 men, 8 women) were received lanthanum carbonate continuously for 52 weeks. The constipation score was 3.74 +/- 1.92 at the start of administration, 1.37 +/- 0.56 12 weeks after administration, and 1.85 +/- 0.63 52 weeks after administration, with significant improvement even 52 weeks after administration (p < 0.05). This study shows that substituting sevelamar hydrochloride with lanthanum carbonate improves constipation symptoms in hemodialysis patients from an early stage, which indicates its usefulness in improving constipation symptoms caused by sevelamar hydrochloride.	[Suzuki, D.; Ichie, T.; Sugiura, Y.] Kainan Hosp, Dept Pharm, Yatomi, Aichi 4988502, Japan; [Suzuki, D.; Ichie, T.; Hayashi, H.; Sugiyama, T.] Gifu Pharmaceut Univ, Lab Pharm Practice & Social Sci, Gifu, Gifu, Japan	Suzuki, D (reprint author), Kainan Hosp, Dept Pharm, Minamihonden 396, Yatomi, Aichi 4988502, Japan.	d_suzuki@kainan.jaaikosei.or.jp					Akatsuka T, 2008, THER APHER DIAL, V12, P216, DOI 10.1111/j.1744-9987.2008.00577.x; Uhlig K, 2010, AM J KIDNEY DIS, V55, P773, DOI 10.1053/j.ajkd.2010.02.340; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Qunibi WY, 2004, KIDNEY INT, V65, P1914, DOI 10.1111/j.1523-1755.2004.00590.x; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Behets GJ, 2004, CURR OPIN NEPHROL HY, V13, P403, DOI 10.1097/01.mnh.0000133973.86816.e9; Chan WLW, 2010, J RENAL NUTR, V20, P270, DOI 10.1053/j.jrn.2009.10.009; Hatakeyama S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-222; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Slatopolsky EA, 1999, KIDNEY INT, V55, P299, DOI 10.1046/j.1523-1755.1999.00240.x; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Zhang CL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-226	14	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	AUG	2015	70	8					522	526		10.1691/ph.2015.5573		5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CO6OV	WOS:000359276900005		
J	Pogrebnjak, AD; Yakushchenko, IV; Bondar, OV; Sobol', OV; Beresnev, VM; Oyoshi, K; Amekura, H; Takeda, Y				Pogrebnjak, A. D.; Yakushchenko, I. V.; Bondar, O. V.; Sobol', O. V.; Beresnev, V. M.; Oyoshi, K.; Amekura, H.; Takeda, Y.			Influence of implantation of Au- ions on the microstructure and mechanical properties of the nanostructured multielement (TiZrHf VNbTa)N coating	PHYSICS OF THE SOLID STATE			English	Article							ALLOYS	It has been found that the phase with the fcc lattice of the NaCl structural type is formed due to the vacuum-arc deposition of the nanostructured multicomponent (TiZrHfVNbTa)N coating. Implantation of negative Au- ions with a dose of 1 x 10(17) cm(-2) leads to the formation of a disordered polycrystalline structure without a preferred orientation of the fcc phase and nanocrystallites from 5-7 to 1-3 nm is size, which are dispersed in a layer up to 35 nm in depth. Nanohardness increases to 33 GPa, and the Vickers hardness reaches 51 GPa. Gold nanoclusters are formed in the near-surface region, while the fcc lattice and the formation of local Au regions are observed in the coating itself. Fragments with the hcp lattice are formed at depths above 180 nm because of the low nitrogen concentration.	[Pogrebnjak, A. D.; Yakushchenko, I. V.; Bondar, O. V.] Sumy State Univ, UA-40007 Sumy, Ukraine; [Sobol', O. V.] Natl Tech Univ Kharkiv Polytech Inst, UA-61002 Kharkov, Ukraine; [Beresnev, V. M.] Kharkov Natl Univ, UA-61022 Kharkov, Ukraine; [Oyoshi, K.; Amekura, H.; Takeda, Y.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Pogrebnjak, AD (reprint author), Sumy State Univ, Ul Rimskogo Korsakova 2, UA-40007 Sumy, Ukraine.	alexp@i.ua	Bondar, Oleksandr/K-9131-2015; Pogrebnjak, Alexander/O-1736-2015	Bondar, Oleksandr/0000-0003-3174-0709; 	International Program for Scientific Collaboration under the Ministry of Education and Science of Ukraine [514];  [0112U001382]	This study was supported by budget programs no. 0112U001382 and 0113U000137, as well as by the International Program for Scientific Collaboration under the support of the Ministry of Education and Science of Ukraine no. 514 (between the Sumy State University and NIMS, Tsukuba, Japan).	Pogrebnjak AD, 2014, MATER CHEM PHYS, V147, P1079, DOI 10.1016/j.matchemphys.2014.06.062; Ivashchenko V, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/2/025007; Feng XG, 2013, NUCL INSTRUM METH B, V301, P29, DOI 10.1016/j.nimb.2013.03.001; Pogrebnjak AD, 2015, INT J REFRACT MET H, V48, P222, DOI 10.1016/j.ijrmhm.2014.07.043; Pogrebnjak AD, 2013, RUSS CHEM REV+, V82, P1135, DOI 10.1070/RC2013v082n12ABEH004344; Zhang Y, 2014, PROG MATER SCI, V61, P1, DOI 10.1016/j.pmatsci.2013.10.001; Kishimoto N, 1998, NUCL INSTRUM METH B, V141, P299, DOI 10.1016/S0168-583X(98)00180-3; Kishimoto N., 1998, J SURF SCI, V4, P220; Komarov F. F., 1990, ION IMPLANTATION MET; Murty BS, 2014, HIGH-ENTROPY ALLOYS, P1; Pogrebnjak A. D., 2013, J SUPERHARD MATER, V35, P356; Pogrebnyak AD, 2013, TECH PHYS LETT+, V39, P280, DOI 10.1134/S1063785013030231; Pogrebnjak AD, 2014, RUSS CHEM REV+, V83, P1027, DOI 10.1070/RCR4407	13	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7834	1090-6460		PHYS SOLID STATE+	Phys. Solid State	AUG	2015	57	8					1559	1564		10.1134/S1063783415080259		6	Physics, Condensed Matter	Physics	CN9US	WOS:000358796000015		
J	Banshchikov, AG; Golosovskii, IV; Krupin, AV; Koshmak, KV; Sokolov, NS; Chernenkov, YP; Yagovkina, MA; Ulin, VP; Tabuchi, M				Banshchikov, A. G.; Golosovskii, I. V.; Krupin, A. V.; Koshmak, K. V.; Sokolov, N. S.; Chernenkov, Yu. P.; Yagovkina, M. A.; Ulin, V. P.; Tabuchi, M.			Epitaxial layers of nickel fluoride on Si(111): Growth and stabilization of the orthorhombic phase	PHYSICS OF THE SOLID STATE			English	Article							EXCHANGE BIAS; TRANSITION; NIF2	The growth and crystal structure of NiF2 layers on CaF2/Si(111) heteroepitaxial substrates have been investigated. It has been shown that molecular beam epitaxy at temperatures of 350-450A degrees C provides a stable epitaxial growth of the metastable orthorhombic NiF2 phase (structural type CaCl2) with a nickel fluoride layer thickness up to 1 mu m in the metastable phase. According to X-ray diffraction, the unit cell parameters in layers of orthorhombic nickel fluoride are a = 4.5680(1) , b = 4.7566(3) , and c = 3.0505(2) , which are very close to the known values for this phase. It has been established that the condition holds over a wide range of growth parameters, which agrees with the results of the qualitative crystallographic analysis of the elements of similarity of the structures under consideration. The formation of a domain texture, the character of which depends on the growth temperature and nickel fluoride layer thickness, has been observed in the heterojunction plane.	[Banshchikov, A. G.; Krupin, A. V.; Koshmak, K. V.; Sokolov, N. S.; Yagovkina, M. A.; Ulin, V. P.] Russian Acad Sci, AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia; [Golosovskii, I. V.; Chernenkov, Yu. P.] Natl Res Ctr, Kurchatov Inst, Konstantinov Petersburg Nucl Phys Inst, Gatchina 188300, Leningrad Oblas, Russia; [Tabuchi, M.] Nagoya Univ, Synchrotron Radiat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Banshchikov, AG (reprint author), Russian Acad Sci, AF Ioffe Phys Tech Inst, Politekhnicheskaya Ul 26, St Petersburg 194021, Russia.	aban@fl.ioffe.ru			Russian Foundation for Basic Research [13-02-00121, 13-02-12429]; Russian Government [14.B25.31.0025]; EC [FP7-2009-IRSES-247518]	This study was supported by the Russian Foundation for Basic Research (project nos. 13-02-00121 and 13-02-12429), the Russian Government (grant no. 14.B25.31.0025), and EC (grant no. FP7-2009-IRSES-247518).	Nogues J, 1999, J MAGN MAGN MATER, V192, P203, DOI 10.1016/S0304-8853(98)00266-2; Skumryev V, 2003, NATURE, V423, P850, DOI 10.1038/nature01687; Shi HT, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214416; MEIKLEJOHN WH, 1956, PHYS REV, V102, P1413, DOI 10.1103/PhysRev.102.1413; AUSTIN AE, 1969, J PHYS CHEM SOLIDS, V30, P1282, DOI 10.1016/0022-3697(69)90389-8; AZZARIA LM, 1961, J PHYS CHEM-US, V65, P889, DOI 10.1021/j100823a503; Banshchikov AG, 2012, TECH PHYS LETT+, V38, P809, DOI 10.1134/S1063785012090039; Golosovsky IV, 2010, J MAGN MAGN MATER, V322, P664, DOI 10.1016/j.jmmm.2009.10.036; Golosovsky IV, 2006, JETP LETT+, V83, P152, DOI 10.1134/S0021364006040059; JAMIESON JC, 1977, J APPL PHYS, V48, P4573, DOI 10.1063/1.323482; JORGENSEN JD, 1978, PHYS REV B, V17, P2212, DOI 10.1103/PhysRevB.17.2212; Kabalkina S. S., 1964, DOKL AKAD NAUK SSSR, V8, P1141; Kabalkina S. S., 1969, SOV PHYS-SOLID STATE, V11, P847; Kaveev AK, 2005, J APPL PHYS, V98, DOI 10.1063/1.1944909; Kyutt RN, 2007, J PHYS D APPL PHYS, V40, P4896, DOI 10.1088/0022-3727/40/16/021; Suturin SM, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/4/046002	16	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7834	1090-6460		PHYS SOLID STATE+	Phys. Solid State	AUG	2015	57	8					1647	1652		10.1134/S106378341508003X		6	Physics, Condensed Matter	Physics	CN9US	WOS:000358796000029		
J	Oba, C; Ito, K; Ichikawa, S; Morifuji, M; Nakai, Y; Ishijima, T; Abe, K; Kawahata, K				Oba, Chisato; Ito, Kyoko; Ichikawa, Satomi; Morifuji, Masashi; Nakai, Yuji; Ishijima, Tomoko; Abe, Keiko; Kawahata, Keiko			Effect of orally administered collagen hydrolysate on gene expression profiles in mouse skin: a DNA microarray analysis	PHYSIOLOGICAL GENOMICS			English	Article						collagen hydrolysate; skin aging; epidermal barrier function; skin elasticity; DNA microarray	HUMAN BLOOD; MATRIX METALLOPROTEINASES; PROLYL-HYDROXYPROLINE; CELL-PROLIFERATION; BARRIER FUNCTION; GROWTH-FACTOR; FIBROBLASTS; ELASTICITY; PEPTIDES; IMPROVES	Dietary collagen hydrolysate has been hypothesized to improve skin barrier function. To investigate the effect of long-term collagen hydrolysate administration on the skin, we evaluated stratum corneum water content and skin elasticity in intrinsically aged mice. Female hairless mice were fed a control diet or a collagen hydrolysate-containing diet for 12 wk. Stratum corneum water content and skin elasticity were gradually decreased in chronologically aged control mice. Intake of collagen hydrolysate significantly suppressed such changes. Moreover, we used DNA microarrays to analyze gene expression in the skin of mice that had been administered collagen hydrolysate. Twelve weeks after the start of collagen intake, no significant differences appeared in the gene expression profile compared with the control group. However, 1 wk after administration, 135 genes were upregulated and 448 genes were downregulated in the collagen group. This suggests that gene changes preceded changes of barrier function and elasticity. We focused on several genes correlated with functional changes in the skin. Gene Ontology terms related to epidermal cell development were significantly enriched in upregulated genes. These skin function-related genes had properties that facilitate epidermal production and differentiation while suppressing dermal degradation. In conclusion, our results suggest that altered gene expression at the early stages after collagen administration affects skin barrier function and mechanical properties. Long-term oral intake of collagen hydrolysate improves skin dysfunction by regulating genes related to production and maintenance of skin tissue.	[Oba, Chisato; Ito, Kyoko; Ichikawa, Satomi; Morifuji, Masashi; Kawahata, Keiko] Meiji Co Ltd, Food Sci Res Labs, Odawara, Kanagawa, Japan; [Nakai, Yuji] Hirosaki Univ, Inst Food Sci, Aomori, Japan; [Ishijima, Tomoko; Abe, Keiko] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Oba, C (reprint author), Meiji, Food Sci Res Labs, 540 Naruda, Odawara, Kanagawa 2500862, Japan.	chisato.ohba@meiji.com					CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; REEVES PG, 1993, J NUTR, V123, P1939; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ohara H, 2010, J DERMATOL, V37, P330, DOI 10.1111/j.1346-8138.2010.00827.x; Boelsma E, 2003, AM J CLIN NUTR, V77, P348; Neerken S, 2004, J BIOMED OPT, V9, P274, DOI [10.1117/1.1645795, 10.1117/1.16457951]; WOESSNER JF, 1991, FASEB J, V5, P2145; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Proksch E, 2014, SKIN PHARMACOL PHYS, V27, P113, DOI 10.1159/000355523; Heinrich U, 2006, J NUTR, V136, P1565; SWARTZENDRUBER DC, 1987, J INVEST DERMATOL, V88, P709, DOI 10.1111/1523-1747.ep12470383; Li J, 2010, AUSTRALAS J DERMATOL, V51, P106, DOI 10.1111/j.1440-0960.2010.00629.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Haratake A, 1997, J INVEST DERMATOL, V108, P319, DOI 10.1111/1523-1747.ep12286474; GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919; Yoon HS, 2014, J MED FOOD, V17, P810, DOI 10.1089/jmf.2013.3060; Hara-Chikuma M, 2008, J INVEST DERMATOL, V128, P2145, DOI 10.1038/jid.2008.70; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Shigemura Y, 2009, J AGR FOOD CHEM, V57, P444, DOI 10.1021/jf802785h; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Oba C, 2013, PHOTODERMATOL PHOTO, V29, P204, DOI 10.1111/phpp.12051; Ichikawa S, 2010, INT J FOOD SCI NUTR, V61, P52, DOI 10.3109/09637480903257711; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Hara M, 2002, J BIOL CHEM, V277, P46616, DOI 10.1074/jbc.M209003200; MAYS PK, 1991, BIOCHEM J, V276, P307; Ohara H, 2007, J AGR FOOD CHEM, V55, P1532, DOI 10.1021/jf062834s; Rogers J, 1996, ARCH DERMATOL RES, V288, P765, DOI 10.1007/BF02505294; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Applied Biosystems, 1997, US B, V2; BOURY-JAMOT M., 2009, HDB EXP PHARM, V190, P205; CAMERON IL, 1972, J GERONTOL, V27, P162; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Fukasawa T, 2010, J AGR FOOD CHEM, V58, P7007, DOI 10.1021/jf1006616; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P1231, DOI 10.1046/j.1523-1747.2002.19648.x; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; Hwang Kyung-A, 2011, Lab Anim Res, V27, P1, DOI 10.5625/lar.2011.27.1.1; Kanda A, 2014, BRIT J NUTR, V111, P2067, DOI 10.1017/S0007114514000233; Liang JA, 2010, J FOOD SCI, V75, pH230, DOI 10.1111/j.1750-3841.2010.01782.x; Marshall D, 2000, J INVEST DERMATOL, V114, P967, DOI 10.1046/j.1523-1747.2000.00955.x; SCHRIEBER R, 1993, DEV BIOL STAND, V80, P195; Scott DK, 2007, BRIT J DERMATOL, V156, P1156, DOI 10.1111/j.1365-2133.2007.07875.x; Shimizu J, 2015, BIOCHEM BIOPH RES CO, V456, P626, DOI 10.1016/j.bbrc.2014.12.006; Skovgaard GRL, 2006, EUR J CLIN NUTR, V60, P1201, DOI 10.1038/sj.ejcn.1602438; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Suyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029483; Team RDC, 2006, LANG ENV STAT COMP	55	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1094-8341	1531-2267		PHYSIOL GENOMICS	Physiol. Genomics	AUG 1	2015	47	8					355	363		10.1152/physiolgenomics.00009.2015		9	Cell Biology; Genetics & Heredity; Physiology	Cell Biology; Genetics & Heredity; Physiology	CO1VC	WOS:000358942800006		
J	Satou, T; Ogawa, Y; Koike, K				Satou, Tadaaki; Ogawa, Yuko; Koike, Kazuo			Relationship Between Emotional Behavior in Mice and the Concentration of (+)-alpha-Santalol in the Brain	PHYTOTHERAPY RESEARCH			English	Article						sedative effect; inhaled administration; intraperitoneal administration; elevated-plus maze test	SKIN TUMOR-DEVELOPMENT; CANCER CHEMOPREVENTIVE AGENT; SANDALWOOD SANTALUM-ALBUM; ALPHA-SANTALOL; INSULARE BERTERO; OIL; MOUSE	We previously reported finding anxiolytic-like activity for sandalwood oil after administration in mice. In this report, we further investigated the emotional behavior associated with inhaled or intraperitoneally administered (+)--santalol, the main component of sandalwood oil, in addition to examining whether pharmacological or neurological transfers are responsible for this behavior. After administration of (+)--santalol by inhalation or intraperitoneal injection, we assessed anxiolytic-like and locomotor activities using elevated-plus maze tests. We also examined the relationship between the emotional behavior and the (+)--santalol brain concentration. Anxiolytic-like activity was not observed immediately after administration or after water-immersion stress for 24h for either the (+)--santalol 2L/L air inhalation or the (+)--santalol 0.03mL/kg (i.p.) administration. However, mice administered (+)--santalol 0.03mL/kg intraperitoneally exhibited a significant decrease in the locomotor activity after exposure to water-immersion stress for 24h. The brain (+)--santalol concentration was 2.6 mu g/g tissue after (+)--santalol 0.03mL/kg (i.p.) administration. The observed shift of (+)--santalol to the brain suggests that this component acts via pharmacological transfer and is responsible for the sedative effect but not the anxiolytic-like activity. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Satou, Tadaaki; Ogawa, Yuko; Koike, Kazuo] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan	Satou, T (reprint author), Toho Univ, Fac Pharmaceut Sci, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	satou@phar.toho-u.ac.jp			JSPS KAKENHI [26350873]	We are grateful to Dr. Naohiro Kuriyama of YMC Co., Ltd., for providing the (+)-alpha-santalol. This work was supported by JSPS KAKENHI Grant Number 26350873.	Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Arasada BL, 2008, ANTICANCER RES, V28, P129; Bommareddy A, 2007, ANTICANCER RES, V27, P2185; Dwivedi C, 2006, CARCINOGENESIS, V27, P1917, DOI 10.1093/carcin/bgl058; Sciarrone D, 2011, J CHROMATOGR A, V1218, P137, DOI 10.1016/j.chroma.2010.10.117; Dwivedi C, 2003, CANCER EPIDEM BIOMAR, V12, P151; Satou T, 2014, FLAVOUR FRAG J, V29, P35, DOI 10.1002/ffj.3176; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Braun NA, 2007, NAT PROD COMMUN, V2, P695; Butaud JF, 2003, J ESSENT OIL RES, V15, P238; Chilampalli C, 2013, Drug Discov Ther, V7, P109; JIROVETZ L, 1992, BIOMED CHROMATOGR, V6, P133, DOI 10.1002/bmc.1130060307; Kaur M, 2005, CARCINOGENESIS, V26, P369, DOI 10.1093/carcin/bgh325; Misra BB, 2013, PHYTOMEDICINE, V20, P409, DOI 10.1016/j.phymed.2012.12.017; Okugawa H, 2000, PHYTOMEDICINE, V7, P417; Okugawa H, 1995, PHYTOMEDICINE, V2, P119, DOI 10.1016/S0944-7113(11)80056-5; Santha S, 2013, PHOTOCHEM PHOTOBIOL, V89, P919, DOI 10.1111/php.12070; Saraswati S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-147; Zhang Xiaoying, 2011, Front Biosci (Schol Ed), V3, P777, DOI 10.2741/s186; Zhang Xiaoying, 2010, BMC Res Notes, V3, P220, DOI 10.1186/1756-0500-3-220; Zhang XH, 2011, J HEBEI AGR SCI, V15, P1; Zhang XH, 2012, NAT PROD COMMUN, V7, P93	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	AUG	2015	29	8					1246	1250		10.1002/ptr.5372		5	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO8LC	WOS:000359419600019		
J	Kojima, H; Nishio, Z; Kobayashi, F; Saito, M; Sasaya, T; Kiribuchi-Otobe, C; Seki, M; Oda, S; Nakamura, T				Kojima, Hisayo; Nishio, Zenta; Kobayashi, Fuminori; Saito, Mika; Sasaya, Takahide; Kiribuchi-Otobe, Chikako; Seki, Masako; Oda, Shunsuke; Nakamura, Toshiki			Identification and validation of a quantitative trait locus associated with wheat yellow mosaic virus pathotype I resistance in a Japanese wheat variety	PLANT BREEDING			English	Article						disease resistance; QTL; wheat; wheat yellow mosaic virus; WYMV	BREAD WHEAT; MICROSATELLITE MARKERS; POLYMYXA-GRAMINIS; D-GENOME; BYMOVIRUS; MAP; SEQUENCE; FREQUENCIES; ASSAY; GENE	Yellow mosaic disease, caused by wheat yellow mosaic virus (WYMV), is one of the most serious diseases of winter wheat (Triticum aestivum L.) in Japan. The three pathotypes of WYMV are distributed in different geographical areas: pathotype I is found mainly in western and central Japan (Kanto), pathotype II in northern Japan (Tohoku and Hokkaido) and pathotype III on the southern island of Japan (Kyushu). A total of 246 doubled-haploid (DH) lines, derived from a cross between Yumechikara' (resistant) and Kitahonami' (susceptible), were evaluated for 2years for their resistance to WYMV pathotype I. A single major quantitative trait locus, Q.Ymym, mapping to chromosome 2D was associated with resistance to pathotype I in Yumechikara'. This is the first time a QTL responsible for pathotype I resistance has been identified. Fine mapping of Q.Ymym indicated that it was on a tight linkage block originating from Yumechikara', and the markers associated with this block will accelerate the development of varieties resistant to WYMV pathotype I.	[Kojima, Hisayo; Kiribuchi-Otobe, Chikako; Oda, Shunsuke] NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Nishio, Zenta] NARO Hokkaido Agr Res Ctr, Memuro Kasai, Hokkaido 0820081, Japan; [Kobayashi, Fuminori] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Saito, Mika; Nakamura, Toshiki] NARO Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan; [Sasaya, Takahide] NARO Kyushu Okinawa Agr Res Ctr, Koshi, Kumamoto 8611192, Japan; [Seki, Masako] NARO Agr Res Ctr, Hokuriku Res Ctr, Joetsu, Niigata 9430193, Japan	Kojima, H (reprint author), NARO Inst Crop Sci, 2-1-18 Kannondai, Tsukuba, Ibaraki 3058518, Japan.	kojimah@affrc.go.jp; tnaka@affrc.go.jp					CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ishikawa G, 2009, THEOR APPL GENET, V118, P499, DOI 10.1007/s00122-008-0916-y; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; CHURCHILL GA, 1994, GENETICS, V138, P963; INAGAKI M, 1990, JPN J BREED, V40, P209; Roder MS, 1998, GENETICS, V149, P2007; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Gupta PK, 2002, THEOR APPL GENET, V105, P413, DOI 10.1007/s00122-002-0865-9; Guyomarc'h H, 2002, THEOR APPL GENET, V104, P1164, DOI 10.1007/s00122-001-0827-7; Namba S, 1998, ARCH VIROL, V143, P631, DOI 10.1007/s007050050319; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Torada A, 2006, THEOR APPL GENET, V112, P1042, DOI 10.1007/s00122-006-0206-5; Doerge RW, 1996, GENETICS, V142, P285; Basten C. J., 1996, QTL CARTOGRAPHER REF; Carroll JE, 2002, CAN J PLANT PATHOL, V24, P465; Chiba T., 1987, ANN REP KANTO TOSAN, V34, P25; Han Chenggui, 2000, Plant Disease, V84, P627, DOI 10.1094/PDIS.2000.84.6.627; IBGSC, 2012, NATURE, V491, P711; Inouye T, 1969, ARCH VIROL, V53, P61; Inouye T., 1969, ARCH VIROL, V143, P631; Khan AA, 2000, GENOME, V43, P477, DOI 10.1139/gen-43-3-477; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kusume Toshimi, 1997, Annals of the Phytopathological Society of Japan, V63, P107; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liu WH, 2005, THEOR APPL GENET, V111, P651, DOI 10.1007/s00122-005-2012-x; Liu WW, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-173; Lu XY, 1998, EUR J PLANT PATHOL, V104, P765; Ma ZQ, 1996, GENOME, V39, P123, DOI 10.1139/g96-017; Netsu O., 2011, ANN REP KANTO TOSAN, V58, P13; Nishio Z, 2010, EUPHYTICA, V176, P223, DOI 10.1007/s10681-010-0229-5; NOLT BL, 1981, PHYTOPATHOLOGY, V71, P1269; Oda S., 1989, NEWSL NATL AGR RES C, V6, P1; Ohki T, 2014, PHYTOPATHOLOGY, V104, P313, DOI 10.1094/PHYTO-06-13-0150-R; Ohto Y., 2005, 6 IWGPVFV S; Ohto Yasuo, 1997, Annals of the Phytopathological Society of Japan, V63, P361; Sawada E., 1927, ARCH VIROL, V14, P444; Sharma S, 2009, THEOR APPL GENET, V119, P783, DOI 10.1007/s00122-009-1088-0; SLYKHUIS JT, 1978, PHYTOPATHOLOGY, V68, P639; Somers D., 2004, SSRS WHEAT MICROSATE; Sourdille P., 2009, GRAINGENES MARKER RE; Sourdille P., 2001, IMPROVEMENT GENETIC, P167; Sourdille P., 2004, WHEAT GENOPLANTE SSR; Stephenson P, 1998, THEOR APPL GENET, V97, P946, DOI 10.1007/s001220050975; Suzuki T., 2010, BREED RES S2, V12, P40; Takeuchi T., 2010, Breeding Research, V12, P1; Wang S, 2006, WINDOWS QTL CARTOGRA; Wang ZG, 2009, CAN J PLANT SCI, V89, P845; Zhu XB, 2012, THEOR APPL GENET, V124, P177, DOI 10.1007/s00122-011-1696-3	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0179-9541	1439-0523		PLANT BREEDING	Plant Breed.	AUG	2015	134	4					373	378		10.1111/pbr.12279		6	Agronomy; Biotechnology & Applied Microbiology; Plant Sciences	Agriculture; Biotechnology & Applied Microbiology; Plant Sciences	CO3NF	WOS:000359064000002		
J	Goncalves, B; Hasson, A; Belcram, K; Cortizo, M; Morin, H; Nikovics, K; Vialette-Guiraud, A; Takeda, S; Aida, M; Laufs, P; Arnaud, N				Goncalves, Beatriz; Hasson, Alice; Belcram, Katia; Cortizo, Millan; Morin, Halima; Nikovics, Krisztina; Vialette-Guiraud, Aurelie; Takeda, Seiji; Aida, Mitsuhiro; Laufs, Patrick; Arnaud, Nicolas			A conserved role for CUP-SHAPED COTYLEDON genes during ovule development	PLANT JOURNAL			English	Article						CUP-SHAPED COTYLEDON genes; boundaries; ovule; development; evolution; Arabidopsis thaliana; Cardamine hirsuta; Pisum sativum; Solanum lycopersicum	SHOOT APICAL MERISTEM; ORGAN BOUNDARY FORMATION; ARABIDOPSIS-THALIANA; MICRORNA REGULATION; LATERAL-SUPPRESSOR; MARGIN DEVELOPMENT; FLOWER DEVELOPMENT; PATTERN-FORMATION; LEAF DEVELOPMENT; AUXIN TRANSPORT	The evolution of plant reproductive strategies has led to a remarkable diversity of structures, especially within the flower, a structure characteristic of the angiosperms. In flowering plants, sexual reproduction depends notably on the development of the gynoecium that produces and protects the ovules. In Arabidopsis thaliana, ovule initiation is promoted by the concerted action of auxin with CUC1 (CUP-SHAPED COTYLEDON1) and CUC2, two genes that encode transcription factors of the NAC family (NAM/ATAF1,2/CUC). Here we highlight an additional role for CUC2 and CUC3 in Arabidopsis thaliana ovule separation. While CUC1 and CUC2 are broadly expressed in the medial tissue of the gynoecium, CUC2 and CUC3 are expressed in the placental tissue between developing ovules. Consistent with the partial overlap between CUC1, CUC2 and CUC3 expression patterns, we show that CUC proteins can physically interact, both in yeast cells and in planta. We found that the cuc2;cuc3 double mutant specifically harbours defects in ovule separation, producing fused seeds that share the seed coat, and suggesting that CUC2 and CUC3 promote ovule separation in a partially redundant manner. Functional analyses show that CUC transcription factors are also involved in ovule development in Cardamine hirsuta. Additionally we show a conserved expression pattern of CUC orthologues between ovule primordia in other phylogenetically distant species with different gynoecium architectures. Taken together these results suggest an ancient role for CUC transcription factors in ovule separation, and shed light on the conservation of mechanisms involved in the development of innovative structures. Significance Statement CUP-SHAPED COTYLEDON transcription factors are key players in boundary definition, an important step in several developmental processes such as primordia initiation, axillary meristem formation, leaf dissection and ovule primordia outgrowth. We identify an additional role for CUC2 and CUC3 transcription factors in ovule separation in Arabidopsis, and provide data that suggests this role is conserved across different species, thus shedding light on the conservation of regulatory mechanisms in different developmental and evolutionary contexts.	[Goncalves, Beatriz; Hasson, Alice; Belcram, Katia; Cortizo, Millan; Morin, Halima; Nikovics, Krisztina; Vialette-Guiraud, Aurelie; Laufs, Patrick; Arnaud, Nicolas] INRA, Inst Jean Pierre Bourgin, UMR 1318, ERL CNRS 3559,Saclay Plant Sci, F-78026 Versailles, France; [Goncalves, Beatriz; Hasson, Alice; Belcram, Katia; Cortizo, Millan; Morin, Halima; Nikovics, Krisztina; Vialette-Guiraud, Aurelie; Laufs, Patrick; Arnaud, Nicolas] AgroParisTech, Inst Jean Pierre Bourgin, UMR 1318, ERL CNRS 3559,Saclay Plant Sci, F-78026 Versailles, France; [Takeda, Seiji] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Cell & Genome Biol, Kyoto 6190244, Japan; [Aida, Mitsuhiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Laufs, P (reprint author), INRA, Inst Jean Pierre Bourgin, UMR 1318, ERL CNRS 3559,Saclay Plant Sci, RD10, F-78026 Versailles, France.	patrick.laufs@versailles.inra.fr; nicolas.arnaud@versailles.inra.fr		Laufs, Patrick/0000-0003-4459-3445	Agence National de la Recherche [ANR-10-BLAN-1614, ANR-12-PDOC-0003]	We would like to thank E. Meyerowitz for providing us the pCUC2::CUC2-VENUS line, L. Gissot for a CFP vector and for split-luciferase vectors. We are thankful to L. Gissot for his helpful advice on the yeast two-hybrid assay and to C. Renne for her invaluable help on the split-luciferase assay technique. Work on this project was funded by two Agence National de la Recherche grants: MorphoLeaf (project reference ANR-10-BLAN-1614) and LeafNet (project reference ANR-12-PDOC-0003). This paper is dedicated to the memory of Jean-Pierre Rulliere.	Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Marrocco K, 2006, PLANT J, V45, P423, DOI 10.1111/j.1365-313X.2005.02635.x; Breuil-Broyer S, 2004, PLANT J, V38, P182, DOI 10.1111/j.1365-313X.2004.02026.x; Takeda S, 2011, PLANT J, V66, P1066, DOI 10.1111/j.1365-313X.2011.04571.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Takada S, 2001, DEVELOPMENT, V128, P1127; Ishida T, 2000, PLANT CELL PHYSIOL, V41, P60; Wang Q, 2014, PLANT CELL, V26, P2068, DOI 10.1105/tpc.114.123059; Aida M, 1999, DEVELOPMENT, V126, P1563; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Kamiuchi Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00165; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Kwon CS, 2006, DEVELOPMENT, V133, P3223, DOI 10.1242/dev.02508; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Bell EM, 2012, P NATL ACAD SCI USA, V109, P21146, DOI 10.1073/pnas.1210789109; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; Galbiati F, 2013, PLANT J, V76, P446, DOI 10.1111/tpj.12309; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Rubio-Somoza I, 2014, CURR BIOL, V24, P2714, DOI 10.1016/j.cub.2014.09.058; Taoka K, 2004, PLANT J, V40, P462, DOI 10.1111/j.1365-313X.2004.02238.x; Larsson E, 2012, ANN BOT-LONDON, V110, P923, DOI 10.1093/aob/mcs151; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P21152, DOI 10.1073/pnas.1210799110; Wang Y, 2014, PLANT CELL, V26, P2055, DOI 10.1105/tpc.114.123083; Hibara K, 2006, PLANT CELL, V18, P2946, DOI 10.1105/tpc.106.045716; Tian CH, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145470; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Cucinotta M., 2014, FRONT PLANT SCI, V5, P1; Nahar MAU, 2012, PLANT CELL PHYSIOL, V53, P1134, DOI 10.1093/pcp/pcs057; Rossmann S, 2015, PLANT J, V81, P837, DOI 10.1111/tpj.12782; Schneitz K, 1998, DEVELOPMENT, V125, P2555; Skinner D. J., 2004, PLANT CELL, V16, P32; SMYTH DR, 1990, PLANT CELL, V2, P755; Vialette-Guiraud ACM, 2011, ANN BOT-LONDON, V107, P1511, DOI 10.1093/aob/mcr024; Zimmermann R, 2005, PLANT MOL BIOL, V58, P669, DOI 10.1007/s11103-005-7702-x	53	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	AUG	2015	83	4					732	742		10.1111/tpj.12923		11	Plant Sciences	Plant Sciences	CO7QQ	WOS:000359356300013		
J	Sojikul, P; Saithong, T; Kalapanulak, S; Pisuttinusart, N; Limsirichaikul, S; Tanaka, M; Utsumi, Y; Sakurai, T; Seki, M; Narangajavana, J				Sojikul, Punchapat; Saithong, Treenut; Kalapanulak, Saowalak; Pisuttinusart, Nuttapat; Limsirichaikul, Siripan; Tanaka, Maho; Utsumi, Yoshinori; Sakurai, Tetsuya; Seki, Motoaki; Narangajavana, Jarunya			Genome-wide analysis reveals phytohormone action during cassava storage root initiation	PLANT MOLECULAR BIOLOGY			English	Article						Manihot esculenta; MeAGL20; MeKNOX1; Microarray; Phytohormones; In vitro storage root initiation	POTATO IPOMOEA-BATATAS; GENE-EXPRESSION PROFILES; SWEET-POTATO; STARCH BIOSYNTHESIS; MANIHOT-ESCULENTA; AUXIN TRANSPORT; TUBER FORMATION; TRANSCRIPTION FACTORS; DOWN-REGULATION; KNOX GENES	Development of storage roots is a process associated with a phase change from cell division and elongation to radial growth and accumulation of massive amounts of reserve substances such as starch. Knowledge of the regulation of cassava storage root formation has accumulated over time; however, gene regulation during the initiation and early stage of storage root development is still poorly understood. In this study, transcription profiling of fibrous, intermediate and storage roots at eight weeks old were investigated using a 60-mer-oligo microarray. Transcription and gene expression were found to be the key regulating processes during the transition stage from fibrous to intermediate roots, while homeostasis and signal transduction influenced regulation from intermediate roots to storage roots. Clustering analysis of significant genes and transcription factors (TF) indicated that a number of phytohormone-related TF were differentially expressed; therefore, phytohormone-related genes were assembled into a network of correlative nodes. We propose a model showing the relationship between KNOX1 and phytohormones during storage root initiation. Exogeneous treatment of phytohormones N-6-benzylaminopurine and 1-Naphthaleneacetic acid were used to induce the storage root initiation stage and to investigate expression patterns of the genes involved in storage root initiation. The results support the hypothesis that phytohormones are acting in concert to regulate the onset of cassava storage root development. Moreover, MeAGL20 is a factor that might play an important role at the onset of storage root initiation when the root tip becomes swollen.	[Sojikul, Punchapat; Narangajavana, Jarunya] Mahidol Univ, Fac Sci, Dept Biotechnol, Ctr Cassava Mol Biotechnol, Bangkok 10400, Thailand; [Saithong, Treenut; Kalapanulak, Saowalak] King Mongkuts Univ Technol, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Thonburi 10150, Thailand; [Saithong, Treenut; Kalapanulak, Saowalak] King Mongkuts Univ Technol, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Lab, Thonburi 10150, Thailand; [Pisuttinusart, Nuttapat; Limsirichaikul, Siripan] Silpakorn Univ, Dept Biopharm, Fac Pharm, Nakhon Pathom 73000, Thailand; [Tanaka, Maho; Utsumi, Yoshinori; Seki, Motoaki] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Yokohama, Kanagawa 2300045, Japan; [Sakurai, Tetsuya] RIKEN Plant Sci Ctr, Integrated Genome Informat Res Unit, Yokohama, Kanagawa 2300045, Japan	Sojikul, P (reprint author), Mahidol Univ, Fac Sci, Dept Biotechnol, Ctr Cassava Mol Biotechnol, Bangkok 10400, Thailand.	punchapat.soj@mahidol.ac.th	Sakurai, Tetsuya/B-2690-2010		Faculty of Science, Mahidol University, Thailand; Thailand Research Fund, Thailand [RSA5780030]; RIKEN Center for Sustainable Resource Science under Strategic Funds for the Promotion of Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was partially supported by (1) Faculty of Science, Mahidol University, Thailand (2) The Thailand Research Fund (RSA5780030), Thailand and (3) RIKEN Center for Sustainable Resource Science under the Strategic Funds for the Promotion of Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We thank Dr. Opas Boonseng (Rayong Field Crops Research Center, Ministry of Agriculture and Cooperatives, Rayong, Thailand) for KU50 field experiments, Assist. Prof. Paweena Traiperm (Department of Plant Science, Faculty of Science, Mahidol University, Bangkok, Thailand) for assistance in microscopic works, and Ms Somkid Bumee (Systems Biology and Bioinformatics Laboratory, Pilot Plant Development and Training Institute, King Mongkut's University of Technology, Bangkok, Thailand) for computational support.	An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Zhang WJ, 2011, PLANT J, V68, P1, DOI 10.1111/j.1365-313X.2011.04668.x; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Miyazawa Y, 1999, PLANT PHYSIOL, V121, P461, DOI 10.1104/pp.121.2.461; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Tanaka M, 2008, J PLANT PHYSIOL, V165, P1726, DOI 10.1016/j.jplph.2007.11.009; Enami K, 2011, PLANT PHYSIOL, V157, P518, DOI 10.1104/pp.111.178897; Rosin FM, 2003, PLANT PHYSIOL, V132, P106, DOI 10.1104/pp.102.015560; Willige BC, 2011, PLANT CELL, V23, P2184, DOI 10.1105/tpc.111.086355; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Gonzalez-Schain ND, 2012, PLANT J, V70, P678, DOI 10.1111/j.1365-313X.2012.04909.x; Testone G, 2012, J EXP BOT, V63, P5417, DOI 10.1093/jxb/ers194; Ku AT, 2008, ANN BOT-LONDON, V102, P57, DOI 10.1093/aob/mcn067; Chen H, 2004, PLANT J, V38, P276, DOI 10.1111/j.1365-313X.2004.02048.x; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Yang J, 2011, J INTEGR PLANT BIOL, V53, P193, DOI 10.1111/j.1744-7909.2010.01018.x; Reilly K, 2007, PLANT MOL BIOL, V64, P187, DOI 10.1007/s11103-007-9144-0; Baud S, 2004, J EXP BOT, V55, P397, DOI 10.1093/jxb/erh047; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Tsiantis M, 1999, PLANT PHYSIOL, V121, P1163, DOI 10.1104/pp.121.4.1163; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Sakamoto T, 2001, PLANT PHYSIOL, V125, P1508, DOI 10.1104/pp.125.3.1508; Noh SA, 2010, J EXP BOT, V61, P1337, DOI 10.1093/jxb/erp399; Tsai YC, 2012, PLANT PHYSIOL, V158, P1666, DOI 10.1104/pp.111.192765; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chen H, 2003, PLANT PHYSIOL, V132, P1391, DOI 10.1104/pp.103.022434; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI DOI 10.1093/NAR/GKQ310; Eguchi T., 2008, Plant Root, V2, P7, DOI 10.3117/plantroot.2.7; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Hajirezaei MR, 2006, J EXP BOT, V57, P2363, DOI 10.1093/jxb/erj207; Ioio RD, 2008, CURR OPIN PLANT BIOL, V11, P23; Li XQ, 2003, PLANT CELL PHYSIOL, V44, P630, DOI 10.1093/pcp/pcg080; Li YZ, 2010, PLANT MOL BIOL, V74, P573, DOI 10.1007/s11103-010-9698-0; McGregor CE, 2006, DIFFERENTIAL EXPRESS; Medina RD, 2007, ANN BOT-LONDON, V99, P409, DOI 10.1093/aob/mcl272; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; Nakajima K, 2004, PLANT CELL, V16, P1178, DOI 10.1105/tpc.017830; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Prammanee S., 2010, Kasetsart Journal, Natural Sciences, V44, P558; Ravi V, 2014, HORTICUL RE, V42, P157; Roumeliotis E, 2012, LANDES BIOSCI, V7, P1360; Roumeliotis E, 2012, J EXP BOT, V63, P4539, DOI 10.1093/jxb/ers132; Rouse-Miller J, 2013, J PLANT BIOCH PHYSL, V1, P117, DOI [10.4172/2329-9029.1000117, DOI 10.4172/2329-9029.1000117]; Sakurai T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-66; Scanlon MJ, 2002, DEVELOPMENT, V129, P2663; Sergeeva LI, 2000, PHYSIOL PLANTARUM, V108, P435, DOI 10.1034/j.1399-3054.2000.100414.x; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Siriwat W, 2012, PROCEDIA COMPUT SCI, V11, P96, DOI 10.1016/j.procs.2012.09.011; SMITH OE, 1970, PHYSIOL PLANTARUM, V23, P599, DOI 10.1111/j.1399-3054.1970.tb06452.x; Teerawanichpan P, 2008, STARCH-STARKE, V60, P696, DOI 10.1002/star.200800226; Townsley BT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00121; Vreugdenhil D, 2007, POTATO BIOL BIOTECHN, P237; Wang QingMei, 2006, Agricultural Sciences in China, V5, P919, DOI 10.1016/S1671-2927(07)60005-4; WATILLON B, 1991, PLANT PHYSIOL, V96, P479, DOI 10.1104/pp.96.2.479; You MK, 2003, FEBS LETT, V536, P101, DOI 10.1016/S0014-5793(03)00035-8	65	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	AUG	2015	88	6					531	543		10.1007/s11103-015-0340-z		13	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CO1VE	WOS:000358943100002		
J	Mikami, M; Toki, S; Endo, M				Mikami, Masafumi; Toki, Seiichi; Endo, Masaki			Comparison of CRISPR/Cas9 expression constructs for efficient targeted mutagenesis in rice	PLANT MOLECULAR BIOLOGY			English	Article						CRISPR/Cas9; Genome editing; Targeted mutagenesis; Rice	RNA-GUIDED ENDONUCLEASE; CAS SYSTEM; CRISPRCAS SYSTEM; PLANTS; ARABIDOPSIS; TRANSFORMATION; NUCLEASES; MULTIPLEX; MODEL	The CRISPR/Cas9 system is an efficient tool used for genome editing in a variety of organisms. Despite several recent reports of successful targeted mutagenesis using the CRISPR/Cas9 system in plants, in each case the target gene of interest, the Cas9 expression system and guide-RNA (gRNA) used, and the tissues used for transformation and subsequent mutagenesis differed, hence the reported frequencies of targeted mutagenesis cannot be compared directly. Here, we evaluated mutation frequency in rice using different Cas9 and/or gRNA expression cassettes under standardized experimental conditions. We introduced Cas9 and gRNA expression cassettes separately or sequentially into rice calli, and assessed the frequency of mutagenesis at the same endogenous targeted sequences. Mutation frequencies differed significantly depending on the Cas9 expression cassette used. In addition, a gRNA driven by the OsU6 promoter was superior to one driven by the OsU3 promoter. Using an all-in-one expression vector harboring the best combined Cas9/gRNA expression cassette resulted in a much improved frequency of targeted mutagenesis in rice calli, and bi-allelic mutant plants were produced in the T-0 generation. The approach presented here could be adapted to optimize the construction of Cas9/gRNA cassettes for genome editing in a variety of plants.	[Mikami, Masafumi; Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Mikami, Masafumi; Toki, Seiichi; Endo, Masaki] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Plant Genome Engn Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan	Endo, M (reprint author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	mendo@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [PGE1001]; CSTI, Cross-ministerial SIP, "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); NIAS Strategic Research Fund	This research was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation PGE1001), Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) and the NIAS Strategic Research Fund.	Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Yamaguchi T, 2004, PLANT CELL, V16, P500, DOI 10.1105/tpc.018044; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Baltes NJ, 2014, TRENDS BIOTECHNOL, V33, P120; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Johnson RA, 2013, PLANT MOL BIOL, V82, P207, DOI 10.1007/s11103-013-0052-1; Johnson RA, 2014, PLANT MOL BIOL, V87, P143; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Ohmori Y, 2011, PLANT J, V65, P77, DOI 10.1111/j.1365-313X.2010.04404.x; Sugio T, 2009, J BIOSCI BIOENG, V109, P170; Wang MB, 2008, RNA, V14, P903, DOI 10.1261/rna.760908; Xu R, 2014, RICE, V7, P923; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	33	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	AUG	2015	88	6					561	572		10.1007/s11103-015-0342-x		12	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CO1VE	WOS:000358943100004		
J	Nakanishi, T; Inaba, M; Inagaki-Katashiba, N; Tanaka, A; Vien, PTX; Kibata, K; Ito, T; Nomura, S				Nakanishi, Takahisa; Inaba, Muneo; Inagaki-Katashiba, Noriko; Tanaka, Akihiro; Vien, Phan Thi Xuan; Kibata, Kayoko; Ito, Tomoki; Nomura, Shosaku			Platelet-derived RANK ligand enhances CCL17 secretion from dendritic cells mediated by thymic stromal lymphopoietin	PLATELETS			English	Article						CCL17; dendritic cells; platelets; RANK ligand; thymic stromal lymphopoietin	ALLERGIC INFLAMMATION; LEUKOCYTE RECRUITMENT; CHEMOKINES MDC; LUNG-TISSUE; T-CELLS; IN-VIVO; ASTHMA; ACTIVATION; INDUCE; TSLP	Dendritic cells (DCs) play an integral role in cellular cascade that initiate and maintain Th2 responses in allergy. In this study, we examined the interaction between platelets and DCs to determine the role of platelets in the intervention of immune responses through modulation of DC functions. Blood-purified myeloid DCs, which had been stimulated with thymic stromal lymphopoietin (TSLP-DCs), formed aggregates with activated platelets. TSLP-DC maturation was induced after the interaction with TRAP6-activated platelets as indicated by an increase in the expression of CD86, CD40, and CD83. In addition, production of a Th2 cell-attracting chemokine, CCL17, was clearly upregulated by coculture of TSLP-DCs with TRAP6-activated platelets. We further found that an expression of RANK ligand (RANKL) on platelets was upregulated by the TRAP6 activation, and that, using the neutralizing antibody against RANKL, the platelet-derived RANKL induces the activation of TSLP-DCs. Thus, activated platelets can intervene in adaptive immune responses through induction of functional modulation of TSLP-DCs. Platelets have the ability to enhance the DC-mediated Th2 response and may contribute to the allergic inflammation. In conclusion, our study provides new insights in platelet functions and the possible mechanism of allergic responses that stem from DCs.	[Nakanishi, Takahisa; Inaba, Muneo; Inagaki-Katashiba, Noriko; Tanaka, Akihiro; Vien, Phan Thi Xuan; Kibata, Kayoko; Ito, Tomoki; Nomura, Shosaku] Kansai Med Univ, Dept Internal Med 1, Hirakata, Osaka 5731010, Japan	Ito, T (reprint author), Kansai Med Univ, Dept Internal Med 1, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	itot@hirakata.kmu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21591289, 24591472, 23590694]	The authors report no declarations of interest. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant numbers 21591289, 24591472, and 23590694).	Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Reschner A, 2008, CLIN EXP IMMUNOL, V152, P219, DOI 10.1111/j.1365-2249.2008.03624.x; Martinson JA, 2004, CYTOTHERAPY, V6, P487, DOI 10.1080/14653240410005249; Pitchford SC, 2003, J ALLERGY CLIN IMMUN, V112, P109, DOI 10.1067/mai.2003.1514; Tamagawa-Mineoka R, 2009, CLIN IMMUNOL, V131, P495, DOI 10.1016/j.clim.2009.01.006; Ferlazzo G, 2009, J CLIN IMMUNOL, V29, P265, DOI 10.1007/s10875-009-9283-y; Kissel K, 2006, TRANSFUSION, V46, P818, DOI 10.1111/j.1537-2995.2006.00802.x; Abi-Younes S, 2001, THROMB RES, V101, P279, DOI 10.1016/S0049-3848(00)00402-3; Kowalska MA, 2000, BLOOD, V96, P50; COYLE AJ, 1990, AM REV RESPIR DIS, V142, P587; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Tamagawa-Mineoka R, 2007, AM J PATHOL, V170, P2019, DOI 10.2353/ajpath.2007.060881; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; Gear ARL, 2001, BLOOD, V97, P937, DOI 10.1182/blood.V97.4.937; Georas SN, 2005, EUR RESPIR J, V26, P1119, DOI 10.1183/09031936.05.00006005; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Johansson MW, 2012, AM J RESP CRIT CARE, V185, P498, DOI 10.1164/rccm.201109-1712OC; Pitchford SC, 2004, BLOOD, V103, P639, DOI 10.1182/blood-2003-05-1707; Fujisawa T, 2002, J ALLERGY CLIN IMMUN, V110, P139, DOI 10.1067/mai.2002.126079; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Ying S, 2005, J IMMUNOL, V174, P8183; Duffau P, 2010, SCI TRANSL MED, V2, P47; Futamura K, 2010, INT ARCH ALLERGY IMM, V152, P353, DOI 10.1159/000288288; Hagihara M, 2004, J IMMUNOL, V172, P5297; Hamzeh-Cognasse H, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-54; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745; Pitchford SC, 2008, AM J RESP CRIT CARE, V177, P604, DOI 10.1164/rccm.200702-214OC; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15; Torii Y, 2008, J IMMUNOL, V181, P5340; Tsuda M, 2007, CLIN EXP IMMUNOL, V150, P322, DOI 10.1111/j.1365-2249.2007.03490.x; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Zhang YL, 2012, IMMUNOL RES, V52, P211, DOI 10.1007/s12026-012-8264-z	41	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0953-7104	1369-1635		PLATELETS	Platelets	AUG	2015	26	5					425	431		10.3109/09537104.2014.920081		7	Cell Biology; Hematology	Cell Biology; Hematology	CO3CO	WOS:000359034400011		
J	Shigekiyo, T; Sekimoto, E; Shibata, H; Ozaki, S; Fujinaga, H; Hirose, T				Shigekiyo, Toshio; Sekimoto, Etsuko; Shibata, Hironobu; Ozaki, Shuji; Fujinaga, Hiroyuki; Hirose, Takanori			Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim	PLATELETS			English	Letter						Acquired amegakaryocytic thrombocytopenic purpura; romiplostim; eltrombopag	OF-THE-LITERATURE; PATIENT		[Shigekiyo, Toshio; Sekimoto, Etsuko; Shibata, Hironobu; Ozaki, Shuji] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima 7700042, Japan; [Fujinaga, Hiroyuki] Tokushima Prefectural Cent Hosp, Dept Cardiol, Tokushima 7700042, Japan; [Hirose, Takanori] Hyogo Canc Ctr, Div Diagnost Pathol, Kobe, Hyogo, Japan	Shigekiyo, T (reprint author), Tokushima Prefectural Cent Hosp, Dept Hematol, 1-10-3 Kuramoto Cho, Tokushima 7700042, Japan.	shigekiyo@tph.gr.jp					Agarwal N, 2006, AM J HEMATOL, V81, P132, DOI 10.1002/ajh.20510; Kuter DJ, 2009, BLOOD, V114, P3748, DOI 10.1182/blood-2009-05-224766; HOFFMAN R, 1991, SEMIN HEMATOL, V28, P303; Cela Iva, 2010, Clin Adv Hematol Oncol, V8, P806; Fukushima T, 2008, LUPUS, V17, P210, DOI 10.1177/0961203307086032; Go RS, 2005, BLOOD REV, V19, P53, DOI 10.1016/j.blre.2004.05.001; KIM HD, 1980, AM J HEMATOL, V9, P117, DOI 10.1002/ajh.2830090112; Lonial S, 1999, BONE MARROW TRANSPL, V24, P1337, DOI 10.1038/sj.bmt.1702063; Lown Robert, 2010, Clin Adv Hematol Oncol, V8, P809; Marie I, 2006, BRIT J DERMATOL, V155, P714, DOI 10.1111/j.1365-2133.2006.07390.x; Rodeghiero Francesco, 2013, Eur J Haematol, V91, P423, DOI 10.1111/ejh.12181; Townsley DM, 2013, INT J HEMATOL, V98, P48, DOI 10.1007/s12185-013-1352-6	12	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0953-7104	1369-1635		PLATELETS	Platelets	AUG	2015	26	5					504	506		10.3109/09537104.2014.913128		3	Cell Biology; Hematology	Cell Biology; Hematology	CO3CO	WOS:000359034400026		
J	Zhang, Y; Muller, M; Xu, B; Yoshida, Y; Horlacher, O; Nikitin, F; Garessus, S; Magdeldin, S; Kinoshita, N; Fujinaka, H; Yaoita, E; Hasegawa, M; Lisacek, F; Yamamoto, T				Zhang, Ying; Muller, Markus; Xu, Bo; Yoshida, Yutaka; Horlacher, Oliver; Nikitin, Frederic; Garessus, Samuel; Magdeldin, Sameh; Kinoshita, Naohiko; Fujinaka, Hidehiko; Yaoita, Eishin; Hasegawa, Miki; Lisacek, Frederique; Yamamoto, Tadashi			Unrestricted modification search reveals lysine methylation as major modification induced by tissue formalin fixation and paraffin embedding	PROTEOMICS			English	Article						Bioinformatics; FFPE tissue; Lysine methylation; Open modification search; Spectral library	FORMALDEHYDE-INDUCED MODIFICATIONS; MASS-SPECTROMETRY; PEPTIDE IDENTIFICATION; ANTIGEN RETRIEVAL; CROSS-LINKING; MS/MS; PROTEINS; MODEL; SURROGATES; PROTEOMICS	Formalin-fixed paraffin-embedded (FFPE) tissue is considered as an appropriate alternative to frozen/fresh tissue for proteomic analysis. Here we study formalin-induced alternations on a proteome-wide level. We compared LC-MS/MS data of FFPE and frozen human kidney tissues by two methods. First, clustering analysis revealed that the biological variation is higher than the variation introduced by the two sample processing techniques and clusters formed in accordance with the biological tissue origin and not with the sample preservation method. Second, we combined open modification search and spectral counting to find modifications that are more abundant in FFPE samples compared to frozen samples. This analysis revealed lysine methylation (+14 Da) as the most frequent modification induced by FFPE preservation. We also detected a slight increase in methylene (+12 Da) and methylol (+30 Da) adducts as well as a putative modification of +58 Da, but they contribute less to the overall modification count. Subsequent SEQUEST analysis and X!Tandem searches of different datasets confirmed these trends. However, the modifications due to FFPE sample processing are a minor disturbance affecting 2-6% of all peptide-spectrum matches and the peptides lists identified in FFPE and frozen tissues are still highly similar.	[Zhang, Ying; Xu, Bo; Yoshida, Yutaka; Magdeldin, Sameh; Kinoshita, Naohiko; Fujinaka, Hidehiko; Yaoita, Eishin; Yamamoto, Tadashi] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Struct Pathol, Niigata 9502181, Japan; [Zhang, Ying; Muller, Markus; Horlacher, Oliver; Nikitin, Frederic; Garessus, Samuel; Lisacek, Frederique] Swiss Inst Bioinformat, Geneva, Switzerland; [Zhang, Ying; Yamamoto, Tadashi] Niigata Univ, Inst Res Collaborat & Promot, Biofluid Biomarker Ctr, Niigata 9502181, Japan; [Xu, Bo] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Magdeldin, Sameh] Suez Canal Univ, Fac Vet Med, Dept Physiol, Ismailia, Egypt; [Fujinaka, Hidehiko] Niigata Natl Hosp, Inst Clin Res, Kashiwazaki, Japan; [Hasegawa, Miki] Niigata Univ, Div Digest & Gen Surg, Niigata 9502181, Japan	Zhang, Y (reprint author), Niigata Univ, Inst Res Collaborat & Promot, Biofluid Biomarker Ctr, Nishi Ku, 8050,Ikarashi 2 No Cho, Niigata 9502181, Japan.	yzhang@med.niigata-u.ac.jp; markus.mueller@isb-sib.ch		Muller, Markus/0000-0003-0907-3583	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) in Japan [228071]; Japan Society for the Promotion of Science [15K19448]	This work was supported by Grant-in-Aid for Publication of Scientific Research Results (228071) from MEXT (Ministry of Education, Culture, Sports, Science, and Technology) in Japan and Grant-in-aid for Young Scientists B (15K19448) from Japan Society for the Promotion of Science.	Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Fowler CB, 2007, LAB INVEST, V87, P836, DOI 10.1038/labinvest.3700596; Rait VK, 2004, LAB INVEST, V84, P300, DOI 10.1038/labinvest.3700041; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; Toews J, 2008, ANAL CHIM ACTA, V618, P168, DOI 10.1016/j.aca.2008.04.049; Toews J, 2010, ANAL CHIM ACTA, V676, P60, DOI 10.1016/j.aca.2010.07.040; STEIN SE, 1994, J AM SOC MASS SPECTR, V5, P859, DOI 10.1016/1044-0305(94)87009-8; Ahrne E, 2011, J PROTEOME RES, V10, P2913, DOI 10.1021/pr200152g; Ahrne E, 2010, PROTEOMICS, V10, P671, DOI 10.1002/pmic.200900502; Tanca A, 2012, J PROTEOMICS, V77, P561, DOI 10.1016/j.jprot.2012.09.033; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Crockett DK, 2005, LAB INVEST, V85, P1405, DOI 10.1038/labinvest.3700343; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Lam H, 2011, METHODS, V54, P424, DOI 10.1016/j.ymeth.2011.01.007; Rait VK, 2004, LAB INVEST, V84, P292, DOI 10.1038/labinvest.3700045; Ashburner M, 2000, NAT GENET, V25, P25; Sprung RW, 2009, MOL CELL PROTEOMICS, V8, P1988, DOI 10.1074/mcp.M800518-MCP200; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Lam H, 2010, J PROTEOME RES, V9, P605, DOI 10.1021/pr900947u; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Tanca A, 2013, PROTEOM CLIN APPL, V7, P252, DOI 10.1002/prca.201200054; Ahrne E, 2011, PROTEOMICS, V11, P4085, DOI 10.1002/pmic.201000665; Guo T, 2007, J HISTOCHEM CYTOCHEM, V55, P763, DOI 10.1369/jhc.7A7177.2007; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; Lam H, 2007, PROTEOMICS, V7, P655, DOI 10.1002/pmic.200600625; Bateman NW, 2011, J PROTEOME RES, V10, P1323, DOI 10.1021/pr101073s; Fowler CB, 2008, LAB INVEST, V88, P185, DOI 10.1038/labinvest.3700708; Guzel C, 2011, J PROTEOME RES, V10, P3274, DOI 10.1021/pr1010795; Huang da W., 2009, NAT PROTOC, V4, P44, DOI [DOI 10.1038/NPR0T.2008.211, 10.1038/nprot.2008.211]; Nirmalan NJ, 2011, J PROTEOME RES, V10, P896, DOI 10.1021/pr100812d; Pevzner PA, 2000, J COMPUT BIOL, V7, P777, DOI 10.1089/10665270050514927; R Development Core Team, 2011, R LANG ENV STAT COMP; Roidl D., 2014, CELL TISSUE RES; Tanca Alessandro, 2014, Clin Proteomics, V11, P28, DOI 10.1186/1559-0275-11-28; Winiewski J. R., 2011, J PROTEOME RES, V10, P3040; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI DOI 10.1038/NMETH.1322	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	AUG	2015	15	15					2568	2579		10.1002/pmic.201400454		12	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CO3ML	WOS:000359061800004		
J	Schilling, J; Nepomuceno, AI; Planchart, A; Yoder, JA; Kelly, RM; Muddiman, DC; Daniels, HV; Hiramatsu, N; Reading, BJ				Schilling, Justin; Nepomuceno, Angelito I.; Planchart, Antonio; Yoder, Jeffrey A.; Kelly, Robert M.; Muddiman, David C.; Daniels, Harry V.; Hiramatsu, Naoshi; Reading, Benjamin J.			Machine learning reveals sex-specific 17-estradiol-responsive expression patterns in white perch (Morone americana) plasma proteins	PROTEOMICS			English	Article						Animal proteomics; Endocrine disrupting compounds; Machine learning; Plasma; Semiquantitative proteomics; Support vector machines	TILAPIA OREOCHROMIS-MOSSAMBICUS; ENDOCRINE-DISRUPTING CHEMICALS; ZEBRAFISH DANIO-RERIO; WASTE-WATER TREATMENT; ESTROGENIC ACTIVITY; STRIPED BASS; MULTIPLE VITELLOGENINS; AQUATIC ENVIRONMENT; STATISTICAL-MODEL; MASS-SPECTROMETRY	With growing abundance and awareness of endocrine disrupting compounds (EDCs) in the environment, there is a need for accurate and reliable detection of EDC exposure. Our objective in the present study was to observe differences within and between the global plasma proteomes of sexually mature male and female white perch (Morone americana) before (Initial Control, IC) and after 17-estradiol (E-2) induction. Semiquantitative nanoLC-MS/MS data were analyzed by machine learning support vector machines (SVMs) and by two-way ANOVA. By ANOVA, the expression levels of 44, 77, and 57 proteins varied significantly by gender, treatment, and the interaction of gender and treatment, respectively. SVMs perfectly classified male and female perch IC and E-2-induced plasma samples using the protein expression data. E-2-induced male and female perch plasma proteomes contained significantly higher levels of the yolk precursors vitellogenin Aa and Ab (VtgAa, VtgAb), as well as latrophilin and seven transmembrane domain-containing protein 1 (Eltd1) and kininogen 1 (Kng1). This is the first report that Eltd1 and Kng1 may be E-2-responsive proteins in fishes and therefore may be useful indicators of estrogen induction.	[Schilling, Justin; Daniels, Harry V.; Reading, Benjamin J.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Nepomuceno, Angelito I.; Muddiman, David C.] N Carolina State Univ, Dept Chem, WM Keck FTMS Lab Human Hlth Res, Raleigh, NC 27695 USA; [Planchart, Antonio] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Planchart, Antonio; Yoder, Jeffrey A.] N Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Yoder, Jeffrey A.] N Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Yoder, Jeffrey A.; Muddiman, David C.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Kelly, Robert M.] N Carolina State Univ, Dept Biomol & Chem Engn, Raleigh, NC 27695 USA; [Hiramatsu, Naoshi] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan	Reading, BJ (reprint author), N Carolina State Univ, Dept Appl Ecol, David Clark Labs 127, Raleigh, NC 27695 USA.	bjreadin@ncsu.edu			North Carolina Agricultural Research Service, Hatch Project [06819]	This research was funded in part by the North Carolina Agricultural Research Service, Hatch Project number 06819. The authors would like to thank Brad Ring and John Davis (North Carolina State University Aquaculture Facility) for care and maintenance of the white perch.	Andrews GL, 2009, J CHROMATOGR B, V877, P948, DOI 10.1016/j.jchromb.2009.02.040; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Rose J, 2002, COMP BIOCHEM PHYS C, V131, P531, DOI 10.1016/S1532-0456(02)00035-2; Chapman RW, 2009, MOL ECOL, V18, P2415, DOI 10.1111/j.1365-294X.2009.04194.x; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Denslow ND, 1999, ECOTOXICOLOGY, V8, P385, DOI 10.1023/A:1008986522208; Davis LK, 2007, BIOL REPROD, V77, P614, DOI 10.1095/biolreprod.107.060947; Kavanagh RJ, 2004, ENVIRON HEALTH PERSP, V112, P898, DOI 10.1289/ehp.6514; Barnthouse Lawrence W., 2009, Integrated Environmental Assessment and Management, V5, P435, DOI 10.1897/IEAM_2008-080.1; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Schilling J, 2014, J PROTEOME RES, V13, P1515, DOI 10.1021/pr401067g; WALLIMANN T, 1992, BIOCHEM J, V281, P21; Muller M, 2008, ENVIRON TOXICOL CHEM, V27, P1649, DOI 10.1897/07-519; Williams VN, 2014, J EXP ZOOL PART A, V321, P301, DOI 10.1002/jez.1859; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Williams RJ, 2003, ENVIRON SCI TECHNOL, V37, P1744, DOI 10.1021/es0202107; Pojana G, 2004, ENVIRON TOXICOL CHEM, V23, P1874, DOI 10.1897/03-222; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Tyler CR, 1999, ENVIRON TOXICOL CHEM, V18, P337, DOI 10.1897/1551-5028(1999)018<0337:AIVTSF>2.3.CO;2; Gokce E, 2011, J AM SOC MASS SPECTR, V22, P2199, DOI 10.1007/s13361-011-0237-2; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Reading BJ, 2011, BIOL REPROD, V84, P392, DOI 10.1095/biolreprod.110.087981; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Hiramatsu N, 2006, MAR BIOL, V149, P35, DOI 10.1007/s00227-005-0214-z; JACKSON LF, 1995, T AM FISH SOC, V124, P563, DOI 10.1577/1548-8659(1995)124<0563:ROWPTA>2.3.CO;2; Reading BJ, 2009, MAR BIOTECHNOL, V11, P169, DOI 10.1007/s10126-008-9133-6; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Ying GG, 2002, ENVIRON INT, V28, P545, DOI 10.1016/S0160-4120(02)00075-2; Hecker M, 2011, ENVIRON SCI POLLUT R, V18, P503, DOI 10.1007/s11356-010-0396-x; CHEN LM, 1992, BIOCHIM BIOPHYS ACTA, V1131, P145, DOI 10.1016/0167-4781(92)90069-C; Babin PJ, 2008, GENE, V413, P76, DOI 10.1016/j.gene.2008.02.001; Chapman RW, 2011, MOL ECOL, V20, P1431, DOI 10.1111/j.1365-294X.2011.05018.x; Esteban S, 2014, SCI TOTAL ENVIRON, V466, P939, DOI 10.1016/j.scitotenv.2013.07.101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Lange IG, 2002, J STEROID BIOCHEM, V83, P219, DOI 10.1016/S0960-0760(02)00225-X; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; Kamman NC, 2005, ECOTOXICOLOGY, V14, P163, DOI 10.1007/s10646-004-6267-9; Manickum T, 2014, SCI TOTAL ENVIRON, V468, P584, DOI 10.1016/j.scitotenv.2013.08.041; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Ylonen A, 1999, EUR J BIOCHEM, V266, P1066, DOI 10.1046/j.1432-1327.1999.00950.x; BAKER HJ, 1978, J BIOL CHEM, V253, P4521; Chapman RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096818; Dennis Jr G., 2003, GENOME BIOL, V4; Gelbke HP, 2004, TOXICOLOGY, V205, P17, DOI 10.1016/j.tox.2004.06.034; Heppell SA, 1999, T AM FISH SOC, V128, P532, DOI 10.1577/1548-8659(1999)128<0532:ELIAEO>2.0.CO;2; Hong L, 2009, COMP BIOCHEM PHYS C, V149, P9, DOI 10.1016/j.cbpc.2008.05.017; Jo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099792; Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683; King W, 1995, FISH PHYSIOL BIOCHEM, V14, P489, DOI 10.1007/BF00004349; KISHIDA M, 1994, J EXP ZOOL, V268, P259, DOI 10.1002/jez.1402680402; Kuster M, 2004, TRAC-TREND ANAL CHEM, V23, P790, DOI 10.1016/j.trac.2004.08.007; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Michalski A., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M111.011015; Nikkilä Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; Reading BJ, 2013, J PROTEOME RES, V12, P1691, DOI 10.1021/pr3010293; Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Tata J. R., 1976, CELL; Ulbrich SE, 2009, BIOL REPROD, V81, P795, DOI 10.1095/biolreprod.108.075184; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; Wang RL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-358; Williams VN, 2014, FISH PHYSIOL BIOCHEM, V40, P395, DOI 10.1007/s10695-013-9852-0; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI DOI 10.1038/NMETH.1322; Witten IH, 2011, MOR KAUF D, P1; Wu X, 2007, J COMPUT BIOL, V14, P1025, DOI 10.1089/cmb.2007.0071; Ylonen A, 2002, EUR J BIOCHEM, V269, P2639, DOI 10.1046/j.1432-1033.2002.02927.x; Ylonen A, 2001, GLYCOBIOLOGY, V11, P523, DOI 10.1093/glycob/11.7.523; Zhou LW, 2008, GENOMICS, V91, P129, DOI 10.1016/j.ygeno.2007.10.007; Zhou LW, 2009, J GENET GENOMICS, V36, P109, DOI 10.1016/S1673-8527(08)60097-1	74	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	AUG	2015	15	15					2678	2690		10.1002/pmic.201400606		13	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CO3ML	WOS:000359061800015		
J	Itami, N; Shiratsuki, S; Shirasuna, K; Kuwayama, T; Iwata, H				Itami, N.; Shiratsuki, S.; Shirasuna, K.; Kuwayama, T.; Iwata, H.			Mitochondrial biogenesis and degradation are induced by CCCP treatment of porcine oocytes	REPRODUCTION			English	Article							DNA COPY NUMBER; MATURATION IN-VITRO; DEVELOPMENTAL COMPETENCE; CYTOPLASMIC MATURATION; BOVINE OOCYTES; MITOPHAGY; PARKIN; REPLICATION; RESVERATROL; ACTIVATION	In this study, we investigated the mitochondrial quality control system in porcine oocytes during meiotic maturation. Cumulus cell oocyte complexes (COCs) collected from gilt ovaries were treated with 10 mu M carbonyl cyanide-m-chlorophenylhydrazone (CCCP; a mitochondrial uncoupler) for 2 h. The CCCP treatment was found to significantly reduce ATP content, increase the amount of phosphorylated AMP-activated protein kinase and elevate reactive oxygen species levels in oocytes. When the CCCP-treated COCs were cultured further for 44 h in maturation medium, the ATP levels were restored and the parthenogenetic developmental rate of oocytes to the blastocyst stage was comparable with that of untreated COCs. To examine the effects of CCCP treatment of oocytes on the kinetics of mitochondrial DNA copy number (Mt number), COCs treated with 0 or 10 mu M CCCP were cultured for 44 h, after which the Mt number was determined by RT-PCR. CCCP treatment was found to increase the Mt number in the modified maturation medium in which mitochondrial degradation was inhibited by MG132, whereas CCCP treatment did not affect the Mt number in the maturation medium lacking MG132. The relative gene expression of TFAM was furthermore shown to be significantly higher in CCCP-treated oocytes than in untreated oocytes. Taken together, the finding presented here suggest that when the mitochondria are injured, mitochondrial biogenesis and degradation are induced, and that these processes may contribute to the recuperation of oocytes.	[Itami, N.; Shiratsuki, S.; Shirasuna, K.; Kuwayama, T.; Iwata, H.] Tokyo Univ Agr, Dept Anim Reprod, Atsugi, Kanagawa 2430034, Japan	Iwata, H (reprint author), Tokyo Univ Agr, Dept Anim Reprod, Funako 1737, Atsugi, Kanagawa 2430034, Japan.	h1iwata@nodai.ac.jp			Promotion and Mutual Aid Corporation for Private Schools of Japan; Ministry of Education, Culture, Sports, Science, and Technology [S0801025]; Japan Society for the Promotion of Science [25450400]	This study was supported by the Promotion and Mutual Aid Corporation for Private Schools of Japan and the Ministry of Education, Culture, Sports, Science, and Technology (Grants-in-Aid for Scientific Research: S0801025) and by a Grant-in-Aid for Scientific Research C (KAKENHI, grant number: 25450400) from the Japan Society for the Promotion of Science.	Iwata H, 2011, REPROD FERT DEVELOP, V23, P424, DOI 10.1071/RD10133; Chiaratti MR, 2010, BIOL REPROD, V82, P76, DOI 10.1095/biolreprod.109.077776; Cui MS, 2011, THERIOGENOLOGY, V75, P638, DOI 10.1016/j.theriogenology.2010.09.031; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI [10.1016/j.mito.2013.04.002, 10.1016/j.mito2013.04.002]; Ge HS, 2012, MOL REPROD DEV, V79, P392, DOI 10.1002/mrd.22042; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Ding WX, 2012, J BIOL CHEM, V287, P42379, DOI 10.1074/jbc.M112.413682; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Kwon KY, 2011, BIOCHEM BIOPH RES CO, V416, P343, DOI 10.1016/j.bbrc.2011.11.038; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Cotterill M, 2013, MOL HUM REPROD, V19, P444, DOI 10.1093/molehr/gat013; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; Cali T, 2013, BBA-MOL BASIS DIS, V1832, P495, DOI 10.1016/j.bbadis.2013.01.004; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Mao J, 2012, THERIOGENOLOGY, V78, P887, DOI 10.1016/j.theriogenology.2012.04.002; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Lee SK, 2014, J REPROD DEVELOP, V60, P128; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Chen YI, 2012, SYNAPSE, V66, P331, DOI 10.1002/syn.21516; Mahrous E, 2012, REPRODUCTION, V144, P177, DOI 10.1530/REP-12-0113; Pawlak P, 2014, J REPROD DEVELOP, V60, P28, DOI 10.1262/jrd.2013-092; Pawlak P, 2012, THERIOGENOLOGY, V78, P2020, DOI 10.1016/j.theriogenology.2012.07.023; Petters R M, 1993, J Reprod Fertil Suppl, V48, P61; Sato D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094488; Shourbagy SH El, 2006, REPRODUCTION, V131, P233, DOI DOI 10.1530/REP.1.00551); Smith LC, 2005, REPROD FERT DEVELOP, V17, P15, DOI 10.1071/RD04084; Takeo S, 2013, MOL REPROD DEV, V80, P508, DOI 10.1002/mrd.22187	33	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	AUG	2015	150	2					97	104		10.1530/REP-15-0037		8	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	CO1WR	WOS:000358947300006		
J	Inoue, T; Aoyama-Ishikawa, M; Kamoshida, S; Nishino, S; Sasano, M; Oka, N; Yamashita, H; Kai, M; Nakao, A; Kotani, J; Usami, M				Inoue, Taketo; Aoyama-Ishikawa, Michiko; Kamoshida, Shingo; Nishino, Satoshi; Sasano, Maki; Oka, Nobuki; Yamashita, Hayato; Kai, Motoki; Nakao, Atsunori; Kotani, Joji; Usami, Makoto			Endogenous interleukin 18 regulates testicular germ cell apoptosis during endotoxemia	REPRODUCTION			English	Article							NECROSIS-FACTOR-ALPHA; CYTOCHROME-C RELEASE; BCL-2 PROTEIN FAMILY; AUTOIMMUNE ORCHITIS; MALE-INFERTILITY; IN-VIVO; IL-18; INFLAMMATION; DEATH; RATS	Orchitis (testicular swelling) often occurs during systemic inflammatory conditions, such as sepsis. Interleukin 18 (IL18) is a proinflammatory cytokine and is an apoptotic mediator during endotoxemia, but the role of IL18 in response to inflammation in the testes was unclear. WT and IL18 knockout (KO) mice were injected lipopolysaccharide (LPS) to induce endotoxemia and examined 12 and 48 h after LPS administration to model the acute and recovery phases of endotoxemia. Caspase activation was assessed using immunohistochemistry. Protein and mRNA expression were examined by western blot and quantitative real-time RT-PCR respectively. During the acute phase of endotoxemia, apoptosis (as indicated by caspase-3 cleavage) was increased in WT mice but not in IL18 KO mice. The death receptor-mediated and mitochondrial-mediated apoptotic pathways were both activated in the WT mice but not in the KO mice. During the recovery phase of endotoxemia, apoptosis was observed in the IL18 KO mice but not in the WT mice. Activation of the death-receptor mediated apoptotic pathway could be seen in the IL18 KO mice but not the WT mice. These results suggested that endogenous IL18 induces germ cell apoptosis via death receptor mediated- and mitochondrial-mediated pathways during the acute phase of endotoxemia and suppresses germ cell apoptosis via death-receptor mediated pathways during recovery from endotoxemia. Taken together, IL18 could be a new therapeutic target to prevent orchitis during endotoxemia.	[Inoue, Taketo; Aoyama-Ishikawa, Michiko; Kamoshida, Shingo; Nishino, Satoshi; Sasano, Maki; Oka, Nobuki; Yamashita, Hayato; Kai, Motoki; Usami, Makoto] Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Suma Ku, Kobe, Hyogo 6540142, Japan; [Inoue, Taketo] Ono Ladies Clin, Ono, Hyogo 6751375, Japan; [Aoyama-Ishikawa, Michiko; Nakao, Atsunori; Kotani, Joji] Hyogo Coll Med, Dept Emergency Disaster & Crit Care Med, Nishinomiya, Hyogo 6638501, Japan	Usami, M (reprint author), Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	musa@kobe-u.ac.jp					Abu Elhija M, 2008, EUR CYTOKINE NETW, V19, P15, DOI 10.1684/ecn.2008.0116; Abu Elhija M, 2008, AM J REPROD IMMUNOL, V60, P361, DOI 10.1111/j.1600-0897.2008.00636.x; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; Theas S, 2003, AM J REPROD IMMUNOL, V50, P166, DOI 10.1034/j.1600-0897.2003.00074.x; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Rettew JA, 2009, ENDOCRINOLOGY, V150, P3877, DOI 10.1210/en.2009-0098; Pellati D, 2008, EUR J OBSTET GYN R B, V140, P3, DOI 10.1016/j.ejogrb.2008.03.009; Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x; Jarazo-Dietrich S, 2012, IMMUNOBIOLOGY, V217, P778, DOI 10.1016/j.imbio.2012.04.007; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Akhtar S, 2011, MOL MED, V17, P88, DOI 10.2119/molmed.2010.00080; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Xiong Q, 2009, TOXICON, V54, P1, DOI 10.1016/j.toxicon.2009.01.035; Theas MS, 2008, HUM REPROD, V23, P1865, DOI 10.1093/humrep/den240; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Bamias G, 2012, CYTOKINE, V59, P451, DOI 10.1016/j.cyto.2012.06.014; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Jacobo P, 2011, AUTOIMMUN REV, V10, P201, DOI 10.1016/j.autrev.2010.09.026; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Metukuri MR, 2010, INFLAMMATION, V33, P235, DOI 10.1007/s10753-009-9177-4; Weidner W, 2013, WORLD J UROL, V31, P717, DOI 10.1007/s00345-013-1082-7; Aoyama M, 2009, SHOCK, V32, P401, DOI 10.1097/SHK.0b013e31819c358a; Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Chan SHH, 2005, FREE RADICAL BIO MED, V39, P603, DOI 10.1016/j.freeradbiomed.2005.04.012; Demir A, 2007, INT J UROL, V14, P268, DOI 10.1111/j.1442-2042.2007.01682.x; Kajihara T, 2006, MED MOL MORPHOL, V39, P203, DOI 10.1007/s00795-006-0334-7; Komsky A, 2011, ANDROLOGIA, V44, P1; Marino E, 2003, CYTOKINE, V22, P142, DOI 10.1016/S1043-4666(03)00150-9; Otsuki Yoshinori, 2004, Medical Electron Microscopy, V37, P163; Ranjan P, 2004, J CELL SCI, V117, P3031, DOI 10.1242/jcs.01121; Reinhart Konrad, 2013, Rev Bras Ter Intensiva, V25, P3, DOI 10.1590/S0103-507X2013000100002; Russell L.D., 1990, HISTOLOGICAL HISTOPA; Shintani M, 2011, BIOMED RES-TOKYO, V32, P379; Silva E, 2012, MINERVA ANESTESIOL, V78, P1215; Strand ML, 2005, MOL CELL ENDOCRINOL, V240, P64, DOI 10.1016/j.mce.2005.05.011; Suescun MO, 2003, BIOL REPROD, V68, P2114, DOI 10.1095/biolreprod.102.011189; Ueno N, 2005, SHOCK, V24, P564, DOI 10.1097/01.shk.0000184285.57375.bc; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010	43	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	AUG	2015	150	2					105	114		10.1530/REP-14-0427		10	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	CO1WR	WOS:000358947300007		
J	Usui, T; Kakamu, K; Chikasada, M				Usui, Takehiro; Kakamu, Kazuhiko; Chikasada, Mitsuko			To introduce recycling or not: A panel data analysis in Japan	RESOURCES CONSERVATION AND RECYCLING			English	Article						Cost minimization of waste management; Prolonging a life span of landfill; Utilizing energy in incineration facility; Municipal decision on recycling; Bayesian panel spatial autoregressive; probit model	MUNICIPAL SOLID-WASTE; ENERGY RECOVERY; GARBAGE; MODELS	Why do municipalities choose recyclables collection although it is more expensive than garbage collection? This study analyzes the determinants of a municipality's decision-making on the collection and separation of recyclables. For this analysis, we use municipal-level panel data on whether municipalities in Japan recycle glass bottles, plastic containers, and paper containers. Applying a Bayesian panel spatial autoregressive probit model, we find that municipalities with refuse-derived fuel (RDF) facilities are less likely to collect and separate plastic containers for the purpose of recycling. Instead, they use plastic containers for generating energy. Furthermore, we find that municipalities holding a self-owning landfill site are more likely to introduce recyclables collection in order to save landfill capacity. We further find that inter-municipal cooperation involving spatial interaction with neighboring municipalities influences the decision-making and collaborative action of municipalities to implement recyclables collection and reduce costs, and that such collaborative action strengthens every year. (C) 2015 Elsevier B.V. All rights reserved.	[Usui, Takehiro; Chikasada, Mitsuko] Soka Univ, Fac Econ, Hachioji, Tokyo 1928577, Japan; [Kakamu, Kazuhiko] Kobe Univ, Grad Sch Business Adm, Kobe, Hyogo, Japan	Usui, T (reprint author), Soka Univ, Fac Econ, 1-236 Tangi Cho, Hachioji, Tokyo 1928577, Japan.	usui@soka.ac.jp			Asahi Glass Foundation; JSPS KAKENHI [25245035, 26380331]	This study was partially supported by the Asahi Glass Foundation and by JSPS KAKENHI Grant Numbers 25245035 and 26380331. Any errors in this paper are the author's responsibility.	Daskalopoulos E, 1998, RESOUR CONSERV RECY, V24, P155, DOI 10.1016/S0921-3449(98)00032-9; Chib S, 1998, BIOMETRIKA, V85, P347, DOI 10.1093/biomet/85.2.347; Allers MA, 2010, ENVIRON RESOUR ECON, V45, P405, DOI 10.1007/s10640-009-9320-6; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Kinnaman TC, 2000, J URBAN ECON, V48, P419, DOI 10.1006/juec.2000.2174; Holloway G, 2002, AGR ECON, V27, P383, DOI 10.1016/S0169-5150(02)00070-1; Consonni S, 2005, WASTE MANAGE, V25, P123, DOI 10.1016/j.wasman.2004.09.007; Callan SJ, 2001, LAND ECON, V77, P548, DOI 10.2307/3146940; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; Anselin L, 1988, LOCAL GOV STUD, V39, P435; Bivand R, 2000, REG SCI URBAN ECON, V30, P203, DOI 10.1016/S0166-0462(99)00038-1; Carroll W., 1995, E ECON J, V21, P215; Central Environment Council, 2005, 30 M COMM WAST MAN R; Dijkgraaf E., 2003, EMPIR ECON, V28, P553, DOI 10.1007/s001810200145; Kakamu K., 2010, HDB REGIONAL EC, P555; Kakamu K, 2008, SPAT ECON ANAL, V3, P305, DOI 10.1080/17421770802353725; KEELER AG, 1994, J ENVIRON ECON MANAG, V27, P205, DOI 10.1006/jeem.1994.1034; Kinnaman TC, 2005, TOPICS EC ANAL POLIC, V5, P1; LeSage J, 2009, STAT TEXTB MONOGR, P1; LeSage JP, 2012, PUBLIC CHOICE, V150, P525, DOI 10.1007/s11127-010-9714-6; Ministry of Economy Trade and Industry, 2003, CONT PACK REC LAW MA; Ministry of Economy Trade and Industry, 2005, YOUK HOUS RIS HOU NO; Ministry of the Environment, 1999, HAIK SYOR JIG JITT C; Ministry of the Environment, 2001, RES COLL REC PROD CO; OECD, 2001, EXT PROD RESP GUID M; OECD, 2008, OECD ENV DAT COMPEND; Porter R., 2002, EC WASTE; Stevens B., 1994, RESOUR RECYCL    NOV; STEVENS BJ, 1978, REV ECON STAT, V60, P438, DOI 10.2307/1924169; Suwa T., 2007, ENV EC POLICY STUDIE, V8, P239; Tierney L., 1994, ANN STAT, V22, P1635	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-3449	1879-0658		RESOUR CONSERV RECY	Resour. Conserv. Recycl.	AUG	2015	101						84	95		10.1016/j.resconrec.2015.05.006		12	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CO2EY	WOS:000358970100009		
J	Tomimatsu, Y; Hibino, R; Ohta, H				Tomimatsu, Yoshiro; Hibino, Ryosuke; Ohta, Hiroyuki			Brown Norway rats, a putative schizophrenia model, show increased electroencephalographic activity at rest and decreased event-related potential amplitude, power, and coherence in the auditory sensory gating paradigm	SCHIZOPHRENIA RESEARCH			English	Article						Schizophrenia; Brown Norway rat; Electroencephalographic oscillation; Event-related potential; Sensory gating; Time-frequency analysis	TO-NOISE RATIO; PREPULSE INHIBITION; WORKING-MEMORY; GAMMA SYNCHRONY; PHASE-LOCKING; OSCILLATIONS; EEG; HALLUCINATIONS; VARIABILITY; SUPPRESSION	In recent schizophrenia clinical research, electroencephalographic (EEG) oscillatory activities induced by a sensory stimulus or behavioral tasks have gained considerable interest as functional and pathophysiological biomarkers, The Brown Norway (EN) rat is a putative schizophrenia model that shows naturally low sensorimotor gating and deficits in cognitive performance, although other phenotypes have not been studied. The present study aimed to investigate the neurophysiological features of BN rats, particularly EEG/event-related potential (ERP). EEG activity was recorded at rest and during the auditory sensory gating paradigm under an awake, freely moving condition. Frequency and ERP analysis were performed along with time-frequency analysis of evoked power and intertrial coherence. Compared with Wistar-Kyoto rats, a well-documented control line, EN rats showed increased EEG power at rest, particularly in the theta and gamma ranges. In ERP analysis, BN rats showed reduced N40-P20 amplitude but normal sensory gating. The rats also showed reduced evoked power and intertrial coherence against auditory stimuli. These results suggest that EN rats show features of EEG/ERP measures clinically relevant to schizophrenia and may provide additional opportunities for translational research. (C) 2015 Elsevier B.V. All rights reserved.	[Tomimatsu, Yoshiro; Hibino, Ryosuke; Ohta, Hiroyuki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Tomimatsu, Y (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	yoshirou.tomimatsu@takeda.com; ryosuke.hibino@takeda.com; hiroyuki.ota@takeda.com			Takeda Pharmaceutical Company Limited	This study was completely funded by Takeda Pharmaceutical Company Limited.	van der Stelt O, 2007, SCHIZOPHRENIA BULL, V33, P955, DOI 10.1093/schbul/sbm016; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Lakatos P, 2013, J NEUROSCI, V33, P11692, DOI 10.1523/JNEUROSCI.0010-13.2013; Siegel S, 2003, NEUROPSYCHOPHARMACOL, V28, P675, DOI 10.1038/sj.npp.1300087; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.0042; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Freedman R, 2003, NEW ENGL J MED, V349, P1738; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189; Schmiedt C, 2005, COGNITIVE BRAIN RES, V25, P936, DOI 10.1016/j.cogbrainres.2005.09.015; Saunders JA, 2012, BEHAV BRAIN RES, V234, P233, DOI 10.1016/j.bbr.2012.06.032; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Swerdlow NR, 2006, NEUROPSYCHOPHARMACOL, V31, P2011, DOI 10.1038/sj.npp.1301043; ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Winterer G, 2000, CLIN NEUROPHYSIOL, V111, P837, DOI 10.1016/S1388-2457(99)00322-3; Baldeweg T, 1998, LANCET, V352, P620, DOI 10.1016/S0140-6736(05)79575-1; Conti LH, 2001, BEHAV GENET, V31, P325, DOI 10.1023/A:1012287527438; Featherstone RE, 2013, PSYCHOPHARMACOLOGY, V227, P639, DOI 10.1007/s00213-013-2997-9; Feifel D, 2011, BEHAV NEUROSCI, V125, P268, DOI 10.1037/a0022691; Foxe JJ, 2011, EUR ARCH PSY CLIN N, V261, P331, DOI 10.1007/s00406-010-0176-0; Gandal MJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.69; Hall MH, 2011, SCHIZOPHRENIA BULL, V37, P778, DOI 10.1093/schbul/sbp134; Hanslmayr S, 2013, HUM BRAIN MAPP, V34, P2266, DOI 10.1002/hbm.22064; Hasey GM, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0388-x; Hu LL, 2012, CLIN EEG NEUROSCI, V43, P23, DOI 10.1177/1550059411429524; International Schizophrenia Consortium, 2008, NATURE, V455, P237, DOI DOI 10.1038/NATURE07239; Korostenskaja M, 2009, CURR PHARM DESIGN, V15, P2573; Lee SH, 2008, PSYCHIAT INVEST, V5, P115, DOI 10.4306/pi.2008.5.2.115; Maxwell CR, 2004, NEUROPSYCHOPHARMACOL, V29, P739, DOI 10.1038/sj.npp.1300376; Milne E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00051; Palmer AA, 2000, BEHAV NEUROSCI, V114, P374, DOI 10.1037/0735-7044.114.2.374; Palmer AA, 2003, PSYCHOPHARMACOLOGY, V165, P270, DOI 10.1007/s00213-002-1258-0; Phillips JM, 2007, NEUROSCIENCE, V144, P1314, DOI 10.1016/j.neuroscience.2006.11.003; Purcell SM, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; Shin YW, 2010, SCHIZOPHR RES, V124, P110, DOI 10.1016/j.schres.2010.08.008; Smith DM, 2013, CLIN NEUROPHYSIOL, V124, P1329, DOI 10.1016/j.clinph.2013.02.004; Swerdlow NR, 2006, NEUROPSYCHOPHARMACOL, V31, P506, DOI 10.1038/sj.npp.1300841; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	AUG	2015	166	1-3					171	177		10.1016/j.schres.2015.05.002		7	Psychiatry	Psychiatry	CO5AO	WOS:000359172200028		
J	Harvey, PD; Siu, CO; Ogasa, M; Loebel, A				Harvey, Philip D.; Siu, Cynthia O.; Ogasa, Masaaki; Loebel, Antony			Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study	SCHIZOPHRENIA RESEARCH			English	Article						Neurocognition; Antipsychotics; Lurasidone; Quetiapine	REVERSES MK-801-INDUCED IMPAIRMENT; PERFORMANCE; TRIAL; ZIPRASIDONE; MEMORY; DRUGS	We previously reported that treatment with 160 mg/d of lurasidone improved cognitive performance in a manner superior to placebo, quetiapine XR 600 mg/d, and lurasidone 80 mg/d, based on a 6-week randomized trial of patients with an acute exacerbation of schizophrenia. The objective of this post-hoc analysis was to explore the cognitive and functional performance of patients whose final doses of lurasidone were 40/80 mg/d, 120 mg/d, and 160 mg/d compared to quetiapine XR 200-800 mg/d (QXR) during a 6-month, double-blind continuation study that followed a short-term trial. Subjects who received final doses of lurasidone 120 mg/d (n = 77) and 160 mg/d (n = 49) showed significantly greater improvement in overall cognitive performance compared to QXR (n = 85) at week 32 (month 6 of the extension study), while those on last doses of 40/80 mg/d (n = 25) showed a trend towards significance at week 32. Mean changes in neurocognitive composite z-score from pretreatment baseline were significant for the 3 lurasidone final dose groups at both weeks 19 and 32, with composite change scores of z = 1.53, z = 1.43, and z = 134 for the lurasidone 40/80 mg/d, 120 mg/d, and 160 mg/d, respectively, at week 32. In contrast, the composite change score was not statistically significant in the overall quetiapine group (z = 0.46), with none of the individual quetiapine doses showing any significant improvement. Functional capacity scores improved in all treatment groups. Our findings indicate improved cognitive performance in patients treated with each of the flexible doses of lurasidone 40-160 mg/d, compared to quetiapine XR 200-800 mg/d. All doses of lurasidone were superior to all doses of quetiapine for cognitive performance. (C) 2015 The Authors. Published by Elsevier B.V.	[Harvey, Philip D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Siu, Cynthia O.] COS & Associates Ltd, Hong Kong, Hong Kong, Peoples R China; [Ogasa, Masaaki] Sumitomo Dainippon Pharma Co Ltd, Chuo Ku, Tokyo, Japan; [Loebel, Antony] Sunovion Pharmaceut Inc, Ft Lee, NJ USA	Harvey, PD (reprint author), Univ Miami, Miller Sch Med, Psychiat & Behav Sci, 1120 NW 14th St,Suite 1450, Miami, FL 33136 USA.				Sunovion Pharmaceuticals Inc	This study was sponsored by Sunovion Pharmaceuticals Inc. The sponsor was involved in the study design and collection of data.	Allison DB, 2009, PSYCHIAT RES, V170, P172, DOI 10.1016/j.psychres.2008.10.007; Nuechterlein KH, 2012, DEV PSYCHOPATHOL, V24, P529, DOI 10.1017/S0954579412000132; Loebel A, 2013, SCHIZOPHR RES, V147, P95, DOI 10.1016/j.schres.2013.03.013; Harvey PD, 2004, PSYCHOPHARMACOLOGY, V172, P324, DOI 10.1007/s00213-003-1652-2; Harvey PD, 2013, EUR NEUROPSYCHOPHARM, V23, P1373, DOI 10.1016/j.euroneuro.2013.08.003; Leifker FR, 2011, SCHIZOPHRENIA BULL, V37, P334, DOI 10.1093/schbul/sbp044; Ishiyama T, 2007, EUR J PHARMACOL, V572, P160, DOI 10.1016/j.ejphar.2007.06.058; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Horisawa T, 2011, BEHAV BRAIN RES, V220, P83, DOI 10.1016/j.bbr.2011.01.034; Bowie CR, 2006, AM J PSYCHIAT, V163, P418, DOI 10.1176/appi.ajp.163.3.418; Loebel A, 2013, SCHIZOPHR RES, V145, P101, DOI 10.1016/j.schres.2013.01.009; Davis JM, 2004, J CLIN PSYCHOPHARM, V24, P192, DOI 10.1097/01.jcp.0000117422.05703.ae; Buchanan RW, 2005, SCHIZOPHRENIA BULL, V31, P5, DOI 10.1093/schbul/sbi020; Harvey PD, 2001, AM J PSYCHIAT, V158, P176, DOI 10.1176/appi.ajp.158.2.176; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Enomoto T, 2008, BEHAV BRAIN RES, V186, P197, DOI 10.1016/j.bbr.2007.08.012; Baldwin CM, 2009, CNS DRUGS, V23, P261, DOI 10.2165/00023210-200923030-00007; Fitzmaurice G, 2004, APPL LONGITUDINAL AN; Harvey PD, 2011, SCHIZOPHR RES, V127, P188, DOI 10.1016/j.schres.2011.01.004; Keefe RSE, 2013, SCHIZOPHRENIA BULL, V39, P417, DOI 10.1093/schbul/sbr153; Loebel A., 2013, CNS SPECTRUMS, V19, P197; Potkin SG, 2009, INT J NEUROPSYCHOPH, V12, P1233, DOI 10.1017/S1461145709000352; Stahl S.M., 2010, J CLIN PSYCHOPHARM, V12, P319; WITEK TJ, 1995, ANN ALLERG ASTHMA IM, V74, P419	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	AUG	2015	166	1-3					334	338		10.1016/j.schres.2015.06.008		5	Psychiatry	Psychiatry	CO5AO	WOS:000359172200053		
J	Sogabe, M				Sogabe, Masashi			Renovation and Sharing in Tokyo - A New Chance for Contentment	SPACE			English	Article									Kanagawa Univ, Yokohama, Kanagawa, Japan	Sogabe, M (reprint author), Kanagawa Univ, Yokohama, Kanagawa, Japan.							0	0	0	SPACE MAGAZINE	SEOUL	52-20 YEONHUI-RO, SEODAEMUN-GU, SEOUL, 120-830, SOUTH KOREA	1228-2472			SPACE	Space	AUG	2015		573					84	87				4	Architecture	Architecture	CO2GQ	WOS:000358974600027		
J	Changhyun, P; Naka, T				Changhyun, Park; Naka, Toshiharu			Change in Dwelling and the Role of the Architect	SPACE			English	Editorial Material									[Naka, Toshiharu] Yamamoto & Field Shop Co Ltd, Yokohama, Kanagawa, Japan; [Naka, Toshiharu] Yokohama Grad Sch Architecture, Yokohama, Kanagawa, Japan								0	0	0	SPACE MAGAZINE	SEOUL	52-20 YEONHUI-RO, SEODAEMUN-GU, SEOUL, 120-830, SOUTH KOREA	1228-2472			SPACE	Space	AUG	2015		573					88	91				4	Architecture	Architecture	CO2GQ	WOS:000358974600028		
J	Zheng, Q; Shimizu, T; Yang, M				Zheng, Qiu; Shimizu, Tetsuhide; Yang, Ming			Numerical Analysis of Temperature Distribution and Its Optimization for Thin Foils in Micro Deep Drawing Assisted by Resistance Heating	STEEL RESEARCH INTERNATIONAL			English	Article						Micro deep drawing; Numerical analysis; Optimization; Resistance heating; Temperature distribution	STRENGTH STEEL PARTS; CONSTITUTIVE MODEL; FORMABILITY	Application of resistance heating to micro metal forming process can achieve not only the improvement of the material formability, but also the less consumption of energy. In this study, finite element (FE) models for the numerical analysis of micro deep drawing process assisted by resistance heating are developed. Coupled thermal-electrical procedure and coupled thermal-displacement dynamic explicit procedure are conducted for the analysis of temperature distribution and material deformation, respectively. The results show that the temperature distribution of the blank is influenced not only by the difference in electrical current density, but also by the heat transfer from the material to the tools. The results of temperature distribution obtained from the simulation show the same tendency with the experiments, which confirms the feasibility of the developed FE models. In addition, to obtain uniform temperature distribution of the blank, the process parameters are optimized. It is demonstrated that the material formability can be improved by obtaining more uniform temperature distribution of the blank.	[Zheng, Qiu; Shimizu, Tetsuhide; Yang, Ming] Tokyo Metropolitan Univ, Grad Sch Syst Design, Hino, Tokyo 1910065, Japan	Zheng, Q (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	qiu-zheng@ed.tmu.ac.jp		Shimizu, Tetsuhide/0000-0002-7810-3777			Gau JT, 2007, J MATER PROCESS TECH, V184, P42, DOI 10.1016/j.jmatprotec.2006.11.003; Zheng Q, 2014, MATER DESIGN, V63, P389, DOI 10.1016/j.matdes.2014.06.039; Karbasian H, 2010, J MATER PROCESS TECH, V210, P2103, DOI 10.1016/j.jmatprotec.2010.07.019; Arentoft M, 2008, INT J MATER FORM, V1, P435, DOI 10.1007/s1228-008-0088-y; Egerer E, 2004, J MANUF PROCESS, V6, P1, DOI 10.1016/S1526-6125(04)70054-7; Huang B. Y., 2006, CHINA MAT ENG CANON, V4, P513; Lee EH, 2014, J MATER PROCESS TECH, V214, P784, DOI 10.1016/j.jmatprotec.2013.11.023; Liu JG, 2012, COMP MATER SCI, V55, P85, DOI 10.1016/j.commatsci.2011.11.018; Maeno T, 2014, CIRP ANN-MANUF TECHN, V63, P301, DOI 10.1016/j.cirp.2014.03.005; Mori K, 2013, J MATER PROCESS TECH, V213, P508, DOI 10.1016/j.jmatprotec.2012.10.005; Mori K, 2012, T NONFERR METAL SOC, V22, pS496, DOI [10.1016/S1003-6326(12)61752-x, 10.1016/S1003-6326(12)61752-X]; Mori K, 2010, CIRP ANN-MANUF TECHN, V59, P291, DOI 10.1016/j.cirp.2010.03.107; Tanabe H., 2011, STEEL RES INT, P1020; Vollertsen F., 2009, MANUF TECHNOL, V58, P566; Yang M, 2015, MATER MANUF PROCESS, V30, P1229, DOI 10.1080/10426914.2013.811740	15	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1611-3683	1869-344X		STEEL RES INT	Steel Res. Int.	AUG	2015	86	8			SI		869	876		10.1002/srin.201400574		8	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CO3NC	WOS:000359063700004		
J	Hata, K; Kazama, S; Nozawa, H; Kawai, K; Kiyomatsu, T; Tanaka, J; Tanaka, T; Nishikawa, T; Yamaguchi, H; Ishihara, S; Sunami, E; Kitayama, J; Watanabe, T				Hata, Keisuke; Kazama, Shinsuke; Nozawa, Hiroaki; Kawai, Kazushige; Kiyomatsu, Tomomichi; Tanaka, Junichiro; Tanaka, Toshiaki; Nishikawa, Takeshi; Yamaguchi, Hironori; Ishihara, Soichiro; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki			Laparoscopic surgery for ulcerative colitis: a review of the literature	SURGERY TODAY			English	Review						Laparoscopic surgery; Ulcerative colitis; Ileal-pouch anal anastomosis; Inflammatory bowel disease; Hand-assisted laparoscopic surgery; Single incision laparoscopic surgery; Robotic surgery	POUCH-ANAL ANASTOMOSIS; INFLAMMATORY-BOWEL-DISEASE; TOTAL ABDOMINAL COLECTOMY; RESTORATIVE PROCTOCOLECTOMY; SUBTOTAL COLECTOMY; BODY-IMAGE; TRIAL; METAANALYSIS; ILEOSTOMY; INCISION	Despite the development of new therapies, including anti-TNF alpha antibodies and immunosuppressants, a substantial proportion of patients with ulcerative colitis (UC) still require surgery. Restorative proctocolectomy with ileal-pouch anal anastomosis is the standard surgical treatment of choice for UC. With the advent of laparoscopic techniques for colorectal surgery, ileal-pouch anal anastomosis has also been performed laparoscopically. This paper reviews the history and current trends in laparoscopic surgery for UC. The accumulation of experience and improvement of laparoscopic devices have shifted the paradigm of UC surgery towards laparoscopic surgery over the past decade. Although laparoscopic surgery requires a longer operation, it provides significantly better short and long-term outcomes. The short-term benefits of laparoscopic surgery over open surgery include shorter hospital stays and fasting times, as well as better cosmesis. The long-term benefits of laparoscopy include better fecundity in young females. Some surgeons favor laparoscopic surgery even for severe acute colitis. More efforts are being made to develop newer laparoscopic methods, such as reduced port surgery, including single incision laparoscopic surgery and robotic surgery.	[Hata, Keisuke; Kazama, Shinsuke; Nozawa, Hiroaki; Kawai, Kazushige; Kiyomatsu, Tomomichi; Tanaka, Junichiro; Tanaka, Toshiaki; Nishikawa, Takeshi; Yamaguchi, Hironori; Ishihara, Soichiro; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan	Watanabe, T (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	khata-tky@umin.ac.jp; toshwatanabe@yahoo.co.jp					Ahmed Ali U, 2009, COCHRANE DB SYST REV, V1; Schiessling S, 2013, LANGENBECK ARCH SURG, V398, P807, DOI 10.1007/s00423-013-1088-z; FAZIO VW, 1995, ANN SURG, V222, P120, DOI 10.1097/00000658-199508000-00003; Larson DW, 2006, ANN SURG, V243, P667, DOI 10.1097/01.sla.0000216762.83407.d2; Bartels SAL, 2013, BRIT J SURG, V100, P726, DOI 10.1002/bjs.9061; Dunker MS, 2001, DIS COLON RECTUM, V44, P1800, DOI 10.1007/BF02234458; Polle SW, 2007, SURG ENDOSC, V21, P1301, DOI 10.1007/s00464-007-9294-9; TRUELOVE SC, 1955, BRIT MED J, V2, P1041; Dunker MS, 2000, SURG ENDOSC-ULTRAS, V14, P911, DOI 10.1007/s004640000262; Roslani AC, 2009, COLORECTAL DIS, V11, P496, DOI 10.1111/j.1463-1318.2008.01647.x; THIBAULT C, 1995, SURG LAPAROSC ENDOSC, V5, P472; Bartels SAL, 2012, ANN SURG, V256, P1045, DOI 10.1097/SLA.0b013e318250caa9; Targownik LE, 2012, AM J GASTROENTEROL, V107, P1228, DOI 10.1038/ajg.2012.127; Rajaratnam SG, 2011, INT J COLORECTAL DIS, V26, P1365, DOI 10.1007/s00384-011-1274-9; Fung AKY, 2013, DIS COLON RECTUM, V56, P786, DOI 10.1097/DCR.0b013e318285b810; Tan JJY, 2006, COLORECTAL DIS, V8, P626, DOI 10.1111/j.1463-1318.2006.00971.x; Nakajima K, 2004, SURG ENDOSC, V18, P582, DOI 10.1007/s00464-003-8135-8; Gash KJ, 2011, SURG ENDOSC, V25, P3877, DOI 10.1007/s00464-011-1814-y; Waljee A, 2006, GUT, V55, P1575, DOI 10.1136/gut.2005.090316; PARKS AG, 1978, BRIT MED J, V2, P85; Filippi J, 2011, CURR DRUG TARGETS, V12, P1440; Wu XJ, 2010, INT J COLORECTAL DIS, V25, P949, DOI 10.1007/s00384-010-0898-5; Telem DA, 2010, SURG ENDOSC, V24, P1616, DOI 10.1007/s00464-009-0819-2; Antolovic Dalibor, 2006, BMC Surg, V6, P13, DOI 10.1186/1471-2482-6-13; Araki Yasumi, 2001, Kurume Medical Journal, V48, P99; Boushey RP, 2007, DIS COLON RECTUM, V50, P1512, DOI 10.1007/s10350-007-0304-8; Brown SR, 2001, DIS COLON RECTUM, V44, P397, DOI 10.1007/BF02234739; Chung TP, 2009, DIS COLON RECTUM, V52, P4, DOI 10.1007/DCR.0b013e3181975701; Geisler DP, 2011, SURG ENDOSC, V25, P2175, DOI 10.1007/s00464-010-1518-8; Gu JY, 2014, SURG ENDOSC, V28, P617, DOI 10.1007/s00464-013-3218-7; Ikeuchi H, 2014, SURG TODAY, V44, P39, DOI 10.1007/s00595-013-0563-z; Jacobs M, 1991, Surg Laparosc Endosc, V1, P144; Larson DW, 2006, ANN SURG, V243, P670; Maartense S, 2004, ANN SURG, V240, P984; Maartense S, 2004, ANN SURG, P91, DOI DOI 10.1097/01.SLA.0000145923.03130.1C; Marcello PW, 2001, DIS COLON RECTUM, V44, P1441, DOI 10.1007/BF02234595; Marohn Hanly EJ, 2005, J GASTROINTEST SURG, V9, P881; McLemore EC, 2012, INT J MED ROBOT COMP, V8, P178, DOI 10.1002/rcs.445; Ouaissi M, 2008, SURG LAPARO ENDO PER, V18, P357, DOI 10.1097/SLE.0b013e3181772d75; Paranjape C, 2012, JSLS-J SOC LAPAROEND, V16, P27, DOI 10.4293/108680812X13291597715826; Peters W R, 1992, J Laparoendosc Surg, V2, P175, DOI 10.1089/lps.1992.2.175; Sahakitrungruang C, 2008, DIS COLON RECTUM, V51, P1137, DOI 10.1007/s10350-008-9253-0; Sardinha TC, 1998, WORLD J SURG, V22, P370; SCHMITT SL, 1994, INT J COLORECTAL DIS, V9, P134, DOI 10.1007/BF00290189; Sonoda Toyooki, 2003, Semin Laparosc Surg, V10, P169, DOI 10.1177/107155170301000403; Stocchi Luca, 2010, Clin Colon Rectal Surg, V23, P248, DOI 10.1055/s-0030-1268251; Uchida K, 2013, SURG TODAY, V43, P1219, DOI 10.1007/s00595-012-0434-z; Watanabe K, 2009, DIS COLON RECTUM, V52, P640, DOI 10.1007/DCR.0b013e31819d47b5; Watanabe T, 2006, MINIM INVASIV THER, V15, P253, DOI 10.1080/13645700600771785; Wexner SD, 2005, SURG CLIN N AM, V85, P35, DOI 10.1016/j.suc.2004.09.009; WEXNER SD, 1992, DIS COLON RECTUM, V35, P651, DOI 10.1007/BF02053755; WILLIAMS NS, 1989, BRIT J SURG, V76, P1109, DOI 10.1002/bjs.1800761103	52	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					933	938		10.1007/s00595-014-1053-7		6	Surgery	Surgery	CO1VP	WOS:000358944300001		
J	Okoshi, K; Kobayashi, K; Kinoshita, K; Tomizawa, Y; Hasegawa, S; Sakai, Y				Okoshi, Kae; Kobayashi, Katsutoshi; Kinoshita, Koichi; Tomizawa, Yasuko; Hasegawa, Suguru; Sakai, Yoshiharu			Health risks associated with exposure to surgical smoke for surgeons and operation room personnel	SURGERY TODAY			English	Review						Surgical smoke; Occupational health; Surgeon; Health problems; Operation room personnel	CARBON-DIOXIDE LASER; ULTRASONICALLY ACTIVATED SCALPEL; HIGH-FREQUENCY ELECTROSURGERY; HUMAN PAPILLOMAVIRUS DNA; ELECTROCAUTERY SMOKE; LAPAROSCOPIC SURGERY; CHEMICAL-COMPOSITION; CANCER-RISK; PLUME; MUTAGENICITY	Although surgical smoke contains potentially hazardous substances, such as cellular material, blood fragments, microorganisms, toxic gases and vapors, many operating rooms (ORs) do not provide protection from exposure to it. This article reviews the hazards of surgical smoke and the means of protecting OR personnel. Our objectives are to promote surgeons' acceptance to adopt measures to minimize the hazards. Depending on its components, surgical smoke can increase the risk of acute and chronic pulmonary conditions, cause acute headaches; irritation and soreness of the eyes, nose and throat; dermatitis and colic. Transmission of infectious disease may occur if bacterial or viral fragments present in the smoke are inhaled. The presence of carcinogens in surgical smoke and their mutagenic effects are also of concern. This review summarizes previously published reports and data regarding the toxic components of surgical smoke, the possible adverse effects on the health of operating room personnel and measures that can be used to minimize exposure to prevent respiratory problems. To reduce the hazards, surgical smoke should be removed by an evacuation system. Surgeons should assess the potential dangers of surgical smoke and encourage the use of evacuation devices to minimize potential health hazards to both themselves and other OR personnel.	[Okoshi, Kae; Kobayashi, Katsutoshi; Kinoshita, Koichi] Japan Baptist Hosp, Dept Surg, Sakyo Ku, Kyoto 6068273, Japan; [Tomizawa, Yasuko] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan; [Hasegawa, Suguru; Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan	Okoshi, K (reprint author), Japan Baptist Hosp, Dept Surg, Sakyo Ku, 47 Yamonomoto Cho, Kyoto 6068273, Japan.	kae_md@kuhp.kyoto-u.ac.jp					Agency for Toxic Substances and Disease Registry, TOX PROF TOL; Al Sahaf OS, 2007, IRISH J MED SCI, V176, P229, DOI 10.1007/s11845-007-0068-0; AMARAL JF, 1994, SURG LAPAROSC ENDOSC, V4, P92; American College of Chest Physicians, 1991, CHEST, V100, P1106; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; Fletcher JN, 1999, AM J SURG, V178, P57, DOI 10.1016/S0002-9610(99)00109-9; TOMITA Y, 1981, MUTAT RES, V89, P145; [Anonymous], 2014, EH40 2005 WORKPL CE; FERENCZY A, 1990, OBSTET GYNECOL, V75, P114; NEZHAT C, 1987, LASER SURG MED, V7, P376, DOI 10.1002/lsm.1900070414; Weld KJ, 2007, J ENDOUROL, V21, P347, DOI 10.1089/end.2006.9994; Ott DE, 1998, J AM ASSOC GYN LAP, V5, P29, DOI 10.1016/S1074-3804(98)80007-8; Capizzi PJ, 1998, LASER SURG MED, V23, P172, DOI 10.1002/(SICI)1096-9101(1998)23:3<172::AID-LSM7>3.0.CO;2-M; Alp E, 2006, J HOSP INFECT, V62, P1, DOI 10.1016/j.jhin.2005.01.014; Hensman C, 1998, SURG ENDOSC-ULTRAS, V12, P1017, DOI 10.1007/s004649900771; [Anonymous], LAS EL PLUM; SAWCHUK WS, 1989, J AM ACAD DERMATOL, V21, P41, DOI 10.1016/S0190-9622(89)70146-8; GATTI JE, 1992, PLAST RECONSTR SURG, V89, P781, DOI 10.1097/00006534-199205000-00001; [Anonymous], CHEM SAMPL INF; Fitzgerald JEF, 2012, SURG ENDOSC, V26, P337, DOI 10.1007/s00464-011-1872-1; [Anonymous], DIATH SURG SMOK; [Anonymous], AG CLASS IARC MON, V1-109; GARDEN JM, 1988, JAMA-J AM MED ASSOC, V259, P1199, DOI 10.1001/jama.259.8.1199; Armstrong DN, 2001, DIS COLON RECTUM, V44, P558, DOI 10.1007/BF02234329; [Anonymous], SURG SMOK; Fan JKM, 2009, ASIAN J SURG, V32, P253, DOI 10.1016/S1015-9584(09)60403-6; Choi SH, 2014, SURG ENDOSC, V28, P2374, DOI 10.1007/s00464-014-3472-3; Barrett WL, 2003, SURG ENDOSC, V17, P979, DOI 10.1007/s00464-002-8584-5; BAGGISH MS, 1987, AM J OBSTET GYNECOL, V156, P1260; BAGGISH MS, 1991, LASER SURG MED, V11, P197, DOI 10.1002/lsm.1900110302; Ball Kay, 2010, AORN J, V92, pe1, DOI 10.1016/j.aorn.2009.10.026; Ball K, 2001, AANA J, V69, P125; Ball Kay, 2010, AORN J, V92, P142, DOI 10.1016/j.aorn.2010.06.002; BEEBE DS, 1993, ANESTH ANALG, V77, P338, DOI 10.1213/00000539-199377020-00021; Benson Stacey M, 2013, AORN J, V97, P457, DOI 10.1016/j.aorn.2013.01.015; Brandon HJ, 1997, SURG SERVICES MANAGE, V3, P14; Bruske-Hohlfeld I, 2008, J OCCUP MED TOXICOL, V3; Coia JE, 2013, J HOSP INFECT, V85, P170, DOI 10.1016/j.jhin.2013.06.020; Cushing H., 1928, SURG GYNECOL OBSTET, V47, P751; Edwards Ben E, 2012, AORN J, V95, P337, DOI 10.1016/j.aorn.2011.07.019; FERENCZY A, 1990, AM J OBSTET GYNECOL, V163, P1271; Gates MA, 2007, SCAND J WORK ENV HEA, V33, P140; Gianella M, 2014, SURG INNOV, V21, P170, DOI 10.1177/1553350613492025; GLOSTER HM, 1995, J AM ACAD DERMATOL, V32, P436, DOI 10.1016/0190-9622(95)90065-9; HALLMO P, 1991, EUR ARCH OTO-RHINO-L, V248, P425, DOI 10.1007/BF01463570; Heinsohn PA, 1991, APPL OCCUP ENV HYG, V6, P773; Hensman C, 1998, AM J SURG, V175, P240, DOI 10.1016/S0002-9610(97)00291-2; Hill DS, 2012, J PLAST RECONSTR AES, V65, P911, DOI 10.1016/j.bjps.2012.02.012; Hirata S, 2013, NIHON SHUJUTSU IGAKU, V34, ps131; Ikramuddin S, 1998, J GASTROINTEST SURG, V2, P84; Ikramuddin S, 1998, J Gastrointest Surg, V2, P580, DOI 10.1016/S1091-255X(98)80060-7; Kokosa J. M., 1989, J LASER APPL, V3, P59; Kubo H., 2013, NIHON SHUJUTSU IGAKU, V34, ps98; Le Moual N, 2013, J OCCUP ENVIRON MED, V55, P973, DOI 10.1097/JOM.0b013e318297325b; Lin YW, 2010, J FORMOS MED ASSOC, V109, P511, DOI 10.1016/S0929-6646(10)60085-X; MCKINLEY IB, 1994, J ENDODONT, V20, P558, DOI 10.1016/S0099-2399(06)80073-7; Navarro-Meza María Cristina, 2013, Rev Peru Med Exp Salud Publica, V30, P41, DOI 10.1590/s1726-46342013000100008; Nduka CC, 1998, SURG ENDOSC-ULTRAS, V12, P1031, DOI 10.1007/s004649900774; Nicola JH, 2002, PHYS MED BIOL, V47, P847, DOI 10.1088/0031-9155/47/5/311; NIOSH, 1988, HLTH HAZ EV REP, P2; Pierce JS, 2011, J OCCUP ENVIRON HYG, V8, P447, DOI 10.1080/15459624.2011.585888; Reymond M A, 1998, J Gastrointest Surg, V2, P406, DOI 10.1016/S1091-255X(98)80030-9; Sagar PM, 1996, BRIT J SURG, V83, P1792, DOI 10.1002/bjs.1800831241; Schultz Leonard, 2014, AORN J, V99, P289, DOI 10.1016/j.aorn.2013.07.020; Takahashi H, 2013, SURG ENDOSC, V27, P2980, DOI 10.1007/s00464-013-2821-y; Taravella MJ, 1999, OPHTHALMOLOGY, V106, P1498, DOI 10.1016/S0161-6420(99)90442-6; Tseng HS, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-31; Ulmer Brenda C, 2008, AORN J, V87, P721, DOI 10.1016/j.aorn.2007.10.012; WISNIEWSKI PM, 1990, J REPROD MED, V35, P1117; Wu JS, 1997, SURG ENDOSC-ULTRAS, V11, P1075, DOI 10.1007/s004649900533; Zhao C, 2013, UROLOGY, V82, pe9	71	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					957	965		10.1007/s00595-014-1085-z		9	Surgery	Surgery	CO1VP	WOS:000358944300003		
J	Yamamoto, M; Orihashi, K; Nishimori, H; Handa, T; Kondo, N; Fukutomi, T; Sato, T				Yamamoto, Masaki; Orihashi, Kazumasa; Nishimori, Hideaki; Handa, Takemi; Kondo, Nobuo; Fukutomi, Takashi; Sato, Takayuki			Efficacy of intraoperative HyperEye Medical System angiography for coronary artery bypass grafting	SURGERY TODAY			English	Article						Indocyanine green; HyperEye Medical System; HEMS; Coronary artery bypass grafting; Transit time flowmeter	INDOCYANINE GREEN ANGIOGRAPHY; OFF-PUMP; SURGERY; PATENCY; FLOW	Purpose When performing coronary artery bypass grafting, anastomotic insufficiency needs to be detected during surgery. We developed a novel indocyanine green angiography system, the HyperEye Medical System (HEMS), which enables color imaging of the bypass flow. This article described the accuracy of HEMS angiography for predicting graft patency. Methods A total of 144 grafts in 40 coronary artery bypass grafting patients were assessed by HEMS angiography, a transit time flowmeter (TTF) during surgery and fluoroscopic angiography 1 year after the operation. Results HEMS angiography showed normal flow in 133 grafts, but abnormal flow in 11. Fluoroscopic angiography showed that 130 of the 133 "normal" grafts were patent (negative predictive value: 97.7 %) and that nine of the 11 "abnormal" grafts were occluded (positive predictive value: 81.8 %). As a result, 134 grafts were assessed as normal and 10 as abnormal by TTF. Fluoroscopic angiography showed that 124 of these 134 grafts were patent (negative predictive value: 92.5 %), whereas two of the 10 grafts were occluded (positive predictive value: 20.0 %). For the 127 grafts with compatible results by the HEMS and TTF assessments, the positive and negative predictive values were 100 and 97.6 %, respectively. Conclusion HEMS angiography of a bypass graft may provide an accurate prediction of the graft patency after surgery.	[Yamamoto, Masaki; Orihashi, Kazumasa; Nishimori, Hideaki; Handa, Takemi; Kondo, Nobuo; Fukutomi, Takashi] Kochi Med Sch, Dept Surg 2, Nankoku, Kochi 7838505, Japan; [Sato, Takayuki] Kochi Med Sch, Dept Cardiovasc Control, Nankoku, Kochi 7838505, Japan	Yamamoto, M (reprint author), Kochi Med Sch, Dept Surg 2, Oko Cho, Nankoku, Kochi 7838505, Japan.	y-masaki@kochi-u.ac.jp			Science and Technology Incubation Program in Advanced Regions from the Japan Science and Technology Agency	The authors would like to thank Clinical Engineers Tomotaka Takesima, Kazuhiro Imakubo, Yuto Sasaki and Kazuhiro Aki (Kochi university) for technical support with the manipulation of the HEMS. This work was supported by a grant from the Science and Technology Incubation Program in Advanced Regions from the Japan Science and Technology Agency.	CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Yamamoto M, 2011, SURG TODAY, V41, P1467, DOI 10.1007/s00595-010-4553-0; Desai ND, 2006, J THORAC CARDIOV SUR, V132, P585, DOI 10.1016/j.jtcvs.2005.09.061; Detter C, 2002, HEART SURG FORUM, V5, P364; Yamamoto M, 2012, EUR J VASC ENDOVASC, V43, P426, DOI 10.1016/j.ejvs.2011.12.030; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Balacumaraswami L, 2005, J THORAC CARDIOV SUR, V130, P315, DOI 10.1016/j.jtcvs.2004.11.033; Budde RPJ, 2009, SURG ENDOSC, V23, P467, DOI 10.1007/s00464-008-0082-y; CANVER CC, 1994, ANN THORAC SURG, V58, P135; D'Ancona G, 2009, J CARDIOTHOR VASC AN, V23, P232, DOI 10.1053/j.jvca.2008.11.008; Detter C, 2007, CIRCULATION, V116, P1007, DOI 10.1161/CIRCULATIONAHA.106.655936; Handa Takemi, 2009, Interact Cardiovasc Thorac Surg, V9, P150, DOI 10.1510/icvts.2008.201418; Handa T, GEN THORAC CARDIOVAS, V58, P68; MCPHERSON DD, 1987, NEW ENGL J MED, V316, P304, DOI 10.1056/NEJM198702053160604; Reuthebuch O, 2004, CHEST, V125, P418, DOI 10.1378/chest.125.2.418; Rubens FD, 2002, HEART SURG FORUM, V5, P141; Sakata R, 2011, GEN THORAC CARDIOVAS, V59, P636; Taggart DP, 2003, ANN THORAC SURG, V75, P870, DOI 10.1016/S0003-4975(02)04669-6	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					966	972		10.1007/s00595-014-1015-0		7	Surgery	Surgery	CO1VP	WOS:000358944300004		
J	Furukawa, H; Hayashi, T; Oyama, A; Funayama, E; Murao, N; Yamao, T; Yamamoto, Y				Furukawa, Hiroshi; Hayashi, Toshihiko; Oyama, Akihiko; Funayama, Emi; Murao, Naoki; Yamao, Takeshi; Yamamoto, Yuhei			Effectiveness of intraoperative indocyanine-green fluorescence angiography during inguinal lymph node dissection for skin cancer to prevent postoperative wound dehiscence	SURGERY TODAY			English	Article						Inguinal lymph node dissection; Wound dehiscence; Indocyanine-green fluorescence angiography	INTRAVENOUS FLUORESCEIN; MALIGNANT-MELANOMA; LYMPHADENECTOMY; GROIN; COMPLICATIONS; RECURRENCE; MORBIDITY; BREAKDOWN; DYE	Purpose The incidence of postoperative wound dehiscence following inguinal lymph node dissection (ILND) is higher than that in other anatomic regions. To prevent wound dehiscence, intraoperative interventions, such as trimming off the ischemic part of the flap before wound closure based on indocyanine-green (ICG) fluorescence angiography, have been introduced in our institute. This report describes a retrospective clinical study of 17 cases, and the objective of the study was to evaluate the clinical efficacy of intraoperative intervention using ICG fluorescence angiography. Method A total of 17 patients who underwent ILND for skin cancer between 2009 and 2013 at our institute were reviewed retrospectively, and the significance of variables, including intervention using ICG fluorescence angiography, was evaluated using Fisher's exact test. Results There were nine cases of wound dehiscence, and two of these cases required a secondary skin graft. Only one case of wound dehiscence developed in the eight patients who underwent intervention based on ICG fluorescence angiography. This procedure was a significant factor influencing the risk of wound dehiscence (p = 0.003) in our study. Conclusion Although this was a small case series, intraoperative intervention based on ICG fluorescence angiography was effective for preventing postoperative wound dehiscence after ILND.	[Furukawa, Hiroshi; Hayashi, Toshihiko; Oyama, Akihiko; Funayama, Emi; Murao, Naoki; Yamao, Takeshi; Yamamoto, Yuhei] Hokkaido Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Furukawa, H (reprint author), Hokkaido Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Kita Ku, Kita-15,Nishi-8, Sapporo, Hokkaido 0608638, Japan.	hfuru@med.hokudai.ac.jp					ABRAHAM V, 1992, BRIT J PLAST SURG, V45, P211, DOI 10.1016/0007-1226(92)90079-D; FLOWER RW, 1976, JOHNS HOPKINS MED J, V138, P33; Chang SB, 2010, ANN SURG ONCOL, V17, P2764, DOI 10.1245/s10434-010-1026-z; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Han LY, 2004, INT J GYNECOL CANCER, V14, P621, DOI 10.1111/j.1048-891X.2004.14411.x; Smith OJ, 2013, J PLAST RECONSTR AES, V66, P472, DOI 10.1016/j.bjps.2012.12.020; Rouzier R, 2003, J AM COLL SURGEONS, V196, P442, DOI 10.1016/S1072-7515(02)01895-1; BUCHANAN RT, 1982, PLAST RECONSTR SURG, V70, P363, DOI 10.1097/00006534-198209000-00013; Chester DL, 2002, BRIT J PLAST SURG, V55, P510, DOI 10.1054/bjps.2002.3890; Guggenheim MM, 2008, ANN SURG, V247, P687, DOI 10.1097/SLA.0b013e318161312a; Holm C., 2010, OPEN SURG ONCOL J, V2, P37; MAGRINA JF, 1981, GYNECOL ONCOL, V11, P96, DOI 10.1016/0090-8258(81)90014-7; Saito T, 2012, J SURG ONCOL, V106, P107, DOI 10.1002/jso.23050; Serpell JW, 2003, ANZ J SURG, V73, P294, DOI 10.1046/j.1445-2197.2003.t01-1-02622.x; SHAW JHF, 1990, BRIT J SURG, V77, P760, DOI 10.1002/bjs.1800770715; SMITH JA, 1979, J UROLOGY, V122, P754; STEIN MR, 1971, AM J OPHTHALMOL, V72, P861	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					973	978		10.1007/s00595-014-0996-z		6	Surgery	Surgery	CO1VP	WOS:000358944300005		
J	Wang, HL; Ikegami, T; Harada, N; Yoshizumi, T; Soejima, Y; Uchiyama, H; Yamashita, YI; Itoh, S; Harimoto, N; Kawanaka, H; Shirabe, K; Maehara, Y				Wang, Huanlin; Ikegami, Toru; Harada, Noboru; Yoshizumi, Tomoharu; Soejima, Yuji; Uchiyama, Hideaki; Yamashita, Yo-Ichi; Itoh, Shinji; Harimoto, Norifumi; Kawanaka, Hirofumi; Shirabe, Ken; Maehara, Yoshihiko			Optimal changes in portal hemodynamics induced by splenectomy during living donor liver transplantation	SURGERY TODAY			English	Article						Living donor liver transplantation; Hyperbilirubinemia; Small for size; Graft dysfunction; Donor age	FOR-SIZE GRAFT; INFLOW MODULATION; PORTACAVAL-SHUNT; LOBE; REGENERATION; IMPACT; PRESSURE; FAILURE	Purposes The purpose of this study was to evaluate the impact of splenectomy in adult-to-adult living donor liver transplantation (LDLT). Methods Adult-to-adult LDLTs (n = 276) were divided into those with simultaneous splenectomy during LDLT (Splenectomy group, n = 154) and those without (Non-Splenectomy group, n = 122). Results In the Splenectomy group, splenectomy decreased the portal venous pressure from 24.0 to 19.1 mmHg (p < 0.001). At the end of surgery, the portal venous pressure was significantly lower and the graft compliance was significantly higher in the Splenectomy group compared with the Non-Splenectomy group. The graft portal venous flow was also better in the Splenectomy group (y = 625-5.1x; r(2) = 0.08, p < 0.01) than in the Non-Splenectomy group (y = 470-2.9x; r(2) = 0.04, p = 0.03). Fourteen days after LDLT, the total bilirubin and ascites output were lower in the Splenectomy group than in the Non-Splenectomy group. Among the patients with hepatitis C, splenectomy was associated with a significantly higher rate of a sustained viral response (59.4 vs. 35.9 %, p = 0.020) than was noted in those without splenectomy (n = 39). There were no patients with post-splenectomy sepsis under vaccination. Conclusions By decreasing the portal pressure and increasing the graft vascular compliance, splenectomy conferred better graft outcomes in adult-to-adult LDLT	[Wang, Huanlin; Ikegami, Toru; Harada, Noboru; Yoshizumi, Tomoharu; Soejima, Yuji; Uchiyama, Hideaki; Yamashita, Yo-Ichi; Itoh, Shinji; Harimoto, Norifumi; Kawanaka, Hirofumi; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Ikegami, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan.	tikesurg@surg2.med.kyushu-u.ac.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by a grant Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan. No financial or other conflicts of interest exist for any of the authors (Ikegami T, et al.).	Kiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198; Troisi R, 2005, AM J TRANSPLANT, V5, P1397, DOI 10.1111/j.1600-6143.2005.00850.x; Tian YH, 2011, HEPATOLOGY, V53, P253, DOI 10.1002/hep.23960; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Umeda Y, 2008, TRANSPLANTATION, V86, P673, DOI 10.1097/TP.0b013e318181e02d; Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108; Ikegami T, 2012, AM J TRANSPLANT, V12, P1886, DOI 10.1111/j.1600-6143.2012.04052.x; Morioka D, 2007, ANN SURG, V245, P315, DOI 10.1097/01.sla.0000236600.24667.a4; Moon JI, 2010, LIVER TRANSPLANT, V16, P864, DOI 10.1002/lt.22094; Boillot O, 2002, LANCET, V359, P406, DOI 10.1016/S0140-6736(02)07593-1; Soejima Y, 2012, AM J TRANSPLANT, V12, P1877, DOI 10.1111/j.1600-6143.2012.04022.x; Shimada M, 2004, HEPATO-GASTROENTEROL, V51, P625; Nagao Y, 2011, HEPATOL RES, V41, P784, DOI 10.1111/j.1872-034X.2011.00828.x; Yamada T, 2008, AM J TRANSPLANT, V8, P847, DOI 10.1111/j.1600-6143.2007.02144.x; Trotter JF, 2006, LIVER TRANSPLANT, V12, P1485, DOI 10.1002/lt.20875; Hiroshige S, 2003, TRANSPLANTATION, V75, P1561, DOI 10.1097/01.TP.0000053755.08825.12; Botha JF, 2010, LIVER TRANSPLANT, V16, P649, DOI 10.1002/lt.22043; Ikegami Toru, 2009, J Am Coll Surg, V208, pe1, DOI 10.1016/j.jamcollsurg.2008.10.034; Ikegami T, 2007, TRANSPLANTATION, V84, P836, DOI 10.1097/01.tp.0000282790.66889.a5; Ikegami T, 2008, HEPATO-GASTROENTEROL, V55, P670; Ikegami T, 2009, HEPATO-GASTROENTEROL, V56, P778; Lüsebrink R, 1994, Transpl Int, V7 Suppl 1, pS634; Taketomi A, 2010, J AM COLL SURGEONS, V211, P456, DOI 10.1016/j.jamcollsurg.2010.04.018; Yagi S, 2005, LIVER TRANSPLANT, V11, P68, DOI 10.1002/lt.20317	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					979	985		10.1007/s00595-014-0999-9		7	Surgery	Surgery	CO1VP	WOS:000358944300006		
J	Adachi, T; Hinoi, T; Egi, H; Shimomura, M; Ohdan, H				Adachi, T.; Hinoi, T.; Egi, H.; Shimomura, M.; Ohdan, H.			Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery	SURGERY TODAY			English	Article						Colorectal cancer; Peritonial carcinomatosis; Synchronous	HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; SYSTEMIC CHEMOTHERAPY; CURATIVE TREATMENT; RANDOMIZED-TRIAL; PHASE-III; ORIGIN; FLUOROURACIL; BEVACIZUMAB; LEUCOVORIN; MANAGEMENT	Purpose To estimate the feasibility and limitations of incomplete cytoreductive surgery and modern systemic chemotherapy in patients with synchronous peritoneal carcinomatosis from colorectal cancer and to identify risk factors for death and factors associated with the patient prognosis. Methods Sixty-five consecutive patients underwent surgery for synchronous peritoneal carcinomatosis from colorectal cancer at Hiroshima University, Japan between 1992 and 2012. The clinical, histological, and survival data were analyzed for independent risk factors and prognostic factors. The patients were retrospectively stratified into two groups according to the extent of surgery: complete cytoreductive surgery or incomplete cytoreductive surgery. Results The median survival times in the complete and incomplete cytoreductive surgery groups were 29.8 and 10.0 months, respectively. Receiving systemic chemotherapy alone was an independent risk factor for death in the incomplete cytoreductive surgery group (P < 0.001). Oxaliplatin and molecular-targeted drug (cetuximab or bevacizumab) therapies were also independent prognostic factors (P < 0.001), whereas irinotecan therapy was not a prognostic factor (P = 0.494). Conclusion Oxaliplatin and molecular-targeted drug therapies improved the overall survival in patients undergoing incomplete cytoreductive surgery. Future trials for patients with synchronous peritoneal carcinomatosis from colorectal cancer should be undertaken, with patients stratified according to treatment with complete cytoreductive surgery or incomplete cytoreductive surgery with modern chemotherapy.	[Adachi, T.; Hinoi, T.; Egi, H.; Shimomura, M.; Ohdan, H.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Minami Ku, Hiroshima 7348551, Japan	Adachi, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	adachitomohiro@hotmail.com					Sadeghi B, 2000, CANCER, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Verwaal VJ, 2008, ANN SURG ONCOL, V15, P2426, DOI 10.1245/s10434-008-9966-2; Franko J, 2010, CANCER-AM CANCER SOC, V116, P3756, DOI 10.1002/cncr.25116; Teo MCC, 2013, ANN SURG ONCOL, V20, P2968, DOI 10.1245/s10434-013-2947-0; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JACQUET P, 1993, CANCER, V72, P1631, DOI 10.1002/1097-0142(19930901)72:5<1631::AID-CNCR2820720523>3.0.CO;2-I; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Park IJ, 2009, ANN SURG, V249, P960, DOI 10.1097/SLA.0b013e3181a57c8f; Verwaal VJ, 2003, J CLIN ONCOL, V21, P3737, DOI 10.1200/JCO.2003.04.187; Koppe MJ, 2006, ANN SURG, V243, P212, DOI 10.1097/01.sla.0000197702.46394.16; Kerscher AG, 2013, BRIT J CANCER, V108, P1432, DOI 10.1038/bjc.2013.82; Glehen O, 2004, J CLIN ONCOL, V22, P3284, DOI 10.1200/JCO.2004.10.012; Lemmens VE, 2011, INT J CANCER, V128, P2717, DOI 10.1002/ijc.25596; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Elias D, 2001, CANCER, V92, P71, DOI 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9; Elias D, 2010, EJSO-EUR J SURG ONC, V36, P456, DOI 10.1016/j.ejso.2010.01.006; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Shen P, 2004, ANN SURG ONCOL, V11, P178, DOI 10.1245/ASO.2004.05.009; Franko J, 2012, J CLIN ONCOL, V30, P263, DOI 10.1200/JCO.2011.37.1039; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Klaver YLB, 2013, EJSO-EUR J SURG ONC, V39, P734, DOI 10.1016/j.ejso.2013.03.003; Mulsow J, 2011, BRIT J SURG, V98, P1785, DOI 10.1002/bjs.7653; Elias D, 2009, J CLIN ONCOL, V27, P681, DOI 10.1200/JCO.2008.19.7160; Kobayashi H, 2010, DIGEST SURG, V27, P473, DOI 10.1159/000320460; Pilati P, 2003, ANN SURG ONCOL, V10, P508, DOI 10.1245/ASO.2003.08.004; Goere D, 2013, ANN SURG, V257, P1065, DOI 10.1097/SLA.0b013e31827e9289; Yan TD, 2006, J CLIN ONCOL, V24, P4011, DOI 10.1200/JCO.2006.07.1142; Folprecht G, 2007, Cancer Treat Res, V134, P425; Glehen O, 2004, Br J Surg, V91, P747, DOI 10.1002/bjs.4473; Glehen O, 2010, CANCER-AM CANCER SOC, V116, P5608, DOI 10.1002/cncr.25356	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					986	992		10.1007/s00595-014-1017-y		7	Surgery	Surgery	CO1VP	WOS:000358944300007		
J	Okita, Y; Kobayashi, M; Araki, T; Fujikawa, H; Yuki, K; Kohei, O; Mikihiro, I; Yuji, T; Ohi, M; Tanaka, K; Inoue, Y; Uchida, K; Mohri, Y; Yamakado, K; Kusunoki, M				Okita, Yoshiki; Kobayashi, Minako; Araki, Toshimitsu; Fujikawa, Hiroyuki; Yuki, Koike; Kohei, Otake; Mikihiro, Inoue; Yuji, Toiyama; Ohi, Msaki; Tanaka, Koji; Inoue, Yasuhiro; Uchida, Keiichi; Mohri, Yasuhiko; Yamakado, Koichiro; Kusunoki, Masato			Impact of Surgical Infection Society/Infectious Disease Society of America-recommended antibiotics on postoperative intra-abdominal abscess with image-guided percutaneous abscess drainage following gastrointestinal surgery	SURGERY TODAY			English	Article						Postoperative abscess; Antibiotics; CT-guided drainage	COMMUNITY-ACQUIRED PNEUMONIA; C-REACTIVE PROTEIN; ABDOMINAL ABSCESSES; COMPUTED-TOMOGRAPHY; CATHETER DRAINAGE; MANAGEMENT; PERITONITIS; DIAGNOSIS; RISK; ULTRASOUND	Purpose The aims of this study were to reveal how using the antibiotics recommended by the 2010 Surgical Infection Society (SIS) and Infectious Disease Society of America (IDSA) guidelines can affect the therapeutic outcomes. Methods We reviewed the cases of 53 patients with a postoperative intra-abdominal abscess without anastomotic leakage after gastrointestinal surgery who underwent image-guided percutaneous abscess drainage (PAD) and concomitant antibiotic therapy. The type of antibiotic initially administered was determined based on the surgeon's judgment. A persistent abscess was defined as one or more PAD procedures resulting in complete resolution after 21 or more days. The recommended antibiotics were defined according to 2010 SIS/IDSA guidelines. Results All 53 patients had complete resolution without the need for surgery. The results of a multivariable analysis revealed that a C-reactive protein level >= 12 mg/dL and non-recommended antibiotics were significant risk factors for a persistent abscess (P = 0.042 and 0.013, respectively). With regard to a fever lasting more than 48 h, there was a significant difference between the recommended (45.1 %) and non-recommended (72.7 %) antibiotic groups (P = 0.046). Conclusions Using the recommended antibiotics may shorten the time to defervescence and reduce the risk of a persistent abscess in patients undergoing PAD for a postoperative abscess after gastrointestinal surgery.	[Okita, Yoshiki; Kobayashi, Minako; Araki, Toshimitsu; Fujikawa, Hiroyuki; Yuki, Koike; Kohei, Otake; Mikihiro, Inoue; Yuji, Toiyama; Ohi, Msaki; Tanaka, Koji; Inoue, Yasuhiro; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 514, Japan; [Yamakado, Koichiro] Mie Univ, Grad Sch Med, Dept Radiol, Tsu, Mie 5148507, Japan	Okita, Y (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 514, Japan.	nyokkin@clin.medic.mie-u.ac.jp					Benoist S, 2002, AM J SURG, V184, P148, DOI 10.1016/S0002-9610(02)00912-1; BROLIN RE, 1984, AM SURGEON, V50, P102; Montravers P, 2006, CRIT CARE MED, V34, P646, DOI 10.1097/01.CCM.0000201889.39443.D2; MOSDELL DM, 1991, ANN SURG, V214, P543, DOI 10.1097/00000658-199111000-00001; Montravers P, 2009, J ANTIMICROB CHEMOTH, V63, P785, DOI 10.1093/jac/dkp005; HEMMING A, 1991, AM J SURG, V161, P593, DOI 10.1016/0002-9610(91)90907-U; BRANUM GD, 1990, ANN SURG, V212, P655, DOI 10.1097/00000658-199012000-00002; MCLEAN TR, 1993, SURG GYNECOL OBSTET, V176, P167; Montravers P, 1996, CLIN INFECT DIS, V23, P486; Bernini A, 1997, DIS COLON RECTUM, V40, P1009, DOI 10.1007/BF02050920; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; Nseir W, 2013, J CRIT CARE, V28, P291, DOI 10.1016/j.jcrc.2012.09.012; Harisinghani MG, 2002, RADIOGRAPHICS, V22, P1353, DOI 10.1148/rg.226025039; Men S, 2002, EUR J RADIOL, V43, P204, DOI 10.1016/S0720-048X(02)00156-0; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Swenson BR, 2009, SURG INFECT, V10, P29, DOI 10.1089/sur.2007.041; GERZOF SG, 1981, NEW ENGL J MED, V305, P653, DOI 10.1056/NEJM198109173051201; Muller-Wille R, 2011, INT J COLORECTAL DIS, V26, P769, DOI 10.1007/s00384-011-1135-6; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Chalmers JD, 2008, AM J MED, V121, P219, DOI 10.1016/j.amjmed.2007.10.033; GOLETTI O, 1993, BRIT J SURG, V80, P336, DOI 10.1002/bjs.1800800323; Golfieri R, 2007, Tech Coloproctol, V11, P197, DOI 10.1007/s10151-007-0354-x; HAAGA JR, 1990, WORLD J SURG, V14, P204; HALASZ NA, 1983, AM J SURG, V146, P112, DOI 10.1016/0002-9610(83)90270-2; JOHNSON WC, 1981, ANN SURG, V194, P510, DOI 10.1097/00000658-198110000-00014; Kusachi S, 2012, J INFECT CHEMOTHER, V18, P152, DOI 10.1007/s10156-011-0307-1; LEVISON MA, 1991, SURG GYNECOL OBSTET, V172, P89; MALANGONI MA, 1990, AM J SURG, V159, P167, DOI 10.1016/S0002-9610(05)80623-3; Montgomery RS, 1996, CLIN INFECT DIS, V23, P28; Montravers P, 2004, ANN SURG, V239, P409, DOI 10.1097/01.sla.0000114214.68169.e9; Okita Y, 2013, SURG TODAY, V43, P1095, DOI 10.1007/s00595-013-0504-x; Shinagawa Nagao, 2010, Jpn J Antibiot, V63, P105; Shinagawa Nagao, 2011, Jpn J Antibiot, V64, P125; SUNSHINE J, 1983, AM J SURG, V145, P615, DOI 10.1016/0002-9610(83)90105-8; vanSonnenberg E, 2001, WORLD J SURG, V25, P362	36	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					993	1000		10.1007/s00595-014-1047-5		8	Surgery	Surgery	CO1VP	WOS:000358944300008		
J	Okita, Y; Kobayashi, M; Araki, T; Fujikawa, H; Koike, Y; Otake, K; Inoue, M; Toiyama, Y; Ohi, M; Tanaka, K; Inoue, Y; Uchida, K; Mohri, Y; Yamakado, K; Kusunoki, M				Okita, Yoshiki; Kobayashi, Minako; Araki, Toshimitsu; Fujikawa, Hiroyuki; Koike, Yuhki; Otake, Kohei; Inoue, Mikihiro; Toiyama, Yuji; Ohi, Masaki; Tanaka, Koji; Inoue, Yasuhiro; Uchida, Keiichi; Mohri, Yasuhiko; Yamakado, Koichiro; Kusunoki, Masato			Impact of Surgical Infection Society/Infectious Disease Society of America-recommended antibiotics on postoperative intra-abdominal abscess with image-guided percutaneous abscess drainage following gastrointestinal surgery (vol 45, pg 993, 2015)	SURGERY TODAY			English	Correction									[Okita, Yoshiki; Kobayashi, Minako; Araki, Toshimitsu; Fujikawa, Hiroyuki; Koike, Yuhki; Otake, Kohei; Inoue, Mikihiro; Toiyama, Yuji; Ohi, Masaki; Tanaka, Koji; Inoue, Yasuhiro; Uchida, Keiichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Dept Gastrointestinal & Pediat Surg, Grad Sch Med, Tsu, Mie 514, Japan; [Yamakado, Koichiro] Mie Univ, Dept Radiol, Grad Sch Med, Tsu, Mie 5148507, Japan	Okita, Y (reprint author), Mie Univ, Dept Gastrointestinal & Pediat Surg, Grad Sch Med, Tsu, Mie 514, Japan.	nyokkin@clin.medic.mie-u.ac.jp					Okita Y, 2015, SURG TODAY, V45, P993, DOI 10.1007/s00595-014-1047-5	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					1001	1001		10.1007/s00595-015-1131-5		1	Surgery	Surgery	CO1VP	WOS:000358944300009		
J	Takata, A; Takiguchi, S; Murakami, K; Miyazaki, Y; Miyata, H; Takahashi, T; Kurokawa, Y; Yamasaki, M; Nakajima, K; Mori, M; Kangawa, K; Doki, Y				Takata, Akihiro; Takiguchi, Shuji; Murakami, Kohei; Miyazaki, Yasuhiro; Miyata, Hiroshi; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Mori, Masaki; Kangawa, Kenji; Doki, Yuichiro			Effects of ghrelin administration on the early postoperative inflammatory response after esophagectomy	SURGERY TODAY			English	Article						Ghrelin; Systemic inflammatory response syndrome (SIRS); Esophagectomy	HEALTHY-SUBJECTS; CONTROLLED-TRIAL; CANCER-PATIENTS; HEART-FAILURE; FOOD-INTAKE; SURGERY; SEPSIS; APPETITE; CACHEXIA; RATS	Purpose Ghrelin is a unique gastric hormone, which has pleiotropic biological functions, including anti-inflammatory effects. The aim of this study was to investigate the effects of administering ghrelin on reducing postoperative systemic inflammation in patients undergoing esophagectomy. Methods The safety and effectiveness of postoperative ghrelin administration were investigated among twenty esophageal cancer patients who underwent esophagectomy between May 2010 and August 2011. Two different regimens of ghrelin administration, twice daily rapid drip infusion (3 mu g/kg, twice a day) or continuous infusion (0.5 mu g/kg/h), were employed. The duration of the systemic inflammatory response syndrome (SIRS) and the hematological parameters were compared between groups. Results Patients treated with ghrelin showed shorter SIRS durations than controls (1.6 +/- 2.7 vs. 4.1 +/- 3.7 days, respectively; p = 0.0065) and also showed lower C-reactive protein concentrations than controls (11.0 +/- 4.6 mg/dL vs. 15.3 +/- 7.3 mg/mL, respectively, on postoperative day 3, p = 0.030). Ghrelin administration was not associated with any adverse events. The incidence of operative morbidity was equivalent between groups. The two ghrelin administration regimens showed similar durations of systemic inflammatory response (rapid drip: 2.2 +/- 3.3 vs. continuous: 1.1 +/- 1.9 days, p = 0.17). Conclusions Postoperative ghrelin administration is safe and may suppress protracted postoperative inflammation in patients who undergo esophagectomies.	[Takata, Akihiro; Takiguchi, Shuji; Murakami, Kohei; Miyazaki, Yasuhiro; Miyata, Hiroshi; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Kangawa, Kenji] Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Osaka, Japan	Takiguchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2 E2, Suita, Osaka 5650871, Japan.	stakiguchi@gesurg.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23591929]; Ministry of Health, Labor, and Welfare of Japan	This work was supported in part by a Grant from the Ministry of Education, Culture, Sports, Science and Technology (No. 23591929), and the Ministry of Health, Labor, and Welfare of Japan.	Akamizu T, 2006, ENDOCR J, V53, P585, DOI 10.1507/endocrj.KR-79; Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Vila G, 2007, J CLIN ENDOCR METAB, V92, P3930, DOI 10.1210/jc.2007-1194; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; SAKAMOTO K, 1994, CYTOKINE, V6, P181, DOI 10.1016/1043-4666(94)90040-X; Yamamoto K, 2013, SURG TODAY, V43, P48, DOI 10.1007/s00595-012-0342-2; Akamizu T, 2004, EUR J ENDOCRINOL, V150, P447, DOI 10.1530/eje.0.1500447; DeBoer MD, 2007, ENDOCRINOLOGY, V148, P3004, DOI 10.1210/en.2007-0016; [Anonymous], 2009, J PHYSIOL PHARMACOL; Yamamoto K, 2010, SURGERY, V148, P31, DOI 10.1016/j.surg.2009.11.026; Xu XB, 2008, ENDOCRINOLOGY, V149, P4183, DOI 10.1210/en.2008-0255; Takiguchi S, 2012, DIGEST DIS SCI, V57, P1238, DOI 10.1007/s10620-011-1986-2; Akamizu T, 2005, J CLIN ENDOCR METAB, V90, P6, DOI 10.1210/jc.2004-1640; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-5110C; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Adachi S, 2010, GASTROENTEROLOGY, V138, P1312, DOI 10.1053/j.gastro.2009.12.058; Zhang HW, 2013, INT J MOL MED, V32, P851, DOI 10.3892/ijmm.2013.1452; Li Y, 2013, ENDOCRINE, V43, P376, DOI 10.1007/s12020-012-9761-5; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Wu RQ, 2009, CRIT CARE MED, V37, P2421, DOI 10.1097/CCM.0b013e3181a557a2; Hiura Y, 2012, CANCER-AM CANCER SOC, V118, P4785, DOI 10.1002/cncr.27430; Wang W, 2009, AM J PHYSIOL-RENAL, V297, pF1032, DOI 10.1152/ajprenal.00044.2009; [Anonymous], 2007, GUID DIAGN TREATM ES; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Nagaya N, 2005, CHEST, V128, P1187, DOI 10.1378/chest.128.3.1187; Nagai Y, 2013, SURG TODAY, V43, P361, DOI 10.1007/s00595-013-0508-6; Shiozaki H, 2001, DIS ESOPHAGUS, V14, P191, DOI 10.1046/j.1442-2050.2001.00206.x; Ariyasu H, 2008, ENDOCRINOLOGY, V149, P3722, DOI 10.1210/en.2007-1650; Kawahara Y, 2010, DIS ESOPHAGUS, V23, P329, DOI 10.1111/j.1442-2050.2009.01010.x; Koch A, 2010, CRIT CARE, V14, DOI 10.1186/cc9029; Koizumi M, 2014, SURG TODAY, V44, P2131, DOI 10.1007/s00595-014-0873-9; Liu XY, 2013, INFLAMMATION, V36, P1286, DOI 10.1007/s10753-013-9667-2; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Nagano T, 2013, SURG TODAY, V43, P1240, DOI 10.1007/s00595-012-0424-1; Nagaya N, 2001, J CLIN ENDOCR METAB, V86, P5854, DOI 10.1210/jc.86.12.5854; Sato N, 2002, ANN SURG, V236, P184, DOI 10.1097/01.SLA.0000022025.67985.53; Shimada H, 2000, SURGERY, V128, P791, DOI 10.1067/msy.2000.108614; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011	41	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					1025	1031		10.1007/s00595-014-1076-0		7	Surgery	Surgery	CO1VP	WOS:000358944300013		
J	Kudou, M; Murayama, Y; Konishi, H; Morimura, R; Komatsu, S; Shiozaki, A; Kuriu, Y; Ikoma, H; Kubota, T; Nakanishi, M; Ichikawa, D; Fujiwara, H; Okamoto, K; Sakakura, C; Kojima, O; Otsuji, E				Kudou, Michihiro; Murayama, Yasutoshi; Konishi, Hirotaka; Morimura, Ryo; Komatsu, Shuhei; Shiozaki, Atsushi; Kuriu, Yoshiaki; Ikoma, Hisashi; Kubota, Takeshi; Nakanishi, Masayoshi; Ichikawa, Daisuke; Fujiwara, Hitoshi; Okamoto, Kazuma; Sakakura, Chouhei; Kojima, Osamu; Otsuji, Eigo			Peritoneal colon cancer metastasis to bilateral inguinal hernia repair sites: report of a case	SURGERY TODAY			English	Article						Peritoneal metastasis; Colon cancer; Inguinal hernia; Inflammation	INFLAMMATORY RESPONSE; CELLS	We report a rare case of peritoneal metastasis from colon cancer being found in the bilateral sites of inguinal hernia repair. The patient was an 85-year-old man who underwent colonoscopy for a positive fecal occult blood test, with a subsequent diagnosis of ascending colon cancer. He had undergone mesh plug repair for bilateral inguinal hernias at another hospital 6 years previously. We performed laparoscopy-assisted right hemi-colectomy and found nodes in the bilateral scars from the inguinal hernioplasty. Biopsy confirmed that both of the nodes were peritoneal metastasis, leading to the assumption that cancer cells disseminated within the abdominal cavity had been implanted at the repair sites, although the mechanism for this was unclear. A relationship between inflammation and peritoneal metastasis has been reported; thus, we speculated that local inflammation resulting from chronic stimulus of mesh plugs and peritoneal trauma caused peritoneal metastasis at the repair sites.	[Kudou, Michihiro; Murayama, Yasutoshi; Konishi, Hirotaka; Morimura, Ryo; Komatsu, Shuhei; Shiozaki, Atsushi; Kuriu, Yoshiaki; Ikoma, Hisashi; Kubota, Takeshi; Nakanishi, Masayoshi; Ichikawa, Daisuke; Fujiwara, Hitoshi; Okamoto, Kazuma; Sakakura, Chouhei; Otsuji, Eigo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Surg, Div Digest Surg,Kamigyo Ku, Kyoto 6028566, Japan; [Kojima, Osamu] Kojima Clin, Ikeda, Osaka 5630055, Japan	Murayama, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Surg, Div Digest Surg,Kamigyo Ku, 465 Kajii Cho Hirokoji Kawaramachi, Kyoto 6028566, Japan.	murayama@koto.kpu-m.ac.jp					Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; van den Tol MP, 2007, DIGEST SURG, V24, P388, DOI 10.1159/000107781; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Ceelen WP, 2009, LANCET ONCOL, V10, P72, DOI 10.1016/S1470-2045(08)70335-8; Bouillot JL, 1999, DIGEST SURG, V16, P158, DOI 10.1159/000018710; Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285; Masato I, 2003, SURG TODAY, V33, P864; Nishizaki C, 2011, FREE RADICAL BIO MED, V51, P773, DOI 10.1016/j.freeradbiomed.2011.05.025; Pocard M, 1999, EUR J SURG ONCOL, V25, P635, DOI 10.1053/ejso.1999.0722; Suefumi A, 2008, J JPN SURG ASS, V69, P2337; Takahisa H, 2009, J JPN SURG ASS, V70, P2751; Union for International Cancer Control, 2009, TNM CLASSIFICATION M; Yu G, 2010, SURG ENDOSC, V24, P2860, DOI 10.1007/s00464-010-1067-1; Yutaka Y, 2000, J GASTROENTEROL, V97, P680	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					1053	1057		10.1007/s00595-014-1037-7		5	Surgery	Surgery	CO1VP	WOS:000358944300017		
J	Kobayashi, S; Igami, T; Ebata, T; Yokoyama, Y; Sugawara, G; Mizuno, T; Nimura, Y; Nagino, M				Kobayashi, Shin-ichiro; Igami, Tsuyoshi; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Nimura, Yuji; Nagino, Masato			Long-term survival following extended hepatectomy with concomitant resection of all major hepatic veins for intrahepatic cholangiocarcinoma: report of a case	SURGERY TODAY			English	Article						Extended left trisectionectomy; Intrahepatic cholangiocarcinoma; Selective portal vein embolization	TRISEGMENTECTOMY; RECONSTRUCTION; EMBOLIZATION; SUBSEGMENT; SEGMENT-6; CANCER	Intrahepatic cholangiocarcinoma involving all major hepatic veins was diagnosed in a 62-year-old man. Multidetector-row computed tomography showed a massive tumor occupying segments 2-5, 7, and 8, with invasion of all major hepatic veins, although the inferior right hepatic vein, draining the venous flow of segment 6, was clearly visualized. Therefore, we planned an extended left trisectionectomy, involving resection of segments 1-5, 7, and 8, with extrahepatic bile duct resection and concomitant resection of all major hepatic veins. We performed portal vein embolization of the right anterior portal branch and the portal branch of segment 7 to identify the demarcation between segments 6 and 7 on the surface of the right lobe. We were able to divide the hepatic parenchyma between segments 6 and 7 and the planned surgery was accomplished, with repositioning of the confluence of the inferior right hepatic vein to prevent outflow blockage. The histological findings were pT3N0M0, Grade2, Stage III, and R0 resection, according to the UICC classification (seventh edition). Although remnant liver metastases were detected 75 months after surgery, the patient is still alive and being treated with chemotherapy, 88 months after surgery. We report this case to demonstrate how using portal vein embolization to identify the hepatic segment helps accomplish extended hepatectomy preserving only one segment and that R0 resection by extended hepatectomy with concomitant resection of all hepatic veins can achieve a satisfactory outcome.	[Kobayashi, Shin-ichiro; Igami, Tsuyoshi; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Nimura, Yuji] Aichi Canc Ctr, Nagoya, Aichi 464, Japan	Nagino, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nagino@med.nagoya-u.ac.jp					Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Uenishi T, 2008, J HEPATO-BILIARY-PAN, V15, P417, DOI 10.1007/s00534-007-1315-5; BAER HU, 1991, BRIT J SURG, V78, P1221, DOI 10.1002/bjs.1800781024; Hemming AW, 2005, J GASTROINTEST SURG, V9, P353, DOI 10.1016/j.gassur.2004.07.012; Igami T, 2011, WORLD J SURG, V35, P2501, DOI 10.1007/s00268-011-1242-0; Igami T, 2009, SURG TODAY, V39, P628, DOI 10.1007/s00595-008-3902-8; Machado MA, 2008, EJSO-EUR J SURG ONC, V34, P247, DOI 10.1016/j.ejso.2007.01.004; Nagino M, 2003, SURGERY, V133, P580, DOI 10.1067/msy.2003.105; OZEKI Y, 1995, SURGERY, V117, P715, DOI 10.1016/S0039-6060(95)80018-2; Sakamoto Y, 2004, SURG TODAY, V34, P482, DOI 10.1007/s00595-003-2742-9; Sobin LH, 2009, TNM CLASSIFICATION M; TAKAYAMA T, 1991, SURGERY, V109, P226; Yedibela S, 2009, ANN SURG ONCOL, V16, P404, DOI 10.1245/s10434-008-0227-1	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					1058	1063		10.1007/s00595-014-1038-6		6	Surgery	Surgery	CO1VP	WOS:000358944300018		
J	Kawamoto, N; Hoashi, T; Kagisaki, K; Watanabe, K; Ichikawa, H				Kawamoto, Naonori; Hoashi, Takaya; Kagisaki, Koji; Watanabe, Ken; Ichikawa, Hajime			Myers' 3-sinus reconstruction for supravalvular aortic stenosis involving left coronary ostium: report of a case	SURGERY TODAY			English	Article						Supravalvular aortic stenosis; Left coronary ostial stenosis; Modified Myers' procedure	ARTERY	A 1-year-old boy with a bicuspid aortic valve, who had undergone successful repair of coarctation of the aorta by extended end-to-end direct anastomosis at the age of 1 month, was found to have mild supravalvular aortic stenosis involving the left coronary ostium. Because he was so young, we performed a modified Myers' all-autologous 3-sinus reconstruction to allow for potential growth. After transecting the ascending aorta just above the sinotubular junction, the superior wall of the left coronary ostium and the aortic root between both commissures were incised longitudinally, and then each of the incised parts was augmented by creating three flaps of distal aortic wall directly. Postoperatively, myocardial scintigram confirmed resolution of the pressure gradient at the supravalvular stenotic portion and improvement of the perfusion defect in the septal-anterior area.	[Kawamoto, Naonori; Hoashi, Takaya; Kagisaki, Koji; Ichikawa, Hajime] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Watanabe, Ken] Kitano Hosp, Dept Pediat, Osaka, Japan	Hoashi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	color_orange0185@yahoo.co.jp; thoashi@surg1.med.osaka-u.ac.jp					MYERS JL, 1993, J THORAC CARDIOV SUR, V105, P281; Goel P, 2001, PEDIATR CARDIOL, V22, P83, DOI 10.1007/s002460010164; Inan BK, 2009, J CARDIAC SURG, V24, P299, DOI 10.1111/j.1540-8191.2008.00795.x; Ishibashi N, 2007, J CARDIAC SURG, V22, P56, DOI 10.1111/j.1540-8191.2007.00341.x; Raanani E, 2004, ANN THORAC SURG, V78, P1610, DOI 10.1016/j.athoracsur.2004.05.036	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					1064	1066		10.1007/s00595-014-1054-6		3	Surgery	Surgery	CO1VP	WOS:000358944300019		
J	Unosawa, S; Ishii, Y; Niino, T				Unosawa, Satoshi; Ishii, Yusuke; Niino, Tetsuya			A persistent sciatic artery aneurysm containing a free-floating thrombus: report of a case	SURGERY TODAY			English	Article						Persistent sciatic artery aneurysm; Free-floating thrombus; Iliac-popliteal artery bypass		A persistent sciatic artery is a rare vascular anomaly in which the sciatic artery, which involutes in the embryonic stage, persists as the blood supply to the lower limb. This vascular anomaly is often associated with aneurysm formation. A persistent sciatic artery aneurysm is a rare cause of peripheral arterial embolic disease. We herein describe the case of a 72-year-old female with a free-floating thrombus in a persistent sciatic artery aneurysm. She underwent iliac-popliteal artery bypass and exclusion of the aneurysm to prevent an embolic event.	[Unosawa, Satoshi; Ishii, Yusuke; Niino, Tetsuya] Natl Hosp Org, Disaster Med Ctr, Dept Cardiovasc Surg, Tachikawa, Tokyo 1900014, Japan	Unosawa, S (reprint author), Natl Hosp Org, Disaster Med Ctr, Dept Cardiovasc Surg, 3256 Midori Chou, Tachikawa, Tokyo 1900014, Japan.	unosaw@gmail.com					van Hooft IM, 2009, EUR J VASC ENDOVASC, V37, P585, DOI 10.1016/j.ejvs.2009.01.014; BRANTLEY SK, 1993, J VASC SURG, V18, P242; IKEZAWA T, 1994, J VASC SURG, V20, P96	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	AUG	2015	45	8					1067	1070		10.1007/s00595-014-0981-6		4	Surgery	Surgery	CO1VP	WOS:000358944300020		
J	Sato, H; Hasegawa, Y; Bollegala, D; Iba, H				Sato, Hiroyuki; Hasegawa, Yoshihiko; Bollegala, Danushka; Iba, Hitoshi			Improved sampling using loopy belief propagation for probabilistic model building genetic programming	SWARM AND EVOLUTIONARY COMPUTATION			English	Article						Genetic programming; Estimation of distribution algorithms; Loopy belief propagation; Probabilistic model building GP	BAYESIAN NETWORK; ALGORITHM; EVOLUTION; INDUCTION; GRAMMAR	In recent years, probabilistic model building genetic programming (PMBGP) for program optimization has attracted considerable interest. PMBGPs generally use probabilistic logic sampling (PLS) to generate new individuals. However, the generation of the most probable solutions (MPSs), i.e., solutions with the highest probability, is not guaranteed. In the present paper, we introduce loopy belief propagation (LBP) for PMBGPs to generate MPSs during the sampling process. We selected program optimization with linkage estimation (POLE) as the foundation of our approach and we refer to our proposed method as POLE-BP. We apply POLE-BP and existing methods to three benchmark problems to investigate the effectiveness of LBP in the context of PMBGPs, and we describe detailed examinations of the behaviors of LBP. We find that POLE-BP shows better search performance with some problems because LBP boosts the generation of building blocks. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Hiroyuki] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan; [Hasegawa, Yoshihiko; Iba, Hitoshi] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138654, Japan; [Bollegala, Danushka] Univ Liverpool, Dept Comp Sci, Liverpool L69 3BX, Merseyside, England	Sato, H (reprint author), Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan.	sato@iba.t.u-tokyo.ac.jp					Hasegawa Y, 2009, IEEE T EVOLUT COMPUT, V13, P858, DOI 10.1109/TEVC.2009.2015574; [Anonymous], 2007, EVOL COMPUT, V15, P369, DOI http://dx.doi.org/10.1162/evco.2007.15.3.369; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Hauschild M, 2011, SWARM EVOL COMPUT, V1, P111, DOI 10.1016/j.swevo.2011.08.003; Yanai K, 2003, IEEE C EVOL COMPUTAT, P1618; Larranaga P, 2012, J HEURISTICS, V18, P795, DOI 10.1007/s10732-012-9208-4; Sastry K, 2003, GENET PROGR SER, V6, P205; Salustowicz R, 1997, EVOL COMPUT, V5, P123, DOI 10.1162/evco.1997.5.2.123; Echegoyen C, 2012, IEEE T EVOLUT COMPUT, V16, P173, DOI 10.1109/TEVC.2010.2102037; Felzenszwalb PF, 2006, INT J COMPUT VISION, V70, P41, DOI 10.1007/s11263-006-7899-4; Baluja S., 1994, TECHNICAL REPORT; Bosman P. A. N., 2004, GECCO 2004 WORKSH P; Etxeberria R., 1999, P 2 S ART INT CIMAF, P332; Farinelli A., 2008, P 7 INT JOINT C AUT, V2, P639; Gathercole C., 1996, P 1 ANN C GEN PROGR, P291; Hank G., 1999, TECHNICAL REPORT; Hasegawa Y., 2006, P 3 AS PAC WORKSH GE, P35; Hasegawa Y, 2007, IEEE C EVOL COMPUTAT, P1043; Hasegawa Y, 2008, IEEE T EVOLUT COMPUT, V12, P750, DOI 10.1109/TEVC.2008.915999; Henrion M., 1986, P UAI, V2, P149; Hirasawa K, 2001, IEEE C EVOL COMPUTAT, P1276, DOI 10.1109/CEC.2001.934337; Langdon W.B., 1997, ADV GENETIC PROGRAMM, V3, P301; Li X., 2012, INT J ADV MANUF TECH, P1; Li X., 2013, IEEE T EVOLUT COMPUT, V1, P99; Lima CF, 2009, LECT NOTES COMPUT SC, V5752, P61, DOI 10.1007/978-3-642-03751-1_5; Looks M., 2005, P 2005 GEN EV COMP C, P747, DOI 10.1145/1068009.1068134; Mabu S., 2015, COMPUTATION, V23, P1; Mendiburu A., 2007, TECHNICAL REPORT; Mitchell M., 1992, P 1 EUR C ART LIF, P245; Pearl J., 1988, PROBABILISTIC REASON; Pelikan M., 98013 U ILL URB CHAM; Punch W. F., 1998, GENETIC PROGRAMMING, V98, P308; Ratle A., 2001, LNCS, V2310, P255; Regolin EN, 2005, LECT NOTES COMPUT SC, V3447, P38; Sato H., 2012, P 2012 IEEE C EV COM, P2089; Shan Y, 2003, IEEE C EVOL COMPUTAT, P1639; Shan Y, 2004, IEEE C EVOL COMPUTAT, P478; Wineberg M, 1994, LECT NOTES COMPUT SC, V866, P292	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2210-6502	2210-6510		SWARM EVOL COMPUT	Swarm Evol. Comput.	AUG	2015	23						1	10		10.1016/j.swevo.2015.02.002		10	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Computer Science	CO3AG	WOS:000359028000001		
J	Eguchi, A; Sugiura, M				Eguchi, Akiko; Sugiura, Masatoshi			Applicability of processability theory to Japanese adolescent EFL learners: A case study of early L2 syntactic and morphological development	SYSTEM			English	Article						Processability theory; Syntactic development; Morphological development; EFL learner; Speech production; Emergence criterion; Communicative task	2ND-LANGUAGE ACQUISITION; FORMULAIC LANGUAGE; ENGLISH; EMERGENCE	Processability theory (PT) predicts that all L2 learners follow fixed developmental schedules due to psycholinguistic constraints, accounting for the development of syntax and morphology within the same framework. Recent studies, however, report some counter-evidence on morphological development. The theory has not been tested sufficiently in EFL contexts. This study examined the applicability of PT to Japanese adolescent EFL learners. Through four communicative tasks, we elicited spontaneous spoken data from 14 Japanese secondary students and cross-sectionally analyzed 15 syntactic and 6 morphological structures using implicational scaling. The study identified four major findings. First, PT prediction is applicable to early EFL learning. Second, there are two different developmental paths and language learners' syntactic development tends to emerge before morphological development. Third, morphological development, particularly phrasal plural-marking, is not always well-mapped to PT prediction. Fourth, formulae seem to play an important role in scaffolding productive use of grammatical structures. These findings indicate that PT needs to be modified to account for the developmental gap between syntax and morphology. They also suggest that L2 instructors should consider language learners' morphological development more in task-based language teaching. Further research should include elaborate analyses of morphological development and the role of formulae in acquiring grammatical structures. (C) 2015 Elsevier Ltd. All rights reserved.	[Eguchi, Akiko; Sugiura, Masatoshi] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Eguchi, A (reprint author), 45-90 Okino, Noda, Kariya 4480803, Japan.	eguchi.akiko@nagoya-u.jp			Toyoaki Scholarship Foundation	This study was supported by Toyoaki Scholarship Foundation. We are grateful to the anonymous reviewers and the editors of System for their valuable comments on our earlier versions of this manuscript.	Foster P, 2000, APPL LINGUIST, V21, P354, DOI 10.1093/applin/21.3.354; DeKeyser RM, 2005, LANG LEARN, V55, P1, DOI 10.1111/j.0023-8333.2005.00294.x; HAKUTA K, 1974, LANG LEARN, V24, P287, DOI 10.1111/j.1467-1770.1974.tb00509.x; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Clahsen H, 2010, LANG LEARN, V60, P21; Jia G, 2007, J SPEECH LANG HEAR R, V50, P1280, DOI 10.1044/1092-4388(2007/090); Housen A, 2009, APPL LINGUIST, V30, P461, DOI 10.1093/applin/amp048; Ellis NC, 2012, ANNU REV APPL LINGUI, V32, P17, DOI 10.1017/S0267190512000025; Bittinger J. M., 1989, HARE TORTOISE; Blom E, 2012, LANG LEARN, V62, P965, DOI 10.1111/j.1467-9922.2012.00715.x; Bonilla C. L, 2014, SECOND LANG RES, V31, P53; Bresnan J, 2001, LEXICAL FUNCTIONAL S; Charters H, 2011, SECOND LANG RES, V27, P509, DOI 10.1177/0267658311405923; Dao L, 2007, THESIS AUSTR NATL U; Di Biase B, 2002, SECOND LANG RES, V18, P274, DOI 10.1191/0267658302sr204oa; Di Biase B., 2013, ROUTLEDGE ENCY 2 LAN, P512; Dyson B, 2009, SECOND LANG RES, V25, P355, DOI 10.1177/0267658309104578; EIKEN, EIKEN GRAD; Ellis N. C, 2002, STUDIES 2 LANGUAGE A, V24, P143, DOI DOI 10.1017/S0272263102002024; Hakansson G, 2002, SECOND LANG RES, V18, P250; Hall T., 2010, TEACHERS COLLEGE COL, V10, P1; Hatch E., 1991, RES MANUAL DESIGN ST; Hawkins R., 2003, LANG ACQUIS, V30, P21; Jiang N, 2007, LANG LEARN, V57, P1, DOI 10.1111/j.1467-9922.2007.00397.x; Johnston M., 1985, SYNTACTIC MORPHOLOGI; Pienemann M, 2005, STUD BILINGUAL, V30, P199; Kawaguchi S, 2005, STUD BILINGUAL, V30, P253; Larsen-Freeman D., 1991, INTRO 2 LANGUAGE ACQ; Lenzing A., 2013, DEV GRAMMATICAL SYST; Levelt William J. M., 1989, SPEAKING INTENTION A; Long M., 2015, 2 LANGUAGE ACQUISITI; Mackey A., 1994, WORKING PAPERS ED LI, V10, P66; Mackey A., 1999, STUDIES 2 LANGUAGE A, V21, P557, DOI DOI 10.1017/S0272263199004027; MacWhinney B., 2000, CHILDES PROJECT TOOL; Mansouri F., 2005, CROSS LINGUISTIC ASP, P116; Nattinger J., 1992, LEXICAL PHRASES LANG; Pallotti G, 2007, APPL LINGUIST, V28, P361, DOI 10.1093/applin/amm018; Peters A, 1983, UNITS LANGUAGE ACQUI; Pfenninger S. E., 2011, STUDIES 2 LANGUAGE L, V1, P401; Pienemann M., 2011, STUDYING PROCESSABIL; Pienemann M., 2012, ROUTLEDGE HDB 2 LANG, P228; Pienemann M., 1993, ESL DEV LANGUAGE LIT, V2, P115; Pienemann M., 1988, STUDIES 2ND LANGUAGE, V10, P217, DOI 10.1017/S0272263100007324; Pienemann Manfred, 1998, LANGUAGE PROCESSING; Pienemann M, 2005, STUD BILINGUAL, V30, P1; Pinker S., 1999, WORDS RULES; Quirk R., 1985, COMPREHENSIVE GRAMMA; Sakai H, 2008, SYSTEM, V36, P534, DOI 10.1016/j.system.2008.03.002; Sinclair J., 1975, ANAL DISCOURSE; Sinclair J. M., 1982, TEACHER TALK; Spinner P, 2011, STUD SECOND LANG ACQ, V33, P529, DOI 10.1017/S0272263111000301; Urano K., 2008, J CHUBU ENGLISH LANG, V37, P41; WEINERT R, 1995, APPL LINGUIST, V16, P180, DOI 10.1093/applin/16.2.180; Yamaguchi Y., 2013, CHILD 2 LANGUAGE LEA; Yamaguchi Y., 2014, ASIAN EFL J, V16, P89; YOUNG R, 1993, APPL LINGUIST, V14, P76, DOI 10.1093/applin/14.1.76; Young R., 1988, STUDIES 2ND LANGUAGE, V10, P281, DOI 10.1017/S0272263100007464; Zhang Y., 2010, FENXI SHIYANSHI, V29, P1; Zhang YY, 2005, STUD BILINGUAL, V30, P155	59	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0346-251X	1879-3282		SYSTEM	System	AUG	2015	52						115	126		10.1016/j.system.2015.05.005		12	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CN9ZC	WOS:000358808700010		
J	Tanaka, S				Tanaka, Shogo			Intercorporeality as a theory of social cognition	THEORY & PSYCHOLOGY			English	Article						behavior matching; embodied interaction; interactional synchrony; intercorporeality; Merleau-Ponty; phenomenology; social cognition	MIRROR-NEURON SYSTEM; FALSE BELIEF; MIND; INFANT; PERCEPTION; SIMULATION; BEHAVIOR; ADULT	The main aim of this article is to revisit Merleau-Ponty's notion of intercorporeality (intercorporeite) and elaborate it as a new theory of social cognition. As is well known, theory of mind has been the central issue in the field of social cognition for more than two decades. In reviewing the basic concepts involved in two major theories (theory theory and simulation theory), I make clear that both theories have been missing the embodied dimension because of their mind-body dualistic supposition. The notion of intercorporeality, in accordance with the recent interaction theory, stresses the role of embodied interactions between the self and the other in the process of social understanding. I develop this notion into two directions and describe the related process of social cognition: one is behavior matching and primordial empathy, the other is interactional synchrony and the sense of mutual understanding. Through these embodied interactions, intersubjective meanings are created and directly shared between the self and the other, without being mediated by mental representations.	Tokai Univ, Liberal Arts Educ Ctr, Hiratsuka, Kanagawa 2591292, Japan	Tanaka, S (reprint author), Tokai Univ, Liberal Arts Educ Ctr, Kitakaname 4-1-1, Hiratsuka, Kanagawa 2591292, Japan.	shg.tanaka@gmail.com			Japan Society for Promotion of Science KAKENHI [24500709]	This work was supported by the Japan Society for Promotion of Science KAKENHI (Grant no. 24500709).	American Psychological Association, 2009, APA CONC DICT PSYCH; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; SIMNER ML, 1971, DEV PSYCHOL, V5, P136, DOI 10.1037/h0031066; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Fuchs T, 2009, PHENOMENOL COGN SCI, V8, P465, DOI 10.1007/s11097-009-9136-4; Fuchs T, 2013, PHENOMENOL COGN SCI, V12, P655, DOI 10.1007/s11097-012-9267-x; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515; Gallagher S, 2001, J CONSCIOUSNESS STUD, V8, P83; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037//0022-3514.76.6.893; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Gallagher S, 2008, CONSCIOUS COGN, V17, P535, DOI 10.1016/j.concog.2008.03.003; GOPNIK A, 1988, CHILD DEV, V59, P26, DOI 10.2307/1130386; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; SCAIFE M, 1975, NATURE, V253, P265, DOI 10.1038/253265a0; Schilbach L, 2008, SOC NEUROSCI, V3, P37, DOI 10.1080/17470910701563228; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; SCHEFLEN AE, 1964, PSYCHIATR, V27, P316; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Astington J. W., 1993, CHILDS DISCOVERY MIN; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Bavelas J. B., 1986, J PERS SOC PSYCHOL, V50, P323; Bernieri F. J., 1991, FUNDAMENTALS NONVERB, P401; CAPPELLA JN, 1981, PSYCHOL BULL, V89, P101, DOI 10.1037//0033-2909.89.1.101; CONDON WS, 1974, CHILD DEV, V45, P456, DOI 10.2307/1127968; Davies M., 1995, FOLK PSYCHOL THEORY; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Dennett D., 1978, BEHAVIOURAL BRAIN SC, V4, P568; Doherty M. J., 2009, THEORY MIND CHILDREN; Gallagher S, 2005, BODY SHAPES MIND; Gallagher S., 2004, PHILOS PSYCHIAT PSYC, V11, P199, DOI [10.1353/ppp.2004.0063, DOI 10.1353/PPP.2004.0063]; Gallagher S, 2012, PHENOMENOLOGICAL MIND, 2ND EDITION, P1; Gibson J. J., 1979, ECOLOGICAL APPROACH; Goldman A. I., 2006, SIMULATING MINDS PHI; Goldman A. I., 1989, MIND LANG, V4, P161, DOI 10.1111/j.1468-0017.1989.tb00249.x; Gopnik A, 2009, PHILOS BABY; Gordon R., 1986, MIND LANG, V1, P158, DOI 10.1111/j.1468-0017.1986.tb00324.x; Hatfield E., 1993, CURRENT DIRECTIONS P, V2, P96, DOI DOI 10.1111/1467-8721.EP10770953; Husserl Edmund, 1970, CARTESIAN MEDITATION; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Julien D., 2009, SOURCEBOOK NONVERBAL, P199; Kendon A., 1970, ACTA PSYCHOL, V32, P101, DOI DOI 10.1016/0001-6918(70)90094-6; Knapp M., 2010, NONVERBAL COMMUNICAT; Kono T, 2005, MIND EXTENDED ENV PR; Lafrance M., 1976, GROUP ORGAN STUD, V1, P328, DOI DOI 10.1177/105960117600100307; Merleau-Ponty M., 2012, PHENOMENOLOGY PERCEP; Merleau-Ponty M., 1964, SIGNS, P159; Merleau-Ponty Maurice, 1964, PRIMACY PERCEPTION, P96; Nagaoka C., 2006, JAPANESE J INTERPERS, V6, P101; Noe A., 2004, ACTION PERCEPTION; Rizzolatti Giacomo, 2008, MIRRORS IN THE BRAIN; Scheler M., 1954, NATURE SYMPATHY; Suzuki T, 2002, J PHILOS SCI SOC JAP, V35, P83; Tanaka S, 2014, ACAD QUARTER, V9, P265; Tanaka S., 2011, THEORETICAL PSYCHOL, P149; Tanaka S, 2013, B LIBERAL ARTS ED CT, V33, P101; Tanaka S, 2014, ENCY J PHENOMENOLOGY, V37, P47; Trees A. R., 2009, SOURCEBOOK NONVERBAL, P251; Varela F. J., 1991, EMBODIED MIND COGNIT	62	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0959-3543	1461-7447		THEOR PSYCHOL	Theory Psychol.	AUG	2015	25	4					455	472		10.1177/0959354315583035		18	Psychology, Multidisciplinary	Psychology	CO4SW	WOS:000359151900003		
J	Kashima, S; Fujiya, M; Konishi, H; Ueno, N; Inaba, Y; Moriichi, K; Tanabe, H; Ikuta, K; Ohtake, T; Kohgo, Y				Kashima, Shin; Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Inaba, Yuhei; Moriichi, Kentaro; Tanabe, Hiroki; Ikuta, Katsuya; Ohtake, Takaaki; Kohgo, Yutaka			Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis	TRANSLATIONAL RESEARCH			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; ULCERATIVE-COLITIS; CROHNS-DISEASE; MAINTAINING REMISSION; TGF-BETA; NECROTIZING ENTEROCOLITIS; ESCHERICHIA-COLI; RANDOMIZED-TRIAL	Inflammatory bowel disease frequently causes intestinal obstruction because of extensive fibrosis. This study investigated whether polyphosphate (poly P), an active molecule derived from Lactobacillus brevis, could improve the fibrosis in a model of chronic colitis. In this study, dextran sodium sulfate (DSS)-induced chronic colitis models and trinitrobenzene sulfonic acid (TNBS)-induced colitis models were used as models of fibrosis. To clarify the mechanism responsible for the observed effects, Caco-2/brush border epithelial (BBE) and naive T helper lymphocyte (THP)-1 cells were treated with lipopolysaccharide (LPS) to induce inflammation. Non-cancer human colon fibroblast (CCD-18) cells were treated with transforming growth factor beta 1 (TGF-beta 1) to induce fibrosis. The expression levels of fibrosis- and inflammation-associated molecules were evaluated by both a Western blotting analysis and reverse transcriptase-polymerase chain reaction (RT-PCR). The histologic inflammation and fibrosis were significantly improved in the group administered poly P in both the DSS and TNBS colitis models. The levels of interleukin 1 beta (IL-1 beta) and tumor necrosis factor alpha (INF-alpha) were significantly decreased by poly P treatment. The expression levels of TGF-beta 1 and collagens in the colitis mice were decreased by poly P. The LPS-induced expressions of IL-1 beta and TGF-beta 1 in Caco-2/BBE cells and of TNF-alpha in THP-1 cells were reduced by poly P treatment. Poly P did not affect the expression of collagens and connective tissue growth factor in the CCD-18 cells. In conclusion, poly P suppresses intestinal inflammation and fibrosis by downregulating the expression of inflammation- and fibrosis-associated molecules in the intestinal epithelium. The administration of poly P is therefore a novel option to treat fibrosis because of chronic intestinal inflammation.	[Kashima, Shin; Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Inaba, Yuhei; Moriichi, Kentaro; Tanabe, Hiroki; Ikuta, Katsuya; Ohtake, Takaaki; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan	Fujiya, M (reprint author), Asahikawa Med Coll, Dept Med, Div Gastroenterol & Hematol Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	fjym@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [23590931, 25860526, 22390148]; Ministry of Health, Labour and Welfare; Ishidsu Shun Memorial Scholarship, Japan	This study was supported by Grants-in-Aid for Scientific Research, no. 23590931 (M.F.), 25860526 (S.K.), and 22390148 (Y.K.) from Ministry of Education, Culture, Sports, Science and Technology in Japan, and Intractable Disease Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, and Ishidsu Shun Memorial Scholarship, Japan.	Allen SJ, 2004, COCHRANE DB SYST REV, V10, P1, DOI [10.1002/14651858.CD003048.pub3, DOI 10.1002/14651858]; Mahavadi S, 2011, INFLAMM BOWEL DIS, V17, P711, DOI 10.1002/ibd.21437; Zocco MA, 2006, ALIMENT PHARM THERAP, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2007.11.041; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Kato K, 2004, ALIMENT PHARM THERAP, V20, P1133, DOI 10.1111/j.1365-2036.2004.02268.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; D'Souza AL, 2002, BRIT MED J, V324, P1361, DOI 10.1136/bmj.324.7350.1361; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Elson CO, 1996, J IMMUNOL, V157, P2174; Hoffmann M, 2011, MOL NUTR FOOD RES, V55, P703, DOI 10.1002/mnfr.201000361; Hume GE, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040477; Johnson BC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub2; Kamada Nobuhiko, 2005, Inflamm Bowel Dis, V11, P455, DOI 10.1097/01.MIB.0000158158.55955.de; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Okamoto K, 2012, INT J COLORECTAL DIS, V27, P1039, DOI 10.1007/s00384-012-1416-8; Padgett RW, 1998, BIOESSAYS, V20, P382, DOI 10.1002/(SICI)1521-1878(199805)20:5<382::AID-BIES5>3.0.CO;2-Q; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Tamizifar B, 2008, WORLD J GASTROENTERO, V14, P243, DOI 10.3748/wjg.14.243	41	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	AUG	2015	166	2					163	175		10.1016/j.trsl.2015.02.002		13	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	CO0DY	WOS:000358821500005		
J	Mawatari, M; Isoda, A; Miyazawa, Y; Sawamura, M; Matsumoto, M				Mawatari, M.; Isoda, A.; Miyazawa, Y.; Sawamura, M.; Matsumoto, M.			A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation	TRANSPLANT INFECTIOUS DISEASE			English	Article						varicella zoster virus; herpes zoster; autologous hematopoietic stem cell transplantation; malignant lymphoma; multiple myeloma	BONE-MARROW-TRANSPLANTATION; LOW-DOSE ACYCLOVIR; HERPES-ZOSTER; RISK-FACTORS; DOUBLE-BLIND; INFECTION; PROPHYLAXIS; COMPLICATIONS; PREVENTION; RECIPIENTS	BackgroundVaricella zoster virus (VZV) reactivation following hematopoietic stem cell transplantation (SCT) is common. To help reduce its incidence and to identify predictive factors for VZV reactivation after autologous SCT (auto-SCT), we conducted a retrospective analysis in patients with hematologic malignancy at our hospital. MethodsWe conducted a single-hospital observational trial with a retrospective case-control analysis of post-auto-SCT VZV reactivation in patients with malignant lymphoma (ML) and multiple myeloma (MM) between January 2001 and December 2010, in the Department of Hematology at our hospital. First, we analyzed the cumulative incidence of VZV reactivation during the post-SCT period. Second, we conducted a case-control analysis to identify the risk factors for VZV reactivation within 1year after SCT. Univariate analyses were performed using Fisher's exact test for categorical variables. A multivariable model and logistic regression were used to assess the risk factors for VZV reactivation. ResultsWe included 97 patients in this study. The median duration of follow-up was 1027days. Forty-two patients experienced VZV reactivation after SCT, while 29 (69.0%) experienced reactivation within 1year after SCT. The cumulative incidence was 30.7% at 1year and 51.2% for the total observation period. Multivariate analysis showed that engraftment after day 10 was an independent risk factor for VZV reactivation (P=0.03). ConclusionsOur study showed a high incidence of VZV reactivation in the first year after auto-SCT in ML and MM patients. Patients with delayed engraftment are at high risk for VZV reactivation and should be considered for prolonged VZV prophylaxis.	[Mawatari, M.] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo 1628655, Japan; [Mawatari, M.; Isoda, A.; Miyazawa, Y.; Sawamura, M.; Matsumoto, M.] Nishigunma Natl Hosp, Div Hematol, Gunma, Japan	Mawatari, M (reprint author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Toyama1-21-1, Tokyo 1628655, Japan.	mawatamo@gmail.com					Akiyama H, 2000, Rinsho Ketsueki, V41, P20; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; LJUNGMAN P, 1986, J INFECT DIS, V153, P840; Kato H, 2010, ANN ONCOL, V21, P1699, DOI 10.1093/annonc/mdq008; Su SH, 2011, BIOL BLOOD MARROW TR, V17, P1012, DOI 10.1016/j.bbmt.2010.10.025; Erard V, 2007, BLOOD, V110, P3071, DOI 10.1182/blood-2007-03-077644; Kanda Y, 2001, BONE MARROW TRANSPL, V28, P689, DOI 10.1038/sj.bmt.1703214; Boeckh M, 2006, BLOOD, V107, P1800, DOI 10.1182/blood-2005-09-3624; LOCKSLEY RM, 1985, J INFECT DIS, V152, P1172; Koc Y, 2000, BIOL BLOOD MARROW TR, V6, P44, DOI 10.1016/S1083-8791(00)70051-6; Miller GG, 2007, AM J TRANSPLANT, V7, P741, DOI 10.1111/j.1600-6143.2006.01718.x; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Asano-Mori Y, 2008, AM J HEMATOL, V83, P472, DOI 10.1002/ajh.21152; ATKINSON K, 1980, TRANSPLANTATION, V29, P47, DOI 10.1097/00007890-198001000-00010; Blennow Ola, 2014, Biol Blood Marrow Transplant, V20, P1646, DOI 10.1016/j.bbmt.2014.06.002; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawasaki H, 1996, J PEDIATR-US, V128, P353, DOI 10.1016/S0022-3476(96)70280-9; Ketterer N, 1999, AM J MED, V106, P191, DOI 10.1016/S0002-9343(98)00409-4; Kim DH, 2008, TRANSPL INFECT DIS, V10, P90, DOI 10.1111/j.1399-3062.2007.00247.x; Klein A, 2011, BONE MARROW TRANSPL, V46, P294, DOI 10.1038/bmt.2010.99; Nakayama Hideki, 1995, Acta Paediatrica Japonica, V37, P302; Offidani M, 2001, CLIN INFECT DIS, V32, P1414, DOI 10.1086/320157; Onozawa M, 2009, BIOL BLOOD MARROW TR, V15, P724, DOI 10.1016/j.bbmt.2009.03.003; Rogers JE, 2011, TRANSPL INFECT DIS, V13, P480, DOI 10.1111/j.1399-3062.2011.00655.x; SCHUCHTER LM, 1989, BLOOD, V74, P1424; Steer CB, 2000, BONE MARROW TRANSPL, V25, P657, DOI 10.1038/sj.bmt.1702190	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	AUG	2015	17	4					544	550		10.1111/tid.12406		7	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	CO8NL	WOS:000359426300006		
J	Miyagi, T; Itonaga, H; Aosai, F; Taguchi, J; Norose, K; Mochizuki, K; Fujii, H; Furumoto, A; Ohama, M; Karimata, K; Yamanoha, A; Taniguchi, H; Sato, S; Taira, N; Moriuchi, Y; Fukushima, T; Masuzaki, H; Miyazaki, Y				Miyagi, T.; Itonaga, H.; Aosai, F.; Taguchi, J.; Norose, K.; Mochizuki, K.; Fujii, H.; Furumoto, A.; Ohama, M.; Karimata, K.; Yamanoha, A.; Taniguchi, H.; Sato, S.; Taira, N.; Moriuchi, Y.; Fukushima, T.; Masuzaki, H.; Miyazaki, Y.			Successful treatment of toxoplasmic encephalitis diagnosed early by polymerase chain reaction after allogeneic hematopoietic stem cell transplantation: two case reports and review of the literature	TRANSPLANT INFECTIOUS DISEASE			English	Article						Toxoplasma gondii; encephalitis; allogeneic hematopoietic stem cell transplantation	BONE-MARROW-TRANSPLANTATION; SEVERE PULMONARY TOXOPLASMOSIS; SINGLE-CENTER EXPERIENCE; GONDII INFECTION; RECIPIENTS; BLOOD; DISEASE	Toxoplasmic encephalitis represents a rare, but often fatal infection after allogeneic hematopoietic stem cell transplantation. Polymerase chain reaction (PCR)-based preemptive therapy is considered promising for this disease, but is not routinely applied, especially in low seroprevalence countries including Japan. We encountered 2 cases of toxoplasmic encephalitis after transplantation that were successfully treated. The diagnosis of toxoplasmic encephalitis in these cases was confirmed by PCR testing when neurological symptoms were observed. Both patients received pyrimethamine and sulfadiazine treatments within 2weeks of the development of neurological symptoms, and remained free of recurrence for 32 and 12months. These results emphasized the importance of the PCR test and immediate treatment after diagnosis for the management of toxoplasmic encephalitis.	[Miyagi, T.; Ohama, M.; Karimata, K.; Yamanoha, A.; Taira, N.] Heartlife Hosp, Dept Hematol, Okinawa, Japan; [Itonaga, H.; Taniguchi, H.; Sato, S.; Moriuchi, Y.] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan; [Aosai, F.; Norose, K.] Chiba Univ, Grad Sch Med, Dept Infect & Host Def, Chiba, Japan; [Aosai, F.] Shinshu Univ, Grad Sch Med, Dept Infect & Host Def, Matsumoto, Nagano 390, Japan; [Taguchi, J.; Miyazaki, Y.] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki 852, Japan; [Mochizuki, K.; Fujii, H.] Nagasaki Univ Hosp, Dept Infect Dis, Nagasaki, Japan; [Masuzaki, H.] Univ Ryukyus, Lab Hematoimmunol, Dept Clin Lab Sci, Sch Hlth Sci,Fac Med, Okinawa, Japan; [Masuzaki, H.] Univ Ryukyus, Div Endocrinol Diabet & Metab, Grad Sch Med, Hematol,Rheumatol,Dept Med 2, Okinawa, Japan	Itonaga, H (reprint author), Sasebo City Gen Hosp, Dept Hematol, 9-3 Hirase, Nagasaki 8578501, Japan.	itonaga-ngs@umin.ac.jp					Menotti J, 2003, J CLIN MICROBIOL, V41, P5313, DOI 10.1128/JCM.41.11.5313-5316.2003; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Delios AM, 2012, J NEURO-ONCOL, V110, P251, DOI 10.1007/s11060-012-0962-9; Chandrasekar PH, 1997, BONE MARROW TRANSPL, V19, P685, DOI 10.1038/sj.bmt.1700736; Sumi M, 2013, INT J HEMATOL, V98, P214, DOI 10.1007/s12185-013-1379-8; Fricker-Hidalgo H, 2009, CLIN INFECT DIS, V48, pE9, DOI 10.1086/595709; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787; Derouin F, 2008, CLIN MICROBIOL INFEC, V14, P1089, DOI 10.1111/j.1469-0691.2008.02091.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Sumi M, 2012, INTERNAL MED, V51, P2943, DOI 10.2169/internalmedicine.51.7837; Martino R, 2005, CLIN INFECT DIS, V40, P67, DOI 10.1086/426447; Mueller-Mang C, 2006, NEURORADIOLOGY, V48, P84, DOI 10.1007/s00234-005-0018-3; Mele A, 2002, BONE MARROW TRANSPL, V29, P691, DOI 10.1038/sj/bmt/1703425; Meers S, 2010, CLIN INFECT DIS, V50, P1127, DOI 10.1086/651266; Busemann C, 2012, ANN HEMATOL, V91, P1081, DOI 10.1007/s00277-012-1406-5; Cavattoni I, 2010, LEUKEMIA LYMPHOMA, V51, P1530, DOI 10.3109/10428194.2010.494260; Small TN, 2000, BONE MARROW TRANSPL, V25, P969, DOI 10.1038/sj.bmt.1702370; Martino R, 2000, CLIN INFECT DIS, V31, P1188, DOI 10.1086/317471; Aoun M, 2006, INT J ANTIMICROB AG, V27, P570, DOI 10.1016/j.ijantimicag.2006.04.001; Bautista G, 2012, TRANSPL INFECT DIS, V14, P496, DOI 10.1111/j.1399-3062.2012.00735.x; Delhaes L, 2010, BONE MARROW TRANSPL, V45, P580, DOI 10.1038/bmt.2009.167; desMedeiros BC, 2001, TRANSPL INFECT DIS, V3, P24; EMERSON RG, 1981, PEDIATRICS, V67, P653; Goebel WS, 2007, PEDIATR BLOOD CANCER, V48, P222, DOI 10.1002/pbc.20537; Kastrup Oliver, 2005, NeuroRx, V2, P324, DOI 10.1007/BF03206674; Laibe S, 2006, J CLIN MICROBIOL, V44, P646, DOI 10.1128/JCM.44.2.646-648.2006; Martino R, 2000, BONE MARROW TRANSPL, V25, P1111, DOI 10.1038/sj.bmt.1702396; Matsuo Y, 2007, EUR J HAEMATOL, V79, P317, DOI 10.1111/j.1600-0609.2007.00919.x; Mulanovich VE, 2011, BONE MARROW TRANSPL, V46, P273, DOI 10.1038/bmt.2010.102; Roemer E, 2001, CLIN INFECT DIS, V32, pE1, DOI 10.1086/317548; Saad R, 1996, BONE MARROW TRANSPL, V18, P211; Slavin MA, 2011, BONE MARROW TRANSPL, V46, P273	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	AUG	2015	17	4					593	598		10.1111/tid.12401		6	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	CO8NL	WOS:000359426300014		
J	Roman, H; Rapicault, M; Miclot, AS; Larenaudie, M; Kawamura, K; Thouroude, T; Chastellier, A; Lemarquand, A; Dupuis, F; Foucher, F; Loustau, S; Hibrand-St Oyant, L				Roman, H.; Rapicault, M.; Miclot, A. S.; Larenaudie, M.; Kawamura, K.; Thouroude, T.; Chastellier, A.; Lemarquand, A.; Dupuis, F.; Foucher, F.; Loustau, S.; Hibrand-St Oyant, L.			Genetic analysis of the flowering date and number of petals in rose	TREE GENETICS & GENOMES			English	Article						Rose; Date of flowering; Number of petals; Genetic determinism	PRUNUS-ARMENIACA L.; TRIFOLIATE ORANGE; AGRONOMIC TRAITS; AFLP MARKERS; TFL1 HOMOLOG; QTL ANALYSIS; ARABIDOPSIS; EXPRESSION; APRICOT; PEACH	Rose is the ornamental species with the highest financial impact. Floral traits such as the number of petals and the date of flowering are major characteristics of ornamental plants. Our objective is to study the genetic determinism of floral traits: date of flowering and number of petals, which are a major issue for rose breeders. The study was conducted on two interspecific populations interconnected by the male parent: H190 x hybrid of Rosa wichurana (referred to asHW) and "The Fairy" x hybrid of Rosa wichurana (referred to as FW). The number of petals and the date of flowering were scored over 2 and 8 years, respectively. A new HW genetic map covering 468 cM and the already available genetic map of the FW population (Kawamura et al. TAG Theor Appl Genet 122: 661-675, 2011) were used for the genetic determinism studies. In each population, half of the hybrids exhibited single flowers (less than 10 petals), whereas the other half revealed double flowers. The number of petals is controlled by the NP gene located on LG3. Additionally, we detected two new major quantitative trait loci (QTLs) on LG2 and LG5, close to RoAP1b and RoRAG, respectively, two genes involved in the control of floral identity. For the date of flowering, three QTLs with a major effect and high stability between years were found on linkage groups 3, 4, and 6, indicating a high stability of QTLs to the changing environment. Candidate genes underlying these QTLs were investigated and key genes were identified. These major QTLs were linked to candidate genes, i.e., the identified QTL on LG4 was linked to RoFT, the one on LG3 to genes involved in gibberellin pathways, and the one on LG6 to RoFD. These QTLs, which are very stable over time, are good candidates to develop markers applicable in marker-assisted selection (MAS).	[Roman, H.; Rapicault, M.; Miclot, A. S.; Larenaudie, M.; Kawamura, K.; Thouroude, T.; Chastellier, A.; Dupuis, F.; Foucher, F.; Hibrand-St Oyant, L.] INRA, Inst Rech Hort & Semences, UMR1345, F-49071 Beaucouze, France; [Roman, H.; Rapicault, M.; Miclot, A. S.; Larenaudie, M.; Kawamura, K.; Thouroude, T.; Chastellier, A.; Dupuis, F.; Foucher, F.; Hibrand-St Oyant, L.] Univ Angers, Inst Rech Hort & Semences, SFR QUASAV 4207, PRES UNAM,UMR1345, F-49045 Angers, France; [Roman, H.; Rapicault, M.; Miclot, A. S.; Larenaudie, M.; Kawamura, K.; Thouroude, T.; Chastellier, A.; Dupuis, F.; Foucher, F.; Hibrand-St Oyant, L.] Agrocampus Ouest, Inst Rech Hort & Semences, UMR1345, F-49045 Angers, France; [Kawamura, K.] Nagoya Univ, Hort Sci Lab, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Lemarquand, A.] INRA Angers Nantes Pays Loire, UE0449, F-49071 Beaucouze, France; [Loustau, S.] Univ Angers, LAREMA, F-49045 Angers, France	Hibrand-St Oyant, L (reprint author), INRA, Inst Rech Hort & Semences, UMR1345, F-49071 Beaucouze, France.	laurence.hibrand-saint-oyant@angers.inra.fr			CASDAR (compte d'affectation speciale pour le developpement agricole et rural) [1028]	We thank Claudine Foubert and the entire team of the experimental unit (INEM) of IRHS for their technical assistance in plant management. Christophe Brouard (UE Horti), Gilles Michel, and Sebastien Pineau are also gratefully acknowledged for their help in collecting data in the field. We thank the PTM ANAN (Muriel Bahut) of the SFR Quasav and the Gentyane platforms (especially Charles Poncet) for the SSR analyses. This research was supported by the CASDAR (compte d'affectation speciale pour le developpement agricole et rural No 1028). We thank Gail Wagman for her comments and the English correction of the manuscript.	Celton JM, 2011, NEW PHYTOL, V192, P378, DOI 10.1111/j.1469-8137.2011.03823.x; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Crespel L, 2002, THEOR APPL GENET, V105, P1207, DOI 10.1007/s00122-002-1102-2; Foster T, 2003, ANN BOT-LONDON, V92, P199, DOI 10.1093/aob/mcg120; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Socquet-Juglard D, 2013, PLANT MOL BIOL REP, V31, P387, DOI 10.1007/s11105-012-0511-x; Debener T, 1999, THEOR APPL GENET, V99, P891, DOI 10.1007/s001220051310; Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Fan S, 2010, NEW PHYTOL, V185, P917, DOI 10.1111/j.1469-8137.2009.03119.x; GARROD JF, 1974, ANN BOT-LONDON, V38, P1025; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Spiller M, 2011, THEOR APPL GENET, V122, P489, DOI 10.1007/s00122-010-1463-x; Dirlewanger E, 2012, HEREDITY, V109, P280, DOI 10.1038/hdy.2012.38; Kawamura K, 2011, THEOR APPL GENET, V122, P661, DOI 10.1007/s00122-010-1476-5; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Campoy JA, 2011, PLANT MOL BIOL REP, V29, P404, DOI 10.1007/s11105-010-0242-9; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Koning-Boucoiran CFS, 2012, THEOR APPL GENET, V125, P591, DOI 10.1007/s00122-012-1855-1; Romeu JF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-52; Linde M, 2006, THEOR APPL GENET, V113, P1081, DOI 10.1007/s00122-006-0367-2; Samach A, 2013, PLANT SCI, V207, P168, DOI 10.1016/j.plantsci.2013.02.006; Campoy JA, 2012, EUR J AGRON, V37, P43, DOI 10.1016/j.eja.2011.10.004; Chmelnitsky I, 2001, PLANT GROWTH REGUL, V35, P207, DOI 10.1023/A:1014465128264; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Colasanti J, 2008, MAIZE FLORAL TRANSIT, V1; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Dubois A, 2010, PLOS ONE, V5, P1; Dugo ML, 2005, THEOR APPL GENET, V111, P511, DOI 10.1007/s00122-005-2042-4; Fornara Fabio, 2010, Cell, V141, DOI 10.1016/j.cell.2010.04.024; Foucher F, 2008, GENOME, V51, P827, DOI 10.1139/G08-067; Hibrand-Saint Oyant L., 2008, Tree Genetics and Genomes, V4, P11; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Kotoda N, 2010, PLANT CELL PHYSIOL, V51, P561, DOI 10.1093/pcp/pcq021; Meng J, 2009, CONSERV GENET, V10, P1973, DOI 10.1007/s10592-009-9871-7; MEYNET J, 1994, AGRONOMIE, V14, P169, DOI 10.1051/agro:19940303; Napp-Zinn K, 1985, HDB FLOWERING, V1, P492; Nishikawa F, 2009, TREE PHYSIOL, V29, P921, DOI 10.1093/treephys/tpp021; Nishikawa F, 2010, TREE PHYSIOL, V30, P431, DOI 10.1093/treephys/tpp122; Oda A, 2012, J EXP BOT, V63, P1461, DOI 10.1093/jxb/err387; Quilot B, 2004, THEOR APPL GENET, V109, P884, DOI 10.1007/s00122-004-1703-z; Randoux M, 2012, J EXP BOT, V63, P6543, DOI 10.1093/jxb/ers310; Roberts AV, 1999, J PLANT GROWTH REGUL, V18, P113, DOI 10.1007/PL00007058; Sanchez-Perez R, 2007, PLANT BREEDING, V126, P310, DOI 10.1111/j.1439-0523.2007.01329.x; Shen LL, 2012, PLANT CELL TISS ORG, V108, P371, DOI 10.1007/s11240-011-0048-y; Sun Y, 2013, MOL BREEDING, V33, P821; Tanaka N, 2014, PLANT BIOTECHNOL-NAR, V31, P11, DOI 10.5511/plantbiotechnology.13.0912a; Tanaka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02641; Van Ooijen JW, 2004, MAPQTL 5 0 SOFTWARE; Van Ooijen JW, 2006, JOINMAP 4 0 SOFTWARE; Verde I, 2002, ACTA HORTIC, P291; Xing W, 2014, SCI HORTIC-AMSTERDAM, V172, P68, DOI 10.1016/j.scienta.2014.03.050; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083023; ZIESLIN N, 1992, SCI HORTIC-AMSTERDAM, V49, P305, DOI 10.1016/0304-4238(92)90166-A	57	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	AUG	2015	11	4							85	10.1007/s11295-015-0906-6		13	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CO8KG	WOS:000359417100022		
J	Silventoinen, K; Jelenkovic, A; Sund, R; Honda, C; Aaltonen, S; Yokoyama, Y; Tarnoki, AD; Tarnoki, DL; Ning, F; Ji, FL; Pang, ZC; Ordonana, JR; Sanchez-Romera, JF; Colodro-Conde, L; Burt, SA; Klump, KL; Medland, SE; Montgomery, GW; Kandler, C; McAdams, TA; Eley, TC; Gregory, AM; Saudino, KJ; Dubois, L; Boivin, M; Haworth, CMA; Plomin, R; Oncel, SY; Aliev, F; Stazi, MA; Fagnani, C; D'Ippolito, C; Craig, JM; Saffery, R; Siribaddana, SH; Hotopf, M; Sumathipala, A; Spector, T; Mangino, M; Lachance, G; Gatz, M; Butler, DA; Bayasgalan, G; Narandalai, D; Freitas, DL; Maia, JA; Harden, KP; Tucker-Drob, EM; Christensen, K; Skytthe, A; Kyvik, KO; Hong, CH; Chong, YS; Derom, CA; Vlietinck, RF; Loos, RJF; Cozen, W; Hwang, AE; Mack, TM; He, MG; Ding, XH; Chang, B; Silberg, JL; Eaves, LJ; Maes, HH; Cutler, TL; Hopper, JL; Aujard, K; Magnusson, PKE; Pedersen, NL; Aslan, AKD; Song, YM; Yang, S; Lee, KY; Baker, LA; Tuvblad, C; Bjerregaard-Andersen, M; Beck-Nielsen, H; Sodemann, M; Heikkila, K; Tan, QH; Zhang, DF; Swan, GE; Krasnow, R; Jang, KL; Knafo-Noam, A; Mankuta, D; Abramson, L; Lichtenstein, P; Krueger, RF; Mcgue, M; Pahlen, S; Tynelius, P; Duncan, GE; Buchwald, D; Corley, RP; Huibregtse, BM; Nelson, TL; Whitfield, KE; Franz, CE; Kremen, WS; Lyons, MJ; Ooki, S; Brandt, I; Nilsen, TS; Inui, F; Watanabe, M; Bartels, M; van Beijsterveldt, TCEM; Wardle, J; Llewellyn, CH; Fisher, A; Rebato, E; Martin, NG; Iwatani, Y; Hayakawa, K; Rasmussen, F; Sung, J; Harris, JR; Willemsen, G; Busjahn, A; Goldberg, JH; Boomsma, DI; Hur, YM; Sorensen, TIA; Kaprio, J				Silventoinen, Karri; Jelenkovic, Aline; Sund, Reijo; Honda, Chika; Aaltonen, Sari; Yokoyama, Yoshie; Tarnoki, Adam D.; Tarnoki, David L.; Ning, Feng; Ji, Fuling; Pang, Zengchang; Ordonana, Juan R.; Sanchez-Romera, Juan F.; Colodro-Conde, Lucia; Burt, S. Alexandra; Klump, Kelly L.; Medland, Sarah E.; Montgomery, Grant W.; Kandler, Christian; McAdams, Tom A.; Eley, Thalia C.; Gregory, Alice M.; Saudino, Kimberly J.; Dubois, Lise; Boivin, Michel; Haworth, Claire M. A.; Plomin, Robert; Oncel, Sevgi Y.; Aliev, Fazil; Stazi, Maria A.; Fagnani, Corrado; D'Ippolito, Cristina; Craig, Jeffrey M.; Saffery, Richard; Siribaddana, Sisira H.; Hotopf, Matthew; Sumathipala, Athula; Spector, Timothy; Mangino, Massimo; Lachance, Genevieve; Gatz, Margaret; Butler, David A.; Bayasgalan, Gombojav; Narandalai, Danshiitsoodol; Freitas, Duarte L.; Maia, Jose Antonio; Harden, K. Paige; Tucker-Drob, Elliot M.; Christensen, Kaare; Skytthe, Axel; Kyvik, Kirsten O.; Hong, Changhee; Chong, Youngsook; Derom, Catherine A.; Vlietinck, Robert F.; Loos, Ruth J. F.; Cozen, Wendy; Hwang, Amie E.; Mack, Thomas M.; He, Mingguang; Ding, Xiaohu; Chang, Billy; Silberg, Judy L.; Eaves, Lindon J.; Maes, Hermine H.; Cutler, Tessa L.; Hopper, John L.; Aujard, Kelly; Magnusson, Patrik K. E.; Pedersen, Nancy L.; Aslan, Anna K. Dahl; Song, Yun-Mi; Yang, Sarah; Lee, Kayoung; Baker, Laura A.; Tuvblad, Catherine; Bjerregaard-Andersen, Morten; Beck-Nielsen, Henning; Sodemann, Morten; Heikkila, Kauko; Tan, Qihua; Zhang, Dongfeng; Swan, Gary E.; Krasnow, Ruth; Jang, Kerry L.; Knafo-Noam, Ariel; Mankuta, David; Abramson, Lior; Lichtenstein, Paul; Krueger, Robert F.; Mcgue, Matt; Pahlen, Shandell; Tynelius, Per; Duncan, Glen E.; Buchwald, Dedra; Corley, Robin P.; Huibregtse, Brooke M.; Nelson, Tracy L.; Whitfield, Keith E.; Franz, Carol E.; Kremen, William S.; Lyons, Michael J.; Ooki, Syuichi; Brandt, Ingunn; Nilsen, Thomas Sevenius; Inui, Fujio; Watanabe, Mikio; Bartels, Meike; van Beijsterveldt, Toos C. E. M.; Wardle, Jane; Llewellyn, Clare H.; Fisher, Abigail; Rebato, Esther; Martin, Nicholas G.; Iwatani, Yoshinori; Hayakawa, Kazuo; Rasmussen, Finn; Sung, Joohon; Harris, Jennifer R.; Willemsen, Gonneke; Busjahn, Andreas; Goldberg, Jack H.; Boomsma, Dorret I.; Hur, Yoon-Mi; Sorensen, Thorkild I. A.; Kaprio, Jaakko			The CODATwins Project: The Cohort Description of Collaborative Project of Development of Anthropometrical Measures in Twins to Study Macro-Environmental Variation in Genetic and Environmental Effects on Anthropometric Traits	TWIN RESEARCH AND HUMAN GENETICS			English	Article						twins; height; BMI; heritability; international comparisons	BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; HUMAN OBESITY; ADOLESCENT DEVELOPMENT; SWEDISH TWIN; HEALTHY TWIN; ADULT HEIGHT; REARED APART; 8 COUNTRIES; REGISTRY	For over 100 years, the genetics of human anthropometric traits has attracted scientific interest. In particular, height and body mass index (BMI, calculated as kg/m(2)) have been under intensive genetic research. However, it is still largely unknown whether and how heritability estimates vary between human populations. Opportunities to address this question have increased recently because of the establishment of many new twin cohorts and the increasing accumulation of data in established twin cohorts. We started a new research project to analyze systematically (1) the variation of heritability estimates of height, BMI and their trajectories over the life course between birth cohorts, ethnicities and countries, and (2) to study the effects of birth-related factors, education and smoking on these anthropometric traits and whether these effects vary between twin cohorts. We identified 67 twin projects, including both monozygotic (MZ) and dizygotic (DZ) twins, using various sources. We asked for individual level data on height and weight including repeated measurements, birth related traits, background variables, education and smoking. By the end of 2014, 48 projects participated. Together, we have 893,458 height and weight measures (52% females) from 434,723 twin individuals, including 201,192 complete twin pairs (40% monozygotic, 40% same-sex dizygotic and 20% opposite-sex dizygotic) representing 22 countries. This project demonstrates that large-scale international twin studies are feasible and can promote the use of existing data for novel research purposes.	[Silventoinen, Karri; Jelenkovic, Aline; Sund, Reijo; Aaltonen, Sari] Univ Helsinki, Dept Social Res, FIN-00014 Helsinki, Finland; [Silventoinen, Karri; Honda, Chika; Inui, Fujio; Watanabe, Mikio; Iwatani, Yoshinori; Hayakawa, Kazuo] Osaka Univ, Grad Sch Med, Osaka, Japan; [Jelenkovic, Aline; Rebato, Esther] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Aaltonen, Sari; Heikkila, Kauko; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Yokoyama, Yoshie] Osaka City Univ, Dept Publ Hlth Nursing, Osaka 558, Japan; [Tarnoki, Adam D.; Tarnoki, David L.] Semmelweis Univ, Dept Radiol & Oncotherapy, H-1085 Budapest, Hungary; [Ning, Feng; Ji, Fuling; Pang, Zengchang] Qingdao Ctr Dis Control & Prevent, Dept Noncommunicable Dis Prevent, Qingdao, Peoples R China; [Ordonana, Juan R.; Colodro-Conde, Lucia] Univ Murcia, Dept Human Anat & Psychobiol, Murcia, Spain; [Ordonana, Juan R.; Sanchez-Romera, Juan F.] IMIB Arrixaca, Murcia, Spain; [Sanchez-Romera, Juan F.] Univ Murcia, Dept Dev & Educ Psychol, Murcia, Spain; [Colodro-Conde, Lucia; Medland, Sarah E.; Montgomery, Grant W.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Burt, S. Alexandra; Klump, Kelly L.] Michigan State Univ, E Lansing, MI 48824 USA; [Kandler, Christian] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [McAdams, Tom A.; Eley, Thalia C.; Plomin, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, London, England; [Gregory, Alice M.] Univ London, Dept Psychol, Goldsmiths, London, England; [Saudino, Kimberly J.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Dubois, Lise] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Boivin, Michel] Univ Laval, Ecole psychol, Quebec City, PQ, Canada; [Haworth, Claire M. A.] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Oncel, Sevgi Y.] Kirikkale Univ, Fac Arts & Sci, Dept Stat, Kirikkale, Turkey; [Aliev, Fazil] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; [Aliev, Fazil] Virginia Commonwealth Univ, Dept Psychol, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Aliev, Fazil; Silberg, Judy L.; Eaves, Lindon J.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Aliev, Fazil] Karabuk Univ, Dept Actuaria & Risk Management, Karabuk, Turkey; [Stazi, Maria A.; Fagnani, Corrado; D'Ippolito, Cristina] Natl Ctr Epidemiol Surveillance & Hlth Promot, Ist Super Sanita, Rome, Italy; [Craig, Jeffrey M.; Saffery, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Craig, Jeffrey M.; Saffery, Richard] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Siribaddana, Sisira H.; Sumathipala, Athula] Inst Res & Dev, Battaramulla, Sri Lanka; [Siribaddana, Sisira H.] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Saliyapura, Sri Lanka; [Hotopf, Matthew] South London & Maudsley NHS Fdn Trust, NIHR Mental Hlth Biomed Res Ctr, London, England; [Hotopf, Matthew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Sumathipala, Athula] Keele Univ, Fac Hlth, SPCR, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England; [Spector, Timothy; Mangino, Massimo; Lachance, Genevieve] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Gatz, Margaret; Baker, Laura A.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Butler, David A.] Natl Acad Sci, Inst Med, Washington, DC 20418 USA; [Bayasgalan, Gombojav; Narandalai, Danshiitsoodol] Healthy Twin Assoc Mongolia, Ulaanbaatar, Mongol Peo Rep; [Narandalai, Danshiitsoodol] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Freitas, Duarte L.] Univ Madeira, Dept Phys Educ & Sport, Funchal, Portugal; [Maia, Jose Antonio] Univ Porto, Fac Sport, CIFI2D, P-4100 Oporto, Portugal; [Harden, K. Paige; Tucker-Drob, Elliot M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Christensen, Kaare; Skytthe, Axel] Univ Southern Denmark, Inst Publ Hlth Epidemiol Biostat & Biodemog, Danish Twin Registry, Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Kyvik, Kirsten O.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Kyvik, Kirsten O.] Odense Univ Hosp, Odense Patient data Explorat Network OPEN, DK-5000 Odense, Denmark; [Hong, Changhee; Chong, Youngsook] Pusan Natl Univ, Dept Psychol, Busan, South Korea; [Derom, Catherine A.; Vlietinck, Robert F.] Katholieke Univ Leuven Hosp, Ctr Human Genet, Louvain, Belgium; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, Charles Bronfman Inst Personalized Med, New York, NY USA; [Cozen, Wendy; Hwang, Amie E.; Mack, Thomas M.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Cozen, Wendy; Mack, Thomas M.] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA; [He, Mingguang; Ding, Xiaohu; Chang, Billy] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [He, Mingguang] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Maes, Hermine H.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Psychiat & Massey Canc Ctr, Richmond, VA USA; [Cutler, Tessa L.] Univ Melbourne, Ctr Epidemiol & Biostat, Australian Twin Registry, Melbourne, Vic, Australia; [Hopper, John L.; Yang, Sarah; Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Aujard, Kelly] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Magnusson, Patrik K. E.; Pedersen, Nancy L.; Aslan, Anna K. Dahl; Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Aslan, Anna K. Dahl] Jonkoping Univ, Sch Hlth Sci, Inst Gerontol, Jonkoping, Sweden; [Song, Yun-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Yang, Sarah; Sung, Joohon] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Lee, Kayoung] Inje Univ, Coll Med, Busan Paik Hosp, Dept Family Med, Busan, South Korea; [Tuvblad, Catherine] Univ Orebro, Sch Law Psychol & Social Work, SE-70182 Orebro, Sweden; [Bjerregaard-Andersen, Morten] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Bjerregaard-Andersen, Morten] Statens Serum Inst, Res Ctr Vitamins & Vaccines, DK-2300 Copenhagen, Denmark; [Bjerregaard-Andersen, Morten; Beck-Nielsen, Henning] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Sodemann, Morten] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Inst Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark; [Zhang, Dongfeng] Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao, Peoples R China; [Swan, Gary E.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Krasnow, Ruth] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA; [Jang, Kerry L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Knafo-Noam, Ariel; Abramson, Lior] Hebrew Univ Jerusalem, Jerusalem, Israel; [Mankuta, David] Hebrew Univ Jerusalem, Sch Med, Hadassah Hosp, Dept Obstet & Gynecol, IL-91010 Jerusalem, Israel; [Krueger, Robert F.; Mcgue, Matt; Pahlen, Shandell] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Duncan, Glen E.; Buchwald, Dedra] Univ Washington, Ctr Clin & Epidemiol Res, Seattle, WA 98195 USA; [Corley, Robin P.; Huibregtse, Brooke M.] Inst Behav Genet, Boulder, CO USA; [Nelson, Tracy L.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Nelson, Tracy L.] Colorado State Univ, Colorado Sch Publ Hlth, Ft Collins, CO 80523 USA; [Whitfield, Keith E.] Duke Univ, Psychol & Neurosci, Durham, NC USA; [Franz, Carol E.; Kremen, William S.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Kremen, William S.] VA San Diego Ctr Excellence Stress & Mental Hlt, La Jolla, CA USA; [Lyons, Michael J.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Ooki, Syuichi] Ishikawa Prefectural Nursing Univ, Dept Hlth Sci, Kahoku, Ishikawa, Japan; [Brandt, Ingunn; Nilsen, Thomas Sevenius] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway; [Inui, Fujio] Kio Univ, Fac Hlth Sci, Nara, Japan; [Bartels, Meike; van Beijsterveldt, Toos C. E. M.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Wardle, Jane; Llewellyn, Clare H.; Fisher, Abigail] UCL, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, Inst Epidemiol & Hlth Care, London, England; [Busjahn, Andreas] HlthTwiSt GmbH, Berlin, Germany; [Goldberg, Jack H.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Hur, Yoon-Mi] Mokpo Natl Univ, Dept Educ, Jeonnam, South Korea; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res,Sect Metab Genet, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, The Capital Reg, Denmark; [Sorensen, Thorkild I. A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Helsinki, Finland; [Kaprio, Jaakko] Inst Mol Med FIMM, Helsinki, Finland	Silventoinen, K (reprint author), Univ Helsinki, Dept Social Res, Populat Res Unit, POB 18, FIN-00014 Helsinki, Finland.	karri.silventoinen@helsinki.fi	mangino, massimo/F-5134-2011; Montgomery, Grant/B-7148-2008; Craig, Jeffrey/B-3484-2012; Medland, Sarah/C-7630-2013; 	Montgomery, Grant/0000-0002-4140-8139; Craig, Jeffrey/0000-0003-3979-7849; Gatz, Margaret/0000-0002-1071-9970; lee, kayoung/0000-0002-2816-554X; Medland, Sarah/0000-0003-1382-380X; Martin, Nicholas/0000-0003-4069-8020; Plomin, Robert/0000-0002-0756-3629; Huibregtse, Brooke/0000-0003-0977-7249	National Institute of Mental Health [R01 MH58354]; National Institute on Aging [1RO1-AG13662-01A2]; National Institutes of Health [R21 AG039572]; WT Grant Foundation; University of London Central Research fund; Medical Research Council [G81/343, G120/635]; Economic and Social Research Council [RES-000-22-2206]; Institute of Social Psychiatry [06/07-11]; Leverhulme Research Fellowship [RF/2/RFG/2008/0145]; Goldsmiths; University of London; National Research Foundation of Korea [NRF-371-2011-1B00047]; Danish Agency for Science, Technology and Innovation; Research Council for Health and Disease; Velux Foundation; US National Institute of Health [P01 AG08761]; Fund of Scientific Research, Flanders; Twins, a non-profit Association for Scientific Research in Multiple Births (Belgium); Global Research Network Program of the National Research Foundation [NRF 2011-220-E00006]; NIDA [DA011015]; Longitudinal Twin Study [HD10333]; National Institute of Health grants [NIA R01 AG018384, R01 AG018386, R01 AG022381, R01 AG022982]; Cooperative Studies Program of the Office of Research & Development of the United States Department of Veterans Affairs; Centre of Research Excellence from the National Health and Medical Research Council [1079102]; Michigan State University from the National Institute of Mental Health (NIMH) [R01-MH081813, R01-MH0820-54, R01-MH092377-02, R21-MH070542-01, R03-MH63851-01]; Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) [R01-HD066040]; MSU Foundation [11-SPG-2518]; California Tobacco-Related Disease Research Program [7RT-0134H, 8RT-0107H, 6RT-0354H]; The National Institutes of Health [1R01ESO15150-01]; National Natural Science Foundation of China [81125007]; Australian National Health and Medical Research Council [437015, 607358]; Bonnie Babes Foundation [BBF20704]; Financial Markets Foundation for Children [032-2007]; Victorian Government's Operational Infrastructure Support Program; ENGAGE-European Network for Genetic and Genomic Epidemiology [201413]; National Institute of Alcohol Abuse and Alcoholism [AA-12502, AA-00145, AA-09203]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Academy of Finland [100499, 205585, 118555, 141054, 265240, 263278, 264146]; Osaka University's International Joint Research Promotion Program; Kirikkale University Research Grant: KKU; TUBITAK [114C117]; European Research Council (ERC) [240994]; European Union's Seventh Framework Programmes ENGAGE Consortium [HEALTH-F4-2007-201413]; BioSHaRE EU [HEALTH-F4-2010-261433]; Seneca Foundation; Regional Agency for Science and Technology, Murcia, Spain [08633/PHCS/08, 15302/PHCS/10]; Ministry of Science and Innovation, Spain [PSI11560-2009]; UK Medical Research Council [G0901245]; UK Biotechnology and Biological Sciences Research Council [31/D19086]; Portuguese agency for research (The Foundation for Science and Technology) [POCI/DES/56834/2004]; National Institutes of Health. [R01 HD068435, R01 MH062375]; Wellcome Trust; European Community's Seventh Framework Programme; National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Netherlands Organization for Scientific Research (NWO); MagW/ZonMW [904-61-090, 985-10-002, 912-10-020, 904-61-193, 480-04-004, 463-06-001, 451-04-034, 400-05-717, Addiction-31160008, Middelgroot-911-09-032, Spinozapremie 56-464-14192]; VU University's Institute for Health and Care Research (EMGO+); European Research Council [ERC-230374]; Avera Institute, Sioux Falls, South Dakota (USA); Cancer Research UK [C1418/A7974];  [5T32DA017637-10];  [NIH RC2 HL103416]	This study was conducted within the CODATwins project (Academy of Finland #266592). Support for participating twin projects: the University of Southern California Twin Study is funded by a grant from the National Institute of Mental Health (R01 MH58354). The Carolina African American Twin Study of Aging (CAATSA) was funded by a grant from the National Institute on Aging (grant 1RO1-AG13662-01A2) to K. E. Whitfield. The NAS-NRC Twin Registry acknowledges financial support from the National Institutes of Health grant number R21 AG039572. Waves 1-3 of Genesis 12-19 were funded by the WT Grant Foundation, the University of London Central Research fund and a Medical Research Council Training Fellowship (G81/343) and Career Development Award (G120/635) to Thalia C. Eley. Wave 4 was supported by grants from the Economic and Social Research Council (RES-000-22-2206) and the Institute of Social Psychiatry (06/07-11) to Alice M. Gregory who was also supported at that time by a Leverhulme Research Fellowship (RF/2/RFG/2008/0145). Wave 5 was supported by funding to Alice M. Gregory from Goldsmiths, University of London. Anthropometric measurements of the Hungarian twins were supported by Medexpert Ltd., Budapest, Hungary. South Korea Twin Registry is supported by National Research Foundation of Korea (NRF-371-2011-1B00047). The Danish Twin Registry is supported by the National Program for Research Infrastructure 2007 from the Danish Agency for Science, Technology and Innovation, The Research Council for Health and Disease, the Velux Foundation and the US National Institute of Health (P01 AG08761). Since its origin, the East Flanders Prospective Survey has been partly supported by grants from the Fund of Scientific Research, Flanders and Twins, a non-profit Association for Scientific Research in Multiple Births (Belgium). Korean Twin-Family Register was supported by the Global Research Network Program of the National Research Foundation (NRF 2011-220-E00006). The Colorado Twin Registry is funded by NIDA funded center grant DA011015 and Longitudinal Twin Study HD10333; Author Huibregtse is supported by 5T32DA017637-10. The Vietnam Era Twin Study of Aging was supported by National Institute of Health grants NIA R01 AG018384, R01 AG018386, R01 AG022381, and R01 AG022982, and, in part, with resources of the VA San Diego Center of Excellence for Stress and Mental Health. The Cooperative Studies Program of the Office of Research & Development of the United States Department of Veterans Affairs has provided financial support for the development and maintenance of the Vietnam Era Twin (VET) Registry. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIA/NIH, or the VA. The Australian Twin Registry is supported by a Centre of Research Excellence (grant ID 1079102) from the National Health and Medical Research Council administered by the University of Melbourne. The Michigan State University Twin Registry has been supported by Michigan State University, as well as grants R01-MH081813, R01-MH0820-54, R01-MH092377-02, R21-MH070542-01, R03-MH63851-01 from the National Institute of Mental Health (NIMH), R01-HD066040 from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD), and 11-SPG-2518 from the MSU Foundation. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH, the NICHD, or the National Institutes of Health.; The California Twin Program was supported by The California Tobacco-Related Disease Research Program (7RT-0134H, 8RT-0107H, 6RT-0354H) and the National Institutes of Health (1R01ESO15150-01). The Guangzhou Twin Eye Study is supported by National Natural Science Foundation of China (grant #81125007). PETS was supported by grants from the Australian National Health and Medical Research Council (grant numbers 437015 and 607358 to JC, and RS), the Bonnie Babes Foundation (grant number BBF20704 to JMC), the Financial Markets Foundation for Children (grant no. 032-2007 to JMC), and by the Victorian Government's Operational Infrastructure Support Program. Data collection and analyses in Finnish twin cohorts have been supported by ENGAGE-European Network for Genetic and Genomic Epidemiology, FP7-HEALTH-F4-2007, grant agreement number 201413, National Institute of Alcohol Abuse and Alcoholism (grants AA-12502, AA-00145, and AA-09203 to R. J. Rose, the Academy of Finland Center of Excellence in Complex Disease Genetics (grant numbers: 213506, 129680), and the Academy of Finland (grants 100499, 205585, 118555, 141054, 265240, 263278 and 264146 to J. Kaprio). K. Silventoinen is supported by Osaka University's International Joint Research Promotion Program. S. Y. Oncel and F. Aliev are supported by Kirikkale University Research Grant: KKU, 2009/43 and TUBITAK grant 114C117. The Longitudinal Israeli Study of Twins was funded by the Starting Grant no. 240994 from the European Research Council (ERC) to Ariel Knafo. Data collection and research stemming from the Norwegian Twin Registry is supported, in part, from the European Union's Seventh Framework Programmes ENGAGE Consortium (grant agreement HEALTH-F4-2007-201413, and BioSHaRE EU (grant agreement HEALTH-F4-2010-261433). The Murcia Twin Registry is supported by the Seneca Foundation, Regional Agency for Science and Technology, Murcia, Spain (08633/PHCS/08 & 15302/PHCS/10) and Ministry of Science and Innovation, Spain (PSI11560-2009). The Twins Early Development Study (TEDS) is supported by a program grant (G0901245) from the UK Medical Research Council and the work on obesity in TEDS is supported in part by a grant from the UK Biotechnology and Biological Sciences Research Council (31/D19086). The Madeira data comes from the following project: genetic and environmental influences on physical activity, fitness, and health: the Madeira family study Project reference: POCI/DES/56834/2004 founded by the Portuguese agency for research (The Foundation for Science and Technology). The Boston University Twin Project is funded by grants (#R01 HD068435 #R01 MH062375) from the National Institutes of Health to K. Saudino. TwinsUK was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The University of Washington Twin Registry is supported by the grant NIH RC2 HL103416 (D. Buchwald, PI). The Netherlands Twin Register acknowledges the Netherlands Organization for Scientific Research (NWO) and MagW/ZonMW grants 904-61-090, 985-10-002, 912-10-020, 904-61-193,480-04-004, 463-06-001, 451-04-034, 400-05-717, Addiction-31160008, Middelgroot-911-09-032, Spinozapremie 56-464-14192; VU University's Institute for Health and Care Research (EMGO+); the European Research Council (ERC-230374), the Avera Institute, Sioux Falls, South Dakota (USA).; Gemini was supported by a grant from Cancer Research UK (C1418/A7974).	Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Lajunen HR, 2012, OBESITY, V20, P583, DOI 10.1038/oby.2011.304; Kaprio J, 2013, TWIN RES HUM GENET, V16, P157, DOI 10.1017/thg.2012.142; van Jaarsveld CHM, 2010, TWIN RES HUM GENET, V13, P72, DOI 10.1375/twin.13.1.72; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; Zheng YF, 2013, TWIN RES HUM GENET, V16, P73, DOI 10.1017/thg.2012.120; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Hur YM, 2008, INT J OBESITY, V32, P1455, DOI 10.1038/ijo.2008.144; Hur YM, 2013, TWIN RES HUM GENET, V16, P1, DOI 10.1017/thg.2012.147; Hur YM, 2013, TWIN RES HUM GENET, V16, P237, DOI 10.1017/thg.2012.123; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Kremen WS, 2013, TWIN RES HUM GENET, V16, P399, DOI 10.1017/thg.2012.86; Strachan E, 2013, TWIN RES HUM GENET, V16, P455, DOI 10.1017/thg.2012.124; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Brescianini S, 2013, TWIN RES HUM GENET, V16, P190, DOI 10.1017/thg.2012.85; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Rhea SA, 2013, TWIN RES HUM GENET, V16, P351, DOI 10.1017/thg.2012.93; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Burt SA, 2013, TWIN RES HUM GENET, V16, P344, DOI 10.1017/thg.2012.87; Loke YJ, 2013, TWIN RES HUM GENET, V16, P13, DOI 10.1017/thg.2012.114; Skytthe A, 2013, TWIN RES HUM GENET, V16, P104, DOI 10.1017/thg.2012.77; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/136905203770326411; Ordonana JR, 2013, TWIN RES HUM GENET, V16, P302, DOI 10.1017/thg.2012.66; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Baker LA, 2013, TWIN RES HUM GENET, V16, P336, DOI 10.1017/thg.2012.127; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Gombojav B, 2013, TWIN RES HUM GENET, V16, P241, DOI 10.1017/thg.2012.130; McAdams TA, 2013, TWIN RES HUM GENET, V16, P134, DOI 10.1017/thg.2012.83; Harden KP, 2013, TWIN RES HUM GENET, V16, P385, DOI 10.1017/thg.2012.97; Nilsen TS, 2013, TWIN RES HUM GENET, V16, P285, DOI 10.1017/thg.2012.117; Iacono WG, 2002, TWIN RES, V5, P482, DOI 10.1375/136905202320906327; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Boivin M, 2013, TWIN RES HUM GENET, V16, P64, DOI 10.1017/thg.2012.129; Avinun R, 2013, TWIN RES HUM GENET, V16, P197, DOI 10.1017/thg.2012.73; Bjerregaard-Andersen M, 2013, TWIN RES HUM GENET, V16, P179, DOI 10.1017/thg.2012.90; Buchwald D, 2014, TWIN RES HUM GENET, V17, P574, DOI 10.1017/thg.2014.67; Busjahn A, 2013, TWIN RES HUM GENET, V16, P163, DOI 10.1017/thg.2012.95; Cozen W, 2013, TWIN RES HUM GENET, V16, P366, DOI 10.1017/thg.2012.134; Dahl AK, 2014, INT J OBESITY, V38, P1133, DOI 10.1038/ijo.2013.204; Davenport C. B., 1923, BODY BUILD ITS INHER; Derom C, 2013, TWIN RES HUM GENET, V16, P58, DOI 10.1017/thg.2012.75; Duan HP, 2013, TWIN RES HUM GENET, V16, P79, DOI 10.1017/thg.2012.113; Dubois L., 2012, PLOS ONE, V7, P1; Elks C.E., 2012, FRONT ENDOCRINOL, V28, P1; Eveleth P. B., 2003, WORLDWIDE VARIATION, V2nd; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Galton F, 1886, J ANTHR I, V15, P246, DOI 10.2307/2841583; Gatz M., 2014, INT J EPIDEMIOLOGY; Gombojav B, 2013, TWIN RES HUM GENET, V16, P248, DOI 10.1017/thg.2012.132; Hao YC, 2013, HUM GENET, V132, P681, DOI 10.1007/s00439-013-1280-9; Hayakawa K, 2013, TWIN RES HUM GENET, V16, P217, DOI 10.1017/thg.2012.141; Hopper JL, 2013, TWIN RES HUM GENET, V16, P34, DOI 10.1017/thg.2012.121; Jang KL, 2013, TWIN RES HUM GENET, V16, P70, DOI 10.1017/thg.2012.70; Kandler C, 2013, TWIN RES HUM GENET, V16, P167, DOI 10.1017/thg.2012.67; Krasnow RE, 2013, TWIN RES HUM GENET, V16, P463, DOI 10.1017/thg.2012.81; Krueger RF, 2002, TWIN RES, V5, P488, DOI 10.1375/136905202320906336; LANGINVAINIO H, 1984, ACTA GENET MED GEMEL, V33, P251; Lango AH, 2010, NATURE, V467, P832, DOI DOI 10.1038/NATURE09410; Lichtenstein P, 2007, TWIN RES HUM GENET, V10, P67, DOI 10.1375/twin.10.1.67; Lilley ECH, 2013, TWIN RES HUM GENET, V16, P424, DOI 10.1017/thg.2012.125; Littvay L, 2013, TWIN RES HUM GENET, V16, P185, DOI 10.1017/thg.2012.76; Maia JAR, 2013, TWIN RES HUM GENET, V16, P296, DOI 10.1017/thg.2012.128; N'Diaye A., 2011, PLOS GENET, V7, P1; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Oncel SY, 2013, TWIN RES HUM GENET, V16, P333, DOI 10.1017/thg.2012.94; Ooki S, 2013, TWIN RES HUM GENET, V16, P221, DOI 10.1017/thg.2012.103; Pearson K., 1903, BIOMETRIKA, V2, P356; Pietilainen K. H., 2008, PLOS MED, V5, pe51, DOI DOI 10.1371/J0URNAL.PMED.0050051; Rasmussen F, 2006, TWIN RES HUM GENET, V9, P883, DOI 10.1375/183242706779462741; Rokholm B., 2011, PLOS ONE, V6, P1; Saudino KJ, 2013, TWIN RES HUM GENET, V16, P449, DOI 10.1017/thg.2012.64; Schizophrenia Working Group of the Psychiatric Genomics C, 2014, NATURE, V511, P421, DOI DOI 10.1038/NATURE13595; SELTZER CC, 1966, ANN NY ACAD SCI, V134, P688, DOI 10.1111/j.1749-6632.1966.tb43055.x; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Sumathipala A, 2013, TWIN RES HUM GENET, V16, P307, DOI 10.1017/thg.2012.119; Sung J, 2006, INT J EPIDEMIOL, V35, P488, DOI 10.1093/ije/dyi294; van Beijsterveldt CEM, 2013, TWIN RES HUM GENET, V16, P252, DOI 10.1017/thg.2012.118; Whitfield KE, 2013, TWIN RES HUM GENET, V16, P476, DOI 10.1017/thg.2012.79; Yokoyama Y, 2013, TWIN RES HUM GENET, V16, P231, DOI 10.1017/thg.2012.82	90	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1832-4274	1839-2628		TWIN RES HUM GENET	Twin Res. Hum. Genet.	AUG	2015	18	4					348	360		10.1017/thg.2015.29		13	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	CO0WM	WOS:000358874400002		
J	Tanaka, S; Miyazawa-Onami, M; Iida, T; Araki, H				Tanaka, Seiji; Miyazawa-Onami, Mayumi; Iida, Tetsushi; Araki, Hiroyuki			iAID: an improved auxin-inducible degron system for the construction of a 'tight' conditional mutant in the budding yeast Saccharomyces cerevisiae	YEAST			English	Article						auxin-inducible degron; Mcm10; Dpb11; S. cerevisiae; conditional mutant	DNA-REPLICATION; GENE-EXPRESSION; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; PROTEINS; EFFICIENT; VERSATILE; PHASE; DISRUPTION; PROMOTERS	Isolation of a 'tight' conditional mutant of a gene of interest is an effective way of studying the functions of essential genes. Strategies that use ubiquitin-mediated protein degradation to eliminate the product of a gene of interest, such as heat-inducible degron (td) and auxin-inducible degron (AID), are powerful methods for constructing conditional mutants. However, these methods do not work with some genes. Here, we describe an improved AID system (iAID) for isolating tight conditional mutants in the budding yeast Saccharomyces cerevisiae. In this method, transcriptional repression by the 'Tet-OFF' promoter is combined with proteolytic elimination of the target protein by the AID system. To provide examples, we describe the construction of tight mutants of the replication factors Dpb11 and Mcm10, dpb11-iAID, and mcm10-iAID. Because Dpb11 and Mcm10 are required for the initiation of DNA replication, their tight mutants are unable to enter S phase. This is the case for dpb11-iAID and mcm10-iAID cells after the addition of tetracycline and auxin. Both the 'Tet-OFF' promoter and the AID system have been shown to work in model eukaryotes other than budding yeast. Therefore, the iAID system is not only useful in budding yeast, but also can be applied to other model systems to isolate tight conditional mutants. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Tanaka, Seiji; Miyazawa-Onami, Mayumi; Araki, Hiroyuki] Natl Inst Genet, Div Microbial Genet, Mishima, Shizuoka 4118540, Japan; [Iida, Tetsushi] Natl Inst Genet, Cytogenet Div, Mishima, Shizuoka 4118540, Japan; [Tanaka, Seiji; Iida, Tetsushi; Araki, Hiroyuki] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Genet, Mishima, Shizuoka, Japan	Tanaka, S (reprint author), Natl Inst Genet, Div Microbial Genet, Mishima, Shizuoka 4118540, Japan.	setanaka@nig.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [24370075, 25131721, 26114716, 2664017]	We thank H. Masukata, M. Yagura and Y. Tanaka for discussions and M. Kanemaki for the plasmids for the original AID system. This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS; Grant Nos 24370075, 25131721 and 26114716 to S.T., and 2664017 to T.I.).	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Labib K, 2001, MOL BIOL CELL, V12, P3658; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Kubota T, 2013, MOL CELL, V50, P273, DOI 10.1016/j.molcel.2013.02.012; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Kanke M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-8; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; vansDeursen F, 2012, EMBO J, V31, P2195; Zilio N, 2012, YEAST, V29, P425, DOI 10.1002/yea.2920	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	AUG	2015	32	8					567	581		10.1002/yea.3080		15	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CO3LT	WOS:000359059800003		
J	Yazawa, T; Imamichi, Y; Miyamoto, K; Khan, MRI; Uwada, J; Umezawa, A; Taniguchi, T				Yazawa, Takashi; Imamichi, Yoshitaka; Miyamoto, Kaoru; Khan, Md. Rafiqul Islam; Uwada, Junsuke; Umezawa, Akihiro; Taniguchi, Takanobu			Regulation of Steroidogenesis, Development, and Cell Differentiation by Steroidogenic Factor-1 and Liver Receptor Homolog-1	ZOOLOGICAL SCIENCE			English	Review						steroidogenesis; transcriptional regulation; gonad; adrenal; steroidogenic factor-1; liver receptor homolog-1	ORPHAN NUCLEAR RECEPTOR; OVARIAN GRANULOSA-CELLS; MESENCHYMAL STEM-CELLS; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; ADRENAL NCI-H295A CELLS; PROTEIN STAR GENE; TRANSCRIPTION FACTOR; BINDING-PROTEIN; GLUCOCORTICOID SYNTHESIS; PROGESTERONE PRODUCTION	Steroidogenic factor-1 (SF-1) and liver receptor homolog-1 (LRH-1) belong to the nuclear receptor superfamily and are categorized as orphan receptors. In addition to other nuclear receptors, these play roles in various physiological phenomena by regulating the transcription of target genes. Both factors share very similar structures and exhibit common functions. Of these, the roles of SF-1 and LRH-1 in steroidogenesis are the most important, especially that of SF-1, which was originally discovered and named to reflect such roles. SF-1 and LRH-1 are essential for steroid hormone production in gonads and adrenal glands through the regulation of various steroidogenesis-related genes. As SF-1 is also necessary for the development of gonads and adrenal glands, it is also considered a master regulator of steroidogenesis. Recent studies have clearly demonstrated that LRH-1 also represents another master regulator of steroidogenesis, which similarly to SF-1, can induce differentiation of non-steroidogenic stem cells into steroidogenic cells. Here, we review the functions of both factors in these steroidogenesis-related phenomena.	[Yazawa, Takashi; Khan, Md. Rafiqul Islam; Uwada, Junsuke; Taniguchi, Takanobu] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan; [Imamichi, Yoshitaka; Miyamoto, Kaoru] Univ Fukui, Dept Biochem, Fac Med Sci, Fukui 9101193, Japan; [Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	Yazawa, T (reprint author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	yazawa@asahikawa-med.ac.jp			JSPS KAKENHI - Japan Society for the Promotion of Science [23590329, 25460378, 26860170]; Smoking Research Foundation; fund for Asahikawa Medical University Creative Research in the Field of Life Science	We thank Ms. S. Tsunoda for administrative support. This work was supported in part by JSPS KAKENHI Grant Number 23590329 (Grant-in-Aid for Scientific Research (C)), 25460378 (Grant-in-Aid for Scientific Research (C)) and 26860170 (Grant-in-Aid for Young Scientists (B)) granted by Japan Society for the Promotion of Science, the Smoking Research Foundation, and the fund for Asahikawa Medical University Creative Research in the Field of Life Science.	Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Yazawa T, 2006, ENDOCRINOLOGY, V147, P4104, DOI 10.1210/en.2006-0162; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; MILLER WL, 1988, ENDOCR REV, V9, P295; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Peng N, 2003, J CLIN ENDOCR METAB, V88, P6020, DOI 10.1210/jc.2003-030880; Labelle-Dumais C, 2007, BIOL REPROD, V77, P217, DOI 10.1095/biolreprod.106.059121; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Morohashi K, 1999, BLOOD, V93, P1586; Hu MC, 2001, MOL ENDOCRINOL, V15, P812, DOI 10.1210/me.15.5.812; Benod C, 2011, P NATL ACAD SCI USA, V108, P16927, DOI 10.1073/pnas.1112047108; Ramayya MS, 1997, J CLIN ENDOCR METAB, V82, P1799, DOI 10.1210/jc.82.6.1799; Crawford PA, 1997, MOL CELL BIOL, V17, P3997; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Zangen D, 2014, J CLIN INVEST, V124, P2071, DOI 10.1172/JCI73186; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Ferraz-de-Souza B, 2011, MOL CELL ENDOCRINOL, V336, P198, DOI 10.1016/j.mce.2010.11.006; Tanaka T, 2007, J MOL ENDOCRINOL, V39, P343, DOI 10.1677/JME-07-0076; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Wang ZN, 2001, J MOL ENDOCRINOL, V27, P255, DOI 10.1677/jme.0.0270255; Miyamoto K, 2011, MOL CELL ENDOCRINOL, V336, P123, DOI 10.1016/j.mce.2010.11.031; Yazawa T, 2011, MOL CELL ENDOCRINOL, V336, P127, DOI 10.1016/j.mce.2010.11.025; Imamichi Y, 2013, MOL CELL ENDOCRINOL, V370, P1, DOI 10.1016/j.mce.2013.02.012; LeersSucheta S, 1997, J BIOL CHEM, V272, P7960; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Volle DH, 2007, GENE DEV, V21, P303, DOI 10.1101/gad.409307; Stocco DM, 2000, J ENDOCRINOL, V164, P247, DOI 10.1677/joe.0.1640247; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Li LA, 1999, MOL ENDOCRINOL, V13, P1588, DOI 10.1210/me.13.9.1588; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561; Jadhav U, 2011, ENDOCRINOLOGY, V152, P2870, DOI 10.1210/en.2011-0219; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Cao GP, 1997, J BIOL CHEM, V272, P33068, DOI 10.1074/jbc.272.52.33068; Ye P, 2009, ENDOCRINOLOGY, V150, P1303, DOI 10.1210/en.2008-0667; Achermann JC, 1999, NAT GENET, V22, P125; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Yazawa T, 2008, ENDOCRINOLOGY, V149, P1786, DOI 10.1210/en.2007-1015; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Pezzi V, 2004, ENDOCRINOLOGY, V145, P2186, DOI 10.1210/en.2003-1366; Mueller M, 2007, ENDOCRINOLOGY, V148, P1445, DOI 10.1210/en.2006-0591; HATANO O, 1994, DEVELOPMENT, V120, P2787; Hasegawa T, 2004, J CLIN ENDOCR METAB, V89, P5930, DOI 10.1210/jc.2004-0935; Kim JW, 2004, J CLIN ENDOCR METAB, V89, P3042, DOI 10.1210/jc.2003-031599; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Imamichi Y, 2014, BBA-GENE REGUL MECH, V1839, P33, DOI 10.1016/j.bbagrm.2013.11.005; Lee YK, 2008, FRONT BIOSCI, V13, P5950, DOI 10.2741/3128; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Yazawa T, 2009, ENDOCRINOLOGY, V150, P3885, DOI 10.1210/en.2008-1310; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368; Mizutani T, 2010, J BIOL CHEM, V285, P28240, DOI 10.1074/jbc.M110.129510; Kawabe S, 2013, ENDOCRINOLOGY, V154, P1648, DOI 10.1210/en.2012-2008; Zhang C, 2013, NAT MED, V19, P1061, DOI 10.1038/nm.3192; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Bland ML, 2000, P NATL ACAD SCI USA, V97, P14488, DOI 10.1073/pnas.97.26.14488; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Zhao LP, 2001, DEVELOPMENT, V128, P147; Baba T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4634; Barnea E, 2000, J BIOL CHEM, V275, P6608, DOI 10.1074/jbc.275.9.6608; Bertolin K, 2014, ENDOCRINOLOGY, V155, P1931, DOI 10.1210/en.2013-1765; Bland ML, 2004, MOL ENDOCRINOL, V18, P941, DOI 10.1210/me.2003-0333; Bouguen G, 2015, STEROIDS; Fatchiyah, 2006, BIOCHEM BIOPH RES CO, V341, P1036; Fernandez-Marcos PJ, 2011, BBA-MOL BASIS DIS, V1812, P947, DOI 10.1016/j.bbadis.2010.12.010; Gojo Satoshi, 2003, Hum Cell, V16, P23, DOI 10.1111/j.1749-0774.2003.tb00125.x; Gondo S, 2008, ENDOCRINOLOGY, V149, P4717, DOI 10.1210/en.2007-1808; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo IC, 2003, J BIOMED SCI, V10, P593, DOI 10.1159/000073524; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; HONDA SI, 1990, J BIOCHEM-TOKYO, V108, P1042; Huang NW, 2005, MOL ENDOCRINOL, V19, P2020, DOI 10.1210/me.2004-0411; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; Kanno M, 2014, BBA-GENE REGUL MECH, V1839, P406, DOI 10.1016/j.bbagrm.2014.03.016; Kawabe K, 1999, MOL ENDOCRINOL, V13, P1267, DOI 10.1210/me.13.8.1267; Kim JW, 2005, J CLIN ENDOCR METAB, V90, P1678, DOI 10.1210/jc.2004-0374; Lazarus KA, 2012, J STEROID BIOCHEM, V130, P138, DOI 10.1016/j.jsbmb.2011.12.017; Lin CJ, 2001, MOL ENDOCRINOL, V15, P1277, DOI 10.1210/me.15.8.1277; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; LYNCH JP, 1993, MOL ENDOCRINOL, V7, P776, DOI 10.1210/me.7.6.776; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; MOROHASHI K, 1993, MOL ENDOCRINOL, V7, P1196, DOI 10.1210/me.7.9.1196; Mullen Eimear M, 2007, PPAR Res, V2007, P61563, DOI 10.1155/2007/61563; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; RICE DA, 1991, MOL ENDOCRINOL, V5, P1552; SCHIMMER BP, 1992, J STEROID BIOCHEM, V43, P937, DOI 10.1016/0960-0760(92)90322-A; SHINODA K, 1995, DEV DYNAM, V204, P22; Sonoyama T, 2012, ENDOCRINOLOGY, V153, P4336, DOI 10.1210/en.2012-1060; Stocco DM, 1997, BIOL REPROD, V56, P328, DOI 10.1095/biolreprod56.2.328; Toyoda M, 2007, INT J HEMATOL, V86, P1, DOI 10.1532/IJH97.07055; Wang XL, 2000, ENDOCRINOLOGY, V141, P3587, DOI 10.1210/en.141.10.3587; Wei X, 2012, CELL PROLIFERAT, V45, P101, DOI 10.1111/j.1365-2184.2012.00809.x; Yanase T, 2006, ENDOCR J, V53, P449, DOI 10.1507/endocrj.KR-74; Yazawa Takashi, 2014, World J Stem Cells, V6, P203, DOI 10.4252/wjsc.v6.i2.203; Zhang CK, 2001, GENE, V273, P239, DOI 10.1016/S0378-1119(01)00586-8; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147; Zhao LP, 2008, MOL ENDOCRINOL, V22, P1403, DOI 10.1210/me.2008-0034	117	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					323	330		10.2108/zs140237		8	Zoology	Zoology	CN9UN	WOS:000358795400001		
J	Okamoto, K; Mori, A; Ikeda, Y				Okamoto, Kohei; Mori, Akira; Ikeda, Yuzuru			Effects of Visual Cues of a Moving Model Predator on Body Patterns in Cuttlefish Sepia pharaonis	ZOOLOGICAL SCIENCE			English	Article						cuttlefish; body pattern; primary defense; predator-prey distance; predator trajectory	CEPHALOPOD DYNAMIC CAMOUFLAGE; DISRUPTIVE COLORATION; NERVOUS-SYSTEM; OFFICINALIS; RESPONSES; PERCEPTION; DEFENSES; CONTRAST; BEHAVIOR; VISION	We examined the effects of predator-prey distance (PPD) and trajectory of the predator on the body patterns that the pharaoh cuttlefish, Sepia pharaonis, shows in response to a predator. A model predator moving in three different trajectories was presented to the cuttlefish: T1, approached the cuttlefish but bypassed above; T2, approached directly toward the cuttlefish; T3, bypassed the cuttlefish both vertically and horizontally. We divided the body patterns that the cuttlefish expressed into seven categories, i.e., "uniform light", "disruptive", "center circle", "dark square", "vertical stripe", "all dark"and "eyespots". In T1, the number of individuals that showed "dark square"increased as the model approached the cuttlefish, whereas the number of individuals that showed "disruptive" decreased. In T2, the number of individuals that showed "all dark"and "eyespots"increased as the model approached the cuttlefish. In T3, the number of individuals that showed "dark square" and "vertical stripe"increased as the model approached the cuttlefish, and it tended to decrease as the model receded from the cuttlefish. These results demonstrate that S. pharaonis changes its body patterns according to PPD and the trajectory of the predator, which would affect predation risk and/or predator perception.	[Okamoto, Kohei; Mori, Akira] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Ikeda, Yuzuru] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan	Okamoto, K (reprint author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	kohei.o@ethol.zool.kyoto-u.ac.jp			Global COE Program of Kyoto University [A06]	We thank the laboratory members of the Department of Chemistry, Biology and Marine Science, Faculty of Science, University of the Ryukyus, for their assistance in collection of cuttlefish eggs, maintainance at Senbaru campus, and transportation to Sesoko Station. We are also indebted to the staff of Sesoko Station, Tropical Biosphere Research Center (TBRC), University of the Ryukyus, for enabling us to conduct this research. We also acknowledge E. Nakajima for reviewing the manuscript. This project was financially supported in part by the Global COE Program (A06) of Kyoto University.	Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Barbosa A, 2007, J EXP BIOL, V210, P1139, DOI 10.1242/jeb.02741; Chiao CC, 2009, VISION RES, V49, P1647, DOI 10.1016/j.visres.2009.04.002; Cooper WE, 2010, ANIM BEHAV, V80, P249, DOI 10.1016/j.anbehav.2010.04.025; Ulmer KM, 2013, BIOL BULL-US, V224, P110; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Stevens M, 2007, P R SOC B, V274, P1457, DOI 10.1098/rspb.2007.0220; Shohet A, 2007, BIOL J LINN SOC, V92, P335, DOI 10.1111/j.1095-8312.2007.00842.x; Adamo SA, 2006, BIOL BULL-US, V210, P192, DOI 10.2307/4134557; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Mathger LM, 2013, VISION RES, V83, P19, DOI 10.1016/j.visres.2013.02.016; Buresch KC, 2011, VISION RES, V51, P2362, DOI 10.1016/j.visres.2011.09.009; Messenger JB, 2001, BIOL REV, V76, P473; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Williamson R, 2004, NEUROSIGNALS, V13, P87, DOI 10.1159/000076160; Cooper WE, 2009, BEHAV ECOL, V20, P665, DOI 10.1093/beheco/arp049; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; Boal JG, 1999, J EXP MAR BIOL ECOL, V235, P307, DOI 10.1016/S0022-0981(98)00187-7; BUDELMANN BU, 1993, PHILOS T ROY SOC B, V340, P93, DOI 10.1098/rstb.1993.0051; Byrne Ruth A., 2010, Ferrantia, V59, P22; Caro T., 2005, ANTIPREDATOR DEFENSE; Carpenter KE, 1989, FAO SPECIES SYNOPSIS, V9, P125; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; Hanlon RT, 1996, CEPHALOPOD BEHAV; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Kiso K, 2007, AQUAC SCI, V55, P367; Komak S, 2005, MAR FRESHW BEHAV PHY, V38, P117, DOI 10.1080/10236240500139206; Langridge KV, 2007, CURR BIOL, V17, pR1044, DOI 10.1016/j.cub.2007.10.028; Langridge KV, 2009, ANIM BEHAV, V77, P847, DOI 10.1016/j.anbehav.2008.11.023; Lee YH, 2010, J COMP PSYCHOL, V124, P261, DOI 10.1037/a0019461; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mather JA, 2013, CAN J ZOOL, V91, P431, DOI 10.1139/cjz-2013-0009; Mather JA, 2010, MAR FRESHW BEHAV PHY, V43, P357, DOI 10.1080/10236244.2010.526760; Mathger LM, 2008, J COMP PHYSIOL A, V194, P577, DOI 10.1007/s00359-008-0332-4; Moynihan M., 1982, ADV ETHOL, V25, P1; Staudinger MD, 2013, BIOL BULL-US, V225, P161; Staudinger MD, 2011, ANIM BEHAV, V81, P585, DOI 10.1016/j.anbehav.2010.12.002; Watanuki N, 2000, FISHERIES SCI, V66, P417, DOI 10.1046/j.1444-2906.2000.00068.x	41	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					336	344		10.2108/zs140288		9	Zoology	Zoology	CN9UN	WOS:000358795400003		
J	Karasawa, S; Nagata, S; Aoki, JI; Yahata, K; Honda, M				Karasawa, Shigenori; Nagata, Satomi; Aoki, Jun-ichi; Yahata, Kensuke; Honda, Masanao			Phylogeographic Study of Whip Scorpions (Chelicerata: Arachnida: Thelyphonida) in Japan and Taiwan	ZOOLOGICAL SCIENCE			English	Article						COI; Kerama Gap; Ryukyu Archipelago; Typopeltis crucifer; Typopeltis stimpsonii	NASUTITERMES-TAKASAGOENSIS ISOPTERA; PHYLOGENETIC TREES; SEQUENCE ALIGNMENT; DNA; POPULATIONS; CONFIDENCE; SPIDERS; MODELS; DIVERSIFICATION; BIOGEOGRAPHY	Whip scorpions (Thelyphonida), comprising an order in the class Arachnida, are distributed from tropical to temperate zones. Two species occur exclusively in Japan and Taiwan, but the border of their distributional ranges is ambiguous in the Central Ryukyus (Japan). We collected new specimens from the Central Ryukyus and revealed that the border of distribution of the two species lies between the Central and Southern Ryukyus, i.e., the Kerama Gap. Moreover, the estimated divergence time (15.8 Mya) of the two species, based on the mitochondrial COI gene, was older than the recently estimated time (1.55 Mya) of formation of the Kerama Gap. These results highlight the risks of a priori assumption solely on the basis of geological data for applying it as a calibration point to some terrestrial animals in this region. Typopeltis stimpsonii was genetically divided into four lineages, two of which turned out to be endemic to the Okinawa Islands. All specimens from the main island of Japan and Shikoku were in one lineage, which was also found in the Amami Islands and Hachijojima Island. This suggests that these specimens may have been dispersed by human activity. Typopeltis crucifer included five genetic lineages. Species collected from Ishigakijima and Iriomotejima Islands were genetically diversified not between the borders of these islands but within Ishigakijima Island. This study also suggests that phylogenetic diversity of the species in the Southern Ryukyus have increased through two times of invasions from Taiwan.	[Karasawa, Shigenori] Fukuoka Univ Educ, Fukuoka 8114192, Japan; [Nagata, Satomi] Koga Kyouseikan High Shool, Fukuoka 8113103, Japan; [Yahata, Kensuke; Honda, Masanao] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan	Karasawa, S (reprint author), Fukuoka Univ Educ, Fukuoka 8114192, Japan.	karashi@fukuoka-edu.ac.jp			Sasagawa Scientific Research Grant from the Japan Science Society; JSPS KAKENHI [25281053]	Permission for collecting Thelyphonids from Ushibuka City was obtained from the Board of Education in Amakusa City, Kumamoto Prefecture. We thank Mr. Yuji Abe (Taga Town Museum), Dr. Yuki Baba (National Institute for Agro-Environmental Science), Dr. Akio Tanigawa (Tokyo University), Dr. Yoh Ihara (Hiroshima Environment and Health Association), Mr. Mitsunobu Kondo (Shimonoseki), Mr. Daiki Miura (Kagawa prefecture), Mr. Keiichi Nakano (Tokyo), Dr. Satoshi Shimano (Hosei University), Dr. Nobuo Tsurusaki (Tottori University), Mr. Shintaro Yamada (Miyazaki Prefectural Museum of Natural and History), Dr. Makoto Yoshida (Wakayama Prefectural Museum of Natural History) for collecting specimens; Dr. Matsuei Shimojana (Okinawa Prefecture) and Mr. Takeshi Sasaki (University of Ryukyus) for advices on the nature of the Ryukyu Archipelago. This work was supported by the Sasagawa Scientific Research Grant from the Japan Science Society and the JSPS KAKENHI, Grant-in-Aid for Scientific Research (B), Grant Number 25281053.	Amato ML, 2008, MOL ECOL, V17, P570, DOI 10.1111/j.1365-294X.2007.03580.x; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/1063515049522629; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Osozawa S, 2012, INT GEOL REV, V54, P1369, DOI 10.1080/00206814.2011.639954; Prendini L, 2005, ORG DIVERS EVOL, V5, P203, DOI 10.1016/j.ode.2004.12.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Suzuki H, 2000, MOL PHYLOGENET EVOL, V15, P15, DOI 10.1006/mpev.1999.0732; Fu YX, 1997, GENETICS, V147, P915; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; TAJIMA F, 1989, GENETICS, V123, P585; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Osozawa S, 2013, ENTOMOL SCI, V16, P267, DOI 10.1111/ens.12037; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.2307/2413622; Schonhofer AL, 2013, MOL PHYLOGENET EVOL, V66, P303, DOI 10.1016/j.ympev.2012.10.001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Azuma S., 2002, CHECK LIST INSECT RY; Bidegaray-Batista L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-317; Esaki T, 1940, ACTA ARACHNOL, V5, P91; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Futuyma D, 2005, EVOLUTION; Garcia J, 2004, ENTOMOL SCI, V7, P245, DOI 10.1111/j.1479-8298.2004.00070.x; Garcia J, 2002, ZOOL SCI, V19, P1141, DOI 10.2108/zsj.19.1141; Hachisuka MU, 1926, IBIS, V68, P235, DOI 10.1111/j.1474-919X.1926.tb07569.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harvey M. S., 2003, CATALOGUE SMALLER AR; Haupt Joachim, 1997, Arthropoda Selecta, V5, P43; Honda M, 2012, MOL PHYLOGENET EVOL, V65, P642, DOI 10.1016/j.ympev.2012.07.019; Ikehara S, 1975, TERRESTRIAL ANIMALS; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Karasawa S, 2012, ZOOL SCI, V29, P527, DOI 10.2108/zsj.29.527; Kimura M, 2002, Okinawa Times amidoh, P19; Kizaki K, 1980, NATURAL HIST RYUKYUS, P8; Kizaki K, 1977, MARINE SCI MONTHLY, V9, P542; Kuroda N, 1931, ZOOL MAG, V43, P172; Maekawa K, 2000, MAR SCI MONTHLY, V32, P235; Motokawa M, 2000, TROPICS, V10, P63; Nakano K, 2009, KAOKU GAITYU, V31, P47; Nakayama K, 1993, GENSEI, V61-62, P27; Ota H, 2002, BIOL J LINN SOC, V76, P493, DOI 10.1046/j.1095-8312.2002.00084.x; Ota H., 2000, TROPICS, V10, P51; Ota H, 2000, POPUL ECOL, V42, P5, DOI 10.1007/s101440050003; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shih HT, 2011, ZOOL ANZ, V250, P457, DOI 10.1016/j.jcz.2011.07.004; Shimojana M, 1999, PICTORIAL KEYS SOIL, P437; Shimojana M, 1972, IDEN, V34, P100; Souza FL, 2003, J HERPETOL, V37, P427, DOI 10.1670/0022-1511(2003)037[0427:PPAOTN]2.0.CO;2; Tanikawa Akio, 2013, Acta Arachnologica, V62, P41; Ujiie H, 1990, NATURE OKINAWA GEOMO, P251; Umezawa K, 1973, SHOKUBUTU BOEKI, V27, P289; Yasuma S, 1982, RYUKYU ISLANDS FORMA; Yeh WB, 2004, ANN ENTOMOL SOC AM, V97, P613, DOI 10.1603/0013-8746(2004)097[0613:GDOLAC]2.0.CO;2	58	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					352	363		10.2108/zs140263		12	Zoology	Zoology	CN9UN	WOS:000358795400005		
J	Tamate, T				Tamate, Tsuyoshi			Interpopulation Comparison of Sex-Biased Mortality and Sexual Size Dimorphism in Sea-Run Masu Salmon, Oncorhynchus masou	ZOOLOGICAL SCIENCE			English	Article						anadromous Oncorhynchus masou; breeding selection; marine phase; sex-specific life histories; trade-offs between growth and mortality	PACIFIC SALMON; RISK-TAKING; POPULATION DIVERGENCE; BREEDING COMPETITION; ATLANTIC SALMON; SOCKEYE-SALMON; NORTHERN JAPAN; GROWTH-RATES; COHO SALMON; HOUSE FINCH	Evolutionary ecologists often expect that natural and sexual selection result in systematic co-occurrence patterns of sex-biased mortality and sexual size dimorphism (SSD) within animal species. However, whether such patterns actually occur in wild animals is poorly examined. The following expectation, the larger sex suffers higher mortality, was primarily tested here for apparently native sea-run masu salmon (Oncorhynchus masou) in three populations in Hokkaido, Japan. Field surveys on sex ratios, body sizes, and ages of smolts and returning adults revealed that two of the three populations exhibited an expected pattern, a female-biased marine mortality and SSD, but one population demonstrated an unexpected co-occurrence of male-biased marine mortality and female-biased SSD. These female-biased SSDs were attributed to faster marine growth of females because of no sex difference in smolt body size. It has been previously suggested that breeding selection favoring large size generally act more strongly in females than in males in Japanese anadromous masu, as there is a weak sexual selection on adult males but universally intensive natural selection on adult females. Thus, this hypothesis explains female-biased SSDs well in all study populations. Interpopulation variation in sex-biased mortality found here might result from differences in marine predation and/or fishing pressures, given that selection driving female-biased SSD makes females forage more aggressively than males during the marine phase. Taken together, these results raise the possibility that evolutionary forces have shaped adaptive sex-specific foraging strategies under relationships between growth and mortality, resulting in co-occurrence patterns of sex-biased mortality and SSD within animal species.	Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Shiogama 9850001, Japan	Tamate, T (reprint author), Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, 3-27-5 Shinhama Cho, Shiogama 9850001, Japan.	tamate@affrc.go.jp			JSPS KAKENHI [20770011, 24570036]	I am indebted to Chitose Yamazaki, Ayako Kuroda, Koh Hasegawa, and Mari Kuroki for their help with the field survey and to Kazumasa Ohkuma, Kentaro Morita and Nobuyuki Nakano for their assistance during this study. I am grateful to Martin Reichard, Thomas Mehner and anonymous reviewers for comments on a previous draft of this manuscript. I would like to thank Enago (www.enago.jp) also for the English language review. This study was supported by JSPS KAKENHI Grant Numbers 20770011 and 24570036.	PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Morita K, 2014, J ANIM ECOL, V83, P1268, DOI 10.1111/1365-2656.12240; VANDENBERGHE EP, 1989, EVOLUTION, V43, P125, DOI 10.2307/2409169; Benito MM, 2007, J EVOLUTION BIOL, V20, P1522, DOI 10.1111/j.1420-9101.2007.01327.x; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Sakurai Y, 2007, DEEP-SEA RES PT II, V54, P2526, DOI 10.1016/j.dsr2.2007.02.007; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Schulte-Hostedde AI, 2002, EVOLUTION, V56, P2519; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Young KA, 2005, P ROY SOC B-BIOL SCI, V272, P167, DOI 10.1098/rspb.2004.2931; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; GROSS MR, 1985, NATURE, V313, P47, DOI 10.1038/313047a0; FLEMING IA, 1994, EVOLUTION, V48, P637, DOI 10.2307/2410475; Kendall NW, 2013, OIKOS, V122, P411, DOI 10.1111/j.1600-0706.2012.20319.x; Johansson F, 2005, BIOL J LINN SOC, V86, P507, DOI 10.1111/j.1095-8312.2005.00549.x; Preziosi RF, 2000, EVOLUTION, V54, P558; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Badyaev AV, 2000, EVOLUTION, V54, P1784; Badyaev AV, 2000, EVOLUTION, V54, P2134; Biro PA, 2003, ECOLOGY, V84, P2419, DOI 10.1890/02-0416; Drenner SM, 2012, PLOS ONE, V7, P1; Einum Sigurd, 2004, P126; Ferguson IM, 2000, J EVOLUTION BIOL, V13, P160, DOI 10.1046/j.1420-9101.2000.00152.x; Fleming Ian A., 2004, P264; Hamon TR, 2005, EVOLUTION, V59, P1104; Hanson NN, 2013, MAR ECOL PROG SER, V475, P249, DOI 10.3354/meps10066; Hayano H, 2003, J FISH BIOL, V62, P237, DOI 10.1046/j.0022-1112.2003.00022.x; HOLTBY LB, 1990, ECOLOGY, V71, P678, DOI 10.2307/1940322; Hoshino H, 2006, FISHERIES SCI, V72, P922, DOI 10.1111/j.1444-2906.2006.01239.x; Kato F., 1991, P447; Kiso Katsuhiro, 1995, Bulletin of the National Research Institute of Fisheries Science, V7, P1; Machidori S, 1985, B INT N PACIFIC FISH, V43, P1; Miyakoshi Y, 2001, FISHERIES SCI, V67, P126, DOI 10.1046/j.1444-2906.2001.00208.x; Miyakoshi Y., 2006, SCI REPORTS HOKKAIDO, V60, P1; Miyakoshi Y, 2004, FISHERIES SCI, V70, P87, DOI 10.1111/j.1444-2906.2003.00775.x; Morita K, 2006, ICES J MAR SCI, V63, P1353, DOI 10.1016/j.icesjms.2006.03.024; Morita SH, 2012, ENVIRON BIOL FISH, V94, P505, DOI 10.1007/s10641-010-9613-1; Nagasawa Kazuya, 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P419; Ogushi S, 2011, J N JAN FISH EC, V39, P103; Ohkuma K., 1988, SCI REP HOKKAIDO SAL, V42, P37; Rohlf FJ, 2012, BIOMETRY; Shimoda K, 2001, SCI REP HOKKAIDO FIS, V55, P7; Spidle AP, 1998, J FISH BIOL, V52, P907, DOI 10.1006/jfbi.1997.0635; Tamate T, 2006, EVOLUTION, V60, P196; Tamate T, 2004, ECOL FRESHW FISH, V13, P96, DOI 10.1111/j.1600-0633.2004.00043.x; Tamate T, 2000, OIKOS, V90, P209, DOI 10.1034/j.1600-0706.2000.900201.x; Tamate T, 2004, FISHERIES MANAG ECOL, V11, P365, DOI 10.1111/j.1365-2400.2004.00405.x; Tamate T, 2008, WATER SCI, V52, P72; TSIGER VV, 1994, CAN J FISH AQUAT SCI, V51, P197, DOI 10.1139/f94-022; Ueda Y, 2003, FISHERIES AQUATIC LI, P48; Weir LK, 2010, ETHOLOGY, V116, P166, DOI 10.1111/j.1439-0310.2009.01723.x; Wong-Munoz J, 2011, EVOL ECOL, V25, P59, DOI 10.1007/s10682-010-9379-0; Yamamoto T, 2014, J FISH BIOL, V84, P256, DOI 10.1111/jfb.12275	56	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					364	371		10.2108/zs140287		8	Zoology	Zoology	CN9UN	WOS:000358795400006		
J	Nyumura, N; Asami, T				Nyumura, Nobuhiro; Asami, Takahiro			Synchronous and Non-Synchronous Semelparity in Sibling Species of Pulmonates	ZOOLOGICAL SCIENCE			English	Article						life cycle; life history; population dynamics; land snail; Bradybaena; Gastropoda	1774 GASTROPODA PULMONATA; THEBA-PISANA MOLLUSCA; LIFE-CYCLE; POPULATION-DYNAMICS; BRADYBAENA-SIMILARIS; SECONDARY PRODUCTION; NORTHERN GREECE; SNAIL; GROWTH; HISTORY	Diverse life histories have been documented in terrestrial pulmonates, which inhabit different regions in climate. Life history traits are often phenotypically plastic and vary depending on the environment. Thus, surveys using designs that control for the confounding effects of environment are needed to evaluate the evolutionary differences between populations of closely related species in the wild. We examined the life histories of sibling species of terrestrial pulmonate within two regions of similar climates. Bradybaena pellucida (BP) is endemic to Japanese islands, and has recently been expanding its distribution northeastward, whereas B. similaris (BS) has been introduced by humans into temperate and tropical regions worldwide. We found that these species exhibit discrete differences in population dynamics and life cycle, despite their close relatedness. The annual life cycle of BP is synchronized among individuals in a population. Thus, BP is univoltine with discontinuous generation. In contrast, BS individuals do not synchronize their growth or reproduction, and thus exhibit overlapping generations. Our results indicate that synchronized and non-synchronized population dynamics diverge relatively rapidly in semelparous pulmonates. This type of difference has not been documented in pulmonate life history, and may have been overlooked because only a few studies have explicitly compared life cycles of closely related species within the same climate. Our results provide a basis for further studies of life history evolution in pulmonates.	[Nyumura, Nobuhiro; Asami, Takahiro] Shinshu Univ, Dept Biol, Matsumoto, Nagano 3908621, Japan	Asami, T (reprint author), Shinshu Univ, Dept Biol, Matsumoto, Nagano 3908621, Japan.	asami99@shinshu-u.ac.jp			Japan Society for the Promotion of Science	We thank M. Okamoto, K. Seki, N. Asami and M. Asami for their help in the field and B. Pall-Gergely for his help in literature survey. This study was partly supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to N.N. and T.A.	Asami T, 1998, AM NAT, V152, P225, DOI 10.1086/286163; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; COWIE RH, 1984, J ANIM ECOL, V53, P311, DOI 10.2307/4359; Asami T, 1997, YURIYAGAI, V5, P31; Asami Takahiro, 1993, Venus the Japanese Journal of Malacology, V52, P155; Asami Takahiro, 1997, Venus the Japanese Journal of Malacology, V56, P35; Asami T, 2002, VENUS, V61, P41; Asami Takahiro, 2008, Basteria, V72, P119; Asami T, 1999, J CONCHOL, V36, P1; BAKER GH, 1988, J APPL ECOL, V25, P867, DOI 10.2307/2403752; Heller J., 2001, P413, DOI 10.1079/9780851993188.0413; BOAG DA, 1979, CAN J ZOOL, V57, P353, DOI 10.1139/z79-041; Carvalho CD, 2008, MOLLUSCAN RES, V28, P171; Chang Chia-Pao, 2002, P241, DOI 10.1079/9780851993201.0241; HELLER J, 1982, J ZOOL, V196, P475; HELLER J, 1990, MALACOLOGIA, V31, P259; Hirano T, 2014, J MOLLUS STUD, V80, P177, DOI 10.1093/mollus/eyu004; Hughes PW, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-90; Kimura K, 2015, ACTA ETHOL, V18, P265, DOI 10.1007/s10211-014-0211-7; KIRKENDALL LR, 1985, AM NAT, V125, P189, DOI 10.1086/284337; Kiss L, 2005, J MOLLUS STUD, V71, P221, DOI 10.1093/mollus/eyi030; KOMAI T, 1955, EVOLUTION, V9, P400, DOI 10.2307/2405475; Kosuge Takeharu, 2000, Venus the Japanese Journal of Malacology, V59, P19; Kozlowski Jan, 2000, Folia Malacologica, V8, P271; Kramarenko S.S., 2013, Ruthenica, V23, P115; Prockow M, 2013, BIOLOGIA, V68, P131, DOI 10.2478/s11756-012-0132-8; Kuznik-Kowalska Elzbieta, 2013, Folia Malacologica, V21, P215; LAM PKS, 1989, J ANIM ECOL, V58, P571, DOI 10.2307/4849; Lazaridou M, 2005, J MOLLUS STUD, V71, P247, DOI 10.1093/mollus/eyi032; Maltz Tomasz Krzysztof, 2003, Folia Malacologica, V11, P63; Natalia LC, 2008, INV REP DEV, V52, P23; Pokryszko Beata M., 2001, Folia Malacologica, V9, P45; Roff D. A., 1992, EVOLUTION LIFE HIST; Seki K, 2008, ZOOL SCI, V25, P1212, DOI 10.2108/zsj.25.1212; Seki Keiichi, 2002, Venus (Tokyo), V61, P41; STAIKOU A, 1990, J MOLLUS STUD, V56, P137, DOI 10.1093/mollus/56.2.137; STAIKOU A, 1990, MALACOLOGIA, V31, P353; STAIKOU A, 1991, ZOOL J LINN SOC-LOND, V101, P179, DOI 10.1111/j.1096-3642.1991.tb00892.x; Wiwegweaw A, 2009, BIOL LETTERS, V5, P240, DOI 10.1098/rsbl.2008.0714; Wiwegweaw A, 2009, ZOOL SCI, V26, P191, DOI 10.2108/zsj.26.191; Young T. P., 2010, NAT ED KNOWL, V3, P2	41	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					372	377		10.2108/zs150020		6	Zoology	Zoology	CN9UN	WOS:000358795400007		
J	Nakano, M; Yamamoto, T; Takakura, KI; Urabe, M				Nakano, Mitsunori; Yamamoto, Tatsuya; Takakura, Koh-Ichi; Urabe, Misako			Unionid Freshwater Mussels in Irrigation Ditches Are Affected by Physical Environmental Factors and Proximity to Paddy Fields	ZOOLOGICAL SCIENCE			English	Article						Nodularia douglasiae biwae; Pronodularia japanensis; Lanceolaria grayana; Sinanodonta japonica; mussel conservation		Irrigation ditches are the major habitat of lotic unionid mussels in Japan. To conserve and rebuild irrigation ditches facilitating mussel conservation, suitable physical environments must be clarified. The effect on mussels of paddy fields connected to ditches also needs to be determined. In this study, physical environmental factors that affect the density of unionid mussels were studied in irrigation ditches in Hikone City, Shiga Prefecture, Japan, to examine whether mussel densities were higher around paddy fields. Generalized linear models were used to analyze physical and paddy field environmental variables affecting mussel density. Our results show that sediment type, sediment softness, water depth, and flow velocity of irrigation ditches affect the density of unionid mussels; the effects of each environment factor and their relative importance differed by species. Specifically, the density of Nodularia douglasiae biwae was higher in ditches with sand-gravel sediment, soft sediment, and not adjoining paddy fields. The density of Pronodularia japanensiswas higher in ditches with sand-gravel sediment and not adjoining paddy fields. The density of Lanceolaria grayana was higher in ditches with high flow velocity, not adjoining paddy fields, close to Lake Biwa. The density of Sinanodonta japonica was higher in ditches with mud sediment, shallow depth, high flow velocity, and not adjoining paddy fields. The densities of all four species were lower in irrigation ditches that were closely connected to paddy fields, suggesting that paddy drainage water negatively affects the survival of the mussels.	[Nakano, Mitsunori] Univ Shiga Prefecture, Grad Sch Environm Sci, Hikone, Shiga 5228533, Japan; [Yamamoto, Tatsuya; Takakura, Koh-Ichi; Urabe, Misako] Univ Shiga Prefecture, Fac Environm Sci, Hikone, Shiga 5228533, Japan	Nakano, M (reprint author), Univ Shiga Prefecture, Grad Sch Environm Sci, 2500 Hassaka, Hikone, Shiga 5228533, Japan.	mitsu6812@yahoo.co.jp					Akiyama Yoshihiro B., 2013, Venus (Tokyo), V71, P191; Akiyama YB, 2010, ZOOL SCI, V27, P912, DOI 10.2108/zsj.27.912; Cohen J., 2003, APPL MULTIPLE REGRES; Hayashi K., 1972, Venus Tokyo, V31, P9; Kakino W, 2008, T JSIDRE, V255, P83; Kitamura JI, 2007, ENVIRON BIOL FISH, V78, P37, DOI 10.1007/s10641-006-9076-6; Kondo Takaki, 2011, Chiribotan, V41, P84; Kondo T., 2008, MONOGRAPH UNIONOIDA; Kondo T, 1998, CONSERVATION BIOL CO, P80; Kondo T, 1998, JAP J ENV ENT ZOOL, V9, P166; Morris TJ, 1996, J N AM BENTHOL SOC, V15, P576, DOI 10.2307/1467808; Negishi Junjiro N., 2008, Japanese Journal of Ecology (Otsu), V58, P37; Negishi Junjiro, 2008, Ecology and Civil Engineering, V11, P195; Ogawa Rikiya, 2000, Memoirs of Osaka Kyoiku University Series III Natural Science and Applied Science, V49, P33; R Development Core Team, 2013, R LANG ENV STAT COMP; Starret WC, 1971, ILLINOIS NATURAL HIS, V30, P265; Strayer DL, 2008, FRESHW ECOL SER, V1, P1; Sugaya Y, 1999, JPN J ENV TOXICAL, V2, P77	18	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					378	382		10.2108/zs150001		5	Zoology	Zoology	CN9UN	WOS:000358795400008		
J	Hirose, E; Yamasaki, H				Hirose, Euichi; Yamasaki, Hiroshi			Fine Structure of the Integumentary Cuticles and Alimentary Tissues of Pycnophyid Kinorhynchs Pycnophyes oshoroensis and Kinorhynchus yushini (Kinorhyncha, Homalorhagida)	ZOOLOGICAL SCIENCE			English	Article						cuticle; mucus layer; pharyngeal crown; pharyngeal bulb; midgut contents; unusual axoneme	ECHINODERES-CAPITATUS KINORHYNCHA; KIELENSIS KINORHYNCHA; CYCLORHAGIDA; ULTRASTRUCTURE; MORPHOLOGY; JAPAN; GENUS; SEA; PROTONEPHRIDIA; SPERMATOZOA	Integumentary and alimentary tissues were ultrastructurally examined in two pycnophyid kinorhynchs, Pycnophyes oshoroensis and Kinorhynchus yushini, to elucidate some aspects of their ecology. The body is entirely enveloped by an epicuticle layer with no gaps between cuticle plates and joints. The cuticular layer has a structure dense enough to prevent invasion by foreign organisms. The cuticular surface is overlaid by a mucus layer that may form a hydrophilic surface. The alimentary contents were heterogeneous, probably including some cellular components, such as chloroplast-like structures. Kinorhynchs likely break down food particles in the pharyngeal bulb by pressing it between the cuticulated epithelia. The pharyngeal crown was located in front of the pharyngeal bulb and had a thick wall with a striated sub-structure. Contraction of the pharyngeal bulb probably increases the internal pressure of the pharyngeal crown; this may be one reason for the thick wall of the pharyngeal crown. Nutrients appear to be taken up by midgut epithelial cells through both absorption via microvilli and endocytosis. Additionally, sperm tails in the testis of P. oshoroensis have unusual axonemes; i.e., an 18+9+2 pattern.	[Hirose, Euichi; Yamasaki, Hiroshi] Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, Nishihara, Okinawa 9030213, Japan	Hirose, E (reprint author), Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, Nishihara, Okinawa 9030213, Japan.	euichi@sci.u-ryukyu.ac.jp			"International Research Hub Project for Climate Change and Coral Reef/Island Dynamics" from the University of the Ryukyus	We thank Mr. K. Shibazaki (Oshoro Marine Station, Hokkaido University) for his assistance in collecting specimens. We are also indebted to Dr. M. V. Sorensen, Dr. Fernando Pardos, and the anonymous reviewer for their valuable comments. This study was supported by the "International Research Hub Project for Climate Change and Coral Reef/Island Dynamics" from the University of the Ryukyus.	BERNHARD CG, 1967, ENDEAVOUR, V26, P79; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; HERMAN RL, 1992, POLAR BIOL, V12, P313; Yamasaki H, 2014, ZOOL SCI, V31, P421, DOI 10.2108/zs140011; Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x; JENSEN P, 1983, MAR BIOL, V74, P319, DOI 10.1007/BF00403458; Hirose E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0552; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ballarin L, 2015, ISJ-INVERT SURVIV J, V12, P82; BROWN R, 1989, ZOOL SCR, V18, P471; Cloney RA, 1996, ACTA ZOOL-STOCKHOLM, V77, P73; Dallai R, 2006, INT REV CYTOL, V254, P45, DOI 10.1016/S0074-7696(06)54002-1; DALLAI R, 1993, J SUBMICR CYTOL PATH, V25, P499; Dal Zotto M, 2013, SYST BIODIVERS, V11, P303, DOI 10.1080/14772000.2013.819045; Ferraguti M, 2006, TISSUE CELL, V38, P1, DOI 10.1016/j.tice.2005.05.001; Ga. Ordonez Dolores, 2000, Journal of Morphology, V246, P161, DOI 10.1002/1097-4687(200012)246:3<161::AID-JMOR1>3.0.CO;2-R; Grzelak K, 2012, POLAR BIOL, V35, P269, DOI 10.1007/s00300-011-1071-5; Hausen H, 2005, HYDROBIOLOGIA, V535, P25, DOI 10.1007/s10750-004-4442-x; Higgins R.P., 1988, P328; Hirose E, 1997, ZOOL SCI, V14, P683, DOI 10.2108/zsj.14.683; Hirose E, 2015, J MAR BIOL ASSOC UK, V95, P1025, DOI 10.1017/S0025315415000119; Hirose E, 2014, ZOOL SCI, V31, P546, DOI 10.2108/zs140064; Holland ND, 1984, BIOL INTEGUMENT, V1, P756; Iseto T, 2010, J MORPHOL, V271, P1185, DOI 10.1002/jmor.10863; Kristensen RM, 1991, MICROSCOPIC ANATOMY, V4, P377; KRISTENSEN RM, 1989, ACTA ZOOL-STOCKHOLM, V70, P13; Martorelli S, 2004, ZOOL ANZ, V243, P85, DOI 10.1016/j.jcz.2004.07.003; MERRIMAN JA, 1973, Z MORPHOL TIERE, V76, P227, DOI 10.1007/BF00298623; NEBELSICK M, 1992, ZOOL SCR, V21, P335, DOI 10.1111/j.1463-6409.1992.tb00335.x; NEBELSICK M, 1992, ACTA ZOOL-STOCKHOLM, V73, P185; NEBELSICK M, 1993, ZOOMORPHOLOGY, V113, P211, DOI 10.1007/BF00403313; Neuhaus B., 2013, HDB ZOOLOGY GASTROTR, V1, P181, DOI DOI 10.1515/9783110272536.1; Neuhaus Birger, 1994, Microfauna Marina, V9, P61; Neuhaus B, 1997, ZOOMORPHOLOGY, V117, P33, DOI 10.1007/s004350050027; Neuhaus B, 2014, ZOOTAXA, V3901, P1, DOI 10.11646/zootaxa.3901.1.1; Neuhaus B, 2013, CAH BIOL MAR, V54, P109; NEUHAUS B, 1988, ZOOMORPHOLOGY, V108, P245, DOI 10.1007/BF00312224; Nielsen C., 1997, MICROSCOPIC ANATOMY, V13, P13; NYHOLM K-G, 1976, ZOON (Uppsala), V4, P121; NYHOLM KG, 1982, J ULTRA MOL STRUCT R, V78, P1, DOI 10.1016/S0022-5320(82)80009-9; Nyholm KG, 1983, REPROD BIOL INVERTEB, V2, P207; Ostergaard P, 2000, J CRUSTACEAN BIOL, V20, P674, DOI 10.1651/0278-0372(2000)020[0674:SATSOT]2.0.CO;2; Sanchez N, 2014, HELGOLAND MAR RES, V68, P221, DOI 10.1007/s10152-014-0383-6; Sanchez N, 2013, SCI MAR, V77, P353, DOI 10.3989/scimar.03769.15A; Sanchez N, 2013, MAR BIOL RES, V10, P17; Santos PJP, 2009, BRAZ J OCEANOGR, V57, P43, DOI 10.1590/S1679-87592009000100005; Sorensen Martin V., 2008, Meiofauna Marina, V16, P21; Yamasaki H, 2014, ZOOKEYS, P27, DOI 10.3897/zookeys.382.6761; Yamasaki H, 2012, ZOOTAXA, P23	49	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					389	395		10.2108/zs150021		7	Zoology	Zoology	CN9UN	WOS:000358795400010		
J	Kage, A; Mogami, Y				Kage, Azusa; Mogami, Yoshihiro			Individual Flagellar Waveform Affects Collective Behavior of Chlamydomonas reinhardtii	ZOOLOGICAL SCIENCE			English	Article						bioconvection; collective motion; eukaryotic flagella; gravitaxis; gyrotaxis	OUTER DYNEIN ARMS; FLUID-DYNAMICS; INNER; BIOCONVECTION; MUTANTS; GRAVITY; MICROORGANISMS; ORIENTATION; TETRAHYMENA; PATTERNS	Bioconvection is a form of collective motion that occurs spontaneously in the suspension of swimming microorganisms. In a previous study, we quantitatively described the "pattern transition," a phase transition phenomenon that so far has exclusively been observed in bioconvection of the unicellular green alga Chlamydomonas. We suggested that the transition could be induced by changes in the balance between the gravitational and shear-induced torques, both of which act to determine the orientation of the organism in the shear flow. As both of the torques should be affected by the geometry of the Chlamydomonas cell, alteration in the flagellar waveform might change the extent of torque generation by altering overall geometry of the cell. Based on this working hypothesis, we examined bioconvection behavior of two flagellar mutants of Chlamydomonas reinhardtii, ida1 and oda2, making reference to the wild type. Flagella of ida1 beat with an abnormal waveform, while flagella of oda2 show a normal waveform but lower beat frequency. As a result, both mutants had swimming speed of less than 50% of the wild type. ida1 formed bioconvection patterns with smaller spacing than those of wild type and oda2. Two-axis view revealed the periodic movement of the settling blobs of ida1, while oda2 showed qualitatively similar behavior to that of wild type. Unexpectedly, ida1 showed stronger negative gravitaxis than did wild type, while oda2-showed relatively weak gravitaxis. These findings suggest that flagellar waveform, not swimming speed or beat frequency, strongly affect bioconvection behavior in C. reinhardtii.	[Kage, Azusa; Mogami, Yoshihiro] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Mogami, Y (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Otsuka 2-1-1, Tokyo 1128610, Japan.	mogami.yoshihiro@ocha.ac.jp			Japan Society for the Promotion of Science for Young Scientists [12J11036]	A. K. was supported by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists (No. 12J11036; from April 2012 to March 2014).	Akiyama A, 2005, J JPN SOC MICROGRAVI, V22, P210; Okita N, 2005, J CELL SCI, V118, P529, DOI 10.1242/jcs.01633; O'Malley S, 2012, B MATH BIOL, V74, P232, DOI 10.1007/s11538-011-9673-1; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; KESSLER JO, 1986, J FLUID MECH, V173, P191, DOI 10.1017/S0022112086001131; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Czirok A, 2000, J EXP BIOL, V203, P3345; Hopkins MM, 2002, J FLUID MECH, V455, P149, DOI 10.1017/S0022112001007339; Hosoya C, 2010, BIOL SCI SPACE, V24, P145; Kage A, 2011, ZOOL SCI, V28, P206, DOI 10.2108/zsj.28.206; Kage A, 2013, J EXP BIOL, V216, P4557, DOI 10.1242/jeb.092791; KAMIYA R, 1991, J CELL BIOL, V112, P441, DOI 10.1083/jcb.112.3.441; King SJ, 1997, J CELL BIOL, V136, P177, DOI 10.1083/jcb.136.1.177; King SM, 2009, CHLAMYDOMONAS SOURCE, V3, P131; Mogami Y, 2001, BIOL BULL, V201, P26, DOI 10.2307/1543522; Mogami Y, 2004, J EXP BIOL, V207, P3349, DOI 10.1242/jeb.01167; Myster SH, 1997, MOL BIOL CELL, V8, P607; PLATT JR, 1961, SCIENCE, V133, P1766, DOI 10.1126/science.133.3466.1766; Roberts AM, 2006, BIOL BULL-US, V210, P78, DOI 10.2307/4134597; Shoji E, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.043001; Suematsu NJ, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064003; ten Hagen B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5829; Wager H, 1911, PHILOS T R SOC LON B, V201, P333, DOI 10.1098/rstb.1911.0007	24	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					396	404		10.2108/zs150015		9	Zoology	Zoology	CN9UN	WOS:000358795400011		
J	Kajihara, H; Ikoma, M; Yamasaki, H; Hiruta, SF				Kajihara, Hiroshi; Ikoma, Maho; Yamasaki, Hiroshi; Hiruta, Shimpei F.			Trilobodrilus itoi sp nov., with a Re-Description of T. nipponicus (Annelida: Dinophilidae) and a MolecularPhylogeny of the Genus	ZOOLOGICAL SCIENCE			English	Article						North Pacific; marine invertebrates; archiannelid; mesopsammon; meiofauna; interstitial	BAYESIAN PHYLOGENETIC INFERENCE; SOUTHEASTERN BRAZILIAN COASTS; RIBOSOMAL DNA-SEQUENCES; SACCOCIRRIDAE ANNELIDA; DORVILLEIDAE ANNELIDA; CRYPTIC DIVERSITY; 28S RDNA; POLYCHAETA; 18S; ARCHIANNELIDA	The marine interstitial annelid Trilobodrilus itoi sp. nov., the sixth member of the genus, is described on the basis of specimens collected intertidally at Ishikari Beach, Hokkaido, Japan; this is the second species in the genus described from the Pacific Rim. In addition, T. nipponicus Uchida and Okuda, 1943 is re-described based on fresh topotypic material from Akkeshi, Hokkaido, Japan. From both species, we determined sequences of the nuclear 18S and 28S rRNA genes, and the mitochondrial cytochrome c oxidase subunit I (COI) gene. Molecular phylogenetic trees based on concatenated sequences of the three genes showed that T. itoi and T. nipponicus form a clade, which was the sister group to a clade containing the two European congeners T. axi Westheide, 1967 and T. heideri Remane, 1925. The Kimura two-parameter distance for COI was 22.5-22.7% between T. itoi and T. nipponicus, comparable with interspecific values in other polychaete genera. We assessed the taxonomic utility of epidermal inclusions and found that the known six species can be classified into three groups.	[Kajihara, Hiroshi; Ikoma, Maho; Hiruta, Shimpei F.] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Yamasaki, Hiroshi] Univ Ryukyus, Fac Sci, Nakagami, Okinawa 9030213, Japan	Kajihara, H (reprint author), Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	kazi@mail.sci.hokudai.ac.jp			JSPS KAKENHI [23370038, 2565013]	We thank Professor Matthew H. Dick for reviewing and editing the manuscript; two anonymous reviewers for constructive criticism on an earlier version of the manuscript; Professor/Director Masahiro Nakaoka and other staff at the Akkeshi Marine Station for providing facilities; Naoya Takeda and Kohtaro Tamura for information on Kalyptorhynchia; Daisuke Shimada for information on nematodes; Shohei Yamauchi for help in collecting; Daisuke Shimada and Shinri Tomioka for assisting with SEM observation; and Keiichi Kakui for assisting with photography. This study was financially supported by JSPS KAKENHI Grant Numbers 23370038 and 2565013.	Worsaae K, 2005, ZOOL SCR, V34, P313, DOI 10.1111/j.1463-6409.2005.00190.x; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; Kim CG, 2000, MOL BIOL EVOL, V17, P137; Kieneke A, 2012, MOL ECOL, V21, P1239, DOI 10.1111/j.1365-294X.2011.05421.x; Di Domenico M, 2014, MOL PHYLOGENET EVOL, V75, P202, DOI 10.1016/j.ympev.2014.02.003; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; OUG E, 1978, SARSIA, V63, P285; Fontaneto D, 2014, INT REV HYDROBIOL, V99, P178, DOI 10.1002/iroh.201301719; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Struck TH, 2006, INTEGR COMP BIOL, V46, P558, DOI 10.1093/icb/icj055; Di Domenico M, 2013, HELGOLAND MAR RES, V67, P733, DOI 10.1007/s10152-013-0358-z; Worsaae K, 2008, J MORPHOL, V269, P1426, DOI 10.1002/jmor.10686; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Tulchinsky AY, 2012, MAR BIOL, V159, P661, DOI 10.1007/s00227-011-1844-y; Schuller M, 2011, POLAR BIOL, V34, P549, DOI 10.1007/s00300-010-0913-x; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Borda E, 2012, ZOOL SCR, V41, P307, DOI 10.1111/j.1463-6409.2012.00529.x; Rundell RJ, 2010, BIOESSAYS, V32, P430, DOI 10.1002/bies.200900116; Worsaae K, 2005, HYDROBIOLOGIA, V535, P319, DOI 10.1007/s10750-004-4417-y; Struck TH, 2008, MOL PHYLOGENET EVOL, V48, P628, DOI 10.1016/j.ympev.2008.05.015; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; WESTHEIDE W, 1987, J NAT HIST, V21, P843, DOI 10.1080/00222938700770501; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Martinez A, 2013, MAR BIOL RES, V9, P676, DOI 10.1080/17451000.2013.765574; Struck TH, 2002, MOL PHYLOGENET EVOL, V25, P190, DOI 10.1016/S1055-7903(02)00231-2; Whiting MF, 1997, SYST BIOL, V46, P1; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Struck TH, 2005, MOL PHYLOGENET EVOL, V37, P619, DOI 10.1016/j.ympev.2005.07.010; Park JK, 2000, MOL PHYLOGENET EVOL, V14, P75, DOI 10.1006/mpev.1999.0691; Kvist S, 2013, CLADISTICS, V29, P435, DOI 10.1111/cla.12015; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Golombek A, 2013, MOL PHYLOGENET EVOL, V68, P312, DOI 10.1016/j.ympev.2013.03.026; AX P, 1968, MAR BIOL, V1, P330, DOI 10.1007/BF00360785; Aylagas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090529; Bacci G, 1962, B ZOOL, V29, P7; Bailey-Brock JH, 2010, PAC SCI, V64, P463, DOI 10.2984/64.3.463; Blake J.A., 1985, B BIOL SOC WASH, V6, P67; BOADEN PJS, 1963, J MAR BIOL ASSOC UK, V43, P239; Burnette AB, 2005, BIOL BULL-US, V208, P213, DOI 10.2307/3593153; Butcher Buntika Areekul, 2012, Zootaxa, V3457, P1; CAMPOY A, 1980, CAH BIOL MAR, V21, P201; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Casu M, 2006, BIOL J LINN SOC, V87, P553, DOI 10.1111/j.1095-8312.2006.00588.x; RAO GC, 1973, P INDIAN ACAD SCI B, V77, P101; Coleman AW, 2002, SCIENCE, V297, P337; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Curini-Galletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033801; Dana J. D., 1853, US EXPLORING EXPEDIT, V14, P689; Di Domenico M, 2014, MAR BIODIVERS, V44, P313, DOI 10.1007/s12526-014-0208-5; Di Domenico M, 2014, HYDROBIOLOGIA, V734, P1, DOI 10.1007/s10750-014-1858-9; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ehlers E, 1901, ABTEILUNGEN MATH PHY; EIBYEJACOBSEN D, 1994, ZOOL SCR, V23, P107, DOI 10.1111/j.1463-6409.1994.tb00379.x; FONTANETO D., 2011, SYSTEMATICS ASS SPEC, V79, P3; FRANSEN ME, 1980, ZOOMORPHOLOGIE, V95, P235, DOI 10.1007/BF00998124; RAO GC, 1968, P INDIAN ACAD SCI B, V67, P24; Grube AE, 1851, REISE AUSSERSTEN NOR, V2, P1; Hanamura Y, 1999, J NAT HIST, V33, P1811, DOI 10.1080/002229399299743; Hanamura Y, 1997, J NAT HIST, V31, P669, DOI 10.1080/00222939700770341; HOSHIDE K, 1971, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V18, P186; Ito T, 1985, ORGANISMS SAND INTER; Ito T, 1970, BENTHOS RES, V1, P21; Ito T., 1968, Journal of the Faculty of Science Hokkaido University Zoology, V16, P369; Jordens J., 2004, J ZOOL SYST EVOL RES, V42, P270; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kinberg J. G. H., 1866, OFVERSIGT KONGLIGA V, V22, P239; Kirkegaard J.B, 1977, P199; Krumbein W.C, 1937, J SEDIMENT PETROL, V7, P3, DOI DOI 10.1306/D4268F8B-2B26-11D7-8648000102C1865D; Leasi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104385; LINNAEUS C., 1766, SYSTEMA NATURAE REGN, VI; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Malmgren AJ, 1865, OFVERS K VETENSK AKA, V22, P181; Martinez A, 2014, CLADISTICS EARLY VIE, DOI [10.1111/cla.12089, DOI 10.1111/CLA.12089]; McIntosh WC, 1869, T ROY SOC EDINBURGH, V25, P305; Meyer-Wachsmuth I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107688; Nybakken James W., 2007, P18; Pallas P. S., 1766, MISCELLANEA ZOOLOGIC; Palumbi SR, 1996, MOL SYSTEMATICS, V2, P205; R Core Team, 2014, R LANG ENV STAT COMP; Rambaut A, 2014, TRACER V 1 6; Rasband WS, 1997, IMAGEJ; Read G, 2014, WORLD POLYCHAETA DAT; Remane A., 1934, Schriften des Naturwissenschaftichen Vereins fuer Schleswig-Holstein, V20, P479; Remane A., 1925, Zoologischer Anzeiger Leipzig, V65, P15; RIEGER RM, 1975, TISSUE CELL, V7, P267, DOI 10.1016/0040-8166(75)90005-1; Riser Nathan W., 1999, Northeastern Naturalist, V6, P211, DOI 10.2307/3858595; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scarpa F, 2015, J EXP MAR BIOL ECOL, V463, P22, DOI 10.1016/j.jembe.2014.10.020; SCHARNOFSKE P, 1986, HELGOLANDER MEERESUN, V40, P419, DOI 10.1007/BF01983821; Schmidt O, 1857, SITZBER AKAD WISS WI, V23, P347; Schulze A, 2007, MOL PHYLOGENET EVOL, V42, P171, DOI 10.1016/j.ympev.2006.06.012; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Sun Y, 2012, INVERTEBR SYST, V26, P539, DOI 10.1071/IS12024; TAJIKA K-I, 1983, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V23, P179; Uchida T, 1943, J FS HOKKAIDO IMP, V8, P301; Verrill A. E., 1873, REPORT INVERTEBRATE, P295; Westheide W., 2008, POLYCHAETES INTERSTI; WESTHEIDE W, 1984, FORTS ZOOL, V29, P265; WESTHEID.W, 1967, HELGOLAND WISS MEER, V16, P207, DOI 10.1007/BF01611704; WIESER WOLFGANG, 1957, TRANS AMER MLCROSC SOC, V76, P275, DOI 10.2307/3223891; Wiklund H, 2009, ZOOTAXA, P43; Williams DM, 2011, BIOGEOGRAPHY MICROSC, P11; WRIGHT LD, 1984, MAR GEOL, V56, P93, DOI 10.1016/0025-3227(84)90008-2; Yamaguchi S, 2003, MAR BIOL, V143, P23, DOI 10.1007/s00227-003-1062-3; Yamanishi R, 1983, BENTHOS RES, V24, P41; Yamasaki H, 2013, MOL PHYLOGENET EVOL, V67, P303, DOI 10.1016/j.ympev.2013.02.016; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	111	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	AUG	2015	32	4					405	417		10.2108/zs140251		13	Zoology	Zoology	CN9UN	WOS:000358795400012		
J	Ishii, K; Lang, N; An, M				Ishii, Kisaburo; Lang, Ng; An, Masatoshi			Discussion: The Future of the City Urban Development in Singapore and Japan	A + U-ARCHITECTURE AND URBANISM			English	Editorial Material									[Ishii, Kisaburo] Infrastructure Minist Land Infrastruct Transport, Tokyo, Japan; [Lang, Ng] Urban Redevelopment Author Singapore, Singapore, Singapore; [An, Masatoshi] Urban Renewal Coordinator Assoc Japan, Tokyo, Japan; [An, Masatoshi] Nikken Sekkei Res Inst, Tokyo, Japan	Ishii, K (reprint author), Infrastructure Minist Land Infrastruct Transport, Tokyo, Japan.							0	0	0	A & U PUBL CO LTD	TOKYO	30-8 YUSHIMA 2-CHOME BUNKYO-KU, TOKYO, 113, JAPAN	0389-9160			A U-ARCHIT URBAN	A U-Archit. Urban.	AUG	2015		539					225	228				4	Architecture	Architecture	CO3DN	WOS:000359036900027		
J	Aizawa, N; Kunikata, H; Nitta, F; Nakazawa, T				Aizawa, Naoko; Kunikata, Hiroshi; Nitta, Fumihiko; Nakazawa, Toru			The relationship between laser speckle flowgraphy-measured optic disc microcirculation and postoperative visual recovery in rhegmatogenous retinal detachment	ACTA OPHTHALMOLOGICA			English	Letter									[Aizawa, Naoko; Kunikata, Hiroshi; Nitta, Fumihiko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 9808574, Japan; [Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 9808574, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 9808574, Japan	Kunikata, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kunikata@oph.med.tohoku.ac.jp					Aizawa N, 2014, CLIN EXP OPHTHALMOL, V42, P702, DOI 10.1111/ceo.12313; Aizawa N, 2013, CLIN EXPT OPHTHALMOL, V42, P293; Rosenbaum DM, 1997, VISION RES, V37, P3445, DOI 10.1016/S0042-6989(96)00328-8; Eshita T, 2004, JPN J OPHTHALMOL, V48, P358, DOI 10.1007/s10384-004-0096-5; Nagahara M, 2000, BRIT J OPHTHALMOL, V84, P31, DOI 10.1136/bjo.84.1.31	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	AUG	2015	93	5					E397	E399		10.1111/aos.12586		3	Ophthalmology	Ophthalmology	CN5AC	WOS:000358440700016		
J	Inoue, T; Tanihara, H; Tokushige, H; Araie, M				Inoue, Toshihiro; Tanihara, Hidenobu; Tokushige, Hideki; Araie, Makoto			Efficacy and safety of SNJ-1656 in primary open-angle glaucoma or ocular hypertension	ACTA OPHTHALMOLOGICA			English	Letter									[Inoue, Toshihiro; Tanihara, Hidenobu] Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Kumamoto 8608556, Japan; [Tokushige, Hideki] Senju Pharmaceut Co Ltd, Osaka, Japan; [Araie, Makoto] Kanto Cent Hosp Mutual Aid Assoc Publ Sch Teacher, Tokyo, Japan	Tanihara, H (reprint author), Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	tanihara@pearl.ocn.ne.jp					Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	AUG	2015	93	5					E393	E395		10.1111/aos.12641		3	Ophthalmology	Ophthalmology	CN5AC	WOS:000358440700013		
J	Narumi, M; Nishitsuka, K; Yamakawa, M; Yamashita, H				Narumi, Mari; Nishitsuka, Koichi; Yamakawa, Mitsunori; Yamashita, Hidetoshi			A survey of vitreous cell components performed using liquid-based cytology	ACTA OPHTHALMOLOGICA			English	Article						immunocytochemistry; liquid-based cytology; vitreoretinal diseases; vitreous cell	RETINAL VEIN OCCLUSION; INTRAOCULAR LYMPHOMA; DIABETIC-RETINOPATHY; IMMUNE DEVIATION; VITRECTOMY; DIAGNOSIS; ANTIGEN	PurposeTo confirm the efficacy of liquid-based cytology (LBC) method in the observation of vitreous cells in various vitreoretinal diseases in human. MethodsVitreous fluid samples from 30 eyes were obtained by 23-gauge 3-port pars plana vitrectomy. After making three ports, we collected vitreous specimen from the core vitreous cavity without infusion. We divided the samples into a quiescent group and an active group based on clinical signs of inflammation. To confirm availability of LBC preparation slides for immunostaining, we also performed immunocytochemistry (ICC) for CD68, RPE65 and DEC-205 (CD205) using LBC slides of 10 cell-rich cases including retinal detachment and endophthalmitis. ResultsUsing LBC method, small amounts of vitreous cells were observed efficiently. Vitreous cells were observed in inflammatory quiescent cases including macular pucker and macular hole. The number of vitreous cells increased significantly in the cases with clinically active inflammation (2297 versus 207 cells/ml, respectively, p<0.01, Mann-Whitney U-test). The ICC results showed the presence of CD68(+) cells in all 10 cases. Large numbers of DEC-205(+) cells were observed in one case with infectious endophthalmitis. In the cases with retinal detachment, the predominant cell type was RPE65(+). Neutrophils and lymphocytes were also observed. ConclusionsThe LBC method makes it possible to examine vitreous specimens easily and efficiently, facilitating the expedient diagnosis of vitreoretinal diseases, and the preparation slides are available for immunocytochemistry. This study also showed that vitreoretinal disease involves the migration of various types of cells including macrophages, neutrophils, lymphocytes, RPE65(+) pigmented cells and DEC-205(+) cells.	[Narumi, Mari; Nishitsuka, Koichi; Yamashita, Hidetoshi] Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, Yamagata 9909585, Japan; [Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Diagnost Pathol, Yamagata 9909585, Japan	Narumi, M (reprint author), Yamagata Univ, Fac Med, Dept Ophthalmol & Visual Sci, 2-2-2 Iidanishi, Yamagata 9909585, Japan.	mari.narumi1101@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science	Toshinori Suzuki and Hitoshi Suzuki helped with the technical execution of all cytology techniques. Rintaro Ohe helped with the pathological analysis. This study was supported by Grantsin-Aid from Ministry of Education, Culture, Sports, Science and Technology, Japan, and Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science.	Abbas A, 2008, CELLULAR MOL IMMUNOL, V5th, P94; Sonoda KH, 2005, IMMUNOLOGY, V116, P390, DOI 10.1111/j.1365-2567.2005.02239.x; Okunuki Y, 2011, AM J OPHTHALMOL, V151, P610, DOI 10.1016/j.ajo.2010.09.030; Kimura K, 2012, JPN J OPHTHALMOL, V56, P383, DOI 10.1007/s10384-012-0150-7; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Intzedy L, 2008, EYE, V22, P289, DOI 10.1038/sj.eye.6702965; KINOSHITA Y, 2011, J JPN SOC CLIN CYTOL, V50, P320; Kronin V, 2000, INT IMMUNOL, V12, P731, DOI 10.1093/intimm/12.5.731; LAZARUS HS, 1994, ARCH OPHTHALMOL-CHIC, V112, P1356; Matsuo T, 2012, OPHTHALMOLOGY, V119, P827, DOI 10.1016/j.ophtha.2011.10.020; Noma H, 2012, CURR EYE RES, V37, P62, DOI 10.3109/02713683.2011.614370; Petrovic MG, 2010, ACTA OPHTHALMOL, V88, pe311, DOI 10.1111/j.1755-3768.2010.02030.x; Rajagopal R, 2011, RETINA-J RET VIT DIS, V31, P435, DOI 10.1097/IAE.0b013e31820a6743; Sakamoto T, 2011, RETINA-J RET VIT DIS, V31, P222, DOI 10.1097/IAE.0b013e3181facfa9; Sen HN, 2009, OCUL IMMUNOL INFLAMM, V17, P133, DOI 10.1080/09273940903108544; Streilein JW, 1997, INVEST OPHTH VIS SCI, V38, P2245; Taoka H, 2010, HUM CELL, V23, P126, DOI 10.1111/j.1749-0774.2010.00093.x; Van Ginderdeuren R, 2014, ACTA OPHTHALMOL, V92, pE388, DOI 10.1111/aos.12360; vansMeurs JC, 2004, BR J OPHTHALMOL, V88, P110; Wakabayashi Y, 2011, RETINA-J RET VIT DIS, V31, P1951, DOI 10.1097/IAE.0b013e31820d3cee; YAMASHITA H, 1986, JPN J OPHTHALMOL, V30, P269; YAMASHITA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P127	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	AUG	2015	93	5					E386	E390		10.1111/aos.12623		5	Ophthalmology	Ophthalmology	CN5AC	WOS:000358440700010		
J	Cravo, P; Napolitano, H; Culleton, R				Cravo, Pedro; Napolitano, Hamilton; Culleton, Richard			How genomics is contributing to the fight against artemisinin-resistant malaria parasites	ACTA TROPICA			English	Review						Malaria; Plasmodium falciparum; Artemisinin resistance; Genomics; Molecular markers	PLASMODIUM-FALCIPARUM MALARIA; PFMDR1 GENE; COMBINATION THERAPY; DRUG-RESISTANCE; INCREASED SENSITIVITY; SELECTIVE SWEEP; SOUTHEAST-ASIA; COPY NUMBER; CAMBODIA; CHLOROQUINE	Plasmodium falciparum, the malignant malaria parasite, has developed resistance to artemisinin, the most important and widely used antimalarial drug at present. Currently confined to Southeast Asia, the spread of resistant parasites to Africa would constitute a public health catastrophe. In this review we highlight the recent contributions of genomics to our understanding how the parasite develops resistance to artemisinin and its derivatives, and how resistant parasites may be monitored and tracked in real-time, using molecular approaches. (C) 2015 Elsevier B.V. All rights reserved.	[Cravo, Pedro] Univ Fed Goias, IPTSP, Lab Genom & Biotechnol GenoBio, BR-74605050 Goiania, Go, Brazil; [Cravo, Pedro; Napolitano, Hamilton] Ctr Univ Anapolis UniEVANGELICA, PPSTMA, BR-75083515 Anapolis, Go, Brazil; [Cravo, Pedro] Univ Nova Lisboa, Inst Higiene & Med Trop, P-1349008 Lisbon, Portugal; [Napolitano, Hamilton] Univ Estadual Goias, Ciencias Exatas & Tecnol, BR-75001970 Anapolis, Go, Brazil; [Culleton, Richard] Nagasaki Univ, Inst Trop Med, Dept Pathol, Malaria Unit, Nagasaki 8528523, Japan	Cravo, P (reprint author), Univ Fed Goias, IPTSP, Lab Genom & Biotechnol GenoBio, BR-74605050 Goiania, Go, Brazil.	pedrovcravo@gmail.com					Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI 10.1172/JCI200421682; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Vinayak S, 2010, J INFECT DIS, V201, P1551, DOI 10.1086/651949; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Sidhu ABS, 2007, J BIOL CHEM, V282, P2494, DOI 10.1074/jbc.M608615200; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; BJORKMAN A, 1990, T ROY SOC TROP MED H, V84, P177, DOI 10.1016/0035-9203(90)90246-B; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Borrmann S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03318; Cravo P., 2006, Anti-Infective Agents in Medicinal Chemistry, V5, P63, DOI 10.2174/187152106774755590; Culleton R.L., 2014, PARASITOL INT, V64, P244; Ding XC, 2011, TRENDS PARASITOL, V27, P73, DOI 10.1016/j.pt.2010.11.006; HARINASU.T, 1965, LANCET, V2, P657; Henriques G, 2014, J INFECT DIS, V210, P2001, DOI 10.1093/infdis/jiu358; Hunja CW, 2013, INT J PARASITOL, V43, P885, DOI 10.1016/j.ijpara.2013.07.001; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; MABERTI S, 1960, Arch Venez Med Trop Parasitol Med, V3, P239; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; MOORE DV, 1961, AM J TROP MED HYG, V10, P5; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Organisation W.H, 2013, WHO MAL REP, P2013; Park DJ, 2012, P NATL ACAD SCI USA, V109, P13052, DOI 10.1073/pnas.1210585109; Price RN, 2000, EXPERT OPIN INV DRUG, V9, P1815, DOI 10.1517/13543784.9.8.1815; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Vinayak S., 2010, PLOS PATHOG, V6; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	AUG	2015	148						1	7		10.1016/j.actatropica.2015.04.007		7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CN5KO	WOS:000358468400001		
J	Lim, PKC; Yamasaki, H; Mak, JW; Wong, SF; Chong, CW; Yap, IKS; Ambu, S; Kumarasamy, V				Lim, P. K. C.; Yamasaki, H.; Mak, J. W.; Wong, S. F.; Chong, C. W.; Yap, I. K. S.; Ambu, S.; Kumarasamy, V.			Field evaluation of a rapid diagnostic test to detect antibodies in human toxocariasis	ACTA TROPICA			English	Article						Human toxocariasis; lmmunodiagnosis; Enzyme-linked immunosorbent assay; Rapid diagnostic test; Recombinant antigen	CANIS INFECTION; ANTIGEN; SEROPREVALENCE; SCHOOLCHILDREN; PREVALENCE; ASSAY; CATI	Human toxocariasis which is caused mainly by the larvae of Toxocara canis and Toxocara cati, is a worldwide zoonotic disease that can be a potentially serious human infection. The enzyme-linked immunosorbent assay (ELISA) using T. canis excretory secretory (TES) antigens harvested from T. canis larvae is currently the serological test for confirming toxocariasis. An alternative to producing large amounts of Toxocara TES and improved diagnosis for toxocariasis is through the development of highly specific recombinant antigens such as the T. canis second stage larva excretory secretory 30 kDa protein (recTES-30). The aim of this study was to evaluate the sensitivity and specificity of a rapid diagnostic kit (RDT, named as iToxocara kit) in comparison to recTES-30 ELISA in Serendah Orang Ash village in Selangor, Malaysia. A total of 133 subjects were included in the study. The overall prevalence rates by ELISA and RDT were 29.3% and 33.1%, respectively, with more positive cases detected in males than females. However, no association was found between toxocariasis and gender or age. The percentage sensitivity, specificity, positive predictive value and negative predictive value of RDT were 85.7%, 90.1%, 80% and 93.2%, respectively. The prevalence for toxocariasis in this population using both ELISA and RDT was 27.1% (36/133) and the K-concordance test suggested good agreement of the two tests with a Cohen's kappa of 0.722, P<0.01. In addition, the followed-up Spearman rank correlation showed a moderately high correlation at R=0.704 and P<0.01. In conclusion, the RDT kit was faster and easier to use than an ELISA and is useful for the laboratory diagnosis of hospitalized cases of toxocariasis. (C) 2015 The Authors. Published by Elsevier B.V.	[Lim, P. K. C.; Mak, J. W.; Wong, S. F.; Ambu, S.; Kumarasamy, V.] Int Med Univ, Sch Med Sci, Kuala Lumpur 57000, Malaysia; [Yamasaki, H.] Natl Inst Infect Dis, Dept Parasitol, Tokyo 1628640, Japan; [Chong, C. W.; Yap, I. K. S.] Int Med Univ, Sch Pharm, Kuala Lumpur 57000, Malaysia	Lim, PKC (reprint author), Int Med Univ, Sch Med Sci, 126 Jalan Jalil Perkasa 19, Kuala Lumpur 57000, Malaysia.	kimchooi_lim@imu.edu.my; hyamasak@nih.go.jp; joonwah_mak@imu.edu.my; shewfung_wong@imu.edu.my; chunwie_chong@imu.edu.my; ivan_yap@imu.edu.my; stephen_ambu@imu.edu.my; verasingam_kumarasamy@imu.edu.my			IMU [IMU 100217]; Ministry of Health, Labour and Welfare, Japan [H25-Sinko-Ippan-014]	We would like to thank the Selangor Orang Asli Department, Malaysia for permission to conduct this research study in Kampung Orang Asli Serendah and IMU Research Laboratory staff who assisted in the questionaire survey and finger prick blood collection. The study was supported by IMU (IMU Grant number IMU 100217) and a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare, Japan (H25-Sinko-Ippan-014) to HY.	Akao Nobuaki, 1997, Parasitology International, V46, P189, DOI 10.1016/S1383-5769(97)00027-5; Romano N, 2010, TROP BIOMED, V27, P585; Yamasaki H, 2000, J CLIN MICROBIOL, V38, P1409; Fong Mun-Yik, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P723; KENNEDY MW, 1989, CLIN EXP IMMUNOL, V75, P493; Roldan WH, 2009, MEM I OSWALDO CRUZ, V104, P411, DOI 10.1590/S0074-02762009000300003; Bojanich MV, 2012, MEM I OSWALDO CRUZ, V107, P194, DOI 10.1590/S0074-02762012000200007; Carmago E.D., 1992, REV INST MED TROP SP, V34, P55; Cassenote AJF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002830; Coelho RDL, 2005, AM J TROP MED HYG, V72, P103; Fan CK, 2005, ANN TROP MED PARASIT, V99, P593, DOI 10.1179/136485905X51373; GILLESPIE SH, 1993, J CLIN PATHOL, V46, P551, DOI 10.1136/jcp.46.6.551; Glickman L, 1978, AM J TROP MED HYG, V27, P92; Hakim S L, 1992, Southeast Asian J Trop Med Public Health, V23, P493; Hakim S L, 1993, Med J Malaysia, V48, P303; Homsy A, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3672188; KENNEDY MW, 1987, PARASITE IMMUNOL, V9, P407, DOI 10.1111/j.1365-3024.1987.tb00519.x; Kim HS, 2014, J KOREAN MED SCI, V29, P1618, DOI 10.3346/jkms.2014.29.12.1618; Lim P.K.C., 1999, INT MED RES J, V3, P67; Magnaval Jean-Francois, 2001, Korean Journal of Parasitology, V39, P1; MASRON T, 2013, J RITSUMEIKAN SOC SC, V6, P75; Mehru Nisha M.H., 2014, THESIS INT MED U; Ngah Z., 1999, INT MED RES J, V3, P73; Nunes Caris Maroni, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P95; PARSONS JC, 1986, AM J TROP MED HYG, V35, P974; Rai Shiba Kumar, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P541; Roddy P, 2008, J CLIN MICROBIOL, V46, P2022, DOI 10.1128/JCM.02303-07; Singh A., 2007, REV OPHTHALMOL, V14, P55; Van De Nguyen, 2013, Korean J Parasitol, V51, P563, DOI 10.3347/kjp.2013.51.5.563; Watthanakulpanich D., 2010, Journal of Tropical Medicine & Parasitology, V33, P44; Wu ZL, 1997, J HELMINTHOL, V71, P77; Yamasaki Hiroshi, 1998, Parasitology International, V47, P171, DOI 10.1016/S1383-5769(98)00016-6; Yamasaki H., 2012, SHONIKA PEDIAT, V54, P65	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	AUG	2015	148						32	37		10.1016/j.actatropica.2015.04.011		6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CN5KO	WOS:000358468400005		
J	Mukaiyama, K; Kamimura, M; Uchiyama, S; Ikegami, S; Nakamura, Y; Kato, H				Mukaiyama, Keijiro; Kamimura, Mikio; Uchiyama, Shigeharu; Ikegami, Shota; Nakamura, Yukio; Kato, Hiroyuki			Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Alkaline phosphatase; Menopausal women; Osteoporosis; Bone turnover	BIOCHEMICAL MARKERS; HEALTHY-CHILDREN; REFERENCE LIMITS; ELDERLY-WOMEN; FEMORAL-NECK; PLASMA; FRACTURES; AGE; OSTEOPOROSIS; ADOLESCENTS	Background Most of the alkaline phosphatase (ALP) isoenzymes are derived from the bones and liver. High levels of ALP are often encountered during routine blood investigation in elderly patients. However, because ALP includes various isoenzymes from other tissues, an accurate diagnosis is usually not possible on the basis of elevated ALP alone. Aims To identify the cause of increased ALP in postmenopausal women. Methods We measured serum ALP in a group of 626 postmenopausal osteoporotic women before and after treatment with a bisphosphonate (either alendronate or risedronate). We analyzed the correlations between ALP levels and bone metabolic markers or hepatic function markers. Results The ALP and BAP levels of people in their 80s were significantly higher than those of people in their 60s. With bisphosphonate therapy, the BAP decreased, and the elevated ALP decreased to normal range levels. ALP was highly and significantly correlated with BAP both before and after treatment. The changes in levels of ALP correlated well with the changes in BAP levels before and after bisphosphonate therapy. Markers of liver function correlated with total ALP (p < 0.01), but the correlation was much smaller than that between ALP and BAP. Discussion Bisphosphonate treatment lowered ALP levels, and this decrease was strongly correlated with a decrease in BAP. Among blood test data, the decrease in BAP had the strongest correlation with the ALP decrease. Conclusion For treatment of osteoporosis, ALP is an acceptable alternative to BAP. Elevated ALP in postmenopausal women is mainly caused by high bone turnover.	[Mukaiyama, Keijiro; Uchiyama, Shigeharu; Ikegami, Shota; Nakamura, Yukio; Kato, Hiroyuki] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 3908621, Japan; [Kamimura, Mikio] Kamimura Clin, Matsumoto, Nagano 3990021, Japan	Mukaiyama, K (reprint author), Shinshu Univ, Sch Med, Dept Orthopaed Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kmuka312@yahoo.co.jp					Woitge HW, 1998, J CLIN ENDOCR METAB, V83, P68, DOI 10.1210/jc.83.1.68; Ingle BM, 1999, OSTEOPOROSIS INT, V10, P399, DOI 10.1007/s001980050246; Gallagher JC, 1998, J BONE MINER RES, V13, P475, DOI 10.1359/jbmr.1998.13.3.475; DresnerPollak R, 1996, CALCIFIED TISSUE INT, V59, P328; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Nishizawa Y, 2005, J BONE MINER METAB, V23, P97, DOI 10.1007/s00774-004-0547-6; CHENG MH, 1979, CLIN CHEM, V25, P692; CHERIAN AG, 1978, AM J CLIN PATHOL, V70, P783; Endo N, 2007, DEFINITION DIAGNOSTI; FLEISHER GA, 1977, CLIN CHEM, V23, P469; GARDNER MD, 1978, J CLIN PATHOL, V31, P1202, DOI 10.1136/jcp.31.12.1202; HOSKING DJ, 1978, J BONE JOINT SURG BR, V60, P61; Iino S, 1995, Nihon Rinsho, V53 Su Pt 1, P276; Kamimura M, 2005, J BONE MINER METAB, V23, P495, DOI 10.1007/s00774-005-0634-3; KELLY A, 1979, J GERONTOL, V34, P37; Kuwa K, 1993, RINSHO KENSA, V37, P473; KUWANA T, 1988, CLIN CHIM ACTA, V173, P273, DOI 10.1016/0009-8981(88)90014-9; Nakagawa H, 2006, J ORTHOP SCI, V11, P135, DOI 10.1007/s00776-005-0990-9; Nishida T, 2001, RINSHO KENSA, V45, P353; Orimo H., 2006, GUIDELINES PREVENTIO; SCHIELE F, 1983, CLIN CHEM, V29, P634; STATLAND BE, 1972, CLIN CHEM, V18, P1468; Takahara K, 2004, J BONE MINER METAB, V22, P618, DOI 10.1007/s00774-004-0532-0; Takahara K, 2004, J ORTHOP SCI, V9, P650, DOI 10.1007/s00776-004-0842-z; WHITAKER KB, 1977, CLIN CHIM ACTA, V80, P209, DOI 10.1016/0009-8981(77)90281-9	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	AUG	2015	27	4					413	418		10.1007/s40520-014-0296-x		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CN5AG	WOS:000358441100003		
J	Chaudhry, KK; Samak, G; Shukla, PK; Mir, H; Gangwar, R; Manda, B; Isse, T; Kawamoto, T; Salaspuro, M; Kaihovaara, P; Dietrich, P; Dragatsis, I; Nagy, LE; Rao, RK				Chaudhry, Kamaljit K.; Samak, Geetha; Shukla, Pradeep K.; Mir, Hina; Gangwar, Ruchika; Manda, Bhargavi; Isse, Toyohi; Kawamoto, Toshihiro; Salaspuro, Mikko; Kaihovaara, Pertti; Dietrich, Paula; Dragatsis, Ioannis; Nagy, Laura E.; Rao, Radha Krishna			ALDH2 Deficiency Promotes Ethanol-Induced Gut Barrier Dysfunction and Fatty Liver in Mice	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Alcohol; Tight Junction; Acetaldehyde; Gut Permeability; Adherens Junction	CACO-2 CELL MONOLAYER; ACETALDEHYDE-INDUCED INCREASE; TIGHT JUNCTION INTEGRITY; PARACELLULAR PERMEABILITY; ALDEHYDE DEHYDROGENASE; L-GLUTAMINE; ALCOHOL; DISEASE; ENDOTOXEMIA; ACTIVATION	BackgroundAcetaldehyde, the toxic ethanol (EtOH) metabolite, disrupts intestinal epithelial barrier function. Aldehyde dehydrogenase (ALDH) detoxifies acetaldehyde into acetate. Subpopulations of Asians and Native Americans show polymorphism with loss-of-function mutations in ALDH2. We evaluated the effect of ALDH2 deficiency on EtOH-induced disruption of intestinal epithelial tight junctions and adherens junctions, gut barrier dysfunction, and liver injury. MethodsWild-type and ALDH2-deficient mice were fed EtOH (1 to 6%) in Lieber-DeCarli diet for 4weeks. Gut permeability invivo was measured by plasma-to-luminal flux of FITC-inulin, tight junction and adherens junction integrity was analyzed by confocal microscopy, and liver injury was assessed by the analysis of plasma transaminase activity, histopathology, and liver triglyceride. ResultsEtOH feeding elevated colonic mucosal acetaldehyde, which was significantly greater in ALDH2-deficient mice. ALDH2(-/-) mice showed a drastic reduction in the EtOH diet intake. Therefore, this study was continued only in wild-type and ALDH2(+/-) mice. EtOH feeding elevated mucosal inulin permeability in distal colon, but not in proximal colon, ileum, or jejunum of wild-type mice. In ALDH2(+/-) mice, EtOH-induced inulin permeability in distal colon was not only higher than that in wild-type mice, but inulin permeability was also elevated in the proximal colon, ileum, and jejunum. Greater inulin permeability in distal colon of ALDH2(+/-) mice was associated with a more severe redistribution of tight junction and adherens junction proteins from the intercellular junctions. In ALDH2(+/-) mice, but not in wild-type mice, EtOH feeding caused a loss of junctional distribution of tight junction and adherens junction proteins in the ileum. Histopathology, plasma transaminases, and liver triglyceride analyses showed that EtOH-induced liver damage was significantly greater in ALDH2(+/-) mice compared to wild-type mice. ConclusionsThese data demonstrate that ALDH2 deficiency enhances EtOH-induced disruption of intestinal epithelial tight junctions, barrier dysfunction, and liver damage.	[Chaudhry, Kamaljit K.; Samak, Geetha; Shukla, Pradeep K.; Mir, Hina; Gangwar, Ruchika; Manda, Bhargavi; Dietrich, Paula; Dragatsis, Ioannis; Rao, Radha Krishna] Univ Tennessee, Dept Physiol, Memphis, TN 38163 USA; [Isse, Toyohi; Kawamoto, Toshihiro] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan; [Salaspuro, Mikko; Kaihovaara, Pertti] Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland; [Nagy, Laura E.] Cleveland Clin Fdn, Cleveland, OH 44195 USA	Rao, RK (reprint author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave,Nash 426, Memphis, TN 38163 USA.	rrao2@uthsc.edu			NIH [AA12307, DK55532, P20 AA017837, R01 AA019673, 1U01AA021890]	This study was supported by NIH grants, AA12307 (RKR), DK55532 (RKR), P20 AA017837 (LEN), R01 AA019673 (LEN), and 1U01AA021890 (LEN). Authors acknowledge Ms. Ernestine Hayes at the Department of Comparative Medicine, UTHSC for her help with tail vein injections and cardiac puncture for collection of blood.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Elamin E, 2014, AM J PHYSIOL-GASTR L, V306, pG677, DOI 10.1152/ajpgi.00236.2013; Sheth P, 2004, ALCOHOL CLIN EXP RES, V28, P797, DOI 10.1097/01.ALC.0000125358.92335.90; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Kirpich IA, 2012, ALCOHOL CLIN EXP RES, V36, P835, DOI 10.1111/j.1530-0277.2011.01673.x; Basuroy S, 2005, AM J PHYSIOL-GASTR L, V289, pG367, DOI 10.1152/ajpgi.00464.2004; Wall TL, 1997, ANN INTERN MED, V127, P376; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; ANDERSON C, 1991, ACTA DERM-VENEREOL, V71, P389; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; MADARA JL, 1986, J CELL BIOL, V102, P2125, DOI 10.1083/jcb.102.6.2125; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Rao RK, 1998, ALCOHOL CLIN EXP RES, V22, P1724, DOI 10.1097/00000374-199811000-00015; Mathurin P, 2000, HEPATOLOGY, V32, P1008, DOI 10.1053/jhep.2000.19621; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Jokelainen K, 2001, CYTOKINE, V16, P36, DOI 10.1006/cyto.2001.0930; Ronis MJ, 2010, ALCOHOL, V44, P157, DOI 10.1016/j.alcohol.2009.11.002; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; BODE JC, 1984, HEPATO-GASTROENTEROL, V31, P30; Duryee MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1931, DOI 10.1097/01.ALC.0000148115.90045.C5; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p15S, DOI 10.1111/j.1530-0277.2001.tb02369.x; Fisher SJ, 2010, J PHARMACOL EXP THER, V332, P326, DOI 10.1124/jpet.109.158642; Isse T, 2002, PHARMACOGENETICS, V12, P621, DOI 10.1097/00008571-200211000-00006; Jokelainen K, 1996, GUT, V39, P100, DOI 10.1136/gut.39.1.100; MADARA JL, 1987, AM J PHYSIOL, V253, pC171; Morimoto K, 1996, ENVIRON HEALTH PERSP, V104, P563, DOI 10.2307/3432824; Nanji AA, 2002, ALCOHOL CLIN EXP RES, V26, P731, DOI 10.1111/j.1530-0277.2002.tb02598.x; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	AUG	2015	39	8					1465	1475		10.1111/acer.12777		11	Substance Abuse	Substance Abuse	CN7NL	WOS:000358621200019		
J	Tokunaga, T; Sakashita, M; Haruna, T; Asaka, D; Takeno, S; Ikeda, H; Nakayama, T; Seki, N; Ito, S; Murata, J; Sakuma, Y; Yoshida, N; Terada, T; Morikura, I; Sakaida, H; Kondo, K; Teraguchi, K; Okano, M; Otori, N; Yoshikawa, M; Hirakawa, K; Haruna, S; Himi, T; Ikeda, K; Ishitoya, J; Iino, Y; Kawata, R; Kawauchi, H; Kobayashi, M; Yamasoba, T; Miwa, T; Urashima, M; Tamari, M; Noguchi, E; Ninomiya, T; Imoto, Y; Morikawa, T; Tomita, K; Takabayashi, T; Fujieda, S				Tokunaga, T.; Sakashita, M.; Haruna, T.; Asaka, D.; Takeno, S.; Ikeda, H.; Nakayama, T.; Seki, N.; Ito, S.; Murata, J.; Sakuma, Y.; Yoshida, N.; Terada, T.; Morikura, I.; Sakaida, H.; Kondo, K.; Teraguchi, K.; Okano, M.; Otori, N.; Yoshikawa, M.; Hirakawa, K.; Haruna, S.; Himi, T.; Ikeda, K.; Ishitoya, J.; Iino, Y.; Kawata, R.; Kawauchi, H.; Kobayashi, M.; Yamasoba, T.; Miwa, T.; Urashima, M.; Tamari, M.; Noguchi, E.; Ninomiya, T.; Imoto, Y.; Morikawa, T.; Tomita, K.; Takabayashi, T.; Fujieda, S.			Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study	ALLERGY			English	Article						chronic rhinosinusitis severity; clinical diagnostic criterion; endoscopic sinus surgery; eosinophilic infiltration; refractory chronic rhinosinusitis	EOSINOPHILIC CHRONIC RHINOSINUSITIS; ENDOSCOPIC SINUS SURGERY; NASAL POLYPS; ASTHMA; RECURRENCE; EXPRESSION; JAPAN; INFLAMMATION; ASSOCIATION; POPULATION	BackgroundChronic rhinosinusitis (CRS) can be classified into CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). CRSwNP displays more intense eosinophilic infiltration and the presence of Th2 cytokines. Mucosal eosinophilia is associated with more severe symptoms and often requires multiple surgeries because of recurrence; however, even in eosinophilic CRS (ECRS), clinical course is variable. In this study, we wanted to set objective clinical criteria for the diagnosis of refractory CRS. MethodsThis was a retrospective study conducted by 15 institutions participating in the Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis (JESREC). We evaluated patients with CRS treated with endoscopic sinus surgery (ESS), and risk of recurrence was estimated using Cox proportional hazard models. Multiple logistic regression models and receiver operating characteristics curves were constructed to create the diagnostic criterion for ECRS. ResultsWe analyzed 1716 patients treated with ESS. To diagnose ECRS, the JESREC scoring system assessed unilateral or bilateral disease, the presence of nasal polyps, blood eosinophilia, and dominant shadow of ethmoid sinuses in computed tomography (CT) scans. The cutoff value of the score was 11 points (sensitivity: 83%, specificity: 66%). Blood eosinophilia (>5%), ethmoid sinus disease detected by CT scan, bronchial asthma, aspirin, and nonsteroidal anti-inflammatory drugs intolerance were associated significantly with recurrence. ConclusionWe subdivided CRSwNP in non-ECRS, mild, moderate, and severe ECRS according to our algorithm. This classification was significantly correlated with prognosis. It is notable that this algorithm may give useful information to clinicians in the refractoriness of CRS before ESS or biopsy.	[Tokunaga, T.; Sakashita, M.; Ninomiya, T.; Imoto, Y.; Morikawa, T.; Tomita, K.; Takabayashi, T.; Fujieda, S.] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Eiheiji, Fukui 9101193, Japan; [Haruna, T.; Okano, M.] Okayama Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Okayama 7008530, Japan; [Asaka, D.; Otori, N.] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan; [Takeno, S.; Hirakawa, K.] Hiroshima Univ, Dept Otorhinolaryngol Head & Neck Surg, Hiroshima, Japan; [Ikeda, K.] Japanese Red Cross Soc, Wakayama Med Ctr, Dept Otorhinolaryngol, Wakayama, Japan; [Nakayama, T.; Haruna, S.] Dokkyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Mibu, Tochigi, Japan; [Seki, N.; Himi, T.] Sapporo Med Univ, Dept Otolaryngol, Sapporo, Hokkaido, Japan; [Ito, S.; Murata, J.; Ikeda, K.] Juntendo Univ, Dept Otorhinolaryngol, Tokyo, Japan; [Sakuma, Y.; Ishitoya, J.] Yokohama City Med Ctr, Dept Otorhinolaryngol, Yokohama, Kanagawa, Japan; [Yoshida, N.; Iino, Y.] Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol, Saitama, Japan; [Terada, T.; Kawata, R.] Osaka Med Coll, Dept Otolaryngol Head & Neck Surg, Osaka, Japan; [Morikura, I.; Kawauchi, H.] Shimane Univ, Dept Otorhinolaryngol, Matsue, Shimane, Japan; [Sakaida, H.; Kobayashi, M.] Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tsu, Mie 514, Japan; [Kondo, K.; Yamasoba, T.] Univ Tokyo, Dept Otolaryngol, Tokyo 113, Japan; [Teraguchi, K.; Miwa, T.] Kanazawa Med Univ, Dept Otorhinolaryngol, Kanazawa, Ishikawa, Japan; [Yoshikawa, M.] Toho Univ, Dept Otorhinolaryngol, Tokyo, Japan; [Urashima, M.] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Tamari, M.] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Resp Dis, Yokohama, Kanagawa, Japan; [Noguchi, E.; Ninomiya, T.] Univ Tsukuba, Dept Med Genet, Ibaraki, Japan	Fujieda, S (reprint author), Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, 23-3 Matsuoka Shimoaizuki, Eiheiji, Fukui 9101193, Japan.	sfujieda@u-fukui.ac.jp	Tamari, Mayumi/N-5378-2015		Japanese Ministry of Health, Labour and Welfare [H22-intractable diseases-general-208, H23, H24-intractable diseases-general-080, H25-Research on measures for intractable disease-general-004]	This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labour and Welfare (H22-intractable diseases-general-208, H23, H24-intractable diseases-general-080, H25-Research on measures for intractable disease-general-004).	Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; Hopkins C, 2007, OTOLARYNG HEAD NECK, V137, P555, DOI 10.1016/j.otohns.2007.02.004; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Takabayashi T, 2012, J ALLERGY CLIN IMMUN, V130, P410, DOI 10.1016/j.jaci.2012.02.046; Tieu DD, 2010, J ALLERGY CLIN IMMUN, V125, P667, DOI 10.1016/j.jaci.2009.11.045; Kim SJ, 2013, OTOLARYNG HEAD NECK, V149, P431, DOI 10.1177/0194599813495363; Jiang N, 2013, AM J RHINOL ALLERGY, V27, P396, DOI 10.2500/ajra.2013.27.3916; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Matsuwaki Y, 2008, INT ARCH ALLERGY IMM, V146, P77, DOI 10.1159/000126066; Cao Ping-Ping, 2009, J Allergy Clin Immunol, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; [Anonymous], 2012, RHINOLOGY, DOI DOI 10.4193/RHINO12.000; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Yamada T, 2000, AM J RHINOL, V14, P143, DOI 10.2500/105065800782102717; Kountakis SE, 2004, LARYNGOSCOPE, V114, P1895, DOI 10.1097/01.mlg.0000147917.43615.e0; Nakayama T, 2011, RHINOLOGY, V49, P392, DOI 10.4193/Rhino10.261; Mendelsohn D, 2011, ANN OTO RHINOL LARYN, V120, P162; Sakuma Y, 2011, AURIS NASUS LARYNX, V38, P583, DOI 10.1016/j.anl.2011.01.007; Hu Y, 2012, LARYNGOSCOPE, V122, P498, DOI 10.1002/lary.22507; Seshadri S, 2012, ALLERGY, V67, P920, DOI 10.1111/j.1398-9995.2012.02848.x; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Szucs E, 2002, AM J RHINOL, V16, P131; Wabnitz DAM, 2005, AM J RHINOL, V19, P91; Soler ZM, 2010, OTOLARYNG HEAD NECK, V142, P64, DOI 10.1016/j.otohns.2009.10.005; Yoshimura Katsuhiro, 2011, Allergology International, V60, P491, DOI 10.2332/allergolint.10-OA-0234; Ikeda K, 2013, LARYNGOSCOPE, V123, pE1, DOI 10.1002/lary.24154; Batra PS, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.24418; Haruna S, 2004, AM J RHINOL, V18, P165; Ishitoya Junichi, 2010, Allergol Int, V59, P239, DOI 10.2332/allergolint.10-RAI-0231; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Makino S, 2000, ALLERGY, V55, P135, DOI 10.1034/j.1398-9995.2000.00090.x	32	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	AUG	2015	70	8					995	1003		10.1111/all.12644		9	Allergy; Immunology	Allergy; Immunology	CN7IS	WOS:000358608500011		
J	Itoh, H; Morita, H				Itoh, Hideshi; Morita, Hodaka			Formal Contracts, Relational Contracts, and the Threat-Point Effect	AMERICAN ECONOMIC JOURNAL-MICROECONOMICS			English	Article							HOLD-UP PROBLEM; STANDARD BREACH REMEDIES; COOPERATIVE INVESTMENTS; INCENTIVE CONTRACTS; EXPLICIT CONTRACTS; IMPLICIT CONTRACTS; FIRM; OWNERSHIP; RENEGOTIATION; INTEGRATION	We investigate whether formal contracts can help in resolving the holdup problem by studying repeated transactions between a seller and a buyer. Contrary to previous findings, we demonstrate that a simple fixed-price contract based on product delivery is of value even when relation-specific investment is purely cooperative. Furthermore, we show that focusing our attention on fixed-price contracts as a form of formal contracts is without loss of generality. The key driving force is a possibility that the relation-specific investment decreases the surplus under no trade. This possibility, although very plausible, has been largely ignored in previous analyses of the holdup problem.	[Itoh, Hideshi] Hitotsubashi Univ, Grad Sch Commerce & Management, Tokyo 1868601, Japan; [Morita, Hodaka] Univ New S Wales, Sch Econ, UNSW Business Sch, Sydney, NSW 2052, Australia	Itoh, H (reprint author), Hitotsubashi Univ, Grad Sch Commerce & Management, 2-1 Naka, Tokyo 1868601, Japan.	hideshi.itoh@r.hit-u.ac.jp; H.Morita@unsw.edu.au	Itoh, Hideshi/H-4171-2011	Itoh, Hideshi/0000-0001-5989-318X	Hitotsubashi University; Japan Society for the Promotion of Science; Australian Research Council	This is a substantially revised version of a paper, earlier versions of which were circulated under a different title, "Formal Contracts, Relational Contracts, and the Holdup Problem." We are grateful to an anonymous referee whose comments made us significantly improve the paper. We thank Murali Agastya, Eric Chou, Robert Gibbons, Shingo Ishiguro, Shinsuke Kambe, Michihiro Kandori, Kieron Meagher, Masahiro Okuno-Fujiwara, Heikki Rantakari, Bill Schworm, Kunal Sengupta, Masatoshi Tsumagari, Michael Waldman, Noriyuki Yanagawa, and the seminar participants at the University of Tokyo, the University of New South Wales, the Chinese University of Hong Kong, the Contract Theory Workshop (CTW), Academia Sinica, the 9th World Congress of the Econometric Society held at University College London, the University of Bristol, Waseda University, the second Annual Organizational Economics Workshop held at the University of Sydney, the National Bureau of Economic Research (NBER) 2009 Conference on Relational Contracts, and Keio University for helpful comments. We also thank Ashley Cheng, Jonathan Lim, and Cheng-Tao Tang who provided excellent research assistance. Part of this research was conducted while the first author was visiting the Center for Economic Studies (CES), University of Munich, and the School of Economics, University of New South Wales. He is grateful to these institutions for their hospitality, as well as to Hitotsubashi University and the Japan Society for the Promotion of Science for their financial support. The second author is grateful for financial support from the Australian Research Council.	Che YK, 1999, AM ECON REV, V89, P125, DOI 10.1257/aer.89.1.125; Baker G, 2001, AM ECON REV, V91, P212, DOI 10.1257/aer.91.2.212; Bernheim BD, 1998, AM ECON REV, V88, P902; HART O, 1990, J POLIT ECON, V98, P1119, DOI 10.1086/261729; MACLEOD WB, 1989, ECONOMETRICA, V57, P447, DOI 10.2307/1912562; Corts KS, 2012, J LAW ECON ORGAN, V28, P550, DOI 10.1093/jleo/ewr023; Andrabi T, 2006, J DEV ECON, V79, P273, DOI 10.1016/j.jdeveco.2006.01.012; WILLIAMSON OE, 1979, J LAW ECON, V22, P233, DOI 10.1086/466942; Edlin AS, 1996, AM ECON REV, V86, P478; Halonen M, 2002, ECON J, V112, P539, DOI 10.1111/1468-0297.00729; Eliashberg J, 2006, MARKET SCI, V25, P638, DOI 10.1287/mksc.1050.0177; Kalnins A, 2004, J LAW ECON ORGAN, V20, P207, DOI 10.1093/jleo.ewh030; Levin J, 2003, AM ECON REV, V93, P835, DOI 10.1257/000282803322157115; Asanuma Banri, 1992, INT ADJUSTMENT JAPAN, P99; Asanumi B., 1989, J JAPANESE INT EC, V3, P1, DOI DOI 10.1016/0889-1583(89)90029-4; BAKER G, 1994, Q J ECON, V109, P1125, DOI 10.2307/2118358; Baker G, 2002, Q J ECON, V117, P39, DOI 10.1162/003355302753399445; Banerjee AV, 2000, Q J ECON, V115, P989, DOI 10.1162/003355300554962; Banerjee S, 2009, J ECON BEHAV ORGAN, V69, P260, DOI 10.1016/j.jebo.2008.10.003; Che YK, 2004, ECONOMETRICA, V72, P1063, DOI 10.1111/j.1468-0262.2004.00526.x; Che YK, 1999, RAND J ECON, V30, P84, DOI 10.2307/2556047; Coase R. H., 1988, J LAW ECON ORGAN, V4, P33; Coase RH, 2000, J LAW ECON, V43, P15, DOI 10.1086/467446; Edlin AS, 2000, J LAW ECON ORGAN, V16, P395; Evans R, 2008, ECONOMETRICA, V76, P459, DOI 10.1111/j.1468-0262.2008.00844.x; GROSSMAN SJ, 1986, J POLIT ECON, V94, P691, DOI 10.1086/261404; Gul F, 2001, ECONOMETRICA, V69, P343, DOI 10.1111/1468-0262.00195; Hart O.D., 1995, FIRMS CONTRACTS FINA; Hirano Ken, 1997, SAPPLIER SISTEMU ATA, P201; Holmstrom B, 1998, J ECON PERSPECT, V12, P73; Itoh Hideshi, 2014, COOPERATIVE IN UNPUB; Iyer Rajkamal, 2012, IMPORTANCE HOL UNPUB; KLEIN B, 1978, J LAW ECON, V21, P297, DOI 10.1086/466922; Kvaloy O, 2009, AM ECON REV, V99, P2193, DOI 10.1257/aer.99.5.2193; Lyon TP, 2004, J LAW ECON ORGAN, V20, P148, DOI 10.1093/jleo/ewh027; MACLEOD WB, 1993, AM ECON REV, V83, P811; Malcomson J. M., 2013, HDB ORG EC, P1014; Morita H, 2001, SCOT J POLIT ECON, V48, P345, DOI 10.1111/1467-9485.00203; Noldeke G, 1998, RAND J ECON, V29, P633, DOI 10.2307/2556087; Pearce DG, 1998, GAME ECON BEHAV, V23, P75, DOI 10.1006/game.1997.0607; Pitchford R, 2004, J ECON THEORY, V114, P88, DOI 10.1016/S0022-0531(03)00120-0; Rajan RG, 1998, Q J ECON, V113, P387, DOI 10.1162/003355398555630; SCHMIDT KM, 1995, ECON LETT, V48, P193, DOI 10.1016/0165-1765(94)00601-W; Schweizer U, 2006, RAND J ECON, V37, P134; Scott RE, 2003, COLUMBIA LAW REV, V103, P1641, DOI 10.2307/3593401; Segal Ilya, 2000, RAND J ECON, V31, P603; Stremitzer A, 2012, J LAW ECON ORGAN, V28, P337, DOI 10.1093/jleo/ewq007; Watson J, 2007, ECONOMETRICA, V75, P55, DOI 10.1111/j.1468-0262.2007.00732.x; Watson Joel, 2009, HOLD UP DURABLE TRAD; WILLIAMSON O.E., 1985, EC I CAPITALISM FIRM	50	0	0	AMER ECONOMIC ASSOC	NASHVILLE	2014 BROADWAY, STE 305, NASHVILLE, TN 37203 USA	1945-7669	1945-7685		AM ECON J-MICROECON	Am. Econ. J.-Microecon.	AUG	2015	7	3					318	346		10.1257/mic.20130111		29	Economics	Business & Economics	CN6WQ	WOS:000358575500012		
J	Takase, H; Sasaki, K; Shinmori, H; Shinohara, A; Mochizuki, C; Kobayashi, H; Saito, H; Matsuo, H; Suzuki, S; Takata, R				Takase, Hideki; Sasaki, Kanako; Shinmori, Hideyuki; Shinohara, Akira; Mochizuki, Chihiro; Kobayashi, Hironori; Saito, Hiroshi; Matsuo, Hironori; Suzuki, Shunji; Takata, Ryoji			Analysis of Rotundone in Japanese Syrah Grapes and Wines using Stir Bar Sorptive Extraction (SBSE) with Heart-Cutting Two-Dimensional GC-MS	AMERICAN JOURNAL OF ENOLOGY AND VITICULTURE			English	Article						aroma; heart-cutting two-dimensional GC/MS; rotundone; stir bar sorptive extraction; SBSE; Syrah; Vitis vinifera	MASS-SPECTROMETRY; COMPOUND; PEPPER; RED	Rotundone, an oxygenated sesquiterpene, is responsible for the peppery aroma in wines. We developed an effective and simple method to determine trace levels of rotundone in grapes and wines. The method uses stir bar sorptive extraction (SBSE) with heart-cutting two-dimensional gas chromatography/mass spectrometry without a pre-extraction process such as solid-phase extraction. The limits of detection and quantitation for rotundone were 2.1 and 6.5 ng/kg in grape and 2.4 and 7.2 ng/L in wine. The recoveries of rotundone from Cabernet Sauvignon grape and wine were 106% (spiked with 120 ng/kg for grape) and 96% (spiked with 120 ng/L for wine), respectively. We demonstrated that rotundone concentrations in Syrah grapes and wines from Ueda were higher (up to 2342 ng/kg and 232 ng/L, respectively) than the maximal rotundone concentrations in Australian Syrah grapes and wines. Findings indicate that some environmental factors in Japan may promote rotundone accumulation in Syrah grapes, and underscores the importance of studying regional characteristics of rotundone accumulation in Syrah grapes.	[Takase, Hideki; Sasaki, Kanako; Takata, Ryoji] Mercian Corp, Lab New Prod & Proc Dev, Fujisawa, Kanagawa 2510057, Japan; [Takase, Hideki; Suzuki, Shunji] Univ Yamanashi, Inst Enol & Viticulture, Kofu, Yamanashi 4000005, Japan; [Shinmori, Hideyuki; Shinohara, Akira; Mochizuki, Chihiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Kobayashi, Hironori; Saito, Hiroshi; Matsuo, Hironori] Chateau Mercian, Koshu, Yamanashi 4091313, Japan	Suzuki, S (reprint author), Univ Yamanashi, Inst Enol & Viticulture, 1-13-1 Kitashin, Kofu, Yamanashi 4000005, Japan.	suzukis@yamanashi.ac.jp					Caputi L, 2011, J AGR FOOD CHEM, V59, P5565, DOI 10.1021/jf200786u; Baltussen E, 1999, J MICROCOLUMN SEP, V11, P737, DOI 10.1002/(SICI)1520-667X(1999)11:10<737::AID-MCS7>3.0.CO;2-4; Siebert TE, 2008, J AGR FOOD CHEM, V56, P3745, DOI 10.1021/jf800184t; Fang Y, 2006, J AGR FOOD CHEM, V54, P8567, DOI 10.1021/jf061396m; Franc C, 2009, J CHROMATOGR A, V1216, P3318, DOI 10.1016/j.chroma.2009.01.103; Prieto A, 2010, J CHROMATOGR A, V1217, P2642, DOI 10.1016/j.chroma.2009.12.051; David F, 2007, J CHROMATOGR A, V1152, P54, DOI 10.1016/j.chroma.2007.01.032; Wood C, 2008, J AGR FOOD CHEM, V56, P3738, DOI 10.1021/jf800183k; Geffroy O, 2014, AUST J GRAPE WINE R, V20, P401, DOI 10.1111/ajgw.12084; Herderich M. J., 2012, ACS SYM SER, V1104, P3; Mattivi F, 2011, RAPID COMMUN MASS SP, V25, P483, DOI 10.1002/rcm.4881; Scarlett NJ, 2014, AUST J GRAPE WINE R, V20, P214, DOI 10.1111/ajgw.12075	12	0	0	AMER SOC ENOLOGY VITICULTURE	DAVIS	PO BOX 1855, DAVIS, CA 95617-1855 USA	0002-9254	1943-7749		AM J ENOL VITICULT	Am. J. Enol. Vitic.	AUG	2015	66	3					398	402		10.5344/ajev.2015.14118		5	Biotechnology & Applied Microbiology; Food Science & Technology; Horticulture	Biotechnology & Applied Microbiology; Food Science & Technology; Agriculture	CN9KY	WOS:000358768400016		
J	Aizawa, K; Tashiro, Y; Kawasaki, R; Yogo, K; Hirata, M; Endo, K; Shimonaka, Y				Aizawa, Ken; Tashiro, Yoshihito; Kawasaki, Ryohei; Yogo, Kenji; Hirata, Michinori; Endo, Koichi; Shimonaka, Yasushi			Epoetin beta pegol retains its biological activity in the presence of the sialic acid metabolic enzyme sialidase	AMERICAN JOURNAL OF HEMATOLOGY			English	Meeting Abstract									[Aizawa, Ken; Tashiro, Yoshihito; Kawasaki, Ryohei; Yogo, Kenji; Hirata, Michinori; Endo, Koichi; Shimonaka, Yasushi] Chugai Pharmaceut Co Ltd, Prod Res Dept, Gotemba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	AUG	2015	90	8					E176	E176				1	Hematology	Hematology	CN5QI	WOS:000358483700054		
J	Trost, N; Hevir, N; Kimakova, P; Hurtukova, L; Feckova, B; Rizner, TL; Komel, R; Solar, P; Debeljak, N				Trost, Nina; Hevir, Neli; Kimakova, Patrcia; Hurtukova, Lenka; Feckova, Barbora; Rizner, Tea Lanisnik; Komel, Radovan; Solar, Peter; Debeljak, Natasa			Erythropoietin receptor modulates breast cancer cell response to tamoxifen treatment	AMERICAN JOURNAL OF HEMATOLOGY			English	Meeting Abstract									[Trost, Nina; Hevir, Neli; Rizner, Tea Lanisnik; Komel, Radovan; Debeljak, Natasa] Univ Ljubljana, Inst Biochem, Fac Med, Ljubljana 61000, Slovenia; [Trost, Nina] Osaka Univ, Immunol Frontier Res Ctr IFReC, Suita, Osaka 565, Japan; [Kimakova, Patrcia; Hurtukova, Lenka; Feckova, Barbora; Solar, Peter] Safarik Univ, Dept Cell Biol, Inst Biol & Ecol, Fac Sci, Kosice, Slovakia								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	AUG	2015	90	8					E155	E155				1	Hematology	Hematology	CN5QI	WOS:000358483700011		
J	Yamamoto, M				Yamamoto, Masayuki			Renal Erythropoietin Producing Cells for Anemia and Fibrosis	AMERICAN JOURNAL OF HEMATOLOGY			English	Meeting Abstract									[Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	AUG	2015	90	8					E174	E174				1	Hematology	Hematology	CN5QI	WOS:000358483700049		
J	Niceta, M; Gripp, KW; Zampino, G; Ciolfi, A; Keppler-Noreuil, K; Niyazov, DM; Leoni, C; Nakane, T; Philip, N; Stabley, D; Sol-Church, K; Tartaglia, M				Niceta, Marcello; Gripp, Karen W.; Zampino, Giuseppe; Ciolfi, Andrea; Keppler-Noreuil, Kim; Niyazov, Dmitriy M.; Leoni, Chiara; Nakane, Takaya; Philip, Nicole; Stabley, Deborah; Sol-Church, Katia; Tartaglia, Marco			MISSENSE MUTATIONS IN MAF CAUSE FINE-LUBINSKY SYNDROME	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Meeting Abstract	35th Annual David W Smith Workshop on Malformations and Morphogenesis	JUL 25-30, 2014	Univ Wisconsin, Madison, WI		Univ Wisconsin				[Niceta, Marcello; Ciolfi, Andrea; Tartaglia, Marco] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Med Genet, Wilmington, DE USA; [Stabley, Deborah; Sol-Church, Katia] Alfred I DuPont Hosp Children, Biomed Res, Wilmington, DE USA; [Zampino, Giuseppe; Leoni, Chiara] Univ Cattolica Sacro Cuore, Dept Pediat, Rome, Italy; [Keppler-Noreuil, Kim] NHGRI, NIH, Bethesda, MD 20892 USA; [Niyazov, Dmitriy M.] Ochsner Clin & Alton Ochsner Med Fdn, Dept Med Genet, New Orleans, LA USA; [Nakane, Takaya] Univ Yamanashi, Dept Pediat, Chuo Ku, Yamanashi, Japan; [Philip, Nicole] Aix Marseille Univ, APHM, Marseille, France; [Philip, Nicole] Aix Marseille Univ, UMR S910, Marseille, France								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	AUG	2015	167	8					1726	1727				2	Genetics & Heredity	Genetics & Heredity	CN7ER	WOS:000358597400103		
J	Niederhoffer, KY; Fahiminiya, S; Eydoux, P; Mawson, J; Nishimura, G; Jerome-Majewska, LA; Patel, MS				Niederhoffer, Karen Y.; Fahiminiya, Somayyeh; Eydoux, Patrice; Mawson, John; Nishimura, Gen; Jerome-Majewska, Loydie A.; Patel, Millan S.			DIAGNOSTIC APPROACH TO THE MARDEN-WALKER-LIKE SPECTRUM OF DISORDERS	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Meeting Abstract	35th Annual David W Smith Workshop on Malformations and Morphogenesis	JUL 25-30, 2014	Univ Wisconsin, Madison, WI		Univ Wisconsin				[Niederhoffer, Karen Y.; Patel, Millan S.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Eydoux, Patrice] Univ British Columbia, Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Mawson, John] Univ British Columbia, Radiol, Vancouver, BC V5Z 1M9, Canada; [Fahiminiya, Somayyeh; Jerome-Majewska, Loydie A.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Nishimura, Gen] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	AUG	2015	167	8					1731	1732				2	Genetics & Heredity	Genetics & Heredity	CN7ER	WOS:000358597400115		
J	Korf, B; Ahmadian, R; Allanson, J; Aoki, Y; Bakker, A; Wright, EB; Denger, B; Elgersma, Y; Gelb, BD; Gripp, KW; Kerr, B; Kontaridis, M; Lazaro, C; Linardic, C; Lozano, R; MacRae, CA; Messiaen, L; Mulero-Navarro, S; Neel, B; Plotkin, S; Rauen, KA; Roberts, A; Silva, AJ; Sittampalam, SG; Zhang, C; Schoyer, L				Korf, Bruce; Ahmadian, Reza; Allanson, Judith; Aoki, Yoko; Bakker, Annette; Wright, Emma Burkitt; Denger, Brian; Elgersma, Ype; Gelb, Bruce D.; Gripp, Karen W.; Kerr, Bronwyn; Kontaridis, Maria; Lazaro, Conxi; Linardic, Corinne; Lozano, Reymundo; MacRae, Calum A.; Messiaen, Ludwine; Mulero-Navarro, Sonia; Neel, Benjamin; Plotkin, Scott; Rauen, Katherine A.; Roberts, Amy; Silva, Alcino J.; Sittampalam, Sitta G.; Zhang, Chao; Schoyer, Lisa			The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Toward a Therapeutic Approach	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						Ras; neurofibromatosis; noonan syndrome; costello syndrome; cardio-facio-cutaneous syndrome	FACIO-CUTANEOUS SYNDROME; NEUROFIBROMATOSIS TYPE-1; GERMLINE MUTATIONS; COSTELLO-SYNDROME; NOONAN SYNDROME; PHENOTYPE; CANCER; SPECTRUM; GAIN	"The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Towards a Therapeutic Approach" was held at the Renaissance Orlando at SeaWorld Hotel (August 2-4, 2013). Seventy-one physicians and scientists attended the meeting, and parallel meetings were held by patient advocacy groups (CFC International, Costello Syndrome Family Network, NF Network and Noonan Syndrome Foundation). Parent and patient advocates opened the meeting with a panel discussion to set the stage regarding their hopes and expectations for therapeutic advances. In keeping with the theme on therapeutic development, the sessions followed a progression from description of the phenotype and definition of therapeutic endpoints, to definition of genomic changes, to identification of therapeutic targets in the RAS/MAPK pathway, to preclinical drug development and testing, to clinical trials. These proceedings will review the major points of discussion. (C) 2015 Wiley Periodicals, Inc.	[Korf, Bruce; Messiaen, Ludwine] Univ Alabama Birmingham, Birmingham, AL USA; [Ahmadian, Reza] Univ Dusseldorf, Dusseldorf, Germany; [Allanson, Judith] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Aoki, Yoko] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Bakker, Annette] Childrens Tumor Fdn, New York, NY USA; [Wright, Emma Burkitt] Manchester Ctr Genom Med, Manchester, Lancs, England; [Wright, Emma Burkitt] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Denger, Brian] Parent Project Muscular Dystrophy, Hackensack, NJ USA; [Elgersma, Ype] Erasmus Univ, NL-3000 DR Rotterdam, Netherlands; [Gelb, Bruce D.; Mulero-Navarro, Sonia] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Wilmington, NC USA; [Kerr, Bronwyn] Manchester Ctr Genom Med, Manchester, Lancs, England; [Kontaridis, Maria; MacRae, Calum A.; Roberts, Amy] Harvard Univ, Sch Med, Boston, MA USA; [Kontaridis, Maria] Beth Israel Deaconess Med Canc Ctr, Boston, MA USA; [Lazaro, Conxi] Catalan Inst Oncol ICO IDIBELL, Barcelona, Spain; [Linardic, Corinne] Duke Univ, Sch Med, Durham, NC USA; [Lozano, Reymundo] UC Calif, Davis, CA USA; [MacRae, Calum A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Neel, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Plotkin, Scott] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rauen, Katherine A.] Univ Calif Davis, Davis MIND Inst, Sacramento, CA 95817 USA; [Roberts, Amy] Boston Childrens Hosp, Boston, MA USA; [Silva, Alcino J.] Univ Calif Los Angeles, Los Angeles, CA USA; [Sittampalam, Sitta G.] NIH, NCATS, Baltimore, MD USA; [Zhang, Chao] Plexxikon Inc, Berkeley, CA USA; [Schoyer, Lisa] RASopathies Network USA, Altadena, CA USA	Korf, B (reprint author), 230 Kaul Human Genet Bldg,720 20th St South, Birmingham, AL 35294 USA.	bkorf@uab.edu					BOS JL, 1989, CANCER RES, V49, P4682; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Upadhyaya M, 2007, AM J HUM GENET, V80, P140, DOI 10.1086/510781; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Jongmans MCJ, 2011, EUR J HUM GENET, V19, P870, DOI 10.1038/ejhg.2011.37; Boyd KP, 2009, J AM ACAD DERMATOL, V61, P1, DOI 10.1016/j.jaad.2008.12.051; Lee BH, 2011, J PEDIATR-US, V159, P1029, DOI 10.1016/j.jpeds.2011.05.024; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Fernandez-Rodriguez J, 2011, HUM MUTAT, V32, P705, DOI 10.1002/humu.21500; Jang SI, 2007, J BIOL CHEM, V282, P20245, DOI 10.1074/jbc.M701609200; Lin AE, 2011, AM J MED GENET A, V155A, P486, DOI 10.1002/ajmg.a.33857; Pros E, 2009, HUM MUTAT, V30, P454, DOI 10.1002/humu.20933; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Tartaglia M, 2010, Mol Syndromol, V1, P2, DOI 10.1159/000276766	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	AUG	2015	167	8					1741	1746		10.1002/ajmg.a.37089		6	Genetics & Heredity	Genetics & Heredity	CN7ER	WOS:000358597400134		
J	Ishitsuka, K; Matsui, H; Michihata, N; Fushimi, K; Nakamura, T; Yasunaga, H				Ishitsuka, Kazue; Matsui, Hiroki; Michihata, Nobuaki; Fushimi, Kiyohide; Nakamura, Tomoo; Yasunaga, Hideo			Medical Procedures and Outcomes of Japanese Patients With Trisomy 18 or Trisomy 13: Analysis of a Nationwide Administrative Database of Hospitalized Patients	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						trisomy18; trisomy13; congenital malformation; neonatal intensive care; survival	NATURAL-HISTORY; CARDIAC-SURGERY; UNITED-STATES; MANAGEMENT; SURVIVAL; INFANTS; MORTALITY; CHILDREN; CARE	The choices of aggressive treatment for trisomy 18 (T18) and trisomy 13 (T13) remain controversial. Here, we describe the current medical procedures and outcomes of patients with T18 and T13 from a nationwide administrative database of hospitalized patients in Japan. We used the database to identify eligible patients with T18 (n = 438) and T13 (n = 133) who were first admitted to one of 200 hospitals between July 2010 and March 2013. Patients were divided into admission at day <7 (early neonatal) and admission at day >= 7 (late neonatal and post neonatal) groups, and we described the medical intervention and status at discharge for each group. In the day <7 groups, surgical interventions were performed for 56 (19.9%) T18 patients and 22 (34.4%) T13 patients, including pulmonary artery banding, and procedures for esophageal atresia and omphalocele. None received intracardiac surgery. The rate of patients discharged to home was higher in the day >= 7 groups than the day <7 groups (T18: 72.6 vs. 38.8%; T13: 73.9 vs. 21.9%, respectively). Our data show that a substantial number of patients with trisomy received surgery and were then discharged home, but, of these, a considerable number required home medical care. This included home oxygen therapy, home mechanical ventilation, and tube feeding. These findings will be useful to clinicians or families who care for patients with T18 and T13. (C) 2015 Wiley Periodicals, Inc.	[Ishitsuka, Kazue; Nakamura, Tomoo] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Tokyo, Japan; [Matsui, Hiroki; Michihata, Nobuaki; Yasunaga, Hideo] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Tokyo 1130033, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Yasunaga, H (reprint author), Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X			Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Embleton ND, 1996, ARCH DIS CHILD, V75, pF38, DOI 10.1136/fn.75.1.F38; Nelson KE, 2012, PEDIATRICS, V129, P869, DOI 10.1542/peds.2011-2139; Rasmussen SA, 2003, PEDIATRICS, V111, P777, DOI 10.1542/peds.111.4.777; Kosho T, 2013, AM J MED GENET A, V161A, P1531, DOI 10.1002/ajmg.a.35990; Courtwright AM, 2011, J PERINATOL, V31, P387, DOI 10.1038/jp.2010.124; Graham EM, 2004, AM J CARDIOL, V93, P801, DOI 10.1016/j.amjcard.2003.12.012; BATY BJ, 1994, AM J MED GENET, V49, P175, DOI 10.1002/ajmg.1320490204; McGraw MP, 2008, PEDIATRICS, V121, P1106, DOI 10.1542/peds.2007-1869; Pont SJ, 2006, AM J MED GENET A, V140A, P1749, DOI 10.1002/ajmg.a.31382; ROOT S, 1994, AM J MED GENET, V49, P170, DOI 10.1002/ajmg.1320490203; Boghossian NS, 2014, PEDIATRICS, V133, P226, DOI 10.1542/peds.2013-1702; Maeda J, 2011, AM J MED GENET A, V155A, P2641, DOI 10.1002/ajmg.a.34285; Kosho T, 2006, AM J MED GENET A, V140A, P937, DOI 10.1002/ajmg.a.31175; Crider KS, 2008, AM J MED GENET A, V146A, P820, DOI 10.1002/ajmg.a.32200; Yasunaga H, 2013, ANN SURG, V257, P640, DOI 10.1097/SLA.0b013e31826fd541; GOLDSTEIN H, 1988, CLIN GENET, V34, P366; BOS AP, 1992, LANCET, V339, P913, DOI 10.1016/0140-6736(92)90940-5; Brewer C M, 2002, J Med Genet, V39, pe54, DOI 10.1136/jmg.39.9.e54; Carey JC, 2005, MANAGEMENT GENETIC S, V2e, P555; Kaneko Y, 2008, AM J MED GENET A, V146A, P1372, DOI 10.1002/ajmg.a.32311; Kobayashi Jotaro, 2010, Gen Thorac Cardiovasc Surg, V58, P223, DOI 10.1007/s11748-009-0431-3; WYLLIE JP, 1994, ARCH DIS CHILD, V71, P343	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	AUG	2015	167	8					1816	1821		10.1002/ajmg.a.37104		6	Genetics & Heredity	Genetics & Heredity	CN7ER	WOS:000358597400143		
J	Yunokawa, M; Tsuta, K; Tanaka, T; Nara, E; Koizumi, F; Ito, J; Sekine, S; Fujiwara, Y; Tamura, K				Yunokawa, Mayu; Tsuta, Koji; Tanaka, Takashi; Nara, Eriko; Koizumi, Fumiaki; Ito, Junko; Sekine, Shigeki; Fujiwara, Yasuhiro; Tamura, Kenji			Back with a Vengeance: Microvascular Tumor Embolism	AMERICAN JOURNAL OF MEDICINE			English	Editorial Material							METASTATIC BREAST-CANCER; CELLS; HYPERTENSION		[Yunokawa, Mayu; Tanaka, Takashi; Nara, Eriko; Fujiwara, Yasuhiro; Tamura, Kenji] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan; [Tsuta, Koji; Ito, Junko; Sekine, Shigeki] Natl Canc Ctr, Dept Pathol, Tokyo 1040045, Japan; [Koizumi, Fumiaki] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Clin Examinat, Tokyo, Japan	Yunokawa, M (reprint author), Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	myunokaw@ncc.go.jp					Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Roberts KE, 2003, AM J MED, V115, P228, DOI 10.1016/S0002-9343(03)00305-X; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; SHEPARD JAO, 1993, RADIOLOGY, V187, P797; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Giorgi U, 2010, ANN ONCOL, V21, P33, DOI 10.1093/annonc/mdp262; McLaughlin VV, 2009, CIRCULATION, V119, P2250, DOI 10.1161/CIRCULATIONAHA.109.192230; Chen W L, 1991, J Formos Med Assoc, V90, P863; SOARES FA, 1993, ARCH PATHOL LAB MED, V117, P827	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	AUG	2015	128	8					834	836		10.1016/j.amjmed.2015.04.004		3	Medicine, General & Internal	General & Internal Medicine	CN4GL	WOS:000358388500026		
J	Asano, R; Asai-Sato, M; Miyagi, Y; Mizushima, T; Koyama-Sato, M; Nagashima, Y; Taguri, M; Sakakibara, H; Hirahara, F; Miyagi, E				Asano, Ryoko; Asai-Sato, Mikiko; Miyagi, Yohei; Mizushima, Taichi; Koyama-Sato, Makiko; Nagashima, Yoji; Taguri, Masataka; Sakakibara, Hideya; Hirahara, Fumiki; Miyagi, Etsuko			Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Article						erythropoietin; myomatous erythrocytosis syndrome; uterine leiomyoma; vessel maturity	MYOMATOUS ERYTHROCYTOSIS SYNDROME; DEPENDENT PRODUCTION; ANGIOGENESIS; PATHOGENESIS; RECEPTOR; THERAPY; HYPOXIA; PATIENT; CELLS	OBJECTIVE: Myomatous erythrocytosis syndrome is a rare complication of uterine leiomyoma caused by erythropoietin (EPO) that is produced by tumor cells. We assessed the EPO expression in leiomyomas and investigated the effects of EPO on the tumor growth. STUDY DESIGN: Tissue samples were collected from 114 patients with uterine leiomyomas who underwent myomectomy or hysterectomy in Yokohama City University Hospital. From 17 patients, the corresponding normal myometrium was also collected. All samples were analyzed for EPO messenger RNA (mRNA) expression by real-time reverse transcription-polymerase chain reaction. EPO protein expression was determined by an enzyme-linked immunosorbent assay. The relationships between EPO expression and clinicopathological features were retrospectively analyzed using the patients' charts. Blood vessel density and maturity were assessed using hematoxylin-eosin staining and CD34 immunohistochemistry. RESULTS: EPO mRNA expression was detected in 108 of 114, or 95%, of the leiomyomas. The mean EPO mRNA expression in the leiomyoma was higher than the corresponding normal myometrium (3836 +/- 4122 vs 1455 +/- 2141; P = .025 by Wilcoxon rank test). The EPO mRNA expression in the leiomyomas varied extensively among samples, ranging from undetectable levels to 18-fold above the mean EPO mRNA of normal myometrium. EPO protein production was observed concomitant with mRNA expression. A positive correlation of leiomyoma size and EPO mRNA expression was shown by Spearman rank correlation coefficient (rho = 0.294; P = .001), suggesting the involvement of EPO in leiomyoma growth. The blood vessel maturity was also significantly increased in EPO-producing leiomyomas (high vessel maturity in high vs low EPO group: 67% vs 20%; P = .013 by Fisher exact test). CONCLUSION: This report demonstrates that EPO is produced in most of conventional leiomyomas and supports a model in which EPO accelerates tumor growth, possibly by inducing vessel maturity. Our study suggests one possible mechanism by which some uterine leiomyomas reach a large size, and the understanding of EPO expression patterns in these tumors may be useful for management of the patients with leiomyomas.	[Asano, Ryoko; Asai-Sato, Mikiko; Mizushima, Taichi; Koyama-Sato, Makiko; Sakakibara, Hideya; Hirahara, Fumiki; Miyagi, Etsuko] Yokohama City Univ, Grad Sch Med, Dept Obstet Gynecol & Mol Reprod Sci, Yokohama, Kanagawa 232, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Div Mol Pathol & Genet, Yokohama, Kanagawa 2410815, Japan; [Nagashima, Yoji] Tokyo Womens Med Univ Hosp, Dept Surg Pathol, Tokyo, Japan	Asai-Sato, M (reprint author), Yokohama City Univ, Grad Sch Med, Dept Obstet Gynecol & Mol Reprod Sci, Yokohama, Kanagawa 232, Japan.	mikikos@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24592524]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24592524) (M.A.-S.).	Suzuki M, 2001, BRIT J HAEMATOL, V113, P49, DOI 10.1046/j.1365-2141.2001.02682.x; Tal R, 2014, HUM REPROD UPDATE, V20, P194, DOI 10.1093/humupd/dmt042; BACHMANN S, 1993, J HISTOCHEM CYTOCHEM, V41, P335; Mayer A, 2008, CANCER RES, V68, P4719, DOI 10.1158/0008-5472.CAN-07-6339; Okazaki T, 2008, NEOPLASIA, V10, P932, DOI 10.1593/neo.08140; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; JELKMANN W, 1992, PHYSIOL REV, V72, P449; Markowski DN, 2014, INT J GYNECOL PATHOL, V33, P568, DOI 10.1097/PGP.0000000000000096; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; Pollio F, 2005, HUM PATHOL, V36, P120, DOI 10.1016/j.humpath.2004.10.009; Cao YH, 2013, TRENDS ENDOCRIN MET, V24, P190, DOI 10.1016/j.tem.2012.10.007; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Conrad KP, 1996, FASEB J, V10, P760; FLEMING AR, 1957, AM J OBSTET GYNECOL, V74, P677; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; LEVGUR M, 1995, OBSTET GYNECOL, V86, P1026, DOI 10.1016/0029-7844(95)00292-Y; Magnanti M, 2001, BLOOD, V98, P2872, DOI 10.1182/blood.V98.9.2872; Masuda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE1038; Sorg H, 2009, FASEB J, V23, P3049, DOI 10.1096/fj.08-109991; Thomson AP, 1953, LANCET, V262, P759, DOI 10.1016/S0140-6736(53)91456-1; West CML, 2001, CANCER RES, V61, P2907; Yasuda Y, 2001, MARC MALPIG SYMP SER, V8, P215; Yoshida M, 1999, LANCET, V354, P216, DOI 10.1016/S0140-6736(99)02273-4	25	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	AUG	2015	213	2							199.e1	10.1016/j.ajog.2015.02.016		8	Obstetrics & Gynecology	Obstetrics & Gynecology	CN6NG	WOS:000358550900017		
J	Sotozono, C; Ueta, M; Nakatani, E; Kitami, A; Watanabe, H; Sueki, H; Iijima, M; Aihara, M; Ikezawa, Z; Aihara, Y; Kano, Y; Shiohara, T; Tohyama, M; Shirakata, Y; Kaneda, H; Fukushima, M; Kinoshita, S; Hashimoto, K				Sotozono, Chie; Ueta, Mayumi; Nakatani, Eiji; Kitami, Amane; Watanabe, Hideaki; Sueki, Hirohiko; Iijima, Masafumi; Aihara, Michiko; Ikezawa, Zenro; Aihara, Yukon; Kano, Yoko; Shiohara, Tetsuo; Tohyama, Mikiko; Shirakata, Yuji; Kaneda, Hideaki; Fukushima, Masanori; Kinoshita, Shigeru; Hashimoto, Koji		Japanese Res Comm Severe Cutaneous	Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							MUCOSAL EPITHELIAL TRANSPLANTATION; ERYTHEMA MULTIFORME MAJUS; SURFACE RECONSTRUCTION; GENE POLYMORPHISMS; JAPANESE PATIENTS; MANIFESTATIONS; EUROSCAR; COMPLICATIONS; DRUGS	PURPOSE: To suggest an objective score for grading the acute ocular severity of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), and to determine predictive factors for severe acute ocular involvement such as ocular surface epithelial defect and/or pseudomembrane formation. DESIGN: Retrospective cohort study. METHODS: The medical records of SJS (n = 87) and TEN (n = 48) patients between 2005 and 2007 were reviewed. An acute ocular severity score was determined on a scale from 0 to 3 (none, mild, severe, and very severe) according to the existence of hyperemia, corneal or conjunctival epithelial defect, and pseudomembrane formation. The associations between the severe acute ocular involvement and factors such as patient age, exposed drugs, systemic severity, and the prevalence of ocular sequelae were examined. RESULTS: The number of cases with score grade 0, 1, 2, and 3 was 19 (21.8%), 31(35.6%), 22 (25.3%), and 15 (17.2%) in 87 SJS cases and 12 (25.0%), 11(22.9%), 17 (35.4%), and 8 (16.7%) in 48 TEN cases. Multivariate logistic regression analysis revealed that patient age (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.96 0.99; P = .007) and nonsteroidal anti-inflammatory drugs NSAIDs or cold remedies (OR, 2.58; 95% CI, 1.26-5.29; P = .010) were predictive factors for severe acute ocular involvement. The prevalence of visual disturbance and eye dryness increased according to the increase of acute ocular severity (P = .001 and P = .007 in SJS; P = .007 and P = .014 in TEN, respectively). CONCLUSIONS: At the onset of SJS/TEN, strict attention should be paid to ocular involvement in young patients and in patients exposed to NSAIDs or cold remedies. ((C) 2015 by Elsevier Inc. All rights reserved.)	[Sotozono, Chie; Ueta, Mayumi; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6020841, Japan; [Kitami, Amane; Watanabe, Hideaki; Sueki, Hirohiko; Iijima, Masafumi] Showa Univ, Sch Med, Dept Dermatol, Tokyo 142, Japan; [Aihara, Michiko; Ikezawa, Zenro] Yokohama City Univ, Med Ctr, Dept Dermatol, Yokohama, Kanagawa 232, Japan; [Aihara, Yukon] Yokohama City Univ, Med Ctr, Dept Pediat, Yokohama, Kanagawa 232, Japan; [Kano, Yoko; Shiohara, Tetsuo] Kyorin Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Tohyama, Mikiko; Shirakata, Yuji; Hashimoto, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Matsuyama, Ehime, Japan; [Nakatani, Eiji; Kaneda, Hideaki; Fukushima, Masanori] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan	Sotozono, C (reprint author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	csotozon@koto.kpu-m.ac.jp			Japanese Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology	Supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor and Welfare, and a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology. All authors attest that they meet the current ICMJE requirements to qualify as authors.	Kaniwa N, 2013, PHARMACOGENOMICS, V14, P1821, DOI 10.2217/pgs.13.180; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P1809, DOI 10.1167/iovs.07-1401; Koizumi N, 2001, ARCH OPHTHALMOL-CHIC, V119, P298; Kaniwa N, 2008, PHARMACOGENOMICS, V9, P1617, DOI 10.2217/14622416.9.11.1617; Stevens AM, 1922, AM J DIS CHILD, V24, P526; Inatomi T, 2006, AM J OPHTHALMOL, V142, P757, DOI 10.1016/j.ajo.2006.06.004; Ueta M, 2008, MOL VIS, V14, P550; Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; Sotozono C, 2013, OPHTHALMOLOGY, V120, P193, DOI 10.1016/j.ophtha.2012.07.053; [Anonymous], 2011, JPN J DERMATOL; Lee HY, 2012, BRIT J DERMATOL, V167, P555, DOI 10.1111/j.1365-2133.2012.11074.x; Schneck J, 2008, J AM ACAD DERMATOL, V58, P33, DOI 10.1016/j.jaad.2007.08.039; Inatomi T, 2006, AM J OPHTHALMOL, V141, P267, DOI 10.1016/j.ajo.2005.09.003; Ueta M, 2007, BRIT J OPHTHALMOL, V91, P962, DOI 10.1136/bjo.2006.113449; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; Morales ME, 2010, AM J OPHTHALMOL, V150, P505, DOI 10.1016/j.ajo.2010.04.026; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Sotozono C, 2014, ACTA OPHTHALMOL, V92, pE447, DOI 10.1111/aos.12397; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Sotozono C, 2007, OPHTHALMOLOGY, V114, P1294, DOI 10.1016/j.ophtha.2006.10.029; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; Watanabe R, 2011, EUR J DERMATOL, V21, P889, DOI 10.1684/ejd.2011.1510; Ueta M, 2007, J ALLERGY CLIN IMMUN, V120, P1457, DOI 10.1016/j.jaci.2007.07.048; Araki Y, 2009, AM J OPHTHALMOL, V147, P1004, DOI 10.1016/j.ajo.2008.12.040; Isogai H, 2013, J TOXICOL, V2013; Kaido M, 2012, AM J OPHTHALMOL, V154, P499, DOI 10.1016/j.ajo.2012.03.044; Paul C, 1996, BRIT J DERMATOL, V134, P710, DOI 10.1111/j.1365-2133.1996.tb06976.x; Roujeau Jean-Claude, 1997, Journal of Dermatology (Tokyo), V24, P726; Sotozono C, 2014, AM J OPHTHALMOL, V158, P983, DOI 10.1016/j.ajo.2014.07.012; Ueta M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04862; Ueta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025209; Ueta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043650; Ueta M, 2007, AM J OPHTHALMOL, V143, P367, DOI 10.1016/j.ajo.2006.09.029; Yagi T, 2011, BRIT J OPHTHALMOL, V95, P1030, DOI 10.1136/bjo.2010.196295; Yamane Yumiko, 2007, Allergol Int, V56, P419, DOI 10.2332/allergolint.O-07-483	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	AUG	2015	160	2					228	237		10.1016/j.ajo.2015.05.002		10	Ophthalmology	Ophthalmology	CN6NY	WOS:000358552700003		
J	Toldi, G; Vasarhelyi, ZE; Rigo, J; Orban, C; Tamassy, Z; Bajnok, A; Shima, T; Saito, S; Molvarec, A				Toldi, Gergely; Vasarhelyi, Zsofia Eszter; Rigo, Janos, Jr.; Orban, Csaba; Tamassy, Zita; Bajnok, Anna; Shima, Tomoko; Saito, Shigeru; Molvarec, Attila			Prevalence of Regulatory T-Cell Subtypes in Preeclampsia	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						CD279; effector Treg; exhausted Treg; Helios; naive Treg; preeclampsia	CD4(+) CD25(BRIGHT); DECREASED NUMBER; PERIPHERAL-BLOOD; DISTINCT SUBSETS; HUMAN-PREGNANCY; MATERNAL BLOOD; DECIDUA; LYMPHOCYTES; TOLERANCE; INFECTION	Problem The prevalence of regulatory T cells (Tregs) is lower in preeclampsia (PE) compared with healthy pregnancy (HP). However, the proportion of recently described Treg subtypes has not been investigated. Method Peripheral blood samples of 19 PE and 21 HP women in the third trimester were evaluated using flow cytometry for the prevalence of activated T cells and naive, effector, thymic, extrathymic, and exhausted Tregs. Results The prevalence of activated T cells and exhausted Tregs was higher in PE than in HP. The prevalence of the functionally most active effector Tregs is decreased, while naive Tregs appear to be unaffected in PE compared with HP. No difference was detected between Tregs according to their origin (thymic or extrathymic). Conclusion The combination of lower effector Treg and higher exhausted Treg prevalence may account for the decrease in the functionality of Tregs in PE.	[Toldi, Gergely; Vasarhelyi, Zsofia Eszter; Rigo, Janos, Jr.; Tamassy, Zita; Molvarec, Attila] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary; [Orban, Csaba; Bajnok, Anna] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Shima, Tomoko; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan	Molvarec, A (reprint author), Baross Utca 27, H-1088 Budapest, Hungary.	molvarec@freemail.hu	Molvarec, Attila/G-5996-2011	Molvarec, Attila/0000-0002-3229-3034	Hungarian Scientific Research Fund (OTKA) [PD 109451, PD 109094]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	This work was supported by the Hungarian Scientific Research Fund (OTKA; Grant Number PD 109451, PD 109094), as well as by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (A.M.). G.T. is an International Society for the Advancement of Cytometry (ISAC) Scholar.	Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Prins JR, 2009, HYPERTENS PREGNANCY, V28, P300, DOI 10.1080/10641950802601237; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Steinborn A, 2008, CLIN IMMUNOL, V129, P401, DOI 10.1016/j.clim.2008.07.032; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Steinborn A, 2012, CLIN EXP IMMUNOL, V167, P84, DOI 10.1111/j.1365-2249.2011.04493.x; Quinn KH, 2013, AM J REPROD IMMUNOL, V69, P533, DOI 10.1111/aji.12077; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Brown JA, 2003, J IMMUNOL, V170, P1257; Tilburgs T, 2008, J IMMUNOL, V180, P5737; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sasaki Y, 2007, CLIN EXP IMMUNOL, V149, P139, DOI 10.1111/j.1365-2249.2007.03397.x; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Toldi G, 2008, ACTA OBSTET GYN SCAN, V87, P1229, DOI 10.1080/00016340802389470; Hsu P, 2012, AM J PATHOL, V181, P2149, DOI 10.1016/j.ajpath.2012.08.032; Saito S, 2003, J REPROD IMMUNOL, V59, P161, DOI 10.1016/S0165-0378(03)00045-7; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006; Darmochwal-Kolarz D, 2007, AM J REPROD IMMUNOL, V58, P39, DOI 10.1111/j.1600-0897.2007.00489.x; Inada K, 2015, J REPROD IMMUNOL, V107, P10, DOI [10.1016/j.jri.2014.09.053, 10.1016/j.jri.2014:09.053]; Pan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034662; Saito S, 2013, AM J REPROD IMMUNOL, V69, P340, DOI 10.1111/aji.12101; Shen T, 2011, VIROL J, V88, P279; Tilburgs T, 2006, PLACENTA, V27, pS47, DOI 10.1016/j.placenta.2005.11.008; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	AUG	2015	74	2					110	115		10.1111/aji.12380		6	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CN6GQ	WOS:000358532800003		
J	Takeuchi, M; Sasaguri, K; Naiki, T; Mitsumori, A; Ito, H; Takahama, J; Yamada, K; Marugami, N; Tsuboyama, T; Okumura, Y; Ohgiya, Y; Kawai, N; Kohri, K; Shibamoto, Y				Takeuchi, Mitsuru; Sasaguri, Kohei; Naiki, Taku; Mitsumori, Akihito; Ito, Hirotoshi; Takahama, Junko; Yamada, Kaori; Marugami, Nagaaki; Tsuboyama, Takahiro; Okumura, Yoshihiro; Ohgiya, Yoshimitstu; Kawai, Noriyasu; Kohri, Kenjiro; Shibamoto, Yuta			MRI Findings of Inverted Urothelial Papilloma of the Bladder	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						diagnostic imaging; inverted papilloma; MRI; urinary bladder neoplasms	URINARY-BLADDER; GROWTH-PATTERNS; SURVEILLANCE; CARCINOMA; CANCER; TRACT	OBJECTIVE. The objective of this study was to characterize MRI findings of inverted urothelial papilloma of the bladder. MATERIALS AND METHODS. Data pertaining to 16 patients with 18 pathologically proven inverted urothelial papillomas of the bladder who had undergone MRI were retrospectively collected from seven institutions. The shape and surface characteristics of the tumors were evaluated using T2-weighted MR images. In addition, the signal intensity of inverted urothelial papillomas was visually assessed on Tl-weighted, T2-weighted, and DW images and on early and delayed phase contrast-enhanced images. RESULTS. The shape of the 18 inverted urothelial papillomas of the bladder was classified as polypoid with a stalk for 16 tumors (89%) and polypoid without a stalk for two tumors (11%). All stalks were surrounded by urine in the bladder. A total of 15 of the tumor surfaces (83%) were nonpapillary and three (17%) were papillary. All 12 of the inverted urothelial papillomas for which evaluable T1-weighted images were available were isointense with the bladder wall. The lesions had a slightly higher signal intensity than the bladder wall in 15 of the patients (83%) and showed isointensity with the bladder wall in three patients (17%). A total of three patients (17%) had tiny hyperintense foci noted on T2-weighted images. All 16 of the inverted urothelial papillomas examined by DWI had very high signal intensity. All 13 of the lesions for which early phase images were obtained using dynamic contrast-enhanced MRI showed strong enhancement. When compared with early phase images, delayed phase images of the same 13 lesions showed that enhancement was stronger in two lesions (15%), similar in six lesions (46%), and weaker in five lesions (38%). CONCLUSION. On MRI, the typical appearance of inverted urothelial papillomas of the bladder is a polypoid shape with a nonpapillary surface and a thin short stalk surrounded by urine. Cystic foci are also occasionally seen within the tumor.	[Takeuchi, Mitsuru; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Takeuchi, Mitsuru; Shibamoto, Yuta] Nagoya City Univ, Sch Med, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Sasaguri, Kohei] Mayo Clin, Dept Radiol, Rochester, MN USA; [Naiki, Taku; Kawai, Noriyasu; Kohri, Kenjiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi 4678601, Japan; [Naiki, Taku; Kawai, Noriyasu; Kohri, Kenjiro] Nagoya City Univ, Sch Med, Nagoya, Aichi 4678601, Japan; [Mitsumori, Akihito] Japanese Red Cross Soc, Himeji Hosp, Dept Radiol, Himeji, Hyogo, Japan; [Ito, Hirotoshi] Kajiicho Med Imaging Ctr, Dept Radiol, Kyoto, Japan; [Takahama, Junko; Marugami, Nagaaki] Nara Med Univ, Dept Radiol, Nara, Japan; [Yamada, Kaori] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan; [Tsuboyama, Takahiro] Osaka Med Coll, Dept Radiol, Osaka, Japan; [Okumura, Yoshihiro] Fukuyama City Hosp, Dept Diagnost & Intervent Radiol, Hiroshima, Japan; [Ohgiya, Yoshimitstu] Showa Univ, Sch Med, Dept Radiol, Tokyo 142, Japan	Takeuchi, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, 1 Kawasumi Mizuho Cho, Nagoya, Aichi 4678601, Japan.	m2rbimn@gmail.com			Japan Society for the Promotion of Science (KAKENHI) [25861116]	This work was supported by the Japan Society for the Promotion of Science (KAKENHI grant-in-aid for scientific research no. 25861116).	Hodges KB, 2011, BJU INT, V107, P532, DOI 10.1111/j.1464-410X.2010.09853.x; Amin MB, 1997, AM J SURG PATHOL, V21, P1057, DOI 10.1097/00000478-199709000-00010; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Terada T, 2013, INT J CLIN EXP PATHO, V6, P766; Albores-Saavedra J, 2009, ANN DIAGN PATHOL, V13, P158, DOI 10.1016/j.anndiagpath.2009.02.009; Ho H, 2006, UROLOGY, V68, P333, DOI 10.1016/j.urology.2006.03.014; POTTS IF, 1963, J UROLOGY, V90, P175; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Asano K, 2003, J UROLOGY, V170, P1209, DOI 10.1097/01.ju.0000085342.15918.d7; Takeuchi M, 2009, RADIOLOGY, V251, P112, DOI 10.1148/radiol.2511080873; Brown AL, 2011, BJU INT, V107, P24, DOI 10.1111/j.1464-410X.2011.10046.x; Kobayashi S, 2011, EUR RADIOL, V21, P2178, DOI 10.1007/s00330-011-2174-7; Patel P, 2013, UROLOGY, V82, P857, DOI 10.1016/j.urology.2013.06.040; Sung MT, 2006, CANCER, V107, P2622, DOI 10.1002/cncr.22311; Cheng CW, 2005, ANZ J SURG, V75, P213, DOI 10.1111/j.1445-2197.2005.03327.x; Witjes JA, 1997, J UROLOGY, V158, P1500, DOI 10.1016/S0022-5347(01)64253-8; Picozzi S, 2013, UROL ONCOL-SEMIN ORI, V31, P1584, DOI 10.1016/j.urolonc.2012.03.009; Barentsz JO, 1996, EUR RADIOL, V6, P129; Sasaki M, 2008, RADIOLOGY, V249, P624, DOI 10.1148/radiol.2492071681; Kanazawa Y, 2012, EUR J RADIOL, V81, P1682, DOI 10.1016/j.ejrad.2011.04.013; Paschkis R., 1927, Z UROL NEPHROL, V21, P315; Saito W, 2000, MAGN RESON IMAGING, V18, P411, DOI 10.1016/S0730-725X(00)00124-7; Takeuchi M, 2013, J MAGN RESON IMAGING, V38, P1299, DOI 10.1002/jmri.24227; Tsujimura A, 1996, Hinyokika Kiyo, V42, P423	24	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	AUG	2015	205	2					311	316		10.2214/AJR.14.13879		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CN4YH	WOS:000358436000029		
J	Nakamura, M; Chida, K; Zuguchi, M				Nakamura, Masaaki; Chida, Koichi; Zuguchi, Masayuki			Novel Dosimeter Using a Nontoxic Phosphor for Real-Time Monitoring of Patient Radiation Dose in Interventional Radiology	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						fluoroscopy; interventional radiology; patient skin dosimeter; radiation protection; real-time dose measurement	SKIN INJURIES; EXPOSURE	OBJECTIVE. To our knowledge, no feasible method exists for real-time measurement of the radiation dose given to the patient during interventional radiology (IR) procedures. Therefore, we produced a prototype of a real-time dosimeter for patients undergoing IR that uses a nontoxic phosphor. The basic characteristics of the real-time dosimeter prototype are comparable to those of the previously used skin dose monitor, with the exception that our prototype has the distinct advantage of including multichannel sensors. CONCLUSION. The novel real-time dosimeter system is expected to be useful for measuring patient exposure to the radiation dose during IR procedures.	[Nakamura, Masaaki; Chida, Koichi; Zuguchi, Masayuki] Tokohu Univ, Coll Med Sci, Dept Radiol Technol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Chida, Koichi] Tohoku Univ, Int Res Inst Disaster Technol, Div Disaster Med Sci, Sendai, Miyagi 980, Japan	Chida, K (reprint author), Tokohu Univ, Coll Med Sci, Dept Radiol Technol, Aoba Ku, 2-1 Seiryou Machi, Sendai, Miyagi 9808575, Japan.	chida@mail.tains.tohoku.ac.jp			Japan Society for the Promotion of Science [26460716, 24300179]	This work was supported by the Japan Society for the Promotion of Science (grant-in-aid for scientific research no. 26460716 and no. 24300179).	Koenig TR, 2001, AM J ROENTGENOL, V177, P13; Chida K, 2006, AM J ROENTGENOL, V186, P774, DOI 10.2214/AJR.04.1653; Balter S, 2014, AM J ROENTGENOL, V202, pW335, DOI 10.2214/AJR.13.12029; Chida K, 2013, AM J ROENTGENOL, V200, P138, DOI 10.2214/AJR.11.8455; Chida K, 2009, ACTA RADIOL, V50, P474, DOI 10.1080/02841850902852752; Chida K, 2007, AM J ROENTGENOL, V189, pW224, DOI 10.2214/AJR.07.2422; Hwang E, 1998, CATHETER CARDIO DIAG, V43, P367, DOI 10.1002/(SICI)1097-0304(199804)43:4<367::AID-CCD1>3.0.CO;2-6; Inaba Y, 2014, J RADIOL PROT, V34, pN65, DOI 10.1088/0952-4746/34/3/N65; International Commission on Radiological Protection, 2000, ANN ICRP, V87, P30; Kamusella P, 2013, ROFO-FORTSCHR RONTG, V185, P241, DOI 10.1055/s-0032-1330316; Kato M, 2012, ACTA RADIOL, V53, P1040, DOI 10.1258/ar.2012.120192; Kato M, 2014, RADIAT PROT DOSIM, V162, P224, DOI 10.1093/rpd/nct300; Nakamura M, 2014, MED PHYS, V41, DOI 10.1118/1.4893534; Tsapaki V, 2009, AM J ROENTGENOL, V193, P559, DOI 10.2214/AJR.08.2115	14	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	AUG	2015	205	2					W202	W206		10.2214/AJR.14.13925		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CN4YH	WOS:000358436000008		
J	Shinmoto, H; Tamura, C; Soga, S; Okamura, T; Horiguchi, A; Asano, T; Kaji, T				Shinmoto, Hiroshi; Tamura, Chiharu; Soga, Shigeyoshi; Okamura, Teppei; Horiguchi, Akio; Asano, Tomohiko; Kaji, Tatsumi			Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						apparent diffusion coefficient; diagnosis; DWI; MRI; prostate neoplasms	ULTRASOUND FUSION; TRANSITION ZONE; ADC MAP; BIOPSY; LOCALIZATION; SPECIMENS; COMBINATION	OBJECTIVE. Diagnosis of anterior prostate cancer is challenging. The purpose of this study was to evaluate the diagnostic performance of T2-weighted imaging and an apparent diffusion coefficient (ADC) map in the detection of anterior prostate cancer and to compare that with the diagnostic performance in the detection of posterior prostate cancer. MATERIALS AND METHODS. We retrospectively reviewed the records of 87 patients who underwent 3-T MRI that included T2-weighted imaging and diffusion-weighted imaging before radical prostatectomy. The prostate gland was divided into anterior and posterior segments, and the radiologists interpreted two protocols (T2-weighted imaging alone vs T2-weighted imaging and an ADC map) and sorted the confidence levels for the presence of prostate cancer into five grades. ROC analysis was performed to evaluate the diagnostic performance of each protocol for the detection of anterior and posterior prostate cancers. We also assessed the relative fractions of sensitivity and specificity between anterior and posterior prostate cancers. Additionally, the ADCs of noncancerous anterior fibromuscular stroma were measured and compared with the ADCs of anterior prostate cancers. RESULTS. The AUCs with T2-weighted imaging alone and with T2-weighted imaging and an ADC map were 0.75 and 0.88 for anterior prostate cancer, respectively, and were 0.70 and 0.81 for posterior prostate cancer. The sensitivity for detecting anterior prostate cancer was 90% and was significantly higher than that for detecting posterior prostate cancer in the protocol using T2-weighted imaging and an ADC map (p = 0.003) when scores of 3-5 were considered as positive for prostate cancer. The ADC was significantly lower in anterior prostate cancer (mean, 0.80 x 10(-3) mm(2)/s) than in noncancerous anterior fibromuscular stroma (1.13 x 10(-3) mm(2)/s) (p < 0.001). CONCLUSION. The protocol using T2-weighted imaging and an ADC map showed higher accuracy for the detection of anterior prostate cancer than for the detection of posterior prostate cancer.	[Shinmoto, Hiroshi; Tamura, Chiharu; Soga, Shigeyoshi; Okamura, Teppei; Kaji, Tatsumi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 3598513, Japan; [Horiguchi, Akio; Asano, Tomohiko] Natl Def Med Coll, Dept Urol, Tokorozawa, Saitama 3598513, Japan	Shinmoto, H (reprint author), Natl Def Med Coll, Dept Radiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	hshinmo@ndmc.ac.jp					Watanabe Y, 2012, J MAGN RESON IMAGING, V35, P1414, DOI 10.1002/jmri.23587; Lim HK, 2009, RADIOLOGY, V250, P145, DOI 10.1148/radiol.2501080207; Vargas HA, 2012, RADIOLOGY, V262, P894, DOI 10.1148/radiol.11110663; Eastham JA, 2007, UROLOGY, V70, DOI 10.1016/j.urology.2007.08.040; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Jager GJ, 1997, RADIOLOGY, V203, P645; Watanabe Y, 2013, J MAGN RESON IMAGING, V37, P1168, DOI 10.1002/jmri.23908; Issa B, 2002, J MAGN RESON IMAGING, V16, P196, DOI 10.1002/jmri.10139; Bouye S, 2009, PROSTATE, V69, P105, DOI 10.1002/pros.20859; Delongchamps NB, 2011, BJU INT, V107, P1411, DOI 10.1111/j.1464-410X.2010.09808.x; Koppie TM, 2006, BJU INT, V98, P1167, DOI 10.1111/j.1464-410X.2006.06578.x; Hambrock T, 2011, RADIOLOGY, V259, P453, DOI 10.1148/radiol.11091409; Wright JL, 2006, UROL ONCOL-SEMIN ORI, V24, P492, DOI 10.1016/j.urolonc.2006.03.003; Katahira K, 2011, EUR RADIOL, V21, P188, DOI 10.1007/s00330-010-1883-7; Sonn GA, 2014, EUR UROL, V65, P809, DOI 10.1016/j.eururo.2013.03.025; Hambrock T, 2010, J UROLOGY, V183, P520, DOI 10.1016/j.juro.2009.10.022; Hoeks CMA, 2013, RADIOLOGY, V266, P207, DOI 10.1148/radiol.12120281; Bott SRJ, 2002, BJU INT, V89, P886, DOI 10.1046/j.1464-410X.2002.02796.x; Singh AK, 2008, BJU INT, V101, P841, DOI 10.1111/j.1464-410X.2007.07348.x; Vourganti S, 2012, J UROLOGY, V188, P2152, DOI 10.1016/j.juro.2012.08.025; Tanimoto A, 2007, J MAGN RESON IMAGING, V25, P146, DOI 10.1002/jmri.20793; Haider MA, 2007, AM J ROENTGENOL, V189, P323, DOI 10.2214/AJR.07.2211; Wright JL, 2010, J UROLOGY, V183, P2213, DOI 10.1016/j.juro.2010.02.017; Marks L, 2013, CURR OPIN UROL, V23, P43, DOI 10.1097/MOU.0b013e32835ad3ee; Wise AM, 2002, UROLOGY, V60, P264, DOI 10.1016/S0090-4295(02)01728-4; Eskicorapci SY, 2004, EUR UROL, V45, P444, DOI 10.1016/j.eururo.2003.11.024; Chen ME, 2000, CANCER, V89, P1800, DOI 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D; Eichelberger LE, 2003, AM J CLIN PATHOL, V120, P386, DOI 10.1309/82U1089XLQGKMMN1; Haarer CF, 2009, J UROLOGY, V182, P1337, DOI 10.1016/j.juro.2009.06.042; HODGE KK, 1989, J UROLOGY, V142, P71; Lawrentschuk N, 2010, BJU INT, V105, P1231, DOI 10.1111/j.1464-410X.2009.08938.x; Pepe MS, 2003, OXFORD STAT SCI SERI, V28, P35; Volkin D, 2014, BJU INT, V114, pE43, DOI 10.1111/bju.12670	33	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	AUG	2015	205	2					W185	W192		10.2214/AJR.14.13392		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CN4YH	WOS:000358436000006		
J	Watanabe, G; Ishida, T; Furuta, A; Takahashi, S; Watanabe, M; Nakata, H; Kato, S; Ishioka, C; Ohuchi, N				Watanabe, Gou; Ishida, Takanori; Furuta, Akihiko; Takahashi, Shin; Watanabe, Mika; Nakata, Hideaki; Kato, Shunsuke; Ishioka, Chikashi; Ohuchi, Noriaki			Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status An Independent Prognostic Factor of Breast Cancer	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						breast cancer; p53; PLK1; p21	WILD-TYPE P53; KINASE-1 PLK1; BIOMARKER PANEL; GENE; EXPRESSION; TUMORS; REPRESSION; MUTATIONS; INDUCTION; THERAPY	It is difficult to predict the TP53 status by p53 immunohistochemistry (IHC). We aimed to improve the accuracy of p53 IHC with p53-regulated proteins for predicting the TP53 mutation status. TP53 mutations were detected in 19 of 38 breast cancer patients (50%). Five of 7 cases of protein-truncating mutation of TP53 were completely negative for p53 IHC, whereas 11 of 12 cases of TP53 point mutation were strongly positive for p53 IHC. Therefore, to avoid false negatives, we extracted p53-dependent universally downregulated genes using microarray analysis from 38 breast cancer patients and 2 p53-inducible cell lines. From 9 commonly repressed genes, we evaluated 3 genes, baculoviral IAP repeat-containing 5 (BIRC5), polo-like kinase 1 (PLK1), and BUB1 mitotic checkpoint serine/threonine kinase (BUB1), which were previously identified as p53-dependent repressed genes. PLK1Allred total score (TS) 5 showed the highest correlation with TP53 mutation. To decrease false positivity, we evaluated p21 IHC. Although strong staining of p21 was observed in 4 cases (10.5%), all 4 were wild-type TP53. Thus, p53 mutation-like (p53mt-like) IHC was identified by p53 TS7,8 with PLK1TS 5 and p21 TS6. p53 mt-like IHC correlated with TP53 mutation (predictive value=0.94). In other 157 breast cancer cases, p53 mt-like was an independent prognostic marker in multivariate analysis and a strong prognostic factor. Stratification with p53 mt-like IHC identified patients with a poorer prognosis. In conclusion, we identified reliable IHC conditions to predict the TP53 status of breast cancer patients.	[Watanabe, Gou; Ishida, Takanori; Ohuchi, Noriaki] Tohoku Univ, Sch Med, Div Surg Oncol, Sendai, Miyagi 9808575, Japan; [Takahashi, Shin; Ishioka, Chikashi] Tohoku Univ, Res Inst Dev Aging & Canc, Dept Clin Oncol, Sendai, Miyagi 9808575, Japan; [Watanabe, Mika] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan; [Furuta, Akihiko] Ishinomaki Red Cross Hosp, Dept Breast Canc Surg, Ishinomaki, Miyagi, Japan; [Nakata, Hideaki] Nerima Gen Hosp, Ctr Kampo Med, Tokyo, Japan; [Kato, Shunsuke] Juntendo Univ Hosp, Div Med oncol, Tokyo, Japan	Watanabe, G (reprint author), Tohoku Univ, Sch Med, Div Surg Oncol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	wago@med.tohoku.ac.jp					ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Cadoo KA, 2013, SURG ONCOL CLIN N AM, V22, P823, DOI 10.1016/j.soc.2013.06.006; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Allred DC, 1998, MODERN PATHOL, V11, P155; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Takahashi S, 2008, CANCER SCI, V99, P324, DOI 10.1111/j.1349-7006.2007.00691.x; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Abdel-Fatah TM, 2010, J PATHOL, V220, P419, DOI 10.1002/path.2663; Ring BZ, 2006, J CLIN ONCOL, V24, P3039, DOI 10.1200/JCO.2006.05.6564; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; Ellis PA, 1997, BRIT J CANCER, V76, P480, DOI 10.1038/bjc.1997.413; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Kikuchi S, 2013, ANTICANCER RES, V33, P3891; King SI, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3136; Kobayashi Takayuki, 2013, BMC Clin Pathol, V13, P5, DOI 10.1186/1472-6890-13-5; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Roth JA, 1996, NAT MED, V2, P985, DOI 10.1038/nm0996-985; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Watanabe G, 2009, CANCER SCI, V100, P2368, DOI 10.1111/j.1349-7006.2009.01316.x	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	AUG	2015	39	8					1026	1034		10.1097/PAS.0000000000000386		9	Pathology; Surgery	Pathology; Surgery	CN4RL	WOS:000358417800002		
J	Lim, D; Ip, PPC; Cheung, ANY; Kiyokawa, T; Oliva, E				Lim, Diana; Ip, Philip P. C.; Cheung, Annie N. Y.; Kiyokawa, Takako; Oliva, Esther			Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						ovarian carcinoma; endometrial carcinoma; endometrioid; endometrioid with clear cells; clear cell; immunohistochemistry	HEPATOCYTE NUCLEAR FACTOR-1-BETA; GENE-EXPRESSION PROFILES; DISTINCT-HISTOLOGIC-TYPE; GRADE SEROUS CARCINOMA; DIAGNOSTIC-UTILITY; POOR-PROGNOSIS; NAPSIN-A; DIFFERENTIAL-DIAGNOSIS; LUNG ADENOCARCINOMA; PROTEIN EXPRESSION	Accurate distinction of clear cell carcinoma (CCC) from endometrioid carcinoma (EC) has important clinical implications, but, not infrequently, EC demonstrates clear cell change (EC-CC), mimicking CCC. We examined whether a panel of immunomarkers can help distinguish between these tumors. Sixty-four CCCs (40 ovarian and 24 uterine), 34 ECs (21 ovarian and 13 uterine), and 34 EC-CCs (6 ovarian and 28 uterine) were stained for HNF1, BAF250a, Napsin A, ER, and PR. Intensity and extent of immunoreactivity was assessed. Fifty-seven of 64 (89%) CCCs, 14/34 (41%) EC-CCs, and 16/34 (47%) ECs expressed HNF1, and 56/64 (88%) CCCs, 4/34 (12%) EC-CCs, and 1/34 (3%) ECs stained for Napsin A. Most CCCs demonstrated at least moderate and diffuse staining for both markers, whereas only focal and weak expression was identified in most EC-CC/EC. Compared to HNF1, Napsin A showed increased specificity (93.0% vs. 55.9%, P<0.0001) and similar sensitivity (87.5% vs. 89.1%) in distinguishing CCC from EC-CC/EC. Thirteen of 64 (20%) CCCs, 6/34 (18%) EC-CCs, and 2/34 (6%) ECs showed loss of BAF250a. ER was expressed by 10/64 (16%) CCCs, 30/34 (88%) EC-CCs, and 33/34 (97%) ECs, whereas PR positivity was identified in 9/64 (14%) CCCs, 26/34 (77%) EC-CCs, and 33/34 (97%) ECs. The majority of EC and EC-CC demonstrated diffuse staining for ER/PR, whereas most CCCs showed very focal positivity. There is a statistically significant difference in HNF1, Napsin A, ER, and PR immunoexpression between CCC and EC/EC-CC, with Napsin A being a more specific marker for CCC than HNF1. Overall, the immunoprofile of EC-CC is more comparable to that of EC than CCC. The use of a panel of immunostains can help distinguish EC-CC from CCC.	[Lim, Diana] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Ip, Philip P. C.; Cheung, Annie N. Y.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Kiyokawa, Takako] Jikei Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Oliva, Esther] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Oliva, E (reprint author), Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St,Warren 2, Boston, MA 02114 USA.	eoliva@partners.org		Ip, Philip Pun Ching/0000-0002-0493-9838			Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P66, DOI 10.1097/PAP.0b013e31823e472e; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; DeLair D, 2013, INT J GYNECOL PATHOL, V32, P541, DOI 10.1097/PGP.0b013e318273fd07; Kenny SL, 2012, AM J SURG PATHOL, V36, P799, DOI 10.1097/PAS.0b013e31824a72c6; Kao YC, 2012, HISTOPATHOLOGY, V61, P760, DOI 10.1111/j.1365-2559.2012.04267.x; Prowse AH, 2006, INT J CANCER, V119, P556, DOI 10.1002/ijc.21845; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI [10.1016/j.ygyno.2009.10.069, 10.1016/j,ygyno.2009.10.069]; Han G, 2008, AM J SURG PATHOL, V32, P955, DOI 10.1097/PAS.0b013e318164edf7; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Zannoni GF, 2012, INT J GYNECOL PATHOL, V31, P507, DOI 10.1097/PGP.0b013e3182518557; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05.0508; Fadare O, 2014, AM J SURG PATHOL, V38, P189, DOI 10.1097/PAS.0000000000000085; KURMAN RJ, 1976, CANCER, V37, P872, DOI 10.1002/1097-0142(197602)37:2<872::AID-CNCR2820370236>3.0.CO;2-L; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Lax SF, 1998, HUM PATHOL, V29, P551, DOI 10.1016/S0046-8177(98)80002-6; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Kato N, 2006, MODERN PATHOL, V19, P83, DOI 10.1038/modpathol.3800492; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Tan DSP, 2013, BRIT J CANCER, V108, P1553, DOI 10.1038/bjc.2013.126; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189; Brasch F, 2003, J BIOL CHEM, V278, P49006, DOI 10.1074/jbc.M306844200; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yamamoto S, 2007, HUM PATHOL, V38, P1074, DOI 10.1016/j.humpath.2006.12.018; Fadare O, 2012, APPL IMMUNOHISTO M M, V20, P580, DOI 10.1097/PAI.0b013e31824973d1; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kounelis S, 2000, MODERN PATHOL, V13, P379, DOI 10.1038/modpathol.3880062; Cirisano FD, 1999, GYNECOL ONCOL, V74, P385, DOI 10.1006/gyno.1999.5505; Schwartz DR, 2002, CANCER RES, V62, P4722; Turner BM, 2012, ARCH PATHOL LAB MED, V136, P163, DOI 10.5858/arpa.2011-0320-OA; Bohn S, 2003, J AM SOC NEPHROL, V14, P2033, DOI 10.1097/01.ASN.0000078808.70309.C4; Ayhan A, 2012, INT J GYNECOL CANCER, V22, P1310, DOI 10.1097/IGC.0b013e31826b5dcc; Silva EG, 2007, AM J SURG PATHOL, V31, P1203, DOI 10.1097/PAS.0b013e3180339ed7; Han GM, 2013, MODERN PATHOL, V26, P1594, DOI 10.1038/modpathol.2013.102; Lowery WJ, 2012, INT J GYNECOL CANCER, V22, P9, DOI 10.1097/IGC.0b013e318231f140; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Kim L, 2008, MODERN PATHOL, V21, P1075, DOI 10.1038/modpathol.2008.95; Matsuura Y, 2007, GYNECOL ONCOL, V104, P406, DOI 10.1016/j.ygyno.2006.08.026; Reid-Nicholson M, 2006, MODERN PATHOL, V19, P1091, DOI 10.1038/modpathol.3800620; CHRISTOPHERSON W M, 1982, Cancer, V49, P1511, DOI 10.1002/1097-0142(19820415)49:8<1511::AID-CNCR2820490802>3.0.CO;2-6; CLIZER EE, 1971, J UROLOGY, V106, P366; Fadare O, 2012, AM J SURG PATHOL, V36, P1107, DOI 10.1097/PAS.0b013e31825dd4b3; Guirguis A, 2008, GYNECOL ONCOL, V108, P370, DOI 10.1016/j.ygyno.2007.10.008; Hoang LN, 2014, HISTOPATHOLOGY, V64, P585, DOI 10.1111/his.12286; Kadivar M, 2013, APPL IMMUNOHISTO M M, V21, P191, DOI 10.1097/PAI.0b013e3182612643; Kurman RJ, 2014, WHO CLASSIFICATION T, P11; Maeda D, 2010, INT J MOL SCI, V11, P5121, DOI 10.3390/ijms11125120; Nagle CM, 2008, EUR J CANCER, V44, P2477, DOI 10.1016/j.ejca.2008.07.009; SILVERBE.SG, 1973, CANCER, V31, P1127, DOI 10.1002/1097-0142(197305)31:5<1127::AID-CNCR2820310514>3.0.CO;2-E; Skirnisdottir I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-524; Woischnik M, 2008, EUR RESPIR J, V31, P1197, DOI 10.1183/09031936.00081207; Yamashita Y, 2015, MODERN PATHOL, V28, P111, DOI 10.1038/modpathol.2014.61	60	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	AUG	2015	39	8					1061	1069		10.1097/PAS.0000000000000436		9	Pathology; Surgery	Pathology; Surgery	CN4RL	WOS:000358417800006		
J	Yoshida, A; Yoshida, H; Yoshida, M; Mori, T; Kobayashi, E; Tanzawa, Y; Yasugi, T; Kawana, K; Ishikawa, M; Sugiura, H; Maeda, D; Fukayama, M; Kawai, A; Hiraoka, N; Motoi, T				Yoshida, Akihiko; Yoshida, Hiroshi; Yoshida, Masayuki; Mori, Taisuke; Kobayashi, Eisuke; Tanzawa, Yoshikazu; Yasugi, Toshiharu; Kawana, Kei; Ishikawa, Mitsuya; Sugiura, Hitoshi; Maeda, Daichi; Fukayama, Masashi; Kawai, Akira; Hiraoka, Nobuyoshi; Motoi, Toru			Myoepithelioma-like Tumors of the Vulvar Region A Distinctive Group of SMARCB1-deficient Neoplasms	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						diagnosis; myoepithelioma; sarcoma; SMARCB1; vulva	EXTRASKELETAL MYXOID CHONDROSARCOMA; MALIGNANT RHABDOID TUMORS; OF-THE-LITERATURE; SOFT-TISSUE; EPITHELIOID SARCOMA; FUSION GENE; PROTEIN EXPRESSION; MOLECULAR ANALYSIS; MIXED TUMORS; EWSR1 GENE	We describe 9 tumors that resemble soft tissue myoepitheliomas but possess certain traits that do not fit perfectly into this category. These tumors, herein referred to as myoepithelioma-like tumors of the vulvar region, occurred in the subcutis of the vulva and surrounding regions of adult women aged 24 to 65 years. Histologically, the tumors measured 2 to 7.7 cm and were well circumscribed, focally encapsulated, and lobulated. Tumor cells had an epithelioid to spindled shape, with fine amphophilic cytoplasm, and uniform nuclei with vesicular chromatin and nucleoli. The tumor stroma was relatively hypervascular, and comprised a mixture of myxoid and nonmyxoid components. Myxoid areas accounted for <5% to 95% of the tumor volume, wherein cells proliferated singly or in a loosely cohesive manner. In nonmyxoid areas, tumors cells grew in diffuse sheets or storiform arrangements. Immunohistochemically, all tested tumors were positive for vimentin, epithelial membrane antigen, and estrogen receptor; most tumors expressed actin. All tumors were negative for S100 protein, glial fibrillary acidic protein, and CD34. Cytokeratin expression was absent in all but 2 tumors, which showed rare positivity. SMARCB1 expression was deficient in all cases. EWSR1, FUS, and NR4A3 rearrangements were absent. All tumors were treated through surgery. Although 3 tumors regrew or recurred after intralesional excision, all 9 patients were alive without metastases at a mean follow-up of 66 months. Myoepithelioma-like tumors of the vulvar region constitute a distinct group of tumors, although future research is required to determine whether they are an unusual subtype of soft tissue myoepitheliomas or a separate disease.	[Yoshida, Akihiko; Yoshida, Hiroshi; Yoshida, Masayuki; Mori, Taisuke; Hiraoka, Nobuyoshi] Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, Tokyo 1040045, Japan; [Kobayashi, Eisuke; Tanzawa, Yoshikazu; Kawai, Akira] Natl Canc Ctr, Dept Musculoskeletal Oncol, Tokyo 1040045, Japan; [Ishikawa, Mitsuya] Natl Canc Ctr, Dept Gynecol, Tokyo 1040045, Japan; [Yasugi, Toshiharu] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gynecol, Tokyo, Japan; [Motoi, Toru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pathol, Tokyo, Japan; [Kawana, Kei] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Maeda, Daichi; Fukayama, Masashi] Univ Tokyo, Dept Pathol, Tokyo, Japan; [Sugiura, Hitoshi] Kawasaki Municipal Hosp, Dept Pathol, Kanagawa, Japan; [Maeda, Daichi] Akita Univ, Dept Cellular & Organ Pathol, Akita 010, Japan	Yoshida, A (reprint author), Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	akyoshid@ncc.go.jp			National Cancer Center Research and Development Fund [26-A-9]	Supported in part by the National Cancer Center Research and Development Fund (26-A-9). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Agaimy A, 2014, AM J SURG PATHOL, V38, P1274, DOI 10.1097/PAS.0000000000000236; Agaimy A, 2015, MODERN PATHOL, V28, P248, DOI 10.1038/modpathol.2014.100; Gleason BC, 2007, AM J SURG PATHOL, V31, P1813, DOI 10.1097/PAS.0b013e31805f6775; Hornick JL, 2009, AM J SURG PATHOL, V33, P542, DOI 10.1097/PAS.0b013e3181882c54; Antonescu CR, 2013, GENE CHROMOSOME CANC, V52, P675, DOI 10.1002/gcc.22063; Michal M, 1999, VIRCHOWS ARCH, V434, P393, DOI 10.1007/s004280050358; Hornick JL, 2003, AM J SURG PATHOL, V27, P1183, DOI 10.1097/00000478-200309000-00001; Miyata M, 2011, J OBSTET GYNAECOL RE, V37, P617, DOI 10.1111/j.1447-0756.2010.01392.x; TSANG WYW, 1992, AM J SURG PATHOL, V16, P1059, DOI 10.1097/00000478-199211000-00004; Brandal P, 2009, GENE CHROMOSOME CANC, V48, P1051, DOI 10.1002/gcc.20706; Bourdeaut F, 2008, PEDIATR BLOOD CANCER, V51, P363, DOI 10.1002/pbc.21632; BRANTON PA, 1993, AM J SURG PATHOL, V17, P509, DOI 10.1097/00000478-199305000-00011; Chen BJ, 2012, AM J SURG PATHOL, V36, P1119, DOI 10.1097/PAS.0b013e31825d532d; Flucke U, 2012, VIRCHOWS ARCH, V460, P621, DOI 10.1007/s00428-012-1240-0; Oliveira AM, 2000, MODERN PATHOL, V13, P900, DOI 10.1038/modpathol.3880161; Brandal P, 2008, GENE CHROMOSOME CANC, V47, P558, DOI 10.1002/gcc.20559; Okamoto S, 2001, HUM PATHOL, V32, P1116, DOI 10.1053/hupa.2001.28226; Mentzel T, 2003, J CUTAN PATHOL, V30, P294, DOI 10.1034/j.1600-0560.2003.00063.x; Venneti S, 2011, AM J SURG PATHOL, V35, P1463, DOI 10.1097/PAS.0b013e318224d2cd; Le Loarer F, 2014, GENE CHROMOSOME CANC, V53, P475, DOI 10.1002/gcc.22159; Guillou L, 1997, AM J SURG PATHOL, V21, P130, DOI 10.1097/00000478-199702000-00002; Laskin WB, 2001, HUM PATHOL, V32, P715, DOI 10.1053/hupa.2001.25588; Schaefer IM, 2014, AM J SURG PATHOL, V38, P816, DOI 10.1097/PAS.0000000000000172; Fisher C, 2014, HISTOPATHOLOGY, V64, P134, DOI 10.1111/his.12269; Antonescu CR, 2010, GENE CHROMOSOME CANC, V49, P1114, DOI 10.1002/gcc.20819; Kurzawa P, 2013, AM J SURG PATHOL, V37, P960, DOI 10.1097/PAS.0b013e3182858a0e; Kohashi K, 2008, AM J SURG PATHOL, V32, P1168, DOI 10.1097/PAS.0b013e318161781a; Nielsen GP, 1997, AM J SURG PATHOL, V21, P1104, DOI 10.1097/00000478-199709000-00016; Chen E, 2010, AM J SURG PATHOL, V34, P707, DOI 10.1097/PAS.0b013e3181d74bdb; Jo VY, 2013, AM J SURG PATHOL, V37, P710, DOI 10.1097/PAS.0b013e3182772bba; Lauer SR, 2013, AM J SURG PATHOL, V37, P719, DOI 10.1097/PAS.0b013e31827813e7; Argenta PA, 2007, GYNECOL ONCOL, V107, P130, DOI 10.1016/j.ygyno.2007.05.045; Bahrami A, 2012, GENE CHROMOSOME CANC, V51, P140, DOI 10.1002/gcc.20938; Deisch J, 2011, PEDIATR DEVEL PATHOL, V14, P353, DOI 10.2350/10-09-0902-OA.1; Fletcher Ch, 2013, WHO CLASSIFICATION T; Flucke U, 2010, HISTOPATHOLOGY, V57, P753, DOI 10.1111/j.1365-2559.2010.03688.x; Folpe AL, 2015, AM J SURG PATHOL; Fukunaga M, 2003, APMIS, V111, P416, DOI 10.1034/j.1600-0463.2003.t01-1-1110206.x; Georgantopoulou C, 2009, EUR J GYNAECOL ONCOL, V30, P203; Goldblum JR, 2014, ENZINGER WEISSS SOFT; van Roggen JFG, 2001, AM J SURG PATHOL, V25, P485; Hinze P, 1999, HISTOPATHOLOGY, V35, P50; Iwasa Y, 2004, AM J SURG PATHOL, V28, P1426, DOI 10.1097/01.pas.0000138002.46650.95; Kilpatrick SE, 1997, AM J SURG PATHOL, V21, P13, DOI 10.1097/00000478-199701000-00002; Kyriazi MA, 2010, INT J GYNECOL PATHOL, V29, P501, DOI 10.1097/PGP.0b013e3181d81cdb; Meenakshi M, 2009, HUM PATHOL, V40, P1747, DOI 10.1016/j.humpath.2009.04.025; Noronha V, 2006, LANCET ONCOL, V7, P270, DOI 10.1016/S1470-2045(06)70619-2; Puls F, 2014, HISTOPATHOLOGY, V65, P917, DOI 10.1111/his.12517; Yoshida A, 2015, HISTOPATHOLOGY, V66, P252, DOI 10.1111/his.12460	49	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	AUG	2015	39	8					1102	1113		10.1097/PAS.0000000000000466		12	Pathology; Surgery	Pathology; Surgery	CN4RL	WOS:000358417800011		
J	Hata, T; Sakata, N; Yoshimatsu, G; Tsuchiya, H; Fukase, M; Ishida, M; Aoki, T; Katayose, Y; Egawa, S; Unno, M				Hata, T.; Sakata, N.; Yoshimatsu, G.; Tsuchiya, H.; Fukase, M.; Ishida, M.; Aoki, T.; Katayose, Y.; Egawa, S.; Unno, M.			Cholestatic Liver Injury After Biliary Reconstruction Impairs Transplanted Islet Viability and Function	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article							EN-Y HEPATICOJEJUNOSTOMY; LONG-TERM-OUTCOMES; TOTAL PANCREATECTOMY; CHRONIC-PANCREATITIS; T-CELLS; AUTOTRANSPLANTATION; MOUSE; GRAFT; STREPTOZOTOCIN; CHOLANGITIS	Islet autotransplantation following total pancreatectomy differs from allograft transplantation with respect to the requirement of biliary reconstruction. Although it is known that careful consideration should be given to postoperative cholestatic liver injury after biliary reconstruction, its direct effects on transplanted islets have not been completely elucidated. In this study, we developed a murine model of postoperative cholestatic liver injury after biliary reconstruction with islet autotransplantation that involved syngeneic intraportal islet transplantation into chemically induced diabetic mice and common bile duct ligation. We assessed the viability and function of the transplanted islets. The impaired viability of transplanted islets and increased blood glucose levels indicated restoration of the diabetic state after common bile duct ligation in this murine model. Furthermore, impaired islet viability and function occurred earlier in the transplanted islets than in the surrounding liver tissues, which was consistent with the faster and higher expression of oxidative stress markers in the transplanted islets. Transplanted islets may be more vulnerable to oxidative stress caused by cholestatic liver injury than the surrounding liver tissue. Therefore, patients should be intensively managed after total pancreatectomy with islet autotransplantation to preserve viability and function of the transplanted islets.	[Hata, T.; Sakata, N.; Yoshimatsu, G.; Tsuchiya, H.; Fukase, M.; Ishida, M.; Aoki, T.; Unno, M.] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan; [Katayose, Y.; Unno, M.] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan; [Egawa, S.] Tohoku Univ, Int Res Inst Disaster Sci, Div Int Cooperat Disaster Med, Grad Sch Med, Sendai, Miyagi, Japan	Sakata, N (reprint author), Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan.	n-sakata@surg1.med.tohoku.ac.jp			Japanese Society for the Promotion of Science [20302151, 22390253, 24659582]; grants of the Pancreas Research Foundation of Japan; Suzuken Memorial Foundation	We thank Emiko Shibuya (Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan) and Fumiko Date (Biomedical Research Core of Tohoku University Graduate School of Medicine) for their technical assistance. This study was supported by Grants-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science, Challenging Exploratory Research (to YK: 20302151) and Scientific Research B (SE: 22390253) and C (NS: 24659582), grants of the Pancreas Research Foundation of Japan (to TH) and the Suzuken Memorial Foundation (to NS).	ACCATINO L, 1981, J LAB CLIN MED, V97, P525; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; GRANKVIST K, 1981, BIOCHEM J, V199, P393; Clayton HA, 2003, TRANSPLANTATION, V76, P92, DOI 10.1097/01.TP.0000054618.03927.70; Crippa S, 2011, SURGERY, V149, P79, DOI 10.1016/j.surg.2010.04.007; Ekeblad S, 2008, CLIN CANCER RES, V14, P7798, DOI 10.1158/1078-0432.CCR-08-0734; Bramis K, 2012, BRIT J SURG, V99, P761, DOI 10.1002/bjs.8713; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0; Gala-Lopez BL, 2013, AM J TRANSPLANT, V13, P2487, DOI 10.1111/ajt.12354; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Bellin MD, 2014, PANCREATOLOGY, V14, P27, DOI 10.1016/j.pan.2013.10.009; Heidt DG, 2007, J GASTROINTEST SURG, V11, P209, DOI 10.1007/s11605-006-0025-7; Muller MW, 2007, ANN SURG, V246, P966, DOI 10.1097/SLA.0b013e31815c2ca3; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Lunsford KE, 2008, AM J TRANSPLANT, V8, P1113, DOI 10.1111/j.1600-6143.2008.02219.x; Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Chinnakotla S, 2014, ANN SURG, V260, P56, DOI 10.1097/SLA.0000000000000569; Chujo D, 2012, CELL TRANSPLANT, V21, P2783, DOI 10.3727/096368912X654993; DUCROTTE P, 1991, AM J GASTROENTEROL, V86, P1255; Ferrari-Lacraz S, 2006, TRANSPLANTATION, V82, P1510, DOI 10.1097/01.tp.0000243168.53126.d2; Hata T, 2013, TRANSPLANTATION, V96, pE40, DOI 10.1097/TP.0b013e3182a049bb; Illouz Severine, 2007, Diabetes Care, V30, pe130, DOI 10.2337/dc07-1075; Jin X, 2010, EXP BIOL MED, V235, P877, DOI 10.1258/ebm.2010.009361; Jindal RM, 2010, NEW ENGL J MED, V362, P1550, DOI 10.1056/NEJMc0912392; Keymeulen B, 1997, DIABETOLOGIA, V40, P1152, DOI 10.1007/s001250050800; Kim TW, 2013, FOOD CHEM TOXICOL, V51, P364, DOI 10.1016/j.fct.2012.10.017; Koulmanda M, 2014, AM J TRANSPLANT, V14, P1543, DOI 10.1111/ajt.12723; Le Blanc-Louvry I, 1999, AM J GASTROENTEROL, V94, P2501; Mattei P, 2006, WORLD J SURG, V30, P1382, DOI 10.1007/s00268-005-0613-9; Mohseni Salehi Monfared Seyed Sajad, 2009, World J Gastroenterol, V15, P1153; Ong SL, 2009, HPB, V11, P613, DOI 10.1111/j.1477-2574.2009.00113.x; Ris F, 2011, TRANSPLANTATION, V91, P895, DOI 10.1097/TP.0b013e31820f0892; Sakata N, 2013, TRANSPLANTATION, V96, P38; Sakata N, 2009, TRANSPLANTATION, V87, P825, DOI 10.1097/TP.0b013e318199c7d2; Sakata N, 2009, ISLETS, V1, P26, DOI 10.4161/isl.1.1.8563	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	AUG	2015	15	8					2085	2095		10.1111/ajt.13266		11	Surgery; Transplantation	Surgery; Transplantation	CN5XC	WOS:000358505600011		
J	Itoh, N; Santa, T; Kato, M				Itoh, Naoki; Santa, Tomofumi; Kato, Masaru			Rapid evaluation of the quantity of drugs encapsulated within nanoparticles by high-performance liquid chromatography in a monolithic silica column	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						HPLC; Monolith; Nanoparticle; Drug; Nanomedicine	LIPOSOME-ASSOCIATED DOXORUBICIN; HUMAN-PLASMA; AMINO-ACIDS; SEPARATION; NANOTECHNOLOGY; SPECTROMETRY; VINCRISTINE; MOLECULES; DELIVERY; CANCER	Drug-containing nanoparticles, the foundation of nanomedicine, provide promise for the safe and effective delivery of drugs to their targets. In this study, we developed a simple method to determine the relative quantities of nanoparticle-encapsulated drugs by HPLC using a commercially available monolithic silica column. Amphotericin B- and irinotecan-containing nanoparticles produced nearly simultaneous elution peaks (similar to 7 min), suggesting that elution was largely driven by hydrodynamic effects and was relatively unaffected by differences in the encapsulated drug. A good correlation was observed between the intensity of the nanoparticle peak and the relative quantity of encapsulated drug. We used our method to characterize the effects of drug quantity and nanoparticle size on drug encapsulation rates within the nanoparticles. Encapsulation increased with increasing quantities of the drug in the preparation solution. This effect was greater for irinotecan than for amphotericin B. Although absolute encapsulation also increased with increasing nanoparticle size, encapsulation efficiency decreased. Thus, the monolith column is suitable for evaluating nanomedicine quality and may be used to evaluate many kinds of nanomaterials.	[Itoh, Naoki; Santa, Tomofumi; Kato, Masaru] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Itoh, Naoki; Santa, Tomofumi; Kato, Masaru] Univ Tokyo, GPLLI Program, Bunkyo Ku, Tokyo 1130033, Japan	Kato, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	masaru-kato@umin.ac.jp			Kakenhi from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; JSPS Core-to-Core Program, A. Advanced Research Networks	This work was supported by grants (Kakenhi) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and JSPS Core-to-Core Program, A. Advanced Research Networks.	Edwards KA, 2006, TALANTA, V68, P1432, DOI 10.1016/j.talanta.2005.08.031; Yokoi T, 2009, CHEM MATER, V21, P3719, DOI 10.1021/cm900993b; Devadasu VR, 2013, CHEM REV, V113, P1686, DOI 10.1021/cr300047q; Sapsford KE, 2011, ANAL CHEM, V83, P4453, DOI 10.1021/ac200853a; Ishizuka F, 2014, J MATER CHEM B, V2, P4153, DOI 10.1039/c4tb00536h; Kranz C, 2011, ANAL BIOANAL CHEM, V399, P2309, DOI 10.1007/s00216-010-4631-6; Yokoi T, 2006, J AM CHEM SOC, V128, P13664, DOI 10.1021/ja065071y; THIES RL, 1990, ANAL BIOCHEM, V188, P65, DOI 10.1016/0003-2697(90)90528-H; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Chin DL, 2002, J CHROMATOGR B, V779, P259, DOI 10.1016/S1570-0232(02)00395-1; Yang F, 2013, J CHROMATOGR A, V1275, P61, DOI 10.1016/j.chroma.2012.12.026; Murayama S, 2013, J MATER CHEM B, V1, P4932, DOI 10.1039/c3tb20828a; Kato M, 2005, ANAL CHEM, V77, P1813, DOI 10.1021/ac048388u; Itoh N, 2014, ANALYST, V139, P4453, DOI 10.1039/c4an00819g; Yamamoto E, 2011, J CHROMATOGR B, V879, P3620, DOI 10.1016/j.jchromb.2011.10.004; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; DRUCKMANN S, 1989, BIOCHIM BIOPHYS ACTA, V980, P381, DOI 10.1016/0005-2736(89)90329-5; Deshpande NM, 2010, J CHROMATOGR B, V878, P315, DOI 10.1016/j.jchromb.2009.11.036; Amamoto T, 2014, CHEM PHARM BULL, V62, P649; Gomez-Hens A, 2006, TRAC-TREND ANAL CHEM, V25, P167, DOI 10.1016/j.trac.2005.07.006; Takagi K, 2014, SOFT MATTER, V10, P3553, DOI 10.1039/c3sm52908h; Mayer LD, 1995, ANAL BIOCHEM, V232, P149, DOI 10.1006/abio.1995.0001; ANZAI K, 1990, BIOCHIM BIOPHYS ACTA, V1021, P21, DOI 10.1016/0005-2736(90)90378-2; Kato M, 2015, J SEP SCI, V38, P468, DOI 10.1002/jssc.201401086; Kato M, 2004, ANAL CHEM, V76, P1896, DOI 10.1021/ac035107u; Murakami M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001385; OKU N, 1983, BIOCHEMISTRY-US, V22, P855, DOI 10.1021/bi00273a023; Sakai-Kato K, 2011, J CHROMATOGR A, V1218, P5520, DOI 10.1016/j.chroma.2011.06.055; Zhang XM, 2004, CHEM PHYS LIPIDS, V127, P113, DOI 10.1016/j.chemphyslip.2003.09.013	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	AUG	2015	407	21					6429	6434		10.1007/s00216-015-8805-0		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CN7WV	WOS:000358646400017		
J	Morota, G; Penagaricano, F; Petersen, JL; Ciobanu, DC; Tsuyuzaki, K; Nikaido, I				Morota, G.; Penagaricano, F.; Petersen, J. L.; Ciobanu, D. C.; Tsuyuzaki, K.; Nikaido, I.			An application of MeSH enrichment analysis in livestock	ANIMAL GENETICS			English	Article						annotation; enrichment analysis; Gene Ontology; Gene; ORA	GENE ONTOLOGY; EXPRESSION; TRAITS; CATTLE; TOOL; ANNOTATION; PREDICTION; MUSCLE; ACID	An integral part of functional genomics studies is to assess the enrichment of specific biological terms in lists of genes found to be playing an important role in biological phenomena. Contrasting the observed frequency of annotated terms with those of the background is at the core of overrepresentation analysis (ORA). Gene Ontology (GO) is a means to consistently classify and annotate gene products and has become a mainstay in ORA. Alternatively, Medical Subject Headings (MeSH) offers a comprehensive life science vocabulary including additional categories that are not covered by GO. Although MeSH is applied predominantly in human and model organism research, its full potential in livestock genetics is yet to be explored. In this study, MeSH ORA was evaluated to discern biological properties of identified genes and contrast them with the results obtained from GO enrichment analysis. Three published datasets were employed for this purpose, representing a gene expression study in dairy cattle, the use of SNPs for genome-wide prediction in swine and the identification of genomic regions targeted by selection in horses. We found that several overrepresented MeSH annotations linked to these gene sets share similar concepts with those of GO terms. Moreover, MeSH yielded unique annotations, which are not directly provided by GO terms, suggesting that MeSH has the potential to refine and enrich the representation of biological knowledge. We demonstrated that MeSH can be regarded as another choice of annotation to draw biological inferences from genes identified via experimental analyses. When used in combination with GO terms, our results indicate that MeSH can enhance our functional interpretations for specific biological conditions or the genetic basis of complex traits in livestock species.	[Morota, G.; Petersen, J. L.; Ciobanu, D. C.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA; [Penagaricano, F.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Penagaricano, F.] Univ Florida, Genet Inst, Gainesville, FL USA; [Tsuyuzaki, K.] Tokyo Univ Sci, Dept Med & Life Sci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan; [Tsuyuzaki, K.; Nikaido, I.] RIKEN, Bioinformat Res Unit, Adv Ctr Comp & Commun, Wako, Saitama, Japan	Morota, G (reprint author), Univ Nebraska, Dept Anim Sci, POB 830908, Lincoln, NE 68583 USA.	morota@unl.edu	NIKAIDO, Itoshi/K-2058-2014; Penagaricano, Francisco/C-8083-2015	Penagaricano, Francisco/0000-0001-6661-3991	University of Nebraska, Lincoln	This work was financially supported by the University of Nebraska, Lincoln.	ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; Pavlidis P, 2012, MOL BIOL EVOL, V29, P3237, DOI 10.1093/molbev/mss136; Nelson SJ, 2004, ST HEAL T, V107, P67; Khatri P, 2005, BIOINFORMATICS, V21, P3587, DOI 10.1093/bioinformatics/bti565; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Sedeno-Cortes AE, 2014, TRENDS GENET, V30, P513, DOI 10.1016/j.tig.2014.10.001; Tsuyuzaki K, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0453-z; Ashburner M, 2000, NAT GENET, V25, P25; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; [Anonymous], 2003, GENOMICS; Garcia-Fernandez M, 2010, ANIM GENET, V41, P324, DOI 10.1111/j.1365-2052.2009.02000.x; Elis S, 2013, J DAIRY SCI, V96, P7591, DOI 10.3168/jds.2013-6615; Cheung WA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-249; Coletti MH, 2001, J AM MED INFORM ASSN, V8, P317; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jani SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-166; Khatib H, 2008, J ANIM SCI, V86, P2063, DOI 10.2527/jas.2007-0791; Li XK, 2008, J BIOL CHEM, V283, P27644, DOI 10.1074/jbc.M804899200; Mirina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049093; Morota G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-109; Nakazato Takeru, 2008, In Silico Biology, V8, P53; Nakazato T, 2009, NUCLEIC ACIDS RES, V37, pW166, DOI 10.1093/nar/gkp483; Osborne John D, 2007, Methods Mol Biol, V377, P223; Penagaricano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072302; Petersen JL, 2014, ANIM GENET, V45, P827, DOI 10.1111/age.12205; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Rempel LA, 2012, J ANIM SCI, V90, P1311, DOI 10.2527/jas.2011-4302; SHERBLOM AP, 1985, J REPROD FERTIL, V74, P509; Soldatos TG, 2015, METHODS, V74, P3, DOI 10.1016/j.ymeth.2014.07.004; Tart JK, 2013, ANIM GENET, V44, P387, DOI 10.1111/age.12028	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	AUG	2015	46	4					381	387		10.1111/age.12307		7	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CN7VI	WOS:000358641800005		
J	Uemoto, Y; Sasaki, S; Sugimoto, Y; Watanabe, T				Uemoto, Y.; Sasaki, S.; Sugimoto, Y.; Watanabe, T.			Accuracy of high-density genotype imputation in Japanese Black cattle	ANIMAL GENETICS			English	Article						bovineHD; minor allele frequency; proportion and correlation	LINKAGE DISEQUILIBRIUM; BREEDING PROGRAMS; DOMESTIC-ANIMALS; POPULATION; ASSOCIATION; HOLSTEIN	Genotype imputation facilitates the identification of missing genotypes on a high-density array using low-density arrays and has great potential for reducing genotyping costs for cattle populations. However, the imputation quality varies across breeds, which have different effective population sizes. Therefore, the accuracy of genotype imputation must be evaluated in each breed. The Japanese Black cattle population has a unique genetic background, and this study aimed to investigate different factors affecting imputation quality in this population. A total of 1368 animals were genotyped using the Illumina BovineHD BeadChip, and the accuracy of imputation was evaluated using information from four lower density arrays. The extent of linkage disequilibrium for this population was relatively higher than that in other beef breeds but lower than that in dairy breeds. The accuracy of arrays with more than 20000 single nucleotide polymorphisms (SNPs) was similar to or higher than that of lower density arrays. In addition, the minor allele frequency of SNPs in the reference population affected the accuracy. The accuracy increased as the size of the reference population increased, up to 400 animals, beyond which there was little increase. A higher genetic relationship between the reference and test populations increased imputation accuracy. These results indicate that high imputation accuracy can be achieved using high-density arrays, having enough reference animals and including relatives in the reference population.	[Uemoto, Y.; Sasaki, S.; Watanabe, T.] Natl Livestock Breeding Ctr, Fukushima 9618511, Japan; [Sugimoto, Y.] Japan Livestock Technol Assoc, Shirakawa Inst Anim Genet, Fukushima 9618511, Japan	Uemoto, Y (reprint author), Natl Livestock Breeding Ctr, Fukushima 9618511, Japan.	y0uemoto@nlbc.go.jp					Nishimura S, 2013, ANIM SCI J, V84, P1, DOI 10.1111/j.1740-0929.2012.01036.x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; VanRaden PM, 2013, J DAIRY SCI, V96, P668, DOI 10.3168/jds.2012-5702; Hickey JM, 2012, CROP SCI, V52, P654, DOI 10.2135/cropsci2011.07.0358; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Nomura T, 2001, J ANIM SCI, V79, P366; Lund MS, 2014, LIVEST SCI, V166, P101, DOI 10.1016/j.livsci.2014.05.008; Corbin LJ, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-9; GODDARD ME, 2009, P ASS ADVMT ANIM BRE, V18, P26; Hayes BJ, 2011, ANIM GENET, V43, P72; Hoze C, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-33; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Nicolazzi E. L., 2014, P 10 WORLD C GEN APP; Pausch H, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-3; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Zhang H, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-26	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	AUG	2015	46	4					388	394		10.1111/age.12314		7	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CN7VI	WOS:000358641800006		
J	Usui, N; Terada, K; Baba, K; Matsuda, K; Usui, K; Tottori, T; Mihara, T; Inoue, Y				Usui, Naotaka; Terada, Kiyohito; Baba, Koichi; Matsuda, Kazumi; Usui, Keiko; Tottori, Takayasu; Mihara, Tadahiro; Inoue, Yushi			Significance of Very-High-Frequency Oscillations (Over 1,000Hz) in Epilepsy	ANNALS OF NEUROLOGY			English	Article							FOCAL CORTICAL DYSPLASIA; INTRACRANIAL EEG; EPILEPTOGENICITY; DISCHARGES	ObjectiveWe previously reported ictal very-high-frequency oscillations (VHFO) of 1,000 to 2,500Hz recorded by subdural macroelectrodes using a 10-kHz sampling rate. The purpose of this study was to clarify the clinical significance of ictal VHFO in neocortical epilepsy. MethodsThis study included 13 patients with neocortical epilepsy who underwent subdural electrode implantation and had at least 1 seizure recorded at a 10-kHz sampling rate and were followed for more than 2 years postoperatively. Extent of resection was determined considering the seizure onset zone (SOZ) and irritative zone, structural lesion, and functional areas. Areas showing VHFO and those with HFO were not taken into consideration. The presence or absence of VHFO (>1,000Hz), HFO (200-1,000Hz) and SOZ, and completeness of resection of these areas were compared with postoperative seizure outcome. ResultsSeven patients had favorable (Engel class Ia) and 6 had unfavorable outcomes (other classes). VHFO was recorded in 6 of 7 patients with a favorable outcome. On the contrary, VHFO was recorded in only 1 of 6 patients with unfavorable outcome. The presence of VHFO was significantly associated with favorable outcome. VHFO was recorded on a limited number of electrodes, and VHFO-generating areas were resected completely, whereas HFO-generating areas and/or SOZ were not always resected completely in both favorable and unfavorable outcome groups. InterpretationThe presence of ictal VHFO may be predictive of favorable outcome. Ictal VHFO may be a more specific marker than ictal HFO or SOZ for identifying the core of epileptogenic zone. Ann Neurol 2015;78:295-302	[Usui, Naotaka; Terada, Kiyohito; Baba, Koichi; Matsuda, Kazumi; Usui, Keiko; Tottori, Takayasu; Mihara, Tadahiro; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka 4208688, Japan	Usui, N (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Aoi Ku, Urushiyama 886, Shizuoka 4208688, Japan.	n-usui@shizuokamind.org			Japan Epilepsy Research Foundation	This study is supported by the Japan Epilepsy Research Foundation (N.U.).	Urbach H, 2002, EPILEPSIA, V43, P33, DOI 10.1046/j.1528-1157.2002.38201.x; Nagasawa T, 2012, HUM BRAIN MAPP, V33, P569, DOI 10.1002/hbm.21233; Ochi A, 2007, EPILEPSIA, V48, P286, DOI 10.1111/j.1528-1167.2007.00923.x; Akiyama T, 2011, EPILEPSIA, V52, P1802, DOI 10.1111/j.1528-1167.2011.03199.x; PALMINI A, 1995, ANN NEUROL, V37, P476, DOI 10.1002/ana.410370410; Jacobs J, 2010, ANN NEUROL, V67, P209, DOI 10.1002/ana.21847; Jacobs J, 2009, BRAIN, V132, P1022, DOI 10.1093/brain/awn351; FERRER I, 1992, ACTA NEUROPATHOL, V83, P647; MATTIA D, 1995, NEUROLOGY, V45, P1391; Otsubo H, 2008, CLIN NEUROPHYSIOL, V119, P862, DOI 10.1016/j.clinph.2007.12.014; Spreafico R, 1998, NEUROLOGY, V50, P27; Usui N, 2010, CLIN NEUROPHYSIOL, V121, P1825, DOI 10.1016/j.clinph.2010.04.018	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	AUG	2015	78	2					295	302		10.1002/ana.24440		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN5WD	WOS:000358501600013		
J	Talanov, Y; Salakhutdinov, L; Adachi, T; Noji, T; Koike, Y				Talanov, Y.; Salakhutdinov, L.; Adachi, T.; Noji, T.; Koike, Y.			EPR Study of the Local Magnetic Field Distribution over the Bi2Sr2Ca1-x Y (x) Cu2O8+y Crystal Surface above the Superconducting Transition Temperature	APPLIED MAGNETIC RESONANCE			English	Article							T-C; DPPH	The magnetic field distribution on the surface of the high-T-c superconductor crystals Bi2Sr2Ca1-x Y (x) Cu2O8+y has been studied in a wide temperature range using electron paramagnetic resonance (EPR) of the surface probe. The changes of the EPR signal broadening and shift with temperature and the probe-sample distance have been investigated. The analysis of obtained data made it possible to conclude that in the large temperature range above the critical temperature, some of the studied crystals are magnetized inhomogeneously. In the samples underdoped with charge carriers, the range is 40 K. Such samples contain inclusions with diamagnetic and paramagnetic magnetization. They are probably formed due to the electron phase separation.	[Talanov, Y.; Salakhutdinov, L.] Zavoisky Phys Tech Inst, Kazan 420029, Russia; [Adachi, T.] Sophia Univ, Dept Engn & Appl Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Noji, T.; Koike, Y.] Tohoku Univ, Dept Appl Phys, Sendai, Miyagi 9808579, Japan	Talanov, Y (reprint author), Zavoisky Phys Tech Inst, Kazan 420029, Russia.	talanov@kfti.knc.ru			Russian Foundation for Basic Research; Academy of Sciences of the Republic of Tatarstan [13-02-97036]; Russian Academy of Sciences [P-20, OF-3]	This work has been supported in part by the Russian Foundation for Basic Research and the Academy of Sciences of the Republic of Tatarstan (project no. 13-02-97036), and the Russian Academy of Sciences through the programs P-20 and OF-3.	Anderson PW, 2007, NAT PHYS, V3, P160, DOI 10.1038/nphys539; Li L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054510; PRESLAND MR, 1991, PHYSICA C, V176, P95, DOI 10.1016/0921-4534(91)90700-9; Wang Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024510; BONTEMPS N, 1991, PHYS REV B, V43, P11512, DOI 10.1103/PhysRevB.43.11512; Cabo L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184520; Carballeira C, 2003, PHYSICA C, V384, P185, DOI 10.1016/S0921-4534(02)01864-6; Franz M, 2007, NAT PHYS, V3, P686, DOI 10.1038/nphys739; Golmes K.K., 2007, NATURE, V447, P569; Iguchi I, 2001, NATURE, V412, P420, DOI 10.1038/35086540; KHASANOV RI, 1993, PHYSICA C, V218, P51, DOI 10.1016/0921-4534(93)90264-Q; Kittel C., 1971, INTRO SOLID STATE PH; RAKVIN B, 1989, SOLID STATE COMMUN, V72, P199, DOI 10.1016/0038-1098(89)90523-1; Talanov Y, 2011, APPL MAGN RESON, V40, P37, DOI 10.1007/s00723-010-0176-2; Tanabe Y, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.074707; VANGERVE.L, 1967, PHYSICA, V33, P207, DOI 10.1016/0031-8914(67)90273-X; Vander N.S., 1968, VEN PHYS REV, V168, P787; VANITTERBEEK A, 1964, PHYSICA, V30, P157, DOI 10.1016/0031-8914(64)90210-1	18	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	AUG	2015	46	8					897	907		10.1007/s00723-015-0685-0		11	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CN6YO	WOS:000358580600005		
J	Abe, T				Abe, Takayuki			Improved Correction of Residual Intensity Nonuniformity in 2D FLAIR MR Images of Brain at 3-T MRI scanner	APPLIED MAGNETIC RESONANCE			English	Article							AUTOMATIC CORRECTION; INHOMOGENEITY; SEGMENTATION; ROBUST; MODEL; FIELD; ALGORITHMS; ACCURATE	The purpose of this study is to correct residual intensity nonuniformities from B-1 inhomogeneities caused by a birdcage body coil. The proposed method modified existing calibration techniques and effectively combined homomorphic filtering. The causes of the nonuniform residual intensity in the brain magnetic resonance resonance (MRI) were investigated by using actual B-1 field mapping with a birdcage body coil and a local receiver coil. The two B-1 field maps were compared. To estimate a residual intensity nonuniformity distribution map, images with a birdcage body coil and images with a local coil were used. Then, a homomorphic filtering technique was effectively applied to only the image produced using a birdcage body coil. The correction map was calculated from the estimated residual intensity nonuniformity distribution map. The image after correction was evaluated. The B-1+ maps were almost the same for different local coils in the same subjects. The B-1+ maps were the same when a birdcage body coil was used as a receiver coil, regardless of whether the local coil was located in the MR scanner or not. However, the B-1+ maps were significantly different between images produced using a birdcage body coil as a receiver coil and those using a local coil as a receiver. The estimated residual nonuniformity map was estimated. The brain MR images obtained by using the proposed method were more uniform than images with conventional corrections. A novel correction method was developed. It has the potential to improve the diagnosis of brain diseases.	Natl Inst Radiol Sci, Inage, Chiba 2638555, Japan	Abe, T (reprint author), Natl Inst Radiol Sci, 4-9-1 Anagawa, Inage, Chiba 2638555, Japan.	takayuki.abe.mri@gmail.com					Achneider E., 1999, MAGN RESON MED, V18, P335; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Vokurka EA, 1999, JMRI-J MAGN RESON IM, V10, P550, DOI 10.1002/(SICI)1522-2586(199910)10:4<550::AID-JMRI8>3.0.CO;2-Q; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; TINCHER M, 1993, IEEE T MED IMAGING, V12, P361, DOI 10.1109/42.232267; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Belaroussi B, 2006, MED IMAGE ANAL, V10, P234, DOI 10.1016/j.media.2005.09.004; Vaughan JT, 2001, MAGNET RESON MED, V46, P24, DOI 10.1002/mrm.1156; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Freeborough PA, 1997, IEEE T MED IMAGING, V16, P623, DOI 10.1109/42.640753; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Cohen MS, 2000, HUM BRAIN MAPP, V10, P204, DOI 10.1002/1097-0193(200008)10:4<204::AID-HBM60>3.0.CO;2-2; Katscher U, 2006, NMR BIOMED, V19, P393, DOI 10.1002/nbm.1049; Arnold JB, 2001, NEUROIMAGE, V13, P931, DOI 10.1006/nimg.2001.0756; Borlot Felippe, 2011, J Pediatr Neurosci, V6, P48, DOI 10.4103/1817-1745.84408; Collines C.M., 2001, MAGN RESON MED, V27, P684; Gonzales R.C., 1992, DIGITAL IMAGE PROCES; INSKO EK, 1993, J MAGN RESON SER A, V103, P82, DOI 10.1006/jmra.1993.1133; Pasquina M., 2003, EUR J RADIOL, V48, P165; Robitaille P.M., 2007, ULTRAHIGH FIELD MAGN; Wang DM, 2002, MAGN RESON IMAGING, V20, P41, DOI 10.1016/S0730-725X(02)00472-1	29	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	AUG	2015	46	8					941	951		10.1007/s00723-015-0696-x		11	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CN6YO	WOS:000358580600009		
J	Kasai, K; Hashiguchi, K; Takahashi, H; Kasai, A; Takeda, S; Nakano, M; Ishikawa, T; Nakamura, T; Miura, T				Kasai, Kosuke; Hashiguchi, Kenro; Takahashi, Hiroki; Kasai, Ayano; Takeda, Sadanori; Nakano, Manabu; Ishikawa, Takashi; Nakamura, Toshiya; Miura, Tomisato			Recombinant production and evaluation of an antibacterial l-amino acid oxidase derived from flounder Platichthys stellatus	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						L-Amino acid oxidase; Antibacterial protein; Staphylococcus aureus; Platichthys stellatus; Glutathione peroxidase; MRSA	ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SKIN MUCUS; OXIDATIVE STRESS; CELLS; APOPTOSIS; PROTEIN; CLONING; GROWTH; VENOM	Fish produce mucus substances as a defensive outer barrier against several bacterial infections. We have recently identified an antibacterial l-amino acid oxidase (psLAAO1) in the mucus layer of the flounder Platichthys stellate. In this study, the antibacterial protein psLAAO1 was expressed as a secretory bioactive recombinant protein in the methylotrophic yeast Pichia pastoris. The recombinant psLAAO1 inhibited the growth of bacteria to the same levels as native psLAAO1 present in mucus. In particular, Staphylococci and Yersinia were strongly suppressed, showing the highest growth retardation of the 21 species and strains tested. Moreover, Staphylococcus epidermidis was most sensitive to psLAAO1 with a minimum inhibitory concentration (MIC) of 0.078 mu g/mL, whereas Escherichia coli was essentially resistant to psLAAO1 with a MIC of > 10 mu g/mL. Interestingly, psLAAO1-treated E. coli were found to upregulate the expression of the btuE gene, which encodes glutathione peroxidase (GPx). The biochemical function of GPx is to reduce free hydrogen peroxide and is induced under response to reactive oxygen species (ROS). Thus, E. coli confers resistance to the reduced free hydrogen peroxide produced by psLAAO1 by increasing GPx levels. Furthermore, the growth of Staphylococcus aureus was completely inhibited in the presence of recombinant psLAAO1. The morphology of psLAAO1-treated S. aureus showed cell surface damage, the formation of large aggregates and the cells showed severe deformations. Western blot analysis showed that psLAAO1 binds to the surface of S. aureus. Therefore, psLAAO1 binds to the surface of LAAO-sensitive S. aureus and directs peroxidative activity at the surface of the bacterial membrane.	[Kasai, Kosuke; Miura, Tomisato] Hirosaki Univ, Grad Sch Hlth Sci, Dept Pathol Anal, Div Med Life Sci, Hirosaki, Aomori, Japan; [Hashiguchi, Kenro] Yokohama City Univ, Med Ctr, Dept Clin Lab, Yokohama, Kanagawa, Japan; [Takahashi, Hiroki] IROM Co Ltd, Tokyo, Japan; [Kasai, Ayano] Hirosaki Municipal Hosp, Dept Clin Lab, Aomori, Japan; [Takeda, Sadanori] Hirosaki Univ, Sch Hlth Sci, Dept Med Technol, Hirosaki, Aomori, Japan; [Nakano, Manabu; Ishikawa, Takashi; Nakamura, Toshiya] Hirosaki Univ, Grad Sch Hlth Sci, Dept Biomed Sci, Div Med Life Sci, Hirosaki, Aomori, Japan	Miura, T (reprint author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Pathol Anal, Div Med Life Sci, 66-1 Hon Cho, Hirosaki, Aomori, Japan.	tomisato@cc.hirosaki-u.ac.jp	Kasai, Kosuke/F-2147-2013		Hirosaki University	We are grateful to Dr. Mineo Senda and Dr. Yoshimitsu Ohtomo for advice and discussion of this work. We thank Yutaro Takabuchi and Reina Tabata for helpful assistance, and Yusei Tsushima for technical support of the scanning electron microscopy analysis. This work was supported in part by a Hirosaki University Grant for Exploratory Research by Young Scientists.	Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kitani Y, 2008, COMP BIOCHEM PHYS B, V149, P394, DOI 10.1016/j.cbpb.2007.10.013; Zhong SR, 2009, TOXICON, V54, P763, DOI 10.1016/j.toxicon.2009.06.004; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Nagashima Y, 2009, COMP BIOCHEM PHYS B, V154, P55, DOI 10.1016/j.cbpb.2009.05.006; Puiffe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054589; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Vargas LJ, 2013, TOXICON, V64, P1, DOI 10.1016/j.toxicon.2012.11.027; [Anonymous], 2011, BIOCHIMIE, DOI [DOI 10.1016/J.BIOCHI.2011.01.009, 10.1016/J.BIOCHI.2011.01.009]; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Hanane-Fadila ZM, 2014, J BIOCHEM MOL TOXIC, V28, P347, DOI 10.1002/jbt.21571; Ehara T, 2002, FEBS LETT, V531, P509, DOI 10.1016/S0014-5793(02)03608-6; Park WH, 2013, MOL MED REP, V7, P1235, DOI 10.3892/mmr.2013.1303; CLIFFORD DP, 1982, MOL CELL BIOCHEM, V49, P143; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Arenas FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015979; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; Butzke D, 2004, CELL DEATH DIFFER, V11, P608, DOI 10.1038/sj.cdd.4401385; Cha MK, 2004, J BIOL CHEM, V279, P8769, DOI 10.1074/jbc.M312388200; Izidoro L. F., 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/19675424738050, DOI 10.1155/2014/196754]; Kanazawa N, 2004, ARCH BIOCHEM BIOPHYS, V422, P103; Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x; Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x; Lee ML, 2014, INT J MED SCI, V11, P593, DOI 10.7150/ijms.8096; Lee ML, 2011, COMP BIOCHEM PHYS C, V153, P237, DOI 10.1016/j.cbpc.2010.11.001; Macheroux P, 2001, EUR J BIOCHEM, V268, P1679, DOI 10.1046/j.1432-1327.2001.02042.x; Murakawa M, 2001, CELL DEATH DIFFER, V8, P298, DOI 10.1038/sj.cdd.4400811; Nagaoka K, 2009, FASEB J, V23, P2514, DOI 10.1096/fj.08-126466; Okubo BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033639; Sant'Ana CD, 2008, BIOCHEM PHARMACOL, V76, P279, DOI 10.1016/j.bcp.2008.05.003; Zhao Y, 2005, TOXICON, V46, P619, DOI 10.1016/j.toxicon.2005.06.022	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	AUG	2015	99	16					6693	6703		10.1007/s00253-015-6428-1		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CN4DO	WOS:000358380300010		
J	Kitagawa, T; Okita, H; Baron, B; Tokuda, K; Nakamura, M; Wang, YF; Akada, J; Hoshida, H; Akada, R; Kuramitsu, Y; Nakamura, K				Kitagawa, Takao; Okita, Hajime; Baron, Byron; Tokuda, Kazuhiro; Nakamura, Mikiko; Wang, Yufeng; Akada, Junko; Hoshida, Hisashi; Akada, Rinji; Kuramitsu, Yasuhiro; Nakamura, Kazuyuki			Mutant screening for oncogenes of Ewing's sarcoma using yeast	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Ewing's sarcoma; EWS/ETS family; ETS domain; Yeast	DNA-BINDING; SACCHAROMYCES-CEREVISIAE; TUMOR-CELLS; INHIBITION; EXPRESSION; FLI-1; TRANSLOCATION; ACTIVATION; FAMILY; GENE	Many fusion genes, which are the result of chromosomal translocation and work as an oncogene, have been recently identified, but their mode of actions is still unclear. Here, we performed a yeast mutant screening for oncogenes of Ewing's sarcoma to easily identify essential regions responsible for fusion protein functions using a yeast genetic system. Three kinds of oncogenes including EWS/FLI1, EWS/ERG, and EWS/E1AF exhibited growth inhibition in yeast. In this screening, we identified 13 single amino acid substitution mutants which could suppress growth inhibition by oncogenes. All of the point mutation positions of the EWS/ETS family proteins were located within the ETS domain, which is responsible for the interaction with a specific DNA motif. Eight-mutated residues within the ETS domain matched to 13 completely conserved amino acid residues in the human ETS domains. Moreover, mutants also showed reduced transcriptional activities on the DKK2 promoter, which is upregulated by the EWS/ETS family, compared to that of the wild type. These results suggest that the ETS domain in the EWS/ETS family proteins may be a primary target for growth inhibition of Ewing's sarcoma and that this yeast screening system can be applied for the functional screening of the oncogenes.	[Kitagawa, Takao; Baron, Byron; Tokuda, Kazuhiro; Wang, Yufeng; Akada, Junko; Kuramitsu, Yasuhiro] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 7558505, Japan; [Okita, Hajime] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Setagaya Ku, Tokyo 1578535, Japan; [Nakamura, Mikiko] Yamaguchi Univ, Innovat Ctr, Ube, Yamaguchi 7558611, Japan; [Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558611, Japan; [Nakamura, Kazuyuki] Tokuyama Med Assoc Hosp, Ctr Clin Labs, Shunan 7450846, Japan	Kitagawa, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	takao-k@yamaguchi-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	We thank Yukie Misumi for their technical support. The authors would like to acknowledge the utilization of the LAS-1000 and a gift of pGL4.74[hRluc/TK] vector and HEK293 cells from the DNA Core Facility of the Center for Gene Research, Yamaguchi University, supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan.	Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; Hu W, 2005, MOL CELL BIOL, V25, P3087, DOI 10.1128/MCB.25.8.3087-3108.2005; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; MAY WA, 1993, MOL CELL BIOL, V13, P7393; Keppler-Ross S, 2008, GENETICS, V179, P705, DOI 10.1534/genetics.108.087080; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Austhel FM, 1999, SHORT PROTOCOLS MOL; Cha-aim K, 2009, GENE, V434, P43, DOI 10.1016/j.gene.2008.12.014; Dohjima T, 2003, MOL THER, V7, P811, DOI 10.1016/S1525-0016(03)00101-1; Fukunaga T, 2013, YEAST, V30, P243, DOI 10.1002/yea.2957; Hoshida H, 2013, APPL MICROBIOL BIOT, V97, P5473, DOI 10.1007/s00253-012-4582-2; Jaishankar S, 1999, ONCOGENE, V18, P5592, DOI 10.1038/sj.onc.1202940; Kovar Heinrich, 1999, Current Opinion in Oncology, V11, P275, DOI 10.1097/00001622-199907000-00007; MAO XH, 1994, J BIOL CHEM, V269, P18216; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Miyagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004634	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	AUG	2015	99	16					6737	6744		10.1007/s00253-015-6621-2		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CN4DO	WOS:000358380300014		
J	Sasaki, T; Shoho, T; Goto, K; Noda, K; Kawatsuki, N; Ono, H				Sasaki, Tomoyuki; Shoho, Takashi; Goto, Kohei; Noda, Kohei; Kawatsuki, Nobuhiro; Ono, Hiroshi			Photoalignment and resulting holographic vector grating formation in composites of low molecular weight liquid crystals and photoreactive liquid crystalline polymers	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							DIFFRACTION PROPERTIES; POLARIZATION HOLOGRAPHY; PHASE GRATINGS; ALIGNMENT; CELLS	Polarization holographic gratings were formed in liquid crystal (LC) cells fabricated from a mixture of low molecular weight nematic LC and a photoreactive liquid crystalline polymer (PLCP) with 4-(4-methoxycinnamoyloxy)biphenyl side groups. The diffraction properties of the gratings were analyzed using theoretical models which were determined based on the polarization patterns of the polarization holography. The results demonstrated that vector gratings comprised of periodic orientation distributions of the LC molecule were induced in the cells based on the axis-selective photoreaction of the PLCP. The vector gratings were erased by applying a sufficiently high voltage to the cells and then were reformed with no hysteresis after the voltage was removed. This phenomenon suggested that the PLCP molecules were stabilized based on the axis-selective photocrosslink reaction and that the LC molecules were aligned by the photocrosslinked PLCP. This LC composite with axis-selective photoreactivity is useful for various optical applications, because of their stability, transparency, and response to applied voltage.	[Sasaki, Tomoyuki; Shoho, Takashi; Noda, Kohei; Ono, Hiroshi] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan; [Goto, Kohei] Nissan Chem Ind, New Prod Res Dept, Funabashi, Chiba 2740052, Japan; [Kawatsuki, Nobuhiro] Univ Hyogo, Dept Appl Chem, Himeji, Hyogo 6712280, Japan	Sasaki, T (reprint author), Nagaoka Univ Technol, Dept Elect Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	sasaki_tomoy@vos.nagaokaut.ac.jp			JSPS KAKENHI [24760265]	This work was partially supported by JSPS KAKENHI Grant Number 24760265.	Honma M, 2012, OPT EXPRESS, V20, P18449, DOI 10.1364/OE.20.018449; Kawatsuki N, 2002, MACROMOLECULES, V35, P706, DOI 10.1021/ma011439u; Crawford GP, 2005, J APPL PHYS, V98, DOI 10.1063/1.2146075; Hikmet RAM, 1998, NATURE, V392, P476, DOI 10.1038/33110; Kuzuwata M, 2012, OPT LETT, V37, P1115, DOI 10.1364/OL.37.001115; Sasaki T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.042503; Nie XY, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734870; Ichimura K, 2000, CHEM REV, V100, P1847, DOI 10.1021/cr980079e; SCHADT M, 1992, JPN J APPL PHYS 1, V31, P2155, DOI 10.1143/JJAP.31.2155; GIBBONS WM, 1991, NATURE, V351, P49, DOI 10.1038/351049a0; KUMAR GS, 1989, CHEM REV, V89, P1915, DOI 10.1021/cr00098a012; CHEN J, 1995, APPL PHYS LETT, V67, P2588, DOI 10.1063/1.115140; Choi H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2162672; Wang XQ, 2013, OPT LETT, V38, P1775, DOI 10.1364/OL.38.001775; Honma M, 2004, APPL OPTICS, V43, P5193, DOI 10.1364/AO.43.005193; TODOROV T, 1984, APPL OPTICS, V23, P4309; SATO S, 1979, JPN J APPL PHYS, V18, P1679, DOI 10.1143/JJAP.18.1679; CHEN AGS, 1992, OPT LETT, V17, P1231, DOI 10.1364/OL.17.001231; GIBBONS WM, 1994, APPL PHYS LETT, V65, P2542, DOI 10.1063/1.112629; JAKEMAN E, 1972, PHYS LETT A, VA 39, P69, DOI 10.1016/0375-9601(72)90332-5; Lin LC, 2007, OPT EXPRESS, V15, P2900, DOI 10.1364/OE.15.002900; Lin RS, 2007, NANO LETT, V7, P1613, DOI 10.1021/nl070559y; Lo KC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2802568; Nikolova L, 2009, POLARIZATION HOLOGRAPHY, P1, DOI 10.1017/CBO9780511581489; Ono H, 2007, J APPL PHYS, V101, DOI 10.1063/1.2749485; Ono H, 2009, J OPT SOC AM B, V26, P1151, DOI 10.1364/JOSAB.26.001151; Ono H, 2009, APPL OPTICS, V48, P309, DOI 10.1364/AO.48.000309; Park S., 2005, ADV MATER, V17, P1390; Sasaki T, 2007, JPN J APPL PHYS 1, V46, P1579, DOI 10.1143/JJAP.46.1579; Sasaki T, 2008, J APPL PHYS, V104, DOI 10.1063/1.2970172; Sasaki T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2106007; Sasaki T, 2007, JPN J APPL PHYS 1, V46, P698, DOI 10.1143/JJAP.46.698; Scharf T., 2007, POLARIZED LIGHT LIQU; Yeh P., 1999, OPTICS LIQUID CRYSTA	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	AUG	2015	120	2					217	222		10.1007/s00340-015-6124-y		6	Optics; Physics, Applied	Optics; Physics	CN6KV	WOS:000358544600004		
J	Takahashi, K; Katori, M; Naruse, M; Ohtsu, M				Takahashi, Kan; Katori, Makoto; Naruse, Makoto; Ohtsu, Motoichi			Stochastic model showing a transition to self-controlled particle-deposition state induced by optical near-fields	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article								We study a stochastic model for the self-controlled particle-deposition process induced by optical near-fields. This process was experimentally realized by Yukutake et al. on an electrode of a novel photovoltaic device as Ag deposition under light illumination, in which the wavelength of incident light is longer than the long-wavelength cutoff of the materials composing the device. Naruse et al. introduced a stochastic cellular automaton model to simulate underlying nonequilibrium processes which are necessary to formulate unique granular Ag film in this deposition process. In the present paper, we generalize their model and clarify the essential role of optical near-fields generated on the electrode surface. We introduce a parameter b indicating the incident light power per site and a function representing the resonance effect of optical near-fields depending on the Ag-cluster size on the surface. Numerical simulation shows a transition from a trivial particle-deposition state to a nontrivial self-controlled particle-deposition state at a critical value b (c), and only in the latter state optical near-fields are effectively generated. The properties of transition in this mesoscopic surface model in nonequilibrium are studied by the analogy of equilibrium phase transitions associated with critical phenomena, and the criteria of transition are reported.	[Takahashi, Kan; Katori, Makoto] Chuo Univ, Dept Phys, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan; [Naruse, Makoto] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan; [Ohtsu, Motoichi] Univ Tokyo, Grad Sch Engn, Nanophoton Res Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Katori, M (reprint author), Chuo Univ, Dept Phys, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	k-takahashi@phys.chuo-u.ac.jp; katori@phys.chuo-u.ac.jp			Japan Society for the Promotion of Science [15K13374, 26400405]	The present authors would like to thank S. Tojo for useful discussions on the present work. This study is supported by the Grant-in-Aid for Challenging Exploratory Research (No. 15K13374) of Japan Society for the Promotion of Science. MK is supported in part by the Grant-in-Aid for Scientific Research (C) (No. 26400405) of Japan Society for the Promotion of Science.	Tojo S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.012508; Pistol C, 2008, IEEE MICRO, V28, P7, DOI 10.1109/MM.2008.91; Franzl T, 2004, NANO LETT, V4, P1599, DOI 10.1021/nl049322h; Chopard B., 1998, CELLULAR AUTOMATA MO; Kawazoe T, 2011, APPL PHYS B-LASERS O, V104, P747, DOI 10.1007/s00340-011-4596-y; Kobayashi K, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.013806; Mahnke R., 2009, PHYS STOCHASTIC PROC; Marro J., 1999, NONEQUILIBRIUM PHASE; Naruse M, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/5/056401; Naruse M, 2011, APPL PHYS B-LASERS O, V105, P185, DOI 10.1007/s00340-011-4708-8; Naruse M., 2014, NANOPHOTONICS INFORM; Ohtsu M., 2014, DRESSED PHOTONS CONC; Ohtsu M, 2008, IEEE J SEL TOP QUANT, V14, P1404, DOI 10.1109/JSTQE.2008.918110; Yatsui T, 2005, NANO LETT, V5, P2548, DOI 10.1021/nl051898z; Yukutake S, 2010, APPL PHYS B-LASERS O, V99, P415, DOI 10.1007/s00340-010-3999-5	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	AUG	2015	120	2					247	254		10.1007/s00340-015-6130-0		8	Optics; Physics, Applied	Optics; Physics	CN6KV	WOS:000358544600008		
J	Arai, T				Arai, Toshiyasu			Intuitionistic fixed point theories over set theories	ARCHIVE FOR MATHEMATICAL LOGIC			English	Article						Fixed point; Intuitionistic logic; Conservative extension; Strictly positive	CUT-ELIMINATION; INDUCTION	In this paper we show that the intuitionistic fixed point theory FiX (i) (T) over set theories T is a conservative extension of T if T can manipulate finite sequences and has the full foundation schema.	Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Arai, T (reprint author), Chiba Univ, Grad Sch Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	tosarai@faculty.chiba-u.jp					Arai T, 1998, ANN PURE APPL LOGIC, V95, P93, DOI 10.1016/S0168-0072(98)00020-7; [Anonymous], 2010, HDB SET THEORY; Arai T., PROOF THEORY 2 UNPUB; Arai T, 2011, ANN PURE APPL LOGIC, V162, P807, DOI 10.1016/j.apal.2011.03.002; Arai T, 2008, MATH LOGIC QUART, V54, P629, DOI 10.1002/malq.200710067; Arai T, 1998, ARCH MATH LOGIC, V37, P149, DOI 10.1007/s001530050089; Arai T, 2013, J MATH LOG, V13, DOI 10.1142/S0219061313500037; Arai T., 2010, PROOFS CATEGORIES CO, P1; Arai T., 2014, J SYMBOLIC LOGIC, V79, P25; Arai T, 2014, J SYMBOLIC LOGIC, V79, P814, DOI 10.1017/jsl.2014.7; Avigad J, 1996, J SYMBOLIC LOGIC, V61, P768, DOI 10.2307/2275783; Barwise J., 1975, ADMISSIBLE SETS STRU; BEESON M, 1979, PAC J MATH, V84, P1; Buchholz W., 1981, LECT NOTES MATH, V897, P188; Buchholz W, 1997, ARCH MATH LOGIC, V37, P21, DOI 10.1007/s001530050079; Buchholz W., 1991, Archive for Mathematical Logic, V30, DOI 10.1007/BF01621472; FEFERMAN S, 1982, PATR LOG S, V109, P171, DOI 10.1016/S0049-237X(08)71364-8; Mints G.E., 2003, CSLI LECT NOTES, V161, P75; Ruede C, 2002, MATH LOGIC QUART, V48, P195; Takeuti G., 1987, PROOF THEORY	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-5846	1432-0665		ARCH MATH LOGIC	Arch. Math. Log.	AUG	2015	54	5-6					531	553		10.1007/s00153-015-0426-y		23	Mathematics; Logic	Mathematics; Science & Technology - Other Topics	CN6YX	WOS:000358581600004		
J	Sakai, H				Sakai, Hiroshi			Simple proofs of from reflection principles without using better scales	ARCHIVE FOR MATHEMATICAL LOGIC			English	Article						Singular Cardinal Hypothesis; Weak Reflection Principle; Fodor-type Reflection Principle	PROPER FORCING AXIOM; STATIONARY SETS	We give simple proofs of the Singular Cardinal Hypothesis from the Weak Reflection Principle and the Fodor-type Reflection Principle which do not use better scales.	Kobe Univ, Grad Sch Syst Informat, Nada Ku, Kobe, Hyogo 6578501, Japan	Sakai, H (reprint author), Kobe Univ, Grad Sch Syst Informat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	hsakai@people.kobe-u.ac.jp			JSPS; FWF	This research was supported by JSPS and FWF under the Japan-Austria Research Cooperative Program "New Developments regarding Forcing in Set Theory".	Doebler P, 2009, MATH RES LETT, V16, P797; FENG Q, 1992, FUND MATH, V140, P175; FOREMAN M, 1988, ANN MATH, V127, P1, DOI 10.2307/1971415; Fuchino S, 2011, FUND MATH, V212, P261, DOI 10.4064/fm212-3-4; Fuchino S, 2010, TOPOL APPL, V157, P1415, DOI 10.1016/j.topol.2009.04.068; Fuchino S., PREPRINT; Sakai H, 2015, J INST MATH JUSSIEU, V14, P69, DOI 10.1017/S1474748013000315; Shelah S., 1994, OXFORD LOGIC GUIDES, V29; Shelah S, 2008, FUND MATH, V198, P95, DOI 10.4064/fm198-2-1; Shelah S., 1998, PERSPECTIVES MATH LO; Shelah S, 2006, ADV MATH, V199, P185, DOI 10.1016/j.aim.2005.01.012; Silver J., 1975, P INT C MATH VANC BC, V1, P265; Solovay R.M., 1971, P TARSK S P S PUR MA, VXXV, P365; VELICKOVIC B, 1992, ADV MATH, V94, P256, DOI 10.1016/0001-8708(92)90038-M; Viale M, 2006, J SYMBOLIC LOGIC, V71, P473, DOI 10.2178/jsl/1146620153; Viale M, 2011, ADV MATH, V228, P2672, DOI 10.1016/j.aim.2011.07.016; Weiss C, 2012, ANN PURE APPL LOGIC, V163, P1710, DOI 10.1016/j.apal.2011.12.017	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-5846	1432-0665		ARCH MATH LOGIC	Arch. Math. Log.	AUG	2015	54	5-6					639	647		10.1007/s00153-015-0432-0		9	Mathematics; Logic	Mathematics; Science & Technology - Other Topics	CN6YX	WOS:000358581600010		
J	Oka, M; Takegawa, K; Kimura, Y				Oka, Manami; Takegawa, Kaoru; Kimura, Yoshio			Enzymatic characterization of a class II lysyl-tRNA synthetase, LysS, from Myxococcus xanthus	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						Lysyl-tRNA synthetase; Diadenosine tetraphosphate; Diadenosine triphosphate; Myxococcus xanthus	ESCHERICHIA-COLI; ADENYLYLATED NUCLEOTIDES; APPPPA; TETRAPHOSPHATE; TYPHIMURIUM; OXIDATION; STRESS; SITE	Lysyl-tRNA synthetases efficiently produce diadenosine tetraphosphate (ANA) from lysyl-AMP with ATP in the absence of tRNA. We characterized recombinant class II lysyl-tRNA synthetase (LysS) from Myxococcus xanthus and found that it is monomeric and requires Mn2+ for the synthesis of ANA. Surprisingly, Ze(2+) inhibited enzyme activity in the presence of Mn2+. When incubated with ATP, Mn2+, lysine, and inorganic pyrophosphatase, LysS first produced ANA and ADP, then converted ANA to diadenosine triphosphate (Ap(3)A), and finally converted Ap(3)A to ADP, the end product of the reaction. Recombinant LysS retained ANA synthase activity without lysine addition. Additionally, when incubated with ANA (minus pyrophosphatase), LysS converted AP(4)A mainly ATP and AMP, or ADP in the presence or absence of lysine, respectively. These results demonstrate that M. xanthus LysS has different enzymatic properties from class II lysyl-tRNA synthetases previously reported. (C) 2015 Elsevier Inc. All rights reserved.	[Oka, Manami; Kimura, Yoshio] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 76107, Japan; [Takegawa, Kaoru] Kyushu Univ, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka, Japan	Kimura, Y (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 76107, Japan.	kimura@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25440087]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25440087).	Wright M, 2006, FEBS J, V273, P3534, DOI 10.1111/j.1742-4658.2006.05361.x; Kisselev LL, 1998, FEBS LETT, V427, P157, DOI 10.1016/S0014-5793(98)00420-7; GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; BLANQUET S, 1983, MOL CELL BIOCHEM, V52, P3; Blanquet S., 2005, AMINOACYL TRNA SYNTH, P227; BOCHNER BR, 1984, CELL, V37, P225, DOI 10.1016/0092-8674(84)90318-0; BREVET A, 1995, J BIOL CHEM, V270, P14439; [陈晓龙 Chen Xiaolong], 2013, [生物物理学报, Acta Biophysica Sinica], V29, P35; Chen XL, 2013, FEBS J, V280, P102, DOI 10.1111/febs.12053; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Desogus G, 2000, BIOCHEMISTRY-US, V39, P8418, DOI 10.1021/bi0006722; DIBBELT L, 1980, NUCLEIC ACIDS RES, V8, P4021, DOI 10.1093/nar/8.17.4021; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Guo RT, 2009, J BIOL CHEM, V284, P28968, DOI 10.1074/jbc.M109.030692; Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200; LEE PC, 1983, J BIOL CHEM, V258, P6827; LEVEQUE F, 1991, J BACTERIOL, V173, P7903; LEVEQUE F, 1990, NUCLEIC ACIDS RES, V18, P305, DOI 10.1093/nar/18.2.305	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	AUG 1	2015	579						33	39		10.1016/j.abb.2015.05.014		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CN6NR	WOS:000358552000005		
J	Matsuda, M; Kono, A				Matsuda, Mitsunobu; Kono, Ayumi			Development and Evaluation of a Psychoeducation Practitioner Training Program (PPTP)	ARCHIVES OF PSYCHIATRIC NURSING			English	Article							CONTROLLED-TRIAL; CHINESE PATIENTS; SCHIZOPHRENIA	The objective of this study was to develop a psychoeducation practitioner training program (PPTP) and to evaluate its usefulness with regard to nursing competencies (knowledge, self-efficacy, attitude, motivation, skills). A mixed-method research design was applied in this study. Some of the quantitative data were a one-group pretest-posttest study. Forty nurses participated in the PPTP, of whom 38 (17 men and 21 women) completed a 2-consecutive-day curriculum (dropout rate: 5%). The PPTP significantly improved nurses' knowledge of, self-efficacy for, and attitude toward psychoeducation. However, the program did not lead to the acquisition of psychoeducational skills. (C) 2015 Elsevier Inc. All rights reserved.	[Matsuda, Mitsunobu] Osaka City Univ, Psychiat & Mental Hlth Nursing, Grad Sch Nursing, Osaka 5450051, Japan; [Kono, Ayumi] Send Kinran Univ, Sch Nursing, Psychiat & Mental Hlth Nursing, Osaka, Japan	Matsuda, M (reprint author), Osaka City Univ, Psychiat & Mental Hlth Nursing, Grad Sch Nursing, Abeno Ku, 1-5-17 Asahi Machi, Osaka 5450051, Japan.	matsuda.mitsunobu@nurs.osaka-cu.ac.jp			Ministry of Education Culture, Sports, Science and Technology of Japan [23593486]	This research was funded by Grants-in-Aid for Scientific Research (C) from the Ministry of Education Culture, Sports, Science and Technology of Japan (no.23593486). A part of this research received the 2014 Best Research Poster Award by the International Society of Psychiatric-Mental Health Nurses.	Aarons Gregory A, 2004, Ment Health Serv Res, V6, P61, DOI 10.1023/B:MHSR.0000024351.12294.65; Aguglia E., 2007, CLIN PRACT EPID MENT, V3, P1; Aho-Mustonen K, 2011, CRIM BEHAV MENT HEAL, V21, P163, DOI 10.1002/cbm.788; Bandura A., 1995, SELF EFFICACY CHANGI; Bechdolf A, 2010, AUST NZ J PSYCHIAT, V44, P144, DOI 10.3109/00048670903393571; Chadzynska M., 2011, ARCH PSYCHIAT PSYCHO, V13, P67; Chien WT, 2013, INT J NURS PRACT, V19, P3, DOI 10.1111/ijn.12015; Chien WT, 2013, PSYCHIAT SERV, V64, P376, DOI 10.1176/appi.ps.002092012; Cynthia C. B., 2012, PSYCHIAT ANN, V42, P205; Defloor T, 2006, J ADV NURS, V56, P669, DOI 10.1111/j.1365-2648.2006.04038.x; Donna R. F., 2011, EFFECTIVE PATIENT ED, Vfourth, P193; Hayama Y., 2002, JAPANESE J CLIN PSYC, V31, P681; Health Labour and Welfare Statistics Association, 2014, J HLTH WELFARE STAT, V61, P477; Holmes H, 1994, Issues Ment Health Nurs, V15, P85, DOI 10.3109/01612849409074937; KISSLING W, 1991, CLIN NEUROPHARMACOL, V14, pS33; Maeda M., 1992, JPN J CLIN PSYCHIAT, V21, P1195; Matsuda M., 2008, NURSE LED VERSION PS; Matsunami M., 2011, Tohoku Journal of Crop Science, P15; Ministry of Health labour and Welfare, 2009, M FUT MENT HLTH WELF; Okumura Y., 2010, SEISHIN IGAKU, V52, P79; Peldcala E. T., 2009, COCHRANE DATABASE SY; Pitschel-Walz G, 2006, J CLIN PSYCHIAT, V67, P443; Renri T., 1995, SEISHIN IGAKU, V37, P1031; Sakano Y, 1989, WASEDA J HUMAN SCI, V2, P91; Sano A., 2005, J JAPAN SOC NRUSING, V7, P9; Shin SK, 2002, PSYCHIATR SERV, V53, P1125, DOI 10.1176/appi.ps.53.9.1125; Xia J, 2011, SCHIZOPHRENIA BULL, V37, P21, DOI 10.1093/schbul/sbq138	27	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9417	1532-8228		ARCH PSYCHIAT NURS	Arch. Psychiatr. Nurs.	AUG	2015	29	4					217	222		10.1016/j.apnu.2015.03.002		6	Nursing; Psychiatry	Nursing; Psychiatry	CN4KB	WOS:000358397900006		
J	Oiwa, H				Oiwa, Hiroshi			Lymphoma Risk in Japanese Patients With Rheumatoid Arthritis: Comment on the Article by Kameda et al	ARTHRITIS CARE & RESEARCH			English	Letter							POSTMARKETING SURVEILLANCE; METHOTREXATE; ASSOCIATION; SAFETY		Hiroshima City Hosp, Hiroshima, Japan	Oiwa, H (reprint author), Hiroshima City Hosp, Hiroshima, Japan.						Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Visser K, 2009, ANN RHEUM DIS, V68, P1094, DOI 10.1136/ard.2008.092668; Kameda T, 2014, ARTHRIT CARE RES, V66, P1302, DOI 10.1002/acr.22306; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Koike T, 2009, J RHEUMATOL, V36, P898, DOI 10.3899/jrheum.080791	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2151-464X	2151-4658		ARTHRIT CARE RES	Arthritis Care Res.	AUG	2015	67	8					1186	1186		10.1002/acr.22568		1	Rheumatology	Rheumatology	CN7LW	WOS:000358617000019		
J	Tsuda, R; Ozawa, T; Kobayashi, E; Hamana, H; Taki, H; Tobe, K; Sugiyama, E; Iwamoto, M; Imura, J; Kishi, H; Muraguchi, A				Tsuda, Reina; Ozawa, Tatsuhiko; Kobayashi, Eiji; Hamana, Hiroshi; Taki, Hirofumi; Tobe, Kazuyuki; Sugiyama, Eiji; Iwamoto, Masahiro; Imura, Johji; Kishi, Hiroyuki; Muraguchi, Atsushi			Monoclonal Antibody Against Citrullinated Peptides Obtained From Rheumatoid Arthritis Patients Reacts With Numerous Citrullinated Microbial and Food Proteins	ARTHRITIS & RHEUMATOLOGY			English	Article							SHARED EPITOPE ALLELES; MICROWELL-ARRAY CHIP; ALPHA-ENOLASE; SINGLE-CELL; B-CELLS; ANTIFILAGGRIN AUTOANTIBODIES; PEPTIDYLARGININE DEIMINASE; PORPHYROMONAS-GINGIVALIS; ANTIKERATIN ANTIBODIES; PERIPHERAL-BLOOD	Objective. To investigate the reactivity of monoclonal anti-citrullinated protein antibody (ACPA) obtained from peripheral blood B cells of rheumatoid arthritis (RA) patients with human autoantigens as well as environmental proteins by determining the essential epitope for the ACPA. Methods. A human monoclonal ACPA (cyclic citrullinated peptide antibody 1 [CCP-Ab1]) was obtained by screening peripheral blood lymphocytes from 31 patients with RA using a novel monoclonal antibody-secreting cell (ASC) screening system, the immunospotarray assay on a chip. The essential epitope for CCP-Ab1 was determined using epitope mapping. Then, human, microbial, and plant proteins that share the essential epitope identified were searched using BLAST. Finally, representative proteins identified by the search were produced in vitro, and their reactivity with CCP-Ab1 was examined. Results. CCP-Ab1 bound CCP in a citrulline-indispensable manner. In CCP, the 6 amino acid residues required for CCP-Ab1 binding were identified. In the BLAST search, 38 human, 56 viral, 1,383 fungal, 547 bacterial, and 1,072 plant proteins were found to share the essential epitope, and CCP-Ab1 reacted with all of the recombinant citrullinated proteins tested, which included the various environmental factors, such as various plant proteins that are part of the daily diet. Conclusion. Our findings demonstrate, for the first time, that a monoclonal ACPA (CCP-Ab1) derived from RA patients cross-reacts not only with various autoantigens but also with numerous plant and microbial proteins. We propose that countless environmental factors, including microbes and diet, may trigger the generation of ACPAs that then cross-react with various citrullinated human autoantigens through molecular mimicry to induce RA.	[Imura, Johji; Kishi, Hiroyuki; Muraguchi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Iwamoto, Masahiro] Jichi Med Univ, Shimotsuke, Tochigi, Japan	Kishi, H (reprint author), Toyama Univ, Dept Immunol, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	immkishi@med.u-toyama.ac.jp	Taki, Hirofumi/I-6284-2012		Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan [MEXT] (KAKENHI) [20591167]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Santen Pharmaceutical; Mitsubishi Tanabe Pharma; AbbVie; Takeda Pharmaceutical; Daiichi Sankyo; Astellas; Pfizer; Ono Pharmaceutical	Supported by the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology, Japan [MEXT] (KAKENHI Grant-in-Aid for Scientific Research 20591167), the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Hokuriku Innovation Cluster for Health Science Program funding and the Platform for Drug Discovery, Informatics, and Structural Life Science Program funding), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Kanae Foundation for the Promotion of Medical Science.; Drs. Ozawa, Kishi, and Muraguchi have a patent application pending for CCP-Ab1 (JP2014-162772A). Dr. Sugiyama has received speaking fees from Santen Pharmaceutical, Mitsubishi Tanabe Pharma, AbbVie, Takeda Pharmaceutical, and Daiichi Sankyo (less than $10,000 each). Dr. Iwamoto has received speaking fees from Astellas, Pfizer, Mitsubishi Tanabe Pharma, and Ono Pharmaceutical (less than $10,000 each) and receives royalties from Chugai for tocilizumab.	McGraw WT, 1999, INFECT IMMUN, V67, P3248; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177; Carmona L, 2010, BEST PRACT RES CL RH, V24, P733, DOI 10.1016/j.berh.2010.10.001; Jin A, 2011, NAT PROTOC, V6, P668, DOI 10.1038/nprot.2011.322; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Hill JA, 2003, J IMMUNOL, V171, P538; Amara K, 2013, J EXP MED, V210, P445, DOI 10.1084/jem.20121486; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Verpoort KN, 2007, ARTHRITIS RHEUM, V56, P3949, DOI 10.1002/art.23127; CZERKINSKY C, 1987, P NATL ACAD SCI USA, V84, P2449, DOI 10.1073/pnas.84.8.2449; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Willemze A, 2012, ANN RHEUM DIS, V71, P268, DOI 10.1136/annrheumdis-2011-200421; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Auger I, 2005, ARTHRITIS RHEUM, V52, P3424, DOI 10.1002/ART.21391; Kobayashi E, 2013, NAT MED, V19, P1542, DOI 10.1038/nm.3358; Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Saal JG, 1999, ARTHRITIS RHEUM, V42, P1485, DOI 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Nielen MMJ, 2004, ARTHRITIS RHEUM, V50, P380, DOI 10.1002/art.20018; Berglin E, 2004, ARTHRITIS RES THER, V6, pR303, DOI 10.1186/ar1187; Sebbag M, 2006, EUR J IMMUNOL, V36, P2250, DOI 10.1002/eji.200535790; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; SEBBAG M, 1995, J CLIN INVEST, V95, P2672, DOI 10.1172/JCI117969; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Lundberg K, 2008, ARTHRITIS RHEUM, V58, P3009, DOI 10.1002/art.23936; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; SIMON M, 1993, J CLIN INVEST, V92, P1387, DOI 10.1172/JCI116713; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bizzaro N, 2001, CLIN CHEM, V47, P1089; Harre U, 2014, CURR OSTEOPOROS REP, V12, P17, DOI 10.1007/s11914-013-0185-9; Karlson EW, 2014, RHEUMATOLOGY OXFORD; Kokkonen H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3237; Ozawa T, 2006, BIOTECHNIQUES, V40, P469, DOI 10.2144/000112123; Ozawa T, 2009, LAB CHIP, V9, P158, DOI 10.1039/b810438g; Ozawa T, 2011, ANTIVIR RES, V91, P283, DOI 10.1016/j.antiviral.2011.06.012; Pratesi F, 2006, ARTHRITIS RHEUM, V54, P733, DOI 10.1002/art.21629; Tajiri K, 2007, CYTOM PART A, V71A, P961, DOI 10.1002/cyto.a.20471; Tokilmitsu Y, 2007, CYTOM PART A, V71A, P1003, DOI 10.1002/cyto.a.20478; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM, V54, P1117, DOI 10.1002/art.21739; VansGaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113; VansVenrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391; vansVenrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1050	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	AUG	2015	67	8					2020	2031		10.1002/art.39161		12	Rheumatology	Rheumatology	CN7JA	WOS:000358609300006		
J	Terao, C; Suzuki, A; Ikari, K; Kochi, Y; Ohmura, K; Katayama, M; Nakabo, S; Yamamoto, N; Suzuki, T; Iwamoto, T; Yurugi, K; Miura, Y; Maekawa, T; Takasugi, K; Kubo, M; Saji, H; Taniguchi, A; Momohara, S; Yamamoto, K; Yamanaka, H; Mimori, T; Matsuda, F				Terao, Chikashi; Suzuki, Akari; Ikari, Katsunori; Kochi, Yuta; Ohmura, Koichiro; Katayama, Masaki; Nakabo, Shuichiro; Yamamoto, Natsuki; Suzuki, Taku; Iwamoto, Takuji; Yurugi, Kimiko; Miura, Yasuo; Maekawa, Taira; Takasugi, Kiyoshi; Kubo, Michiaki; Saji, Hiroh; Taniguchi, Atsuo; Momohara, Shigeki; Yamamoto, Kazuhiko; Yamanaka, Hisashi; Mimori, Tsuneyo; Matsuda, Fumihiko			An Association Between Amino Acid Position 74 of HLA-DRB1 and Anti-Citrullinated Protein Antibody Levels in Japanese Patients With Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							PEPTIDE ANTIBODY; SHARED EPITOPE; ALLELES; HLA; STRATIFICATION; CLASSIFICATION; SUSCEPTIBILITY; DETERMINANTS; POPULATION; CRITERIA	Objective. Anti-citrullinated protein antibodies (ACPAs) are highly specific to rheumatoid arthritis (RA), and strong associations between HLA-DRB1 alleles and ACPA levels have been detected in RA patients. We undertook this study to elucidate the associations between particular amino acid positions in HLA-DRB1 and ACPA levels in patients with RA. Methods. We analyzed ACPA data on a total of 4,371 Japanese ACPA-positive RA patients in whom HLA-DRB1 allele genotyping had been performed. Generalized linear regression analysis and omnibus testing were carried out to determine associations of HLA-DRB1 alleles, amino acid residues, or amino acid positions with levels of ACPA. Results. HLA-DRB1*09:01 and HLA-DR15 were confirmed to be associated with ACPA levels. HLA-DRB1*08:03 and DRB1*14:06 were associated with reduced and increased ACPA levels, respectively. We detected a strong association between ACPA levels and amino acid position 74 (P = 1.9 x 10(-51)). The association was mainly conferred by alanine residue (P = 4.5 x 10(-51)). After adjustment for position 74, amino acid positions 60 and 57 were found to be associated with ACPA levels. Amino acid positions 74 and 57 had previously been reported to be associated with susceptibility to ACPA-positive RA in Asians. Combinations of the amino acid residues at position 74 and position 60 or 57 could induce improvement in Akaike's information criterion comparable to that induced by the 5 significant HLA-DRB1 alleles (HLA-DRB1*08:03, DRB1*09:01, DRB1*14:06, DRB1*15:01, and DRB1*15:02). Conclusion. Amino acid position 74 in HLA-DRB1 is strongly associated with ACPA levels in ACPA-positive RA, as well as with RA susceptibility. The mechanisms of ACPA production and susceptibility to ACPA-positive RA seem to partly overlap.	[Terao, Chikashi; Ohmura, Koichiro; Katayama, Masaki; Nakabo, Shuichiro; Yamamoto, Natsuki; Mimori, Tsuneyo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan; [Suzuki, Akari; Kochi, Yuta; Kubo, Michiaki] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Ikari, Katsunori; Suzuki, Taku; Iwamoto, Takuji; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Tokyo, Japan; [Yurugi, Kimiko; Miura, Yasuo; Maekawa, Taira] Kyoto Univ Hosp, Kyoto 606, Japan; [Takasugi, Kiyoshi] Dohgo Spa Hosp, Matsuyama, Ehime, Japan; [Saji, Hiroh] HLA Lab, Kyoto, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Sci, Tokyo 113, Japan; [Matsuda, Fumihiko] INSERM, U852, Kyoto, Japan; [Matsuda, Fumihiko] Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama, Japan	Terao, C (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Sakyo Ku, Shogoin Kawahara Cho 54, Kyoto 6068507, Japan.	a0001101@kuhp.kyoto-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Rheumatism Foundation; Waksman Foundation; Mitsubishi Pharma Research Foundation; UCB; Pfizer; Chugai; Eisai; Bristol-Myers Squibb; Boehringer Ingelheim; Astellas; AbbVie; Janssen; Asahi Kasei; Santen; Ono Pharmaceutical; Daiichi Sankyo; Teijin; AstraZeneca; Mitsubishi Tanabe; Nippon Kayaku; Takeda; Nippon Shinyaku	Supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by research grants from the Japan Rheumatism Foundation, the Waksman Foundation, and the Mitsubishi Pharma Research Foundation.; Dr. K. Yamamoto has received consulting fees, speaking fees, and/or honoraria from UCB, Pfizer, Chugai, Eisai, Bristol-Myers Squibb, and Boehringer Ingelheim (less than $10,000 each) and from Astellas, AbbVie, Janssen, Asahi Kasei, Santen, Ono Pharmaceutical, Daiichi Sankyo, Teijin, AstraZeneca, Mitsubishi Tanabe, Nippon Kayaku, Takeda, and Nippon Shinyaku (more than $10,000 each).	Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; Kroot EJJA, 2000, ARTHRITIS RHEUM, V43, P1831, DOI 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Lundberg K, 2013, ANN RHEUM DIS, V72, P652, DOI 10.1136/annrheumdis-2012-201484; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Irigoyen P, 2005, ARTHRITIS RHEUM, V52, P3813, DOI 10.1002/art.21419; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Mackie SL, 2012, GENES IMMUN, V13, P120, DOI 10.1038/gene.2011.60; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI 10.1093/nar/GKG070; Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Laki J, 2012, ARTHRITIS RHEUM-US, V64, P2078, DOI 10.1002/art.34421; Terao C, 2012, ANN RHEUM DIS, V71, P1095, DOI 10.1136/annrheumdis-2011-200907; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bizzaro N, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4148; Burnham K. P., 2002, MODEL SELECTION MULT; Cui J, 2009, MOL MED, V15, P136, DOI 10.2119/molmed.2009.00008; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Freed BM, 2011, ARTHRITIS RHEUM-US, V63, P3733, DOI 10.1002/art.30636; Gardette A, 2014, JOINT BONE SPINE, V81, P416, DOI 10.1016/j.jbspin.2014.06.001; Okada Y, 2010, ANN RHEUM DIS, V69, P1569, DOI 10.1136/ard.2009.118018; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Terao C, 2013, RHEUMATOLOGY, V52, P1769, DOI 10.1093/rheumatology/ket241; Terao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020457; Terao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040067	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	AUG	2015	67	8					2038	2045		10.1002/art.39133		8	Rheumatology	Rheumatology	CN7JA	WOS:000358609300008		
J	Fujimoto, M; Serada, S; Suzuki, K; Nishikawa, A; Ogata, A; Nanki, T; Hattori, K; Kohsaka, H; Miyasaka, N; Takeuchi, T; Naka, T				Fujimoto, Minoru; Serada, Satoshi; Suzuki, Katsuya; Nishikawa, Ayumi; Ogata, Atsushi; Nanki, Toshihiro; Hattori, Kunihiro; Kohsaka, Hitoshi; Miyasaka, Nobuyuki; Takeuchi, Tsutomu; Naka, Tetsuji			Leucine-Rich alpha(2)-Glycoprotein as a Potential Biomarker for Joint Inflammation During Anti-Interleukin-6 Biologic Therapy in Rheumatoid Arthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; EULAR RECOMMENDATIONS; ALPHA-2 GLYCOPROTEIN; DISEASE; TOCILIZUMAB; MANAGEMENT; ANTIBODY	Objective. To investigate whether leucine-rich alpha(2)-glycoprotein (LRG) could be a biomarker for disease activity during interleukin-6 (IL-6) blockade treatment of rheumatoid arthritis (RA). Methods. In 59 RA patients who were treated with tocilizumab for 24 weeks, serum LRG levels were determined by enzyme-linked immunosorbent assay. RA disease activity was evaluated by the Clinical Disease Activity Index (CDAI). Receiver operating characteristic (ROC) curve analysis was used to examine the diagnostic performance of LRG and other biomarkers. In monkeys with experimental autoimmune arthritis, swollen joint counts, joint pathologic changes, and blood levels of C-reactive protein (CRP) and LRG were evaluated after treatment with anti-IL-6 receptor antibody. Results. Among tocilizumab-treated RA patients, those with active disease (CDAI >2.8) had significantly higher serum LRG levels compared to those whose disease was in remission. ROC curve analysis suggested that the LRG level was more useful than the CRP or matrix metalloproteinase 3 level or the erythrocyte sedimentation rate in discriminating between remission and active disease during therapy with tocilizumab. In monkeys treated with IL-6 blockade, joint scores were more closely correlated with LRG levels than with CRP levels. Histologic analysis of joints revealed that LRG levels correlated significantly with granulomatous tissue formation, cartilage degeneration, and bone destruction in IL-6 blockade-treated monkeys with low levels of CRP. Conclusion. Under conditions of IL-6 inhibition, LRG was more useful than other biomarkers in discriminating between active and inactive disease in human RA and in detecting joint inflammation in experimental arthritis. LRG may serve as a convenient biomarker for RA disease activity during IL-6 blockade treatment.	[Fujimoto, Minoru; Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat, Ibaraki, Osaka 5670085, Japan; [Suzuki, Katsuya; Nishikawa, Ayumi; Takeuchi, Tsutomu] Keio Univ, Sch Med, Tokyo, Japan; [Ogata, Atsushi] Osaka Univ, Grad Sch Med, Osaka, Japan; [Nanki, Toshihiro; Kohsaka, Hitoshi; Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Tokyo, Japan; [Nanki, Toshihiro] Teikyo Univ, Tokyo 173, Japan; [Hattori, Kunihiro] Chugai Pharmaceut, Gotemba, Japan	Naka, T (reprint author), Natl Inst Biomed Innovat, Lab Immune Signal, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	tnaka@nibiohn.go.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Ministry of Health, Labor, and Welfare of Japan (Health and Labor Sciences Research Grant for Research on Development of New Drugs [H24-bio-ippan-002]; Abbott Japan; Bristol-Myers K.K.; Pfizer Japan; Mitsubishi Tanabe Pharma; Chugai Pharmaceutical; Astellas Pharma; Janssen Pharmaceutical K.K.; Santen Pharmaceutical; UCB Japan; Eisai; Takeda Pharmaceutical; Daiichi Sankyo; AbbVie; Ono Pharmaceutical; Teijin Pharma; Eli Lilly Japan K.K.; Asahi Kasei Pharma; Novartis Pharma K.K; Asahi Kasei Medical K.K.; Astra Zeneca K.K.; Celtrion; Nipponkayaku; Novartis Pharma K.K.; Santen; Pharmaceutical; SymBio Pharmaceutical; Taisho Toyama Pharmaceutical; Mitsubishi Tanabe Pharm	Supported by the Ministry of Health, Labor, and Welfare of Japan (Health and Labor Sciences Research Grant for Research on Development of New Drugs H24-bio-ippan-002).; Dr. Ogata has received consulting fees, speaking fees, and/or honoraria from Abbott Japan, Bristol-Myers K.K., Pfizer Japan, and Mitsubishi Tanabe Pharma (less than $10,000 each) and Chugai Pharmaceutical (more than $10,000). Dr. Nanki has received consulting fees, speaking fees, and/or honoraria from Astellas Pharma, Janssen Pharmaceutical K.K., Santen Pharmaceutical, UCB Japan, Mitsubishi Tanabe Pharma, Eisai, Takeda Pharmaceutical, Daiichi Sankyo, Bristol-Myers K.K., and AbbVie (less than $10,000 each) and Chugai Pharmaceutical (more than $10,000), and research grants from Mitsubishi Tanabe Pharma, Eisai, Takeda Pharmaceutical, Ono Pharmaceutical, Daiichi Sankyo, Teijin Pharma, Eli Lilly Japan K.K., Bristol-Myers K.K., AbbVie, and Chugai Pharmaceutical. Dr. Kohsaka has received consulting fees, speaking fees, and/or honoraria from Teijin Pharma, Chugai Pharmaceutical, Mitsubishi Tanabe Pharma, Takeda Pharmaceutical, AbbVie, Ono Pharmaceutical, UCB Japan, Astellas Pharma, and Asahi Kasei Pharma (less than $10,000 each). Dr. Miyasaka has received consulting fees, speaking fees, and/or honoraria from Eisai (more than $10,000) and research grants from Abbott Japan, Astellas Pharma, Bristol-Myers K.K., Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Mitsubishi Tanabe Pharma, Novartis Pharma K.K, and Takeda Pharmaceutical. Dr. Takeuchi has received consulting fees, speaking fees, and/or honoraria from AbbVie, Asahi Kasei Medical K.K., Astellas Pharma, Astra Zeneca K.K., Bristol-Myers K.K., Celtrion, Chugai Pharmaceutical, Daiichi Sankyo, Elisai, Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma, Nipponkayaku, Novartis Pharma K.K., Pfizer Japan, and Takeda Pharmaceutical (less than $10,000 each) and research grants from AbbVie, Asahi Kasei Pharma, Astellas Pharma, Bristol-Myers K.K., Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Mitsubishi Tanabe Pharma, Pfizer Japan, Santen, Pharmaceutical, Takeda Pharmaceutical, Teijin Pharma, SymBio Pharmaceutical, and Taisho Toyama Pharmaceutical. Dr. Naka has received research grants from Chugai Pharmaceutical.	Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Gabay C, 1999, NEW ENGL J MED, V340, P448; Kato A, 2008, EXP MOL PATHOL, V84, P262, DOI 10.1016/j.yexmp.2008.03.003; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; Serada S, 2012, INFLAMM BOWEL DIS, V18, P2169, DOI 10.1002/ibd.22936; Sharif M, 1998, ARTHRITIS RHEUM, V41, P1203, DOI 10.1002/1529-0131(199807)41:7<1203::AID-ART9>3.0.CO;2-2; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Tanaka T, 2013, RHEUMATOLOGY SUNNYVA; Uchiyama Y, 2008, BIOL PHARM BULL, V31, P1159, DOI 10.1248/bpb.31.1159	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	AUG	2015	67	8					2056	2060		10.1002/art.39164		5	Rheumatology	Rheumatology	CN7JA	WOS:000358609300010		
J	Akasaki, Y; Reixach, N; Matsuzaki, T; Alvarez-Garcia, O; Olmer, M; Iwamoto, Y; Buxbaum, JN; Lotz, MK				Akasaki, Yukio; Reixach, Natalia; Matsuzaki, Tokio; Alvarez-Garcia, Oscar; Olmer, Merissa; Iwamoto, Yukihide; Buxbaum, Joel N.; Lotz, Martin K.			Transthyretin Deposition in Articular Cartilage: A Novel Mechanism in the Pathogenesis of Osteoarthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							GLYCATION END-PRODUCTS; SENILE SYSTEMIC AMYLOIDOSIS; CARPAL-TUNNEL-SYNDROME; CHONDROITIN SULFATE; BILATERAL CARPAL; SYNOVIAL-FLUID; KNEE-JOINT; IN-VITRO; RECEPTOR; CHONDROCYTES	Objective. Amyloid deposits are prevalent in osteoarthritic (OA) joints. We undertook this study to define the dominant precursor and to determine whether the deposits affect chondrocyte functions. Methods. Amyloid deposition in human normal and OA knee cartilage was determined by Congo red staining. Transthyretin (TTR) in cartilage and synovial fluid was analyzed by immunohistochemistry and Western blotting. The effects of recombinant amyloidogenic and nonamyloidogenic TTR variants were tested in human chondrocyte cultures. Results. Normal cartilage from young donors did not contain detectable amyloid deposits, but 7 of 12 aged normal cartilage samples (58%) and 12 of 12 OA cartilage samples (100%) had Congo red staining with green birefringence under polarized light. TTR, which is located predominantly at the cartilage surfaces, was detected in all OA cartilage samples and in a majority of aged normal cartilage samples, but not in normal cartilage samples from young donors. Chondrocytes and synoviocytes did not contain significant amounts of TTR messenger RNA. Synovial fluid TTR levels were similar in normal and OA knees. In cultured chondrocytes, only an amyloidogenic TTR variant induced cell death as well as the expression of proinflammatory cytokines and extracellular matrix-degrading enzymes. The effects of amyloidogenic TTR on gene expression were mediated in part by Toll-like receptor 4, receptor for advanced glycation end products, and p38 MAPK. TTR-induced cytotoxicity was inhibited by resveratrol, a plant polyphenol that stabilizes the native tetrameric structure of TTR. Conclusion. These findings are the first to suggest that TTR amyloid deposition contributes to cell and extracellular matrix damage in articular cartilage in human OA and that therapies designed to reduce TTR amyloid formation might be useful.	[Akasaki, Yukio; Reixach, Natalia; Matsuzaki, Tokio; Alvarez-Garcia, Oscar; Olmer, Merissa; Buxbaum, Joel N.; Lotz, Martin K.] Scripps Res Inst, La Jolla, CA 92037 USA; [Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan	Lotz, MK (reprint author), Scripps Res Inst, Dept Mol & Expt Med, MEM-161,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	mlotz@scripps.edu			NIH [AG-032285, AG-007996]; Sam and Rose Stein Endowment Fund	Supported by the NIH (grants AG-032285 to Dr. Reixach and AG-007996 to Dr. Lotz) and the Sam and Rose Stein Endowment Fund.	Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Steenvoorden MMC, 2006, ARTHRITIS RHEUM, V54, P253, DOI 10.1002/art.21523; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Akasaki Y, 2014, OSTEOARTHR CARTILAGE, V22, P162, DOI 10.1016/j.joca.2013.11.004; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Sekijima Y, 2011, HUM PATHOL, V42, P1785, DOI 10.1016/j.humpath.2011.03.004; Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Bank RA, 1998, BIOCHEM J, V330, P345; Sousa MM, 2001, J NEUROSCI, V21, P7576; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Teng MH, 2001, LAB INVEST, V81, P385; Anoopkumar-Dukie S, 2005, BRIT J RADIOL, V78, P945, DOI 10.1259/bjr/54004230; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Buxbaum JN, 2012, FASEB J, V26, P2283, DOI 10.1096/fj.11-189571; Sousa MM, 2001, AM J PATHOL, V159, P1993; Rappley I, 2014, BIOCHEMISTRY-US, V53, P1993, DOI 10.1021/bi500171j; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Carames B, 2013, ARTHRITIS RHEUM-US, V65, P1843, DOI 10.1002/art.37977; Bourgault S, 2011, BIOCHEM BIOPH RES CO, V410, P707, DOI 10.1016/j.bbrc.2011.04.133; Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Elsaman AM, 2013, SEMIN ARTHRITIS RHEU, V43, P405, DOI 10.1016/j.semarthrit.2013.07.004; Tanskanen M, 2008, ANN MED, V40, P232, DOI 10.1080/07853890701842988; ATHANASOU NA, 1992, HISTOPATHOLOGY, V20, P41, DOI 10.1111/j.1365-2559.1992.tb00914.x; Benson MD, 1996, CIBA F SYMP, V199, P104; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; BURKHARDT D, 1995, RHEUMATOL INT, V14, P235, DOI 10.1007/BF00262089; Buxbaum Joel N., 2004, Current Opinion in Rheumatology, V16, P67, DOI 10.1097/00002281-200401000-00013; BYWATERS EG, 1970, ANN RHEUM DIS, V29, P294, DOI 10.1136/ard.29.3.294; Cecil DL, 2005, J IMMUNOL, V175, P8296; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; CORNWELL GG, 1988, BIOCHEM BIOPH RES CO, V154, P648, DOI 10.1016/0006-291X(88)90188-X; DICKSON PW, 1985, J BIOL CHEM, V260, P8214; EGAN MS, 1982, ARTHRITIS RHEUM, V25, P204, DOI 10.1002/art.1780250214; FELDING P, 1982, BIOCHIM BIOPHYS ACTA, V716, P446, DOI 10.1016/0304-4165(82)90040-X; Gobezie R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2172; Gu YJ, 2014, J ZHEJIANG UNIV-SC B, V15, P92, DOI 10.1631/jzus.B1300046; Hongo M, 1991, J Cardiol, V21, P391; Jin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091611; LADEFOGED C, 1986, ANN RHEUM DIS, V45, P668, DOI 10.1136/ard.45.8.668; MITROVIC DR, 1985, RHEUMATOL INT, V5, P83, DOI 10.1007/BF00270302; Monteiro FA, 2006, FEBS LETT, V580, P3451, DOI 10.1016/j.febslet.2006.05.020; Niggemeyer O, 2011, ARCH ORTHOP TRAUM SU, V131, P637, DOI 10.1007/s00402-010-1187-z; Niggemeyer O, 2011, HIP INT, V21, P98, DOI 10.5301/HIP.2011.6300; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Saito S, 2005, BIOCHEMISTRY-US, V44, P11122, DOI 10.1021/bi050327i; Sohn DH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3555; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Sunk IG, 2008, OSTEOARTHR CARTILAGE, V16, P1336, DOI 10.1016/j.joca.2008.03.024; Takanashi T, 2013, AMYLOID, V20, P151, DOI 10.3109/13506129.2013.803190; Takei Y, 2003, INTERNAL MED, V42, P1050, DOI 10.2169/internalmedicine.42.1050; Takei Y, 2002, AMYLOID, V9, P252, DOI 10.3109/13506120209114102; Takinami Yoshihiko, 2013, Biomark Insights, V8, P85, DOI 10.4137/BMI.S11966; Yammani RR, 2006, ARTHRITIS RHEUM, V54, P2901, DOI 10.1002/art.22042	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	AUG	2015	67	8					2097	2107		10.1002/art.39178		11	Rheumatology	Rheumatology	CN7JA	WOS:000358609300015		
J	Maeda, K; Kosugi, T; Sato, W; Kojima, H; Sato, Y; Kamimura, D; Kato, N; Tsuboi, N; Yuzawa, Y; Matsuo, S; Murakami, M; Maruyama, S; Kadomatsu, K				Maeda, Kayaho; Kosugi, Tomoki; Sato, Waichi; Kojima, Hiroshi; Sato, Yuka; Kamimura, Daisuke; Kato, Noritoshi; Tsuboi, Naotake; Yuzawa, Yukio; Matsuo, Seiichi; Murakami, Masaaki; Maruyama, Shoichi; Kadomatsu, Kenji			CD147/Basigin Limits Lupus Nephritis and Th17 Cell Differentiation in Mice by Inhibiting the Interleukin-6/STAT-3 Pathway	ARTHRITIS & RHEUMATOLOGY			English	Article							REGULATORY T-CELLS; IMMUNOGLOBULIN SUPERFAMILY; AUTOIMMUNE INFLAMMATION; DIABETIC-NEPHROPATHY; HELPER-CELLS; TGF-BETA; CD147; ERYTHEMATOSUS; BASIGIN/CD147; ROLES	Objective. Interleukin-17 (IL-17)-producing T cells (Th17 cells) play critical roles in the pathogenesis of immune-related diseases, including systemic lupus erythematosus. However, the fundamental mechanism regulating Th17 cell differentiation is not fully understood. Recently, we demonstrated that plasma levels of CD147/basigin (Bsg) in patients with lupus nephritis (LN) were closely associated with disease activity. but the molecular mechanism involving Bsg has been elusive. Here, we addressed the role of Bsg in the pathogenesis of LN. Methods. Injections of pristane (2,6,10,14-tetramethylpentadecane [TMPD]) were administered to Bsg(-/-) or Bsg(+/+) mice to induce LN. The mice were killed 6 months after being injected, for histologic and biochemical analyses of the kidneys and spleens. Results. Pristane induced LN more strikingly in Bsg(-/-) mice than in Bsg(+/+) mice, even though humoral autoimmunity was similarly increased in both genotypes. The increased number of Th17, but not Th1, Treg cells, was augmented in Bsg(-/-) mice. The expression of IL-17 was also increased in the kidneys of Bsg(-/-) mice, in proportion to LN disease activity. Furthermore, treatment with anti-IL-17 antibody reduced LN disease activity in Bsg(-/-) mice. Complementary to these phenotypes of Bsg(-/-) mice, Bsg expression was enhanced in activated CD4+ T cells in vivo and in vitro. Bsg deficiency selectively augmented in vitro differentiation of naive CD4+ T cells to Th17 cells and STAT-3 phosphorylation during this differentiation. Moreover, STAT-3 phosphorylation was suppressed by crosslinking of Bsg with its antibody. Conclusion. Bsg plays an indispensable role in Th17 cell differentiation as a negative regulator by suppressing the IL-6/STAT-3 pathway.	[Maeda, Kayaho; Kosugi, Tomoki; Sato, Waichi; Kojima, Hiroshi; Sato, Yuka; Kato, Noritoshi; Tsuboi, Naotake; Matsuo, Seiichi; Maruyama, Shoichi; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Kamimura, Daisuke; Murakami, Masaaki] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan; [Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Toyoake, Aichi 47011, Japan	Kadomatsu, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Mol Biol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kkadoma@med.nagoya-u.ac.jp	Kadomatsu, Kenji/G-8083-2012		Ministry of Health, Labor, and Welfare of Japan [90584681]	Dr. Kosugi's work was supported in part by the Ministry of Health, Labor, and Welfare of Japan (Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, 90584681).	Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Kato N, 2011, AM J PATHOL, V178, P572, DOI 10.1016/j.ajpath.2010.10.009; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Summers SA, 2014, CLIN EXP IMMUNOL, V176, P341, DOI 10.1111/cei.12287; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Lech M, 2010, J PATHOL, V220, P596, DOI 10.1002/path.2678; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Harris TJ, 2007, J IMMUNOL, V179, P4313; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Yang J, 2009, ARTHRITIS RHEUM, V60, P1472, DOI 10.1002/art.24499; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Amarilyo G, 2014, J IMMUNOL, V193, P540, DOI 10.4049/jimmunol.1400931; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Maeda-Hori M, 2014, LUPUS, V23, P342, DOI 10.1177/0961203314520840; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Crispin JC, 2008, J IMMUNOL, V181, P8761; Solstad T, 2011, BLOOD, V118, P5141, DOI 10.1182/blood-2011-02-339242; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Kurebayashi Y, 2013, GENES CELLS, V18, P247, DOI 10.1111/gtc.12039; Chen S, 2004, BIOCHEM BIOPH RES CO, V324, P147, DOI 10.1016/j.bbrc.2004.08.232; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Herrera-Diaz C., 2012, AUTOIMMUNE DIS, V2012, DOI DOI 10.1155/2012/849684; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Kato N, 2009, J AM SOC NEPHROL, V20, P1565, DOI 10.1681/ASN.2008090957; Koch C, 1999, INT IMMUNOL, V11, P777, DOI 10.1093/intimm/11.5.777; Kosugi T, 2007, LAB INVEST, V87, P903, DOI 10.1038/labinvest.3700599; Liu XB, 2008, J IMMUNOL, V180, P6070; Pistol G, 2007, J CELL MOL MED, V11, P339, DOI 10.1111/j.1582-4934.2007.00022.x; Renno T, 2002, J IMMUNOL, V168, P4946; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Staffler G, 2003, J IMMUNOL, V171, P1707; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	AUG	2015	67	8					2185	2195		10.1002/art.39155		11	Rheumatology	Rheumatology	CN7JA	WOS:000358609300024		
J	Asashima, H; Tsuboi, H; Takahashi, H; Hirota, T; Iizuka, M; Kondo, Y; Matsui, M; Matsumoto, I; Sumida, T				Asashima, Hiromitsu; Tsuboi, Hiroto; Takahashi, Hiroyuki; Hirota, Tomoya; Iizuka, Mana; Kondo, Yuya; Matsui, Minoru; Matsumoto, Isao; Sumida, Takayuki			The Anergy Induction of M3 Muscarinic Acetylcholine Receptor-Reactive CD4+T Cells Suppresses Experimental Sialadenitis-like Sjogren's Syndrome	ARTHRITIS & RHEUMATOLOGY			English	Article							ALTERED PEPTIDE LIGAND; CD4(+) T-CELLS; LABIAL SALIVARY-GLANDS; E3 UBIQUITIN LIGASE; CLONAL ANERGY; MOLECULAR-MECHANISMS; TRANSCRIPTION FACTOR; AUTOIMMUNE-DISEASE; ACTIVATION; ANTIBODIES	Objective. Autoreactive CD4+ T cells are involved in the pathogenesis of Sjogren's syndrome (SS). The aim of the present study was to clarify the dominant T cell epitopes of M3 muscarinic acetylcholine receptor (M3R) and to establish a new antigen-specific therapy for SS using an experimental mouse model. Methods. Production of cytokines from M3R-reactive CD4+ T cells, after culture with various M3R peptides, was analyzed by enzyme-linked immunosorbent assay. Adoptive cell transfer was performed using splenocytes from M3R(-/-) mice that were immunized with M3R peptides or phosphate buffered saline plus H37Ra as a control. Rag1(-/-) mice were inoculated with the splenocytes and examined for the development of sialadenitis. Altered peptide ligands (APLs) of the T cell epitopes, with substitutions in amino acid residues at T cell receptor contact sites, were synthesized, and the ability of the APLs to suppress sialadenitis was evaluated. The mechanisms underlying such effects were assessed. Results. CD4+ M3R-reactive T cells produced interleukin-17 (IL-17) and interferon-gamma (IFN gamma) in response to the N-terminal 1 (N1) and 1st extracellular loop peptides of M3R, and Rag1(-/-) mice that received N1- and/or 1st peptide-immunized splenocytes developed sialadenitis. Among the designed APLs, N1-APL7 (N -> S at amino acid 15) significantly suppressed IFN gamma production in vitro, and also suppressed sialadenitis in vivo. Levels of early growth response 2 in CD4+ T cells from the cervical lymph nodes of N1-APL7-treated mice were significantly higher than those of control mice, and cell proliferation was reversed by administration of exogenous IL-2. Levels of the anergy-related molecules itchy homolog E3 ubiquitin-protein ligase, Casitas B-lineage lymphoma b, gene related to anergy in lymphocytes, and Deltex-1 were significantly higher in CD4+ T cells cultured with N1-APL7. Conclusion. The major T cell epitopes were from the N1 and 1st peptide regions. Moreover, N1-APL7, selected as the antagonistic APL in vitro, also suppressed sialadenitis through the induction of anergy. This is a potentially useful strategy for regulating pathogenic T cell infiltration in SS.	[Asashima, Hiromitsu; Tsuboi, Hiroto; Takahashi, Hiroyuki; Hirota, Tomoya; Iizuka, Mana; Kondo, Yuya; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Tsukuba, Ibaraki 3058575, Japan; [Matsui, Minoru] Fureai Higashitotsuka Hosp, Yokohama, Kanagawa, Japan	Sumida, T (reprint author), Univ Tsukuba, Fac Med, Div Internal Med, 1-1-1 Tenoudai, Tsukuba, Ibaraki 3058575, Japan.	tsumida@md.tsukuba.ac.jp			Research Program for Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan (Health and Labor Sciences Research Grant Program); Ministry of Education, Culture, Sports, Science and Technology, Japan	Supported by the Research Program for Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan (Health and Labor Sciences Research Grant Program) and by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; ADAMSON TC, 1983, J IMMUNOL, V130, P203; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Halse AK, 1999, CLIN EXP IMMUNOL, V115, P203; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Naito Y, 2005, ANN RHEUM DIS, V64, P510, DOI 10.1136/ard.2004.025478; Dawson LJ, 2006, ARTHRITIS RHEUM, V54, P1165, DOI 10.1002/art.21764; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Harris JE, 2004, J IMMUNOL, V173, P7331; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153; Park JE, 2012, J BIOL CHEM, V287, P19765, DOI 10.1074/jbc.M112.349688; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Tengner P, 1998, ARTHRITIS RHEUM, V41, P2238, DOI 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Bacman S, 2001, INVEST OPHTH VIS SCI, V42, P321; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; DesMagistris MT, 1992, CELL, V68, P625; Frauwirth KA, 2000, J IMMUNOL, V164, P2987; Gordon BP, 2007, AUTON NEUROSCI-BASIC, V133, P3; GREENSPA.JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4; Hsu TS, 2014, J IMMUNOL, V193, P1672, DOI 10.4049/jimmunol.1301416; Iizuka M, 2015, MOD RHEUMATOL, V25, P158, DOI 10.3109/14397595.2014.884683; Iizuka M, 2013, MOD RHEUMATOL, V23, P614, DOI 10.1007/s10165-012-0785-8; Iizuka M, 2010, J AUTOIMMUN, V35, P383, DOI 10.1016/j.jaut.2010.08.004; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; Kaushansky N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027860; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; Matsumoto I, 1999, INT J MOL MED, V3, P485; Matusi M, 2000, P NATL ACAD SCI USA, V97, P9579; Naito Y, 2006, ANN RHEUM DIS, V65, P269, DOI 10.1136/ard.2005.039065; Nakamura Y, 2008, ANN RHEUM DIS, V67, P136, DOI 10.1136/ard.2007.072421; NAMEKAWA T, 1995, J RHEUMATOL, V22, P2092; Nicholson LB, 1997, P NATL ACAD SCI USA, V94, P9279, DOI 10.1073/pnas.94.17.9279; Okamura T, 2012, ANN RHEUM DIS, V71, P96, DOI 10.1136/annrheumdis-2011-200588; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Ramon HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012904; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; Seroogy CM, 2004, J IMMUNOL, V173, P79; Sumida T, 1997, ARTHRITIS RHEUM, V40, P2271, DOI 10.1002/art.1780401225; Sumitomo S, 2013, JAKSTAT, V2; Young DA, 2000, J IMMUNOL, V164, P3563	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	AUG	2015	67	8					2213	2225		10.1002/art.39163		13	Rheumatology	Rheumatology	CN7JA	WOS:000358609300027		
J	Terao, C; Matsumura, T; Yoshifuji, H; Kirino, Y; Maejima, Y; Nakaoka, Y; Takahashi, M; Amiya, E; Tamura, N; Nakajima, T; Origuchi, T; Horita, T; Matsukura, M; Kochi, Y; Ogimoto, A; Yamamoto, M; Takahashi, H; Nakayamada, S; Saito, K; Wada, Y; Narita, I; Kawaguchi, Y; Yamanaka, H; Ohmura, K; Atsumi, T; Tanemoto, K; Miyata, T; Kuwana, M; Komuro, I; Tabara, Y; Ueda, A; Isobe, M; Mimori, T; Matsuda, F				Terao, Chikashi; Matsumura, Takayoshi; Yoshifuji, Hajime; Kirino, Yohei; Maejima, Yasuhiro; Nakaoka, Yoshikazu; Takahashi, Meiko; Amiya, Eisuke; Tamura, Natsuko; Nakajima, Toshiki; Origuchi, Tomoki; Horita, Tetsuya; Matsukura, Mitsuru; Kochi, Yuta; Ogimoto, Akiyoshi; Yamamoto, Motohisa; Takahashi, Hiroki; Nakayamada, Shingo; Saito, Kazuyoshi; Wada, Yoko; Narita, Ichiei; Kawaguchi, Yasushi; Yamanaka, Hisashi; Ohmura, Koichiro; Atsumi, Tatsuya; Tanemoto, Kazuo; Miyata, Tetsuro; Kuwana, Masataka; Komuro, Issei; Tabara, Yasuharu; Ueda, Atsuhisa; Isobe, Mitsuaki; Mimori, Tsuneyo; Matsuda, Fumihiko			BRIEF REPORT Takayasu Arteritis and Ulcerative Colitis: High Rate of Co-Occurrence and Genetic Overlap	ARTHRITIS & RHEUMATOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; ASSOCIATION; CLASSIFICATION; RISK	Objective. Takayasu arteritis (TAK) is a systemic vasculitis affecting large arteries and large branches of the aorta. Ulcerative colitis (UC) is a prevalent autoimmune colitis. Since TAK and UC share HLA-B*52:01 and IL12B as genetic determinants, and since there are case reports of the co-occurrence of these diseases, we hypothesized that UC is a common complication of TAK. We undertook this study to perform a large-scale analysis of TAK, both to evaluate the prevalence of concurrent cases of TAK and UC and to identify and estimate susceptibility genes shared between the 2 diseases. Methods. We analyzed a total of 470 consecutive patients with TAK from 14 institutions. We characterized patients with TAK and UC by analyzing clinical manifestations and genetic components. Genetic overlapping of TAK and UC was evaluated with the use of UC susceptibility single-nucleotide polymorphisms by comparing risk directions and effect sizes between susceptibility to the 2 diseases. Results. Thirty of 470 patients with TAK had UC (6.4% [95% confidence interval 4.3-9.0]). This percentage was strikingly higher than that expected from the prevalence of UC in Japan. Patients with TAK complicated with UC developed TAK at an earlier stage of life (P=0.0070) and showed significant enrichment of HLA-B*52:01 compared to TAK patients without UC (P=1.0 x 10(-5)) (odds ratio 12.14 [95% confidence interval 2.96-107.23]). The 110 non-HLA markers of susceptibility to UC significantly displayed common risk directions with susceptibility to TAK (P=0.0054) and showed significant departure of permutation P values from expected P values (P < 1.0 x 10(-10)). Conclusion. UC is a major complication of TAK. These 2 diseases share a significant proportion of their genetic background, and HLA-B*52:01 may play a central role in their co-occurrence.	[Terao, Chikashi; Yoshifuji, Hajime; Takahashi, Meiko; Nakajima, Toshiki; Kawaguchi, Yasushi; Ohmura, Koichiro; Mimori, Tsuneyo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan; [Matsumura, Takayoshi; Amiya, Eisuke; Matsukura, Mitsuru; Kochi, Yuta; Miyata, Tetsuro; Komuro, Issei] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kirino, Yohei; Ueda, Atsuhisa] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Maejima, Yasuhiro; Tamura, Natsuko; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Tokyo, Japan; [Nakaoka, Yoshikazu] Osaka Univ, Grad Sch Med, Osaka, Japan; [Origuchi, Tomoki] Nagasaki Univ, Sch Hlth Sci, Nagasaki 852, Japan; [Horita, Tetsuya; Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ogimoto, Akiyoshi] Ehime Univ, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Yamamoto, Motohisa; Takahashi, Hiroki] Sapporo Med Univ, Sapporo, Hokkaido, Japan; [Nakayamada, Shingo; Saito, Kazuyoshi] Univ Occupat & Environm Hlth, Sch Med, Kitakyushu, Fukuoka, Japan; [Wada, Yoko; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan; [Kawaguchi, Yasushi; Yamanaka, Hisashi] Tokyo Womens Med Univ, Tokyo, Japan; [Tanemoto, Kazuo] Kawasaki Med Univ, Kurashiki, Okayama, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Tokyo, Japan	Terao, C (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Sakyo Ku, Shogoin Kawahara cho 54, Kyoto 6068507, Japan.	a0001101@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research [KAKENHI] [25860809]; Japan Rheumatism Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japanese Intractable Diseases Research Foundation; Ministry of Health, Labor, and Welfare of Japan; Japanese Circulation Society	Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research [KAKENHI]; 25860809), the Japan Rheumatism Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Japanese Intractable Diseases Research Foundation, the Ministry of Health, Labor, and Welfare of Japan, and the Japanese Circulation Society (Translational Research Promotion Program grant to Dr. Nakaoka).	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Isobe M, 2013, INT J CARDIOL, V168, P3, DOI 10.1016/j.ijcard.2013.01.022; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; HIWATASHI N, 1995, J GASTROENTEROL, V30, P13; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Mizuki N, 1999, ARTHRITIS RHEUM, V42, P1961, DOI 10.1002/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7; Terao C, 2013, AM J HUM GENET, V93, P289, DOI 10.1016/j.ajhg.2013.05.024; Bansal R, 2003, INT J CARDIOL, V88, P91, DOI 10.1016/S0167-5273(02)00371-6; Christou A, 2012, HELL J CARDIOL, V53, P400; DesMenthon M, 2009, ARTHRITIS RHEUM, V61, P1287; Ferro José M, 2014, Handb Clin Neurol, V120, P595, DOI 10.1016/B978-0-7020-4087-0.00040-1; Gecse Krisztina, 2011, Inflamm Bowel Dis, V17, pE69, DOI 10.1002/ibd.21731; Hibi T, 2006, IBD RES, V4, P189; ITO I, 1975, JPN CIRC J, V39, P459; Ozaki S, 2011, CIRC J, V75, P474, DOI 10.1253/circj.CJ-88-0007; Lango AH, 2010, NATURE, V467, P832, DOI DOI 10.1038/NATURE09410; Lee JCW, 1999, GUT, V44, P196; Ogawa H, 2009, SURG FRONT, V16, P44; Oshitani Nobuhide, 2005, Nihon Rinsho, V63, P874; Saruhan-Direskeneli G, 2013, AM J HUM GENET, V93, P298, DOI 10.1016/j.ajhg.2013.05.026; Sharma B K, 1992, Heart Vessels Suppl, V7, P37, DOI 10.1007/BF01744542; Takahashi N, 2011, MED SCI MONITOR, V17, pCS81; Terao C, 2014, INT J RHEUM DIS, V17, P238, DOI 10.1111/1756-185X.12309; Terao C, 2013, RHEUMATOLOGY, V52, P1769, DOI 10.1093/rheumatology/ket241; Watanabe R, 2014, MOD RHEUMATOL, V24, P372, DOI 10.3109/14397595.2013.854045	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	AUG	2015	67	8					2226	2232		10.1002/art.39157		7	Rheumatology	Rheumatology	CN7JA	WOS:000358609300028		
J	Singer, J; Hoang, H; Ochiai, C				Singer, Jane; Hai Hoang; Ochiai, Chiho			Post-displacement community resilience: Considering the contribution of indigenous skills and cultural capital among ethnic minority Vietnamese	ASIA PACIFIC VIEWPOINT			English	Article						community capitals; community resilience; dam-induced displacement; resettlement; sustainable rural livelihoods	DISASTER; CONTEXT; VIOLENCE	Despite an improving regulatory framework and policies governing compensation and resettlement, the majority of the millions displaced worldwide each year by hydropower dam construction continue to experience marginalisation and impoverishment, suggesting that external financial support must be supplemented by strengthened community-based resilience. In order to understand more about the innate resources of displaced rural communities, we applied a community resilience approach to two resettled Co-tu ethnic minority villages in an upland area in central Vietnam to identify their community capitals and their application in improving livelihoods and living conditions. We found that weak human and financial capital constrained the ability of the resettled residents to adopt new livelihoods or migrate to seek employment. Reduced forest and river access also problematised responses to a lack of agricultural land. However, traditionally strong village affinity and social networks were retained. In addition, indigenous skills such as housing construction, honed by a highly mobile traditional lifestyle, allowed residents to construct culturally significant structures like community houses and modify or augment received housing stock. These elements of social and cultural capital eased the process of post-resettlement adaptation. We conclude that governments should reassess current resettlement policies that prioritise financial compensation and should incorporate awareness of the adaptive resilience and limitations fostered by indigenous knowledge and practices in resettlement action plans.	[Singer, Jane; Ochiai, Chiho] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto 6068501, Japan; [Hai Hoang] Univ Danang, Int Cooperat Dept, Danang, Vietnam	Singer, J (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto 6068501, Japan.	singer.jane.6e@kyoto.u.ac.jp; haivn87@hotmail.com; ochiai.chiho.2x@kyoto-u.ac.jp			Japan Society for the Promotion of Science [23651036]	This work was supported by the Japan Society for the Promotion of Science # 23651036 (Evaluating Impacts and Community Resilience of Dam-Displaced Indigenous Villages in Central Vietnam).	Ahern J, 2006, J EPIDEMIOL COMMUN H, V60, P766, DOI 10.1136/jech.2006.042069; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Berkes F, 2013, SOC NATUR RESOUR, V26, P5, DOI 10.1080/08941920.2012.736605; Walsh F, 2007, FAM PROCESS, V46, P207, DOI 10.1111/j.1545-5300.2007.00205.x; AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Paton D, 2001, NAT HAZARDS, V24, P157, DOI 10.1023/A:1011882106373; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Ahmed R, 2004, S AFR J PSYCHOL, V34, P386; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Arhem K., 2010, PAPERS SOCIAL ANTHR; Asian Development Bank, 2007, BEN SHAR MECH PEOPL; Baulch B, 2007, J DEV STUD, V43, P1151, DOI 10.1080/02673030701526278; Bourdieu Pierre, 1986, HDB THEORY RES SOCIO, P241, DOI DOI 10.1177/0265532207083743; Bui T. M. H., 2011, INT J WATER RESOUR D, V27, P769; Cernea M. M., 2000, Risks and reconstruction: experiences of resettlers and refugees., P11; Cernea M., 2013, INT C DEV IND DISPL; Cernea MM, 2003, INT SOC SCI J, V55, P37, DOI 10.1111/1468-2451.5501004; Clauss-Ehlers CS, 2002, J SOC DISTRESS HOMEL, V11, P265, DOI 10.1023/A:1016804930977; Dalton RJ, 2002, COMP SOCIOL, V1, P369, DOI 10.1163/156913302100418646; Downing T., 2009, DEV DISPOSSESSION AN, P225; Flora C. B., 2004, J CONT WATER RES ED, V128, P6; Hirschon R., 2000, RISKS RECONSTRUCTION, P393; Holling C. S., 2002, PANARCHY UNDERSTANDI, P25; Joerin J, 2011, COMM ENV DISAST RISK, V6, P47, DOI 10.1108/S2040-7262(2011)0000006009; Kaniasty K, 2000, AM J COMMUN PSYCHOL, V28, P545, DOI 10.1023/A:1005192616058; Kimhi S, 2004, J COMMUNITY PSYCHOL, V32, P439, DOI 10.1002/jcop.20012; Koenig D., 2006, DEV INDUCED DISPLACE; Lin N., 2001, SOCIAL CAPITAL THEOR; Luu H., 2007, GOTEBORG U KATUIC ET; Lux SJ, 2004, PUBLIC ADMIN DEVELOP, V24, P173, DOI 10.1002/pad.283; Magis K., 2010, SOC NATUR RESOUR, V23, P410; Maguire B., 2008, ASSESSING COMMUNITYS; Matsuda Y., 2013, THESIS KYOTO U JAPAN; Oliver-Smith A., 2006, DEV INDUCED DISPLACE, P141; Osman-Elasha B., 2006, 42 AICC; Scoones I., 1998, 72 IDS U SUSS; Scudder T., 2005, FUTURE LARGE DAMS DE; Scudder T., 2009, DEV DISPOSSESSION CR, P25; Sherrieb K., 2010, SOCIAL INDICATORS RE, V99, P1; Ta D., 2002, UNDERSTANDING KATU C; United States Department of Agriculture Forest Service (USDAFS), 2011, INDICATOR MINNESOTA, V6, P38; United States Department of Homeland Security (USDHS), 2011, HOM SEC ADV COUNC CO; Wolfers J., 2010, SUBJECTIVE WELL BEIN	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-7456	1467-8373		ASIA PAC VIEWP	Asia Pac. Viewp.	AUG	2015	56	2					208	222		10.1111/apv.12057		15	Area Studies; Geography	Area Studies; Geography	CN6FZ	WOS:000358531000002		
J	Yasuda, CI; Matsuo, K; Wada, S				Yasuda, Chiaki I.; Matsuo, Kento; Wada, Satoshi			Previous mating experience increases fighting success during male-male contests in the hermit crab Pagurus nigrofascia	BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY			English	Article						Copulation experience; Competitive ability; Male mating success; Pagurus hermit crab	BINARY INDIVIDUAL RECOGNITION; MALE-MALE COMPETITION; IN-HOUSE CRICKETS; ANIMAL CONTESTS; FEMALE CHOICE; MATE CHOICE; BODY-SIZE; BEHAVIOR; WINNER; SPIDER	Prior social experience often affects subsequent competitive interactions and their outcomes. Although the effects of prior contest experience have been widely examined, effects of mating experience remain less well examined. We examined, in males of the hermit crab Pagurus nigrofascia, whether males successively copulated with more than one female and whether males with copulation experience differed in their subsequent contest behaviors and probability of winning in male-male contests compared to males without copulation experience. The copulation experience of intruders was manipulated and the contest behaviors compared between mated and unmated groups. Males mated with several females regardless of the male body size. Compared with unmated intruders, intruders with mating experience succeeded more often in taking over females and did so within a shorter period particularly when the male-male contests occurred over females with a long time to molt. These results suggest that mated males of P. nigrofascia overestimate the female quality and/or enhance the competitive performance similar to the "winner effect" that is a positive feedback from prior winning experience to future contests.	[Yasuda, Chiaki I.; Matsuo, Kento; Wada, Satoshi] Hokkaido Univ, Grad Sch Fisheries Sci, Lab Marine Biol & Biodivers, Hakodate, Hokkaido 0410821, Japan	Yasuda, CI (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, Lab Marine Biol & Biodivers, 3-1-1 Minato Cho, Hakodate, Hokkaido 0410821, Japan.	chiaki.y.0210@gmail.com			JSPS Research Fellowship for Young Scientists [25-2149]; KAKENHI [23440228]	We are grateful for Ms. Y. Hasaba and Dr. C. Norman for valuable comments. Additional thanks go to the referees for their extensive and supportive comments and contributions. This study was financially supported by JSPS Research Fellowship for Young Scientists (No. 25-2149) to CY and Grants-in-Aid for Scientific Research (KAKENHI, No. 23440228) to SW.	Akaike H, 1983, INT STAT I, V50, P277; Andersson M., 1994, SEXUAL SELECTION; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Whitehouse MEA, 1997, ANIM BEHAV, V53, P913, DOI 10.1006/anbe.1996.0313; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Okada K, 2010, BEHAV ECOL SOCIOBIOL, V64, P361, DOI 10.1007/s00265-009-0852-0; Sato T, 2007, ANIM BEHAV, V73, P331, DOI 10.1016/j.anbehav.2006.05.016; Kasumovic MM, 2010, BEHAV ECOL, V21, P404, DOI 10.1093/beheco/arp204; Yasuda C, 2012, ANIM BEHAV, V84, P385, DOI 10.1016/j.anbehav.2012.05.007; Arnott G, 2008, ANIM BEHAV, V76, P529, DOI 10.1016/j.anbehav.2008.04.019; Lehner SR, 2011, ETHOLOGY, V117, P949, DOI 10.1111/j.1439-0310.2011.01962.x; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Kralj-Fiser S, 2011, ANIM BEHAV, V81, P933, DOI 10.1016/j.anbehav.2011.02.010; Taylor PW, 2003, ANIM BEHAV, V65, P1195, DOI 10.1006/anbe.2003.2169; Yasuda C, 2011, MAR BIOL, V158, P2327, DOI 10.1007/s00227-011-1736-1; Guevara-Fiore P, 2012, ANIM BEHAV, V84, P1023, DOI 10.1016/j.anbehav.2012.07.028; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; COX DR, 1972, J R STAT SOC B, V34, P187; Payne RJH, 1997, ANIM BEHAV, V54, P109, DOI 10.1006/anbe.1996.0391; Hsu YY, 1999, ANIM BEHAV, V57, P903, DOI 10.1006/anbe.1998.1049; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Perez-Staples D, 2010, ETHOLOGY, V116, P778, DOI 10.1111/j.1439-0310.2010.01790.x; Schuett GW, 1997, ANIM BEHAV, V54, P213, DOI 10.1006/anbe.1996.0417; Bridge AP, 2000, P ROY SOC B-BIOL SCI, V267, P273; Briffa M, 2013, ANIMAL CONTESTS, P86; Brown WD, 2007, ETHOLOGY, V113, P457, DOI 10.1111/j.1439-0310.2007.01357.x; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; Chamorro-Florescano IA, 2008, BEHAVIOUR, V145, P1811; Dugatkin LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019924; Gherardi F, 2004, J ZOOL, V263, P23, DOI 10.1017/S0952836904004807; Gherardi F, 2004, BEHAV ECOL SOCIOBIOL, V55, P524, DOI 10.1007/s00265-003-0734-9; Goshima S, 1998, ECOL RES, V13, P151, DOI 10.1046/j.1440-1703.1998.00254.x; Goshima Seiji, 1996, Crustacean Research, V25, P86; Hack MA, 1997, ETHOLOGY, V103, P488; Hardy ICW, 2013, ANIMAL CONTESTS, P1, DOI 10.1017/CBO9781139051248; HAZLETT B A, 1968, PUBB STA ZOOL NAPOLI, V36, P238; Judge KA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1971, DOI 10.1007/s00265-010-1008-y; Kendall MS, 1999, J EXP MAR BIOL ECOL, V239, P23, DOI 10.1016/S0022-0981(99)00022-2; Killian KA, 2008, J INSECT BEHAV, V21, P535, DOI 10.1007/s10905-008-9148-x; Kou R, 2013, HORM BEHAV, V64, P546, DOI 10.1016/j.yhbeh.2013.07.007; Mariette MM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1514; Okamura S, 2010, J ETHOL, V28, P323, DOI 10.1007/s10164-009-0188-2; Payne RJH, 1996, J THEOR BIOL, V183, P185, DOI 10.1006/jtbi.1996.0212; R Core Team, 2013, R LANG ENV STAT COMP; Sainte-Marie Bernard, 2007, P191; SUGA Y, 2006, INT J ASIAN STUD, V3, P77, DOI DOI 10.1017/S1479591405000239; Suzuki Y, 2012, MAR BIOL, V159, P1991, DOI 10.1007/s00227-012-1986-6; Tanikawa Daisuke, 2012, Japanese Journal of Benthology, V67, P15; Van Son TC, 2006, ANIM BEHAV, V71, P61, DOI 10.1016/j.anbehav.2005.03.018; Wada S, 1999, J EXP MAR BIOL ECOL, V239, P289, DOI 10.1016/S0022-0981(99)00045-3; Yasuda CI, 2014, ANIM BEHAV, V96, P49, DOI 10.1016/j.anbehav.2014.07.021	51	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-5443	1432-0762		BEHAV ECOL SOCIOBIOL	Behav. Ecol. Sociobiol.	AUG	2015	69	8					1287	1292		10.1007/s00265-015-1941-x		6	Behavioral Sciences; Ecology; Zoology	Behavioral Sciences; Environmental Sciences & Ecology; Zoology	CN8ZK	WOS:000358734700005		
J	Sugiura, Y; Sugiura, T				Sugiura, Yoshinori; Sugiura, Tomoko			Emotional intensity reduces later generalized anxiety disorder symptoms when fear of anxiety and negative problem-solving appraisal are low	BEHAVIOUR RESEARCH AND THERAPY			English	Article						Emotional intensity; Generalized anxiety disorder; Worry; Fear of emotions; Problem solving; Moderator	STATE WORRY QUESTIONNAIRE; MODEL; DYSREGULATION; COMPONENTS; METAANALYSIS; MINDFULNESS; NEUROTICISM; VALIDATION; AVOIDANCE; VALIDITY	While research based on the emotion dysregulation model indicates a positive relationship between intense emotions and generalized anxiety disorder (GAD) symptoms, emotion-focused intervention involves the use of techniques to enhance emotional experiences, based on the notion that GAD patients are engaging in avoidance strategies. To reveal the conditions under which intense emotions lead to reduced GAD symptoms, we designed a longitudinal study to monitor changes in GAD symptoms among students (N = 129) over 3 months. Our focus was on possible moderators of the effect of emotional intensity. Results indicated that when fear of emotions and negative appraisals about problem solving were low, negative emotional intensity reduced later GAD symptoms. Moreover, under the condition of high responsibility to continue thinking, emotional intensity tended to reduce later GAD symptoms. Results suggest that reduced fear of emotions and reduced negative appraisals about problem solving may enhance the use of emotional processing techniques (e.g., emotional exposure). The interaction between responsibility to continue thinking and emotional intensity requires further examination. (C) 2015 The Authors. Published by Elsevier Ltd.	[Sugiura, Yoshinori; Sugiura, Tomoko] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima, Hiroshima 7398521, Japan; [Sugiura, Tomoko] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Japan Soc Promot Sci, Higashihiroshima, Hiroshima 7398521, Japan	Sugiura, Y (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Higashihiroshima, Hiroshima 7398521, Japan.	ysugiura@hiroshima-u.ac.jp			JSPS [26380929, 13J40120]	This study was supported by a JSPS Grant-in-Aid for Scientific Research (C) to the first author (No: 26380929) and a JSPS Grant-in-Aid for JSPS Fellows to the second author (No: 13J40120).	Andrews G, 2010, DEPRESS ANXIETY, V27, P134, DOI 10.1002/da.20658; Dugas MJ, 2012, J ABNORM CHILD PSYCH, V40, P863, DOI 10.1007/s10802-012-9611-1; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Mennin DS, 2009, J ANXIETY DISORD, V23, P866, DOI 10.1016/j.janxdis.2009.04.006; Hale WW, 2010, J CLIN PSYCHIAT, V71, P942, DOI 10.4088/JCP.09m05506blu; Roemer L, 2005, COGNITIVE THER RES, V29, P71, DOI 10.1007/s10608-005-1650-2; Stober J, 1998, BEHAV RES THER, V36, P645, DOI 10.1016/S0005-7967(98)00031-X; Newman MG, 2011, CLIN PSYCHOL REV, V31, P371, DOI 10.1016/j.cpr.2011.01.008; Llera SJ, 2014, BEHAV THER, V45, P283, DOI 10.1016/j.beth.2013.12.011; Pascual-Leone A, 2007, J CONSULT CLIN PSYCH, V75, P875, DOI 10.1037/0022-006X.75.6.875; LARSEN RJ, 1987, J RES PERS, V21, P1, DOI 10.1016/0092-6566(87)90023-7; Roemer L, 2009, BEHAV THER, V40, P142, DOI 10.1016/j.beth.2008.04.001; Ehring T, 2008, INT J COGN THER, V1, P192, DOI 10.1680/ijct.2008.1.3.192; Stapinski LA, 2010, BEHAV RES THER, V48, P1097, DOI 10.1016/j.brat.2010.07.012; Olatunji BO, 2010, BEHAV THER, V41, P212, DOI 10.1016/j.beth.2009.03.001; Sugiura Y, 2004, PERS INDIV DIFFER, V37, P169, DOI 10.1016/j.paid.2003.08.009; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; McLaughlin KA, 2007, BEHAV THER, V38, P23, DOI 10.1016/j.beth.2006.03.003; Gross JJ, 1997, J PERS SOC PSYCHOL, V72, P435, DOI 10.1037/0022-3514.72.2.435; Behar E, 2009, J ANXIETY DISORD, V23, P1011, DOI 10.1016/j.janxdis.2009.07.006; Turk CL, 2005, COGNITIVE THER RES, V29, P89, DOI 10.1007/s10608-005-1651-1; Williams KE, 1997, BEHAV RES THER, V35, P239, DOI 10.1016/S0005-7967(96)00098-8; Lawton MP, 2001, CURR DIR PSYCHOL SCI, V10, P120, DOI 10.1111/1467-8721.00130; Mennin DS, 2007, BEHAV THER, V38, P284, DOI 10.1016/j.beth.2006.09.001; Aldao A, 2013, PERSPECT PSYCHOL SCI, V8, P155, DOI 10.1177/1745691612459518; [Anonymous], 2008, JAPANESE J INTERPERS; BACHOROWSKI JA, 1994, PERS INDIV DIFFER, V17, P191, DOI 10.1016/0191-8869(94)90025-6; Hanrahan F, 2013, CLIN PSYCHOL REV, V33, P120, DOI 10.1016/j.cpr.2012.10.008; Berggren N, 2013, BIOL PSYCHOL, V92, P440, DOI 10.1016/j.biopsycho.2012.03.007; Newman MG, 2013, ANNU REV CLIN PSYCHO, V9, P275, DOI 10.1146/annurev-clinpsy-050212-185544; Newman MG, 2002, BEHAV THER, V33, P215, DOI 10.1016/S0005-7894(02)80026-0; Kerns CE, 2014, J PSYCHOPATHOL BEHAV, V36, P115, DOI 10.1007/s10862-013-9372-3; Mennin DS, 2005, BEHAV RES THER, V43, P1281, DOI 10.1016/j.brat.2004.08.008; Berenbaum H, 2010, CLIN PSYCHOL REV, V30, P962, DOI 10.1016/j.cpr.2010.06.011; Borkovec T. D., 2004, MINDFULNESS ACCEPTAN, P209; Borkovec TD, 2004, GENERALIZED ANXIETY DISORDER: ADVANCES IN RESEARCH AND PRACTICE, P77; Bryant FB, 1996, J RES PERS, V30, P223, DOI 10.1006/jrpe.1996.0015; Cuijpers P, 2014, CLIN PSYCHOL REV, V34, P130, DOI 10.1016/j.cpr.2014.01.002; Dugas MJ, 2007, BEHAV THER, V38, P169, DOI 10.1016/j.beth.2006.07.002; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037//0033-2909.99.1.20; Gordon O., 2009, 37 ANN CONV BRIT ASS; Kanetsuki M., 2010, JAPANESE J RES EMOTI, V18, P42; McFatter RM, 1998, PERS INDIV DIFFER, V24, P747, DOI 10.1016/S0191-8869(97)00220-1; Mennin DS, 2006, J CONTEMP PSYCHOTHER, V36, P95, DOI [10.1007/s10879-006-9012-2, DOI 10.1007/S10879-006-9012-2]; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Sugiura T, 2013, PSYCHOL REP, V113, P1, DOI 10.2466/02.09.PR0.113x14z3; Sugiura Y, 2007, BEHAV RES THER, V45, P1619, DOI 10.1016/j.brat.2006.08.001; SUGIURA Y., 2000, ARCH PSYCHIAT DIAGNO, V11, P175; Takebayashi Y., 2012, ARCH PSYCHIAT DIAGNO, V5, P89	49	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	AUG	2015	71						27	33		10.1016/j.brat.2015.05.015		7	Psychology, Clinical	Psychology	CN4HO	WOS:000358391400004		
J	Takada, Y				Takada, Yoshitake			Morisita's prosperity index revisited	BIODIVERSITY AND CONSERVATION			English	Editorial Material						Diversity; Community; Abundance; Effective number of species; Partition	DIVERSITY	In order to develop a composite measure of community species diversity and abundance, a generalization of Morisita's prosperity index is proposed. Using Hill's diversity representation, the prosperity index is a product of the total number of individuals and the effective number of species in a community. A series of prosperity indices can be derived using a parameter (Hill's number). As an analogy of component partitions of species diversity, regional, within, and between components are also defined. The prosperity index will be useful for practical aspects related to conservation and management.	Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuo Ku, Niigata 9518121, Japan	Takada, Y (reprint author), Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuo Ku, Suido Cho 1-5939-22, Niigata 9518121, Japan.	yotak@affrc.go.jp					PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Gotelli Nicholas J., 2011, P39; Maurer Brian A., 2011, P55; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Morisita M, 1967, NATURE ECOLOGICAL ST, P95; Muko S, 2011, J THEOR BIOL, V273, P130, DOI 10.1016/j.jtbi.2010.12.032	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0960-3115	1572-9710		BIODIVERS CONSERV	Biodivers. Conserv.	AUG	2015	24	8					2093	2097		10.1007/s10531-015-0933-5		5	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CN7VX	WOS:000358643500015		
J	Ikegame, K; Yoshida, T; Yoshihara, S; Daimon, T; Shimizu, H; Maeda, Y; Ueda, Y; Kaida, K; Ishii, S; Taniguchi, K; Okada, M; Tamaki, H; Okumura, H; Kaya, H; Kurokawa, T; Kodera, Y; Taniguchi, S; Kanda, Y; Ogawa, H				Ikegame, Kazuhiro; Yoshida, Takashi; Yoshihara, Satoshi; Daimon, Takashi; Shimizu, Hiroaki; Maeda, Yoshinobu; Ueda, Yasunori; Kaida, Katsuji; Ishii, Shinichi; Taniguchi, Kyoko; Okada, Masaya; Tamaki, Hiroya; Okumura, Hirokazu; Kaya, Hiroyasu; Kurokawa, Toshiro; Kodera, Yoshihisa; Taniguchi, Shuichi; Kanda, Yoshinobu; Ogawa, Hiroyasu			Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Haploidentical stem cell transplantation; Reduced-intensity conditioning; Anti-T lymphocyte globulin; Steroid	VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; DONOR TRANSPLANTATION; PROGNOSTIC-FACTORS; UNRELATED DONORS; SIBLING DONOR; GRAFT; PREVENTION	Racial and ethnic disparities have been reported in clinical trial/research participation, utilization of autologous and allogeneic blood and marrow transplantation (BMT), and availability of allogeneic donors. We performed a population-based cohort study to investigate adult hematologic malignancy referrals to a US tertiary cancer center, utilization of BMT, and participation in clinical trial, survey, and biospecimen research by race. US Census Data and the New York State Public Access Cancer Epidemiology Database identified the racial distribution of the general population and new hematologic malignancy cases in the primary catchment area. From 2005 to 2011, 1106 patients aged 18 to 75 years were referred for BMT consultation; although the rate of BMT among hematologic malignancy referrals did not differ by race, the reasons for not receiving a BMT did. Participation in biospecimen research did not vary by race; however, African Americans and other minorities were significantly less likely to participate in survey research than European Americans. Although rates of hematologic malignancy referrals and use of BMT for minorities appear to be low (<10%), they closely reflect the race distribution of all hematologic malignancy cases and the western New York population. African Americans are equally likely as other races to participate in biospecimen banking, but further study is needed to understand reasons for lower participation in survey research. (C) 2015 American Society for Blood and Marrow Transplantation.	[Ikegame, Kazuhiro; Yoshihara, Satoshi; Kaida, Katsuji; Ishii, Shinichi; Taniguchi, Kyoko; Okada, Masaya; Tamaki, Hiroya; Ogawa, Hiroyasu] Hyogo Coll Med, Div Hematol, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Yoshida, Takashi; Okumura, Hirokazu; Kaya, Hiroyasu; Kurokawa, Toshiro] Toyama Prefectural Cent Hosp, Dept Internal Med, Toyama, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan; [Shimizu, Hiroaki] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gumma, Japan; [Maeda, Yoshinobu] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Ueda, Yasunori] Kurashiki Cent Hosp, Dept Hematol Oncol, Transfus & Hemapheresis Ctr, Kurashiki, Okayama, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Sch Med, Dept Promot Blood & Marrow Transplantat, Aichi, Japan; [Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Haematol, Tokyo, Japan; [Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan	Ogawa, H (reprint author), Hyogo Coll Med, Div Hematol, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ogawah@hyo-med.ac.jp			Allergic Disease and Immunology from the Health and Labour Sciences Research Grants for Clinical Cancer Research from the Ministry of Health, Labour and Welfare, Japan [H20-016, H23-009]	This work was supported in part by a grant for Allergic Disease and Immunology (H20-016, H23-009) from the Health and Labour Sciences Research Grants for Clinical Cancer Research from the Ministry of Health, Labour and Welfare, Japan.	Amsterdam A, 2002, MOL CELL ENDOCRINOL, V189, P1, DOI 10.1016/S0303-7207(01)00722-5; Lee KH, 2011, BLOOD, V118, P2609, DOI 10.1182/blood-2011-02-339838; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; O'Donnell PV, 2002, BIOL BLOOD MARROW TR, V8, P377, DOI 10.1053/bbmt.2002.v8.pm12171484; Bouazzaoui A, 2011, EXP HEMATOL, V39, P238, DOI 10.1016/j.exphem.2010.11.006; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Basara N, 2005, BONE MARROW TRANSPL, V35, P1011, DOI 10.1038/sj.bmt.1704957; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Ichinohe T, 2004, BLOOD, V104, P3821, DOI 10.1182/blood-2004-03-1212; Kasamon YL, 2010, BIOL BLOOD MARROW TR, V16, P482, DOI 10.1016/j.bbmt.2009.11.011; Bacigalupo A, 2001, BLOOD, V98, P2942, DOI 10.1182/blood.V98.10.2942; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; AVERSA F, 1994, BLOOD, V84, P3948; Kurosawa S, 2010, HAEMATOL-HEMATOL J, V95, P1857, DOI 10.3324/haematol.2010.027516; Michallet MC, 2003, TRANSPLANTATION, V75, P657, DOI 10.1097/01.TP.0000053198.99206.E6; Brunstein CG, 2011, BLOOD, V118, P282, DOI 10.1182/blood-2011-03-344853; Wong R, 2005, BIOL BLOOD MARROW TR, V11, P108, DOI 10.1016/j.bbmt.2004.10.008; Ogawa H, 2006, BIOL BLOOD MARROW TR, V12, P1073, DOI 10.1016/j.bbmt.2006.06.007; Duval M, 2010, J CLIN ONCOL, V28, P3730, DOI 10.1200/JCO.2010.28.8852; Michallet MC, 2003, BLOOD, V102, P3719, DOI 10.1182/blood-2003-04-1075; Shimony O, 2012, J CLIN IMMUNOL, V32, P173, DOI 10.1007/s10875-011-9599-2; Doney K, 2003, BIOL BLOOD MARROW TR, V9, P472, DOI 10.1016/S1083-8791(03)00149-6; Genestier L, 1998, BLOOD, V91, P2360; Lu DP, 2006, BLOOD, V107, P3065, DOI 10.1182/blood-2005-052146; ARMITAGE JO, 1994, NEW ENGL J MED, V330, P827, DOI 10.1056/NEJM199403243301206; ATKINSON K, 1991, AUST NZ J MED, V21, P850, DOI 10.1111/j.1445-5994.1991.tb01406.x; Bacigalupo A, 2012, HEMATOL-AM SOC HEMAT, P223, DOI 10.1182/asheducation-2012.1.223; CHAO NJ, 1993, NEW ENGL J MED, V329, P1225, DOI 10.1056/NEJM199310213291703; EIZURU Y, 1991, MICROBIOL IMMUNOL, V35, P1015; Federmann B, 2012, HAEMATOL-HEMATOL J, V97, P1523, DOI 10.3324/haematol.2011.059378; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Ikegame K, 2005, CLIN LAB HAEMATOL, V27, P139, DOI 10.1111/j.1365-2257.2005.00675.x; Kanda J, 2013, BIOL BLOOD MARROW TR, V19, P247, DOI 10.1016/j.bbmt.2012.09.017; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang HJ, 2004, BONE MARROW TRANSPL, V34, P939, DOI 10.1038/sj.bmt.1704720; Lee SE, 2013, INT J HEMATOL, V97, P640, DOI 10.1007/s12185-013-1312-1; Liberman AC, 2009, ANN NY ACAD SCI, V1153, P6, DOI 10.1111/j.1749-6632.2008.03958.x; Mapara MY, 2002, BLOOD, V100, P1903, DOI 10.1182/blood-2002-01-0023; Nishiwaki S, 2013, BONE MARROW TRANSPL, V48, P1369, DOI 10.1038/bmt.2013.20; Ogawa H, 2004, TRANSPLANTATION, V78, P488, DOI 10.1097/01.TP.0000128627.28212.D7; Oyekunle AA, 2006, BONE MARROW TRANSPL, V37, P45, DOI 10.1038/sj.bmt.1705207; Remberger M, 1999, BONE MARROW TRANSPL, V24, P823, DOI 10.1038/sj.bmt.1701991; Ruutu T, 2000, BLOOD, V96, P2391; Schleuning M, 2003, BONE MARROW TRANSPL, V32, P243, DOI 10.1038/sj.bmt.1704135; STORB R, 1990, BLOOD, V76, P1037	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	AUG	2015	21	8					1495	1505		10.1016/j.bbmt.2015.04.012		11	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CN6PW	WOS:000358557700022		
J	Karmakar, C; Kimura, Y; Palaniswami, M; Khandoker, A				Karmakar, Chandan; Kimura, Yoshitaka; Palaniswami, Marimuthu; Khandoker, Ahsan			Analysis of fetal heart rate asymmetry before and after 35 weeks of gestation	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Article						Fetal heart rate variability; Heart rate asymmetry (HRA); Poincare plot; HRA index	RATE-VARIABILITY; INTRAPARTUM CARDIOTOCOGRAPHY; BAROREFLEX SENSITIVITY; AUTONOMIC REGULATION; BEHAVIORAL STATES; SPECTRAL-ANALYSIS; WAVELET ANALYSIS; RENAL-FAILURE; POINCARE PLOT; RATE SIGNAL	In this study, we have investigated the evidence of fetal heart rate asymmetry and how the fetal heart rate asymmetry changes before and after 35 weeks of gestation. Noninvasive fetal electrocardiogram (fECG) signals from 45 pregnant women at the gestational age from 16 to 41 weeks with normal single pregnancies were analysed. A nonlinear parameter called heart rate asymmetry (HRA) index that measures time asymmetry of RR interval time-series signal was used to understand the changes of HRA in early and late fetus groups. Results indicate that fetal HRA measured by Porta's Index (PI) consistently increases after 35 weeks gestation compared to foetus before 32 weeks of gestation. It might be due to significant changes of sympatho-vagal balance towards delivery with more sympathetic surge. On the other hand, Guzik's Index (GI) showed a mixed effect i.e., increases at lower lags and decreases at higher lags. Finally, fHRA could potentially help identify normal and the pathological autonomic nervous system development. (C) 2015 Elsevier Ltd. All rights reserved.	[Karmakar, Chandan; Palaniswami, Marimuthu; Khandoker, Ahsan] Univ Melbourne, Dept Elect & Elect Engn, Melbourne, Vic 3010, Australia; [Karmakar, Chandan] Deakin Univ, Ctr Pattern Recognit & Data Analyt, Geelong, Vic 3217, Australia; [Kimura, Yoshitaka] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Khandoker, Ahsan] Khalifa Univ Sci Technol & Res, Dept Biomed Engn, Abu Dhabi, U Arab Emirates	Karmakar, C (reprint author), Univ Melbourne, Dept Elect & Elect Engn, Melbourne, Vic 3010, Australia.	karmakar@unimelb.edu.au; ykimura@med.tohoku.ac.jp; palani@unimelb.edu.au; ahsank@unimelb.edu.au			Australian Research Council (ARC) [LP100200184]; Atom Medical Corporation, Japan	This study was supported by an Australian Research Council (ARC) linkage project (LP100200184) with Atom Medical Corporation, Japan.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Alfirevic Z., 2006, COCHRANE DATABASE SY, V3; Lange S, 2005, MED BIOL ENG COMPUT, V43, P481, DOI 10.1007/BF02344729; DAWES GS, 1990, AM J OBSTET GYNECOL, V162, P170; TOMIYAMA O, 1980, CLIN SCI, V58, P21; QUINN A, 1994, BRIT J OBSTET GYNAEC, V101, P866, DOI 10.1111/j.1471-0528.1994.tb13547.x; Palomaki O, 2006, J PERINAT MED, V34, P298, DOI 10.1515/JPM.2006.057; GOUGH NAJ, 1993, PHYSIOL MEAS, V14, P309, DOI 10.1088/0967-3334/14/3/009; Schneider U, 2008, J PERINAT MED, V36, P433, DOI 10.1515/JPM.2008.059; Van Leeuwen P, 2013, AUTON NEUROSCI-BASIC, V178, P24, DOI 10.1016/j.autneu.2013.01.005; Lange S, 2009, EARLY HUM DEV, V85, P131, DOI 10.1016/j.earlhumdev.2008.07.004; Felgueiras CS, 1998, MED BIOL ENG COMPUT, V36, P197, DOI 10.1007/BF02510743; Georgoulas G, 2006, INT J ARTIF INTELL T, V15, P411, DOI 10.1142/S0218213006002746; Furukawa S, 2011, REPROD SCI, V18, P172, DOI 10.1177/1933719110385129; Salamalekis E, 2002, BJOG-INT J OBSTET GY, V109, P1137, DOI 10.1016/S1470-0328(02)01988-2; PINCUS SM, 1992, OBSTET GYNECOL, V79, P249; Guzik P, 2010, INT J CARDIOL, V144, P138, DOI 10.1016/j.ijcard.2008.12.151; RENOU P, 1969, AM J OBSTET GYNECOL, V105, P949; Ferrario M, 2006, IEEE T BIO-MED ENG, V53, P119, DOI 10.1109/TBME.2005.859809; CHAFFIN DG, 1991, AM J OBSTET GYNECOL, V165, P1425; Goncalves H, 2007, EARLY HUM DEV, V83, P585, DOI 10.1016/j.earthumdev.2006.12.006; GAGNON R, 1987, AM J OBSTET GYNECOL, V157, P743; Cavalcanti S, 1996, IEEE T BIO-MED ENG, V43, P982, DOI 10.1109/10.536899; Gieraltowski J, 2013, AUTON NEUROSCI-BASIC, V178, P29, DOI 10.1016/j.autneu.2013.01.009; Dunajski Z, 1995, STUD APPL ELECTROMAG, V7, P704; Schneider U, 2009, PHYSIOL MEAS, V30, P215, DOI 10.1088/0967-3334/30/2/008; Goncalves H, 2006, MED BIOL ENG COMPUT, V44, P847, DOI 10.1007/s11517-006-0105-6; Karmakar C, 2012, AUSTRALAS PHYS ENG S, V35, P465, DOI 10.1007/s13246-012-0173-x; Voss A, 1996, CARDIOVASC RES, V31, P419; Lerma C, 2003, CLIN PHYSIOL FUNCT I, V23, P72; Martinez-Garcia P, 2012, CLIN AUTON RES, V22, P289, DOI 10.1007/s10286-012-0173-7; Bernardes J, 1997, INT J GYNECOL OBSTET, V57, P33, DOI 10.1016/S0020-7292(97)02846-4; Karmakar CK, 2009, PHYSIOL MEAS, V30, P1227, DOI 10.1088/0967-3334/30/11/007; Guzik P, 2010, HYPERTENS RES, V33, P1199, DOI 10.1038/hr.2010.138; Sato M, 2007, IEEE T BIO-MED ENG, V54, P49, DOI 10.1109/TBME.2006.883791; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Ottesen JT, 1997, J MATH BIOL, V36, P41, DOI 10.1007/s002850050089; Steer PJ, 2008, SEMIN FETAL NEONAT M, V13, P2, DOI 10.1016/j.siny.2007.09.005; Warrick PA, 2010, IEEE T BIO-MED ENG, V57, P771, DOI 10.1109/TBME.2009.2035818; WEISS G, 1975, J APPL PROBAB, V12, P831, DOI 10.2307/3212735; Khandoker AH, 2013, COMPUT CARDIOL CONF, P453; Guzik P, 2006, BIOMED TECH, V51, P272, DOI 10.1515/BMT.2006.054; Druzin M., 1989, STATE ART CLIN PERIN, V16, P627; Ferrario M, 2009, MED BIOL ENG COMPUT, V47, P911, DOI 10.1007/s11517-009-0502-8; Guzik P, 2013, CLIN AUTON RES, V23, P91, DOI 10.1007/s10286-013-0188-8; Hamilton EF, 2013, J PERINAT MED, V41, P83, DOI 10.1515/jpm-2012-0024; Healthcare G., 1997, J OBSTET GYNECOL NEO, V26, P635; James T N, 1970, Am J Cardiol, V25, P213, DOI 10.1016/0002-9149(70)90581-3; Kikuchi A., 2005, EARLY HUM DEV, V81, P655; Kimura Y., 2012, OPEN MED DEVICES J, V4, P7; Kimura Y., 1996, AM J PHYSIOL, V271, pH1333; Ohta T, 1999, FETAL DIAGN THER, V14, P92, DOI 10.1159/000020896; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Rooth G., 1987, INT J GYNECOL OBSTET, V25, P159; Signorini MG, 2003, IEEE T BIO-MED ENG, V50, P365, DOI 10.1109/TBME.2003.808824; Camm AJ, 1996, CIRCULATION, V93, P1043; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950	57	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	AUG	2015	21						43	48		10.1016/j.bspc.2015.05.010		6	Engineering, Biomedical; Medical Laboratory Technology	Engineering; Medical Laboratory Technology	CN7PU	WOS:000358627300006		
J	Fukuhara, H; Inoue, K; Kurabayashi, A; Furihata, M; Shuin, T				Fukuhara, Hideo; Inoue, Keiji; Kurabayashi, Atsushi; Furihata, Mutsuo; Shuin, Taro			Performance of 5-aminolevulinic-acid-based photodynamic diagnosis for radical prostatectomy	BMC UROLOGY			English	Article							POSITIVE SURGICAL MARGINS; ACID; CANCER; CARCINOMA; BLADDER; FLUORESCENCE	Background: The aim of this study was to investigate whether we could detect positive surgical margins during open and laparoscopic radical prostatectomy by 5-aminolevulinic acid (ALA) photodynamic diagnosis (PDD) and mapping of red fluorescence in human prostate cancer cells. Methods: All 52 patients were diagnosed with prostate cancer by biopsy. They had a positive core in the apex or highly suspicious positive margins. Open and laparoscopic radical prostatectomy was performed in 18 and 34 cases, respectively. One gram of ALA solution was given intraoperatively, orally through a stomach tube. An endoscopic PDD system, including a D-Light C, CCU Tricam SLII/3CCD CH Tricam-P PDD, and HOPKINS II Straight Forward Telescope 0 degrees, was used. The D-Light C light source was equipped with a band-pass filter. The CCU Tricam SLII/3CCD CHTricam-P PDD video camera system was equipped with a long-pass filter. The laparoscopy optic component was equipped with a yellow long-pass filter. Results: One of the 52 patients had a red-fluorescent-positive margin of the excised whole prostate and the positive surgical margin was histologically confirmed. In the section of excised prostate, we obtained 141 biopsied samples. The sensitivity and specificity were 75.0 % and 87.3 %, respectively. Conclusions: Intraoperative ALA-PDD is feasible. However, heat degeneration and length of positive surgical margin have crucial influences on red fluorescence. In future, a randomized clinical trial should be carried out.	[Fukuhara, Hideo; Inoue, Keiji; Shuin, Taro] Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan; [Kurabayashi, Atsushi; Furihata, Mutsuo] Kochi Med Sch, Dept Pathol, Nankoku, Kochi 7838505, Japan	Inoue, K (reprint author), Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan.	keiji@kochi-u.ac.jp			Department of Urology, Kochi Medical School	This work was supported by the Department of Urology, Kochi Medical School.	Zaak D, 2002, CANCER, V95, P1234, DOI 10.1002/cncr.10821; STEINBACH P, 1995, PHOTOCHEM PHOTOBIOL, V62, P887; Adam C, 2009, EUR UROL, V55, P1281, DOI 10.1016/j.eururo.2009.02.027; Fukuhara H, 2013, PHOTODIAGN PHOTODYN, V10, P399, DOI 10.1016/j.pdpdt.2013.03.003; Yossepowitch O, 2009, EUR UROL, V55, P87, DOI 10.1016/j.eururo.2008.09.051; Terakawa T, 2008, INT J UROL, V15, P704, DOI 10.1111/j.1442-2042.2008.02057.x; Cheng L, 1999, CANCER, V86, P1775, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1775::AID-CNCR20>3.0.CO;2-L; Zaak D, 2008, UROLOGY, V72, P345, DOI 10.1016/j.urology.2007.12.086; Walsh PC, 1998, J UROLOGY, V160, P2418, DOI 10.1016/S0022-5347(01)62202-X; Sasaki H, 2009, INT J UROL, V16, P664, DOI 10.1111/j.1442-2042.2009.02328.x; Wright JL, 2010, J UROLOGY, V183, P2213, DOI 10.1016/j.juro.2010.02.017; D'Amico AV, 2002, CANCER, V95, P281, DOI 10.1002/cncr.10657; Stephenson AJ, 2009, J UROLOGY, V182, P1357, DOI 10.1016/j.juro.2009.06.046; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Blute ML, 1997, UROLOGY, V50, P733, DOI 10.1016/S0090-4295(97)00450-0; Filbeck T, 1999, J ENDOUROL, V13, P117, DOI 10.1089/end.1999.13.117; Ganzer R, 2009, J ENDOUROL, V23, P1387, DOI 10.1089/end.2009.0374; Honda N, 2011, J BIOMED OPT, V16; Hungerhuber E, 2007, UROLOGY, V69, P260, DOI 10.1016/j.urology.2006.10.015; Inoue K, 2012, CANCER-AM CANCER SOC, V118, P1062, DOI 10.1002/cncr.26378; Koenig F, 1999, BJU INT, V83, P129, DOI 10.1046/j.1464-410X.1999.00917.x; Kreigmair M, 1996, J UROLOGY, V155, P105; Kreigmair M, 1994, UROLOGY, V44, P836; Matsuda T, 2006, JPN J CLIN ONCOL, V42, P139; Miyoshi N, 2002, JAP SOC LASER MED, V23, P81; Naito S, 2008, J UROLOGY, V180, P904, DOI 10.1016/j.juro.2008.05.047	26	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2490			BMC UROL	BMC Urol.	AUG 1	2015	15								78	10.1186/s12894-015-0073-y		6	Urology & Nephrology	Urology & Nephrology	CO0GC	WOS:000358827100001		
J	Jia, N; Yang, ZH; Xie, MW; Mitani, Y; Tong, JX				Jia, Ning; Yang, Zhaohui; Xie, Mowen; Mitani, Yasuhiro; Tong, Jianxing			GIS-based three-dimensional slope stability analysis considering rainfall infiltration	BULLETIN OF ENGINEERING GEOLOGY AND THE ENVIRONMENT			English	Article						Rainfall-induced slope failure; Green and Ampt model; 3D-limit equilibrium method; Geographic information system; Wetting front	AMPT INFILTRATION; LANDSLIDE HAZARD; GREEN; SOILS; MODEL; WATER	Rainfall-induced landslides are a major cause of slope failure in mountainous areas. As rainfall begins to infiltrate a slope the wetting front advances into the soil and reduces its shear strength. Slope failures occur when the reduced shear strength becomes less than the resisting shear strength needed for equilibrium. These areas of instability are usually located near the ground surface where pore-water pressure changes rapidly during infiltration. The wetting front depth in a slope plays an important role in slope stability. In this study a well-known infiltration model, the Green and Ampt model, is integrated into three GIS-based three-dimensional limit equilibrium methods to assess the impact of rainfall on slope stability. This infiltration model can predict the depth of the wetting front during steady and unsteady rainfall. The applied three-dimensional methods are modified according to different positions of the wetting front to reflect the influence of rainfall on slope stability. This approach is capable of calculating safety factors corresponding to individual rainfall events and is also capable of predicting the corresponding failure time. The accuracy of the presented study has been verified by simulating the failure process of a real landslide triggered by a rainstorm.	[Jia, Ning; Tong, Jianxing] China Acad Bldg Res, Inst Fdn Engn, Beijing, Peoples R China; [Yang, Zhaohui] China Inst Water Resources & Hydropower Res, Beijing, Peoples R China; [Xie, Mowen] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Beijing 100083, Peoples R China; [Mitani, Yasuhiro] Kyushu Univ, Grad Sch Engn, Dept Civil & Struct Engn, Fukuoka 812, Japan	Jia, N (reprint author), China Acad Bldg Res, Inst Fdn Engn, Beijing, Peoples R China.	ninjanin@yeah.net					Alexander DE, 2008, GEOMORPHOLOGY, V94, P261, DOI 10.1016/j.geomorph.2006.09.022; Cho SE, 2002, J GEOTECH GEOENVIRON, V128, P756, DOI 10.1061/(ASCE)1090-0241(2002)128:9(756); Xie MW, 2006, COMPUT GEOTECH, V33, P260, DOI 10.1016/j.compgeo.2006.07.003; Ogden FL, 1997, J IRRIG DRAIN E-ASCE, V123, P386, DOI 10.1061/(ASCE)0733-9437(1997)123:5(386); Trigila A, 2010, LANDSLIDES, V7, P455, DOI 10.1007/s10346-010-0213-0; van Westen CJ, 2006, B ENG GEOL ENVIRON, V65, P167, DOI 10.1007/s10064-005-0023-0; Ng CWW, 2001, CAN GEOTECH J, V38, P1049, DOI 10.1139/cgj-38-5-1049; Jia GW, 2009, ENG GEOL, V106, P92, DOI 10.1016/j.enggeo.2009.03.003; Crosta GB, 2003, NAT HAZARD EARTH SYS, V3, P81; Kim J, 2004, ENG GEOL, V75, P251, DOI 10.1016/j.enggeo.2004.06.017; HUNGR O, 1989, CAN GEOTECH J, V26, P679; Xie MW, 2004, COMPUT GEOTECH, V31, P267, DOI 10.1016/j.compgeo.2004.03.003; Ng CWW, 1998, COMPUT GEOTECH, V22, P1, DOI 10.1016/S0266-352X(97)00036-0; CHU ST, 1978, WATER RESOUR RES, V14, P461, DOI 10.1029/WR014i003p00461; Casagli N, 2006, LANDSLIDES, V3, P13, DOI 10.1007/s10346-005-0007-y; Gasmo JM, 2000, COMPUT GEOTECH, V26, P145, DOI 10.1016/S0266-352X(99)00035-X; Burrough P A, 1998, PRINCIPLES GEOGRAPHI; Chang MS, 2002, CAN GEOTECH J, V39, P799, DOI 10.1139/T02-020; Duncan J. M., 2005, SOIL STRENGTH SLOPE; Duncan JM, 1996, J GEOTECH ENG-ASCE, V122, P577, DOI 10.1061/(ASCE)0733-9410(1996)122:7(577); Govindaraju RS, 1996, J HYDROL, V178, P337, DOI 10.1016/0022-1694(95)02796-3; Green WH, 1911, J AGR SCI, V4, P1; Hovland HJ, 1977, ASCE J GEOTECHNICAL, V103, P971; Kim YK, 2010, J GEOTECH GEOENVIRON, V136, P248, DOI 10.1061/(ASCE)GT.1943-5606.0000160; Lysandros P, 2012, J GEOTECH GEOENVIRON, V138, P1158; Muntohar AS, 2010, NAT HAZARDS, V54, P967, DOI 10.1007/s11069-010-9518-5; Ormsby T, 2001, GETTING KNOW ARCGIS; PHILIP J. R., 1957, SOIL SCI, V83, P345, DOI 10.1097/00010694-195705000-00002; Qi Z, 2006, COMP FINITE DIFFEREN; Qiu C, 2007, ENVIRON GEOL, V52, P1569, DOI 10.1007/s00254-006-0601-x; RAWLS WJ, 1983, J HYDRAUL ENG-ASCE, V109, P62; Richards R., 1931, PHYSICS, V1, P318; Serrano SE, 2003, J HYDROL ENG, V8, P158, DOI 10.1061/(ASCE)1084-0699(2003)8:3(158); SMITH RE, 1993, WATER RESOUR RES, V29, P133, DOI 10.1029/92WR02093; West Nippon Expressway Company Limited, 2010, GEOL HAZ INV REP LAN	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9529	1435-9537		B ENG GEOL ENVIRON	Bull. Eng. Geol. Environ.	AUG	2015	74	3					919	931		10.1007/s10064-014-0661-1		13	Engineering, Environmental; Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CN4DV	WOS:000358381100020		
J	Aydan, O; Kumsar, H				Aydan, Omer; Kumsar, Halil			Assessment of the earthquake potential of the west Aegean region of Turkey based on seismicity, tectonics, crustal deformation and geo-archaeological evidence and its geotechnical aspects	BULLETIN OF ENGINEERING GEOLOGY AND THE ENVIRONMENT			English	Article						West Aegean region; Earthquake; Liquefaction; Strong motion attenuation; Design spectra; Active faults; Tectonics; Crustal deformation; Seismicity	PEAK HORIZONTAL ACCELERATION; EVOLUTION; ANATOLIA; GRABEN; ATTENUATION; IZMIR; FIELD; GPS	The western Aegean region of Turkey is highly populated; the centrally-located city of Izmir is the third largest city in Turkey. This region has suffered very large earthquakes in the past, of which one of the most devastating occurred in 1928. Some areas are particularly prone to severe ground liquefaction. This study is concerned with the earthquake potential of the region, focusing on a possible earthquake faulting mechanism and its associated characteristics based on historical and current regional seismicity, tectonics, crustal deformation and geo-archaeological evidence. The first part of the study presents a faulting mechanism, tectonics, recurrences and the fundamental characteristics of existing faults and past earthquakes. Then, the characteristics of potential earthquakes are discussed in light of evaluations of recent crustal deformation and empirical relations developed for Turkey by the first author. The final part presents geotechnical aspects, including liquefaction and the characteristics of strong ground motions recorded in the region, such as spectral acceleration, attenuation of maximum ground acceleration and velocity. Furthermore, their possible implications are discussed in view of current Turkish seismic design codes. The faulting mechanism of regional earthquakes has indicated that the classical horst-graben concept does not explain the earthquake mechanism in the region of concern. The magnitude of earthquakes inferred from the length and type of known active faults may be up to 7.7. Based on an evaluation of crustal deformation in the region, the highest disturbing stress and mean stress concentration with a compressive character occurs in close proximity to A degrees zmir. The spectral accelerations generally exceed those of Turkish seismic design codes. The liquefaction potential in areas of alluvial quaternary deposits is particularly high and is one of the major geotechnical issues in light of historical records and evaluations presented in this manuscript.	[Aydan, Omer] Univ Ryukyus, Dept Civil Engn & Architecture, Nishihara, Okinawa 90301, Japan; [Kumsar, Halil] Pamukkale Univ, Dept Geol Engn, Denizli, Turkey	Aydan, O (reprint author), Univ Ryukyus, Dept Civil Engn & Architecture, Nishihara, Okinawa 90301, Japan.	aydan@tec.u-ryukyu.ac.jp; hkumsar@pau.edu.tr					Altunel E, 1999, J GEOL SOC LONDON, V156, P241, DOI 10.1144/gsjgs.156.2.0241; Altunel E., 1998, TURKISH J EARTH SCI, V7, P25; AMBRASEYS NN, 1988, EARTHQUAKE ENG STRUC, V17, P1, DOI 10.1002/eqe.4290170101; JOYNER WB, 1981, B SEISMOL SOC AM, V71, P2011; CAMPBELL KW, 1981, B SEISMOL SOC AM, V71, P2039; McClusky S, 2000, J GEOPHYS RES-SOL EA, V105, P5695, DOI 10.1029/1999JB900351; EYIDOGAN H, 1985, GEOPHYS J ROY ASTR S, V81, P569, DOI 10.1111/j.1365-246X.1985.tb06423.x; HANCOCK PL, 1987, J STRUCT GEOL, V9, P573, DOI 10.1016/0191-8141(87)90142-8; Yilmaz Y, 2000, GEOL SOC SPEC PUBL, V173, P353, DOI 10.1144/GSL.SP.2000.173.01.17; Aktug B, 2006, J GEODYN, V41, P471, DOI 10.1016/j.jog.2006.01.004; Ulusay R, 2004, ENG GEOL, V74, P265, DOI 10.1016/j.enggeo.2004.04.002; Bozkurt E, 2003, GEODIN ACTA, V16, P61, DOI 10.1016/S0985-3111(03)00002-0; [Anonymous], 1988, P 9 WORLD C EARTHQ E; Gulen L, 2002, B SEISMOL SOC AM, V92, P230, DOI 10.1785/0120000815; Aydan O, 2012, B ENG GEOL ENVIRON, V71, P637, DOI 10.1007/s10064-012-0435-6; [Anonymous], 2007, URK SEISM COD, P159; Aydan, 2001, GEOLOGICAL ENG, V25, P1; Aydan O, 2002, J SCH MARINE SCI TEC, V54, P21; Aydan O, 2011, 7 NAT C EARTHQ ENG I, P1; Aydan O, 2007, 6 NAT C EARTHQ ENG T, V1, P563; Aydan O, 1997, 97007 TDVTR TURK EAR; Aydan O, 2003, 02487 TDVKT TURK EAR, P1; Aydan O, 2000, INT C GIS EARTH SCI; Aydan O, 2012, P INT S ENG LESS LEA, P1914; Aydan O, 2000, S SEISM W AN IZM, P279; Aydan O, 2011, ADV ROCK DYNAMICS AP, P341; Aydan O., 2002, EARTHQUAKE STRUCTURA, V19, P199; Aydan O, 2000, YERBILIMLERI, V22, P21; Aydan O, 2004, YERBILIMLERI, V30, P91; Aydan O, 2012, ENCY SUSTAINABILITY, P3233; Aydan O, 1996, 11 WORLD C EARTHQ EN; Aydan O, 2000, YERBILIMLERI, V22, P223; AYDAN O, 2006, J SCH MAR SCI TECHNO, V4, P77; Aydan O, 2005, IESCA 05 IZM TURK, P225; Aydan O, 2000, P 12 WORLD C EARTHQ, P7; Aydan O, 2013, B I OCEAN RES DEV TO, V34, P1; Ayhan E, 1981, CATALOG EARTHQUAKES; Barka AA, 1997, ACTIVE TECTONICS NW, P55; Bozkurt E, 2004, GEOL MAG, V141, P63, DOI 10.1017/S0016756803008379; Bozkurt E, 2001, INT J EARTH SCI, V89, P728, DOI 10.1007/s005310000141; Canitez N, 1967, 25 ITU MAD FAK YER F; Emre O, 2005, 10754 MTA, P80; Ergin K, 1967, CATALOG EARTHQUAKES; Eskisar T, 2014, ENG GEOL, V172, P95; ETHZ, 2013, MOM TENS SOL; Eyidogan H, 1991, TURKIYE BUYUK DEPREM, P198; Genc CS, 2001, GEODIN ACTA, V14, P45, DOI 10.1016/S0985-3111(00)01061-5; Gencoglu S, 1990, TURKIYENIN DEPREM TE; Gulen L, 1989, NATO ADV STUDIES I C, VC258, P143; HARVARD, 2013, GLOB CMT; Izmir Municipality, 2000, RADIUS PROJ DEPR RIS; Kalafat D., 2009, CATALOGUE SOURCE PAR; Ketin I, 1973, UMUMI JEOLOJI, P30; Kuribayahsi E., 1975, SOILS FOUND, V15, P81, DOI DOI 10.3208/SANDF1972.15.4_81; Port and Harbour Research Institute Japan, 1997, HDB LIQ REM RECL LAN; Reilinger RE, 1997, J GEOPHYS RES-SOL EA, V102, P9983, DOI 10.1029/96JB03736; Rojay B, 2005, GEODIN ACTA, V18, P317, DOI 10.3166/ga.18.317-331; Saroglu F., 1992, TURKIYE DIRI FAY HAR; Sengor A. M. C., 1987, CONTINENTAL EXTENSIO, V28, P575; Seyitoglu G, 1996, J GEODYN, V22, P145, DOI 10.1016/0264-3707(96)00004-X; Soysal H, 1981, 341 TBAG IST U EARTH; Tezcan S, 1996, 96001 TDVTR TURK EAR, P26; Tezcan S, 1996, 96005 TDVTR; Turkelli N., 1995, JEOFIZIK, V9-10, P343; Ulusay R, 2000, S EARTHQ POT W AN IZ, P279; USGS, 2013, US GEOL SURV USGS GL	66	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9529	1435-9537		B ENG GEOL ENVIRON	Bull. Eng. Geol. Environ.	AUG	2015	74	3					1037	1055		10.1007/s10064-014-0684-7		19	Engineering, Environmental; Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CN4DV	WOS:000358381100029		
J	Aydan, O				Aydan, Omer			Crustal stress changes and characteristics of damage to geo-engineering structures induced by the Great East Japan Earthquake of 2011	BULLETIN OF ENGINEERING GEOLOGY AND THE ENVIRONMENT			English	Article						The Great 2011 Earthquake of East Japan; Crustal stress change; Damage; Geo-engineering structure; Tsunami	ACCELERATION	T he Great 2011 Earthquake of East Japan, with a moment magnitude of 9.0, occurred off the shore of the Tohoku Region of Japan. Although seismologists anticipated an earthquake with a magnitude of 7.5 in the source area, the magnitude of this earthquake was much greater than anticipated. Furthermore, the level of the tsunami induced by this earthquake also exceeded expectations. Therefore, damage caused by the tsunami was tremendous and more than 18,000 people perished due to insufficient counter-measures. The author first presents characteristics of the earthquake and its associated tsunami and then describes damage to some geo-engineering structures. The final part of the article describes lessons learned from this earthquake and proposes recommendations. Changes in crustal stress occurred as forecasted by computations and in situ stress measurements. However, it is expected the orientation of the maximum principal stress would remain almost the same as those prior to the earthquake. The scale and number of slope failures were much larger on the hanging wall side of the earthquake fault as compared to those on the foot-wall side. It has also become clear that the scale of natural slope failures is much larger than that of cut-slopes (man-made) and, therefore, more attention should be given to potential natural rock slope failures. In addition, slope failures may also be induced by tsunamis, thus necessitating further studies on the effect of tsunamis on rock slopes, with consideration of their structural geological features. Strong ground shaking induced the collapse of semi-underground tunnel portals in the abandoned Oya quarries. In addition to potential caving of abandoned mines and quarries during earthquakes due to either pillar failure and/or roof failure, groundwater may present additional impacts on immersed mines. Sinkholes are thought to be due to ground rupture induced by the sloshing of groundwater in inclined shafts. Tsunami waves inundated many tunnels on the Onagawa, Minami-Sanriku and Kesennuma railways, although they did not cause any major structural damage. However, consideration should be given to the impact of high internal hydrostatic water pressure on conventional tunnels when they are located in tsunami-prone areas.	Univ Ryukyus, Dept Civil Engn & Architecture, Nishihara, Okinawa 90301, Japan	Aydan, O (reprint author), Univ Ryukyus, Dept Civil Engn & Architecture, Nishihara, Okinawa 90301, Japan.	aydan@tec.u-ryukyu.ac.jp					Acheson D. J., 1990, ELEMENTARY FLUID DYN; JOYNER WB, 1981, B SEISMOL SOC AM, V71, P2011; Lin WR, 2013, SCIENCE, V339, P687, DOI 10.1126/science.1229379; [Anonymous], 2008, J SCH MAR SCI TECHNO; ABE K, 1979, J GEOPHYS RES, V84, P1561, DOI 10.1029/JB084iB04p01561; Ulusay R, 2004, ENG GEOL, V74, P265, DOI 10.1016/j.enggeo.2004.04.002; Aydan O, 2010, ROCK MECH ROCK ENG, V43, P857, DOI 10.1007/s00603-010-0105-6; Aydan O, 2012, B ENG GEOL ENVIRON, V71, P637, DOI 10.1007/s10064-012-0435-6; Aydan O, 2012, P INT S ENG LESS LEA, P981; Aydan O, 2002, J SCH MARINE SCI TEC, V54, P21; Aydan O, 2011, P 1 INT C GEOT CONST, P505; Aydan O, 2003, TURK EARTHQ FDN TDV, V24-87, P1; Aydan O., 2011, P 7 NAT C EARTHQ ENG, P1; Aydan O, 2007, P 6 NAT C EARTHQ ENG, V1, P563; Aydan O, 2011, ADV ROCK DYNAMICS AP, P341; Aydan O., 2002, EARTHQUAKE STRUCTURA, V19, P199; Aydan O, 2012, P 65 YEARS MAH VARD, P17; Aydan O, 2000, YERBILIMLERI, V22, P21; Aydan O, 2004, YERBILIMLERI, V30, P91; Aydan O, 2012, ENCY SUSTAINABILITY, P3233; Aydan O., 2012, J JAPAN ASS EARTHQUA, V12, P229; Aydan O, 2013, P 6 INT S SIT ROCK S, P8; Aydan O, 2000, YERBILIMLERI, V22, P223; Aydan O, 2012, INT J GEOMECH, V12, P14, DOI 10.1061/(ASCE)GM.1943-5622.0000040; Aydan O, 2013, P 47 US ROCK MECH GE, P10; AYDAN O, 2006, J SCH MAR SCI TECHNO, V4, P77; Aydan O, 2013, B I OCEAN RES DEV TO, V34, P1; Aydan O, 2004, P 3 AS ROCK MECH S K, V1, P525; Bryant E., 2001, TSUNAMI UNDERRATED H; Fukushima Y, 1988, P 9 WCEE TOK, P343; Iida K, 1963, P TSUM M ASS 10 PAC, P7; Iwatate T, 2011, P 1 INT C GEOT CONST, P511; KEEFER DK, 1984, GEOL SOC AM BULL, V95, P406; Koketsu K, 2012, P INT S ENG LESS LEA, P1; Port Authority Research Institute (PARI), 2011, SPEC; Sakaguchi K, 2013, P 13 JAP S ROCK MECH, P513	36	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9529	1435-9537		B ENG GEOL ENVIRON	Bull. Eng. Geol. Environ.	AUG	2015	74	3					1057	1070		10.1007/s10064-014-0668-7		14	Engineering, Environmental; Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CN4DV	WOS:000358381100030		
J	Suddeepong, A; Chai, JC; Shen, SL; Carter, J				Suddeepong, Apichat; Chai, Jinchun; Shen, Shuilong; Carter, John			Deformation behaviour of clay under repeated one-dimensional unloading-reloading	CANADIAN GEOTECHNICAL JOURNAL			English	Article						groundwater fluctuation; land subsidence; oedometer test; repeated unloading-reloading	LONG-TERM CONSOLIDATION; LAND SUBSIDENCE	The deformation of clayey soil under repeated cycles of unloading and reloading has been investigated in oedometer tests using both undisturbed and reconstituted Ariake clay samples. The test results indicate that even for repeated unloading-reloading in the overconsolidated stress range, the deformation of the soil sample is not purely elastic and there is an accumulation of permanent deformation. Based on the test results, a model has been proposed for predicting unloading-reloading-induced deformation. The proposed model has been used to simulate the behaviour of a clayey soil deposit in the Saga Plain, Japan, in response to groundwater fluctuation. Good agreement between the simulation and the field measurements indicates that the proposed model can be used to predict land subsidence induced by groundwater fluctuations.	[Suddeepong, Apichat; Chai, Jinchun] Saga Univ, Dept Civil Engn & Architecture, Saga, Saga 8408502, Japan; [Shen, Shuilong] Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai 200240, Peoples R China; [Shen, Shuilong] Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, Shanghai 200240, Peoples R China; [Carter, John] Univ Newcastle, Fac Engn & Built Environm, Callaghan, NSW 2308, Australia	Chai, JC (reprint author), Saga Univ, Dept Civil Engn & Architecture, 1 Honjo Machi, Saga, Saga 8408502, Japan.	chai@cc.saga-u.ac.jp			National Basic Research Program of China (973 Program) [2015CB057800]	Some of the field data from Saga Plain were provided by Dr. Akira Sakai at Saga University. We appreciate his generous help very much. The research work described herein was partially supported by the National Basic Research Program of China (973 Program: 2015CB057800).	Chai JC, 2004, GEOTECHNIQUE, V54, P143, DOI 10.1680/geot.54.2.143.36332; Watabe Y, 2008, SOILS FOUND, V48, P495, DOI 10.3208/sandf.48.495; [Anonymous], 2006, D2487 ASTM; Shen SL, 2013, CAN GEOTECH J, V50, P1129, DOI 10.1139/cgj-2013-0042; Watabe Y, 2012, SOILS FOUND, V52, P449, DOI 10.1016/j.sandf.2012.05.005; Bhattacharya AK., 2013, ELECT J GEOTECHNICAL, V18, P1683; Butterfield R, 2011, SOILS FOUND, V51, P253, DOI 10.3208/sandf.51.253; Carter J.P., 1982, SOIL MECH TRANSIENT, P219; Hung WC, 2012, ENG GEOL, V147, P78, DOI 10.1016/j.enggeo.2012.07.018; JSA, 2009, A1217 JSA JIS; Leroueil S., 2006, P 13 DAN EUR C GEOT, V2, P55; Miura N., 1988, P INT S SHALL SEA LO, P151; Modoni G, 2013, ENG GEOL, V167, P59, DOI 10.1016/j.enggeo.2013.10.014; Sakai A., 2001, LOWLAND TECHNOL INT, V3, P24	14	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-3674	1208-6010		CAN GEOTECH J	Can. Geotech. J.	AUG	2015	52	8					1035	1044		10.1139/cgj-2014-0216		10	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CN7HV	WOS:000358606100003		
J	Torigoe, T; Sato, S; Sanada, A				Torigoe, Tsukasa; Sato, Seiichi; Sanada, Akiko			Extracardiac Interatrial Tunnel and Atrial Septal Defect Closed With a Single Atrial Septal Occluder in an Adolescent Girl	CANADIAN JOURNAL OF CARDIOLOGY			English	Article								In contrast to the atrial septal defect (ASD) as a congenital interatrial shunt, the extracardiac interatrial tunnel is extremely rare. We report the first percutaneous closure of this entity during closure of a secundum ASD after careful investigation of ischemic risk in a 15-year-old girl. The extracardiac interatrial tunnel could entail interatrial shunt, and, if misidentified as an ASD, could result in lethal procedural complications during surgical or catheter interventions. In our case, the tunnel was also morphologically similar to the cardiac arterial/venous system. Therefore, careful investigation of its potential relationship with coronary circulation was required before its closure.	[Torigoe, Tsukasa; Sato, Seiichi] Niigata City Gen Hosp, Dept Pediat & Neonatol, Niigata 9501197, Japan; [Sanada, Akiko] Niigata City Gen Hosp, Dept Cardiol, Niigata 9501197, Japan	Torigoe, T (reprint author), Niigata City Gen Hosp, Dept Pediat & Neonatol, Chuo Ku, 463-7 Shumoku, Niigata 9501197, Japan.	tsukasa-t-vw12@zd5.so-net.ne.jp					Kanadasi M, 2005, INT J CARDIOVAS IMAG, V21, P379, DOI 10.1007/s10554-004-6135-y; Saremi F, 2012, RADIOGRAPHICS, V32, pE1, DOI 10.1148/rg.321115014; Waldman JD, 2001, PEDIATR CARDIOL, V22, P397	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	AUG	2015	31	8							1073.e17	10.1016/j.cjca.2015.03.002		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN4UM	WOS:000358425800024		
J	Konishi, A; Shinke, T; Otake, H; Takaya, T; Osue, T; Kinutani, H; Kuroda, M; Takahashi, H; Terashita, D; Shite, J; Hirata, K				Konishi, Akihide; Shinke, Toshiro; Otake, Hiromasa; Takaya, Tomofumi; Osue, Tsuyoshi; Kinutani, Hiroto; Kuroda, Masaru; Takahashi, Hachidai; Terashita, Daisuke; Shite, Junya; Hirata, Ken-ichi			Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer-Coated Stent Implantation	CANADIAN JOURNAL OF CARDIOLOGY			English	Article							SIROLIMUS-ELUTING STENTS; CORONARY-ARTERY-DISEASE; BARE-METAL STENTS; FOLLOW-UP; CLINICAL-OUTCOMES; JAPANESE PATIENTS; NEOATHEROSCLEROSIS; PACLITAXEL; ATHEROSCLEROSIS; INFLAMMATION	Background: The Nobori (Terumo Corporation, Tokyo, Japan) is a biolimus A9-eluting stent (BES) featured with a biodegradable polymer coated on the abluminal side only. We previously reported that favourable vessel healing was achieved at 6-12 months after BES implantation. However, detailed long-term vessel reaction after BES deployment is unclear. Methods: Twenty-two BESs were serially evaluated using optical coherence tomography (OCT) at 6, 12, and 24 months after stenting. Average neointimal thickness, uncovered struts, and neointimal unevenness score (each cross-section as maximum neointimal thickness in 1 cross section divided by the average neointimal thickness of the same cross-section) were manually measured. In addition, we evaluated the percentage of struts with peri-strut low-intensity area (a region around stent struts that homogenously showed less intensity than the surrounding tissue, which suggests fibrin deposition or impaired neointima maturation), thrombi, and atherogenic neointimas (neointimas containing a diffuse border and poor-signal region with invisible struts due to marked signal attenuation). Results: Serial OCT observation revealed a small gradual increase in neointimal thickness from 6 to 24 months (73 +/- 24 mm; 81 +/- 26 mm; and 108 +/- 35 mm, respectively, P = 0.001) with a nonsignificant decrease in the lumen area (6.36 +/- 1.98 mm(2); 6.18 +/- 2.04 mm(2); and 5.87 +/- 2.06 mm(2); P = 0.72). Frequency of uncovered struts (3.89 +/- 3.91%; 1.55 +/- 1.63%; and 0.23 +/- 0.67%; P = 0.001), neointimal unevenness score (1.95 +/- 0.18% to 1.86 +/- 0.19% to 1.78 +/- 0.17; P = 0.012), percentage of thrombi (5%, 0%, and 0%; P = 0.37) and peri-strut low-intensity area (6.8%, 5.1%, and 1.6%; P = 0.017) decreased from 6 to 12 and 24 months. Atherogenic neointima was not observed in the event-free OCT cohort. Conclusions: The Nobori stent achieved acceptable long-term vessel healing, mostly without adverse vessel reactions.	[Konishi, Akihide; Shinke, Toshiro; Otake, Hiromasa; Takaya, Tomofumi; Osue, Tsuyoshi; Kinutani, Hiroto; Kuroda, Masaru; Takahashi, Hachidai; Terashita, Daisuke; Shite, Junya; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan	Shinke, T (reprint author), Kobe Univ, Grad Sch Med, Dept Cardiol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shinke@med.kobe-u.ac.jp		Takaya, Tomofumi/0000-0001-5775-8072			Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Matsumoto D, 2007, EUR HEART J, V28, P961, DOI 10.1093/eurheartj/ehl413; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443; Byrne RA, 2009, JACC-CARDIOVASC INTE, V2, P291, DOI 10.1016/j.jcin.2008.11.015; Won H, 2013, INT J CARDIOVAS IMAG, V29, P1255, DOI 10.1007/s10554-013-0223-9; Takano M, 2009, J AM COLL CARDIOL, V55, P26, DOI 10.1016/j.jacc.2009.08.032; Otake H, 2009, JACC-CARDIOVASC INTE, V2, P459, DOI 10.1016/j.jcin.2009.03.003; Teramoto T, 2010, CIRC J, V74, P1257, DOI 10.1253/circj.CJ-10-0189; Guagliumi G, 2012, JACC-CARDIOVASC INTE, V5, P12, DOI 10.1016/j.jcin.2011.09.018; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Jaffer FA, 2011, J AM COLL CARDIOL, V57, P2516, DOI 10.1016/j.jacc.2011.02.036; Gonzalo N, 2010, REV ESP CARDIOL, V63, P893, DOI 10.1016/S0300-8932(10)70201-3; Kochman J, 2013, CARDIOL J, V20, P247, DOI 10.5603/CJ.2013.0069; Konishi A, 2014, CIRC J, V78, P1882, DOI 10.1253/circj.CJ-13-1474; Kuramitsu S, 2014, ATHEROSCLEROSIS, V237, P23, DOI 10.1016/j.atherosclerosis.2014.08.031; Lavi S, 2014, CAN J CARDIOL, V30, P855, DOI 10.1016/j.cjca.2014.02.009; Lee SY, 2013, EUROINTERVENTION, V9, P945, DOI 10.4244/EIJV9I8A158; Nakagawa M, 2014, CAN J CARDIOL, V30, P904, DOI 10.1016/j.cjca.2014.01.020; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Nishio R, 2012, CIRC J, V76, P2348, DOI 10.1253/circj.CJ-12-0476; Otake H, 2012, INT J CARDIOL, V157, P38, DOI 10.1016/j.ijcard.2010.11.006; Otsuka Y, 2011, CATHETER CARDIO INTE, V78, P1078, DOI 10.1002/ccd.23096; Pendyala LK, 2012, JACC-CARDIOVASC INTE, V5, P436, DOI 10.1016/j.jcin.2011.11.013; Takano M, 2010, CIRC-CARDIOVASC INTE, V3, P476, DOI 10.1161/CIRCINTERVENTIONS.110.957118; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3	26	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	AUG	2015	31	8					980	988		10.1016/j.cjca.2015.02.036		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN4UM	WOS:000358425800007		
J	Kudo, K; Hotta, K; Ichihara, E; Yoshioka, H; Kunimasa, K; Tsubouchi, K; Iwasaku, M; Kato, Y; Oze, I; Takigawa, N; Tanimoto, M; Kiura, K				Kudo, Kenichiro; Hotta, Katsuyuki; Ichihara, Eiki; Yoshioka, Hiroshige; Kunimasa, Kei; Tsubouchi, Kazuya; Iwasaku, Masahiro; Kato, Yuka; Oze, Isao; Takigawa, Nagio; Tanimoto, Mitsune; Kiura, Katsuyuki			Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Lung cancer; Gefitinib; Body surface area; EGFR-TKI	MUTATIONS; EFFICACY; PHARMACOKINETICS; TUMORS; TRIAL	Background The approved dose of gefitinib is fixed, without adjustment for physical size. We demonstrated previously that its efficacy was affected by body surface area (BSA) in patients with EGFR-mutant non-small cell lung cancer (NSCLC). To validate these observations, we assessed the association between BSA and the efficacy of gefitinib using a different patient cohort. Methods Prospective cohort data from 115 NSCLC patients with EGFR-mutant tumours, who received gefitinib monotherapy between 2007 and 2012, were analysed. Results Gefitinib was less effective in individuals with a high BSA (>= 1.5 m(2)) in EGFR-mutant NSCLC compared with those with a low BSA (< 1.5 m(2)). The median progression-free survival (PFS) in the high- and low-BSA groups was 4.2 and 8.5 months, respectively, although there was no difference in survival among the whole NSCLC cohort. Multivariate analysis also showed a significant effect of BSA on PFS (hazard ratio 1.72; 95 % confidence interval 1.08-2.74; p = 0.021). Sensitivity analysis revealed that the use of the BSA cut-off level around 1.50 m(2) was robust for detecting subpopulations that would benefit less from gefitinib monotherapy. Conclusion We found in the prospective cohort data that BSA could affect the efficacy of gefitinib monotherapy in patients with EGFR-mutant NSCLC, suggesting that BSA-based dose setting of gefitinib monotherapy might be further investigated, despite the fact that no molecular-targeted agent described to date undergoes dose adjustment according to BSA.	[Kudo, Kenichiro; Hotta, Katsuyuki; Ichihara, Eiki; Kato, Yuka; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Resp Med, Okayama 7008558, Japan; [Hotta, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama 7008558, Japan; [Yoshioka, Hiroshige; Kunimasa, Kei; Tsubouchi, Kazuya; Iwasaku, Masahiro] Kurashiki Cent Hosp, Dept Resp Med, Okayama, Japan; [Oze, Isao] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Aichi, Japan; [Takigawa, Nagio] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan	Hotta, K (reprint author), Okayama Univ Hosp, Dept Resp Med, 2-5-1,Shikata, Okayama 7008558, Japan.	kudoken19800411@yahoo.co.jp; khotta@md.okayama-u.ac.jp; eitchy7@gmail.com; hirotin@kchnet.or.jp; keikunimasa@gmail.com; kazuya_t1981@yahoo.co.jp; iwasakusaku@yahoo.co.jp; yukakatorinu@yahoo.co.jp; ozeisao@gmail.com; ntakigaw@gmail.com; tanimoto@md.okayama-u.ac.jp; kkiura@md.okayama-u.ac.jp					Kawaguchi T, 2009, INT J HEMATOL, V89, P642, DOI 10.1007/s12185-009-0315-4; Nakamura Y, 2010, J THORAC ONCOL, V5, P1404, DOI 10.1097/JTO.0b013e3181e59a7b; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Du Bois D, 1916, ARCH INTERN MED, V17, P863; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Igawa S, 2014, CANCER CHEMOTH PHARM, V74, P939, DOI 10.1007/s00280-014-2570-1; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ichihara E, 2013, LUNG CANCER, V81, P435, DOI 10.1016/j.lungcan.2013.05.021; Ichihara E, 2012, J CLIN ONCOL S, V30; Sacco JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008933	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					251	256		10.1007/s00280-015-2789-5		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900004		
J	Kawashima, R; Kawakami, F; Maekawa, T; Yamamoto, H; Koizumi, W; Ichikawa, T				Kawashima, Rei; Kawakami, Fumitaka; Maekawa, Tatsunori; Yamamoto, Hajime; Koizumi, Wasaburo; Ichikawa, Takafumi			Elemental diet moderates 5-fluorouracil-induced gastrointestinal mucositis through mucus barrier alteration	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Elemental diet (Elental); 5-Fluorouracil; Gastrointestinal mucositis; Mucin; PGM34	INDUCED GASTRIC DAMAGE; CROHNS-DISEASE; CANCER-THERAPY; CARBOHYDRATE MOIETY; MONOCLONAL-ANTIBODY; CYTOKINE PRODUCTION; ORAL GLUTAMINE; MUCOSAL INJURY; RAT; CHEMOTHERAPY	Purpose There are reports that elemental diet (ED) ameliorates oral mucositis caused by antineoplastic chemotherapy. Although this effectiveness may be partly due to high nutrient absorption, the effects of chemotherapy on mucosal defense mechanisms remain unclear. We investigated the effects of oral supplementation with ED on mucin in 5-fluorouracil (5-FU)-induced intestinal mucositis. Methods 5-FU was administered to rats orally once daily, and ED was supplied orally twice daily for 5 days. The severity of mucositis was assessed by length, dry tissue weight, and villus height of the intestinal tract. Using anti-mucin monoclonal antibody, we compared the immunoreactivity in the gastrointestinal (GI) tract and mucin content by histological and biochemical examinations. Results Oral supplementation with ED reduced histological damage and loss of length, dry tissue weight, and villus height induced by 5-FU administration. ED markedly altered PGM34 antibody immunoreactivity and mucin contents in the small intestine of rats with 5-FU-induced mucositis. Conclusion ED may possibly be more effective for the prevention of antineoplastic chemotherapy-induced mucositis through the activation of GI mucus cells.	[Kawashima, Rei; Kawakami, Fumitaka; Maekawa, Tatsunori; Ichikawa, Takafumi] Kitasato Univ, Grad Sch Med Sci, Dept Biochem Regulat, Minami Ku, Sagamahara, Kanagawa 2520373, Japan; [Kawashima, Rei; Kawakami, Fumitaka; Maekawa, Tatsunori; Ichikawa, Takafumi] Kitasato Univ, Dept Biochem, Sch Allied Hlth Sci, Minami Ku, Sagamahara, Kanagawa 2520373, Japan; [Kawashima, Rei] Natl Ctr Global Hlth & Med, Res Inst, Dept Gastroenterol, Shinjuku Ku, Tokyo 1628655, Japan; [Yamamoto, Hajime; Koizumi, Wasaburo] Kitasato Univ, Sch Med, Dept Gastroenterol, Minami Ku, Sagamahara, Kanagawa 2520373, Japan	Ichikawa, T (reprint author), Kitasato Univ, Grad Sch Med Sci, Dept Biochem Regulat, Minami Ku, 1-15-1 Kitasato, Sagamahara, Kanagawa 2520373, Japan.	t.ichika@kitasato-u.ac.jp			School of Allied Health Sciences, Kitasato University; Kitasato University (Kitasato University Research Grant for Young Researchers)	We express our sincere appreciation to S. Sugawara for technical assistance. This study was supported by a grant from the School of Allied Health Sciences, Kitasato University. Grant from Kitasato University (Kitasato University Research Grant for Young Researchers) supported this research.	Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Sonis ST, 2004, CANCER, V100, P1995, DOI 10.1002/cncr.20162; Lochs H, 2006, CLIN NUTR, V25, P260, DOI 10.1016/j.clnu.2006.01.007; Ichikawa T, 2009, J GASTROEN HEPATOL, V24, P488, DOI 10.1111/j.1440-1746.2008.05667.x; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; SLAVIN RE, 1978, CANCER, V42, P1747, DOI 10.1002/1097-0142(197810)42:4<1747::AID-CNCR2820420413>3.0.CO;2-T; Andou A, 2009, GASTROENTEROLOGY, V136, P564, DOI 10.1053/j.gastro.2008.09.062; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Sukhotnik I, 2009, DIGESTION, V79, P5, DOI 10.1159/000191209; Rubenstein EB, 2004, CANCER-AM CANCER SOC, V100, P2026, DOI 10.1002/cncr.20163; GERDES J, 1984, J IMMUNOL, V133, P1710; AZUUMI Y, 1980, GUT, V21, P533, DOI 10.1136/gut.21.6.533; Fukui Tadahisa, 2011, Gan To Kagaku Ryoho, V38, P2597; Gerlach C, 1997, LAB INVEST, V77, P697; Gerlach C, 1997, HEPATOLOGY, V26, P573, DOI 10.1002/hep.510260307; Homan M, 2005, NAT CLIN PRACT GASTR, V2, P572, DOI 10.1038/ncpgasthep0338; Ikezawa T, 2005, BIOMED RES-TOKYO, V26, P147, DOI 10.2220/biomedres.26.147; Ishihara K, 1996, GLYCOCONJUGATE J, V13, P857, DOI 10.1007/BF00702350; JEBB SA, 1994, BRIT J CANCER, V70, P732, DOI 10.1038/bjc.1994.385; KOJIMA Y, 1992, SCAND J GASTROENTERO, V27, P764, DOI 10.3109/00365529209011180; Leitao RFC, 2008, CANCER CHEMOTH PHARM, V61, P215, DOI 10.1007/s00280-007-0463-2; Matsui T, 2005, J GASTROENTEROL, V40, P25, DOI 10.1007/BF02990575; Ogata Yutaka, 2012, Gan To Kagaku Ryoho, V39, P583; Okuno SH, 1999, AM J CLIN ONCOL-CANC, V22, P258, DOI 10.1097/00000421-199906000-00009; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; Saegusa Y, 2008, SCAND J GASTROENTERO, V43, P59, DOI 10.1080/00365520701579662; Saegusa Y, 2008, SCAND J GASTROENTERO, V43, P531, DOI 10.1080/00365520701811693; Sartori S, 1996, CANCER, V78, P1477, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1477::AID-CNCR15>3.0.CO;2-X; Shirasaka Tetsuhiko, 2006, Gan To Kagaku Ryoho, V33 Suppl 1, P4; Tsubokawa D, 2007, FEBS J, V274, P1833, DOI 10.1111/j.1742-4658.2007.05731.x; Yamamoto H, 2013, BIOMED RES INT, DOI 10.1155/2013/276186; Yamamoto T, 2005, INFLAMM BOWEL DIS, V11, P580, DOI 10.1097/01.MIB.0000161307.58327.96	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					269	277		10.1007/s00280-015-2790-z		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900006		
J	Ueda, S; Kawakami, H; Nishina, S; Sakiyama, T; Nonagase, Y; Okabe, T; Tamura, T; Nakagawa, K				Ueda, Shinya; Kawakami, Hisato; Nishina, Shinichi; Sakiyama, Tsutomu; Nonagase, Yoshikane; Okabe, Takafumi; Tamura, Takao; Nakagawa, Kazuhiko			Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Esophageal cancer; Triple combination therapy	SQUAMOUS-CELL CARCINOMA; 5-FLUOROURACIL; CISPLATIN; CHEMOTHERAPY; PLATINUM(II); SCHEDULE	Purpose The aims of this dose-escalating phase I study were to determine the maximum tolerable dose (MTD) and recommended dose (RD) of 5-fluorouracil (5-FU), docetaxel, and nedaplatin (UDON) combination therapy for future phase II studies, and to evaluate the safety and efficacy of this regimen in patients with untreated recurrent or metastatic esophageal cancer. Methods Patients were administered 5-FU on days 1-5, docetaxel on days 1 and 15, and nedaplatin on day 1 at 4-week intervals. The dose levels of 5-FU/docetaxel/nedaplatin were escalated as follows (mg/m(2)): level 1, 800/30/80; level 2, 800/30/90; and level 3, 800/35/90. Toxicity was evaluated using Common Terminology Criteria for Adverse Events version 4.0. Results Overall, nine patients were enrolled in this study. All patients had an Eastern Cooperative Oncology Group performance status of 0 or 1 and were diagnosed with squamous cell carcinoma. No dose-limiting toxicity was observed at any level, and planned dose escalation was completed without reaching the MTD. No grade 4 or higher toxicity was observed in this study. The observed grade 3 hematological toxicities included neutropenia in five patients (55.6 %) and leukopenia in three patients (33.3 %). None of the patients developed febrile neutropenia, and no grade 3 or 4 non-hematological toxicities were observed. The overall response rate was 77.8 %, including two complete responses, and the disease control rate was 100 %. Conclusion The RD of UDON was identified as level 3. The good tolerability and high antitumor efficacy of this regimen warrant further evaluation in this setting.	[Ueda, Shinya; Kawakami, Hisato; Nishina, Shinichi; Sakiyama, Tsutomu; Nonagase, Yoshikane; Okabe, Takafumi; Tamura, Takao; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Osaka 5898511, Japan	Kawakami, H (reprint author), Kinki Univ, Fac Med, Dept Med Oncol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	kawakami_h@dotd.med.kindai.ac.jp					AKAZA H, 1992, CANCER CHEMOTH PHARM, V31, P187, DOI 10.1007/BF00685546; Anand BS, 1998, DIGEST DIS SCI, V43, P2255, DOI 10.1023/A:1026618706464; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Engels FK, 2005, EUR J CANCER, V41, P1117, DOI 10.1016/j.ejca.2005.02.016; Overman MJ, 2010, CANCER-AM CANCER SOC, V116, P1446, DOI 10.1002/cncr.24925; IIZUKA T, 1992, JPN J CLIN ONCOL, V22, P172; Ajani JA, 2002, ONCOLOGY-NY, V16, P89; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Muro K, 2004, ANN ONCOL, V15, P955, DOI 10.1093/annonc/mdh231; Osaka Y, 2011, ANTICANCER RES, V31, P633; Tebbutt NC, 2010, BRIT J CANCER, V102, P475, DOI 10.1038/sj.bjc.6605522; SASAKI Y, 1989, CANCER CHEMOTH PHARM, V23, P243, DOI 10.1007/BF00451649; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; FUKUDA M, 1990, CANCER CHEMOTH PHARM, V26, P393, DOI 10.1007/BF02994087; Yokota T, 2011, ANTICANCER RES, V31, P3535; Cen P, 2007, CURR OPIN GASTROEN, V23, P631; Hironaka S, 2014, CANCER SCI, V105, P1189, DOI 10.1111/cas.12486; Kato K, 2014, ESOPHAGUS-TOKYO, V11, P183, DOI 10.1007/s10388-014-0427-7; Marin Flavia Andreia, 2010, Arquivos de Gastroenterologia, V47, P348, DOI 10.1590/S0004-28032010000400006; Minamide J, 2007, GAN TO KAGAKU RYOHO, V34, P49; Miyazaki T, 2013, CANCER CHEMOTH PHARM, V71, P853, DOI 10.1007/s00280-013-2076-2; Riccardi D, 1999, CANC CONTROL, V6, P64; SASAKI Y, 1990, JPN J CANCER RES, V81, P196; SUZUMURA Y, 1989, ANTICANCER RES, V9, P1083; Taguchi T, 1992, Gan To Kagaku Ryoho, V19, P483; Yoshioka T, 1999, INTERNAL MED, V38, P844, DOI 10.2169/internalmedicine.38.844	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					279	285		10.1007/s00280-015-2799-3		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900007		
J	Ezaki, T; Kosaka, T; Mizuno, R; Shinojima, T; Kikuchi, E; Miyajima, A; Oya, M				Ezaki, Taisuke; Kosaka, Takeo; Mizuno, Ryuichi; Shinojima, Toshiaki; Kikuchi, Eiji; Miyajima, Akira; Oya, Mototsugu			Efficacy of treatment with a GnRH antagonist in prostate cancer patients previously treated with a GnRH agonist	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						GnRH antagonist; Prostate cancer; PSA failure; Androgen-deprivation therapy	ABIRATERONE ACETATE; THERAPY; ENZALUTAMIDE; DOCETAXEL; SURVIVAL	Purpose The efficacy of switching from a GnRH agonist to a GnRH antagonist for prostate cancer patients resistant to treatment with the GnRH agonist has not been fully characterized yet. We aimed to evaluate the efficacy of the switch to a GnRH antagonist in patients with PSA failure after hormonal therapy with a GnRH agonist. Methods We retrospectively examined 18 patients with prostate cancer who received androgen-deprivation therapy and who were treated with a GnRH antagonist (degarelix) after they showed an elevated PSA while on GnRH agonist therapy. We evaluated the characteristics of the patients and analyzed some clinical factors for their potential association with the patient response to the switch. Results The median PSA at the switch was 7.9 (0.37-1709) ng/ml, and the median testosterone level was 0.17 (< 0.08-0.81) ng/ml. Three months after the switch, the median PSA level was 11.3 (0.22-2636) ng/ml, and the median testosterone level was 0.14 (< 0.08-0.23) ng/ml. The PSA decreased in six patients (33.3 %) 1 month after the switch, and in three of them it decreased by more than 50 % by 3 months after the switch. Univariate analyses revealed that the lower number of prior treatment lines for prostate cancer before the switch was associated with a favorable decrease in PSA. Conclusion Switching from GnRH agonist to GnRH antagonist therapy was effective for some prostate cancer patients with PSA failure. The small number of prior treatment lines for prostate cancer before the switch was significantly associated with a good PSA response.	[Ezaki, Taisuke; Kosaka, Takeo; Mizuno, Ryuichi; Shinojima, Toshiaki; Kikuchi, Eiji; Miyajima, Akira; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, Tokyo 1608582, Japan	Kosaka, T (reprint author), Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	takemduro@gmail.com					Suzuki H, 2008, J UROLOGY, V180, P921, DOI 10.1016/j.juro.2008.05.045; Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; Scher HI, 1999, J NATL CANCER I, V91, P244, DOI 10.1093/jnci/91.3.244; Crawford ED, 2011, J UROLOGY, V186, P889, DOI 10.1016/j.juro.2011.04.083; Schrader AJ, 2014, EUR UROL, V65, P30, DOI 10.1016/j.eururo.2013.06.042; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; Noonan KL, 2013, ANN ONCOL, V24, P1802, DOI 10.1093/annonc/mdt138; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; Masson-Lecomte A, 2013, WORLD J UROL, V31, P339, DOI 10.1007/s00345-012-0841-1; Raddin RS, 2011, ANTI-CANCER DRUG, V22, P299, DOI 10.1097/CAD.0b013e328342d54b	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					301	306		10.1007/s00280-015-2798-4		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900009		
J	Yamashita, F; Komoto, I; Oka, H; Kuwata, K; Takeuchi, M; Nakagawa, F; Yoshisue, K; Chiba, M				Yamashita, Fumiaki; Komoto, Ikumi; Oka, Hiroaki; Kuwata, Keizo; Takeuchi, Mayuko; Nakagawa, Fumio; Yoshisue, Kunihiro; Chiba, Masato			Exposure-dependent incorporation of trifluridine into DNA of tumors and white blood cells in tumor-bearing mouse	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						TAS-102; Trifluridine; DNA; Granulocyte macrophages; Tipiracil hydrochloride; Pharmacokinetics	CHEMOTHERAPY-INDUCED NEUTROPENIA; METASTATIC COLORECTAL-CANCER; SOLID TUMORS; IN-VITRO; ANTITUMOR-ACTIVITY; LUNG-CANCER; PHASE-I; TAS-102; MURINE; PROGENITORS	Purpse Trifluridine (TFT) is an antitumor component of a novel nucleoside antitumor agent, TAS-102, which consists of TFT and tipiracil hydrochloride (thymidine phosphorylase inhibitor). Incorporation of TFT into DNA is a probable mechanism of antitumor activity and hematological toxicity. The objective of this study was to examine the TFT incorporation into tumor- and white blood cell-DNA, and to elucidate the mechanism of TFT-related effect and toxicity. TFT effect on the colony formation of mouse bone marrow cells was also investigated. Methods Pharmacokinetics of TFT was determined in nude mice after single oral administration of TAS-102, while the antitumor activity and body weight change were evaluated in the tumor-bearing nude mice after multiple oral administrations for 2 weeks. TFT concentrations in the blood- and tumor-DNA were determined by LC/MS/MS. The colony formation was evaluated by CFU-GM assay. Results TFT systemic exposure in plasma increased dose-dependently. The tumor growth rate and body weight gain decreased dose-dependently, but TFT concentrations in the DNA of tumor tissues and white blood cells increased dose-dependently. TFT inhibited colony formation of bone marrow cells in a concentration-dependent manner. Conclusions A significant relationship between systemic exposure of TFT and pharmacological effects including the antitumor activity and body weight change was well explained by the TFT incorporation into DNA. TFT inhibited proliferations of mouse bone marrow cells and human colorectal carcinoma cells implanted to nude mice dose-dependently. The highest tolerable TFT exposure provides the highest antitumor activity, and the hematological toxicity may serve as a potential surrogate indicator of TAS-102 efficacy.	[Yamashita, Fumiaki; Komoto, Ikumi; Kuwata, Keizo; Takeuchi, Mayuko; Yoshisue, Kunihiro; Chiba, Masato] Taisho Pharmaceut Co Ltd, Pharmacokinet Res Labs, Tsukuba, Ibaraki 3002611, Japan; [Oka, Hiroaki] Taisho Pharmaceut Co Ltd, Toxicol Lab, Kawaguchi, Tokushima 7710194, Japan; [Nakagawa, Fumio] Taisho Pharmaceut Co Ltd, Optimal Medicat Res Lab, Kawaguchi, Tokushima 7710194, Japan	Yamashita, F (reprint author), Taisho Pharmaceut Co Ltd, Pharmacokinet Res Labs, 3 Okubo, Tsukuba, Ibaraki 3002611, Japan.	f-yamashita@taiho.co.jp					Yamanaka T, 2007, BRIT J CANCER, V97, P37, DOI 10.1038/sj.bjc.6603831; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Emura T, 2004, INT J ONCOL, V25, P571; Overman MJ, 2008, INVEST NEW DRUG, V26, P445, DOI 10.1007/s10637-008-9142-3; Doi T, 2012, BRIT J CANCER, V107, P429, DOI 10.1038/bjc.2012.274; Rambach L, 2014, WORLD J GASTROENTERO, V20, P1565, DOI 10.3748/wjg.v20.i6.1565; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5; Di Maio M, 2005, LANCET ONCOL, V6, P669, DOI 10.1016/S1470-2045(05)70255-2; Temmink OH, 2005, ANTI-CANCER DRUG, V16, P285, DOI 10.1097/00001813-200503000-00007; DU DL, 1990, CANCER RES, V50, P4038; EricksonMiller CL, 1997, CANCER CHEMOTH PHARM, V39, P467, DOI 10.1007/s002800050600; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Hong DS, 2006, CANCER, V107, P1383, DOI 10.1002/cncr.22125; PARCHMENT RE, 1994, J NATL CANCER I, V86, P273, DOI 10.1093/jnci/86.4.273; Suzuki N, 2011, INT J ONCOL, V39, P263, DOI 10.3892/ijo.2011.1003; Tanaka N, 2014, ONCOL REP, V32, P2319, DOI 10.3892/or.2014.3487; YOSHINO T, 2014, ANN ONCOL, V25, P114	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					325	333		10.1007/s00280-015-2805-9		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900012		
J	Nagao, S; Nishio, S; Okada, S; Otsuki, T; Fujiwara, K; Tanabe, H; Takano, M; Hasumi, Y; Takei, Y; Hasegawa, T; Matsumoto, T; Fujiwara, K; Takekuma, M; Nakamura, K; Shimada, M; Suzuki, M; Kigawa, J				Nagao, Shoji; Nishio, Shin; Okada, Satoshi; Otsuki, Takeo; Fujiwara, Kiyoshi; Tanabe, Hiroshi; Takano, Masashi; Hasumi, Yoko; Takei, Yuji; Hasegawa, Tetsuya; Matsumoto, Takashi; Fujiwara, Keiichi; Takekuma, Munetaka; Nakamura, Kazuto; Shimada, Muneaki; Suzuki, Mitsuaki; Kigawa, Junzo			What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Recurrent endometrial cancer; Second-line chemotherapy; Platinum sensitivity; AP therapy; TC therapy	GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-II TRIAL; PACLITAXEL PLUS FILGRASTIM; OVARIAN-CANCER; CARCINOMA; CHEMOTHERAPY; CISPLATIN; DOXORUBICIN; THERAPY	Purpose We previously reported that the concept of "platinum sensitivity" could be applied to recurrent endometrial cancer. We conducted an ancillary analysis to determine an appropriate second-line regimen for patients who received a platinum agent as first-line chemotherapy. Methods We extracted and reanalyzed data of patients treated with doxorubicin and cisplatin (AP), paclitaxel and carboplatin (TC), or docetaxel and carboplatin (DC) as first- and second-line chemotherapies from the SGSG012/GOTIC004/Intergroup study. Results We identified 216 patients: 38 received AP as first-line chemotherapy, of which 36 received TC or DC (Tax-C) as second-line chemotherapy; and 178 received Tax-C as first-line chemotherapy, of which 51 received AP and 127 received Tax-C as second-line chemotherapy. Median progression-free survival (PFS) and overall survival (OS) after second-line chemotherapy decreased in the order of Tax-C followed by Tax-C (10 and 48 months, respectively), AP followed by Tax-C (9 and 23 months, respectively), and Tax-C followed by AP (3 and 12 months, respectively). Median PFS and OS after second-line chemotherapy for platinum-resistant patients receiving Tax-C as first-line chemotherapy were longer in Tax-C than in AP (7 and 23 vs. 3 and 10 months, respectively) as second-line chemotherapy [hazard ratio (HR) 3.255, 95 % confidence interval (CI) 1.908-5.555, p < 0.0001; HR 3.179, 95 % CI 1.835-5.507, p < 0.0001, respectively]. Median PFS and OS after second-line chemotherapy for platinum-sensitive patients receiving Tax-C as first-line chemotherapy were almost equivalent to those receiving Tax-C or AP as second-line chemotherapy. Conclusions For platinum-resistant recurrent endometrial cancer patients, Tax-C may be preferred over AP as second-line chemotherapy.	[Nagao, Shoji; Fujiwara, Kiyoshi] Hyogo Canc Ctr, Dept Gynecol Oncol, Akashi, Hyogo 6738558, Japan; [Nishio, Shin] Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan; [Okada, Satoshi] Univ Tsukuba, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan; [Otsuki, Takeo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Tanabe, Hiroshi] Jikei Univ, Kashiwa Hosp, Dept Obstet & Gynecol, Kashiwa, Chiba 2778567, Japan; [Takano, Masashi] Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama 3598513, Japan; [Hasumi, Yoko] Saitama Canc Ctr, Dept Gynecol Oncol, Kita Adachi, Saitama 3620806, Japan; [Takei, Yuji; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Hasegawa, Tetsuya] Yokohama City Univ, Sch Med, Dept Obstet & Gynecol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Matsumoto, Takashi] Shikoku Canc Ctr, Dept Gynecol Oncol, Matsuyama, Ehime 7910280, Japan; [Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka City 3501241, Japan; [Takekuma, Munetaka] Shizuoka Canc Ctr, Dept Gynecol Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Nakamura, Kazuto] Gunma Univ, Grad Sch Med, Dept Obstet & Gynecol, Maebashi, Gunma 3718511, Japan; [Shimada, Muneaki] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 6838504, Japan; [Kigawa, Junzo] Matsue City Hosp, Matsue, Shimane 6908509, Japan	Nagao, S (reprint author), Hyogo Canc Ctr, Dept Gynecol Oncol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	nagao@hp.pref.hyogo.jp					Fleming GF, 2007, J CLIN ONCOL, V25, P2983, DOI 10.1200/JCO.2007.10.8431; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Makker V, 2013, INT J GYNECOL CANCER, V23, P929, DOI 10.1097/IGC.0b013e3182915c20; MARKMAN M, 1991, J CLIN ONCOL, V9, P389; Miller D, 2012, GYNECOL ONCOL, V125, P771, DOI 10.1016/j.ygyno.2012.03.034; Thigpen JT, 2004, J CLIN ONCOL, V22, P3902, DOI 10.1200/JCO.2004.02.088; Fleming GF, 2004, ANN ONCOL, V15, P1173, DOI 10.1093/annonc/mdh316; Parmar MKB, 2003, LANCET, V361, P2099; Nagao S, 2013, GYNECOL ONCOL, V131, P567, DOI 10.1016/j.ygyno.2013.09.021; BLACKLEDGE G, 1989, BRIT J CANCER, V59, P650, DOI 10.1038/bjc.1989.132; Homesley HD, 2008, INT J CLIN ONCOL, V13, P62, DOI 10.1007/s10147-007-0731-5; Katsumata N, 2005, BRIT J CANCER, V93, P999, DOI 10.1038/sj.bjc.6602817; Mazgani M, 2008, GYNECOL ONCOL, V111, P474, DOI 10.1016/j.ygyno.2008.08.029; McMeekin DS, CORPUS EPITHELIAL TU, V6th; THIGPEN JT, 1984, AM J CLIN ONCOL-CANC, V7, P253, DOI 10.1097/00000421-198406000-00010	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					335	342		10.1007/s00280-015-2793-9		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900013		
J	Nomura, M; Oze, I; Abe, T; Komori, A; Narita, Y; Masuishi, T; Taniguchi, H; Kadowaki, S; Ura, T; Andoh, M; Kawai, R; Uemura, N; Ishihara, M; Tanaka, T; Tajika, M; Niwa, Y; Muro, K; Muto, M				Nomura, Motoo; Oze, Isao; Abe, Tetsuya; Komori, Azusa; Narita, Yukiya; Masuishi, Toshiki; Taniguchi, Hiroya; Kadowaki, Shigenori; Ura, Takashi; Andoh, Masashi; Kawai, Ryosuke; Uemura, Norihisa; Ishihara, Makoto; Tanaka, Tsutomu; Tajika, Masahiro; Niwa, Yasumasa; Muro, Kei; Muto, Manabu			Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Esophageal cancer; Neoadjuvant chemotherapy; Surgery; Propensity score analysis	CHEMORADIOTHERAPY; CHEMOTHERAPY; RADIOTHERAPY; SURGERY; THERAPY; TRIAL	Purpose To investigate the influence of addition of docetaxel to neoadjuvant chemotherapy (NAC) with cisplatin plus 5-fluorouracil (CF) in patients with clinical stage III or T3 esophageal squamous cell carcinoma. Methods Information about 209 esophageal cancer patients with stage III or T3 disease, who underwent NAC consisting of CF with or without docetaxel, was reviewed. The survival outcomes were analyzed using the Kaplan-Meier method and propensity score-adjusted Cox proportional hazards models. The relevant variables were included in the propensity score model. Results NAC was administered to 149 patients in the CF group and 60 patients in the docetaxel plus CF (DCF) group. Overall, 129 patients treated with CF and 58 patients treated with DCF underwent surgery after NAC. The overall response rate was significantly higher in the DCF group compared with the CF group (61.0 vs. 43.2 %, p = 0.021). After matching, recurrence-free survival did not differ statistically between the CF and DCF groups [hazard ratio (HR) 0.83, 95 % confidence interval (CI) 0.50-1.37, p = 0.46]. After matching, the improvement in overall survival in the DCF group reached statistical significance (HR 0.49, 95 % CI 0.24-0.999, p = 0.050). No significant differences in rate of locoregional or distant recurrences were observed between the CF and DCF groups (53.0 vs. 48.3 %, p = 0.54). Conclusions NAC with DCF is superior to CF in patients with clinical stage III or T3 esophageal squamous cell carcinoma.	[Nomura, Motoo; Komori, Azusa; Narita, Yukiya; Masuishi, Toshiki; Taniguchi, Hiroya; Kadowaki, Shigenori; Ura, Takashi; Andoh, Masashi; Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Nomura, Motoo; Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, Kyoto 6068507, Japan; [Oze, Isao] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Abe, Tetsuya; Kawai, Ryosuke; Uemura, Norihisa] Aichi Canc Ctr Hosp, Dept Gastrointestinal Surg, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Ishihara, Makoto; Tanaka, Tsutomu; Tajika, Masahiro; Niwa, Yasumasa] Aichi Canc Ctr Hosp, Dept Endoscopy, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Nomura, M (reprint author), Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	excell@hkg.odn.ne.jp					Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Donahue JM, 2009, ANN THORAC SURG, V87, P392, DOI 10.1016/j.athoracsur.2008.11.001; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P752, DOI 10.1093/jjco/hyt061; Hara H, 2013, CANCER SCI, V104, P1455, DOI 10.1111/cas.12274; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Urschel JD, 2003, AM J SURG, V185, P538, DOI 10.1016/S0002-9610(03)00066-7; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Isono K, 2004, ESOPHAGUS, V1, P61; Tachimori Y, 2015, ESOPHAGUS-TOKYO, V12, P130, DOI 10.1007/s10388-015-0489-1; Ui T, 2015, DIS ESOPHAGUS, V28, P180, DOI 10.1111/dote.12187; Ura T, 2010, ASCO GASTR CANC S	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					357	363		10.1007/s00280-015-2806-8		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900015		
J	Mitsui, Y; Sato, Y; Miyamoto, H; Fujino, Y; Takaoka, T; Miyoshi, J; Kagawa, M; Ohnuma, H; Hirakawa, M; Kubo, T; Osuga, T; Sagawa, T; Sato, Y; Takahashi, Y; Katsuki, S; Okuda, T; Takimoto, R; Kobune, M; Nobuoka, T; Hirata, K; Kato, J; Takayama, T				Mitsui, Yasuhiro; Sato, Yasushi; Miyamoto, Hiroshi; Fujino, Yasuteru; Takaoka, Toshi; Miyoshi, Jinsei; Kagawa, Miwako; Ohnuma, Hiroyuki; Hirakawa, Masahiro; Kubo, Tomohiro; Osuga, Takahiro; Sagawa, Tamotsu; Sato, Yasuhiro; Takahashi, Yasuo; Katsuki, Shinich; Okuda, Toshinori; Takimoto, Rishu; Kobune, Masayoshi; Nobuoka, Takayuki; Hirata, Koichi; Kato, Junji; Takayama, Tetsuji			Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Gastric cancer; HER2; Trastuzumab; Feasibility	PHASE-III TRIAL; PLUS CISPLATIN; DOCETAXEL; S-1; FLUOROURACIL; CHEMOTHERAPY; THERAPY	We previously reported that a triplet combination of docetaxel, cisplatin, and S-1 (DCS) is active against metastatic gastric cancer with a very high response rate of 87.1 % in a phase II study. Recently, the efficacy of trastuzumab (T-mab) for the treatment of HER2-positive gastric cancer has been reported. Therefore, we investigated the feasibility and preliminary efficacy of DCS + T-mab (DCS-T) for unresectable HER2-positive metastatic gastric cancer. Patients received oral S-1 (40 mg/m(2) b.i.d.) on days 1-14, intravenous cisplatin (60 mg/m(2)), docetaxel (50 mg/m(2)), and T-mab (8 mg/kg in the first cycle and 6 mg/kg in the second cycle and thereafter) on day 8 every 3 weeks. The study included 16 patients: median age, 60 (34-76) years; males/females, 11:5; intestinal-type/diffuse-type histology, 11:5; and HER2 3+/2+(FISH+), 13:3. The completion rate until the third cycle was 87.5 % (14/16) (95 %CI 71.3-103.7 %). Adverse events of grade 3/4 severity during the first 3 cycles were: leukopenia/neutropenia, 50.0:75.0 %; febrile neutropenia, 12.5 %; diarrhea, 12.5 %; and stomatitis, 12.5 %. All of these side effects were manageable and well controlled. There were no treatment-related deaths. The overall response rate was 93.8 % (15/16), and the response rate in patients with measurable lesions was 100 % (15/15). The median cycle to response was only 1 (1-3 cycles). Non-curative factors disappeared in 56.3 % (9/16) of patients, and conversion surgery (R0 resection) was performed in all these cases. Pathological response rates in primary and metastatic lesions were 88.9 % (8/9) and 100 % (9/9), respectively. The median PFS and OS were not reached during the median follow-up time of 18.3 months ranged from 11.0 to 34.3 months. DCS-T was feasible in patients with unresectable HER2-positive metastatic gastric cancer. The observed response was very promising and warrants further investigation. UMIN000005603.	[Mitsui, Yasuhiro; Miyamoto, Hiroshi; Fujino, Yasuteru; Takaoka, Toshi; Miyoshi, Jinsei; Kagawa, Miwako; Takayama, Tetsuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Gastroenterol & Oncol, Tokushima 7708503, Japan; [Sato, Yasushi; Ohnuma, Hiroyuki; Hirakawa, Masahiro; Kubo, Tomohiro; Osuga, Takahiro; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Sagawa, Tamotsu; Sato, Yasuhiro; Takahashi, Yasuo] Hokkaido Canc Ctr, Div Gastroenterol, Shiroishi Ku, Sapporo, Hokkaido 0030804, Japan; [Katsuki, Shinich] Otaru Ekisaikai Hosp, Div Gastroenterol, Otaru, Hokkaido 0470031, Japan; [Okuda, Toshinori] Oji Gen Hosp, Dept Gastroenterol, Tomakomai 0530021, Japan; [Nobuoka, Takayuki; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Takayama, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	takayama@md.pikara.ne.jp			TAIHO Pharmaceutical Co., Ltd. (Tokyo, Japan)	We thank the following doctors for their assistance in this study: Gangi Kuroiwa, M.D., Michiaki Hirayama, M.D., and Hiroyuki Kuroda, M.D., Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine, Sapporo, Japan. We also thank Dr Hiroaki Mikasa (Medical Education Center, Tokushima University) for his advice for manuscript preparation. This study was partly supported by the research fund from TAIHO Pharmaceutical Co., Ltd. (Tokyo, Japan) described bellow. The sponsor played no role in the design or conduct of the study; in the collection, management, analysis, or interpretation of data; or in the preparation, review, or approval of the manuscript.	SULKES A, 1994, BRIT J CANCER, V70, P380, DOI 10.1038/bjc.1994.310; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Sakata Y, 1998, EUR J CANCER, V34, P1715, DOI 10.1016/S0959-8049(98)00211-1; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Takayama T, 2007, BRIT J CANCER, V97, P851, DOI 10.1038/sj.bjc.6603957; Sato Y, 2010, CANCER CHEMOTH PHARM, V66, P721, DOI 10.1007/s00280-009-1215-2; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Dickson JLB, 2004, EUR J GASTROEN HEPAT, V16, P255, DOI 10.1097/10.meg.0000108279.74393.b6; Einzig AI, 1996, MED ONCOL, V13, P87; Garcia M., 2007, GLOBAL CANC FACTS FI; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Koizumi W, 2014, J CANCER RES CLIN, V140, P319, DOI 10.1007/s00432-013-1563-5; Shah MA, 2004, SEMIN ONCOL, V31, P574, DOI 10.1053/j.seminoncol.2004.04.013	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					375	382		10.1007/s00280-015-2807-7		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900017		
J	Chua, C; Tan, IB; Yamada, Y; Rha, SY; Yong, WP; Ong, WS; Tham, CK; Ng, M; Tai, DWM; Iwasa, S; Lim, HY; Choo, SP				Chua, Clarinda; Tan, Iain Beehuat; Yamada, Yasuhide; Rha, Sun Young; Yong, Wei Peng; Ong, Whee Sze; Tham, Chee Kian; Ng, Matthew; Tai, David W. M.; Iwasa, Satoru; Lim, Hwee Yong; Choo, Su-Pin			Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Gastric cancer; HER2; Trastuzumab; HER2-positive gastric; Gastroesophageal junction (GEJ) cancers; TS-one (S-1); Cisplatin	ORAL FLUOROPYRIMIDINE S-1; HER-2 AMPLIFICATION; PLUS CISPLATIN; CHEMOTHERAPY; ADENOCARCINOMA; FLUOROURACIL; VALIDATION; PROGNOSIS; CARCINOMA; THERAPY	The use of trastuzumab, a monoclonal antibody targeting the HER2 protein, in combination with 5-fluorouracil/platinum-based chemotherapy improves survival in patients with HER2-positive advanced gastric cancer. In addition, TS-one (S-1)/platinum is also used as a standard of care in Asian countries. However, little is known about the combination of S-1/cisplatin chemotherapy and trastuzumab in patients with HER2-positive advanced gastric/gastroesophageal junction (GEJ) cancer. We conducted a single-arm, two-stage, open-label, multicenter phase II study. Trastuzumab was administered intravenously on day 1 of the first cycle at 8 mg/kg and 6 mg/kg on day 1 of subsequent cycles. Cisplatin was administered intravenously at 60 mg/m(2) on day 1 of each cycle after trastuzumab. S-1 was administered orally [based on body surface area (BSA)] twice a day for 14 days in a 3-weekly cycle. Patients with BSA of < 1.25 received a total of 80 mg of S-1, those with BSA a parts per thousand yen1.5 received 120 mg, and the remaining received 100 mg daily in two divided doses. All evaluable patients experienced tumor reduction during the trial. The primary end point (overall survival rate) was 59.3 %, with a clinical benefit rate of 66.7 %. Median progression-free survival was 7.4 months; 62.6 % patients were free from disease progression at 6 months. Median overall survival was 14.6 months, and the median time to treatment failure was 6.0 months. The combination of trastuzumab with S-1 and cisplatin demonstrated good activity, was generally well tolerated, and is a feasible treatment option in the first-line treatment of HER2-positive advanced gastric/GEJ cancers.	[Chua, Clarinda; Tan, Iain Beehuat; Tham, Chee Kian; Ng, Matthew; Tai, David W. M.; Lim, Hwee Yong; Choo, Su-Pin] Natl Canc Ctr Singapore, Med Oncol, Singapore 169610, Singapore; [Tan, Iain Beehuat] Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Singapore 138672, Singapore; [Yamada, Yasuhide; Iwasa, Satoru] Natl Canc Ctr, Gastrointestinal Oncol, Chuo Ku, Tokyo 1040045, Japan; [Rha, Sun Young] Yonsei Canc Ctr, Internal Med, Seoul 120752, South Korea; [Yong, Wei Peng] Natl Univ Singapore Hosp, Haematol Oncol, Singapore 119074, Singapore; [Ong, Whee Sze] Natl Canc Ctr Singapore, Clin Trials & Epidemiol Sci, Singapore 169610, Singapore	Choo, SP (reprint author), Natl Canc Ctr Singapore, Med Oncol, 11 Hosp Dr, Singapore 169610, Singapore.	choosupin@nccs.com.sg			Taiho Pharmaceutical Co.	We are grateful to Taiho Pharmaceutical Co. for supporting this trial with a study Grant and to Professor Atsushi Ohtsu who was an advisor. We would like to thank Ms Yeo Ai Ling for her assistance in editing this article.	Abe S, 2010, JPN J CLIN ONCOL, V40, P302, DOI 10.1093/jjco/hyp177; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Marx AH, 2009, HUM PATHOL, V40, P769, DOI 10.1016/j.humpath.2008.11.014; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Bozzetti C, 2011, BRIT J CANCER, V104, P1372, DOI 10.1038/bjc.2011.121; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Hsu JT, 2011, ONCOLOGIST, V16, P1706, DOI 10.1634/theoncologist.2011-0199; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Kurokawa Y, 2014, BRIT J CANCER, V110, P1163, DOI 10.1038/bjc.2014.18; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Chu QSC, 2004, CLIN CANCER RES, V10, P4913, DOI 10.1158/1078-0432.CCR-04-0469; Gunturu KS, 2013, THER ADV MED ONCOL, V5, P143, DOI 10.1177/1758834012469429; Nagashima Fumio, 2005, Gastric Cancer, V8, P6, DOI 10.1007/s10120-004-0306-3; Sato Yasuhiro, 2005, Int J Clin Oncol, V10, P40, DOI 10.1007/s10147-004-0451-z; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Wagner AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub2; Yamanaka T, 2008, CANCER CHEMOTH PHARM, V61, P335, DOI 10.1007/s00280-007-0595-4	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					397	408		10.1007/s00280-015-2811-y		12	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900019		
J	Doi, T; Tamura, K; Tanabe, Y; Yonemori, K; Yoshino, T; Fuse, N; Kodaira, M; Bando, H; Noguchi, K; Shimamoto, T; Ohtsu, A				Doi, Toshihiko; Tamura, Kenji; Tanabe, Yuko; Yonemori, Kan; Yoshino, Takayuki; Fuse, Nozomu; Kodaira, Makoto; Bando, Hideaki; Noguchi, Kazuo; Shimamoto, Takashi; Ohtsu, Atsushi			Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						MK-2206; pan-AKT inhibitor; Pharmacokinetics; Phase I study; Skin toxicity	LUNG-CANCER; IN-VITRO; RESISTANCE; TRASTUZUMAB; EFFICACY; TRIAL; VIVO	MK-2206 is an oral, highly selective inhibitor of AKT. The safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of MK-2206 was evaluated in Japanese patients with advanced solid tumors. Patients received a single oral dose of MK-2206 according to an every other day (QOD) dosing schedule or a once weekly (QW) dosing schedule in repeating 28-day treatment cycles, with a 7-day rest after only the first cycle. The dose-limiting toxicities (DLTs) were evaluated during Cycle 1. Full PK sampling was performed during Cycle 1. Twenty-four patients were treated at 45 mg (n = 3) or 60 mg (n = 9) QOD or at 135 mg (n = 3) or 200 mg (n = 9) QW. One patient experienced a DLT at 60 mg QOD, and three patients experienced DLTs at 200 mg QW. No DLTs were observed at 45 mg QOD or at 135 mg QW. The DLTs included mucosal inflammation, hyponatremia, face edema, erythema multiforme, and hyperglycemia. Common adverse events related to MK-2206 included rash, an elevated insulin c-peptide level, stomatitis, pyrexia, eosinophilia, leukopenia, and hyperglycemia. PK differences in MK-2206 exposure were observed between Japanese patients and non-Japanese patients. The higher exposure in Japanese patients was likely caused by the relatively lower weight of Japanese patients versus non-Japanese patients. No tumor responses were observed, but six patients exhibited stable disease lasting longer than 4 months. MK-2206 has an acceptable safety profile in Japanese patients with advanced solid tumors and warrants further investigation.	[Doi, Toshihiko; Yoshino, Takayuki; Fuse, Nozomu; Bando, Hideaki] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan; [Tamura, Kenji; Tanabe, Yuko; Yonemori, Kan; Kodaira, Makoto] Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan; [Ohtsu, Atsushi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan; [Noguchi, Kazuo; Shimamoto, Takashi] MSD KK, Chiyoda Ku, Tokyo 1028667, Japan	Doi, T (reprint author), Natl Canc Ctr Hosp East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tdoi@east.ncc.go.jp			MSD K.K. (Tokyo, Japan)	The authors would like to thank Mikio Ishii (MSD K.K.) for PK analysis, and Shi Rong Han (MSD K.K.) for statistical analysis. Research funding was provided by MSD K.K. (Tokyo, Japan).	Ji Y, 2007, CLIN TRIALS, V4, P235, DOI 10.1177/1740774507079442; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Brognard J, 2001, CANCER RES, V61, P3986; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hu LM, 2002, CANCER RES, V62, P1087; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Curry JL, 2014, INT J DERMATOL, V53, P376, DOI 10.1111/ijd.12205; Biondo A, 2011, J CLIN ONCOL S, V29; Hudis C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3577; Lu W, 2009, P 100 ANN M AM ASS C; Molife LR, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-1; Yan L, 2009, P 100 ANN M AM ASS C; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yap TA, 2014, CLIN CANCER RES, V15, P5672, DOI [10.1158/1078-0432, DOI 10.1158/1078-0432]	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	AUG	2015	76	2					409	416		10.1007/s00280-015-2810-z		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CN6ZA	WOS:000358581900020		
J	Kudo, Y; Suda, K; Yoshimoto, H; Teramachi, Y; Kishimoto, S; Iemura, M; Matsuishi, T				Kudo, Yoshiyuki; Suda, Kenji; Yoshimoto, Hironaga; Teramachi, Yozo; Kishimoto, Shintaro; Iemura, Motofumi; Matsuishi, Toyojiro			Trans-pulmonary echocardiography as a guide for device closure of patent ductus arteriosus	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						intracardiac echocardiography; Amplatzer duct occluder; aortography; monitoring tool; residual shunt	3-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ATRIAL SEPTAL-DEFECTS; INTRACARDIAC ECHOCARDIOGRAPHY; TRANSCATHETER CLOSURE; VALVE-REPLACEMENT; GUIDANCE	ObjectivesThe aim of this study was to develop trans-pulmonary echocardiography (TPE) to guide device closure of patent ductus arteriosus (DC-PDA). BackgroundAortography requires a large amount of contrast yet may give us an inadequate image to evaluate anatomy or residual shunt in patients with large PDA or dilated vessels and is precluded in patients with renal dysfunction. Practically, there is no imaging modality to monitor the entire procedure except for trans-esophageal echocardiography that requires general anesthesia. MethodsSubjects were seven patients with ages ranged from 6- to 77-years old and body weight>15 kg. The size of the PDA ranged from 1.8 to 6.3 mm with pulmonary to systemic flow ratios from 1.2 to 2.2. During DC-PDA using Ampaltzer Duct Occluder or coil, an intra-cardiac echocardiographic (ICE) catheter was advanced into pulmonary arteries and standard views were developed to guide DC-PDA. ResultsWe have developed two standard views; the main pulmonary artery view (MPA view) and the left pulmonary artery view (LPA view). The MPA view provided aortic short axis view equivalent to that seen by trans-thoracic echocardiography in children. The LPA view, obtained by the echo probe in the LPA and turned it up upside down, provided long axis view of the PDA allowing more precise anatomical evaluation. TPE allowed us to monitor the entire procedure and determine residual shunts. ConclusionsTPE in the MPA and LPA view can be an effective guide for DC-PDA. This report leads to new application of this imaging device. (c) 2015 Wiley Periodicals, Inc.	[Kudo, Yoshiyuki; Suda, Kenji; Yoshimoto, Hironaga; Kishimoto, Shintaro; Matsuishi, Toyojiro] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan; [Teramachi, Yozo; Iemura, Motofumi] St Marys Hosp, Dept Pediat Cardiol, Kurume, Fukuoka, Japan	Suda, K (reprint author), Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Asahi Machi 67, Kurume, Fukuoka 8300011, Japan.	suda_kenji@med.kurumeu.ac.jp					Hijazi ZM, 2001, CATHETER CARDIO INTE, V52, P194, DOI 10.1002/1522-726X(200102)52:2<194::AID-CCD1046>3.0.CO;2-4; Bartel T, 2011, J AM SOC ECHOCARDIOG, V24, P966, DOI 10.1016/j.echo.2011.04.009; Pass RH, 2004, J AM COLL CARDIOL, V44, P513, DOI 10.1016/j.jacc.2004.03.074; Awad SM, 2015, PEDIATR CARDIOL, V36, P76, DOI 10.1007/s00246-014-0967-6; Bartel T, 2014, EUR HEART J, V35, P69, DOI 10.1093/eurheartj/eht411; Bartel T, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq114; Baruteau AE, 2014, ARCH CARDIOVASC DIS, V107, P122, DOI 10.1016/j.acvd.2014.01.008; Chuang YC, 2011, ECHOCARDIOGR-J CARD, V28, pE101, DOI 10.1111/j.1540-8175.2010.01343.x; Dello Russo A, 2010, MINERVA CARDIOANGIOL, V58, P333; Inohara T, 2014, J INVASIVE CARDIOL, V26, pE95; Lam J, 2001, ECHOCARDIOGR-J CARD, V18, P197, DOI 10.1046/j.1540-8175.2001.00197.x; Marek T, 2009, CIRCULATION, V120, pE92, DOI 10.1161/CIRCULATIONAHA.109.867093; Patel A, 2006, CATHETER CARDIO INTE, V68, P287, DOI 10.1002/ccd.20824; Vaina Sophia, 2006, EuroIntervention, V1, P454	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	AUG	2015	86	2					264	270		10.1002/ccd.25879		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN5TN	WOS:000358493700029		
J	Nakano, M; Hirano, K; Yamauchi, Y; Iida, O; Soga, Y; Kawasaki, D; Yamaoka, T; Suematsu, N; Suzuki, K				Nakano, Masatsugu; Hirano, Keisuke; Yamauchi, Yasutaka; Iida, Osamu; Soga, Yoshimitsu; Kawasaki, Daizo; Yamaoka, Terutosh; Suematsu, Nobuhiro; Suzuki, Kenji			Three-year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in hemodialysis patients with minor or major tissue loss	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						critical limb ischemia; infrapopliteal angioplasty; hemodialysis	PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STAGE RENAL-DISEASE; BYPASS-SURGERY; REVASCULARIZATION; ATHERECTOMY; PROGNOSIS; ARTERIES; INTERVENTIONS; METAANALYSIS; PREDICTORS	Objectives and BackgroundAmong hemodialysis (HD)-dependent patients with critical limb ischemia (CLI), Endovascular therapy (EVT) of isolated infrapopliteal lesions improves limb salvage. Accordingly, we sought to determine the outcomes of this group of patients based on the extent of tissue loss at baseline. MethodsFrom 2004 to 2011, 449 consecutive HD patients with CLI had ischemic wounds and underwent EVT for isolated infrapopliteal lesions. The minor tissue loss (MI) group was confirmed by 340 HD patients with wounds located distal to the metatarsophalangeal joints, and the major tissue loss (MA) group included 109 HD patients with wounds that extended beyond this point. The two groups were compared for limb salvage and amputation free survival (AFS) rates by Kaplan-Meier analysis. ResultsThere was no significant difference in the percentage of diabetic patients (MI: 76.5 vs. MA: 75.2%). The percentage with direct flow to the wound site was lower in the MA group than in the MI group (MI: 63.5 vs. MA: 45.9%, P<0.01). After EVT the MI group had a significantly better limb salvage rate (MI: 83.7 vs. MA: 71.2% at 3 years, P<0.01), and AFS rate (MI: 44.1 vs. MA: 29.1% at 3 years, P<0.01) compared to the MA group. ConclusionsEVT is an efficient treatment for HD patients with minor tissue loss, achieving >80% limb salvage rates at 3 years. However, AFS rates in all HD patients with tissue loss are <50% at 3 years, making their prognosis poor. (c) 2015 Wiley Periodicals, Inc.	[Nakano, Masatsugu; Hirano, Keisuke] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa 2300012, Japan; [Yamauchi, Yasutaka] Kikuna Mem Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Iida, Osamu] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan; [Kawasaki, Daizo] Hyogo Coll Med, Div Cardiovasc, Nishinomiyo, Japan; [Yamaoka, Terutosh] Matsuyama Red Cross Hosp, Dept Vasc Surg, Matsuyama, Ehime, Japan; [Suematsu, Nobuhiro] Fukuoka Red Cross Hosp, Dept Cardiol, Fukuoka, Japan; [Suzuki, Kenji] Sendai Kosei Hosp, Dept Cardiol, Sendai, Miyagi, Japan	Nakano, M (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa 2300012, Japan.	m_nakano@tobu.saiseikai.or.jp					Abou-Zamzam AM, 2007, ANN VASC SURG, V21, P458, DOI 10.1016/j.avsg.2006.12.006; Nakano M, 2013, J ENDOVASC THER, V20, P113, DOI 10.1583/11-3782.1; Zeller T, 2007, J ENDOVASC THER, V14, P232, DOI 10.1583/1545-1550(2007)14[232:TRADAO]2.0.CO;2; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Gray BH, 2010, ANN VASC SURG, V24, P349, DOI 10.1016/j.avsg.2009.07.034; O'Hare AM, 2004, J VASC SURG, V39, P709, DOI 10.1016/j.jvs.2003.11.038; Simons JP, 2010, J VASC SURG, V51, P1419, DOI 10.1016/j.jvs.2010.01.083; Matzke S, 2001, ANN CHIR GYNAECOL, V90, P19; Kawarada O, 2012, CATHETER CARDIO INTE, V80, P861, DOI 10.1002/ccd.24370; Peregrin JH, 2010, CARDIOVASC INTER RAD, V33, P720, DOI 10.1007/s00270-010-9881-3; Giles KA, 2008, J VASC SURG, V48, P128, DOI 10.1016/j.jvs.2008.02.027; Brosi P, 2005, J ENDOVASC THER, V12, P704, DOI 10.1583/05-1638MR.1; Fusaro M, 2013, JACC-CARDIOVASC INTE, V6, P1284, DOI 10.1016/j.jcin.2013.08.007; Lantis JC, 2001, J VASC SURG, V33, P1171, DOI 10.1067/mva.2001.115607; Combe C, 2009, AM J KIDNEY DIS, V54, P680, DOI 10.1053/j.ajkd.2009.04.035; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Takahara M, 2010, DIABETES CARE, V33, P2538, DOI [10.2337/dc10-0939, 10.2337/dc10.0939]; Liistro F, 2013, CIRCULATION, V128, P615, DOI 10.1161/CIRCULATIONAHA.113.001811; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Fernandez N, 2010, J VASC SURG, V52, P834, DOI 10.1016/j.jvs.2010.04.070; Faglia E, 2009, DIABETES CARE, V32, P822, DOI 10.2337/dc08-1223; Das T, 2014, CATHETER CARDIO INTE, V83, P115, DOI 10.1002/ccd.25046; Soderstrom MI, 2010, ANN SURG, V252, P765, DOI 10.1097/SLA.0b013e3181fc3c73; Conte MS, 2009, J VASC SURG, V50, P1462, DOI 10.1016/j.jvs.2009.09.044; Fernandez N, 2011, J VASC SURG, V54, P722, DOI 10.1016/j.jvs.2011.03.232; Khan MUN, 2009, J VASC SURG, V49, P1440, DOI 10.1016/j.jvs.2009.02.226; Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005; Dosluoglu HH, 2012, J VASC SURG, V56, P361, DOI 10.1016/j.jvs.2012.01.054; Dormandy J A, 2000, J Vasc Surg, V31, pS1; Kumada Y, 2008, NEPHROL DIAL TRANSPL, V23, P3996, DOI 10.1093/ndt/gfn378; Lin CW, 2010, DIABETES RES CLIN PR, V90, P167, DOI 10.1016/j.diabres.2010.08.002; Pua U, 2008, ANN ACAD MED SINGAP, V37, P224; Sadek M, 2009, J VASC SURG, V49, P638, DOI 10.1016/j.jvs.2008.10.021; Stoner MC, 2007, J VASC SURG, V46, P289, DOI 10.1016/j.jvs.2007.04.019; Taylor SM, 2006, J VASC SURG, V44, P747, DOI 10.1016/j.jvs.2006.06.015	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	AUG	2015	86	2					289	298		10.1002/ccd.25676		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN5TN	WOS:000358493700033		
J	Watanabe, Y; Chevalier, B; Hayashida, K; Leong, T; Bouvier, E; Arai, T; Farge, A; Hovasse, T; Garot, P; Cormier, B; Morice, MC; Lefevre, T				Watanabe, Yusuke; Chevalier, Bernard; Hayashida, Kentaro; Leong, Tora; Bouvier, Erik; Arai, Takahide; Farge, Arnaud; Hovasse, Thomas; Garot, Philippe; Cormier, Bertrand; Morice, Marie-Claude; Lefevre, Thierry			Comparison of multislice computed tomography findings between bicuspid and tricuspid aortic valves before and after transcatheter aortic valve implantation	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						transcatheter aortic valve implantation; bicuspid aortic valve; multislice computed tomography	HIGH-RISK PATIENTS; HEART-DISEASE; STENOSIS; REGURGITATION; REPLACEMENT; SYSTEM; CALCIFICATION; PROSTHESIS; IMPACT	AimsThis study sought to compare the multislice computed tomography (MSCT) characteristics of bicuspid aortic valves (BAV) and tricuspid aortic valves (TAV) before and after implantation of the CoreValve (Medtronic, Santa Rosa, California) or the Edwards SapienXT (Edwards Lifesciences, Irvine, CA). Methods and ResultsFrom March 2009 to March 2013, a total of 67 TAVI patients who had both pre- and post-procedural MSCT were studied. Eleven patients underwent TAVI in BAV with the CoreValve (n=6) or SapienXT (n=5) and 56 patients underwent TAVI in TAV with the CoreValve (n=38) or SapienXT (n=18). The BAV group was similar to the TAV group except for a higher pre-procedural mean pressure gradient (53.117.4 vs. 48.8 +/- 20.4 mm Hg, P=0.03), a larger annulus perimeter (89.3 +/- 9.0 vs. 81.8 +/- 8.1 mm, P=0.03) and a higher aortic valve calcium volume (1262.7 +/- 396.0 vs. 556.4 +/- 461.9 mm(3), P<0.01). In the CoreValve group, post-procedural mean pressure gradient was significantly higher in the BAV group (11.0 +/- 2.6 vs. 8.2 +/- 2.8 mm Hg, P=0.04) and a smaller valve area/pre-annulus area ratio was observed at each level of the prosthesis (base of the stent frame 81.7%+/- 14.9% vs. 94.7%+/- 15.0%, P=0.06, annulus level 74.3%+/- 16.7% vs. 89.9%+/- 10.5%, P=0.03, leaflet level 64.6%+/- 13.1% vs. 81.2%+/- 13.2%, P<0.01). This was not observed in the Edwards group. ConclusionsCompared to TAV, patients with BAV have higher gradients, larger annulus perimeters and more calcified valves. Higher post procedural gradient and valve underexpansion were frequently observed after CoreValve implantation. Further MSCT study is required to demonstrate the efficacy of TAVI in BAV. (c) 2015 Wiley Periodicals, Inc.	[Watanabe, Yusuke] Teikyo Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo 173, Japan; [Watanabe, Yusuke; Chevalier, Bernard; Leong, Tora; Bouvier, Erik; Arai, Takahide; Farge, Arnaud; Hovasse, Thomas; Garot, Philippe; Cormier, Bertrand; Morice, Marie-Claude; Lefevre, Thierry] Inst Cardiovasc Paris Sud, Dept Cardiol & Cardiovasc Surg, F-91300 Massy, France; [Hayashida, Kentaro] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Chevalier, B (reprint author), Inst Cardiovasc Paris Sud, 6 Ave Noyer Lambert, F-91300 Massy, France.	bchevali@aol.com					Feuchtner GM, 2006, J HEART VALVE DIS, V15, P494; Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063; Zamorano JL, 2011, EUR HEART J, V32, P2189, DOI 10.1093/eurheartj/ehr259; Wijesinghe N, 2010, JACC-CARDIOVASC INTE, V3, P1122, DOI 10.1016/j.jcin.2010.08.016; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Blanke P, 2010, EUR J CARDIO-THORAC, V38, P750, DOI 10.1016/j.ejcts.2010.03.039; Roberts WC, 2012, AM J CARDIOL, V109, P1632, DOI 10.1016/j.amjcard.2012.01.390; John D, 2010, JACC-CARDIOVASC INTE, V3, P233, DOI 10.1016/j.jcin.2009.11.015; Schultz CJ, 2009, J AM COLL CARDIOL, V54, P911, DOI 10.1016/j.jacc.2009.04.075; Hayashida K, 2013, CIRC-CARDIOVASC INTE, V6, P284, DOI 10.1161/CIRCINTERVENTIONS.112.000084; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Hayashida K, 2011, JACC-CARDIOVASC INTE, V4, P851, DOI 10.1016/j.jcin.2011.03.019; Ewe SH, 2011, AM J CARDIOL, V108, P1470, DOI 10.1016/j.amjcard.2011.07.007; Costopoulos C, 2014, AM J CARDIOL, V113, P1390, DOI 10.1016/j.amjcard.2014.01.412; Bauer T, 2014, AM J CARDIOL, V113, P518, DOI 10.1016/j.amjcard.2013.10.023; Leipsic J, 2011, JACC-CARDIOVASC IMAG, V4, P416, DOI 10.1016/j.jcmg.2011.01.014; Sabet HY, 1999, MAYO CLIN PROC, V74, P14; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Meredith IT, 2014, EUROINTERVENTION, V9, P1264, DOI 10.4244/EIJV9I11A216; Delgado V, 2010, EUR HEART J, V31, P1114, DOI 10.1093/eurheartj/ehq018; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P1247, DOI 10.1016/j.jcin.2012.09.003; Koos R, 2011, INT J CARDIOL, V150, P142, DOI 10.1016/j.ijcard.2010.03.004; Chiam PTL, 2010, JACC-CARDIOVASC INTE, V3, P559, DOI 10.1016/j.jcin.2009.11.024; Willson AB, 2012, JACC-CARDIOVASC INTE, V5, P525, DOI 10.1016/j.jcin.2012.03.007; Himbert D, 2012, AM J CARDIOL, V110, P877, DOI 10.1016/j.amjcard.2012.04.064; Hayashida K, 2012, EUROINTERVENTION, V8, P546, DOI 10.4244/EIJV8I5A85; Binder RK, 2012, EUROINTERVENTION, V8, pQ83, DOI 10.4244/EIJV8SQA15; Delgado Victoria, 2009, Circ Cardiovasc Imaging, V2, pe12, DOI 10.1161/CIRCIMAGING.108.809434; ISNER JM, 1990, J AM COLL CARDIOL, V15, P1104; Nombela-Franco L, 2012, JACC-CARDIOVASC INTE, V5, P499, DOI 10.1016/j.jcin.2012.02.010; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Schultz Carl J, 2010, EuroIntervention, V6 Suppl G, pG6, DOI 10.4244/; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Steinberger J, 2000, PEDIATRICS, V105, P815, DOI 10.1542/peds.105.4.815; Watanabe Y, 2015, CATHETER CARDIO INTE, V85, P667, DOI 10.1002/ccd.25486	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	AUG	2015	86	2					323	330		10.1002/ccd.25830		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN5TN	WOS:000358493700039		
J	Tanaka, Y; Tanaka, M; Saito, S				Tanaka, Yutaka; Tanaka, Masashi; Saito, Shigeru			Elective valve-in-valve implantation for migration of a corevalve in a patient with bicuspid aortic valve stenosis	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						aortic valve disease; transcatheter valve implantation; structural heart disease intervention	DISLOCATION	Transcatheter aortic valve implantation for bicuspid aortic valve stenosis (BAVS) is controversial, as its unfavorable anatomy may lead to device dislocation or malfunctioning. If device failure occurs, the bailout intervention can be more complex and technically challenging. We here report a unique case of late migration of a CoreValve (Medtronic, MN) implanted in a patient with BAVS, who was successfully treated with elective valve-in-valve implantation using the first valve as a firm scaffold after waiting for it to adhere at the migrated position. This new strategy may represent a useful salvage option for some patients with prosthesis migration. (c) 2015 Wiley Periodicals, Inc.	[Tanaka, Yutaka; Saito, Shigeru] Shonan Kamakura Gen Hosp, Dept Cardiol, Kamakura, Kanagawa 2478533, Japan; [Tanaka, Yutaka; Saito, Shigeru] Shonan Kamakura Gen Hosp, Catheterizat Lab, Kamakura, Kanagawa 2478533, Japan; [Tanaka, Masashi] Shonan Kamakura Gen Hosp, Dept Cardiovasc Surg, Kamakura, Kanagawa 2478533, Japan	Tanaka, Y (reprint author), Shonan Kamakura Gen Hosp, Dept Cardiol, 1370-1 Okamoto, Kamakura, Kanagawa 2478533, Japan.	yutakatanaka_circ@yahoo.co.jp					Wijesinghe N, 2010, JACC-CARDIOVASC INTE, V3, P1122, DOI 10.1016/j.jcin.2010.08.016; Piazza N, 2009, CATHETER CARDIO INTE, V73, P530, DOI 10.1002/ccd.21822; Kang JW, 2013, JACC-CARDIOVASC IMAG, V6, P150, DOI 10.1016/j.jcmg.2012.11.007; Hayashida K, 2013, CIRC-CARDIOVASC INTE, V6, P284, DOI 10.1161/CIRCINTERVENTIONS.112.000084; Ferrari E, 2010, ANN THORAC SURG, V90, P630, DOI 10.1016/j.athoracsur.2009.12.080; Costopoulos C, 2014, AM J CARDIOL, V113, P1390, DOI 10.1016/j.amjcard.2014.01.412; Himbert D, 2012, AM J CARDIOL, V110, P877, DOI 10.1016/j.amjcard.2012.04.064; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; Geisbusch S, 2010, CIRC-CARDIOVASC INTE, V3, P531, DOI 10.1161/CIRCINTERVENTIONS.110.944983; Kahlert P, 2010, CIRC-CARDIOVASC INTE, V3, P523, DOI 10.1161/CIRCINTERVENTIONS.110.959692; Ong SH, 2011, CATHETER CARDIO INTE, V77, P1071, DOI 10.1002/ccd.22902; Zahn R, 2010, CLIN RES CARDIOL, V99, P99, DOI 10.1007/s00392-009-0088-z	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	AUG	2015	86	2					334	338		10.1002/ccd.25796		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN5TN	WOS:000358493700041		
J	Morii, M; Fukumoto, Y; Kubota, S; Yamaguchi, N; Nakayama, Y; Yamaguchi, N				Morii, Mariko; Fukumoto, Yasunori; Kubota, Sho; Yamaguchi, Noritaka; Nakayama, Yuji; Yamaguchi, Naoto			Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest	CELL BIOLOGY INTERNATIONAL			English	Article						cell cycle; checkpoint recovery; DNA damage; imatinib; PDGFR; c-Kit	DOUBLE-STRAND BREAKS; GASTROINTESTINAL STROMAL TUMORS; POLO-LIKE KINASE-1; NUCLEAR-LOCALIZATION; TYROSINE KINASES; MAMMALIAN-CELLS; PROTEIN-KINASE; C-ABL; ATM; FAMILY	The DNA damage checkpoint arrests cell cycle progression to allow time for DNA repair. After completion of DNA repair, checkpoint activation is terminated, and cell cycle progression is resumed in a process called checkpoint recovery. The activation of the checkpoint has been studied in depth, but little is known about recovery from the DNA damage checkpoint. Recently we showed that Src family kinases promote recovery from the G2 DNA damage checkpoint. Here we show that imatinib inhibits inactivation of ATM/ATR signaling pathway to suppress recovery from Adriamycin/doxorubicin-induced DNA damage checkpoint arrest. Imatinib and pazopanib, two distinct inhibitors of PDGFR/c-Kit family kinases, delayed recovery from checkpoint arrest and inhibited the subsequent S-G2-M transition after Adriamycin exposure. By contrast, imatinib and pazopanib did not delay the recovery from checkpoint arrest in the presence of an ATM/ATR inhibitor caffeine. Consistently, imatinib induced a persistent activation of ATR-Chk1 signaling. By the way, the maintenance of G2 checkpoint arrest is largely dependent on ATR-Chk1 signaling. However, unlike Src inhibition, imatinib did not delay the recovery from checkpoint arrest in the presence of an ATM inhibitor KU-55933. Furthermore, imatinib induced a persistent activation of ATM-KAP1 signaling, and a possible involvement of imatinib in an ATM-dependent DNA damage response is suggested. These results reveal that imatinib inhibits recovery from Adriamycin-induced DNA damage checkpoint arrest in an ATM/ATR-dependent manner and raise the possibility that imatinib may inhibit resumption of tumor proliferation after chemo- and radiotherapy.	[Morii, Mariko; Fukumoto, Yasunori; Kubota, Sho; Yamaguchi, Noritaka; Nakayama, Yuji; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan	Fukumoto, Y (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan.	fukumoto@faculty.chiba-u.jp; nyama@faculty.chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by grants-in-aid for Scientific Research, Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment), Program for Leading Graduate Schools (Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics), and JSPS fellows from the Japanese Ministry of Education, Culture, Sports, Science and Technology. S. K. was Global-COE research assistant and is JSPS fellow. M. M. is research assistant of LGS.	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Gonzalez I, 2004, CLIN CANCER RES, V10, P751, DOI 10.1158/1078-0432.CCR-0778-03; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Kohn EA, 2003, CANCER RES, V63, P31; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Taniguchi M, 1999, CANCER RES, V59, P4297; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Kumar R, 2007, MOL CANCER THER, V6, P2012, DOI 10.1158/1535-7163.MCT-07-0193; KASTAN MB, 1991, CANCER RES, V51, P6304; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Calonge TM, 2008, DNA REPAIR, V7, P136, DOI 10.1016/j.dnarep.2007.07.017; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Fukumoto Y, 2014, J BIOL CHEM, V289, P12313, DOI 10.1074/jbc.M113.533752; Fukumoto Y, 2014, BIOCHEM BIOPH RES CO, V450, P885, DOI 10.1016/j.bbrc.2014.06.078; Fukumoto Y, 2014, BIOCHEM BIOPH RES CO, V452, P542, DOI 10.1016/j.bbrc.2014.08.113; Hong SM, 2007, MODERN PATHOL, V20, P562, DOI 10.1038/modpathol.3800771; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Ishiguro K, 2009, LEUKEMIA RES, V33, P1249, DOI 10.1016/j.leukres.2009.01.022; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Maurel J, 2010, CANCER-AM CANCER SOC, V116, P3692, DOI 10.1002/cncr.25111; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Scotlandi K, 2003, J CLIN ONCOL, V21, P1952, DOI 10.1002/JCO.2003.11.111; Shibata A, 2010, MOL CELL BIOL, V30, P371; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Weigel MT, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-412; Zhang L, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-38	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	AUG	2015	39	8					923	932		10.1002/cbin.10460		10	Cell Biology	Cell Biology	CN5FD	WOS:000358454300005		
J	Inagaki, R; Ninomiya, M; Tanaka, K; Koketsu, M				Inagaki, Ryuta; Ninomiya, Masayuki; Tanaka, Kaori; Koketsu, Mamoru			Synthesis, Characterization, and Antileukemic Properties of Naphthoquinone Derivatives of Lawsone	CHEMMEDCHEM			English	Article						antileukemic activity; glutathione; lapachol; natural products; quinones	RESISTANT STAPHYLOCOCCUS-AUREUS; NATURALLY OCCURRING QUINONES; BETA-LAPACHONE; ALPHA-LAPACHONE; PYRANONAPHTHOQUINONE DERIVATIVES; TRYPANOSOMA-CRUZI; CANCER-CELLS; IN-VITRO; CYTOTOXICITY; CONSTITUENTS	Naphthoquinones are considered privileged structures for anticancer drug molecules. The Heck reaction of 2-hydroxy-1,4-naphthoquinone (lawsone) with 1-bromo-3-methyl-2-butene offered easy access to lapachol. Several naturally occurring linear and angular heterocyclic quinoids (-lapachone, -lapachone, dunnione, and related analogues) were prepared from lapachol. Furthermore, we demonstrated that the synthetic naphthoquinones inhibit cell proliferation in human leukemia HL-60 cells. In particular, angular-type derivatives were found to possess moderate cytotoxicity and to elevate the levels of intracellular glutathione disulfide (GSSG). Our work highlights the significant potential of naturally occurring angular-series naphthoquinones as antileukemic agents.	[Inagaki, Ryuta; Ninomiya, Masayuki; Koketsu, Mamoru] Gifu Univ, Dept Mat Sci & Technol, Fac Engn, Gifu 5011193, Japan; [Ninomiya, Masayuki; Koketsu, Mamoru] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan; [Tanaka, Kaori] Gifu Univ, Div Anaerobe Res, Life Sci Res Ctr, Gifu 5011194, Japan; [Tanaka, Kaori] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011194, Japan	Inagaki, R (reprint author), Gifu Univ, Dept Mat Sci & Technol, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan.	koketsu@gifu-u.ac.jp					Khambay BPS, 1999, J AGR FOOD CHEM, V47, P770, DOI 10.1021/jf980769j; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Orlikova B, 2014, CANCER TREAT RES, V159, P123, DOI 10.1007/978-3-642-38007-5_8; Hussain H, 2007, ARKIVOC, P145; Sun JS, 1998, TETRAHEDRON LETT, V39, P8221, DOI 10.1016/S0040-4039(98)01880-2; Macedo L, 2013, PHYTOMEDICINE, V21, P25, DOI 10.1016/j.phymed.2013.08.010; WILSON I, 1986, J MED CHEM, V29, P1381, DOI 10.1021/jm00158a010; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Salas C, 2008, BIOORGAN MED CHEM, V16, P668, DOI 10.1016/j.bmc.2007.10.038; Inagaki R, 2013, CHEM PHARM BULL, V61, P670, DOI 10.1248/cpb.c13-00011; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P506, DOI 10.1016/j.intimp.2006.12.006; GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Li YZ, 2003, P NATL ACAD SCI USA, V100, P2674, DOI 10.1073/pnas.0538044100; Machado TB, 2003, INT J ANTIMICROB AG, V21, P279, DOI 10.1016/S0924-8579(02)00349-7; BURNETT AR, 1968, J CHEM SOC C, P850, DOI 10.1039/j39680000850; BURNETT AR, 1967, J CHEM SOC C, P2100, DOI 10.1039/j39670002100; Cadelis MM, 2012, SYNLETT, P2939, DOI 10.1055/s-0032-1317541; Cheng XF, 2012, MOL PHARMACEUT, V9, P3476, DOI 10.1021/mp300296m; da Silva EN, 2009, TETRAHEDRON LETT, V50, P1550, DOI 10.1016/j.tetlet.2009.01.058; de Sousa JR, 2006, J NAT PROD, V69, P1225, DOI 10.1021/np068004q; Emadi A, 2011, BIOORGAN MED CHEM, V19, P7057, DOI 10.1016/j.bmc.2011.10.005; INOUE K, 1983, PHYTOCHEMISTRY, V22, P737, DOI 10.1016/S0031-9422(00)86973-3; Joshi J. C., 1973, PHYTOCHEMISTRY, V12, P942; Kakumu A, 2014, BIOORG MED CHEM LETT, V24, P4286, DOI 10.1016/j.bmcl.2014.07.022; Kazantzi G., 2007, SYNLETT; Kim IS, 2013, CANCER CHEMOTH PHARM, V72, P699, DOI 10.1007/s00280-013-2230-x; Krishnan P, 2000, BIOCHEM PHARMACOL, V60, P1367, DOI 10.1016/S0006-2952(00)00437-8; MEHENDALE AR, 1975, PHYTOCHEMISTRY, V14, P801, DOI 10.1016/0031-9422(75)83039-1; MOCK J, 1973, AUST J CHEM, V26, P1121; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; PAULINO M, 1994, AN ASOC QUIM ARGENT, V82, P371; Paulino M, 2008, EUR J MED CHEM, V43, P2238, DOI 10.1016/j.ejmech.2007.12.023; Salas CO, 2011, CURR MED CHEM, V18, P144; VenturaPinto A., 2009, MOLECULES, V14, P4570; Wang X, 2011, B KOREAN CHEM SOC, V32, P153, DOI 10.5012/bkcs.2011.32.1.153; WU TS, 1988, PHYTOCHEMISTRY, V27, P3787, DOI 10.1016/0031-9422(88)83017-6	39	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1860-7179	1860-7187		CHEMMEDCHEM	ChemMedChem	AUG	2015	10	8					1413	1423		10.1002/cmdc.201500189		11	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CN6AQ	WOS:000358516200013		
J	Liu, LJ; Long, Q; Aoki, T; Zhang, G; Kaneko, T; Teraguchi, M; Zhang, CH; Wang, YD				Liu, Lijia; Long, Qing; Aoki, Toshiki; Zhang, Geng; Kaneko, Takashi; Teraguchi, Masahiro; Zhang, Chunhong; Wang, Yudan			A Helical Polyphenylacetylene Having Amino Alcohol Moieties Without Chiral Side Groups as a Chiral Ligand for the Asymmetric Addition of Diethylzinc to Benzaldehyde	CHIRALITY			English	Article						chiral polymer ligand; one-handed helical main-chain; poly(substituted acetylene); achiral amino alcohol	SENSE-SELECTIVE POLYMERIZATION; POLY(PHENYLACETYLENE)S; POLYMERS; PHENYLACETYLENES; CATALYST; ORGANOCATALYSTS; POLYACETYLENES; CONFORMATION; ACETYLENES; MEMBRANES	One-handed helical polyphenylacetylenes having achiral amino alcohol moieties, but no chiral side groups, were synthesized by the helix-sense-selective copolymerization of an achiral phenylacetylene having an amino alcohol side group with a phenylacetylene having two hydroxyl groups. Since the resulting helical copolymers were successfully utilized as chiral ligands for the enantioselective alkylation of benzaldehyde with diethylzinc, we can conclude that the main-chain chirality based on the one-handed helical conformation is useful for the chiral catalysis of an asymmetric reaction for the first time. The enantioselectivities of the reaction were controlled by the optical purities of the helical polymer ligands. In addition, the polymer ligands could be easily recovered by precipitation after the reaction. Chirality 27:454-458, 2015. (c) 2015 Wiley Periodicals, Inc.	[Liu, Lijia; Long, Qing; Zhang, Chunhong; Wang, Yudan] Harbin Engn Univ, Polymer Mat Res Ctr, Key Lab Superlight Mat & Surface Technol, Minist Educ,Coll Mat Sci & Chem Engn, Harbin 150001, Peoples R China; [Aoki, Toshiki; Zhang, Geng; Kaneko, Takashi; Teraguchi, Masahiro] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan	Liu, LJ (reprint author), Harbin Engn Univ, Polymer Mat Res Ctr, Key Lab Superlight Mat & Surface Technol, Minist Educ,Coll Mat Sci & Chem Engn, Harbin 150001, Peoples R China.	liulijia@hrbeu.edu.cn; toshaoki@eng.niigata-u.ac.jp			National Science Foundation of China [21204014.51373044.LC201404]; Fundamental Research Funds for the Central Universities, China; Harbin Engineering University [HEUCFT1009.HEUCFQ1417.HEUCF20151009]; Daicel Corporation (Tokyo, Japan);  [19350054]	Contract grant sponsor: Grant-in-Aid for Scientific Research (B), Japan; Contract grant number: No.19350054.; Contract grant sponsor: National Science Foundation of China; Contract grant number: 21204014.51373044.LC201404.; Contract grant sponsor: Fundamental Research Funds for the Central Universities, China and Harbin Engineering University; Contract grant number: No. HEUCFT1009.HEUCFQ1417.HEUCF20151009.; Contract grant sponsor: Daicel Corporation (Tokyo, Japan).	SIMIONESCU CI, 1977, J POLYM SCI POL CHEM, V15, P2497, DOI 10.1002/pol.1977.170151018; TABATA M, 1990, POLYM J, V22, P1105, DOI 10.1295/polymj.22.1105; Rudick JG, 2008, ACCOUNTS CHEM RES, V41, P1641, DOI 10.1021/ar800086w; Liu LJ, 2013, J AM CHEM SOC, V135, P602, DOI 10.1021/ja3113214; Aoki T, 2006, POLYMER, V47, P4867, DOI 10.1016/j.polymer.2006.04.047; Aoki T, 2003, J AM CHEM SOC, V125, P6346, DOI 10.1021/ja021233o; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Liu LJ, 2010, MACROMOLECULES, V43, P9268, DOI 10.1021/ma101999k; Iamsaard S, 2014, NAT CHEM, V6, P229, DOI [10.1038/nchem.1859, 10.1038/NCHEM.1859]; Yamamoto T, 2009, ANGEW CHEM INT EDIT, V48, P539, DOI 10.1002/anie.200803719; Cui JX, 2012, CHEM COMMUN, V48, P4341, DOI 10.1039/c2cc00036a; Suzuki N, 2013, J AM CHEM SOC, V135, P13073, DOI 10.1021/ja405570q; Percec V, 2006, J AM CHEM SOC, V128, P16365, DOI 10.1021/ja0665848; Akai Y, 2012, J AM CHEM SOC, V134, P11092, DOI 10.1021/ja303506k; Cheuk KKL, 2003, MACROMOLECULES, V36, P9752, DOI 10.1021/ma035340u; Otsuka I, 2007, MACROMOLECULES, V40, P8930, DOI 10.1021/ma7020776; Teraguchi M, 2012, ACS MACRO LETT, V1, P1258, DOI 10.1021/mz300309c; Zang Y, 2012, CHEM COMMUN, V48, P4761, DOI 10.1039/c2cc00030j; Sanda F, 2005, CHEM LETT, V34, P1642, DOI 10.1246/cl.2005.1642; Faigl F, 2014, TETRAHEDRON LETT, V55, P6891, DOI 10.1016/j.tetlet.2014.10.101; Akagi K, 2009, CHEM REV, V109, P5354, DOI 10.1021/cr900198k; Aoki T, 2004, J POLYM SCI POL CHEM, V42, P4502, DOI 10.1002/pola.20356; AOKI T, 1993, CHEM LETT, P2009, DOI 10.1246/cl.1993.2009; Cheuk KKL, 2007, MACROMOLECULES, V40, P2633, DOI 10.1021/ma062629d; Gou SH, 2011, APPL ORGANOMET CHEM, V25, P110, DOI 10.1002/aoc.1724; KISHIMOTO Y, 1994, J AM CHEM SOC, V116, P12131, DOI 10.1021/ja00105a095; Leiras R, 2015, CHEM SCI, V6, P246; Liu LJ, 2013, MACROMOL RAPID COMM, V34, P1140, DOI 10.1002/marc.201300318; Maeda K, 2007, MACROMOLECULES, V40, P6783, DOI 10.1021/ma071529k; Miyabe T, 2009, CHIRALITY, V21, P44, DOI 10.1002/chir.20604; Noyori R, 1994, ASYMMETRIC CATALYSIS, P255; Reggelin M, 2004, P NATL ACAD SCI USA, V101, P5461, DOI 10.1073/pnas.0307443101; Sanda F, 2005, MACROMOLECULES, V38, P8149, DOI 10.1021/ma051529p	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					454	458		10.1002/chir.22455		5	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100002		
J	Zang, Y; Yin, GW; Aoki, T; Teraguchi, M; Kaneko, T; Ma, LQ; Jia, HG				Zang, Yu; Yin, Guanwu; Aoki, Toshiki; Teraguchi, Masahiro; Kaneko, Takashi; Ma, Liqun; Jia, Hongge			Synthesis of a Fluorine-Containing Cis-Cisoidal One-Handed Helical Polyphenylacetylene and Application of Highly Selective Photocyclic Aromatization Product on Oxygen Permselective Membrane	CHIRALITY			English	Article						phenylacetylene; helix-sense-selective polymerization; SCAT; oxygen/nitrogen; permselectivity	POLYMERIC MEMBRANES; POLYACETYLENE; PHENYLACETYLENES; PERMEABILITY; LENGTHS; STATE	A novel phenylacetylene monomer having a perfluorinated alkyl group (M-F) was synthesized and polymerized in a chiral catalytic system to yield a one-handed helical polymer. The ability and efficiency of the chiral induction of the fluorine-containing monomer in the helix-sense-selective polymerization (HSSP) was much higher than those of a monomer having the corresponding alkyl group (M-H) we reported before. The resulting polymer P-F showed cis-cisoidal one-handed helical conformation, and was suitable for highly selective photocyclic aromatization (SCAT) to give a 2D surface modifier (T-F). Oxygen permselectivity through a base polymer membrane was highly enhanced from 1.83 to 2.36 by adding a small amount (1-5wt%) of the 2D surface modifier T-F. The improvement was thought to be caused by improvement of solution selectivity on the membrane surface which the 2D surface modifier effectively covered. Chirality 27:459-463, 2015. (c) 2015 Wiley Periodicals, Inc.	[Zang, Yu; Aoki, Toshiki; Ma, Liqun; Jia, Hongge] Qiqihar Univ, Coll Mat Sci & Engn, Qiqihar 161006, Heilongjiang, Peoples R China; [Yin, Guanwu; Aoki, Toshiki; Teraguchi, Masahiro; Kaneko, Takashi] Niigata Univ, Fac Engn, Nishi Ku, Niigata, Japan	Zang, Y (reprint author), Qiqihar Univ, Coll Mat Sci & Engn, Wenhua St 42, Qiqihar 161006, Heilongjiang, Peoples R China.	zangyu.25@163.com; toshaoki@eng.niigata-u.ac.jp			National Natural Science Foundation of China [21404064, U1162123, 51103076, 21376127]; Overseas Scholars Foundation of the Education Department of Heilongjiang province of China [1254HQ008]; Natural Science Foundation of Heilongjiang Province of China [ZD201101]	Contract grant sponsor: National Natural Science Foundation of China; Contract grant number: (21404064), (U1162123), (51103076), and (21376127).; Contract grant sponsor: Overseas Scholars Foundation of the Education Department of Heilongjiang province of China; Contract grant number: 1254HQ008.; Contract grant sponsor: Natural Science Foundation of Heilongjiang Province of China; Contract grant number: ZD201101.	Shiotsuki M, 2011, POLYM CHEM-UK, V2, P1044, DOI 10.1039/c0py00333f; Rudick JG, 2008, ACCOUNTS CHEM RES, V41, P1641, DOI 10.1021/ar800086w; Liu LJ, 2013, J AM CHEM SOC, V135, P602, DOI 10.1021/ja3113214; CHIANG CK, 1977, PHYS REV LETT, V39, P1098, DOI 10.1103/PhysRevLett.39.1098; Wang JJ, 2014, POLYMER, V55, P1384, DOI 10.1016/j.polymer.2013.11.046; Aoki T, 2003, J AM CHEM SOC, V125, P6346, DOI 10.1021/ja021233o; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Zang Y, 2015, POLYMER, V56, P199, DOI 10.1016/j.polymer.2014.11.042; Aoki T, 2005, POLYM J, V37, P717, DOI 10.1295/polymj.37.717; Miyata M, 2014, CHEM LETT, V43, P1476, DOI 10.1246/cl.140469; Percec V, 2006, J AM CHEM SOC, V128, P16365, DOI 10.1021/ja0665848; Liu JZ, 2009, CHEM REV, V109, P5799, DOI 10.1021/cr900149d; Shirakawa H, 2001, ANGEW CHEM INT EDIT, V40, P2575; Sanders DE, 2013, POLYMER, V54, P4729, DOI 10.1016/j.polymer.2013.05.075; Zang Y, 2012, CHEM COMMUN, V48, P4761, DOI 10.1039/c2cc00030j; TSUCHIHARA K, 1991, J AM CHEM SOC, V113, P8548, DOI 10.1021/ja00022a066; Johansson G, 1996, MACROMOLECULES, V29, P646, DOI 10.1021/ma9511558; Akagi K, 2009, CHEM REV, V109, P5354, DOI 10.1021/cr900198k; AOKI T, 1993, CHEM LETT, P2009, DOI 10.1246/cl.1993.2009; Li J, 2012, CHEM LETT, V41, P1462, DOI 10.1246/cl.2012.1462; Miyata M, 2013, POLYMER, V54, P4431, DOI 10.1016/j.polymer.2013.05.063; ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Saidi S, 2005, J POLYM SCI POL CHEM, V43, P3737, DOI 10.1002/pola.20851; Sato T, 2013, POLYMER, V54, P2231, DOI 10.1016/j.polymer.2013.03.008; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Wang JJ, 2013, CHEM LETT, V42, P1090, DOI 10.1246/cl.130372	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					459	463		10.1002/chir.22441		5	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100003		
J	Momiyama, N; Okamoto, H; Shimizu, M; Terada, M				Momiyama, Norie; Okamoto, Hiroshi; Shimizu, Masahiro; Terada, Masahiro			Synthetic Method for 2,2 '-Disubstituted Fluorinated Binaphthyl Derivatives and Application as Chiral Source in Design of Chiral Mono-Phosphoric Acid Catalyst	CHIRALITY			English	Article						fluorinated binaphthyl; axial chirality; organocatalyst; chiral BrOnsted acid; chiral phosphoric acid	MANNICH-TYPE REACTION; COMBINED SALT CATALYSTS; IMINO-ENE REACTIONS; BRONSTED ACID; ASYMMETRIC CATALYSIS; DICARBOXYLIC-ACID; AMIDE BASES; LEWIS-ACID; BINOL; ESTERS	A practical synthetic method for 2,2'-disubstituted fluorinated binaphthyl derivatives was achieved using magnesium bis(2,2,6,6-tetramethylpiperamide) [Mg(TMP)(2)], prepared from LiTMP (2 equiv) and MgBr2 (1 equiv), which allows for access to a variety of fluorinated binaphthyl compounds. The utility of the fluorinated binaphthyl backbone was evaluated in F10BINOL derived chiral mono-phosphoric acid (R)-19 as the chiral BrOnsted acid catalyst. The catalyst (R)-19 performs exceptionally well in the catalytic enantioselective imino-ene reaction, demonstrating the potential of a fluorinated binaphthyl framework. Chirality 27:464-475, 2015. (c) 2015 Wiley Periodicals, Inc.	[Momiyama, Norie] Grad Univ Adv Studies SOKENDAI, Dept Life & Coordinat Complex Mol Sci, Inst Mol Sci, Grad Sch Phys Sci, Okazaki, Aichi 4448787, Japan; [Okamoto, Hiroshi; Shimizu, Masahiro; Terada, Masahiro] Tohoku Univ, Dept Chem, Grad Sch Sci, Sendai, Miyagi 9808578, Japan; [Terada, Masahiro] Tohoku Univ, Res & Analyt Ctr Giant Mol, Grad Sch Sci, Sendai, Miyagi 9808578, Japan	Momiyama, N (reprint author), Grad Univ Adv Studies SOKENDAI, Dept Life & Coordinat Complex Mol Sci, Inst Mol Sci, Grad Sch Phys Sci, Okazaki, Aichi 4448787, Japan.	momiyama@ims.ac.jp; mterada@m.tohoku.ac.jp			 [21750087]	Contract grant sponsor: Young Scientists B; Contract grant number: 21750087.	Akiyama T, 2012, ASYMMETRIC SYNTHESIS, P261; Akiyama T, 2012, SCI SYNTHESIS ASYMME, V2, P169; Jiao P, 2008, ANGEW CHEM INT EDIT, V47, P2411, DOI 10.1002/anie.200705314; Ratjen L, 2011, ANGEW CHEM INT EDIT, V50, P754, DOI 10.1002/anie.201005954; Haag B, 2011, ANGEW CHEM INT EDIT, V50, P9794, DOI 10.1002/anie.201101960; Drury WJ, 1998, J AM CHEM SOC, V120, P11006, DOI 10.1021/ja982257r; Hashimoto T, 2007, J AM CHEM SOC, V129, P10054, DOI 10.1021/ja0713375; Yang C, 2013, J ORG CHEM, V78, P7076, DOI 10.1021/jo400915f; Wang QG, 2013, J AM CHEM SOC, V135, P15334, DOI 10.1021/ja408747m; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533; Cheon CH, 2008, J AM CHEM SOC, V130, P9246, DOI 10.1021/ja8041542; Coric I, 2012, NATURE, V483, P315, DOI 10.1038/nature10932; Kaupmees K, 2013, ANGEW CHEM INT EDIT, V52, P11569, DOI 10.1002/anie.201303605; Suzuki S, 2006, TETRAHEDRON-ASYMMETR, V17, P504, DOI 10.1016/j.tetasy.2005.12.029; Henderson KW, 2001, CHEM-EUR J, V7, P3430, DOI 10.1002/1521-3765(20010817)7:16<3430::AID-CHEM3430>3.0.CO;2-1; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Morgan MM, 2013, ORGANOMETALLICS, V32, P317, DOI 10.1021/om3011195; Garcia-Garcia P, 2009, ANGEW CHEM INT EDIT, V48, P4363, DOI 10.1002/anie.200901768; EATON PE, 1989, J AM CHEM SOC, V111, P8016, DOI 10.1021/ja00202a054; Caplan NA, 2004, ANGEW CHEM INT EDIT, V43, P1685, DOI 10.1002/anie.200352534; EATON PE, 1993, J AM CHEM SOC, V115, P10195, DOI 10.1021/ja00075a039; Bhadury PS, 2014, CURR ORG CHEM, V18, P127, DOI 10.2174/138527281801140121154544; Manabe K, 2008, SYNTHESIS-STUTTGART, P2645, DOI 10.1055/s-2008-1067182; Han J, 2006, J PHYS CHEM A, V110, P257, DOI 10.1021/jp052824e; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Campeau LC, 2006, J AM CHEM SOC, V128, P581, DOI 10.1021/ja055819x; Ferraris D, 2002, J AM CHEM SOC, V124, P67, DOI 10.1021/ja016838j; Cai D, 2004, ORG SYNTH, P93; Hashimoto T, 2013, J SYN ORG CHEM JPN, V71, P472; Hatano M, 2010, SYNTHESIS-STUTTGART, P3785, DOI 10.1055/s-0030-1258296; Hatano M, 2014, ASIAN J ORG CHEM, V3, P352, DOI 10.1002/ajoc.201300256; Hirashima S, 2013, J SYN ORG CHEM JPN, V71, P1116; Kampen Daniela, 2010, Top Curr Chem, V291, P395, DOI 10.1007/978-3-642-02815-1_1; Mohr J, 2014, ORGANOMETALLICS, V33, P1108, DOI 10.1021/om500128a; Morrison DJ, 2006, CHEM COMMUN, P2875, DOI 10.1039/b605716k; Noji R, 2013, ORG LETT, V15, P1946; Noyori R., 1994, ASYMMETRIC CATALYSIS; Oliver LH, 2008, TETRAHEDRON LETT, V49, P4636, DOI 10.1016/j.tetlet.2008.05.075; Ooi T, 2003, J ORG CHEM, V68, P4576, DOI 10.1021/jo030032f; Pandiaraju S, 2001, J AM CHEM SOC, V123, P3850, DOI 10.1021/ja0039942; Parmar D, 2014, CHEM REV, V114, P9047, DOI 10.1021/cr5001496; Peng FZ, 2011, CURR ORG CHEM, V15, P4144; Terada M, 2010, SYNTHESIS-STUTTGART, P1929, DOI 10.1055/s-0029-1218801; Terada M, 2008, CHEM COMMUN, P4097, DOI 10.1039/b807577h; Terada M, 2012, SCI SYNTHESIS ASYMME, V2, P219; Terada M, 2011, SYNLETT, P1255, DOI 10.1055/s-0030-1260545; vansGemmeren M, 2014, ALDRICHIM ACTA, V47, P3; Wang Y, 2000, TETRAHEDRON, V56, P4447, DOI 10.1016/S0040-4020(00)00368-9; Yekta S, 2004, J FLUORINE CHEM, V125, P517, DOI 10.1016/j.jfluchem.2003.11.024; Yudin AK, 2000, ORG LETT, V2, P41, DOI 10.1021/ol991244v	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					464	475		10.1002/chir.22429		12	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100004		
J	Nakayama, N; Goto, H				Nakayama, Naofumi; Goto, Hitoshi			Theoretical Electronic Circular Dichroism Study of 1,3-Diene Derivatives for the Elucidation of ECD Spectra of 1,3-Cyclohexadiene and Its Derivatives	CHIRALITY			English	Article						1,3-cyclohexadiene; time-dependent density functional theory (TD-DFT); conformation; lowest excited state; rotatory strength	CONJUGATED CISOID DIENES; CH/PI HYDROGEN-BOND; OPTICAL-ACTIVITY; DIHYDRODIOL METABOLITES; CD AMPLITUDE; CHIRALITY; CONFORMATION; CHROMOPHORES; ENHANCEMENT; RULE	The origin of P- or M-chirality of methyl substituted 1,3-cyclohexadienes are elucidated by time-dependent density functional theory (TD-DFT) calculation of 1,3-cyclohexadiene derivatives and acyclic 1,3-dienes. The sign-inversion of the rotatory strength of the lowest excited state between 1,3-cyclohexadiene and (5R)-axial-methyl-1,3-cyclohexadiene is caused by the conformation around the (C=)C-C(-Me) dihedral angle. The correlation between the sign of the rotatory strength and conformation has been found not only in methyl substituted derivatives but also fluoro substituted compounds. Chirality 27:476-478, 2015. (c) 2015 Wiley Periodicals, Inc.	[Nakayama, Naofumi] CONFLEX Corp, Tokyo, Japan; [Goto, Hitoshi] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan	Goto, H (reprint author), Toyohashi Univ Technol, Dept Comp Sci & Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	gotoh@tut.jp					Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; MOSCOWITZ A, 1961, J AM CHEM SOC, V83, P4661, DOI 10.1021/ja01483a040; Burgstahler A. W., 1970, J AM CHEM SOC, V92, P7601, DOI 10.1021/ja00729a024; Burgstahler AW, 2002, CHIRALITY, V14, P180, DOI 10.1002/chir.10067; BURGSTAHLER AW, 1982, J AM CHEM SOC, V104, P6873, DOI 10.1021/ja00388a108; BURGSTAHLER AW, 1976, J AM CHEM SOC, V98, P3015, DOI 10.1021/ja00426a057; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GAWRONSKI J, 1980, J CHEM SOC CHEM COMM, P346, DOI 10.1039/c39800000346; Gawronski JK, 2005, J AM CHEM SOC, V127, P4308, DOI 10.1021/ja042895b; Hansen AE, 2000, J PHYS CHEM A, V104, P11362, DOI 10.1021/jp001899+; Kwit M, 2011, COMPREHENSIVE CHIROP; Kwit M, 2011, CHIRALITY, V23, P744, DOI 10.1002/chir.20974; LIGHTNER DA, 1981, J AM CHEM SOC, V103, P5314, DOI 10.1021/ja00408a007; MORIARTY RM, 1979, J AM CHEM SOC, V101, P6804, DOI 10.1021/ja00517a003; ROSENFIELD JS, 1977, J AM CHEM SOC, V99, P3209, DOI 10.1021/ja00452a002; Takahashi O, 2012, RSC ADV, V2, P10891, DOI 10.1039/c2ra21446f; Takahashi O, 2013, NEW J CHEM, V37, P843, DOI 10.1039/c2nj40955k; WEIGANG OE, 1979, J AM CHEM SOC, V101, P1965, DOI 10.1021/ja00502a007	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					476	478		10.1002/chir.22465		3	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100005		
J	Natori, K; Iwayama, T; Yamabe, O; Kitamoto, Y; Ikeda, H; Sakamoto, K; Hattori, T; Miyano, S				Natori, Koichi; Iwayama, Taizo; Yamabe, Osamu; Kitamoto, Yuichi; Ikeda, Hiroshi; Sakamoto, Kenkichi; Hattori, Tetsutaro; Miyano, Sotaro			Photoracemization of Blestriarene C and Its Analogs	CHIRALITY			English	Article						biaryl synthesis; photoreaction; racemization; atropisomerism; photooxidation	NUCLEOPHILIC AROMATIC-SUBSTITUTION; CONVENIENT SYNTHESIS; LIQUID-CRYSTALS; PHOTOCYCLIZATION; PHOTOCHEMISTRY	Two analogs of blestriarene C (4,4'-dimethoxy-1,1'-biphenanthrene-2,2',7,7'-tetraol) bearing no 7,7'-dihydroxy (3) and 4,4'-dimethoxy groups 4 were prepared. Unlike blestriarene C (1), compounds 3 and 4, as well as 1,1'-biphenanthrene-2,2'-diol (5), do not racemize under fluorescent lamp illumination. Cyclic voltammetry analysis reveals that compound 1 has a lower half-wave potential (E-1/2) than compounds 3, 4, 5, suggesting that a redox cycle is involved in the racemization. Compound 1 racemizes by absorbing UV light corresponding to the L-1(b) band. During the reaction, no side products are observed. The racemization is significantly inhibited under nitrogen. Based on these observations, we propose a feasible mechanism for the easy racemization of compound 1, which is mediated by a cation radical generated in situ by a reversible photo-induced oxygen oxidation. Chirality 27:479-486, 2015. (c) 2015 Wiley Periodicals, Inc.	[Natori, Koichi; Iwayama, Taizo; Yamabe, Osamu; Kitamoto, Yuichi; Hattori, Tetsutaro; Miyano, Sotaro] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Ikeda, Hiroshi] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Osaka, Japan; [Sakamoto, Kenkichi] Shizuoka Univ, Fac Sci, Dept Chem, Shizuoka 4228017, Japan	Hattori, T (reprint author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, 6-6-11 Aramaki Aoba, Sendai, Miyagi 9808579, Japan.	hattori@orgsynth.che.tohoku.ac.jp					Flegel M, 2008, CAN J CHEM, V86, P161, DOI 10.1139/V07-143; CACCHI S, 1986, TETRAHEDRON LETT, V27, P5541, DOI 10.1016/S0040-4039(00)85262-4; Kovacs A, 2008, PHYTOCHEMISTRY, V69, P1084, DOI 10.1016/j.phytochem.2007.12.005; Hattori T, 2003, J ORG CHEM, V68, P2099, DOI 10.1021/jo026747k; Burnham KS, 1998, J AM CHEM SOC, V120, P12619, DOI 10.1021/ja982464r; Cavazza M, 1996, J AM CHEM SOC, V118, P9990, DOI 10.1021/ja960516b; FERINGA B, 1977, TETRAHEDRON LETT, P4447; FU JM, 1988, TETRAHEDRON LETT, V29, P5459, DOI 10.1016/S0040-4039(00)80786-8; HATTORI T, 1993, B CHEM SOC JPN, V66, P3034, DOI 10.1246/bcsj.66.3034; Hattori T, 1998, J AM CHEM SOC, V120, P9086, DOI 10.1021/ja981797l; Hattori T, 1996, SYNTHESIS-STUTTGART, P514; Hayashi K, 1978, Jpn. Kokai Tokkyo Koho, Patent No. [JP7818549, 7818549]; IRIE M, 1977, J PHYS CHEM-US, V81, P969, DOI 10.1021/j100525a009; MAJUMDER PL, 1990, PHYTOCHEMISTRY, V29, P271, DOI 10.1016/0031-9422(90)89048-E; Morikawa T, 2006, CHEM PHARM BULL, V54, P506, DOI 10.1248/cpb.54.506; Shi YJ, 1997, CHEM COMMUN, P273, DOI 10.1039/a606487f; Solntsev KM, 2009, ISR J CHEM, V49, P227, DOI 10.1560/IJC.49.2.227; YAMAKI M, 1989, PHYTOCHEMISTRY, V28, P3503, DOI 10.1016/0031-9422(89)80373-5; ZHANG MB, 1992, J PHYS CHEM-US, V96, P3063, DOI 10.1021/j100186a053; ZIMMERMA.HE, 1972, J AM CHEM SOC, V94, P498, DOI 10.1021/ja00757a030	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					479	486		10.1002/chir.22447		8	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100006		
J	Nishiyama, S; Urushibara, K; Masu, H; Azumaya, I; Kagechika, H; Tanatani, A				Nishiyama, Shizuka; Urushibara, Ko; Masu, Hyuma; Azumaya, Isao; Kagechika, Hiroyuki; Tanatani, Aya			Conformational and Chiral Properties of Cyclic-tri(N-methyl-meta-benzamide) Bearing Amidino Groups	CHIRALITY			English	Article						cyclic amide; crystal structure; dimer; capsule; chiral induction	ANION RECOGNITION; ENCAPSULATION; CALIXARENES; MOLECULES; THIOUREA; BINDING; RECEPTORS; TRIAMIDES; CRYSTAL; CAPSULE	Cyclic triamides 4 bearing amidino groups at the meta position of the phenyl rings were synthesized, and their conformational properties in the crystal and in solution were examined. Compound 4a exists as a capsule-type dimer of the enantiomers with a bowl-shaped syn conformation in the crystal state. Compound 4 exists mainly in the syn form in solution, and chiral induction was observed upon addition of a chiral acid to a solution of 4a. Chirality 27:487-491, 2015. (c) 2015 Wiley Periodicals, Inc.	[Nishiyama, Shizuka; Urushibara, Ko; Tanatani, Aya] Ochanomizu Univ, Dept Chem, Fac Sci, Tokyo 1128610, Japan; [Masu, Hyuma] Chiba Univ, Ctr Analyt Instrumentat, Chiba, Japan; [Azumaya, Isao] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan	Tanatani, A (reprint author), Ochanomizu Univ, Dept Chem, Fac Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	tanatani.aya@ocha.ac.jp					TSCHAEN DM, 1994, SYNTHETIC COMMUN, V24, P887, DOI 10.1080/00397919408011310; Yashima E, 1999, NATURE, V399, P449, DOI 10.1038/20900; Caltagirone C, 2008, CHEM-EUR J, V14, P10236, DOI 10.1002/chem.200801639; Otto S, 2003, J AM CHEM SOC, V125, P7804, DOI 10.1021/ja0351589; Jose DA, 2007, TETRAHEDRON LETT, V48, P3695, DOI 10.1016/j.tetlet.2007.03.120; Choi KH, 2003, J AM CHEM SOC, V125, P10241, DOI 10.1021/ja034563x; SHINKAI S, 1993, TETRAHEDRON, V49, P8933, DOI 10.1016/S0040-4020(01)91215-3; Conn MM, 1997, CHEM REV, V97, P1647, DOI 10.1021/cr9603800; Sessler JL, 2005, J AM CHEM SOC, V127, P11442, DOI 10.1021/ja0522938; Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G; Coquiere D, 2009, ORG BIOMOL CHEM, V7, P2485, DOI 10.1039/b902456e; Kivrak A, 2014, TETRAHEDRON, V70, P817, DOI 10.1016/j.tet.2013.12.043; Yashima E, 2008, ACCOUNTS CHEM RES, V41, P1166, DOI 10.1021/ar800091w; Kawauchi T, 2008, J AM CHEM SOC, V130, P11889, DOI 10.1021/ja8048805; Amendola V, 2010, CHEM-EUR J, V16, P4368, DOI 10.1002/chem.200903190; Asadi A, 2011, J AM CHEM SOC, V133, P10682, DOI 10.1021/ja203602u; Azumaya I, 2003, TETRAHEDRON, V59, P2325, DOI 10.1016/S0040-4020(03)00235-7; Azumaya I, 1996, TETRAHEDRON LETT, V37, P5003, DOI 10.1016/0040-4039(96)00995-1; ELHADI FE, 1980, TETRAHEDRON LETT, V21, P4215, DOI 10.1016/S0040-4039(00)93692-X; Fujimoto N, 2012, CHEM COMMUN, V48, P4809, DOI 10.1039/c2cc18177k; GUTSCHE CD, 1983, ACCOUNTS CHEM RES, V16, P161, DOI 10.1021/ar00089a003; GUTSCHE CD, 1990, PURE APPL CHEM, V62, P485, DOI 10.1351/pac199062030485; Imabeppu F, 2006, TETRAHEDRON LETT, V47, P413, DOI 10.1016/j.tetlet.2005.11.082; Jin Z-Y, 2014, CYCLODEXTRIN CHEM PR; Kakuta H, 2010, TETRAHEDRON, V66, P8254, DOI 10.1016/j.tet.2010.08.049; Hayashita T, 2000, CHEM COMMUN, P755, DOI 10.1039/a909758i; Rebek J, 2005, ANGEW CHEM INT EDIT, V44, P2068, DOI 10.1002/anie.200462839; Rebek J, 1999, ACCOUNTS CHEM RES, V32, P278, DOI 10.1021/ar970201g	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					487	491		10.1002/chir.22476		5	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100007		
J	Zhang, CH; Ma, R; Wang, HL; Sakai, R; Satoh, T; Kakuchi, T; Liu, LJ; Okamoto, Y				Zhang, Chunhong; Ma, Rui; Wang, Hailun; Sakai, Ryosuke; Satoh, Toshifumi; Kakuchi, Toyoji; Liu, Lijia; Okamoto, Yoshio			Influence of Helical Structure on Chiral Recognition of Poly(phenylacetylene)s Bearing Phenylcarbamate Residues of L-Phenylglycinol and Amide Linage as Pendants	CHIRALITY			English	Article						chiral recognition; poly(phenylacetylene); helical structure; CSP; HPLC	PERFORMANCE LIQUID-CHROMATOGRAPHY; ETHYL-ESTER PENDANTS; STATIONARY PHASES; SILICA-GEL; HPLC; DERIVATIVES; ENANTIOSEPARATION; POLYPHENYLACETYLENE; RESOLUTION; POLYMERIZATION	Four poly(phenylacetylene)s (PPA-1, PPA-2, PPA-3, PPA-4) bearing phenylcarbamate residues of L-phenylglycinol and amide linkage as pendants were prepared to be used as chiral stationary phases (CSPs) for high-performance liquid chromatography (HPLC), and the influences of coating solvents, dimethylformamide (DMF) and tetrahydrofuran (THF), which were used for coating the polymers on silica gel, on the helical structure of the polymers and their chiral recognition abilities were investigated. The structure analysis of PPA-1, PPA-2, PPA-3, PPA-4 by H-1 nuclear magnetic resonance (NMR), size exclusion chromatography (SEC), optical rotation, and circular dichroism (CD) spectra indicated that the polymers possess the cis-transoidal structure with dynamic helical conformation. The polymers in THF seem to have shorter conjugated helical main chains along with a tighter twist conformation than those in DMF. The chiral recognition abilities of PPA-1, PPA-2, PPA-3, PPA-4 with the different helical structures induced by the coating solvents were evaluated as the CSPs in HPLC. The helical structures of PPA-1, PPA-2, PPA-3, PPA-4 induced with THF are preferable for chiral recognition for some racemates compared to those induced with DMF, and higher chiral recognition abilities of PPA-1, PPA-2, PPA-3, PPA-4 were achieved using THF. Chirality 27:500-506, 2015. (c) 2015 Wiley Periodicals, Inc.	[Zhang, Chunhong; Ma, Rui; Wang, Hailun; Liu, Lijia; Okamoto, Yoshio] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Polymer Mat Res Ctr,Minist Educ, Harbin 150001, Peoples R China; [Sakai, Ryosuke] Asahikawa Natl Coll Technol, Dept Chem Mat, Asahikawa, Hokkaido, Japan; [Satoh, Toshifumi; Kakuchi, Toyoji] Hokkaido Univ, Fac Engn, Grad Sch Chem Sci & Engn, Div Biotechnol & Macromol Chem, Sapporo, Hokkaido 060, Japan; [Okamoto, Yoshio] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Zhang, CH (reprint author), Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Polymer Mat Res Ctr,Minist Educ, Harbin 150001, Peoples R China.	zhangchunhong97@163.com; okamoto@apchem.nagoya-u.ac.jp			National Nature Science Foundation of China [51373044.21204014]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20111568]; Fundamental Research Funds for the Central Universities, China [HEUCFT1009]; Daicel Corporation (Tokyo, Japan); Harbin Engineering University	Contract grant sponsor: National Nature Science Foundation of China; Contract grant numbers: 51373044.21204014.; Contract grant sponsor: Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Contract grant number: 20111568.; Contract grant sponsor: Fundamental Research Funds for the Central Universities, China; Contract grant number: HEUCFT1009.; Contract grant sponsor: Daicel Corporation (Tokyo, Japan) and Harbin Engineering University.	SIMIONESCU CI, 1977, J POLYM SCI POL CHEM, V15, P2497, DOI 10.1002/pol.1977.170151018; KISHIMOTO Y, 1995, MACROMOLECULES, V28, P6662, DOI 10.1021/ma00123a037; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Ward TJ, 2010, ANAL CHEM, V82, P4712, DOI 10.1021/ac1010926; Okamoto Y, 1998, REACT FUNCT POLYM, V37, P183, DOI 10.1016/S1381-5148(97)00135-1; Tamura K, 2011, POLYM CHEM-UK, V2, P91, DOI 10.1039/c0py00164c; Miyabe T, 2012, CHEM SCI, V3, P863, DOI 10.1039/c1sc00708d; OKAMOTO Y, 1986, J CHROMATOGR, V363, P173, DOI 10.1016/S0021-9673(01)83736-5; Okamoto Y, 2008, CHEM SOC REV, V37, P2593, DOI 10.1039/b808881k; Yamamoto C, 2008, CHIRALITY, V20, P288, DOI 10.1002/chir.20430; Shimomura K, 2014, NAT CHEM, V6, P429, DOI [10.1038/nchem.1916, 10.1038/NCHEM.1916]; Yamamoto C, 2004, B CHEM SOC JPN, V77, P227, DOI 10.1246/bcsj.77.227; Zhang CH, 2013, MACROMOLECULES, V46, P8406, DOI 10.1021/ma4015802; Ikai T, 2009, CHEM REV, V109, P6077, DOI 10.1021/cr8005558; AOKI T, 1993, CHEM LETT, P2009, DOI 10.1246/cl.1993.2009; Chai TT, 2015, CHIRALITY, V27, P32, DOI 10.1002/chir.22385; Cheuk KKL, 2003, MACROMOLECULES, V36, P5947, DOI 10.1021/ma0344543; Fukushima T, 2006, MACROMOLECULES, V39, P3103, DOI 10.1021/ma0527597; Kakuchi R, 2009, MACROMOLECULES, V42, P1476, DOI 10.1021/ma8025892; Kakuchi R, 2008, CHEM-EUR J, V14, P10259, DOI 10.1002/chem.200801235; Kubota T, 2003, CHIRALITY, V15, P77, DOI 10.1002/chir.10169; Lin HZ, 2008, CHIRALITY, V20, P386, DOI 10.1002/chir.20457; Milko P, 2013, PHYS CHEM CHEM PHYS, V15, P6113, DOI 10.1039/c3cp44444a; Naito Y, 2012, CHEM LETT, V28, P809; OKAMOTO Y, 1986, CHEM LETT, P983, DOI 10.1246/cl.1986.983; Tamura K, 2011, B CHEM SOC JPN, V84, P741, DOI 10.1246/bcsj.20110074; YASHIMA E, 1994, J CHEM SOC CHEM COMM, P1811, DOI 10.1039/c39940001811; Yashima E, 1996, KOREA POLYM J, V4, P39; Zhang CH, 2015, J POLYM SCI POL CHEM, V53, P809, DOI 10.1002/pola.27506; Zhang CH, 2013, ACTA POLYM SIN, P811, DOI 10.3724/SP.J.1105.2013.13054; Zhang CH, 2013, J POLYM SCI POL CHEM, V51, P2271, DOI 10.1002/pola.26611	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					500	506		10.1002/chir.22453		7	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100009		
J	Kumano, D; Iwahana, S; Iida, H; Shen, CS; Crassous, J; Yashima, E				Kumano, Daisuke; Iwahana, Soichiro; Iida, Hiroki; Shen, Chengshuo; Crassous, Jeanne; Yashima, Eiji			Enantioseparation on Riboflavin Derivatives Chemically Bonded to Silica Gel as Chiral Stationary Phases for HPLC	CHIRALITY			English	Article						riboflavin; chiral recognition; chiral stationary phase; helicene	PERFORMANCE LIQUID-CHROMATOGRAPHY; HELICAL POLYMERS; LIGAND-EXCHANGE; SEPARATION; ENANTIOMERS; RECOGNITION; RESOLUTION; HELICENES; CELLULOSE; AMYLOSE	Acetylated and/or 3,5-dimethylphenylcarbamated riboflavins were prepared and the resulting riboflavin derivatives as well as natural riboflavin were regioselectively immobilized on silica gel through chemical bonding at the 5'-O- or 3-N-position of the riboflavin to develop novel chiral stationary phases (CSPs) for enantioseparation by high-performance liquid chromatography (HPLC). The chiral recognition abilities of the obtained CSPs were significantly dependent on the structures of the riboflavin derivatives, the position of the chemical bonding on the silica gel, and the structures of the racemic compounds. The CSPs bonded at the 5'-O-position on the silica gel tended to well separate helicene derivatives, while the CSPs bonded at the 3-N-position composed of acetylated and 3,5-dimethylphenylcarbamated riboflavins showed a better resolving ability toward helicene derivatives and bulky aromatic racemic alcohols, respectively, and some of them were completely separated into the enantiomers. The observed difference in the chiral recognition abilities of these riboflavin-based CSPs is discussed based on the difference in their structures, including the substituents of riboflavin and the positions immobilized on the silica gel. Chirality 27:507-517, 2015. (c) 2015 Wiley Periodicals, Inc.	[Kumano, Daisuke; Iwahana, Soichiro; Iida, Hiroki; Shen, Chengshuo; Yashima, Eiji] Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Nagoya, Aichi 4648603, Japan; [Shen, Chengshuo; Crassous, Jeanne] Univ Rennes 1, CNRS, UMR 6226, Sci Chim Rennes, Rennes, France	Yashima, E (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	yashima@apchem.nagoya-u.ac.jp	Iida, Hiroki/H-3431-2012; 	Crassous, Jeanne/0000-0002-4037-6067	Japan Society for the Promotion of Science	This work was supported in part by a Grant-in-Aid for Scientific Research (S) (to E.Y.) and a Grant-in-Aid for Young Scientists (B) (to H.I.) from the Japan Society for the Promotion of Science. C.S. expresses his thanks for the Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," MEXT, Japan.	Iida H, 2014, CHEM-EUR J, V20, P4257, DOI 10.1002/chem.201400234; Maier NM, 2001, J CHROMATOGR A, V906, P3, DOI 10.1016/S0021-9673(00)00532-X; Lammerhofer M, 2008, ADV CHROMATOGR, V46, P1; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Shen C, 2014, CHEM SCI, V5, P1915, DOI 10.1039/c3sc53442a; Tamura K, 2011, POLYM CHEM-UK, V2, P91, DOI 10.1039/c0py00164c; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Miyabe T, 2012, CHEM SCI, V3, P863, DOI 10.1039/c1sc00708d; OKAMOTO Y, 1986, J CHROMATOGR, V363, P173, DOI 10.1016/S0021-9673(01)83736-5; Okamoto Y, 2008, CHEM SOC REV, V37, P2593, DOI 10.1039/b808881k; Yashima E, 2001, J CHROMATOGR A, V906, P105, DOI 10.1016/S0021-9673(00)00501-X; Hyun MH, 2005, B KOREAN CHEM SOC, V26, P1153; Cavazzini A, 2011, ANAL CHIM ACTA, V706, P205, DOI 10.1016/j.aca.2011.08.038; Enomoto N, 1996, ANAL CHEM, V68, P2798, DOI 10.1021/ac960002v; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Okamoto Y, 1998, ANGEW CHEM INT EDIT, V37, P1020, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1020::AID-ANIE1020>3.0.CO;2-5; Roussel C, 2004, J CHROMATOGR A, V1037, P311, DOI 10.1016/j.chroma.2004.01.065; Iida H, 2012, J AM CHEM SOC, V134, P15103, DOI 10.1021/ja306159t; Francotte ER, 2001, J CHROMATOGR A, V906, P379, DOI 10.1016/S0021-9673(00)00951-1; Yamamoto C, 2004, B CHEM SOC JPN, V77, P227, DOI 10.1246/bcsj.77.227; Anger E, 2012, J AM CHEM SOC, V134, P15628, DOI 10.1021/ja304424t; Davankov VA, 2003, J CHROMATOGR A, V1000, P891, DOI 10.1016/S0021-9673(03)00304-2; Ikai T, 2009, CHEM REV, V109, P6077, DOI 10.1021/cr8005558; Nakano T, 2001, J CHROMATOGR A, V906, P205, DOI 10.1016/S0021-9673(00)00944-4; D'Acquarica I, 2008, ADV CHROMATOGR, V46, P109; Ding P, 2014, SCI CHINA CHEM, V57, P1492, DOI 10.1007/s11426-014-5206-8; Gonzalo G, 2013, CHEMCATCHEM, V5, P403; Ju SY, 2012, J AM CHEM SOC, V134, P13196, DOI 10.1021/ja305250g; KIM YH, 1980, J AM CHEM SOC, V102, P5915, DOI 10.1021/ja00538a040; KOLLER H, 1983, J CHROMATOGR, V282, P89, DOI 10.1016/S0021-9673(00)91594-2; Muller F., 1971, METHODS ENZYMOL B, V18, P453; Nakai Y, 2012, J PHYS CHEM A, V116, P7372, DOI 10.1021/jp304576g; TAKAHASHI H, 1991, TETRAHEDRON, V47, P6215, DOI 10.1016/S0040-4020(01)86553-4; VEIGL E, 1994, J CHROMATOGR A, V660, P255, DOI 10.1016/0021-9673(94)85120-4; YASHIMA E, 1994, J CHROMATOGR A, V677, P11, DOI 10.1016/0021-9673(94)80539-3	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					507	517		10.1002/chir.22452		11	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100010		
J	Li, G; Shen, J; Li, Q; Okamoto, Y				Li, Geng; Shen, Jun; Li, Qiang; Okamoto, Yoshio			Synthesis and Enantioseparation Ability of Xylan Bisphenylcarbamate Derivatives as Chiral Stationary Phases in HPLC	CHIRALITY			English	Article						xylan; phenylcarbamate; enantioseparation; resolution; chiral stationary phases; CSP; high-performance liquid chromatography, HPLC	PERFORMANCE LIQUID-CHROMATOGRAPHY; SILICA-GEL; ENANTIOMERS; RESOLUTION; POLYSACCHARIDES; CELLULOSE; SEPARATION; AMYLOSE	Ten novel xylan bisphenylcarbamate derivatives bearing meta- and para-substituents on their phenyl groups were synthesized and their chiral recognition abilities were evaluated as the chiral stationary phases (CSPs) for high-performance liquid chromatography (HPLC) after coating them on macroporous silica. The chiral recognition abilities of these CSPs depended on the nature, position, and number of the substituents on the phenyl moieties. The introduction of an electron-donating group was more attractive than an electron-withdrawing group to improve the chiral recognition ability of the xylan phenylcarbamate derivatives. Among the CSPs discussed in this study, xylan bis(3,5-dimethylphenylcarbamate)-based CSP seems to possess the highest resolving power for many racemates, and the meta-substituted CSPs showed relatively better chiral recognition than the para-substituted ones. For some racemates, the xylan bis(3,5-dimethylphenylcarbamate) derivative exhibited higher enantioselectivity than the CSP based on cellulose tris(3,5-dimethylphenylcarbamate). Chirality 27:518-522, 2015 (c) 2015 Wiley Periodicals, Inc.	[Li, Geng; Shen, Jun; Li, Qiang; Okamoto, Yoshio] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Polymer Mat Res Ctr,Minist Educ, Harbin 150001, Peoples R China; [Okamoto, Yoshio] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Shen, J (reprint author), Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Polymer Mat Res Ctr,Minist Educ, Harbin 150001, Peoples R China.	shenjun@hrbeu.edu.cn; okamoto@apchem.nagoya-u.ac.jp			National Natural Science Foundation of China [21474024, 51073046]; Fundamental Research Funds for the Central Universities [HEUCFT1009, HEUCF20151009]; Daicel Corporation (Tokyo, Japan)	The authors acknowledge the support of the National Natural Science Foundation of China (No 21474024, 51073046) and the Fundamental Research Funds for the Central Universities (HEUCFT1009, HEUCF20151009). This work was also partially supported by Daicel Corporation (Tokyo, Japan).	Alanazi AM, 2014, CHIRALITY, V26, P194, DOI 10.1002/chir.22296; CHANKVETADZE B, 1995, J CHROMATOGR A, V694, P101, DOI 10.1016/0021-9673(94)00729-S; OKAMOTO Y, 1994, J CHROMATOGR A, V666, P403, DOI 10.1016/0021-9673(94)80400-1; Okamoto Y, 1998, REACT FUNCT POLYM, V37, P183, DOI 10.1016/S1381-5148(97)00135-1; OKAMOTO Y, 1986, J CHROMATOGR, V363, P173, DOI 10.1016/S0021-9673(01)83736-5; Okamoto Y, 2008, CHEM SOC REV, V37, P2593, DOI 10.1039/b808881k; Shen J, 2010, J CHROMATOGR A, V1217, P1041, DOI 10.1016/j.chroma.2009.07.027; CHANKVETADZE B, 1994, J CHROMATOGR A, V670, P39, DOI 10.1016/0021-9673(94)80278-5; Okamoto Y, 1998, ANGEW CHEM INT EDIT, V37, P1020, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1020::AID-ANIE1020>3.0.CO;2-5; Martinez SE, 2014, CHIRALITY, V26, P419, DOI 10.1002/chir.22343; OKAMOTO Y, 1987, J CHROMATOGR, V389, P95, DOI 10.1016/S0021-9673(01)94414-0; Francotte ER, 2001, J CHROMATOGR A, V906, P379, DOI 10.1016/S0021-9673(00)00951-1; Shen J, 2013, J CHROMATOGR A, V1286, P41, DOI 10.1016/j.chroma.2013.02.020; Ikai T, 2009, CHEM REV, V109, P6077, DOI 10.1021/cr8005558; Zhang LL, 2014, J CHROMATOGR A, V1365, P86, DOI 10.1016/j.chroma.2014.09.002; OKAMOTO Y, 1984, J AM CHEM SOC, V106, P5357, DOI 10.1021/ja00330a057; Francotte E., 2006, CHIRALITY DRUG RES; KOLLER H, 1983, J CHROMATOGR, V282, P89, DOI 10.1016/S0021-9673(00)91594-2; Okamoto Y, 2009, J POLYM SCI POL CHEM, V47, P1731, DOI 10.1002/pola.23215; Shen J, 2014, J CHROMATOGR A, V1363, P51, DOI 10.1016/j.chroma.2014.06.042; Subramanians G, 2007, CHIRAL SEPARATION TE; Yashima E, 1995, B CHEM SOC JPN, V68, P3289, DOI 10.1246/bcsj.68.3289	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					518	522		10.1002/chir.22472		5	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100011		
J	Takenaka, K; Lin, XJ; Takizawa, S; Sasai, H				Takenaka, Kazuhiro; Lin, Xianjin; Takizawa, Shinobu; Sasai, Hiroaki			Structural Features and Asymmetric Environment of i-Pr-SPRIX Ligand	CHIRALITY			English	Article						chiral ligand; spiro framework; isoxazoline; asymmetric environment; palladium; enantioselective catalysis; oxidative cyclization	CHIRAL LIGAND; CYCLIZATION; CATALYSIS; DIPHOSPHINE; DESIGN; ACIDS; OXIDE	Novel chiral diisopropyl spiro bis(isoxazoline) ligands, anti-i-Pr-SPRIX and syn-i-Pr-SPRIX, were designed and synthesized. Their catalytic utility, X-ray crystallographic analyses, and complexation studies demonstrated the structural features of tetraisopropyl spiro bis(isoxazoline) ligand, i-Pr-SPRIX, which is a prominent ligand in various enantioselective Pd catalytic processes: All i-Pr groups work in collaboration to create an effective asymmetric environment. Chirality 27:532-537, 2015. (c) 2015 Wiley Periodicals, Inc.	[Takenaka, Kazuhiro; Lin, Xianjin; Takizawa, Shinobu; Sasai, Hiroaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Sasai, H (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	sasai@sanken.osaka-u.ac.jp			Advanced Catalytic Transformation program for Carbon utilization (ACT-C); MEXT; JSPS; Core Research for Evolutionary Science and Technology (CREST)	This study was supported by Advanced Catalytic Transformation program for Carbon utilization (ACT-C), Core Research for Evolutionary Science and Technology (CREST), a Grant-in-Aid for Scientific Research from MEXT, and the JSPS Japanese-German Graduate Externship. We thank the technical staff of the ISIR Comprehensive Analysis Center at Osaka University for assistance.	ANNUNZIATA R, 1987, J ORG CHEM, V52, P4674, DOI 10.1021/jo00230a004; Tsujihara T, 2009, J AM CHEM SOC, V131, P3452, DOI 10.1021/ja809965e; Ding KL, 2009, CHEM-ASIAN J, V4, P32, DOI 10.1002/asia.200800192; Takenaka K, 2011, ORG LETT, V13, P3506, DOI 10.1021/ol201314m; Tsujihara T, 2009, J ORG CHEM, V74, P9274, DOI 10.1021/jo901778a; Xie JH, 2008, ACCOUNTS CHEM RES, V41, P581, DOI 10.1021/ar700137z; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Ramalingan C, 2011, TETRAHEDRON, V67, P2889, DOI 10.1016/j.tet.2011.02.057; Takenaka K, 2008, TETRAHEDRON-ASYMMETR, V19, P2492, DOI 10.1016/j.tetasy.2008.10.019; HOUK KN, 1985, J AM CHEM SOC, V107, P7227, DOI 10.1021/ja00310a105; Bajracharya GB, 2010, CHEM COMMUN, V46, P9064, DOI 10.1039/c0cc02352c; Zhu SF, 2012, ACCOUNTS CHEM RES, V45, P1365, DOI 10.1021/ar300051u; Takenaka K, 2014, ANGEW CHEM INT EDIT, V53, P4675, DOI 10.1002/anie.201311172; Jacquet O, 2011, TETRAHEDRON-ASYMMETR, V22, P1490, DOI 10.1016/j.tetasy.2011.08.023; Wang XM, 2014, J AM CHEM SOC, V136, P405, DOI 10.1021/ja410707q; Bajracharya GB, 2009, B CHEM SOC JPN, V82, P285, DOI 10.1246/bcsj.82.285; Armarego W. L. F., 2013, PURIFICATION LAB CHE; Dussault PH, 1996, TETRAHEDRON, V52, P12381, DOI 10.1016/0040-4020(96)00744-2; Gabr RK, 2013, CHEM-EUR J, V19, P9518, DOI 10.1002/chem.201203189; HRUBIEC RT, 1984, J ORG CHEM, V49, P431, DOI 10.1021/jo00177a008; Koranne PS, 2007, TETRAHEDRON-ASYMMETR, V18, P919, DOI 10.1016/j.tetasy.2007.04.010; Liu X, 2014, ANGEW CHEM INT EDIT, V53, P1978, DOI 10.1002/anie.201309521; Sala X, 2008, EUR J ORG CHEM, P6197, DOI 10.1002/ejoc.200800913; Takenaka K, 2010, ORG LETT, V12, P3480, DOI 10.1021/ol1013069; Takenaka K, 2010, TETRAHEDRON-ASYMMETR, V21, P767, DOI 10.1016/j.tetasy.2010.04.060; Takenaka K, 2013, CHEM COMMUN, V49, P11224, DOI 10.1039/c3cc44797a; Takenaka K, 2011, ADV SYNTH CATAL, V353, P1067, DOI 10.1002/adsc.201000926; Takenaka K, 2010, TETRAHEDRON-ASYMMETR, V21, P379, DOI 10.1016/j.tetasy.2010.03.006; Wakita K, 2007, TETRAHEDRON-ASYMMETR, V18, P372, DOI 10.1016/j.tetasy.2007.02.004; Wakita K, 2004, HETEROCYCLES, V62, P831	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	AUG	2015	27	8					532	537		10.1002/chir.22467		6	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CN7VT	WOS:000358643100013		
J	Saito, T; Umebachi, R; Namera, A; Oikawa, H; Miyazaki, S; Fujita, Y; Inokuchi, S				Saito, Takeshi; Umebachi, Rimako; Namera, Akira; Oikawa, Hiroshi; Miyazaki, Shota; Fujita, Yuji; Inokuchi, Sadaki			Identification and Quantification of Aconitines and Colchicine in Serum, Urine, and Plants using MonoSpin C-18 and LC-MSMS	CHROMATOGRAPHIA			English	Article						Aconitines; Colchicine; Monolithic spin column; LC-MS/MS	PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; DIETARY-SUPPLEMENTS; HERBAL MEDICINE; BODY-FLUIDS; ALKALOIDS; INGESTION; MESACONITINE; SEPARATION; OVERDOSE	Aconitum and Colchicum are known to be highly toxic plants based on their respective toxins, namely aconite and colchicine. Aconite and colchicine poisoning generally occurs because of misidentification and contamination, and is also associated with homicide and suicide cases. The detection of aconitines and colchicine in body fluids and leftovers plays an important role in clinical and forensic toxicology investigation of suspected food poisoning by natural poisons. Therefore, we have developed and validated a rapid determination of aconitine, hypaconitine, jesaconitine, mesaconitine, and colchicine in serum, urine, and plants using liquid chromatography-tandem mass spectrometry. All targeted compounds, together with internal standards, were extracted from serum and urine using a C-18 monolithic spin column. Recovery of all compounds from serum, spiked at concentrations of 0.1, 0.8, 6, and 18 ng mL(-1), ranged from 96.8 to 101.4 %. Recovery of all compounds from urine, spiked at concentrations of 0.1, 8, 80 and 190 ng mL(-1), ranged from 96.6 to 101.9 %. The intra- and inter-assay accuracy and precision (expressed as relative standard deviation, %RSD) evaluated for all compounds were within 96.7-103.2 % and 1.7-11.5 %, respectively. Detection limits and quantitation limits of aconitines and colchicine for serum and urine were 0.05 and 0.1 ng mL(-1), respectively. This method had a chromatographic run time of 7.0 min. Calibration curves for serum and urine ranged from 0.1 to 20 ng mL(-1) for serum and 0.1-200 ng mL(-1) for urine, respectively. The validated method was successfully applied to clinical aconitine and colchicine poisoning cases.	[Saito, Takeshi; Umebachi, Rimako; Inokuchi, Sadaki] Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, Isehara, Kanagawa 2591143, Japan; [Namera, Akira] Hiroshima Univ, Dept Forens Med, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Oikawa, Hiroshi; Miyazaki, Shota] GL Sci Inc, Tokyo, Japan; [Fujita, Yuji] Iwate Med Univ, Sch Med, Dept Emergency Med, Morioka, Iwate 020, Japan	Saito, T (reprint author), Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan.	saito@is.icc.u-tokai.ac.jp			Japan Society for the Promotion of Science [25460878]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 25460878) from the Japan Society for the Promotion of Science.	Yang Y, 2010, J CHROMATOGR B, V878, P2811, DOI 10.1016/j.jchromb.2010.08.032; Sun B, 2009, RAPID COMMUN MASS SP, V23, P1221, DOI 10.1002/rcm.3992; Chan TYK, 2009, HUM EXP TOXICOL, V28, P795, DOI 10.1177/0960327109353056; Bao Y, 2011, ELECTROPHORESIS, V32, P1515, DOI 10.1002/elps.201100040; Wong SK, 2009, J AOAC INT, V92, P111; Milne ST, 1998, AM J EMERG MED, V16, P603, DOI 10.1016/S0735-6757(98)90228-5; Carlier J, 2015, J CHROMATOGR B, V975, P65, DOI 10.1016/j.jchromb.2014.10.028; Pullela R, 2008, J FORENSIC SCI, V53, P491, DOI 10.1111/j.1556-4029.2007.00647.x; Finkelstein Y, 2010, CLIN TOXICOL, V48, P407, DOI 10.3109/15563650.2010.495348; Ng SW, 2013, J CHROMATOGR B, V942, P63, DOI 10.1016/j.jchromb.2013.10.020; Boehm KM, 2011, J EMERG MED, V41, P298, DOI 10.1016/j.jemermed.2009.08.044; Bourgogne E, 2013, BIOANALYSIS, V5, P2889, DOI 10.4155/bio.13.258; Chung KKW, 2012, TALANTA, V97, P491, DOI 10.1016/j.talanta.2012.05.004; Fujita Y, 2007, J ANAL TOXICOL, V31, P132; Ito K, 1998, J CHROMATOGR B, V714, P197, DOI 10.1016/S0378-4347(98)00235-7; Ito K, 2000, J ANAL TOXICOL, V24, P348; Kang XQ, 2010, J CHROMATOGR SCI, V48, P860; Kurasawa K., 1993, JPN J TOXICOL, V6, P185; Liu HT, 2009, ANAL CHIM ACTA, V638, P88, DOI 10.1016/j.aca.2009.02.006; Nagesh KR, 2011, J FORENSIC LEG MED, V18, P285, DOI 10.1016/j.jflm.2011.04.008; Niitsu H, 2013, FORENSIC SCI INT, V227, P111, DOI 10.1016/j.forsciint.2012.10.021; Ono Takiyoshi, 2009, Legal Medicine, V11, P132, DOI 10.1016/j.legalmed.2008.11.001; Amrollahi-Sharifabadi M, 2013, AM J FOREN MED PATH, V34, P295, DOI 10.1097/PAF.0000000000000059; Sussman JS, 2004, THER DRUG MONIT, V26, P688, DOI 10.1097/00007691-200412000-00017; Vaclavik L, 2014, ANAL CHIM ACTA, V810, P45, DOI 10.1016/j.aca.2013.12.006; Weakley-Jones B, 2001, AM J FOREN MED PATH, V22, P203, DOI 10.1097/00000433-200106000-00020; Zhang CH, 2012, CHROMATOGRAPHIA, V75, P499, DOI 10.1007/s10337-012-2216-6	27	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	AUG	2015	78	15-16					1041	1048		10.1007/s10337-015-2921-z		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CN7FI	WOS:000358599200009		
J	Hokimoto, S; Yasuda, S; Sueta, D; Tsujita, K; Sakamoto, K; Yamamuro, M; Izumiya, Y; Arima, Y; Usuku, H; Sumida, Y; Kojima, S; Kaikita, K; Kanazawa, H; Yamabe, H; Ogawa, H				Hokimoto, Seiji; Yasuda, Satoshi; Sueta, Daisuke; Tsujita, Kenichi; Sakamoto, Kenji; Yamamuro, Megumi; Izumiya, Yasuhiro; Arima, Yuichiro; Usuku, Hiroki; Sumida, Yoko; Kojima, Sunao; Kaikita, Koichi; Kanazawa, Hisanori; Yamabe, Hiroshige; Ogawa, Hisao			Overview of the 79th Annual Scientific Meeting of the Japanese Circulation Society - Late-Breaking Cardiovascular Medicine From Japan -	CIRCULATION JOURNAL			English	Article; Proceedings Paper	79th Annual Scientific Meeting of the Japanese-Circulation-Society (JCS) on Late-Breaking Cardiovascular Medicine from Japan	APR 24-26, 2015	Osaka, JAPAN	Japanese Circulat Soc		Cardiology; Cardiovascular diseases; Evidence-based medicine; Japanese Circulation Society	CONTROLLED-TRIAL; THERAPY	The 79th Annual Scientific Meeting of the Japanese Circulation Society was held in Osaka on April 24-26, 2015. The main theme was "Late-breaking Cardiovascular Medicine from Japan". Recently, optimal medical treatment has been guided by evidence-based medicine. We aim to emphasize the research findings and advances in cardiology from Japan, in the hope that Japan will become one of the leaders in the field worldwide. Unlike previous meetings, this annual scientific meeting was held in late April. Approximately 18,000 people, including medical doctors, healthcare professionals, and management staff, attended. The meeting was successfully completed, and included discussions on state-of-the art medicine.	[Hokimoto, Seiji; Sueta, Daisuke; Tsujita, Kenichi; Sakamoto, Kenji; Yamamuro, Megumi; Izumiya, Yasuhiro; Arima, Yuichiro; Usuku, Hiroki; Kojima, Sunao; Kaikita, Koichi; Kanazawa, Hisanori; Yamabe, Hiroshige; Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Yasuda, Satoshi; Sumida, Yoko; Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Cardiovasc Med, Suita, Osaka, Japan	Hokimoto, S (reprint author), Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp					Fuster JJ, 2015, DIABETES, V64, P1235, DOI 10.2337/db14-1164; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Kojima S, 2013, CIRC J, V77, P2841, DOI 10.1253/circj.CJ-13-1011; Rogers JH, 2011, EUR HEART J, V32, P2350, DOI 10.1093/eurheartj/ehr101; Kario K, 2015, CIRC J, V79, P1222, DOI 10.1253/circj.CJ-15-0150; Fuku Y, 2014, CIRC J, V78, P1357, DOI 10.1253/circj.CJ-13-1220; Craige SM, 2015, CIRC J, V79, P1145, DOI 10.1253/circj.CJ-15-0464; Noda T, 2014, CIRC J, V78, P1989, DOI 10.1253/circj.CJ-14-0589	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1675	1679		10.1253/circj.CJ-15-0675		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900005		
J	Machino, T; Sekiguchi, Y				Machino, Takeshi; Sekiguchi, Yukio			Positive Pocket Cultures From Cardiac Implantable Electrophysiological Devices Without Infection	CIRCULATION JOURNAL			English	Editorial Material							ASYMPTOMATIC BACTERIAL-COLONIZATION; RHYTHM MANAGEMENT DEVICES; REPLACEMENT; PREVALENCE; SONICATION; DIAGNOSIS		[Machino, Takeshi; Sekiguchi, Yukio] Univ Tsukuba, Cardiovasc Div, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Sekiguchi, Y (reprint author), Univ Tsukuba, Cardiovasc Div, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	yseki@md.tsukuba.ac.jp					Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Rohacek M, 2010, CIRCULATION, V121, P1691, DOI 10.1161/CIRCULATIONAHA.109.906461; Mason PK, 2011, PACE, V34, P143, DOI 10.1111/j.1540-8159.2010.02820.x; Pichlmaier M, 2008, EUROPACE, V10, P1067, DOI 10.1093/europace/eun191; Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283; Kleemann T, 2010, EUROPACE, V12, P58, DOI 10.1093/europace/eup334; Klug D, 2010, EUROPACE, V12, P5, DOI 10.1093/europace/eup402; Nakatani S, 2013, CIRC J, V77, P1558, DOI 10.1253/circj.CJ-12-1101; Okada M, 2015, CIRC J, V79, P1712, DOI 10.1253/circj.CJ-15-0133; Sandoe JAT, 2015, J ANTIMICROB CHEMOTH, V70, P325, DOI 10.1093/jac/dku383; Turtiainen J, 2014, EUR J VASC ENDOVASC, V47, P411, DOI 10.1016/j.ejvs.2013.12.025	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1680	1681		10.1253/circj.CJ-15-0645		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900006		
J	Abe, H; Koretsune, Y				Abe, Haruhiko; Koretsune, Yukihiro			New Modified CHA(2)DS(2)-VA Scoring System for Japanese Patients With Non-Valvular Atrial Fibrillation	CIRCULATION JOURNAL			English	Editorial Material							J-RHYTHM REGISTRY; RISK STRATIFICATION; NATIONWIDE COHORT; STROKE RISK; FEMALE SEX; GUIDELINES		[Abe, Haruhiko; Koretsune, Yukihiro] Osaka Natl Hosp, Natl Hosp Org, Inst Clin Res, Osaka 5400006, Japan	Koretsune, Y (reprint author), Osaka Natl Hosp, Inst Clin Res, Chuo Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	koretune@onh.go.jp					Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Mikkelsen AP, 2012, J THROMB HAEMOST, V10, P1745, DOI 10.1111/j.1538-7836.2012.04853.x; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Inoue H, 2014, AM J CARDIOL, V113, P957, DOI 10.1016/j.amjcard.2013.11.057; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Tomita H, 2015, CIRC J, V79, P1719, DOI 10.1253/circj.CJ-15-0095; Covel CL, 2014, THROMB HAEMOSTASIS, V111, P385, DOI 10.1160/TH13-04-0347; Friberg L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3522; January CT, 2014, CIRCULATION, V130, pE199, DOI 10.1161/CIR.0000000000000041; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Olesen JB, 2012, CHEST, V141, P147, DOI 10.1378/chest.11-0862; Suzuki S, 2015, CIRC J, V79, P432, DOI 10.1253/circj.CJ-14-1131	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1682	1684		10.1253/circj.CJ-15-0653		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900007		
J	Niwano, S				Niwano, Shinichi			Is Circulating Fibroblast Growth Factor 23 a Surrogate Marker or Active Mediator for the Construction of Atrial Fibrillation Substrate?	CIRCULATION JOURNAL			English	Editorial Material							CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; FGF23; KLOTHO; METABOLISM; MORTALITY; PHOSPHATE		[Niwano, Shinichi] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa 2520374, Japan	Niwano, S (reprint author), Kitasato Univ, Sch Med, Dept Cardiovasc Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	shniwano@med.kitasato-u.ac.jp					Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Kurokawa S, 2014, CIRC J, V78, P1950, DOI 10.1253/circj.CJ-13-1587; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Gutierrez OM, 2013, J RENAL NUTR, V23, P250, DOI 10.1053/j.jrn.2013.01.024; Miyamura M, 2015, CIRC J, V79, P1742, DOI 10.1253/circj.CJ-15-0413; Niwano S, 2011, CIRC J, V75, P662, DOI 10.1253/circj.CJ-10-0673	17	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1685	1686		10.1253/circj.CJ-15-0506		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900008		
J	Nishino, M				Nishino, Masami			Echocardiographic Surrogate Marker for Diabetic Cardiomyopathy	CIRCULATION JOURNAL			English	Editorial Material							CORONARY FLOW RESERVE; DIASTOLIC DYSFUNCTION; DOPPLER-ECHOCARDIOGRAPHY; HYPERTENSIVE PATIENTS		Osaka Rosai Hosp, Div Cardiol, Sakai, Osaka 5918025, Japan	Nishino, M (reprint author), Osaka Rosai Hosp, Div Cardiol, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.	mnishino@orh.go.jp					Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Jensen MT, 2015, JACC-CARDIOVASC IMAG, V8, P400, DOI 10.1016/j.jcmg.2014.12.020; KANNEL WB, 1979, CIRCULATION, V59, P8; Bando YK, 2014, CIRC J, V78, P576, DOI 10.1253/circj.CJ-13-1564; Galderisi M, 2006, J AM COLL CARDIOL, V48, P1548, DOI 10.1016/j.jacc.2006.07.033; Lisi E, 2015, INT J CARDIOL, V187, P686, DOI 10.1016/j.ijcard.2015.02.037; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Enomoto M, 2015, CIRC J, V79, P1749, DOI 10.1253/circj.CJ-15-0012; Kawata T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-121; Liu PP, 1999, AM J CARDIOL, V84, P23, DOI 10.1016/S0002-9149(99)00361-6; Masugata H, 2008, CLIN EXP HYPERTENS, V30, P520, DOI 10.1080/10641960802251909; Nishino M, 2006, CIRC J, V70, P1415, DOI 10.1253/circj.70.1415; Ofstad AP, 2015, J DIABETES, V7, P779, DOI 10.1111/1753-0407.12239	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1687	1688		10.1253/circj.CJ-15-0540		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900009		
J	Sato, N				Sato, Naoki			Lessons and Perspectives on Heart Failure Management From Considerations Based on the CHART-2 Study	CIRCULATION JOURNAL			English	Editorial Material							CARDIOMYOPATHY; OUTCOMES		[Sato, Naoki] Nippon Med Sch, Musashi Kosugi Hosp, Cardiol & Intens Care Unit, Kawasaki, Kanagawa 2118533, Japan	Sato, N (reprint author), Nippon Med Sch, Musashi Kosugi Hosp, Cardiol & Intens Care Unit, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	nms-nd@nms.ac.jp					Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Kajimoto K, 2014, CLIN J AM SOC NEPHRO, V9, P1912, DOI 10.2215/CJN.04400514; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; Mebazaa A, 2013, J AM COLL CARDIOL, V61, P820, DOI 10.1016/j.jacc.2012.11.054; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Ezekowitz JA, 2009, J AM COLL CARDIOL, V53, P13, DOI 10.1016/j.jacc.2008.08.067; Eurich DT, 2005, DIABETES CARE, V28, P2345, DOI 10.2337/diacare.28.10.2345; Dei Cas Alessandra, 2015, Curr Probl Cardiol, V40, P7, DOI 10.1016/j.cpcardiol.2014.09.002; HAMBY RI, 1974, JAMA-J AM MED ASSOC, V229, P1749, DOI 10.1001/jama.229.13.1749; Miura M, 2015, CIRC J, V79, P1764, DOI 10.1253/circj.CJ-15-0096	11	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1689	1690		10.1253/circj.CJ-15-0712		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900010		
J	Kawasaki, M				Kawasaki, Masanori			Tissue Characterization of Coronary Plaques as a Key to Reno-Cardiac Syndrome	CIRCULATION JOURNAL			English	Editorial Material							BACKSCATTER INTRAVASCULAR ULTRASOUND; INDOXYL SULFATE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; ARTERY-DISEASE; ASSOCIATION		Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu 5011194, Japan	Kawasaki, M (reprint author), Gifu Univ, Grad Sch Med, Dept Cardiol, 1-1 Yanagido, Gifu 5011194, Japan.	masanori@ya2.so-net.ne.jp					Adelibieke Y, 2013, CIRC J, V77, P1326, DOI 10.1253/circj.CJ-12-0884; Yoshikawa D, 2014, CIRC J, V78, P2477, DOI 10.1253/circj.CJ-14-0401; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P637, DOI 10.1038/ncpneph0673; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Nakayama N, 2013, CIRC J, V77, P424, DOI 10.1253/circj.CJ-12-0630; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Masai N, 2010, CIRC J, V74, P2216, DOI 10.1253/circj.CJ-10-0117; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Shimazu S, 2013, CIRC J, V77, P390, DOI 10.1253/circj.CJ-12-0715; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Yamaguchi K, 2014, CIRC J, V78, P240, DOI 10.1253/circj.CJ-13-0741; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Levin A, 2000, AM J KIDNEY DIS, V36, pS24, DOI 10.1053/ajkd.2000.19928; Ozaki Y, 2015, CIRC J, V79, P808, DOI 10.1253/circj.CJ-14-0758; Ronco C, 2012, HEART FAIL REV, V17, P151, DOI 10.1007/s10741-010-9224-0; Yamazaki H, 2015, CIRC J, V79, P1773, DOI 10.1253/circj.CJ-15-0019	17	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1691	1692		10.1253/circj.CJ-15-0679		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900011		
J	Shimohama, T; Ako, J				Shimohama, Takao; Ako, Junya			Inside Out, Outside in - Vasa Vasorum and Coronary Spasm	CIRCULATION JOURNAL			English	Editorial Material							DRUG-ELUTING STENTS; INTRAPLAQUE HEMORRHAGE; MICROVESSELS; PROGRESSION; ARTERY		[Shimohama, Takao; Ako, Junya] Kitasato Univ, Cardiovasc Med, Sagamihara, Kanagawa 2520374, Japan	Ako, J (reprint author), Kitasato Univ, Cardiovasc Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	jako@kitasato-u.ac.jp					Staub D, 2010, STROKE, V41, P41, DOI 10.1161/STROKEAHA.109.560342; Hamilos MI, 2008, J AM COLL CARDIOL, V51, P2123, DOI 10.1016/j.jacc.2007.12.059; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Mitsutake Y, 2012, JACC-CARDIOVASC INTE, V5, P966, DOI 10.1016/j.jcin.2012.06.010; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Sluimer JC, 2009, J AM COLL CARDIOL, V53, P1517, DOI 10.1016/j.jacc.2008.12.056; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Cheema AN, 2006, J AM COLL CARDIOL, V47, P1067, DOI 10.1016/j.jacc.2005.08.076; Nakazawa G, 2014, EUROINTERVENTION, V10, P717, DOI [10.4244/EIJV10I6A124, 10.4244/EIJV1016A124]; Nishimiya K, 2015, CIRC J, V79, P1323, DOI 10.1253/circj.CJ-15-0078; Nishimiya K, 2014, CIRC J, V78, P2516, DOI 10.1253/circj.CJ-14-0485; Nishimiya K, 2015, CIRC J, V79, P1787, DOI 10.1253/circj.CJ-15-0149; Tian Jinwei, 2014, Am Heart J, V167, P884, DOI 10.1016/j.ahj.2014.03.013	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1693	1694		10.1253/circj.CJ-15-0698		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900012		
J	Iihara, K; Nishimura, A				Iihara, Koji; Nishimura, Ataru			Maternal Death Due to Stroke Associated With Pregnancy-Induced Hypertension	CIRCULATION JOURNAL			English	Editorial Material							INTRACRANIAL VENOUS THROMBOSIS; RISK-FACTORS; PUERPERIUM; JAPAN; HEMORRHAGE		[Iihara, Koji; Nishimura, Ataru] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 8128582, Japan	Iihara, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kiihara@ns.med.kyushu-u.ac.jp					Roberts JM, 2013, OBSTET GYNECOL, V122, P1122; Kuklina EV, 2011, STROKE, V42, P2564, DOI 10.1161/STROKEAHA.110.610592; SHARSHAR T, 1995, STROKE, V26, P930; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Jaigobin C, 2000, STROKE, V31, P2948; Kittner SJ, 1996, NEW ENGL J MED, V335, P768, DOI 10.1056/NEJM199609123351102; Bateman BT, 2006, NEUROLOGY, V67, P424, DOI 10.1212/01.wnl.0000228277.84760.a2; Lanska DJ, 2000, STROKE, V31, P1274; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; Hasegawa J, 2015, CIRC J, V79, P1835, DOI 10.1253/circj.CJ-15-0297; Lanska DJ, 1998, NEUROLOGY, V51, P1622; Satoh H, 2013, CIRC J, V77, P725, DOI 10.1253/circj.CJ-12-1001; Takahashi JC, 2014, J STROKE CEREBROVASC, V23, pE65, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.017; Takahashi JC, 2012, NEUROL MED-CHIR, V52, P304	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1695	1696		10.1253/circj.CJ-15-0701		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900013		
J	Kamouchi, M				Kamouchi, Masahiro			Aortic Dissection as a Possible Underlying Cause of Acute Ischemic Stroke	CIRCULATION JOURNAL			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; INTERNATIONAL REGISTRY; NEUROLOGICAL SYMPTOMS; THROMBOLYSIS; MANAGEMENT; SECONDARY; PATIENT		[Kamouchi, Masahiro] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 8128582, Japan	Kamouchi, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	kamouchi@hcam.med.kyushu-u.ac.jp					Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; Gaul C, 2007, STROKE, V38, P292, DOI 10.1161/01.STR.0000254594.33408.b1; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Mehta RH, 2002, J AM COLL CARDIOL, V40, P685, DOI 10.1016/S0735-1097(02)02005-3; Trimarchi S, 2005, J THORAC CARDIOV SUR, V129, P112, DOI 10.1016/j.jtcvs.2004.09.005; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5; Chua CH, 2005, J THORAC CARDIOV SUR, V130, P1222, DOI 10.1016/j.jtcvs.2005.06.023; Diercks DB, 2015, ANN EMERG MED, V65, P32, DOI 10.1016/j.annemergmed.2014.11.002; Fessler AJ, 2000, NEUROLOGY, V54, P1010; Gaul C, 2008, CEREBROVASC DIS, V26, P1, DOI 10.1159/000135646; Hong KS, 2009, J CLIN NEUROL, V5, P49, DOI 10.3988/jcn.2009.5.1.49; von Kodolitsch Y, 2000, ARCH INTERN MED, V160, P2977, DOI 10.1001/archinte.160.19.2977; Kurabayashi M, 2014, CIRC J, V78, P1928, DOI 10.1253/circj.CJ-14-0198; Mendes A, 2012, NEUROL SCI, V33, P107, DOI 10.1007/s10072-011-0616-2; Noel M, 2010, CLIN NEUROL NEUROSUR, V112, P695, DOI 10.1016/j.clineuro.2010.03.021; Ramalingam V S, 2010, Indian J Med Sci, V64, P385, DOI 10.4103/0019-5359.100342; Takeuchi S, 2009, NEUROL INDIA, V57, P808, DOI 10.4103/0028-3886.59487; Uchino K, 2005, J NEUROIMAGING, V15, P281, DOI 10.1177/1051228405277402; Yoshimuta T, 2015, CIRC J, V79, P1841, DOI 10.1253/circj.CJ-15-0050	19	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1697	1698		10.1253/circj.CJ-15-0683		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900014		
J	Yamamoto, K; Komori, K; Banno, H; Narita, H; Kodama, A; Sugimoto, M				Yamamoto, Kiyohito; Komori, Kimihiro; Banno, Hiroshi; Narita, Hiroshi; Kodama, Akio; Sugimoto, Masayuki			Validation of Patient Selection for Endovascular Aneurysm Repair or Open Repair of Abdominal Aortic Aneurysm - Single-Center Study	CIRCULATION JOURNAL			English	Article						Abdominal aortic aneurysm; Endovascular aneurysm repair; Open surgery; Patient selection	RISK-FACTORS; ISCHEMIA; SURGERY; METAANALYSIS; OUTCOMES; HERNIA; TRIAL	Background: To validate the criteria for endovascular aneurysm repair (EVAR) or open repair of abdominal aortic aneurysm (AAA) at Nagoya University Hospital, the results of both treatments were retrospectively compared. Methods and Results: Patient selection for EVAR was primarily based on suitable anatomy, minimum age 75 years, and significant comorbidity. From June 2007 to April 2014, 426 patients were treated via EVAR (EVAR group) and 346 patients were treated with open surgery (OS group). The mortality rates of the EVAR and OS groups were not significantly different (0.2% vs. 1.1%; P=0.33). Patient age, operation time, amount of bleeding, and duration of hospital stay were significantly lower in the EVAR group compared with the OS group. The incidence of comorbidity was higher in the EVAR group compared with the OS group. The incidence of early postoperative complications was significantly higher in the OS group, whereas the incidence of late complications for both groups was similar. The cumulative aneurysm-related survival rates were similar (98.9% vs. 98.5%; P=0.767). The cumulative survival rates and reintervention-free rates at 5 years were lower for the EVAR group (76% vs. 89%, P=0.019; 81% vs. 89%, P=0.046). Conclusions: Patient selection practices and criteria for EVAR and open repair at Nagoya University Hospital are generally acceptable.	[Yamamoto, Kiyohito; Komori, Kimihiro; Banno, Hiroshi; Narita, Hiroshi; Kodama, Akio; Sugimoto, Masayuki] Nagoya Univ, Grad Sch Med, Dept Surg, Div Vasc Surg, Nagoya, Aichi 4668550, Japan	Yamamoto, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Vasc Surg,Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	kiyoto@med.nagoya-u.ac.jp					De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; Henriksen NA, 2013, J VASC SURG, V57, P1524, DOI 10.1016/j.jvs.2012.11.119; Geisbusch P, 2011, J VASC SURG, V54, P1605, DOI 10.1016/j.jvs.2011.06.096; Antoniou GA, 2011, J VASC SURG, V54, P1175, DOI 10.1016/j.jvs.2011.02.065; Sicard GA, 2006, J VASC SURG, V44, P229, DOI 10.1016/j.jvs.2006.04.034; Benoit AG, 2005, J VASC SURG, V42, P884, DOI 10.1016/j.jvs.2005.07.032; Pane B, 2014, J CARDIOVASC SURG, V55, P257; Lovegrove RE, 2008, BRIT J SURG, V95, P677, DOI 10.1002/bjs.6240; JOHNSTON KW, 1989, J VASC SURG, V9, P437, DOI 10.1067/mva.1989.vs0090437; BREWSTER DC, 1991, SURGERY, V109, P447; Epstein D, 2014, BRIT J SURG, V101, P623, DOI 10.1002/bjs.9464; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Stather PW, 2013, BRIT J SURG, V100, P863, DOI 10.1002/bjs.9101; Banno H, 2012, SURG TODAY, V42, P1206, DOI 10.1007/s00595-012-0320-8; Biancari F, 2010, J VASC SURG, V51, P1354; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Handa N, 2014, CIRC J, V78, P1104, DOI 10.1253/circj.CJ-14-0131; Ihara T, 2013, ANN VASC SURG, V27, P154, DOI 10.1016/j.avsg.2012.03.009; Ishimaru S, 2013, CIRC J, V77, P789, DOI 10.1253/circj.CJ-66-0057; Perry RJT, 2008, J VASC SURG, V48, P272, DOI 10.1016/j.jvs.2008.03.040; Senekowitsch C, 2006, J VASC SURG, V43, P689, DOI 10.1016/j.jvs.2005.12.016	22	0	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1699	1705		10.1253/circj.CJ-14-1160		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900015		
J	Kishima, H; Mine, T; Ashida, K; Sugahara, M; Kodani, T; Masuyama, T				Kishima, Hideyuki; Mine, Takanao; Ashida, Kenki; Sugahara, Masataka; Kodani, Takeshi; Masuyama, Tohru			Does Left Atrial Appendage Morphology Influence Left Atrial Appendage Flow Velocity?	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Computed tomography; Flow velocity; Left atrial appendage; Transesophageal echocardiography	ACUTE ISCHEMIC-STROKE; CATHETER ABLATION; IN-VIVO; FIBRILLATION; RISK; ECHOCARDIOGRAPHY; THROMBOEMBOLISM; CLASSIFICATION	Background: The shape of the left atrial appendage (LAA) might affect thrombus formation. The chicken wing-type LAA (CW) has been reported as unlikely to influence stroke events in atrial fibrillation (AF) patients, so we investigated whether LAA shapes could influence LAA function. Methods and Results: We studied 102 patients (64 men, age 65+/-9 years) who underwent transthoracic echocardiography, transesophageal echocardiography (TEE), and cardiac computed tomography prior to catheter ablation (CA) for AF. LAA morphology were classified into 2 types: (1) CW: LAA with a bend in its shape and (2) non-CW type (NCW): LAA without any bends. All patients were classified into these groups using a cutoff value of LAA flow velocity (LAAFV). Patients with LAAFV <35 cm/s were classified as the low LAAFV group (Low FV, n=37). The patients with LAAFV >35 cm/s were classified as normal LAAFV group (Normal FV, n=65). The NCW type was detected in 25/102 patients (25%). In multivariate analysis, the patients with Low FV were associated with NCW type (P=0.0429, odds ratio [OR] 9.664, 95% confidence interval [CI] 1.075-86.900) and higher B-type natriuretic peptide (BNP) (P=0.0350, OR 1.012 for each 1 pg/ml increase in BNP, 95% CI 1.001-1.022). Conclusions: The NCW-type LAA and higher BNP were associated with lower LAAFV. One reason for the frequent cardiogenic stroke in patients with the NCW-type LAA may be the lower LAAFV.	[Kishima, Hideyuki; Mine, Takanao; Ashida, Kenki; Sugahara, Masataka; Kodani, Takeshi; Masuyama, Tohru] Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Kishima, H (reprint author), Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	kishima@hyo-med.ac.jp					Abe Y, 2000, JPN CIRC J, V64, P411, DOI 10.1253/jcj.64.411; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Ujino K, 2006, AM J CARDIOL, V98, P1185, DOI 10.1016/j.amjcard.2006.05.040; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036; Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065; Al-Saady NM, 1999, HEART, V82, P547; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; Goldman ME, 1999, J AM SOC ECHOCARDIOG, V12, P1080, DOI 10.1016/S0894-7317(99)70105-7; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961; Matsuo Y, 2014, CIRC J, V78, P619, DOI 10.1253/circj.CJ-13-0828; Tamura H, 2012, J CARDIOL, V60, P126, DOI 10.1016/j.jjcc.2012.02.010; Ito T, 1998, AM J CARDIOL, V81, P1056, DOI 10.1016/S0002-9149(98)00011-3; WOLF PA, 1991, STROKE, V22, P983; Machino-Ohtsuka T, 2013, CIRC J, V77, P1695, DOI 10.1253/circj.CJ-12-1518; Anselmino M, 2014, HEART RHYTHM, V11, P2, DOI 10.1016/j.hrthm.2013.10.020; Goldberg YH, 2010, EUR J ECHOCARDIOGR, V11, P290, DOI 10.1093/ejechocard/jep216; Iwakura K, 2011, AM J CARDIOL, V107, P417, DOI 10.1016/j.amjcard.2010.09.042; Kimura K, 2005, J NEUROL NEUROSUR PS, V76, P679, DOI 10.1136/jnnp.2004.048827; Obel OA, 2005, HEART, V91, P764, DOI 10.1136/hrt.2003.030940; Tabata T, 1996, J Am Soc Echocardiogr, V9, P857, DOI 10.1016/S0894-7317(96)90478-2; Tomita F, 2000, JPN CIRC J, V64, P653, DOI 10.1253/jcj.64.653	25	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1706	1711		10.1253/circj.CJ-14-1380		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900016		
J	Okada, M; Kashiwase, K; Hirata, A; Nemoto, T; Matsuo, K; Murakami, A; Ueda, Y				Okada, Masato; Kashiwase, Kazunori; Hirata, Akio; Nemoto, Takayoshi; Matsuo, Koshi; Murakami, Ayaka; Ueda, Yasunori			Bacterial Contamination During Pacemaker Implantation Is Common and Does Not Always Result in Infection	CIRCULATION JOURNAL			English	Article						Bacterial colonization; Cardiovascular implantable electronic devises; Infection	CARDIOVERTER-DEFIBRILLATORS; PERMANENT PACEMAKER; DEVICE INFECTIONS; CARDIAC DEVICES; RISK-FACTORS; ENDOCARDITIS; MANAGEMENT; COLONIZATION; DIAGNOSIS; SONICATION	Background: Bacterial cultures of cardiovascular implantable electronic devices removed from patients without clinical infection are often positive, and the cultured bacteria are different from those at the time of clinical infection. This discrepancy has not been adequately explained. We hypothesized that the cause is bacterial contamination at operation and compared the results of bacterial cultures between patients with de novo pacemaker implantation and those with pacemaker replacement. Methods and Results: We prospectively enrolled consecutive 100 patients who underwent cardiac pacemaker implantation (49 de novo implantations, 51 replacements). We took swab cultures from inside the generator pocket (1) immediately after the creation of new pocket or removal of old generator, (2) after connection of leads to new generator, and (3) after pocket lavage. Swab cultures were positive in 272 (45%) of 600 samples. The majority of the cultured bacteria were Propionibacterium species. No statistical difference was detected between de novo implantations and replacements in the positive ratio of swab cultures. The positive ratio was not correlated with the number of previous device replacements. Conclusions: The positive ratio of swab cultures was not different between new implantations and replacements, suggesting that a positive culture merely indicates contamination of bacteria during operation rather than colonization.	[Okada, Masato; Kashiwase, Kazunori; Hirata, Akio; Nemoto, Takayoshi; Matsuo, Koshi; Murakami, Ayaka; Ueda, Yasunori] Osaka Police Hosp, Cardiovasc Div, Osaka 5430035, Japan	Ueda, Y (reprint author), Osaka Police Hosp, Cardiovasc Div, Tennoji Ku, 10-31 Kitayama Cho, Osaka 5430035, Japan.	yellowplaque@gmail.com					Lekkerkerker JC, 2009, HEART, V95, P715, DOI 10.1136/hrt.2008.151985; Chua JD, 2000, ANN INTERN MED, V133, P604; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Da Costa A, 1998, CIRCULATION, V97, P1791; Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47; Baraki H, 2013, CIRC J, V77, P2032, DOI 10.1253/circj.CJ-12-1364; Victor F, 1999, HEART, V81, P82; Massoure PL, 2007, PACE, V30, P12; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Sohail MR, 2008, MAYO CLIN PROC, V83, P46, DOI 10.4065/83.1.46; Rohacek M, 2010, CIRCULATION, V121, P1691, DOI 10.1161/CIRCULATIONAHA.109.906461; Mason PK, 2011, PACE, V34, P143, DOI 10.1111/j.1540-8159.2010.02820.x; Klug D, 1997, CIRCULATION, V95, P2098; de Oliveira JC, 2009, CIRC-ARRHYTHMIA ELEC, V2, P29, DOI 10.1161/CIRCEP.108.795906; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Aoki Makoto, 2004, Rinsho Ketsueki, V45, P446; Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283; Karchmer AW, 2002, INFECT DIS CLIN N AM, V16, P477, DOI 10.1016/S0891-5520(01)00005-8; Nakatani S, 2013, CIRC J, V77, P1558, DOI 10.1253/circj.CJ-12-1101; Osmonov D, 2013, J CARDIOL, V61, P175, DOI 10.1016/j.jjcc.2012.08.019; Silaruks S, 2010, J AM COLL CARDIOL, V55, P886; Turtiainen J, 2014, EUR J VASC ENDOVASC, V47, P411, DOI 10.1016/j.ejvs.2013.12.025	23	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1712	1718		10.1253/circj.CJ-15-0133		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900017		
J	Tomita, H; Okumura, K; Inoue, H; Atarashi, H; Yamashita, T; Origasa, H; Tsushima, E				Tomita, Hirofumi; Okumura, Ken; Inoue, Hiroshi; Atarashi, Hirotsugu; Yamashita, Takeshi; Origasa, Hideki; Tsushima, Eiki		J-RHYTHM Registry Investigators	Validation of Risk Scoring System Excluding Female Sex From CHA(2)DS(2)-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation	CIRCULATION JOURNAL			English	Article						CHA(2)DS(2)-VASc score; CHA(2)DS(2)-VA score; Female sex; Nonvalvular atrial fibrillation; Thromboembolism	J-RHYTHM REGISTRY; ISCHEMIC-STROKE; PREDICTING STROKE; INTRACRANIAL HEMORRHAGE; STRATIFICATION SCHEMA; ANTICOAGULATION; THROMBOEMBOLISM; EVENTS; SUBANALYSIS; PREVENTION	Background: Because the current Japanese guideline recommends CHADS(2) score-based risk stratification in nonvalvular atrial fibrillation (NVAF) patients and does not list female sex as a risk for thromboembolic events, we designed the present study to compare the CHA(2)DS(2)-VASc and CHA(2)DS(2)-VA scores in the J-RHYTHM Registry. Methods and Results: We prospectively assessed the incidence of thromboembolic events for 2 years in 997 NVAF patients without warfarin treatment (age 68+/-12 years, 294 females). The predictive value of the CHA(2)DS(2)VASc and CHA(2)DS(2)-VA scores for thromboembolic events was evaluated by c-statistic difference and net reclassification improvement (NRI). Thromboembolic events occurred in 7/294 females (1.2%/year) and 23/703 males (1.6%/year) (odds ratio 0.72 for female to male, 95% confidence interval (CI) 0.28-1.62, P=0.44). No sex difference was found in patient groups stratified by CHA(2)DS(2)-VASc and CHA(2)DS(2)-VA scores. There were significant c-statistic difference (0.029, Z=2.3, P=0.02) and NRI (0.11, 95% CI 0.01-0.20, P=0.02), with the CHA(2)DS(2)-VA score being superior to the CHA(2)DS(2)-VASc score. In patients with CHA(2)DS(2)-VASc scores 0 and 1 (n=374), there were markedly significant c-statistic difference (0.053, Z=6.6, P<0.0001) and NRI (0.11, 95% CI 0.07-0.14, P<0.0001), again supporting superiority of CHA(2)DS(2)-VA to CHA(2)DS(2)-VASc score. Conclusions: In Japanese NVAF patients, the CHA(2)DS(2)-VA score, a risk scoring system excluding female sex from CHA(2)DS(2)-VASc, may be more useful in risk stratification for thromboembolic events than CHA2DS2-VASc score, especially in identifying truly low-risk patients.	[Tomita, Hirofumi; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan; [Inoue, Hiroshi] Toyama Univ, Sch Med, Dept Internal Med 2, Toyama 930, Japan; [Origasa, Hideki] Toyama Univ, Sch Med, Div Biostat & Clin Epidemiol, Toyama 930, Japan; [Atarashi, Hirotsugu] Tama Nagayama Hosp, Nippon Med Sch, Dept Cardiol, Tama, Japan; [Yamashita, Takeshi] Cardiovasc Inst Hosp, Tokyo, Japan; [Tsushima, Eiki] Hirosaki Univ, Grad Sch Hlth Sci, Dept Phys Therapy, Hirosaki, Aomori 0368562, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	okumura@hirosaki-u.ac.jp			Japan Heart Foundation	This study was planned by the Japanese Society of Electrocardiology and supported by a grant from the Japan Heart Foundation.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Mikkelsen AP, 2012, J THROMB HAEMOST, V10, P1745, DOI 10.1111/j.1538-7836.2012.04853.x; Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; Guo YT, 2013, INT J CARDIOL, V168, P904, DOI 10.1016/j.ijcard.2012.10.052; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Siu CW, 2014, HEART RHYTHM, V11, P1401, DOI 10.1016/j.hrthm.2014.04.021; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Inoue H, 2014, AM J CARDIOL, V113, P957, DOI 10.1016/j.amjcard.2013.11.057; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Nakagami H, 1998, AM HEART J, V136, P528, DOI 10.1016/S0002-8703(98)70231-5; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Pisters R, 2012, CIRC J, V76, P2289, DOI 10.1253/circj.CJ-12-1036; Atarashi H, 2011, J CARDIOL, V57, P95, DOI 10.1016/j.jjcc.2010.09.002; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; Covel CL, 2014, THROMB HAEMOSTASIS, V111, P385, DOI 10.1160/TH13-04-0347; Friberg L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3522; Ho CW, 2015, STROKE, V46, P23, DOI 10.1161/STROKEAHA.114.006476; Inoue H, 2000, AM J CARDIOL, V86, P852, DOI 10.1016/S0002-9149(00)01105-X; Inoue H, 2014, CIRC J, V78, P2388, DOI 10.1253/circj.CJ-14-0507; January CT, 2014, CIRCULATION, V130, pE199, DOI 10.1161/CIR.0000000000000041; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Inoue H, 2011, CIRC J, V75, P2357, DOI 10.1253/circj.CJ-11-0427; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Overvad TF, 2014, THROMB HAEMOSTASIS, V112, P789, DOI 10.1160/TH14-06-0545; Ruigomez A, 2009, INT J CARDIOL, V136, P186, DOI 10.1016/j.ijcard.2008.04.050; Suzuki S, 2015, CIRC J, V79, P432, DOI 10.1253/circj.CJ-14-1131; Yamashita T, 2015, J CARDIOL, V65, P175, DOI 10.1016/j.jjcc.2014.07.013	35	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1719	U315		10.1253/circj.CJ-15-0095		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900018		
J	Kiuchi, K; Okajima, K; Tanaka, N; Yamamoto, Y; Sakai, N; Kanda, G; Shimane, A; Yokoi, K; Teranishi, J; Aoki, K; Chimura, M; Kono, S; Takahashi, Y; Matsuyama, S; Tsubata, H; Miyata, T; Matsuoka, Y; Toba, T; Ohishi, S; Sawada, T; Tsukishiro, Y; Onishi, T; Kobayashi, S; Moriya, F; Takai, H; Yamada, S; Taniguchi, Y; Yasaka, Y; Kawai, H				Kiuchi, Kunihiko; Okajima, Katsunori; Tanaka, Naoko; Yamamoto, Yoko; Sakai, Nahoko; Kanda, Gaku; Shimane, Akira; Yokoi, Kiminobu; Teranishi, Jin; Aoki, Kousuke; Chimura, Misato; Kono, Shingo; Takahashi, Yuu; Matsuyama, Sonoko; Tsubata, Hideo; Miyata, Taishi; Matsuoka, Yuki; Toba, Takayoshi; Ohishi, Shogo; Sawada, Takahiro; Tsukishiro, Yasue; Onishi, Tetsuari; Kobayashi, Seiichi; Moriya, Fumie; Takai, Hiromi; Yamada, Shinichiro; Taniguchi, Yasuyo; Yasaka, Yoshinori; Kawai, Hiroya			Novel Compression Tool to Prevent Hematomas and Skin Erosions After Device Implantation	CIRCULATION JOURNAL			English	Article						Anticoagulation therapy; Device implantation; Hematomas; Skin erosions	ATRIAL-FIBRILLATION; BLEEDING COMPLICATIONS; ANTIPLATELET THERAPY; ORAL ANTICOAGULANTS; JAPANESE PATIENTS; WARFARIN; METAANALYSIS; DABIGATRAN; PACEMAKER; SAFETY	Background: The incidence of hematoma formation following implantation of a cardiovascular implantable electronic device (CIED) is estimated to be 5% even if a pressure dressing is applied. It is unclear whether a pressure dressing can really compress the pocket in different positions. Furthermore, the adhesive tape for fixing pressure dressings can tear the skin. We developed a new compression tool for preventing hematomas and skin erosions. Methods and Results: We divided 46 consecutive patients receiving anticoagulation therapy who underwent CIED implantation into 2 groups (Group I: conventional pressure dressing, Group II: new compression tool). The pressure on the pocket was measured in both the supine and standing positions. The incidence of hematomas was compared between the 2 groups. The pressure differed between the supine and standing positions in Group I, but not in Group II (Group I: 14.8+/-7.1 mmHg vs. 11.3+/-9.9 mmHg, P=0.013; Group II: 13.5+/-2.8 mmHg vs. 13.5+/-3.5 mmHg, P=0.99). The incidence of hematomas and skin erosions was documented in 2 (8.7%) and 3 (13%) Group I patients, respectively. No complications were documented in Group II. Conclusions: The new compression tool can provide adequate continuous pressure on the pocket, regardless of body position. This device may reduce the incidence of hematomas and skin erosions after CIED implantation.	[Kiuchi, Kunihiko; Okajima, Katsunori; Kanda, Gaku; Shimane, Akira; Yokoi, Kiminobu; Teranishi, Jin; Aoki, Kousuke; Chimura, Misato; Kono, Shingo; Takahashi, Yuu; Matsuyama, Sonoko; Tsubata, Hideo; Miyata, Taishi; Matsuoka, Yuki; Toba, Takayoshi; Ohishi, Shogo; Sawada, Takahiro; Tsukishiro, Yasue; Onishi, Tetsuari; Kobayashi, Seiichi; Yamada, Shinichiro; Taniguchi, Yasuyo; Yasaka, Yoshinori; Kawai, Hiroya] Himeji Cardiovasc Ctr, Dept Cardiol, Himeji, Hyogo 6700981, Japan; [Tanaka, Naoko; Yamamoto, Yoko; Sakai, Nahoko; Moriya, Fumie; Takai, Hiromi] Himeji Cardiovasc Ctr, Dept Nursing, Himeji, Hyogo 6700981, Japan	Kiuchi, K (reprint author), Himeji Cardiovasc Ctr, Dept Cardiol, 520 Kou, Himeji, Hyogo 6700981, Japan.	kunihikokiuchi@yahoo.co.jp					Kosiuk J, 2014, EUROPACE, V16, P1028, DOI 10.1093/europace/eut423; Korantzopoulos P, 2011, EUROPACE, V13, P1669, DOI 10.1093/europace/eur210; Bernard ML, 2012, CIRC-ARRHYTHMIA ELEC, V5, P468, DOI 10.1161/CIRCEP.111.969105; Tompkins C, 2010, J AM COLL CARDIOL, V55, P2376, DOI 10.1016/j.jacc.2009.12.056; Kutinsky IB, 2010, CIRC-ARRHYTHMIA ELEC, V3, P312, DOI 10.1161/CIRCEP.109.917625; Rowley CP, 2013, AM J CARDIOL, V111, P1165, DOI 10.1016/j.amjcard.2012.12.046; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Fujiwara R, 2012, J ARRHYTHMIA, V28, P96; Harding ME, 2014, HEART RHYTHM, V11, P737, DOI 10.1016/j.hrthm.2014.01.003; Henley J, 2013, DERMATOL RES PRACT, V2013; Kodani E, 2015, CIRC J, V79, P325, DOI 10.1253/circj.CJ-14-1057; Kosiuk J, 2014, CIRC J, V78, P2402, DOI 10.1253/circj.CJ-14-0665; Nammas W, 2014, ANN MED, V46, P177, DOI 10.3109/07853890.2014.894285; Özcan Kazım Serhan, 2013, J Cardiol, V62, P127, DOI 10.1016/j.jjcc.2013.03.002; Piromchai Patorn, 2008, BMC Ear Nose Throat Disord, V8, P1, DOI 10.1186/1472-6815-8-1; Senoo K, 2015, CIRC J, V79, P339, DOI 10.1253/circj.CJ-14-1042; Yokoshiki H, 2013, CIRC J, V77, P2003, DOI 10.1253/circj.CJ-12-1507	17	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1727	1732		10.1253/circj.CJ-15-0341		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900019		
J	Wada, Y; Aiba, T; Matsuyama, T; Nakajima, I; Ishibashi, K; Miyamoto, K; Yamada, Y; Okamura, H; Noda, T; Satomi, K; Morita, Y; Kanzaki, H; Kusano, K; Anzai, T; Kamakura, S; Ishibashi-Ueda, H; Shimizu, W; Horie, M; Yasuda, S; Ogawa, H				Wada, Yuko; Aiba, Takeshi; Matsuyama, Taka-aki; Nakajima, Ikutaro; Ishibashi, Kohei; Miyamoto, Koji; Yamada, Yuko; Okamura, Hideo; Noda, Takashi; Satomi, Kazuhiro; Morita, Yoshiaki; Kanzaki, Hideaki; Kusano, Kengo; Anzai, Toshihisa; Kamakura, Shiro; Ishibashi-Ueda, Hatsue; Shimizu, Wataru; Horie, Minoru; Yasuda, Satoshi; Ogawa, Hisao			Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function	CIRCULATION JOURNAL			English	Article						Arrhythmias; Fibrosis; Histopathology; Hypertrophic cardiomyopathy; Prognosis	CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; VENTRICULAR ENDOMYOCARDIAL BIOPSY; SUDDEN CARDIAC DEATH; MYOCARDIAL FIBROSIS; COMPLICATION RATE; PROGNOSTIC VALUE; DISEASE; DISARRAY; RISK	Background: The natural history of hypertrophic cardiomyopathy (HCM) varies from an asymptomatic benign course to a poor prognosis. Myocardial fibrosis may play a critical role in ventricular tachyarrhythmias (VT/VF); however, the clinical significance of tissue fibrosis by right ventricular (RV) biopsy in the long-term prognosis of HCM patients remains unclear. Methods and Results: We enrolled 185 HCM patients (mean age, 57+/-14 years). The amount of fibrosis (%area) was quantified using a digital microscope. Hemodynamic, echocardiographic, and electrophysiologic parameters were also evaluated. Patients with severe fibrosis had longer QRS duration and positive late potential (LP) on signal-averaged ECG, resulting in a higher incidence of VT/VF. At the 5+/-4 year follow-up, VT/VF occurred in 31 (17%) patients. Multivariate Cox regression analysis revealed that tissue fibrosis (hazard ratio (HR): 1.65; P=0.003 per 10% increase), lower left ventricular ejection fraction (HR: 0.64; P=0.001 per 10% increase), and positive SAECG (HR: 3.14; P=0.04) led to a greater risk of VT/VF. The combination of tissue fibrosis severity and lower left ventricular ejection fraction could be used to stratify the risk of lethal arrhythmic events in HCM patients. Conclusions: Myocardial fibrosis in RV biopsy samples may contribute to abnormal conduction delay and spontaneous VT/VF, leading to a poor prognosis in HCM patients.	[Wada, Yuko; Aiba, Takeshi; Nakajima, Ikutaro; Ishibashi, Kohei; Miyamoto, Koji; Yamada, Yuko; Okamura, Hideo; Noda, Takashi; Satomi, Kazuhiro; Kanzaki, Hideaki; Kusano, Kengo; Anzai, Toshihisa; Kamakura, Shiro; Shimizu, Wataru; Yasuda, Satoshi; Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Matsuyama, Taka-aki; Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Clin Pathol, Suita, Osaka 5658565, Japan; [Yamada, Yuko] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka 5658565, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Wada, Yuko; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 52021, Japan	Aiba, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	aiba@hsp.ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967	Ministry of Health, Labour, and Welfare of Japan [2010-145]; MEXT of Japan [24591086]; Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center [26-6-6 Wada]; Research Grant for Cardiovascular Diseases from Ministry of Health, Labour, and Welfare of Japan [H24-033];  [22136011 A02]	This work was supported by grants from the Ministry of Health, Labour, and Welfare of Japan (2010-145); a Grant-in-Aid for Scientific Research on Innovative Areas (22136011 A02, Aiba); a Grant-in-Aid for Scientific Research (C) (24591086 Aiba) from MEXT of Japan; a Research Grant for Cardiovascular Diseases (H24-033 Shimizu, Aiba) from the Ministry of Health, Labour, and Welfare of Japan; and an Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center (26-6-6 Wada).	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545; Varnava AM, 2000, HEART, V84, P476, DOI 10.1136/heart.84.5.476; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Kawara T, 2001, CIRCULATION, V104, P3069, DOI 10.1161/hc5001.100833; Kono AK, 2011, J MAGN RESON IMAGING, V34, P50, DOI 10.1002/jmri.22602; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Hen Y, 2014, CIRC J, V78, P929, DOI 10.1253/circj.CJ-13-0979; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Moon J, 2013, CIRC J, V77, P1742, DOI 10.1253/circj.CJ-12-1378; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Ling LH, 2012, J AM COLL CARDIOL, V60, P2402, DOI 10.1016/j.jacc.2012.07.065; DAVIES MJ, 1995, HISTOPATHOLOGY, V26, P493, DOI 10.1111/j.1365-2559.1995.tb00267.x; Maron BJ, 2013, CIRCULATION, V127, P585, DOI 10.1161/CIRCULATIONAHA.112.136085; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Holzmann M, 2008, CIRCULATION, V118, P1722, DOI 10.1161/CIRCULATIONAHA.107.743427; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Moravsky G, 2013, JACC-CARDIOVASC IMAG, V6, P587, DOI 10.1016/j.jcmg.2012.09.018; Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1; Bongioanni S, 2007, AM J CARDIOL, V100, P503, DOI 10.1016/j.amjcard.2007.03.049; CRIPPS TR, 1990, J AM COLL CARDIOL, V15, P956; Goto D, 2012, J CARDIOL, V61, P65; Kamiyama N, 1997, J ELECTROCARDIOL, V30, P301, DOI 10.1016/S0022-0736(97)80042-8; Maron BJ, 2012, LANCET, V381, P242; Schumacher B, 2005, CIRCULATION, V112, P2096, DOI 10.1161/CIRCULATIONAHA.104.515643	31	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1733	U333		10.1253/circj.CJ-15-0104		12	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900020		
J	Miyamura, M; Fujita, S; Morita, H; Sakane, K; Okamoto, Y; Sohmiya, K; Hoshiga, M; Ishizaka, N				Miyamura, Masatoshi; Fujita, Shu-ichi; Morita, Hideaki; Sakane, Kazushi; Okamoto, Yusuke; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu			Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Chronic kidney disease; Fibroblast growth factor 23; Phosphate	CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; ATHEROSCLEROSIS RISK; PARATHYROID-HORMONE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR HEALTH; RENAL-DISEASE; FGF23; COMMUNITIES; HEART	Background: Atrial fibrillation (AF) occurs more frequently among patients with renal dysfunction. We investigated the possible association between prevalence of AF and serum fibroblast growth factor 23 (FGF23), which has been shown to be increased in subjects with renal dysfunction. Methods and Results: Among the total enrollment of 851 cardiac patients, 188 patients had AF (paroxysmal AF, 95; non-paroxysmal AF, 93). Prevalence of AF for FGF23 octile had a U-shaped relationship with the lowest prevalence at the fifth octile. On logistic regression analysis, when the third FGF23 quartile was used as the reference, the first and fourth FGF23 quartiles were associated with prevalence of AF with an odds ratio (OR) of 3.34 (95% confidence interval [CI]: 1.89-5.88) and 2.58 (95% CI: 1.45-4.58), respectively, after adjusting for confounding factors including estimated glomerular filtration rate (eGFR). Among the subgroup of 416 patients for whom serum parathyroid hormone and 25-hydroxy vitamin D data were available, OR of the first and the fourth FGF23 quartile were calculated to be 3.52 and 2.97, respectively, when further adjusted for these two variables in the statistical model. Conclusions: Serum FGF23 had a U-shaped relationship with prevalence of AF among Japanese cardiac patients, which was independent of other calcium/phosphate metabolism-related parameters and eGFR. Pathophysiology underlying the observed link, if at all, awaits further investigation.	[Miyamura, Masatoshi; Fujita, Shu-ichi; Morita, Hideaki; Sakane, Kazushi; Okamoto, Yusuke; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Takatsuki, Osaka 5698686, Japan	Ishizaka, N (reprint author), Osaka Med Coll, Dept Cardiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ishizaka@poh.osaka-med.ac.jp					Ali FN, 2014, J PEDIATR-US, V165, P738, DOI 10.1016/j.jpeds.2014.06.027; Alonso A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001082; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Bansal N, 2013, CIRCULATION, V127, P569, DOI 10.1161/CIRCULATIONAHA.112.123992; Horio T, 2010, J HYPERTENS, V28, P1738, DOI 10.1097/HJH.0b013e32833a7dfe; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Tamez H, 2012, AM HEART J, V164, P902, DOI 10.1016/j.ahj.2012.09.018; Mathew JS, 2014, CIRCULATION, V130, P298, DOI 10.1161/CIRCULATIONAHA.113.005499; Silswal N, 2014, AM J PHYSIOL-ENDOC M, V307, pE426, DOI 10.1152/ajpendo.00264.2014; Deo R, 2010, J CARD FAIL, V16, P55, DOI 10.1016/j.cardfail.2009.07.002; Rosiak M, 2010, CARDIOL J, V17, P437; Winkelmayer WC, 2011, J AM SOC NEPHROL, V22, P349, DOI 10.1681/ASN.2010050459; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Negishi K, 2010, CIRC J, V74, P2734, DOI 10.1253/circj.CJ-10-0355; Ananthapanyasut W, 2010, CLIN J AM SOC NEPHRO, V5, P173, DOI 10.2215/CJN.03170509; Iguchi Y, 2008, CIRC J, V72, P909, DOI 10.1253/circj.72.909; Touchberry CD, 2013, AM J PHYSIOL-ENDOC M, V304, pE863, DOI 10.1152/ajpendo.00596.2012; Sano F, 2014, CIRC J, V78, P955, DOI 10.1253/circj.CJ-13-1387; Uzum AK, 2010, EUR J ENDOCRINOL, V163, P825, DOI 10.1530/EJE-10-0591; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Faul C, 2012, CURR OPIN NEPHROL HY, V21, P369, DOI 10.1097/MNH.0b013e32835422c4; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Brandenburg VM, 2014, ATHEROSCLEROSIS, V237, P53, DOI 10.1016/j.atherosclerosis.2014.08.037; Fujita S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082735; Hennersdorf MG, 2007, HYPERTENS RES, V30, P535, DOI 10.1291/hypres.30.535; Inoue H, 2014, CIRC J, V78, P2388, DOI 10.1253/circj.CJ-14-0507; Itoh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00247; JCS Joint Working Group, 2013, CIRC J, V77, P249; Jover E, 2013, ANN MED, V45, P274, DOI 10.3109/07853890.2012.732702; Kalyanasundaram A, 2014, CIRCULATION, V130, P295, DOI 10.1161/CIRCULATIONAHA.114.011034; Lindberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060658; Loncar G, 2011, J ENDOCRINOL INVEST, V34, pE78, DOI 10.3275/7256; Lopez FL, 2013, AM J CARDIOL, V111, P857, DOI 10.1016/j.amjcard.2012.11.045; Misialek JR, 2013, CIRC J, V77, P323, DOI 10.1253/circj.CJ-12-0886; Ratanapo S, 2013, AM HEART J, V165, pE21, DOI 10.1016/j.ahj.2013.02.022; Raviele A, 2011, J CARDIOVASC ELECTR, V22, P383, DOI 10.1111/j.1540-8167.2010.01954.x; Rienstra M, 2011, J AM COLL CARDIOL, V57, P2542, DOI 10.1016/j.jacc.2011.01.041; Sciacqua A, 2014, INT J CARDIOL, V175, P90, DOI 10.1016/j.ijcard.2014.04.259; Seiler Sarah, 2011, Eur Heart J, V32, P2688, DOI 10.1093/eurheartj/ehr215; Shibata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073184; Tamez H, 2013, AM HEART J, V165, pE23, DOI 10.1016/j.ahj.2013.02.023; Tomita T, 2013, HEART VESSELS, V28, P497, DOI 10.1007/s00380-012-0264-3; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	47	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1742	1748		10.1253/circj.CJ-15-0413		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900021		
J	Enomoto, M; Ishizu, T; Seo, Y; Yamamoto, M; Suzuki, H; Shimano, H; Kawakami, Y; Aonuma, K				Enomoto, Mami; Ishizu, Tomoko; Seo, Yoshihiro; Yamamoto, Masayoshi; Suzuki, Hiroaki; Shimano, Hitoshi; Kawakami, Yasushi; Aonuma, Kazutaka			Subendocardial Systolic Dysfunction in Asymptomatic Normotensive Diabetic Patients	CIRCULATION JOURNAL			English	Article						Diabetic cardiomyopathy; Longitudinal strain; Subendocardial dysfunction	LEFT-VENTRICULAR DYSFUNCTION; HEART-FAILURE; ECHOCARDIOGRAPHY; MELLITUS; ASSOCIATION; GUIDELINES; STENOSIS; STRAIN	Background: It remains uncertain whether diabetes itself causes specific echocardiographic features of myocardial morphology and function in the absence of hypertension or ischemic heart disease. The purpose of the present study was to determine the characteristics of pure diabetic cardiomyopathy-related echocardiographic morphology and function using layer-by-layer evaluation with myocardial strain echocardiography. Methods and Results: We enrolled 104 patients with poorly controlled type 2 diabetes mellitus (mean HbA1c level, 10%) with (n=74) or without (n=40) hypertension and 24 age-and sex-matched healthy volunteers. Patients with coronary artery stenosis or structural heart disease were excluded. Myocardial layer-specific strain was analyzed by speckle tracking echocardiography. Compared with the healthy control group, the normotensive diabetes group showed no significant difference in ejection fraction, left ventricular mass index, diastolic properties, left atrial volume index, or B-type natriuretic protein (BNP) level, but global longitudinal strain and subendocardial radial strain were significantly deteriorated. The deterioration of longitudinal strain correlated with body mass index (R=0.49, P<0.01) and blood pressure (R=0.36, P<0.01) in the normotensive diabetes group. Conclusions: Deterioration of left ventricular longitudinal shortening accompanied by decreased subendocardial wall thickening are the characteristic functional abnormalities of diabetic cardiomyopathy in patients without hypertrophy, diastolic dysfunction, or elevated BNP. Obesity and blood pressure may also play important roles in this strain abnormality in asymptomatic patients with type 2 diabetes.	[Enomoto, Mami; Ishizu, Tomoko; Seo, Yoshihiro; Yamamoto, Masayoshi; Aonuma, Kazutaka] Univ Tsukuba, Cardiovasc Div, Fac Med, Inst Clin Med, Tsukuba, Ibaraki 3058575, Japan; [Ishizu, Tomoko; Kawakami, Yasushi] Univ Tsukuba, Dept Clin Lab Med, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Suzuki, Hiroaki; Shimano, Hitoshi; Kawakami, Yasushi] Univ Tsukuba, Div Endocrinol & Metab, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Ishizu, T (reprint author), Univ Tsukuba, Cardiovasc Div, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tomoco@md.tsukuba.ac.jp					Aguilar D, 2010, AM J CARDIOL, V105, P373, DOI 10.1016/j.amjcard.2009.09.041; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Nakai H, 2009, EUR J ECHOCARDIOGR, V10, P926, DOI 10.1093/ejechocard/jep097; Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149; Ishizu T, 2010, EUR J ECHOCARDIOGR, V11, P377, DOI 10.1093/ejechocard/jep221; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; STREETER DD, 1969, CIRC RES, V24, P339; Ernande L, 2010, J AM SOC ECHOCARDIOG, V23, P1266, DOI 10.1016/j.echo.2010.09.007; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Bando YK, 2014, CIRC J, V78, P576, DOI 10.1253/circj.CJ-13-1564; Ng ACT, 2009, AM J CARDIOL, V104, P1398, DOI 10.1016/j.amjcard.2009.06.063; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142; Fujihara K, 2014, J ATHEROSCLER THROMB, V21, P799; Ishizu T, 2011, CIRC J, V75, P1934, DOI 10.1253/circj.CJ-10-1085; Kishi S, 2014, JACC-HEART FAIL, V2, P500, DOI 10.1016/j.jchf.2014.03.001; Ma H, 2008, J HUAZHONG U SCI-MED, V28, P719, DOI 10.1007/s11596-008-0624-5; Mizuguchi Y, 2010, J CARDIOL, V55, P23, DOI 10.1016/j.jjcc.2009.07.006; Oyama J, 2014, CIRC J, V78, P819, DOI 10.1253/circj.CJ-13-1561; Seo Y, 2004, J AM SOC ECHOCARDIOG, V17, P1266, DOI 10.1016/j.echo.2004.08.028	22	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1749	1755		10.1253/circj.CJ-15-0012		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900022		
J	Miura, M; Sakata, Y; Miyata, S; Nochioka, K; Takada, T; Tadaki, S; Ushigome, R; Yamauchi, T; Sato, K; Onose, T; Tsuji, K; Abe, R; Takahashi, J; Shimokawa, H				Miura, Masanobu; Sakata, Yasuhiko; Miyata, Satoshi; Nochioka, Kotaro; Takada, Tsuyoshi; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Sato, Kenjiro; Onose, Takeo; Tsuji, Kanako; Abe, Ruri; Takahashi, Jun; Shimokawa, Hiroaki		CHART-2 Investigators	Prognostic Impact of Diabetes Mellitus in Chronic Heart Failure According to Presence of Ischemic Heart Disease - With Special Reference to Nephropathy -	CIRCULATION JOURNAL			English	Article						Chronic heart failure; Diabetes; Ischemic heart disease; Nephropathy; Prognosis	URINARY ALBUMIN EXCRETION; MICROVASCULAR COMPLICATIONS; FOLLOW-UP; ASSOCIATION; PREVALENCE; FRAMINGHAM; CHART-2; RISK; POPULATION; HEMOGLOBIN	Background: It is unclear whether the prognostic impact of diabetes mellitus (DM) in chronic heart failure (CHF) is influenced by ischemic heart disease (IHD) and/or nephropathy. Methods and Results: We enrolled 4,065 consecutive patients with stage C/D CHF (mean age, 69.0 years; 68.7% male) in the CHART-2 Study (n=10,219). We defined DM as current history of DM treatment or HbA1c >= 6.5% (National Glycohemoglobin Standardization Program [NGSP]), and nephropathy as urine albumin: creatinine ratio >= 30 mg/g or urine dipstick test >=(+/-) at enrollment. Impacts of DM and nephropathy on the composite of death, myocardial infarction, stroke, and HF admission were examined. Among the 4,065 patients, 1,448 (35.6%) had DM, while IHD and nephropathy were also noted in 1,644 (40.4%) and in 1,549 (38.1%), respectively. During the median follow-up of 2.88 years, 1,025 (25.2%) reached the composite endpoint. On multivariate Cox regression, DM was significantly associated with the composite endpoint in all patients (HR, 1.17; P=0.02), and in those with IHD (HR, 1.38; P=0.004), but not in those without IHD (HR, 1.12; P=0.22; P for interaction=0.12). Furthermore, when the patients were stratified by nephropathy, DM was associated with worse prognosis only in the IHD patients with nephropathy. Conclusions: The prognostic impact of DM was more evident in patients with IHD than in those without IHD, particularly when complicated with nephropathy.	[Miura, Masanobu; Sakata, Yasuhiko; Nochioka, Kotaro; Takada, Tsuyoshi; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Sato, Kenjiro; Onose, Takeo; Tsuji, Kanako; Abe, Ruri; Takahashi, Jun; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Miyata, Satoshi] Tohoku Univ, Grad Sch Med, Dept Evidence Based Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Sakata, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sakatayk@cardio.med.tohoku.ac.jp			Ministry of Health, Labour, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Japan	We thank all members of the Tohoku Heart Failure Society and the staff of the Departments of Cardiovascular Medicine and Evidence-Based Cardiovascular Medicine for their kind contributions (Supplementary File 1). This study was supported in part by Grants-in-Aid from the Ministry of Health, Labour, and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Andersson C, 2010, SCAND CARDIOVASC J, V44, P37, DOI 10.3109/14017430903312438; Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Satoh-Asahara N, 2013, METABOLISM, V62, P347, DOI 10.1016/j.metabol.2012.09.004; Domanski M, 2003, J AM COLL CARDIOL, V42, P914, DOI 10.1016/S0735-1097(03)00856-8; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Lieb W, 2006, NEPHROL DIAL TRANSPL, V21, P2780, DOI 10.1093/ndt/gfl364; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Aguilar D, 2009, J AM COLL CARDIOL, V54, P422, DOI 10.1016/j.jacc.2009.04.049; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Miura M, 2014, CIRC J, V78, P2276, DOI 10.1253/circj.CJ-14-0387; White SL, 2011, AM J KIDNEY DIS, V58, P19, DOI 10.1053/j.ajkd.2010.12.026; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; [Anonymous], 2013, KIDNEY INT S, V3, P1, DOI DOI 10.1038/KISUP.2012.73; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Whiteley L, 2005, DIABETES CARE, V28, P1588, DOI 10.2337/diacare.28.7.1588; Dries DL, 2001, J AM COLL CARDIOL, V38, P421, DOI 10.1016/S0735-1097(01)01408-5; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Miura M, 2012, EUR J HEART FAIL, V14, P367, DOI 10.1093/eurjhf/hfs001; Erqou S, 2013, EUR J HEART FAIL, V15, P185, DOI 10.1093/eurjhf/hfs156; Haneda M, 2015, CLIN EXP NEPHROL, V19, P1, DOI 10.1007/s10157-014-1057-z; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Konta Tsuneo, 2007, Clin Exp Nephrol, V11, P51, DOI 10.1007/s10157-006-0458-z; Lind M, 2011, LANCET, V378, P140, DOI 10.1016/S0140-6736(11)60471-6; Miura M, 2014, CIRC J, V78, P2890, DOI 10.1253/circj.CJ-14-0787; R Core Team, 2012, R LANG ENV STAT COMP; Shiba N, 2008, CIRC J, V72, P173, DOI 10.1253/circj.72.173; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6	33	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1764	U366		10.1253/circj.CJ-15-0096		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900024		
J	Yamazaki, H; Yamaguchi, K; Soeki, T; Wakatsuki, T; Niki, T; Taketani, Y; Kitaoka, A; Kusunose, K; Ise, T; Tobiume, T; Yagi, S; Iwase, T; Yamada, H; Sata, M				Yamazaki, Hiromu; Yamaguchi, Koji; Soeki, Takeshi; Wakatsuki, Tetsuzo; Niki, Toshiyuki; Taketani, Yoshio; Kitaoka, Atsunori; Kusunose, Kenya; Ise, Takayuki; Tobiume, Takeshi; Yagi, Shusuke; Iwase, Takashi; Yamada, Hirotsugu; Sata, Masataka			Impact of Indoxyl Sulfate, a Uremic Toxin, on Non-Culprit Coronary Plaque Composition Assessed on Integrated Backscatter Intravascular Ultrasound	CIRCULATION JOURNAL			English	Article						Coronary plaque; Indoxyl sulfate; Integrated backscatter intravascular ultrasound	CHRONIC KIDNEY-DISEASE; OXIDE SYNTHASE INHIBITOR; STAGE RENAL-DISEASE; OXIDATIVE STRESS; P-CRESOL; ASYMMETRICAL DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; TISSUE CHARACTERIZATION; STATIN THERAPY; HYPERTENSION	Background: Uremic toxin has emerged as an important determinant of cardiovascular risk. The aim of this study was to examine the relationship between serum uremic toxin and coronary plaque composition on integrated backscatter intravascular ultrasound (IB-IVUS). Methods and Results: IB-IVUS was performed in 47 patients with planned treatment for angina pectoris. Non-culprit intermediate plaque analyzed in this study had to be >5mm apart from the intervention site. 3-D IB-IVUS analysis was performed to determine percent lipid volume (LV) and fibrous volume (FV). We also measured serum uremic toxins (indoxyl sulfate [IS], asymmetric dimethylarginine [ADMA], and p-cresol [PC]). Glomerular filtration rate correlated with IS (r=-0.329, P=0.04), but did not correlate with ADMA or PC. Percent LV correlated with IS ( r=0.365, P=0.02), but did not correlate with ADMA or PC. Percent FV also correlated with IS (r=-0.356, P=0.03), but did not correlate with ADMA or PC. On multivariate regression, only IS was associated with percent LV (r=0.359, P=0.04) and percent FV (r=-0.305, P=0.04) independently of potentially confounding coronary risk factors. Conclusions: Among the uremic toxins, serum IS might be a novel useful biomarker to detect and monitor lipid-rich coronary plaque on IB imaging.	[Yamazaki, Hiromu; Yamaguchi, Koji; Soeki, Takeshi; Wakatsuki, Tetsuzo; Kusunose, Kenya; Ise, Takayuki; Tobiume, Takeshi; Yagi, Shusuke; Iwase, Takashi; Yamada, Hirotsugu; Sata, Masataka] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Kitaoka, Atsunori] Tokushima Univ Hosp, Med Engn Ctr, Tokushima 7708503, Japan; [Niki, Toshiyuki; Taketani, Yoshio] Shikoku Med Ctr Children & Adults, Dept Cardiovasc Med, Zentsuji, Kagawa, Japan	Yamaguchi, K (reprint author), Tokushima Univ Hosp, Dept Cardiovasc Med, 2-50-1 Kuramoto Cho, Tokushima 7708503, Japan.	yamakoji3@tokushima-u.ac.jp					Al Za'abi M, 2013, J CHROMATOGR SCI, V51, P40, DOI 10.1093/chromsci/bms103; Ando H, 2011, CIRC J, V75, P383, DOI 10.1253/circj.CJ-10-0815; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Vanholder R, 1999, NEPHROL DIAL TRANSPL, V14, P2813, DOI 10.1093/ndt/14.12.2813; Lim PS, 2002, BLOOD PURIFICAT, V20, P537, DOI 10.1159/000066962; Zoccali C, 2002, J AM SOC NEPHROL, V13, P490; Nakayama N, 2013, CIRC J, V77, P424, DOI 10.1253/circj.CJ-12-0630; Masai N, 2010, CIRC J, V74, P2216, DOI 10.1253/circj.CJ-10-0117; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Hattori K, 2012, JACC-CARDIOVASC IMAG, V5, P169, DOI 10.1016/j.jcmg.2011.11.012; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Miyazaki H, 1999, CIRCULATION, V99, P1141; Shimoishi K, 2007, PHARM RES, V24, P1283, DOI 10.1007/s11095-007-9248-x; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Hiro T, 2001, CIRCULATION, V103, P1206; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Matsuoka H, 1997, HYPERTENSION, V29, P242; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Dou L, 2002, KIDNEY INT, V62, P1999, DOI 10.1046/j.1523-1755.2002.t01-1-00651.x; Otagiri K, 2011, CIRC J, V75, P633, DOI 10.1253/circj.CJ-10-0600; VANHOLDER R, 1995, KIDNEY INT, V47, P510, DOI 10.1038/ki.1995.64; Muraoka Y, 2013, CIRC J, V77, P363, DOI 10.1253/circj.CJ-12-0575; Yamaguchi K, 2014, CIRC J, V78, P240, DOI 10.1253/circj.CJ-13-0741; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Komiyama N, 2000, AM HEART J, V140, P565, DOI 10.1067/mhj.2000.109217; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Ohota M, 2012, CIRC J, V76, P1678, DOI 10.1253/circj.CJ-11-1157; Pretorius CJ, 2013, CLIN CHIM ACTA, V419, P122, DOI 10.1016/j.cca.2013.02.008; Schaar AJ, 2003, CIRCULATION, V108, P2636; Yilmaz MI, 2006, AM J KIDNEY DIS, V47, P42, DOI 10.1053/j.ajkd.2005.09.029	35	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1773	1779		10.1253/circj.CJ-15-0019		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900025		
J	Nishimiya, K; Matsumoto, Y; Shindo, T; Hanawa, K; Hasebe, Y; Tsuburaya, R; Shiroto, T; Takahashi, J; Ito, K; Ishibashi-Ueda, H; Yasuda, S; Shimokawa, H				Nishimiya, Kensuke; Matsumoto, Yasuharu; Shindo, Tomohiko; Hanawa, Kenichiro; Hasebe, Yuhi; Tsuburaya, Ryuji; Shiroto, Takashi; Takahashi, Jun; Ito, Kenta; Ishibashi-Ueda, Hatsue; Yasuda, Satoshi; Shimokawa, Hiroaki			Association of Adventitial Vasa Vasorum and Inflammation With Coronary Hyperconstriction After Drug-Eluting Stent Implantation in Pigs In Vivo	CIRCULATION JOURNAL			English	Article						Adventitia; Rho-kinase; Spasm; Stents; Vasoconstriction	BARE-METAL STENTS; RHO-KINASE; EXPERIMENTAL HYPERCHOLESTEROLEMIA; VASCULAR INFLAMMATION; ARTERY-DISEASE; PORCINE MODEL; GROWTH-FACTOR; CYPHER STENT; RESPONSES; ATHEROSCLEROSIS	Background: The importance of adventitial inflammation has been implicated for the pathogenesis of coronary artery disease. However, the roles of adventitial changes in drug-eluting stent (DES)-induced coronary hyperconstriction remain largely unknown. In the present study, this issue in pigs in vivo with a special reference to adventitial vasa vasorum (VV) formation and Rho-kinase activation, a central mechanism of coronary vasospasm, was examined. Methods and Results: Each animal received a sirolimus-eluting stent (SES) and a biolimus A9-eluting stent (BES), one in the left anterior descending and another in the left circumflex coronary arteries in a randomized manner (n=18). After 1, 3 and 6 months, coronary vasomotion was examined. At 1 month, coronary vasoconstriction to serotonin was significantly enhanced at the SES edges as compared with the BES edges (SES, 52 +/- 7% vs. BES, 22 +/- 3%, P<0.01), which was equally prevented by a selective Rho-kinase inhibitor, hydroxyfasudil. A significant difference in vasoconstriction between SES and BES was sustained for 6 months. A micro-CT showed VV augmentation at the SES site, extending to the proximal and distal edges. Immunostainings demonstrated that VV formation, macrophage infiltration in the adventitia and Rho-kinase expressions/activation were significantly enhanced at the SES edges as compared with the BES edges. Conclusions: The DES with durable polymers enhances VV formation and inflammation in the adventitia, associating with the pathogenesis of DES-induced coronary hyperconstriction through Rho-kinase activation in pigs in vivo.	[Nishimiya, Kensuke; Matsumoto, Yasuharu; Shindo, Tomohiko; Hanawa, Kenichiro; Hasebe, Yuhi; Tsuburaya, Ryuji; Shiroto, Takashi; Takahashi, Jun; Ito, Kenta; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan; [Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan	Shimokawa, H (reprint author), Tohoku Univ, Grad Sch Med, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9808574, Japan.	shimo@cardio.med.tohoku.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan [H22-Shinkin-004]; Tohoku University Hospital; Global COE Project;  [18890018]	This work was supported, in part, by the grants-in-aid for the Scientific Research (18890018) and the Global COE Project (F02), and the grants-in-aid (H22-Shinkin-004) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan (to H.S.) and the grant for young investigators of translational research from Tohoku University Hospital (to Y.M.).	Aizawa K, 2012, CIRC J, V76, P2552, DOI 10.1253/circj.CJ-12-0662; Wilson SH, 2002, CIRCULATION, V105, P415, DOI 10.1161/hc0402.104119; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Carter AJ, 2004, CARDIOVASC RES, V63, P617, DOI 10.1016/j.cardiores.2004.04.029; Miyata K, 2000, ARTERIOSCL THROM VAS, V20, P2351; Hamilos MI, 2008, J AM COLL CARDIOL, V51, P2123, DOI 10.1016/j.jacc.2007.12.059; AIKAWA M, 1993, CIRC RES, V73, P1000; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Garg S, 2013, NAT REV CARDIOL, V10, P248, DOI 10.1038/nrcardio.2013.13; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Campbell KA, 2012, CIRC RES, V110, P889, DOI 10.1161/CIRCRESAHA.111.263186; Shiroto T, 2009, J AM COLL CARDIOL, V54, P2321, DOI 10.1016/j.jacc.2009.07.045; Maseri A, 2009, CIRC J, V73, P394; Tada N, 2010, CIRC-CARDIOVASC INTE, V3, P174, DOI 10.1161/CIRCINTERVENTIONS.109.877522; Virmani R, 2003, HEART, V89, P133, DOI 10.1136/heart.89.2.133; Fukumoto Y, 1997, J CARDIOVASC PHARM, V29, P222, DOI 10.1097/00005344-199702000-00011; Drinane M, 2009, CIRC RES, V104, P337, DOI 10.1161/CIRCRESAHA.108.184622; Tanaka K, 2011, ATHEROSCLEROSIS, V215, P366, DOI 10.1016/j.atherosclerosis.2011.01.016; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kandabashi T, 2000, CIRCULATION, V101, P1319; Hirata Y, 2011, J AM COLL CARDIOL, V58, P248, DOI 10.1016/j.jacc.2011.01.048; FORMAN MB, 1985, NEW ENGL J MED, V313, P1138, DOI 10.1056/NEJM198510313131807; GRASER T, 1986, CARDIOVASC RES, V20, P299, DOI 10.1093/cvr/20.4.299; Herrmann J, 2001, CARDIOVASC RES, V51, P762, DOI 10.1016/S0008-6363(01)00347-9; Hiranuma N, 2014, CIRC J, V78, P2665, DOI 10.1253/circj.CJ-14-0315; Kwon HM, 1998, J AM COLL CARDIOL, V32, P2072, DOI 10.1016/S0735-1097(98)00482-3; Nihei T, 2014, CIRC J, V78, P1183, DOI 10.1253/circj.CJ-13-1458; Nishimiya K, 2015, CIRC J, V79, P1323, DOI 10.1253/circj.CJ-15-0078; Nishimiya K, 2014, CIRC J, V78, P2516, DOI 10.1253/circj.CJ-14-0485; Pendyala LK, 2012, JACC-CARDIOVASC INTE, V5, P436, DOI 10.1016/j.jcin.2011.11.013; Sahler LG, 2008, J MED IMAG RADIAT ON, V52, P570, DOI 10.1111/j.1440-1673.2008.02020.x; Shibata M, 2001, HISTOCHEM CELL BIOL, V116, P471, DOI 10.1007/s00418-001-0336-4; Shimokawa H, 2014, EUR HEART J, V35, P3180, DOI 10.1093/eurheartj/ehu427; Takeda Morihiko, 2013, Cardiovasc Interv Ther, V28, P272, DOI 10.1007/s12928-012-0155-7; Tsuburaya R, 2012, EUR HEART J, V33, P791, DOI 10.1093/eurheartj/ehr145; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3	42	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1787	U401		10.1253/circj.CJ-15-0149		20	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900027		
J	Kurishima, C; Inuzuka, R; Kuwata, S; Iwamoto, Y; Sugimoto, M; Saiki, H; Ishido, H; Masutani, S; Senzaki, H				Kurishima, Clara; Inuzuka, Ryo; Kuwata, Seiko; Iwamoto, Yoichi; Sugimoto, Masaya; Saiki, Hirofumi; Ishido, Hirotaka; Masutani, Satoshi; Senzaki, Hideaki			Influence of Left Ventricular Stiffness on Hemodynamics in Patients With Untreated Atrial Septal Defects	CIRCULATION JOURNAL			English	Article						Cardiac catheterization; Congenital heart defects; Vascular resistance	PRESERVED EJECTION FRACTION; CONGENITAL HEART-DISEASE; TRANSCATHETER CLOSURE; DIASTOLIC FUNCTION; FAILURE; ADULT; CHILDREN; GUIDELINES; MANAGEMENT; OXYGEN	Background: Although left ventricular (LV) stiffening with age is believed to increase left-to-right shunting in patients with atrial septal defects (ASD), clinical data have not confirmed this. We sought determinants of the pulmonary-to-systemic flow ratio (Qp/Qs) in patients with untreated ASD. Methods and Results: We retrospectively studied 180 patients with ASD who underwent percutaneous ASD closure between 2007 and 2011. Qp/Qs and LV stiffness were measured before ASD closure. The median age of the subjects was 18 years, and 117 (65.0%) were female. The mean ASD size adjusted for square root of body surface area (BSA) was 14.4 +/- 4.2 mm/m, and the Qp/Qs was 2.28 +/- 0.74. Adjusted ASD size most strongly related to Qp/Qs (r = 0.74, P < 0.0001). Multivariate analysis revealed that LV stiffness was a significant predictor of Qp/Qs, independently of adjusted ASD size and vascular resistance (P = 0.0015). Based on the multivariate model that accounts for the effects of LV stiffness and vascular resistance, the minimal adjusted diameter that can cause a Qp/Qs of 2.0 was predicted to be 7.3 mm/m. Conclusions: Qp/Qs in ASD can change significantly depending on LV stiffness, suggesting that it would increase with age. An ASD > 7.3 mm/m in diameter has the potential to cause significant left-to-right shunting, and may require closure regardless of hemodynamic status at the time of assessment.	[Kurishima, Clara; Kuwata, Seiko; Iwamoto, Yoichi; Saiki, Hirofumi; Ishido, Hirotaka; Masutani, Satoshi; Senzaki, Hideaki] Saitama Med Univ, Div Pediat Cardiol, Saitama, Japan; [Inuzuka, Ryo] Univ Tokyo, Dept Pediat, Tokyo, Japan; [Sugimoto, Masaya] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan	Senzaki, H (reprint author), Saitama Med Ctr, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	hsenzaki@saitama-med.ac.jp					Webb G, 2006, CIRCULATION, V114, P1645, DOI 10.1161/CIRCULATIONAHA.105.592055; STEELE PM, 1987, CIRCULATION, V76, P1037; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.09.046; Hanslik A, 2006, PEDIATRICS, V118, P1560, DOI 10.1542/peds.2005-3037; Connelly MS, 1998, CAN J CARDIOL, V14, P395; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Botto LD, 2001, PEDIATRICS, V107, pE32, DOI 10.1542/peds.107.3.e32; RADZIK D, 1993, J AM COLL CARDIOL, V22, P851; Masutani S, 2011, J CARD FAIL, V17, P957, DOI 10.1016/j.cardfail.2011.07.003; Burkhoff D, 2003, CIRCULATION, V107, P656, DOI 10.1161/01.CIR.0000053947.82595.03; Geva T, 2014, LANCET, V383, P1921, DOI 10.1016/S0140-6736(13)62145-5; LITTLE WC, 1995, CIRCULATION, V92, P1933; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; LAFARGE CG, 1970, CARDIOVASC RES, V4, P23, DOI 10.1093/cvr/4.1.23; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690; Fuse S, 2001, AM J CARDIOL, V88, P1447, DOI 10.1016/S0002-9149(01)02134-8; Goto T, 2013, CIRC J, V77, P123, DOI 10.1253/circj.CJ-12-0733; Masutani S, 2012, HEART VESSELS, V27, P71, DOI 10.1007/s00380-011-0122-8; Masutani S, 2013, CIRC J, V77, P2375, DOI 10.1253/circj.CJ-12-1271; Sakata Y, 2013, CIRC J, V77, P886, DOI 10.1253/circj.CJ-13-0214; SWAN HJC, 1959, CIRCULATION, V20, P66; Team RDC, 2008, R LANG ENV STAT COMP; Yoshikawa WS, 2013, CIRC J, V77, P741, DOI 10.1253/circj.CJ-12-0779	26	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1823	1827		10.1253/circj.CJ-14-1351		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900031		
J	Takeuchi, D; Honda, K; Shinohara, T; Inai, K; Toyohara, K; Nakanishi, T				Takeuchi, Daiji; Honda, Kei; Shinohara, Tokuko; Inai, Kei; Toyohara, Keiko; Nakanishi, Toshio			Incidence, Clinical Course, and Risk Factors of Amiodarone-Induced Thyroid Dysfunction in Japanese Adults With Congenital Heart Disease	CIRCULATION JOURNAL			English	Article						Amiodarone; Congenital heart disease; Japanese; Thyroid dysfunction	INDUCED THYROTOXICOSIS; THERAPY; HYPOTHYROIDISM; WITHDRAWAL; MANAGEMENT; LONG	Background: Although amiodarone (AMD)-induced thyroid dysfunction (AITD) is an important complication of AMD therapy, little is known about AITD in adult Japanese patients with congenital heart disease (CHD). Methods and Results: We retrospectively studied 131 adult patients with CHD who were on low-dose AMD (median, 150 mg/day). The median patient age was 28 years, and the median follow-up was 44 months. The incidence, clinical course, and risk factors of AITD, including AMD-induced thyrotoxicosis (AIT) and AMD-induced hypothyroidism (AIH), were evaluated. The total incidence of AITD was 30% (AIT: 18%, n=24; AIH: 12%, n=16). Approximately 67% of patients with AIT displayed deterioration of tachyarrhythmia, and 38% patients underwent steroid therapy. Although thyroid function and symptoms associated with AIT improved within 6 months after diagnosis in most patients with AIT (92%), 1 patient died suddenly during an acute phase of AIT. No patient with AIH exhibited deterioration of tachyarrhythmia, and 9 patients underwent thyroid hormone replacement therapy. Cox multivariate analysis identified no independent risk factor for AIT, whereas liver dysfunction (hazard ratio 2.573; 95% confidence interval 1.102-5.795) was an independent risk factor for AIH. Conclusions: AITD commonly occurred in adult Japanese patients with CHD even though they were on a low-dose AMD regimen. Risk factors for AITD may vary according to ethnicity and diet.	[Takeuchi, Daiji; Honda, Kei; Shinohara, Tokuko; Inai, Kei; Toyohara, Keiko; Nakanishi, Toshio] Tokyo Womens Med Univ, Dept Pediat Cardiol, Tokyo 1628666, Japan	Takeuchi, D (reprint author), Tokyo Womens Med Univ, Dept Pediat Cardiol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ptakeuci@hij.twmu.ac.jp					RAO RH, 1986, J CLIN ENDOCR METAB, V62, P563; Bouchardy J, 2009, CIRCULATION, V120, P1679, DOI 10.1161/CIRCULATIONAHA.109.866319; Thorne SA, 1999, CIRCULATION, V100, P149; LATINI R, 1984, CLIN PHARMACOKINET, V9, P136; Conen D, 2007, J AM COLL CARDIOL, V49, P2350, DOI 10.1016/j.jacc.2007.02.054; Fujiwara Y, 2013, SHINZO, V45, P1101; Harjai KJ, 1997, ANN INTERN MED, V126, P63; HAWTHORNE GC, 1985, ARCH INTERN MED, V145, P1016, DOI 10.1001/archinte.145.6.1016; Khairy P, 2014, HEART RHYTHM, V11, pE102, DOI [10.1016/j.hrthm.2014.05.009, 10.1016/j.hrthm.2014.0.5.009]; Newman CM, 1998, HEART, V79, P121; O'Sullivan AJ, 2006, EUR J ENDOCRINOL, V154, P533, DOI 10.1530/eje.1.02122; Sato K, 1999, ENDOCR J, V46, P443, DOI 10.1507/endocrj.46.443; Shiga T, 2001, JPN CIRC J, V65, P958, DOI 10.1253/jcj.65.958; Shinohara T, 2013, CIRC J, V77, P2875, DOI 10.1253/circj.CJ-13-1242; Stan MN, 2014, ENDOCR PRACT, V20, P33, DOI 10.4158/EP13059.OR; Stan MN, 2012, J THYROID RES, V2012; Stan MN, 2013, INT J CARDIOL, V167, P821, DOI 10.1016/j.ijcard.2012.02.015; Yagishita A, 2013, CIRC J, V77, P2898, DOI 10.1253/circj.CJ-13-0220; Yiu KH, 2009, J CLIN ENDOCR METAB, V94, P109, DOI 10.1210/jc.2008-1907	19	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1828	1834		10.1253/circj.CJ-15-0042		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900032		
J	Hasegawa, J; Ikeda, T; Sekizawa, A; Tanaka, H; Nakata, M; Murakoshi, T; Katsuragi, S; Osato, K; Ishiwata, I; Kinoshita, K				Hasegawa, Junichi; Ikeda, Tomoaki; Sekizawa, Akihiko; Tanaka, Hiroaki; Nakata, Masahiko; Murakoshi, Takeshi; Katsuragi, Shinji; Osato, Kazuhiro; Ishiwata, Isamu; Kinoshita, Katsuyuki		Maternal Death Exploratory	Maternal Death Due to Stroke Associated With Pregnancy-Induced Hypertension	CIRCULATION JOURNAL			English	Article						Hemolysis; elevated liver enzymes and low platelet count (HELLP) syndrome; Intracerebral hemorrhage; Maternal death; Pregnancy-induced hypertension; Stroke	DISEASE; PUERPERIUM; JAPAN; HEMORRHAGE; MORTALITY; MORBIDITY; DELIVERY; WOMEN	Background: The aim of this study was to clarify the clinical features of maternal death due to stroke associated with pregnancy-induced hypertension (PIH) in Japan. Methods and Results: Reported maternal deaths occurring between 2010 and 2012 throughout Japan were analyzed by the Maternal Death Exploratory Committee. Among a total of 154 reports of maternal death, those due to stroke with (n=12) or without (n=13) PIH were compared. Cerebral stroke occurred more frequently in the third trimester and during the second stage of labor in deaths with PIH, whereas it occurred at any time point in deaths not involving PIH. Although 83% of patients with PIH who died had experienced initial symptoms in a hospital, more than half of them required maternal transport due to lack of medical resources. Among the patients without PIH, some vascular abnormalities were identified, but no evidence was found among the patients with PIH. In addition, 58% of PIH cases resulting in stroke were complicated by hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome. Conclusions: Appropriate management of PIH during pregnancy and labor, including anti-hypertensive therapy and early maternal transport to tertiary hospital, may reduce the maternal death rate.	[Hasegawa, Junichi; Sekizawa, Akihiko] Showa Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1428666, Japan; [Ikeda, Tomoaki; Tanaka, Hiroaki; Osato, Kazuhiro] Mie Univ, Sch Med, Dept Obstet & Gynecol, Tsu, Mie, Japan; [Nakata, Masahiko] Toho Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan; [Murakoshi, Takeshi] Seirei Hamamatsu Gen Hosp, Div Perinatol, Maternal & Perinatal Care Ctr, Hamamatsu, Shizuoka, Japan; [Katsuragi, Shinji] Sakakibara Heart Inst, Dept Obstet & Gynecol, Tokyo, Japan; [Ishiwata, Isamu] Ishiwata Obstet & Gynecol Hosp, Ibaraki, Japan; [Kinoshita, Katsuyuki] Seijo Kinoshita Hosp, Tokyo, Japan	Hasegawa, J (reprint author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	hasejun@oak.dti.ne.jp			JAOG	We give special thanks to all the doctors of the facilities reporting maternal deaths. This work was supported by JAOG.	Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066; SHARSHAR T, 1995, STROKE, V26, P930; Lo JO, 2013, CURR OPIN OBSTET GYN, V25, P124, DOI 10.1097/GCO.0b013e32835e0ef5; Jaigobin C, 2000, STROKE, V31, P2948; Takahashi JC, 2010, NEUROL MED-CHIR, V50, P824; Clark SL, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.031; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Liang CC, 2006, EUR J NEUROL, V13, P1256, DOI 10.1111/j.1468-1331.2006.01490.x; AWADA A, 1995, INT J GYNECOL OBSTET, V48, P157, DOI 10.1016/0020-7292(94)02281-3; Horton JC, 1990, NEUROSURGERY, V27, P871; Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, 2014, GUID OBST PRACT JAP; Niwa K, 2012, CIRC J, V76, P240, DOI 10.1253/circj.CJ-88-0023; Jeng JS, 2004, CEREBROVASC DIS, V18, P290, DOI 10.1159/000080354; Mothers' and Children's Health Organization, 2014, MAT CHILD HLTH STAT; Salonen Ros H, 2001, EPIDEMIOLOGY, V12, P456; Sekizawa A, 2015, SAVING MOTHERS LIVES; Takahashi JC, 2014, J STROKE CEREBROVASC, V23, pE65, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.017; Takahashi JC, 2012, NEUROL MED-CHIR, V52, P304; Tanaka H, 2015, CIRC J, V79, P1357, DOI 10.1253/circj.CJ-14-1228; Treadwell SD, 2008, POSTGRAD MED J, V84, P238, DOI 10.1136/pgmj.2007.066167; Watanabe K, 2013, HYPERTENS RES PREGNA, V1, P3; Witlin AG, 2000, AM J OBSTET GYNECOL, V183, P83, DOI 10.1067/mob.2000.105427; Yoshimatsu J, 2014, J OBSTET GYNAECOL RE, V40, P1267, DOI 10.1111/jog.12336	23	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1835	U467		10.1253/circj.CJ-15-0297		28	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900033		
J	Yoshimuta, T; Yokoyama, H; Okajima, T; Tanaka, H; Toyoda, K; Nagatsuka, K; Higashi, M; Hayashi, K; Kawashiri, MA; Yasuda, S; Yamagishi, M				Yoshimuta, Tsuyoshi; Yokoyama, Hiroyuki; Okajima, Toshiya; Tanaka, Hiroshi; Toyoda, Kazunori; Nagatsuka, Kazuyuki; Higashi, Masahiro; Hayashi, Kenshi; Kawashiri, Masa-aki; Yasuda, Satoshi; Yamagishi, Masakazu			Impact of Elevated D-Dimer on Diagnosis of Acute Aortic Dissection With Isolated Neurological Symptoms in Ischemic Stroke	CIRCULATION JOURNAL			English	Article						Acute aortic dissection; D-Dimer; Stroke	TISSUE-PLASMINOGEN ACTIVATOR; PULMONARY-EMBOLISM; FIBRIN; COAGULATION; EPIDEMIOLOGY; BIOMARKERS; GUIDELINES; INFARCTION; ANEURYSM; SUBTYPES	Background: Plasma D-dimer is known to be a useful clinical marker of thrombogenic status, and D-Dimer is used as a diagnostic marker for acute aortic dissection (AAD). Little is known, however, regarding the clinical value of D-Dimer for diagnosis of asymptomatic AAD in patients with ischemic stroke. We investigated whether D-dimer could be used for early diagnosis of AAD with isolated neurological symptoms in ischemic stroke patients. Methods and Results: We evaluated a total of 1,236 consecutive patients with symptomatic ischemic stroke without chest or back pain who underwent either head computed tomography or magnetic resonance imaging. D-Dimer was measured within 24 h after onset. There were 9 patients with Stanford type A AAD and they had significantly higher D-Dimer than the patients without AAD (mean, 46.47+/-54.48 mu g/ml; range, 6.9-167.1 mu g/ml vs. 2.33+/-3.58 mu g/ml, 0.3-57.9 mu g/ml, P<0.001). When a cut-off of 6.9 mu g/ml was adopted for D-Dimer on the basis of receiver operating characteristics analysis, the sensitivity and specificity for AAD were 100% and 94.8%, respectively, while the positive and negative predictive values were 14.7% and 100%, respectively. Conclusions: D-Dimer might be a useful marker for the early diagnosis of AAD with isolated neurological symptoms in ischemic stroke patients. Whole-body contrast-enhanced computed tomography should be performed in ischemic stroke patients who have high D-dimer.	[Yoshimuta, Tsuyoshi; Hayashi, Kenshi; Kawashiri, Masa-aki; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med Sci, Div Cardiovasc Med, Kanazawa, Ishikawa 9208641, Japan; [Okajima, Toshiya] Takarazuka City Hosp, Div Cardiol, Takarazuka, Hyogo, Japan; [Yokoyama, Hiroyuki; Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan; [Tanaka, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Osaka, Japan; [Toyoda, Kazunori; Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Stroke, Osaka, Japan; [Higashi, Masahiro] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Osaka, Japan	Yoshimuta, T (reprint author), Kanazawa Univ, Grad Sch, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	tyoshimu@med.kanazawa-u.ac.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845			Ageno W, 2002, ARCH INTERN MED, V162, P2589, DOI 10.1001/archinte.162.22.2589; Suzuki T, 2009, CIRCULATION, V119, P2702, DOI 10.1161/CIRCULATIONAHA.108.833004; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; VIOLI F, 1993, HEPATOLOGY, V17, P78, DOI 10.1016/0270-9139(93)90195-S; Yu MJ, 2000, CRIT CARE MED, V28, P1777, DOI 10.1097/00003246-200006000-00013; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Eggebrecht H, 2004, J AM COLL CARDIOL, V44, P804, DOI 10.1016/j.jacc.2004.04.053; Wannamethee SG, 2012, STROKE, V43, P1206, DOI 10.1161/STROKEAHA.111.636373; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Gaul C, 2007, STROKE, V38, P292, DOI 10.1161/01.STR.0000254594.33408.b1; Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Blanco M, 1999, ACTA NEUROL SCAND, V99, P232; Bossone E, 2013, CIRCULATION, V128, pS175, DOI 10.1161/CIRCULATIONAHA.112.000327; Bucek RA, 2001, THROMB RES, V103, P17, DOI 10.1016/S0049-3848(00)00367-4; COSTANTINI V, 1993, THROMB HAEMOSTASIS, V69, P406; Daily P O, 1970, Ann Thorac Surg, V10, P237; Fessler AJ, 2000, NEUROLOGY, V54, P1010; Flemming KD, 1999, STROKE, V30, P477; GOLDHABER SZ, 1988, AM HEART J, V116, P505, DOI 10.1016/0002-8703(88)90625-4; GOLDHABER SZ, 1993, JAMA-J AM MED ASSOC, V270, P2819, DOI 10.1001/jama.270.23.2819; Hagen PG, 2000, JAMA-J AM MED ASSOC, V283, P897; Ishimaru S, 2013, CIRC J, V77, P789, DOI 10.1253/circj.CJ-66-0057; Kurabayashi M, 2014, CIRC J, V78, P1928, DOI 10.1253/circj.CJ-14-0198; Ono N, 1991, STROKE, V22, P1369; ONO N, 1991, STROKE, V22, P1369; Pacini D, 2013, INT J CARDIOL, V167, P2806, DOI 10.1016/j.ijcard.2012.07.008; PERNAMBUCO JRB, 1993, HEPATOLOGY, V18, P1350, DOI 10.1016/0270-9139(93)90223-A; RIDKER PM, 1994, CIRCULATION, V90, P2236; TAKANO K, 1991, STROKE, V22, P12; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; Tokuda Y, 2014, CIRC J, V78, P2431, DOI 10.1253/circj.CJ-14-0565; Weber T, 2003, CHEST, V123, P1375, DOI 10.1378/chest.123.5.1375; Yamazumi K, 1998, AM J SURG, V175, P297, DOI 10.1016/S0002-9610(98)00014-2; Yoshimuta T, 2012, J ECHOCARDIOGR, V10, P38; Yoshimuta T, 2010, INTERNAL MED, V49, P83, DOI 10.2169/internalmedicine.49.2838	36	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1841	1845		10.1253/circj.CJ-15-0050		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900034		
J	Hung, GU; Hung, CH; Chen, TY; Kung, WM; Wei, CY; Kao, CH; Uchiyama, S				Hung, Guang-Uei; Hung, Chao-Hsien; Chen, Tai-Yi; Kung, Woon-Man; Wei, Cheng-Yu; Kao, Chia-Hung; Uchiyama, Shinichiro			Identification of Suspected Ruptured Atherosclerotic Plaque in Acute Ischemic Stroke on F-18-Sodium Fluoride Positron Emission Tomography-Computed Tomography	CIRCULATION JOURNAL			English	Editorial Material									[Hung, Guang-Uei] Chang Bing Show Chwan Mem Hosp, Dept Nucl Med, Changhua, Taiwan; [Hung, Chao-Hsien; Wei, Cheng-Yu] Chang Bing Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Chen, Tai-Yi] Chang Bing Show Chwan Mem Hosp, Dept Radiol, Changhua, Taiwan; [Hung, Guang-Uei] Cent Taiwan Univ Sci & Technol, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Kung, Woon-Man; Wei, Cheng-Yu] Chinese Culture Univ, Dept Exercise & Hlth Promot, Coll Educ, Taipei, Taiwan; [Kung, Woon-Man] Lotung Poh Ai Hosp, Lo Hsu Fdn, Dept Neurosurg, Yilan, Taiwan; [Wei, Cheng-Yu] Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Kao, Chia-Hung] China Med Univ, Dept Nucl Med, Sch Med, Taichung, Taiwan; [Uchiyama, Shinichiro] Int Univ Hlth & Welf, Clin Res Ctr Med, Tokyo, Japan; [Uchiyama, Shinichiro] Sanno Hosp, Ctr Brain & Cerebral Vessels, Tokyo, Japan; [Uchiyama, Shinichiro] Sanno Med Ctr, Tokyo, Japan	Wei, CY (reprint author), Chang Bing Show Chwan Mem Hosp, Dept Neurol, 6 Lugong Rd, Lugang Town 505, Changhua County, Taiwan.	yuyu@seed.net.tw; d10040@mail.cmuh.org.tw					Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nighoghossian N, 2005, STROKE, V36, P2764, DOI 10.1161/01.STR.0000190895.51934.43; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; Yamashita A, 2013, CIRC J, V77, P2626, DOI 10.1253/circj.CJ-12-1463; Chen WG, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0364-4; Kawasaki T, 2011, CIRC J, V75, P2013, DOI 10.1253/circj.CJ-11-0570	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	AUG	2015	79	8					1855	1857		10.1253/circj.CJ-14-1404		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN6VQ	WOS:000358572900037		
J	Keino, H; Watanabe, T; Sato, Y; Shudo, K; Kitaoka, Y; Harada, T; Okada, AA				Keino, Hiroshi; Watanabe, Takayo; Sato, Yasuhiko; Shudo, Koichi; Kitaoka, Yasushi; Harada, Takayuki; Okada, Annabelle A.			Retinoic acid receptor stimulation ameliorates experimental autoimmune optic neuritis	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						experimental autoimmune optic neuritis; retinoid; Th1; Th17	MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MIDBRAIN DOPAMINERGIC-NEURONS; T-CELLS; MULTIPLE-SCLEROSIS; TH17 CELLS; AM80; ENCEPHALOMYELITIS; DIFFERENTIATION; SUPPRESSION; PROTEIN	BackgroundTo determine whether all-trans retinoic acid or a synthetic retinoic acid receptor-/-specific agonist, Am80, can reduce the degree of experimental autoimmune optic neuritis in mice with experimental autoimmune encephalomyelitis. MethodsOptic neuritis was induced in C57BL/6 mice by immunizing them with myelin oligodendrocyte glycoprotein(35-55). All-trans retinoic acid (350g/mouse/time point) or Am80 (5mg/kg/time point) was administered every other day from day 0 to day 20. The degree of experimental autoimmune encephalomyelitis was scored and histopathological analysis of the optic neuritis was performed on day 22 after the immunization. In vivo-primed draining lymph node cells obtained from vehicle-treated or all-trans retinoic acid-treated mice were stimulated with myelin oligodendrocyte glycoprotein(35-55), and the culture supernatant was collected for assays of interferon- and interleukin-17. ResultsAll-trans retinoic acid treatment significantly reduced the clinical score of experimental autoimmune encephalomyelitis and the severity of the optic neuritis by histopathological analysis. The production of interferon- and interleukin-17 was significantly reduced in all-trans retinoic acid-treated mice compared with vehicle-treated mice. Am80 treatment also significantly decreased the severity of the optic neuritis in mice with experimental autoimmune encephalomyelitis. ConclusionsThese findings demonstrate that all-trans retinoic acid and Am80 treatment were able to reduce the severity of optic neuritis in mice with experimental autoimmune encephalomyelitis. Activation of retinoic acid receptor-/ may be a molecular target for the treatment of autoimmune optic neuritis induced by Th1 or Th17-dominated immune responses.	[Keino, Hiroshi; Watanabe, Takayo; Okada, Annabelle A.] Kyorin Univ, Sch Med, Dept Ophthalmol, Mitaka, Tokyo 1818611, Japan; [Sato, Yasuhiko] Kyorin Univ, Sch Med, Div Radioisotope Res, Mitaka, Tokyo 1818611, Japan; [Shudo, Koichi] Tokyo Metropolitan Inst Med Sci, Res Fdn ITSUU Lab, Setagaya Ku, Tokyo 113, Japan; [Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, Tokyo 113, Japan; [Kitaoka, Yasushi] St Marianna Univ, Sch Med, Dept Ophthalmol, Kawasaki, Kanagawa, Japan	Keino, H (reprint author), Kyorin Univ, Sch Med, Dept Ophthalmol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	keino@eye-center.org			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Miwako I, 2007, DRUGS TODAY, V43, P563, DOI 10.1358/dot.2007.43.8.1072615; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Matsuda R, 2012, INVEST OPHTH VIS SCI, V53, P7235, DOI 10.1167/iovs.12-10587; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Nishimori H, 2012, BLOOD, V119, P285, DOI 10.1182/blood-2011-01-332478; Katsuki H, 2009, J NEUROCHEM, V110, P707, DOI 10.1111/j.1471-4159.2009.06171.x; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kurauchi Y, 2011, J NEUROCHEM, V116, P323, DOI 10.1111/j.1471-4159.2010.06916.x; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; Storch MK, 1998, BRAIN PATHOL, V8, P681; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Keino H, 2011, INVEST OPHTH VIS SCI, V52, P1548, DOI 10.1167/iovs.10-5963; Tobita T, 1997, BLOOD, V90, P967; Chambon P, 1996, FASEB J, V10, P940; Xiao S, 2008, J IMMUNOL, V181, P2277; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; Kwok SK, 2012, J IMMUNOL, V189, P1062, DOI 10.4049/jimmunol.1102706; Shao H, 2004, INVEST OPHTH VIS SCI, V45, P4060, DOI 10.1167/iovs.04-0554; Guo XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013083; Hoorbakht Hedieh, 2012, Open Ophthalmol J, V6, P65, DOI 10.2174/1874364101206010065; Kang BY, 2000, BRIT J PHARMACOL, V130, P581, DOI 10.1038/sj.bjp.0703345; Miyabe C, 2013, ARTHRITIS RHEUM-US, V65, P503, DOI 10.1002/art.37784; Nozaki Y, 2006, CLIN IMMUNOL, V119, P272, DOI 10.1016/j.clim.2005.11.012; Ohyanagi N, 2009, ARTHRITIS RHEUM, V60, P3118, DOI 10.1002/art.24930; POTTER NT, 1992, INVEST OPHTH VIS SCI, V33, P1717; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P681, DOI 10.1167/iovs.06-0553; Stevens DB, 1999, J IMMUNOL, V162, P7501	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1442-6404	1442-9071		CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	AUG	2015	43	6					558	567		10.1111/ceo.12308		10	Ophthalmology	Ophthalmology	CN8XC	WOS:000358728000010		
J	Yokota, T; Kamimura, N; Igarashi, T; Takahashi, H; Ohta, S; Oharazawa, H				Yokota, Takashi; Kamimura, Naomi; Igarashi, Tsutomu; Takahashi, Hiroshi; Ohta, Shigeo; Oharazawa, Hideaki			Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						antioxidant; molecular hydrogen; oxidative stress; retina	CELL-DEATH; GLUTAMATE; CULTURE; SUPEROXIDE; APOPTOSIS; GLAUCOMA; GROWTH; OXYGEN; MODEL; MICE	BackgroundOxidative and nitrative processes have an important role in the pathogenesis of glaucomatous neurodegeneration. Oxidative stress occurs when cellular production of reactive oxygen species outweighs the protective capacity of antioxidant defences. Reactive oxygen species are generated as by-products of cellular metabolism, primarily in the mitochondria. Herein, we present a novel investigation of the effects of molecular hydrogen (H-2) on retinal cells exposed to oxidative stress. MethodsWe cultured adult rat retinal tissues in an organotypic culture system with a nitric oxide donor, S-nitroso-N-acetylpenicillamine, in the presence or absence of H-2. Loss of mitochondrial membrane potential and apoptosis of retinal cells were analysed using a MitoTMRE detection kit and TdT-mediated dUTP nick end labeling (TUNEL) assay, respectively. Tyrosine nitration levels and oxidative stress damage in the retina were evaluated using immunohistochemical staining. Retinal damage was quantified by measuring the numbers of cells in the ganglion cell and inner nuclear layers and the thickness of the retina. ResultsH(2) suppressed loss of mitochondrial membrane potential and apoptosis in retinal cells. Moreover, H-2 decreased the tyrosine nitration level and suppressed oxidative stress damage in retinal cells. S-nitroso-N-acetylpenicillamine treatment decreased the cell numbers in the ganglion cell layer and inner nuclear layer, but the presence of H-2 inhibited this reduction. These findings suggest that H-2 has a neuroprotective effect against retinal cell oxidative damage, presumably by scavenging peroxynitrite. ConclusionsH(2) reduces cellular peroxynitrite, a highly toxic reactive nitrogen species. Thus, H-2 may be an effective and novel clinical tool for treating glaucoma and other oxidative stress-related diseases.	[Yokota, Takashi; Kamimura, Naomi; Ohta, Shigeo] Grad Sch Med, Inst Dev & Aging Sci, Dept Biochem & Cell Biol, Kawasaki, Kanagawa, Japan; [Igarashi, Tsutomu; Takahashi, Hiroshi] Nippon Med Sch, Musashikosugi Hosp, Dept Ophthalmol, Kawasaki, Kanagawa 2118533, Japan; [Oharazawa, Hideaki] Nippon Med Sch, Dept Ophthalmol, Tokyo 113, Japan	Oharazawa, H (reprint author), Nippon Med Sch, Musashikosugi Hosp, Dept Ophthalmol, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	hideaki@nms.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21592248, 24500871]	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 21592248 and 24500871).	Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Bermel C, 2009, MOL CELL NEUROSCI, V42, P427, DOI 10.1016/j.mcn.2009.09.005; Fatokun AA, 2008, FRONT BIOSCI, V13, P3288, DOI 10.2741/2926; Jayaraman S, 2005, J IMMUNOL METHODS, V306, P68, DOI 10.1016/j.jim.2005.07.024; Scaduto RC, 1999, BIOPHYS J, V76, P469; Ohta S, 2011, CURR PHARM DESIGN, V17, P2241; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Oharazawa H, 2010, INVEST OPHTH VIS SCI, V51, P487, DOI 10.1167/iovs.09-4089; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299; Leaver SG, 2006, GLIA, V53, P467, DOI 10.1002/glia.20311; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Ciani E, 1996, BRAIN RES, V728, P1; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dreyer EB, 1999, JAMA-J AM MED ASSOC, V281, P306, DOI 10.1001/jama.281.4.306; Feigenspan A, 2010, INVEST OPHTH VIS SCI, V51, P1789, DOI 10.1167/iovs.09-4113; Haefliger IO, 1999, SURV OPHTHALMOL, V43, pS59, DOI 10.1016/S0039-6257(99)00025-9; Hanaoka Teruyasu, 2011, Med Gas Res, V1, P18, DOI 10.1186/2045-9912-1-18; Manabe S, 2002, NEUROSCI LETT, V334, P33, DOI 10.1016/S0304-3940(02)01047-9; Misko TP, 1998, J BIOL CHEM, V273, P15646, DOI 10.1074/jbc.273.25.15646; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Xin H, 2007, J NEUROSCI METH, V159, P35, DOI 10.1016/j.jneumeth.2006.06.013; Zhang SSM, 2002, METHODS, V28, P439, DOI 10.1016/S1046-2023(02)00263-3	28	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1442-6404	1442-9071		CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	AUG	2015	43	6					568	577		10.1111/ceo.12525		10	Ophthalmology	Ophthalmology	CN8XC	WOS:000358728000011		
J	Takada, S; Tanaka, R; Kurita, N; Ishii, K; Kaburaki, T				Takada, Sachiko; Tanaka, Rie; Kurita, Naoyuki; Ishii, Kiyoshi; Kaburaki, Toshikatsu			Vogt-Koyanagi-Harada disease in 3-year-old boy	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Letter							CHILDREN		[Takada, Sachiko] Nadogaya Hosp, Dept Ophthalmol, Kashiwa, Chiba, Japan; [Takada, Sachiko; Tanaka, Rie; Kaburaki, Toshikatsu] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Kurita, Naoyuki; Ishii, Kiyoshi] Saitama Red Cross Hosp, Dept Ophthalmol, Saitama, Saitama, Japan	Takada, S (reprint author), Nadogaya Hosp, Dept Ophthalmol, Kashiwa, Chiba, Japan.						Abu El-Asrar AM, 2008, EYE, V22, P1124, DOI 10.1038/sj.eye.6702859; Al Hemidan AI, 2006, EUR J OPHTHALMOL, V16, P173; Berker N, 2007, OCUL IMMUNOL INFLAMM, V15, P351, DOI 10.1080/09273940701459453; GRUICH MJ, 1995, PEDIATR NEUROL, V13, P50, DOI 10.1016/0887-8994(95)00112-S; Tabbara KF, 1998, ACTA OPHTHALMOL SCAN, V76, P723, DOI 10.1034/j.1600-0420.1998.760619.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1442-6404	1442-9071		CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	AUG	2015	43	6					593	594		10.1111/ceo.12512		2	Ophthalmology	Ophthalmology	CN8XC	WOS:000358728000014		
J	Toublanc, N; Du, XL; Liu, Y; Chen, Q; Singh, P; Chan, R; Stockis, A				Toublanc, Nathalie; Du, Xinlu; Liu, Yun; Chen, Qian; Singh, Pritibha; Chan, Robert; Stockis, Armel			Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects	CLINICAL DRUG INVESTIGATION			English	Article							DOSE PHARMACOKINETICS; PLACEBO	Background and Objective Levetiracetam is available in China as adjunctive oral therapy for partial-onset seizures. This study was conducted to evaluate the bioequivalence between single-dose intravenous infusion and oral levetiracetam 1500 mg (Part A), and to assess the pharmacokinetics of multiple-dose intravenous infusion at the same dose (Part B) in healthy Chinese subjects. Methods Part A was an open-label, crossover comparison (intravenous vs. oral), while Part B was a double-blind, parallel-group study of intravenous levetiracetam versus intravenous placebo administered for 5 days. Results Bioequivalence was demonstrated between the 45-min intravenous infusion and oral tablets, with geometric mean area under the plasma concentration-time curve (AUC) from time 0 to infinity (AUC(infinity)) 492.3 and 506.8 mu g.h/mL, and geometric mean maximum concentration (C-max) 65.12 and 55.93 mu g/mL for intravenous infusion and oral dosing, respectively. Linear pharmacokinetics were demonstrated (geometric least-squares mean AUC during the dosing interval tau at steady state (AUC(tau,ss)) 475.6 mu g.h/mL; geometric least-squares mean AUC(infinity) after single dose 501.7 mu ga.h/mL; linearity factor = 0.948). Geometric mean C-max (77.44 mu g/mL) and AUC (tau,ss) (475.6 mu g.h/mL) of intravenous infusion levetiracetam 1500 mg after multiple doses were within the expected range, based on their respective single-dose values and the terminal half-life of levetiracetam after a single dose (7.13 h). A theoretical accumulation of approximately 40 % would be expected after multiple doses, which is consistent with the calculated accumulation of 18.0 and 43.5 % (R-max and R-AUC, respectively). Conclusions Intravenous infusion of levetiracetam is bioequivalent to oral levetiracetam in healthy Chinese subjects and is a suitable alternative for levetiracetam administration in patients who are temporarily unable to take their medication orally.	[Toublanc, Nathalie; Stockis, Armel] UCB Pharma, B-1420 Braine Lalleud, Belgium; [Du, Xinlu] UCB Pharma, Shanghai, Peoples R China; [Liu, Yun; Chen, Qian] Shanghai Xuhui Cent Hosp, Shanghai, Peoples R China; [Singh, Pritibha] UCB Pharma, Monheim, Germany; [Chan, Robert] UCB Pharma, Tokyo, Japan	Toublanc, N (reprint author), UCB Pharma, Chemin Foriest, B-1420 Braine Lalleud, Belgium.	Nathalie.Toublanc@ucb.com			UCB Pharma	This study was funded by UCB Pharma, who were involved in the design and conduct of the study, and collection, management, and analysis of the data.	Perucca E, 2003, EPILEPSY RES, V53, P47, DOI 10.1016/S0920-1211(02)00250-4; Ramael S, 2006, CLIN THER, V28, P734, DOI 10.1016/j.clinthera.2006.05.004; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; Patsalos PN, 2000, PHARMACOL THERAPEUT, V85, P77, DOI 10.1016/S0163-7258(99)00052-2; Baulac M, 2007, EPILEPSIA, V48, P589, DOI 10.1111/j.1528-1167.2006.00959.x; Stockis Armel, 2009, Expert Rev Clin Pharmacol, V2, P339, DOI 10.1586/ecp.09.16; Yamamoto J, 2014, CLIN DRUG INVEST, V34, P819, DOI 10.1007/s40261-014-0237-7; Zhao Q, 2007, BRIT J CLIN PHARMACO, V63, P614, DOI 10.1111/j.1365-2125.2006.02782.x	8	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-2563	1179-1918		CLIN DRUG INVEST	Clin. Drug Invest.	AUG	2015	35	8					495	503		10.1007/s40261-015-0303-9		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CN8BM	WOS:000358661800003		
J	Nishida, M; Shigematsu, A; Sato, M; Kudo, Y; Omotehara, S; Horie, T; Iwai, T; Endo, T; Iguchi, A; Shibuya, H; Hatanaka, K; Shimizu, C; Teshima, T				Nishida, Mutsumi; Shigematsu, Akio; Sato, Megumi; Kudo, Yusuke; Omotehara, Satomi; Horie, Tatsunori; Iwai, Takahito; Endo, Tomoyuki; Iguchi, Akihiro; Shibuya, Hitoshi; Hatanaka, Kanako; Shimizu, Chikara; Teshima, Takanori			Ultrasonographic evaluation of gastrointestinal graft-versus-host disease after hematopoietic stem cell transplantation	CLINICAL TRANSPLANTATION			English	Article						color Doppler; gastrointestinal tract; graft-versus-host disease; hematopoietic stem cell transplantation; methylprednisolone; ultrasonography	CONTRAST-ENHANCED ULTRASOUND; INTESTINAL GRAFT; RECTAL BIOPSY; BONE-MARROW; ACUTE GVHD; SONOGRAPHY; CT; COMPLICATIONS; TOMOGRAPHY; BOWEL	Gastrointestinal graft-versus-host disease (GI-GVHD) is a major and life-threatening complication of hematopoietic stem cell transplantation (HSCT). This study evaluated the efficacy of ultrasonography (US) for assessing and monitoring GI-GVHD. GI tract was evaluated by US in 81 patients. US findings were positive in 43 patients, including 11 false positive, and negative in 38 patients. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of US for the diagnosis of GI-GVHD were 100%, 78%, 74%, 100%, and 86%, respectively. Diffuse wall thickening of the ileum was the most frequent finding in patients with GI-GVHD. Severity of GI-GVHD was correlated with the thickness of internal low echoic layer of the wall, the echogenicity of mesenteric fat tissue, and the intensity of Doppler signaling. We classified US findings of GI-GVHD into four USgrades. There was a significant correlation between clinical stage of GI-GVHD and the US grade. These ultrasonographic abnormalities were improved with clinical improvement of GI-GVHD upon treatment. Thus, US is an effective and efficient non-invasive means of identifying the extent and severity of GI-GVHD and monitoring response to treatment.	[Nishida, Mutsumi; Shigematsu, Akio; Kudo, Yusuke; Omotehara, Satomi; Iwai, Takahito; Shibuya, Hitoshi; Shimizu, Chikara] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido 0608648, Japan; [Nishida, Mutsumi; Sato, Megumi; Kudo, Yusuke; Omotehara, Satomi; Horie, Tatsunori; Iwai, Takahito] Hokkaido Univ Hosp, Diagnost Ctr Sonog, Sapporo, Hokkaido 0608648, Japan; [Shigematsu, Akio; Endo, Tomoyuki; Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido 060, Japan; [Sato, Megumi; Horie, Tatsunori] Hokkaido Univ Hosp, Dept Radiol Technol, Sapporo, Hokkaido 0608648, Japan; [Iguchi, Akihiro] Hokkaido Univ Hosp, Dept Pediat, Sapporo, Hokkaido 0608648, Japan; [Hatanaka, Kanako] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 0608648, Japan	Nishida, M (reprint author), Hokkaido Univ Hosp, Div Lab & Transfus Med, Kita Ku, N14 W5, Sapporo, Hokkaido 0608648, Japan.	mutuni@med.hokudai.ac.jp			JSPS KAKENHI [25293217]; Health and Labor Science Research Grant	This study was partly supported by JSPS KAKENHI (25293217 to T.T.) and a Health and Labor Science Research Grant (T.T.).	AIBE T, 1986, SCAND J GASTROENTERO, V21, P6, DOI 10.3109/00365528609091857; Dignan FL, 2012, BRIT J HAEMATOL, V158, P30, DOI 10.1111/j.1365-2141.2012.09129.x; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; SALE GE, 1979, AM J SURG PATHOL, V3, P291, DOI 10.1097/00000478-197908000-00001; Kirkpatrick IDC, 2003, RADIOLOGY, V226, P668, DOI 10.1148/radiol.2263011932; Stelljes M, 2008, BLOOD, V111, P2909, DOI 10.1182/blood-2007-10-119164; Yoshida S, 2005, ABDOM IMAGING, V30, P518, DOI 10.1007/s00261-004-0287-z; EPSTEIN RJ, 1980, GASTROENTEROLOGY, V78, P764; KIMMEY MB, 1989, GASTROENTEROLOGY, V96, P433; Horton KM, 2000, RADIOGRAPHICS, V20, P399; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Benedetti E, 2013, BONE MARROW TRANSPL, V48, P1421, DOI 10.1038/bmt.2013.65; DOHMEN K, 1991, J CLIN ULTRASOUND, V19, P321, DOI 10.1002/jcu.1870190602; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Haber HP, 2000, AM J ROENTGENOL, V174, P118; JONES B, 1986, AM J ROENTGENOL, V146, P691; Klein SA, 2001, BRIT J HAEMATOL, V115, P929, DOI 10.1046/j.1365-2141.2001.03221.x; Nishida M, 2002, J MED ULTRASON, V29, P153; Schreyer AG, 2011, BONE MARROW TRANSPL, V46, P1006, DOI 10.1038/bmt.2010.232; Sey MSL, 2013, J ULTRAS MED, V32, P1413, DOI 10.7863/ultra.32.8.1413; Shimoni A, 2012, BRIT J RADIOL, V85, pE416, DOI 10.1259/bjr/60038597; Yamanaka T, 2002, DIGEST ENDOSC, V14, P39, DOI 10.1046/j.1443-1661.2002.00163.x	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0902-0063	1399-0012		CLIN TRANSPLANT	Clin. Transplant.	AUG	2015	29	8					697	704		10.1111/ctr.12570		8	Surgery; Transplantation	Surgery; Transplantation	CN5QZ	WOS:000358485700006		
J	Fukuyama, K; Kuri, N				Fukuyama, Katusi; Kuri, Noriyuki			The central limit theorem for complex Riesz-Raikov sums	COMPTES RENDUS MATHEMATIQUE			English	Article							ITERATED LOGARITHM; LAW	For complex Riesz-Raikov sums, the central limit theorem is proved. As a byproduct, metric discrepancy results are proved for complex geometric progressions. (C) 2015 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.	[Fukuyama, Katusi; Kuri, Noriyuki] Kobe Univ, Dept Math, Kobe, Hyogo 6578501, Japan	Fukuyama, K (reprint author), Kobe Univ, Dept Math, Kobe, Hyogo 6578501, Japan.	fukuyama@math.kobe-u.ac.jp; nrkuri@math.kobe-u.ac.jp			KAKENHI [24340017, 24340020]	The first author is supported by KAKENHI 24340017 and 24340020.	Aistleitner C, 2010, T AM MATH SOC, V362, P5967; Fukuyama K, 2008, ACTA MATH HUNG, V118, P155, DOI 10.1007/s10474-007-6201-8; Conze JP, 2012, DISCRETE CONT DYN-A, V32, P1597, DOI 10.3934/dcds.2012.32.1597; FUKUYAMA K, 1994, PROBAB THEORY REL, V100, P57, DOI 10.1007/BF01204953; Fukuyama K., 2012, RIMS KOKYUROKU BES B, VB29, P45; Fukuyama K., 2010, DEPENDENCE PROBABILI, P233; KAC M, 1946, ANN MATH, V47, P33, DOI 10.2307/1969033; KOMLOS J, 1972, ACTA SCI MATH, V33, P237; Leonov V.P., 1964, SOME APPL HIGHER SEM; Lobbe T., 2014, ARXIV14082202V1; MONRAD D, 1991, PROBAB THEORY REL, V88, P381, DOI 10.1007/BF01418867; MORICZ F, 1976, ACTA SCI MATH, V38, P127; PETIT B, 1992, PROBAB THEORY REL, V93, P407, DOI 10.1007/BF01192715; Philipp W., 1977, ANN PROBAB, V5, P319, DOI 10.1214/aop/1176995795; Zaremba S. K., 1968, ANN POL MATH, V21, P85	15	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1631-073X	1778-3569		CR MATH	C. R. Math.	AUG	2015	353	8					749	753		10.1016/j.crma.2015.04.020		5	Mathematics	Mathematics	CO0BT	WOS:000358815800016		
J	Shimojima, K; Okamoto, N; Yamamoto, T				Shimojima, Keiko; Okamoto, Nobuhiko; Yamamoto, Toshiyuki			Characteristics of 2p15-p16.1 microdeletion syndrome: Review and description of two additional patients	CONGENITAL ANOMALIES			English	Review						2p15-p16; 1 microdeletion syndrome; autistic features; intellectual disability; USP34; XPO1	MB DELETION; 2P15-16.1; HAPLOINSUFFICIENCY; MECHANISMS; DISEASE; TARGET; 2P15; XPO1	Many new microdeletion syndromes have been characterized in the past decade, including 2p15-p16.1 microdeletion syndrome. More than 10 patients with this syndrome have been described. Recently, we encountered two additional patients with 2p15-p16.1 microdeletion syndrome. All patients showed variable degrees of intellectual disability, with the autistic features characteristic of this syndrome. Seven out of 16 patients (44%) showed structural abnormalities in the brain, which is also an important feature of this syndrome. The shortest region of microdeletion overlap among the patients includes two genes, USP34 and XPO1. Although these genes have some functional relevance to cancer, they have not been associated with neurological functions. Diagnosis of additional patients with 2p15-p16.1 microdeletion syndrome and identification of pathogenic mutations in this region will help identify the genes responsible for the neurological features of the syndrome.	[Shimojima, Keiko; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan	Yamamoto, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ward, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamamoto.toshiyuki@twmu.ac.jp			Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST), Kawaguchi, Japan; Japan Society for the Promotion of Science (JSPS) [24791090]; Japan Epilepsy Research Foundation (JERF); Kanae Foundation for the promotion of Medical Science in Japan; Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan	We would like to express our gratitude to the patients and their families for their cooperation. This work was mainly supported by a grant from the Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST), Kawaguchi, Japan and was partially supported by a Grant-in-Aid for Young Scientists (B) (24791090), from the Japan Society for the Promotion of Science (JSPS), a grant from the Japan Epilepsy Research Foundation (JERF), and a grant from the Kanae Foundation for the promotion of Medical Science in Japan (KS), and a Grant-in-Aid for Scientific Research from Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan (TY).	Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Chabchoub E, 2008, J MED GENET, V45, P189, DOI 10.1136/jmg.2007.056176; Liang JS, 2009, J MED GENET, V46, P645, DOI 10.1136/jmg.2008.059220; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Shimojima K, 2012, J HUM GENET, V57, P593, DOI 10.1038/jhg.2012.77; Felix TM, 2010, AM J MED GENET A, V152A, P2604, DOI 10.1002/ajmg.a.33612; Piccione M, 2012, EUR J MED GENET, V55, P238, DOI 10.1016/j.ejmg.2012.01.014; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Prontera P, 2011, AM J MED GENET A, V155A, P2473, DOI 10.1002/ajmg.a.33875; Fannemel M, 2014, EUR J MED GENET, V57, P513, DOI 10.1016/j.ejmg.2014.05.008; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; desLeeuw N, 2008, J MED GENET, V45, P122; Florisson JMG, 2013, AM J MED GENET A, V161A, P244, DOI 10.1002/ajmg.a.35632; Hancarova M, 2013, AM J MED GENET A, V161A, P865, DOI 10.1002/ajmg.a.35783; Hucthagowder V, 2012, EUR J MED GENET, V55, P485, DOI 10.1016/j.ejmg.2012.04.003; Jorgez CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107028; Kau TR, 2003, DRUG DISCOV TODAY, V8, P78, DOI 10.1016/S1359-6446(02)02562-X; Muqbil I, 2014, CURR PHARM DESIGN, V20, P56; Nevado J, 2014, GENET MOL BIOL, V37, P210, DOI 10.1590/S1415-47572014000200007; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Wohlleber E, 2011, EUR J MED GENET, V54, P67, DOI 10.1016/j.ejmg.2010.09.012	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	AUG	2015	55	3					125	132		10.1111/cga.12112		8	Pediatrics	Pediatrics	CN6FR	WOS:000358530200001		
J	Kitamura, A; Miyauchi, N; Hamada, H; Hiura, H; Chiba, H; Okae, H; Sato, A; John, RM; Arima, T				Kitamura, Akane; Miyauchi, Naoko; Hamada, Hirotaka; Hiura, Hitoshi; Chiba, Hatsune; Okae, Hiroaki; Sato, Akiko; John, Rosalind M.; Arima, Takahiro			Epigenetic alterations in sperm associated with male infertility	CONGENITAL ANOMALIES			English	Review						assisted reproductive technologies; DNA methylation; genomic imprinting; genomic imprinting disorders; male infertility	ASSISTED REPRODUCTIVE TECHNOLOGY; BECKWITH-WIEDEMANN-SYNDROME; IN-VITRO FERTILIZATION; SILVER-RUSSELL-SYNDROME; DNA METHYLATION ERRORS; PRADER-WILLI-SYNDROME; IMPRINTED GENES; ANGELMAN-SYNDROME; SEMEN QUALITY; POLYCHLORINATED-BIPHENYLS	The most common form of male infertility is a low sperm count, known as oligozoospermia. Studies suggest that oligozoospermia is associated with epigenetic alterations. Epigenetic alterations in sperm, which may arise due to the exposure of gametes to environmental factors or those that pre-exist in the sperm of infertile individuals, may contribute to the increased incidence of normally rare imprinting disorders in babies conceived after assisted reproductive technology using the sperm of infertile men. Genomic imprinting is an important developmental process whereby the allelic activity of certain genes is regulated by DNA methylation established during gametogenesis. The aberrant expression of several imprinted genes has been linked to various diseases, malignant tumors, lifestyle and mental disorders in humans. Understanding how infertility and environmental factors such as reproductive toxicants, certain foods, and drug exposures during gametogenesis contribute to the origins of these disorders via defects in sperm is of paramount importance. In this review, we discuss the association of epigenetic alterations with abnormal spermatogenesis and the evidence that epigenetic processes, including those required for genomic imprinting, may be sensitive to environmental exposures during gametogenesis, fertilization and early embryonic development. In addition, we review imprinting diseases and their relationships with environmental factors. While the plasticity of epigenetic marks may make these more susceptible to modification by the environment, this also suggests that aberrant epigenetic marks may be reversible. A greater understanding of this process and the function of epidrugs may lead to the development of new treatment methods for many adult diseases in the future.	[Kitamura, Akane; Miyauchi, Naoko; Hamada, Hirotaka; Hiura, Hitoshi; Chiba, Hatsune; Okae, Hiroaki; Sato, Akiko; Arima, Takahiro] Tohoku Univ Grad Sch Med, Dept Informat Genet, Environm & Genome Res Ctr, Sendai, Miyagi 9808575, Japan; [John, Rosalind M.] Cardiff Sch Biosci, Cardiff, S Glam, Wales	Arima, T (reprint author), Tohoku Univ Grad Sch Med, Dept Informat Genet, Environm & Genome Res Ctr, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	tarima@med.tohoku.ac.jp			Ministry of Health, Labour and Welfare of the Japanese Government [26310301]; Scientific Research (KAKENHI) [25670691, 24613001, 26870036, 26870033]; Takeda Science Foundation	This work was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare of the Japanese Government (Health Labour Sciences Research Grant, Research on Measures for Intractable Diseases 26310301), Scientific Research (KAKENHI) (Exploratory Research 25670691, Scientific Research (C) 24613001, Grant-in-Aid for Young Scientists (B), 26870036, 26870033), as well as the Takeda Science Foundation (TA).	Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Andrews SC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-53; Boissonnas CC, 2013, FERTIL STERIL, V99, P624, DOI 10.1016/j.fertnstert.2013.01.124; Kagami M, 2007, J ASSIST REPROD GEN, V24, P131, DOI 10.1007/s10815-006-9096-3; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Hiura H, 2012, HUM REPROD, V27, P2541, DOI 10.1093/humrep/des197; Sato A, 2007, HUM REPROD, V22, P26, DOI 10.1093/humrep/del316; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Lillycrop KA, 2005, J NUTR, V135, P1382; Gosden R, 2003, LANCET, V361, P1975, DOI 10.1016/S0140-6736(03)13592-1; Chang AS, 2005, FERTIL STERIL, V83, P349, DOI 10.1016/j.fernstert.2004.07.964; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Bowdin S, 2007, HUM REPROD, V22, P3237, DOI 10.1093/humrep/dem268; Chiba H, 2013, PEDIATR INT, V55, P542, DOI 10.1111/ped.12185; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Carrell DT, 2001, J ANDROL, V22, P604; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Maher ER, 2005, HUM MOL GENET, V14, pR133, DOI 10.1093/hmg/ddi107; Carrell DT, 2007, HUM REPROD UPDATE, V13, P313, DOI 10.1093/humupd/dm1057; Ludwig M, 2005, J MED GENET, V42, P289, DOI 10.1136/jmg.2004.026930; Keck C, 1998, HUM REPROD UPDATE, V4, P891, DOI 10.1093/humupd/4.6.891; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kallen B, 2010, BIRTH DEFECTS RES A, V88, P137, DOI 10.1002/bdra.20645; Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Lee J, 2002, DEVELOPMENT, V129, P1807; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Lim D, 2009, HUM REPROD, V24, P741, DOI 10.1093/humrep/den406; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Benchaib M, 2003, FERTIL STERIL, V80, P947, DOI 10.1016/S0015-0282(03)01151-8; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Doornbos ME, 2007, HUM REPROD, V22, P2476, DOI 10.1093/humrep/dem172; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Kobayashi H, 2009, EUR J HUM GENET, V17, P1582, DOI 10.1038/ejhg.2009.68; Rossignol S, 2006, J MED GENET, V43, P902, DOI 10.1136/jmg.2006.042135; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Hata K, 2002, DEVELOPMENT, V129, P1983; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/88313; Sutcliffe AG, 2006, HUM REPROD, V21, P1009, DOI 10.1093/humrep/dei405; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1; WOLFF H, 1995, FERTIL STERIL, V63, P1143; Ushijima T, 2006, J GASTROENTEROL, V41, P401, DOI 10.1007/s00535-006-1846-6; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Carrell DT, 1999, FERTIL STERIL, V71, P511, DOI 10.1016/S0015-0282(98)00498-1; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Dada R, 2012, J ASSIST REPROD GEN, V29, P213, DOI 10.1007/s10815-012-9715-0; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Aoki VW, 2005, HUM REPROD, V20, P1298, DOI 10.1093/humrep/deh798; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; John RM, 2011, DIFFERENTIATION, V81, P270, DOI 10.1016/j.diff.2011.01.007; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Orstavik KH, 2003, AM J HUM GENET, V72, P218, DOI 10.1086/346030; Horsthemke B, 2006, CYTOGENET GENOME RES, V113, P292, DOI 10.1159/000090844; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; Bale Tracy L, 2014, Dialogues Clin Neurosci, V16, P297; BALHORN R, 1988, EXPERIENTIA, V44, P52, DOI 10.1007/BF01960243; Barlow D. P., 2014, COLD SPRING HARB PER, V6, DOI DOI 10.1101/CSHPERSPECT.A018382; BELOKOPYTOVA IA, 1993, MOL REPROD DEV, V34, P53, DOI 10.1002/mrd.1080340109; Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; Bonaldi A, 2011, AM J MED GENET A, V155A, P2479, DOI 10.1002/ajmg.a.34023; Bonde JP, 2008, ENVIRON HEALTH PERSP, V116, P269, DOI 10.1289/ehp.10700; CHEVAILLIER P, 1987, LANCET, V2, P806; Cleaton MAM, 2014, ANNU REV GENOM HUM G, V15, P93, DOI 10.1146/annurev-genom-091212-153441; Cumming JA, 2009, FERTIL STERIL, V91, P1486, DOI 10.1016/j.fertnstert.2008.07.1756; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; Emiliani S, 2000, HUM REPROD, V15, P2371, DOI 10.1093/humrep/15.11.2371; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Galli-Tsinopoulou A, 2008, HORM-INT J ENDOCRINO, V7, P77; Gianotten J, 2003, MOL HUM REPROD, V9, P587, DOI 10.1093/moleht/gag081; Gold JA, 2014, GENET MED, V16, P164, DOI 10.1038/gim.2013.97; Guo YL, 2000, LANCET, V356, P1240, DOI 10.1016/S0140-6736(00)02792-6; Hartmann S, 2006, MOL HUM REPROD, V12, P407, DOI 10.1093/molehr/ga1040; Haugen V, 2011, J WOUND OSTOMY CONT, V38, P155, DOI 10.1097/WON.0b013e31820ad0fd; Hiura Hitoshi, 2014, Reproductive Medicine and Biology, V13, P193, DOI 10.1007/s12522-014-0183-3; Honda S, 2001, BIOCHEM BIOPH RES CO, V282, P493, DOI 10.1006/bbrc.2001.4585; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Jacob KJ, 2013, CLIN GENET, V84, P326, DOI 10.1111/cge.12143; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Kondrashov A, 2012, NATURE, V488, P467, DOI 10.1038/488467a; Korrovits P, 2008, UROLOGY, V71, P1010, DOI 10.1016/j.urology.2007.12.082; Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P336, DOI 10.1053/j.spid.2005.07.001; Manning M, 2001, INT J ANDROL, V24, P87, DOI 10.1046/j.1365-2605.2001.00274.x; Marques CJ, 2010, FERTIL STERIL, V94, P585, DOI 10.1016/j.fertnstert.2009.02.051; McAuliffe ME, 2012, HUM REPROD, V27, P2918, DOI 10.1093/humrep/des302; Miura K, 2005, J HUM GENET, V50, P1, DOI 10.1007/s10038-004-0216-6; Moll AC, 2003, LANCET, V361, P309, DOI 10.1016/S0140-6736(03)12332-X; Razavi S, 2003, ANDROLOGIA, V35, P238, DOI 10.1046/j.1439-0272.2003.00566.x; Richthoff J, 2003, ENVIRON HEALTH PERSP, V111, P409, DOI 10.1289/ehp.5767; Sato A, 2011, FERTIL STERIL, V95, P129, DOI 10.1016/j.fertnstert.2010.06.076; Shimizu Y, 2004, ULTRASOUND OBST GYN, V24, P208, DOI 10.1002/uog.1088; Svensson J, 2005, ACTA PAEDIATR, V94, P1163, DOI 10.1080/08035250510030125; Thompson JR, 2005, SEMIN REPROD MED, V23, P285, DOI 10.1055/s-2005-872457; Toft G, 2005, ECOTOX ENVIRON SAFE, V60, P15, DOI 10.1016/j.ecoenv.2004.07.010; Toft G, 2006, EPIDEMIOLOGY, V17, P450, DOI 10.1097/01.ede.0000221769.41028.d2; Tunster SJ, 2011, DIS MODEL MECH, V4, P814, DOI 10.1242/dmm.007328; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; vansMontfoort AP, 2012, HUM REPROD UPDATE, V18, P171; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151	131	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	AUG	2015	55	3					133	144		10.1111/cga.12113		12	Pediatrics	Pediatrics	CN6FR	WOS:000358530200002		
J	Okamoto, T; Nagaya, K; Kawata, Y; Asai, H; Tsuchida, E; Nohara, F; Okajima, K; Azuma, H				Okamoto, Toshio; Nagaya, Ken; Kawata, Yumi; Asai, Hiroko; Tsuchida, Etsushi; Nohara, Fumikatsu; Okajima, Kazuki; Azuma, Hiroshi			Novel compound heterozygous mutations in DYNC2H1 in a patient with severe short-rib polydactyly syndrome type III phenotype	CONGENITAL ANOMALIES			English	Article						DYNC2H1; dynein; microtubule binding; phenotype-genotype correlation; short-rib polydactyly syndrome type III	ASPHYXIATING THORACIC DYSTROPHY; DYNEIN MOTOR DOMAIN; TRANSPORT PROTEIN; CRYSTAL-STRUCTURE; DISORDER	Short-rib polydactyly syndrome type III is an autosomal recessive lethal skeletal ciliopathy, which is phenotypically similar to nonlethal asphyxiating thoracic dystrophy. Mutations in DYNC2H1 have been identified in both of these disorders, indicating that they are variants of a single disorder. However, short-rib polydactyly syndrome type III is the more severe variant. Here, we report novel compound heterozygous mutations in DYNC2H1 (p.E1894fsX10 and p.R3004C) in a patient with typical short-rib polydactyly syndrome type III phenotype. R3004 is located within the microtubule-binding domain of DYNC2H1, and its substitution is predicted to disrupt the interaction with microtubules. Considering the severe phenotype of our patient, our findings suggest that R3004 may be a key residue for the microtubule-binding affinity of dynein.	[Okamoto, Toshio; Nagaya, Ken; Kawata, Yumi; Asai, Hiroko; Tsuchida, Etsushi; Nohara, Fumikatsu; Okajima, Kazuki; Azuma, Hiroshi] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido 0788510, Japan	Okamoto, T (reprint author), Asahikawa Med Univ, Dept Pediat, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	toshio5p@asahikawa-med.ac.jp					Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; McInerney-Leo AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/j.ajhg.2013.06.022; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Huber C, 2013, AM J HUM GENET, V93, P926, DOI 10.1016/j.ajhg.2013.10.007; Baujat G, 2013, J MED GENET, V50, P91, DOI 10.1136/jmedgenet-2012-101282; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Cavalcanti DP, 2011, J MED GENET, V48, P88, DOI 10.1136/jmg.2009.069468; Schmidts M, 2013, AM J HUM GENET, V93, P932, DOI 10.1016/j.ajhg.2013.10.003; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; MEIZNER I, 1995, PRENATAL DIAG, V15, P665, DOI 10.1002/pd.1970150713; NAUMOFF P, 1977, RADIOLOGY, V122, P443; Verma I C, 1975, Birth Defects Orig Artic Ser, V11, P167; WU MH, 1995, AM J MED GENET, V55, P279, DOI 10.1002/ajmg.1320550307	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	AUG	2015	55	3					155	157		10.1111/cga.12098		3	Pediatrics	Pediatrics	CN6FR	WOS:000358530200005		
J	Hayashi, Y; Suzumori, N; Sugiura, T; Sugiura-Ogasawara, M				Hayashi, Yuko; Suzumori, Nobuhiro; Sugiura, Tokio; Sugiura-Ogasawara, Mayumi			Prenatal findings of holoprosencephaly	CONGENITAL ANOMALIES			English	Article						chromosome; holoprosencephaly; prenatal diagnosis; ultrasound		Holoprosencephaly (HPE) is a rare brain abnormality characterized by an incomplete cleavage of the primitive prosencephalon of forebrain during early embryogenesis. To determine the clinical characteristics and outcome of fetuses with HPE, we retrospectively analyzed nine patients who were prenatally diagnosed as fetal HPE by ultrasounds. The mean diagnostic weeks were 20 weeks of gestation. Two cases died within one day after birth. The chromosomal examinations were performed in seven cases (trisomy 18: n=2; trisomy 13: n=2; 45,XX,der(18)t(18;21)(p10;p10)mat: n=1; normal karyotype: n=2). In our HPE cases, most cases had serious facial anomalies and poor prognosis. Our data suggested that the early prenatal diagnosis of HPE allowed time for parental counseling and delivery planning.	[Hayashi, Yuko; Suzumori, Nobuhiro; Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Hayashi, Yuko; Suzumori, Nobuhiro; Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Div Clin & Mol Genet, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Sugiura, Tokio] Nagoya City Univ, Dept Pediat & Neonatol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Hayashi, Yuko] Nagoya East Med Ctr, Dept Obstet & Gynecol, Nagoya, Aichi, Japan	Suzumori, N (reprint author), Nagoya City Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Mizuho Ku, Kawasumi 1,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	og.n.suz@med.nagoya-cu.ac.jp					DEMYER W, 1964, PEDIATRICS, V34, P256; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; Gekas Jean, 2012, J Prenat Med, V6, P36; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; Roach E, 1975, Birth Defects Orig Artic Ser, V11, P294; Roessler E, 2012, MOL GENET METAB, V105, P658, DOI 10.1016/j.ymgme.2012.01.005; Sepulveda W, 2009, J ULTRAS MED, V28, P1077; Solomon B. D., 2012, MOL SYNDROMOL, V3, P140, DOI DOI 10.1159/000341253); Suzumori N, 2015, J GENET COUNS, V24, P117, DOI 10.1007/s10897-014-9744-1	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	AUG	2015	55	3					161	163		10.1111/cga.12103		3	Pediatrics	Pediatrics	CN6FR	WOS:000358530200007		
J	Kiyokoba, R; Hidaka, N; Sakata, Y; Hachisuga, K; Fukushima, K; Kato, K				Kiyokoba, Ryo; Hidaka, Nobuhiro; Sakata, Yukiyo; Hachisuga, Kazuhisa; Fukushima, Kotaro; Kato, Kiyoko			Fetal cytomegalovirus infection manifesting as transient pancytopenia	CONGENITAL ANOMALIES			English	Article						cytomegalovirus; fetal blood transfusion; pancytopenia; phagocytosis	CELLS	We encountered a patient with a fetal cytomegalovirus infection manifesting as pancytopenia and thoracic hypoplasia. The fetal anemia was treated by transfusion via the umbilical cord, and did not progress after 22 weeks' gestation. The neutropenia resolved spontaneously, and only thrombocytopenia was persistent at birth. The severe thoracic hypoplasia led to pulmonary hypertension and required intensive postnatal respiratory management. Our experience suggests that pancytopenia is a possible manifestation in fetuses infected with cytomegalovirus. This may be transient, resolving spontaneously during fetal life; however, caution should be taken with blood counts, particularly platelet counts, after delivery. In addition, clinicians should carefully follow the thoracic volume in cytomegalovirus-infected fetuses and consider the possibility of postnatal severe respiratory insufficiency.	[Kiyokoba, Ryo; Hidaka, Nobuhiro; Sakata, Yukiyo; Hachisuga, Kazuhisa; Fukushima, Kotaro; Kato, Kiyoko] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka 8128582, Japan	Hidaka, N (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hidaka.nobuhiro.484@m.kyushu-u.ac.jp					AlmeidaPorada GD, 1996, LEUKEMIA LYMPHOMA, V21, P217; Koklu E, 2009, EUR J PEDIATR, V168, P1409, DOI 10.1007/s00431-009-0941-0; Malm G, 2007, SEMIN FETAL NEONAT M, V12, P154, DOI 10.1016/j.siny.2007.01.012; DROSE JA, 1991, RADIOLOGY, V178, P369; FONG K, 1988, AM J OBSTET GYNECOL, V158, P1154; Hernandez-Andrade E, 2004, ULTRASOUND OBST GYN, V23, P442, DOI 10.1002/uog.1009; MACIEJEWSKI JP, 1992, BLOOD, V80, P170; MANDELBROT L, 1988, Fetal Therapy, V3, P60; SIMMONS P, 1990, P NATL ACAD SCI USA, V87, P1386, DOI 10.1073/pnas.87.4.1386	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	AUG	2015	55	3					164	166		10.1111/cga.12104		3	Pediatrics	Pediatrics	CN6FR	WOS:000358530200008		
J	Takenouchi, T; Awazu, M; Eggermann, T; Kosaki, K				Takenouchi, Toshiki; Awazu, Midori; Eggermann, Thomas; Kosaki, Kenjiro			Adult phenotype of Russell-Silver syndrome: A molecular support for Barker-Brenner's theory	CONGENITAL ANOMALIES			English	Article						adult-onset diseases; developmental origins of health and disease; epigenetics; insulin-like growth factor 2; russell-silver syndrome	DISEASE; 11P15	Developmental Origins of Health and Disease theory stems from large-scale epidemiologic observation. The presumed mechanism for this hypothesis includes epigenetic changes; however, it remains to be elucidated if individuals with intrauterine growth retardation and epigenetic changes confirmed at the molecular level are indeed susceptible to adult-onset disease. Here we document three individuals with Russell-Silver syndrome, a prototypic condition caused by hypomethylation of the differently methylated imprinting center region 1 (ICR1) between the IGF2 and H19 loci on chromosome 11p15. At follow-up, the three patients developed adult-onset diseases such as obesity, hypertension, and diabetes mellitus in their early 20s. The presence of molecularly confirmed epigenetic changes in these patients provides a biological basis for Barker-Brenner's theory at an individual level.	[Takenouchi, Toshiki; Awazu, Midori] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Takenouchi, Toshiki; Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo 1608582, Japan; [Eggermann, Thomas] Rhein Westfal TH Aachen, Inst Human Genet, Aachen, Germany	Kosaki, K (reprint author), Keio Univ, Sch Med, Ctr Med Genet, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kkosaki@z3.keio.jp			Ministry of Health, Labour and Welfare, Japan	This work was supported by research on rare and intractable diseases from the Ministry of Health, Labour and Welfare, Japan.	BARKER DJP, 1989, LANCET, V2, P577; BRENNER BM, 1988, AM J HYPERTENS, V1, P335; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Eggermann T, 2008, CLIN GENET, V73, P79, DOI 10.1111/j.1399-0004.2007.00930.x; Yoshihashi H, 2000, AM J HUM GENET, V67, P476, DOI 10.1086/302997	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	AUG	2015	55	3					167	169		10.1111/cga.12105		3	Pediatrics	Pediatrics	CN6FR	WOS:000358530200009		
J	Ariyasu, S; Yanai, H; Sato, M; Shinno, Y; Taniguchi, K; Yamadori, I; Miki, Y; Sato, Y; Yoshino, T; Takahashi, K				Ariyasu, S.; Yanai, H.; Sato, M.; Shinno, Y.; Taniguchi, K.; Yamadori, I.; Miki, Y.; Sato, Y.; Yoshino, T.; Takahashi, K.			Simultaneous immunostaining with anti-S100P and anti-SV40 antibodies revealed the origin of BK virus-infected decoy cells in voided urine samples	CYTOPATHOLOGY			English	Article						BK virus-infected cells; S100P; SV40; simultaneous immunostaining; urine cytology	POLYOMAVIRUS-ASSOCIATED NEPHROPATHY; TRANSPLANT RECIPIENTS; RENAL-TRANSPLANTATION; UROTHELIAL CARCINOMA; CYTOLOGY; DIFFERENTIATION; ALLOGRAFTS; DIAGNOSIS; DISEASE; UPDATE	BackgroundMethods for determining the origin of BK virus (BKV)-infected cells (decoy cells) in clinical urine samples have not been established although they could enhance the diagnosis of BKV infection in immunocompromised patients. MethodsWe performed simultaneous immunostaining with anti-S100P (a urothelial marker) and anti-SV40 antibodies in 66 clinical urine samples exhibiting SV40 positivity and a decoy-cell appearance on Papanicolaou staining. The clinical voided urine samples included seven cases of renal transplantation, 47 cases of cancer therapy and 12 cases of non-neoplastic disease. SurePath liquid-based cytology was used for the urine samples. ResultsBKV-infected cells were categorized as SV40(+)/S100P(+) and SV40 (+)/S100p(-). SV40(+)/S100P(-) cells were found in 55 cases (83.4%); nine cases (13.6%) carried both SV40(+)/S100P(-) and SV40(+)/S100P(+) cells. The former were identified as BKV infection in renal tubules and the latter in both the renal tubules and urothelial epithelia. The remaining two cases (3.0%) had only SV40(+)/S100P(+) cells of urothelial origin. ConclusionSimultaneous immunostaining with anti-S100P and anti-SV40 is a useful method for determining the origin of BKV-infected cells in clinical urine samples from immunocompromised patients such as renal transplantation recipients.	[Ariyasu, S.; Sato, Y.; Takahashi, K.] Okayama Univ, Grad Sch Hlth Sci, Dept Med Technol, Okayama, Japan; [Ariyasu, S.; Shinno, Y.; Taniguchi, K.] Okayama Med Ctr, Natl Hosp Org, Dept Clin Lab, Okayama, Okayama 7011192, Japan; [Yanai, H.] Okayama Univ Hosp, Dept Pathol, Okayama, Japan; [Sato, M.] Shikoku Canc Ctr, Dept Clin Lab, Natl Hosp Org, Mastuyama, Japan; [Yamadori, I.] Hiroshima City Hiroshima Citizens Hosp, Dept Pathol, Hiroshima, Japan; [Miki, Y.] Kochi Gakuen Coll, Dept Med Technol, Kochi, Japan; [Yoshino, T.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan	Ariyasu, S (reprint author), Okayama Med Ctr, Natl Hosp Org, Dept Clin Lab, Kita Ward, 1711-1 Tamasu, Okayama, Okayama 7011192, Japan.	sariyasu@okayama3.hosp.go.jp					Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Gulmann C, 2013, HUM PATHOL, V44, P164, DOI 10.1016/j.humpath.2012.05.018; Cimbaluk D, 2009, DIAGN CYTOPATHOL, V37, P773, DOI 10.1002/dc.21147; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Chuang AY, 2007, AM J SURG PATHOL, V31, P1246, DOI 10.1097/PAS.0b013e31802f5d33; Nickeleit V, 2006, TRANSPLANT INT, V19, P960, DOI 10.1111/j.1432-2277.2006.00360.x; Drachenberg CB, 2005, HUM PATHOL, V36, P1245, DOI 10.1016/j.humpath.2005.08.009; Pappo O, 1996, MODERN PATHOL, V9, P105; Wadei HM, 2006, AM J TRANSPLANT, V6, P1025, DOI 10.1111/j.1600-6143.2006.01296.x; Alexiev BA, 2013, HUM PATHOL, V44, P908, DOI 10.1016/j.humpath.2012.09.019; Nickeleit V, 2000, NEPHROL DIAL TRANSPL, V15, P324, DOI 10.1093/ndt/15.3.324; Hirsch HH, 2003, LANCET INFECT DIS, V3, P611, DOI 10.1016/S1473-3099(03)00770-9; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0; Wu TH, 2009, SOIL BIOL BIOCHEM, V41, P849, DOI 10.1016/j.soilbio.2009.02.003; Bonvoisin C, 2008, TRANSPLANTATION, V85, P42; COLEMAN DV, 1975, ACTA CYTOL, V19, P93; Drachenberg CB, 1999, HUM PATHOL, V30, P970, DOI 10.1016/S0046-8177(99)90252-6; Herawi M, 2006, AM J SURG PATHOL, V30, P345; Koukoulaki M, 2008, CYTOPATHOLOGY, V19, P385, DOI 10.1111/j.1365-2303.2008.00576.x; Li RM, 2013, VIROLOGY, V440, P41, DOI 10.1016/j.virol.2013.01.024; Ohsaki H, 2013, CYTOPATHOLOGY, V24, P52, DOI 10.1111/j.1365-2303.2012.00958.x; RZIHA HJ, 1978, MED MICROBIOL IMMUN, V165, P73, DOI 10.1007/BF02122742; SHINOHARA T, 1993, J MED VIROL, V41, P301, DOI 10.1002/jmv.1890410408; Wadei HM, 2012, TRANSPLANTATION, V94, P43; Yanagita Emmy, 2011, Appl Immunohistochem Mol Morphol, V19, P509, DOI 10.1097/PAI.0b013e318212f027	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0956-5507	1365-2303		CYTOPATHOLOGY	Cytopathology	AUG	2015	26	4					250	255		10.1111/cyt.12213		6	Cell Biology; Pathology	Cell Biology; Pathology	CN8WY	WOS:000358727600007		
J	Takahara, M				Takahara, Mitsuyoshi			Impact of HbA(1c), Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308-315	DIABETES CARE			English	Letter									[Takahara, Mitsuyoshi] Osaka Univ, Grad Sch Med, Dept Diabet Care Med, Suita, Osaka, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan	Takahara, M (reprint author), Osaka Univ, Grad Sch Med, Dept Diabet Care Med, Suita, Osaka, Japan.	takahara@endmet.med.osaka-u.ac.jp					Nordwall M, 2015, DIABETES CARE, V38, P308, DOI 10.2337/dc14-1203	1	1	1	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0149-5992	1935-5548		DIABETES CARE	Diabetes Care	AUG	2015	38	8					E123	E123		10.2337/dc15-0652		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CN8EY	WOS:000358673200008		
J	Nishimura, A; Kasai, T; Tamura, H; Yamato, A; Yasuda, D; Nagasawa, K; Okubo, M; Narui, K; Mori, Y				Nishimura, Akihiro; Kasai, Takatoshi; Tamura, Haruko; Yamato, Azusa; Yasuda, Daijiro; Nagasawa, Kaoru; Okubo, Minoru; Narui, Koji; Mori, Yasumichi			Relationship between sleep disordered breathing and diabetic retinopathy: Analysis of 136 patients with diabetes	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Sleep disorders; Sleep apnea syndrome; Diabetic retinopathy; Retinal disease; Diabetic angiopathies; Intermittent hypoxia	POSITIVE AIRWAY PRESSURE; HEART-FAILURE; CARDIOVASCULAR-DISEASE; APNEA SYNDROME; PREVALENCE; MEN; HYPOXIA; HEALTH; ADULTS; RISK	Aims: Sleep disordered breathing (SDB) is associated with poor glycemic control. However, whether SDB contributes to diabetic microangiopathies, especially diabetic retinopathy (DR), is unknown. The aim of this study was to assess the relationship between SDB and DR. Methods: Between January 2010 and November 2012, 136 patients underwent a sleep test and were divided into two groups according to the presence or absence of DR. Sleep test results and known risk factors for DR were compared between groups. Optic fundi were examined using indirect ophthalmoscope or retinal photographs and diagnosed by experienced ophthalmologists. Multivariate stepwise (backward) logistic regression analysis was performed to assess factors associated with DR. Results: Ninety-nine patients without DR (NDR) and 37 patients with DR were assessed. Patients in the DR group had significantly longer duration of diabetes, were more likely to have hypertension and cardiovascular disease (CVD), and were more likely to be taking angiotensin converting enzyme inhibitors or angiotensin receptor blockers (p = 0.000 for each). In the multivariate backward logistic regression analysis, minimum SO2 (odds ratio [OR], 0.89; p = 0.001), HbA1c (OR, 1.40; p = 0.021), duration of diabetes (OR, 1.23; p < 0.001), and history of CVD (OR, 8.96; p = 0.008) remained significant. Conclusions: Minimum SO2 values were associated with DR independent from glycemic control level, duration of diabetes, and history of CVD. This finding suggests that SDB may contribute to the development of DR not through frequency, but due to the degree of intermittent hypoxia. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nishimura, Akihiro; Yamato, Azusa; Yasuda, Daijiro; Nagasawa, Kaoru; Okubo, Minoru; Mori, Yasumichi] Toranomon Gen Hosp, Dept Endocrinol & Metab, Tokyo, Japan; [Kasai, Takatoshi; Tamura, Haruko; Narui, Koji] Toranomon Gen Hosp, Sleep Ctr, Tokyo, Japan; [Kasai, Takatoshi] Juntendo Univ, Sch Med, Dept Cardiol, Cardio Resp Sleep Med, Tokyo 113, Japan	Nishimura, A (reprint author), Toranomon Gen Hosp, Dept Endocrinol & Metab, Tokyo, Japan.	toranishi@gmail.com					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Gami AS, 2013, J AM COLL CARDIOL, V62, P610, DOI 10.1016/j.jacc.2013.04.080; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Aronsohn RS, 2010, AM J RESP CRIT CARE, V181, P507, DOI 10.1164/rccm.200909-1423OC; Arden GB, 2012, DOC OPHTHALMOL, V124, P15, DOI 10.1007/s10633-011-9305-y; Kasai T, 2008, CHEST, V133, P690, DOI 10.1378/chest.07-1901; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Ejaz S, 2008, DIABETES OBES METAB, V10, P53, DOI 10.1111/j.1463-1326.2007.00795.x; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Kasai T, 2012, CIRCULATION, V126, P1495, DOI 10.1161/CIRCULATIONAHA.111.070813; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Schulz R, 2002, AM J RESP CRIT CARE, V165, P67; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/rccm.2103001; Mason RH, 2012, RETINA-J RET VIT DIS, V32, P1791, DOI 10.1097/IAE.0b013e318259568b; Kasai T, 2011, J AM COLL CARDIOL, V57, P119, DOI 10.1016/j.jacc.2010.08.627; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Krieger J, 1997, CHEST, V112, P875, DOI 10.1378/chest.112.4.875; Shiba T, 2010, AM J OPHTHALMOL, V149, P959, DOI 10.1016/j.ajo.2010.01.006; Ozol D, 2011, SLEEP BREATH, V15, P295, DOI 10.1007/s11325-010-0380-1; Banerjee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079521; Buyukaydin B, 2012, DIABETES RES CLIN PR, V98, P140, DOI 10.1016/j.diabres.2012.07.007; Collop Nancy A, 2007, J Clin Sleep Med, V3, P737; Einhorn Daniel, 2007, Endocr Pract, V13, P355; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Kato M, 2011, J CARDIOL, V58, P74, DOI 10.1016/j.jjcc.2011.03.005; Kern Timothy S, 2007, Exp Diabetes Res, V2007, P95103, DOI 10.1155/2007/95103; Tahrani AA, 2012, AM J RESP CRIT CARE, V186, P434, DOI 10.1164/rccm.201112-2135OC; West SD, 2010, DIABETIC MED, V27, P423, DOI 10.1111/j.1464-5491.2010.02962.x; Yamada Y, 2011, AM THOR SOC INT C	34	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	AUG	2015	109	2					306	311		10.1016/j.diabres.2015.05.015		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CN6OT	WOS:000358554800015		
J	Iwasaki, S; Kozawa, J; Fukui, K; Iwahashi, H; Imagawa, A; Shimomura, I				Iwasaki, Shingo; Kozawa, Junji; Fukui, Kenji; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro			Coefficient of variation of R-R interval closely correlates with glycemic variability assessed by continuous glucose monitoring in insulin-depleted patients with type 1 diabetes	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Autonomic function; Coefficient of variation of R-R interval; Continuous glucose monitoring; Glycemic variability; Type 1 diabetes	CORONARY-ARTERY CALCIUM; AUTONOMIC NEUROPATHY; HYPOGLYCEMIA UNAWARENESS; FAILURE; INSTABILITY; MECHANISMS; STABILITY; SECRETION; MELLITUS; ADULTS	Aims: In type 1 diabetic patients, insulin secretory capacity, meals and physical activity correlate with glycemic variability. Autonomic function associated with gastrointestinal motility and counterregulatory hormone secretion is another candidate which correlates with glucose variability. The aim of this study is to clarify a new clinical parameter associated with glycemic variability in insulin-depleted patients with type 1 diabetes. Methods: We studied 31 inpatients with type 1 diabetes. We evaluated glycemic variability calculated by continuous glucose monitoring, clinical parameters and the coefficient of variation of R-R interval (CVR-R). Glycemic variability was also assessed during the daytime and nighttime. Results: The CVR-R showed a significant negative correlation with the whole-day standard deviation (SD) (r = -0.50, p = 0.007), mean amplitude of glycemic excursions (MAGE) (r = -0.47, p = 0.011), M-value (r = -0.38, p = 0.048) and mean of daily differences (MODD) (r = -0.59, p = 0.001). The CVR-R also showed a significant negative correlation with the nighttime SD (r = -0.59, p = 0.001), MAGE (r = -0.47, p = 0.011), M-value (r = -0.53, p = 0.004) and MODD (r = -0.65, p = 0.0003). And furthermore, the CVR-R also showed a significant negative correlation with the daytime SD (r = -0.44, p = 0.019) and MAGE (r = -0.50, p = 0.006), but not with the daytime M-value or MODD. The nighttime SD was significantly higher in patients with diabetic polyneuropathy than in patients without it (p = 0.016), while the CVR-R was significantly lower in patients with polyneuropathy than in patients without it (p = 0.009). Conclusions: CVR-R is closely correlated with glycemic variability, especially during nighttime, in insulin-depleted patients with type 1 diabetes. Measuring CVR-R may help us to presume the degree of glycemic variability in those patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Iwasaki, Shingo; Kozawa, Junji; Fukui, Kenji; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Fukui, Kenji] Osaka Univ, Grad Sch Med, Dept Community Med, Suita, Osaka, Japan	Imagawa, A (reprint author), Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan.	aimagawa@endmet.med.osaka-u.ac.jp					American Diabetes Association, 2013, DIABETES CARE, V36, P67; Stahn A, 2014, DIABETES CARE, V37, P516, DOI 10.2337/dc13-0600; Cryer PE, 2013, NEW ENGL J MED, V369, P362, DOI 10.1056/NEJMra1215228; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; SERVICE FJ, 1987, DIABETES CARE, V10, P225; COX DJ, 1994, J CLIN ENDOCR METAB, V79, P1659, DOI 10.1210/jc.79.6.1659; Brazeau AS, 2013, DIABETES RES CLIN PR, V99, P19, DOI 10.1016/j.diabres.2012.10.024; Lucini D, 2013, ACTA DIABETOL, V50, P341, DOI 10.1007/s00592-012-0416-z; Parillo M, 2011, DIABETIC MED, V28, P227, DOI 10.1111/j.1464-5491.2010.03176.x; Richardson T, 2004, DIABETES CARE, V27, P1127, DOI 10.2337/diacare.27.5.1127; FUKUDA M, 1988, DIABETES, V37, P81, DOI 10.2337/diabetes.37.1.81; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; SERVICE FJ, 1970, DIABETES, V19, P644; MOLNAR GD, 1972, DIABETOLOGIA, V8, P342, DOI 10.1007/BF01218495; Kuenen JC, 2011, DIABETES CARE, V34, P1843, DOI 10.2337/dc10-2217; Sartore G, 2012, ACTA DIABETOL, V49, pS153, DOI 10.1007/s00592-012-0391-4; Gill G, 2009, DIABETOLOGIA, V52, P42, DOI 10.1007/s00125-008-1177-7; HOELDTKE RD, 1982, ANN INTERN MED, V96, P459; Arbelaez AM, 2013, DIABETES, V62, P3999, DOI 10.2337/db13-1360; Aronson D, 1997, DIABETOLOGIA, V40, P476, DOI 10.1007/s001250050704; Awoniyi O, 2013, CURR DIABETES REP, V13, P669, DOI 10.1007/s11892-013-0411-y; Bakatselos SO, 2011, DIABETES RES CLIN PR, V93, P92; Cicmir I J, 1980, Horm Metab Res Suppl, V9, P73; Darwiche G, 2001, J DIABETES COMPLICAT, V15, P128, DOI 10.1016/S1056-8727(00)00143-4; Howorka K, 1998, ACTA DIABETOL, V35, P1; Malfitano C, 2012, J CARDIOVASC PHARM, V59, P58, DOI 10.1097/FJC.0b013e3182354776; Manohar C, 2012, DIABETES CARE, V35, P2493, DOI 10.2337/dc11-2381; Middlekauff HR, 2014, J AM COLL CARDIOL, V64, P1740, DOI 10.1016/j.jacc.2014.06.1201; Miki T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0125-8; Moheet A, 2014, J CLIN ENDOCR METAB, V99, P664, DOI 10.1210/jc.2013-3493; Molon G, 2007, PACE, V30, P1267, DOI 10.1111/j.1540-8159.2007.00849.x; OKA H, 1995, J AUTONOM NERV SYST, V52, P203, DOI 10.1016/0165-1838(94)00152-A; Ramzan Z, 2011, DIGEST DIS SCI, V56, P2646, DOI 10.1007/s10620-011-1810-z; SCHLICHT.J, 1965, ACTA MED SCAND, V177, P95; Schrieks IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086199; Shannon DC, 1987, AM J PHYSIOL, V253, P874; Shibasaki S, 2010, J DIABETES INVEST, V1, P283, DOI 10.1111/j.2040-1124.2010.00059.x; Snell-Bergeon JK, 2010, DIABETIC MED, V27, P1436, DOI 10.1111/j.1464-5491.2010.03127.x; Soupal J, 2014, DIABETES TECHNOL THE, V16, P198, DOI 10.1089/dia.2013.0205; Tsutsumi C, 2013, DIABETOL INT, V4, P156; Yasuda H, 2007, DIABETES RES CLIN PR, V77, P178	42	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	AUG	2015	109	2					397	403		10.1016/j.diabres.2015.05.021		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CN6OT	WOS:000358554800027		
J	Otani, T; Yokoyama, H; Uchigata, Y				Otani, Toshika; Yokoyama, Hiroki; Uchigata, Yasuko			Changes in the prognosis of Japanese patients who developed type 1 diabetes before the age of 30 years	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Type 1 diabetes mellitus; Mortality; Standardized mortality ratio (SMR); Life-table analysis; Cox's proportional hazard model	CAUSE-SPECIFIC MORTALITY; ONSET; MELLITUS; COHORT; IDDM	Aims: We investigated changes in vital prognosis according to the year at diagnosis of type 1 diabetes mellitus (T1DM) in a hospital-based survey. Methods: Of 1054 Japanese subjects diagnosed as T1DM between 1952 and 1999 before the age of 30 and consulted the diabetes center between 1962 and 1999, the survival status up to 2010 or 20 years of follow-up was investigated. Subjects were divided by the year at diagnosis of T1DM: before 1979 (Group A: n = 359), 1980 to 1989 (Group B: n = 400), and 1990 to 1999 (Group C: n = 295). The mortality (/100,000 person years) and standardized mortality ratio (SMR) were calculated, and the effect of year at diagnosis of T1DM was explored by the Cox proportional hazard model. Results: The survival status was confirmed in 90.0%. The mortality rate (95% CI) and age and sex adjusted SMR (95% CI) were 457 (288-627) and 3.0 (1.9-4.2) in Group A, 265 (143-387) and 2.2 (1.2-3.2) in Group B, and 144 (29-259) and 1.6 (0.3-2.9) in Group C, respectively. The cumulative survival rate was significantly different according to the year at diagnosis of T1DM (p = 0.0239). Cox's proportional hazard model revealed that Groups B and C had significantly lower risks of death than Group A after adjustment for gender and age at diagnosis of T1DM (HR 0.48 [95% CI 0.26-0.87] for Group B and HR 0.25 [95% CI 0.09-0.60] for Group C). Conclusion: This study indicated that vital prognosis is improving according to the year at diagnosis of T1DM and suggested the need of a nationwide survey. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Otani, Toshika] Saitama Mem Hosp, Saitama, Japan; [Otani, Toshika; Uchigata, Yasuko] Tokyo Womens Med Univ, Ctr Diabet, Sch Med, Tokyo, Japan; [Yokoyama, Hiroki] Jiyugaoka Med Clin, Internal Med, Obihiro, Hokkaido, Japan	Uchigata, Y (reprint author), Tokyo Womens Med Coll, Ctr Diabet, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 162, Japan.	dryokoyama@yokoyamanaika.com; uchigata@dmc.twmu.ac.jp					Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Morimoto A, 2013, DIABETOLOGIA, V56, P2171, DOI 10.1007/s00125-013-3001-2; DECKERT T, 1978, DIABETOLOGIA, V14, P371, DOI 10.1007/BF01228131; KITAGAWA T, 1995, AM J EPIDEMIOL, V142, P612; LAPORTE RE, 1991, DIABETES CARE, V14, P49; ORCHARD TJ, 1991, DIABETES CARE, V14, P55; Kohno H, 2008, SHONI SHISHUNKI NO H, P13; Maruyama Akiko, 1994, Journal of the Japan Diabetes Society, V37, P599; Nishimura R, 1997, Nihon Rinsho, V55 Suppl, P544; Uchigata Y, 2004, J DIABETES COMPLICAT, V18, P155, DOI 10.1016/S1056-8727(03)00111-9; Uchigata Y, 2008, DIABETES RES CLIN PR, V82, P80, DOI 10.1016/j.diabres.2008.06.021	12	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	AUG	2015	109	2					434	439		10.1016/j.diabres.2015.04.024		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CN6OT	WOS:000358554800032		
J	Yamaguchi, S; Ikejima, M; Furukawa, A; Abe, M; Nakazaki, M; Ishihara, H				Yamaguchi, Suguru; Ikejima, Midori; Furukawa, Asami; Abe, Masanori; Nakazaki, Mitsuhiro; Ishihara, Hisamitsu			Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Hypoglycemia; Octreotide; DPP-4 inhibitor; Sulfonylurea	SAFETY	We describe a type 2 diabetes patient with persistent hypoglycemia caused by sulfonylurea misuse on top of a DPP-4 inhibitor. Hyperinsulinemia was exaggerated by dextrose administration, but was successfully treated with octreotide. Since many patients are currently treated with DPP-4 inhibitors, the importance of octreotide has been increasing. For refractory sulfonylurea-induced hypoglycemia, especially when the patient is also being given an incretin-based therapy, octreotide should be considered. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Yamaguchi, Suguru; Ikejima, Midori; Furukawa, Asami; Nakazaki, Mitsuhiro; Ishihara, Hisamitsu] Nihon Univ, Sch Med, Div Diabet & Metab Dis, Tokyo, Tokyo 1738610, Japan; [Abe, Masanori] Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Tokyo 1738610, Japan	Yamaguchi, S (reprint author), 30-1 Oyaguchi Kamicho, Tokyo, Tokyo 1738610, Japan.	yamaguchi.suguru@nihon-u.ac.jp					BOYLE PJ, 1993, J CLIN ENDOCR METAB, V76, P752, DOI 10.1210/jc.76.3.752; Dougherty Patrick P, 2010, J Med Toxicol, V6, P199, DOI 10.1007/s13181-010-0064-z; Dougherty PP, 2013, PEDIATR EMERG CARE, V29, P292, DOI 10.1097/PEC.0b013e31828503cf; Glatstein M, 2012, CLIN TOXICOL, V50, P795, DOI 10.3109/15563650.2012.734626; Gonzalez Rita R, 2007, Endocr Pract, V13, P417; Green RS, 2003, J EMERG MED, V25, P283, DOI 10.1016/S0736-4679(03)00204-X; Lajara R, 2014, CLIN THER, V36, P1595, DOI 10.1016/j.clinthera.2014.07.020; Sato D, 2012, INT J CLIN PHARM-NET, V34, P917, DOI 10.1007/s11096-012-9694-3	8	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	AUG	2015	109	2					E8	E10		10.1016/j.diabres.2015.05.008		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CN6OT	WOS:000358554800002		
J	Korman, A; Kutten, S; Masuzawa, T				Korman, Amos; Kutten, Shay; Masuzawa, Toshimitsu			Fast and compact self-stabilizing verification, computation, and fault detection of an MST	DISTRIBUTED COMPUTING			English	Article						Distributed network algorithms; Locality; Proof labels; Minimum spanning tree; Distributed property verification; Self-stabilization; Fast fault detection; Local fault detection	SPANNING TREE CONSTRUCTION; DISTRIBUTED VERIFICATION; LABELING SCHEMES; LEADER ELECTION; NETWORKS; ALGORITHM; TIME; GRAPHS; PROTOCOLS; SYSTEMS	This paper demonstrates the usefulness of distributed local verification of proofs, as a tool for the design of self-stabilizing algorithms. In particular, it introduces a somewhat generalized notion of distributed local proofs, and utilizes it for improving the time complexity significantly, while maintaining space optimality. As a result, we show that optimizing the memory size carries at most a small cost in terms of time, in the context of minimum spanning tree (MST). That is, we present algorithms that are both time and space efficient for both constructing an MST and for verifying it. This involves several parts that may be considered contributions in themselves. First, we generalize the notion of local proofs, trading off the time complexity for memory efficiency. This adds a dimension to the study of distributed local proofs, which has been gaining attention recently. Specifically, we design a (self-stabilizing) proof labeling scheme which is memory optimal (i.e., bits per node), and whose time complexity is in synchronous networks, or time in asynchronous ones, where is the maximum degree of nodes. This answers an open problem posed by Awerbuch et al. (1991). We also show that time is necessary, even in synchronous networks. Another property is that if faults occurred, then, within the required detection time above, they are detected by some node in the locality of each of the faults. Second, we show how to enhance a known transformer that makes input/output algorithms self-stabilizing. It now takes as input an efficient construction algorithm and an efficient self-stabilizing proof labeling scheme, and produces an efficient self-stabilizing algorithm. When used for MST, the transformer produces a memory optimal self-stabilizing algorithm, whose time complexity, namely, , is significantly better even than that of previous algorithms (the time complexity of previous MST algorithms that used memory bits per node was , and the time for optimal space algorithms was ). Inherited from our proof labeling scheme, our self-stabilising MST construction algorithm also has the following two properties: (1) if faults occur after the construction ended, then they are detected by some nodes within time in synchronous networks, or within time in asynchronous ones, and (2) if faults occurred, then, within the required detection time above, they are detected within the locality of each of the faults. We also show how to improve the above two properties, at the expense of some increase in the memory.	[Korman, Amos] CNRS, F-75013 Paris, France; [Korman, Amos] Univ Paris Diderot, F-75013 Paris, France; [Kutten, Shay] Technion Israel Inst Technol, Fac IE&M, Informat Syst Grp, IL-32000 Haifa, Israel; [Masuzawa, Toshimitsu] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Korman, A (reprint author), CNRS, F-75013 Paris, France.	amos.korman@liafa.univ-paris-diderot.fr; masuzawa@ist.osaka-u.ac.jp			France Ministry of Science; Israel Ministry of Science; ANR; INRIA; Israel Science Foundation; Technion funds for security research; JSPS [(B)26280022]	Supported in part by a France-Israel cooperation grant ("Mutli-Computing" project) from the France Ministry of Science and Israel Ministry of Science, by the ANR projects ALADDIN and PROSE, by the INRIA project GANG, by a grant from the Israel Science Foundation, by the Technion funds for security research, and by JSPS Grant-in-Aid for Scientific Research ((B)26280022).	Afek Y, 1997, THEOR COMPUT SCI, V186, P199, DOI 10.1016/S0304-3975(96)00286-1; Afek Y., 1991, WDAG, P15; Afek Y., 1998, CHIC J THEOR COMPUT; Aggarwal S., 1993, LECT NOTES COMPUT SC, V761, P400; Katz M, 2004, SIAM J COMPUT, V34, P23, DOI 10.1137/S0097539703433912; Fraigniaud P, 2001, LECT NOTES COMPUT SC, V2076, P757; Goemans MX, 2006, ANN IEEE SYMP FOUND, P273; DIJKSTRA EW, 1974, COMMUN ACM, V17, P643, DOI 10.1145/361179.361202; Gavoille C, 2004, J ALGORITHM, V53, P85, DOI 10.1016/j.jalgor.2004.05.002; Das Sarma A, 2012, SIAM J COMPUT, V41, P1235, DOI 10.1137/11085178X; TARJAN RE, 1979, J ACM, V26, P690, DOI 10.1145/322154.322161; MCQUILLAN JM, 1980, IEEE T COMMUN, V28, P711, DOI 10.1109/TCOM.1980.1094721; DALAL YK, 1987, IEEE T SOFTWARE ENG, V13, P398, DOI 10.1109/TSE.1987.233171; Bui A, 2007, DISTRIB COMPUT, V20, P3, DOI 10.1007/s00446-007-0030-4; Lotker Z, 2006, DISTRIB COMPUT, V18, P453, DOI 10.1007/s00446-005-0127-6; Antonoiu G., 1997, EUROPAR, V1300, P480, DOI 10.1007/BFb0002773; ARORA A, 1994, IEEE T COMPUT, V43, P1026, DOI 10.1109/12.312126; AWERBUCH B, 1985, INFORM PROCESS LETT, V20, P147, DOI 10.1016/0020-0190(85)90083-3; Awerbuch B, 2007, IEEE T DEPEND SECURE, V4, P180, DOI 10.1109/TDSC.2007.1007; Awerbuch B., 1991, FOCS91 P 31 ANN IEEE, P268; AWERBUCH B, 1987, STOC, V1987, P230; Awerbuch B., 1993, STOC93 P 25 ANN ACM, P652; Awerbuch B., 1991, FOCS91 P 31 ANN IEEE, P258; Awerbuch Baruch, 1994, LECT NOTES COMPUTER, V857, P326; Azar Y, 2010, ACM T ALGORITHMS, V6, DOI 10.1145/1798596.1798601; Blin L, 2010, LECT NOTES COMPUT SC, V6343, P480, DOI 10.1007/978-3-642-15763-9_46; Blin L, 2009, LECT NOTES COMPUT SC, V5805, P407, DOI 10.1007/978-3-642-04355-0_43; Boulinier C., 2004, P 23 ANN ACM S PRINC, P150, DOI 10.1145/1011767.1011790; CHANG EJH, 1982, IEEE T SOFTWARE ENG, V8, P391, DOI 10.1109/TSE.1982.235573; CHLAMTAC I, 1987, IEEE T COMPUT, V36, P1209; COLLIN Z, 1994, INFORM PROCESS LETT, V49, P297, DOI 10.1016/0020-0190(94)90103-1; Cournier A, 2001, INT CON DISTR COMP S, P91; Datta AK, 2010, LECT NOTES COMPUT SC, V6366, P35; Datta AK, 2008, LECT NOTES COMPUT SC, V5340, P109, DOI 10.1007/978-3-540-89335-6_11; DIXON B, 1992, SIAM J COMPUT, V21, P1184, DOI 10.1137/0221070; Dixon B, 1997, ALGORITHMICA, V17, P11, DOI 10.1007/BF02523235; Dolev S, 1999, ACTA INFORM, V36, P447, DOI 10.1007/s002360050180; Dolev S., 2000, SELF STABILIZATION; Dolev S., 1994, DISTRIB COMPUT, V7, P3; Even S., 1979, GRAPH ALGORITHMS; Fraigniaud P, 2011, ANN IEEE SYMP FOUND, P708, DOI 10.1109/FOCS.2011.17; FRAIGNIAUD P, 2012, LECT NOTES COMPUTER, V7702, P224; Fraigniaud P, 2012, LECT NOTES COMPUT SC, V7611, P371, DOI 10.1007/978-3-642-33651-5_26; Gallager R., 1983, ACM T PROGR LANG SYS, V4, P66; Garay J., 1993, FOCS, P659; Ghosh S., 1996, Proceedings of the Fifteenth Annual ACM Symposium on Principles of Distributed Computing, DOI 10.1145/248052.248057; GOLDREICH O, 1987, ACTA INFORM, V24, P79, DOI 10.1007/BF00290707; Goos M, 2011, PODC 11: PROCEEDINGS OF THE 2011 ACM SYMPOSIUM PRINCIPLES OF DISTRIBUTED COMPUTING, P159; Gupta SKS, 2003, J PARALLEL DISTR COM, V63, P87, DOI 10.1016/S0743-7315(02)00029-1; Higham L., 2001, DISC01, P194; ISRAELI A, 1990, PROCEEDINGS OF THE NINTH ANNUAL ACM SYMPOSIUM ON PRINCIPLES OF DISTRIBUTED COMPUTING, P119, DOI 10.1145/93385.93409; Jayaram G.M., 2000, JACM, V47, P244; KATZ S, 1993, DISTRIB COMPUT, V7, P17, DOI 10.1007/BF02278852; Kor L., 2011, STACS, P69; Korman A, 2008, DISTRIB COMPUT, V21, P141, DOI 10.1007/s00446-008-0061-5; Korman A, 2007, DISTRIB COMPUT, V20, P253, DOI 10.1007/s00446-007-0025-1; Korman A, 2010, DISTRIB COMPUT, V22, P215, DOI 10.1007/s00446-010-0095-3; Kutten S., 1995, Proceedings of the Fourteenth Annual ACM Symposium on Principles of Distributed Computing, DOI 10.1145/224964.224990; Naor M., 1993, STOC, P184; Peleg D., 2000, DISTRIBUTED COMPUTIN; Peleg D, 2000, SIAM J COMPUT, V30, P1427, DOI 10.1137/S0097539700369740; SEGALL A, 1983, IEEE T INFORM THEORY, V29, P23, DOI 10.1109/TIT.1983.1056620; Stomp F. A., 1993, Proceedings of the 2nd Israel Symposium on Theory and Computing Systems (Cat. No.93TH0520-7), DOI 10.1109/ISTCS.1993.253472; Varghese G, 1992, THESIS MIT	64	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-2770	1432-0452		DISTRIB COMPUT	Distrib. Comput.	AUG	2015	28	4					253	295		10.1007/s00446-015-0242-y		43	Computer Science, Theory & Methods	Computer Science	CN9PH	WOS:000358780800004		
J	Wang, LR				Wang, Leran			Fertility and unemployment in a social security system	ECONOMICS LETTERS			English	Article						Fertility; Unemployment; Pay-as-you-go pension; Child allowances		This study analyzes how endogenous fertility and unemployment are affected by a social security system in an overlapping generations model. The analysis reveals that for any given minimum wage, the pension may improve fertility and decrease unemployment. (C) 2015 Elsevier B.V. All rights reserved.	Keio Univ, Grad Sch Econ, Minato Ku, Tokyo 1088345, Japan	Wang, LR (reprint author), Keio Univ, Grad Sch Econ, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.	orakuzenn@gmail.com					BARRO RJ, 1989, ECONOMETRICA, V57, P481, DOI 10.2307/1912563; CIGNO A, 1992, J POPUL ECON, V5, P319, DOI 10.1007/BF00163064; Cigno A., 1993, EUROPEAN J POLITICAL, V9, P505, DOI 10.1016/0176-2680(93)90036-T; Fanti L, 2010, ECON LETT, V109, P147, DOI 10.1016/j.econlet.2010.08.035; Fanti L., 2007, EC B, V10, P1; Hohm F., 1975, DEMOGRAPHY, V12, P629	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	AUG	2015	133						19	23		10.1016/j.econlet.2015.05.014		5	Economics	Business & Economics	CN5HT	WOS:000358461100006		
J	Chuang, HW				Chuang, Hongwei			Volatility persistence in stock market	ECONOMICS LETTERS			English	Article						Financial network; Realized volatility; Long memory; Systemic risk	TRADING VOLUME; NETWORKS	By using the unique dataset that consists of all brokers' daily trading information, I propose an empirical methodology to construct a Granger-causality financial network to study the relationship between dynamics of volatility and information diffusion in a stock market. The financial network I proposed not only provides a new way to describe mutual interconnectedness of brokers in the market, but the empirical results also show the financial network density is positively correlated to the realized volatility of the market. (C) 2015 Elsevier B.V. All rights reserved.	Tohoku Univ, Grad Sch Econ & Management, Aoba Ward, Sendai, Miyagi 9808576, Japan	Chuang, HW (reprint author), Tohoku Univ, Grad Sch Econ & Management, Aoba Ward, 27-1 Kawauchi, Sendai, Miyagi 9808576, Japan.	hongwei@econ.tohoku.ac.jp			ISHII Memorial Securities Research Promotion Foundation Research Fund [ISHII-2014-310]	Thanks for seminar participants in National Chung Hsing University, Tohoku University, 2014 JAFEE Summer Meeting in Seijo University, and the DSSR Center in Tohoku University. Thanks for the research found support from 2014 ISHII Memorial Securities Research Promotion Foundation Research Fund (ISHII-2014-310).	Andersen TG, 1996, J FINANC, V51, P169, DOI 10.2307/2329306; [Anonymous], 2012, ACM T KNOWL DISOV DA; CLARK PK, 1973, ECONOMETRICA, V41, P135, DOI 10.2307/1913889; Lobato IN, 2000, J BUS ECON STAT, V18, P410, DOI 10.2307/1392223; Ozsoylev HN, 2011, J ECON THEORY, V146, P2252, DOI 10.1016/j.jet.2011.10.003; Barber BM, 2009, REV FINANC STUD, V22, P609, DOI 10.1093/rfs/hhn046; Andersen TG, 2003, ECONOMETRICA, V71, P579, DOI 10.1111/1468-0262.00418; EPPS TW, 1976, ECONOMETRICA, V44, P305, DOI 10.2307/1912726; Bollerslev T, 1999, J BUS ECON STAT, V17, P9, DOI 10.2307/1392235; DeMarzo PM, 2003, Q J ECON, V118, P909, DOI 10.1162/00335530360698469; Ozsoylev HN, 2014, REV FINANC STUD, V27, P1323, DOI 10.1093/rfs/hht065; Pareek Ankur, 2012, INFORM NETWORKS IMPL; Walden Johan, 2013, TRADING PROFITS VOLA	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	AUG	2015	133						64	67		10.1016/j.econlet.2015.05.018		4	Economics	Business & Economics	CN5HT	WOS:000358461100016		
J	Matsuki, T; Sugimoto, K; Satoma, K				Matsuki, Takashi; Sugimoto, Kimiko; Satoma, Katsuhiko			Effects of the Bank of Japan's current quantitative and qualitative easing	ECONOMICS LETTERS			English	Article						Quantitative easing; Qualitative easing; Markov-switching vector autoregression; Impulse response	MONETARY-POLICY; INTEREST-RATES; ZERO	This paper examines how the Bank of Japan's current quantitative and qualitative easing affects the Japanese economy by using a Markov-switching vector autoregression model on daily economic data during January 2012 August 2014. The results reveal that quantitative easing by expanding the monetary base significantly lowers short-term interest rates and raises inflation rates. In addition, the lowered interest rates positively affect inflation rates. Qualitative easing through purchases of long-term government bonds and exchange-traded funds increases economic activity. Purchases of exchange-traded funds stimulate the stock and foreign exchange markets in Japan, while purchases of Japan real estate investment trusts do not have any effect. (C) 2015 Elsevier B.V. All rights reserved.	[Matsuki, Takashi] Osaka Gakuin Univ, Fac Econ, Suita, Osaka 5648511, Japan; [Sugimoto, Kimiko] Konan Univ, Hirao Sch Management, Nishinomiya, Hyogo 6638204, Japan; [Satoma, Katsuhiko] Osaka Gakuin Univ, Fac Commerce, Suita, Osaka 5648511, Japan	Matsuki, T (reprint author), Osaka Gakuin Univ, Fac Econ, 2-36-1 Kishibeminami, Suita, Osaka 5648511, Japan.	matsuki@ogu.ac.jp			Osaka Bankers Association	The authors would like to acknowledge the Osaka Bankers Association for the award of a research grant in 2014.	[Anonymous], 2014, EURASIAN EC REV; Bernanke BS, 2004, AM ECON REV, V94, P85, DOI 10.1257/0002828041302118; Eggertsson GB, 2003, BROOKINGS PAP ECO AC, P139; Ehrmann M, 2003, ECON LETT, V78, P295, DOI 10.1016/S0165-1765(02)00256-2; Fujiwara I, 2006, J JPN INT ECON, V20, P434, DOI 10.1016/j.jjie.2006.02.001; Hayashi F., 2014, NBER WORKING PAPERS, P1; Honda Y., 2013, JPN J MONET FINANC E, V1, P1; Inoue T, 2008, J JPN INT ECON, V22, P320, DOI 10.1016/j.jjie.2007.11.002	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	AUG	2015	133						112	116		10.1016/j.econlet.2015.05.025		5	Economics	Business & Economics	CN5HT	WOS:000358461100028		
J	Hayasaka, D; Kuwayama, N; Takeo, A; Ishida, T; Mano, H; Inoue, MN; Nagai, T; Sanchez-Bayo, F; Goka, K; Sawahata, T				Hayasaka, Daisuke; Kuwayama, Naoki; Takeo, Azuma; Ishida, Takanobu; Mano, Hiroyuki; Inoue, Maki N.; Nagai, Takashi; Sanchez-Bayo, Francisco; Goka, Koichi; Sawahata, Takuo			Different acute toxicity of fipronil baits on invasive Linepithema humile supercolonies and some non-target ground arthropods	ECOTOXICOLOGY			English	Article						Chemical controls; Eradication; Intra- and inter-species variation; Invasive species; Species sensitivity distributions (SSD); Susceptibility; Terrestrial arthropods	ARGENTINE ANTS HYMENOPTERA; SPECIES SENSITIVITY DISTRIBUTIONS; DAPHNIA-MAGNA; BIOLOGICAL INVASIONS; ALLOZYME GENOTYPES; PEST-MANAGEMENT; FORMICIDAE; INSECTICIDES; COPPER; JAPAN	Fipronil is one of the most effective insecticides to control the invasive ant Linepithema humile, but its effectiveness has been assessed without considering the genetic differences among L. humile supercolonies. We hypothesized that the susceptibility of the ant to fipronil might differ among supercolonies. If so, dosage and concentration of fipronil may need to be adjusted for effective eradication of each supercolony. The relative sensitivities of four L. humile supercolonies established in Hyogo (Japan) to fipronil baits were examined based on their acute toxicity (48-h LC50). Toxicities of fipronil to seven ground arthropods, including four native ant species, one native isopoda, and two cockroaches were also determined and compared to that of L. humile supercolonies using species sensitivity distributions. Marked differences in susceptibility of fipronil were apparent among the supercolonies (P < 0.008), with the 'Japanese main supercolony' (271 mu g L-1) being five to ten times more sensitive to fipronil than other colonies (1183-2782 mu g L-1). Toxicities to non-target species (330-2327 mu g L-1) were in the same range as that of L. humile, and SSDs between the two species groups were not significantly different (t = -1.389, P = 0.180), suggesting that fipronil's insecticidal activity is practically the same for L. humile as for non-target arthropods. Therefore, if the invasive ant is to be controlled using fipronil, this would also affect the local arthropod biodiversity. Only the 'Japanese main supercolony' can be controlled with appropriate bait dosages of fipronil that would have little impact on the other species.	[Hayasaka, Daisuke; Kuwayama, Naoki; Takeo, Azuma; Ishida, Takanobu; Sawahata, Takuo] KINDAI Univ, Fac Agr, Nara 6318505, Japan; [Mano, Hiroyuki] PWRI, Water Environm Res Grp, Tsukuba, Ibaraki 3058516, Japan; [Inoue, Maki N.] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Nagai, Takashi] NIAES, Organochem Div, Tsukuba, Ibaraki 3058604, Japan; [Sanchez-Bayo, Francisco] Univ Sydney, Fac Agr & Environm, Eveleigh, NSW 2015, Australia; [Goka, Koichi] NIES, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3050053, Japan	Hayasaka, D (reprint author), KINDAI Univ, Fac Agr, 3327-204 Nakamachi, Nara 6318505, Japan.	awayotou@hotmail.com			Environment Research and Technology Development Fund (ERTDF) of the Ministry of the Environment, Japan [4-1401]	Some specimens of the two cockroach species and of Pristomyrmex punctatus were provided by Earth Chemical Co., Ltd., Japan. We thank Kurumi Morishita for her kind assistance with the toxicity tests. The authors wish to thank Dr. Rafael Barbieri and Dr. Tomoyuki Yokoi for valuable technical advices. Our special thanks to Shinobu Ando of Ministry of the Environment, Japan for permission to raise the invasive Linepithema humile in our laboratory (permit number 13000057). This study was supported by the Environment Research and Technology Development Fund (ERTDF) (4-1401, Leader: Koichi Goka) of the Ministry of the Environment, Japan, 2014. The paper benefited from the constructive comments of two anonymous reviewers as referees.	Frampton GK, 2006, ENVIRON TOXICOL CHEM, V25, P2480, DOI 10.1897/05-438R.1; Barata C, 2002, ENVIRON SCI TECHNOL, V36, P3045, DOI 10.1021/es.0158556; Hooper-Bui LM, 2000, J ECON ENTOMOL, V93, P858, DOI 10.1603/0022-0493-93.3.858; Sunamura E, 2009, BIOL INVASIONS, V11, P2329, DOI 10.1007/s10530-008-9419-7; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolysis.33.010802.150444; Inoue MN, 2013, DIVERS DISTRIB, V19, P29, DOI 10.1111/j.1472-4642.2012.00934.x; Duboudin C, 2004, ENVIRON TOXICOL CHEM, V23, P489, DOI 10.1897/03-159; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.1890/1540-9295(2005)003[0012:ISPMAF]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Valles SM, 1997, J ECON ENTOMOL, V90, P1254; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; COLE LM, 1993, PESTIC BIOCHEM PHYS, V46, P47, DOI 10.1006/pest.1993.1035; Rust MK, 2004, J ECON ENTOMOL, V97, P1017, DOI 10.1603/0022-0493(2004)097[1017:DTAACF]2.0.CO;2; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Barbieri RF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2157; Sugiyama T, 2000, JPN J APPL ENTOMOL Z, V44, P127, DOI 10.1303/jjaez.2000.127; Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; [Anonymous], 2002, ENVIRON TOXICOL CHEM, DOI DOI 10.1002/ETC.5620210523; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.RO7-02; Collins HL, 1998, FLA ENTOMOL, V81, P407, DOI 10.2307/3495930; Zhao XL, 2005, J PHARMACOL EXP THER, V314, P363, DOI 10.1124/jpet.104.077891; Kiffney PM, 1996, ENVIRON TOXICOL CHEM, V15, P1352, DOI 10.1897/1551-5028(1996)015<1352:SDROMT>2.3.CO;2; Okaue M, 2007, ENTOMOL SCI, V10, P337, DOI 10.1111/j.1479-8298.2007.00228.x; Brix KV, 2001, ENVIRON TOXICOL CHEM, V20, P1846, DOI 10.1897/1551-5028(2001)020<1846:AAACCR>2.0.CO;2; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Krushelnycky PD, 2008, ECOL APPL, V18, P1547, DOI 10.1890/07-1293.1; Holway DA, 1999, ECOLOGY, V80, P238; Aldenberg T, 2000, ECOTOX ENVIRON SAFE, V46, P1, DOI 10.1006/eesa.1999.1869; Tsutsui ND, 2001, EVOLUTION, V55, P976, DOI 10.1554/0014-3820(2001)055[0976:PGACSO]2.0.CO;2; Ritz C, 2010, ENVIRON TOXICOL CHEM, V29, P220, DOI 10.1002/etc.7; ANZECC ARMCANZ, 2000, AUSTR NZ GUID FRESH; BAIRD DJ, 1991, ECOTOX ENVIRON SAFE, V21, P257, DOI 10.1016/0147-6513(91)90064-V; CHAGNON NL, 1989, ENVIRON TOXICOL CHEM, V8, P319, DOI 10.1897/1552-8618(1989)8[319:DSOAGI]2.0.CO;2; Choe DH, 2010, J ECON ENTOMOL, V103, P1761, DOI 10.1603/EC10154; Costa HS, 1999, J AGR URBAN ENTOMOL, V16, P37; ECB (European Chemicals Bureau), 2003, TECHN GUID DOC RIS 2; GANT DB, 1998, PESTICIDES FUTURE, V2, P147; Garcia-Munoz E, 2010, ARCH ENVIRON CON TOX, V59, P312, DOI 10.1007/s00244-010-9473-x; Gentz MC, 2009, J APPL ENTOMOL, V133, P229, DOI 10.1111/j.1439-0418.2008.01326.x; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Harris R.J., 2002, Science for Conservation (Wellington), V196, P1; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P421, DOI 10.1007/s10646-011-0802-2; Hayasaka D, 2015, J PESTIC SCI, V39, P172; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P191, DOI 10.1007/s10646-011-0778-y; Hayasaka D, 2013, J PESTIC SCI, V38, P44, DOI 10.1584/jpestics.D12-061; HICKEY CW, 1989, NEW ZEAL J MAR FRESH, V23, P131; Hoang TC, 2011, ENVIRON TOXICOL CHEM, V30, P997, DOI 10.1002/etc.462; Inoue MN, 2015, APPL ENTOMOL ZOOL, V50, P331, DOI 10.1007/s13355-015-0338-7; Jiang W, 2013, PEST MANAG SCI, V70, P271; Klotz JH, 2009, SOCIOBIOLOGY, V54, P101; Lach L, 2008, DIVERS DISTRIB, V14, P281, DOI 10.1111/j.1472-4642.2007.00410.x; Lorente C, 2015, SCI TOTAL ENVIRON, V503, P151, DOI 10.1016/j.scitotenv.2014.06.108; Lowe S., 2000, INVASIVE SPECIES SPE, V12, P12; Ministry of the Environment Japan, 2013, CONTR MAN ARG REV VE; Muyssen BTA, 2005, CHEMOSPHERE, V61, P1159, DOI 10.1016/j.chemosphere.2005.02.076; Nagai T, 2012, J PESTIC SCI, V37, P233, DOI 10.1584/jpestics.D11-047; OECD Guidelines for the Testing of Chemicals Test, 1998, OECD GUID TEST CHEM; Oranization for Economic Cooperation and Development (OECD), 1995, GUID DOC AQ EFF ASS; Pino FG, 2005, J HELMINTHOL, V79, P333; Posthuma II L., 2001, SPECIES SENSITIVITY; R Development Core Team, 2014, R LANG ENV STAT COMP; Rico A, 2010, ARCH ENVIRON CON TOX, V58, P765, DOI 10.1007/s00244-009-9409-5; Ritz C, 2005, J STAT SOFTW, V12, P1; RIVM, 2001, GUID DOC DER ENV RIS; Rouco M, 2014, OECOLOGIA, V175, P1179, DOI 10.1007/s00442-014-2963-1; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Rust MK, 2003, J ENTOMOL SCI, V38, P159; Sanchez-Bayo F, 2012, J ENV ANAL TOXICOL, VS4, pS4; Scharf ME, 2004, J ECON ENTOMOL, V97, P601, DOI 10.1603/0022-0493-97.2.601; SCHLUETER MA, 1995, ENVIRON TOXICOL CHEM, V14, P1727, DOI 10.1897/1552-8618(1995)14[1727:SOCJFM]2.0.CO;2; Silverman J, 2008, ANNU REV ENTOMOL, V53, P231, DOI 10.1146/annurev.ento.53.103106.093450; Soeprono AM, 2004, SOCIOBIOLOGY, V44, P669; Sunamura E, 2012, AGR RES UPDATES, V2, P207; Sunamura E, 2007, SOCIOBIOLOGY, V50, P659; USEPA, 1996, EPA737F96005 USEPA; USEPA, 1985, GUID DER NUM NAT WAT; White GL, 1998, INT J PEST MANAGE, V44, P115, DOI 10.1080/096708798228419; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391; Wiltz BA, 2009, J ECON ENTOMOL, V102, P2279	82	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0963-9292	1573-3017		ECOTOXICOLOGY	Ecotoxicology	AUG	2015	24	6					1221	1228		10.1007/s10646-015-1483-z		8	Ecology; Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CN6ZL	WOS:000358583100003		
J	Ikegami, Y; Konno, S; Isosu, T; Obara, S; Hakozaki, T; Akatsu, M; Murakawa, M				Ikegami, Yukihiro; Konno, Shinichi; Isosu, Tsuyoshi; Obara, Shinju; Hakozaki, Takahiro; Akatsu, Masahiko; Murakawa, Masahiro			Current state of emergency medicine in Fukushima 4 years after the Great East Japan Earthquake	EMERGENCY MEDICINE JOURNAL			English	Editorial Material									[Ikegami, Yukihiro; Isosu, Tsuyoshi; Obara, Shinju; Hakozaki, Takahiro; Murakawa, Masahiro] Fukushima Med Univ, Sch Med, Dept Anesthesiol, Fukushima 9601295, Japan; [Ikegami, Yukihiro; Konno, Shinichi; Akatsu, Masahiko] Fukushima Med Univ, Sch Med, Dept Disaster & Comprehens Med, Fukushima 9601295, Japan	Ikegami, Y (reprint author), Fukushima Med Univ, Sch Med, Dept Anesthesiol, 1 Hikarigaoka, Fukushima 9601295, Japan.	yikegami@fmu.ac.jp						0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	AUG	2015	32	8					665	667		10.1136/emermed-2014-204622		3	Emergency Medicine	Emergency Medicine	CN7BK	WOS:000358588300022		
J	Ferdouse, F; Hossain, MA; Paul, SK; Ahmed, S; Mahmud, MC; Ahmed, R; Haque, AKMF; Khan, MNAA; Ghosh, S; Urushibara, N; Kobayashi, N				Ferdouse, Faria; Hossain, Muhammad Akram; Paul, Shyamal Kumar; Ahmed, Salma; Mahmud, Md Chand; Ahmed, Rajib; Haque, A. K. M. Fazlul; Khan, M. Nur-a-Alam; Ghosh, Souvik; Urushibara, Noriko; Kobayashi, Nobumichi			Rickettsia felis Infection among Humans, Bangladesh, 2012-2013	EMERGING INFECTIOUS DISEASES			English	Letter							AFRICA; FEVER		[Ferdouse, Faria; Hossain, Muhammad Akram; Paul, Shyamal Kumar; Ahmed, Salma; Mahmud, Md Chand; Ahmed, Rajib; Haque, A. K. M. Fazlul; Khan, M. Nur-a-Alam] Mymensingh Med Coll, Mymensingh, Bangladesh; [Ghosh, Souvik; Urushibara, Noriko; Kobayashi, Nobumichi] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Ghosh, Souvik] Ross Univ, Sch Vet Med, St Kitts, W Ind Assoc St	Kobayashi, N (reprint author), Sapporo Med Univ, Sch Med, Dept Hyg, Chuo Ku, S-1 W-17, Sapporo, Hokkaido 0608556, Japan.	nkobayas@sapmed.ac.jp					Angelakis E, 2012, AM J TROP MED HYG, V86, P711, DOI 10.4269/ajtmh.2012.11-0424; Zhang JL, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0682-1; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Perez-Osorio CE, 2008, EMERG INFECT DIS, V14, P1019, DOI 10.3201/eid1407.071656; SCHRIEFER ME, 1994, J CLIN MICROBIOL, V32, P949; Mediannikov O, 2013, EMERG INFECT DIS, V19, P1775, DOI 10.3201/eid1911.130361; Dittrich S, 2014, EMERG INFECT DIS, V20, P1402, DOI 10.3201/eid2008.131308; Marie JL, 2006, AM J TROP MED HYG, V74, P436; Edouard S, 2014, EMERG INFECT DIS, V20, P1780, DOI 10.3201/eid2010.140905; Lai CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095810	10	0	0	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	AUG	2015	21	8					1483	1485		10.3201/eid2108.150328		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CN5GR	WOS:000358458300038		
J	Iwatsuki, T; Hagiwara, H; Ohmori, K; Munemoto, T; Onoe, H				Iwatsuki, Teruki; Hagiwara, Hiroki; Ohmori, Kazuaki; Munemoto, Takashi; Onoe, Hironori			Hydrochemical disturbances measured in groundwater during the construction and operation of a large-scale underground facility in deep crystalline rock in Japan	ENVIRONMENTAL EARTH SCIENCES			English	Article						Crystalline rocks; Groundwater monitoring; Hydrochemistry; Underground laboratory experiments	LEVEL RADIOACTIVE-WASTE; EXCAVATION DAMAGED ZONE; HYDROGEOCHEMICAL CONDITIONS; TUNNEL CONSTRUCTION; URANIUM DEPOSIT; NATURAL ANALOG; SWEDEN; REPOSITORY; EVOLUTION; STORAGE	Changes in the hydrochemical conditions of groundwater were evaluated following the construction of a large-scale underground facility at the Mizunami Underground Research Laboratory (MIU), Japan. The facility was constructed to a depth of 500 m in sedimentary and granitic rocks. Drawdown of the groundwater level in the range of several tens to hundreds of meters was observed up to hundreds of meters away from the shafts during the first ten years of facility construction and operation. Subsequent changes in groundwater chemistry occurred due to upconing of high-salinity groundwater from the deepest part of the shaft and the infiltration of low-salinity shallow groundwater. We predict that future deep groundwater chemistry in the vicinity of the MIU facility will resemble that of the present-day shallow groundwater. Multivariate statistical analysis provides fundamental insights into such a site. We found that the extent of hydrochemical variability related to MIU construction and operation was dependent on the distance from the facility shafts and galleries and on hydrogeological compartmentalization resulting from lithological boundaries (such as permeable conglomerates vs. more compact lithological units) and other features (such as faults or clay layers). We conclude that hydrochemical impact assessment of groundwater in low-permeability rock is essential prior to the construction of such a facility. This should include characterization of hydrogeological structures and compartments to propose suitable location of shafts and galleries.	[Iwatsuki, Teruki; Ohmori, Kazuaki; Munemoto, Takashi; Onoe, Hironori] Japan Atom Energy Agcy, Tono Geosci Ctr, Gifu 5096132, Japan; [Hagiwara, Hiroki] Japan Atom Energy Agcy, Fukushima Environm Safety Ctr, Fukushima, Fukushima 9608034, Japan	Iwatsuki, T (reprint author), Japan Atom Energy Agcy, Tono Geosci Ctr, 1-64 Yamanouchi, Gifu 5096132, Japan.	iwatsuki.teruki@jaea.go.jp					Younger PL, 2000, J CONTAM HYDROL, V44, P47, DOI 10.1016/S0169-7722(00)00090-5; Berner U, 2013, PHYS CHEM EARTH, V64, P46, DOI 10.1016/j.pce.2013.03.007; Kosakowski G, 2013, PHYS CHEM EARTH, V64, P65, DOI 10.1016/j.pce.2013.01.003; Farnham IM, 2003, ANAL CHIM ACTA, V490, P123, DOI 10.1016/S0003-2670(03)00350-7; Martinez-Landa L, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003458; Vales F, 2004, APPL CLAY SCI, V26, P197, DOI 10.1016/j.clay.2003.12.032; Marty NCM, 2009, J HYDROL, V364, P58, DOI 10.1016/j.jhydrol.2008.10.013; Tsang CF, 2005, INT J ROCK MECH MIN, V42, P109, DOI 10.1016/j.ijrmms.2004.08.003; Bossart P, 2002, ENG GEOL, V66, P19, DOI 10.1016/S0013-7952(01)00140-5; Cai M, 2005, TUNN UNDERGR SP TECH, V20, P301, DOI 10.1016/j.tust.2004.12.002; Thury M, 1999, ENG GEOL, V52, P347, DOI 10.1016/S0013-7952(99)00015-0; Sato T, 2000, ENG GEOL, V56, P97, DOI 10.1016/S0013-7952(99)00136-2; Iwatsuki T, 2005, APPL GEOCHEM, V20, P2283, DOI 10.1016/j.apgeochem.2005.09.002; Cai M, 2001, INT J ROCK MECH MIN, V38, P1135, DOI 10.1016/S1365-1609(01)00068-5; BANWART S, 1994, WATER RESOUR RES, V30, P1747, DOI 10.1029/94WR00155; Bauer S, 2013, ENVIRON EARTH SCI, V70, P3935, DOI 10.1007/s12665-013-2883-0; Cesano D, 2000, TUNN UNDERGR SP TECH, V15, P153, DOI 10.1016/S0886-7798(00)00043-2; Daimaru S, 2010, P 13 INT C ENV REM R, P149; Domenech C, 2006, R06108 SKB; Flint AL, 2001, REV GEOPHYS, V39, P447, DOI 10.1029/1999RG000075; Font-Capo J, 2012, GEOL ACTA, V10, P395, DOI 10.1344/105.000001773; Gascoyne M, 1995, APPL GEOCHEM, V10, P657, DOI 10.1016/0883-2927(95)00034-8; Grenier C, 2009, HYDROGEOL J, V17, P1051, DOI 10.1007/s10040-008-0415-x; Ii H, 1997, ENVIRON GEOL, V31, P76; Joyce S, 2010, R08108 SKB; Kumazaki N, 2003, TN74002003005 JNC DE; Laaksoharju M, 1999, APPL GEOCHEM, V14, P835, DOI 10.1016/S0883-2927(99)00023-2; Lee E, 2015, ENVIRON EARTH SCI, V73, P1179, DOI 10.1007/s12665-014-3473-5; Lee J, 2003, ENVIRON GEOL, V43, P901; Maejima T, 2003, TUNN UNDERGR SP TECH, V18, P223, DOI 10.1016/S0886-7798(03)00031-2; Mahara Y, 2001, APPL GEOCHEM, V16, P291, DOI 10.1016/S0883-2927(00)00032-9; Martinez-Landa L, 2006, J HYDROL, V325, P222, DOI 10.1016/j.jhydrol.2005.10.017; Metcalfe R, 2003, GROUNDWATER ENG RECE, P555; Ohyama T, 2008, P 36 IAH C; Olsson OL, 1996, P INT C DEEP GEOL DI, P101; Onoe H, 2011, 19 INT C NUCL ENG; Priyanto DG, 2014, GEOL SOC SPEC PUBL, V400, P399, DOI 10.1144/SP400.38; Saegusa H, 2003, GROUNDWATER ENG RECE, P563; Saegusa H, 2010, 2010067 JAEA; Sasao E, 2006, GEOCHEM-EXPLOR ENV A, V6, P5, DOI 10.1144/1467-7873/05-084; Shimono M, 2004, P ISRM INT S 3 AS RO, P359; Stober I, 2007, HYDROGEOL J, V15, P213, DOI 10.1007/s10040-006-0094-4; Takeuchi S, 2004, P 2 INT S DYN FLUID, P349; Utada M, 2003, RESOUR GEOL, V53, P293, DOI 10.1111/j.1751-3928.2003.tb00178.x; Yang FR, 2008, ENG GEOL, V103, P39; Yuguchi T, 2013, J MINER PETROL SCI, V108, P1, DOI 10.2465/jmps.120801b; Yuguchi T, 2011, CONTRIB MINERAL PETR, V162, P1063, DOI 10.1007/s00410-011-0640-5	47	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	AUG	2015	74	4					3041	3057		10.1007/s12665-015-4337-3		17	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CN3JB	WOS:000358320700021		
J	Zhou, CF; Fan, XX; Ning, ZG; Li, PX; Liu, CC; Yang, PL; Liu, YZ; Shi, Z; Li, YK				Zhou, Chunfa; Fan, Xiaoxuan; Ning, Zigong; Li, Pengxiang; Liu, Chengcheng; Yang, Peiling; Liu, Yaoze; Shi, Ze; Li, Yunkai			Reducing riverbed infiltration using mixtures of sodium bentonite and clay	ENVIRONMENTAL EARTH SCIENCES			English	Article						Reclaimed water; Sodium bentonite; Reducing infiltration; Nitrogen; Phosphate	SORPTION; WATER	Using reclaimed water has become one of the most effective ways to solve the problem of urban water shortage. Using mixtures of sodium bentonite and clay to reduce infiltration is an important safeguard measure to meet the need of groundwater recharge and water quality safety. The microscopic structure of sodium bentonite was studied with environmental scanning electron microscopy. The effect of different mix ratios of sodium bentonite and clay on the performance of reducing infiltration was studied with constant head infiltration experiments and adsorption of ammonium and phosphate with the batch method. The results showed that the dry particles of sodium bentonite had lamellar and compact structure, after absorbing water, and both the number and size of pores gradually reduced to become uniform distributions. With the increase of bentonite mix ratio (10-20 % of the total dry weight), the infiltration coefficient of the mixed materials decreased exponentially (R (2) = 0.95). Linear, Freundlich, and Langmuir equations could be used to describe adsorption of N/P on the mixed materials. There were significant correlations between adsorption parameters (S (m) and MBC) and bentonite mix ratio. The effect of removing ammonium with mixtures was better than that of phosphate. Considering synthetically the capability of reducing infiltration and decontamination, a mixture of 19 % bentonite and 81 % clay was a suitable model in the Yongding River in Beijing plain segment.	[Zhou, Chunfa; Fan, Xiaoxuan; Ning, Zigong; Liu, Chengcheng; Yang, Peiling; Shi, Ze; Li, Yunkai] China Agr Univ, Coll Water Conservancy & Civil Engn, Beijing 100083, Peoples R China; [Ning, Zigong; Li, Pengxiang] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0600809, Japan; [Liu, Yaoze] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA	Li, YK (reprint author), China Agr Univ, Coll Water Conservancy & Civil Engn, Beijing 100083, Peoples R China.	liyunkai@126.com			National Natural Science Fund of China [51321001]; Key Project of the Beijing Eleventh-Five Year Research Program [D090409004009004]; Special Fund for Water Conservancy scientific Research in the Public Interest [201001067]	We are grateful for financial support from the National Natural Science Fund of China (No. 51321001), Key Project of the Beijing Eleventh-Five Year Research Program (No. D090409004009004), Special Fund for Water Conservancy scientific Research in the Public Interest (NO. 201001067).	Braida WJ, 2003, ENVIRON SCI TECHNOL, V37, P409, DOI 10.1021/es020660z; Khan SA, 1995, WASTE MANAGE, V15, P641, DOI 10.1016/0956-053X(96)00049-9; Ayari F, 2005, DESALINATION, V185, P391, DOI 10.1016/j.desal.2005.04.046; Duan YL, 2011, THESIS YAN SHAN U QI; Gan YP, 2010, ADV TREATMENT RECYCL, P3; He JT, 2010, CHIN J NAT, V06, P348; Hu HY, 2011, RECLAIMED WATER QUAL, P18; Ma CP, 2007, THESIS TIANJIN U TIA; OECD, 2000, GUID TEST CHEM, P1; Pusino A, 2004, J AGR FOOD CHEM, V52, P3453; [涂逢樟 TU Fengzhang], 2007, [功能材料, Journal of Functional Materials], V38, P53; Wang GH, 2005, PET DRILL TECH, V33, P19; [徐义军 XU Yijun], 2008, [灌溉排水学报, Journal of Irrigation and Drainage], V27, P14; Yang Q, 2011, BEIJING WATER, V02, P01; Yu DM, 2010, THESIS HARBIN I TU H; Zhang HT, 2007, THESIS TONGJI U SHAN; Zhang WeiLi, 2004, Scientia Agricultura Sinica, V37, P1018; Zhou CF, 2013, APPL MECH MATER, V395-396, P678, DOI 10.4028/www.scientific.net/AMM.395-396.678; Zhu Jing-nan, 2010, Huanjing Kexue, V31, P1299	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	AUG	2015	74	4					3089	3098		10.1007/s12665-015-4347-1		10	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CN3JB	WOS:000358320700025		
J	Meten, M; Bhandary, NP; Yatabe, R				Meten, Matebie; Bhandary, Netra Prakash; Yatabe, Ryuichi			Application of GIS-based fuzzy logic and rock engineering system (RES) approaches for landslide susceptibility mapping in Selelkula area of the Lower Jema River Gorge, Central Ethiopia	ENVIRONMENTAL EARTH SCIENCES			English	Article						GIS; Fuzzy logic; Rock engineering system; Interaction matrix; Landslide susceptibility; Ethiopia	LOGISTIC-REGRESSION; NATURAL SLOPE; HAZARD; NILE; MODELS; JAPAN; INSTABILITY; EVOLUTION; BASALTS; REGION	Landslide susceptibility mapping is an important tool for disaster management and development activities such as planning of transportation infrastructure, settlement and agriculture. Selelkula area of the Jema River Gorge in Central Ethiopian Highland was chosen as a study area. Fuzzy logic (FL) and rock engineering system (RES) in a GIS environment were employed to prepare landslide susceptibility maps for this area. Data sets including slope, aspect, profile curvature, plan curvature, lithology, land use, distance from river and distance from lineament were generated using the field data, remote sensing and GIS. In FL, the fuzzy membership values were calculated by normalizing the frequency ratio values of each factor's class in a range between 0 and 1. Then, the fuzzy membership values were combined by fuzzy AND, fuzzy OR, fuzzy gamma, fuzzy sum and fuzzy product operators. A total of twelve landslide susceptibility maps were produced using FL and the best map was chosen based on area under the curve (AUC) of the receiver operating characteristic (ROC) curve and the highest difference between minimum and maximum susceptibility index values. Based on these criteria, the landslide susceptibility map produced using fuzzy gamma (gamma = 0.8) operator was selected. RES is a semi-quantitative method which assigns each factor's classes a value between 0 and 4 based on the principles of Hudson (Rock engineering systems, theory and practice. Ellis Horwood, Chichester, 1992) and uses an interaction matrix through a coding system of five values in previous researches but a coding system of nine values has been used in this study to provide a wider range of values for interactions among each pair of landslide factors and each landslide factor with a landslide. Unlike other methods, RES has a freedom to evaluate and assign each interaction based on expert's knowledge and experience. But it also bears the problem of subjectivity in assigning the interaction values. On the other hand, FL is completely data driven and does not show any subjectivity in assigning values for each factor class. The prediction accuracies of FL and RES, which can be determined from ROC curves, were found to be 87.2 and 88.6 %, respectively. For validation purpose, the existing landslides were overlaid over the two landslide susceptibility maps and the percentage of landslides in each susceptibility class was calculated. The percentages of landslides that fall in the high and very high susceptibility classes are slightly higher in RES than FL method and hence the former is more accurate in predicting the future landslide occurrence than the later.	[Meten, Matebie; Bhandary, Netra Prakash; Yatabe, Ryuichi] Ehime Univ, Grad Sch Sci & Engn, Geo Disaster Res Lab, Matsuyama, Ehime 7908577, Japan	Meten, M (reprint author), Ehime Univ, Grad Sch Sci & Engn, Geo Disaster Res Lab, 3 Bunkyo, Matsuyama, Ehime 7908577, Japan.	matebe21@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan	We would like to thank Kiran Prasad Acharya for his brief help in some part of the data analysis phases. The first author is also grateful to the Ministry of Education, Culture, Sports, Science and Technology of Japan for the scholarship grant provided for the doctoral research.	Gerscovich DMS, 2006, ENG GEOL, V88, P23, DOI 10.1016/j.enggeo.2006.07.008; Ayalew L, 2004, LANDSLIDES, V1, P73, DOI 10.1007/s10346-003-0006-9; Ercanoglu M, 2002, ENVIRON GEOL, V41, P720, DOI 10.1007/s00254-001-0454-2; Thiery Y, 2007, GEOMORPHOLOGY, V92, P38, DOI 10.1016/j.geomorph.2007.02.020; [Anonymous], 2007, ENG GEOL; Terlien MTJ, 1998, ENVIRON GEOL, V35, P124; Lee S, 2004, GEOSCI J, V8, P51, DOI 10.1007/BF02910278; Rozos D, 2011, ENVIRON EARTH SCI, V63, P49, DOI 10.1007/s12665-010-0687-z; Chung CJF, 1999, PHOTOGRAMM ENG REM S, V65, P1389; Coulie E, 2003, EARTH PLANET SC LETT, V206, P477, DOI 10.1016/S0012-821X(02)01089-0; Akgun A, 2011, COMPUT GEOSCI-UK, V37, P1515, DOI 10.1016/j.cageo.2010.09.006; Kieffer B, 2004, J PETROL, V45, P793, DOI 10.1093/petrology/egg112; CAPALDI G, 1987, LITHOS, V20, P433, DOI 10.1016/0024-4937(87)90028-4; Ohlmacher GC, 2003, ENG GEOL, V69, P331, DOI 10.1016/S0013-7952(03)00069-3; Pik R, 2003, EARTH PLANET SC LETT, V215, P73, DOI 10.1016/S0012-821X(03)00457-6; WOLDEGABRIEL G, 1990, GEOL SOC AM BULL, V102, P439, DOI 10.1130/0016-7606(1990)102<0439:GGARBD>2.3.CO;2; Pradhan B, 2011, ENVIRON EARTH SCI, V63, P329, DOI 10.1007/s12665-010-0705-1; Yilmaz I, 2009, B ENG GEOL ENVIRON, V68, P459, DOI 10.1007/s10064-009-0188-z; Cervi F, 2010, LANDSLIDES, V7, P433, DOI 10.1007/s10346-010-0207-y; Ayalew L, 2004, GEOMORPHOLOGY, V57, P95, DOI 10.1016/S0169-555X(03)00085-0; Ayalew L, 2005, ENG GEOL, V81, P432, DOI 10.1016/j.enggeo.2005.08.004; Hofmann C, 1997, NATURE, V389, P838; Gani NDS, 2006, J AFR EARTH SCI, V44, P135, DOI 10.1016/j.jafrearsci.2005.10.007; Begueria S, 2006, NAT HAZARDS, V37, P315, DOI 10.1007/s11069-005-5182-6; [Anonymous], 2001, GEOL SOC AM SPEC PAP; Fell R, 2008, ENG GEOL, V102, P85, DOI 10.1016/j.enggeo.2008.03.022; Lee S, 2007, ENVIRON GEOL, V52, P615, DOI 10.1007/s00254-006-0491-y; Ayenew T, 2005, ENG GEOL, V77, P1, DOI 10.1016/j.enggeo.2004.07.002; Ercanoglu M, 2004, ENG GEOL, V75, P229, DOI 10.1016/j.enggeo.2004.06.001; Clerici A, 2006, ENVIRON GEOL, V50, P941, DOI 10.1007/s00254-006-0264-7; Saha AK, 2005, LANDSLIDES, V2, P61, DOI 10.1007/s10346-004-0039-8; Ayalew L, 2005, GEOMORPHOLOGY, V65, P15, DOI 10.1016/j.geomorph.2004.06.010; Pradhan B, 2010, COMPUT ENVIRON URBAN, V34, P216, DOI 10.1016/j.compenvurbsys.2009.12.004; Pistocchi A, 2002, ENVIRON GEOL, V41, P765, DOI 10.1007/s002540100440; Ruff M, 2008, GEOMORPHOLOGY, V94, P314, DOI 10.1016/j.geomorph.2006.10.032; Wolfenden E, 2004, EARTH PLANET SC LETT, V224, P213, DOI 10.1016/j.epsl.2004.04.022; Marty B, 1996, EARTH PLANET SC LETT, V144, P223, DOI 10.1016/0012-821X(96)00158-6; Dahal RK, 2008, GEOMORPHOLOGY, V102, P496, DOI 10.1016/j.geomorph.2008.05.041; Pradhan B, 2010, J INDIAN SOC REMOT, V38, P301, DOI 10.1007/s12524-010-0020-z; Bonham-Carter G.F., 1994, COMPUTER METHODS GEO, V13, P398; Bonini M, 2005, TECTONICS, V24, DOI [10.1029/2004TC001680, 10.1029/2004TC00168]; Carson M. A., 1972, HILLSLOPE FORM PROCE; Castellanos Abella EA, 2008, GEOMORPHOLOGY, V94, P453, DOI DOI 10.1016/J.GEOMORPH.2006.10.038; Chung CJ, 2006, COMPUT GEOSCI-UK, V32, P1052, DOI 10.1016/j.cageo.2006.02.003; Costa JE, 1981, SURFICIAL GEOLOGY BU; Davis PM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013676; Gani N., 2007, GSA TODAY, V17, P4, DOI DOI 10.1130/GSAT01709A.1; Gorsevski P. V., 2006, Transactions in GIS, V10, P395, DOI 10.1111/j.1467-9671.2006.01004.x; Hack J. T., 1960, 347 US GEOL SURV; Hirota K, 1995, ADV FUZZY SYSTEMS AP, V2; Hudson J, 1992, ROCK ENG SYSTEMS THE; HUDSON JA, 1992, Q J ENG GEOL, V25, P93, DOI 10.1144/GSL.QJEG.1992.025.02.03; JIAO Y, 1995, INT J ROCK MECH MIN, V32, P491, DOI 10.1016/0148-9062(95)00038-I; Kayastha P, 2012, FRONT EARTH SCI-PRC, V6, P420, DOI 10.1007/s11707-012-0337-8; KhaloKakaie R, 2012, ARAB J GEOSCI, V5, P263, DOI 10.1007/s12517-010-0150-1; Mazzoccola DF, 1996, Q J ENG GEOL, V29, P37, DOI 10.1144/GSL.QJEGH.1996.029.P1.03; MCDOUGALL I, 1975, NATURE, V254, P207, DOI 10.1038/254207a0; Mohr P, 1967, B GEOPHYSICAL OBSERV, V10, P79; Mohr P., 1988, CONTINENTAL FLOOD BA, P63; Pradhan B, 2010, INT J COMPUT INT SYS, V3, P370; Pradhan B, 2009, APPL GEOMATICS, V1, P3; Rafiee R, 2015, ROCK MECH ROCK ENG, V48, P1207, DOI 10.1007/s00603-014-0614-9; Regmi NR, 2010, GEOMORPHOLOGY, V122, P25, DOI 10.1016/j.geomorph.2010.05.009; Reneau SL, 1987, REV ENG GEOL, VVII, P165; Rozos D, 2008, LANDSLIDES, V5, P261, DOI 10.1007/s10346-008-0117-4; Russo A, 1994, NEUES JB GEOLOGIE PA, V5, P291; TERLIEN MTJ, 1995, ADV NAT TECHNOL HAZ, V5, P57; Wan SA, 2009, ENG GEOL, V108, P237, DOI 10.1016/j.enggeo.2009.06.014; Weissel JK, 1995, FRACTALS PETROLEUM G, P127; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhu Lei, 2006, Journal of Zhejiang University (Science), V7, DOI 10.1631/jzus.2006.A2007; Zimmermann HJ, 1999, PRACTICAL APPL FUZZY	72	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	AUG	2015	74	4					3395	3416		10.1007/s12665-015-4377-8		22	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CN3JB	WOS:000358320700047		
J	Tri, DQ; Don, NC; Ching, CY; Mishra, PK				Tri, Doan Quang; Don, Nguyen Cao; Ching, Chen Yi; Mishra, P. K.			Application of environmental sensitivity index (ESI) maps of shorelines to coastal oil spills: a case study of Cat Ba Island, Vietnam	ENVIRONMENTAL EARTH SCIENCES			English	Article						Cat Ba Island in Vietnam; Lach Huyen port; Environmental sensitivity index (ESI); Shoreline classification; Oil spill model	SEA	The transportation of crude diesel oil in Lach Huyen port (Cat Ba Island) in Northeast Vietnam has increased due to industry development. These areas support tankers and other ships, which therefore increases the potential for oil spills from ships's and or tankers's collision. This paper presents the development of a two-dimensional hydrodynamic model for prediction of oil spill trajectories. An oil spill model combining with a GIS supportive software was also established to simulate hydrodynamic flow and the transportation of crude oil trajectories to the environment. Both models were calibrated and validated using field data. The GIS supportive software was applied for mapping the environmental sensitivity index that accounts for digital databases as well as for the abundant biodiversity and coastal geomorphologic features of the shoreline. The simulation results from the hydrodynamic flow model showed that the hydrodynamic flow regime in the study area is complicated due to the influence of seabed geometries with many small islands and riverine estuaries. Results from the oil spill model revealed that an oil spill even at Lach Huyen port would affect and spread out across a vast area. Environmental sensitivity maps of the shoreline for the Cat Ba ecosystem were subsequently constructed to explain how oil spills affect the marine environment. This study can be used to provide the information and preparedness for coastline managers in their effort to protect shoreline from major oil or chemical disasters.	[Tri, Doan Quang; Ching, Chen Yi] DaYeh Univ, Dept Environm Engn, Changhua, Taiwan; [Mishra, P. K.] Mendel Univ Brno, Dept Wood Sci, Brno, Czech Republic; [Don, Nguyen Cao] NIES, Tsukuba, Ibaraki 3050053, Japan; [Don, Nguyen Cao] Saga Natl Univ, Inst Lowland & Marine Res, Saga 8408502, Japan	Don, NC (reprint author), Thuyloi Univ, 175 Tay Son Rd, Hanoi, Vietnam.	ncaodonwru@gmail.com	mishra, pawan kumar/B-4852-2014	mishra, pawan kumar/0000-0002-5600-0435	Da-Yeh University of Taiwan	We are grateful to thank Ly DT, Ha TN and Khuong VH for their assistance with the collection of land use, topography, meteorological, and oceanographic data. We are thankful to HMEC and IMER for this research opportunity and for the facilities used to perform the study. The research was financially supported in part by Da-Yeh University of Taiwan.	Aamo OM, 1997, PROCEEDINGS OF THE TWENTIETH ARCTIC AND MARINE OILSPILL PROGRAM (AMOP) TECHNICAL SEMINAR, VOLS 1 AND 2, P289; Ajibola VO, 2011, INT J ENVIRON RES, V5, P901; Vethamony P, 2007, ENVIRON POLLUT, V148, P438, DOI 10.1016/j.envpol.2006.12.017; Daling PS, 1999, SPILL SCI TECHNOL B, V5, P63, DOI 10.1016/S1353-2561(98)00051-6; JANSSEN PAEM, 1991, J PHYS OCEANOGR, V21, P1631, DOI 10.1175/1520-0485(1991)021<1631:QLTOWW>2.0.CO;2; JANSSEN PAEM, 1989, J PHYS OCEANOGR, V19, P745, DOI 10.1175/1520-0485(1989)019<0745:WISATD>2.0.CO;2; Belkhiri L, 2011, INT J ENVIRON RES, V5, P537; Brebbia CA, 2002, WATER STUDIES, V11, P480; Brebbia CA, 2004, ENV STUDIES, V10, P484; Daniel R, 2012, INT J ENVIRON RES, V6, P711; Dimitrov AN, 2011, INT J ENVIRON RES, V6, P435; Epstein PR, 2002, OIL LIFE CYCLE ANAL; Huang JC, 1983, P 1983 OIL SPILL C W, P313; Kavian A, 2011, INT J ENVIRON RES, V5, P939; Kolluru VS, 1994, P 17 ARCT MAR OIL SP, P867; Komen GJ, 1994, DYNAMICS MODELLING O, P560; Li Z, 1999, ENV HYDRAULICS; Mackay D., 1980, MATH MODEL OIL SPILL; MICHEL J, 1978, ENVIRON GEOL, V2, P107; Mwegoha WJS, 2011, INT J ENVIRON RES, V5, P307; Najafi A, 2011, INT J ENVIRON RES, V5, P277; Nash J. E., 1970, J HYDROL, V10, P282, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NOAA, 2002, 11 NOAA NOS OR R; Piccini C, 2012, INT J ENVIRON RES, V6, P853; Quan Nguyen Van, 2010, Journal of Ecology and Field Biology, V33, P23, DOI 10.5141/JEFB.2010.33.1.023; Sadatipour SMT, 2012, INT J ENVIRON RES, V6, P645; Wang SD, 2005, OCEAN ENG, V32, P1556, DOI 10.1016/j.oceaneng.2004.12.010; YAPA PD, 1994, J MARINE SYST, V4, P453, DOI 10.1016/0924-7963(94)90021-3; Young IR, 1999, ELSEVIER OCEAN ENG S, V2, P306, DOI [10.1016/so378-3839(00)00061-1, DOI 10.1016/S0378-3839(00)00061-1]	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	AUG	2015	74	4					3433	3451		10.1007/s12665-015-4380-0		19	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CN3JB	WOS:000358320700049		
J	Zhang, Y; Gao, Y; Shi, R; Chen, DD; Wang, XJ; Kamijima, M; Sakai, K; Nakajima, T; Khalequzzaman, M; Zhou, YJ; Zheng, Y; Bao, PP; Tian, Y				Zhang, Yan; Gao, Yu; Shi, Rong; Chen, Didi; Wang, Xiaojin; Kamijima, Michihiro; Sakai, Kiyoshi; Nakajima, Tamie; Khalequzzaman, Md.; Zhou, Yijun; Zheng, Ying; Bao, Pingping; Tian, Ying			Household pesticide exposure and the risk of childhood acute leukemia in Shanghai, China	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Child; Acute leukemia; Household; Pesticides; Case-control; China	CHILDREN	Childhood acute leukemia (AL) is the most common malignant tumor in children, but its etiology remains largely unknown. We investigated the relationship between household exposure to pesticides and childhood AL. Between 2009 and 2010 in Shanghai, a total of 248 newly diagnosed cases of AL and 111 gender-, age-, and hospital-matched controls were included. Five nonspecific dialkyl phosphate (DAP) metabolites of organophosphate pesticides (OPPs) [including dimethyl phosphate (DMP), diethyl phosphate (DEP), dimethyl thiophosphate (DMTP), diethyl thiophosphate (DETP), and diethyl dithiophosphate (DEDTP)] in the urine were analyzed by gas chromatography. The results showed that the median DMP, DEP, DMTP, DETP, and DEDEP levels adjusted for creatinine (Cr) in cases (13.2, 10.0, 31.3, 8.5, and 6.1 mu g g(-1), respectively) were all significantly elevated compared with those in controls (3.6, 3.6, 13.3, 2.7, and 1.7 mu g g(-1), respectively) (P < 0.05). The household use of mosquito repellent was significantly associated with an increased risk of childhood AL (odds ratio (OR) = 1.9; 95 % confidence interval (CI) 1.2-3.1). Moreover, higher exposures were significantly associated with an elevated risk of childhood AL for DMs, DEs, and DAPs. Our findings support the notion that the household use of pesticides may play a role in the etiology of childhood AL and provide some evidence to warrant further investigation of the link between household pesticide exposures and childhood AL in Shanghai.	[Zhang, Yan; Gao, Yu; Shi, Rong; Chen, Didi; Zhou, Yijun; Tian, Ying] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200025, Peoples R China; [Wang, Xiaojin] Shanghai Jiao Tong Univ, Sch Med, Dept Biostat, Shanghai 200025, Peoples R China; [Kamijima, Michihiro] Nagoya City Univ, Grad Sch Med Sci, Dept Occupat & Environm Hlth, Nagoya, Aichi, Japan; [Sakai, Kiyoshi] Nagoya City Publ Hlth Res Inst, Dept Environm Hlth, Nagoya, Aichi, Japan; [Nakajima, Tamie; Khalequzzaman, Md.] Nagoya City Univ, Sch Med, Dept Occupat & Environm Hlth, Nagoya, Aichi 467, Japan; [Zheng, Ying; Bao, Pingping] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Tian, Ying] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE, Shanghai 200025, Peoples R China; [Tian, Ying] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200025, Peoples R China	Gao, Y (reprint author), Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Dept Environm Hlth, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	gaoyu_ciel@sjtu.edu.cn; tianmiejp@sjtu.edu.cn			Natural Science Foundation of China [30901171, 81172625]; Science and Technology Commission of Shanghai Municipality [09ZR141650, 12ZR1416100]; Shanghai Key Discipline Construction Project of Shanghai Municipal Public Health [12GWZX0401]; Shanghai Jiaotong University School of Medicine Foundation [12XJ10006, 12XJ10042]	We are extremely grateful to all the mothers and children who took part and to the doctors and nurses in the Shanghai Children's Hospital, Xinhua Hospital, Shanghai Children Medical Center, and the Children's Hospital of Fudan University for their cooperation and help. We gratefully acknowledge the contribution of Professor Shilu Tong (School of Public Health and Institute of Health and Biomedical Innovation, Queensland University of Technology) for his comments and English editing on our manuscript. We also thank the staff and students of the Department of Environmental Health, Shanghai Jiao Tong University, whose efforts made the study possible. The study was supported by grants from the Natural Science Foundation of China (Grant Nos. 30901171 and 81172625), the Science and Technology Commission of Shanghai Municipality (Grant Nos. 09ZR141650 and 12ZR1416100), Shanghai Key Discipline Construction Project of Shanghai Municipal Public Health (Grant No. 12GWZX0401), and the Shanghai Jiaotong University School of Medicine Foundation (Grant Nos. 12XJ10006 and 12XJ10042).	BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Coronado GD, 2004, ENVIRON HEALTH PERSP, V112, P142, DOI 10.1289/eph.6412; Ritz B, 2008, RADIAT PROT DOSIM, V132, P148, DOI 10.1093/rpd/ncn268; BENNETT JM, 1985, ANN INTERN MED, V103, P460; [Anonymous], 2009, 4 CDCP; Soldin OP, 2009, THER DRUG MONIT, V31, P495, DOI 10.1097/FTD.0b013e3181aae982; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Ding GD, 2012, ENVIRON SCI TECHNOL, V46, P2911, DOI 10.1021/es202583d; Ma XM, 2002, ENVIRON HEALTH PERSP, V110, P955; Menegaux F, 2006, OCCUP ENVIRON MED, V63, P131, DOI 10.1136/oem.2005.023036; Arcury TA, 2006, AM J IND MED, V49, P751, DOI 10.1002/ajim.20354; Buffler PA, 2005, CANCER INVEST, V23, P60, DOI 10.1081/CNV-200046402; Crinnion WJ, 2010, ALTERN MED REV, V15, P101; Meinert R, 2000, AM J EPIDEMIOL, V151, P639; Bao PP, 2009, PEDIATR BLOOD CANCER, V53, P13, DOI 10.1002/pbc.21939; Turner MC, 2010, ENVIRON HEALTH PERSP, V118, P33, DOI 10.1289/ehp.0900966; Rudant J, 2007, ENVIRON HEALTH PERSP, V115, P1787, DOI 10.1289/ehp.10596; He F, 1997, Zhonghua Yu Fang Yi Xue Za Zhi, V31, P197; Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46, DOI DOI 10.1080/1047322X.1990.10389587; IARC, 1991, IARC MON EV CARC RIS, V53, P5; Ichimaru M, 1978, RADIAT RES, V19, P262; Jiang ZK, 2006, ZHONGHUA WEI SHENG S, V12, P413; Meinert R, 2000, AM J EPIDEMIOL, V151, P647; Wang P, 2011, ENVIRON INT, V42, P100; Yang DR, 1998, ZHONGHUA LAO DONG WE, V16, P348; Yang YL, 2003, CHINESE J HLTH LAB, V13, P24; [张妍 Zhang Yan], 2011, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V45, P41	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	AUG	2015	22	15					11755	11763		10.1007/s11356-015-4362-5		9	Environmental Sciences	Environmental Sciences & Ecology	CN3MM	WOS:000358330800051		
J	Bom, VLP; de Castro, PA; Winkelstroter, LK; Marine, M; Hori, JI; Ramalho, LNZ; dos Reis, TF; Goldman, MHS; Brown, NA; Rajendran, R; Ramage, G; Walker, LA; Munro, CA; Rocha, MC; Malavazi, I; Hagiwara, D; Goldman, GH				Pedro Bom, Vincius Leite; de Castro, Patricia Alves; Winkelstroeter, Lizziane K.; Marine, Marcal; Hori, Juliana I.; Zambelli Ramalho, Leandra Naira; dos Reis, Thaila Fernanda; Goldman, Maria Helena S.; Brown, Neil Andrew; Rajendran, Ranjith; Ramage, Gordon; Walker, Louise A.; Munro, Carol A.; Rocha, Marina Campos; Malavazi, Iran; Hagiwara, Daisuke; Goldman, Gustavo H.			The Aspergillus fumigatus sitA Phosphatase Homologue Is Important for Adhesion, Cell Wall Integrity, Biofilm Formation, and Virulence	EUKARYOTIC CELL			English	Article							PROTEIN-KINASE-C; PREVENTS IMMUNE RECOGNITION; OXIDATIVE STRESS-RESPONSE; AIRBORNE FUNGAL SPORES; SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; CANDIDA-ALBICANS; INVASIVE ASPERGILLOSIS; TRANSCRIPTION FACTORS; BETA-GLUCANS	Aspergillus fumigatus is an opportunistic pathogenic fungus able to infect immunocompromised patients, eventually causing disseminated infections that are difficult to control and lead to high mortality rates. It is important to understand how the signaling pathways that regulate these factors involved in virulence are orchestrated. Protein phosphatases are central to numerous signal transduction pathways. Here, we characterize the A. fumigatus protein phosphatase 2A SitA, the Saccharomyces cerevisiae Sit4p homologue. The sitA gene is not an essential gene, and we were able to construct an A. fumigatus null mutant. The Delta sitA strain had decreased MpkA phosphorylation levels, was more sensitive to cell wall-damaging agents, had increased beta-(1,3)-glucan and chitin, was impaired in biofilm formation, and had decreased protein kinase C activity. The Delta sitA strain is more sensitive to several metals and ions, such as MnCl2, CaCl2, and LiCl, but it is more resistant to ZnSO4. The Delta sitA strain was avirulent in a murine model of invasive pulmonary aspergillosis and induces an augmented tumor necrosis factor alpha (TNF-alpha) response in mouse macrophages. These results stress the importance of A. fumigatus SitA as a possible modulator of PkcA/MpkA activity and its involvement in the cell wall integrity pathway.	[Pedro Bom, Vincius Leite; de Castro, Patricia Alves; Winkelstroeter, Lizziane K.; Marine, Marcal; Hori, Juliana I.; dos Reis, Thaila Fernanda; Brown, Neil Andrew; Goldman, Gustavo H.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Zambelli Ramalho, Leandra Naira] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Rajendran, Ranjith; Ramage, Gordon] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow Dent Sch,Infect & Immun Res Grp, Glasgow, Lanark, Scotland; [Walker, Louise A.] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Rocha, Marina Campos; Malavazi, Iran] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Paulo, Brazil; [Hagiwara, Daisuke] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Goldman, Gustavo H.] Natl Lab Sci & Technol Bioethanol CTBE, Campinas, SP, Brazil	Goldman, GH (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	ggoldman@usp.br	Malavazi, Iran/E-4132-2013; 	Rajendran, Ranjith/0000-0002-1069-7986	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	We thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for providing financial support.	da Rocha AB, 2002, ONCOLOGIST, V7, P17, DOI 10.1634/theoncologist.7-1-17; Beck T, 1999, NATURE, V402, P689; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Masuda CA, 2000, J BIOL CHEM, V275, P30957, DOI 10.1074/jbc.M004869200; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Sussman A, 2004, EUKARYOT CELL, V3, P932, DOI 10.1128/EC.3.4.932-943.2004; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Jarvis WD, 1999, INVEST NEW DRUG, V17, P227, DOI 10.1023/A:1006328303451; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Lee CM, 2004, MOL MICROBIOL, V51, P691, DOI 10.1046/j.1365-2958.2003.03879.x; Aimanianda V, 2010, VIRULENCE, V1, P185, DOI 10.4161/viru.1.3.11317; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Carrion SD, 2013, J IMMUNOL, V191, P2581, DOI 10.4049/jimmunol.1300748; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Perez-Nadales E, 2014, FUNGAL GENET BIOL, V70, P42, DOI 10.1016/j.fgb.2014.06.011; Shepardson KM, 2013, MICROBES INFECT, V15, P259, DOI 10.1016/j.micinf.2012.11.010; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; SUTTON A, 1991, MOL CELL BIOL, V11, P2133; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; de la Torre-Ruiz MA, 2002, J BIOL CHEM, V277, P33468, DOI 10.1074/jbc.M203515200; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Käfer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0; Sellam A, 2014, EUKARYOT CELL, V13, P675, DOI 10.1128/EC.00292-13; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Gibbons JG, 2013, TRENDS MICROBIOL, V21, P14, DOI 10.1016/j.tim.2012.09.005; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Reyes G, 2006, EUKARYOT CELL, V5, P1934, DOI 10.1128/EC.00178-06; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Mehrad B, 1999, J IMMUNOL, V162, P1633; Xue T, 2004, EUKARYOT CELL, V3, P557, DOI 10.1128/EC.3.2.557-560.2004; Arpaia G, 1999, MOL GEN GENET, V262, P314; Beauvais A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003716; Shopova I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00141; Dinamarco TM, 2012, EUKARYOT CELL, V11, P518, DOI 10.1128/EC.00016-12; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Hayashi N, 2005, CURR GENET, V47, P359, DOI 10.1007/s00294-005-0577-1; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Jacinto Estela, 2007, V365, P323; Juvvadi PR, 2007, BIOCHEM J, V405, P533, DOI 10.1042/BJ20061678; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; MANN DJ, 1993, EMBO J, V12, P4833; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; May GS, 2005, MED MYCOL, V43, pS83, DOI 10.1080/13693780400024784; MAY GS, 2008, MYCOLOGY S, V26, P121; Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591; Montero-Lomeli M, 2002, J BIOL CHEM, V277, P21542, DOI 10.1074/jbc.M201977200; Müller Sebastian, 2012, BMC Genomics, V13, P519, DOI 10.1186/1471-2164-13-519; Samantaray S, 2013, EUKARYOT CELL, V12, P288, DOI 10.1128/EC.00246-12; Sambrook J., 1989, MOL CLONING LAB MANU; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taramelli D, 1996, J MED VET MYCOL, V34, P49; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Winkelstroter LK, 2015, MOL MICROBIOL, V96, P42, DOI 10.1111/mmi.12919; Yamaguchi Hideyo, 2002, Journal of Infection and Chemotherapy, V8, P374, DOI 10.1007/s10156-002-0201-y; Zabrocki P, 2002, MOL MICROBIOL, V43, P835, DOI 10.1046/j.1365-2958.2002.02786.x	77	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1535-9778	1535-9786		EUKARYOT CELL	Eukaryot. Cell	AUG	2015	14	8					728	744		10.1128/EC.00008-15		17	Microbiology; Mycology	Microbiology; Mycology	CN8DB	WOS:000358667000001		
J	Takeuchi, A; Okamoto, N; Fujinaga, S; Morita, H; Shimizu, J; Akiyama, T; Ninomiya, S; Takanashi, J; Kubo, T				Takeuchi, Akihito; Okamoto, Nobuhiko; Fujinaga, Shoko; Morita, Hirosuke; Shimizu, Junya; Akiyama, Tomoyuki; Ninomiya, Shinsuke; Takanashi, Jun-ichi; Kubo, Toshihide			Progressive brain atrophy in Schinzel-Giedion syndrome with a SETBP1 mutation	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						Schinzel-Giedion syndrome; SETBP1; Brain atrophy; Magnetic resonance imaging; Diffusion weighted imaging	FEATURES	Schinzel-Giedion syndrome is a rare congenital malformation syndrome. Recently, SETBP1 was identified as the causative gene. Herein, we present a Japanese boy with Schinzel-Giedion syndrome resulting from a novel mutation in SETBP1 in order to establish the clinical features and serial MRI findings associated with the syndrome. On the third day of life, the boy was referred to our hospital because of facial abnormalities and feeding difficulty. Midfacial retraction, frontal bossing, deep groove under the eyes, upturned nose, low-set ears, bilateral cryptorchidism, and generalized hypertrichosis were identified on admission. At the age of 7 months, epileptic spasms in series occurred. Based on characteristic facial and skeletal abnormalities and severe developmental delay, we clinically diagnosed him with Schinzel-Giedion syndrome. Direct sequencing of the SETBP1 gene revealed a heterozygous mutation (p.Ile871Ser) in exon 4. Although neither cardiac defect nor choanal stenosis were present in our case, the phenotype of our case was nearly identical to those of previously reported cases confirmed by genetic analysis. Serial MRI from the age of 1 month-3 years revealed progressive brain atrophy, especially in the white matter and basal ganglia. However, myelination was age-appropriate and no obvious abnormal signals in the white matter were seen. Diffusion weighted imaging revealed no abnormal findings. Accumulation of MRI data including diffusion weighted imaging from Schinzel-Giedion syndrome cases is needed to understand the mechanism underlying progressive brain atrophy in this syndrome. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Takeuchi, Akihito; Morita, Hirosuke] Natl Hosp Org, Okayama Med Ctr, Dept Neonatol, Okayama 7011192, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Fujinaga, Shoko; Shimizu, Junya; Kubo, Toshihide] Natl Hosp Org, Okayama Med Ctr, Dept Pediat, Okayama 7011192, Japan; [Akiyama, Tomoyuki] Okayama Univ Hosp, Dept Child Neurol, Okayama, Japan; [Ninomiya, Shinsuke] Kurashiki Cent Hosp, Dept Med Genet, Kurashiki, Okayama, Japan; [Takanashi, Jun-ichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Yachiyo, Japan	Takeuchi, A (reprint author), Natl Hosp Org, Okayama Med Ctr, Dept Neonatol, Kita Ku, 1711-1 Tamasu, Okayama 7011192, Japan.	gmd18025@s.okayama-u.ac.jp					Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Carvalho E, 2015, AM J MED GENET A, V167, P1039, DOI 10.1002/ajmg.a.36789; Grosso S, 2003, BRAIN DEV-JPN, V25, P294, DOI 10.1016/S0387-7604(02)00232-2; Jones Kenneth Lyons, 2013, SMITHS RECOGNIZABLE, P302; Ko JM, 2013, CHILD NERV SYST, V29, P525, DOI 10.1007/s00381-013-2047-2; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; López-González V, 2015, An Pediatr (Barc), V82, pe12, DOI 10.1016/j.anpedi.2014.06.017; MACLENNAN AC, 1991, J MED GENET, V28, P547, DOI 10.1136/jmg.28.8.547; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Shah AM, 1999, AM J MED GENET, V82, P344, DOI 10.1002/(SICI)1096-8628(19990212)82:4<344::AID-AJMG13>3.0.CO;2-H; Suphapeetiporn K, 2011, CLIN GENET, V79, P391, DOI 10.1111/j.1399-0004.2010.01552.x; Watanabe S, 2012, BRAIN DEV-JPN, V34, P151, DOI 10.1016/j.braindev.2011.03.010	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	AUG	2015	58	8					369	371		10.1016/j.ejmg.2015.05.006		3	Genetics & Heredity	Genetics & Heredity	CN9SF	WOS:000358788600001		
J	Horn, D; Prescott, T; Houge, G; Braekke, K; Rosendahl, K; Nishimura, G; FitzPatrick, DR; Spranger, J				Horn, Denise; Prescott, Trine; Houge, Gunnar; Braekke, Kristin; Rosendahl, Karen; Nishimura, Gen; FitzPatrick, David R.; Spranger, Juergen			A Novel Oculo-Skeletal syndrome with intellectual disability caused by a particular MAB21L2 mutation	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						Rhizomelia; Anophthalmia; Intellectual disability; MAB21L2	PEROXISOME BIOGENESIS DISORDERS; MALFORMATIONS; DYSPLASIA; GENETICS	We describe a novel recognizable phenotype characterized by anophthalmia, a distinctive skeletal dysplasia and intellectual disability. Radiographic anomalies include severe rhizomelic shortness of the limbs and abnormal joint formation. Recent exome studies showed that these characteristics are part of the phenotypic spectrum of MAB21L2 gene mutations which cause a range of structural eye malformations such as microphthalmia/anophthalmia and ocular coloboma. The two unrelated individuals described here in detail are heterozygous carriers of the same de novo missense mutation c.151C > T (p.Arg51Cys) in MAB21L2. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Horn, Denise] Charite, Inst Med Genet & Humangenet, D-13353 Berlin, Germany; [Prescott, Trine] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Houge, Gunnar] Haukeland Hosp, Ctr Med Genet, N-5021 Bergen, Norway; [Braekke, Kristin] Oslo Univ Hosp, Dept Pediat, Oslo, Norway; [Rosendahl, Karen] Univ Bergen, Dept Clin Med 1, N-5020 Bergen, Norway; [Rosendahl, Karen] Haukeland Hosp, N-5021 Bergen, Norway; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Tokyo, Japan; [FitzPatrick, David R.] MRC, Human Genet Unit, MRC Inst Med Genet & Mol Med, Edinburgh, Midlothian, Scotland	Horn, D (reprint author), Charite, Inst Med Genet & Humangenet, Augustenburger Pl 1, D-13353 Berlin, Germany.	denise.horn@charite.de		FitzPatrick, David/0000-0003-4861-969X			Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; Kamoda T, 2001, PEDIATR RADIOL, V31, P81, DOI 10.1007/s002470000401; URBACH D, 1986, CLIN GENET, V29, P83	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	AUG	2015	58	8					387	391		10.1016/j.ejmg.2015.06.003		5	Genetics & Heredity	Genetics & Heredity	CN9SF	WOS:000358788600005		
J	Taniguchi, F; Enatsu, A; Ota, I; Toda, T; Arata, K; Harada, T				Taniguchi, Fuminori; Enatsu, Akiko; Ota, Ikuko; Toda, Toshiko; Arata, Kazuya; Harada, Tasuku			Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma	EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY			English	Article						DRSP; Low dose oral contraceptive pills; Ovarian endometrioma	OVARIAN ENDOMETRIOMAS; STROMAL CELLS; HORMONAL CONTRACEPTIVES; PELVIC PAIN; PROLIFERATION; DROSPIRENONE; EXPRESSION; MANAGEMENT; CYSTECTOMY; WOMEN	Objectives: Low dose oral contraceptive pills (OCPs) that contain synthetic estrogen and progestin are often used to relieve chronic pelvic pain associated with endometriosis. We sought to evaluate the efficacy of drospirenone/ethinylestradiol (DRSP/EE) with low-dose estrogen in treating endometrioma. Study design: A prospective clinical study in six hospitals and one clinic in Japan was conducted. Forty-nine 23- to 45-year-old patients who suffered from endometriosis-associated dysmenorrhea were included in the study. The primary endpoint was the change in size of ovarian endometrioma as measured by transvaginal ultrasonography. The secondary endpoint was the change in dysmenorrhea as evaluated by VAS (visual analog scale) scores before treatment and at 3 and 6 cycles of treatment. In addition, serum CA125, anti-mullerian hormone (AMH), interleukin (IL)-6, and IL-8 were evaluated after 6 cycles of treatment. Results: The maximum diameter and volume of the ovarian endometrioma significantly decreased after 3 and 6 cycles compared with pretreatment. VAS scores of dysmenorrhea pain were also reduced after 1, 3 and 6 cycles. A significant correlation between the reduced size of the endometrioma and the decline of VAS scores was found. The levels of serum CA125 and AMH concentration were decreased after 6 cycles. No significant changes were observed in serum IL-6 and IL-8. Conclusion: Low dose DRSP/EE therapy is a promising treatment not only to reduce the size of endometrioma but also for dysmenorrhea. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Taniguchi, Fuminori; Arata, Kazuya; Harada, Tasuku] Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori 6838504, Japan; [Enatsu, Akiko] Four Seasons Ladies Clin, Chuo Ku, Tokyo 1030013, Japan; [Ota, Ikuko] Kurashiki Heisei Hosp, Dept Obstet & Gynecol, Kurashiki, Okayama 7100826, Japan; [Toda, Toshiko] Matsue Seikyo Gen Hosp, Dept Obstet & Gynecol, Matsue, Shimane 6908522, Japan	Taniguchi, F (reprint author), Tottori Univ, Fac Med, Dept Obstet & Gynecol, 36-7 Nishi Cho, Yonago, Tottori 6838504, Japan.	tani4327@med.tottori-u.ac.jp			Bayer Yakuhin, Ltd., Osaka, Japan	Funding for this study was provided in part by Bayer Yakuhin, Ltd., Osaka, Japan.	Liu XS, 2007, OBSTET GYNECOL, V109, P1411, DOI 10.1097/01.AOG.0000265215.87717.8b; Harada T, 1997, AM J OBSTET GYNECOL, V176, P593, DOI 10.1016/S0002-9378(97)70553-2; Crosignani P, 2006, HUM REPROD UPDATE, V12, P179, DOI 10.1093/humupd/dmi049; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Tsudo T, 2000, FERTIL STERIL, V73, P205, DOI 10.1016/S0015-0282(99)00496-3; Yonkers KA, 2005, OBSTET GYNECOL, V106, P492, DOI 10.1097/01.AOG.0000175834.77215.2e; Rana N, 1996, J REPROD MED, V41, P384; VERCELLINI P, 1993, FERTIL STERIL, V60, P75; Roman H, 2010, HUM REPROD, V25, P1428, DOI 10.1093/humrep/deq069; Janssen EB, 2013, HUM REPROD UPDATE, V19, P570, DOI 10.1093/humupd/dmt016; Tsujioka H, 2009, J OBSTET GYNAECOL RE, V35, P782, DOI 10.1111/j.1447-0756.2009.01017.x; Vessey M, 2003, LANCET, V362, P185, DOI 10.1016/S0140-6736(03)13907-4; Li HWR, 2011, CONTRACEPTION, V83, P582, DOI 10.1016/j.contraception.2010.09.007; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Mabrouk M, 2012, GYNECOL ENDOCRINOL, V28, P451, DOI 10.3109/09513590.2011.634936; Seifer DB, 2007, FERTIL STERIL, V88, P539, DOI 10.1016/j.fertnstert.2007.02.014; Gleicher N, 2010, FERTIL STERIL, V94, P2824, DOI 10.1016/j.fertnstert.2010.04.067; Meresman GF, 2002, FERTIL STERIL, V77, P1141, DOI 10.1016/S0015-0282(02)03099-6; Sugita A, 2013, FERTIL STERIL, V100, P516, DOI 10.1016/j.fertnstert.2013.03.032; van den Berg MH, 2010, HUM REPROD, V25, P1520, DOI 10.1093/humrep/deq071; Bentzen JG, 2012, REPROD BIOMED ONLINE, V25, P612, DOI 10.1016/j.rbmo.2012.09.001; Harada T, 2008, FERTIL STERIL, V90, P1583, DOI 10.1016/j.fertnstert.2007.08.051; Sakamoto Y, 2003, J CLIN ENDOCR METAB, V88, P730, DOI 10.1210/jc.2002-020666; Koltun W, 2011, EUR J OBSTET GYN R B, V155, P171, DOI 10.1016/j.ejogrb.2010.12.027; Benaglia L, 2010, HUM REPROD, V25, P678, DOI 10.1093/humrep/dep464; Vigano P, 2004, BEST PRACT RES CL OB, V18, P177, DOI 10.1016/j.bpobgyn.2004.01.007; Barad DH, 2013, REPROD BIOL ENDOCRIN, V4, P28; Dólleman M, 2013, J Clin Endocrinol Metab, V98, P2106, DOI 10.1210/jc.2012-3995; Endrikat J, 2007, EUR J CONTRACEP REPR, V12, P220, DOI 10.1080/13625180701440818; Gylfason JT, 2010, AM J EPIDEMIOL, V172, P237, DOI 10.1093/aje/kwq143; Iwabe T, 2000, J CLIN ENDOCR METAB, V85, P824, DOI 10.1210/jc.85.2.824; Ruiz-Flores FJ, 2012, CURR OPIN OBSTET GYN, V24, P136, DOI 10.1097/GCO.0b013e32835175d9; Taniguchi F, 2009, MOL CELL ENDOCRINOL, V307, P196, DOI 10.1016/j.mce.2009.04.012	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-2115	1872-7654		EUR J OBSTET GYN R B	Eur. J. Obstet. Gynecol. Reprod. Biol.	AUG	2015	191						116	120		10.1016/j.ejogrb.2015.06.006		5	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CN7RH	WOS:000358631200023		
J	Makino, S; Hirai, C; Itakura, A; Takeda, S; Yoshikawa, H; Li, ZS; Kawabata, K; Tanaka, H				Makino, Shintaro; Hirai, Chihiro; Itakura, Atsuo; Takeda, Satoru; Yoshikawa, Hideki; Li, Zisheng; Kawabata, Ken-ichi; Tanaka, Hiroki			Evaluation of uterine blood flow: a new method using contrast-enhanced ultrasound	EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY			English	Letter									[Makino, Shintaro; Hirai, Chihiro; Itakura, Atsuo; Takeda, Satoru] Juntendo Univ, Fac Med, Tokyo, Japan; [Yoshikawa, Hideki; Kawabata, Ken-ichi; Tanaka, Hiroki] Hitachi Ltd, Cent Res Lab, Med Syst Res Dept, Tokyo, Japan; [Li, Zisheng] Hitachi Ltd, Cent Res Lab, Intelligent Media Syst Res Dept, Tokyo, Japan	Makino, S (reprint author), Juntendo Univ, Fac Med, Tokyo, Japan.	shintaro@juntendo.ac.jp					You JS, 2012, AM J EMERG MED, V30, P1229, DOI 10.1016/j.ajem.2011.06.012; Calabrese E, 2014, J ULTRAS MED, V33, P1685, DOI 10.7863/ultra.33.9.1685; Tang SS, 2013, AM J EMERG MED, V31, P1240, DOI 10.1016/j.ajem.2013.04.034	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-2115	1872-7654		EUR J OBSTET GYN R B	Eur. J. Obstet. Gynecol. Reprod. Biol.	AUG	2015	191						143	144		10.1016/j.ejogrb.2015.04.009		2	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CN7RH	WOS:000358631200031		
J	Ito, Y; Akimoto, T; Cho, K; Yamada, M; Tanino, M; Dobata, T; Kitaichi, M; Kumaki, S; Kinugawa, Y				Ito, Yukie; Akimoto, Takuma; Cho, Kazutoshi; Yamada, Masafumi; Tanino, Mishie; Dobata, Tomoyuki; Kitaichi, Masanori; Kumaki, Satoru; Kinugawa, Yoshikazu			A late presenter and long-term survivor of alveolar capillary dysplasia with misalignment of the pulmonary veins	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						ACD/MPV; FOXF1; Mild phenotype; CT; Biopsy		This report demonstrates a late presenter and long-term survivor (38 months old) of alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV) and with a heterozygous frameshift mutation in FOXF1. The mild phenotype may be due to his residual normal lung tissue as demonstrated in the chest computed tomography (CT) and histopathological findings. Conclusion: We report the longest survivor of ACD/MPV. The mild phenotype is most likely due to the patient's residual normal lung tissue.	[Ito, Yukie; Dobata, Tomoyuki; Kumaki, Satoru; Kinugawa, Yoshikazu] Teine Keijinkai Hosp, Dept Pediat, Teine Ku, Sapporo, Hokkaido 0068555, Japan; [Akimoto, Takuma; Cho, Kazutoshi] Hokkaido Univ Hosp, Matern & Perinatal Care Ctr, Sapporo, Hokkaido 060, Japan; [Yamada, Masafumi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Tanino, Mishie] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan; [Kitaichi, Masanori] Kinki Chuo Chest Med Ctr, Dept Pathol, Natl Hosp Org, Sakai, Osaka, Japan	Kumaki, S (reprint author), Teine Keijinkai Hosp, Dept Pediat, Teine Ku, 1 Jo,12-1-40 Maeda, Sapporo, Hokkaido 0068555, Japan.	yukieito@hotmail.co.jp; t-akimo@huhp.hokudai.ac.jp; chotarou@med.hokudai.ac.jp; yamadam@med.hokudai.ac.jp; tanino@med.hokudai.ac.jp; tdobata@hotmail.com; kitaichi@kch.hosp.go.jp; kumaki@med.tohoku.ac.jp; ykinugawa@tkeijinkai.gr.jp					Ahmed Sheikh, 2008, Pediatr Crit Care Med, V9, pe43, DOI 10.1097/PCC.0b013e31818e383e; BOGGS S, 1994, J PEDIATR-US, V124, P125, DOI 10.1016/S0022-3476(94)70267-5; Bishop NB, 2011, AM J RESP CRIT CARE, V184, P172, DOI 10.1164/rccm.201010-1697CI; ABDALLAH HI, 1993, CRIT CARE MED, V21, P628, DOI 10.1097/00003246-199304000-00026; Shankar V, 2006, PEDIATR CRIT CARE ME, V7, P177, DOI 10.1097/01.PCC.0000202570.58016.67; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Kodama Y, 2012, PEDIATR INT, V54, P923, DOI 10.1111/j.1442-200X.2012.03712.x; Sato Masaaki, 2014, Gen Thorac Cardiovasc Surg, V62, P594, DOI 10.1007/s11748-014-0418-6; Sen P, 2013, HUM MUTAT, V34, P801, DOI 10.1002/humu.22313	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	AUG	2015	174	8					1123	1126		10.1007/s00431-015-2543-3		4	Pediatrics	Pediatrics	CN7XY	WOS:000358650500017		
J	Tagami, T; Matsui, H; Yasunaga, H				Tagami, Takashi; Matsui, Hiroki; Yasunaga, Hideo			Defining low-dose corticosteroid: the pendulum still oscillates	EUROPEAN RESPIRATORY JOURNAL			English	Letter							COMMUNITY-ACQUIRED PNEUMONIA; SURVIVING SEPSIS CAMPAIGN; SEPTIC SHOCK; INTERNATIONAL GUIDELINES; MANAGEMENT; TRIAL		[Tagami, Takashi; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138555, Japan; [Tagami, Takashi] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan	Tagami, T (reprint author), Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138555, Japan.	t-tagami@nms.ac.jp					Tagami T, 2015, EUR RESPIR J, V45, P463, DOI 10.1183/09031936.00081514; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Garcia-Vidal C, 2007, EUR RESPIR J, V30, P951, DOI 10.1183/09031936,00027607; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Ricard JD, 2015, EUR RESPIR J, V45, P305, DOI 10.1183/09031936.00225414; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88	9	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	AUG	2015	46	2					574	576		10.1183/09031936.00030415		4	Respiratory System	Respiratory System	CN9UQ	WOS:000358795800041		
J	Dierickx, EG; Shultz, AJ; Sato, F; Hiraoka, T; Edwards, SV				Dierickx, Elisa G.; Shultz, Allison J.; Sato, Fumio; Hiraoka, Takashi; Edwards, Scott V.			Morphological and genomic comparisons of Hawaiian and Japanese Black-footed Albatrosses (Phoebastria nigripes) using double digest RADseq: implications for conservation	EVOLUTIONARY APPLICATIONS			English	Article						Black-footed Albatross; conservation genomics; double digest RADseq; gene flow; integrative taxonomy; Izu-Torishima; Midway Island; Phoebastria nigripes; population differentiation; subspecies	WHITE-CAPPED ALBATROSSES; POPULATION-STRUCTURE; GENETIC DIVERSITY; MITOCHONDRIAL-DNA; SNP DISCOVERY; MICROSATELLITE MARKERS; COLONIZATION HISTORY; AVIAN PHYLOGEOGRAPHY; ATLANTIC SALMON; HYBRID ZONE	Evaluating the genetic and demographic independence of populations of threatened species is important for determining appropriate conservation measures, but different technologies can yield different conclusions. Despite multiple studies, the taxonomic status and extent of gene flow between the main breeding populations of Black-footed Albatross (Phoebastria nigripes), a Near-Threatened philopatric seabird, are still controversial. Here, we employ double digest RADseq to quantify the extent of genomewide divergence and gene flow in this species. Our genomewide data set of 9760 loci containing 3455 single nucleotide polymorphisms yielded estimates of genetic diversity and gene flow that were generally robust across seven different filtering and sampling protocols and suggest a low level of genomic variation ( per site=similar to 0.00002-0.00028), with estimates of effective population size (N-e=similar to 500-15881) falling far below current census size. Genetic differentiation was small but detectable between Japan and Hawaii (F-ST approximate to 0.038 0.049), with no F-ST outliers. Additionally, using museum specimens, we found that effect sizes of morphological differences by sex or population rarely exceeded 4%. These patterns suggest that the Hawaiian and Japanese populations exhibit small but significant differences and should be considered separate management units, although the evolutionary and adaptive consequences of this differentiation remain to be identified.	[Dierickx, Elisa G.; Shultz, Allison J.; Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Dierickx, Elisa G.; Shultz, Allison J.; Edwards, Scott V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Dierickx, Elisa G.] Univ Cambridge, Dept Zool, Cambridge, England; [Sato, Fumio; Hiraoka, Takashi] Yamashina Inst Ornithol, Abiko, Chiba, Japan	Edwards, SV (reprint author), Harvard Univ, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	sedwards@fas.harvard.edu		Shultz, Allison/0000-0002-2089-4086	National Science Foundation	We thank the Yamashina Institute for Ornithology and the Burke Museum of Natural History and Culture for the generous tissue loan, and the Museum of Comparative Zoology (Harvard University), the Bernice Pauahi Bishop Museum, the American Museum of Natural History, the Los Angeles County Museum, the Yamashina Institute for Ornithology, the Santa Barbara Museum of Natural History and the Field Museum for providing morphological measurements of museum specimens. Members of the Edwards laboratory group provided helpful discussion in the early phases of the project. Elizabeth Flint, K. Yoshiyashu and Shirly Doell provided helpful information on banding records. Jennifer Couget and Christian Daly gave advice and assistance with the Illumina sequencing. Vicki Friesen engaged in helpful dialogue about the interpretation of results. Peter Beerli helped with data formatting for Migrate-N and gave useful discussion of results. Two anonymous reviewers, Associate Editor Louis Bernatchez and Michael Brooke provided helpful comments on earlier drafts. The Conservation Science and Behavioural Ecology groups at the University of Cambridge helped frame the results in the context of conservation. Research in Scott Edwards' laboratory is supported by grants from the National Science Foundation.	Abbott CL, 2003, MOL ECOL, V12, P2747, DOI 10.1046/j.1365-294X.2003.01944.x; Abbott CL, 2003, MOL ECOL, V12, P2953, DOI 10.1046/j.1365-294X.2003.01980.x; Ando H, 2014, PAC SCI, V68, P309, DOI 10.2984/68.3.1; Angeloni F, 2014, CONSERV GENET, V15, P331, DOI 10.1007/s10592-013-0541-4; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Taylor SA, 2014, CURR BIOL, V24, P671, DOI 10.1016/j.cub.2014.01.069; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Oostermeijer JGB, 2003, BIOL CONSERV, V113, P389, DOI 10.1016/S0006-3207(03)00127-7; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2004.02437.x; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Pritchard JK, 2000, GENETICS, V155, P945; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Wright S, 1931, GENETICS, V16, P0097; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Harvey MG, 2015, PEERJ, V3, DOI 10.7717/peerj.895; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8278.2004.00828.x; Harvey MG, 2015, MOL PHYLOGENET EVOL, V83, P305, DOI 10.1016/j.ympev.2014.10.023; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Hohenlohe PA, 2013, MOL ECOL, V22, P3002, DOI 10.1111/mec.12239; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Harris RB, 2014, EVOLUTION, V68, P501, DOI 10.1111/evo.12280; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Brito P, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Taylor SA, 2014, EVOLUTION, V68, P3066, DOI 10.1111/evo.12510; Ellegren H, 2007, CYTOGENET GENOME RES, V117, P120, DOI 10.1159/000103172; [Anonymous], 2013, GEN VERS 6 1 6; Chan KMA, 2005, EVOLUTION, V59, P720; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Ogden R, 2013, MOL ECOL, V22, P3112, DOI 10.1111/mec.12234; Zink RM, 2010, J AVIAN BIOL, V41, P1, DOI 10.1111/j.1600-048X.2009.04903.x; Carling MD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000160; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; Moore JS, 2014, MOL ECOL, V23, P5680, DOI 10.1111/mec.12972; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BARROWCLOUGH G F, 1978, Bird-Banding, V49, P333; Beerli Peter, 2009, V17, P42; Bjordal H., 1983, FAUNA NORVEGICA C, V62, P105; Brumfield R., 2002, TRENDS ECOL EVOL, V18, P249; Buburuzan Laura, 2007, Analele Stiintifice ale Universitatii "Al. I. Cuza" din Iasi (Serie Noua) Sectiunea II a Genetica si Biologie Moleculara, V8, P25; Burg TM, 2004, MOL ECOL, V13, P2345, DOI 10.1111/j.1365-294X.2004.02232.x; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2006, COSEWIC ASS STAT REP; Cousins K., 2000, POPULATION BIOL BLAC; Eda Masaki, 2008, Ornithological Science, V7, P109, DOI 10.2326/1347-0558-7.2.109; Edwards SV, 2001, UASGCP REP, V2001, P115; Fay JC, 1999, MOL BIOL EVOL, V16, P1003; Flint E., 2007, ANN NEST COUNTS HATC; Harrison C. S., 1990, SEABIRDS HAWAII NATU; Hutcherson K., 2011, CNN; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; International Union for Conservation of Nature (IUCN), 2013, IUCN RED LIST THREAT; Kuczynski Lechoslaw, 2002, Bonner Zoologische Beitraege, V51, P127; McCormack JE, 2011, MOL PHYLOGENET EVOL, V66, P526, DOI DOI 10.1016/J.YMPEV.2011.12.007; Milot E, 2007, P R SOC B, V274, P779, DOI 10.1098/rspb.2006.0221; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Naughton MB, 2007, CONSERVATION ACTION; Nunn G., 2000, MOL BIOL EVOL, V15, P1360; Ohara M, 2006, PLANT SPEC BIOL, V21, P1, DOI 10.1111/j.1442-1984.2006.00145.x; Palkovacs EP, 2014, EVOL APPL, V7, P212, DOI 10.1111/eva.12111; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; RHEINDT FE, 2013, SYSTEMATIC BIOL, V0063; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Ryynanen HJ, 2007, J HERED, V98, P692, DOI 10.1093/jhered/esm093; SLADE RW, 1992, P ROY SOC B-BIOL SCI, V249, P163, DOI 10.1098/rspb.1992.0099; Storlazzi CD, 2013, 20131069 US GEOL SUR; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Veran S, 2007, J APPL ECOL, V44, P942, DOI 10.1111/j.1365-2664.2007.01346.x; Wakeley J., 2008, COALESCENT THEORY IN; Walsh HE, 2005, CONSERV GENET, V6, P289, DOI 10.1007/s10592-004-7824-8; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yaacov D. B., 2012, PLOS ONE, V7; Young LC, 2010, J ZOOL, V281, P232, DOI 10.1111/j.1469-7998.2010.00698.x	100	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-4571			EVOL APPL	Evol. Appl.	AUG	2015	8	7					662	678		10.1111/eva.12274		17	Evolutionary Biology	Evolutionary Biology	CN1FF	WOS:000358162500004		
J	Lin, YH; Chen, ZH; Kato, S				Lin, Yanhui; Chen, Zhiheng; Kato, Seiya			Receptor-selective IL-4 mutein modulates inflammatory vascular cell phenotypes and attenuates atherogenesis in apolipoprotein E-knockout mice	EXPERIMENTAL AND MOLECULAR PATHOLOGY			English	Article						IL-4; Endothelial cells; Vascular smooth muscle cells; Macrophages; Atherogenesis; Apo-E knockout mouse	SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; GAMMA-CHAIN; IL-4/IL-13 ANTAGONIST; ADHESION MOLECULE-1; SIGNAL-TRANSDUCTION; HUMAN INTERLEUKIN-4; TH2 CYTOKINES; MOUSE MODEL; T-CELLS	The therapeutic potential of interleukin-4-mediated immunomodulation has not been proven in atherogenesis. Type I IL-4 receptor consists of IL-4R alpha and a common gamma chain, whereas type II IL-4R is a heterodimer of IL-4Ra and IL-13R alpha 1. Reportedly, the human IL-4 mutein IL-4/R121E is able to act as an IL-4RI-specific agonist. Here, we investigated the effect of receptor-specific IL-4 mutein on vascular cell phenotypes and atherogenesis. Initially, a plasmid expressing murine IL-4/Q116E, analogous to human IL-4/R121E, was transfected to vascular lineage cells in-vitro. IL-4/Q116E induced the activation of STAT6 in b.End3 endothelial cells, Mm1 macrophages, and splenocytes isolated from C57BL6/J (B6) mice, but it failed to activate STAT6 in SMC and J774.1 macrophages. IL-4/Q116E induced the expression of vascular cell adhesion protein-1 in b.End3 cells but not in SMC. IL-4/Q116E did not exhibit pro-inflammatory actions in either macrophage cell line. Splenocytes were also infected with an adenovirus vector expressing IL-4/Q116E (AdIL-4/Q116E). Enzyme-linked immunosorbent assay for interferon-gamma, IL-10 and IL-13 revealed that AdIL-4/Q116E-infected splenocytes showed Th2 deviation. Th2 deviation and M2 marker up-regulation were further revealed in ex-vivo assays using the splenocytes isolated from AdIL-4/Q116E-infected apolipoprotein-E knockout (ApoEKO) mice. Finally, adenoviral induction of IL-4/Q116E, but not wild type IL-4, double mutein IL-4/Q116D/Y119D or control beta-galactosidase, significantly attenuated in-vivo atherogenesis of ApoEKO mice. Our data suggest that IL-4 signaling plays a pivotal role in the regulation of vascular cell phenotypes, and atherogenesis. The IL-4RI-selective mutein IL-4/Q116E may have therapeutic potential in vascular diseases. (C) 2015 Elsevier Inc. All rights reserved.	[Lin, Yanhui; Chen, Zhiheng] Cent S Univ, Dept Hlth Management, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Lin, Yanhui; Kato, Seiya] Univ Ryukyus, Dept Pathol & Cell Biol, Grad Sch Med, Okinawa, Japan	Lin, YH (reprint author), Third Xiangya Hosp, Dept Hlth Management, Changsha 410013, Hunan, Peoples R China.	linyanhui19798@hotmail.com			 [16590328]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) to S.K. (No.16590328). We also gratefully acknowledge the technical assistance of Ms. Junko Shiroma.	Andersson A, 1997, EUR J IMMUNOL, V27, P1762, DOI 10.1002/eji.1830270725; King VL, 2007, AM J PATHOL, V171, P2040, DOI 10.2353/ajpath0.2007.060857; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Mijatovic T, 1997, J BIOL CHEM, V272, P14394, DOI 10.1074/jbc.272.22.14394; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; WILLIAMS RL, 1988, CELL, V52, P121; Orlandi A, 2010, BIOCHEM PHARMACOL, V79, P1706, DOI 10.1016/j.bcp.2010.01.027; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Murata T, 1999, INT J HEMATOL, V69, P13; Sasaguri T, 1998, ATHEROSCLEROSIS, V138, P247, DOI 10.1016/S0021-9150(97)00296-7; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; KRUSE N, 1992, EMBO J, V11, P3237; Zhou XH, 1996, AM J PATHOL, V149, P359; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Lee YW, 2006, ARCH PHARM RES, V29, P1, DOI 10.1007/BF02977462; NOBLE A, 1995, IMMUNOLOGY, V85, P357; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138; Cortes JR, 2007, J IMMUNOL, V179, P3881; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Koga M, 2007, CIRC RES, V101, P348, DOI 10.1161/CIRCRESAHA.106.147256; Antoniu SA, 2010, CURR OPIN INVEST DR, V11, P1286; BONSCH D, 1995, J BIOL CHEM, V270, P8452; Boothby M, 2001, IMMUNOL RES, V23, P179, DOI 10.1385/IR:23:2-3:179; Doucet C, 2002, EUR J IMMUNOL, V32, P2437, DOI 10.1002/1521-4141(200209)32:9<2437::AID-IMMU2437>3.0.CO;2-N; Grunewald SM, 1997, J BIOL CHEM, V272, P1480; Guillot C, 2001, J IMMUNOL, V166, P5225; Hamilton TA, 2002, IMMUNOL RES, V25, P229, DOI 10.1385/IR:25:3:229; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Junttila I.S., 2008, J EXP MED, V205, P2595; Kato S, 1999, EXP MOL PATHOL, V66, P39, DOI 10.1006/exmp.1999.2235; Kidd Parris, 2003, Altern Med Rev, V8, P223; King VL, 2002, ARTERIOSCL THROM VAS, V22, P456, DOI 10.1161/hq0302.104905; Kozarsky KF, 1996, NAT GENET, V13, P54, DOI 10.1038/ng0596-54; Lunov O., 2012, ARTERIOSCLER THROMB, V32, P1445; MASINOVSKY B, 1990, J IMMUNOL, V145, P2886; Morioka T, 2009, BRIT J DERMATOL, V160, P1172, DOI 10.1111/j.1365-2133.2009.09069.x; Morishima Y, 2010, CURR OPIN INVEST DR, V11, P1229; MURAHASHI N, 1992, BIOTECHNOL APPL BIOC, V16, P152; Nishikubo K, 2003, GENE THER, V10, P2119, DOI 10.1038/sj.gt.3302131; PAUL WE, 1991, BLOOD, V77, P1859; Reinemer P, 2000, ANGEW CHEM INT EDIT, V39, P2834, DOI 10.1002/1521-3773(20000818)39:16<2834::AID-ANIE2834>3.0.CO;2-K; Ross R, 1999, NEW ENGL J MED, V340, P115; Schnyder B, 1996, AM J PATHOL, V149, P1369; Shanafelt AB, 1998, P NATL ACAD SCI USA, V95, P9454, DOI 10.1073/pnas.95.16.9454; Simoes S, 1999, BIOSCIENCE REP, V19, P601, DOI 10.1023/A:1020275114185; Tomkinson A, 2001, J IMMUNOL, V166, P5792; Wright PS, 1999, J CELL PHYSIOL, V180, P381, DOI 10.1002/(SICI)1097-4652(199909)180:3<381::AID-JCP9>3.0.CO;2-F; Zavorotinskaya T, 2003, MOL THER, V7, P155, DOI 10.1016/S1525-0016(02)00050-3	54	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4800	1096-0945		EXP MOL PATHOL	Exp. Mol. Pathol.	AUG	2015	99	1					116	127		10.1016/j.yexmp.2015.06.007		12	Pathology	Pathology	CO0BD	WOS:000358814200019		
J	Inagaki, N; Goda, M; Yokota, S; Maruyama, N; Iijima, H				Inagaki, Nobuya; Goda, Maki; Yokota, Shoko; Maruyama, Nobuko; Iijima, Hiroald			Safety and efficacy of canagliflozin in Japanese patients with type 2 diabetes mellitus: post hoc subgroup analyses according to body mass index in a 52-week open-label study	EXPERT OPINION ON PHARMACOTHERAPY			English	Review						body mass index; canagliflozin; Japanese; safety; type 2 diabetes mellitus	DOUBLE-BLIND; POOLED ANALYSIS; ADVERSE EVENTS; CELL FUNCTION; RISK-FACTORS; INSULIN; OBESITY; HYPOGLYCEMIA; GLUCOSE; PLACEBO	Background: The safety and efficacy of sodium glucose co-transporter 2 inhibitors in non-obese compared with obese patients with type 2 diabetes mellitus is unknown. Methods: We conducted post hoc analyses of the results of a 52-week open-label study of Japanese type 2 diabetes mellitus patients treated with 100 or 200 mg canagliflozin. Patients were divided into four subgroups according to their baseline body mass index (BMI): group I, BMI < 22 kg/m(2); group II, BMI >= 22 to < 25 kg/m(2); group III, BMI >= 25 to < 30 kg/m(2) and group IV, BMI >= 30 kg/m(2). Results: The overall safety was similar among the four BMI subgroups, although there were slight differences in terms of the incidences of hypoglycemia, asymptomatic hypoglycemia, female genital infections and proportions of patients with total ketone body levels exceeding 1000 mu mol/l at any time for both canagliflozin doses. Hemoglobin A1c, fasting plasma glucose and body weight decreased significantly from baseline to week 52 at both canagliflozin doses. The changes in hemoglobin A1c, and fasting plasma glucose were not significantly different among the four BMI subgroups for either dose. Conclusion: Canagliflozin was tolerated in patients irrespective of their BMI at the start of treatment, although some caution may be needed.	[Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Goda, Maki; Iijima, Hiroald] Mitsubishi Tanabe Pharma Corp, Pharmacovigilance & Qual Assurance Div, Med Affairs Dept, Tokyo 1038405, Japan; [Yokota, Shoko] Mitsubishi Tanabe Pharma Corp, Dev Div, Data Sci Dept, Tokyo 1038405, Japan; [Maruyama, Nobuko] Mitsubishi Tanabe Pharma Corp, Dev Div, Clin Res Dept 2, Tokyo 1038405, Japan	Goda, M (reprint author), Mitsubishi Tanabe Pharma Corp, Pharmacovigilance & Qual Assurance Div, Med Affairs Dept, Chuo Ku, Tokyo 1038405, Japan.	gouda.maki@mm.mt-pharma.co.jp			Mitsubishi Tanabe Pharma Corp.; Astellas Pharma Inc.; AstraZeneca K.K.; Bristol-Myers K.K.; Daiichi Sankyo Co., Ltd.; Eli Lilly Japan K.K.; GlaxoSmithKline K.K.; Japan Tobacco Inc.; Kissei Pharmaceutical Co., Ltd.; Kyowa Hakko Kirin Co., Ltd.; MSD K.K.; Nippon Boehringer Ingelheim Co., Ltd.; Novartis Pharma K.K.; Novo Nordisk Pharma Ltd.; Ono Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Roche Diagnostics K.K.; Sanofi K.K.; Shiratori Pharmaceutical Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Taisho Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.	N Inagaki has received consulting fees and research support from and has served on speakers bureaus for Mitsubishi Tanabe Pharma Corp.; has received consulting fees and/or research support from Astellas Pharma Inc., AstraZeneca K.K., Bristol-Myers K.K., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., GlaxoSmithKline K.K., Japan Tobacco Inc., Kissei Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., MSD K.K., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Pfizer Japan Inc., Roche Diagnostics K.K., Sanofi K.K., Shiratori Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd.; and has served on speakers bureaus for AstraZeneca K.K., Daiichi Sankyo Co., Ltd., Kowa Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., MSD K.K., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sumitomo Dainippon Pharma Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. All other authors are employees of Mitsubishi Tanabe Pharma Corp. Canagliflozin was developed by Mitsubishi Tanabe Pharma Corp. in collaboration with Janssen Research & Development, LLC. This study was funded by Mitsubishi Tanabe Pharma Corp. The authors thank ND Smith, PhD, for providing editorial support, which was funded by Mitsubishi Tanabe Pharma Corp. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Amiel SA, 2008, DIABETIC MED, V25, P245; Inagaki N, 2013, DIABETES OBES METAB, V15, P1136, DOI 10.1111/dom.12149; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Hirji I, 2012, J DIABETES COMPLICAT, V26, P501, DOI 10.1016/j.jdiacomp.2012.06.012; Sha S, 2014, DIABETES OBES METAB, V16, P1087, DOI 10.1111/dom.12322; Shorr RI, 1997, ARCH INTERN MED, V157, P1681, DOI 10.1001/archinte.157.15.1681; Nomura S, 2010, J MED CHEM, V53, P6355, DOI 10.1021/jm100332n; Inagaki N, 2014, EXPERT OPIN PHARMACO, V15, P1501, DOI 10.1517/14656566.2014.935764; Inagaki N, 2015, J DIABETES INVEST, V6, P210, DOI 10.1111/jdi.12266; Devineni D, 2012, DIABETES OBES METAB, V14, P539, DOI 10.1111/j.1463-1326.2012.01558.x; Yabe D, 2015, EXPERT OPIN DRUG SAF, V14, P795, DOI 10.1517/14740338.2015.1034105; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; Barnett AH, 2010, INT J CLIN PRACT, V64, P1121, DOI 10.1111/j.1742-1241.2009.02332.x; Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722; Daousi C, 2006, POSTGRAD MED J, V82, P280, DOI 10.1136/pmj.2005.039032; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Sone H, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12151-4; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Brunetti P, 2007, INT J CLIN PRACT, V61, P3, DOI 10.1111/j.1742-1241.2007.01359.x; Cox M, 2000, CARBOHYDRATE BIOSYNT, P722; Dailey GE, 2013, DIABETES OBES METAB, V15, P1085, DOI 10.1111/dom.12131; Horikawa C, 2014, J DIABETES INVEST, V5, P176, DOI 10.1111/jdi.12146; Kahn SE, 2001, J NUTR, V131, p354S; Kushiyama A, 2013, J DIABETES INVEST, V4, P540, DOI 10.1111/jdi.12090; Mannucci E, 2004, J ENDOCRINOL INVEST, V27, P535; Saito Y., 2011, J JAPAN SOC STUDY OB, V17, P1; Sinclair A, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-37; Sone H, 2004, LANCET, V363, P248, DOI 10.1016/S0140-6736(03)15348-2; Tanaka S, 2014, J CLIN ENDOCR METAB, V99, pE2692, DOI 10.1210/jc.2014-1855	29	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-6566	1744-7666		EXPERT OPIN PHARMACO	Expert Opin. Pharmacother.	AUG	2015	16	11					1577	1591		10.1517/14656566.2015.1055250		15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CN5GS	WOS:000358458400003		
J	Takeda, A; Tamano, H				Takeda, Atsushi; Tamano, Haruna			Regulation of extracellular Zn2+ homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease	EXPERT OPINION ON THERAPEUTIC TARGETS			English	Review						Alzheimer's disease; amyloid-beta; hippocampus; Zn2+ signaling	LONG-TERM POTENTIATION; MILD COGNITIVE IMPAIRMENT; A-BETA OLIGOMERS; CENTRAL-NERVOUS-SYSTEM; D-ASPARTATE RECEPTOR; IN-VIVO; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY; CORTICAL-NEURONS; MOUSE-BRAIN	Introduction: The hippocampus plays an important role in spatial and declarative memory. Zn2+ is released from glutamatergic (zincergic) neuron terminals in the hippocampus and serves as a signal factor. Synaptic Zn2+ homeostasis is critical for cognitive activity in the hippocampus. Amyloid-beta (A beta) is a candidate for the pathogenesis of Alzheimer's disease (AD) and interacts with Zn2+. Areas covered: This paper gives an overview of the interaction between A beta and Zn2+ in the extracellular compartment in the pathophysiology of AD. A beta is aggregated with Zn2+ and the aggregation of A beta-peptides is widely considered to be the critical step in the pathogenesis of AD. The reader will gain an understanding of recent studies on the importance of the interaction of A beta with Zn2+ in the pathophysiology and therapeutic strategy of AD. Extracellular Zn2+ in the hippocampus is a therapeutic target for AD. Expert opinion: Recent studies show that the inhibition of the interaction of A beta with extracellular Zn2+ ameliorates the pathophysiology of AD and that extracellular Zn2+ in the hippocampus is involved in transiently A beta-induced cognition deficits. Zn2+ may play as a key-mediating factor in pathophysiology in which A beta is involved and is a targeting molecule to prevent the pathogenesis of AD.	[Takeda, Atsushi; Tamano, Haruna] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, Shizuoka 4228526, Japan	Takeda, A (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp					Adlard PA, 2009, J NEUROSCI, V29, P4004; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145, DOI 10.1016/S0074-7742(08)60279-2; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Takeda A, 2013, METALLOMICS, V5, P417, DOI 10.1039/c3mt20269k; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI [10.1021/ja076282l, 10.1021/ja0762821]; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; Zhao DY, 2004, J NEUROPHYSIOL, V92, P2853, DOI 10.1152/jn.00485.2004; Lee JY, 2011, BRAIN RES, V1418, P12, DOI 10.1016/j.brainres.2011.08.055; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Matlack KES, 2014, P NATL ACAD SCI USA, V111, P4013, DOI 10.1073/pnas.1402228111; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Morley JE, 2010, J ALZHEIMERS DIS, V19, P441, DOI [10.3233/JAD-2009-1230, 10.3233/JAD-2010-1230]; Sensi SL, 1997, J NEUROSCI, V17, P9554; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534; Wang ZR, 2014, ACS CHEM NEUROSCI, V5, P952, DOI 10.1021/cn500119g; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Wang T, 2012, J ALZHEIMERS DIS, V29, P549, DOI 10.3233/JAD-2011-111874; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI [10.1016/j.jalz.2007.08.006, 10.1016/j.ja1z.2007.08.006]; Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Colvin RA, 2006, BRAIN RES, V1085, P1, DOI 10.1016/j.brainres.2006.02.043; Jack CR, 1999, NEUROLOGY, V52, P1397; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nm1433; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; MANTYH PW, 1993, J NEUROCHEM, V61, P1171, DOI 10.1111/j.1471-4159.1993.tb03639.x; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Zhang YH, 2013, CURR ALZHEIMER RES, V10, P494; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Minami A, 2006, J NEUROSCI RES, V83, P167, DOI 10.1002/jnr.20714; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Barili P, 1997, MECH AGEING DEV, V99, P83, DOI 10.1016/S0047-6374(97)00095-X; Cardenas-Aguayo M. C., 2014, PHYSL ROLE AMYLOID B, P1; Costa RO, 2012, AGING CELL, V11, P823, DOI 10.1111/j.1474-9726.2012.00848.x; Emmetsberger J, 2010, J NEUROSCI, V30, P6538, DOI 10.1523/JNEUROSCI.6250-09.2010; Hane Francis, 2014, Biomolecules, V4, P101, DOI 10.3390/biom4010101; HERSHEY CO, 1983, NEUROLOGY, V33, P1350; Holscher Christian, 2007, Eur J Pharmacol, V561, P85, DOI 10.1016/j.ejphar.2007.01.040; Kabogo D, 2010, NEUROBIOL AGING, V31, P1164, DOI 10.1016/j.neurobiolaging.2008.08.009; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MARTINEZGUIJARRO FJ, 1991, J NEUROCYTOL, V20, P834, DOI 10.1007/BF01191734; Nacher J, 2000, BRAIN BEHAV EVOLUT, V56, P38, DOI 10.1159/000006676; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Pan LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070681; Sekler I, 2002, J COMP NEUROL, V447, P201, DOI 10.1002/cne.10224; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Takamura Y, 2014, NEUROBIOL AGING, V35, P532, DOI 10.1016/j.neurobiolaging.2013.08.037; Takeda A, 2006, BIOMETALS, V19, P565, DOI 10.1007/s10534-005-6145-9; Takeda A., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/491597; Takeda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028615; Takeda A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00026; Takeda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115923; Takeda A, 2011, MOL NEUROBIOL, V44, P167; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Wang PN, 2006, NEUROBIOL AGING, V27, P1797, DOI 10.1016/j.neurobiolaging.2005.10.002; Watt NT, 2010, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/971021, DOI 10.4061/2011/971021]	84	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1472-8222	1744-7631		EXPERT OPIN THER TAR	Expert Opin. Ther. Targets	AUG	2015	19	8					1051	1058				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CN9GS	WOS:000358755900005		
J	Morisawa, T; Kida, H; Kusumi, F; Okinaga, S; Ohana, M				Morisawa, Toshiyuki; Kida, Hajime; Kusumi, Fusako; Okinaga, Satoshi; Ohana, Masaya			Endoscopic Submucosal Dissection Using Head-mounted Display	GASTROENTEROLOGY			English	Editorial Material							NEOPLASMS; OUTCOMES		[Morisawa, Toshiyuki; Kida, Hajime; Kusumi, Fusako; Okinaga, Satoshi; Ohana, Masaya] Tenri Hosp, Dept Gastroenterol & Hepatol, Tenri, Nara 6328552, Japan	Morisawa, T (reprint author), Tenri Hosp, Dept Gastroenterol & Hepatol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.	mrsw-tsyk@kb3.so-net.ne.jp					Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Niimi K, 2010, ENDOSCOPY, V42, P723, DOI 10.1055/s-0030-1255675; Higuchi K, 2013, GASTROINTEST ENDOSC, V78, P704, DOI 10.1016/j.gie.2013.04.182; Minnich DJ, 2003, J LAPAROENDOSC ADV A, V13, P333, DOI 10.1089/109264203769681754; Prendergast CJ, 2009, J LAPAROENDOSC ADV A, V19, P237	5	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	AUG	2015	149	2					290	U69		10.1053/j.gastro.2015.04.056		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4VX	WOS:000358429600017		
J	Hayashi, Y; Bardsley, MR; Toyomasu, Y; Milosavljevic, S; Gajdos, GB; Choi, KM; Reid-Lombardo, K; Kendrick, ML; Bingener-Casey, J; Tang, CM; Sicklick, JK; Gibbons, SJ; Farrugia, G; Taguchi, T; Gupta, A; Rubin, BP; Fletcher, JA; Ramachandran, A; Ordog, T				Hayashi, Yujiro; Bardsley, Michael R.; Toyomasu, Yoshitaka; Milosavljevic, Srdjan; Gajdos, Gabriella B.; Choi, Kyoung Moo; Reid-Lombardo, KMarie; Kendrick, Michael L.; Bingener-Casey, Juliane; Tang, Chih-Min; Sicklick, Jason K.; Gibbons, Simon J.; Farrugia, Gianrico; Taguchi, Takahiro; Gupta, Anu; Rubin, Brian P.; Fletcher, Jonathan A.; Ramachandran, Abhijit; Ordog, Tamas			Platelet-Derived Growth Factor Receptor-alpha Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1	GASTROENTEROLOGY			English	Article						Signal Transduction; Stem Cells; Receptor Tyrosine Kinase; Cancer	FIBROBLAST-LIKE CELLS; INTERSTITIAL-CELLS; MURINE STOMACH; C-KIT; CAJAL; INHIBITION; PROGENITORS; KINASE; MODEL; GIST	BACKGROUND & AIMS: In gastrointestinal muscles, v-kit Hardy- Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) is predominantly expressed by interstitial cells of Cajal (ICC) and platelet-derived growth factor receptor-alpha (PDGFRA) polypeptide is expressed by so-called fibroblast-like cells. KIT and PDGFRA have been reported to be coexpressed in ICC precursors and gastrointestinal stromal tumors (GISTs), which originate from the ICC lineage. PDGFRA signaling has been proposed to stimulate growth of GISTs that express mutant KIT, but the effects and mechanisms of selective blockade of PDGFRA are unclear. We investigated whether inhibiting PDGFRA could reduce proliferation of GIST cells with mutant KIT via effects on the KIT-dependent transcription factor ETV1. METHODS: We studied 53 gastric, small intestinal, rectal, or abdominal GISTs collected immediately after surgery or archived as fixed blocks at the Mayo Clinic and University of California, San Diego. In human GIST cells carrying imatinibsensitive and imatinib-resistant mutations in KIT, PDGFRA was reduced by RNA interference (knockdown) or inhibited with crenolanib besylate (a selective inhibitor of PDGFRA and PDGFRB). Mouse ICC precursors were retrovirally transduced to overexpress wild-type Kit. Cell proliferation was analyzed by methyltetrazolium, 5-ethynyl-2'-deoxyuridine incorporation, and Ki-67 immunofluorescence assays; we also analyzed growth of xenograft tumors in mice. Gastric ICC and ICC precursors, and their PDGFRA(+) subsets, were analyzed by flow cytometry and immunohistochemistry in wild-type, Kit(+/copGFP), Pdgfra(+/eGFP), and NOD/ShiLtJ mice. Immunoblots were used to quantify protein expression and phosphorylation. RESULTS: KIT and PDGFRA were coexpressed in 3%-5% of mouse ICC, 35%-44% of ICC precursors, and most human GIST samples and cell lines. PDGFRA knockdown or inhibition with crenolanib efficiently reduced proliferation of imatinib-sensitive and imatinib-resistant KIT(+)ETV1(+)PDGFRA(+) GIST cells (50% maximal inhibitory concentration = 5-32 nM), but not of cells lacking KIT, ETV1, or PDGFRA (50% maximal inhibitory concentration >230 nM). Crenolanib inhibited phosphorylation of PDGFRA and PDGFRB, but not KIT. However, Kit overexpression sensitized mouse ICC precursors to crenolanib. ETV1 knockdown reduced KIT expression and GIST proliferation. Crenolanib down-regulated ETV1 by inhibiting extracellular-signal-regulated kinase (ERK)-dependent stabilization of ETV1 protein and also reduced expression of KIT and PDGFRA. CONCLUSIONS: In KIT-mutant GIST, inhibition of PDGFRA disrupts a KIT-ERK-ETV1-KIT signaling loop by inhibiting ERK activation. The PDGFRA inhibitor crenolanib might be used to treat patients with imatinib-resistant, KIT-mutant GIST.	[Hayashi, Yujiro; Bardsley, Michael R.; Toyomasu, Yoshitaka; Milosavljevic, Srdjan; Gajdos, Gabriella B.; Choi, Kyoung Moo; Gibbons, Simon J.; Farrugia, Gianrico; Ordog, Tamas] Mayo Clin, Physiol & Biomed Engn, Enter Neurosci Program, Rochester, MN 55906 USA; Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55906 USA; [Reid-Lombardo, KMarie; Kendrick, Michael L.; Bingener-Casey, Juliane] Mayo Clin, Dept Surg, Rochester, MN 55906 USA; [Tang, Chih-Min; Sicklick, Jason K.] Univ Calif San Diego, Moores Canc Ctr, Div Surg Oncol, San Diego, CA 92103 USA; [Farrugia, Gianrico] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Taguchi, Takahiro] Kochi Univ, Grad Sch Kuroshio Sci, Div Human Hlth & Med Sci, Kochi 780, Japan; [Gupta, Anu; Rubin, Brian P.] Cleveland Clin, Lerner Res Inst, Dept Pathol, Cleveland, OH 44106 USA; [Rubin, Brian P.; Fletcher, Jonathan A.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA; [Rubin, Brian P.; Fletcher, Jonathan A.] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Fletcher, Jonathan A.] Harvard Univ, Sch Med, Boston, MA USA; [Ramachandran, Abhijit] AROG Pharmaceut LLC, Dallas, TX USA	Ordog, T (reprint author), Mayo Clin, Physiol & Biomed Engn, Guggenheim 10,200 1st St SW, Rochester, MN 55906 USA.	ordog.tamas@mayo.edu			National Institutes of Health [R01DK058185, P01DK068055, R01DK057061, P30DK084567, P30CA015083, P50CA127003, U54CA168512, K08CA168999]; Life Raft Group; Virginia and Daniel K. Ludwig Trust for Cancer Research; Mayo Clinic Center for Individualized Medicine	This work was supported in part by National Institutes of Health grants R01DK058185, P01DK068055, R01DK057061, P30DK084567, P30CA015083, P50CA127003, U54CA168512, K08CA168999, The Life Raft Group, the Virginia and Daniel K. Ludwig Trust for Cancer Research, and the Mayo Clinic Center for Individualized Medicine ( http://mayoresearch.mayo.edu/center-for-individualized-medicine). The funding agencies had no role in the study analysis or writing of the manuscript. Its contents are solely the responsibility of the authors.	Heinrich MC, 2012, CLIN CANCER RES, V18, P4375, DOI 10.1158/1078-0432.CCR-12-0625; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Lewis NL, 2009, J CLIN ONCOL, V27, P5262, DOI 10.1200/JCO.2009.21.8487; Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Groneberg D, 2013, GASTROENTEROLOGY, V145, P188, DOI 10.1053/j.gastro.2013.03.042; DeCaprio JA, 2014, CURR OPIN ONCOL, V26, P415, DOI 10.1097/CCO.0000000000000090; Kurahashi M, 2011, J PHYSIOL-LONDON, V589, P697, DOI 10.1113/jphysiol.2010.201129; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Asuzu DT, 2011, NEUROGASTROENT MOTIL, V23, pE309, DOI 10.1111/j.1365-2982.2011.01730.x; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Hayashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076822; Heldin CH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009100; Horvath VJ, 2005, DIABETES, V54, P1528, DOI 10.2337/diabetes.54.5.1528; Iino S, 2009, ARCH HISTOL CYTOL, V72, P107; Izbeki F, 2010, J PHYSIOL-LONDON, V588, P3101, DOI 10.1113/jphysiol.2010.191023; Klein S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2626; Kurahashi M, 2008, NEUROGASTROENT MOTIL, V20, P521, DOI 10.1111/j.1365-2982.2007.01055.x; Negri T, 2009, J PATHOL, V217, P103, DOI 10.1002/path.2450; Ordog T, 2004, AM J PHYSIOL-GASTR L, V286, pG351, DOI 10.1152/ajpgi.00281.2003; Ran LL, 2015, CANCER DISCOV, V5, P304, DOI 10.1158/2159-8290.CD-14-0985; Ro S, 2010, GASTROENTEROLOGY, V138, pe1061; Schwamb B, 2015, INT J CANC; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Zhu MJ, 2007, ONCOGENE, V26, P6386, DOI 10.1038/sj.onc.1210464	34	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	AUG	2015	149	2					420	+		10.1053/j.gastro.2015.04.006		29	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4VX	WOS:000358429600035		
J	Bettaieb, A; Jiang, JX; Sasaki, Y; Chao, TI; Kiss, Z; Chen, XL; Tian, JJ; Katsuyama, M; Yabe-Nishimura, C; Xi, YN; Szyndralewiez, C; Schroder, K; Shah, A; Brandes, RP; Haj, FG; Torok, NJ				Bettaieb, Ahmed; Jiang, Joy X.; Sasaki, Yu; Chao, Tzu-I; Kiss, Zsofia; Chen, Xiangling; Tian, Jijing; Katsuyama, Masato; Yabe-Nishimura, Chihiro; Xi, Yannan; Szyndralewiez, Cedric; Schroeder, Kathrin; Shah, Ajay; Brandes, Ralph P.; Haj, Fawaz G.; Toeroek, Natalie J.			Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice	GASTROENTEROLOGY			English	Article						Mouse Model; Stress Signaling; Obesity; Inflammation	FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; NADPH OXIDASES; OXIDATIVE STRESS; PROTEIN-KINASE; NONALCOHOLIC STEATOHEPATITIS; GLUCOSE-HOMEOSTASIS; REACTIVE OXYGEN; MORBIDLY OBESE; PKR ACTIVATION	BACKGROUND & AIMS: Reactive oxidative species (ROS) are believed to be involved in the progression of nonalcoholic steatohepatitis (NASH). However, little is known about the sources of ROS in hepatocytes or their role in disease progression. We studied the effects of nicotinamide adenine dinucleotide phosphate reduced oxidase 4 (NOX4) in liver tissues from patients with NASH and mice with steatohepatitis. METHODS: Liver biopsy samples were obtained from 5 patients with NASH, as well as 4 patients with simple steatosis and 5 patients without steatosis (controls) from the University of California, Davis Cancer Center Biorepository. Mice with hepatocyte-specific deletion of NOX4 (NOX4(hepKO)) and NOX4(floxp+/+) C57BL/6 mice (controls) were given fast-food diets (supplemented with high-fructose corn syrup) or choline-deficient L-amino acid defined diets to induce steatohepatitis, or control diets, for 20 weeks. A separate group of mice were given the NOX4 inhibitor (GKT137831). Liver tissues were collected and immunoblot analyses were performed determine levels of NOX4, markers of inflammation and fibrosis, double-stranded RNA-activated protein kinase, and phospho-eIF-2 alpha kinase-mediated stress signaling pathways. We performed hyperinsulinemic-euglycemic clamp studies and immunoprecipitation analyses to determine the oxidation and phosphatase activity of PP1C. RESULTS: Levels of NOX4 were increased in patients with NASH compared with controls. Hepatocyte-specific deletion of NOX4 reduced oxidative stress, lipid peroxidation, and liver fibrosis in mice with diet-induced steatohepatitis. A small molecule inhibitor of NOX4 reduced liver inflammation and fibrosis and increased insulin sensitivity in mice with diet-induced steatohepatitis. In primary hepatocytes, NOX4 reduced the activity of the phosphatase PP1C, prolonging activation of double-stranded RNA-activated protein kinase and phosphorylation of extracellular signal-regulated kinase-mediated stress signaling. Mice with hepatocyte-specific deletion of NOX4 and mice given GKT137831 had increased insulin sensitivity. CONCLUSIONS: NOX4 regulates oxidative stress in the liver and its levels are increased in patients with NASH and mice with diet-induced steatohepatitis. Inhibitors of NOX4 reduce liver inflammation and fibrosis and increase insulin sensitivity, and might be developed for treatment of NASH.	[Bettaieb, Ahmed; Xi, Yannan; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Jiang, Joy X.; Sasaki, Yu; Chao, Tzu-I; Kiss, Zsofia; Chen, Xiangling; Tian, Jijing; Toeroek, Natalie J.] Univ Calif Davis, Dept Med Gastroenterol & Hepatol, Sacramento, CA 95817 USA; [Jiang, Joy X.; Sasaki, Yu; Chao, Tzu-I; Kiss, Zsofia; Chen, Xiangling; Tian, Jijing; Toeroek, Natalie J.] VA Med Ctr, Sacramento, CA USA; [Katsuyama, Masato; Yabe-Nishimura, Chihiro] Kyoto Prefectural Univ Med, Kyoto, Japan; [Szyndralewiez, Cedric] Genkyotex, Geneva, Switzerland; [Schroeder, Kathrin; Brandes, Ralph P.] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Shah, Ajay] Kings Coll London British Heart Fdn Ctr, London, England	Torok, NJ (reprint author), Univ Calif Davis, Med Ctr, Patient Support Serv Bldg,4150 V St,Suite 3500, Sacramento, CA 95817 USA.	njtorok@ucdavis.edu			 [DK083283];  [01BX002418];  [DK095359];  [DK059635]	This study was supported by the DK083283 and 01BX002418 (to Natalie J. Torok) and DK095359 (to Fawaz G. Haj). Yale Mouse Metabolic Phenotyping Center funded by DK059635.	de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Tronel C, 2014, NEUROCHEM INT, V64, P73, DOI 10.1016/j.neuint.2013.10.012; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Jiang JX, 2013, HEPATOLOGY, V58, P1339, DOI 10.1002/hep.26491; Jammi NV, 2001, NUCLEIC ACIDS RES, V29, P3020; Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P131, DOI 10.1097/MPG.0b013e31822578db; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Gorin Y, 2013, FREE RADICAL BIO MED, V61, P130, DOI 10.1016/j.freeradbiomed.2013.03.014; Jiang JX, 2010, GASTROENTEROLOGY, V139, P1375, DOI 10.1053/j.gastro.2010.05.074; Syn WK, 2009, CLIN LIVER DIS, V13, P565, DOI 10.1016/j.cld.2009.07.003; Nakamura T, 2014, DIABETES, V63, P526, DOI 10.2337/db13-1019; Bohinc BN, 2012, CLIN LIVER DIS, V16, P549, DOI 10.1016/j.cld.2012.05.002; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Medici V, 2010, OBESITY, V18, P2268, DOI 10.1038/oby.2010.95; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Wang H, 2014, CIRCULATION, V129, P1397, DOI 10.1161/CIRCULATIONAHA.113.002209; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Jiang JX, 2009, J HEPATOL, V51, P139, DOI 10.1016/j.jhep.2009.03.024; Sukumar P, 2013, DIABETES, V62, P2130, DOI 10.2337/db12-1294; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Sumida Y, 2013, FREE RADICAL RES, V47, P869, DOI 10.3109/10715762.2013.837577; Bai GX, 2014, GENE, V540, P62, DOI 10.1016/j.gene.2014.02.026; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Ben Mosbah I, 2010, Cell Death Dis, V1, pe52, DOI 10.1038/cddis.2010.29; Carvalho MA, 2012, ENDOCRINOLOGY, V153, P5261, DOI 10.1210/en.2012-1400; Feldstein AE, 2011, ANTIOXID REDOX SIGN, V15, P421, DOI 10.1089/ars.2011.3897; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Ibrahim SH, 2014, LIVER INT, V34, P427, DOI 10.1111/liv.12353; Peidis P, 2011, CELL DEATH DIFFER, V18, P145, DOI 10.1038/cdd.2010.76; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Subichin M, 2015, SURG OBES RELAT DIS, V11, P137, DOI 10.1016/j.soard.2014.06.015; Williams BRG., 2001, SCI STKE, V2001, pre2, DOI DOI 10.1126/STKE.2001.89.RE2	55	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	AUG	2015	149	2					468	+		10.1053/j.gastro.2015.04.009		23	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4VX	WOS:000358429600039		
J	Sawada, T; Maeno, K; Joh, T				Sawada, Takeshi; Maeno, Ken; Joh, Takashi			Esophageal Ulcer in a Lung Cancer Patient	GASTROENTEROLOGY			English	Editorial Material							ADVERSE-EVENT; CRIZOTINIB		[Sawada, Takeshi; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Maeno, Ken] Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan	Sawada, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan.						Park J, 2013, LUNG CANCER, V81, P495, DOI 10.1016/j.lungcan.2013.06.017; Srivastava N, 2013, J THORAC ONCOL, V8, pE23, DOI 10.1097/JTO.0b013e31827e2451; Takakuwa O, 2014, MOL CLIN ONCOL, V2, P121	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	AUG	2015	149	2					E6	E7		10.1053/j.gastro.2014.12.050		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4VX	WOS:000358429600003		
J	Kashiwagi, M; Tamiya, N; Murata, M				Kashiwagi, Masayo; Tamiya, Nanako; Murata, Masako			Characteristics of visiting nurse agencies with high home death rates: A prefecture-wide study in Japan	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						home care supporting clinic; home death rate; home end-of-life care; home-visiting nursing services; visiting nurse agency	CANCER-PATIENTS; CARE; PLACE	AimThe purpose of the present study was to identify characteristics of visiting nurse agencies (VNA) in Japan with high home death rates by a prefecture-wide survey. MethodsA cross-sectional study of visiting nurse agencies (n=101) in Ibaraki Prefecture, Japan, was completed. Data included the basic characteristics of each VNA, the type of services provided, level of coordination with other service providers, total number of VNA patients who died per year and place of death and contractual relationship with home-care supporting clinics providing end-of-life care services in the home 24h a day. The VNA characteristics were analyzed by logistic regression, using the home death rate per VNA as a dependent variable. ResultsA total 69 agencies, excluding those that did not report number of deaths (n=14) and those without deaths during the year (n=6), were analyzed. The median home death rate of the 69 VNA was 29.8%. The results of logistic regression analysis showed that higher home death rate was significantly associated with lack of attachment to a hospital, existence of a contractual relationship with home-care supporting clinics and existence of an interactive information exchange through telephone/face-to-face communication with attending physicians. ConclusionsIn order to increase the home death rate of people using VNA, policymakers must consider establishing home-based service systems within the community that can provide home end-of-life care services 24h a day, and support the interactive exchange of information between the visiting nurse and the attending physician. Geriatr Gerontol Int 2015; 15: 936-943.	[Kashiwagi, Masayo] Yokohama City Univ, Sch Med, Dept Nursing Management, Yokohama, Kanagawa 232, Japan; [Kashiwagi, Masayo; Tamiya, Nanako] Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Murata, Masako] Ibaraki Nursing Assoc, Mito, Ibaraki, Japan	Tamiya, N (reprint author), Univ Tsukuba, Dept Hlth Serv Res, Fac Med, 1-1-1 Tenno Dai, Tsukuba, Ibaraki 3058575, Japan.	ntamiya@md.tsukuba.ac.jp			KAKENHI - Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25463613]	The authors acknowledge the VNA nurse managers who participated in this study. This study was supported by KAKENHI (25463613) Grant-in-Aid for Scientific Research (C), funded by The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Akiyama A, 2012, ARCH GERONTOL GERIAT, V54, P383; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Bell CL, 2010, J PAIN SYMPTOM MANAG, V39, P591, DOI 10.1016/j.jpainsymman.2009.07.007; Cardenas-Turanzas M, 2010, J PAIN SYMPTOM MANAG, V41, P880; DONABEDI.A, 1969, AM J PUBLIC HEALTH N, V59, P1833, DOI 10.2105/AJPH.59.10.1833; Fujikawa A, 2001, J JPN ACAD HOME CARE, V14, P76; Fukui S, 2011, ANN ONCOL, V22, P2113, DOI 10.1093/annonc/mdq719; Hayashi T, 2011, ARCH GERONTOL GERIAT, V53, P242, DOI 10.1016/j.archger.2010.12.005; Houttekier D, 2010, J PALLIAT MED, V13, P1461, DOI 10.1089/jpm.2010.0279; Institute for Health Economics and Policy, RES REP 2004 PROV UT; Ishikawa H, 2007, J PALLIAT CARE, V23, P255; Kashiwagi M, 2008, JPN J PRIM CARE, V31, P229; Lin HC, 2007, PALLIATIVE MED, V21, P705, DOI 10.1177/0269216307083033; Ministry of Health Labour and Welfare, SURV I EST LONG TERM; Ministry of Health Labour and Welfare, VIT STAT 2011; Murray MA, 2009, ONCOL NURS FORUM, V36, P69, DOI 10.1188/09.ONF.69-77; Sugimoto H, 2003, J JPN SOCIOGERONTOL, V25, P37	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					936	943		10.1111/ggi.12372		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900002		
J	Kawakami, R; Murakami, H; Sanada, K; Tanaka, N; Sawada, SS; Tabata, I; Higuchi, M; Miyachi, M				Kawakami, Ryoko; Murakami, Haruka; Sanada, Kiyoshi; Tanaka, Noriko; Sawada, Susumu S.; Tabata, Izumi; Higuchi, Mitsuru; Miyachi, Motohiko			Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						anthropometric; body composition; dual-energy X-ray absorptiometry; Japanese; muscle strength	MINI NUTRITIONAL ASSESSMENT; BODY-COMPOSITION; OLDER PERSONS; MORTALITY; PREVALENCE; DISABILITY; CONSENSUS; HEALTHY; GENDER; AGE	AimTo examine the relationship between calf circumference and muscle mass, and to evaluate the suitability of calf circumference as a surrogate marker of muscle mass for the diagnosis of sarcopenia among middle-aged and older Japanese men and women. MethodsA total of 526 adults aged 40-89 years participated in the present cross-sectional study. The maximum calf circumference was measured in a standing position. Appendicular skeletal muscle mass was measured using dual-energy X-ray absorptiometry, and the skeletal muscle index was calculated as appendicular skeletal muscle mass divided by the square of the height (kg/m(2)). The cut-off values for sarcopenia were defined as a skeletal muscle index of less than -2 standard deviations of the mean value for Japanese young adults, as defined previously. ResultsCalf circumference was positively correlated with appendicular skeletal muscle (r=0.81 in men, r=0.73 in women) and skeletal muscle index (r=0.80 in men, r=0.69 in women). In receiver operating characteristic analysis, the optimal calf circumference cut-off values for predicting sarcopenia were 34cm (sensitivity 88%, specificity 91%) in men and 33cm (sensitivity 76%, specificity 73%) in women. ConclusionsCalf circumference was positively correlated with appendicular skeletal muscle mass and skeletal muscle index, and could be used as a surrogate marker of muscle mass for diagnosing sarcopenia. The suggested cut-off values of calf circumference for predicting low muscle mass are <34cm in men and <33cm in women. Geriatr Gerontol Int 2015; 15: 969-976.	[Kawakami, Ryoko] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Higuchi, Mitsuru] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Kawakami, Ryoko; Murakami, Haruka; Tanaka, Noriko; Sawada, Susumu S.; Miyachi, Motohiko] Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo 162, Japan; [Kawakami, Ryoko] Japan Soc Promot Sci, Tokyo, Japan; [Sanada, Kiyoshi; Tabata, Izumi] Ritsumeikan Univ, Coll Sport & Hlth Sci, Kyoto, Shiga, Japan	Miyachi, M (reprint author), Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	miyachi@nih.go.jp			Ministry of Health, Labor, and Welfare of Japan; Japan Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan (M. Miyachi and A. Harada) and a Grant-in-Aid from the Japan Society for the Promotion of Science Fellows (R. Kawakami).	Abe T, 2012, AGING CLIN EXP RES, V24, P657, DOI 10.3275/8758; Tanko LB, 2002, METABOLISM, V51, P69, DOI 10.1053/meta.2002.28960; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Nindl BC, 2002, J APPL PHYSIOL, V92, P1611, DOI 10.1152/japplphysiol.00892.2001; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059; Gallagher D, 1997, J APPL PHYSIOL, V83, P229; Bonnefoy M, 2002, GERONTOLOGY, V48, P162, DOI 10.1159/000052836; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; MARTIN AD, 1990, MED SCI SPORT EXER, V22, P729, DOI 10.1249/00005768-199010000-00027; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Guigoz Y, 1996, NUTR REV, V54, pS59; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772; Jonathan T, 2013, AM J HUM BIOL, V25, P637, DOI 10.1002/ajhb.22423; Landi F, 2014, CLIN NUTR, V33, P539, DOI 10.1016/j.clnu.2013.07.013; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Mason C, 2008, OBESITY, V16, P2690, DOI 10.1038/oby.2008.438; Sanada K, 2009, EUR J CLIN NUTR, V63, P465, DOI 10.1038/sj.ejcn.1602977; Tsai AC, 2011, BRIT J NUTR, V105, P275, DOI 10.1017/S0007114510003429; Wijnhoven HAH, 2010, J GERONTOL A-BIOL, V65, P1107, DOI 10.1093/gerona/glq100	27	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					969	976		10.1111/ggi.12377		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900006		
J	Miura, Y; Takehara, K; Nakagami, G; Amemiya, A; Kanazawa, T; Kimura, N; Kishi, C; Koyano, Y; Tamai, N; Nakamura, T; Kawashima, M; Tsunemi, Y; Sanada, H				Miura, Yuka; Takehara, Kimie; Nakagami, Gojiro; Amemiya, Ayumi; Kanazawa, Toshiki; Kimura, Nao; Kishi, Chihiro; Koyano, Yuiko; Tamai, Nao; Nakamura, Tetsuro; Kawashima, Makoto; Tsunemi, Yuichiro; Sanada, Hiromi			Screening for tinea unguium by thermography in older adults with subungual hyperkeratosis	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						aged; nail diseases; onychomycosis; sensitivity and specificity; thermography	TOENAIL ONYCHOMYCOSIS; EPIDEMIOLOGY	AimThe purpose of the present study was to assess the difference in foot temperature between tinea unguium-positive older adults with subungual hyperkeratosis and tinea unguium-negative older adults with subungual hyperkeratosis to develop a temperature-based screening method for tinea unguium. MethodsThe present cross-sectional, observational study investigated 51 residents with subungual hyperkeratosis in two facilities covered by long-term care insurance between October 2011 and December 2011. One dermatologist recorded the clinical signs of abnormal toenails. Nail specimens were collected from all abnormal nails, and the presence of tinea unguium was confirmed when fungus was detected by direct microscopy. Foot temperature was measured by infrared thermography. A receiver operating characteristic curve was used to assess the ability to determine whether residents with subungual hyperkeratosis have tinea unguium and to determine the cut-off point. ResultsAmong the people with subungual hyperkeratosis, the mean toe temperature in the tinea unguium-positive group (30.22.6 degrees C) was significantly lower than that in the tinea unguium-negative group (32.8 +/- 3.2 degrees C, P=0.001). The area under the receiver operating characteristic curve was 0.74 (95% confidence interval 0.621-0.876), and the threshold temperature was set at 33.0 degrees C, resulting in a sensitivity of 81.8% and specificity of 65.7%. ConclusionOur study suggests that foot temperature can be used to screen for tinea unguium in people with subungual hyperkeratosis. This non-invasive and simple screening method would help clinicians to set priorities in terms of carrying out direct microscopy to diagnose tinea unguium in elderly residents in care facilities. Geriatr Gerontol Int 2015; 15: 991-996.	[Miura, Yuka; Nakagami, Gojiro; Amemiya, Ayumi; Kanazawa, Toshiki; Kimura, Nao; Koyano, Yuiko; Tamai, Nao; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo 1130033, Japan; [Miura, Yuka; Amemiya, Ayumi] Univ Tokyo, Grad Sch Med, Japan Soc Promot Sci, Tokyo 1130033, Japan; [Takehara, Kimie] Univ Tokyo, Grad Sch Med, Dept Nursing Adm, Tokyo 1130033, Japan; [Kishi, Chihiro] St Lukes Int Hosp, Tokyo, Japan; [Nakamura, Tetsuro] Shukokai Med Corp, Tokyo, Japan; [Kawashima, Makoto; Tsunemi, Yuichiro] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan	Sanada, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hsanada-tky@umin.ac.jp			Daiwa Securities Health Foundation; Chiyoda Mutual Life Foundation; St. Luke's Life Science Institute; Japan Foundation Aging for Health	This survey was partly supported by grants from Daiwa Securities Health Foundation, Chiyoda Mutual Life Foundation, St. Luke's Life Science Institute and Japan Foundation Aging for Health.	WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240; Minkoumou SN, 2012, INT J DERMATOL, V51, P1474, DOI 10.1111/j.1365-4632.2012.05509.x; Loo DS, 2007, DRUG AGING, V24, P293, DOI 10.2165/00002512-200724040-00003; Gupta AK, 1998, BRIT J DERMATOL, V139, P665; Roberts DT, 2003, BRIT J DERMATOL, V148, P402, DOI 10.1046/j.1365-2133.2003.05242.x; Watanabe S, 2010, J DERMATOL, V37, P397, DOI 10.1111/j.1346-8138.2009.00741.x; Gupta AK, 2000, J EUR ACAD DERMATOL, V14, P466, DOI 10.1046/j.1468-3083.2000.00124.x; Seebacher C, 2007, MYCOSES, V50, P321, DOI 10.1111/j.1439-0507.2006.01351.x; Baran R, 2011, CLIN DERMATOL, V29, P54, DOI 10.1016/j.clindermatol.2010.07.008; Garcia-Doval I, 2010, BRIT J DERMATOL, V163, P743, DOI 10.1111/j.1365-2133.2010.09930.x; Mohri S., 2008, Japanese Journal of Medical Mycology, V49, P1, DOI 10.3314/jjmm.49.1; Sato H, 1989, CLIN DERMATOL, V31, P1735; Ueda I., 1955, NAGOYA MED, V69, P695; Watanabe S, 2001, JPN J DERMATOL, V14, P2101	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					991	996		10.1111/ggi.12380		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900009		
J	Tobu, S; Noguchi, M; Kurata, S; Kakinoki, H; Udo, K; Tokuda, Y; Uozumi, J				Tobu, Shohei; Noguchi, Mitsuru; Kurata, Saya; Kakinoki, Hiroaki; Udo, Kazuma; Tokuda, Yuji; Uozumi, Jiro			Usefulness of Blocksom vesicostomy in elderly men with chronic urinary retention and severe dementia	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						Blocksom vesicostomy; dementia; elderly males; self-decannulation; urinary retention	BLADDER	AimIn the present article, we present the usefulness of Blocksom vesicostomy in elderly men with chronic urinary retention. MethodsWe carried out Blocksom vesicostomy in four patients between January 2011 and September 2013. We followed up all patients over 6 months. We checked their general and urinary condition based on interviews with their family members. ResultsThe etiology of urinary retention included prostate cancer and neurogenic bladder. All of the patients had severe dementia. We successfully managed the urinary treatment of all patients, although their general conditions gradually deteriorated. ConclusionsIn general, this type of vesicostomy is not a popular urinary treatment; however, Blocksom vesicostomy can be useful for treating elderly men with chronic urinary retention and severe dementia. Geriatr Gerontol Int 2015; 15: 997-1000.	[Tobu, Shohei; Noguchi, Mitsuru; Kurata, Saya; Kakinoki, Hiroaki; Udo, Kazuma; Tokuda, Yuji; Uozumi, Jiro] Saga Univ, Dept Urol, Fac Med, Saga 8498501, Japan	Noguchi, M (reprint author), Saga Univ, Dept Urol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	nogman@cc.saga-u.ac.jp					BLOCKSOM BH, 1957, J UROLOGY, V78, P398; BLOCKSOM B H Jr, 1956, Trans South Cent Sect Am Urol Assoc, V51, P1; Duckett J W Jr, 1974, Urol Clin North Am, V1, P485; Johannes H, 1998, ATRAS UROLOGIC SURG, VSecond, P633; Morrisroe SN, 2005, BJU INT, V96, P397, DOI 10.1111/j.1464-410X.2005.05638.x; Vastyan AM, 2005, EUR J PEDIATR SURG, V15, P170, DOI 10.1055/s-2005-837609	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					997	1000		10.1111/ggi.12381		4	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900010		
J	Suzuki, R; Kikutani, T; Yoshida, M; Yamashita, Y; Hirayama, Y				Suzuki, Ryo; Kikutani, Takeshi; Yoshida, Mitsuyoshi; Yamashita, Yoshihisa; Hirayama, Yoji			Prognosis-related factors concerning oral and general conditions for homebound older adults in Japan	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						activities of daily living; elderly; nutrition; occlusion; prognosis	MINI-NUTRITIONAL ASSESSMENT; MASTICATORY PERFORMANCE; SERUM-ALBUMIN; MORTALITY; COMMUNITY; CARE; MALNUTRITION; POPULATION; INDEX	PurposeThe present study examined the relationship between oral function, such as eating/swallowing, and life prognosis among a homebound elderly population, considering physical and mental function. MethodsThe participants were 511 homebound older adults aged 65 years or older living in four Japanese prefectures. Sex, age, activities of daily living (ADL), cognitive function, underlying disease, nutritional status as Mini-Nutritional Assessment-Short Form (MNA((R))-SF), swallowing function, dietary modification and occlusal status were examined at baseline. Participants were categorized into poor outcome (died or admitted to hospital or nursing home) and good outcome (still under home care) groups at 1-year follow up, and significant related baseline factors were analyzed. In addition, these groups were compared by the ADL subgroup divided into <60 (lower) and 60 (higher) by Barthel Index. ResultsIn total, 473 participants were followed up (poor outcome group 177 [37.4%], good outcome group 296 [62.6%]). Sex, age, ADL, MNA((R))-SF, swallowing function, dietary modification and occlusal support were significantly different between these groups. Logistic regression analysis showed that sex and MNA((R))-SF score were significantly related to prognosis in the lower ADL group, and sex, age, Charlson Comorbidity Index and occlusal support were significantly related in the higher ADL group. ConclusionsADL was strongly correlated with life prognosis in homebound older adults. Within the higher ADL participants, occlusal support was related to this outcome. Geriatr Gerontol Int 2015; 15: 1001-1006.	[Suzuki, Ryo; Hirayama, Yoji] Tokyo Med Univ Hosp, Dept Gen Med & Primary Care, Tokyo, Japan; [Suzuki, Ryo; Kikutani, Takeshi] Nippon Dent Univ Tama Oral Rehabil Clin, Div Rehabil Speech & Swallowing Disorders, Tokyo, Japan; [Kikutani, Takeshi] Nippon Dent Univ Tokyo, Grad Sch Life Dent, Div Clin Oral Rehabil, Tokyo, Japan; [Yoshida, Mitsuyoshi] Hiroshima City Rehabil Hosp, Dept Dent, Hiroshima, Japan; [Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka 812, Japan; [Hirayama, Yoji] Tokyo Med Univ, Dept Gen Med, Tokyo 1608402, Japan	Kikutani, T (reprint author), Nippon Dent Univ Tama Oral Rehabil Clin, Div Rehabil Speech & Swallowing Disorders, 4-44-19 Higashi Cho, Koganei, Tokyo 1840011, Japan.	kikutani@tky.ndu.ac.jp			Ministry of Health, Labor and Welfare	This study was supported by the Ministry of Health, Labor and Welfare. The authors are grateful to all the participants, care managers, physicians and dentists who participated in this study.	Kikutani T, 2009, ODONTOLOGY, V97, P38, DOI 10.1007/s10266-008-0094-z; Kitamura K, 2010, TOHOKU J EXP MED, V221, P29, DOI 10.1620/tjem.221.29; ZENNER PM, 1995, DYSPHAGIA, V10, P27, DOI 10.1007/BF00261276; Okada K, 2010, GERIATR GERONTOL INT, V10, P56, DOI 10.1111/j.1447-0594.2009.00560.x; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P145; Samnieng Patcharaphol, 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P291, DOI 10.1080/21551197.2011.591271; Kikutani T, 2013, GERIATR GERONTOL INT, V13, P50, DOI 10.1111/j.1447-0594.2012.00855.x; Tsai AC, 2008, BRIT J NUTR, V100, P152, DOI 10.1017/S0007114507873600; Jensen GL, 2010, JPEN-PARENTER ENTER, V34, P156, DOI 10.1177/0148607110361910; Wakimoto P, 2001, J GERONTOL A-BIOL, V56, P65; BURKE WJ, 1988, ARCH NEUROL-CHICAGO, V45, P31; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Izawa S, 2006, CLIN NUTR, V25, P962, DOI 10.1016/j.clnu.2006.05.006; Kikutani T, 2003, JPN J GERODONT, V18, P10; Lesourd B, 2004, J Nutr Health Aging, V8, P28; MAHONEY F I, 1965, Md State Med J, V14, P61; Miura H, 1998, Asia Pac J Public Health, V10, P43; Nordenram G, 2001, AGING CLIN EXP RES, V13, P370; Ogawa K, 1997, Nihon Ronen Igakkai Zasshi, V34, P492; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366; Semba RD, 2006, J NUTR HEALTH AGING, V10, P161; Sudo Eiichi, 2002, Nihon Ronen Igakkai Zasshi, V39, P427; Vandewoude MF, 2012, J AGING RES, V2012	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1001	1006		10.1111/ggi.12382		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900011		
J	Murakami, M; Hirano, H; Watanabe, Y; Sakai, K; Kim, H; Katakura, A				Murakami, Masaharu; Hirano, Hirohiko; Watanabe, Yutaka; Sakai, Katsuhiko; Kim, Hunkyoung; Katakura, Akira			Relationship between chewing ability and sarcopenia in Japanese community-dwelling older adults	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						chewing ability; color-changeable gum; community; elderly; sarcopenia	80-YEAR-OLD POPULATION; NUTRITIONAL-STATUS; MUSCLE MASS; PERFORMANCE; WOMEN; QUALITY; HEALTH; IMPACT; TRIAL; LIFE	AimIt has been reported that if nutrient intake is unbalanced, muscle mass, muscle strength and physical performance declines, and therefore it is important to maintain chewing ability to keep a balanced nutrient intake. However, the relationship between chewing ability and sarcopenia has not been previously reported. Therefore, the present study investigated the relationship between chewing ability and sarcopenia in addition to known sarcopenia-related factors. MethodsWe examined 761 participants (average age 73.05.1 years), who lived in the Itabashi city of Tokyo. Our research was designed to examine the relationship between chewing ability and sarcopenia. We carried out regression analysis to analyze the relationship with sarcopenia-related factors with consideration of the age of the participants. ResultsThe 761 participants were divided into two groups in terms of the stage of sarcopenia according to whether there was a deterioration of muscle strength or physical performance. Furthermore, we carried out logistic regression analyses on the value as a dependent variable, including known sarcopenia-related factors. There were significant correlations of sarcopenia with age (odds ratio 2.37, 95% confidence interval 1.52-3.70), body mass index (odds ratio 0.75, 95% confidence interval 0.69-0.81) and chewing ability (odds ratio 2.18, 95% confidence interval 1.21-3.93). ConclusionsThe present study shows that chewing ability is related to sarcopenia, which is equal to the relationship with the known factor of age by odds ratio. Geriatr Gerontol Int 2015; 15: 1007-1012.	[Murakami, Masaharu; Sakai, Katsuhiko; Katakura, Akira] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Tokyo, Japan; [Hirano, Hirohiko; Kim, Hunkyoung] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo 1730015, Japan; [Watanabe, Yutaka] Natl Ctr Geriatr & Gerontol, Div Oral & Dent Surg, Dept Adv Med, Oral Dis Res, Aichi, Japan	Hirano, H (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	hhirano@tmig.or.jp					Mithal A, 2013, OSTEOPOROSIS INT, V24, P1555, DOI 10.1007/s00198-012-2236-y; Kim H, 2007, J AM GERIATR SOC, V55, P1932, DOI 10.1111/j.1532-5415.2007.01447.x; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Kimura Y, 2013, GERIATR GERONTOL INT, V13, P718, DOI 10.1111/ggi.12006; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; DONNER MW, 1985, GASTROINTEST RADIOL, V10, P196; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Matsui Y, 1996, J ORAL REHABIL, V23, P530, DOI 10.1111/j.1365-2842.1996.tb00891.x; Viana JU, 2013, BRAZ J PHYS THER, V17, P373, DOI [10.1590/S1413-35552012005000102, 10.1590/S1413-35552013005000102]; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Kagawa R, 2012, INT J PROSTHODONT, V25, P368; Takata Y, 2004, ORAL DIS, V10, P44, DOI 10.1046/j.1354-523X.2003.00972.x; Xue QL, 2008, J GERONTOL A-BIOL, V63, P984; Tamura F, 2012, DYSPHAGIA, V27, P556, DOI 10.1007/s00455-012-9407-z; Suzuki T, 2004, J BONE MINER METAB, V22, P602, DOI 10.1007/s00774-004-0530-2; Arai H, 2014, GERIATR GERONTOL INT, V14, P1, DOI 10.1111/ggi.12236; Fried LP, 2001, J GERONTOL A-BIOL, V56, P146, DOI DOI 10.1093/GER0NA/56.3.M146; Ishikawa Yasutaka, 2007, Journal of Medical and Dental Sciences, V54, P65; Kamiyama Miho, 2010, J Prosthodont Res, V54, P24, DOI 10.1016/j.jpor.2009.08.001; Mann T, 2013, AUST DENT J, V58, P200, DOI 10.1111/adj.12064; Ministry of Hearth Labour and Welfare, 2009, IMPR MAN MOT FUNCT; Mints VW, 1977, DIS TEMPOROMANDIBULA, P197; Moriya S, 2012, GERODONTOLOGY, V27, P1; REISINE ST, 1989, COMMUNITY DENT ORAL, V17, P7, DOI 10.1111/j.1600-0528.1989.tb01816.x; Suzuki Y, 1997, J GRAVIT PHYSL, V4, P46; Takata Y, 2006, J ORAL REHABIL, V33, P330, DOI 10.1111/j.1365-2842.2005.01567.x	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1007	1012		10.1111/ggi.12399		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900012		
J	Kim, M; Shinkai, S; Murayama, H; Mori, S				Kim, Miji; Shinkai, Shoji; Murayama, Hiroshi; Mori, Seijiro			Comparison of segmental multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body composition in a community-dwelling older population	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						bioelectrical impedance analysis; body composition; dual-energy X-ray absorptiometry; obesity; older adults; sarcopenia	SKELETAL-MUSCLE MASS; FAT MASS; BIOIMPEDANCE ANALYSIS; FUNCTIONAL DECLINE; PHYSICAL-ACTIVITY; SOFT-TISSUE; SARCOPENIA; ADULTS; WOMEN; ACCURACY	AimThe purpose of the present study was to examine the agreement of segmental multifrequency bioelectrical impedance analysis (SMF-BIA) for the assessment of whole-body and appendicular fat mass (FM) and lean soft tissue mass (LSTM) compared with dual-energy X-ray absorptiometry (DXA) in a community-dwelling Japanese older population. MethodsThe study population included 551 community-dwelling Japanese older adults (241 men and 310 women) aged between 65 and 87 years. Agreement between SMF-BIA and DXA for whole-body and appendicular body composition was assessed using simple linear regression and Bland-Altman analysis. ResultsHigh coefficients of determination (R-2) were observed for whole-body FM (R-2=0.91, standard error of estimate [SEE]=1.4kg in men and R-2=0.94, SEE=1.2kg in women) between SMF-BIA and DXA. The R-2 coefficient for whole-body LSTM was higher in men (R-2=0.88, SEE=1.9kg) than in women (R-2=0.83, SEE=1.5kg). There was systematic bias with overestimation of whole-body FM and underestimation of whole-body LSTM by SMF-BIA. Proportional bias was noted for measurement of whole-body FM and LSTM in both men and women, but there was no proportional bias between the two methods for measurement of appendicular LSTM (r=0.05, P=0.428 and r=-0.10, P=0.070 for men and women, respectively). ConclusionSMF-BIA is a good alternative for estimating the whole-body and appendicular FM and LSTM in a community-dwelling Japanese older population, although it overestimated FM and underestimated LSTM when validated against DXA. Geriatr Gerontol Int 2015; 15: 1013-1022.	[Kim, Miji] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo 1730015, Japan; [Shinkai, Shoji; Murayama, Hiroshi] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo 1730015, Japan; [Mori, Seijiro] Tokyo Metropolitan Geriatr Hosp, Dept Internal Med, Tokyo 173, Japan	Kim, M (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	mijiak@tmig.or.jp			Japan Society for the Promotion of Science [21390212]; Leading Project for Personalized Medicine of the Ministry of Education, Culture, Sports, Science and Technology of Japan [09042037]	We are deeply grateful to the study participants and to the staff of the Tokyo Metropolitan Institute of Gerontology for their cooperation. This work was supported by a Grant-in-Aid for Scientific Research ([B] no. 21390212) to SS from Japan Society for the Promotion of Science and a grant (No. 09042037) to SM from the Leading Project for Personalized Medicine of the Ministry of Education, Culture, Sports, Science and Technology of Japan. Study concept and design: Miji Kim and Shoji Shinkai. Acquisition of data: Miji Kim, Shoji Shinkai and Hiroshi Murayama. Analysis and interpretation of data: all authors. Drafting of the manuscript: Miji Kim and Shoji Shinkai. Critical revision of the manuscript for important intellectual content: all authors.	Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Wang ZM, 1999, AM J PHYSIOL-ENDOC M, V276, pE995; Toombs RJ, 2012, OBESITY, V20, P30, DOI 10.1038/oby.2011.211; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; Genton L, 2002, NUTRITION, V18, P66, DOI 10.1016/S0899-9007(01)00700-6; Lim JS, 2009, PEDIATR INT, V51, P263, DOI 10.1111/j.1442-200X.2008.02698.x; Gibson AL, 2008, AM J CLIN NUTR, V87, P332; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; [Anonymous], 2009, ANTIAGING MED; Gallagher D, 1997, J APPL PHYSIOL, V83, P229; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52; Kim M, 2013, EUR J CLIN NUTR, V67, P395, DOI 10.1038/ejcn.2013.9; Volgyi E, 2008, OBESITY, V16, P700, DOI 10.1038/oby.2007.94; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Hughes VA, 2002, AM J CLIN NUTR, V76, P473; Yamada M, 2013, J AM MED DIR ASSOC, V14, P911, DOI 10.1016/j.jamda.2013.08.015; Tanimoto Y, 2013, GERIATR GERONTOL INT, V13, P958, DOI 10.1111/ggi.12037; Shafer KJ, 2009, NUTRITION, V25, P25, DOI 10.1016/j.nut.2008.07.004; Bedogni G, 2002, EUR J CLIN NUTR, V56, P1143, DOI 10.1038/sj.ejcn.1601466; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Sillanpaa E, 2014, OBESITY, V22, P101, DOI 10.1002/oby.20583; Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; BLAND JM, 1986, LANCET, V1, P307; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Coin A, 2012, CLIN NUTR, V31, P506, DOI 10.1016/j.clnu.2012.01.012; Dittmar M., 2003, AM J PHYS ANTHROPOL, V122, P362; Goran MI, 1998, INT J OBESITY, V22, P135, DOI 10.1038/sj.ijo.0800555; Heymsfield SB, 2000, EUR J CLIN NUTR, V54, pS26; Lohman T. G., 1992, ADV BODY COMPOSITION; Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015; Pietrobelli A, 1998, EUR J CLIN NUTR, V52, P507, DOI 10.1038/sj.ejcn.1600592; Schaap LA, 2013, EPIDEMIOL REV, V35, P51, DOI 10.1093/epirev/mxs006; Shinkai Shoji, 2013, Nihon Koshu Eisei Zasshi, V60, P596	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1013	1022		10.1111/ggi.12384		10	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900013		
J	Watanabe, K; Ouchi, M; Ohara, M; Kameda, W; Susa, S; Oizumi, T; Wada, M; Suzuki, T; Kawanami, T; Oba, K; Kato, T				Watanabe, Kentaro; Ouchi, Motoshi; Ohara, Makoto; Kameda, Wataru; Susa, Shinji; Oizumi, Toshihide; Wada, Manabu; Suzuki, Tatsuya; Kawanami, Toru; Oba, Kenzo; Kato, Takeo			Change of carotid intima-media thickness is associated with age in elderly Japanese patients without a history of cardiovascular disease	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						carotid intima-media thickness; carotid ultrasonography; diabetes; elderly; hypertension	LIPID-LOWERING THERAPY; CHRONIC KIDNEY-DISEASE; ARTERY INTIMA; RISK-FACTORS; CORONARY ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; DIABETES-MELLITUS; PROGRESSION; SUBANALYSIS	AimThe present study aimed to evaluate the relationship between the change of carotid intima-media thickness (CIMT) and clinical characteristics in Japanese patients without a history of cardiovascular disease. MethodsThe study participants were 149 Japanese patients without a history of cardiovascular disease treated in our outpatient department. The in all participants CIMT was measured with ultrasonography at baseline and after a mean interval of 2.4 years. Study participants were divided into a middle-aged group (younger than 65 years: n=59) and an elderly group (65 years or older: n=90). The annual CIMT change (CIMT) was calculated, and the associations between CIMT and clinical characteristics, including age, were evaluated in both groups. ResultsThe CIMT was significantly correlated with age in all participants (r=0.222; P<0.05) and in elderly participants (r=0.234; P<0.05), but was not correlated with other risk factors. The annual CIMT was significantly higher in elderly participants (0.0150.096mm) than in middle-aged participants (-0.018 +/- 0.088mm; P<0.05). Multivariate linear regression analysis with CIMT as a dependent variable and risk factors as independent variables showed that CIMT was significantly associated with age in all participants (=0.002; P<0.05) and in elderly participants (=0.004; P<0.05), but not with other risk factors. ConclusionsAnnual CIMT change is associated with age, rather than with other clinical characteristics, including traditional cardiovascular risk factors, such as diabetes and hypertension, in elderly Japanese patients without a history of cardiovascular disease. Geriatr Gerontol Int 2015; 15: 1023-1030.	[Watanabe, Kentaro; Kameda, Wataru; Susa, Shinji; Oizumi, Toshihide; Wada, Manabu; Kawanami, Toru; Kato, Takeo] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata 9909585, Japan; [Ouchi, Motoshi] Dokkyo Med Univ, Sch Med, Dept Pharmacol & Toxicol, Mibu, Tochigi, Japan; [Ohara, Makoto] Showa Univ, Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Tokyo 142, Japan; [Suzuki, Tatsuya; Oba, Kenzo] Nippon Med Sch, Div Geriatr Med, Tokyo 113, Japan	Watanabe, K (reprint author), Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, 2-2-2 Iidanishi, Yamagata 9909585, Japan.	kentaro@med.id.yamagata-u.ac.jp					OLEARY DH, 1991, STROKE, V22, P1155; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Barbieri M, 2013, ATHEROSCLEROSIS, V227, P349, DOI 10.1016/j.atherosclerosis.2012.12.018; Hirohata A, 2010, J AM COLL CARDIOL, V55, P976, DOI 10.1016/j.jacc.2009.09.062; Yilmaz MI, 2010, AM J NEPHROL, V31, P214, DOI 10.1159/000272936; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Wada M, 2007, J NEUROL SCI, V255, P27, DOI 10.1016/j.jns.2007.01.066; Nohara R, 2013, CIRC J, V77, P1526, DOI 10.1253/circj.CJ-12-1149; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Herder M, 2012, STROKE, V43, P1818, DOI 10.1161/STROKEAHA.111.646596; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Yamazaki T, 2013, INT HEART J, V54, P33; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Bots ML, 1997, CIRCULATION, V96, P1432; Geng DF, 2011, ATHEROSCLEROSIS, V218, P214, DOI 10.1016/j.atherosclerosis.2011.05.004; Turner RC, 1998, BRIT MED J, V316, P823; Baldassarre D, 2013, ARTERIOSCL THROM VAS, V33, P2273, DOI 10.1161/ATVBAHA.113.301844; Yokoi H, 2014, INT HEART J, V55, P146; Yanase T, 2006, AM J HYPERTENS, V19, P1206, DOI 10.1016/j.amjhyper.2006.05.010; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Herder M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-77; Ikeda H, 2009, DIABETES RES CLIN PR, V83, P50, DOI 10.1016/j.diabres.2008.10.014; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Naito T, 2007, GERIATR GERONTOL INT, V7, P229, DOI 10.1111/j.1447-0594.2007.00410.x; Nakayama T, 2010, INT J CARDIOL, V138, P157, DOI 10.1016/j.ijcard.2008.08.031; Nozue T, 2012, CIRC J, V76, P2188, DOI 10.1253/circj.CJ-11-1303; Patel YR, 2013, DIABETES-METAB RES, V29, P582, DOI 10.1002/dmrr.2433; Polak JF, 2010, J ULTRAS MED, V29, P1759; Sagae Michio, 2010, Yamagata Medical Journal, V28, P51; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Tanaka M, 2012, J STROKE CEREBROVASC, V21, P47, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.018; Tripolt NJ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-95; Watanabe K, 2006, GERIATR GERONTOL INT, V6, P87, DOI 10.1111/j.1447-0594.2006.00329.x	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1023	1030		10.1111/ggi.12402		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900014		
J	Kim, M; Yoshida, H; Sasai, H; Kojima, N; Kim, H				Kim, Miji; Yoshida, Hideyo; Sasai, Hiroyuki; Kojima, Narumi; Kim, Hunkyung			Association between objectively measured sleep quality and physical function among community-dwelling oldest old Japanese: A cross-sectional study	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						accelerometer; oldest old; physical function; sleep; physical activity	AGE-RELATED-CHANGES; C-REACTIVE PROTEIN; ELDERLY PERSONS; WAKE IDENTIFICATION; DAYTIME SLEEPINESS; FUNCTION DECLINE; BODY-COMPOSITION; CORTISOL-LEVELS; YOUNG-ADULTS; GAIT SPEED	AimThe present study examined the association between objective measures of sleep quality and performance-based measures of physical function in community-dwelling oldest old Japanese. MethodsThis cross-sectional study included 207 community-dwelling adults aged 80years or older (92 men, 115 women; age 83.52.6years [range 80-95years]). Participants wore an accelerometer (ActiGraph GT3X+) on their non-dominant wrist for 24h per day over seven consecutive nights. Sleep parameters included total sleep time, sleep efficiency and wake after sleep onset during the night for a week. Performance-based physical function measures were handgrip strength, knee extension strength, and usual and maximum walking speeds. Multivariable linear regression was carried out to determine the associations between weekly sleep parameter averages and physical function measures. ResultsApproximately 24% of participants had a total sleep time of less than 6h a night, and 13% had greater than 8h a night. Overall, average daily physical activity was 1771.8 +/- 520.6 (counts/min/day). In multiple linear regression, sleep efficiency and wake after sleep onset were significantly associated with maximum walking speed (=0.277; 95% confidence interval [CI] 0.103 to 0.351 and =-0.214; 95% CI -0.339 to -0.082, respectively) and usual walking speed (=0.200, 95% CI 0.035 to 0.305 and =-0.174; 95% CI -0.341 to -0.064, respectively), after adjusting for potential confounding factors including daily physical activity. Both sleep qualities were also independently associated with knee extension strength. However, wake after sleep onset was not associated with handgrip strength. ConclusionObjectively measured sleep quality was associated with physical function in the oldest old. Further research is required to identify the temporality of associations between sleep and physical function. Geriatr Gerontol Int 2015; 15: 1040-1048.	[Kim, Miji; Yoshida, Hideyo; Kojima, Narumi; Kim, Hunkyung] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo 1730015, Japan; [Sasai, Hiroyuki] Japan Soc Promot Sci, Tokyo, Japan; [Sasai, Hiroyuki] Univ Tsukuba, Fac Med, Ibaraki, Japan	Kim, M (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	mijiak@tmig.or.jp			Japan Society for the Promotion of Science [23700820, 26750349]	We are deeply grateful to the study participants and staff of the Tokyo Metropolitan Institute of Gerontology for their cooperation. This work was supported by a Grant-in-Aid for Young Scientists ([B] no. 23700820 and no. 26750349) awarded to Miji Kim by the Japan Society for the Promotion of Science. Study concept and design: MK. Acquisition of data: MK, HK, YH and KN. Analyses and interpretation of the data: MK and SH. Drafting of the manuscript: MK. Critical revision of the manuscript for important intellectual content: All authors.	Ferrie JE, 2013, AM J EPIDEMIOL, V178, P956, DOI 10.1093/aje/kwt072; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Ancoli-Israel S, 2003, SLEEP, V26, P342; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; FOLEY DJ, 1995, SLEEP, V18, P425; Legrand D, 2014, J AM GERIATR SOC, V62, P1030, DOI 10.1111/jgs.12840; Peel NM, 2013, J GERONTOL A-BIOL, V68, P39, DOI 10.1093/gerona/gls174; Whitney CW, 1998, SLEEP, V21, P27; Brach JS, 2004, J AM GERIATR SOC, V52, P502, DOI 10.1111/j.1532-5415.2004.52154.x; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Yasunaga A, 2008, J AGING PHYS ACTIV, V16, P3; van den Berg JF, 2009, SLEEP, V32, P1367; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; Goldman SE, 2007, SLEEP, V30, P1317; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Van Den Berg JF, 2008, J SLEEP RES, V17, P295, DOI 10.1111/j.1365-2869.2008.00638.x; Chasens ER, 2007, J SLEEP RES, V16, P60, DOI 10.1111/j.1365-2869.2007.00576.x; Ohayon MM, 2004, SLEEP, V27, P1255; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Taaffe DR, 2000, J GERONTOL A-BIOL, V55, pM709; Forrest KYZ, 2006, J GERONTOL A-BIOL, V61, P1194; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207; Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6; Unruh ML, 2008, J AM GERIATR SOC, V56, P1218, DOI 10.1111/j.1532-5415.2008.01755.x; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P649, DOI 10.1093/gerona/glq017; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Tamakoshi A, 2004, SLEEP, V27, P51; Fetveit A, 2009, GERIATR GERONTOL INT, V9, P220, DOI 10.1111/j.1447-0594.2009.00537.x; Patel SR, 2004, SLEEP, V27, P440; COLE RJ, 1992, SLEEP, V15, P461; Cohen-Mansfield J, 2012, SLEEP, V35, P1003, DOI 10.5665/sleep.1970; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Vgontzas AN, 2003, J CLIN ENDOCR METAB, V88, P2087, DOI 10.1210/jc.2002-021176; Patel SR, 2009, SLEEP, V32, P200; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; GUR RC, 1987, ARCH GEN PSYCHIAT, V44, P617; GURALNIK JM, 1989, J GERONTOL, V44, pM141; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161; Huang AJ, 2007, OBSTET GYNECOL, V109, P909, DOI 10.1097/01.AOG.0000258277.01497.4b; Kim MJ, 2012, GERIATR GERONTOL INT, V12, P50, DOI 10.1111/j.1447-0594.2011.00726.x; Kojima N, 2014, GERIATR GERONTOL INT, V14, P674, DOI 10.1111/ggi.12158; Luo JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081261; Mesas AE, 2010, J AM GERIATR SOC, V58, P1870, DOI 10.1111/j.1532-5415.2010.03071.x; Nobrega PVD, 2014, GERIATR GERONTOL INT, V14, P605, DOI 10.1111/ggi.12144; O'Connell SE, 2014, ANN HUM BIOL, V41, P1, DOI 10.3109/03014460.2013.827737; Ohayon MM, 2005, SLEEP, V28, P981; PRINZ PN, 1990, NEW ENGL J MED, V323, P520; Reyes S, 2013, AGING CLIN EXP RES, V25, P175, DOI 10.1007/s40520-013-0028-7; SADEH A, 1994, SLEEP, V17, P201; Spira AP, 2012, J AM GERIATR SOC, V60, P1092, DOI 10.1111/j.1532-5415.2012.03968.x; Spirduso W.W., 2005, PHYS DIMENSIONS AGIN; Stenholm S, 2011, SLEEP, V34, P1583, DOI 10.5665/sleep.1402; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119; World Population Ageing, 2013, WORLD POP AG 2013	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1040	1048		10.1111/ggi.12396		9	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900016		
J	Sanada, H; Nakagami, G; Koyano, Y; Iizaka, S; Sugama, J				Sanada, Hiromi; Nakagami, Gojiro; Koyano, Yuiko; Iizaka, Shinji; Sugama, Junko			Incidence of skin tears in the extremities among elderly patients at a long-term medical facility in Japan: A prospective cohort study	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						epidemiology; dermatology; nursing care; preventive medicine; skin tears		AimThere is a lack of data from cohort studies for the incidence of skin tears among an elderly population in an Asian country. We estimated the cumulative incidence of skin tear, and identify its risk factor. MethodsThe present prospective cohort study was carried out at a long-term medical facility in Japan. Participants included patients (n=368) aged 65 years or older receiving hospital care. The 3-month cumulative incidence of skin tears was estimated by identifying them using direct inspection of the extremities. In order to find the risk factors for the skin tear incidence, odds ratios and their 95% confidence intervals of skin tear development in association with the factors were estimated using logistic regression analyses. ResultsA total of 14 patients developed skin tears, and their cumulative incidence was 3.8%. No patients with skin tears developed multiple wounds on their extremities. Half of the skin tears occurred on the outside of the right forearm, and just three skin tears were found in the lower legs. Multiple logistic analyses showed that pre-existing skin tears (odds ratio 15.42, 95% confidence interval 3.53-67.43, P<0.001) and a 6-point decrease in the total score of the Braden Scale (odds ratio 0.10, 95% confidence interval 0.01-0.83, P<0.033) were significantly associated with skin tear development. ConclusionsPatients with pre-existing skin tears and a low score of the Braden Scale have a higher risk of skin tear development during 3 months. These factors could be used to identify patients requiring prevention care for skin tears. Geriatr Gerontol Int 2015; 15: 1058-1063.	[Sanada, Hiromi; Nakagami, Gojiro; Koyano, Yuiko; Iizaka, Shinji] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo 1130033, Japan; [Sugama, Junko] Kanagawa Univ, Wellness Promot Sci Ctr, Inst Med Pharmaceut & Hlth Sci, Kanagawa, Ishikawa, Japan	Sanada, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hsanada-tky@umin.ac.jp			Japan Society for the Promotion of Science [25670990]	The authors acknowledge all of the participants, and the staff of the long-term medical facility, for their kind cooperation and support. This work was supported by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science (25670990: Hiromi Sanada). No potential conflicts of interest were disclosed.	Diridollou S, 2007, INT J DERMATOL, V46, P11, DOI 10.1111/j.1365-4632.2007.03455.x; Bank D, 2006, OSTOMY WOUND MANAG, V52, P38; Xu XT, 2009, AM J EMERG MED, V27, P729, DOI 10.1016/j.ajem.2008.05.015; BERGSTROM N, 1987, NURS RES, V36, P205; Brillhart Barbara, 2005, Rehabil Nurs, V30, P85; Carville K, 2007, PRIM INTENT, V15, P18; Coelho SG, 2013, EXP DERMATOL, V22, P266, DOI 10.1111/exd.12116; Groom M, 2010, J WOUND OSTOMY CONT, V37, P46, DOI 10.1097/WON.0b013e3181c68c89; Holmes Regina F, 2013, Home Healthc Nurse, V31, P90, DOI 10.1097/NHH.0b013e31827f458a; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kennedy P, 2011, J AM GERIATR SOC, V59, P1547, DOI 10.1111/j.1532-5415.2011.03520.x; LeBlanc Kimberly, 2011, Adv Skin Wound Care, V24, P2, DOI 10.1097/01.ASW.0000405316.99011.95; MAHONEY F I, 1965, Md State Med J, V14, P61; Mahoney M, 2011, J WOUND OSTOMY CONT, V38, P635, DOI 10.1097/WON.0b013e31822fc3e5; MALONE ML, 1991, J AM GERIATR SOC, V39, P591; McBride MR, 2004, ANNU REV NURS RES, V22, P161; McGough-Csarny J, 1998, OSTOMY WOUND MANAG, V44, P14; McLane Kathleen M, 2004, J Wound Ostomy Continence Nurs, V31, P168; Payne R L, 1993, Ostomy Wound Manage, V39, P16	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1058	1063		10.1111/ggi.12405		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900018		
J	Aoki, M; Kawahata, H; Sotobayashi, D; Yu, H; Moriguchi, A; Nakagami, H; Ogihara, T; Morishita, R				Aoki, Motokuni; Kawahata, Hirohisa; Sotobayashi, Daisuke; Yu, Hisahiro; Moriguchi, Atsushi; Nakagami, Hironori; Ogihara, Toshio; Morishita, Ryuichi			Effect of angiotensinII receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						angiotensinII receptor blocker; bone metabolism; bone mineral density; disuse syndrome; hypertension	CONVERTING ENZYME-INHIBITOR; SPINAL-CORD-INJURY; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CALCIUM-CHANNEL; BIOCHEMICAL MARKERS; BLOOD-PRESSURE; BETA-BLOCKERS; BED REST; OSTEOPOROSIS	AimsAlthough recent studies suggest that several antihypertensive drugs could reduce the risk of bone fracture, it is still unclear how these drugs act on bone remodeling, especially in elderly women with severe osteoporosis with disuse syndrome. In the present study, we investigated the effects of a calcium channel blocker (CCB) and an angiotensinII receptor blocker (ARB) on bone metabolism in elderly bedridden women with hypertension and disuse syndrome. MethodsElderly bedridden women (aged >75 years) receiving antihypertensive therapy treated with CCB were recruited in the present study. The participants were divided into two groups - CCB group and ARB group - and followed up to 12months. ResultsMarkers of bone resorption were markedly increased, suggesting accelerated bone resorption in the participants of the present study. In the follow-up period, the patients treated with a CCB showed a significant decrease in bone mineral density in a time-dependent manner, accompanied by a significant increase in bone resorption markers, whereas treatment with olmesartan inhibited bone loss, associated with attenuation of increased bone resorption markers. Bone mineral density of femoral neck in the CCB group was significantly lower than that in the ARB group at 6months. ConclusionThe present study showed inhibitory effects of an ARB on bone resorption in hypertensive patients with accelerated bone resorption, such as elderly bedridden women, and indicated an important role of the renin-angiotensin system in bone metabolism. In elderly hypertensive patients, ARB might be expected to have additional beneficial potential to maintain bone health in bedridden patients. Geriatr Gerontol Int 2015; 15: 1064-1072.	[Aoki, Motokuni; Kawahata, Hirohisa; Sotobayashi, Daisuke; Ogihara, Toshio] Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka 5598611, Japan; [Yu, Hisahiro; Moriguchi, Atsushi] Hanwa Daini Senboku Hosp, Osaka, Japan; [Nakagami, Hironori] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Osaka, Japan; [Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Osaka, Japan	Aoki, M (reprint author), Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Suminoe Ku, 1-26-16 Nanko Kita, Osaka 5598611, Japan.	aoki@morinomiya-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Daiichi Sankyo Co. Ltd.; Daiichi Sankyo; Mitsubishi-Tanabe; Takeda; Daiichi-Sankyo; AnGes MG; Novartis; Shionogi; Boeringher; Astellas Pharma; Rohto	We are grateful to the study volunteers and their families for their participation. This work was supported by a Grant-in-Aid for Scientific Promoted Research from the Japan Society for the Promotion of Science (JSPS) and by Daiichi Sankyo Co. Ltd. The cost of this clinical study was supported by Daiichi Sankyo, which sells olmesartan. Motokuni Aoki received a grant from Daiichi Sankyo. Toshio Ogihara and Ryuichi Morishita received honoraria for lecture fees from Daiichi Sankyo. The Department of Clinical Gene Therapy was financially supported by Mitsubishi-Tanabe, Takeda, Daiichi-Sankyo, AnGes MG, Novartis, Shionogi, Boeringher, Astellas Pharma and Rohto.	ALBERS MM, 1991, BONE, V12, P39, DOI 10.1016/8756-3282(91)90053-L; Rejnmark L, 2006, J BONE MINER RES, V21, P163, DOI 10.1359/JBMR.051003; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Solomon DH, 2011, J BONE MINER RES, V26, P1561, DOI 10.1002/jbmr.356; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6; Pasco JA, 2004, J BONE MINER RES, V19, P19, DOI 10.1359/JBMR.0301214; Cappuccio FP, 1999, LANCET, V354, P971, DOI 10.1016/S0140-6736(99)01437-3; Schoofs MWCJ, 2003, ANN INTERN MED, V139, P476; Perez-Castrillon JL, 2003, J HUM HYPERTENS, V17, P107, DOI 10.1038/sj.jjh.1001520; Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011; Vestergaard P, 1998, SPINAL CORD, V36, P790, DOI 10.1038/sj.sc.3100648; Perez-Castrillon JL, 2003, AM J HYPERTENS, V16, P453, DOI 10.1016/S0895-7061(03)00845-8; Schlienger RG, 2004, JAMA-J AM MED ASSOC, V292, P1326, DOI 10.1001/jama.292.11.1326; Ishijima M, 2006, EXP CELL RES, V312, P3075, DOI 10.1016/j.yexcr.2006.06.003; Reid IR, 2000, AM J MED, V109, P362, DOI 10.1016/S0002-9343(00)00510-6; Rejnmark L, 2006, J HYPERTENS, V24, P581, DOI 10.1097/01.hjh.0000203845.26690.cb; Cappuccio FP, 2000, J NEPHROL, V13, P169; Zerwekh JE, 1998, J BONE MINER RES, V13, P1594, DOI 10.1359/jbmr.1998.13.10.1594; Tsuda K, 2001, AM J HYPERTENS, V14, P704, DOI 10.1016/S0895-7061(01)01303-6; Brater DC, 1998, NEW ENGL J MED, V339, P387; Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]; Liu J, 2013, BONE, V54, P151, DOI 10.1016/j.bone.2013.01.044; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Shimizu H, 2009, HYPERTENS RES, V32, P786, DOI 10.1038/hr.2009.99; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; DUARTE CG, 1971, NEW ENGL J MED, V284, P828, DOI 10.1056/NEJM197104152841506; Fiore CE, 1999, HORM METAB RES, V31, P31, DOI 10.1055/s-2007-978693; IMAOKA M, 1991, CLIN EXP PHARMACOL P, V18, P631, DOI 10.1111/j.1440-1681.1991.tb01637.x; Jamal SA, 2009, OSTEOPOROSIS INT, V20, P737, DOI 10.1007/s00198-008-0727-7; Marchetti M E, 1996, J Shoulder Elbow Surg, V5, P471, DOI 10.1016/S1058-2746(96)80020-6; MCCARRON DA, 1980, HYPERTENSION, V2, P162; MORIMOTO S, 1991, CONTRIB NEPHROL, V90, P94; RESNICK LM, 1983, NEW ENGL J MED, V309, P888, DOI 10.1056/NEJM198310133091504; RICO H, 1993, MINER ELECTROL METAB, V19, P337; Shimizu H, 2012, HYPERTENS RES, V35, P77, DOI 10.1038/hr.2011.143; Vico L, 1987, BONE, V2, P283; Zacharieva S, 2003, METHOD FIND EXP CLIN, V25, P209, DOI 10.1358/mf.2003.25.3.769642	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1064	1072		10.1111/ggi.12406		9	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900019		
J	Doi, T; Shimada, H; Park, H; Makizako, H; Tsutsumimoto, K; Uemura, K; Nakakubo, S; Hotta, R; Suzuki, T				Doi, Takehiko; Shimada, Hiroyuki; Park, Hyuntae; Makizako, Hyuma; Tsutsumimoto, Kota; Uemura, Kazuki; Nakakubo, Sho; Hotta, Ryo; Suzuki, Takao			Cognitive function and falling among older adults with mild cognitive impairment and slow gait	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						cognition; elderly; gait; mild cognitive impairment; neuropsychological assessment	RISK; DEMENTIA; FRAILTY; PEOPLE; SPEED; ASSOCIATION; DYSFUNCTION; PREDICTOR; DECLINE	AimTo examine the association of the combination of slow gait and mild cognitive impairment (MCI) with cognitive function and falling in community-dwelling older people. MethodsParticipants were selected from the Obu Study of Health Promotion for the Elderly (n=3400), and underwent gait examination and a battery of neuropsychological examinations, including the Mini-Mental State Examination and the National Center for Geriatrics and Gerontology Functional Assessment Tool (tablet version of Trail Making Test Part A and B, Symbol Digit Substitution Task, Figure selection task, Word memory and Story memory), and were interviewed with a series of questionnaires including medical history, physical activity, geriatric depression scale and fall history. ResultsParticipants were classified into control (n=2281), slow gait speed (SG; n=278), MCI (n=673) and MCI with SG (MCI+SG; n=168) groups. All cognitive functions were significantly affected by the group factor, even adjusting for participant characteristics as covariates (P<0.001). Post-hoc analysis showed that the control group had better performance than the other groups, and the MCI+SG group had worse performance than the other groups in all cognitive functions (all P<0.05). In multiple logistic regression analysis, SG and MCI were independently associated with falling (all P<0.05), and MCI+SG had a higher odds ratio for falling (adjusted OR 1.99, 95% CI 1.08-3.65). ConclusionsOur findings support the idea that slow gait and MCI were related, and concurrently associated with falling. Motor function among MCI subjects should be focused on to assess profile risks. Geriatr Gerontol Int 2015; 15: 1073-1078.	[Doi, Takehiko; Shimada, Hiroyuki; Park, Hyuntae; Makizako, Hyuma; Tsutsumimoto, Kota; Uemura, Kazuki; Nakakubo, Sho; Hotta, Ryo] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, Obu, Aichi 4748511, Japan; [Doi, Takehiko; Makizako, Hyuma; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi 4748511, Japan; [Doi, Takehiko; Makizako, Hyuma; Uemura, Kazuki] Japan Soc Promot Sci, Tokyo, Japan	Doi, T (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Res & Dev Support Independent Life Elderly, Sect Hlth Promot, 35 Gengo, Obu, Aichi 4748511, Japan.	take-d@ncgg.go.jp			Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); National Center for Geriatrics and Gerontology, Japan [22-16];  [23300205]	We thank the Obu city office for help with participant recruitment. This work was supported by Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); a Grant-in-Aid for Scientific Research (B) (grant number 23300205); and Research Funding for Longevity Sciences (22-16) from the National Center for Geriatrics and Gerontology, Japan. No potential conflicts of interest were disclosed.	Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Hausdorff JM, 2013, J GERONTOL A-BIOL, V68, P409, DOI 10.1093/gerona/glt002; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Zheng JJJ, 2012, J GERONTOL A-BIOL, V67, P1085, DOI 10.1093/gerona/gls063; Solfrizzi V, 2013, ALZHEIMERS DEMENT, V9, P113, DOI 10.1016/j.jalz.2011.09.223; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Buchman AS, 2013, NEUROLOGY, V80, P2055, DOI 10.1212/WNL.0b013e318294b462; Waite LM, 2005, J NEUROL SCI, V229, P89, DOI 10.1016/j.jns.204.11.009; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Rosano C, 2012, AGE AGEING, V41, P58, DOI 10.1093/ageing/afr113; Liu-Ambrose TY, 2008, PHYS THER, V88, P1482, DOI 10.2522/ptj.20080117; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Zheng JJJ, 2011, STROKE, V42, P2086, DOI 10.1161/STROKEAHA.110.610360; Faulkner KA, 2007, J AM GERIATR SOC, V55, P570, DOI 10.1111/j.1532-5415.2007.01147.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; MURASE N, 2003, J HLTH WELFARE STAT, V49, P1; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424	29	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1073	1078		10.1111/ggi.12407		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900020		
J	Nanao, M; Kojima, T; Yamaguchi, Y; Ogawa, S; Akishita, M				Nanao, Michiko; Kojima, Taro; Yamaguchi, Yasuhiro; Ogawa, Sumito; Akishita, Masahiro			An elderly man with rapidly progressive depression and activities of daily living decline: Case report of late-onset hypogonadism syndrome	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter							MEN; MALES		[Nanao, Michiko; Kojima, Taro; Yamaguchi, Yasuhiro; Ogawa, Sumito; Akishita, Masahiro] Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Tokyo, Japan	Nanao, M (reprint author), Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Tokyo, Japan.						Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76; Kobayashi K, 2008, INT J IMPOT RES, V20, P544, DOI 10.1038/ijir.2008.27; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Corona G, 2012, ASIAN J ANDROL, V14, P251, DOI 10.1038/aja.2011.138; Buvat J, 2013, J SEX MED, V10, P245, DOI 10.1111/j.1743-6109.2012.02783.x; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Toba K, 2002, GERIATR GERONTOL INT, V2, P23, DOI 10.1046/j.1444-1586.2002.00016.x	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	AUG	2015	15	8					1098	1099		10.1111/ggi.12502		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CN6FF	WOS:000358528900024		
J	Keppel, G; Kavousi, J				Keppel, Gunnar; Kavousi, Javid			Effective climate change refugia for coral reefs	GLOBAL CHANGE BIOLOGY			English	Letter							OCEAN		[Keppel, Gunnar] Univ S Australia, Sch Nat & Built Environm, Adelaide, SA 5001, Australia; [Keppel, Gunnar] Univ S Australia, Barbara Hardy Inst, Adelaide, SA 5001, Australia; [Kavousi, Javid] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan	Keppel, G (reprint author), Univ S Australia, Sch Nat & Built Environm, GPO Box 2471, Adelaide, SA 5001, Australia.	gunnar.keppel@unisa.edu.au					Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Keppel G, 2015, FRONT ECOL ENVIRON, V13, P106, DOI 10.1890/140055; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947; Cacciapaglia C, 2015, GLOBAL CHANGE BIOL, V21, P2272, DOI 10.1111/gcb.12851; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Manzello DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041715; vansHooidonk R., 2014, GLOBAL CHANGE BIOL, V20, P103, DOI DOI 10.1111/GCB.12394	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	AUG	2015	21	8					2829	2830		10.1111/gcb.12936		2	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CN5QU	WOS:000358485200001		
J	Feng, ZZ; Rutting, T; Pleijel, H; Wallin, G; Reich, PB; Kammann, CI; Newton, PCD; Kobayashi, K; Luo, YJ; Uddling, J				Feng, Zhaozhong; Ruetting, Tobias; Pleijel, Hakan; Wallin, Goeran; Reich, Peter B.; Kammann, Claudia I.; Newton, Paul C. D.; Kobayashi, Kazuhiko; Luo, Yunjian; Uddling, Johan			Constraints to nitrogen acquisition of terrestrial plants under elevated CO2	GLOBAL CHANGE BIOLOGY			English	Article						carbon dioxide; crops; diversity; FACE; fertilization; forest; grassland; growth dilution; meta-analysis; nitrogen	ATMOSPHERIC CARBON-DIOXIDE; RICE YIELD ENHANCEMENT; DRY-MATTER PRODUCTION; ENRICHMENT FACE; SEASONAL-CHANGES; GRAZED PASTURE; NITRATE ASSIMILATION; CHEMICAL-COMPOSITION; FOREST PRODUCTIVITY; GROWTH-RESPONSE	A key part of the uncertainty in terrestrial feedbacks on climate change is related to how and to what extent nitrogen (N) availability constrains the stimulation of terrestrial productivity by elevated CO2 (eCO(2)), and whether or not this constraint will become stronger over time. We explored the ecosystem-scale relationship between responses of plant productivity and N acquisition to eCO(2) in free-air CO2 enrichment (FACE) experiments in grassland, cropland and forest ecosystems and found that: (i) in all three ecosystem types, this relationship was positive, linear and strong (r(2) = 0.68), but exhibited a negative intercept such that plant N acquisition was decreased by 10% when eCO(2) caused neutral or modest changes in productivity. As the ecosystems were markedly N limited, plants with minimal productivity responses to eCO(2) likely acquired less N than ambient CO2-grown counterparts because access was decreased, and not because demand was lower. (ii) Plant N concentration was lower under eCO(2), and this decrease was independent of the presence or magnitude of eCO(2)-induced productivity enhancement, refuting the long-held hypothesis that this effect results from growth dilution. (iii) Effects of eCO(2) on productivity and N acquisition did not diminish over time, while the typical eCO(2)-induced decrease in plant N concentration did. Our results suggest that, at the decennial timescale covered by FACE studies, N limitation of eCO(2)-induced terrestrial productivity enhancement is associated with negative effects of eCO(2) on plant N acquisition rather than with growth dilution of plant N or processes leading to progressive N limitation.	[Feng, Zhaozhong; Ruetting, Tobias; Pleijel, Hakan; Wallin, Goeran; Uddling, Johan] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Feng, Zhaozhong] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China; [Ruetting, Tobias] Univ Gothenburg, Dept Earth Sci, S-40530 Gothenburg, Sweden; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia; [Kammann, Claudia I.] Univ Giessen, Dept Plant Ecol, D-35392 Giessen, Germany; [Newton, Paul C. D.] AgRes Grasslands, Palmerston North, New Zealand; [Kobayashi, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Luo, Yunjian] Chinese Acad Sci, Inst Urban Environm, Xiamen 361021, Peoples R China	Feng, ZZ (reprint author), Univ Gothenburg, Dept Biol & Environm Sci, POB 461, S-40530 Gothenburg, Sweden.	zhzhfeng201@hotmail.com; johan.uddling@bioenv.gu.se			Strategic Research Area Biodiversity and Ecosystem Services in a Changing Climate (BECC), Sweden; Hundred Talents Programme of Chinese Academy of Sciences; Swedish Research Council Formas [214-2010-382]; Department of Energy [DOE/DE-FG02-96ER62291]; National Science Foundation [NSF Biocomplexity 0322057, NSF LTER DEB 9411972]; DEB [0080382, 0620652]; NSF LTREB [0716587]	We are grateful to the authors of the studies whose valuable field work provided the data for this meta-analysis. The study was financially supported by the Strategic Research Area Biodiversity and Ecosystem Services in a Changing Climate (BECC, www.becc.lu.se/), Sweden. The first and last authors were also supported by the Hundred Talents Programme of Chinese Academy of Sciences and the Swedish Research Council Formas (214-2010-382), respectively. BioCON research has been supported by the Department of Energy (DOE/DE-FG02-96ER62291) and the National Science Foundation (NSF Biocomplexity 0322057, NSF LTER DEB 9411972 (1994-2000), DEB 0080382 (2000-2006), and DEB 0620652 (2006-2012), and NSF LTREB 0716587).	Adamsen FJ, 2005, AGRON J, V97, P160; Shimono H, 2009, J EXP BOT, V60, P523, DOI 10.1093/jxb/ern288; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; McMurtrie RE, 2008, FUNCT PLANT BIOL, V35, P521, DOI 10.1071/FP08128; Lindroth RL, 2001, ENVIRON POLLUT, V115, P395, DOI 10.1016/S0269-7491(01)00229-9; Talhelm AF, 2014, GLOBAL CHANGE BIOL, V20, P2492, DOI 10.1111/gcb.12564; Kim HY, 2003, GLOBAL CHANGE BIOL, V9, P826, DOI 10.1046/j.1365-2486.2003.00641.x; Zaehle S, 2014, NEW PHYTOL, V202, P803, DOI 10.1111/nph.12697; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Kammann C, 2005, BASIC APPL ECOL, V6, P351, DOI 10.1016/j.baae.2005.01.011; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; Hu SJ, 2006, PLANT SOIL, V289, P47, DOI 10.1007/s11104-006-9093-4; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Newton PCD, 2010, PLANT SOIL, V336, P433, DOI 10.1007/s11104-010-0493-0; Kim HY, 2001, NEW PHYTOL, V150, P223, DOI 10.1046/j.1469-8137.2001.00111.x; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Yang LX, 2009, FIELD CROP RES, V112, P7, DOI 10.1016/j.fcr.2009.01.008; Yang LX, 2006, FIELD CROP RES, V98, P12, DOI 10.1016/j.fcr.2005.11.003; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; [Anonymous], 2002, CHIN J APPL ECOL; Kongstad J, 2012, ECOSYSTEMS, V15, P269, DOI 10.1007/s10021-011-9508-9; RASTETTER EB, 1992, WATER AIR SOIL POLL, V64, P327, DOI 10.1007/BF00477109; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Norby RJ, 2006, ECOLOGY, V87, P5, DOI 10.1890/04-1950; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Iversen CM, 2010, NEW PHYTOL, V186, P346, DOI 10.1111/j.1469-8137.2009.03122.x; Finzi AC, 2007, P NATL ACAD SCI USA, V104, P14014, DOI 10.1073/pnas.0706518104; Loladze I, 2002, TRENDS ECOL EVOL, V17, P457, DOI 10.1016/S0169-5347(02)02587-9; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; McCarthy HR, 2010, NEW PHYTOL, V185, P514, DOI 10.1111/j.1469-8137.2009.03078.x; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Gruters U, 2006, J APPL BOT FOOD QUAL, V80, P116; McGrath JM, 2013, PLANT CELL ENVIRON, V36, P697, DOI 10.1111/pce.12007; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Lee TD, 2011, GLOBAL CHANGE BIOL, V17, P2893, DOI 10.1111/j.1365-2486.2011.02435.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Curtis PS, 1996, PLANT CELL ENVIRON, V19, P127, DOI 10.1111/j.1365-3040.1996.tb00234.x; Esmeijer-Liu AJ, 2009, PLANT SOIL, V316, P311, DOI 10.1007/s11104-008-9783-1; Larsen KS, 2011, GLOBAL CHANGE BIOL, V17, P1884, DOI 10.1111/j.1365-2486.2010.02351.x; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Rutting T, 2010, GLOBAL CHANGE BIOL, V16, P2530, DOI 10.1111/j.1365-2486.2009.02089.x; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; COMINS HN, 1993, ECOL APPL, V3, P666, DOI 10.2307/1942099; Schneider MK, 2004, GLOBAL CHANGE BIOL, V10, P1377, DOI 10.1111/j.1365-2486.2004.00803.x; Ellsworth DS, 2004, GLOBAL CHANGE BIOL, V10, P2121, DOI 10.1111/j.1365-2486.2004.00867.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Gifford RM, 2000, PLANT SOIL, V224, P1, DOI 10.1023/A:1004790612630; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; McDonald EP, 2002, FUNCT PLANT BIOL, V29, P1115, DOI 10.1071/FP02007; Weigel HJ, 2012, EUR J AGRON, V43, P97, DOI 10.1016/j.eja.2012.05.011; Bloom Arnold J., 2014, Nature Climate Change, V4, DOI 10.1038/nclimate2183; Bloom AJ, 2012, ECOLOGY, V93, P355, DOI 10.1890/11-0485.1; DESGRAAFF MA, 2006, GLOBAL CHANGE BIOL, V12, P2077; Dijkstra FA, 2008, FUNCT ECOL, V22, P975, DOI 10.1111/j.1365-2435.2008.01398.x; Falster D, 2006, SMATR STANDARDISED M; Finzi AC, 2001, ECOLOGY, V82, P470, DOI 10.1890/0012-9658(2001)082[0470:FLPCAD]2.0.CO;2; Gloser V, 2000, PLANT SOIL, V227, P291, DOI 10.1023/A:1026538213199; Hebeisen T, 1997, GLOB CHANGE BIOL, V3, P149, DOI 10.1046/j.1365-2486.1997.00073.x; Huang JianYe, 2004, Scientia Agricultura Sinica, V37, P1824; Hungate BA, 2004, SCIENCE, V304, P1291, DOI 10.1126/science.1095549; International Panel on Climate Change (IPCC), 2013, CLIMATE CHANGE 2013, P465; Ko J, 2010, AGR FOREST METEOROL, V150, P1331, DOI 10.1016/j.agrformet.2010.06.004; LesQuere C, 2013, EARTH SYSTEM SCI DAT, V5, P165, DOI DOI 10.5194/ESSD-5-165-2013; LesQuere C, 2009, NATURE GEOSCIENCE, V17, P831; Li FY, 2014, GLOBAL CHANGE BIOL, V20, P228, DOI 10.1111/gcb.12358; Long S. P., 1992, TOPICS PHOTOSYNTHESI, V2, P69; Newton PCD, 2014, GLOBAL CHANGE BIOL, V20, P158, DOI 10.1111/gcb.12301; Norby RJ, 2009, CARBON DIOXIDE INFOR; Parton WJ, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001193; Pleijel H, 2012, GLOBAL CHANGE BIOL, V18, P596, DOI 10.1111/j.1365-2486.2011.2489.x; Poorter H, 1997, PLANT CELL ENVIRON, V20, P472, DOI 10.1046/j.1365-3040.1997.d01-84.x; Reich PB, 2009, BIOCON BIODIVERSITY; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Rosenberg MS, 2000, METAWIN STAT SOFTWAR, P128; Ross DJ, 2004, PLANT SOIL, V260, P183, DOI 10.1023/B:PLSO.0000030188.77365.46; Rutting T, 2015, NUTR CYCL AGROECOSYS, V101, P285, DOI 10.1007/s10705-015-9683-8; Shimono H, 2008, GLOBAL CHANGE BIOL, V14, P276, DOI 10.1111/j.1365-2486.2007.01498.x; Strain B, 1983, CO2 PLANTS RESPONSE, P177; Watanabe T, 2013, BIOGEOSCIENCES, V10, P8269, DOI 10.5194/bg-10-8269-2013; Yang Lian-xin, 2007, Yingyong Shengtai Xuebao, V18, P339; Yang LX, 2007, FIELD CROP RES, V100, P189, DOI 10.1016/j.fcr.2006.07.003; Yang Lian-xin, 2007, Yingyong Shengtai Xuebao, V18, P519; Zanetti S, 1997, OECOLOGIA, V112, P17, DOI 10.1007/s004420050278	93	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	AUG	2015	21	8					3152	3168		10.1111/gcb.12938		17	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CN5QU	WOS:000358485200028		
J	Urashima, T; Sun, YL; Fukuda, K; Hirayama, K; Taufik, E; Nakamura, T; Saito, T; Merchant, J; Green, B; Messer, M				Urashima, Tadasu; Sun, Yiliang; Fukuda, Kenji; Hirayama, Kentaro; Taufik, Epi; Nakamura, Tadashi; Saito, Tadao; Merchant, Jim; Green, Brian; Messer, Michael			Chemical characterization of milk oligosaccharides of the eastern quoll (Dasyurus viverrinus)	GLYCOCONJUGATE JOURNAL			English	Article						Eastern quoll; Milk oligosaccharides; Marsupials	LACTATING MAMMARY-GLANDS; WALLABY MACROPUS-EUGENII; MARSUPIAL-MILK; TAMMAR WALLABY; BIOSYNTHESIS; C-13-NMR	Structural characterizations of marsupial milk oligosaccharides have been performed in four species to date: the tammar wallaby (Macropus eugenii), the red kangaroo (Macropus rufus), the koala (Phascolarctos cinereus) and the common brushtail possum (Trichosurus vulpecula). To clarify the homology and heterogeneity of milk oligosaccharides among marsupials, the oligosaccharides in the carbohydrate fraction of eastern quoll milk were characterized in this study. Neutral and acidic oligosaccharides were separated and characterized by H-1-nuclear magnetic resonance spectroscopy and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The structures of the neutral oligosaccharides were Gal(beta 1-3)Gal(beta 1-4)Glc (3'-galactosyllactose), Gal(beta 1-3)Gal(beta 1-3)Gal(beta 1-4)Glc (3",3'-digalactosyllactose), Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (lacto-N-novopentaose I), Gal(beta 1-3)Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (galactosyl lacto-N-novopentaose I), Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-3)Gal(beta 1-4)Glc (galactosyl lacto-N-novopentaose II), Gal(beta 1-3)[Gal(beta 1-3)Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (galactosyl lacto-N-novopentaose III) and Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (lacto-N-novooctaose). The structures of the acidic oligosaccharides detected are Neu5Ac(alpha 2-3)Gal(beta 1-4)Glc (3'-sialyllactose), Gal(beta 1-3)(O-3-sulfate)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (lacto-N-novopentaose I sulfate a), Gal(beta 1-3)[Gal(beta 1-4)(O-3-sulfate)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (lacto-N-novopentaose I sulfate b), Neu5Ac(alpha 2-3)Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (sialyl lacto-N-novopentaose a), Gal(beta 1-3)[Neu5Ac(alpha 2-3)Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc (sialyl lacto-N-novopentaose c), Neu5Ac(alpha 2-3) Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc, and Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-3)[Gal(beta 1-4)GlcNAc(beta 1-6)]Gal(beta 1-4)Glc with an alpha(2-3) Neu5Ac linked to beta(1-4)Gal residue of either branch of Gal(beta 1-4)GlcNAc(beta 1-6) units. The most predominant oligosaccharides in the carbohydrate fraction of mid-lactation milk were found to be lacto-N-novopentaose I and lacto-N-novooctaose, i.e., branched oligosaccharides that contain N-acetylglucosamine. The predominance of these branched oligosaccharides, rather than of a series of linear beta(1-3) linked galacto oligosaccharides, appears to be the main feature of the eastern quoll milk oligosaccharides that differentiates them from those of the tammar wallaby and the brushtail possum.	[Urashima, Tadasu; Sun, Yiliang; Fukuda, Kenji; Hirayama, Kentaro] Obihiro Univ Agr & Vererinary Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan; [Nakamura, Tadashi] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan; [Taufik, Epi] Bogor Agr Univ, Fac Anim Sci, Bogor 16680, Indonesia; [Saito, Tadao] Tohoku Univ, Grad Sch Agr, Sendai, Miyagi 9818555, Japan; [Green, Brian] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Messer, Michael] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	Urashima, T (reprint author), Obihiro Univ Agr & Vererinary Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan.	urashima@obihiro.ac.jp					DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Urashima T, 2014, GLYCOCONJUGATE J, V31, P387, DOI 10.1007/s10719-014-9533-y; Anraku T, 2012, GLYCOCONJUGATE J, V29, P147, DOI 10.1007/s10719-012-9372-7; BRADBURY JH, 1983, CARBOHYD RES, V122, P327, DOI 10.1016/0008-6215(83)88344-X; COLLINS JG, 1981, CARBOHYD RES, V92, P136; JENNESS R, 1964, COMP BIOCHEM PHYSIOL, V13, P339, DOI 10.1016/0010-406X(64)90028-3; MESSER M, 1982, CARBOHYD RES, V102, P316, DOI 10.1016/S0008-6215(00)88076-3; MESSER M, 1987, COMP BIOCHEM PHYS B, V88, P1083, DOI 10.1016/0305-0491(87)90009-5; MESSER M, 1977, AUST J BIOL SCI, V30, P379; MESSER M, 1991, BIOCHIM BIOPHYS ACTA, V1077, P79, DOI 10.1016/0167-4838(91)90528-8; MESSER M, 1979, AUST J BIOL SCI, V32, P519; MESSER M, 1980, CARBOHYD RES, V83, P327, DOI 10.1016/S0008-6215(00)84545-0; Urashima T, 2013, GLYCOCONJUGATE J, V30, P801, DOI 10.1007/s10719-013-9484-8; URASHIMA T, 1992, BIOCHIM BIOPHYS ACTA, V1117, P223, DOI 10.1016/0304-4165(92)90083-7; Urashima T., 2007, COMPREHENSIVE GLYCOS, P695; URASHIMA T, 1994, BBA-GEN SUBJECTS, V1200, P64, DOI 10.1016/0304-4165(94)90028-0; Ursshima T., 2001, GLYCOCONJ J, V18, P357	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	AUG	2015	32	6					361	370		10.1007/s10719-015-9600-z		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN6ZR	WOS:000358583800003		
J	Date, K; Ohyama, M; Ogawa, H				Date, Kimie; Ohyama, Mami; Ogawa, Haruko			Carbohydrate-binding activities of coagulation factors fibrinogen and fibrin	GLYCOCONJUGATE JOURNAL			English	Article						Carbohydrate-binding protein; Coagulation factor; Fibrin; Fibrinogen; Fibrin clot	SIALIC-ACID; HYALURONIC-ACID; POLYMERIZATION; GLYCOPROTEINS; LOCALIZATION; CONVERSION; THROMBIN; MANNOSE; PLASMA; CHAINS	The coagulation factors fibrinogen and fibrin play important roles in the final stage of the blood coagulation cascade. It has not been revealed whether fibrinogen has lectin activity or not. Here we demonstrate that fibrinogen and fibrin have carbohydrate-specific binding activities that inhibit fibrin clot formation. A solid-phase binding study using sugar-biotinyl polymer probes revealed that fibrinogen has the highest affinity to mannose (Man) in both the presence and absence of 5 mM Ca2+. Fibrin, which is proteolytically produced from fibrinogen by thrombin, binds to the same sugar residues as fibrinogen in the presence of 5 mM Ca2+, while it markedly binds to N-acetylneuraminic acid in the absence of Ca2+. Thrombin-induced fibrin polymerization was monitored by turbidity at 350 nm. In the presence of Ca2+, Man and sugars having N-acetyl groups were found to inhibit the increase in turbidity, but only Man inhibited it in the absence of Ca2+. Scanning electron microscopy observation of fibrin clots formed in the presence of various sugars showed that fibrin fibers formed in the presence of Man and N-acetyl group sugars were thinner and more branched. In contrast, thrombin has neither carbohydrate-binding activity nor is affected by sugars. These results suggest that carbohydrates and glycoconjugates may regulate fibrin clot formation in vivo.	[Date, Kimie; Ohyama, Mami; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Date, Kimie; Ohyama, Mami; Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan	Ogawa, H (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan.	ogawa.haruko@ocha.ac.jp					AKIHAMA S, 1995, YAKUGAKU ZASSHI, V115, P537; Alton G, 1997, BIOCHEM MOL MED, V60, P127, DOI 10.1006/bmme.1997.2574; Yakovlev S, 2003, BIOCHEMISTRY-US, V42, P7709, DOI 10.1021/bi0344073; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x; LEBOEUF RD, 1987, BIOCHEMISTRY-US, V26, P6052, DOI 10.1021/bi00393a016; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003; Siebenlist KR, 2005, BLOOD, V106, P2730, DOI 10.1182/blood-2005-01-0240; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; Niwa K, 2008, THROMB RES, V121, P773, DOI 10.1016/j.thromres.2007.07.007; BOYER MH, 1972, BLOOD-J HEMATOL, V39, P382; Gray E., 2012, HDB EXP PHARM, V207, P43, DOI DOI 10.1007/978-3-642-23056-1_3; KUNICKI TJ, 1989, BLUT, V59, P30, DOI 10.1007/BF00320245; LEBOEUF RD, 1986, J BIOL CHEM, V261, P2586; MIRSHAHI M, 1987, THROMB RES, V48, P279, DOI 10.1016/0049-3848(87)90440-3; Morris TA, 2007, THROMB RES, V119, P257, DOI 10.1016/j.thromres.2006.02.010; OKUDE M, 1993, BIOL PHARM BULL, V16, P448; Ono S, 1972, J Med Genet, V9, P254, DOI 10.1136/jmg.9.3.254; Pieters M, 2008, THROMB HAEMOSTASIS, V99, P691, DOI 10.1160/TH07-11-0699; Soedamah-Muthu SS, 2008, DIABETOLOGIA, V51, P493, DOI 10.1007/s00125-007-0905-8; Taguchi T, 2003, CLIN CHEM, V49, P181, DOI 10.1373/49.1.181; Takekawa H, 2006, J BIOL CHEM, V281, P8528, DOI 10.1074/jbc.M513773200	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	AUG	2015	32	6					385	392		10.1007/s10719-015-9603-9		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN6ZR	WOS:000358583800005		
J	Sakamoto, N; Sato, N; Oikawa, K; Talib, AK; Sugiyama, E; Minoshima, A; Tanabe, Y; Takeuchi, T; Akasaka, K; Saijo, Y; Kawamura, Y; Hasebe, N				Sakamoto, Naka; Sato, Nobuyuki; Oikawa, Kensuke; Talib, Ahmed Karim; Sugiyama, Eitaro; Minoshima, Akiho; Tanabe, Yasuko; Takeuchi, Toshiharu; Akasaka, Kazumi; Saijo, Yasuaki; Kawamura, Yuichiro; Hasebe, Naoyuki			Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia	HEART RHYTHM			English	Article						T-wave afternans; Cardiac magnetic resonance imaging; Late gadolinium enhancement; Hypertrophic cardiomyopathy; Ventricular tachycardia; Ventricular fibrillation	SUDDEN-DEATH RISK; ISCHEMIC CARDIOMYOPATHY; DEFIBRILLATOR THERAPY; MYOCARDIAL FIBROSIS; PROGNOSTIC VALUE; HEART-FAILURE; STRATIFICATION; REPOLARIZATION; ARRHYTHMIAS; FIBRILLATION	BACKGROUND The presence of myocardial scar detected by late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) imaging has been described as a good independent predictor of mortality in patients with hypertrophic cardiomyopathy (HCM). Time-domain T-wave alternans (TWA) is also a potential predictor of cardiac mortality in patients with Left ventricular dysfunction. OBJECTIVE The purpose of this study was to elucidate the relationship between LGE distribution and TWA in patients with HCM. METHODS CMR and TWA analyses using Holler monitoring were performed in 42 patients with HCM. The average transmural extent of LGE was scored as 1-4 in each segment, and the sum of the LGE scores (total LGE score) was calculated for each patient. The correlation between the maximal time-domain TWA voltage and LGE findings was analyzed, and the differences in time-domain TWA voltage, total LGE score, and cardiac function assessed by CMR imaging in the presence or absence of ventricular tachycardia (VT) were also compared. RESULTS The total LGE score was significantly and positively correlated with the maximal time-domain TWA voltage (r = 0.59; P < .001). Furthermore, the total LGE score and maximal time-domain TWA voltage were significantly greater in patients who had episodes of VT (n = 21) than in those without VT (23 +/- 7 vs 10 +/- 8; P < .001 and 87 +/- 26 mu V vs 62 +/- 12 mu V; P < .001, respectively). However, the left ventricular ejection fraction did not statistically differ between patients with VT and those without VT (56% +/- 14% vs 61% 7%; P = .102). CONCLUSION The magnitude of the localized LGE was significantly correlated with abnormalities in ventricular repolarization as assessed by TWA and QT dispersion.	[Sakamoto, Naka; Sato, Nobuyuki; Talib, Ahmed Karim; Sugiyama, Eitaro; Minoshima, Akiho; Tanabe, Yasuko; Takeuchi, Toshiharu; Saijo, Yasuaki; Kawamura, Yuichiro; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Cardiol, Asahikawa, Hokkaido 0788510, Japan; [Oikawa, Kensuke; Akasaka, Kazumi] Asahikawa Med Univ, Dept Pathol, Asahikawa, Hokkaido 0788510, Japan; [Saijo, Yasuaki] Asahikawa Med Univ, Div Community Med & Epidemiol, Dept Hlth Sci, Asahikawa, Hokkaido 0788510, Japan	Hasebe, N (reprint author), Asahikawa Med Univ, Dept Cardiol, Midorigaoka Higashi 2-1-1, Asahikawa, Hokkaido 0788510, Japan.	nsato@asahikawa-med.ac.jp					Gehi AK, 2005, J AM COLL CARDIOL, V46, P75, DOI 10.1016/j.jacc.2005.03.059; Bloomfield DM, 2004, CIRCULATION, V110, P1885, DOI 10.1161/01.CIR.0000143160.14610.53; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; Kon-No Y, 2001, J CARDIOVASC ELECTR, V12, P759, DOI 10.1046/j.1540-8167.2001.00759.x; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; Exner DV, 2007, J AM COLL CARDIOL, V50, P2275, DOI 10.1016/j.jacc.2007.08.042; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Iles L, 2008, J AM COLL CARDIOL, V52, P1574, DOI 10.1016/j.jacc.2008.06.049; Nearing BD, 2002, J APPL PHYSIOL, V92, P541; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; Chauhan VS, 2006, AM J PHYSIOL-HEART C, V290, pH79, DOI 10.1152/ajpheart.00648.2005; Chow T, 2006, J AM COLL CARDIOL, V47, P1820, DOI 10.1016/j.jacc.2005.11.079; Almaas VM, 2014, HEART, V100, P631, DOI 10.1136/heartjnl-2013-304923; Bloomfield DM, 2006, J AM COLL CARDIOL, V47, P456, DOI 10.1016/j.jacc.2005.11.026; Armoundas AA, 1998, AM J CARDIOL, V82, P1127, DOI 10.1016/S0002-9149(98)00570-0; CALKINS H, 1993, CIRCULATION, V88, P172; Chow T, 2007, J AM COLL CARDIOL, V49, P50, DOI 10.1016/j.jacc.2006.06.079; Harada M, 2003, AM J CARDIOL, V92, P998, DOI 10.1016/S0002-9149(03)00988-3; Kuroda N, 2002, CIRC J, V66, P457, DOI 10.1253/circj.66.457; Kuroda N, 2001, JPN CIRC J, V65, P974, DOI 10.1253/jcj.65.974; Nieminen T, 2010, ANN NONINVAS ELECTRO, V15, P276, DOI 10.1111/j.1542-474X.2010.00376.x; Salerno-Uriarte JA, 2007, J AM COLL CARDIOL, V50, P1896, DOI 10.1016/j.jacc.2007.09.004; Sasaki K, 2009, HEART RHYTHM, V6, P332; Selvaraj RJ, 2007, AM J PHYSIOL-HEART C, V292, pH1262, DOI 10.1152/ajpheart.00913.2006; Selvaraj RJ, 2009, EUROPACE, V11, P1529, DOI 10.1093/europace/eup295; Shi C, 2013, ACTA PHYSIOL, V208, P95, DOI 10.1111/apha.12071; Shimada H, 2012, AM J CARDIOL, V110, P1446, DOI 10.1016/j.amjcard.2012.06.054; Uchimura-Makita Y, 2014, J CARDIOVASC ELECTR, V25, P1021, DOI 10.1111/jce.12441; Verrier RL, 2011, J AM COLL CARDIOL, V50, P1309; Yamanari H, 2000, ANN NONINVAS ELECTRO, V5, P60, DOI 10.1111/j.1542-474X.2000.tb00247.x	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	AUG	2015	12	8					1747	1755		10.1016/j.hrthm.2015.04.028		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN4FN	WOS:000358386100007		
J	Akahoshi, Y; Kako, S; Nakano, H; Ugai, T; Wada, H; Yamasaki, R; Ishihara, Y; Kawamura, K; Sakamoto, K; Sato, M; Ashizawa, M; Terasako-Saito, K; Kimura, S; Kikuchi, M; Nakasone, H; Yamazaki, R; Kanda, J; Nishida, J; Kanda, Y				Akahoshi, Yu; Kako, Shinichi; Nakano, Hirofumi; Ugai, Tomotaka; Wada, Hidenori; Yamasaki, Ryoko; Ishihara, Yuko; Kawamura, Koji; Sakamoto, Kana; Sato, Miki; Ashizawa, Masahiro; Terasako-Saito, Kiriko; Kimura, Shun-ichi; Kikuchi, Misato; Nakasone, Hideki; Yamazaki, Rie; Kanda, Junya; Nishida, Junji; Kanda, Yoshinobu			Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning	HEMATOLOGY			English	Article						Hematopoietic stem cell transplantation; Total body irradiation; Cyclophosphamide; Graft-versus-host disease; Transplantation conditioning	VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; PLASMACYTOID DENDRITIC CELLS; TUMOR LYSIS SYNDROME; ADMINISTRATION ORDER; GRAFT; CYCLOPHOSPHAMIDE; BUSULFAN; CHEMOTHERAPY; COMBINATION	Objectives: Limited data are available on the effect of how cyclophosphamide (CY) and total body irradiation (TBI) are administered. We analyzed the effect of the interval from TBI to hematopoietic stem cell transplantation (HSCT) on the outcome of HSCT. Methods: Adult patients who underwent HSCT using myeloablative conditioning consisting of TBI and CY were retrospectively analyzed. They were divided into three groups according to the duration between the start of TBI and HSCT (Group A: 2-4 days, Group B: 5-8 days, Group C: 9-10 days). Results: Seventy-five adult patients were included. The 3-year overall survival rate was 56, 47, and 77% in Groups A, B, and C, respectively (P = 0.14). Similarly, there was no significant difference among the three groups with respect to progression-free survival (57, 47, and 72%, P = 0.17), relapse rate (32, 37, and 16%, P = 0.29), or non-relapse mortality (8, 14, and 12%, P = 0.81). In addition, we observed no significant difference among the three groups with respect to the incidence of grade II-IV acute graftversus- host disease (GVHD) (31, 47, and 32%, respectively, P = 0.56) and that of chronic GVHD (23, 23, and 22%, respectively, P = 0.97). Discussion and conclusion: Although recipient immune system at HSCT might be affected by the timing of TBI, the duration between the start of TBI and HSCT did not influence the outcome of HSCT using myeloablative conditioning with TBI and CY.	[Akahoshi, Yu; Kako, Shinichi; Nakano, Hirofumi; Ugai, Tomotaka; Wada, Hidenori; Yamasaki, Ryoko; Ishihara, Yuko; Kawamura, Koji; Sakamoto, Kana; Sato, Miki; Ashizawa, Masahiro; Terasako-Saito, Kiriko; Kimura, Shun-ichi; Kikuchi, Misato; Nakasone, Hideki; Yamazaki, Rie; Kanda, Junya; Nishida, Junji; Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Saitama 3308503, Japan	Kanda, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Internal Med, Div Hematol,Omiya Ku, 1-847 Amanuma, Saitama, Saitama 3308503, Japan.	ycanda-tky@umin.ac.jp					Li HM, 2012, J IMMUNOL, V188, P3804, DOI 10.4049/jimmunol.1102795; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Machishima T, 2013, CLIN TRANSPLANT, V27, P749, DOI 10.1111/ctr.12213; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Sadeghi B, 2008, BONE MARROW TRANSPL, V41, P895, DOI 10.1038/sj.bmt.1705996; Dzionek A, 2000, J IMMUNOL, V165, P6037; HANDE KR, 1993, AM J MED, V94, P133, DOI 10.1016/0002-9343(93)90174-N; Kanda Y, 2005, BIOL BLOOD MARROW TR, V11, P881, DOI 10.1016/j.bbmt.2005.07.005; Clift RA, 1999, BLOOD, V94, P3960; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Banovic T, 2009, J IMMUNOL, V182, P912; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Koyama M, 2012, NAT MED, V18, P135, DOI 10.1038/nm.2597; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Cairo MS, 2004, BRIT J HAEMATOL, V127, P3, DOI 10.1111/j.1365-2141.2004.05094.x; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Del Toro Gustavo, 2005, Clin Adv Hematol Oncol, V3, P54; FEFER A, 1974, NEW ENGL J MED, V290, P1389, DOI 10.1056/NEJM197406202902501; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Goans RE, 2001, HEALTH PHYS, V81, P446, DOI 10.1097/00004032-200110000-00009; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato M, 2014, J PEDIAT HEMATOL ONC, V36, pE9, DOI 10.1097/MPH.0b013e318279e81c; Kerbauy FR, 2009, BONE MARROW TRANSPL, V43, P883, DOI 10.1038/bmt.2008.404; Kroger N, 2001, BONE MARROW TRANSPL, V27, P349, DOI 10.1038/sj.bmt.1702802; Nilsson C, 2005, EXP HEMATOL, V33, P380, DOI 10.1016/j.exphem.2004.12.003; Ringden O, 1996, BRIT J HAEMATOL, V93, P637, DOI 10.1046/j.1365-2141.1996.d01-1681.x; Shi-Xia Xu, 2010, Leuk Lymphoma, V51, P50, DOI 10.3109/10428190903419130; WEIDEN PL, 1979, BLOOD, V54, P1039	28	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1024-5332	1607-8454		HEMATOLOGY	Hematology	AUG	2015	20	7					410	415		10.1179/1607845414Y.0000000217		6	Hematology	Hematology	CN7KB	WOS:000358612100006		
J	Roayaie, S; Jibara, G; Tabrizian, P; Park, JW; Yang, JJ; Yan, LN; Schwartz, M; Han, GH; Izzo, F; Chen, M; Blanc, JF; Johnson, P; Kudo, M; Roberts, LR; Sherman, M				Roayaie, Sasan; Jibara, Ghalib; Tabrizian, Parissa; Park, Joong-Won; Yang, Jijin; Yan, Lunan; Schwartz, Myron; Han, Guohong; Izzo, Francesco; Chen, Mishan; Blanc, Jean-Frederic; Johnson, Philip; Kudo, Masatoshi; Roberts, Lewis R.; Sherman, Morris			The role of hepatic resection in the treatment of hepatocellular cancer	HEPATOLOGY			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PORTAL-HYPERTENSION; SURGICAL RESECTION; RADIOFREQUENCY ABLATION; PARTIAL-HEPATECTOMY; MILAN CRITERIA; CARCINOMA; SURGERY; TRIAL; CONTRAINDICATION	Current guidelines recommend surgical resection as the primary treatment for a single hepatocellular cancer (HCC) with Child's A cirrhosis, normal serum bilirubin, and no clinically significant portal hypertension. We determined how frequently guidelines were followed and whether straying from them impacted survival. BRIDGE is a multiregional cohort study including HCC patients diagnosed between January 1, 2005 and June 30, 2011. A total of 8,656 patients from 20 sites were classified into four groups: (A) 718 ideal resection candidates who were resected; (B) 144 ideal resection candidates who were not resected; (C) 1,624 nonideal resection candidates who were resected; and (D) 6,170 nonideal resection candidates who were not resected. Median follow-up was 27 months. Log-rank and Cox's regression analyses were conducted to determine differences between groups and variables associated with survival. Multivariate analysis of all ideal candidates for resection (A+B) revealed a higher risk of mortality with treatments other than resection. For all resected patients (A+C), portal hypertension and bilirubin >1 mg/dL were not associated with mortality. For all patients who were not ideal candidates for resection (C+D), resection was associated with better survival, compared to embolization and other treatments, but was inferior to ablation and transplantation. Conclusions: The majority of patients undergoing resection would not be considered ideal candidates based on current guidelines. Not resecting ideal candidates was associated with higher mortality. The study suggests that selection criteria for resection may be modestly expanded without compromising outcomes, and that some nonideal candidates may still potentially benefit from resection over other treatment modalities. (Hepatology 2015;62:440-451	[Roayaie, Sasan] Lenox Hill Hosp, North Shore LIJ Hlth Syst, New York, NY 10022 USA; [Jibara, Ghalib] Brookdales Med Ctr, Dept Urol, Brooklyn, NY USA; [Tabrizian, Parissa; Schwartz, Myron] Mt Sinai Med Ctr, New York, NY 10029 USA; [Park, Joong-Won] Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea; [Yang, Jijin] Second Mil Med Univ, Changhai Hosp, Dept Intervent Radiol, Shanghai, Peoples R China; [Yan, Lunan] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China; [Han, Guohong] Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Dept Hepatol & Digest Intervent Radiol, Xian 710032, Peoples R China; [Izzo, Francesco] G Pascale Fdn, Natl Canc Inst Naples, Hepatobiliary Unit, Naples, Italy; [Chen, Mishan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Blanc, Jean-Frederic] Hop St Andre, Hepatol & Digest Oncol Unit, Bordeaux, France; [Johnson, Philip] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Kudo, Masatoshi] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; [Roberts, Lewis R.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Sherman, Morris] Univ Toronto, Toronto, ON, Canada; [Sherman, Morris] Univ Hlth Network, Toronto, ON, Canada	Roayaie, S (reprint author), Lenox Hill Hosp, North Shore LIJ Hlth Syst, 110 East 59th St,Suite 10B, New York, NY 10022 USA.	sasan.roayaie@gmail.com					Cucchetti A, 2009, ANN SURG, V250, P922, DOI 10.1097/SLA.0b013e3181b977a5; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Feng K, 2012, J HEPATOL, V57, P794, DOI [10.1016/j.jhep.2012.05.007, 10.1016/j.jhep.2012.07.022]; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Borzio M, 2013, FUTURE ONCOL, V9, P283, DOI [10.2217/fon.12.183, 10.2217/FON.12.183]; Yin L, 2014, J HEPATOL, V61, P82, DOI [10.1016/j.jhep.2014.03.012, 10.1016/j.jhep.2014.04.005]; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Torzilli G, 2013, ANN SURG, V257, P929, DOI 10.1097/SLA.0b013e31828329b8; Capussotti L, 2006, WORLD J SURG, V30, P992, DOI 10.1007/s00268-005-0524-9; Peng ZW, 2012, CANCER-AM CANCER SOC, V118, P4725, DOI 10.1002/cncr.26561; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Choi SH, 2013, WORLD J GASTROENTERO, V19, P366, DOI 10.3748/wjg.v19.i3.366; Berzigotti A, 2015, HEPATOLOGY, V61, P526, DOI 10.1002/hep.27431; Torzilli G, 2008, ARCH SURG-CHICAGO, V143, P1082, DOI 10.1001/archsurg.143.11.1082; Llovet JM, 2012, J HEPATOL, V56, P908; Farinati F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-33; Giannini EG, 2013, LIVER INT, V33, P1594, DOI 10.1111/liv.12199; Iranmanesh P, 2014, J HEPATOL, V60, P969, DOI 10.1016/j.jhep.2013.12.015; Kobayashi T, 2011, J HEPATO-BIL-PAN SCI, V18, P689, DOI 10.1007/s00534-011-0379-4; Kuroda S, 2011, WORLD J SURG, V35, P834, DOI 10.1007/s00268-010-0929-y; Masuda T, 2013, J HEPATO-BIL-PAN SCI, V20, P370, DOI 10.1007/s00534-012-0540-8; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	24	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	AUG	2015	62	2					440	451		10.1002/hep.27745		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN5EX	WOS:000358453700017		
J	Honda, A; Ikegami, T; Matsuzaki, Y				Honda, Akira; Ikegami, Tadashi; Matsuzaki, Yasushi			Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate	HEPATOLOGY RESEARCH			English	Editorial Material							PRIMARY BILIARY-CIRRHOSIS; COMBINATION THERAPY; AUTOANTIBODIES; PROGRESSION; DISEASE		[Honda, Akira; Ikegami, Tadashi; Matsuzaki, Yasushi] Tokyo Med Univ, Ibaraki Med Ctr, Div Gastroenterol & Hepatol, Ami, Ibaraki, Japan	Honda, A (reprint author), Tokyo Med Univ, Ibaraki Med Ctr, Div Gastroenterol & Hepatol, Ami, Ibaraki, Japan.						Muratori P, 2003, AM J GASTROENTEROL, V98, P431, DOI 10.1016/S0002-9270(02)05925-7; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; Bizzaro N, 2012, CLIN REV ALLERG IMMU, V42, P288, DOI 10.1007/s12016-010-8234-y; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; VanNorstrand MD, 1997, HEPATOLOGY, V25, P6, DOI 10.1002/hep.510250103; Iwasaki S, 2008, HEPATOL RES, V38, P557, DOI 10.1111/j.1872-034X.2007.00305.x; Nakamura M, 2005, J HEPATOL, V42, P386, DOI 10.1016/j.jhep.2004.11.016; Iwasaki S, 1999, HEPATOL RES, V16, P12, DOI 10.1016/S1386-6346(99)00033-9; Czaja AJ, 2010, DIGEST DIS SCI, V55, P2144, DOI 10.1007/s10620-010-1268-4; Itakura J, 2004, HEPATOL RES, V29, P216, DOI 10.1016/j.hepres.2004.04.001; Honda A, 2013, HEPATOLOGY, V57, P1931, DOI 10.1002/hep.26018; Nakamura M, 2007, HEPATOL RES, V37, pS412, DOI 10.1111/j.1872-034X.2007.00244.x; Nakamuras M, 2014, HEPATOL RES, DOI [10.1111/hepr.12423, DOI 10.1111/HEPR.12423]; Yoshioka Y, 2014, HEPATOL RES, V44, P947, DOI 10.1111/hepr.12210	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					827	828		10.1111/hepr.12461		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100001		
J	Sato, I; Shimbo, T; Kawasaki, Y; Mizokami, M; Masaki, N				Sato, Izumi; Shimbo, Takuro; Kawasaki, Yohei; Mizokami, Masashi; Masaki, Naohiko			Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database	HEPATOLOGY RESEARCH			English	Article						chronic hepatitis C virus infection; database; elderly; interferon	VIRUS-INFECTION; PEGINTERFERON ALPHA-2A; REDUCTION THERAPY; TREATMENT-NAIVE; GENOTYPE 1B; RIBAVIRIN; METAANALYSIS; COMBINATION; SOFOSBUVIR; TRIALS	Aim: Although interferon (IFN) treatment in elderly patients with chronic hepatitis C virus (HCV) infection has increased with the aging Japanese population, few studies have examined the efficacy and safety of IFN treatment in this population. We investigated the efficacy and safety of IFN treatment in elderly patients with chronic HCV infection using the Japanese Interferon Database. Methods: Records of IFN treatment in 36 prefectures in Japan from December 2009 to April 2013 were examined. Patients with HCV infection who received IFN treatment were selected. We compared the sustained virological response (SVR) rate and the withdrawal from treatment proportion among elderly patients (>= 75 years) with those among younger patients (<65 years, 65-74 years). Results: We identified 15267 patients with chronic HCV infection as the study cohort from the database. Of these, 310 patients were elderly with a mean age of 76.7 +/- 1.95 years (2.03%; men, 155; women, 155), and the majority (87%) were treated with pegylated IFN. Lower SVR rates (aged <64 years, 65.3%; aged 65-74 years, 49.6%; aged >= 75 years, 46.5%; P<0.001) and higher withdrawal from treatment proportions (aged <64 years, 15.0%; aged 65-74 years, 21.5%; aged >= 75 years, 32.4%; P<0.001) were observed with aging. Conclusion: We conclude that elderly patients with chronic HCV infection taking IFN therapy achieved lower SVR rates and a higher withdrawal from treatment proportion than younger patients.	[Sato, Izumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Study & Informat, Tokyo 1628655, Japan; [Kawasaki, Yohei] Tokyo Univ Sci, Dept Math, Tokyo 162, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Fukushima, Japan; [Mizokami, Masashi; Masaki, Naohiko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Tokyo 1628655, Japan	Sato, I (reprint author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Study & Informat, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	izumisato-tky@umin.ac.jp			Ministry of Health, Labor and Welfare, Japan	THE AUTHORS THANK Ms Mikako Kajio and Ms Asako Horihata for technical assistance during data analysis. The large contributions by the 36 prefectural members and all of the medical staff engaged in long-term interferon treatment and data collection are particularly acknowledged. Financial support was provided by the Grant-in-Aid from the Ministry of Health, Labor and Welfare, Japan (Research on Hepatitis: 2009-2014) to N. M.	Di Bisceglie AM, 2003, AM J GASTROENTEROL, V98, P2060, DOI 10.1016/S0002-9270(03)00552-5; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Minami T, 2013, J GASTROENTEROL, V48, P254, DOI 10.1007/s00535-012-0631-y; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Singal AK, 2011, DIGEST DIS SCI, V56, P2221, DOI 10.1007/s10620-011-1765-0; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Arase Y, 2012, HEPATOL RES, V42, P750, DOI 10.1111/j.1872-034X.2012.00982.x; Arase Y, 2012, HEPATOL RES, V42, P949, DOI 10.1111/j.1872-034X.2012.01008.x; Editors of the Drafting Committee for Hepatitis Management Guidelines: the Japan Society of Hepatology, 2013, HEPATOL RES, V43, P1; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Nishikawa Hiroki, 2012, BMC Res Notes, V5, P135, DOI 10.1186/1756-0500-5-135; Sato Izumi, 2013, Drug Healthc Patient Saf, V5, P143, DOI 10.2147/DHPS.S45347; Zhao SH, 2010, CLIN THER, V32, P1565, DOI 10.1016/j.clinthera.2010.08.009	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					829	836		10.1111/hepr.12419		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100002		
J	Suda, G; Yamamoto, Y; Nagasaka, A; Furuya, K; Kudo, M; Chuganji, Y; Tsukuda, Y; Tsunematsu, S; Sato, F; Terasita, K; Nakai, M; Horimoto, H; Sho, T; Natsuizaka, M; Ogawa, K; Ohnishi, S; Chuma, M; Fujita, Y; Abe, R; Taniguchi, M; Nakagawa, M; Asahina, Y; Sakamoto, N				Suda, Goki; Yamamoto, Yoshiya; Nagasaka, Astushi; Furuya, Ken; Kudo, Mineo; Chuganji, Yoshimichi; Tsukuda, Yoko; Tsunematsu, Seiji; Sato, Fumiyuki; Terasita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Kouji; Ohnishi, Shunsuke; Chuma, Makoto; Fujita, Yasuyuki; Abe, Riichiro; Taniguchi, Miki; Nakagawa, Mina; Asahina, Yasuhiro; Sakamoto, Naoya		NORTE Study Grp	Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions	HEPATOLOGY RESEARCH			English	Article						drug-induced hypersensitivity syndrome; granulysin; hepatitis C virus; telaprevir; toxic epidermal necrolysis	CHRONIC HEPATITIS-C; STEVENS-JOHNSON SYNDROME; GENOTYPE 1 INFECTION; TOXIC EPIDERMAL NECROLYSIS; DIRECT-ACTING ANTIVIRALS; VIRUS-INFECTION; HCV; RIBAVIRIN; PEGINTERFERON; THERAPY	Aim: Telaprevir-based therapy for chronic hepatitis C patients is effective; however, the high prevalence of dermatological reactions is an outstanding issue. The mechanism and characteristics of such adverse reactions are unclear; moreover, predictive factors remain unknown. Granulysin was recently reported to be upregulated in the blisters of patients with Stevens-Johnson syndrome (SJS). Therefore, we investigated the risk factors for severe telaprevir-induced dermatological reactions as well as the association between serum granulysin levels and the severity of such reactions. Methods: A total of 89 patients who received telaprevir-based therapy and had complete clinical information were analyzed. We analyzed the associations between dermatological reactions and clinical factors. Next, we investigated the time-dependent changes in serum granulysin levels in five and 14 patients with grade 3 and non-grade 3 dermatological reactions, respectively. Results: Of the 89 patients, 57 patients had dermatological reactions, including nine patients with grade 3. Univariate analysis revealed that grade 3 dermatological reactions were significantly associated with male sex. Moreover, serum granulysin levels were significantly associated with the severity of dermatological reactions. Three patients with grade 3 dermatological reaction had severe systemic manifestations including SJS, drug-induced hypersensitivity syndrome, and systemic lymphoid swelling and high-grade fever; all were hospitalized. Importantly, among the three patients, two patients' serum granulysin levels exceeded 8ng/mL at onset and symptoms deteriorated within 6 days. Conclusion: Male patients are at high risk for severe telaprevir-induced dermatological reactions. Moreover, serum granulysin levels are significantly associated with the severity of dermatological reactions and may be a predictive factor in patients treated with telaprevir-based therapy.	[Suda, Goki; Tsukuda, Yoko; Tsunematsu, Seiji; Sato, Fumiyuki; Terasita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Kouji; Ohnishi, Shunsuke; Chuma, Makoto; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido 0608638, Japan; [Yamamoto, Yoshiya] Hakodate City Hosp, Hakodate, Hokkaido, Japan; [Nagasaka, Astushi] Sapporo City Gen Hosp, Sapporo, Hokkaido, Japan; [Furuya, Ken] Hokkaido Social Insurance Hosp, Sapporo, Hokkaido, Japan; [Kudo, Mineo] Sapporo Hokuyu Hosp, Sapporo, Hokkaido, Japan; [Fujita, Yasuyuki; Abe, Riichiro] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan; [Chuganji, Yoshimichi] Tokyo Metropolitan Bokuto Gen Hosp, Tokyo, Japan; [Taniguchi, Miki; Nakagawa, Mina; Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan	Suda, G (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	gsudgast@pop.med.hokudai.ac.jp	Ohnishi, Shunsuke/A-5982-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan	THIS STUDY WAS supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for the Promotion of Science, and the Ministry of Health, Labour and Welfare of Japan. The authors would like to thank all patients and their families as well as the investigators and staff of the 22 participating institutions. The principal investigators of the NORTE study sites are listed below in alphabetical order: Junichi Yoshida (Sapporo Social Insurance General Hospital), Atsushi Nagasaka (Sapporo City General Hospital), Akira Fuzinaga, Manabu Onodera (Abashiri-Kosei General Hospital), Hideaki Kikuchi, Tomofumi Atarashi (Obihiro-Kosei General Hospital), Ken Furuya (Hokkaido Social Insurance Hospital), Yukio Oohara, Sousi Kimura (National Hospital Organization Hokkaido Medical Center), Takuto Miyagihima (Kushiro Rosai Hosspital), Takashi Meguro (Hokkaido Gastroenterology Hospital), Akiyoshi Saga (Aiiku Hospital), Mineo Kudou (Sapporo Hokuyu Hospital), Jun Konno (Hakodate General Central Hospital), Kenichi Kumagaya (Hakodate Medical Association Hospital), Nobuaki Akakura (Sapporo Medical Center NTT EC), Tomoe Kobayashi (Tomakomai City Hospital), Uebayashi Minoru (Japanese Red Cross Kitami Hospital), Hiroshi Katou (Iwamizawa Municipal General Hospital), Yasuyuki Kunieda (Wakkanai City Hospital), Miki Tateyama (Tomakomai Nissho Hospital), Munenori Okamoto (Sapporo Century Hospital), Izumi Tunematsu (Touei Hospital) and Chuganji Yoshimichi (Tokyo Metropolitan Bokuto Hospital).	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536; Roujeau JC, 2013, JAMA DERMATOL, V149, P152, DOI 10.1001/jamadermatol.2013.938; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Fujita Y, 2011, J AM ACAD DERMATOL, V65, P65, DOI 10.1016/j.jaad.2010.04.042; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Abe R, 2009, ANN INTERN MED, V151, P514; Ogawa K, 2003, EUR J IMMUNOL, V33, P1925, DOI 10.1002/eji.200323977; Saigusa S, 2007, J GASTROEN HEPATOL, V22, P1322, DOI 10.1111/j.1440-1746.2006.04796.x; Cacoub P, 2012, J HEPATOL, V56, P455, DOI 10.1016/j.jhep.2011.08.006; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Lubbe J, 2005, BRIT J DERMATOL, V153, P1088, DOI 10.1111/j.1365-2133.2005.06931.x; Sakamoto N, 2011, J MED VIROL, V83, P871, DOI 10.1002/jmv.22038; Shimada N, 2014, HEPATOL RES; Torii H, 2013, J DERMATOL, V40, P587, DOI 10.1111/1346-8138.12199; Toyota J, 2013, J VIRAL HEPATITIS, V20, P167, DOI 10.1111/j.1365-2893.2012.01640.x; Yamada I, 2012, J VIRAL HEPATITIS, V19, pE112, DOI 10.1111/j.1365-2893.2011.01514.x	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					837	845		10.1111/hepr.12421		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100003		
J	Nakamura, M; Kondo, H; Tanaka, A; Komori, A; Ito, M; Yamamoto, K; Ohira, H; Zeniya, M; Hashimoto, E; Honda, M; Kaneko, S; Ueno, Y; Kikuchi, K; Shimoda, S; Harada, K; Arai, K; Miyake, Y; Abe, M; Taniai, M; Saibara, T; Sakisaka, S; Takikawa, H; Onji, M; Tsubouchi, H; Nakanuma, Y; Ishibashi, H				Nakamura, Minoru; Kondo, Hisayoshi; Tanaka, Atsushi; Komori, Atsumasa; Ito, Masahiro; Yamamoto, Kazuhide; Ohira, Hiromasa; Zeniya, Mikio; Hashimoto, Etsuko; Honda, Masao; Kaneko, Shuichi; Ueno, Yoshiyuki; Kikuchi, Kentaro; Shimoda, Shinji; Harada, Kenichi; Arai, Kuniaki; Miyake, Yasuhiro; Abe, Masanori; Taniai, Makiko; Saibara, Toshiji; Sakisaka, Shotaro; Takikawa, Hajime; Onji, Morikazu; Tsubouchi, Hirohito; Nakanuma, Yasuni; Ishibashi, Hiromi			Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis	HEPATOLOGY RESEARCH			English	Article						anticentromere antibody; anti-gp210 antibody; bezafibrate; biochemical response to treatment; histological staging and grading for primary biliary cirrhosis; ursodeoxycholic acid	URSODEOXYCHOLIC ACID; GENETIC POLYMORPHISMS; GRADING SYSTEM; PROGRESSION; BEZAFIBRATE; SUSCEPTIBILITY; ASSOCIATION; ANTIBODIES; PROGNOSIS; EFFICACY	Aim: The aim of the present study is to evaluate the factors influencing biochemical response to treatment and the value of biochemical response for predicting long-term outcomes in Japanese patients with primary biliary cirrhosis (PBC). Methods: Biochemical response to ursodeoxycholic acid (UDCA) or UDCA plus bezafibrate was defined as good (upper limit of normal [ULN]), fair (1.5 x ULN) or poor (>1.5 x ULN) at 2 years after initiation of UDCA treatment. Associations between various factors (including age, sex, autoantibody status and histological variables at baseline), biochemical response to treatment and long-term outcomes were evaluated in 164 Japanese PBC patients. Results: Anti-gp210 positivity and a higher bile duct loss score were significant risk factors for worse alkaline phosphatase (ALP) response (odds ratios [OR], 2.78 and 1.85, respectively). Age, anti-gp210 positivity and anticentromere positivity were significant risk factors for worse alanine aminotransferase (ALT) response (OR, 1.05, 4.0 and 2.77, respectively). Anti-gp210 positivity and a higher hepatitis score were significant risk factors for worse immunoglobulin (Ig)M response (OR, 2.10 and 2.06, respectively). Worse ALP and IgM response were significant risk factors for progression to late-stage disease without jaundice (OR, 2.27 and 2.32, respectively). Worse ALT response was a significant risk factor for progression to late-stage disease with persistent jaundice (OR, 11.11). Conclusion: Biochemical response to treatment at 2 years, which is influenced by autoantibody status and histological variables at baseline, can predict long-term outcomes in Japanese patients with PBC.	[Nakamura, Minoru; Komori, Atsumasa; Ito, Masahiro; Ishibashi, Hiromi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Omura 8568562, Japan; [Kondo, Hisayoshi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Nakamura, Minoru] Minist Hlth Labor & Welf Japan, Headquaters Working Intractable Hepatobiliary Dis, Tokyo, Japan; [Tanaka, Atsushi; Miyake, Yasuhiro; Takikawa, Hajime] Teikyo Univ Sch Med, Dept Med, Tokyo, Japan; [Zeniya, Mikio] Tokyo Jikei Univ Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Hashimoto, Etsuko; Taniai, Makiko] Tokyo Womens Med Univ, Dept Med & Gastroenterol, Tokyo, Japan; [Yamamoto, Kazuhide] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan; [Ohira, Hiromasa] Fukushima Med Univ Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan; [Honda, Masao; Kaneko, Shuichi; Arai, Kuniaki] Kanazawa Univ Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Harada, Kenichi; Nakanuma, Yasuni] Kanazawa Univ Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan; [Ueno, Yoshiyuki] Tohoku Univ Grad Sch Med, Div Gastroenterol, Sendai, Miyagi, Japan; [Kikuchi, Kentaro] Teikyo Univ Mizonokuchi Hosp, Dept Internal Med, Kawasaki, Kanagawa, Japan; [Shimoda, Shinji] Kyushu Univ Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Japan; [Sakisaka, Shotaro] Fukuoka Univ Sch Med, Dept Gastroenterol & Med, Fukuoka, Japan; [Abe, Masanori; Onji, Morikazu] Ehime Univ Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime, Japan; [Saibara, Toshiji] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Tsubouchi, Hirohito] Kagoshima Univ Grad Sch Med & Dent Sci, Dept Digest & Lifestyle Related Dis, Kagoshima, Japan	Nakamura, M (reprint author), Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, 2-1001-1 Kubara, Omura 8568562, Japan.	nakamuram@nmc.hosp.go.jp		Ishibashi, Hiromi/0000-0002-5005-6921	Ministry of Health, Labor and Welfare of Japan; Japan Society for Promotion of Science [20590800, 23591006]; National Hospital Organization (NHO)	WE THANK THE patients for their participation in this study. We thank Dr Hiroshi Yatsuhashi, Dr Shinya Nagaoka and Dr Seigo Abiru (NHO Nagasaki Medical Center, Omura Japan), and other doctors working at the university hospitals participating in this gp210 working of the Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labor and Welfare of Japan for their roles in patient care, obtaining informed consent, and clinical data and blood sample collection. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for Promotion of Science (#20590800, #23591006) to Minoru Nakamura, by a Grant-in-Aid for Clinical Research from the National Hospital Organization (NHO) to Minoru Nakamura, and by the Research Program of Intractable Disease provided by the Ministry of Health, Labor and Welfare of Japan to Hiromi Ishibashi.	Kumagi T, 2010, AM J GASTROENTEROL, V105, P2186, DOI 10.1038/ajg.2010.216; Kurihara T, 2002, AM J GASTROENTEROL, V97, P212; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; Hiramatsu K, 2006, HISTOPATHOLOGY, V49, P466, DOI 10.1111/j.1365-2559.2006.02537.x; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Corpechot C, 2002, GASTROENTEROLOGY, V122, P652, DOI 10.1053/gast.2002.31880; Aiba Y, 2011, J GASTROENTEROL, V46, P1203, DOI 10.1007/s00535-011-0417-7; Nakamura M, 2010, HEPATOL RES, V40, P494, DOI 10.1111/j.1872-034X.2010.00631.x; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; Iwasaki S, 2008, HEPATOL RES, V38, P557, DOI 10.1111/j.1872-034X.2007.00305.x; Nakamura M, 2005, J HEPATOL, V42, P386, DOI 10.1016/j.jhep.2004.11.016; Nakanuma Y, 2010, PATHOL INT, V60, P167, DOI 10.1111/j.1440-1827.2009.02500.x; Azemoto N, 2011, HEPATOL RES, V41, P310, DOI 10.1111/j.1872-034X.2011.00782.x; Takeuchi Y, 2011, J GASTROEN HEPATOL, V26, P1395, DOI 10.1111/j.1440-1746.2011.06737.x; Poupon R, 2008, J HEPATOL, V49, P1038, DOI 10.1016/j.jhep.2008.07.027; Poupon RE, 2003, J HEPATOL, V39, P12, DOI 10.1016/S0168-8278(03)00192-2; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lens S, 2014, LIVER INT, V34, P197, DOI 10.1111/liv.12290; Poupon R, 2010, J HEPATOL, V52, P745, DOI 10.1016/j.jhep.2009.11.027; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1016/j.gastro.2004.11.009; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Czaia A., 2010, DIGEST DIS SCI, V55, P2144; Degott C, 1999, HEPATOLOGY, V29, P1007, DOI 10.1002/hep.510290444; European Association for the Study of the Liver, 2009, J HEPATOL, V51, P237, DOI DOI 10.1016/J.JHEP.2009.04.009; Inamine T, 2013, J GASTROENTEROL, V48, P1160, DOI 10.1007/s00535-012-0730-9; Juran BD, 2010, J AUTOIMMUN, V35, P181, DOI 10.1016/j.jaut.2010.06.005; Ohishi Y, 2014, J GASTROENTEROL, V49, P332, DOI 10.1007/s00535-013-0795-0; Papastergiou V, 2013, ALIMENT PHARM THER; Poupon Raoul, 2003, Clin Liver Dis, V7, P865, DOI 10.1016/S1089-3261(03)00092-8; TheIntractable Hepatobiliary Disease Study Group supported by the Ministry of Health Labor and Welfare of Japan Working Subgroup (English version) for Clinical Practice Guidelines for Primary BiliaryCirrhosisf, 2014, HEPATOL RES S1, V44, P71	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					846	855		10.1111/hepr.12423		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100004		
J	Takatsuki, M; Soyama, A; Hidaka, M; Kinoshita, A; Adachi, T; Kitasato, A; Kuroki, T; Eguchi, S				Takatsuki, Mitsuhisa; Soyama, Akihiko; Hidaka, Masaaki; Kinoshita, Ayaka; Adachi, Tomohiko; Kitasato, Amane; Kuroki, Tamotsu; Eguchi, Susumu			Prospective study of the safety and efficacy of intermittent inflow occlusion (Pringle maneuver) in living donor left hepatectomy	HEPATOLOGY RESEARCH			English	Article						hepatectomy; ischemic reperfusion injury; liver transplantation; living donor; Pringle maneuver	TOLL-LIKE RECEPTOR; ISCHEMIA/REPERFUSION INJURY; LIVER-TRANSPLANTS; RESECTION	Aim: The impact of intermittent inflow occlusion (Pringle maneuver) in living donor hepatectomy on the outcome of both the donor and the recipient is unknown. The aim of this study is to elucidate the safety and efficacy of Pringle maneuver in living donor hepatectomy. Methods: Twenty consecutive cases of living donors who underwent left hepatectomy were prospectively divided into two groups, with (Group A, n=10) or without (Group B, n=10) the Pringle maneuver during hepatectomy. Intraoperative blood loss, postoperative liver functions in the donors and recipient outcome were reviewed. Results: Median blood loss was significantly less in group A than in group B. Median alanine aminotransferase was significantly higher on postoperative day 1 in group A than in group B, but the difference was not significant at 7days after surgery. Eight of 10 recipients in each group survived with good graft function with a median follow-up period of 20 months in group A and 19 months in group B. Conclusion: The Pringle maneuver was safely applied in living donor hepatectomy, but the only benefit was the reduction of blood loss during the donor surgery, and no positive impact on the recipient outcome.	[Takatsuki, Mitsuhisa; Soyama, Akihiko; Hidaka, Masaaki; Kinoshita, Ayaka; Adachi, Tomohiko; Kitasato, Amane; Kuroki, Tamotsu; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Takatsuki, M (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	takapon@net.nagasaki-u.ac.jp					Imamura H, 2002, LANCET, V360, P2049, DOI 10.1016/S0140-6736(02)11995-7; Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007; Figueras J, 2005, ANN SURG, V241, P582, DOI 10.1097/01.sla.0000157168.26021.b8; Croome KP, 2014, J HEPATO-BIL-PAN SCI, V21, P269, DOI 10.1002/jhbp.40; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Devey L, 2009, TRANSPLANTATION, V88, P308, DOI 10.1097/TP.0b013e3181ae3067; Eguchi S, 2008, SURG TODAY, V38, P795, DOI 10.1007/s00595-007-3729-8; Huynh L, 2012, J IMMUNOL, V188, P3447, DOI 10.4049/jimmunol.1102211; Imamura H, 2004, LIVER TRANSPLANT, V10, P771, DOI 10.1002/lt.20158; Lai JC, 2011, AM J TRANSPLANT, V11, P296, DOI 10.1111/j.1600-6143.2010.03385.x; Miller CM, 2004, LIVER TRANSPLANT, V10, P244, DOI 10.1002/lt.20071; Park Jae Berm, 2012, Liver Transpl, V18, P129, DOI 10.1002/lt.22409; Pietsch UC, 2010, CLIN HEMORHEOL MICRO, V44, P269, DOI 10.3233/CH-2010-1276; Shen XD, 2011, LIVER TRANSPLANT, V17, P201, DOI 10.1002/lt.22214; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Takatsuki M, 2011, J HEPATO-BIL-PAN SCI, V18, P170, DOI 10.1007/s00534-010-0322-0; Takatsuki M, 2009, AM J SURG, V197, pE25, DOI 10.1016/j.amjsurg.2008.01.019; Torzilli G, 2012, ANN SURG, V255, P270, DOI 10.1097/SLA.0b013e318232b375	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					856	862		10.1111/hepr.12406		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100005		
J	Fujiwara, K; Yasui, S; Yonemitsu, Y; Arai, M; Kanda, T; Nakano, M; Oda, S; Yokosuka, O				Fujiwara, Keiichi; Yasui, Shin; Yonemitsu, Yutaka; Arai, Makoto; Kanda, Tatsuo; Nakano, Masayuki; Oda, Shigeto; Yokosuka, Osamu			Importance of the poor prognosis of severe and fulminant hepatitis in the elderly in an era of a highly aging society: Analysis in a Japanese center	HEPATOLOGY RESEARCH			English	Article						acute liver failure; fulminant hepatitis; old age; outcome; severe hepatitis	ACUTE LIVER-FAILURE; DISEASES STUDY-GROUP; EARLY INDICATORS; TRANSPLANTATION; ETIOLOGY; EXPERIENCE; CRITERIA; VOLUME; STAGE	AimOlder age has been widely believed to be associated with a poor prognosis of acute liver failure. We aimed to evaluate the impact of older age on outcomes of Japanese patients with severe and fulminant hepatitis in an era of a highly aging society. MethodsWe investigated 105 consecutive adult patients with fulminant hepatitis (FH) or severe hepatitis (SH) admitted to our liver unit between 2000 and 2013, consisting of 14 elderly patients (65 years) and 91 younger ones (<65 years). ResultsIn elderly patients, the proportion of women was greater (P<0.001), the levels of aspartate aminotransferase and lactate dehydrogenase on admission were lower (P=0.011 and P=0.010, respectively), and the survival rate without liver transplantation was lower (P=0.024) than younger ones. Two of seven SH and all seven FH elderly patients died, whereas all 45 SH and 16 of 46 FH younger patients recovered. Seventy-one percent of elderly patients had underlying diseases with medications, and 57% had additional complications after the start of treatment for acute liver failure. Patients aged 70 years or more showed even poorer prognoses than younger ones and those aged 65-69 years (P=0.0052 and P=0.036, respectively). ConclusionOlder age was associated with a poor prognosis of patients with SH and FH. One of the reasons other than complications and loss of organ reserve by aging would be that elderly patients consulted us at a more advanced stage of illness than younger ones.	[Fujiwara, Keiichi; Yasui, Shin; Yonemitsu, Yutaka; Arai, Makoto; Kanda, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan; [Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba 2608670, Japan; [Nakano, Masayuki] Ofuna Chuo Hosp, Div Pathol, Kamakura, Kanagawa, Japan	Fujiwara, K (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	fujiwara-cib@umin.ac.jp			Ministry of Health, Labor and Welfare of Japan by the Intractable Hepato-Biliary Disease Study Group of Japan	WE ARE INDEBTED to all our colleagues at the liver unit of our hospital who cared for the patients described herein. This study was supported in part by a Health Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan as a project by the Intractable Hepato-Biliary Disease Study Group of Japan.	Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Oketani M, 2013, HEPATOL RES, V43, P97, DOI 10.1111/j.1872-034X.2012.01105.x; Barshes NR, 2006, TRANSPLANTATION, V81, P195, DOI 10.1097/01.tp.0000188149.90975.63; WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222; Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x; Fujiwara K, 2014, HEPATOL RES, V44, P491, DOI 10.1111/hepr.12148; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439; Fujiwara K, 2008, HEPATOL RES, V38, P646, DOI 10.1111/j.1872-034X.2008.00322.x; O'Grady J, 2014, J HEPATOL, V60, P663, DOI 10.1016/j.jhep.2013.10.024; Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733; Schiodt FV, 1999, LIVER TRANSPLANT SUR, V5, P29, DOI 10.1002/lt.500050102; Fujiwara K, 2013, HEPATOL INT, V7, P335, DOI 10.1007/s12072-012-9402-3; Bernal W, 2009, J HEPATOL, V50, P306, DOI 10.1016/j.jhep.2008.09.012; Germani G, 2012, J HEPATOL, V57, P288, DOI [10.1016/j.jhep.2012.03.017, 10.1016/j.jhep.2012.05.005]; MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; Mochida S, 2014, HEPATOL RES, V44, P365, DOI 10.1111/hepr.12295; Fujiwara K, 2011, HEPATOL RES, V41, P133, DOI 10.1111/j.1872-034X.2010.00755.x; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Dhiman RK, 2007, LIVER TRANSPLANT, V13, P814, DOI 10.1002/lt.21050; Fujiwara K, 2002, GUT, V51, P82, DOI 10.1136/gut.51.1.82; Martin GM, 2007, CECIL MED, V23rd; Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3; Schiodt FV, 2009, LIVER TRANSPLANT, V15, P1481, DOI 10.1002/lt.21865; Schmucker DL, 2011, CURR GERONTOL GERIAT, V2011, DOI DOI 10.1155/2011/526379; Trey C, 1970, Prog Liver Dis, V3, P282	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					863	871		10.1111/hepr.12426		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100006		
J	Orito, E; Hasebe, C; Kurosaki, M; Osaki, Y; Joko, K; Watanabe, H; Kimura, H; Nishijima, N; Kusakabe, A; Izumi, N				Orito, Etsuro; Hasebe, Chitomi; Kurosaki, Masayuki; Osaki, Yukio; Joko, Kouji; Watanabe, Hiroshi; Kimura, Hiroyuki; Nishijima, Norihiro; Kusakabe, Atsunori; Izumi, Namiki		Japanese Red Cross Liver Network	Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy	HEPATOLOGY RESEARCH			English	Article						hepatitis B surface antigen seroclearance; hepatitis B virus DNA; hepatocellular carcinoma; liver cirrhosis; nucleoside; nucleotide analog therapy; risk factors	SURFACE-ANTIGEN; NATURAL-HISTORY; INFECTION; LAMIVUDINE; ENTECAVIR; FIBROSIS	AimSome patients develop hepatocellular carcinoma (HCC) during nucleoside/nucleotide analog (NA) therapy even if alanine aminotransferase (ALT) or hepatitis B virus (HBV) DNA levels are sufficiently reduced. The aim of this study is to identify the risk factors of development of HCC during NA therapy. MethodsSix hundred and two patients were analyzed who were continuously receiving NA for chronic HBV infection. The patients who developed HCC previously or within 1year of therapy were excluded. In the patients studied, the median duration of therapy was 90months. A total of 492 patients had chronic hepatitis (CH) and 110 had liver cirrhosis (LC). ResultsIn 602 patients, the rate of normalization of ALT, loss of serum HBV DNA and development of HCC were 90.4%, 55.4%, and 6.1%, respectively. The significant risk factors of development of HCC were LC status and duration of therapy. The annual incidence of HCC in LC patients was 2.53%/year, compared with 0.34%/year in CH patients. When the relation between the incidence of HCC and the response to therapy was evaluated, in patients with normalization of ALT level, loss of HBV DNA by real-time polymerase chain reaction or hepatitis B e-antigen seroconversion, the incidences of HCC was reduced to some extent. However, none of the patients who achieved hepatitis B surface antigen (HBsAg) seroclearance during NA therapy developed HCC. ConclusionLC status was the significant risk factor of development of HCC during NA therapy. However, none of the patients who showed HBsAg seroclearance developed HCC. The ultimate goal of therapy for reduced risk of HCC may be HBsAg seroclearance.	[Orito, Etsuro; Kusakabe, Atsunori] Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Nagoya, Aichi 4668650, Japan; [Hasebe, Chitomi] Japanese Red Cross Asahikawa Hosp, Dept Gastroenterol, Asahikawa, Hokkaido, Japan; [Kurosaki, Masayuki; Izumi, Namiki] Japanese Red Cross Musashino Hosp, Dept Gastroenterol, Musashino, Tokyo, Japan; [Osaki, Yukio; Nishijima, Norihiro] Japanese Red Cross Osaka Hosp, Dept Gastroenterol, Osaka, Japan; [Joko, Kouji] Japanese Red Cross Matsuyama Hosp, Dept Gastroenterol, Matsuyama, Ehime, Japan; [Watanabe, Hiroshi] Japanese Red Cross Fukuoka Hosp, Dept Gastroenterol, Fukuoka, Japan; [Kimura, Hiroyuki] Japanese Red Cross Kyoto Daiichi Hosp, Dept Gastroenterol, Kyoto, Japan	Orito, E (reprint author), Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Showa Ku, 2-9 Myoken Cho, Nagoya, Aichi 4668650, Japan.	orito@nagoya2.jrc.or.jp			Ministry of Health Labor and Welfare of Japan	THIS STUDY WAS supported by grants from the Ministry of Health Labor and Welfare of Japan. The authors appreciate the cooperation of the following members of the Japanese Red Cross Liver Network: Dr T. Tamada, Takatsuki Red Cross Hospital; Dr M. Fujii, Kobe Red Cross Hospital; Dr T. Abe, Maebashi Red Cross Hospital; Dr T. Kawanami, Otsu Red Cross Hospital; Dr R. Narita, Oita Red Cross Hospital; Dr S. Tsuruta, Japanese Red Cross Nagasaki Genbaku Hospital; Dr Y. Uchida, Matsue Red Cross Hospital; Dr A. Mitsuda, Tottori Red Cross Hospital; and Dr T. Sato, Nasu Red Cross Hospital, Japan.	Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Chu CM, 2006, SEMIN LIVER DIS, V26, P142, DOI 10.1055/s-2006-939752; Park BK, 2007, J GASTROEN HEPATOL, V22, P383, DOI 10.1111/j.1440-1746.2007.04857.x; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Hosaka T, 2013, J GASTROENTEROL, V48, P930, DOI 10.1007/s00535-012-0688-7; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Feld JJ, 2009, HEPATOLOGY, V49, pS96, DOI 10.1002/hep.22977; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Kurokawa M, 2012, J GASTROENTEROL, V47, P577, DOI 10.1007/s00535-011-0522-7; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Kobashi H, 2011, HEPATOL RES, V41, P405, DOI 10.1111/j.1872-034X.2011.00785.x; European Association for the Study of the Liver, 2012, J HEPATOL, V57, P167, DOI DOI 10.1016/J.JHEP.2012.02.010]; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Mallet V, 2008, ALIMENT PHARM THER, V29, P409; Matsubara N, 2009, TRANSFUSION, V49, P585, DOI 10.1111/j.1537-2995.2008.02026.x; Tejima K, 2010, J GASTROENTEROL, V45, P876, DOI 10.1007/s00535-010-0233-5	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					872	879		10.1111/hepr.12427		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100007		
J	Mawatari, S; Uto, H; Moriuchi, A; Tabu, K; Muromachi, K; Tabu, E; Oda, K; Imanaka, D; Oshige, A; Nakazawa, J; Kumagai, K; Tamai, T; Okamoto, H; Tsubouchi, H; Ido, A				Mawatari, Seiichi; Uto, Hirofumi; Moriuchi, Akihiro; Tabu, Kazuaki; Muromachi, Kaori; Tabu, Eriko; Oda, Kohei; Imanaka, Dai; Oshige, Akihiko; Nakazawa, Junichi; Kumagai, Kotaro; Tamai, Tsutomu; Okamoto, Hiroaki; Tsubouchi, Hirohito; Ido, Akio			Horizontal transmission of de novo hepatitis B between spouses: A case report	HEPATOLOGY RESEARCH			English	Article						de novo hepatitis; hepatitis B virus reactivation; immunosuppressive therapy; intrafamilial transmission; peripheral blood stem cell transplantation	VIRUS-INFECTION; CORE PROMOTER; REACTIVATION; CHEMOTHERAPY; MUTATIONS; LIVER; PERSISTENCE; PREVENTION; FULMINANT; THERAPY	We report a female patient with acute hepatitis B due to horizontal transmission of hepatitis B virus from her husband, who suffered from de novo hepatitis B. A 48-year-old man underwent peripheral blood stem cell transplantation (PBSCT) for adult T-cell leukemia/lymphoma. Nine months after the initial treatment, he was referred to our hospital because of jaundice. Laboratory data showed elevated serum aminotransferase levels and hepatitis B surface antigen (HBsAg) positivity. We diagnosed de novo hepatitis B because a pre-PBSCT serum sample was negative for HBsAg and positive for anti-hepatitis B core antibody (HBcAb). His liver function improved with entecavir therapy. Two months after his diagnosis of hepatitis B, his 31-year-old wife was admitted with fever and appetite loss. She was diagnosed with acute hepatitis B because of increased serum aminotransferase levels and HBsAg and immunoglobulin M HBcAb positivity. Sequencing of HBV DNA in the serum obtained from both patients showed 99.9% homology. Therefore, we diagnosed her acute hepatitis B as due to horizontal transmission of de novo hepatitis B from her husband. HBV derived from de novo hepatitis B should be considered a potential source of infection, although intrafamilial transmission of de novo hepatitis B is rare.	[Mawatari, Seiichi; Uto, Hirofumi; Tabu, Kazuaki; Muromachi, Kaori; Tabu, Eriko; Oda, Kohei; Imanaka, Dai; Oshige, Akihiko; Nakazawa, Junichi; Kumagai, Kotaro; Tamai, Tsutomu; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima, Kagoshima 8908544, Japan; [Moriuchi, Akihiro; Tsubouchi, Hirohito; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept HGF Tissue Repair & Regenerat Med, Kagoshima, Kagoshima 8908544, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan; [Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Tochigi, Japan	Uto, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908544, Japan.	hirouto@m2.kufm.kagoshima-u.ac.jp	Okamoto, Hiroaki/H-4371-2011	Okamoto, Hiroaki/0000-0003-0827-0964			MICHALAK TI, 1994, J CLIN INVEST, V93, P230, DOI 10.1172/JCI116950; Oketani M, 2012, HEPATOL RES, V42, P627, DOI 10.1111/j.1872-034X.2012.00998.x; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Zuckerman J, 2007, LANCET INFECT DIS, V7, P410, DOI 10.1016/S1473-3099(07)70136-6; [Anonymous], 2009, HEPATOLOGY; Alexopoulou A, 2006, J VIRAL HEPATITIS, V13, P591, DOI 10.1111/j.1365-2893.2006.00728.x; Uemoto S, 1998, TRANSPLANTATION, V65, P494, DOI 10.1097/00007890-199802270-00007; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P452, DOI 10.1016/j.cgh.2011.10.041; Kusumoto S, 2009, INT J HEMATOL, V90, P13, DOI 10.1007/s12185-009-0359-5; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Aomatsu T, 2010, EUR J PEDIATR, V169, P167, DOI 10.1007/s00431-009-1000-6; Aritomi T, 1998, J GASTROEN HEPATOL, V13, P1125, DOI 10.1111/j.1440-1746.1998.tb00588.x; Chen FW, 2013, LIVER INT, V33, P1203, DOI 10.1111/liv.12154; Chen PM, 2002, TRANSPLANTATION, V74, P182, DOI 10.1097/00007890-200207270-00007; European Association for the Study of the Liver, 2012, J HEPATOL, V57, P167, DOI DOI 10.1016/J.JHEP.2012.02.010]; FONG TL, 1993, HEPATOLOGY, V18, P1313, DOI 10.1016/0270-9139(93)90217-B; KASHIWAGI S, 1985, MICROBIOL IMMUNOL, V29, P951; Komatsu H, 2012, J INFECT DIS, V206, P478, DOI 10.1093/infdis/jis293; KUHNS M, 1992, GASTROENTEROLOGY, V103, P1649; Mulyanto, 2011, J MED VIROL, V83, P54, DOI 10.1002/jmv.21931; Palmore TN, 2009, CLIN GASTROENTEROL H, V7, P1130, DOI 10.1016/j.cgh.2009.06.027; Tsubouchi H, 2009, KANZO, V50, P38; Weinbaum CM, 2009, HEPATOLOGY, V49, P35; World Health Organization, HEP B	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	AUG	2015	45	8					933	938		10.1111/hepr.12422		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN7GA	WOS:000358601100013		
J	Kimura, H; Hayashi-Takanaka, Y; Stasevich, TJ; Sato, Y				Kimura, Hiroshi; Hayashi-Takanaka, Yoko; Stasevich, Timothy J.; Sato, Yuko			Visualizing posttranslational and epigenetic modifications of endogenous proteins in vivo	HISTOCHEMISTRY AND CELL BIOLOGY			English	Review						Chromatin; Epigenetics; Posttranslational protein modification; Live cell imaging	RNA-POLYMERASE-II; HISTONE MODIFICATIONS; LIVING CELLS; DNA METHYLATION; HUMAN-DISEASE; TRANSCRIPTION; CANCER; ACETYLATION; CHROMATIN; DYNAMICS	Protein localization and dynamics can now be visualized in living cells using the fluorescent protein fusion technique, but it is still difficult to selectively detect molecules with a specific function. As a posttranslational protein modification is often associated with a specific function, marking specifically modified protein molecules in living cells is a way to track an important fraction of protein. In the nucleus, histones are subjected to a variety of modifications such as acetylation and methylation that are associated with epigenetic gene regulation. RNA polymerase II, an enzyme that transcribes genes, is also differentially phosphorylated during the initiation and elongation of transcription. To understand the mechanism of gene regulation in vivo, we have developed methods to track histone and RNA polymerase II modifications using probes derived from modification-specific monoclonal antibodies. In Fab-based live endogenous modification labeling (FabLEM), fluorescently labeled antigen-binding fragments (Fabs) are loaded into cells. Fabs bind to target modifications in the nucleus with a binding time of a second to tens of seconds, and so the modification can be tracked without disturbing cell function. For tracking over longer periods of time or in living animals, we have also developed a genetically encoded system to express a modification-specific intracellular antibody (mintbody). Transgenic fruit fly and zebrafish that express histone H3 Lys9 acetylation-specific mintbody developed normally and remain fertile, suggesting that visualizing histone modifications in any tissue in live animals has become possible. These live cell modification tracking techniques will facilitate future studies on epigenetic regulation related to development, differentiation, and disease. Moreover, these techniques can be applied to any other protein modification, opening up new avenues in broad areas in biology and medicine.	[Kimura, Hiroshi; Hayashi-Takanaka, Yoko; Sato, Yuko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Stasevich, Timothy J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Kimura, H (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	hkimura@bio.titech.ac.jp			Japan Society for Promotion of Science; Core Research for Evolutional Science and Technology from Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization of Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Naohito Nozaki (MAB Institute Inc.) for generating hybridomas. H. Kimura was supported by grants-in-aid from the Japan Society for Promotion of Science, the Core Research for Evolutional Science and Technology from Japan Science and Technology Agency, the New Energy and Industrial Technology Development Organization of Japan, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ahmad Z. A., 2012, CLIN DEV IMMUNOL, V2012, DOI [10.1155/2012/98025022474489, DOI 10.1155/2012/980250, http://dx.doi.org/10.1155/2012/980250]; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Aoki K, 2012, CANCER SCI, V103, P614, DOI 10.1111/j.1349-7006.2011.02196.x; Eberhart A, 2013, CHROMOSOME RES, V21, P535, DOI 10.1007/s10577-013-9375-7; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yokoyama Y, 2013, CANCER SCI, V104, P889, DOI 10.1111/cas.12166; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Eberhart A, 2012, CHROMOSOME RES, V20, P849, DOI 10.1007/s10577-012-9318-8; Jeronimo C, 2013, CHEM REV, V113, P8491, DOI 10.1021/cr4001397; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Bowman EA, 2014, NUCLEUS-PHILA, V5, P224, DOI 10.4161/nucl.29347; Stasevich TJ, 2014, METHODS, V70, P77, DOI 10.1016/j.ymeth.2014.08.002; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Butler JS, 2012, EPIGENOMICS-UK, V4, P163, DOI [10.2217/epi.12.3, 10.2217/EPI.12.3]; Luger K, 1997, NATURE, V389, P251; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Stasevich TJ, 2011, CHROMOSOMA, V120, P533, DOI 10.1007/s00412-011-0340-y; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Kvam E, 2010, PROTEIN ENG DES SEL, V23, P489, DOI 10.1093/protein/gzq022; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Chalfie M, 2009, P NATL ACAD SCI USA, V106, P10073, DOI 10.1073/pnas.0904061106; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; Goto H, 2014, METHODS MOL BIOL, V1131, P21, DOI 10.1007/978-1-62703-992-5_2; Hayashi-Takanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106271; Kamiunten T, 2015, HISTOCHEM CELL BIOL, V143, P259, DOI 10.1007/s00418-014-1284-0; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kimura H, 2005, DNA REPAIR, V4, P939, DOI 10.1016/j.dnarep.2005.04.012; Kimura H, 1999, MOL CELL BIOL, V19, P5383; Kimura H, 2010, CURR OPIN CELL BIOL, V22, P412, DOI 10.1016/j.ceb.2010.02.004; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Sasaki K, 2012, BIOORGAN MED CHEM, V20, P1887, DOI 10.1016/j.bmc.2012.01.018; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02436; Yokoyama Y, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3681	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	AUG	2015	144	2					101	109		10.1007/s00418-015-1344-0		9	Cell Biology; Microscopy	Cell Biology; Microscopy	CN9QG	WOS:000358783300001		
J	Tada, H; Orii, H				Tada, Haru; Orii, Hidefumi			Dynamic intracellular localization of Dazl protein during Xenopus germline development	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Germ plasm; Primordial germ cell; RNA-binding protein; DAZ; Xdazl; Meiosis	CELL DEVELOPMENT; FAMILY PROTEINS; MESSENGER-RNAS; GENE ENCODES; STEM-CELLS; PLASM; DIFFERENTIATION; TRANSLATION; AZOOSPERMIA; SPERMATOGENESIS	Xenopus dazl encoding an RNA-binding protein has been identified as a component of the germ plasm and is involved in the migration and differentiation of the primordial germ cells (PGCs). Here, we investigated the intracellular localization of Dazl in germline cells throughout the lifetime of Xenopus. In early embryogenesis, Dazl was detected initially in the germ plasm and then translocated to a perinuclear region. Then, it was detected within the nucleus in PGCs. Dazl was observed only in the cytoplasm in PGCs when sex differentiation began in the gonads. Dazl was distributed in both the nucleus and cytoplasm of the primary oogonium and spermatogonium, but only in the cytoplasm of the secondary oogonium and spermatogonium. In spermatocytes, Dazl was distributed throughout cytoplasm and localized at the spindles and cytoplasm during meiosis. Then, it was detected as speckles in the nucleus in the round spermatid. The dynamic intracellular localization suggests that Dazl is a multifunctional protein regulating RNA metabolism required for Xenopus germline development.	[Tada, Haru; Orii, Hidefumi] Univ Hyogo, Dept Life Sci, Kamigori, Hyogo 6781297, Japan	Tada, H (reprint author), Rikkyo Univ, Sch Sci, Dept Life Sci, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1788501, Japan.	harutada@rikkyo.ac.jp			Japan Society for the Promotion of Science KAKENHI [257228]	We are grateful to Koichi Mita (Tokushima Bunri Univ.) and Masakane Yamashita (Hokkaido Univ.) for the anti-Xdazl monoclonal antibody (referred to as anti-Dazl in this study), and Hideo Nishitani and Fumiko Hirose (Univ. Hyogo) for the anti-tubulin antibody. We thank Shin-ichiro Nishitani (Minoo-Higashi high school) for staging meiosis, and Kensuke Kataoka, Midori Kitao and Kenji Watanabe (Univ. Hyogo) for sharing their preliminary data. We also thank members of our laboratory, especially Makoto Mochii and Yoshihiko Umesono, for their support and encouragement. This study was supported in part by Japan Society for the Promotion of Science KAKENHI (Grant Number 257228) to HT.	Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kim B, 2012, DEVELOPMENT, V139, P568, DOI 10.1242/dev.075846; Vera Y, 2002, J ANDROL, V23, P622; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Kronja I, 2011, PHILOS T R SOC B, V366, P3638, DOI 10.1098/rstb.2011.0084; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Ruggiu M, 1997, NATURE, V389, P73; Houston DW, 2000, DEVELOPMENT, V127, P447; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/reprod/126.5.589; Yu Z, 2009, J MOL CELL BIOL, V1, P93, DOI 10.1093/jmcb/mjp026; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Berekelya LA, 2007, DIFFERENTIATION, V75, P546, DOI 10.1111/j.1432-0436.2006.00160.x; Cheng MH, 1998, DEV BIOL, V204, P567, DOI 10.1006/dbio.1998.9098; Hasegawa E, 2006, DEV BIOL, V295, P689, DOI 10.1016/j.ydbio.2006.04.002; He J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073996; Houston DW, 1998, DEVELOPMENT, V125, P171; Kataoka K, 2006, MECH DEVELOP, V123, P746, DOI 10.1016/j.mod.2006.07.006; Kurihara Y, 2004, ARCH HISTOL CYTOL, V67, P325, DOI 10.1679/aohc.67.325; Lee KH, 2006, EMBO J, V25, P4263, DOI 10.1038/sj.emboj.7601304; Lin YM, 2001, MOL HUM REPROD, V7, P1015, DOI 10.1093/molehr/7.11.1015; MacArthur H, 2000, MECH DEVELOP, V95, P291, DOI 10.1016/S0925-4773(00)00357-9; Mita K, 2000, MECH DEVELOP, V94, P251, DOI 10.1016/S0925-4773(00)00295-1; Nieuwkoop P., 1994, NORMAL TABLE XENOPUS; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Tada H, 2012, DEV BIOL, V371, P86, DOI 10.1016/j.ydbio.2012.08.014; Taguchi A, 2012, DEV GROWTH DIFFER, V54, P767, DOI 10.1111/dgd.12005; Taguchi A, 2015, INT J DEV BIOL, V59; Takeda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007513; Vangompel MJ, 2011, SPERMATOGENESIS, V1, P36, DOI DOI 10.4161/SPMG.1.1.14659; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Venkatarama T, 2010, DEVELOPMENT, V137, P651, DOI 10.1242/dev.038554; VILLALPANDO I, 1990, International Journal of Developmental Biology, V34, P281; Yamaguchi T, 2013, BIOL OPEN, V2, P191, DOI 10.1242/bio.20123111	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	AUG	2015	144	2					157	166		10.1007/s00418-015-1323-5		10	Cell Biology; Microscopy	Cell Biology; Microscopy	CN9QG	WOS:000358783300006		
J	Yoshioka, Y; Kozawa, E; Urakawa, H; Arai, E; Futamura, N; Zhuo, LS; Kimata, K; Ishiguro, N; Nishida, Y				Yoshioka, Yutaka; Kozawa, Eiji; Urakawa, Hiroshi; Arai, Eisuke; Futamura, Naohisa; Zhuo, Lisheng; Kimata, Koji; Ishiguro, Naoki; Nishida, Yoshihiro			Inhibition of hyaluronan synthesis alters sulfated glycosaminoglycans deposition during chondrogenic differentiation in ATDC5 cells	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Chondrogenesis; Hyaluronan; ATDC5; Extracellular matrix	HUMAN ARTICULAR CHONDROCYTES; LIMB BUD; IN-VITRO; PG-M; MATRIX; 4-METHYLUMBELLIFERONE; ACID; CARTILAGE; PROTEOGLYCANS; AGGREGATION	In chondrogenic differentiation, expression and collaboration of specific molecules, such as aggrecan and type II collagen, in extracellular matrix (ECM) are crucial. However, few studies have clarified the roles of hyaluronan (HA) in proteoglycan aggregation during chondrogenic differentiation. We assessed the roles of HA in sulfated glycosaminoglycans deposition during chondrogenic differentiation by means of 4-methylumbelliferone (4-MU), an HA synthase inhibitor, using ATDC5 cells. ATDC5 cells were treated with 0.5 mM 4-MU for 7 or 21 days after induction of chondrogenic differentiation with insulin. Depositions of sulfated glycosaminoglycans were evaluated with Alcian blue staining. mRNA expression of ECM molecules was determined using real-time RT-PCR. The deposition of aggrecan and versican was investigated with immunohistochemical staining using specific antibodies. Effects of 4-MU on HA concentrations were analyzed by HA binding assay. 4-MU suppressed the positivity of Alcian blue staining, although this delay was reversible. Interestingly, stronger positivity of Alcian blue staining was observed at day 21 in cultures with 4-MU discontinuation than in the control. 4-MU significantly increased the mRNA expression of aggrecan, versican, and type II collagen, which was consistent with increased deposition of aggrecan and versican. The HA concentration in ECM and cell-associated region was significantly suppressed with 4-MU treatment. We conclude that the inhibition of HA synthesis slows sulfated glycosaminoglycans deposition during chondrogenic differentiation despite the increased deposition of other ECM molecules. Transient starvation of HA with 4-MU accelerates chondrogenic ECM formation, suggesting its potential to stimulate chondrogenic differentiation with adequate use.	[Yoshioka, Yutaka; Kozawa, Eiji; Urakawa, Hiroshi; Arai, Eisuke; Futamura, Naohisa; Ishiguro, Naoki; Nishida, Yoshihiro] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 4801195, Japan; [Zhuo, Lisheng; Kimata, Koji] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 4801195, Japan	Nishida, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	ynishida@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20591751]; Suzuken Memorial Foundation	The authors thank Ms. Eri Ishihara for secretarial assistance. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid 20591751 for Scientific Research (C)], and by the Suzuken Memorial Foundation. Funding sources had no role in the study design, collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Arai E, 2011, BRIT J CANCER, V105, P1839, DOI 10.1038/bjc.2011.459; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Shibata S, 2003, J ANAT, V203, P425, DOI 10.1046/j.1469-7580.2003.00226.x; KNUDSON CB, 1993, FASEB J, V7, P1233; Nishida Y, 2004, OSTEOARTHR CARTILAGE, V12, P374, DOI 10.1016/j.joca.2004.01.008; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Urakawa H, 2012, INT J CANCER, V130, P454, DOI 10.1002/ijc.26014; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; HASCALL VC, 1974, J BIOL CHEM, V249, P4232; Julovi SM, 2004, ARTHRITIS RHEUM, V50, P516, DOI 10.1002/art.20004; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P206, DOI 10.1002/1529-0131(200001)43:1<206::AID-ANR25>3.0.CO;2-1; Schwartz NB, 1998, CHEM-BIOL INTERACT, V109, P143, DOI 10.1016/S0009-2797(97)00129-4; KNUDSON CB, 1985, DEV BIOL, V112, P308, DOI 10.1016/0012-1606(85)90401-4; HARDINGHAM TE, 1992, FASEB J, V6, P861; LAURENT TC, 1992, FASEB J, V6, P2397; Clarkin CE, 2011, MATRIX BIOL, V30, P163, DOI 10.1016/j.matbio.2011.01.002; KIMATA K, 1986, J BIOL CHEM, V261, P3517; KNUDSON W, 1993, P NATL ACAD SCI USA, V90, P4003, DOI 10.1073/pnas.90.9.4003; Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; Schwartz Z, 2011, AM J VET RES, V72, P42, DOI 10.2460/ajvr.72.1.42; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Suzuki A, 2005, BBA-MOL CELL RES, V1743, P57, DOI 10.1016/j.bbamer.2004.08.007; Yoshikawa K, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-56; Zhu L, 2010, INT ARCH ALLERGY IMM, V153, P223, DOI 10.1159/000314362	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	AUG	2015	144	2					167	177		10.1007/s00418-015-1325-3		11	Cell Biology; Microscopy	Cell Biology; Microscopy	CN9QG	WOS:000358783300007		
J	Hipkaeo, W; Chomphoo, S; Pakkarato, S; Sakaew, W; Sawatpanich, T; Hozumi, Y; Polsan, Y; Hipkaeo, D; Goto, K; Kondo, H				Hipkaeo, Wiphawi; Chomphoo, Surang; Pakkarato, Sawetree; Sakaew, Waraporn; Sawatpanich, Tarinee; Hozumi, Yasukazu; Polsan, Yada; Hipkaeo, Damrong; Goto, Kaoru; Kondo, Hisatake			Selective localization of diacylglycerol kinase (DGK)zeta in the terminal tubule cells in the submandibular glands of early postnatal mice	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						DGK zeta; Terminal tubule cells; Submandibular gland; Mice	SUB-MANDIBULAR GLANDS; RAT PAROTID ACINI; NUCLEAR-LOCALIZATION; PHORBOL ESTER; NEONATAL-RAT; SIGNAL-TRANSDUCTION; SUBMAXILLARY GLAND; AMYLASE SECRETION; MOLECULAR-CLONING; GANGLION NEURONS	The present immunohistochemical study was attempted to localize in the submandibular glands of mice at various postnatal stages a diacylglycerol kinase (DGK) isoform termed DGK zeta which is characterized by a nuclear localization signal and a nuclear export signal. This attempt was based on following facts: the continuous postnatal differentiation of glandular cells in the rodent submandibular gland, the regulatory role of DGK in the activity of protein kinase C (PKC) through attenuation of diacylglycerol (DAG), and the possible involvement of PKC in various cellular activities including the saliva secretion as well as the cell differentiation. As a result, a selective localization of immunoreactivity for DGK zeta was detected in terminal tubule (TT) cells which comprise a majority of the newborn acinar structure and differentiate into the intercalated duct cells and/or the acinar cells. The immunoreactivity was deposited in portions of the cytoplasm lateral and basal to the nucleus, but not in the nuclei themselves. Although the immunoreactive TT cells remained until later stages in female specimen than in male, they eventually disappeared in both sexes by young adult stages. The present finding suggests that the regulatory involvement of DGK zeta in PKC functions via control of DAG is exerted in the differentiation of the TT cells. In addition, another possible involvement of DGK zeta in the regulation of secretion of the TT cells as well as its functional significance of its nuclear localization in the submandibular ganglion cells was also discussed.	[Hipkaeo, Wiphawi; Chomphoo, Surang; Pakkarato, Sawetree; Sakaew, Waraporn; Sawatpanich, Tarinee; Polsan, Yada; Hipkaeo, Damrong; Kondo, Hisatake] Khon Kaen Univ, Fac Med, Nanomorphol Based Apply Res Grp, Khon Kaen 40002, Thailand; [Hipkaeo, Wiphawi; Chomphoo, Surang; Pakkarato, Sawetree; Sakaew, Waraporn; Sawatpanich, Tarinee; Polsan, Yada; Hipkaeo, Damrong; Kondo, Hisatake] Khon Kaen Univ, Fac Med, Dept Anat, Electron Microscopy Unit, Khon Kaen 40002, Thailand; [Hozumi, Yasukazu; Goto, Kaoru] Yamagata Univ, Sch Med, Dept Anat, Yamagata 99023, Japan	Hipkaeo, W (reprint author), Khon Kaen Univ, Fac Med, Nanomorphol Based Apply Res Grp, Khon Kaen 40002, Thailand.	wiphawi@kku.ac.th			Faculty of Medicine, Khon Kaen University [I57326, RG57301]	The authors would like to acknowledge the research grants from Faculty of Medicine, Khon Kaen University (Nos. I57326 and RG57301).	ALVARES EP, 1975, ARCH HISTOL JAPON, V38, P177; AMANO O, 1991, J HISTOCHEM CYTOCHEM, V39, P1707; Amano O, 1998, HISTOCHEM J, V30, P591, DOI 10.1023/A:1003258514766; Kim H, 2012, NEUROSCIENCE, V226, P348, DOI 10.1016/j.neuroscience.2012.08.055; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; ZAJICEK G, 1985, ANAT REC, V213, P150, DOI 10.1002/ar.1092130206; Evangelisti C, 2009, CELL SIGNAL, V21, P801, DOI 10.1016/j.cellsig.2009.01.027; BARKA T, 1980, J HISTOCHEM CYTOCHEM, V28, P836; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; Tanaka T, 2013, J CELL SCI, V126, P2785, DOI 10.1242/jcs.118711; Hozumi Y, 2013, J HISTOCHEM CYTOCHEM, V61, P462, DOI 10.1369/0022155413483574; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; CUTLER LS, 1974, DEV BIOL, V41, P31, DOI 10.1016/0012-1606(74)90280-2; Goto K, 2008, TOHOKU J EXP MED, V214, P199, DOI 10.1620/tjem.214.199; DENNY PC, 1990, ANAT REC, V226, P489, DOI 10.1002/ar.1092260411; Hozumi Y, 2003, EUR J NEUROSCI, V18, P1448, DOI 10.1046/j.1460-9568.2003.02871.x; Hozumi Y, 2010, J HISTOCHEM CYTOCHEM, V58, P119, DOI 10.1369/jhc.2009.954347; BALL WD, 1978, DIFFERENTIATION, V10, P147, DOI 10.1111/j.1432-0436.1978.tb00957.x; BALL WD, 1988, DEV BIOL, V129, P464, DOI 10.1016/0012-1606(88)90393-4; Clemens KJ, 1992, J CELL SCI, V103, P881; Culp DJ, 2011, J DENT RES, V90, P1469, DOI 10.1177/0022034511422817; Denny PC, 1999, ANAT REC, V256, P84; DVORAK M, 1969, Z ZELLFORSCH MIK ANA, V99, P346, DOI 10.1007/BF00337607; GOTO K, 2013, ADV BIOL REGUL, V54, P242; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; GOTO K, 1994, P NATL ACAD SCI USA, V91, P13042, DOI 10.1073/pnas.91.26.13042; GRESIK EW, 1975, CELL TISSUE RES, V157, P411; GRESIK EW, 1980, J HISTOCHEM CYTOCHEM, V28, P860; Hecht R, 2000, ANAT REC, V258, P349, DOI 10.1002/(SICI)1097-0185(20000401)258:4<349::AID-AR3>3.0.CO;2-9; Heppner TJ, 2003, AUTON NEUROSCI-BASIC, V105, P35, DOI 10.1016/S1566-0702(03)00024-9; Hipkaeo W, 2004, J HISTOCHEM CYTOCHEM, V52, P479; Kamaishi H, 2004, AUTON NEUROSCI-BASIC, V111, P15, DOI 10.1016/j.autneu.2004.01.002; Kanoh H, 2002, J BIOCHEM, V131, P629; Lee SY, 2010, J BIOL CHEM, V285, P10939, DOI 10.1074/jbc.M109.048868; LEESON CR, 1959, J ANAT, V93, P287; Los AP, 2006, J BIOL CHEM, V281, P858, DOI 10.1074/jbc.M502693200; MOREIRA JE, 1991, AM J ANAT, V191, P167, DOI 10.1002/aja.1001910204; NAUNTOFTE B, 1986, AM J PHYSIOL, V251, pC175; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Okada M, 2011, EXP CELL RES, V317, P2853, DOI 10.1016/j.yexcr.2011.09.014; Putney Jr JW, 1983, MOL PHARM, V26, P261; Rasmussen H, 1986, NEW ENGL J MED, V314; Sasaki H, 2006, CELL TISSUE RES, V326, P35, DOI 10.1007/s00441-006-0219-z; SOLTOFF SP, 1995, J BIOL CHEM, V270, P13490; SRIVASTAVA HC, 1977, J ANAT, V123, P459; Sumner AD, 2008, J MOL NEUROSCI, V36, P141, DOI 10.1007/s12031-008-9103-5; TAKUMA T, 1986, FEBS LETT, V199, P53, DOI 10.1016/0014-5793(86)81222-4; TOJYO Y, 1993, JPN J PHARMACOL, V63, P439, DOI 10.1254/jjp.63.439; Yamada E, 2002, NEUROSCI RES, V43, P179, DOI 10.1016/S0168-0102(02)00039-1; YAMASHIN.S, 1972, J HISTOCHEM CYTOCHEM, V20, P855; Yoshimura K, 2002, PFLUG ARCH EUR J PHY, V444, P586, DOI 10.1007/s00424-002-0844-7; Zinzen KM, 2004, GENE, V334, P23, DOI 10.1016/j.gene.2004.03.014	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	AUG	2015	144	2					185	193		10.1007/s00418-015-1328-0		9	Cell Biology; Microscopy	Cell Biology; Microscopy	CN9QG	WOS:000358783300009		
J	Kawashima, T; Yew, KS; Zhou, Y; Ang, DS; Bera, MK; Zhang, HZ				Kawashima, T.; Yew, K. S.; Zhou, Y.; Ang, D. S.; Bera, M. K.; Zhang, H. Z.			Restoration of Postbreakdown Gate Oxide by White-Light Illumination	IEEE ELECTRON DEVICE LETTERS			English	Article						CMOS memory; gate oxide breakdown; high-kappa gate oxide; time dependent dielectric breakdown	RELIABILITY	From conductive-atomic-force-microscope probe measurement, we show that electrical conduction through a nanoscale percolation path in the MOSFET gate oxide can be disrupted, either completely or partially, by white-light illumination. This phenomenon is consistently observed in the SiO2 and HfO2 gate-oxide materials, and thus is believed to have originated from a common mechanism-light-stimulated oxygen migration and recombination with vacancy sites that constitute the percolation path. The finding points to the prospect of reliability rejuvenation by the light-assisted restoration of postelectrical-breakdown gate oxides, as well as light-enabled memory operation based on logic MOSFET devices.	[Kawashima, T.; Yew, K. S.; Zhou, Y.; Ang, D. S.; Bera, M. K.; Zhang, H. Z.] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Kawashima, T.] Toshiba Co Ltd, Yokohama, Kanagawa 2350017, Japan	Kawashima, T (reprint author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore.	edsang@ntu.edu.sg			Ministry of Education, Singapore [MOE2013-T2-2-099, RG 78/12]	This work was supported by the Ministry of Education, Singapore, under Grant MOE2013-T2-2-099 and Grant RG 78/12.	Ribes G, 2005, IEEE T DEVICE MAT RE, V5, P5, DOI 10.1109/TDMR.2005.845236; Duffy DM, 2012, NUCL INSTRUM METH B, V277, P21, DOI 10.1016/j.nimb.2011.12.059; Depas M, 1996, IEEE T ELECTRON DEV, V43, P1499, DOI 10.1109/16.535341; Cartier E, 2009, 2009 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM, VOLS 1 AND 2, P486, DOI 10.1109/IRPS.2009.5173301; Yang JJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215201; Suehle JS, 2002, IEEE T ELECTRON DEV, V49, P958, DOI 10.1109/TED.2002.1003712; Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5; Butcher B, 2013, 2013 5TH IEEE INTERNATIONAL MEMORY WORKSHOP (IMW), P52, DOI 10.1109/IMW.2013.6582096; Crespo-Yepes A, 2010, IEEE ELECTR DEVICE L, V31, P543, DOI 10.1109/LED.2010.2045732; El Kamel F, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3541961; Kita K., 2008, IEDM, P1; Li X, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2974792; McKenna KP, 2009, MICROELECTRON ENG, V86, P1751, DOI 10.1016/j.mee.2009.03.125; Monsieur F., 2002, P INT REL PHYS S, P45; Raghavan N, 2011, IEEE ELECTR DEVICE L, V32, P252, DOI 10.1109/LED.2010.2099096; Selim FA, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.174102	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	AUG	2015	36	8					748	750		10.1109/LED.2015.2445788		3	Engineering, Electrical & Electronic	Engineering	CN6UR	WOS:000358570300004		
J	Mizukami, M; Oku, S; Cho, SI; Tatetsu, M; Abiko, M; Mamada, M; Sakanoue, T; Suzuri, Y; Kido, J; Tokito, S				Mizukami, Makoto; Oku, Shinya; Cho, Seung-Il; Tatetsu, Masahiro; Abiko, Miho; Mamada, Masashi; Sakanoue, Tomo; Suzuri, Yoshiyuki; Kido, Junji; Tokito, Shizuo			A Solution-Processed Organic Thin-Film Transistor Backplane for Flexible Multiphoton Emission Organic Light-Emitting Diode Displays	IEEE ELECTRON DEVICE LETTERS			English	Article						Organic thin-film transistors; dielectrics; display; organic light-emitting diodes; organic semiconductors		An active matrix backplane based on solution-processed organic thin-film transistors (OTFTs) has been developed for flexible displays having multiphoton organic light-emitting diodes (OLEDs). The OTFT device has a bottom-gate/bottom-contact type structure consisting of a polyethylene naphthalate-based flexible substrate covered with patterned gate electrodes and a gate dielectric of UV-cured cardo-polymer. Teflon AF was used for a hydrophobic bank structure that defines active regions of the OTFTs, and the organic semiconductor was coated by solution shearing. The OTFT backplane fabricated here had 384 x 128 pixels at a resolution of 300 dpi; images and video were successfully displayed on the resulting flexible multiphoton-emission OLED display.	[Mizukami, Makoto; Oku, Shinya; Cho, Seung-Il; Tatetsu, Masahiro; Abiko, Miho; Mamada, Masashi; Suzuri, Yoshiyuki] Yamagata Univ, Innovat Ctr Organ Elect, Yonezawa, Yamagata 9920119, Japan; [Sakanoue, Tomo] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo 1698555, Japan; [Kido, Junji; Tokito, Shizuo] Yamagata Univ, Res Ctr Organ Elect, Yonezawa, Yamagata 9920119, Japan	Mizukami, M (reprint author), Yamagata Univ, Innovat Ctr Organ Elect, Yonezawa, Yamagata 9920119, Japan.	m_mizukami@yz.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology through Regional Innovation Strategy Support Program for Region Focused on Reinforcement of International Competitiveness, Japan	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology through the Regional Innovation Strategy Support Program for Region Focused on Reinforcement of International Competitiveness, Japan.	Pu YJ, 2015, ADV MATER, V27, P1327, DOI 10.1002/adma.201403973; Gundlach DJ, 2008, NAT MATER, V7, P216, DOI 10.1038/nmat2122; Smith J, 2012, ADV MATER, V24, P2441, DOI 10.1002/adma.201200088; Mizukami M, 2006, IEEE ELECTR DEVICE L, V27, P249, DOI 10.1109/LED.2006.870413; Hong S., 2014, SID S DIGEST, V45, P334; Lee TW, 2005, ADV MATER, V17, P2180, DOI 10.1002/adma.200401672; Liu ZH, 2009, IEEE T ELECTRON DEV, V56, P176, DOI 10.1109/TED.2008.2010580; Mizuuchi K, 2002, ELEC COMP C, P924, DOI 10.1109/ECTC.2002.1008211; NAG M, 2014, SID S DIGEST TECH PA, V45, P248; Nomoto K., 2010, SID S MAY, V41, P1155; Oku S., 2013, P 74 AUT M JPN SOC A; Sakanoue T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.101602; Takei T., 2011, NHK STRL R D, V128, P42; Yamaguchi H., 2012, SID S, V43, P1002	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	AUG	2015	36	8					841	843		10.1109/LED.2015.2443184		3	Engineering, Electrical & Electronic	Engineering	CN6UR	WOS:000358570300035		
J	Niraula, M; Yasuda, K; Takai, N; Matsumoto, M; Suzuki, Y; Tsukamoto, Y; Ito, Y; Sugimoto, S; Kouno, S; Yamazaki, D; Agata, Y				Niraula, M.; Yasuda, K.; Takai, N.; Matsumoto, M.; Suzuki, Y.; Tsukamoto, Y.; Ito, Y.; Sugimoto, S.; Kouno, S.; Yamazaki, D.; Agata, Y.			Surface Processing of CdTe Detectors Using Hydrogen Bromide-Based Etching Solution	IEEE ELECTRON DEVICE LETTERS			English	Article						CdTe; surface etching; nuclear radiation detector; spectroscopy	RADIATION DETECTORS; LEAKAGE CURRENTS; CDZNTE; PERFORMANCE	Chemical etching of CdTe crystals using hydrogen bromide (HBr)-based etchant was studied and its effectiveness in detector leakage current, gamma radiation detection performance was compared with that of a conventional Br-methanol (BM) etched detector. It was found that effect of surface leakage in total detector leakage current was lower in the HBr-processed detectors, and they also exhibited better radiation detection performances than that of the conventional BM-etched detectors. A slight variation in surface chemical states was found in these differently processed crystals which could be related to the observed differences in detector properties.	[Niraula, M.; Yasuda, K.; Takai, N.; Matsumoto, M.; Suzuki, Y.; Tsukamoto, Y.; Ito, Y.; Sugimoto, S.; Kouno, S.; Yamazaki, D.; Agata, Y.] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi 4668555, Japan	Niraula, M (reprint author), Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi 4668555, Japan.	m.niraula@nitech.ac.jp			Japan Society for the Promotion of Science (JSPS) [A-25242048]	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research A-25242048.	Mandal KC, 2012, IEEE T NUCL SCI, V59, P1504, DOI 10.1109/TNS.2012.2202324; Szeles C, 2008, IEEE T NUCL SCI, V55, P572, DOI 10.1109/TNS.2007.914034; Srivastav V, 2005, OPTO-ELECTRON REV, V13, P197; Bhagwat V, 2006, J ELECTRON MATER, V35, P1613, DOI 10.1007/s11664-006-0206-x; Burger A, 1998, P SOC PHOTO-OPT INS, V3446, P154, DOI 10.1117/12.312886; Chen H., 2009, P SOC PHOTO-OPT INS, V7449; Crocco J., 2012, J APPL PHYS, V112; Hossain A., 2013, J ELECT MAT, V43, P2771; James RB, 1998, J ELECTRON MATER, V27, P788, DOI 10.1007/s11664-998-0055-x; Mescher MJ, 1999, IEEE T NUCL SCI, V46, P2289, DOI 10.1109/23.819319; Rouse A. A., 2001, P IEEE NUCL SCI S NO, P2459; Rybka AV, 2001, NUCL INSTRUM METH A, V458, P248, DOI 10.1016/S0168-9002(00)00868-8; Tari S, 2014, J ELECTRON MATER, V43, P2978, DOI 10.1007/s11664-014-3167-5	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	AUG	2015	36	8					856	858		10.1109/LED.2015.2450835		3	Engineering, Electrical & Electronic	Engineering	CN6UR	WOS:000358570300040		
J	Kadowaki, Y; Ishii, H				Kadowaki, Yuki; Ishii, Hideaki			Event-Based Distributed Clock Synchronization for Wireless Sensor Networks	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						Clock synchronization; multi-agent consensus; sensor networks	MULTIAGENT SYSTEMS; AVERAGE CONSENSUS	In wireless sensor networks, a high level of accuracy is required in time synchronization to maintain time consistency of sensed data and to reduce idle listening times. In this technical note, we propose two fully distributed protocols for time synchronization. They are based on algorithms of multi-agent consensus and hence do not require any leader node. Further, they employ an event-based scheme to enhance communication efficiency. We analyze their convergence properties and show that clock synchronization can be achieved with less communication at guaranteed precision.	[Kadowaki, Yuki; Ishii, Hideaki] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan	Kadowaki, Y (reprint author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan.	kadowaki@sc.dis.titech.ac.jp; ishii@dis.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23760385]; Aihara Project, the FIRST program from JSPS; CSTP	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant-in-Aid for Scientific Research No. 23760385 and by the Aihara Project, the FIRST program from JSPS initiated by CSTP. Recommended by Associate Editor C. De Persis.	Freris NM, 2012, IEEE DECIS CONTR P, P1411, DOI 10.1109/CDC.2012.6427110; Seyboth GS, 2013, AUTOMATICA, V49, P245, DOI 10.1016/j.automatica.2012.08.042; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Cai K, 2012, AUTOMATICA, V48, P2750, DOI 10.1016/j.automatica.2012.08.003; Wu YC, 2011, IEEE SIGNAL PROC MAG, V28, P124, DOI 10.1109/MSP.2010.938757; He JP, 2014, IEEE T AUTOMAT CONTR, V59, P660; Moreau L, 2005, IEEE T AUTOMAT CONTR, V50, P169, DOI 10.1109/TAC.2004.841888; Heemels WPMH, 2012, IEEE DECIS CONTR P, P3270, DOI 10.1109/CDC.2012.6425820; Schenato L, 2011, AUTOMATICA, V47, P1878, DOI 10.1016/j.automatica.2011.06.012; Freris NM, 2011, IEEE T AUTOMAT CONTR, V56, P1352, DOI 10.1109/TAC.2010.2089210; Carli R, 2011, IEEE T AUTOMAT CONTR, V56, P1146, DOI 10.1109/TAC.2011.2107051; Barooah P, 2007, IEEE CONTR SYST MAG, V27, P57, DOI 10.1109/MCS.2007.384125; Hartfiel D. J., 1998, LECT NOTES MATH, V1695; Kadowaki Y, 2013, IEEE DECIS CONTR P, P6747, DOI 10.1109/CDC.2013.6760958; Kim S, 2007, PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS, P254, DOI 10.1145/1236360.1236395; Maroti M., 2004, P 2 INT C EMB NETW S, P39, DOI 10.1145/1031495.1031501; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Solis R, 2006, IEEE DECIS CONTR P, P2734, DOI 10.1109/CDC.2006.377675; Xiao F., 2012, P 31 CHIN CONTR C, P6239	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	AUG	2015	60	8					2266	2271		10.1109/TAC.2014.2372932		6	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CN7VN	WOS:000358642500029		
J	Kosuge, A; Ishizuka, S; Taguchi, M; Ishikuro, H; Kuroda, T				Kosuge, Atsutake; Ishizuka, Shu; Taguchi, Masao; Ishikuro, Hiroki; Kuroda, Tadahiro			Analysis and Design of an 8.5-Gb/s/Link Multi-Drop Bus Using Energy-Equipartitioned Transmission Line Couplers	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						DRAM interface; multi-drop bus; transceiver; transmission line coupler	MEMORY INTERFACE; TRANSCEIVER; CMOS	An 8.5-Gb/s/link non-contact multi-drop bus is presented. The signal reflections that limit the data rates of conventional multi-drop bus interfaces are dramatically reduced by using transmission line couplers at each signal branching point. As an energy-equipartitioned technique provides the same signal level to every port, wider receiver margin is achieved. The data rate is improved by 1.8 times compared to the most advanced multi-drop bus interface. The theoretical analysis and design techniques of energy-equipartitioned transmission line couplers are discussed in this paper. The design methodologies were verified through simulations performed by using a full-3D EM-simulator and experiments with FR4 test boards. Due to the low-cut characteristics of the couplers, the low-frequency components are cut off so that differentiated pulses arrive at the receiver input point. A receiver detects and recovers the received pulses by integrating them using hysteresis characteristics. The design techniques of the transceiver for the transmission line couplers are also discussed in this paper. The proposed methods were verified by using a test chip fabricated with a 90-nm CMOS process. Experiments with a prototype of an eight-drop multi-drop bus system confirmed BER < 10(-14) at a data rate of 8.5-Gb/s/link. The measured timing margin at the far-end module was 0.49-UI at a BER of 10(-12). The power consumption of the transceiver was 75.6-mW at a supply voltage of 1.2-V.	[Kosuge, Atsutake; Ishizuka, Shu; Taguchi, Masao; Ishikuro, Hiroki; Kuroda, Tadahiro] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan	Kosuge, A (reprint author), Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.	kosuge@kuroda.elec.keio.ac.jp; ishizuka@kuroda.elec.keio.ac.jp; taguchi@kuroda.elec.keio.ac.jp; ishikuro@elec.keio.ac.jp; kuroda@elec.keio.ac.jp			CREST/JST	This work was supported by CREST/JST.	Kaviani K, 2012, IEEE J SOLID-ST CIRC, V47, P926, DOI 10.1109/JSSC.2012.2185370; Bucher M, 2014, IEEE J SOLID-ST CIRC, V49, P127, DOI 10.1109/JSSC.2013.2280308; Miura N, 2007, IEEE J SOLID-ST CIRC, V42, P111, DOI 10.1109/JSSC.2006.886554; Poulton J, 2007, IEEE J SOLID-ST CIRC, V42, P2745, DOI 10.1109/JSSC.2007.908692; Lee H, 2009, IEEE J SOLID-ST CIRC, V44, P1235, DOI 10.1109/JSSC.2009.2014199; Bae S.-J., 2004, IEEE ISSCC, P244; Chi HJ, 2011, IEEE J SOLID-ST CIRC, V46, P2053, DOI 10.1109/JSSC.2011.2136590; Fredriksson H, 2009, IEEE T ADV PACKAGING, V32, P675, DOI 10.1109/TADVP.2009.2013818; Fukuda K, 2010, IEEE J SOLID-ST CIRC, V45, P2838, DOI 10.1109/JSSC.2010.2075410; Hall S. H., 2009, ADV SIGNAL INTEGRITY; Hossain M, 2010, IEEE T CIRCUITS-I, V57, P270, DOI 10.1109/TCSI.2009.2019391; Kosuge A., 2012, P IEEE CUST INT CIRC; Kosuge A, 2014, IEEE J SOLID-ST CIRC, V49, P223, DOI 10.1109/JSSC.2013.2282113; Oh TY, 2014, ISSCC DIG TECH PAP I, V57, P430; Osaka H., 2001, P HOT INT 9 AUG, V9, P63; Pozar D. M., 2011, MICROWAVE ENG; Shekhar S., 2013, P IEEE CUST INT CIRC, P1; Shimon T., 2003, IEEE INT SOL STAT CI, P184; Shin W.-Y., 2011, ISSCC, P494; Suzuki K., 2012, IEEE AS SOL STAT CIR, P137; Takeya T, 2013, IEEE J SOLID-ST CIRC, V48, P790, DOI 10.1109/JSSC.2013.2242711; Williams R. D., P JEDEC SERV MEM FOR; Yun W., 2012, ISSCC, P52; Zerbe JL, 2001, IEEE J SOLID-ST CIRC, V36, P752, DOI 10.1109/4.918912	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	AUG	2015	62	8					2122	2131		10.1109/TCSI.2015.2437515		10	Engineering, Electrical & Electronic	Engineering	CN7LN	WOS:000358616100024		
J	El-Sankary, K; Asai, T; Motomura, M; Kuroda, T				El-Sankary, Kamal; Asai, Tetsuya; Motomura, Masato; Kuroda, Tadahiro			Crosstalk Rejection in 3-D-Stacked Interchip Communication With Blind Source Separation	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS II-EXPRESS BRIEFS			English	Article						Blind source separation (BSS); crosstalk rejection; interchip communication; three-dimensional (3-D) integrated circuits (ICs)	ROBUST; ARRAY	A blind source separation (BSS) is proposed to reject the crosstalk between inductive-coupling channels in 3-D systems. The phase and permutation ambiguities inherent to BSS are compensated for in the proposed technique. A continuous-time natural gradient BSS with integrator output swing bounding, which is amenable for high-speed implementation, is also proposed. Techniques to reduce the implementation complexity for a large channel array are presented. The proposed technique shows substantial improvement results for crosstalk rejection in a high-crosstalk-coupling environment. In addition, for a 3 x 3 array channel with 1 Gb/s/channel, with a crosstalk-to-signal ratio of -3 dB, a bit-error rate of 10(-11) is obtained compared to 10(-4) without BSS.	[El-Sankary, Kamal] Dalhousie Univ, Dept Elect & Comp Engn, Halifax, NS B3H 4R2, Canada; [Asai, Tetsuya; Motomura, Masato] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Kuroda, Tadahiro] Keio Univ, Dept Elect & Elect Engn, Kuroda Lab, Yokohama, Kanagawa 2238522, Japan	El-Sankary, K (reprint author), Dalhousie Univ, Dept Elect & Comp Engn, Halifax, NS B3H 4R2, Canada.	kamal.el-sankary@dal.ca; asai@ist.hokudai.ac.jp; motomura@ist.hokudai.ac.jp; kuroda@elec.keio.ac.jp			Canadian Natural Sciences and Engineering Research Council (NSERC)	This work was supported in part by the Canadian Natural Sciences and Engineering Research Council (NSERC). This brief was recommended by Associate Editor S. Palermo.	Amari S, 1997, NEURAL NETWORKS, V10, P1345, DOI 10.1016/S0893-6080(97)00039-7; Amari S, 1996, ADV NEUR IN, V8, P757; Miura N, 2007, IEEE J SOLID-ST CIRC, V42, P111, DOI 10.1109/JSSC.2006.886554; Cichocki A, 1998, NEUROCOMPUTING, V22, P113, DOI 10.1016/S0925-2312(98)00052-6; Baker J. R., 2011, U.S. Patent, Patent No. 7916054; Holobar A., 2004, THESIS U MARIBOR MAR; Kramer AH, 1996, IEEE MICRO, V16, P20, DOI 10.1109/40.540077; Latif MA, 2006, IEEE SIGNAL PROC LET, V13, P117, DOI [10.1109/LSP.2005.862622, 10.1109/LPS.2005.862622]; Miura N, 2007, IEEE J SOLID-ST CIRC, V42, P410, DOI 10.1109/JSSC.2006.889354; Roman G., 2001, IEEE T CIRCUITS-II, V48, P930; Sawada H, 2004, IEEE T SPEECH AUDI P, V12, P530, DOI 10.1109/TSA.2004.832994; Yoichi Y., 2008, IEEE J SOLID-ST CIRC, V43, P2363	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-7747	1558-3791		IEEE T CIRCUITS-II	IEEE Trans. Circuits Syst. II-Express Briefs	AUG	2015	62	8					726	730		10.1109/TCSII.2015.2415258		5	Engineering, Electrical & Electronic	Engineering	CN7LZ	WOS:000358617300002		
J	Huang, C; Mok, PKT				Huang, Cheng; Mok, Philip K. T.			A Delay-Line-Based Voltage-to-Duty-Cycle Controller for High-Frequency PWM Switching Converters	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS II-EXPRESS BRIEFS			English	Article						circuit delay; fully integrated converters; high frequency; pulsewidth modulation (PWM); voltage-to-duty-cycle (V2D)	INTEGRATED BUCK CONVERTER; EFFICIENCY	As the switching frequency of a pulsewidth modulation dc-dc converter increases, the circuit delays become comparable to a switching cycle and raises challenges for the controller design. In this paper, a delay-line-based voltage-to-duty-cycle (V2D) controller is proposed to replace the conventional ramp-comparator-based V2D controller, which significantly simplifies the circuitry and logical complexity of the controller design and relieves the delay-related hassles and limitations for high-frequency converters switching at tens or hundreds of megahertz. The design includes a linearity-compensated voltage-to-current (V2I) cell, a current-starved current-to-duty-cycle (I2D) cell, and a bias current calibration loop, while no ramps or comparators are required. The controller is fabricated in a UMC 0.13-mu m process and measured at 100 MHz, with comparison to a ramp-comparator-based V2D controller. In addition to the benefits of simplified design complexity, the proposed V2D shows an extended controllable duty-cycle range of 0.93 and reduced power consumption by at least half.	[Huang, Cheng; Mok, Philip K. T.] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Kowloon, Hong Kong, Peoples R China	Huang, C (reprint author), Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.	hcxab@connect.ust.hk; eemok@ece.ust.hk			Research Grant Council of Hong Kong, SAR [16207014]	This work was supported in part by a grant from the Research Grant Council of Hong Kong, SAR, under Project 16207014. This brief was recommended by Associate Editor Y.-S. Hwang.	Huang C, 2013, IEEE J SOLID-ST CIRC, V48, P2977, DOI 10.1109/JSSC.2013.2286545; Belloni M, 2008, INT POWER ELECT ELEC, P789, DOI 10.1109/SPEEDHAM.2008.4581258; CHENG L, 2014, P IEEE INT SOL STAT, V57, P84; Du MM, 2011, IEEE J SOLID-ST CIRC, V46, P1928, DOI 10.1109/JSSC.2011.2151470; Huang C, 2013, IEEE J SOLID-ST CIRC, V48, P2595, DOI 10.1109/JSSC.2013.2274826; Moazedi M., 2011, P 19 IR C EL ENG MAY, P1; Peng H, 2013, IEEE T CIRCUITS-I, V60, P2213, DOI 10.1109/TCSI.2013.2239157; SCHROM G, 2007, P IEEE APPL POW EL C, P727; Vaisband I., 2013, IEEE INT S CIRC SYST, P2251; Yang PH, 2002, IEEE J SOLID-ST CIRC, V37, P1348, DOI 10.1109/JSSC.2002.803050	10	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-7747	1558-3791		IEEE T CIRCUITS-II	IEEE Trans. Circuits Syst. II-Express Briefs	AUG	2015	62	8					751	755		10.1109/TCSII.2015.2433332		5	Engineering, Electrical & Electronic	Engineering	CN7LZ	WOS:000358617300007		
J	Shimada, N; Torikai, H				Shimada, Naoki; Torikai, Hiroyuki			A Novel Asynchronous Cellular Automaton Multicompartment Neuron Model	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS II-EXPRESS BRIEFS			English	Article						Asynchronous; cellular automaton; field-programmable gate array (FPGA); multicompartment; neuron model	SPIKING NEURONS; BIFURCATIONS; RESPONSES; FPGA	A novel multicompartment neuron model (a novel multicompartment dendrite-soma model), the dynamics of which is described by coupled asynchronous cellular automata, is presented. It is shown that the presented model can reproduce typical dendritic phenomena observed in biological neurons and multicompartment neuron models. It is also shown that the presented model consumes fewer hardware resources than the conventional model. Furthermore, field-programmable gate array experiments validate the reproductions of the dendritic phenomena.	[Shimada, Naoki] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Osaka 5608531, Japan; [Torikai, Hiroyuki] Kyoto Sangyo Univ, Fac Comp Sci & Engn, Dept Comp Sci, Kyoto 6038555, Japan	Shimada, N (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Osaka 5608531, Japan.	torikai@cse.kyoto-su.ac.jp			KAKENHI [24700225]	This work was supported by KAKENHI under Grant 24700225. This brief was recommended by Associate Editor T. S. Gotarredona.	Ambroise M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00215; Matsubara T, 2013, IEEE T NEUR NET LEAR, V24, P736, DOI 10.1109/TNNLS.2012.2230643; Hishiki T, 2011, IEEE T NEURAL NETWOR, V22, P752, DOI 10.1109/TNN.2011.2116802; Soleimani H, 2012, IEEE T CIRCUITS-I, V59, P2991, DOI 10.1109/TCSI.2012.2206463; Matsubara T, 2011, IEEE T CIRCUITS-II, V58, P677, DOI 10.1109/TCSII.2011.2161705; Arthur JV, 2011, IEEE T CIRCUITS-I, V58, P1034, DOI 10.1109/TCSI.2010.2089556; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Hashimoto S, 2010, IEEE T CIRCUITS-I, V57, P2168, DOI 10.1109/TCSI.2010.2041507; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Izawa M, 2015, IEICE T FUND ELECTR, VE98A, P684, DOI 10.1587/transfun.E98.A.684; Izhikevich E M, 2007, DYNAMICAL SYSTEMS NE; Noguchi T, 2013, IEEE T CIRCUITS-II, V60, P111, DOI 10.1109/TCSII.2012.2235015; RALL WILFRID, 1962, BIOPHYS JOUR, V2, P145; Shimada N., 2014, P IEEE IJCNN, P2496	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-7747	1558-3791		IEEE T CIRCUITS-II	IEEE Trans. Circuits Syst. II-Express Briefs	AUG	2015	62	8					776	780		10.1109/TCSII.2015.2433471		5	Engineering, Electrical & Electronic	Engineering	CN7LZ	WOS:000358617300012		
J	Kurachi, I; Kobayashi, K; Okihara, M; Kasai, H; Hatsui, T; Hara, K; Miyoshi, T; Arai, Y				Kurachi, Ikuo; Kobayashi, Kazuo; Okihara, Masao; Kasai, Hiroki; Hatsui, Takaki; Hara, Kazuhiko; Miyoshi, Toshinobu; Arai, Yasuo			Analysis of Effective Gate Length Modulation by X-Ray Irradiation for Fully Depleted SOI p-MOSFETs	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Review						Fully depleted-silicon-on-insulator (FD-SOI); gate length modulation; MOSFET; sidewall spacer; X-ray radiation hardness	TOTAL-DOSE IRRADIATION; TRANSISTOR RESPONSE; RADIATION; TECHNOLOGY; DAMAGE	An X-ray irradiation degradation mechanism has been investigated for fully depleted-silicon-on-insulator (FD-SOI) p-channel MOSFETs (p-MOSFETs). It is found that the drain current degradation by the X-ray irradiation has gate length dependence showing 20% degradation for L = 0.2 mu m, while 8% for L = 10 mu m after the 1.4 kGy(Si) X-ray irradiation. Using Terada's method, it was found that the degradation is not due to mobility degradation but due to radiation-induced gate length modulation (RIGLEM) and the associated increase of source and drain parasitic resistance. The major cause of degradation induced by the RIGLEM is explained by an analytical model, assuming a positive charge generation in sidewall spacers. It can be suggested that the X-ray irradiation degradation of FD-SOI p-MOSFET can be improved by optimizing the lightly doped drain region.	[Kurachi, Ikuo; Miyoshi, Toshinobu; Arai, Yasuo] High Energy Accelerator Res Org, Ibaraki 3050801, Japan; [Kobayashi, Kazuo; Hatsui, Takaki] RIKEN SPring 8 Ctr, Sayo 6715148, Japan; [Okihara, Masao] Lapis Semicond Co Ltd, Yokohama, Kanagawa 2228575, Japan; [Kasai, Hiroki] Lapis Semicond Miyagi Co Ltd, Ohhira, Miyagi 9813693, Japan; [Hara, Kazuhiko] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Kurachi, I (reprint author), High Energy Accelerator Res Org, Ibaraki 3050801, Japan.	kurachii@post.kek.jp; kkoba@spring8.or.jp; okihara274@mnf.lapis-semi.com; kasai774@myg.lapis-semi.com; hatsui@spring8.or.jp; hara@hep.px.tsukuba.ac.jp; tmiyoshi@post.kek.jp; yasuo.arai@kek.jp			KEK Detector Technology Project within the Ministry of Education, Culture, Sports, Science and Technology [25109001]; X-Ray Free Electron Laser Priority Strategy Program through the Ministry of Education, Culture, Sports, Science and Technology; KAKENHI through the Japan Society for the Promotion of Science [13321217]	This work was supported in part by the Grants-in-Aid for Scientific Research (KAKENHI) through the KEK Detector Technology Project within the Ministry of Education, Culture, Sports, Science and Technology under Grant 25109001, in part by the X-Ray Free Electron Laser Priority Strategy Program through the Ministry of Education, Culture, Sports, Science and Technology, and in part by KAKENHI through the Japan Society for the Promotion of Science under Grant 13321217. The review of this paper was arranged by Editor E. Rosenbaum.	Xu C, 2001, IEEE ELECTR DEVICE L, V22, P248, DOI 10.1109/55.919244; Schwank JR, 2008, IEEE T NUCL SCI, V55, P1833, DOI 10.1109/TNS.2008.2001040; Faccio F, 2005, IEEE T NUCL SCI, V52, P2413, DOI 10.1109/TNS.2005.860698; TERADA K, 1979, JPN J APPL PHYS, V18, P953, DOI 10.1143/JJAP.18.953; Kudo T, 2014, IEEE T NUCL SCI, V61, P1444, DOI 10.1109/TNS.2014.2321766; Schwank JR, 2003, IEEE T NUCL SCI, V50, P522, DOI 10.1109/TNS.2003.812930; BALASINSKI A, 1993, IEEE T NUCL SCI, V40, P1286, DOI 10.1109/23.273540; DIERICKX B, 1993, IEEE T NUCL SCI, V40, P753, DOI 10.1109/23.256656; Arai Y., 2006, IEEE NUCL SCI S C RE, V3, P1440; BALASINSKI A, 1992, IEEE T NUCL SCI, V39, P1998, DOI 10.1109/23.211396; Bulgheroni A, 2004, NUCL INSTRUM METH A, V535, P398, DOI 10.1016/j.nima.2004.07.160; CHEN WL, 1991, IEEE T NUCL SCI, V38, P1124, DOI 10.1109/23.124084; Flament O, 2003, IEEE T NUCL SCI, V50, P2316, DOI 10.1109/TNS.2003.822594; Hatsui T., 2013, P INT IM SENS WORKSH, P305; Honda S., 2014, P TIPP; Ichikawa F, 2004, SOLID STATE ELECTRON, V48, P999, DOI 10.1016/j.sse.2003.12.028; Miyoshi T, 2013, NUCL INSTRUM METH A, V732, P530, DOI 10.1016/j.nima.2013.06.029; Okihara M, 2012, IEEE NUCL SCI CONF R, P471; Schwank JR, 2000, IEEE T NUCL SCI, V47, P604, DOI 10.1109/23.856487; Wei HF, 1996, IEEE T ELECTRON DEV, V43, P1200, DOI 10.1109/16.506769; Xue SB, 2009, J APPL PHYS, V105, DOI 10.1063/1.3106163	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	AUG	2015	62	8					2371	2376		10.1109/TED.2015.2443797		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CN5XS	WOS:000358507600001		
J	Asubar, JT; Kobayashi, Y; Yoshitsugu, K; Yatabe, Z; Tokuda, H; Horita, M; Uraoka, Y; Hashizume, T; Kuzuhara, M				Asubar, Joel T.; Kobayashi, Yohei; Yoshitsugu, Koji; Yatabe, Zenji; Tokuda, Hirokuni; Horita, Masahiro; Uraoka, Yukiharu; Hashizume, Tamotsu; Kuzuhara, Masaaki			Current Collapse Reduction in AlGaN/GaN HEMTs by High-Pressure Water Vapor Annealing	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						AlGaN/GaN high-electron-mobility transistor (HEMT); current collapse; high-pressure water vapor annealing (HPWVA); normalized dynamic R-ON (NDR); ON-resistance; X-ray photoelectron spectroscopy (XPS)	FIELD-EFFECT TRANSISTORS; DYNAMIC ON-RESISTANCE; SURFACE PASSIVATION; MODULATING PLATE; GALLIUM OXIDE; GAN; SUPPRESSION; DEPOSITION; OXIDATION; HYDROGEN	We have demonstrated for the first time a remarkable reduction of current collapse in AlGaN/GaN high-electron-mobility transistors (HEMTs) by high-pressure water vapor annealing (HPWVA). The device subjected to HPWVA exhibited considerably low dynamic ON-resistance (R-ON), suggesting highly improved performance of these devices. Analyses of the results on normalized dynamic RON experiments have shown the elimination of deeper traps by HPWVA, leading to the substantially reduced current collapse. X-ray photoelectron spectroscopy (XPS) studies revealed a significant increase in the oxygen core-level O 1s peak. Moreover, angle-resolved XPS suggested the formation of surface oxide layer. These results indicate that the effective reduction of current collapse in the HPWVA-processed samples is likely due to the incorporation of active oxygen species generated by the HPWV into the AlGaN surface. These oxygen atoms eventually fill up near-surface nitrogen vacancies and promote the formation of Ga2O3 native oxide and possibly Ga2O suboxide, which is known to be an excellent III-V surface passivant. HPWVA is a relatively simple, low-damage, and low-temperature process, and hence, it is found to be a highly feasible and promising alternative for realizing AlGaN/GaN HEMTs with improved performance.	[Asubar, Joel T.; Kobayashi, Yohei; Tokuda, Hirokuni; Kuzuhara, Masaaki] Univ Fukui, Dept Elect Engn, Fukui 9108507, Japan; [Yoshitsugu, Koji; Horita, Masahiro; Uraoka, Yukiharu] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Yatabe, Zenji; Hashizume, Tamotsu] Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0608628, Japan	Asubar, JT (reprint author), Univ Fukui, Dept Elect Engn, Fukui 9108507, Japan.	joel@u-fukui.ac.jp; kobayashi2012y@gmail.com; yo-koji@ms.naist.jp; zenji.yatabe@rciqe.hokudai.ac.jp; htokuda@u-fukui.ac.jp; horita@ms.naist.jp; uraoka@ms.naist.jp; hashi@rciqe.hokudai.ac.jp; kuzuhara@fuee.u-fukui.ac.jp	Yatabe, Zenji/A-5506-2012; Hashizume, Tamotsu/A-6539-2012	Yatabe, Zenji/0000-0003-2069-6677; 			Akatsu T, 1999, J APPL PHYS, V86, P7146, DOI 10.1063/1.371804; Lee DS, 2011, IEEE ELECTR DEVICE L, V32, P755, DOI 10.1109/LED.2011.2132751; Mishra UK, 2002, P IEEE, V90, P1022, DOI 10.1109/JPROC.2002.1021567; Ohi K, 2013, IEEE T ELECTRON DEV, V60, P2997, DOI 10.1109/TED.2013.2266663; Tajima M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.020203; Hashizume T, 2004, APPL SURF SCI, V234, P387, DOI 10.1016/j.apsusc.2004.05.091; Green BM, 2000, IEEE ELECTR DEVICE L, V21, P268, DOI 10.1109/55.843146; Ando Y, 2003, IEEE ELECTR DEVICE L, V24, P289, DOI 10.1109/LED.2003.812532; Hashizume T, 2003, J VAC SCI TECHNOL B, V21, P1828, DOI 10.1116/1.1585077; Saito W, 2007, IEEE T ELECTRON DEV, V54, P1825, DOI 10.1109/TED.2007.901150; Vetury R, 2001, IEEE T ELECTRON DEV, V48, P560, DOI 10.1109/16.906451; Hashizume T, 2003, APPL PHYS LETT, V83, P2952, DOI 10.1063/1.1616648; SHOCKLEY W, 1952, PHYS REV, V87, P835, DOI 10.1103/PhysRev.87.835; Priyantha W, 2011, J CRYST GROWTH, V323, P103, DOI 10.1016/j.jcrysgro.2010.11.122; Butt DP, 1999, J NUCL MATER, V264, P71, DOI 10.1016/S0022-3115(98)00484-X; Houssa M, 2009, MRS BULL, V34, P504, DOI 10.1557/mrs2009.138; Hasan MT, 2013, IEEE ELECTR DEVICE L, V34, P1379, DOI 10.1109/LED.2013.2280712; Brennan B., 2012, APPL PHYS LETT, V101; Gregusova D, 2007, SEMICOND SCI TECH, V22, P947, DOI 10.1088/0268-1242/22/8/021; Hale MJ, 2003, J CHEM PHYS, V119, P6719, DOI 10.1063/1.1601596; Hinkle CL, 2009, ECS TRANSACTIONS, V19, P387, DOI 10.1149/1.3119561; Hinkle C. L., 2009, APPL PHYS LETT, V94; Hori Y., 2013, J APPL PHYS, V114; Hung TH, 2014, IEEE ELECTR DEVICE L, V35, P312, DOI 10.1109/LED.2013.2296659; Jimenez A, 2002, IEEE ELECTR DEVICE L, V23, P306; Jin D, 2012, PROC INT SYMP POWER, P333; Kawanago T, 2014, IEEE T ELECTRON DEV, V61, P785, DOI 10.1109/TED.2014.2299556; Milojevic M., 2011, APPL PHYS LETT, V99; Moulder J. F., 1993, HDB XRAY PHOTOELECTR, P14; Okamoto Y, 2004, IEEE T ELECTRON DEV, V51, P2217, DOI 10.1109/TED.2004.838453; Passlack M, 2005, MATERIALS FUNDAMENTALS OF GATE DIELECTRICS, P403, DOI 10.1007/1-4020-3078-9_12; Punchaipetch P, 2006, JPN J APPL PHYS 2, V45, pL120, DOI 10.1143/JJAP.45.L120; Shiozaki N., 2009, J APPL PHYS, V105; Winn D. L., 2007, J CHEM PHYS, V127; Yoshitsugu K., 2013, IEICE TECH REP, V113, P7	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	AUG	2015	62	8					2423	2428		10.1109/TED.2015.2440442		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CN5XS	WOS:000358507600009		
J	Feng, H; Yang, WT; Onozawa, Y; Yoshimura, T; Tamenori, A; Sin, JKO				Feng, Hao; Yang, Wentao; Onozawa, Yuichi; Yoshimura, Takashi; Tamenori, Akira; Sin, Johnny K. O.			Transient Turn-ON Characteristics of the Fin p-Body IGBT	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Electromagnetic interference (EMI) noise; fin p-body; insulated gate bipolar transistor (IGBT); reverse-recovery dV/dt controllability; turn-ON energy loss (E-ON)	CAPACITANCE; NOISE	In this paper, the transient turn-ON performance of the 1200 V-class fin p-body insulated gate bipolar transistor (Fin-p IGBT) is numerically analyzed and experimentally characterized. Analysis shows that the gate self-charging effect at the turn-ON transient of the device can effectively be suppressed due to its unique structural features of wide trenches and spacer gates. As a result, the Fin-p IGBT demonstrates excellent controllability on the turn-ON dV(CE)/dt of the IGBT, and hence the reverse-recovery dV(KA)/dt of the free-wheeling diode. Compared with conventional floating p-body IGBTs, the Fin-p IGBT can achieve a significant reduction (up to 82%) in the reverse-recovery dV(KA)/dt, which is of great merit in suppressing the electromagnetic interference noise. Moreover, the turn-ON energy loss of the Fin-p IGBT can be reduced by 53% compared with that of the conventional one at the same reverse-recovery dV(KA)/dt of 10 kV/mu s.	[Feng, Hao; Yang, Wentao; Sin, Johnny K. O.] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China; [Onozawa, Yuichi; Yoshimura, Takashi; Tamenori, Akira] Fuji Elect Co Ltd, Matsumoto, Nagano 3900821, Japan	Feng, H (reprint author), Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China.	hfeng@ust.hk; wyangag@ust.hk; onozawa-yuichi@fujielectric.co.jp; yoshimura-takashi@fujielectric.co.jp; tamenori-akira@fujielectric.co.jp; eesin@ust.hk			Fuji Electric Company, Ltd. [FEDT04]	This work was supported by Fuji Electric Company, Ltd., under Grant FEDT04. The review of this paper was arranged by Editor M. Darwish.	Otsuki M, 2003, IEEE T ELECTRON DEV, V50, P1525, DOI [10.1109/TED.2003.813505, 10.1109/TED.2003813505]; [Anonymous], 2001, MEDICI VERS 2001 4; Watanabe S, 2011, PROC INT SYMP POWER, P48, DOI 10.1109/ISPSD.2011.5890787; [Anonymous], 2009, FAST SWITCH DIOD IDP; [Anonymous], 2014, TRENCHSTOP 5 IGBT KE; Toyota Y, 2013, PROC INT SYMP POWER, P29, DOI 10.1109/ISPSD.2013.6694391; Omura I, 1999, IEEE T ELECTRON DEV, V46, P237, DOI 10.1109/16.737464; [Anonymous], 2011, EMC DES IGBT MOD; Baliga B. J., 2008, FUNDAMENTALS POWER S, P244; Bhalla A., 1999, P ISPSD 99, P41; Feng H, 2015, IEEE ELECTR DEVICE L, V36, P591, DOI 10.1109/LED.2015.2426197; Hille F, 2007, INT SYM POW SEMICOND, P109, DOI 10.1109/ISPSD.2007.4294944; Kitagawa M., 1993, International Electron Devices Meeting 1993. Technical Digest (Cat. No.93CH3361-3), DOI 10.1109/IEDM.1993.347221; Laska T., 2000, P 12 ISPSD, P355; Momota S., 2000, P 12 ISPSD 2000, P359; Nakamura K., 2002, P ISPSD 02, P277; Onozawa Y, 2007, IEEE T IND APPL, V43, P513, DOI 10.1109/TIA.2006.890024; Onozawa Y, 2005, INT SYM POW SEMICOND, P207; Onozawa Y, 2008, INT SYM POW SEMICOND, P80; Onozawa Y, 2007, INT SYM POW SEMICOND, P13, DOI 10.1109/ISPSD.2007.4294920; Oyama K., 2001, Proceedings of the 13th International Symposium on Power Semiconductor Devices & ICs. IPSD '01 (IEEE Cat. No.01CH37216), DOI 10.1109/ISPSD.2001.934642; Rupp R., 2006, P IEEE INT S POW SEM, P1; Tsukuda M, 2008, INT SYM POW SEMICOND, P185; Yamaguchi M., 2004, Proceedings of the 16th International Symposium on Power Semiconductor Devices & IC's	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	AUG	2015	62	8					2555	2561		10.1109/TED.2015.2445350		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CN5XS	WOS:000358507600029		
J	Shibata, N; Gotoh, Y				Shibata, Nobutaro; Gotoh, Yoshinori			High-Density RAM/ROM Macros Using CMOS Gate-Array Base Cells: Hierarchical Verification Technique for Reducing Design Cost	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						CMOS; gate array; hierarchical verification; high density; high speed; low power; macro; memory-oriented base cell; RAM; ROM	HIGH-PERFORMANCE; SRAM; TECHNOLOGY	A gate array has a great advantage in that the extra cost required for customizing VLSI masks is low and the lead time needed to obtain an ASIC is short. Hence, it is widely and generally used in the ASIC industry as a major semicustomized VLSI design methodology. This paper presents high-density RAM/ROM macros using memory-oriented CMOS gate-array base cells. The metatile methodology along with a hierarchical verification technique is used for macro design; all the interconnection wires needed to generate a RAM/ROM macro are installed in each physical leaf cell by way of preparation. The macro size is configurable regarding both word count and bit width. Moreover, back annotations after generating a macro are not necessary because there are no unknown factors such as parasitic resistance and/or capacitance. To reduce the power consumption of RAM/ROM macros, six narrow-channel MOSFETs (two pMOSs and four nMOSs) are prepared in the base cell, resulting in a new 10-transistor-type base cell. Using one single base cell, we can implement an SRAM cell (up to two ports), a 4-bit ROM cell, or a 2-input logic gate. When designing the ROM cell, we adopt a double-rail bitline scheme to shorten the bitline delay. Another high-speed technique is to use a new current-mirror sense amplifier. Owing to the high sensitivity (47 mV) of this amplifier, we have successfully reduced the required read bitline signal from 300 to 100 mVpp. With regards to layout techniques, we propose a new high-density address decoder using a subdecoder and complex logic gates. In addition, some verification techniques using phantom base cells are devised. These techniques are confirmed with a gate-array RAM/ROM macro test chip fabricated with a 0.6-mu m low cost, CMOS process. With a two-port SRAM with 256 cells/bitline, the address access time under typical conditions of 3.3 V and 25 degrees C is 7.125 ns and the power-supply current at a 40-MHz operation is 3.8 mA for an I/O-data width of 1 bit.	[Shibata, Nobutaro; Gotoh, Yoshinori] NTT Microsyst Integrat Labs, Atsugi, Kanagawa 2430198, Japan	Shibata, N (reprint author), NTT Microsyst Integrat Labs, Atsugi, Kanagawa 2430198, Japan.						[Anonymous], 2013, EPS ASIC PROD CAT 20; MIZUNO T, 1994, IEEE T ELECTRON DEV, V41, P2216, DOI 10.1109/16.333844; Cheng KL, 2007, INT EL DEVICES MEET, P243; DUCHENE P, 1989, IEEE J SOLID-ST CIRC, V24, P576, DOI 10.1109/4.32010; Gotoh Y., 1992, ICD9260 IEICE, P53; Hashimoto M., 1992, IEEE CUST INT CIRC C; Ikeda N., 1993, IEEE CUST INT CIRC C; ISHIBASHI K, 1994, IEEE J SOLID-ST CIRC, V29, P411, DOI 10.1109/4.280689; Kobayashi T., 1988, IEEE CUST INT CIRC C; Mistry K., 2007, P IEEE INT EL DEV M, P247; Miyashita T, 2007, INT EL DEVICES MEET, P251, DOI 10.1109/IEDM.2007.4418915; Murayama M., 1989, IEEE CUST INT CIRC C; Ohe R., 1989, ICD8966 IEICE, P71; Ohkura I., 1982, IEEE P CICC, P307; Okabe M., 1989, IEEE INT SOL STAT CI, P180, DOI 10.1109/ISSCC.1989.48250; Sasaki Y, 1995, 1995 SYMPOSIUM ON VLSI CIRCUITS, P123, DOI 10.1109/VLSIC.1995.520716; Sawada H., 1990, IEEE  INT C COMP AID, P240; Shibata M., 1994, ICD94100 IEICE, P31; Shibata N, 2010, IEEE J SOLID-ST CIRC, V45, P1856, DOI 10.1109/JSSC.2010.2051262; SHIBATA N, 1993, IEICE T ELECTRON, VE76C, P1641; Shibata N, 2006, IEEE J SOLID-ST CIRC, V41, P728, DOI 10.1109/JSSC.2005.864124; Shibata N., 1998, IEICE T C, VJ81-C-II, P550; Shibata N., 1998, IEICE T C II, VJ81-C-II, P698; Shibata N., 2014, IEICE GEN C DIG TECH, P111; Shibata N., 1995, IEICE T J C, VJ78-C-II, P473; Shimizu Y., 2003, IEICE T ELECTRON, VJ86-C, P726; Suehiro Y., 1988, IEEE CUST INT CIRC C; Takahashi H., 1985, ISSCC, P124; Urano M., 1992, ICD91221 IEICE, P51; VANDEGOOR AJ, 1993, IEEE DES TEST COMPUT, V10, P8, DOI 10.1109/54.199799; Veendrick H., 1990, 37 IEEE INT SOL STAT, P86, DOI 10.1109/ISSCC.1990.110141; Wong T., 1986, IEEE CUST INT CIRC C, P568	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	AUG	2015	23	8					1415	1428		10.1109/TVLSI.2014.2341352		14	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CN5YX	WOS:000358511300004		
J	Endo, S; Li, Y; Homma, N; Sakiyama, K; Ohta, K; Fujimoto, D; Nagata, M; Katashita, T; Danger, JL; Aoki, T				Endo, Sho; Li, Yang; Homma, Naofumi; Sakiyama, Kazuo; Ohta, Kazuo; Fujimoto, Daisuke; Nagata, Makoto; Katashita, Toshihiro; Danger, Jean-Luc; Aoki, Takafumi			A Silicon-Level Countermeasure Against Fault Sensitivity Analysis and Its Evaluation	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						Advanced encryption standard (AES); application-specified integrated circuit (ASIC) implementation; fault sensitivity analysis (FSA); side-channel analysis		In this paper, we present an efficient countermeasure against fault sensitivity analysis (FSA) based on configurable delay blocks (CDBs). FSA is a new type of fault attack, which exploits the relationship between fault sensitivity (FS) and secret information. Previous studies reported that it could break cryptographic modules equipped with conventional countermeasures against differential fault analysis (DFA), such as redundancy calculation, masked AND-OR, and wave dynamic differential logic. The proposed countermeasure can thwart both DFA and FSA attacks based on setup time violation faults. The proposed ideas are to use a CDB as a time base for detection and to combine the technique with Li's countermeasure concept that removes the dependency between FSs and secret data. The postmanufacture configuration of the CDBs allows minimization of the overhead in operating frequency that comes from manufacture variability. In this paper, we also present an implementation of the proposed countermeasure in application-specified integrated circuit, and describe its configuration method. We then investigate the hardware overhead of the proposed countermeasure for an advanced encryption standard processor and demonstrate its validity through an experiment.	[Endo, Sho; Homma, Naofumi; Aoki, Takafumi] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan; [Li, Yang; Sakiyama, Kazuo; Ohta, Kazuo] Univ Electrocommun, Grad Sch Informat & Engn, Tokyo 1828585, Japan; [Fujimoto, Daisuke; Nagata, Makoto] Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo 6578501, Japan; [Katashita, Toshihiro] Natl Inst Adv Ind Sci & Technol, Res Ctr Informat Secur, Tokyo 1010021, Japan; [Danger, Jean-Luc] Telecom ParisTech, Inst Telecom, Lab Traitement & Commun Informat, F-75013 Paris, France	Endo, S (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan.	endo@aoki.ecei.tohoku.ac.jp; liyang@uec.ac.jp; homma@aoki.ecei.tohoku.ac.jp; saki@inf.uec.ac.jp; kazuo.ohta@uec.ac.jp; fujimoto@cs26.scitec.kobe-u.ac.jp; nagata@cs.kobe-u.ac.jp; t-katashita@aist.go.jp; jean-luc.danger@telecom-paristech.fr; aoki@ecei.tohoku.ac.jp					Biham E, 1997, LECT NOTES COMPUT SC, V1294, P513; Moradi A, 2010, LECT NOTES COMPUT SC, V6225, P125, DOI 10.1007/978-3-642-15031-9_9; Li Y, 2010, LECT NOTES COMPUT SC, V6225, P320; Aoki Laboratory, 2014, CRYPT HARDW PROJ; Boneh D., 1997, EUROCRYPT97, V1233, P37, DOI DOI 10.1007/3-540-69053-0; Deleganes D., 2002, S VLSI CIRC FEB; Endo S, 2012, 2012 WORKSHOP ON FAULT DIAGNOSIS AND TOLERANCE IN CRYPTOGRAPHY (FDTC), P95, DOI 10.1109/FDTC.2012.12; Endo S., 2011, J CRYPTOGRAPH ENG, V1, P265; Gandolfi K., 2001, CHES 2001, V2162, P251, DOI 10.1007/3-540-44709-1_21; Satoh A, 2008, LECT NOTES COMPUT SC, V5154, P100, DOI 10.1007/978-3-540-85053-3_7; Kocher P., 1999, LECT NOTES COMPUTER, V1666, P388, DOI DOI 10.1007/3-540-48405-1; Kocher P., 1996, LECT NOTES COMPUTER, V1109, P104; Li Y, 2012, IEICE T FUND ELECTR, VE95A, P234, DOI 10.1587/transfun.E95.A.234; Moradi A., 2011, P IACR CRYPT ERPINT; Moradi A, 2011, LECT NOTES COMPUT SC, V6917, P292; Research Center for Information Security (RCIS) of National Institute of Advanced Industrial Science and Technology, 2013, SASEBO PROJ OV; Saeki M, 2009, LECT NOTES COMPUT SC, V5747, P189; Satoh A., 2001, LNCS, V2248, P239; Selmane N, 2011, IET INFORM SECUR, V5, P181, DOI 10.1049/iet-ifs.2010.0238; Tiri K., 2004, P DES AUT TEST EUR C, V2004, P246	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	AUG	2015	23	8					1429	1438		10.1109/TVLSI.2014.2339892		10	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CN5YX	WOS:000358511300005		
J	Lin, J; Mano, I; Miyahara, M; Matsuzawa, A				Lin, James; Mano, Ibuki; Miyahara, Masaya; Matsuzawa, Akira			Ultralow-Voltage High-Speed Flash ADC Design Strategy Based on FoM-Delay Product	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						Analog-to-digital converter (ADC); delay interpolation; figure-of-merit (FoM)-delay (FD) product; flash; high speed; ultralow voltage (ULV)	DYNAMIC COMPARATOR; CIRCUIT TECHNIQUES; PIPELINED ADC; DIGITAL CMOS; ANALOG; TRANSCEIVER	This paper discusses the ultralow-voltage (ULV) design strategy for high-speed flash analog-to-digital converters (ADCs). A lower supply voltage decreases the energy consumption at the cost of conversion speed. In this paper, a new index, the figure-of-merit (FoM)-delay (FD) product, is introduced to provide a balance between the energy efficiency and conversion speed. As a prototype, a 0.5 V, 420-MS/s, and 7-bit, flash ADC is developed using a 90-nm CMOS technology to demonstrate the validity of ULV operation. To overcome the challenges associated with a reduced supply voltage, a double-tail latched comparator with a variable capacitance calibration technique using metal-oxide-metal capacitors is implemented. An all-digital time-domain delay interpolation technique further enhances the resolution with very little additional power consumption. Using two-way time-interleaving, the prototype ADC achieves an effective number of bits (ENOB) of 5.5 bits while operating at 420 MS/s consuming a total power of 4.1 mW. The lowest measured FoM is the 195 fJ/conv.-step during single-channel operation at 210 MS/s, which results in an extremely low FD product of 0.93 pJ x ns/conv.-step.	[Lin, James; Mano, Ibuki; Miyahara, Masaya; Matsuzawa, Akira] Tokyo Inst Technol, Dept Phys Elect, Tokyo 1528552, Japan	Lin, J (reprint author), Tokyo Inst Technol, Dept Phys Elect, Tokyo 1528552, Japan.	james@ssc.pe.titech.ac.jp; mano@ssc.pe.titech.ac.jp; masaya@ssc.pe.titech.ac.jp; matsu@ssc.pe.titech.ac.jp			New Energy and Industrial Technology Development Organization; Ministry of Internal Affairs and Communications; Core Research for Evolutionary Science and Technology in Japan Science and Technology Agency; Semiconductor Technology Academic Research Center, Tokyo, Japan; Huawei; Berkeley Design Automation for the use of the Analog FastSPICE Platform, Berkeley, CA, USA; VLSI Design and Education Center; Cadence Design Systems, Inc., Yokohama, Japan	This work was supported in part by the New Energy and Industrial Technology Development Organization; in part by the Ministry of Internal Affairs and Communications; in part by the Core Research for Evolutionary Science and Technology in Japan Science and Technology Agency; in part by the Semiconductor Technology Academic Research Center, Tokyo, Japan; in part by Huawei; in part by Berkeley Design Automation for the use of the Analog FastSPICE Platform, Berkeley, CA, USA; and in part by VLSI Design and Education Center in collaboration with Cadence Design Systems, Inc., Yokohama, Japan.	Verbruggen B, 2009, IEEE J SOLID-ST CIRC, V44, P874, DOI 10.1109/JSSC.2009.2012449; Okada K, 2013, IEEE J SOLID-ST CIRC, V48, P46, DOI 10.1109/JSSC.2012.2218066; Walden RH, 1999, IEEE J SEL AREA COMM, V17, P539, DOI 10.1109/49.761034; Sundstrom T, 2009, IEEE T CIRCUITS-I, V56, P509, DOI 10.1109/TCSI.2008.2002548; Chatterjee S, 2005, IEEE J SOLID-ST CIRC, V40, P2373, DOI 10.1109/JSSC.2005.856280; Miyahara M, 2008, IEEE ASIAN SOLID STA, P269, DOI 10.1109/ASSCC.2008.4708780; Lee S, 2012, IEEE J SOLID-ST CIRC, V47, P1603, DOI 10.1109/JSSC.2012.2191184; Shikata A, 2012, IEEE J SOLID-ST CIRC, V47, P1022, DOI 10.1109/JSSC.2012.2185352; [Anonymous], 2013, INT TECHNOLOGY ROADM; Cook BW, 2006, IEEE J SOLID-ST CIRC, V41, P2757, DOI 10.1109/JSSC.2006.884801; Pun KP, 2007, IEEE J SOLID-ST CIRC, V42, P496, DOI 10.1109/JSSC.2006.891716; Muller R, 2012, IEEE J SOLID-ST CIRC, V47, P232, DOI 10.1109/JSSC.2011.2163552; Asada Yusuke, 2009, Proceedings of Technical Papers. 2009 IEEE Asian Solid-State Circuits Conference (A-SSCC 2009), DOI 10.1109/ASSCC.2009.5357198; Daly DC, 2009, IEEE J SOLID-ST CIRC, V44, P3030, DOI 10.1109/JSSC.2009.2032699; Deng W., 2010, P IEEE AS SOL STAT C, P93; Fiorenza JK, 2006, IEEE J SOLID-ST CIRC, V41, P2658, DOI 10.1109/JSSC.2006.884330; Gambini S., 2006, P AS SOL STAT CIRC C, P47; Giannini V., 2008, IEEE ISSCC, P238; Harpe P., 2013, IEEE ISSCC, P270; Shen JH, 2008, IEEE J SOLID-ST CIRC, V43, P787, DOI 10.1109/JSSC.2008.917470; Kim J., 2011, P BIONLP SHAR TASK 2, P1; Kim YJ, 2007, IEEE CUST INTEGR CIR, P185; KURODA T, 1995, IEICE T ELECTRON, VE78C, P334; Lin J., 2012, P IEEE INT C EL DEV; Matsuzawa A., 2011, Proceedings of the 2011 IEEE 9th International Conference on ASIC (ASICON 2011), DOI 10.1109/ASICON.2011.6157233; Matsuzawa A, 2009, 2009 IEEE 8TH INTERNATIONAL CONFERENCE ON ASIC, VOLS 1 AND 2, PROCEEDINGS, P218, DOI 10.1109/ASICON.2009.5351489; Miyahara M., 2010, P IEEE AS SOL STAT C, P177; Murmann B., 2013, ADC PERFORMANCE SURV; MUTOH S, 1995, IEEE J SOLID-ST CIRC, V30, P847, DOI 10.1109/4.400426; Paik D, 2012, IEICE T FUND ELECTR, VE95A, P456, DOI 10.1587/transfun.E95.A.456; Proesel JE, 2008, IEEE CUST INTEGR CIR, P153; Shu Y. S., 2012, P VLSI CIRC HON, P26	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	AUG	2015	23	8					1518	1527		10.1109/TVLSI.2014.2340995		10	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CN5YX	WOS:000358511300013		
J	Iwasa, T; Matsuzaki, T; Tungalagsuvd, A; Munkhzaya, M; Kuwahara, A; Yasui, T; Irahara, M				Iwasa, Takeshi; Matsuzaki, Toshiya; Tungalagsuvd, Altankhuu; Munkhzaya, Munkhsaikhan; Kuwahara, Akira; Yasui, Toshiyuki; Irahara, Minoru			Prenatal undernutrition increases the febrile response to lipopolysaccharides in adulthood in male rats	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Febrile response; IUGR; Hypothalamus	FEMALE RATS; INFLAMMATORY RESPONSES; LEPTIN SURGE; INJECTION; IMMUNITY; OBESITY; AGE	It has been reported that prenatal undernutrition affects the development of the peripheral immune system. In this study, the effects of prenatal undernutrition on the febrile response and hypothalamic innate immune system were evaluated in male rats. Pregnant rats were divided into normally nourished (NN) and undernourished groups (UN). The febrile and anorectic responses to lipopolysaccharides (LPS) were evaluated in the offspring of NN and UN dams. The hypothalamic expression levels of pro-inflammatory cytokines, toll-like receptor 4 (TLR4), and neuropeptide Y (NPY) were also evaluated. The UN rats exhibited significantly lighter body weights than the NN rats at birth; however, their mean body weight was the same as that of the NN rats by postnatal day 10. In adulthood, the UN rats exhibited significantly stronger febrile responses than the NN rats, and the anorectic responses of the UN rats also tended to be stronger than those of the NN rats. On the other hand, no differences in hypothalamic interleukin (IL)-1 beta, IL-6, tumor necrosis factor-alpha, TLR4, or NPY mRNA expression were detected between the NN and UN rats. These results suggest that prenatal undernutrition has long-lasting effects on the febrile response to LPS. However, the precise mechanism underlying these effects and their pathophysiological significance remain unclear. (C) 2015 ISDN. Published by Elsevier Ltd. All rights reserved.	[Iwasa, Takeshi; Matsuzaki, Toshiya; Tungalagsuvd, Altankhuu; Munkhzaya, Munkhsaikhan; Kuwahara, Akira; Irahara, Minoru] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Obstet & Gynecol, Tokushima 7708503, Japan; [Yasui, Toshiyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Reprod Technol, Tokushima 7708503, Japan	Iwasa, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Obstet & Gynecol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	iwasa.takeshi@tokushima-u.ac.jp					Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Breier BH, 2001, MOL CELL ENDOCRINOL, V185, P73, DOI 10.1016/S0303-7207(01)00634-7; FERGUSON AC, 1978, J PEDIATR-US, V93, P52, DOI 10.1016/S0022-3476(78)80599-X; Iwasa T, 2014, CYTOKINE, V65, P65, DOI 10.1016/j.cyto.2013.10.004; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Ellis S, 2005, FASEB J, V19, P1519, DOI 10.1096/fj.04-3569fje; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Breton C, 2008, AJP ENDOCRINOL METAB, V296, pE462; CHANDRA RK, 1981, PEDIATRICS, V67, P407; Equils Ozlem, 2005, Clin Dev Immunol, V12, P59, DOI 10.1080/17402520400008905; Godfrey K. M., 2000, AM J CLIN NUTR, V71, P1344; Iwasa T, 2014, INT J DEV NEUROSCI, V35, P52, DOI 10.1016/j.ijdevneu.2014.03.007; Iwasa T, 2014, J NEUROIMMUNOL, V277, P50, DOI 10.1016/j.jneuroim.2014.09.017; Kim YW, 2007, J PHYSIOL SCI, V57, P159, DOI 10.2170/physiolsci.RP003407; Mouihate A, 2003, ENDOCRINOLOGY, V144, P2454, DOI 10.1210/en.2002-0093; Mouihate Abdeslam, 2012, Dev Neurosci, V34, P318, DOI 10.1159/000339852; Plata-Salaman C.R., 2001, INT J OBESITY, V25, P48	18	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	AUG	2015	44						1	5		10.1016/j.ijdevneu.2015.04.004		5	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CN5KP	WOS:000358468500001		
J	Ikeda, T; Tsuji, T				Ikeda, Tatsunori; Tsuji, Takeshi			Advanced surface-wave analysis for 3D ocean bottom cable data to detect localized heterogeneity in shallow geological formation of a CO2 storage site	INTERNATIONAL JOURNAL OF GREENHOUSE GAS CONTROL			English	Article						Surface-wave analysis; CO2 storage; Scholte waves; 3D Vs structure; 3D attenuation structure; Geological heterogeneity	CROSS-CORRELATION ANALYSIS; RAYLEIGH-WAVES; AZIMUTHAL ANISOTROPY; SEISMOGENIC ZONE; PORE PRESSURE; INVERSION; DISPERSION; VELOCITY; JAPAN; ATTENUATION	To characterize heterogeneous geological formation with high-resolution, we propose a surface-wave analysis method for estimation of the spatial variation of S-wave velocity and attenuation coefficients. We applied the proposed method to the 3D ocean bottom cable (OBC) seismic data acquired at the Tomakomai CO2 storage site in Japan. By inversion of the observed dispersion curves of surface-wave (Scholte-wave in offshore survey), we successfully estimated the high-resolution pseudo-3D S-wave velocity structure for the shallow geological formation. We observed the dominant higher modes of the surface-wave, generated by the complex velocity structure such as inclusions of low-velocity layers. The interpretation based on the dispersion curves (or inverted S-wave velocities) and attenuation coefficients identified the lithological boundary in shallow formation across the 3D seismic survey area, but no fractures were detected. Our proposed method to estimate pseudo-3D S-wave velocity and attenuation structure can provide vital information for the CO2 geological storage, as it provides useful data for evaluation of CO2 leakage paths and estimation of permeability heterogeneity used in reservoir simulation. Moreover, it improves the accuracy of reflection seismic profile for deep structural analysis, and enhances estimations of lithology strength used for geomechanical modeling. (C) 2015 Elsevier Ltd. All rights reserved.	[Ikeda, Tatsunori; Tsuji, Takeshi] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Tsuji, T (reprint author), Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan.	tsuji@i2cner.kyushu-u.ac.jp	Tsuji, Takeshi/I-5679-2014	Tsuji, Takeshi/0000-0003-0951-4596	JST/JICA-SATREPS; JSPS [15H01143]; International Institute for Carbon Neutral Energy Research - World Premier International Research Center Initiative, MEXT, Japan	We thank associate editor Charles Jenkins and two anonymous reviewers for constructive comments that improved the manuscript. We gratefully acknowledge the Ministry of Economy, Trade and Industry (METI) and the Japan CCS Co., Ltd. (JCCS); the seismic data used in this study was acquired under the project of JCCS commissioned by METI. This work is partially supported by and JST/JICA-SATREPS, and JSPS Grant-in-Aid for Scientific Research on Innovative Areas (15H01143). This work is further supported by the International Institute for Carbon Neutral Energy Research, sponsored by the World Premier International Research Center Initiative, MEXT, Japan.	Alvizuri C, 2011, GEOPHYS J INT, V186, P1135, DOI 10.1111/j.1365-246X.2011.05093.x; Ikeda T, 2013, GEOPHYSICS, V78, pEN95, DOI 10.1190/GEO2013-0010.1; Yamanaka H, 1996, B SEISMOL SOC AM, V86, P436; Park CB, 1999, GEOPHYSICS, V64, P800, DOI 10.1190/1.1444590; Foti S, 2011, SURV GEOPHYS, V32, P777, DOI 10.1007/s10712-011-9134-2; Lai CG, 2002, SOIL DYN EARTHQ ENG, V22, P923, DOI 10.1016/S0267-7261(02)00116-1; Xu Z, 2012, GEOPHYS J INT, V189, P1085, DOI 10.1111/j.1365-246X.2012.05411.x; Tanase D, 2013, ENRGY PROCED, V37, P6571, DOI 10.1016/j.egypro.2013.06.589; Hayashi K, 2004, EXPLOR GEOPHYS, V35, P7, DOI 10.1071/EG04007; Xia JH, 2009, J EARTH SCI, V20, P563, DOI 10.1007/s12583-009-0047-7; Socco LV, 2010, GEOPHYSICS, V75, pA83, DOI 10.1190/1.3479491; Tsuji T, 2014, EARTH PLANET SC LETT, V396, P165, DOI 10.1016/j.epsl.2014.04.011; Xia JH, 1999, GEOPHYSICS, V64, P691, DOI 10.1190/1.1444578; Tsuji T, 2011, GEOPHYSICS, V76, pWA71, DOI 10.1190/1.3560018; Xia JH, 2002, J APPL GEOPHYS, V51, P121, DOI 10.1016/S0926-9851(02)00228-8; TOKIMATSU K, 1992, J GEOTECH ENG-ASCE, V118, P1529, DOI 10.1061/(ASCE)0733-9410(1992)118:10(1529); Abe M, 2013, ENRGY PROCED, V37, P6326, DOI 10.1016/j.egypro.2013.06.561; Misbah AS, 2014, GEOPHYSICS, V79, pEN25, DOI 10.1190/GEO2013-0028.1; Bergamo P, 2014, GEOPHYSICS, V79, pEN77, DOI 10.1190/GEO2013-0314.1; Bolero D., 2013, LEADING EDGE, V32, P638; Foti S., 2014, SURFACE WAVE METHODS; Foti S, 2004, NEAR SURF GEOPHYS, V2, P231; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Gucunski N., 1992, Soil Dynamics and Earthquake Engineering, V11, DOI 10.1016/0267-7261(92)90036-D; Harkrider D.G., 1964, Bulletin of the Seismological Society of America, V54; HARKRIDE.DG, 1970, B SEISMOL SOC AM, V60, P1937; Hayashi K., 2004, P 110 SEGJ C, V11, P39; Hayashi K., 2008, THESIS KYOTO U; Heisey J.S, 1982, 2562 U TEX CTR TRANS; Ikeda T, 2015, GEOPHYSICS, V80, pEN1, DOI 10.1190/GEO2014-0018.1; Ikeda T, 2014, J GEOPHYS RES-SOL EA, V119, P8964, DOI 10.1002/2014JB011567; Ikeda T., EARTH PLANETS UNPUB; Ikeda T., 2015, S APPL GEOPH ENG ENV; Kitsunezaki C., 1990, J JSNDS, V9, P1; Lu L, 2006, ACOUST PHYS+, V52, P701, DOI 10.1134/S106377100606011X; Ludwig W.J., 1970, SEISMIC REFRACTION 1, V4, P74; Park C.B., 1998, SEG, V17, P1377, DOI DOI 10.1190/1.1820161; Roy Soumya, 2010, Leading Edge, V29, DOI 10.1190/1.3496915; Saito M., 1988, SEISMOLOGICAL ALGORI; SAITO M, 1993, BUTSURI TANSA, V46, P283; Sen M., 1995, GLOBAL OPTIMIZATION; Strobbia C., 2010, 1 BREAK, V28, P103; Tsuji T, 2012, GEOPHYSICS, V77, pEN17, DOI [10.1190/geo2011-0222.1, 10.1190/GEO2011-0222.1]	43	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-5836	1878-0148		INT J GREENH GAS CON	Int. J. Greenh. Gas Control	AUG	2015	39						107	118		10.1016/j.ijggc.2015.04.020		12	Energy & Fuels; Engineering, Environmental	Energy & Fuels; Engineering	CN7PS	WOS:000358627100010		
J	Berghout, N; Kuramochi, T; van den Broek, M; Faaij, A				Berghout, Niels; Kuramochi, Takeshi; van den Broek, Machteld; Faaij, Andre			Techno-economic performance and spatial footprint of infrastructure configurations for large scale CO2 capture in industrial zones A case study for the Rotterdam Botlek area (part A)	INTERNATIONAL JOURNAL OF GREENHOUSE GAS CONTROL			English	Article						CCS; Industry; Techno-economic; Regional case study	ENERGY EFFICIENCY; CARBON CAPTURE; TECHNOLOGY; PROSPECTS; BIOMASS; FACILITIES; HYDROGEN; HEAT; COAL; ABSORPTION	This study developed a method to assess the techno-economic performance and spatial footprint of CO2 capture infrastructure configurations in industrial zones. The method has been successfully applied to a cluster of sixteen industrial plants in the Dutch industrial Botlek area (7.1 MtCO(2)/y) for 2020-2030. The configurations differ inter alia regarding capture technology (post-, pre-, oxyfuel combustion) and location of capture components (centralized vs. plant site). Results indicate that oxyfuel combustion with centralized oxygen production and decentralized CO2 compression is the most cost effective and realistic configuration when applying CO2 capture to all industrial plants (61(sic)/tCO(2); 5.8 MtCO(2)/y avoided), mainly due to relatively low energy costs compared to post- and pre-combustion. However, oxyfuel combustion at plant level is economically preferable when capturing CO2 from only the three largest industrial plants. For post-combustion, a separated absorber-stripper configuration (73(sic)/tCO(2); 7.1 MtCO(2)/y avoided) is preferable from a cost perspective, due to economic scale effects of capture equipment. The optimal pre-combustion configuration shows a slightly less favorable performance (81(sic)/tCO(2); 4.4 MtCO(2)/y avoided). Whereas many industrial plants have insufficient space available for capture equipment, centralized/hybrid configurations show no insurmountable space issues. The deployment of the most favorable configurations is addressed in Part B. (C) 2015 Elsevier Ltd. All rights reserved.	[Berghout, Niels; van den Broek, Machteld] Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands; [Kuramochi, Takeshi] IGES, Climate & Energy Area, Hayama, Kanagawa, Japan; [Faaij, Andre] Univ Groningen, Energy Acad Europe, Energy & Sustainabil Res Inst Groningen, Groningen, Netherlands	Berghout, N (reprint author), Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands.	n.a.berghout@uu.nl			Dutch government (Ministry of Economic Affairs); CATO-2 consortium	This research has been carried out in the context of the CATO-2-program. CATO-2 is the Dutch national research program on CO<INF>2</INF> Capture and Storage technology (CCS). The program is financially supported by the Dutch government (Ministry of Economic Affairs) and the CATO-2 consortium parties. We would like to thank the two interviewed CO<INF>2</INF> capture experts, who wish to remain anonymous, for their valuable inputs on possible CO<INF>2</INF> capture infrastructure configurations.	Agentschap NL, 2010, PROTOCOL MONITORING; Air Liquide, 2010, EL MIL 2010; Air Products, 2010, EL MIL 2010; Akzo Nobel, 2010, EL MIL 2010; Allam R, 2005, CARBON DIOXIDE CAPTURE FOR STORAGE IN DEEP GEOLOGIC FORMATIONS - RESULTS FROM THE CO2 CAPTURE PROJECT, VOLS 1 AND 2, P451; Allam R, 2005, CARBON DIOXIDE CAPTURE FOR STORAGE IN DEEP GEOLOGIC FORMATIONS - RESULTS FROM THE CO2 CAPTURE PROJECT, VOLS 1 AND 2, P513; AMEC, 2010, TECHNICAL REPORT; Saygin D, 2011, ENERGY, V36, P5779, DOI 10.1016/j.energy.2011.05.019; Berstad D, 2011, ENRGY PROCED, V4, P1737, DOI 10.1016/j.egypro.2011.02.048; [Anonymous], 2008, CARB CAPT STOR NETW; van Straelen J, 2010, INT J GREENH GAS CON, V4, P316, DOI 10.1016/j.ijggc.2009.09.022; Hamelinck CN, 2002, J POWER SOURCES, V111, P1, DOI 10.1016/S0378-7753(02)00220-3; Kuramochi T, 2013, RENEW SUST ENERG REV, V19, P328, DOI 10.1016/j.rser.2012.10.051; Berghout N, 2013, INT J GREENH GAS CON, V17, P259, DOI 10.1016/j.ijggc.2013.04.022; Knoope MMJ, 2014, INT J GREENH GAS CON, V22, P25, DOI 10.1016/j.ijggc.2013.12.016; Kuramochi T, 2010, INT J GREENH GAS CON, V4, P511, DOI 10.1016/j.ijggc.2009.12.008; Andersson V, 2014, INT J GREENH GAS CON, V21, P1, DOI 10.1016/j.ijggc.2013.11.016; Feron PHM, 2002, SEP PURIF TECHNOL, V27, P231, DOI 10.1016/S1383-5866(01)00207-6; Damen K, 2009, INT J GREENH GAS CON, V3, P217, DOI 10.1016/j.ijggc.2008.09.005; Ho MT, 2011, INT J GREENH GAS CON, V5, P49, DOI 10.1016/j.ijggc.2010.06.004; Meerman JC, 2013, INT J GREENH GAS CON, V16, P311, DOI 10.1016/j.ijggc.2013.01.051; Bolland O, 2003, ADV ENVIRON RES, V7, P901, DOI 10.1016/S1093-0191(02)00085-0; Kuramochi T, 2012, PROG ENERG COMBUST, V38, P87, DOI 10.1016/j.pecs.2011.05.001; Peeters ANM, 2007, INT J GREENH GAS CON, V1, P396, DOI 10.1016/S1750-5836(07)00068-0; Meerman JC, 2012, INT J GREENH GAS CON, V9, P160, DOI 10.1016/j.ijggc.2012.02.018; Meerman JC, 2012, RENEW SUST ENERG REV, V16, P6083, DOI 10.1016/j.rser.2012.06.030; Switzer L, 2005, CARBON DIOXIDE CAPTURE FOR STORAGE IN DEEP GEOLOGIC FORMATIONS - RESULTS FROM THE CO2 CAPTURE PROJECT, VOLS 1 AND 2, P561; Kreutz T, 2005, INT J HYDROGEN ENERG, V30, P769, DOI 10.1016/j.ijhydene.2004.08.001; Johansson D, 2012, INT J GREENH GAS CON, V8, P217, DOI 10.1016/j.ijggc.2012.02.007; Appl M., 1997, HYDROGEN NITROGEN J, P101; Arcadis, 2009, B0CE9057000032 MIN H; AVR, 2010, EL MIL 2010; Benton D., 2015, DECARBONISING BRIT I; Berghout N., ASSESSING A IN PRESS; Billingham B.M.A., 2012, NACE INT CORR 2012 C; Biopetrol, 2010, EL MIL 2010; Blok K., 2007, INTRO ENERGY ANAL; Bolland O., 1993, COMPENDIUM EEU COURS; Branan C., 2005, RULES THUMB CHEM ENG; Bureau G., 2011, DELIVERABLE D4 1 1 E; Cabot, 2010, EL MIL 2010; Cargill, 2010, EL MIL 2010; CBS, 2011, AARDG EL GEM TAR; CESAR, 2011, D2 4 3 EUR BEST PRAC; Chakravarti S., 2001, 1 NAT C CARB SEQ PRA, P11; CMS, 2013, SOL PAN PRIC COMP PR; Conline Rhenania, 2012, CONL COAT; Cummings A.L., 2005, BRIMST SULF C MPR SE, P1; DECC, 2009, C08003930000 DECC; DOE/NETL, 2002, PROC EQ COST EST FIN; DOE/NETL, 2007, DOENETL401110907; Dresser-Rand, 2015, VEND QUOT POW CAP CA; DSM, 2010, EL MIL 2010; ECN/PBL, 2010, ECNE10004 PBL; EIGA, 2004, 12104E EIGA IGC; EIGA, 2012, 1312E EIGA IGC AISBL; Enecal, 2010, EL MIL 2010; E.on, 2011, KCPFWMCAPLIS0002 DEC; E.on, 2011, KCPFSWCPDLIS0001 DEC; Esso, 2010, EL MIL 2010; Etsu Shin, 2011, 2004010 LWB; Eurogen, 2010, EL MIL 2010; Evonik Carbon Black, 2010, EL MIL 2010; Feron P.H.M., 2005, PROGR POSTCOMBUSTION; Fischer K.S., 2005, INTEGRATING MEA REGE; Florin N., 2009, ASSESSMENT VALIDITY; Freriks A., 2011, DACE PRIC, V28th; Gasunie, 2012, OFF AANLS AARDG; GCCSI, 2010, DEG CCS READ APPR IN; Grahn M, 2007, BIOMASS BIOENERG, V31, P747, DOI 10.1016/j.biombioe.2007.05.001; Gronvold MS, 2005, CARBON DIOXIDE CAPTURE FOR STORAGE IN DEEP GEOLOGIC FORMATIONS - RESULTS FROM THE CO2 CAPTURE PROJECT, VOLS 1 AND 2, P133; GTW, 2007, GAS TURB WORLD HDB 2; Hegerland G., 2006, TECHNICAL POSSIBILIT, V8; Hurenkamp J., 2011, COMMUNICATION; Hurst P, 2005, CARBON DIOXIDE CAPTURE FOR STORAGE IN DEEP GEOLOGIC FORMATIONS - RESULTS FROM THE CO2 CAPTURE PROJECT, VOLS 1 AND 2, P117; IEA, 2014, EN TECHN PERSP 2014; IEA GHG, 2007, 200712 IEA GHG R D P; IEA GHG, 2005, 20059 IEA GHG R D PR; IEA GHG, 2005, RETR CO2 CAPT NAT GA; IEA GHG, 2000, PH331 IEA GHG R D PR; IEA GHG, 2007, 20077 IEA GHG R D PR; IEA GHG, 2006, IEA GHG CO2 EM DAT V; IEA GHG, 2008, 20083 IEA GHG R D PR; IEA GHG, 2010, 201005 IEA GHG R D P; IEA GHG, 2008, 20089 IEA GHG R D PR; IHS CERA, 2014, DOWNSTR CAP COSTS IN; INL, 2010, 23843 INL; International Energy agency (IEA), 2014, WORLD EN OUTL 2014; International Energy Agency (IEA), 2010, WORLD EN OUTL 2010; IPCC, 2014, CLIM CHANG 2014 MIT; IPPC, 2006, DRAFT REF DOC BEST A; Johansson D, 2013, ENERG CONVERS MANAGE, V66, P127, DOI 10.1016/j.enconman.2012.09.026; Kiewiet J., 2012, PERSONAL COMMUNICATI; Larson E.D, 2005, GASIFICATION BASED F; Lindeburg M.R, 2013, CHEM ENG REFERENCE M, VSeventh; LMNO, 2014, GAS VISC CALC; Lowe C, 2011, ENRGY PROCED, V4, P1058, DOI 10.1016/j.egypro.2011.01.155; Lyondell, 2010, EL MIL 2010; Midthun K, 2012, J NAT GAS SCI ENG, V7, P44, DOI 10.1016/j.jngse.2012.03.007; MIE, 2012, STRUCT BUISL; NASA, 1996, 174015 NASA NSS OFF; NEA, 2010, MON PLANS ANN EM REP; NEN, 2012, 3651 NEN; NEN, 2012, 3650 NEN; NETL, 2010, DOE20101397 NETL, V1; Nienoord M, 2012, COMMUNICATION; Norstebo VS, 2012, INT J GREENH GAS CON, V9, P52, DOI 10.1016/j.ijggc.2012.03.002; NREL, 2009, NRELTP56046267; OANDA, 2014, CURR CONV; Oda J, 2007, ENERG ECON, V29, P868, DOI 10.1016/j.eneco.2007.01.003; Ogden JM, 2006, TECHNO EC MODELS CAR; Pipeliner, 2012, CO2 AFVOERSYSTEEM BO; Pipeliner, 2012, CO2 AFVANG TRANSPORT; Rabou L.P.L.M., 2006, ECNE06026; Ramirez A., 2011, COMET INTEGRATED INF; RAP, 2010, EL MIL 2010; RCI, 2009, CO2 CAPT TRANSP STOR; RCI, 2011, CO2 CAPT STOR ROTT N; Rotterdam Municipality, 2010, HDB LEIDINGEN ROTTER; Roussanaly S, 2013, INT J GREENH GAS CON, V12, P341, DOI 10.1016/j.ijggc.2012.05.008; Rutkowski M, 2005, CURRENT 2005 HYDROGE; Saygin D, 2013, INT J GREENH GAS CON, V18, P23, DOI 10.1016/j.ijggc.2013.05.032; ScottishPower, 2011, UK CARB CAPT STOR DE; SenterNovem, 2006, HANDL BESL EXT VEIL; Simbeck D.R., 2005, HYDROGEN COSTS CO2 C; Sinclair Knight Merz J., 2009, SPACE REQUIREMNTS PO; Sipocz N, 2011, ENRGY PROCED, V4, P1941, DOI 10.1016/j.egypro.2011.02.074; Spero C., 2008, 1 INT OX COMB C; Steel prices, 2012, PRIJSST; Tijmensen Faaij A.P.C., 2002, BIOMASS BIOENERG, V23, P129; UNIDO/IEA, 2011, TECHN ROADM CARB CAP; Van Horssen A., 2009, IMPACTS CO2 CAPTURE; van den Broek M, 2011, ENERG POLICY, V39, P2000, DOI 10.1016/j.enpol.2011.01.036; Visser and Smit Hanab, 2014, STOOMP BOTL W; White V., 2009, WORKSH OP FLEX POW P; WILKINSON MB, 2003, GREENHOUSE GAS CONTR, V1, P69, DOI DOI 10.1016/B978-008044276-1/50012-X; Zanganeh K.E., 2004, INT C GREENH GAS TEC, P1; ZEP, 2013, CO2 CAPT STOR CCS EN; ZEP (Zero Emissions Platform), 2011, COSTS CO2 CAPT POSTD	139	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-5836	1878-0148		INT J GREENH GAS CON	Int. J. Greenh. Gas Control	AUG	2015	39						256	284		10.1016/j.ijggc.2015.05.019		29	Energy & Fuels; Engineering, Environmental	Energy & Fuels; Engineering	CN7PS	WOS:000358627100025		
J	Mito, S; Xue, ZQ; Satoh, H				Mito, Saeko; Xue, Ziqiu; Satoh, Hisao			Experimental assessment of well integrity for CO2 geological storage: Batch experimental results on geochemical interactions between a CO2-brine mixture and a sandstone-cement-steel sample	INTERNATIONAL JOURNAL OF GREENHOUSE GAS CONTROL			English	Article						CCS; Geological storage; Wellbore integrity; Carbonation; Portland cement; Carbon steel casing	SEQUESTRATION CONDITIONS; CARBONATED BRINE; DEGRADATION; EXPOSURE	A wellbore constructed in a CO2 geological storage site is considered to be a potential leakage path. Some laboratory experiments showed serious degradation of wellbore cement while a filed experience indicated integrity of the cement over 30 years. To fill the knowledge gap, we prepared a simulated well sample: a carbon steel bar (J-55) was embedded and fixed with Portland cement (Class A) in a hole made in the centre of a sandstone core sample. Batch experiments were conducted at similar to reservoir conditions: 0.5 M NaCl brine, 50 degrees C and 10 MPa. Simulated well samples were exposed to (1) supercritical CO2, (2) CO2-saturated brine or (3) both CO2 and CO2-saturated brine. Results show that the cement was carbonated to the depth of a few millimetres and the interior cement was not altered after 56 reaction days; also, the alteration of the steel casing was minimal. Apparently, in the sandstone surrounding, the cement seemed to prevent direct interaction between the cement and CO2 and to provide buffer area of pH and/or of carbonate precipitation. The alteration depths for the cement exposed to supercritical CO2 and CO2-saturated brine over 30 years were estimated at 4.6 mm and 2.1 mm, respectively. Our experimental results were consistent with the previous results of CO2-enhanced oil recovery field samples (1-10 mm thick of orange carbonated zone) that were collected from the wells which were exposed to CO2 for over 30 years. (C) 2015 Elsevier Ltd. All rights reserved.	[Mito, Saeko; Xue, Ziqiu] Res Inst Innovat Technol Earth RITE, Kizugawa, Kyoto 6190292, Japan; [Satoh, Hisao] Mitsubishi Mat Corp, Naka, Ibaraki 3110102, Japan	Mito, S (reprint author), Res Inst Innovat Technol Earth RITE, 9-2 Kizugawadai, Kizugawa, Kyoto 6190292, Japan.	mito@rite.or.jp			Ministry of Economy, Trade and Industry of Japan (METI)	This work was supported by the Ministry of Economy, Trade and Industry of Japan (METI) under the grant 'CCS Demonstration Project in Japan' organized by JCCS and 'Development of Safety Assessment Technology for Carbon Dioxide Capture and Storage' organized by RITE. We thank Dr. Y. Asahara and Ms. M. Sasaki, RITE, for contributing batch experiments. For fruitful discussions regarding microscopic studies, we acknowledge Mr. H. Kato and Mr. K Yamaguchi, Mitsubishi Materials Corporation, and Ms. A. Ozawa, Mitsubishi Materials Techno Corporation. Dr. K. Nakano, RITE, gave us insightful suggestions regarding micro XRD analysis and designed the Graphical Abstract. The casing material was provided by Mr. H. Wada, Marubeni-Itochu Techno Steel Inc. Special thanks for Mr. K. Awazu, Nara office of Kisojiban Consultants Co., Ltd, who helped prepare the composite sample.	Kutchko BG, 2009, ENVIRON SCI TECHNOL, V43, P3947, DOI 10.1021/es803007e; Matteo EN, 2012, INT J GREENH GAS CON, V7, P181, DOI 10.1016/j.ijggc.2011.07.012; Duguid A, 2010, INT J GREENH GAS CON, V4, P546, DOI 10.1016/j.ijggc.2009.11.001; Rimmele G, 2008, CEMENT CONCRETE RES, V38, P1038, DOI 10.1016/j.cemconres.2008.03.022; Asahara Y, 2013, ENRGY PROCED, V37, P5738, DOI 10.1016/j.egypro.2013.06.496; [Anonymous], 2010, INT J GREENH GAS CON, DOI DOI 10.1016/J.IJGGC.2009.10.010; Jacquemet N, 2012, APPL GEOCHEM, V27, P782, DOI 10.1016/j.apgeochem.2011.12.004; Zhang M, 2011, INT J GREENH GAS CON, V5, P826, DOI 10.1016/j.ijggc.2010.11.006; Carey JW, 2007, INT J GREENH GAS CON, V1, P75, DOI 10.1016/S1750-5836(06)00004-1; Kutchko BG, 2008, ENVIRON SCI TECHNOL, V42, P6237, DOI 10.1021/es800049r; Kutchko BG, 2007, ENVIRON SCI TECHNOL, V41, P4787, DOI 10.1021/es062828c; Rochelle CA, 2013, APPL GEOCHEM, V30, P161, DOI 10.1016/j.apgeochem.2012.09.007; Duguid A, 2009, ENRGY PROCED, V1, P3181, DOI 10.1016/j.egypro.2009.02.101; Barlet-Gouedard V, 2009, INT J GREENH GAS CON, V3, P206, DOI 10.1016/j.ijggc.2008.07.005; Scherer GW, 2009, INT J GREENH GAS CON, V3, P731, DOI 10.1016/j.ijggc.2009.08.002; Carey JW, 2010, INT J GREENH GAS CON, V4, P272, DOI 10.1016/j.ijggc.2009.09.018; Bachu S, 2009, INT J GREENH GAS CON, V3, P494, DOI 10.1016/j.ijggc.2008.11.002; API, 2002, 10A API; Duguid A, 2011, INT J GREENH GAS CON, V5, P1413, DOI 10.1016/j.ijggc.2011.06.007; Satoh H, 2013, ENRGY PROCED, V37, P5781, DOI 10.1016/j.egypro.2013.06.501; Sweatman R.E., 2009, SPE INT C CO2 CAPT S	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-5836	1878-0148		INT J GREENH GAS CON	Int. J. Greenh. Gas Control	AUG	2015	39						420	431		10.1016/j.ijggc.2015.06.007		12	Energy & Fuels; Engineering, Environmental	Energy & Fuels; Engineering	CN7PS	WOS:000358627100037		
J	Wang, KF; Kitamura, T; Wang, B				Wang, K. F.; Kitamura, T.; Wang, B.			Nonlinear pull-in instability and free vibration of micro/nanoscale plates with surface energy - A modified couple stress theory model	INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES			English	Article						Pull-in instability; Vibration; Surface energy; Geometrically nonlinear strain; Micro/nanoscale plate; Couple stress theory	REDUCED-ORDER MODEL; DISTRIBUTED ELECTROSTATIC FORCE; BENDING ANALYSIS; CIRCULAR PLATES; CASIMIR FORCE; CLOSED-FORM; MEMS; ELASTICITY; BEHAVIOR; MICROSTRUCTURE	Effects of surface energy on the pull-in instability and free vibration of electrostatically actuated micro/nanoscale plates are analyzed based on the modified couple stress theory. A reduced-order model is derived to consider the geometrically nonlinear strain, surface energy, the Casimir force and the material length scale simultaneously. Results show that the pull-in voltage and fundamental frequency of the plate are considerably enhanced by the material length scale, surface energy and geometrically nonlinear deformation. However, these quantities are weakened with the inclusion of Casimir force. The effects of surface energy and the material length scale become more significant if the thickness decreases. In addition, the effects of surface energy and geometrically nonlinear strain on the pull-in voltage are the largest for a square plate. (C) 2015 Elsevier Ltd. All rights reserved.	[Wang, K. F.; Wang, B.] Harbin Inst Technol, Grad Sch Shenzhen, Harbin 150001, Peoples R China; Kyoto Univ, Dept Mech Engn, Kyoto 6068501, Japan; [Wang, B.] Univ Western Sydney, Inst Infrastruct Engn, Penrith, NSW 2751, Australia	Wang, KF (reprint author), Harbin Inst Technol, Grad Sch Shenzhen, Harbin 150001, Peoples R China.	wangkaifa@126.com			National Natural Science Foundation of China [11372086]; Natural Science Foundation of Guangdong Province of China [2014A030313696]; ARC Future Fellowship Program [FT100100211]	The authors are grateful to the National Natural Science Foundation of China (Project no. 11372086) and Natural Science Foundation of Guangdong Province of China (Project no. 2014A030313696) for the support of their research. BLW was also supported by the ARC Future Fellowship Program (Grant no. FT100100211).	Asghari M, 2012, INT J ENG SCI, V51, P292, DOI 10.1016/j.ijengsci.2011.08.013; Gao XL, 2014, Z ANGEW MATH PHYS, V65, P393, DOI 10.1007/s00033-013-0343-z; Xie WC, 2003, NONLINEAR DYNAM, V31, P243, DOI 10.1023/A:1022914020076; Stolken JS, 1998, ACTA MATER, V46, P5109, DOI 10.1016/S1359-6454(98)00153-0; Ansari R, 2011, INT J ENG SCI, V49, P1204, DOI 10.1016/j.ijengsci.2011.06.005; Chao PCP, 2006, J MICROMECH MICROENG, V16, P986, DOI 10.1088/0960-1317/16/5/016; Ansari R, 2014, INT J NONLIN MECH, V67, P16, DOI 10.1016/j.ijnonlinmec.2014.05.012; Zhao XP, 2004, J MICROMECH MICROENG, V14, P900, DOI 10.1088/0960-1317/14/7/009; He J, 2008, NANO LETT, V8, P1798, DOI 10.1021/nl0733233; Lam DCC, 2003, J MECH PHYS SOLIDS, V51, P1477, DOI 10.1016/S0022-5096(03)00053-X; Bordag M, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.125018; Baghani M, 2012, INT J ENG SCI, V54, P99, DOI 10.1016/j.ijengsci.2012.01.001; Nayfeh AH, 2004, J MICROMECH MICROENG, V14, P1711, DOI 10.1088/0960-1317/14/12/016; McFarland AW, 2005, J MICROMECH MICROENG, V15, P1060, DOI 10.1088/0960-1317/15/5/024; Ma JB, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/50/505708; He J, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3050108; Wang GF, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3117505; Batra RC, 2008, J SOUND VIB, V315, P939, DOI 10.1016/j.jsv.2008.02.008; Batra RC, 2008, INT J SOLIDS STRUCT, V45, P3558, DOI 10.1016/j.ijsolstr.2008.02.019; Assadi A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3437041; Batra RC, 2008, SENSORS-BASEL, V8, P1048, DOI 10.3390/s8021048; Yin L, 2011, ACTA MECH SINICA-PRC, V27, P445, DOI 10.1007/s10409-011-0449-z; Shaat M, 2014, INT J MECH SCI, V84, P208, DOI 10.1016/j.ijmecsci.2014.04.020; Yang F, 2002, INT J SOLIDS STRUCT, V39, P2731, DOI 10.1016/S0020-7683(02)00152-X; GURTIN ME, 1975, ARCH RATION MECH AN, V57, P291; Wang GF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2746950; Wang KF, 2014, INT J NONLIN MECH, V59, P69, DOI 10.1016/j.ijnonlinmec.2013.11.004; FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9; Ru CQ, 2010, SCI CHINA PHYS MECH, V53, P536, DOI 10.1007/s11433-010-0144-8; Rahaeifard M, 2011, SENSOR ACTUAT A-PHYS, V171, P370, DOI 10.1016/j.sna.2011.08.025; Thai HT, 2013, COMPOS STRUCT, V95, P142, DOI 10.1016/j.compstruct.2012.08.023; Ramezani A, 2007, INT J SOLIDS STRUCT, V44, P4925, DOI [10.1016/j.ijsolstr.2006.12.015, 10.1016/j.ijsolstr.2007.12.015]; Younis MI, 2003, J MICROELECTROMECH S, V12, P672, DOI 10.1109/JMEMS.2003.818069; Hung ES, 1999, J MICROELECTROMECH S, V8, P497, DOI 10.1109/84.809065; Mahmoud FF, 2012, J MECH SCI TECHNOL, V26, P3555, DOI 10.1007/s12206-012-0871-z; Gies H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.220401; Shaat M, 2015, INT J ENG SCI, V90, P58, DOI 10.1016/j.ijengsci.2015.02.002; Liu DB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.244301; Nayfeh AH, 2007, NONLINEAR DYNAM, V48, P153, DOI 10.1007/s11071-006-9079-z; Shaat M, 2014, INT J MECH SCI, V79, P31, DOI 10.1016/j.ijmecsci.2013.11.022; Hirakata H, 2011, MAT SCI ENG A-STRUCT, V528, P8120, DOI 10.1016/j.msea.2011.07.071; Ke CH, 2005, J APPL MECH-T ASME, V72, P726, DOI 10.1115/1.1985435; Arenas JP, 2003, J SOUND VIB, V266, P912, DOI 10.1016/S0022-460X(03)00056-7; Assadi A, 2008, J APPL PHYS, V108; Bochobza-Degani O, 2002, J MICROELECTROMECH S, V11, P612, DOI 10.1109/JMEMS.2002.803280; Farokhi H, 2015, INT J MECH SCI, V90, P133, DOI 10.1016/j.ijmecsci.2014.11.002; Kitamura T, 2004, JSME INT J A-SOLID M, V47, P106, DOI 10.1299/jsmea.47.106; Kitamura T, 2011, FRACTURE NANOMECHANICS, P1, DOI 10.4032/9789814303118; LEGTENBERG R, 1994, SENSOR ACTUAT A-PHYS, V45, P57, DOI 10.1016/0924-4247(94)00812-4; Li YL, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2013.0473; Machauf A, 2005, J MICROMECH MICROENG, V15, P2309, DOI 10.1088/0960-1317/15/12/013; Mukherjee S, 2005, COMPUT STRUCT, V83, P758, DOI 10.1016/j.compstruc.2004.08.023; Pelesko J. A., 2002, MODELING MEMS NEMS; Rashvand K, 2014, INT J ENG, V27, P375; Shaat M, 2015, MICROSYST TECHNOL; Shaat M, 2013, INT J MECH SCI, V75, P223, DOI 10.1016/j.ijmecsci.2013.07.001; Shenoy VB, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.094104; Vogl GW, 2005, J MICROMECH MICROENG, V15, P684, DOI 10.1088/0960-1317/15/4/002; Yang J, 2012, COMPUT STRUCT, V96-97, P25, DOI 10.1016/j.compstruc.2012.01.008	59	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7403	1879-2162		INT J MECH SCI	Int. J. Mech. Sci.	AUG	2015	99						288	296		10.1016/j.ijmecsci.2015.05.006		9	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CN7PA	WOS:000358625300027		
J	Choi, YH; Kim, EY; Mikami, K; Nam, TJ				Choi, Youn Hee; Kim, Eun-Young; Mikami, Koji; Nam, Taek Jeong			Chemoprotective effects of a recombinant protein from Pyropia yezoensis and synthetic peptide against acetaminophen-induced Chang liver cell death	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						Pyropia yezoensis; recombinant protein; chemo-protective effect; acetaminophen-induced cell death	RECEPTOR SIGNALING PATHWAY; GROWTH-FACTOR-I; PORPHYRA-YEZOENSIS; HIZIKIA-FUSIFORMIS; IEC-6 CELLS; INJURY; ACTIVATION; TOXICITY; EXTRACT; ALGA	In the present study, the chemoprotective effects of recombinant Pyropia yezoensis (P. yezoensis) protein 1 (PYP1) were examined in acetaminophen (APAP)-treated Chang liver cells. The analysis of P. yezoensis revealed the presence of both mature and immature variants of PYP1. PYP1s, designated as PYP1 (15 kDa), PYP1-AC (12 kDa) and PYP1-B (5 kDa), were successfully expressed in Escherichia coli, and their chemoprotective effects were then examined. In addition, a peptide of 11 residues (ALEGGKSSGGG), which is a common sequence at the N-terminus all of the PYP1s, was synthesized and examined. The effects of treatment with PYP1s and the synthetic peptide (SP) on cell proliferation were determined by MTS assay. Our results clearly demonstrated that treatment with all the PYP1s and SP significantly promoted the proliferation of Chang liver cells, protecting them against APAP. Thus, we concluded that recombinant PYP1s exert protective effects against injury to Chang liver cells.	[Choi, Youn Hee; Kim, Eun-Young; Nam, Taek Jeong] Pukyong Natl Univ, Inst Fisheries Sci, Busan 619911, South Korea; [Mikami, Koji] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Nam, TJ (reprint author), Pukyong Natl Univ, Inst Fisheries Sci, 474 Ilgwang Ro, Busan 619911, South Korea.	namtj@pknu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A6A1028677]	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2012R1A6A1028677). We are grateful to Ms. Megumi Akita for her technical assistance.	Mohamed S, 2012, TRENDS FOOD SCI TECH, V23, P83, DOI 10.1016/j.tifs.2011.09.001; Fan YJ, 2013, FOOD CHEM TOXICOL, V55, P172, DOI 10.1016/j.fct.2013.01.003; Park SJ, 2014, INT J ONCOL, V45, P1011, DOI 10.3892/ijo.2014.2509; Ramachandran A, 2011, TOXICOL APPL PHARM, V251, P226, DOI 10.1016/j.taap.2011.01.004; Suetsuna K, 1998, J MAR BIOTECHNOL, V6, P163; Lee MK, 2015, INT J MOL MED, V35, P909, DOI 10.3892/ijmm.2015.2111; Lee MK, 2015, INT J MOL MED, V35, P533, DOI 10.3892/ijmm.2014.2037; Choi EY, 2009, FOOD CHEM TOXICOL, V47, P134, DOI 10.1016/j.fct.2008.10.026; Hwang HJ, 2008, PHYTOTHER RES, V22, P1149, DOI 10.1002/ptr.2368; Lee WM, 2004, HEPATOLOGY, V40, P6, DOI 10.1002/hep.20293; Harnedy PA, 2011, J PHYCOL, V47, P218, DOI 10.1111/j.1529-8817.2011.00969.x; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Cover C, 2005, TOXICOL SCI, V84, P201, DOI 10.1093/toxsci/kfi065; Ray SD, 1999, ARCH BIOCHEM BIOPHYS, V369, P42, DOI 10.1006/abbi.1999.1333; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Shin ES, 2011, INT J MOL MED, V28, P809, DOI 10.3892/ijmm.2011.729; Murray BA, 2007, CURR PHARM DESIGN, V13, P773, DOI 10.2174/138161207780363068; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; Choi YH, 2015, INT J MOL MED, V35, P271, DOI 10.3892/ijmm.2014.1992; COLLIEC S, 1991, THROMB RES, V64, P143, DOI 10.1016/0049-3848(91)90114-C; Funahashi H, 2001, JPN J CANCER RES, V92, P483; Gong Y, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-44; Hwang HJ, 2007, TOXICOLOGY, V230, P76, DOI 10.1016/j.tox.2006.11.001; Hwang HJ, 2008, FOOD CHEM TOXICOL, V46, P3475, DOI 10.1016/j.fct.2008.08.032; MORSE ANC, 1991, BIOACTIVE COMPOUNDS FROM MARINE ORGANISMS, WITH EMPHASIS ON THE INDIAN OCEAN, P167; Oliveira FA, 2005, J ETHNOPHARMACOL, V98, P103, DOI 10.1016/j.jep.2005.01.036; Raghavendran HRB, 2005, PHYTOTHER RES, V19, P113, DOI 10.1002/ptr.1552; Rajaraman G, 2006, TOXICOL APPL PHARM, V217, P225, DOI 10.1016/j.taap.2006.09.005; Saito M., 2005, Journal of Japanese Society of Nutrition and Food Science, V58, P177; Shon YH, 2002, BIOL PHARM BULL, V25, P1427, DOI 10.1248/bpb.25.1427; Suetsuna K, 2001, US Patent, Patent No. 6217879B1; Uji T, 2012, MOL BIOL REP, V39, P7973, DOI 10.1007/s11033-012-1643-7; Xie YC, 2014, TOXICOL APPL PHARM, V279, P266, DOI 10.1016/j.taap.2014.05.010	33	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	AUG	2015	36	2					369	376		10.3892/ijmm.2015.2253		8	Medicine, Research & Experimental	Research & Experimental Medicine	CN8GE	WOS:000358677000006		
J	Akazawa, Y; Hasegawa, T; Yoshimura, Y; Chosa, N; Asakawa, T; Ueda, K; Sugimoto, A; Kitamura, T; Nakagawa, H; Ishisaki, A; Iwamoto, T				Akazawa, Yuki; Hasegawa, Tomokazu; Yoshimura, Yoshitaka; Chosa, Naoyuki; Asakawa, Takeyoshi; Ueda, Kimiko; Sugimoto, Asuna; Kitamura, Takamasa; Nakagawa, Hiroshi; Ishisaki, Akira; Iwamoto, Tsutomu			Recruitment of mesenchymal stem cells by stromal cell-derived factor 1 alpha in pulp cells from deciduous teeth	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						stromal cell-derived factor 1 alpha; C-X-C chemokine receptor type 4; pulp cells; deciduous teeth	PERIODONTAL-LIGAMENT CELLS; FIBROBLAST GROWTH FACTOR-2; BONE-MARROW; PROGENITOR CELLS; IN-VITRO; LIVER; DIFFERENTIATION; REGENERATION; EXPRESSION; MUSCLE	Dental pulp cells (DPCs), including dental pulp (DP) stem cells, play a role in dentine repair under certain conditions caused by bacterial infections associated with caries, tooth fracture and injury. Mesenchymal stem cells (MSCs) have also been shown to be involved in this process of repair. However, the mechanisms through which MSCs are recruited to the DP have not yet been elucidated. Therefore, the aim of the present in vitro study was to investigate whether stromal cell-derived factor 1 alpha (SDF1)-C-X-C chemokine receptor type 4 (CXCR4) signaling is involved in tissue repair in the DP of deciduous teeth. A single-cell clone from DPCs (SDP11) and UE7T-13 cells were used as pulp cells and MSCs, respectively. The MG-63 and HuO9 cells, two osteosarcoma cell lines, were used as positive control cells. Reverse transcription polymerase chain reaction (RT-PCR) revealed that all cell lines (SDP11, UE7T-13 MG-63 and HuO9) were positive for both SDF1 and CXCR4 mRNA expression. Moreover, immunocytochemical analysis indicated that SDF1 and CXCR4 proteins were expressed in the SDP11 and UE7T-13 cells. SDF1 was also detected in the cell lysates (CLs) and conditioned medium (CM) collected from the SDP11 and UE7T-13 cells, and AMD3100, a specific antagonist of CXCR4, inhibited the migration of the UE7T-13 cells; this migration was induced by treatment with CM, which was collected from the SDP11 cells. In addition, real-time PCR showed that the expression of SDF1 in the SDP11 cells was inhibited by treatment with 20 ng/ml fibroblast growth factor (FGF)-2, and exposure to AZD4547, an inhibitor of the FGF receptor, blocked this inhibition. Collectively, these data suggest that SDF1 produced by DP plays an important role in homeostasis, repair and regeneration via the recruitment of MSCs.	[Akazawa, Yuki; Ueda, Kimiko; Nakagawa, Hiroshi; Iwamoto, Tsutomu] Tokushima Univ Hosp, Dept Pediat Dent, Tokushima, Japan; [Hasegawa, Tomokazu; Sugimoto, Asuna; Kitamura, Takamasa; Iwamoto, Tsutomu] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pediat Dent, Tokushima 7708504, Japan; [Yoshimura, Yoshitaka] Hokkaido Univ, Grad Sch Dent Med, Div Oral Pathol Sci, Dept Mol Cell Pharmacol, Sapporo, Hokkaido 0608586, Japan; [Chosa, Naoyuki; Ishisaki, Akira] Iwate Med Univ, Sch Dent, Dept Oral Biochem, Morioka, Iwate 0208505, Japan; [Asakawa, Takeyoshi] Showa Univ, Div Dent Persons Disabil, Dept Special Needs Dent, Sch Dent, Tokyo 1458515, Japan	Hasegawa, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pediat Dent, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	hasegawa@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25463182, 26293435, 25670869, 26861790]; Japan Society for the Promotion Science (JSPS); Futokukai Foundation	The present study was supported in part by Grants-in-Aid for Scientific Research (C) (no. 25463182 to T.H.) and (B) (no. 26293435 to T.I.), Grants-in Aid for Exploratory Research (no. 25670869 to T.I.), and Grants-in-Aid for Young Scientists (B) (no. 26861790 to Y.A.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); the Japan Society for the Promotion Science (JSPS); and the Futokukai Foundation (to Y.A., 2013).	Asano Y, 2007, HEPATOL RES, V37, P1080, DOI 10.1111/j.1872-034X.2007.00206.x; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13; Luster AD, 1998, NEW ENGL J MED, V338, P436; Lv ZL, 2013, MOL CELLS, V36, P119, DOI 10.1007/s10059-013-0043-8; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Kim YS, 2010, J ENDODONT, V36, P1824, DOI 10.1016/j.joen.2010.08.020; Shimomura T, 2007, HEPATOL RES, V37, P1068, DOI 10.1111/j.1872-034X.2007.00162.x; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Orchardson R, 2001, Dent Update, V28, P200; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Farges JC, 2009, J EXP ZOOL PART B, V312B, P425, DOI 10.1002/jez.b.21259; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Murakami S, 2011, PERIODONTOL 2000, V56, P188, DOI 10.1111/j.1600-0757.2010.00365.x; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Trubiani O, 2008, J CELL PHYSIOL, V214, P706, DOI 10.1002/jcp.21266; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Zhou J, 2011, J CELL PHYSIOL, V226, P2081, DOI 10.1002/jcp.22538; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Kimura K, 2002, CLIN EXP METASTAS, V19, P477, DOI 10.1023/A:1020395816633; Fujii S, 2010, CELL TISSUE RES, V342, P233, DOI 10.1007/s00441-010-1037-x; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Aomatsu E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03652; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Hasegawa T, 2012, INT J MOL MED, V30, P35, DOI 10.3892/ijmm.2012.957; Hasegawa T, 2010, EXP THER MED, V1, P477, DOI 10.3892/etm_00000074; Hasegawa T, 2010, INT J MOL MED, V26, P701, DOI 10.3892/ijmm_00000516; Kimura Yasuyuki, 2014, Front Cell Dev Biol, V2, P19, DOI 10.3389/fcell.2014.00019; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Orchardson R, 2001, DENT UPDATE, V28, P208; Sugiyama T, 2006, IMMUNITY, V25, P977; Tsuchiya A, 2012, DIGEST DIS SCI, V57, P2892, DOI 10.1007/s10620-012-2239-8	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	AUG	2015	36	2					442	448		10.3892/ijmm.2015.2247		7	Medicine, Research & Experimental	Research & Experimental Medicine	CN8GE	WOS:000358677000014		
J	Akashi, M; Hashikawa, K; Kakei, Y; Sakakibara, A; Hasegawa, T; Minamikawa, T; Komori, T				Akashi, M.; Hashikawa, K.; Kakei, Y.; Sakakibara, A.; Hasegawa, T.; Minamikawa, T.; Komori, T.			Sequential evaluation for bone union of transferred fibula flaps in reconstructed mandibles: panoramic X-ray versus computed tomography	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						free fibula osteocutaneous flap; mandibulectomy; bone union; panoramic X-ray; computed tomography	MANDIBULAR RECONSTRUCTION; TIBIAL FRACTURES; NONUNION; FIXATION; OUTCOMES; MASS	The purpose of this study was to sequentially evaluate bone union of fibular grafts in mandibular reconstruction. Patients who underwent routine follow-up computed tomography (CT) and panoramic X-ray imaging during a period of >= 2 years were enrolled. On panoramic X-ray images, bone union was scored as 0 (absent callus formation) or 1 (complete callus formation). On CT images, a scale of 0 to 2 was used (0, absent callus formation; 1, complete callus formation only on the labial side; 2, complete callus formation on both the labial and lingual side). A total of 56 bone junctions were evaluated in 20 patients. Five of 56 junctions (9%) in four of 20 patients (20%) showed radiological non-union (panoramic X-ray score = 0, CT score = 0 or 1) at 2 years after surgery. All bone junctions with radiological nonunion were located at the mandibular angle. No categorical values, including diabetes mellitus and radiation therapy, were significantly associated with radiological non-union. In conclusion, assessing at least two sides (i.e. labial and lingual sides) on CT images is adequate to evaluate bone union in transferred fibula flaps. Careful fixation at the mandibular angle may improve the rate of bone union.	[Akashi, M.; Kakei, Y.; Sakakibara, A.; Hasegawa, T.; Minamikawa, T.; Komori, T.] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan; [Hashikawa, K.] Kobe Univ, Grad Sch Med, Dept Plast Surg, Kobe, Hyogo 6500017, Japan	Akashi, M (reprint author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Chuo Ku, Kusunoki Cho 7-5-1, Kobe, Hyogo 6500017, Japan.	akashim@med.kobe-u.ac.jp					Anne-Gaelle B, 2011, ORAL ONCOL, V47, P1099, DOI 10.1016/j.oraloncology.2011.07.016; De Santis G, 2004, PLAST RECONSTR SURG, V113, P88, DOI 10.1097/01.PRS.0000090723.98704.36; [Anonymous], 2013, JPN J HEAD NECK CANC; Abe Yoshiro, 2014, J Med Invest, V61, P318; Wong RCW, 2011, INT J ORAL MAX SURG, V40, P393, DOI 10.1016/j.ijom.2010.11.023; Tsuchiya S, 2011, HEAD NECK-J SCI SPEC, V33, P383, DOI 10.1002/hed.21460; Tay WH, 2014, INJURY, V45, P1653, DOI 10.1016/j.injury.2014.06.025; Virgin FW, 2010, LARYNGOSCOPE, V120, P663, DOI 10.1002/lary.20791; Whelan DB, 2002, J BONE JOINT SURG BR, V84B, P15, DOI 10.1302/0301-620X.84B1.11347; Shibuya Y, 2013, J ORAL REHABIL, V40, P484, DOI 10.1111/joor.12066; [Anonymous], 2008, JPN J HEAD NECK CANC; TAYLOR GI, 1975, PLAST RECONSTR SURG, V55, P533, DOI 10.1097/00006534-197505000-00002; Morshed S, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.G.01556; Kooistra BW, 2010, J ORTHOP TRAUMA, V24, pS81, DOI 10.1097/BOT.0b013e3181ca3fd1; Disa JJ, 1999, PLAST RECONSTR SURG, V103, P1371, DOI 10.1097/00006534-199904050-00005; Bak M, 2010, ORAL ONCOL, V46, P71, DOI 10.1016/j.oraloncology.2009.11.006; Craig ES, 2015, MICROSURG, V35, P29, DOI 10.1002/micr.22229; DESANTIS G, 2004, PLAST RECONSTR SURG, V113, P99; Disa JJ, 1997, AM J SURG, V174, P503; HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014; Kim JH, 2005, LARYNGOSCOPE, V115, P1697, DOI 10.1097/01.mlg.0000174952.98927.9f; Nishikawa K., 1999, JPN J HEAD NECK CANC, V25, P130; Smeele LE, 1999, HEAD NECK-J SCI SPEC, V21, P315, DOI 10.1002/(SICI)1097-0347(199907)21:4<315::AID-HED4>3.0.CO;2-W; TAYLOR GI, 1977, ORTHOP CLIN N AM, V8, P425; Tie Y, 2006, J CRANIO MAXILL SURG, V34, P290, DOI 10.1016/j.jcms.2006.03.004; Trignano E, 2013, MICROSURG, V33, P527, DOI 10.1002/micr.22159; Vannabouathong C, 2011, INJURY, V42, P314, DOI 10.1016/j.injury.2010.11.048; Yla-Kotola TM, 2013, J RECONSTR MICROSURG, V29, P427, DOI 10.1055/s-0033-1343953	28	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	AUG	2015	44	8					942	947		10.1016/j.ijom.2015.04.014		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CN7PR	WOS:000358627000002		
J	Ishida, S; Shibuya, Y; Kobayashi, M; Komori, T				Ishida, S.; Shibuya, Y.; Kobayashi, M.; Komori, T.			Assessing stomatognathic performance after mandibulectomy according to the method of mandibular reconstruction	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						stomatognathic performance; mandibular reconstruction; mandibulectomy; mandibular movement; masticatory muscles; masticatory performance	QUALITY-OF-LIFE; MIXING ABILITY TEST; MASTICATORY PERFORMANCE; HEMIMANDIBULECTOMY; RESECTION; PATIENT; CANCER; FORCE; FOOD	The aim of this study was to investigate stomatognathic performance after mandibulectomy. Twenty-six subjects were classified into two groups: the mandibular continuity (MC) group were reconstructed and kept in MC, while the mandibular non-continuity (MNC) group lost MC. Stomatognathic performance was evaluated using the Oral Health Impact Profile in Japanese (OHIP-J), a colour-changing chewing gum, a gummy jelly, Sato's questionnaire, electromyography (EMG) of the masticatory muscles, and mandibular movement. The OHIP-J and modified Sato's questionnaire revealed that the physical and eating disability of the MNC group was significantly more severe than that of the MC group (P < 0.05). The mean EMG activity of the anterior temporalis muscle in the relaxed state was significantly higher in the MNC group than in the MC group (P < 0.05). The mean masticating/relaxing ratio of EMG activities for the masseter muscle was lower in the MNC group than in the MC group (P < 0.05). The maximum mouth opening range of the MNC group was greater than that of the MC group (P < 0.05). Accordingly, the MC group had good results for physical and eating ability. The MNC group suffered from muscle fatigue but had the advantage of a greater maximum mouth opening range.	[Ishida, S.; Kobayashi, M.; Komori, T.] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan; [Shibuya, Y.] Nagoya City Univ, Grad Sch Med Sci, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4678601, Japan	Shibuya, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Oral & Maxillofacial Surg, Mizuho Ku, 1 Kawasumi Cho, Nagoya, Aichi 4678601, Japan.	shibuya@med.nagoya-cu.ac.jp					MANLY RS, 1950, J DENT RES, V29, P448, DOI 10.1177/00220345500290040701; KOMISAR A, 1990, LARYNGOSCOPE, V100, P364; Shibuya Y, 2013, J ORAL REHABIL, V40, P191, DOI 10.1111/joor.12023; Sugiura T, 2009, J ORAL REHABIL, V36, P159, DOI 10.1111/j.1365-2842.2008.01917.x; Speksnijder CM, 2009, EUR J ORAL SCI, V117, P580, DOI 10.1111/j.1600-0722.2009.00675.x; URKEN ML, 1991, LARYNGOSCOPE, V101, P935; Curtis DA, 1997, HEAD NECK-J SCI SPEC, V19, P287, DOI 10.1002/(SICI)1097-0347(199707)19:4<287::AID-HED7>3.0.CO;2-X; [Anonymous], 2005, J PROSTHET DENT, V94, P10; Baqaien MA, 2007, J ORAL REHABIL, V34, P27, DOI 10.1111/j.1365-2842.2006.01690.x; Boudarham J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094138; CURTIS TA, 1975, J PROSTHET DENT, V34, P539, DOI 10.1016/0022-3913(75)90042-6; ENDO N, 1972, ORAL SURG ORAL MED O, V34, P390, DOI 10.1016/0030-4220(72)90315-5; Ferguson SA, 2013, HUM FACTORS, V55, P1077, DOI 10.1177/0018720813482328; Hashikawa K, 2008, JPN J HEAD NECK CANC, V34, P412; Kadota C, 2008, J ORAL REHABIL, V35, P408, DOI 10.1111/j.1365-2842.2007.01814.x; Kamiyama Miho, 2010, J Prosthodont Res, V54, P24, DOI 10.1016/j.jpor.2009.08.001; Koyama S, 2005, J ORAL REHABIL, V32, P635, DOI 10.1111/j.1365-2842.2005.01483.x; Linsen S, 2009, J PAIN SYMPTOM MANAG, V37, P94, DOI 10.1016/j.jpainsymman.2006.12.019; MARUNICK M, 1992, J PROSTHET DENT, V67, P835, DOI 10.1016/0022-3913(92)90596-3; MARUNICK MT, 1990, J PROSTHET DENT, V63, P566, DOI 10.1016/0022-3913(90)90078-Q; MARUNICK MT, 1992, J ORAL REHABIL, V19, P289, DOI 10.1111/j.1365-2842.1992.tb01104.x; Namaki Shunsuke, 2004, J Oral Sci, V46, P113, DOI 10.2334/josnusd.46.113; Otomaru Takafumi, 2009, J Prosthodont Res, V53, P111, DOI 10.1016/j.jpor.2009.02.003; SATO Y, 1989, J PROSTHET DENT, V62, P50, DOI 10.1016/0022-3913(89)90047-4; SCHLIEPHAKE H, 1995, J CRANIO MAXILL SURG, V23, P243, DOI 10.1016/S1010-5182(05)80215-X; Shiga H, 2012, J PROSTHODONT RES, V56, P166, DOI 10.1016/j.jpor.2012.02.001; Takahashi Miyuki, 1999, Journal of Medical and Dental Sciences, V46, P93; Weijnen FG, 2002, ARCH ORAL BIOL, V47, P393, DOI 10.1016/S0003-9969(02)00014-6; Wilson KM, 1998, LARYNGOSCOPE, V108, P1574, DOI 10.1097/00005537-199810000-00028	29	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	AUG	2015	44	8					948	955		10.1016/j.ijom.2015.03.011		8	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CN7PR	WOS:000358627000003		
J	Moroi, A; Ishihara, Y; Sotobori, M; Iguchi, R; Kosaka, A; Ikawa, H; Yoshizawa, K; Marukawa, K; Ueki, K				Moroi, A.; Ishihara, Y.; Sotobori, M.; Iguchi, R.; Kosaka, A.; Ikawa, H.; Yoshizawa, K.; Marukawa, K.; Ueki, K.			Changes in occlusal function after orthognathic surgery in mandibular prognathism with and without asymmetry	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						bite force; osteotomy; asymmetry	SKELETAL CLASS-III; FORT-I OSTEOTOMY; BITE FORCE; SURGICAL-CORRECTION; CONTACT AREA; MORPHOLOGY; MUSCLES	This study aimed to evaluate the postoperative changes in masticatory function in patients with jaw deformities with or without asymmetry treated by orthognathic surgery. Thirty female patients who underwent a Le Fort I osteotomy with sagittal split ramus osteotomy (SSRO) were enrolled. The patients were divided into symmetry and asymmetry groups. The bite force, occlusal contact area, and bite force balance were measured before and at 1, 3, and 6 months and 1 year after surgery; these measurements were compared statistically within and between the two groups. In the symmetry group, there was a significant difference in the preoperative bite force and the 1 month postoperative bite force (P = 0.0033). In the asymmetry group, the bite force before surgery was significantly different from that at 1 month (P = 0.0375) and at 1 year (P = 0.0353) after surgery. Significant differences in the bite force were also observed between the following time points: 1 month and 1 year (P = 0.0003), 3 months and 1 year (P = 0.0034), and 1 month and 6 months (P = 0.0486). The occlusal contact area, bite force, and occlusal balance tended to change after Le Fort I osteotomy with SSRO, with a significantly improved bite force in patients with asymmetry before surgery.	[Moroi, A.; Ishihara, Y.; Sotobori, M.; Iguchi, R.; Kosaka, A.; Ikawa, H.; Yoshizawa, K.; Marukawa, K.; Ueki, K.] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg, Yamanashi 4093898, Japan	Moroi, A (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg,Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	amoroi@yamanashi.ac.jp					Kim YG, 1997, J ORAL MAXIL SURG, V55, P121, DOI 10.1016/S0278-2391(97)90224-X; Nagai I, 2001, BRIT J ORAL MAX SURG, V39, P429, DOI 10.1054/bjom.2001.0681; Goto TK, 2008, J ORAL REHABIL, V35, P594, DOI 10.1111/j.1365-2842.2007.01837.x; XU JA, 1994, DENTOMAXILLOFAC RAD, V23, P154; PROFFIT WR, 1989, J ORAL MAXIL SURG, V47, P457, DOI 10.1016/0278-2391(89)90277-2; [Anonymous], 1991, J NATL MED COLL; Iwase M, 2006, INT J ORAL MAX SURG, V35, P1102, DOI 10.1016/j.ijom.2006.08.014; Trpkova B, 2000, ANGLE ORTHOD, V70, P81; Harada K, 2003, ORAL SURG ORAL MED O, V95, P649, DOI 10.1067/moe.2003.239; Ellis E, 1996, J ORAL MAXIL SURG, V54, P176, DOI 10.1016/S0278-2391(96)90443-7; Fushima K, 1999, J ORAL REHABIL, V26, P752, DOI 10.1046/j.1365-2842.1999.00447.x; Hirasawa T, 1978, J JAP SOC DENT APP M, V19, P298; Iwase M, 1998, J ORAL MAXIL SURG, V56, P850, DOI 10.1016/S0278-2391(98)90013-1; Maness W L, 1987, Quintessence Int, V18, P287; SOLBERG WK, 1986, AM J ORTHOD DENTOFAC, V89, P326, DOI 10.1016/0002-9416(86)90055-2; THOMAS GP, 1995, J ORAL MAXIL SURG, V53, P673, DOI 10.1016/0278-2391(95)90168-X; TRAUNER R, 1957, Oral Surg Oral Med Oral Pathol, V10, P677, DOI 10.1016/S0030-4220(57)80063-2; Ueki K, 2005, EUR J ORTHODONT, V27, P501, DOI 10.1093/ejo/cji029; Ueki K, 2007, ORAL SURG ORAL MED O, V104, P38, DOI 10.1016/j.tripleo.2006.11.018; Ueki K, 2007, INT J ORAL MAX SURG, V36, P301, DOI 10.1016/j.ijom.2006.09.022; Ueki K, 2009, J ORAL MAXIL SURG, V67, P67, DOI 10.1016/j.joms.2008.06.018	21	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	AUG	2015	44	8					971	976		10.1016/j.ijom.2015.03.015		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CN7PR	WOS:000358627000006		
J	Arimoto, S; Hasegawa, T; Okamoto, N; Shioyasono, A; Tateishi, C; Akashi, M; Suzuki, H; Furudoi, S; Komori, T				Arimoto, S.; Hasegawa, T.; Okamoto, N.; Shioyasono, A.; Tateishi, C.; Akashi, M.; Suzuki, H.; Furudoi, S.; Komori, T.			Determining the location of the internal maxillary artery on ultrasonography and unenhanced magnetic resonance imaging before orthognathic surgery	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						maxillary artery; ultrasonography; magnetic resonance imaging; intraoral vertical ramus osteotomy	VERTICAL RAMUS OSTEOTOMY; MANDIBULAR PROGNATHISM; COMPLICATIONS	The purpose of this study was to examine the efficacy of ultrasonography (US) and unenhancedmagnetic resonance imaging(MRI) to determine the location of the internal maxillary artery (IMA) beforeorthognathic surgery. The study subjects were 19 patients (seven males and twelve females) with mandibular prognathismseen at the authors' institution between March 2012 and April 2013.The distance from the skin to the IMA (S-IMA)and the distance from the mandibular notch to the IMA (MN-IMA) were measured. Using the US and coronal MRI images, S-IMA(cl)and MN-IMA(cl) in the closed position and S-IMA(op) and MN-IMA(op) in the open position were measured at a total of four points in each cross-section. There were significant correlations between the distances measured on coronal MRI and US for all groups (P < 0.05). A total of 35 (92%) IMAs were classified as clear and three (8%) as unclear based on the US findings. Regarding the location of the IMA, 37 of the 38 sides studied (97%) were of the lateral type, while only one (3%) was of the medial type. The results of this study indicate that US can be used effectively to determine the location of the IMA.	[Arimoto, S.; Hasegawa, T.; Okamoto, N.; Shioyasono, A.; Tateishi, C.; Akashi, M.; Suzuki, H.; Furudoi, S.; Komori, T.] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan	Hasegawa, T (reprint author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hasetaku@med.kobe-u.ac.jp					Adachi B, 1928, ARTERIENSYSTEM JAPAN, VI, P85; Panula K, 2001, J ORAL MAXIL SURG, V59, P1128, DOI 10.1053/joms.2001.26704; Chang HP, 2006, J FORMOS MED ASSOC, V105, P781; Costa F, 2001, Int J Adult Orthodon Orthognath Surg, V16, P121; FISHMAN MC, 1986, RADIOL CLIN N AM, V24, P485; Fujita T, 1932, J STOMATOL SOC JPN, V6, P250; Ghali GE, 2000, J ORAL MAXIL SURG, V58, P313, DOI 10.1016/S0278-2391(00)90063-6; Hayashi X, 2006, JPN J JAW DEFORM, V16, P12; Ikakura K, 1961, KOUKU KAIBOU KENKYU, V18, P91; Kodama Y, 2011, JPN J JAW DEFORM, V21, P232; LANIGAN DT, 1991, J ORAL MAXIL SURG, V49, P713; LANIGAN D T, 1988, International Journal of Adult Orthodontics and Orthognathic Surgery, V3, P215; LASKER GW, 1951, ANAT REC, V109, P119, DOI 10.1002/ar.1091090109; Lauber H, 1901, ANAT ANZEIGER, V19, P444; Li CJ, 2012, J ORAL MAXIL SURG, V70, P1300, DOI 10.1016/j.joms.2012.01.003; Maeda S, 2012, ANAT SCI INT, V87, P187, DOI 10.1007/s12565-012-0146-x; OISHI K, 1990, Annals of Physiological Anthropology, V9, P291; Salvolini E, 2002, Radiol Med, V103, P526; Stark DD, 1999, MAGNETIC RESONANCE I, V1, P234; Takarada T, 1958, SHIKWA GAKUHO, V58, P1; TUINZING DB, 1985, INT J ORAL MAXILLOF, V14, P319, DOI 10.1016/S0300-9785(85)80020-X	21	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	AUG	2015	44	8					977	983		10.1016/j.ijom.2015.04.007		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CN7PR	WOS:000358627000007		
J	Toftegaard, KL; Gustafsson, LN; Uwakwe, R; Andersen, UA; Becker, T; Bickel, GG; Bork, B; Cordes, J; Frasch, K; Jacobsen, BA; Kilian, R; Larsen, JI; Lauber, C; Mogensen, B; Rossler, W; Tsuchiya, KJ; Munk-Jorgensen, P				Toftegaard, Kristian L.; Gustafsson, Lea Norgreen; Uwakwe, Richard; Andersen, Ulla A.; Becker, Thomas; Bickel, Graziella Giacometti; Bork, Bernhard; Cordes, Joachim; Frasch, Karel; Jacobsen, Bent Ascanius; Kilian, Reinhold; Larsen, Jens Ivar; Lauber, Christoph; Mogensen, Birthe; Roessler, Wulf; Tsuchiya, Kenji J.; Munk-Jorgensen, Povl			Where are patients who have co-occurring mental and physical diseases located?	INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY			English	Article						Pathway to care; collaboration; physical disease; psychiatric illness	HELP-SEEKING PATHWAYS; NEGATIVE SYMPTOMS; 1ST EPISODE; LIFE-STYLE; PSYCHIATRIC-PATIENTS; EXCESS MORTALITY; EARLY PSYCHOSIS; HEALTH-CARE; SCHIZOPHRENIA; DEPRESSION	Background: Patients with a psychiatric illness have a higher prevalence of physical diseases and thus a higher morbidity and mortality. Aim: The main aim was to investigate where patients with co-occurring physical diseases and mental disorders (psychotic spectrum or mood) in the health and social service system are identified most frequently before admission into psychiatry. The second aim was to compare the differences in the treatment routes taken by the patients before entry into psychiatric services in all the participating countries (Denmark, Germany, Japan, Nigeria and Switzerland). Methodology: On admission to a psychiatric service, patients diagnosed with schizophrenia, schizotypal or delusional disorders (International Classification of Diseases-10 (ICD-10) group F2) or mood (affective) disorders (ICD-10 group F3) and a co-morbid physical condition (cardiovascular disease, diabetes mellitus and overweight) were asked with which institutions or persons they had been in contact with in the previous 6months. Results: Patients from Denmark, Germany and Switzerland with mental disorders had almost the same contact pattern. Their primary contact was to public or private psychiatry, with a contact percentage of 46%-91%; in addition, general practice was a common contact, with a margin of 41%-93%. Similar tendencies are seen in Japan despite the small sample size. With regard to general practice, this is also the case with Nigerian patients. However, religious guidance or healing was rarely sought by patients in Europe and Japan, while in Nigeria about 80% of patients with mental disorders had contacted this type of service. Conclusion: Promoting prophylactic work between psychiatry and the general practice sector may be beneficial in diminishing physical conditions such as cardiovascular disease, diabetes mellitus and overweight in patients with mental disorders in European countries and Japan. In Nigeria (a low-to-middle-income country), religious guides or healers, along with general practitioners, are the most frequently contacted, and they therefore seem to be the most obvious partner to collaborate with.	[Toftegaard, Kristian L.; Gustafsson, Lea Norgreen; Munk-Jorgensen, Povl] Aarhus Univ Hosp, Dept Organ Psychiat Disorder & Emergency Ward, DK-8240 Risskov, Denmark; [Uwakwe, Richard] Nnamdi Azikiwe Univ, Fac Med, Nnewi, Nigeria; [Andersen, Ulla A.] Odense Univ Hosp, DK-5000 Odense, Denmark; [Becker, Thomas; Frasch, Karel; Kilian, Reinhold] Univ Ulm, BKH Gunzburg, Dept Psychiat 2, D-89069 Ulm, Germany; [Bickel, Graziella Giacometti] Cantonal Hosp, Marsens Fribourg, Switzerland; [Bork, Bernhard] Hosp Psychiat, Augustenborg Tonder, Denmark; [Cordes, Joachim] Univ Dusseldorf, Fac Med, Dept Psychiat & Psychotherapy, Dusseldorf, Germany; [Jacobsen, Bent Ascanius] Aalborg Univ Hosp, Aalborg Hosp, Aalborg, Denmark; [Larsen, Jens Ivar] Aalborg Univ Hosp, Aalborg Psychiat Hosp, Aalborg, Denmark; [Lauber, Christoph] Jura Bernois Bienne Seeland, Serv Psychiat, Biel, Switzerland; [Mogensen, Birthe] Psychiat Hosp Slagelse, Slagelse, Denmark; [Roessler, Wulf] Psychiat Univ Hosp, Zurich, Switzerland; [Tsuchiya, Kenji J.] Hamamatsu Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka, Japan	Munk-Jorgensen, P (reprint author), Aarhus Univ Hosp, Dept Organ Psychiat Disorder & Emergency Ward, Skovagervej 2, DK-8240 Risskov, Denmark.	povlmunk@rm.dk			Eli Lilly	Eli Lilly supported the first planning meeting held in Aalborg, Denmark.	ABIODUN OA, 1995, PSYCHIATR SERV, V46, P823; Agyapong V. I., 2012, INT J FAMILY MED, V2012, DOI 10.1155/2012/575381; Kilian R, 2006, ACTA PSYCHIAT SCAND, V114, P242, DOI 10.1111/j.1600-0447.2006.00850.x; GATER R, 1991, PSYCHOL MED, V21, P761; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; Stapelberg NJC, 2011, AUST NZ J PSYCHIAT, V45, P351, DOI 10.3109/00048674.2011.570427; Lincoln C, 1998, BRIT J PSYCHIAT, V172, P21; Berk M, 2013, ACTA PSYCHIAT SCAND, V127, P38, DOI 10.1111/acps.12124; Stowkowy J, 2013, EARLY INTERV PSYCHIA, V7, P80, DOI 10.1111/j.1751-7893.2012.00368.x; Razali SM, 2000, INT J SOC PSYCHIATR, V46, P281, DOI 10.1177/002076400004600405; Temmingh HS, 2008, SOC PSYCH PSYCH EPID, V43, P727, DOI 10.1007/s00127-008-0358-5; Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Malla AK, 2002, ACTA PSYCHIAT SCAND, V105, P431, DOI 10.1034/j.1600-0447.2002.02139.x; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; GATER R, 1991, BRIT J PSYCHIAT, V159, P90, DOI 10.1192/bjp.159.1.90; Platz C, 2006, SOC PSYCH PSYCH EPID, V41, P967, DOI 10.1007/s00127-006-0117-4; Fuchs J, 2004, SOC PSYCH PSYCH EPID, V39, P375, DOI 10.1007/s00127-004-0767-z; Dipasquale S, 2013, J PSYCHIATR RES, V47, P197, DOI 10.1016/j.jpsychires.2012.10.005; Mazzoncini R, 2010, ACTA PSYCHIAT SCAND, V121, P351, DOI 10.1111/j.1600-0447.2009.01483.x; Castagnini A, 2013, ACTA PSYCHIAT SCAND, V128, P370, DOI 10.1111/acps.12077; Burnett R, 1999, PSYCHOL MED, V29, P475, DOI 10.1017/S0033291798008125; Burns JK, 2011, INT J SOC PSYCHIATR, V57, P538, DOI 10.1177/0020764010390199; Steel Z, 2006, AUST NZ J PSYCHIAT, V40, P347, DOI 10.1080/j.1440-1614.2006.01801.x; Fridgen GJ, 2013, SOC PSYCH PSYCH EPID, V48, P1033, DOI 10.1007/s00127-012-0628-0; Simpson JC, 1996, SCHIZOPHRENIA BULL, V22, P485; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Chadda RK, 2001, INT J SOC PSYCHIATR, V47, P71, DOI 10.1177/002076400104700406; Chong SA, 2005, INT J SOC PSYCHIATR, V51, P55, DOI 10.1177/0020764005053278; Frasch K., 2012, INT J SOC PSYCHIAT, V59, P757; Goldberg D., 2005, ORIGINS COURSE COMMO; Harangozo J, 2013, INT J SOC PSYCHIAT, V60, P359; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Jack-Ide Izibeloko Omi, 2013, Pan Afr Med J, V14, P159, DOI 10.11604/pamj.2013.14.159.1970; Janszky I, 2007, BIOL PSYCHIAT, V62, P25, DOI 10.1016/j.biopsych.2006.08.039; Larsen JI, 2013, AUST NZ J PSYCHIAT, V47, P250, DOI 10.1177/0004867412463614; Malla AK, 2004, J NERV MENT DIS, V192, P455, DOI 10.1097/01.nmd.0000131804.34977.c1; Odejide Olabisi, 2003, World Psychiatry, V2, P164; POGUEGEILE MF, 1985, SCHIZOPHRENIA BULL, V11, P427; Smith DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002808; Temilola M. J., 2013, INT J SOC PSYCHIAT, V60, P377, DOI [10.1177/0020764013491738, DOI 10.1177/0020764013491738]; Truyers C, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-132; World Health Organization, 1992, ICD 10 CLASS MENT BE	45	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0020-7640	1741-2854		INT J SOC PSYCHIATR	Int. J. Soc. Psychiatr.	AUG	2015	61	5					456	464		10.1177/0020764014552866		9	Psychiatry	Psychiatry	CN6LH	WOS:000358545800005		
J	Zhang, Y; Hashimoto, S; Fujii, C; Hida, S; Ito, K; Matsumura, T; Sakaizawa, T; Morikawa, M; Masuki, S; Nose, H; Higuchi, K; Nakajima, K; Taniguchi, S				Zhang, Y.; Hashimoto, S.; Fujii, C.; Hida, S.; Ito, K.; Matsumura, T.; Sakaizawa, T.; Morikawa, M.; Masuki, S.; Nose, H.; Higuchi, K.; Nakajima, K.; Taniguchi, S.			NFB2 Gene as a Novel Candidate that Epigenetically Responds to Interval Walking Training	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						interval walking training (IWT); methylation; genome-wide methylation assay; NFB; inflammation; aging	STYLE-RELATED DISEASES; PHYSICAL-FITNESS; SKELETAL-MUSCLE; KAPPA-B; EXERCISE; METHYLATION; PROTEIN; EXPRESSION; CELLS; ASC	Physical fitness has been reported to decrease the risk of lifestyle-related diseases. The present study evaluated genome-wide methylation under the hypothesis that interval walking training (IWT) imparted beneficial effects on health, particularly by epigenetically ameliorating susceptibility to inflammation. We screened DNA from peripheral blood samples via genome-wide microarray for genes whose methylation was affected by IWT, paying special attention to promoter regions, and identified over 40 hyper- or hypo-methylated genes following IWT that were not witnessed in controls. We next selected genes in which the degree of methylation change in the promoter region was correlated with energy consumption following IWT. In this way, we found the NFB2 gene to have increased methylation in multiple regions of its promoter sequence following participation in an exercise regimen. Next, IWT-induced NFB2 hyper-methylation was confirmed by a quantitative PyroSequencing assessment of methylation in samples obtained from independent subjects who also underwent IWT. The increase in NFB2 gene promoter methylation by IWT indicates that this regimen may suppress pro-inflammatory cytokines. Thus, these results provide an additional line of evidence that IWT is advantageous in promoting health from an epigenetic perspective by ameliorating susceptibility to inflammation.	[Zhang, Y.; Hashimoto, S.; Fujii, C.; Hida, S.; Ito, K.; Matsumura, T.; Sakaizawa, T.; Taniguchi, S.] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Inst Pathogenesis & Dis Prevent, Matsumoto, Nagano 3908621, Japan; [Fujii, C.; Hida, S.; Morikawa, M.; Masuki, S.; Nose, H.; Taniguchi, S.] Shinshu Univ Interdisciplinary Cluster Cutting Ed, Dept Adv Med Hlth Promot, Inst Biomed Sci, Matsumoto, Nagano, Japan; [Morikawa, M.; Masuki, S.; Nose, H.] Shinshu Univ, Grad Sch Med, Dept Sports Med Sci, Inst Pathogenesis & Dis Prevent, Matsumoto, Nagano 3908621, Japan; [Higuchi, K.] Shinshu Univ, Grad Sch Med, Dept Aging Biol, Inst Pathogenesis & Dis Prevent, Matsumoto, Nagano 3908621, Japan; [Nakajima, K.] Matsumoto Univ, Dept Sports & Hlth Sci, Fac Human Hlth Sci, Matsumoto, Nagano, Japan	Taniguchi, S (reprint author), Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Inst Pathogenesis & Dis Prevent, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	stangch@shinshu-u.ac.jp			Japan Society for the Promotion of Science [2535088401]; Ministry of Health, Labor, and Welfare; Ministry of Economy, Trade, and Industry of Japan; Shinshu University	This study was supported in part by grants from the Japan Society for the Promotion of Science (2535088401), the Ministry of Health, Labor, and Welfare (Comprehensive Research on Aging and Health), and the Ministry of Economy, Trade, and Industry of Japan. This research was also supported in part by the Shinshu University Partnership Project between Shinshu University, Jukunen Taiikudaigaku Research Center, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Matsumoto City. We thank Drs. A. Sakurai and T. Kosho of the Shinshu University Gene Research Consortium for their support.	Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Patel S, 2012, CIRCULATION, V126, P1385, DOI 10.1161/CIRCULATIONAHA.112.105452; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; Nemoto K, 2007, MAYO CLIN PROC, V82, P803; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Nakajima K, 2010, INT J SPORTS MED, V31, P671, DOI 10.1055/s-0029-1246140; Lira FS, 2009, CELL BIOCHEM FUNCT, V27, P458, DOI 10.1002/cbf.1594; Morikawa M, 2011, BRIT J SPORT MED, V45, P216, DOI 10.1136/bjsm.2009.064816; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Harriss DJ, 2011, INT J SPORTS MED, V32, P819, DOI 10.1055/s-0031-1287829; Kaarniranta K, 2009, EXP GERONTOL, V44, P685, DOI 10.1016/j.exger.2009.09.002; Blumental-Perry A, 2012, CURR MOL MED, V12, P883; Bocklandt S, 2011, PLOS ONE, V6, P14821; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Hollyfield G J, 2010, INVEST OPHTH VIS SCI, V51, P1276; Masuki S, 2011, HYPERTENSION, V55, P747; Mori M, 2009, J PHYSIOL-LONDON, V587, P5577, DOI 10.1113/jphysiol.2009.179283; Yamazaki T, 2009, MED SCI SPORT EXER, V41, P2213, DOI 10.1249/MSS.0b013e3181a9c452	28	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2015	36	9					769	775		10.1055/s-0035-1547221		7	Sport Sciences	Sport Sciences	CN8DO	WOS:000358668300012		
J	Toyoda, K; Arihiro, S; Todo, K; Yamagami, H; Kimura, K; Furui, E; Terasaki, T; Shiokawa, Y; Kamiyama, K; Takizawa, S; Okuda, S; Okada, Y; Kameda, T; Nagakane, Y; Hasegawa, Y; Mochizuki, H; Ito, Y; Nakashima, T; Takamatsu, K; Nishiyama, K; Kario, K; Sato, S; Koga, M				Toyoda, Kazunori; Arihiro, Shoji; Todo, Kenichi; Yamagami, Hiroshi; Kimura, Kazumi; Furui, Eisuke; Terasaki, Tadashi; Shiokawa, Yoshiaki; Kamiyama, Kenji; Takizawa, Shunya; Okuda, Satoshi; Okada, Yasushi; Kameda, Tomoaki; Nagakane, Yoshinari; Hasegawa, Yasuhiro; Mochizuki, Hiroshi; Ito, Yasuhiro; Nakashima, Takahiro; Takamatsu, Kazuhiro; Nishiyama, Kazutoshi; Kario, Kazuomi; Sato, Shoichiro; Koga, Masatoshi		SAMURAI Study Investigators	Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI-NVAF Study	INTERNATIONAL JOURNAL OF STROKE			English	Article						acute stroke care; anticoagulation; atrial fibrillation; embolism; prevention	TRANSIENT ISCHEMIC ATTACK; PREDICTING STROKE; SUBGROUP ANALYSIS; WARFARIN; DABIGATRAN; ASSOCIATION; PREVENTION; GUIDELINES; APIXABAN; TRIAL	BackgroundLarge clinical trials are lack of data on non-vitamin K antagonist oral anticoagulants for acute stroke patients. AimTo evaluate the choice of oral anticoagulants at acute hospital discharge in stroke patients with nonvalvular atrial fibrillation and clarify the underlying characteristics potentially affecting that choice using the multicenter Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-NVAF registry (ClinicalTrials.gov NCT01581502). MethodThe study included 1192 acute ischemic stroke/transient ischemic attack patients with nonvalvular atrial fibrillation (527 women, 77799 years old) between September 2011 and March 2014, during which three nonvitamin K antagonist oral anticoagulant oral anticoagulants were approved for clinical use. Oral anticoagulant choice at hospital discharge (median 23-day stay) was assessed. ResultsWarfarin was chosen for 650 patients, dabigatran for 203, rivaroxaban for 238, and apixaban for 25. Over the three 10-month observation periods, patients taking warfarin gradually decreased to 465% and those taking nonvitamin K antagonist oral anticoagulants increased to 480%. As compared with warfarin users, patients taking nonvitamin K antagonist oral anticoagulants included more men, were younger, more frequently had small infarcts, and had lower scores for poststroke CHADS(2), CHA(2)DS(2)-VASc, and HAS-BLED, admission National Institutes of Health stroke scale, and discharge modified Rankin Scale. Nonvitamin K antagonist oral anticoagulants were started at a median of four-days after stroke onset without early intracranial hemorrhage. Patients starting nonvitamin K antagonist oral anticoagulants earlier had smaller infarcts and lower scores for the admission National Institutes of Health stroke scale and the discharge modified Rankin Scale than those starting later. Choice of nonvitamin K antagonist oral anticoagulants was independently associated with 20-day or shorter hospitalization (OR 246, 95% CI 187-324). ConclusionsWarfarin use at acute hospital discharge was still common in the initial years after approval of nonvitamin K antagonist oral anticoagulants, although nonvitamin K antagonist oral anticoagulant users increased gradually. The index stroke was milder and ischemia-risk indices were lower in nonvitamin K antagonist oral anticoagulant users than in warfarin users. Early initiation of nonvitamin K antagonist oral anticoagulants seemed safe.	[Toyoda, Kazunori; Arihiro, Shoji; Sato, Shoichiro; Koga, Masatoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Todo, Kenichi] Kobe City Med Ctr Gen Hosp, Dept Neurol, Kobe, Hyogo, Japan; [Yamagami, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan; [Kimura, Kazumi] Kawasaki Med Univ, Dept Stroke Med, Kurashiki, Okayama, Japan; [Furui, Eisuke] Kohnan Hosp, Dept Stroke Neurol, Sendai, Miyagi, Japan; [Terasaki, Tadashi] Japanese Red Cross Kumamoto Hosp, Dept Neurol, Kumamoto, Kumamoto, Japan; [Shiokawa, Yoshiaki] Kyorin Univ Sch Med, Dept Neurosurg & Stroke Ctr, Mitaka, Tokyo, Japan; [Kamiyama, Kenji] Nakamura Mem Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Takizawa, Shunya] Tokai Univ Sch Med, Dept Neurol, Isehara, Kanagawa, Japan; [Okuda, Satoshi] NHO Nagoya Med Ctr, Dept Neurol, Nagoya, Aichi, Japan; [Okada, Yasushi] NHO Kyushu Med Ctr, Dept Neurol & Cerebrovasc Med, Fukuoka, Fukuoka, Japan; [Kameda, Tomoaki] Jichi Med Univ Sch Med, Div Neurol, Shimotsuke, Tochigi, Japan; [Nagakane, Yoshinari] Kyoto Second Red Cross Hosp, Dept Neurol, Kyoto, Honshu, Japan; [Hasegawa, Yasuhiro] St Marianna Univ Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan; [Mochizuki, Hiroshi] South Miyagi Med Ctr, Dept Neurol, Ogawara, Miyagi, Japan; [Ito, Yasuhiro] TOYOTA Mem Hosp, Dept Neurol, Toyota, Aichi, Japan; [Nakashima, Takahiro] NHO Kagoshima Med Ctr, Dept Cerebrovasc Med, Kagoshima, Kagoshima, Japan; [Takamatsu, Kazuhiro] Brain Attack Ctr Ota Mem Hosp, Dept Neurol, Fukuyama, Hiroshima, Japan; [Nishiyama, Kazutoshi] Kitasato Univ Sch Med, Dept Neurol, Sagamihara, Kanagawa, Japan; [Kario, Kazuomi] Jichi Med Univ Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan	Toyoda, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	toyoda@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015; Kobayashi, Junjiro/J-8547-2015	Toyoda, Kazunori/0000-0002-8346-9845; 	Ministry of Health, Labour and Welfare, Japan [H23-Junkanki-Ippan-010]; Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center [H23-4-3]	This study was supported in part by a Grant-in-Aid (H23-Junkanki-Ippan-010) from the Ministry of Health, Labour and Welfare, Japan, and an Intramural Research Fund (H23-4-3) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Shibazaki K, 2013, J NEUROL SCI, V331, P90, DOI 10.1016/j.jns.2013.05.016; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Husted S, 2014, THROMB HAEMOSTASIS, V111, P781, DOI 10.1160/TH14-03-0228; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Okata T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113641	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	AUG	2015	10	6					836	842		10.1111/ijs.12452		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CN5EB	WOS:000358451500020		
J	Iwata, K; Doi, A; Nakamura, T; Yoshida, H				Iwata, K.; Doi, A.; Nakamura, T.; Yoshida, H.			The validity of three sputum smears taken in one day for discontinuing isolation of tuberculosis patients	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						pulmonary tuberculosis; respiratory isolation; sputum smear		We conducted a retrospective comparative study of acid-fast bacilli (AFB) smear sensitivity according to time of specimen collection to assess whether three consecutive AFB smears collected in 1 day are useful when deciding to discontinue respiratory isolation of patients with pulmonary tuberculosis (TB). A total of 236 sputum specimens from 119 patients with pulmonary TB were used for the analysis. There was no statistical difference in AFB smear sensitivity of early-morning sputum and those collected later (P = 0.186). This may allow us to collect all specimens in a single day and discontinue respiratory isolation of TB patients earlier.	[Iwata, K.] Kobe Univ Hosp, Div Infect Dis, Kobe, Hyogo 6500017, Japan; [Doi, A.] Kobe City Med Ctr Gen Hosp, Div Infect Dis, Kobe, Hyogo, Japan; [Nakamura, T.] Kobe Univ Hosp, Dept Lab Med, Kobe, Hyogo 6500017, Japan; [Yoshida, H.] Kobe Univ Hosp, Dept Infect Control, Kobe, Hyogo 6500017, Japan	Iwata, K (reprint author), Kobe Univ Hosp, Div Infect Dis, Chuo Ku, 7-5-2 Kusunokicho, Kobe, Hyogo 6500017, Japan.	kiwata@med.kobe-u.ac.jp					ANDREWS R H, 1959, Tubercle, V40, P155, DOI 10.1016/S0041-3879(59)80034-9; Mathew P, 2002, J CLIN MICROBIOL, V40, P3482, DOI 10.1128/JCM.40.9.3482-3484.2002; Centers for Disease Control and Prevention, 2005, GUID PREV TRANSM MYC; Centers for Disease Control and Prevention, 1994, GUID PREV TRANSM MYC; Charles S, 2006, INFECT CONT HOSP EP, V27, P515; Iseman M D, 2000, CLIN GUIDE TUBERCULO; Van Deun A, 2002, INT J TUBERC LUNG D, V6, P222	7	0	0	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	AUG	2015	19	8					918	920		10.5588/ijtld.15.0159		3	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	CN6OC	WOS:000358553100010		
J	Kawatsu, L; Uchimura, K; Kobayashi, M; Ishikawa, N				Kawatsu, L.; Uchimura, K.; Kobayashi, M.; Ishikawa, N.			Overview of the tuberculosis burden in prison institutions in Japan, 2000-2012	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						TB; prisons; risk factors		BACKGROUND: Although prison inmates in Japan are considered a high-risk group for tuberculosis (TB), little is known about the overall TB burden in prisons. OBJECTIVE: To estimate the incidence and epidemiological characteristics of TB among inmates in Japan, and to perform an ecological analysis to identify an association between socio-economic factors and TB incidence in prisons. METHOD: Using the annual reports on correctional statistics, we calculated TB incidence among inmates between 2000 and 2012. Multivariate analysis was conducted with selected socio-economic variables to examine their impact on overall and age-specific incidence. RESULTS: The average TB incidence between 2000 and 2012 among inmates was 255.0 per 100 000 population. The proportion of foreigners among new inmates was the best predictor of overall TB incidence, as well as of incidence among inmates aged 20-29 and 30-39 years. The proportion of those working in the construction industry before being arrested was the best predictor of incidence among those aged 40-49 and 50-59 years. CONCLUSION: TB incidence among inmates was approximately 11 times higher than in the general population. A more detailed analysis of patient information is needed to identify specific risk groups within the incarcerated population and improve case finding.	[Kawatsu, L.; Uchimura, K.] Japan AntiTB Assoc, Res Inst TB, Dept Epidemiol & Clin Res, Kiyose, Tokyo 2048533, Japan; [Kobayashi, M.] Tama Juvenile Training Sch, Tokyo, Japan; [Ishikawa, N.] RIT JATA, Off Director, Tokyo, Japan	Kawatsu, L (reprint author), Japan AntiTB Assoc, Res Inst TB, Dept Epidemiol & Clin Res, 3-1-24 Matsuyama, Kiyose, Tokyo 2048533, Japan.	kawatsu@jata.or.jp			Ministry of Health Labour and Welfare (Tokyo, Japan)	Funding for the study was received from the Ministry of Health Labour and Welfare (Tokyo, Japan) Grant-in-Aid for Scientific Research.	Ferreira MMC, 1996, J ACQ IMMUN DEF SYND, V13, P177; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1; Centers for Disease Control and Prevention, 1999, MMWR-MORBID MORTAL W, V48, P1; EVANS R, 1977, J ASIAN STUD, V36, P477, DOI 10.2307/2054095; Fry RS, 2005, INT J TUBERC LUNG D, V9, P1027; Hanau-Bercot B, 2000, INT J TUBERC LUNG D, V4, P853; Igari Hidetoshi, 2009, Kekkaku, V84, P701; Kimura Tomoko, 2002, Kekkaku, V77, P597; Koda Y, 2001, J CORRECTIONAL MED, V50, P10; Koffi N, 1997, INT J TUBERC LUNG D, V1, P250; Marco A, 1998, EUR RESPIR J, V12, P967, DOI 10.1183/09031936.98.12040967; Ministry of Justice, 2012, WHIT PAP ON CRIM; Ministry of Justice, 2000, ANN REP CORR STAT; Nakanishi Y, JPN J PUBLIC HLTH, V44, P769; Nishimori Y, 1997, J CORRECTIONAL MED, V4, P64; Ohtake F, 2010, DO2010J007 OSIPP; Pleumpanupat W, 2003, INT J TUBERC LUNG D, V7, P472; Tsushima M., 2010, JPN J SOCIOL CRIMINO, V35, P8; Tsushima M., 1996, J SOCIOECONOMICS, V25, P497, DOI 10.1016/S1053-5357(96)90041-4; Wong M Y, 2000, INT J TUBERC LUNG D, V12, P93; World Health Organization, 2014, PRIS AND HLTH, P56	22	0	0	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	AUG	2015	19	8					921	926		10.5588/ijtld.14.0692		6	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	CN6OC	WOS:000358553100011		
J	Miyajima, A; Kosaka, T; Kikuchi, E; Oya, M				Miyajima, Akira; Kosaka, Takeo; Kikuchi, Eiji; Oya, Mototsugu			Renin-angiotensin system blockade: Its contribution and controversy	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						angiogenesis; angiotensin II; carcinogenesis; fibrosis; inflammation	II TYPE-1 RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; BREAST-CANCER CELLS; CONVERTING-ENZYME-INHIBITOR; PANCREATIC DUCTAL ADENOCARCINOMA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; UNILATERAL URETERAL OBSTRUCTION; URINARY-TRACT SYMPTOMS; SMOOTH-MUSCLE-CELLS	AngiotensinII is a key biological peptide in the renin-angiotensin system that regulates blood pressure and renal hemodynamics, and extensive experimental studies have shown that angiotensinII promotes diverse fibrotic changes and induces neovascularization in several inflammatory diseases. It is known that angiotensinII can be controlled using renin-angiotensin system blockade when angiotensinII is the main factor inducing a particular disease, and renin-angiotensin system blockade has assumed a central role in the treatment of inflammatory nephritis, cardiovascular disorders and retinopathy. In contrast, renin-angiotensin system blockade was found to have not only these effects but also other functions, such as inhibition of cancer growth, angiogenesis and metastasis. Numerous studies have sought to elucidate the mechanisms and support these antitumor effects. However, a recent meta-analysis showed that renin-angiotensin system blockade use might in fact increase the incidence of cancer, so renin-angiotensin system blockade use has become somewhat controversial. Although the renin-angiotensin system has most certainly made great contributions to experimental models and clinical practice, some issues still need to be resolved. The present review discusses the contribution and controversy surrounding the renin-angiotensin system up to the present time.	[Miyajima, Akira; Kosaka, Takeo; Kikuchi, Eiji; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo 1608582, Japan	Miyajima, A (reprint author), Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	akiram@keio.jp					Alhusban A, 2014, J PHARMACOL EXP THER, V350, P635, DOI 10.1124/jpet.114.216382; Amer H, 2014, KIDNEY INT, V85, P240, DOI 10.1038/ki.2013.400; Anandanadesan R, 2008, J GASTROINTEST SURG, V12, P57, DOI 10.1007/s11605-007-0403-9; Lu GC, 2009, STROKE, V40, P3876, DOI 10.1161/STROKEAHA.109.559989; Inigo SD, 2009, LEUKEMIA RES, V33, P810, DOI 10.1016/j.leukres.2008.09.029; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Shimizu S, 2014, INT J UROL, V21, P856, DOI 10.1111/iju.12501; Tanaka N, 2011, BRIT J CANCER, V105, P1331, DOI 10.1038/bjc.2011.399; Fujita M, 2005, CARCINOGENESIS, V26, P271, DOI 10.1093/carcin/bgh324; Borre M, 1998, BRIT J CANCER, V78, P940, DOI 10.1038/bjc.1998.605; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Comiter C, 2012, BJU INT, V109, P1841, DOI 10.1111/j.1464-410X.2011.10580.x; Pupilli C, 1999, J AM SOC NEPHROL, V10, P245; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; De Paepe B, 2001, HISTOCHEM CELL BIOL, V116, P247; Phull H, 2007, NEUROUROL URODYNAM, V26, P81, DOI 10.1002/nau.20339; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Peters H, 1998, KIDNEY INT, V54, P1570, DOI 10.1046/j.1523-1755.1998.00164.x; Suganuma T, 2005, CLIN CANCER RES, V11, P2686, DOI 10.1158/1078-0432.CCR-04-1946; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; ISHIDOYA S, 1995, KIDNEY INT, V47, P1285, DOI 10.1038/ki.1995.183; Papp M, 2002, AM J PHYSIOL-LUNG C, V282, pL713, DOI 10.1152/ajplung.00103.2001; Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.000007577.18006.89; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Miyajima A, 2002, CANCER RES, V62, P4176; [Anonymous], 2011, UROLOGY; Ronquist G, 2004, PROSTATE, V58, P50, DOI 10.1002/pros.10294; Tatokoro M, 2011, CANCER SCI, V102, P137, DOI 10.1111/j.1349-7006.2010.01756.x; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Itabashi H, 2008, HEPATOL RES, V38, P601, DOI 10.1111/j.1872-034X.2007.00304.x; Arrieta O, 2005, BRIT J CANCER, V92, P1247, DOI 10.1038/sj.bjc.6602483; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; GOLDFARB DA, 1994, J UROLOGY, V151, P208; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Nakai Y, 2010, BRIT J CANCER, V103, P1644, DOI 10.1038/sj.bjc.6605955; Ruiz-Ortega M, 2000, CIRC RES, V86, P1266; Kosaka T, 2010, PROSTATE, V70, P162, DOI 10.1002/pros.21049; Bettencourt MC, 1998, J UROLOGY, V160, P459, DOI 10.1016/S0022-5347(01)62925-2; Fujimoto Y, 2001, FEBS LETT, V495, P197, DOI 10.1016/S0014-5793(01)02377-8; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Uemura H, 2003, MOL CANCER THER, V2, P1139; Kosaka T, 2007, PROSTATE, V67, P41, DOI 10.1002/pros.20486; Huang F, 2008, J LIPID RES, V49, P521, DOI 10.1194/jlr.M700329-JLR200; Keizman D, 2011, EUR J CANCER, V47, P1955, DOI 10.1016/j.ejca.2011.04.019; Amaya K, 2004, INT J ONCOL, V25, P849; Muscella A, 2003, J CELL PHYSIOL, V197, P61, DOI 10.1002/jcp.10336; Ito H, 2013, NEUROUROL URODYNAM, V32, P70, DOI 10.1002/nau.22267; Zhao YB, 2010, J CELL PHYSIOL, V225, P168, DOI 10.1002/jcp.22209; Yoshiji H, 2009, J HEPATOL, V51, P315, DOI 10.1016/j.jhep.2009.04.011; Yuge K, 2012, ANN SURG ONCOL, V19, P3987, DOI 10.1245/s10434-012-2568-z; Dayyani F, 2011, J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Wilop S, 2009, J CANCER RES CLIN, V135, P1429, DOI 10.1007/s00432-009-0587-3; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Catapano F, 2008, AM J KIDNEY DIS, V52, P475, DOI 10.1053/j.ajkd.2008.03.008; Herr D, 2008, GYNECOL ONCOL, V109, P418, DOI 10.1016/j.ygyno.2008.02.019; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Brennan MF, 2007, J AM COLL SURGEONS, V204, P1005; Arafat HA, 2007, J AM COLL SURGEONS, V204, P996, DOI 10.1016/j.jamcollsurg.2007.01.067; Araujo WF, 2015, UROL ONCOL; Border WA, 1998, KIDNEY INT, V54, P1390, DOI 10.1046/j.1523-1755.1998.00127.x; Carl-McGrath S, 2007, CANCER BIOL THER, V6, P1218; Cavalera M, 2014, TRANSL RES, V164, P323, DOI 10.1016/j.trsl.2014.05.001; Chehl N, 2009, J GASTROINTEST SURG, V13, P2189, DOI 10.1007/s11605-009-1055-8; Chin HJ, 2011, J KOREAN MED SCI, V26, P59, DOI 10.3346/jkms.2011.26.1.59; Chisi JE, 2000, BRIT J HAEMATOL, V109, P563, DOI 10.1046/j.1365-2141.2000.02073.x; Cho ST, 2012, UROLOGY, V80, pe1; Christian JB, 2008, J NATL CANCER I, V100, P1223, DOI 10.1093/jnci/djn262; Chua CC, 1998, BBA-MOL CELL RES, V1401, P187, DOI 10.1016/S0167-4889(97)00129-8; Del Vecchio L, 2007, NAT CLIN PRACT NEPHR, V3, P42, DOI 10.1038/ncpneph0362; desBono JS, 2010, LANCET, V376, P1147; desBono JS, 2011, NEW ENGL J MED, V364, P1995; Dolley-Hitze T, 2010, BRIT J CANCER, V103, P1698, DOI 10.1038/sj.bjc.6605866; Fryzek JP, 2006, BREAST CANCER RES TR, V97, P231, DOI 10.1007/s10549-005-9091-x; Geara Abdallah S, 2009, Transplant Rev (Orlando), V23, P151, DOI 10.1016/j.trre.2009.04.002; Greco S, 2003, J CELL PHYSIOL, V196, P370, DOI 10.1002/jcp.10313; Hii SI, 1998, BRIT J CANCER, V77, P880, DOI 10.1038/bjc.1998.145; Hunyady L, 1999, J AM SOC NEPHROL, V10, pS47; Ibrahim HN, 2013, J AM SOC NEPHROL, V24, P320, DOI 10.1681/ASN.2012080777; Inwang ER, 1997, BRIT J CANCER, V75, P1279, DOI 10.1038/bjc.1997.217; Isobe A, 2008, HUM REPROD, V23, P440, DOI 10.1093/humrep/dem247; Josefsson A, 2005, EUR UROL, V48, P577, DOI 10.1016/j.eururo.2005.05.016; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kosaka T, 2013, BRIT J CANCER, V108, P2123, DOI 10.1038/bjc.2013.169; Kosugi M, 2006, CLIN CANCER RES, V12, P2888, DOI 10.1158/1078-0432.CCR-05-2213; Kosugi M, 2009, UROLOGY, V73, P655, DOI 10.1016/j.urology.2008.10.031; Krupski T, 2000, UROLOGY, V55, P743, DOI 10.1016/S0090-4295(99)00598-1; LesNoble FA, 1991, EUR J PHARMACOL, V195, P305; Li XP, 2003, AM J PATHOL, V163, P2523, DOI 10.1016/S0002-9440(10)63607-3; Link WT, 2014, REGUL TOXICOL PHARM, V70, P555, DOI 10.1016/j.yrtph.2014.09.002; MAGGI M, 1995, REGUL PEPTIDES, V56, P175, DOI 10.1016/0167-0115(95)00016-5; Matsuyama M, 2010, EXP THER MED, V1, P301, DOI 10.3892/etm_00000046; Miyajima A, 2015, ANN SURG ONCOL, DOI [10.1245/s10434-015-4436-0, DOI 10.1245/S10434-015-4436-0]; Muscella A, 2002, J ENDOCRINOL, V173, P315, DOI 10.1677/joe.0.1730315; Neo JH, 2007, J GASTROEN HEPATOL, V22, P577, DOI 10.1111/j.1440-1746.2006.04797.x; Ohtake T, 2008, HYPERTENS RES, V31, P387, DOI 10.1291/hypres.31.387; Perron L, 2004, CANCER CAUSE CONTROL, V15, P535, DOI 10.1023/B:CACO.0000036152.58271.5e; Ramos ACS, 2013, LIFE SCI, V93, P820, DOI 10.1016/j.lfs.2013.09.008; Ramos ACS, 2014, EUR J PHARMACOL, V738, P285, DOI 10.1016/j.ejphar.2014.05.038; Ronquist G, 2009, SCAND J UROL NEPHROL, V43, P32, DOI 10.1080/00365590802468875; Shirotake S, 2012, AM J PATHOL, V180, P1008, DOI 10.1016/j.ajpath.2011.11.027; Sitzmann JV, 1994, ANN SURG, V219, P6; SITZMANN JV, 1994, ANN SURG, V219, P500, DOI 10.1097/00000658-199405000-00008; Takahashi T, 1999, AM J PHYSIOL-HEART C, V276, pH1927; Tanaka N, 2012, BRIT J CANCER, V106, P290, DOI 10.1038/bjc.2011.565; Tanaka N, 2010, MOL CANCER THER, V9, P2982, DOI 10.1158/1535-7163.MCT-10-0535; Teranishi J, 2008, PROSTATE, V68, P1666, DOI 10.1002/pros.20835; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Tylicki L, 2002, J RENAL NUTR, V12, P122, DOI 10.1053/jren.2002.31764; Uemura Hiroji, 2005, Int J Clin Oncol, V10, P405, DOI 10.1007/s10147-005-0520-y; Watanabe Y, 2003, CLIN CANCER RES, V9, P6497; Wysocki PJ, 2006, CLIN CANCER RES, V12, P4095, DOI 10.1158/1078-0432.CCR-05-2489; Yasumatsu R, 2004, J CANCER RES CLIN, V130, P567, DOI 10.1007/s00432-004-0582-7; Zhang JD, 2011, AM J PHYSIOL-RENAL, V301, pF723, DOI 10.1152/ajprenal.00271.2011; Zhao YB, 2008, ACTA BIOCH BIOPH SIN, V40, P304, DOI 10.1111/j.1745-7270.2008.00402.x	118	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					721	730		10.1111/iju.12827		10	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800002		
J	Hongo, F; Kawauchi, A; Ueda, T; Fujihara-Iwata, A; Nakamura, T; Naya, Y; Kamoi, K; Okihara, K; Miki, T				Hongo, Fumiya; Kawauchi, Akihiro; Ueda, Takashi; Fujihara-Iwata, Atsuko; Nakamura, Terukazu; Naya, Yoshio; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu			Laparoscopic off-clamp partial nephrectomy using soft coagulation	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						laparoscopy; off-clamp; partial nephrectomy; renal cell cancer; soft coagulation	RENAL-CELL CARCINOMA; NEPHRON-SPARING SURGERY; COMPLICATIONS; GUIDELINES; COHORT; TUMORS	ObjectivesTo assess the effectiveness of soft coagulation in off-clamp laparoscopic partial nephrectomy. MethodsA total of 32 patients with renal tumors underwent laparoscopic partial nephrectomy with off-clamp using soft coagulation between May 2012 and September 2013. Tumor resection was carried out using a combination of bipolar forceps and a ball electrode using the soft coagulation system without hilar clamping. The outcomes of these patients were compared with those of 30 patients treated with hilar clamping. ResultsThis off-clamp procedure was successfully completed in 31 cases. No significant differences were observed in the mean age (60 vs 61years), sex (male/female; 25/7 vs 20/10), mean RENAL nephrometry score (5.7 vs 5.8), mean body mass index (24.4 vs 23) or tumor size (15mm vs 16mm) between the two groups. No significant differences were noted in positive surgical margins (0 vs 0) or blood loss (104 vs 115cc) as well. In contrast, a significant difference was noted in the total operative time (278 vs 238min). Serum creatinine percentage changes at 3months were 6.4 versus 7.3% in the off-clamp and hilum-clamp groups, respectively, which were not significantly different. ConclusionsOff-clamp laparoscopic partial nephrectomy can be safely carried out by using a soft coagulation technique.	[Hongo, Fumiya; Ueda, Takashi; Fujihara-Iwata, Atsuko; Nakamura, Terukazu; Naya, Yoshio; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Dept Urol, Kyoto 6028566, Japan; [Kawauchi, Akihiro] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 52021, Japan	Hongo, F (reprint author), Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	fhongo@koto.kpu-m.ac.jp					Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Singh D, 2005, J UROLOGY, V174, P2256, DOI 10.1097/01.ju.0000181827.49239.8c; Fergany AF, 2000, J UROLOGY, V163, P442, DOI 10.1016/S0022-5347(05)67896-2; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Rizkala ER, 2013, UROLOGY, V82, P100, DOI 10.1016/j.urology.2013.03.042; Motzer RJ, 2009, J NATL COMPR CANC NE, V7, P618; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Hung AJ, 2013, J UROLOGY, V189, P36, DOI 10.1016/j.juro.2012.09.042; Gill IS, 2012, J UROLOGY, V187, P807, DOI 10.1016/j.juro.2011.10.146; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Van Poppel H, 2011, EUR UROL, V60, P662, DOI 10.1016/j.eururo.2011.06.040; Scoll BJ, 2010, UROLOGY, V75, P1328, DOI 10.1016/j.urology.2009.10.040; Bensalah K, 2008, BJU INT, V101, P467, DOI 10.1111/j.1464-410X.2007.07276.x; Ogan K, 2003, J ENDOUROL, V17, P295, DOI 10.1089/089277903322145468; Fujioka T, 2009, INT J UROL, V16, P339, DOI 10.1111/j.1442-2042.2008.02242.x; Harmon WJ, 2000, UROLOGY, V56, P754, DOI 10.1016/S0090-4295(00)00766-4; Janetschek G, 2007, EUR UROL, V52, P1303, DOI 10.1016/j.eururo.2007.05.006; Moinzadeh A, 2005, J UROLOGY, V174, P317, DOI 10.1097/01.ju.0000161587.95033.c9; Naeem N, 2011, J ENDOUROL, V25, P101, DOI 10.1089/end.2010.0272; Otas T, 2014, INT J UROL, V21, P244; Otas T, 2013, JPN J UROL SURG, V26, P83; Otas T, 2011, JPN J UROL SURG, V24, P273; Rais-Bahrami S, 2011, BJU INT, V109, P1376; Reidenbachs HD, 1992, OPERATIVE MANUAL END, P44; Sundaram CP, 2003, UROLOGY, V61, P906, DOI 10.1016/S0090-4295(02)02550-5; Terai A, 2004, EUR UROL, V45, P744, DOI 10.1016/j.eururo.2004.02.007; Zeltser IS, 2008, BJU INT, V101, P36, DOI 10.1111/j.1464-410X.2007.07176.x	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					731	734		10.1111/iju.12808		4	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800003		
J	Ota, T				Ota, Tomonori			Editorial Comment to Laparoscopic off-clamp partial nephrectomy using soft coagulation	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Kameda Med Ctr, Dept Urol, Chiba, Japan	Ota, T (reprint author), Kameda Med Ctr, Dept Urol, Chiba, Japan.	norinoriritritnorinoriritrit@gmail.com					Ota T, 2014, INT J UROL, V21, P244, DOI 10.1111/iju.12276; Hongo F, 2015, INT J UROL, V22, P731, DOI 10.1111/iju.12808	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					735	735		10.1111/iju.12819		1	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800004		
J	Tatsugami, K; Shinohara, N; Kondo, T; Yamasaki, T; Eto, M; Tsushima, T; Terachi, T; Naito, S				Tatsugami, Katsunori; Shinohara, Nobuo; Kondo, Tsunenori; Yamasaki, Toshinari; Eto, Masatoshi; Tsushima, Tomoyasu; Terachi, Toshiro; Naito, Seiji		Japanese Soc Renal Canc	Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						cytoreductive nephrectomy; Japanese; kidney; metastasis; renal cell carcinoma	INTERFERON-ALPHA; SURVIVAL; CANCER	ObjectiveTo assess the efficacy of cytoreductive nephrectomy for Japanese patients with primary metastatic renal cell carcinoma in the cytokine and targeted therapy era. MethodsThe present retrospective study evaluated 330 Japanese patients with renal cell carcinoma who had synchronous metastases at diagnosis between 2001 and 2010. The characteristics of patients who did and did not undergo cytoreductive nephrectomy were compared. ResultsOf the 330 patients, 254 (77.0%) underwent cytoreductive nephrectomy. Patients who underwent cytoreductive nephrectomy were younger; had better Karnofsky Performance Status; higher rates of lung metastases only and systemic therapy; lower rates of increased lactate dehydrogenase concentration and liver and multiple metastases; and a lower Memorial Sloan Kettering Cancer Center risk score. Independent predictors of poorer overall survival included clinical stage T3/4; poorer Memorial Sloan Kettering Cancer Center risk and Karnofsky Performance Status; increased C-reactive protein concentration; and absence of cytoreductive nephrectomy and systemic therapy. Median overall survival was significantly longer in the patients who did rather than did not undergo cytoreductive nephrectomy, irrespective of systemic treatment. In patients without cytoreductive nephrectomy, median overall survival was significantly longer in those who received targeted (15.5months; hazard ratio 0.45; 95% confidence interval 0.21-0.94), but not by cytokine (8.2months; hazard ratio 0.72; 95% confidence interval 0.36-1.46) compared with no systemic treatment (4.4months). ConclusionsOverall survival seems to be significantly longer in patients undergoing cytoreductive nephrectomy. However, prospective trials are required to confirm our results, as targeted therapy might improve the survival even in the absence of cytoreductive nephrectomy.	[Tatsugami, Katsunori; Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 8128582, Japan; [Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan; [Kondo, Tsunenori] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan; [Yamasaki, Toshinari] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Eto, Masatoshi] Kumamoto Univ, Dept Urol, Fac Life Sci, Kumamoto, Japan; [Tsushima, Tomoyasu] Okayama Med Ctr, Div Urol, Okayama, Japan; [Terachi, Toshiro] Tokai Univ, Sch Med, Dept Urol, Hiratsuka, Kanagawa 25912, Japan	Tatsugami, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ktatsu@uro.med.kyushu-u.ac.jp			Pfizer; Novartis; Otsuka Pharmaceutical; GlaxoSmithKline	Dr Katsunori Tatsugami received honoraria from Pfizer, Novartis and GlaxoSmithKline; and research funding from Pfizer and Novartis. Dr Nobuo Shinohara received honoraria from Pfizer, GlaxoSmithKline and Novartis. Dr Tsunenori Kondo received honoraria from Pfizer and GlaxoSmithKline. Dr Masatoshi Eto received honoraria from Bayer, Sumitomo Dainippon Pharma, Pfizer, Novartis, Otsuka Pharmaceutical, Shionogi, Ono Pharmaceutical and GlaxoSmithKline; research funding from Pfizer and Novartis; and fees for promotional materials from Bayer, Pfizer and GlaxoSmithKline. Dr Toshiro Terachi received honoraria from GlaxoSmithKline. Dr Seiji Naito received honoraria from Bayer, Pfizer, Novartis, Otsuka Pharmaceutical and GlaxoSmithKline; and research funding from Pfizer, Novartis, Otsuka Pharmaceutical and GlaxoSmithKline. The other authors declare no conflict of interest.	Aben KKH, 2011, EUR J CANCER, V47, P2023, DOI 10.1016/j.ejca.2011.03.002; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Richey SL, 2011, ANN ONCOL, V22, P1048, DOI 10.1093/annonc/mdq563; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Choueiri TK, 2011, J UROLOGY, V185, P60, DOI 10.1016/j.juro.2010.09.012; Heng DYC, 2014, EUR UROL, V66, P704, DOI 10.1016/j.eururo.2014.05.034; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Zini L, 2009, UROLOGY, V73, P342, DOI 10.1016/j.urology.2008.09.022; Culp SH, 2010, CANCER-AM CANCER SOC, V116, P3378, DOI 10.1002/cncr.25046; Contis SL, 2014, INT J CANCER, V139, P2245; Tsaos CK, 2012, WORLD J UROL, V31, P1535; Wood CG, 2003, UROL CLIN N AM, V30, P581, DOI 10.1016/S0094-0143(03)00026-0; Yous D, 2011, J UROLOGY, V185, P54	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					736	740		10.1111/iju.12803		5	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800005		
J	Sakai, N; Taguri, M; Kobayashi, K; Noguchi, S; Ikeda, S; Koh, H; Satomi, Y; Furuhata, A				Sakai, Naoki; Taguri, Masataka; Kobayashi, Kazuki; Noguchi, Sumio; Ikeda, Shigeru; Koh, Hideshige; Satomi, Yoshiaki; Furuhata, Akihiko			Clinical outcomes of prostate cancer patients in Yokosuka City, Japan: A comparative study between cases detected by prostate-specific antigen-based screening in Yokosuka and those detected by other means	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						clinical outcomes; mortality; prostate cancer; prostate-specific antigen; screening	RANDOMIZED PROSTATE; FOLLOW-UP; MORTALITY; TRIAL	ObjectivesTo investigate whether prostate-specific antigen-based screening reduced the prostate cancer mortality rate in Yokosuka, Japan. MethodsWe carried out a cohort study, in which we compared clinical outcomes between patients detected by prostate-specific antigen-based screening (S group n=524) versus those detected by other means (NS group n=1044). Clinical and pathological factors were evaluated using Cox regression analyses and the Kaplan-Meier method. ResultsA total of 1.5% (8/524) of patients in the S group and 6.7% (70/1044) of those in the NS group died from prostate cancer during follow up. A total of 8.0% (42/524) of patients in the S group and 11.4% (119/1044) in the NS group died from other causes. The 10-year cancer specific survival rates of the S and NS groups were 97% and 86%, respectively (P<0.001). The median age was significantly lower in the S group than the NS group: 71 and 73years, respectively (P<0.001). The rate of Gleason score 8-10 was significantly lower in the S group than the NS group: 9.7% and 16.7%, respectively (P<0.001). The rate of patients with metastasis or prostate-specific antigen 100ng/mL or more was significantly lower in the S group than the NS group: 7.8% and 23.0%, respectively (P<0.001). On multivariate analysis, Gleason score 8-10 compared with Gleason score 6 was independently associated with cancer-specific survival (hazard ratio 4.808, 95% confidence interval 1.044-22.14, P=0.044). ConclusionsProstate-specific antigen-based population screening in Yokosuka City might help to reduce the prostate cancer mortality rate.	[Sakai, Naoki; Kobayashi, Kazuki; Noguchi, Sumio] Yokosuka Kyosai Hosp, Dept Urol, Yokosuka, Kanagawa 2388558, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokosuka, Kanagawa, Japan; [Ikeda, Shigeru] Kinugasa Hosp, Dept Urol, Yokosuka, Kanagawa, Japan; [Koh, Hideshige] Yokosuka City Uwamachi Hosp, Dept Urol, Yokosuka, Kanagawa, Japan; [Satomi, Yoshiaki] Satomi Jin Hinyokika, Dept Urol, Yokosuka, Kanagawa, Japan; [Furuhata, Akihiko] Furuhata Hinyokika Clin, Dept Urol, Yokosuka, Kanagawa, Japan	Sakai, N (reprint author), Yokosuka Kyosai Hosp, Dept Urol, 1-16 Yonegahamadori, Yokosuka, Kanagawa 2388558, Japan.	naochloeredalert@jcom.home.ne.jp					MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Crawford ED, 2011, J CLIN ONCOL, V29, P355, DOI 10.1200/JCO.2010.30.5979; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Auss G, 2007, EUR UROL, V51, P659; Carters HB, 2013, J UROLOGY, V190, P1134; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Bergdahl AG, 2013, EUR UROL, V64, P703, DOI 10.1016/j.eururo.2013.05.024; Kitagawa Yasuhide, 2013, Prostate Int, V1, P65, DOI 10.12954/PI.12017; Matsuda T, 2010, JPN J CLIN ONCOL, V40, P1192, DOI 10.1093/jjco/hyq109; Noguchi Sumio, 2008, Hinyokika Kiyo, V54, P197; Popioleks M, 2013, EUR UROL, V63, P423; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					747	752		10.1111/iju.12806		6	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800008		
J	Izumi, K				Izumi, Kouji			Editorial Comment from Dr Izumi to Clinical outcomes of prostate cancer patients in Yokosuka City, Japan: A comparative study between cases detected by prostate-specific antigen-based screening in Yokosuka and those detected by other means	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan	Izumi, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan.	azuizu2003@yahoo.co.jp					Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; Itos K, 2008, INT J UROL, V15, P763; Kitagawa Yasuhide, 2013, Prostate Int, V1, P65, DOI 10.12954/PI.12017; Sakai N, 2015, INT J UROL, V22, P747, DOI 10.1111/iju.12806	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					752	753		10.1111/iju.12807		2	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800009		
J	Mitsuzuka, K; Koga, H; Sugimoto, M; Arai, Y; Ohyama, C; Kakehi, Y; Naito, S				Mitsuzuka, Koji; Koga, Hirofumi; Sugimoto, Mikio; Arai, Yoichi; Ohyama, Chikara; Kakehi, Yoshiyuki; Naito, Seiji			Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						active surveillance; biopsy; indication; prostate cancer; questionnaire	ANTIGEN KINETICS; FOLLOW-UP; MEN; COHORT; COMPLICATIONS; MANAGEMENT; BIOPSIES; CRITERIA; PROGRAM; IMPACT	ObjectiveTo understand the current practice pattern of active surveillance using a nationwide survey among Japanese urologists. MethodsA new questionnaire about active surveillance was developed and mailed to 863 training institutes in January 2014. The questionnaire included indications for active surveillance, percentage of active surveillance for localized prostate cancer, problems with active surveillance, which protocol was used, timing of first repeat biopsy, use of prostate-specific antigen or doubling time and use of magnetic resonance imaging. ResultsA total of 2133 Japanese urologists in the 632 training institutes answered the questionnaire. The median age was 42years (26-84years). Of the responders, 26.9% had no use of active surveillance for localized prostate cancer. The Prostate Cancer Research International: Active Surveillance criteria were most frequently used (29.7%), followed by a low-risk group without a definitive follow-up protocol (29.4%). Regarding repeat biopsy, 40.6% carried it out at 1year after active surveillance initiation, but 24.1% did not usually carry it out and 31.8% carried it out only when they considered it necessary. Magnetic resonance imaging was used routinely in 22.2% and as required in 67.6%. Re-biopsy or magnetic resonance imaging was less carried out in general hospitals than in universities. The percentage of no usual repeat biopsy was significantly higher in urologists who had more than 10years of experience. Repeat biopsies (60.3%), inadequate inclusion criteria (49.9%), psychological burden for patients (43.7%), unexpected progression (41.1%) and unknown long-term outcomes (40.6%) were considered the major problems of active surveillance in the responders. ConclusionsThe practice pattern of active surveillance varies widely among Japanese urologists. It is necessary to gain a correct understanding of active surveillance.	[Mitsuzuka, Koji; Arai, Yoichi] Tohoku Univ, Sch Med, Dept Urol, Sendai, Miyagi 9808574, Japan; [Koga, Hirofumi] Hara Sanshin Hosp, Dept Urol, Fukuoka, Japan; [Sugimoto, Mikio; Kakehi, Yoshiyuki] Kagawa Univ, Fac Med, Dept Urol, Takamatsu, Kagawa 760, Japan; [Ohyama, Chikara] Hirosaki Univ, Sch Med, Dept Urol, Hirosaki, Aomori 036, Japan; [Naito, Seiji] Kyushu Univ, Sch Med, Dept Urol, Fukuoka 812, Japan	Mitsuzuka, K (reprint author), Tohoku Univ, Sch Med, Dept Urol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mitsuzuka@uro.med.tohoku.ac.jp					Womble PR, 2014, J UROLOGY, V191, P1787, DOI 10.1016/j.juro.2013.12.026; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Stamatakis L, 2013, CANCER-AM CANCER SOC, V119, P3359, DOI 10.1002/cncr.28216; Ehdaie B, 2014, J UROLOGY, V191, P660, DOI 10.1016/j.juro.2013.08.088; Mohler JL, 2014, J NATL COMPR CANC NE, V12, P686; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Dall'Era MA, 2008, CANCER, V112, P2664, DOI 10.1002/cncr.23502; Loeb S, 2013, EUR UROL, V64, P876, DOI 10.1016/j.eururo.2013.05.049; Park BH, 2014, BJU INT, V113, P864, DOI 10.1111/bju.12423; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Parker C, 2004, LANCET ONCOL, V5, P101, DOI 10.1016/S1470-2045(04)01384-1; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Ploussard G, 2011, EUR UROL, V59, P422, DOI 10.1016/j.eururo.2010.11.044; Thomsen FB, 2014, J SURG ONCOL, V109, P830, DOI 10.1002/jso.23584; Mullins JK, 2014, BJU INT, V113, P844, DOI 10.1111/bju.12473; Duffield AS, 2009, J UROLOGY, V182, P2274, DOI 10.1016/j.juro.2009.07.024; Iremashvili V, 2013, BJU INT, V111, P396, DOI 10.1111/j.1464-410X.2012.11295.x; Loeb S, 2013, J UROLOGY, V190, P1742, DOI 10.1016/j.juro.2013.05.054; Ross AE, 2010, J CLIN ONCOL, V28, P2810, DOI 10.1200/JCO.2009.25.7311; Mitsuzuka K, 2013, BJU INT, V111, P914, DOI 10.1111/j.1464-410X.2012.11658.x; Moore CM, 2014, CURR OPIN UROL, V24, P280, DOI 10.1097/MOU.0000000000000040; European Association of Urology, 2014, GUIDELINES PROSTATE; Hirama H, 2014, J CANCER RES CLIN, V140, P257, DOI 10.1007/s00432-013-1566-2; Kakehi Y, 2008, JPN J CLIN ONCOL, V38, P122, DOI 10.1093/jjco/hym161; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Lawrentschuk N, 2010, BJU INT, V105, P1231, DOI 10.1111/j.1464-410X.2009.08938.x; Volkin D, 2014, BJU INT, V114, pE43	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					754	759		10.1111/iju.12813		6	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800011		
J	Funahashi, Y				Funahashi, Yasuhito			Editorial Comment to Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: A prospective single-center investigation	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan	Funahashi, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan.	yfunahashi@med.nagoya-u.ac.jp					Pisco J, 2013, RADIOLOGY, V266, P668, DOI 10.1148/radiol.12111601; Pisco JM, 2011, J VASC INTERV RADIOL, V22, P11, DOI 10.1016/j.jvir.2010.09.030; Gaos YA, 2014, RADIOLOGY, V270, P920; Kurbatovs D, 2014, UROLOGY, V84, P400; Pisco JM, 2011, J VASC INTERV RADIOL, V22, P20; Wang MQ, 2015, INT J UROL, V22, P766, DOI 10.1111/iju.12797	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					772	772		10.1111/iju.12812		1	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800015		
J	Nakazawa, R; Sato, Y; Sasaki, H; Shibagaki, Y; Kimura, K; Chikaraishi, T				Nakazawa, Ryuto; Sato, Yuichi; Sasaki, Hideo; Shibagaki, Yugo; Kimura, Kenjiro; Chikaraishi, Tatsuya			Pharmacokinetic analysis of cyclosporine in a renal transplant recipient with congenital absence of the portal vein	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						congenital absence of the portal vein; cyclosporine; kidney transplantation; nephrotic syndrome; therapeutic drug monitoring	LIVER-TRANSPLANTATION; KIDNEY; METABOLISM	Here we report therapeutic drug monitoring of cyclosporine in a kidney transplant recipient lacking enterohepatic circulation. The patient developed steroid-resistant nephrotic syndrome at age 14years, and was medicated with an oral cyclosporine microemulsion. However, her cyclosporine trough level was unexpectedly elevated, and subsequent investigations showed that she was deficient in drug metabolism as a result of the congenital absence of the portal vein. Her renal function gradually decreased and she became dialysis-dependent at the age of 21years, and kidney transplantation was planned. Based on pretransplant therapeutic drug monitoring, we started cyclosporine microemulsion at half of the conventional dosage. After transplantation, the dosage was successfully adjusted to achieve a target trough level. The post-transplant course was stable with no symptoms of rejection or cyclosporine-associated nephrotoxicity.	[Nakazawa, Ryuto; Sato, Yuichi; Sasaki, Hideo; Chikaraishi, Tatsuya] St Marianna Univ, Dept Urol, Sch Med, Kawasaki, Kanagawa 2168511, Japan; [Shibagaki, Yugo; Kimura, Kenjiro] St Marianna Univ, Dept Internal Med, Sch Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa 2168511, Japan	Nakazawa, R (reprint author), St Marianna Univ, Dept Urol, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	ryuto@marianna-u.ac.jp					Wakamoto H, 1999, BRAIN DEV-JPN, V21, P425, DOI 10.1016/S0387-7604(99)00049-2; WU CY, 1995, CLIN PHARMACOL THER, V58, P492, DOI 10.1016/0009-9236(95)90168-X; Benet LZ, 1996, J CONTROL RELEASE, V39, P139, DOI 10.1016/0168-3659(95)00147-6; Aoyama T, 2005, YAKUGAKU ZASSHI, V125, P441, DOI 10.1248/yakushi.125.441; Gordon-Burroughs S, 2014, TRANSPL P, V46, P2418, DOI 10.1016/j.transproceed.2014.04.012; Guariso G, 1998, EUR J PEDIATR, V157, P287, DOI 10.1007/s004310050812; Nashan B, 2005, TRANSPLANT INT, V18, P768, DOI 10.1111/j.1432-2277.2005.00151.x; PTACHCINSKI RJ, 1986, CLIN PHARMACOKINET, V11, P107; Shinkai M, 2001, J PEDIATR SURG, V36, P1026, DOI 10.1053/jpsu.2001.24731; Wong WC, 2005, TRANSPLANTATION, V80, P289, DOI 10.1097/01.tp.0000168436.76784.45	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					785	787		10.1111/iju.12830		3	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800018		
J	Minagawa, T; Kato, H; Ogawa, T; Uehara, T; Ishizuka, O				Minagawa, Tomonori; Kato, Haruaki; Ogawa, Teruyuki; Uehara, Takeshi; Ishizuka, Osamu			Usefulness of sonourethrography for penile abscess as a result of xanthogranulomatous granuloma in the corpus cavernosum of an adult: A case report	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						corpus cavernosum; sonourethrography; ultrasonography; urethra; xanthogranulomatous granuloma	JUVENILE XANTHOGRANULOMA	A 75-year-old man presented with a 4-month history of a swollen and painful penis. Computed tomography showed a round-shaped mass measuring 3x2cm in the corpus cavernosum. Percutaneous drainage of the penile mass was carried out and a course of antibiotics was prescribed. Viral, fungal and selective bacterial cultures were negative. Total penectomy and urethroperineal fistula formation were carried out because of penile pain. Histopathological diagnosis was xanthogranulomatous granuloma of the corpus cavernosum. Before surgery, sonourethrography was carried out under general anesthesia. Sonourethrography is an infrequently used modality to observe the male urethra under urinary micturition or injection of saline. We previously reported modified sonourethrography with retrograde jelly injection. In the present case, sonourethrography successfully showed the damaged and deformed urethra including the abscess cavity and fistula. Although xanthogranulomatous granuloma is rare, the findings reported here showed the usefulness of sonourethrography for morphological evaluation of the male urethra.	[Minagawa, Tomonori; Kato, Haruaki; Ogawa, Teruyuki; Ishizuka, Osamu] Shinshu Univ, Sch Med, Dept Urol, Matsumoto, Nagano 3908621, Japan; [Uehara, Takeshi] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan	Minagawa, T (reprint author), Shinshu Univ, Sch Med, Dept Urol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	minagawat@shinshu-u.ac.jp					COZZUTTO C, 1988, PATHOL RES PRACT, V183, P395; GOODMAN M, 1979, MEDICINE, V58, P171; Bradford RK, 2009, PEDIATR RADIOL, V39, P176, DOI 10.1007/s00247-008-1056-x; Gupta N, 2006, BJU INT, V98, P149, DOI 10.1111/j.1464-410X.2006.06234.x; HAUTMANN RE, 1993, J UROLOGY, V150, P456; Lopez V, 2010, J AM ACAD DERMATOL, V62, P524, DOI 10.1016/j.jaad.2009.02.005; Minagawas T, 2010, J MED ULTRASON, V37, P507; RIFKIN MD, 1984, RADIOLOGY, V153, P791; RODRIGUEZ J, 1976, ARCH DERMATOL, V112, P43, DOI 10.1001/archderm.112.1.43; Seos 3rd Y, 2007, J SEX MED, V4, P1763	10	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					788	790		10.1111/iju.12816		3	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800019		
J	Inoue, M; Fujii, Y; Yokoyama, M; Saito, K; Numao, N; Kihara, K				Inoue, Masaharu; Fujii, Yasuhisa; Yokoyama, Minato; Saito, Kazutaka; Numao, Noboru; Kihara, Kazunori			Progression of hypertension after partial nephrectomy in patients with renal tumors: A preliminary report	INTERNATIONAL JOURNAL OF UROLOGY			English	Article							OUTCOMES		[Inoue, Masaharu; Fujii, Yasuhisa; Yokoyama, Minato; Saito, Kazutaka; Numao, Noboru; Kihara, Kazunori] Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Tokyo, Japan	Inoue, M (reprint author), Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Tokyo, Japan.	y-fujii.uro@tmd.ac.jp					Fujii Y, 2008, UROLOGY, V72, P598, DOI 10.1016/j.urology.2008.04.054; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Kihara K, 2015, INT J UROL, V22, P349, DOI 10.1111/iju.12687; KIMS SP, 2012, J UROLOGY, V188, P51; Scosyrev E, 2014, EUR UROL, V65, P372, DOI 10.1016/j.eururo.2013.06.044; Smyth A, 2012, J CLIN HYPERTENS, V14, P216, DOI 10.1111/j.1751-7176.2012.00601.x; Yokoyama M, 2011, J UROLOGY, V185, P2066, DOI 10.1016/j.juro.2011.02.005	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					797	798		10.1111/iju.12794		2	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800024		
J	Sakurai, T				Sakurai, Toshihiko			Editorial Comment to Progression of hypertension after partial nephrectomy in patients with renal tumors: A preliminary report	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Yamagata Univ, Fac Med, Dept Urol, Yamagata 990, Japan	Sakurai, T (reprint author), Yamagata Univ, Fac Med, Dept Urol, Yamagata 990, Japan.	tsakurai@med.id.yamagata-u.ac.jp					Zargar H, 2014, J UROLOGY, V191, P1418, DOI 10.1016/j.juro.2014.01.103; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Chedid A, 2006, AM J HYPERTENS, V19, P500, DOI 10.1016/j.amjhyper.2005.08.015; Inoue M, 2015, INT J UROL, V22, P797, DOI 10.1111/iju.12794	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					798	799		10.1111/iju.12815		2	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800025		
J	Kawai, T; Suzuki, M; Otsuka, M; Nakazono, S; Tanaka, Y; Homma, Y				Kawai, Taketo; Suzuki, Motofumi; Otsuka, Masafumi; Nakazono, Shusaku; Tanaka, Yoshinori; Homma, Yukio			Hypertensive crisis during hemostasis of adrenal bleeding using a soft-coagulation device	INTERNATIONAL JOURNAL OF UROLOGY			English	Article									[Kawai, Taketo; Nakazono, Shusaku; Tanaka, Yoshinori] Japanese Red Cross Musashino Hosp, Dept Urol, Tokyo, Japan; [Suzuki, Motofumi] Tokyo Teishin Hosp, Dept Urol, Tokyo, Japan; [Otsuka, Masafumi; Homma, Yukio] Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo, Japan	Kawai, T (reprint author), Japanese Red Cross Musashino Hosp, Dept Urol, Tokyo, Japan.	uromotofumi@gmail.com					Ota T, 2014, INT J UROL, V21, P244, DOI 10.1111/iju.12276; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fransson BA, 2009, VET SURG, V38, P490, DOI 10.1111/j.1532-950X.2009.00533.x; Hirokawa F, 2011, SURGERY, V149, P438, DOI 10.1016/j.surg.2009.11.015; NAKAGAWA Y, 2008, J HEPATOBILIARY PANC, V15, P359; Sakuragi Tohru, 2009, Interact Cardiovasc Thorac Surg, V9, P767, DOI 10.1510/icvts.2009.212696	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	AUG	2015	22	8					799	800		10.1111/iju.12779		2	Urology & Nephrology	Urology & Nephrology	CN8FL	WOS:000358674800026		
J	Morizane, S; Yumioka, T; Yamaguchi, N; Masago, T; Honda, M; Sejima, T; Takenaka, A				Morizane, Shuichi; Yumioka, Tetsuya; Yamaguchi, Noriya; Masago, Toshihiko; Honda, Masashi; Sejima, Takehiro; Takenaka, Atsushi			Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						Nephroureterectomy; C-reactive protein; Estimated glomerular filtration rate; Upper urinary tract urothelial carcinoma	TRANSITIONAL-CELL CARCINOMA; PROGNOSTIC-FACTORS; SURVIVAL; CANCER; CHEMOTHERAPY; GRADE	To investigate the prognostic indicators, including clinicopathological and preoperative hematological factors, in patients undergoing radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC), and to develop a prognostic factor-based risk stratification model. The clinicopathological data and preoperative parameters were collected from 345 UTUC patients treated with RNU without neoadjuvant therapy, retrospectively. The prognostic values of preoperative hematological parameters and clinicopathological factors were evaluated. Then, a risk stratification model was developed to predict poor survival after RNU using the regression coefficients of multivariate analysis. In multivariate analysis, high serum C-reactive protein (CRP) levels (a parts per thousand yen0.5 mg/dl), low estimated glomerular filtration rate (eGFR) levels (< 50 ml/min/1.73 m(2)), Eastern Cooperative Oncology Group Performance status a parts per thousand yen1, number of tumor foci > 1, tumor grade (G3), positive LN, and positive surgical margin were independent factors predicting poor cancer-specific survival (CSS). Patients were stratified into three groups, and the risk stratification model revealed significant differences in CSS between the three subgroups. The 5-year CSS in patients at low, intermediate, and high risk was 92.7, 75.4, and 31.5 %, respectively. This study indicates that preoperative hematological markers, such as low eGFR and high CRP levels predict a poor survival in patients with UTUC. Our risk stratification model may provide physicians with useful prognostic information for identifying patients who may be candidates for multimodal treatment.	[Morizane, Shuichi; Yumioka, Tetsuya; Yamaguchi, Noriya; Masago, Toshihiko; Honda, Masashi; Sejima, Takehiro; Takenaka, Atsushi] Tottori Univ, Div Urol, Dept Surg, Fac Med, Yonago, Tottori 6838504, Japan	Sejima, T (reprint author), Tottori Univ, Div Urol, Dept Surg, Fac Med, 86 Nishi Cho, Yonago, Tottori 6838504, Japan.	sejimat@grape.med.tottori-u.ac.jp					Casamassima A, 2005, J UROLOGY, V173, P52, DOI 10.1097/01.ju.0000146713.50673.e5; Novara G, 2010, EUR UROL, V57, P1064, DOI 10.1016/j.eururo.2009.12.029; Inamoto T, 2012, INT J CLIN ONCOL, V17, P256, DOI 10.1007/s10147-011-0284-5; Porten S, 2014, CANCER-AM CANCER SOC, V120, P1794, DOI 10.1002/cncr.28655; Yates DR, 2012, BRIT J CANCER, V106, P1083, DOI 10.1038/bjc.2012.64; Rink M, 2012, J UROLOGY, V188, P398, DOI 10.1016/j.juro.2012.04.009; Cha EK, 2012, EUR UROL, V61, P818, DOI 10.1016/j.eururo.2012.01.021; Yoshida S, 2008, BJU INT, V101, P978, DOI 10.1111/j.1464-410X.2007.07408.x; Zigeuner R, 2010, EUR UROL, V57, P575, DOI 10.1016/j.eururo.2009.11.035; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; Colin P, 2012, ANN SURG ONCOL, V19, P3613, DOI 10.1245/s10434-012-2453-9; Eltz S, 2008, BJU INT, V102, P532, DOI 10.1111/j.1464-410X.2008.07659.x; Favaretto RL, 2010, EUR UROL, V58, P574, DOI 10.1016/j.eururo.2010.07.003; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Otto W, 2011, WORLD J UROL, V29, P487, DOI 10.1007/s00345-011-0645-8; Cho KS, 2007, UROLOGY, V70, P662, DOI 10.1016/j.urology.2007.06.1106; Saito K, 2007, BJU INT, V100, P269, DOI 10.1111/j.1464-410X.2007.06934.x; Pierce BL, 2009, BREAST CANCER RES TR, V114, P155, DOI 10.1007/s10549-008-9985-5; Fromont G, 2005, EUR UROL, V48, P764, DOI 10.1016/j.eururo.2005.07.005; Roupret M, 2013, J UROLOGY, V189, P1662, DOI 10.1016/j.juro.2012.10.057; Morizane S, 2013, INT UROL NEPHROL, V45, P99, DOI 10.1007/s11255-012-0347-1; David KA, 2009, CANCER, V115, P1435, DOI 10.1002/cncr.24147; Huang PC, 2006, INT J UROL, V13, P864, DOI 10.1111/j.1442-2042.2006.01429.x; Kuroda M, 1998, JPN J CLIN ONCOL, V28, P497, DOI 10.1093/jjco/28.8.497; Li WM, 2009, J UROLOGY, V182, P451, DOI 10.1016/j.juro.2009.04.026; Martinez-Salamanca JI, 2012, BJU INT, V109, P1155, DOI 10.1111/j.1464-410X.2011.10479.x; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; SENGELOV L, 1994, CANCER, V74, P123, DOI 10.1002/1097-0142(19940701)74:1<123::AID-CNCR2820740121>3.0.CO;2-T; Suyama T, 2011, INT J UROL, V18, P43, DOI 10.1111/j.1442-2042.2010.02671.x; The Japanese Urological Association TJSoP Japan Radiological Society, 2011, GEN RUL CLIN PATH ST, V1st	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	AUG	2015	47	8					1335	1341		10.1007/s11255-015-1033-x		7	Urology & Nephrology	Urology & Nephrology	CN7FQ	WOS:000358600000014		
J	Terada, T				Terada, Tadashi			Pleomorphic adenoma of spermatic cord	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Letter									Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Shizuoka 4248636, Japan	Terada, T (reprint author), Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Miyakami 1231, Shizuoka 4248636, Japan.	piyo0111jp@yahoo.co.jp					Terada T, 2008, PATHOL INT, V58, P801, DOI 10.1111/j.1440-1827.2008.02315.x; Terada T, 2013, INT J CLIN EXP PATHO, V6, P978; Terada T, 2010, PATHOL INT, V60, P330, DOI 10.1111/j.1440-1827.2010.02521.x; Terada T, 2011, PATHOL INT, V61, P99, DOI 10.1111/j.1440-1827.2010.02638.x	4	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	AUG	2015	47	8					1357	1359		10.1007/s11255-015-1045-6		3	Urology & Nephrology	Urology & Nephrology	CN7FQ	WOS:000358600000017		
J	Sato, K; Miura, Y; Marui, Y; Tanaka, K; Tomikawa, S				Sato, Kazushige; Miura, Yuichi; Marui, Yuhji; Tanaka, Kiho; Tomikawa, Shinji			Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Letter							LIVER-TRANSPLANTATION; MUTISM; DYSARTHRIA; RECIPIENTS		[Sato, Kazushige] Tosendo Hosp, Dept Gen Med, Toda, Miyagi 9870165, Japan; [Sato, Kazushige; Miura, Yuichi] Tohoku Univ, Grad Sch Med, Dept Surg, Adv Surg Sci & Technol Div, Sendai, Miyagi 980, Japan; [Marui, Yuhji; Tanaka, Kiho; Tomikawa, Shinji] Toranomon Gen Hosp, Dept Renal Transplantat Surg, Nephrol Ctr, Kawasaki, Kanagawa, Japan	Sato, K (reprint author), Tosendo Hosp, Dept Gen Med, 70-3 Wakuya, Toda, Miyagi 9870165, Japan.	satokazu@med.tohoku.ac.jp					Sierra-Hidalgo F, 2009, CLIN NEUROPHARMACOL, V32, P293, DOI 10.1097/WNF.0b013e3181a77fab; Sokol DK, 2003, PEDIATR NEUROL, V28, P156, DOI 10.1016/S0887-8994(02)00502-7; Bilbao I, 2014, TRANSPL P, V46, P3104, DOI 10.1016/j.transproceed.2014.10.001; Boeve BF, 1996, MAYO CLIN PROC, V71, P969; Bronster DJ, 2000, TRANSPLANTATION, V70, P979, DOI 10.1097/00007890-200009270-00017; Jeng KS, 2014, TRANSPL P, V46, P880, DOI 10.1016/j.transproceed.2013.11.097; REYES J, 1990, TRANSPLANTATION, V50, P1043; Perdomo KT, 2012, J NEPHROL, V25, P839, DOI 10.5301/jn.5000080; Vearrier D, 2011, AM J THER, V18, pE274, DOI 10.1097/MJT.0b013e3181debc6f	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	AUG	2015	47	8					1437	1438		10.1007/s11255-015-1026-9		2	Urology & Nephrology	Urology & Nephrology	CN7FQ	WOS:000358600000030		
J	Ikehata, M				Ikehata, Masaru			On finding an obstacle embedded in the rough background medium via the enclosure method in the time domain	INVERSE PROBLEMS			English	Article						enclosure method; inverse obstacle scattering; through-the wall; rough background	WALL	A mathematical method for through-wall imaging via wave phenomena in the time domain is introduced. The method makes use of a single reflected wave over a finite time interval and gives us a criterion whether a penetrable obstacle exists or not in a general rough background medium. Moreover, if the obstacle exists, the lower and upper estimates of the distance between the obstacle and the center point of the support of the initial data are given. As an evidence of the potential of the method two applications are also given.	Hiroshima Univ, Inst Engn, Math Lab, Higashi 7398527, Japan	Ikehata, M (reprint author), Hiroshima Univ, Inst Engn, Math Lab, Higashi 7398527, Japan.	ikehata@amath.hiroshima-u.ac.jp			Japan Society for the Promotion of Science [25400155]	The author thanks the referees for their valuable and constructive comments. The author was partially supported by Grant-in-Aid for Scientific Research (C)(No. 25400155) of Japan Society for the Promotion of Science.	Amin MG, 2013, J ELECTRON IMAGING, V22, DOI 10.1117/1.JEI.22.3.030901; Catapano I, 2010, IEEE GEOSCI REMOTE S, V7, P685, DOI 10.1109/LGRS.2010.2045473; Baranoski EJ, 2008, J FRANKLIN I, V345, P556, DOI 10.1016/j.jfranklin.2008.01.005; Ahmad F, 2008, IEEE GEOSCI REMOTE S, V5, P176, DOI 10.1109/LGRS.2008.915742; Courant R, 1937, METHODEN MATH PHYS, V2; Dautray R., 1992, MATH ANAL NUMERICAL; Gilbarg D., 1983, ELLIPTIC PARTIAL DIF; HANSEN S, 1987, MATH ANN, V279, P125, DOI 10.1007/BF01456195; Ikehata M, 1999, INVERSE PROBL, V15, P1231, DOI 10.1088/0266-5611/15/5/308; Ikehata Masaru, 2012, Inverse Problems, V28, DOI 10.1088/0266-5611/28/4/045010; Ikehata M., 2000, Journal of Inverse and Ill-Posed Problems, V8; Ikehata M, 2012, INVERSE PROBL, V28, DOI 10.1088/0266-5611/28/12/125003; Ikehata M, 2015, INVERSE PROBLEMS COM, V2; Ikehata M, 2007, APPL ANAL, V86, P963, DOI 10.1080/00036810701460834; Ikehata M, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/5/055010; Ikehata M, 2014, INVERSE PROBL, V30, DOI 10.1088/0266-5611/30/4/045011; Ikehata M, 2013, INVERSE PROBL, V29, DOI 10.1088/0266-5611/29/8/085013; Majda A., 1977, COMMUN PART DIFF EQ, V2, P395, DOI 10.1080/03605307708820035; OLVER FWJ, 1974, ASYMPTOTICS SPECIAL; Petkov V, 1982, J MATH PURE APPL, V60, P65; PETKOV V, 1982, MATH PROC CAMBRIDGE, V92, P361, DOI 10.1017/S030500410006000X; Uhlmann G, 2004, GEOMETRIC METHODS IN, V137, P263; Zetik R, 2006, P SOC PHOTO-OPT INS, V6201, pI2010, DOI 10.1117/12.667989	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0266-5611	1361-6420		INVERSE PROBL	Inverse Probl.	AUG	2015	31	8							085011	10.1088/0266-5611/31/8/085011		21	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CN6OU	WOS:000358554900011		
J	Naushad, M; ALOthman, ZA; Awual, MR; Alam, MM; Eldesoky, GE				Naushad, Mu.; ALOthman, Z. A.; Awual, Md. Rabiul; Alam, Mohammad Mezbaul; Eldesoky, G. E.			Adsorption kinetics, isotherms, and thermodynamic studies for the adsorption of Pb2+ and Hg2+ metal ions from aqueous medium using Ti(IV) iodovanadate cation exchanger	IONICS			English	Article						Adsorption; Toxic metal ions; Ti(IV) iodovanadate; Kinetics; Thermodynamics	ACTIVATED CARBON; DISTRIBUTION COEFFICIENTS; MERCURY CONTAMINATION; COCONUT SHELL; REMOVAL; SORPTION; LEAD; EQUILIBRIUM; WATER; EFFLUENTS	In the current study, Ti(IV) iodovanadate cation exchanger (TIV) was synthesized and applied for the removal of Pb2+ and Hg2+ metal ions from the aqueous medium. The adsorption studies were performed by the batch techniques and adsorption parameters viz. contact time, pH, initial metal ion concentration, and temperature were also investigated. The optimum adsorption of Pb2+ (95 %) and Hg2+ (65 %) were observed at pH 6. The pseudo-second order equation represented the adsorption kinetics with high correlation coefficient. Langmuir model showed the best fitting to the isotherm equilibrium data, with a maximum adsorption capacity of 18.8 mg g(-1) for Pb2+ and 17.2 mg g(-1) for Hg2+. Furthermore, thermodynamic factors, i.e., Delta G, Delta H, and Delta S, indicated that adsorption of Pb2+ and Hg2+ onto TIV were spontaneous, endothermic, and feasible in the temperature range of 293-323 K.	[Naushad, Mu.; ALOthman, Z. A.; Alam, Mohammad Mezbaul; Eldesoky, G. E.] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia; [Awual, Md. Rabiul] Japan Atom Energy Agcy SPring 8, Quantum Beam Sci Ctr, Actinide Coordinat Chem Grp, Mikazuki, Hyogo 6795148, Japan	Naushad, M (reprint author), King Saud Univ, Coll Sci, Dept Chem, Bldg 5, Riyadh 11451, Saudi Arabia.	shad81@rediffmail.com			Deanship of Scientific Research at King Saud University [RGP-VPP-130]	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project no. RGP-VPP-130.	Adams DH, 2010, SCI TOTAL ENVIRON, V408, P5808, DOI 10.1016/j.scitotenv.2010.08.019; Al-Othman ZA, 2011, CHEM ENG J, V166, P639, DOI 10.1016/j.cej.2010.11.036; AL-Othman ZA, 2011, J INORG ORGANOMET P, V21, P547, DOI 10.1007/s10904-011-9491-9; AlOthman ZA, 2013, J IND ENG CHEM, V19, P956, DOI 10.1016/j.jiec.2012.11.016; Pehlivan E, 2009, J HAZARD MATER, V164, P982, DOI 10.1016/j.jhazmat.2008.08.115; Yardim MF, 2003, CHEMOSPHERE, V52, P835, DOI 10.1016/S0045-6535(03)00267-4; Depci T, 2012, CHEM ENG J, V200, P224, DOI 10.1016/j.cej.2012.06.077; Ng JCY, 2003, CHEMOSPHERE, V52, P1021, DOI 10.1016/S0045-6535(03)00223-6; Chen AH, 2008, J HAZARD MATER, V154, P184, DOI 10.1016/j.jhazmat.2007.10.009; Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S1385-8947(98)00076-X; Meena AK, 2008, J HAZARD MATER, V150, P604, DOI 10.1016/j.jhazmat.2007.05.030; Nabi SA, 2007, J HAZARD MATER, V142, P404, DOI 10.1016/j.jhazmat.2006.08.039; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Piani R, 2005, APPL GEOCHEM, V20, P1546, DOI 10.1016/j.apgeochem.2005.04.003; Tran HV, 2010, MAT SCI ENG C-MATER, V30, P304, DOI 10.1016/j.msec.2009.11.008; Naushad M, 2013, TALANTA, V115, P15, DOI 10.1016/j.talanta.2013.04.015; Nabi SA, 2010, CHEM ENG J, V158, P100, DOI 10.1016/j.cej.2009.12.011; Manohar DM, 2002, WATER RES, V36, P1609, DOI 10.1016/S0043-1354(01)00362-1; Dong J, 2008, APPL SURF SCI, V254, P3522, DOI 10.1016/j.apsusc.2007.11.048; Wang QH, 2011, J HAZARD MATER, V186, P1076, DOI 10.1016/j.jhazmat.2010.11.107; Sekar M, 2004, J COLLOID INTERF SCI, V279, P307, DOI 10.1016/j.jcis.2004.06.042; Sharma G, 2014, CHEM ENG J, V251, P413, DOI 10.1016/j.cej.2014.04.074; Momcilovic M, 2011, DESALINATION, V276, P53, DOI 10.1016/j.desal.2011.03.013; Feng QG, 2004, J COLLOID INTERF SCI, V278, P1, DOI 10.1016/j.jcis.2004.05.030; CANO JVF, 2013, APPL SURF SCI, V276, P682; Chubar N, 2011, J COLLOID INTERF SCI, V357, P198, DOI 10.1016/j.jcis.2011.01.098; EPA Environmental Protection Agency, 1990, EPA625590025; Freundlich H., 1939, Journal of the American Chemical Society, V61, DOI 10.1021/ja01877a071; Goel J, 2004, ADSORPT SCI TECHNOL, V22, P257, DOI 10.1260/0263617041503453; Guerra D.J.L., 2013, WATER RESOURCES IND, V4, P32; Han RP, 2006, J HAZARD MATER, V137, P1569, DOI 10.1016/j.jhazmat.2006.04.045; KARTHIKEYAN J, 1986, WATER RES, V20, P449, DOI 10.1016/0043-1354(86)90192-2; Lagergren S., 1898, KUNGLIGA SVENSKA VET, V24, P1; Nabi SA, 2007, COLLOID SURFACE A, V293, P175, DOI 10.1016/j.colsurfa.2006.07.026; Nabi SA, 2006, REACT FUNCT POLYM, V66, P495, DOI 10.1016/j.reactfunctpolym.2005.10.002; Nabi SA, 2010, CHEM ENG J, V165, P529, DOI 10.1016/j.cej.2010.09.064; Sharma P, 2011, DESALINATION, V267, P277, DOI 10.1016/j.desal.2010.09.040; Sitting M., 1981, HDB TOXIC HAZARDOUS; Tan ZQ, 2011, FUEL, V90, P1471, DOI 10.1016/j.fuel.2010.12.004; World Health Organization, WHO INT STAND DRINK	40	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0947-7047	1862-0760		IONICS	Ionics	AUG	2015	21	8					2237	2245		10.1007/s11581-015-1401-7		9	Chemistry, Physical; Electrochemistry; Physics, Condensed Matter	Chemistry; Electrochemistry; Physics	CN8CL	WOS:000358665100016		
J	Hashimoto, S; Adachi, M; Iwata, F				Hashimoto, Shigetaka; Adachi, Makoto; Iwata, Futoshi			Investigation of shear force of a single adhesion cell using a self-sensitive cantilever and fluorescence microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SURFACE FREE-ENERGY; MAGNETIC TWEEZERS; CYTOSKELETON; SPECTROSCOPY; ATTACHMENT	In this paper, we describe a measurement system based on an atomic force microscope (AFM) for the measurement of the shear force and detachment energy of a single adhesion cell on a substrate. The shear force was quantitatively measured from the deflection of a self-sensitive cantilever that was employed for the simple configuration of the AFM manipulator. The shear force behavior of a single cell detaching from the substrate was observed. By staining cells with a fluorescence dye, the deformation shape of the cell being pushed with the cantilever could be clearly observed. The shear force and detachment energy of the cell increased with the size of the cell. The difference in the shear force of single cells on different substrates with different surface energies was quantitatively evaluated. The loading force applied to a single cell increased with the feed speed of the cantilever. The viability of cells after measurement under different feed speeds of the cantilever was also evaluated. (C) 2015 The Japan Society of Applied Physics	[Hashimoto, Shigetaka; Adachi, Makoto; Iwata, Futoshi] Shizuoka Univ, Grad Sch Engn, Dept Mech Engn, Hamamatsu, Shizuoka 4328561, Japan; [Iwata, Futoshi] Shizuoka Univ, Res Inst Elect, Hamamatsu, Shizuoka 4328011, Japan	Hashimoto, S (reprint author), Shizuoka Univ, Grad Sch Engn, Dept Mech Engn, Hamamatsu, Shizuoka 4328561, Japan.	tmfiwat@ipc.shizuoka.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); CREST of Japan Science and Technology Agency (JST)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and CREST of the Japan Science and Technology Agency (JST).	Abraham MR, 2005, CIRC RES, V97, P159, DOI 10.1161/01.RES.0000174794.22491.a0; Andersson M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2752606; Kabza K, 2000, J CHEM EDUC, V77, P63; Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020; Taubenberger AV, 2014, TISSUE ENG PART B-RE, V20, P40, DOI 10.1089/ten.TEB.2013.0125; Palmer CP, 2008, EUR BIOPHYS J BIOPHY, V37, P359, DOI 10.1007/s00249-007-0219-2; Alcaraz J, 2003, BIOPHYS J, V84, P2071; Zatloukal K, 2004, J PATHOL, V204, P367, DOI 10.1002/path.1649; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Ramaekers FCS, 2004, J PATHOL, V204, P351, DOI 10.1002/path.1665; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471; Smith BA, 2005, BIOPHYS J, V88, P2994, DOI 10.1529/biophysj.104.046649; Maruthamuthu V, 2010, CURR OPIN CELL BIOL, V22, P583, DOI 10.1016/j.ceb.2010.07.010; Neuman KC, 2008, NAT METHODS, V5, P491, DOI [10.1038/nmeth.1218, 10.1038/NMETH.1218]; Kollmannsberger P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804771; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Ozcan C, 2007, J BIOMAT SCI-POLYM E, V18, P759, DOI 10.1163/156856207781034124; Iwata F, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.08LB14; Kokkinos PA, 2012, J MATER SCI-MATER M, V23, P1489, DOI 10.1007/s10856-012-4628-0; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; Lee C. C., 2004, J MED BIOL ENG, V24, P51; Matthews BD, 2004, BIOCHEM BIOPH RES CO, V313, P758, DOI 10.1016/j.bbrc.2003.12.005; MCCLAY DR, 1981, P NATL ACAD SCI-BIOL, V78, P4975, DOI 10.1073/pnas.78.8.4975; OWENS NF, 1988, J CELL SCI, V91, P269; REUTELINGSPERGER CPM, 1994, J MATER SCI-MATER M, V5, P361, DOI 10.1007/BF00058964; Satriano C, 2003, NUCL INSTRUM METH B, V208, P287, DOI 10.1016/S0168-583X(03)00647-5; Schaal F, 2009, J EUR OPT SOC-RAPID, V4, DOI 10.2971/jeos.2009.09028; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y; Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u; Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2; Zenkiewicz M., 2007, J ACHIEV MAT MANUF E, V24, P137; Zisman W.A., 1964, CONTACT ANGLE WETTAB, P1, DOI DOI 10.1021/BA-1964-0043.CH001	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB03	10.7567/JJAP.54.08LB03		7	Physics, Applied	Physics	CN8BX	WOS:000358663300007		
J	Hiura, S; Ikeuchi, A; Shirini, S; Subagyo, A; Sueoka, K				Hiura, Satoshi; Ikeuchi, Akira; Shirini, Soraya; Subagyo, Agus; Sueoka, Kazuhisa			Correlation between OH density and Fe electronic states of H/Fe3O4(001) film surfaces studied by scanning tunneling microscopy/spectroscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HYDROGEN ADSORPTION; 1ST PRINCIPLES; FE3O4(001); MAGNETITE; WATER; RECONSTRUCTION; SPECTROSCOPY; MICROSCOPY; FE3O4(100); INSIGHTS	We report two types of adsorption structures in H/Fe3O4(001) film surfaces and the correlation between OH density and Fe electronic states, which have been studied by scanning tunneling microscopy/spectroscopy (STM/STS). Two types of bright protrusions (BPs), whose lengths along the atomic rows are different, are observed in the STM images. The shorter and longer BPs consist of Fe atoms with one and with two OH groups neighbor, respectively. In addition, STS measurements show the higher local density of states (LDOS) just below the Fermi level of Fe atoms with increasing neighboring OH groups. The variation can be attributed to the difference in the gain of electrons from H atoms, which is due to the difference in the number of neighboring OH groups. These results reveal that surface OH density is a factor for determining the LDOS just below the Fermi level of surface Fe atoms. (C) 2015 The Japan Society of Applied Physics	[Hiura, Satoshi; Ikeuchi, Akira; Shirini, Soraya; Subagyo, Agus; Sueoka, Kazuhisa] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan	Hiura, S (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan.	hiura@nano.ist.hokudai.ac.jp	Sueoka, Kazuhisa/H-3196-2011		 [22221007]	This work was partially supported by a Grant-in-Aid for Scientific Research S (No. 22221007).	Stanka B, 2000, SURF SCI, V448, P49, DOI 10.1016/S0039-6028(99)01182-6; Weiss W, 2002, PROG SURF SCI, V70, P1, DOI 10.1016/S0079-6816(01)00056-9; Novotny Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.216103; YANASE A, 1984, J PHYS SOC JPN, V53, P312, DOI 10.1143/JPSJ.53.312; Parkinson GS, 2011, J AM CHEM SOC, V133, P12650, DOI 10.1021/ja203432e; Parkinson GS, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125413; LANG ND, 1986, PHYS REV B, V34, P5947, DOI 10.1103/PhysRevB.34.5947; STROSCIO JA, 1986, PHYS REV LETT, V57, P2579, DOI 10.1103/PhysRevLett.57.2579; Opel M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/3/033001; Mulakaluri N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.176102; Fonin M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.104436; Novotny Z, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195410; Parkinson GS, 2013, NAT MATER, V12, P724, DOI [10.1038/nmat3667, 10.1038/NMAT3667]; ZHANG Z, 1991, PHYS REV B, V44, P13319, DOI 10.1103/PhysRevB.44.13319; Lodziana Z, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.206402; FEENSTRA RM, 1994, PHYS REV B, V50, P4561, DOI 10.1103/PhysRevB.50.4561; Bliem R, 2014, ACS NANO, V8, P7531, DOI 10.1021/nn502895s; Kado T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890852; Tartaj P, 2011, ADV MATER, V23, P5243, DOI 10.1002/adma.201101368; Pentcheva R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.126101; Chambers SA, 2000, SURF SCI, V450, pL273, DOI 10.1016/S0039-6028(00)00230-2; Hiura S, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.205411; Hiura S., 2014, E J SURF SCI NANOTEC, V12, P26; Ikeuchi A, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.08K602, 10.1143/JJAP.51.08KB02]; Jordan K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085416; Kurahashi M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.193402; Mulakaluri N, 2010, J PHYS CHEM C, V114, P11148, DOI 10.1021/jp100344n; Mulakaluri N, 2012, J PHYS CHEM C, V116, P16447, DOI 10.1021/jp302259d; Pentcheva R, 2008, SURF SCI, V602, P1299, DOI 10.1016/j.susc.2008.01.006; Pratt A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180409; Pratt A, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/6/064010; Shvets IV, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155406; Subagyo A, 2005, J MAGN MAGN MATER, V290, P1037, DOI 10.1016/j.jmmm.2004.11.366; Sun X, 2011, SURF SCI, V605, P1067, DOI 10.1016/j.susc.2011.03.006; Sun X, 2014, PHYS CHEM CHEM PHYS, V16, P95, DOI [10.1039/c3cp53272k, 10.1039/c3cp53272]; Tobin JG, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/31/315218	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB02	10.7567/JJAP.54.08LB02		4	Physics, Applied	Physics	CN8BX	WOS:000358663300006		
J	Kageshima, M; Fukui, K; Komeda, T; Nakajima, K; Nakayama, T; Sumitomo, K; Takahashi, T; Uchihashi, T				Kageshima, Masami; Fukui, Ken-ichi; Komeda, Tadahiro; Nakajima, Ken; Nakayama, Tomonobu; Sumitomo, Koji; Takahashi, Takuji; Uchihashi, Takayuki			Scanning Probe Microscopy FOREWORD	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Editorial Material									[Kageshima, Masami] Kansai Med Univ, Moriguchi, Osaka, Japan; [Fukui, Ken-ichi] Osaka Univ, Suita, Osaka 565, Japan; [Komeda, Tadahiro; Nakajima, Ken] Tohoku Univ, Sendai, Miyagi 980, Japan; [Nakayama, Tomonobu] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Sumitomo, Koji] Nippon Telegraph & Tel Corp, Tokyo, Japan; [Takahashi, Takuji] Univ Tokyo, Tokyo 1138654, Japan; [Uchihashi, Takayuki] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan	Kageshima, M (reprint author), Kansai Med Univ, Moriguchi, Osaka, Japan.		Nakajima, Ken/A-7875-2010	Nakajima, Ken/0000-0001-7495-0445				0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08L001	10.7567/JJAP.54.08L001		1	Physics, Applied	Physics	CN8BX	WOS:000358663300001		
J	Kanazawa, K; Nishimura, T; Yoshida, S; Shigekawa, H; Kuroda, S				Kanazawa, Ken; Nishimura, Taku; Yoshida, Shoji; Shigekawa, Hidemi; Kuroda, Shinji			Cr impurity-induced electronic states in ZnTe(110) surface	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FERROMAGNETIC SEMICONDUCTORS; GAAS; ATOM; MN	The impurity states of Cr atoms, which substituted Zn sites in the topmost layer of a p-type ZnTe(110) surface, were investigated by scanning tunneling microscopy/spectroscopy (STM/STS) and we firstly observed Cr-induced impurity states in the energy gap region of the host ZnTe including the unoccupied states by STS. Furthermore, we compared the observed energy levels and spatial distributions of the local density of states with those in the previous theoretical study [Katayama-Yoshida et al., Phys. Status Solidi A 204, 15 (2007)] and successfully identified the impurity states as the respective spin-polarized impurity states predicted by the theoretical study. (C) 2015 The Japan Society of Applied Physics	[Kanazawa, Ken; Nishimura, Taku; Yoshida, Shoji; Shigekawa, Hidemi; Kuroda, Shinji] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Kanazawa, K (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	kanazawa@ims.tsukuba.ac.jp			JSPS KAKENHI [22226003, 24310086, 25870103]	This work was supported by JSPS KAKENHI Grant Numbers 22226003, 24310086, and 25870103.	Garleff JK, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035303; Saito H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207202; Kuroda S, 2007, NAT MATER, V6, P440, DOI 10.1038/nmat1910; Yakunin AM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216806; Garleff JK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075313; Lee DH, 2010, SCIENCE, V330, P1807, DOI 10.1126/science.1197434; Jancu JM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.196801; Katayama-Yoshida H, 2007, PHYS STATUS SOLIDI A, V204, P15, DOI 10.1002/pssa.200673021; Dietl T, 2010, NAT MATER, V9, P965, DOI [10.1038/nmat2898, 10.1038/NMAT2898]; Fuechsle M, 2012, NAT NANOTECHNOL, V7, P242, DOI [10.1038/nnano.2012.21, 10.1038/NNANO.2012.21]; Verduijn J, 2013, NANO LETT, V13, P1476, DOI 10.1021/nl304518v; Kitchen D, 2006, NATURE, V442, P436, DOI 10.1038/nature04971; Yakunin AM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.256402; Bocquel J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.075421; Celebi C, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085308; Dietl T, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.187; Kanazawa K, 2014, NANOSCALE, V6, P14667, DOI 10.1039/c4nr04826a; Lee DH, 2011, NANO LETT, V11, P2004, DOI 10.1021/nl2003686; Muhlenberend S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115301; Richardella A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045318; Stroppa A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195335; Wierts A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799254; Yoshida S, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.032401	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB01	10.7567/JJAP.54.08LB01		4	Physics, Applied	Physics	CN8BX	WOS:000358663300005		
J	Mieda, E; Azumi, R; Shimada, S; Tanaka, M; Shimizu, T; Ando, A				Mieda, Eiko; Azumi, Reiko; Shimada, Satoru; Tanaka, Miyuki; Shimizu, Tetsuo; Ando, Atsushi			Nanoprobe characterization of MoS2 nanosheets fabricated by Li-intercalation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TRANSITION-METAL DICHALCOGENIDES; MOLYBDENUM-DISULFIDE; EXFOLIATED MOS2; 2-DIMENSIONAL NANOSHEETS; LITHIUM INTERCALATION; SINGLE-LAYER; NANOCOMPOSITES; COMPOSITES; GROWTH	We have fabricated MoS2 nanosheets by using a liquid-phase Li-intercalation method. To develop a process for the preparation of highly dispersed single-layer MoS2 nanosheets in water, we studied the mechanism of intercalation and exfoliation of MoS2. The water desorption behavior of the MoS2 nanosheets during heat treatment was investigated by in situ atomic force microscopy (AFM) and scanning transmission electron microscopy (STEM). By the analysis of each measurement, the amount of desorbed water existing in the interlayer and on the surface of MoS2 nanosheets could be estimated. Furthermore, we observed the water absorption behavior of Li-intercalated MoS2 by X-ray diffraction (XRD). From the results, we found that the layer distance was expanded to a thickness of more than two layers of water molecules intercalated by water absorption. These results are important to develop an effective approach to fabricate high-yield, single-layer MoS2 nanosheets dispersion based on a Li-intercalation method. (C) 2015 The Japan Society of Applied Physics	[Mieda, Eiko; Ando, Atsushi] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Azumi, Reiko; Shimada, Satoru] AIST, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Tanaka, Miyuki; Shimizu, Tetsuo] AIST, NanoSyst Res Inst, Tsukuba, Ibaraki 3058562, Japan	Mieda, E (reprint author), Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058568, Japan.	atsushi-ando@aist.go.jp					Ling X, 2014, NANO LETT, V14, P464, DOI 10.1021/nl4033704; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Benavente E, 2002, COORDIN CHEM REV, V224, P87, DOI 10.1016/S0010-8545(01)00392-7; Rezania B, 2014, NANO LETT, V14, P3993, DOI 10.1021/nl5013689; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Eda G, 2011, NANO LETT, V11, P5111, DOI 10.1021/nl201874w; DINES MB, 1975, MATER RES BULL, V10, P287, DOI 10.1016/0025-5408(75)90115-4; Xu MS, 2013, CHEM REV, V113, P3766, DOI 10.1021/cr300263a; Liu KK, 2012, NANO LETT, V12, P1538, DOI 10.1021/nl2043612; Lotya M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/26/265703; Smith RJ, 2011, ADV MATER, V23, P3944, DOI 10.1002/adma.201102584; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; JOENSEN P, 1987, J PHYS C SOLID STATE, V20, P4043, DOI 10.1088/0022-3719/20/26/009; Li Q, 2004, NANO LETT, V4, P277, DOI 10.1021/nl035011f; Guardia L, 2014, RSC ADV, V4, P14115, DOI 10.1039/c4ra00212a; Xiao J, 2010, CHEM MATER, V22, P4522, DOI 10.1021/cm101254j; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Ganatra R, 2014, ACS NANO, V8, P4074, DOI 10.1021/nn405938z; Radisavljevic B, 2011, ACS NANO, V5, P9934, DOI 10.1021/nn203715c; Stephenson T, 2014, ENERG ENVIRON SCI, V7, P209, DOI 10.1039/c3ee42591f; Backes C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5576; Benavente E, 1997, MATER RES BULL, V32, P709, DOI 10.1016/S0025-5408(97)00037-8; Feng XM, 2014, COMPOS SCI TECHNOL, V93, P76, DOI 10.1016/j.compscitech.2013.11.016; Funaki K, 2014, PHYS STATUS SOLIDI A, V211, P901, DOI 10.1002/pssa.201330507; Jeffery AA, 2014, J PHYS CHEM C, V118, P1386, DOI 10.1021/jp410918c; Jiang SD, 2014, RSC ADV, V4, P3253, DOI 10.1039/c3ra45911j; MATTHEIS.LF, 1973, PHYS REV B, V8, P3719, DOI 10.1103/PhysRevB.8.3719; Nicolosi V., 2013, SCIENCE, V340, P1402; Taguchi Y, 1998, LANGMUIR, V14, P6550, DOI 10.1021/la980551r; Tsai HL, 1997, CHEM MATER, V9, P875, DOI 10.1021/cm960516a; Zheng J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3995	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB07	10.7567/JJAP.54.08LB07		5	Physics, Applied	Physics	CN8BX	WOS:000358663300011		
J	Miyagi, T; Sasahara, A; Tomitori, M				Miyagi, Tomoaki; Sasahara, Akira; Tomitori, Masahiko			Difference in etching between Si(111) and (001) surfaces induced by atomic hydrogen irradiation observed by noncontact atomic force microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EPITAXIAL-GROWTH; PLASMA; SI; PHASE; CVD	The surfaces of Si(001) and Si(111) treated in a hydrogen fluoride solution were observed by noncontact atomic force microscopy (nc-AFM) under successive irradiation with atomic H generated using a hot W filament as a H-2 cracker. The observation and irradiation were repeated in a vacuum chamber equipped with an nc-AFM system and the cracker. We found that etch pits formed on the (001) surface with increasing atomic H irradiation time, but not on the (111) surface. From the nc-AFM observation, we evaluated the average rates of etch-pit enlargement in depth and radius on the (001) surface. The rate in depth was higher than that in radius. The formation of deep etch pits was possibly attributed to the evolution of facets vertical to the (001) surface as the side walls of the pits. The water contact angles on the surfaces were measured, which increased with atomic H irradiation, indicating that the irradiation reinforces the H termination of the surfaces. (C) 2015 The Japan Society of Applied Physics	[Miyagi, Tomoaki; Sasahara, Akira; Tomitori, Masahiko] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Miyagi, T (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.	tomitori@jaist.ac.jp			JSPS KAKENHI Grant [24246014, 26600024, 26630330]	This work was supported by JSPS KAKENHI Grant Numbers 24246014, 26600024, and 26630330. The AFM system used in this study was constructed under a project of the Japan Science and Technology Agency (JST) for the Development of Systems and Technology for Advanced Measurement and Analysis (the SENTAN Program) with Shimadzu Corporation.	Shang HM, 2005, J MATER SCI, V40, P3587, DOI 10.1007/s10853-005-2892-9; Sato T, 2007, JPN J APPL PHYS 1, V46, P6796, DOI 10.1143/JJAP.46.6796; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Baluch AS, 2004, J VAC SCI TECHNOL A, V22, pL1, DOI 10.1116/1.1722203; BORNSCHEUER KH, 1993, J VAC SCI TECHNOL A, V11, P2822, DOI 10.1116/1.578647; Dinger A, 2000, CHEM PHYS LETT, V320, P405, DOI 10.1016/S0009-2614(00)00268-2; HIGASHI GS, 1991, APPL PHYS LETT, V58, P1656, DOI 10.1063/1.105155; Hiraoka YS, 2002, JPN J APPL PHYS 1, V41, P784, DOI 10.1143/JJAP.41.784; Holloway P. H., 1995, HDB COMPOUND SEMICON, P270; Izumi A, 2000, MICROELECTRON ENG, V51-2, P495, DOI 10.1016/S0167-9317(99)00504-3; Jo SK, 1997, SURF SCI, V394, pL162, DOI 10.1016/S0039-6028(97)00801-7; MacRitchie F., 1990, CHEM INTERFACES, P112; MORITA Y, 1995, APPL PHYS LETT, V67, P2654, DOI 10.1063/1.114326; NAGAYOSHI H, 1994, JPN J APPL PHYS 2, V33, pL621, DOI 10.1143/JJAP.33.L621; Sasaki K, 1998, VACUUM, V51, P537, DOI 10.1016/S0042-207X(98)00250-4; Sasaki K, 1998, JPN J APPL PHYS 1, V37, P402, DOI 10.1143/JJAP.37.402; Wanka HN, 1997, J PHYS D APPL PHYS, V30, pL28, DOI 10.1088/0022-3727/30/8/002; WEI Y, 1995, APPL PHYS LETT, V66, P1818, DOI 10.1063/1.113332; Yamamoto M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.026503	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB08	10.7567/JJAP.54.08LB08		5	Physics, Applied	Physics	CN8BX	WOS:000358663300012		
J	Miyata, K; Miyazawa, K; Mohammad, S; Akrami, R; Fukuma, T				Miyata, Kazuki; Miyazawa, Keisuke; Mohammad, Seyed; Akrami, Reza; Fukuma, Takeshi			Improvements in fundamental performance of liquid-environment atomic force microscopy with true atomic resolution	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Review							OPTICAL VIDEODISC PLAYERS; BEAM DEPOSITED TIPS; CANTILEVERS; FABRICATION; MOLECULES; LAYERS; NOISE; SCALE	Recently, there have been significant advancements in liquid-environment atomic force microscopy (AFM) with true atomic resolution. The technical advancements are followed by a rapid expansion of its application area. Examples include subnanometer-scale imaging of biological systems and three-dimensional measurements of water distributions (i.e., hydration structures) and fluctuating surface structures. However, to continue this progress, we should improve the fundamental performance of liquid-environment dynamic-mode AFM. The present AFM technique does not allow real-time imaging of atomic-scale dynamic phenomena at a solid-liquid interface. This has hindered atomic-level understanding of crystal growth and dissolution, catalytic reactions and metal corrosion processes. Improvement in force sensitivity is required not only for such a high-speed imaging but also for various surface property measurements using a high-resolution AFM technique. In this review, we summarize recent works on the improvements in the force sensitivity and operation speed of atomic-resolution dynamic-mode AFM for liquid-environment applications. (C) 2015 The Japan Society of Applied Physics	[Miyata, Kazuki; Miyazawa, Keisuke; Mohammad, Seyed; Akrami, Reza; Fukuma, Takeshi] Kanazawa Univ, Div Elect Engn & Comp Sci, Kanazawa, Ishikawa 9201192, Japan; [Fukuma, Takeshi] Japan Sci & Technol Agcy, ACT C, Kawaguchi, Saitama 3320012, Japan	Fukuma, T (reprint author), Kanazawa Univ, Div Elect Engn & Comp Sci, Kanazawa, Ishikawa 9201192, Japan.	fukuma@staff.kanazawa-u.ac.jp	Miyata, Kazuki/L-2913-2015		JSPS KAKENHI [25706023]; ACT-C, Japan Science and Technology Agency	This work was supported by JSPS KAKENHI (25706023), and ACT-C, Japan Science and Technology Agency.	Akrami SMR, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/45/455701; Akrami SMR, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904029; OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451; Giessibl FJ, 1999, APPL SURF SCI, V140, P352, DOI 10.1016/S0169-4332(98)00553-4; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Fukuma T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3086418; UMEDA N, 1991, J VAC SCI TECHNOL B, V9, P1318, DOI 10.1116/1.585187; Fukuma T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999856; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Higgins MJ, 2006, BIOPHYS J, V91, P2532, DOI 10.1529/biophysj.106.085688; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Asakawa H, 2012, ACS NANO, V6, P9013, DOI 10.1021/nn303229j; Basak S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2202232; Fukuma T, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1896938; Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638; Fukuma T, 2007, BIOPHYS J, V92, P3603, DOI 10.1529/biophysj.106.100651; Fukuma T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016101; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Kobayashi K, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803742; Wendel M, 1995, APPL PHYS LETT, V67, P3732, DOI 10.1063/1.115365; Voitchovsky K, 2010, NAT NANOTECHNOL, V5, P401, DOI [10.1038/nnano.2010.67, 10.1038/NNANO.2010.67]; MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807; ARIMOTO A, 1986, APPL OPTICS, V25, P1398; FUJII T, 1991, J VAC SCI TECHNOL B, V9, P666, DOI 10.1116/1.585483; Fukuma T, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/13/135706; Fukuma T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2405361; Hosaka S, 1999, MICROELECTRON ENG, V46, P109, DOI 10.1016/S0167-9317(99)00027-1; JARVIS SP, 1993, REV SCI INSTRUM, V64, P3515, DOI 10.1063/1.1144276; Kindt JH, 2004, NANOTECHNOLOGY, V15, P1131, DOI 10.1088/0957-4484/15/9/005; LEE KL, 1991, J VAC SCI TECHNOL B, V9, P3562, DOI 10.1116/1.585845; Miyata K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4830048; Miyata K, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4802262; Miyazawa K, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/10/105707; OJIMA M, 1986, APPL OPTICS, V25, P1404; XIMEN HY, 1992, ULTRAMICROSCOPY, V42, P1526, DOI 10.1016/0304-3991(92)90477-2; Yamada H, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.095007; YAMAKI M, 1992, J VAC SCI TECHNOL B, V10, P2447, DOI 10.1116/1.586038; Yang JL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895482	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LA03	10.7567/JJAP.54.08LA03		6	Physics, Applied	Physics	CN8BX	WOS:000358663300004		
J	Nakamura, M; Huang, H; Kanazawa, K; Taninaka, A; Yoshida, S; Takeuchi, O; Shigekawa, H				Nakamura, Miki; Huang, Hui; Kanazawa, Ken; Taninaka, Atsushi; Yoshida, Shoji; Takeuchi, Osamu; Shigekawa, Hidemi			Formation of homochiral glycine/Cu(111) quantum corral array realized using alanine nuclei	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LOCAL-STRUCTURE DETERMINATION; SURFACES; GLYCINE; MONOLAYERS; CU(111); CU(100)	Glycine has enantiomeric isomers on a Cu(111) surface through the dissociation of hydrogen from the carboxyl group and forms an array of quantum corrals of similar to 1.3 nm diameter. Stable homo-chiral glycinate trimers are formed in the first step, which subsequently form a network with a hexagonal arrangement. However, domains with R- or S-chirality coexist with the same probability. On the other hand, alpha-alanine has D- and L-chirality in nature and forms a similar quantum corral array on Cu(111) with R- and S-chirality, respectively. Here, by using alpha-alanine molecules as nuclei, the chirality of glycine molecules was controlled and a homochiral quantum corral array was successfully formed, which indicates the possibility that the optical isomers can be separated through a method such as preferential crystallization. (C) 2015 The Japan Society of Applied Physics	[Nakamura, Miki; Huang, Hui; Kanazawa, Ken; Taninaka, Atsushi; Yoshida, Shoji; Takeuchi, Osamu; Shigekawa, Hidemi] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Nakamura, M (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.				Japan Society for the Promotion of Science [22226003]	Support from the Japan Society for the Promotion of Science in the form of Grants-in-Aid for Scientific Research is acknowledged (22226003).	Efstathiou V, 2003, SURF SCI, V531, P304, DOI 10.1016/S0039-6028(03)00541-7; Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; Mugarza A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.115702; Duncan DA, 2012, SURF SCI, V606, P1435, DOI 10.1016/j.susc.2012.05.011; Kanazawa K, 2011, CHEM COMMUN, V47, P11312, DOI 10.1039/c1cc11829c; Bartels L, 2010, NAT CHEM, V2, P87, DOI [10.1038/nchem.517, 10.1038/NCHEM.517]; Barth JV, 2002, J AM CHEM SOC, V124, P7991, DOI 10.1021/ja0256764; Zhao XY, 2003, LANGMUIR, V19, P809, DOI 10.1021/la0267037; Sayago DI, 2005, SURF SCI, V590, P76, DOI 10.1016/j.susc.2005.06.008; Poirier GE, 1997, CHEM REV, V97, P1117, DOI 10.1021/cr960074m; Duncan DA, 2012, J PHYS CHEM C, V116, P9985, DOI 10.1021/jp300377x; Kanazawa K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216102; Elemans JAAW, 2009, ANGEW CHEM INT EDIT, V48, P7298, DOI 10.1002/anie.200806339; Yokoyama T, 2001, NATURE, V413, P619; Yitamben EN, 2013, J PHYS CHEM C, V117, P11757, DOI 10.1021/jp400074r; Weigelt S, 2006, NAT MATER, V5, P112, DOI 10.1038/nmat1558; Kanazawa K, 2007, J AM CHEM SOC, V129, P740, DOI 10.1021/ja066318u; Kanazawa K, 2015, SURF SCI, V632, pL1, DOI 10.1016/j.susc.2014.07.022; Lingenfelder M., 2007, ANGEW CHEM, V119, P4576, DOI 10.1002/ange.200700194; Liu N., 2007, ANGEW CHEM, V119, P7757, DOI 10.1002/ange.200701675; Seibel J, 2013, J AM CHEM SOC, V135, P7434, DOI 10.1021/ja402012j	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB05	10.7567/JJAP.54.08LB05		4	Physics, Applied	Physics	CN8BX	WOS:000358663300009		
J	Sakurai, S; Yamazaki, K; Ushiki, T; Iwata, F				Sakurai, Satoshi; Yamazaki, Koji; Ushiki, Tatsuo; Iwata, Futoshi			Development of a single cell electroporation method using a scanning ion conductance microscope with a theta nanopipette	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							GENE-TRANSFER; IN-VIVO; LIVING CELLS; DELIVERY; DNA; EXPRESSION; MECHANISM; RECEPTOR; VECTORS; GROWTH	We developed a novel electroporation method using a scanning ion conductance microscope (SICM) with a theta capillary nanopipette probe that has two apertures at the edge of the pipette. One aperture of the pipette probe was used to control the pipette-surface distance and to apply pulse voltage for electroporation. The other was used to eject material over the cell by local electrophoresis. Using the nanopipette, propidium iodide was successfully introduced into a targeted single Hela cell without influencing the surrounding cells. Furthermore, by scanning the theta nanopipette probe using the SICM, the morphological behaviors of the electroporated cells could be observed. (C) 2015 The Japan Society of Applied Physics	[Sakurai, Satoshi; Yamazaki, Koji; Iwata, Futoshi] Shizuoka Univ, Fac Engn, Dept Mech Engn, Hamamatsu, Shizuoka 4328561, Japan; [Ushiki, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Div Microscop Anat & Bioimaging, Niigata 9518510, Japan; [Iwata, Futoshi] Shizuoka Univ, Res Inst Elect, Hamamatsu, Shizuoka 4328011, Japan	Sakurai, S (reprint author), Shizuoka Univ, Fac Engn, Dept Mech Engn, Hamamatsu, Shizuoka 4328561, Japan.	iwata.futoshi@shizuoka.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); CREST of Japan Science and Technology Agency (JST)	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and from CREST of the Japan Science and Technology Agency (JST).	Abraham MR, 2005, CIRC RES, V97, P159, DOI 10.1161/01.RES.0000174794.22491.a0; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Chen C, 2006, MED BIOL ENG COMPUT, V44, P5, DOI 10.1007/s11517-005-0020-2; HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851; Novak P, 2014, NANO LETT, V14, P1202, DOI 10.1021/nl404068p; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P1972, DOI 10.1073/pnas.0435906100; Neumann E, 1999, BIOELECTROCH BIOENER, V48, P3, DOI 10.1016/S0302-4598(99)00008-2; Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Nadappuram BP, 2013, ANAL CHEM, V85, P8070, DOI 10.1021/ac401883n; McKelvey K, 2014, J AM CHEM SOC, V136, P13735, DOI 10.1021/ja506139u; Takahashi Y, 2011, ANGEW CHEM INT EDIT, V50, P9638, DOI 10.1002/anie.201102796; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; Zhao L, 2008, NMR BIOMED, V21, P159, DOI 10.1002/nbm.1173; TSONG TY, 1987, METHOD ENZYMOL, V149, P248; PRAUSNITZ MR, 1993, P NATL ACAD SCI USA, V90, P10504, DOI 10.1073/pnas.90.22.10504; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/nmeth.1306, 10.1038/NMETH.1306]; Babakinejad B, 2013, ANAL CHEM, V85, P9333, DOI 10.1021/ac4021769; Bird MM, 2003, J ANAT, V203, P379, DOI 10.1046/j.1469-7580.2003.00222.x; Garcia-Ocana A, 2003, J BIOL CHEM, V278, P343, DOI 10.1074/jbc.M207848200; Hattori Y, 2004, BIOCHEM BIOPH RES CO, V317, P992, DOI 10.1016/j.bbrc.2004.03.141; Hwang SH, 2001, GENE THER, V8, P1276, DOI 10.1038/sj.gt.3301510; Ikuta T, 2004, BIOCHEM BIOPH RES CO, V317, P545, DOI 10.1016/j.bbrc.2004.03.076; Ito K, 1998, THERIOGENOLOGY, V50, P1093, DOI 10.1016/S0093-691X(98)00210-6; Iwata F, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.036701; Kasparov S, 2004, PROG BIOPHYS MOL BIO, V84, P251, DOI 10.1016/j.pbiomolbio.2003.11.011; Muhlhauser J, 1996, GENE THER, V3, P145; PICKERING JG, 1994, CIRCULATION, V89, P13; Shevchuk AI, 2012, J CELL BIOL, V197, P499, DOI 10.1083/jcb.201109130; Suzuki T, 1998, FEBS LETT, V425, P436, DOI 10.1016/S0014-5793(98)00284-1; Tsulaia TV, 2003, J BIOMED SCI, V10, P328, DOI 10.1159/000070098; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB04	10.7567/JJAP.54.08LB04		6	Physics, Applied	Physics	CN8BX	WOS:000358663300008		
J	Uehara, Y; Katano, S; Kuwahara, M; Suzuki, T				Uehara, Yoichi; Katano, Satoshi; Kuwahara, Masashi; Suzuki, Tetsu			Electromagnetic properties of scanning tunneling microscope tip-sample gap in the terahertz frequency range	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LIGHT-EMISSION SPECTROSCOPY; JUNCTIONS	We have investigated electromagnetic properties of the tip-sample gap of a scanning tunneling microscope (STM) in the terahertz (THz) spectral range. Light in the STM is emitted from the current source excited by tunneling electrons through dipole radiation processes. The antenna factor that measures the efficiency of the dipole radiation contains a factor proportional to the square of the angular frequency. of the STM light. Hence, it might occur that STM light emissions in the THz spectral range become undetectably weak. The antenna factors for samples of Au and TiO2, whose plasma frequencies are in the UV and THz spectral ranges, respectively, were investigated as a function of the radius a of curvarure of the W tip. We have found that the effect of omega(2) in the antenna factor can be compensated for using a tip having an a of approximately 1500 nm. (C) 2015 The Japan Society of Applied Physics	[Uehara, Yoichi; Katano, Satoshi] Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan; [Kuwahara, Masashi] AIST, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Suzuki, Tetsu] Sendai Natl Coll Technol, Sendai, Miyagi 9893128, Japan	Uehara, Y (reprint author), Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan.				Ministry of Education, Culture, Sports, Science and Technology [26610078]	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Grant No. 26610078).	Katano S, 2010, J PHYS CHEM LETT, V1, P2763, DOI 10.1021/jz100808y; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; JOHANSSON P, 1990, PHYS REV B, V42, P9210, DOI 10.1103/PhysRevB.42.9210; UEHARA Y, 1992, JPN J APPL PHYS 1, V31, P2465, DOI 10.1143/JJAP.31.2465; HONE D, 1978, APPL PHYS LETT, V33, P203, DOI 10.1063/1.90275; BERNDT R, 1993, PHYS REV LETT, V71, P3493, DOI 10.1103/PhysRevLett.71.3493; Gimzewski J. K., 1988, P SOC PHOTO-OPT INS, V1009, P274; Iida W, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.095202; Jackson J. D., 2001, CLASSICAL ELECTRODIN, V3rd, P412; KIRTLEY JR, 1983, PHYS REV B, V27, P4601, DOI 10.1103/PhysRevB.27.4601; Lynch D. W., 1998, HDB OPTICAL CONSTANT, P286; Lynch D. W., 1998, HDB OPTICAL CONSTANT, P357; Ribarsky M. W., 1998, HDB OPTICAL CONSTANT, P798; Tsuruoka T, 2002, APPL PHYS LETT, V80, P3748, DOI 10.1063/1.1480467; Uehara Y., UNPUB; Uehara Y, 2001, APPL PHYS LETT, V79, P1718, DOI 10.1063/1.1404136	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB06	10.7567/JJAP.54.08LB06		3	Physics, Applied	Physics	CN8BX	WOS:000358663300010		
J	Yamamoto, S; Kosugai, H				Yamamoto, Shin-ichi; Kosugai, Hiroki			High photoelectron emission from Co-diffused MgO deposited using arc plasma gun	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PROBE FORCE MICROSCOPY; OXIDE THIN-FILMS; CHEMICAL-VAPOR-DEPOSITION; DISPLAY PANELS; MICROSTRUCTURE; OXIDATION; GROWTH	MgO has several advantageous characteristics and has been applied in various fields. In this study, we deposited Co nanoparticles in an island pattern on a Si substrate using an arc plasma gun (APG). We subsequently formed a MgO thin film on this substrate by metal-organic decomposition (MOD), which enables the formation of films in the atmosphere, thereby yielding a double-layer structure. The MgO thin film formed on Co nanoparticles deposited using the APG with 500 pulses of arc discharge exhibited improved crystallinity and photoelectron emission at least threefold higher than that of a MgO thin film formed directly without depositing Co nanoparticles. Although the transmittance of the specimen formed by depositing Co nanoparticles was initially 30% or lower, it increased to greater than 90% after the formation of the MgO thin film and the dispersion of the Co nanoparticles in the MgO thin film during heat treatment at 900 degrees C. Our results clarify that the characteristics of MgO thin films are markedly improved by depositing Co nanoparticles before forming the films. The results of Kelvin probe force microscopy (KPFM) indicate that the outermost surface of the Co material had become CoO (cobalt oxide) with the dispersion of Co nanoparticles in the MgO thin film. The lattice parameter of CoO nanoparticles (an-axis lattice parameter of 4.2615 angstrom) after heating matches well with that of MgO (4.2126 angstrom). The MgO thin films that grew in conjunction with the CoO nanoparticles were highly crystallized. We successfully established a high-performance, cost-effective bottom-up process that requires no ion injection by dispersing Co nanoparticles in a MgO thin film through heat treatment. (C) 2015 The Japan Society of Applied Physics	[Yamamoto, Shin-ichi; Kosugai, Hiroki] Ryukoku Univ, Fac Sci & Technol, Dept Elect & Informat, Otsu, Shiga 5202194, Japan	Yamamoto, S (reprint author), Ryukoku Univ, Fac Sci & Technol, Dept Elect & Informat, Otsu, Shiga 5202194, Japan.	shin@rins.ryukoku.ac.jp			Joint Research Center for Science and Technology of Ryukoku University	This work was supported by the Joint Research Center for Science and Technology of Ryukoku University.	Barreca D, 2001, CHEM MATER, V13, P588, DOI 10.1021/cm00104lx; Cheng CS, 1998, MATER CHEM PHYS, V53, P225, DOI 10.1016/S0254-0584(98)00044-3; Glatzel T, 2005, JPN J APPL PHYS 1, V44, P5370, DOI 10.1143/JJAP.44.5370; Uchida G, 2009, J APPL PHYS, V106, DOI 10.1063/1.3253723; FAN JCC, 1974, J APPL PHYS, V45, P3742, DOI 10.1063/1.1663854; HENRICH VE, 1974, J APPL PHYS, V45, P5484, DOI 10.1063/1.1663270; Tang S, 1998, CATAL LETT, V51, P169, DOI 10.1023/A:1019034412036; Mane AU, 2003, J CRYST GROWTH, V254, P368, DOI 10.1016/S0022-0248(03)01156-4; Cho JH, 1999, THIN SOLID FILMS, V350, P173, DOI 10.1016/S0040-6090(99)00295-3; HAGELINWEAVER HAE, 2004, SURF SCI, V235, P420, DOI DOI 10.1016/J.APSUSC.2004.02.062; Honjo Takamitsu, 2009, e-Journal of Surface Science and Nanotechnology, V7, DOI 10.1380/ejssnt.2009.791; Kato K, 2005, JPN J APPL PHYS 1, V44, P7605, DOI 10.1143/JJAP.44.7605; MURAD WA, 1988, PHYS STATUS SOLIDI A, V106, pK143, DOI 10.1002/pssa.2211060246; Nishikawa M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.01BE04; Ok JW, 2009, THIN SOLID FILMS, V517, P4152, DOI 10.1016/j.tsf.2009.02.017; Ozasa K, 2008, JPN J APPL PHYS, V47, P5630, DOI 10.1143/JJAP.47.5630; Park CS, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09MF14; Pejova B, 2001, MATER RES BULL, V36, P161, DOI 10.1016/S0025-5408(00)00479-7; Phokharatkul D, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2969290; Ram SK, 2009, THIN SOLID FILMS, V517, P6252, DOI 10.1016/j.tsf.2009.02.111; Sakurai T., 2005, E J SURF SCI NANOTEC, V3, P179, DOI 10.1380/ejssnt.2005.179; Serizawa K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DJ14; Son LN, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.025803; Tanabe D, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.113101; Yamaguchi I., 2000, Journal of the Magnetics Society of Japan, V24; Yamamoto S, 2008, JPN J APPL PHYS, V47, P6160, DOI 10.1143/JJAP.47.6160; Yamamoto SI, 2007, JPN J APPL PHYS 1, V46, P5647, DOI 10.1143/JJAP.46.5647; Yuasa S., 2009, SYNTHESIOLOGY, V2, P211	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			2				08LB09	10.7567/JJAP.54.08LB09		6	Physics, Applied	Physics	CN8BX	WOS:000358663300013		
J	Oshio, A; Yoshii, Y; Ono, K; Hashimoto, T; Satoh, T				Oshio, Ayako; Yoshii, Yuta; Ono, Koji; Hashimoto, Takashi; Satoh, Takahiro			Erythema induratum of Bazin with anti-phospholipid antibodies	JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT			German	Letter							PULMONARY TUBERCULOSIS; ANTICARDIOLIPIN		[Oshio, Ayako; Yoshii, Yuta; Ono, Koji; Hashimoto, Takashi; Satoh, Takahiro] Natl Def Med Coll, Dept Dermatol, Tokorozawa, Saitama 3598513, Japan	Satoh, T (reprint author), Natl Def Med Coll, Dept Dermatol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	tasaderm@ndmc.ac.jp					Elkayam O, 2007, INT J TUBERC LUNG D, V11, P306; Casanova-Roman M, 2002, SCAND J INFECT DIS, V34, P393, DOI 10.1080/00365540110080269; Goodridge A, 2012, TUBERCULOSIS, V92, P243, DOI 10.1016/j.tube.2012.02.004; Marruchella A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-33; Sater MS, 2012, EUR J OBSTET GYN R B, V163, P170, DOI 10.1016/j.ejogrb.2012.04.001	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1610-0379	1610-0387		J DTSCH DERMATOL GES	J. Dtsch. Dermatol. Ges.	AUG	2015	13	8					810	811		10.1111/ddg.12624		2	Dermatology	Dermatology	CN6IG	WOS:000358537500009		
J	Nakamura, Y; Teramoto, Y; Sato, S; Fujisawa, Y; Yamada, K; Yamamoto, A				Nakamura, Yasuhiro; Teramoto, Yukiko; Sato, Sayuri; Fujisawa, Yasuhiro; Yamada, Katsuhiro; Yamamoto, Akifumi			Long-term control of pleural metastasis in Stewart-Treves syndrome with single-agent chemotherapies followed by maintenance chemotherapy	JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT			German	Letter							SOFT-TISSUE SARCOMAS; WEEKLY PACLITAXEL; CUTANEOUS ANGIOSARCOMA; DOXORUBICIN		[Nakamura, Yasuhiro; Teramoto, Yukiko; Sato, Sayuri; Yamada, Katsuhiro; Yamamoto, Akifumi] Saitama Med Univ, Int Med Ctr, Dept Skin Oncology Dermatol, Hidaka, Saitama 3501298, Japan; [Fujisawa, Yasuhiro] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan	Nakamura, Y (reprint author), Saitama Med Univ, Int Med Ctr, Dept Skin Oncology Dermatol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	ynakamur@saitama-med.ac.jp					STEWART FW, 1948, CANCER, V1, P1, DOI 10.1002/1097-0142(194805)1:1<1::AID-CNCR2820010102>3.0.CO;2-G; Penel N, 2008, J CLIN ONCOL, V26, P5269, DOI 10.1200/JCO.2008.17.3146; Italiano A, 2012, CANCER-AM CANCER SOC, V118, P3330, DOI 10.1002/cncr.26599; Penel N, 2012, ANN ONCOL, V23, P517, DOI 10.1093/annonc/mdr138; Schlemmer M, 2008, EUR J CANCER, V44, P2433, DOI 10.1016/j.ejca.2008.07.037; Nagano T, 2007, CANCER, V110, P648, DOI 10.1002/cncr.22822; Mocellin S, 2006, CANCER TREAT REV, V32, P9, DOI 10.1016/j.ctrv.2005.10.003; EDMONSON JH, 1993, J CLIN ONCOL, V11, P1269; Fujisawa Y, 2014, BRIT J DERMATOL, V171, P1493, DOI 10.1111/bjd.13110; Goetze Steven, 2004, J Dtsch Dermatol Ges, V2, P49; Ruocco V, 2002, J AM ACAD DERMATOL, V47, P124, DOI 10.1067/mjd.2002.120909	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1610-0379	1610-0387		J DTSCH DERMATOL GES	J. Dtsch. Dermatol. Ges.	AUG	2015	13	8					818	820		10.1111/ddg.12630		3	Dermatology	Dermatology	CN6IG	WOS:000358537500012		
J	Matsuo, K; Elmazi, D; Liu, Y; Sakamoto, S; Barolli, L				Matsuo, Keita; Elmazi, Donald; Liu, Yi; Sakamoto, Shinji; Barolli, Leonard			A multi-modal simulation system for wireless sensor networks: a comparison study considering stationary and mobile sink and event	JOURNAL OF AMBIENT INTELLIGENCE AND HUMANIZED COMPUTING			English	Article						WSNs; Radio models; Goodput; Depletion; Delay; Network topology	CLUSTERING APPROACH; AD HOC	The wireless sensor networks (WSNs) are a sensing, computing and communication infrastructure that are able to observe and respond to phenomena in the natural environment and in our physical and cyber infrastructure. In order to simulate WSNs, we implemented a simulation system. We implement our system as a multi-model system considering different topologies, radio models, routing protocols and number of nodes. In this work, we consider the goodput, depletion and delay metrics to evaluate the performance of WSNs for AODV and DSR routing protocols considering TwoRayGround and Shadowing radio models, lattice and random topologies, and different number of nodes. We investigate the performance of WSNs for stationary and mobile sink, and stationary and mobile event. The simulation results have shown that for both stationary and mobile sinks, the goodput decreases with the increase of number of sensor nodes. In the case of mobile sink, the goodput is stable and better than in case of stationary sink, especially when the number of nodes is increased. In case of mobile sink, the consumed energy is better than stationary sink (about half of stationary sink). In case of mobile sink, the consumed energy of lattice topology is better than random topology for large number of nodes. In the case of mobile event, the goodput of AODV is better than DSR and it is stable. For large number of nodes, the goodput of DSR is low and unstable. In the case of mobile event, the depletion of Shadowing is lower than TwoRayGround. For low transmission rate, the delay of Shadowing is lower than TwoRayGround. However, for large transmission rate, the delay of Shadowing is higher than TwoRayGround.	[Matsuo, Keita] Fukuoka Prefectural Fukuoka Tech High Sch, Sawara Ku, Fukuoka, Fukuoka 8148520, Japan; [Elmazi, Donald] Polytech Univ Tirana, Tirana, Albania; [Liu, Yi; Sakamoto, Shinji; Barolli, Leonard] FIT, Higashi Ku, Fukuoka 8110295, Japan	Sakamoto, S (reprint author), FIT, Higashi Ku, 3-30-1 Wajiro Higashi, Fukuoka 8110295, Japan.	matuo-k7@fku.ed.jp; donald.elmazi@gmail.com; ryuui1010@gmail.com; shinji.t.sakamoto@gmail.com; barolli@fit.ac.jp					[Anonymous], 2002, IEEE COMMUNICATI MAY, DOI DOI 10.1109/MCOM.2002.1006984; Al-Karaki JN, 2004, IEEE WIREL COMMUN, V11, P6, DOI 10.1109/MWC.2004.1368893; Younis O, 2004, IEEE T MOBILE COMPUT, V3, P366, DOI 10.1109/TMC.2004.41; Akan OB, 2005, IEEE ACM T NETWORK, V13, P1003, DOI 10.1109/TNET.2005.857076; Lee JS, 2012, IEEE SENS J, V12, P2891, DOI 10.1109/JSEN.2012.2204737; Werner-Allen G, 2006, IEEE INTERNET COMPUT, V10, P18, DOI 10.1109/MIC.2006.26; Chen CL, 2013, COMPUT SCI INF SYST, V10, P589, DOI 10.2298/CSIS120907025C; Barolli L, 2013, INT C NETWB INFO, P194, DOI 10.1109/NBiS.2013.104; Briscoe G, 2006, 1 INT C BIOINSP MOD, P17; Carlsen S, 2009, P 3 INT C DIG EC TEC, P39; Castiglione A, 2015, J COMPUT SYST SCI, V81, P1464, DOI 10.1016/j.jcss.2014.12.022; Chang E, 2006, VISION DEBI I DIGITA; Donward I, 2004, NRLFR55220410073; Giordano S, 2007, IEEE COMMUN MAG, V45, P68, DOI 10.1109/MCOM.2007.343614; Perkins C. E., 2008, AD HOC NETWORKING; Wang Q, 2013, 2013 IEEE 27TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P278, DOI 10.1109/WAINA.2013.265; Wang Q, 2013, 4 INT C EM INT DAT W, P617; Yang T, 2013, 2013 IEEE 27TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P371, DOI 10.1109/WAINA.2013.104; Yang T, 2010, IEEE INT C ADV INF N, P245; Yang T, 2012, COMPUTER SCI CONVERG, P659; Zhou G., 2006, ACM T SENSOR NETWORK, V2, P221, DOI DOI 10.1145/1149283.1149287	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-5137	1868-5145		J AMB INTEL HUM COMP	J. Ambient Intell. Humaniz. Comput.	AUG	2015	6	4			SI		519	529		10.1007/s12652-015-0277-8		11	Computer Science, Artificial Intelligence; Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CN8CQ	WOS:000358665700011		
J	Prihandana, GS; Ito, H; Tanimura, K; Yagi, H; Hori, Y; Soykan, O; Sudo, R; Miki, N				Prihandana, Gunawan Setia; Ito, Hikaru; Tanimura, Kohei; Yagi, Hiroshi; Hori, Yuki; Soykan, Orhan; Sudo, Ryo; Miki, Norihisa			Solute diffusion through fibrotic tissue formed around protective cage system for implantable devices	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						implant; micro; fibrotic tissue; cage; diffusion	ENCAPSULATES SUBCUTANEOUS IMPLANTS; MEMBRANE	This article presents the concept of an implantable cage system that can house and protect implanted biomedical sensing and therapeutic devices in the body. Cylinder-shaped cages made of porous polyvinyl alcohol (PVA) sheets with an 80-mu m pore size and/or stainless steel meshes with 0.54-mm openings were implanted subcutaneously in the dorsal region of rats for 5 weeks. Analysis of the explanted cages showed the formation of fibrosis tissue around the cages. PVA cages had fibrotic tissue growing mostly along the outer surface of cages, while stainless steel cages had fibrotic tissue growing into the inside surface of the cage structure, due to the larger porosity of the stainless steel meshes. As the detection of target molecules with short time lags for biosensors and mass transport with low diffusion resistance into and out of certain therapeutic devices are critical for the success of such devices, we examined whether the fibrous tissue formed around the cages were permeable to molecules of our interest. For that purpose, bath diffusion and microfluidic chamber diffusion experiments using solutions containing the target molecules were performed. Diffusion of sodium, potassium and urea through the fibrosis tissue was confirmed, thus suggesting the potential of these cylindrical cages surrounded by fibrosis tissue to successfully encase implantable sensors and therapeutic apparatus. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1180-1187, 2015.	[Prihandana, Gunawan Setia; Ito, Hikaru; Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokoahama, Kanagawa, Japan; [Tanimura, Kohei; Sudo, Ryo] Keio Univ, Dept Syst Design Engn, Yokoahama, Kanagawa, Japan; [Yagi, Hiroshi] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan; [Hori, Yuki] Medtron Japan Co Ltd, Dept Strategy & Business Dev, Minato Ku, Tokyo, Japan; [Soykan, Orhan] Medtronic Inc, Dept Ventures & New Therapies, Fridley, MN USA	Miki, N (reprint author), Keio Univ, Dept Mech Engn, Yokoahama, Kanagawa, Japan.	miki@mech.keio.ac.jp	Miki, Norihisa/F-7659-2014		Medtronic, Inc	Contract grant sponsor: Medtronic, Inc	Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E; Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556; Prihandana GS, 2013, MATERIALS, V6, P4309, DOI 10.3390/ma6104309; GILLIGAN BJ, 1994, DIABETES CARE, V17, P882, DOI 10.2337/diacare.17.8.882; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Degan TW, 2013, US Patents, Patent No. [8,585,635, 8585635]; Gu Y, 2007, J MICROMECH MICROENG, V17, P2308, DOI 10.1088/0960-1317/17/11/018; MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209; Prihandana GS, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40024; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P598, DOI 10.1002/(SICI)1097-4636(19980615)40:4<598::AID-JBM11>3.0.CO;2-C; Soykan O, 2014, US Patent, Patent No. [8,641,659, 8641659]	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	AUG	2015	103	6					1180	1187		10.1002/jbm.b.33298		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CN5QQ	WOS:000358484700005		
J	Kobayashi, M; Haraguchi, Y; Shimizu, T; Mizuuchi, K; Iseki, H				Kobayashi, Mari; Haraguchi, Yuji; Shimizu, Tatsuya; Mizuuchi, Kiminori; Iseki, Hiroshi			Real-time, noninvasive optical coherence tomography of cross-sectional living cell-sheets in vitro and in vivo	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						cell sheet technology; cross-sectional observation; optical coherence tomography; three-dimensional tissue; transplantation	RENAL NERVE ABLATION; CARTILAGE DEFECTS; CULTURE SURFACES; TISSUE; TRANSPLANTATION; SYSTEM; GRAFTS; RECONSTRUCTION; REGENERATION; FABRICATION	Cell sheet technology has a history of application in regenerating various tissues, having successfully completed several clinical trials using autologous cell sheets. Tomographic analysis of living cell sheets is an important tool in the field of cell sheet-based regenerative medicine and tissue engineering to analyze the inner structure of layered living cells. Optical coherence tomography (OCT) is commonly used in ophthalmology to noninvasively analyze cross-sections of target tissues at high resolution. This study used OCT to conduct real-time, noninvasive analysis of living cell sheet cross sections. OCT showed the internal structure of cell sheets in tomographic images synthesized with backscatter signals from inside the living cell sheet without invasion or damage. OCT observations were used to analyze the static and dynamic behaviors of living cell sheets in vitro and in vivo including (1) the harvesting process of a C2C12 mouse skeletal myoblast sheet from a temperature-responsive culture surface; (2) cell-sheet adhesion onto various surfaces including a culture surface, a synthetic rubber glove, and the dorsal subcutaneous tissue of rats; and (3) the real-time propagation of beating rat cardiac cells within cardiac cell sheets. This study showed that OCT technology is a powerful tool in the field of cell sheet-based regenerative medicine and tissue engineering. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1267-1273, 2015.	[Kobayashi, Mari; Iseki, Hiroshi] Tokyo Womens Med Univ, Joint Grad Sch, Tokyo 1628666, Japan; [Kobayashi, Mari; Iseki, Hiroshi] Waseda Univ, Shinjuku Ku, Tokyo 1628666, Japan; [Kobayashi, Mari; Mizuuchi, Kiminori] Panason Healthcare, Minato Ku, Tokyo 1058433, Japan; [Haraguchi, Yuji; Shimizu, Tatsuya; Iseki, Hiroshi] Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan	Shimizu, T (reprint author), Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan.	shimizu.tatsuya@twmu.ac.jp			Formation of Innovation Center for Fusion of Advanced Technologies (Special Coordination Funds for Promoting Science and Technology "Cell Sheet Tissue Engineering Center (CSTEC)); Ministry of Education, Culture, Sports Science, and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS) (Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)); Council for Science and Technology Policy (CSTP); Panasonic Healthcare Co. Ltd.	Contract grant sponsors: Formation of Innovation Center for Fusion of Advanced Technologies (Special Coordination Funds for Promoting Science and Technology "Cell Sheet Tissue Engineering Center (CSTEC)); Ministry of Education, Culture, Sports Science, and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS) (Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)); Council for Science and Technology Policy (CSTP), Panasonic Healthcare Co. Ltd.	Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K; Chachques JC, 2007, CELL TRANSPLANT, V16, P927, DOI 10.3727/096368907783338217; [Anonymous], 2011, J BIOCHIP TISSUE S; Kim DY, 2013, P NATL ACAD SCI USA, V110, P14354, DOI 10.1073/pnas.1307315110; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Kanellopoulos AJ, 2013, CORNEA, V32, P1493, DOI 10.1097/ICO.0b013e3182a15cee; Tadakuma K, 2013, BIOMATERIALS, V34, P9018, DOI 10.1016/j.biomaterials.2013.08.006; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kanzaki M, 2008, EUR J CARDIO-THORAC, V34, P864, DOI 10.1016/j.ejcts.2008.05.048; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Shimada Y, 2012, DENT MATER J, V31, P409, DOI 10.4012/dmj.2011-244; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Wojtkowski M, 2002, J BIOMED OPT, V7, P457, DOI 10.1117/1.1482379; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Haraguchi Y, 2010, TISSUE ENG PART C-ME, V16, P685, DOI 10.1089/ten.TEC.2009.0459; Burillon C, 2012, INVEST OPHTH VIS SCI, V53, P1325, DOI 10.1167/iovs.11-7744; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Kim K, 2012, BIOMATERIALS, V33, P1406, DOI 10.1016/j.biomaterials.2011.10.084; Haraguchi Y, 2006, BIOMATERIALS, V27, P4765, DOI 10.1016/j.biomaterials.2006.04.034; Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2; Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Milligan CJ, 2009, NAT PROTOC, V4, P244, DOI 10.1038/nprot.2008.230; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Templin C, 2013, EUR HEART J, V34, P2141, DOI 10.1093/eurheartj/eht141; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978; Shinoka Toshiharu, 2008, Yale Journal of Biology and Medicine, V81, P161; Egami M, 2014, ARCH PHARM RES, V37, P96, DOI 10.1007/s12272-013-0299-8; Ierna S, 2013, INT J CARDIOL, V165, pE35, DOI 10.1016/j.ijcard.2012.10.056; Lee K, 2009, J BIOMED MATER RES B, V89B, P252, DOI 10.1002/jbm.b.31199; Ohashi K, 2011, TRANSPL P, V43, P3188, DOI 10.1016/j.transproceed.2011.10.027; Rasband WS, 1997, IMAGEJ; Secco GG, 2013, INT J CARDIOL, V168, P5024, DOI 10.1016/j.ijcard.2013.07.167; Templin C, 2010, EUR HEART J, V31, P1792, DOI 10.1093/eurheartj/ehq168	47	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	AUG	2015	103	6					1267	1273		10.1002/jbm.b.33309		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CN5QQ	WOS:000358484700014		
J	Naruse, Y; Nogami, A; Harimura, Y; Ishibashi, M; Noguchi, Y; Sekiguchi, Y; Sato, A; Aonuma, K				Naruse, Yoshihisa; Nogami, Akihiko; Harimura, Yoshie; Ishibashi, Mayu; Noguchi, Yuichi; Sekiguchi, Yukio; Sato, Akira; Aonuma, Kazutaka			Difference in the Clinical Characteristics of Ventricular Fibrillation Occurrence in the Early Phase of an Acute Myocardial Infarction Between Patients With and Without J Waves	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						acute myocardial infarction; early repolarization; ECG; J-wave; percutaneous coronary intervention; ventricular fibrillation	SUDDEN CARDIAC DEATH; EARLY REPOLARIZATION; ARRHYTHMIAS; PREVALENCE; ELEVATION; RISK; ELECTROCARDIOGRAM; DEFINITION; DISEASE	Characteristics of VF in AMI Patients with J Waves IntroductionWe recently showed that the presence of J waves increases the risk of ventricular fibrillation (VF) occurrence in the early phase of an acute myocardial infarction (AMI). This study aimed to evaluate the clinical characteristics of VF occurrences in the early phase of an AMI between patients with and without J waves. Methods and ResultsThis retrospective, observational study included 281 consecutive patients with an AMI (69 12 years; 207 men) in whom 12-lead ECGs before AMI onset could be evaluated. The patients were classified based on a VF occurrence <48 hours after AMI onset and the presence of J waves. J waves were electrocardiographically defined as an elevation of the terminal portion of the QRS complex of >0.1 mV from baseline in at least 2 contiguous inferior or lateral leads. VF occurred in 24 patients, and J waves were present in 37. VF occurrence was more prevalent in the patients with than without J waves (27% vs. 6%; P < 0.001). Among the 244 patients without J waves, peak creatine kinase level (P < 0.01), number of diseased coronary arteries (P < 0.01), and male sex (P < 0.05) were higher in the patients with than without VF occurrence. However, among the 37 patients with J waves, there was no significant difference in these variables. There was no association between the location of J waves and the infarct area. ConclusionsIn patients with AMI, those with J waves were more likely to develop VF and less likely to have high-risk clinical characteristics than those without J waves.	[Naruse, Yoshihisa; Nogami, Akihiko; Harimura, Yoshie; Ishibashi, Mayu; Sekiguchi, Yukio; Sato, Akira; Aonuma, Kazutaka] Univ Tsukuba, Cardiovasc Div, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Noguchi, Yuichi] Tsukuba Med Ctr Hosp, Cardiovasc Div, Tsukuba, Ibaraki, Japan	Nogami, A (reprint author), Univ Tsukuba, Cardiovasc Med, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	akihiko-ind@umin.ac.jp			Ministry of Health, Labour and Welfare, Japan [H21-Nanchi-Ippan-059, H22-Nanchi-Ippan-144, H24-Nanchi-Ippan-033]	This research was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare, Japan (Intractable Diseases Conquest Research on H21-Nanchi-Ippan-059; Intractable Diseases Conquest Research: H22-Nanchi-Ippan-144; and Intractable Diseases Conquest Research on H24-Nanchi-Ippan-033).	Gussak I, 2000, J ELECTROCARDIOL, V33, P299, DOI 10.1054/jelc.2000.18106; Takagi M, 2013, HEART RHYTHM, V10, P533, DOI 10.1016/j.hrthm.2012.12.023; Uberoi A, 2011, CIRCULATION, V124, P2208, DOI 10.1161/CIRCULATIONAHA.111.047191; Heng SJ, 2012, J AM COLL CARDIOL, V60, P947, DOI 10.1016/j.jacc.2012.03.061; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; Patel RB, 2010, CIRC-ARRHYTHMIA ELEC, V3, P489, DOI 10.1161/CIRCEP.109.921130; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; Patel RB, 2012, AM J CARDIOL, V110, P615, DOI 10.1016/j.amjcard.2012.04.042; Mehta M, 1999, CLIN CARDIOL, V22, P59; Volpi A, 1998, AM J CARDIOL, V82, P265, DOI 10.1016/S0002-9149(98)00336-1; Caliskan K, 2012, J CARDIOVASC ELECTR, V23, P938, DOI 10.1111/j.1540-8167.2012.02325.x; Brugada J, 1998, CIRCULATION, V97, P457; Naruse Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P506, DOI 10.1161/CIRCEP.111.966952; Senter S, 2009, CLEV CLIN J MED, V76, P159, DOI 10.3949/ccjm.75a.08092; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Piccini JP, 2008, AM J MED, V121, P797, DOI 10.1016/j.amjmed.2008.04.024; Mehta RH, 2009, JAMA-J AM MED ASSOC, V301, P1779, DOI 10.1001/jama.2009.600; Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010; Rudic B, 2012, HEART RHYTHM, V9, P1295, DOI 10.1016/j.hrthm.2012.03.006; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Gheeraert PJ, 2006, EUR HEART J, V27, P2499, DOI 10.1093/eurheartj/ehl218; Sekiguchi Y, 2013, J CARDIOVASC ELECTR, V24, P902, DOI 10.1111/jce.12154; Tikkanen JT, 2012, CIRC-ARRHYTHMIA ELEC, V5, P714, DOI 10.1161/CIRCEP.112.970863; Watanabe H, 2010, HEART RHYTHM, V7, P647, DOI 10.1016/j.hrthm.2010.01.012	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	AUG	2015	26	8					872	878		10.1111/jce.12691		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CN8JK	WOS:000358686300009		
J	Oheda, M; Inamasu, J; Moriya, S; Kumai, T; Kawazoe, Y; Nakae, S; Kato, Y; Hirose, Y				Oheda, Motoki; Inamasu, Joji; Moriya, Shigeta; Kumai, Tadashi; Kawazoe, Yushi; Nakae, Shunsuke; Kato, Yoko; Hirose, Yuichi			Early rebleeding in patients with subarachnoid haemorrhage under intensive blood pressure management	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Blood pressure; Early rebleeding; Nicardipine; Subarachnoid haemorrhage	INTRACEREBRAL HEMORRHAGE; CEREBRAL ANEURYSMS; ANGIOGRAPHY; DISSECTION; PROGNOSIS; IMPACT; TRIAL; ULTRA; RISK	The objective of this study was to report the frequency and clinical characteristics of early rebleeding in subarachnoid haemorrhage (SAH) patients who underwent intensive blood pressure (BP) management. Patients with aneurysmal SAH frequently present to the emergency department (ED) with elevated BP. Intensive BP management has been recommended to lower the risk of early rebleeding. However, few studies have reported the frequency of early rebleeding in SAH patients undergoing BP management. In our institution, SAH patients with systolic BP (SBP) > 140 mmHg received continuous intravenous nicardipine to maintain their SBP within 120 20 mmHg after diagnosis. An attempt to implement intensive BP management was made on 309 consecutive SAH patients who presented to our ED within 48 hours of SAH onset. Overall, 24 (7.8%) of the 309 patients sustained early rebleeding. Fifteen patients sustained early rebleeding before the implementation of BP management, and the other nine sustained early rebleeding after the implementation of BP management. Therefore, the frequency of early rebleeding under BP management was 3.1% (9/294). When the 309 patients were dichotomised using ED SBP of 140 mmHg as a cut off (SBP > 140 mmHg; n = 239 versus SBP <= 140 mmHg; n = 70), the latter counter-intuitively exhibited a significantly higher frequency of early rebleeding (5.9% versus 14.2%; p = 0.04). This relatively low frequency of early rebleeding under BP management may be acceptable. However, early rebleeding is not eradicated even with strict BP control as factors other than elevated BP are involved. ED SBP within the target range (SBP <= 140 mmHg) does not negate the risk of early rebleeding. Other treatment options that reduce the risk should also be explored. (C) 2015 Elsevier Ltd. All rights reserved.	[Oheda, Motoki; Inamasu, Joji; Moriya, Shigeta; Kumai, Tadashi; Kawazoe, Yushi; Nakae, Shunsuke; Kato, Yoko; Hirose, Yuichi] Fujita Hlth Univ Hosp, Dept Neurosurg, Toyoake, Aichi 4701192, Japan	Inamasu, J (reprint author), Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	inamasu@fujita-hu.ac.jp					Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Butcher KS, 2013, STROKE, V44, P620, DOI 10.1161/STROKEAHA.111.000188; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Culyer V, 2013, J STROKE CEREBROVASC, V22, P1225, DOI 10.1016/j.jstrokecerebrovasdis.2012.02.015; De Marchis GM, 2014, J NEUROL NEUROSUR PS, V85, P56, DOI 10.1136/jnnp-2013-305051; Fujii Y, 1996, J NEUROSURG, V84, P35, DOI 10.3171/jns.1996.84.1.0035; Germans MR, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-143; Guo LM, 2011, WORLD NEUROSURG, V76, P253; Guo LM, 2011, WORLD NEUROSURG, V76, P292, DOI 10.1016/j.wneu.2011.03.025; Hashiguchi A, 2007, NEUROSURG REV, V30, P151, DOI 10.1007/s10143-007-0068-6; Inamasu J, 2009, RESUSCITATION, V80, P977, DOI 10.1016/j.resuscitation.2009.05.010; Inamasu J, 2003, CEREBROVASC DIS, V16, P306, DOI 10.1159/000071135; Kusumi M, 2005, ACTA NEUROCHIR, V147, P831, DOI 10.1007/s00701-005-0541-3; Li SM, 2011, J CLIN NEUROSCI, V18, P789, DOI 10.1016/j.jocn.2010.11.006; LINDSAY KW, 1982, J NEUROSURG, V56, P628, DOI 10.3171/jns.1982.56.5.0628; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; Ohkuma H, 2001, STROKE, V32, P1176; Parkhutik V, 2012, J STROKE CEREBROVASC, V21, P755, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.002; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS100, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.011; Shirani P, 2013, STROKE, V44, pA51; Tang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099536; Tanno Y, 2007, J NEUROL SCI, V258, P11, DOI 10.1016/j.jns.2007.01.074; Yasui T, 1996, SURG NEUROL, V45, P564; Yasui T, 1996, SURG NEUROL, V45, P560, DOI 10.1016/0090-3019(95)00360-6	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2015	22	8					1338	1342		10.1016/j.jocn.2015.02.024		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN4GZ	WOS:000358389900023		
J	Seki, M; Takizawa, T; Suzuki, S; Shimizu, T; Shibata, H; Ishii, T; Hasegawa, T; Suzuki, N				Seki, M.; Takizawa, T.; Suzuki, S.; Shimizu, T.; Shibata, H.; Ishii, T.; Hasegawa, T.; Suzuki, N.			Adult phenylketonuria presenting with subacute severe neurologic symptoms	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Adult; MRI; Neurological deterioration; Phenylketonuria; SPECT	WHITE-MATTER ABNORMALITIES	We report a 48-year-old Japanese woman with phenylketonuria (PKU) who presented with severe neurological symptoms more than 30 years after discontinuation of dietary treatment. She was diagnosed with PKU at 6-years-old and was treated with a phenylalanine restricted diet until she was 15 years old. When she was 48-years-old she started having difficulty walking. After several months, she presented with severe disturbance of consciousness and was admitted. She was diagnosed as having neurological complications associated with PKU. We observed temporal changes in her laboratory data, brain MRI and single-photon emission computed tomography (SPECT) scan findings. Brain MRI on T2-weighted, fluid-attenuated inversion recovery and diffusion-weighted images revealed high intensity lesions in her bilateral frontal lobes and 123I-IMP SPECT showed marked and diffuse hypoperfusion in the bilateral cerebrum and cerebellum. After the resumption of dietary treatment, serum phenylalanine concentrations immediately decreased to the normal range. However, her neurological symptoms took longer to improve. We also found no clear temporal association between MRI findings and clinical severity. SPECT abnormalities showed marked improvement after treatment. It is well known that PKU patients who discontinue the dietary restriction from their childhood develop minor neurological impairments. However, PKU patients with late-onset severe neurological symptoms are very rare. To our knowledge, this is the first report regarding SPECT findings of PKU patients with late-onset severe neurological deterioration. (C) 2015 Elsevier Ltd. All rights reserved.	[Seki, M.; Takizawa, T.; Suzuki, S.; Shimizu, T.; Suzuki, N.] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan; [Shibata, H.; Ishii, T.; Hasegawa, T.] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo 1608582, Japan	Seki, M (reprint author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sekimori709@gmail.com	Shimizu, Toshihiko/M-4870-2013; Suzuki, Shigeaki/N-9555-2013; Suzuki, Norihiro/J-5125-2013				Pietz J, 1998, EUR J PEDIATR, V157, P824, DOI 10.1007/s004310050945; Trefz F, 2011, MOL GENET METAB, V104, pS26, DOI 10.1016/j.ymgme.2011.08.025; Leuzzi V, 2007, J INHERIT METAB DIS, V30, P209, DOI 10.1007/s10545-006-0399-4; Hanley WB, 2004, AM J MED, V117, P590, DOI 10.1016/j.amjmed.2004.03.042; CLEARY MA, 1995, J PEDIATR-US, V127, P251, DOI 10.1016/S0022-3476(95)70303-9; Anderson PJ, 2010, MOL GENET METAB, V99, pS3, DOI 10.1016/j.ymgme.2009.10.005; MCCOMBE PA, 1992, J NEUROL NEUROSUR PS, V55, P359, DOI 10.1136/jnnp.55.5.359; Hoeks MPA, 2009, NETH J MED, V67, P2; SEASHORE MR, 1985, PEDIATRICS, V75, P226; THOMPSON AJ, 1990, LANCET, V336, P602, DOI 10.1016/0140-6736(90)93401-A	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2015	22	8					1361	1363		10.1016/j.jocn.2015.02.011		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN4GZ	WOS:000358389900028		
J	Toji, T; Takata, K; Sato, Y; Miyata-Takata, T; Hayashi, E; Habara, T; Maeda, Y; Tanimoto, M; Yoshino, T				Toji, Tomohiro; Takata, Katsuyoshi; Sato, Yasuharu; Miyata-Takata, Tomoko; Hayashi, Eiko; Habara, Toshiyuki; Maeda, Yoshinobu; Tanimoto, Mitsune; Yoshino, Tadashi			Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma	JOURNAL OF CLINICAL PATHOLOGY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; NON-HODGKIN-LYMPHOMA; CELL LYMPHOMA; PERIPHERAL-BLOOD; SIL-2R LEVEL; LEUKEMIA; MALIGNANCIES; CARCINOMA; SURVIVAL	Acute lymphoblastic leukaemia/lymphoma (ALL/LBL) is an aggressive form of non-Hodgkin's lymphoma (NHL) affecting B-cells or T-cells, respectively. The serum level of soluble interleukin-2 receptor (sIL-2R) is known to reflect the immune activity and tumour volume in aggressive NHL; however, the release of sIL-2R in LBL has not been extensively studied. Further, the relationship between sIL-2R release and the expression level of IL-2R alpha subunit (CD25) remains unknown. In the present study, we examined the serum level of sIL-2R in 23 patients with T lymphoblactic lymphoma (T-LBL) and compared these with the levels in 20 patient with T acute lymphoblastic leukaemia (T-ALL), 40 patients with diffuse large B-cell lymphoma (DLBCL) and 40 patients with peripheral T-cell lymphoma (PTCL), not otherwise specified. The release of sIL-2R into the serum in patients with T-LBL was significantly lower than that for T-ALL, DLBCL and PTCL (p<0.001). Immunohistochemistry revealed that CD25 expression was correlated with the serum level of sIL-2R in T-LBL (p=0.0069), whereas no correlation was found to exist between serum sIL-2R levels and CD25 expression in patients with DLBCL (p=0.348) and PTCL (p=0.266). Furthermore, double immunohistochemical analysis revealed that CD25-positive cells were also found to be Foxp3-positive non-neoplastic T-cells. In conclusion, CD25-positive non-neoplastic T-cells in T-LBL are presumed to be the primary source of sIL-2R, and the low number of cells present results in a lower level of sIL-2R released into the serum compared with the other aggressive and highly aggressive lymphomas.	[Toji, Tomohiro; Takata, Katsuyoshi; Sato, Yasuharu; Miyata-Takata, Tomoko; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008558, Japan; [Hayashi, Eiko] Iwakuni Med Ctr, Dept Pathol, Iwakuni, Japan; [Habara, Toshiyuki] Mutual Aid Assoc Publ Sch Teachers, Chugoku Cent Hosp, Dept Clin Lab, Hiroshima, Japan; [Maeda, Yoshinobu; Tanimoto, Mitsune] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama 7008558, Japan	Takata, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	katsuyoshi.t@h5.dion.ne.jp					KAMIHIRA S, 1994, CANCER, V73, P2753, DOI 10.1002/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X; Lindqvist CA, 2010, IMMUNOLOGY, V131, P371, DOI 10.1111/j.1365-2567.2010.03308.x; WAGNER DK, 1987, J CLIN ONCOL, V5, P1262; Moon Y, 2004, ANN CLIN LAB SCI, V34, P410; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Goto H, 2005, J CANCER RES CLIN, V131, P73, DOI 10.1007/s00432-004-0600-9; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Liotta F, 2011, BJU INT, V107, P1500, DOI 10.1111/j.1464-410X.2010.09555.x; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; Wasik MA, 1996, ARCH DERMATOL, V132, P42, DOI 10.1001/archderm.132.1.42; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Janik JE, 2004, BLOOD, V104, P3355, DOI 10.1182/blood-2003-11-3922; Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Jiskra J, 2009, CLIN EXP IMMUNOL, V156, P211, DOI 10.1111/j.1365-2249.2009.03897.x; Jones D, 2004, CLIN CANCER RES, V10, P5587, DOI 10.1158/1078-0432.CCR-0721-03; Kitagawa JI, 2009, J CANCER RES CLIN, V135, P53, DOI 10.1007/s00432-008-0440-0; Lee W, 2005, ANN CLIN LAB SCI, V35, P407; Nakase K, 2005, CANCER DETECT PREV, V29, P256, DOI 10.1016/j.cdp.2005.03.001; PIZZOLO G, 1987, BRIT J CANCER, V55, P427, DOI 10.1038/bjc.1987.83; PUI CH, 1988, BLOOD, V71, P1135; Swerdlow S, 2008, WHO CLASSIFICATION T; Wang LS, 2000, CLIN CANCER RES, V6, P1445; WASIK MA, 1994, AM J PATHOL, V144, P1089; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yoshida N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078730	26	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	AUG	2015	68	8					622	627		10.1136/jclinpath-2015-202934		6	Pathology	Pathology	CN7AP	WOS:000358586200006		
J	Kojima, M; Puppa, G; Kirsch, R; Basturk, O; Frankel, WL; Vieth, M; Lugli, A; Sheahan, K; Yeh, M; Lauwers, GY; Risio, M; Shimazaki, H; Iwaya, K; Kage, M; Akiba, J; Ohkura, Y; Horiguchi, S; Shomori, K; Kushima, R; Nomura, S; Ajioka, Y; Adsay, V; Ochiai, A				Kojima, Motohiro; Puppa, Giacomo; Kirsch, Richard; Basturk, Olca; Frankel, Wendy L.; Vieth, Michael; Lugli, Alessandro; Sheahan, Kieran; Yeh, Matthew; Lauwers, Greg Y.; Risio, Mauro; Shimazaki, Hideyuki; Iwaya, Keiichi; Kage, Masayoshi; Akiba, Jun; Ohkura, Yasuo; Horiguchi, Shinichiro; Shomori, Kohei; Kushima, Ryoji; Nomura, Shogo; Ajioka, Yoichi; Adsay, Volkan; Ochiai, Atsushi			Blood and lymphatic vessel invasion in pT1 colorectal cancer: an international concordance study	JOURNAL OF CLINICAL PATHOLOGY			English	Article							VASCULAR INVASION; LYMPHOVASCULAR INVASION; NODE METASTASIS; VENOUS INVASION; CARCINOMA; INTEROBSERVER; VARIABILITY; PATHOLOGY; RECTUM; COLON	Aim This study was performed to evaluate the concordance in pathological assessments of blood and lymphatic vessel invasion (BLI) in pT1 colorectal cancers and to assess the effect of diagnostic criterion on consistency in the assessment of BLI. Methods Forty consecutive patients undergoing surgical resection of pT1 colorectal cancers were entered into this study. H&E-stained, D2-40-stained and elastica-stained slides from the tumours were examined by 18 pathologists from seven countries. The 40 cases were divided into two cohorts with 20 cases each. In cohort 1, pathologists diagnosed BLI using criteria familiar to them; all Japanese pathologists used a criterion of BLI from the Japanese Society for Cancer of the Colon and Rectum (JSCCR). In cohort 2, all pathologists used the JSCCR diagnostic criterion. Results In cohort 1, diagnostic concordance was moderate in the US/Canadian and European pathologists. There were no differences in the consistency compared with results for Japanese pathologists, and no improvement in the diagnostic concordance was found for using the JSCCR criterion. However, in cohort 2, the JSCCR criterion decreased the consistency of BLI diagnosis in the US/Canadian and European pathologists. The level of decreased consistency in the assessment of BLI was different between the US/Canadian and European pathologists. Conclusions A uniform criterion strongly influences the diagnostic consistency of BLI but may not always improve the concordance. Further study is required to achieve an objective diagnosis of BLI in colorectal cancer. The varying effects of diagnostic criterion on the pathologists from Japan, the USA/Canada and Europe might reflect varied interpretations of the criterion. Internationally accepted criterion should be developed by participants from around the world.	[Kojima, Motohiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba 2778577, Japan; [Puppa, Giacomo] Hop Univ Geneve 1, Dept Pathol, Geneva, Switzerland; [Kirsch, Richard] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Basturk, Olca] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Frankel, Wendy L.] Ohio State Univ, Dept Pathol, Med Ctr, Columbus, OH 43210 USA; [Vieth, Michael] Inst Pathol, Bayreuth, Germany; [Lugli, Alessandro] Univ Bern, Inst Pathol, Bern, Switzerland; [Sheahan, Kieran] St Vincents Univ Hosp, Dept Pathol, Dublin 4, Ireland; [Yeh, Matthew] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Lauwers, Greg Y.] Massachusetts Gen Hosp, Dept Pathol, Gastrointestinal Pathol Serv, Boston, MA 02114 USA; [Risio, Mauro] IRCCS, Candiolo Canc Inst FPO, Dept Pathol, Turin, Italy; [Shimazaki, Hideyuki; Iwaya, Keiichi] Natl Def Med Coll, Dept Pathol, Saitama, Japan; [Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Fukuoka, Japan; [Akiba, Jun] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan; [Ohkura, Yasuo] Kyorin Univ, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Horiguchi, Shinichiro] Tokyo Metropolitan Komagome Hosp, Dept Pathol, Tokyo, Japan; [Shomori, Kohei] Sanin Rosai Hosp, Div Pathol, Tottori, Japan; [Kushima, Ryoji] Shiga Univ Med Sci Hosp, Div Diagnost Pathol, Otsu, Shiga, Japan; [Nomura, Shogo] Natl Canc Ctr, Ctr Res Adm & Support, Div Biostat, Tokyo 104, Japan; [Ajioka, Yoichi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pathol, Niigata, Japan; [Adsay, Volkan] Emory Univ, Sch Med, Pathol & Lab Med, Atlanta, GA USA	Ochiai, A (reprint author), Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	aochiai@east.ncc.go.jp			Japanese Society for Cancer of the Colon and Rectum (JSCCR); Ministry of Health, Labor and Welfare, Japan [26-A-8, 19]	This work was supported by the Japanese Society for Cancer of the Colon and Rectum (JSCCR) and Grant-in-Aid for Cancer Research (26-A-8, 19) from the Ministry of Health, Labor and Welfare, Japan.	Akishima-Fukasawa Y, 2011, HISTOPATHOLOGY, V59, P470, DOI 10.1111/j.1365-2559.2011.03964.x; Kirsch R, 2013, AM J SURG PATHOL, V37, P200, DOI 10.1097/PAS.0b013e31826a92cd; Tominaga K, 2005, DIS COLON RECTUM, V48, P92, DOI 10.1007/S10350-004-0751-4; Dotan E, 2011, SEMIN ONCOL, V38, P511, DOI 10.1053/j.seminoncol.2011.05.005; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Suzuki A, 2009, AM J SURG PATHOL, V33, P1601, DOI 10.1097/PAS.0b013e3181ae29d6; TALBOT IC, 1981, HISTOPATHOLOGY, V5, P141, DOI 10.1111/j.1365-2559.1981.tb01774.x; Kingston EF, 2007, DIS COLON RECTUM, V50, P1867, DOI 10.1007/s10350-007-9021-6; Puppa G, 2012, HISTOPATHOLOGY, V61, P562, DOI 10.1111/j.1365-2559.2012.04270.x; Puppa G, 2011, AM J SURG PATHOL, V35, P465, DOI 10.1097/PAS.0b013e31820ac84a; Kojima M, 2013, J CLIN PATHOL, V66, P551, DOI 10.1136/jclinpath-2012-201076; Harris EI, 2008, AM J SURG PATHOL, V32, P1816, DOI 10.1097/PAS.0b013e3181816083; Baumhoer D, 2010, INT J COLORECTAL DIS, V25, P741, DOI 10.1007/s00384-010-0890-0; Brown CE, 1938, SURG GYNECOL OBSTET, V66, P611; Chen B ZD, 2005, P 30 ANN SAS US GROU; Chung CK, 1982, ANN THORAC SURG, V33, P599; Cserni G, 2013, J CLIN PATHOL, V66, P543, DOI 10.1136/jclinpath-2013-201587; Fan LF, 2010, J GASTROEN HEPATOL, V25, P1556, DOI 10.1111/j.1440-1746.2010.06304.x; GILCHRIST KW, 1982, HUM PATHOL, V13, P170, DOI 10.1016/S0046-8177(82)80121-4; Ito Masahiro, 2007, Breast Cancer, V14, P381, DOI 10.2325/jbcs.14.381; MINSKY B, 1989, DIS COLON RECTUM, V32, P794, DOI 10.1007/BF02562132; Mohammed RAA, 2007, AM J SURG PATHOL, V31, P1825, DOI 10.1097/PAS.0b013e31806841f6; NEWLAND RC, 1995, CANCER, V76, P564, DOI 10.1002/1097-0142(19950815)76:4<564::AID-CNCR2820760405>3.0.CO;2-Z; PAGNINI CA, 1985, VIRCHOWS ARCH A, V406, P213; Puppa G, 2011, AM J SURG PATHOL, V35, P468, DOI DOI 10.1097/PAS.0B013E31820AC84A]; Sobin LH, 2009, TNM CLASSIFICATION M, V7th, P15; Washington KBK, 2009, PROTOCOL EXAMINATION	27	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	AUG	2015	68	8					628	632		10.1136/jclinpath-2014-202805		5	Pathology	Pathology	CN7AP	WOS:000358586200007		
J	Mochizuki, H; Kakigi, R				Mochizuki, Hideki; Kakigi, Ryusuke			Itch and brain	JOURNAL OF DERMATOLOGY			English	Review						cerebral response to itch; contagious itch; functional brain imaging; itch suppression; pleasurability derived from scratching	HISTAMINE-INDUCED ITCH; POSITRON-EMISSION-TOMOGRAPHY; PRIMARY SOMATOSENSORY CORTEX; INDUCED DOPAMINE RELEASE; HUMAN CEREBRAL-CORTEX; ATOPIC-DERMATITIS; PAIN PERCEPTION; LASER STIMULATION; EVOKED-POTENTIALS; SPATIAL ATTENTION	Itch is an unpleasant somatic sensation that evokes the urge to scratch. Chronic itch is a severe problem that diminishes quality of life. There are many patients suffering from chronic itch across the world. The brain is the final terminal to receive itch-related signals from the body and plays an important role in perceiving the itch sensation. Thus, to understand the cerebral mechanism of itch perception and how this mechanism differs between healthy subjects and chronic itch patients is important for advancing our understanding on the pathophysiology of chronic itch. Itch is suppressed by scratching or applying painful stimuli. The pleasurable sensation evoked by scratching an itch increases the urge to scratch. Viewing others in itch or imagining the itch sensation may evoke real itch sensations and the scratching response. To understand the mechanisms responsible for these phenomena may provide useful information for the development of treatment of itch and advance our understanding of the cerebral mechanism of itch and scratch. Several functional brain imaging studies have addressed these issues and reported interesting findings. In this review article, the authors discussed the findings of previous studies and how they have advanced our understanding of the central mechanisms of itch, scratch and chronic itch.	[Mochizuki, Hideki] Temple Univ, Sch Med, Dept Dermatol, Temple Itch Ctr, Philadelphia, PA 19140 USA; [Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan	Mochizuki, H (reprint author), Temple Univ, Sch Med, Dept Dermatol, Temple Itch Ctr, 3322 North Broad St,Suite 212, Philadelphia, PA 19140 USA.	hideki.mochizuki@tuhs.temple.edu					Akiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022665; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Cruccu G, 2003, BRAIN, V126, P2246, DOI 10.1093/brain/awg227; McCabe C, 2007, EUR J NEUROSCI, V25, P1855, DOI 10.1111/j.1460-9568.2007.05445.x; McClernon FJ, 2009, PSYCHOPHARMACOLOGY, V204, P25, DOI 10.1007/s00213-008-1436-9; Ploner M, 1999, J NEUROPHYSIOL, V81, P3100; [Anonymous], 2006, J ORAL MAXILLOFAC SU; Heide W, 2001, EUR J NEUROSCI, V13, P1177, DOI 10.1046/j.0953-816x.2001.01472.x; Kanda M, 2000, BRAIN RES, V853, P282, DOI 10.1016/S0006-8993(99)02274-X; Papoiu ADP, 2012, NEUROIMAGE, V59, P3611, DOI 10.1016/j.neuroimage.2011.10.099; EHLERS A, 1995, J CONSULT CLIN PSYCH, V63, P624, DOI 10.1037//0022-006X.63.4.624; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Ishiuji Y, 2009, BRIT J DERMATOL, V161, P1072, DOI 10.1111/j.1365-2133.2009.09308.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Darsow U, 2000, J INVEST DERMATOL, V115, P1029, DOI 10.1046/j.1523-1747.2000.00193.x; Lavda AC, 2012, BRIT J DERMATOL, V167, P970, DOI 10.1111/j.1365-2133.2012.11183.x; Leknes SG, 2007, J NEUROPHYSIOL, V97, P415, DOI 10.1152/jn.00070.2006; Kuhn S, 2012, NEUROIMAGE, V61, P289, DOI 10.1016/j.neuroimage.2012.02.065; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Niddam DM, 2008, NEUROIMAGE, V39, P1299, DOI 10.1016/j.iieuroiinage.2007.09.051; Holle H, 2012, P NATL ACAD SCI USA, V109, P19816, DOI 10.1073/pnas.1216160109; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Schneider G, 2008, EUR J PAIN, V12, P834, DOI 10.1016/j.ejpain.2007.12.003; Frot M, 2007, CEREB CORTEX, V17, P610, DOI 10.1093/cercor/bhk007; Rothman S, 1941, PHYSIOL REV, V21, P357; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Timmermann L, 2001, J NEUROPHYSIOL, V86, P1499; Smolka MN, 2006, PSYCHOPHARMACOLOGY, V184, P577, DOI 10.1007/s00213-005-0080-x; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; DONG WK, 1994, J NEUROPHYSIOL, V72, P542; Yosipovitch G, 2013, NEW ENGL J MED, V368, P1625, DOI 10.1056/NEJMcp1208814; Mantovani A, 2013, PSYCHIAT RES, V210, P1026, DOI 10.1016/j.psychres.2013.08.054; VOGT BA, 1990, J COMP NEUROL, V299, P64, DOI 10.1002/cne.902990105; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Garcia-Larrea L, 2012, NEUROPHYSIOL CLIN, V42, P299, DOI 10.1016/j.neucli.2012.06.001; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.00965.2001; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Treede RD, 2000, PAIN, V87, P113, DOI 10.1016/S0304-3959(00)00350-X; Napadow V, 2014, CEREB CORTEX, V24, P873, DOI 10.1093/cercor/bhs363; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Mochizuki H, 2003, PAIN, V105, P339, DOI 10.1016/S0304-3959(03)00249-5; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Herde L, 2007, J NEUROPHYSIOL, V98, P2347, DOI 10.1152/jn.00475.2007; Mochizuki H, 2014, J NEUROPHYSIOL, V111, P488, DOI 10.1152/jn.00374.2013; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; FRIED I, 1991, J NEUROSCI, V11, P3656; Filbey FM, 2008, NEUROPSYCHOPHARMACOL, V33, P1391, DOI 10.1038/sj.npp.1301513; Schmelz M, 1997, J NEUROSCI, V17, P8003; Ogiso T, 2000, NEUROREPORT, V11, P1345, DOI 10.1097/00001756-200004270-00039; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Bae BG, 2012, ACTA DERM-VENEREOL, V92, P57, DOI 10.2340/00015555-1189; Bar KJ, 2002, NEUROREPORT, V13, P805; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Bergeret L, 2011, ACTA DERM-VENEREOL, V91, P504, DOI 10.2340/00015555-1067; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499; desAraujo IE, 2003, EUR J NEUROSCI, V18, P2059; Desbordes G, 2014, NEUROIMAGE-CLIN, V7, P213; DONG WK, 1989, BRAIN RES, V484, P314, DOI 10.1016/0006-8993(89)90375-2; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Faymonville ME, 2006, J PHYSIOLOGY-PARIS, V99, P463, DOI 10.1016/j.jphysparis.2006.03.018; Forss N, 2005, NEUROIMAGE, V24, P132, DOI 10.1016/j.neuroimage.2004.09.032; Hanifin Jon M, 2007, Dermatitis, V18, P82, DOI 10.2310/6620.2007.06034; HSIEH JC, 1994, J NEUROPHYSIOL, V72, P3004; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; Inui K, 2003, EUR J NEUROSCI, V18, P2859, DOI 10.1046/j.1460-9568.2003.02995.x; Kakigi R, 2005, CLIN NEUROPHYSIOL, V116, P743, DOI 10.1016/j.clinph.2004.11.016; Mochizuki H, 2009, J NEUROPHYSIOL, V102, P2657, DOI 10.1152/jn.00460.2009; Mochizuki H, 2013, PAIN, V154, P1989, DOI 10.1016/j.pain.2013.06.007; Mochizuki H, 2008, NEUROIMAGE, V39, P911, DOI 10.1016/j.neuroimage.2007.09.025; MYRICK H, 2000, DRUG ALCOHOL DEPEN, V60, P207; Nakata H, 2008, NEUROIMAGE, V42, P858, DOI 10.1016/j.neuroimage.2008.05.017; Niemeier V., 2000, DERMATOL PSYCHOSOM, V1, P15, DOI [10.1159/000057993, DOI 10.1159/000057993]; Ogden J, 2009, PSYCHOL HEALTH MED, V14, P695, DOI 10.1080/13548500903311547; Opsommer E, 2001, NEUROSCI LETT, V298, P41, DOI 10.1016/S0304-3940(00)01718-3; Papoiu ADP, 2014, J NEUROPHYSIOL, V112, P1729, DOI 10.1152/jn.00827.2013; Papoiu ADP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082389; Ploner M, 2000, J NEUROPHYSIOL, V83, P1770; Saper CB, 2000, PRINCIPLES NEURAL SC, V4th, P889; Schulz-Stubner S, 2004, REGION ANESTH PAIN M, V29, P549, DOI 10.1016/j.rapm.2004.09.022; Schut C, 2013, ACTA DERM-VENEREOL, V93, P57, DOI 10.2340/00015555-1415; Stander S, 2010, DERMATOLOGY, V221, P229, DOI 10.1159/000319862; Walter B, 2005, J INVEST DERMATOL, V125, P380, DOI 10.1111/j.0022-202X.2005.23817.x; Weisshaar E, 2012, ACTA DERM-VENEREOL, V92, P493, DOI 10.2340/00015555-1402; Yosipovitch G, 2007, BRIT J DERMATOL, V156, P629, DOI 10.1111/j.1365-2133.2006.07711.x; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x	101	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					761	767		10.1111/1346-8138.12956		7	Dermatology	Dermatology	CN8IK	WOS:000358683500001		
J	Aihara, M; Kano, Y; Fujita, H; Kambara, T; Matsukura, S; Katayama, I; Azukizawa, H; Miyachi, Y; Endo, Y; Asada, H; Miyagawa, F; Morita, E; Kaneko, S; Abe, R; Ochiai, T; Sueki, H; Watanabe, H; Nagao, K; Aoyama, Y; Sayama, K; Hashimoto, K; Shiohara, T				Aihara, Michiko; Kano, Yoko; Fujita, Hiroyuki; Kambara, Takeshi; Matsukura, Setsuko; Katayama, Ichiro; Azukizawa, Hiroaki; Miyachi, Yoshiki; Endo, Yuichiro; Asada, Hideo; Miyagawa, Fumi; Morita, Eishin; Kaneko, Sakae; Abe, Riichiro; Ochiai, Toyoko; Sueki, Hirohiko; Watanabe, Hideaki; Nagao, Keisuke; Aoyama, Yumi; Sayama, Koji; Hashimoto, Koji; Shiohara, Tetsuo		SJS TEN Study Grp	Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis	JOURNAL OF DERMATOLOGY			English	Article						corticosteroid; i; v; immunoglobulin; Stevens-Johnson syndrome; therapy; toxic epidermal necrolysis	DOSE INTRAVENOUS IMMUNOGLOBULINS; RETROSPECTIVE ANALYSIS; METAANALYSIS; DERMATOLOGY; EXPERIENCE; SCORTEN; CELLS	Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and life-threatening cutaneous adverse drug reactions. While there is no established therapy for SJS/TEN, systemic corticosteroids, plasma exchange and i.v. immunoglobulin (IVIG) have been used as treatment. The efficacy of IVIG is still controversial because total doses of IVIG used vary greatly from one study to another. The aim of this study was to evaluate the efficacy of IVIG, administrated for 5days consecutively, in an open-label, multicenter, single-arm study in patients with SJS or TEN. IVIG (400mg/kg per day) administrated for 5days consecutively was performed as an additional therapy to systemic steroids in adult patients with SJS or TEN. Efficacy on day 7 of IVIG was evaluated. Parameters to assess clinical outcome were enanthema including ophthalmic and oral lesions, cutaneous lesions and general condition. These parameters were scored and recorded before and after IVIG. We enrolled five patients with SJS and three patients with TEN who did not respond sufficiently to systemic steroids before IVIG administration. All of the patients survived and the efficacy on day 7 of the IVIG was 87.5% (7/8 patients). Prompt amelioration was observed in skin lesions and enanthema in the patients in whom IVIG therapy was effective. Serious side-effects from the use of IVIG were not observed. IVIG (400mg/kg per day) administrated for 5days consecutively seems to be effective in patients with SJS or TEN. IVIG administrated together with steroids should be considered as a treatment modality for patients with refractory SJS/TEN. Further studies are needed to define the therapeutic efficacy of IVIG.	[Aihara, Michiko; Fujita, Hiroyuki] Yokohama City Univ, Sch Med, Dept Dermatol, Yokohama, Kanagawa 2360004, Japan; [Kano, Yoko; Shiohara, Tetsuo] Kyorin Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Ochiai, Toyoko] Nihon Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Sueki, Hirohiko; Watanabe, Hideaki] Showa Univ, Sch Med, Dept Dermatol, Tokyo 142, Japan; [Nagao, Keisuke] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Kambara, Takeshi; Matsukura, Setsuko] Yokohama City Univ, Med Ctr, Dept Dermatol, Yokohama, Kanagawa 232, Japan; [Katayama, Ichiro; Azukizawa, Hiroaki] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Miyachi, Yoshiki; Endo, Yuichiro] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Asada, Hideo; Miyagawa, Fumi] Nara Med Univ, Dept Dermatol, Kashihara, Nara 634, Japan; [Morita, Eishin; Kaneko, Sakae] Shimane Univ, Fac Med, Dept Dermatol, Izumo, Shimane, Japan; [Abe, Riichiro] Hokkaido Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido 060, Japan; [Aoyama, Yumi] Okayama Univ, Dept Dermatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Sayama, Koji] Ehime Univ, Sch Med, Dept Dermatol, Matsuyama, Ehime 790, Japan; [Hashimoto, Koji] Ehime Prefectural Univ Hlth Sci, Tobe, Ehime, Japan	Aihara, M (reprint author), Yokohama City Univ, Sch Med, Dept Dermatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	maihara1@med.yokohama-cu.ac.jp			Nihon Pharmaceutical	This study was funded by Nihon Pharmaceutical, but none of the researchers engaged in this study were financially supported by the company. Hashimoto and Shiohara received compensation for their work as consultants. The other authors declare no conflict of interest.	Brown KM, 2004, J BURN CARE REHABIL, V25, P81, DOI 10.1097/01.BCR.0000105096.93526.27; Hirahara K, 2013, J AM ACAD DERMATOL, V69, P496, DOI 10.1016/j.jaad.2013.04.007; Wetter DA, 2010, MAYO CLIN PROC, V85, P131, DOI 10.4065/mcp.2009.0379; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chen JB, 2010, EUR J DERMATOL, V20, P743, DOI 10.1684/ejd.2010.1077; Huang YC, 2012, BRIT J DERMATOL, V167, P424, DOI 10.1111/j.1365-2133.2012.10965.x; Yang YS, 2009, INT J DERMATOL, V48, P1122, DOI 10.1111/j.1365-4632.2009.04166.x; [Anonymous], 2011, JPN J DERMATOL; Kunimi Yuko, 2011, Allergology International, V60, P525, DOI 10.2332/allergolint.11-OA-0309; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Abe R, 2003, AM J PATHOL, V162, P1515, DOI 10.1016/S0002-9440(10)64284-8; Mydlarski PR, 2006, J CUTAN MED SURG, V10, P205, DOI 10.2310/7750.2006.00048; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Chung WH, 2012, J DERMATOL SCI, V66, P190, DOI 10.1016/j.jdermsci.2012.04.002; Kirchhof MG, 2014, J AM ACAD DERMATOL, V71, P941, DOI 10.1016/j.jaad.2014.07.016; Enk A, 2009, EUR J DERMATOL, V19, P90, DOI 10.1684/ejd.2008.0580; Kim KJ, 2005, ACTA DERM-VENEREOL, V85, P497, DOI 10.1080/00015550510038232; Rajaratnam R, 2010, CLIN EXP DERMATOL, V35, P853, DOI 10.1111/j.1365-2230.2010.03826.x; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; Narita YM, 2011, J DERMATOL, V38, P236, DOI 10.1111/j.1346-8138.2010.01154.x; Barron SJ, 2015, INT J DERMATOL, V54, P108, DOI 10.1111/ijd.12423; Lee HY, 2013, BRIT J DERMATOL, V169, P1304, DOI 10.1111/bjd.12607; Egan CA, 1999, J AM ACAD DERMATOL, V40, P458, DOI 10.1016/S0190-9622(99)70497-4; Kessel A, 2007, J IMMUNOL, V179, P5571; Feldmeyer L, 2011, ARCH DERMATOL, V147, P1440, DOI 10.1001/archdermatol.2011.1610; Nozaki Y, 2015, J DERMATOL, V42, P439, DOI 10.1111/1346-8138.12819; Saito N., 2014, SCI TRANSL MED, V6; Smith SD, 2010, AUSTRALAS J DERMATOL, V51, P227, DOI 10.1111/j.1440-0960.2009.00578.x; Spornraft-Ragaller P, 2006, HAUTARZT, V57, P185, DOI 10.1007/s00105-006-1104-0; Stella M, 2007, BURNS, V33, P452, DOI 10.1016/j.burns.2006.08.014; Tan SK, 2012, ACTA DERM-VENEREOL, V92, P62, DOI 10.2340/00015555-1169; Trent JT, 2007, EXPERT REV DERMATOLO, V2, P299, DOI 10.1586/17469872.2.3.299; Wootton CI, 2011, ARCH DERMATOL, V147, P1437, DOI 10.1001/archdermatol.2011.300; Yamane Yumiko, 2007, Allergol Int, V56, P419, DOI 10.2332/allergolint.O-07-483	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					768	777		10.1111/1346-8138.12925		10	Dermatology	Dermatology	CN8IK	WOS:000358683500002		
J	Hakuta, A; Fujita, H; Kanaoka, M; Watanabe, M; Izumi, K; Watanabe, T; Komitsu, N; Itoh, M; Tanito, K; Takahashi, Y; Aihara, M				Hakuta, Amiko; Fujita, Hiroyuki; Kanaoka, Miwa; Watanabe, Midori; Izumi, Kanako; Watanabe, Tomoya; Komitsu, Noriko; Itoh, Munenari; Tanito, Katsumi; Takahashi, Yukitoshi; Aihara, Michiko			Reduction of interleukin-10 production by B cells in intractable toxic epidermal necrolysis	JOURNAL OF DERMATOLOGY			English	Article						anti-CD20 antibody; B-cell depletion therapy; interleukin-10; regulatory B cell; toxic epidermal necrolysis	STEVENS-JOHNSON SYNDROME; RITUXIMAB	Several interleukin (IL)-10 producing B-cell subsets have been identified recently. However, few studies have examined the role of them in toxic epidermal necrolysis (TEN). We describe a 41-year-old woman with TEN who had B-cell lymphoma and a history of treatments including B-cell depletion therapy. Her re-epithelization was still ongoing after 7months, despite treatments. To investigate her immune system, we compared cytokine and chemokine production from B cells and non-B cells isolated from the patient and another non-lymphoma TEN patient. IL-10 production from B cells decreased in the patient compared with the control TEN-only patient. Cytokine and chemokine levels from non-B cells involved in inflammation were elevated in the patient compared with the control patient. In conclusion, this study demonstrates that IL-10 from B cells as well as regulatory T cells is critical in the pathogenesis of TEN, and that B-cell dysfunction based on B-cell lymphoma and B-cell depletion therapy may be involved in the intractability of TEN.	[Hakuta, Amiko; Fujita, Hiroyuki; Kanaoka, Miwa; Watanabe, Midori; Izumi, Kanako; Watanabe, Tomoya; Komitsu, Noriko; Aihara, Michiko] Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Yokohama, Kanagawa 232, Japan; [Itoh, Munenari; Tanito, Katsumi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan	Fujita, H (reprint author), 3-9 Fukuura,Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan.	fuji_fuji_fuji_0101@yahoo.co.jp			JSPS KAKENHI [24790534]; Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan [H26-nanchi(nan)-ippan-081]	We thank Professor Takashi Hashimoto of Kurume University Institute of Cutaneous Cell Biology, Kurume, for their help in analyzing indirect immunofluorescent test, ELISA and immunoblotting test. This work was partially supported by JSPS KAKENHI (grant no. 24790534) and by Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (H26-nanchi(nan)-ippan-081).	Nassif A, 2004, J INVEST DERMATOL, V123, P850, DOI 10.1111/j.0022-202X.2004.23439.x; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Dass S, 2007, ARTHRITIS RHEUM, V56, P2715, DOI 10.1002/art.22811; Chung Wen-Hung, 2010, Allergology International, V59, P325, DOI 10.2332/allergolint.10-RAI-0261; Narita YM, 2011, J DERMATOL, V38, P236, DOI 10.1111/j.1346-8138.2010.01154.x; Bouaziz JD, 2014, CURR MOL MED, V12, P519; Fujita H, 2014, BRIT J DERMATOL, V171, P1585, DOI 10.1111/bjd.13162; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Saito N., 2014, SCI TRANSL MED, V6; Schwartz RA, 2013, J AM ACAD DERMATOL, V173, pe1	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					804	808		10.1111/1346-8138.12909		5	Dermatology	Dermatology	CN8IK	WOS:000358683500007		
J	Miyagawa, T; Kadono, T; Taniguchi, T; Nakamura, K; Saigusa, R; Yoshizaki, A; Miyagaki, T; Yamada, D; Masui, Y; Sato, S				Miyagawa, Takuya; Kadono, Takafumi; Taniguchi, Takashi; Nakamura, Kouki; Saigusa, Ryosuke; Yoshizaki, Ayumi; Miyagaki, Tomomitsu; Yamada, Daisuke; Masui, Yuri; Sato, Shinichi			Cutaneous apocrine carcinoma of the scrotum: A case with widespread subcutaneous induration	JOURNAL OF DERMATOLOGY			English	Article						cutaneous apocrine carcinoma; scrotum; widespread subcutaneous induration	AXILLA	Cutaneous apocrine carcinoma (CAC) is a rare malignancy. It develops predominantly in the regions where apocrine glands are distributed. Some cases of CAC have been reported in the axilla and the inguinal regions, but only a few in the scrotum. We herein report a case of CAC which widely spread over both sides of the whole scrotum with plate-like hard induration, and such a manifestation has never been reported before. CAC is known to have high rates of local recurrence or metastasis, and the efficacy of radiotherapy or chemotherapy has not been established. As therapeutic options for CAC are limited, it is critical to reach the diagnosis and treat at an early stage.	[Miyagawa, Takuya; Kadono, Takafumi; Taniguchi, Takashi; Nakamura, Kouki; Saigusa, Ryosuke; Yoshizaki, Ayumi; Miyagaki, Tomomitsu; Yamada, Daisuke; Masui, Yuri; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan	Kadono, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tkadono-tky@umin.ac.jp					Robson A, 2008, AM J SURG PATHOL, V32, P682, DOI 10.1097/PAS.0b013e3181590ba4; Pai RR, 2008, DIAGN CYTOPATHOL, V36, P739, DOI 10.1002/dc.20889; Campobasso D, 2015, PATHOL RES PRACT, V211, P264, DOI 10.1016/j.prp.2014.12.010; Fujisawa Y, 2014, J DERMATOL, V41, P280, DOI 10.1111/1346-8138.12414; Guo JJ, 2014, INT J CLIN EXP PATHO, V7, P8266; Hall BJ, 2012, AM J DERMATOPATH, V34, P438, DOI 10.1097/DAD.0b013e31822e6895; Hollowell KL, 2012, J SURG ONCOL, V105, P415, DOI 10.1002/jso.22023; Ogata D, 2014, INT J CLIN ONCOL, V19, P712, DOI 10.1007/s10147-013-0594-x; PATIES C, 1993, CANCER, V71, P375, DOI 10.1002/1097-0142(19930115)71:2<375::AID-CNCR2820710218>3.0.CO;2-4; Terada T, 2013, INT J DERMATOL, V52, P504, DOI 10.1111/j.1365-4632.2011.05079.x	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					815	817		10.1111/1346-8138.12914		3	Dermatology	Dermatology	CN8IK	WOS:000358683500010		
J	Kanayama, Y; Fukai, K; Sugawara, K; Tsuruta, D				Kanayama, Yoshie; Fukai, Kazuyoshi; Sugawara, Koji; Tsuruta, Daisuke			Circumscribed palmoplantar hypokeratosis in a barber: Successful treatment using cryotherapy	JOURNAL OF DERMATOLOGY			English	Letter							PALMAR HYPOKERATOSIS		[Kanayama, Yoshie] Ikuwakai Mem Hosp, Dept Dermatol, Osaka 5440004, Japan; [Fukai, Kazuyoshi; Sugawara, Koji; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan	Kanayama, Y (reprint author), Ikuwakai Mem Hosp, Dept Dermatol, Ikuno Ku, 3-20-29 Tatsumikita, Osaka 5440004, Japan.	yoshiekana@med.osaka-cu.ac.jp					Boffa MJ, 2007, J EUR ACAD DERMATOL, V21, P420, DOI 10.1111/j.1468-3083.2006.01908.x; Perez A, 2002, J AM ACAD DERMATOL, V47, P21, DOI 10.1067/mjd.2002.120466; Resnik KS, 2006, AM J DERMATOPATH, V28, P112, DOI 10.1097/01.dad.0000193825.90552.4e; Yasuda M, 2011, BRIT J DERMATOL, V164, P204	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					818	819		10.1111/1346-8138.12932		2	Dermatology	Dermatology	CN8IK	WOS:000358683500011		
J	Kato, Y; Yamamoto, T				Kato, Yasunobu; Yamamoto, Toshiyuki			Stucco keratosis in a patient with esophageal cancer	JOURNAL OF DERMATOLOGY			English	Letter									[Kato, Yasunobu; Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima 9601295, Japan	Kato, Y (reprint author), Fukushima Med Univ, Dept Dermatol, 1 Hikarigaoka, Fukushima 9601295, Japan.	ykato@fmu.ac.jp					Hafner C, 2010, BRIT J DERMATOL, V162, P508, DOI 10.1111/j.1365-2133.2009.09488.x; Aso K, 1985, RINSHO DERMA, V27, P615; SHALL L, 1991, ACTA DERM-VENEREOL, V71, P258; Yamamoto T., 2013, EXP REV DERMATOL, V8, P541	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					819	820		10.1111/1346-8138.12905		2	Dermatology	Dermatology	CN8IK	WOS:000358683500012		
J	Kamiya, K; Aoyama, Y; Yamaguchi, M; Tokura, Y; Iwatsuki, K				Kamiya, Koji; Aoyama, Yumi; Yamaguchi, Mari; Tokura, Yoshiki; Iwatsuki, Keiji			Detection of autoantibodies against the calcium-dependent epitopes of desmoglein 3 by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with mammalian cell expression system	JOURNAL OF DERMATOLOGY			English	Letter							PEMPHIGUS-VULGARIS		[Kamiya, Koji; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Kamiya, Koji; Aoyama, Yumi; Yamaguchi, Mari; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama, Okayama 7008558, Japan	Aoyama, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, 2-5-1 Shikata Cho Kitaku, Okayama, Okayama 7008558, Japan.	ymaoyama@cc.okayama-u.ac.jp					Yokouchi M, 2009, J INVEST DERMATOL, V129, P2156, DOI 10.1038/jid.2009.61; Kamiya K, 2012, BRIT J DERMATOL, V167, P252, DOI 10.1111/j.1365-2133.2012.10929.x; Demitsu T, 2014, ACTA DERM-VENEREOL, V94, P601, DOI 10.2340/00015555-1776; Kamiya K, 2013, J DERMATOL SCI, V70, P190, DOI 10.1016/j.jdermsci.2013.02.011; Toumi A, 2013, J DERMATOL SCI, V70, P19, DOI 10.1016/j.jdermsci.2013.02.002	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					825	827		10.1111/1346-8138.12906		3	Dermatology	Dermatology	CN8IK	WOS:000358683500016		
J	Kabuto, M; Fujimoto, N; Honda, S; Tanaka, T				Kabuto, Miho; Fujimoto, Noriki; Honda, Shinichiro; Tanaka, Toshihiro			Successful treatment with long-term use of minocycline for Morbihan disease showing mast cell infiltration: A second case report	JOURNAL OF DERMATOLOGY			English	Letter									[Kabuto, Miho; Fujimoto, Noriki; Honda, Shinichiro; Tanaka, Toshihiro] Shiga Univ Med Sci, Dept Dermatol, Otsu, Shiga 5202192, Japan	Fujimoto, N (reprint author), Shiga Univ Med Sci, Dept Dermatol, Otsu, Shiga 5202192, Japan.	noriki@belle.shiga-med.ac.jp					Nagasaka T, 2008, CLIN EXP DERMATOL, V33, P764, DOI 10.1111/j.1365-2230.2008.02892.x; Fujimoto N, 2015, ACTA DERM-VENEREOL, V95, P368, DOI 10.2340/00015555-1954; Hu Stephanie W, 2012, Dermatol Online J, V18, P27; Sandler C, 2005, INFLAMM RES, V54, P304, DOI 10.1007/s00011-005-1358-5; Smith LA, 2012, ARCH DERMATOL, V148, P1395, DOI 10.1001/archdermatol.2012.3109	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					827	828		10.1111/1346-8138.12908		2	Dermatology	Dermatology	CN8IK	WOS:000358683500017		
J	Yanaba, K; Umezawa, Y; Sakakihara, R; Chiba, M; Ito, T; Kikuchi, S; Fukuchi, O; Asahina, A; Saeki, H; Nakagawa, H				Yanaba, Koichi; Umezawa, Yoshinori; Sakakihara, Reiko; Chiba, Miki; Ito, Toshihiro; Kikuchi, Sota; Fukuchi, Osamu; Asahina, Akihiko; Saeki, Hidehisa; Nakagawa, Hidemi			Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis	JOURNAL OF DERMATOLOGY			English	Letter							AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; ELEVATION; COLLEGE; DISEASE; SAFETY		[Yanaba, Koichi; Umezawa, Yoshinori; Sakakihara, Reiko; Chiba, Miki; Ito, Toshihiro; Kikuchi, Sota; Fukuchi, Osamu; Asahina, Akihiko; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo 1058461, Japan; [Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan	Yanaba, K (reprint author), Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan.	yanaba@jikei.ac.jp					KOHNO N, 1993, AM REV RESPIR DIS, V148, P637; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Harigai M, 2013, MOD RHEUMATOL, V23, P284, DOI 10.1007/s10165-012-0657-2; Mabuchi T, 2014, J DERMATOL, V41, P1136, DOI 10.1111/1346-8138.12681; Takamura A, 2013, MOD RHEUMATOL, V23, P297, DOI 10.1007/s10165-012-0658-1	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					828	829		10.1111/1346-8138.12918		2	Dermatology	Dermatology	CN8IK	WOS:000358683500018		
J	Tofuku, Y; Nobeyama, Y; Nakagawa, H				Tofuku, Yukari; Nobeyama, Yoshimasa; Nakagawa, Hidemi			Case of collagenous fibroma (desmoplastic fibroblastoma) with vascular hyperplasia in the boundary area detected by Doppler sonography and histopathological examination	JOURNAL OF DERMATOLOGY			English	Letter									[Tofuku, Yukari; Nobeyama, Yoshimasa; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo 1058461, Japan	Nobeyama, Y (reprint author), Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, 25-8 Nishi Shimbashi 3 Chome, Tokyo 1058461, Japan.	nobederm@jikei.ac.jp					Nielsen GP, 1996, MODERN PATHOL, V9, P781; Bonardi M, 2013, J ULTRASOUND, V17, P53; EVANS HL, 1995, AM J SURG PATHOL, V19, P1077, DOI 10.1097/00000478-199509000-00012; Park JM, 2012, J DERMATOL, V39, P420, DOI 10.1111/j.1346-8138.2011.01373.x; Yamamoto A, 2013, SKELETAL RADIOL, V42, P141, DOI 10.1007/s00256-012-1484-4	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					831	832		10.1111/1346-8138.12919		2	Dermatology	Dermatology	CN8IK	WOS:000358683500020		
J	Yanagihara, S; Kobayashi, H; Kamo, R; Hirata, C; Hiruma, M; Nishimura, K; Yaguchi, T; Yoshida, Y; Yamamoto, O; Tsuruta, D				Yanagihara, Shigeto; Kobayashi, Hiromi; Kamo, Riei; Hirata, Chika; Hiruma, Masataro; Nishimura, Kazuko; Yaguchi, Takashi; Yoshida, Yuichi; Yamamoto, Osamu; Tsuruta, Daisuke			Chromoblastomycosis caused by Fonsecaea nubica: First report from Japan	JOURNAL OF DERMATOLOGY			English	Letter									[Yanagihara, Shigeto; Kobayashi, Hiromi; Kamo, Riei; Hirata, Chika; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan; [Yanagihara, Shigeto; Yoshida, Yuichi; Yamamoto, Osamu] Tottori Univ, Div Dermatol, Dept Med Sensory & Motor Organs, Fac Med, Yonago, Tottori 6838503, Japan; [Hiruma, Masataro] Ochanomizu Inst Med Mycol & Allergol, Tokyo, Japan; [Nishimura, Kazuko; Yaguchi, Takashi] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan	Yanagihara, S (reprint author), Tottori Univ, Div Dermatol, Dept Med Sensory & Motor Organs, Fac Med, 86 Nishi Machi, Yonago, Tottori 6838503, Japan.	shigetoo@med.tottori-u.ac.jp					Najafzadeh MJ, 2010, MED MYCOL, V48, P800, DOI 10.3109/13693780903503081; de Hoog GS, 2004, MED MYCOL, V42, P405, DOI 10.1080/13693780410001661464; Vicente VA, 2010, VET MICROBIOL, V158, P109; Yaguchi T, 2007, MYCOSES, V50, P255, DOI 10.1111/j.1439-0507.2007.01383.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					833	834		10.1111/1346-8138.12898		2	Dermatology	Dermatology	CN8IK	WOS:000358683500021		
J	Yamanaka, K; Murota, H; Goto, H; Yamamoto, S; Katayama, I; Taniguchi, Y; Mizutani, H				Yamanaka, Keiichi; Murota, Hiroyuki; Goto, Hiroyuki; Yamamoto, Shinya; Katayama, Ichiro; Taniguchi, Yoshiki; Mizutani, Hitoshi			Pyoderma gangrenosum and annular erythema associated with Sjogren's syndrome controlled with minocycline	JOURNAL OF DERMATOLOGY			English	Letter									[Yamanaka, Keiichi; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 5148507, Japan; [Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan; [Goto, Hiroyuki; Yamamoto, Shinya; Taniguchi, Yoshiki] Yokkaichi Municipal Hosp, Dept Dermatol, Yokaichi, Japan	Yamanaka, K (reprint author), Mie Univ, Grad Sch Med, Dept Dermatol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	yamake@clin.medic.mie-u.ac.jp					Patel F, 2015, ACTA DERM-VENEREOL, V95, P525, DOI 10.2340/00015555-2008; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Griffin MO, 2011, PHARMACOL RES, V63, P102, DOI 10.1016/j.phrs.2010.10.004; Katayama I, 2010, MOD RHEUMATOL, V20, P123, DOI 10.1007/s10165-009-0257-y	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					834	836		10.1111/1346-8138.12897		3	Dermatology	Dermatology	CN8IK	WOS:000358683500022		
J	Motegi, S; Uchiyama, A; Toki, S; Yamada, K; Amano, H; Ishikawa, O				Motegi, Sei-ichiro; Uchiyama, Akihiko; Toki, Sayaka; Yamada, Kazuya; Amano, Hiroo; Ishikawa, Osamu			Successful treatment of neutrophilic dermatosis in patient with Crohn's disease with granulocyte and monocyte adsorption apheresis	JOURNAL OF DERMATOLOGY			English	Letter									[Motegi, Sei-ichiro; Uchiyama, Akihiko; Toki, Sayaka; Yamada, Kazuya; Amano, Hiroo; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gunma 3718511, Japan	Motegi, S (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	smotegi@gunma-u.ac.jp					Cohen PR, 2009, AM J CLIN DERMATOL, V10, P301, DOI 10.2165/11310730-000000000-00000; Kanekura T, 2006, THER APHER DIAL, V10, P247, DOI 10.1111/j.1744-9987.2006.00369.x; Ikeda S, 2013, J AM ACAD DERMATOL, V68, P609, DOI 10.1016/j.jaad.2012.09.037; Kato S, 2012, J CROHNS COLITIS, V6, P787, DOI 10.1016/j.crohns.2012.02.005; Sanchez-Garcia J, 2010, J GASTROEN HEPATOL, V25, P1869, DOI 10.1111/j.1440-1746.2010.06377.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					836	837		10.1111/1346-8138.12910		2	Dermatology	Dermatology	CN8IK	WOS:000358683500023		
J	Ohashi, T; Yasunobu, K; Yamamoto, T				Ohashi, Takenobu; Yasunobu, Kato; Yamamoto, Toshiyuki			Peristomal pyoderma gangrenosum: A report of three cases	JOURNAL OF DERMATOLOGY			English	Letter									[Ohashi, Takenobu; Yasunobu, Kato; Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima, Fukushima 9601295, Japan	Ohashi, T (reprint author), Fukushima Med Univ, Dept Dermatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	ohtk0084@yahoo.co.jp					Alkhouri N, 2009, INFLAMM BOWEL DIS, V15, P803, DOI 10.1002/ibd.20748; Brooklyn TN, 2006, GUT, V55, P505, DOI 10.1136/gut.2005.074815; DeMartyn LE, 2014, OSTOMY WOUND MANAG, V60, P50; Fahmy M, 2012, AM J GASTROENTEROL, V107, P794, DOI 10.1038/ajg.2012.42; Lyon CC, 2000, J AM ACAD DERMATOL, V42, P992, DOI 10.1016/S0190-9622(00)90292-5	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					837	838		10.1111/1346-8138.12928		2	Dermatology	Dermatology	CN8IK	WOS:000358683500024		
J	Miyakawa, B; Iwata, Y; Mizoguchi, Y; Arima, M; Yagami, A; Matsunaga, K				Miyakawa, Beni; Iwata, Yohei; Mizoguchi, Yoshikazu; Arima, Masaru; Yagami, Akiko; Matsunaga, Kayoko			Case of malignant melanoma developing from the dermal component of a small intradermal nevus	JOURNAL OF DERMATOLOGY			English	Letter									[Miyakawa, Beni; Iwata, Yohei; Arima, Masaru; Yagami, Akiko; Matsunaga, Kayoko] Fujita Hlth Univ, Dept Dermatol, Toyoake, Aichi 4701192, Japan; [Mizoguchi, Yoshikazu] Fujita Hlth Univ, Dept Diagnost Pathol, Toyoake, Aichi 4701192, Japan	Miyakawa, B (reprint author), Fujita Hlth Univ, Sch Med, Dept Dermatol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	beni0408@hotmail.com					ILLIG L, 1985, ARCH DERMATOL, V121, P1274, DOI 10.1001/archderm.121.10.1274; Kiyohara T, 2003, ACTA DERM-VENEREOL, V83, P397, DOI 10.1080/00015550310013060; Saita T, 1995, JPN J DERMATOL, V105, P1644; TAJIMA Y, 1994, AM J DERMATOPATH, V16, P301, DOI 10.1097/00000372-199406000-00013; Tsuda M, 2007, RINSHO DERMA, V49, P965	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					838	839		10.1111/1346-8138.12907		2	Dermatology	Dermatology	CN8IK	WOS:000358683500025		
J	Hiraoka, H; Ozawa, T; Sowa-Osako, J; Ichimura, T; Kimata-Teramoto, I; Isozumi, R; Kaneko, A; Tsuruta, D				Hiraoka, Hiroyuki; Ozawa, Toshiyuki; Sowa-Osako, Junko; Ichimura, Tomoyuki; Kimata-Teramoto, Isao; Isozumi, Rie; Kaneko, Akira; Tsuruta, Daisuke			Repeated myiasis in a female vulvar squamous cell carcinoma caused by Lucilia sericata and Sarcophaga crassipalpis	JOURNAL OF DERMATOLOGY			English	Letter									[Hiraoka, Hiroyuki; Ozawa, Toshiyuki; Sowa-Osako, Junko; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 5458585, Japan; [Ichimura, Tomoyuki] Osaka City Univ, Grad Sch Med, Dept Gynecol, Osaka 5458585, Japan; [Kimata-Teramoto, Isao; Isozumi, Rie; Kaneko, Akira] Osaka City Univ, Grad Sch Med, Dept Parasitol, Osaka 5458585, Japan	Ozawa, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	ozawa@med.osaka-cu.ac.jp					Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Francesconi F, 2012, CLIN MICROBIOL REV, V25, P79, DOI [10.1128/​CMR.00010-11, 10.1128/CMR.00010-11]; Kano R, 1971, GUIDANCE INSPECTION, P4; Uni Shigehiko, 2006, Medical Entomology and Zoology, V57, P235	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					840	841		10.1111/1346-8138.12911		2	Dermatology	Dermatology	CN8IK	WOS:000358683500026		
J	Nakahara, T; Yamada, Y; Itoh, E; Kido-Nakahara, M; Oda, Y; Kiryu, H; Furue, M				Nakahara, Takeshi; Yamada, Yuichi; Itoh, Eriko; Kido-Nakahara, Makiko; Oda, Yoshinao; Kiryu, Hiromaro; Furue, Masutaka			Case of ossifying epithelioid hemangioendothelioma on the forearm	JOURNAL OF DERMATOLOGY			English	Letter							TUMOR		[Nakahara, Takeshi; Itoh, Eriko] Kyushu Univ, Grad Sch Med Sci, Div Skin Surface Sensing, Fukuoka 8128582, Japan; [Nakahara, Takeshi; Itoh, Eriko; Kido-Nakahara, Makiko; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 8128582, Japan; [Yamada, Yuichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Kiryu, Hiromaro] Fukuoka Inst Dermatopathol, Fukuoka, Japan	Nakahara, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Div Skin Surface Sensing,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakahara@dermatol.med.kyushu-u.ac.jp					WEIDNER N, 1991, ULTRASTRUCT PATHOL, V15, P481; Miettinen M, 2008, AM J SURG PATHOL, V32, P996, DOI 10.1097/PAS.0b013e318160736a; WEISS SW, 1982, CANCER, V50, P970, DOI 10.1002/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z; Clarke LE, 2008, J CUTAN PATHOL, V35, P236, DOI 10.1111/j.1600-0560.2007.00790.x; Kiryu H, 1996, J CUTAN PATHOL, V23, P558, DOI 10.1111/j.1600-0560.1996.tb01449.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					841	842		10.1111/1346-8138.12915		2	Dermatology	Dermatology	CN8IK	WOS:000358683500027		
J	Takahashi, C; Uehara, J; Ohishi, Y; Honma, M; Ishida-Yamamoto, A; Iwasaki, T; Takahashi, I; Iizuka, H				Takahashi, Chiaki; Uehara, Jiro; Ohishi, Yasushi; Honma, Masaru; Ishida-Yamamoto, Akemi; Iwasaki, Takeshi; Takahashi, Ichiro; Iizuka, Hajime			Malignant melanoma on female clitoris with bidirectional upper and lower lymphatic flow	JOURNAL OF DERMATOLOGY			English	Letter									[Takahashi, Chiaki; Uehara, Jiro; Ohishi, Yasushi; Honma, Masaru; Ishida-Yamamoto, Akemi; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Iwasaki, Takeshi; Takahashi, Ichiro] Japan Red Cross Kitami Hosp, Dept Dermatol, Kitami, Hokkaido, Japan	Takahashi, C (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	chiaki06@asahikawa-med.ac.jp					Wechter ME, 2004, J AM ACAD DERMATOL, V50, P554, DOI 10.1016/j.jaad.2003.07.026; Raber G, 1996, CANCER, V78, P2353, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2353::AID-CNCR13>3.0.CO;2-#; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Shibuya Y, 2011, SKIN CANC, V26, P148	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					842	844		10.1111/1346-8138.12921		3	Dermatology	Dermatology	CN8IK	WOS:000358683500028		
J	Yanagihara, M; Oiso, N; Tanaka, H; Narita, T; Enoki, E; Kimura, M; Nakamine, H; Matsumura, I; Kawada, A				Yanagihara, Midori; Oiso, Naoki; Tanaka, Hirokazu; Narita, Tomohiko; Enoki, Eisuke; Kimura, Masatomo; Nakamine, Hirokazu; Matsumura, Itaru; Kawada, Akira			Aleukemic solitary cutaneous myeloid sarcoma	JOURNAL OF DERMATOLOGY			English	Letter									[Yanagihara, Midori; Oiso, Naoki; Narita, Tomohiko; Kawada, Akira] Kinki Univ, Fac Med, Dept Dermatol, Osaka, Japan; [Tanaka, Hirokazu; Matsumura, Itaru] Kinki Univ, Fac Med, Dept Hematol & Rheumatol, Osaka, Japan; [Enoki, Eisuke; Kimura, Masatomo] Kinki Univ, Fac Med, Dept Pathol, Osaka, Japan; [Nakamine, Hirokazu] Japan Baptist Med Fdn, Dept Lab Med, Kyoto, Japan	Oiso, N (reprint author), Kinki Univ, Fac Med, Dept Dermatol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	naoiso@med.kindai.ac.jp					Hurley MY, 2013, ACTA DERM-VENEREOL, V93, P319, DOI 10.2340/00015555-1458; Aboutalebi A, 2013, J CUTAN PATHOL, V40, P996, DOI 10.1111/cup.12231; Benet C, 2011, AM J CLIN PATHOL, V135, P278, DOI 10.1309/AJCPFMNYCVPDEND0; Morgan EA, 2014, LEVERS HISTOPATHOLOG, V11th, P1116; Swerdlow S, 2008, WHO CLASSIFICATION T	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	AUG	2015	42	8					844	845		10.1111/1346-8138.12924		2	Dermatology	Dermatology	CN8IK	WOS:000358683500029		
J	Rahman, M; Nakamura, K; Kizuki, M				Rahman, Mosiur; Nakamura, Keiko; Kizuki, Masashi			Socioeconomic differences in the prevalence, awareness, and control of diabetes in Bangladesh	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Diabetes; Pre-diabetes; Awareness; Treatment; Socio-economic status	POPULATION; MELLITUS; TYPE-2; CARE	Aims: To explore the association of the socioeconomic status (SES) in Bangladesh with diabetes prevalence, awareness, and control. Methods: A population sample of 7540 individuals from the 2011 Bangladesh Demographic Health Survey was used. A composite variable of education and wealth calculated the SES indicator. Besides prevalence (age-sex adjusted) of diabetes and pre-diabetes, three other points were analyzed with the socio-demographic characteristics: awareness of diabetes, diabetics receiving medication and adequacy of treatment (measured by achieving normal fasting plasma glucose). Results: The age-sex adjusted prevalence of diabetes and pre-diabetes were 10.8% and 25.0%, respectively, in the study population (n = 7540). Prevalence of diabetes was 7.2% in the low SES (n = 2147) and 17.9% in the high SES group (n = 2,418). Among diabetics (n = 879), 39.7% were aware of their disease, 35.5% were receiving medication, and 13.0% were receiving adequate medication. Diabetic patients from the medium or high SES group had an increased likelihood of being aware of their disease and of receiving medication. Conclusions: Contrary to other developed countries, diabetes in Bangladesh is more prevalent among the higher SES group. Due to the high prevalence of pre-diabetes, lack of awareness of diabetes and less likelihood of receiving adequate treatment in lower SES group, there is potential for the rapid increase of diabetes. Urgent preventive measures are needed to control the impending diabetes epidemic. (C) 2015 Elsevier Inc. All rights reserved.	[Rahman, Mosiur; Nakamura, Keiko] Tokyo Med & Dent Univ, Grad Sch Med, Dept Int Hlth & Med, Div Publ Hlth, Tokyo 1138519, Japan; [Kizuki, Masashi] Tokyo Med & Dent Univ, Grad Sch Med, Div Publ Hlth, Hlth Promot, Tokyo 1138519, Japan	Rahman, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Div Publ Hlth, Int Hlth & Med,Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	swaponru_2000@yahoo.com					Afroza A., 2011, OPEN DIABETES J, V4, P6; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS81, DOI DOI 10.2337/DC14-S081; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Sayeed MA, 2003, DIABETES CARE, V26, P1034, DOI 10.2337/diacare.26.4.1034; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Bonds DE, 2003, DIABETES CARE, V26, P1040, DOI 10.2337/diacare.26.4.1040; Rajput R, 2012, METAB SYNDR RELAT D, V10, P443, DOI 10.1089/met.2012.0067; Bangladesh Bureau of Statistics, 2011, HOUS INC EXP SURV 20; Bhowmik B, 2013, DIABETIC MED, V30, pE70, DOI 10.1111/dme.12088; Centers for Disease Control and Prevention, 2013, DIAB REP CARD 2012; Cumbrera OA, 2013, DIABETOL METAB SYNDR, V5, P69; DOWSE GK, 1991, DIABETES CARE, V14, P968, DOI 10.2337/diacare.14.11.968; International Diabetes Federation, 2006, DEF DIAGN DIAB MELL; International Diabetes Federation (IDF), 2012, COUNTR EST TABL 2011; Islam M. A., 2014, AUST J BASIC APPL SC, V8, P40; Le Cai, 2011, Trop Med Int Health, V16, P1070, DOI 10.1111/j.1365-3156.2011.02805.x; Lynch J, 2000, SOCIAL EPIDEMIOLOGY, P13; Marmot M., 2009, SOCIAL STANDING AFFE; National Institute of Population Research and Training Mitra and Associates & Macro International, 2013, BANGL DEM HLTH SURV; Unwin N, 2011, IDF DIABETES ATLAS; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103594	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	AUG	2015	29	6					788	793		10.1016/j.jdiacomp.2015.04.011		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CO0CK	WOS:000358817500009		
J	Shibata, Y				Shibata, Yoshiyuki			Negative structure and object movement in Japanese	JOURNAL OF EAST ASIAN LINGUISTICS			English	Article						A-scrambling; Case-particle; Japanese; Negative structure; Object movement	POSITIVE POLARITY; QUANTIFIER SCOPE; WORD-ORDER; MORPHOLOGY; ENGLISH; CONCORD; GRAMMAR; SYNTAX	This paper investigates negative structure in Japanese. The scope of Japanese negation appears to be narrower than that of English, which has led to different treatment of Japanese and English negation in the literature. I propose an analysis that maintains the same negative structure for Japanese and English. I demonstrate that all the scope facts regarding negative sentences in Japanese can be accounted for if we assume obligatory object movement into the TP-domain in Japanese, that is, the difference between Japanese and English is not the structural position of negation but the existence of this obligatory object movement in Japanese. The analysis also involves a discussion of scopal properties of certain elements such as focused or disjunctive phrases, which play a crucial role to determine the position of objects. Then I argue that the obligatory object movement in Japanese is driven by the need for accusative Case-particle licensing, on the basis of the observation that objects without a Case-particle are generally immobile in Japanese. I show that this analysis leads to a new perspective on A-scrambling in Japanese.	[Shibata, Yoshiyuki] Mie Univ, Liberal Arts Ctr, Tsu, Mie 5148507, Japan; [Shibata, Yoshiyuki] Univ Connecticut, Dept Linguist, Storrs, CT 06269 USA	Shibata, Y (reprint author), Mie Univ, Liberal Arts Ctr, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.				National Science Foundation [BCS-0920888]	This material is based upon work supported by the National Science Foundation under grant BCS-0920888 (PI: Zeljko Boskovic). For helpful comments and suggestions, I thank Jonathan Bobaljik, Jon Gajewski, Toru Ishii, Magdalena Kaufmann, Susi Wurmbrand, and especially Zeljko Boskovic and Mamoru Saito. I also thank participants of GLOW in Asia IX, Japanese/Korean Linguistic Conference 22, Penn Linguistics Colloquium 23, and WAFL 9, where portions of the material in Sects. 2-4 were presented. I am also grateful to Nobu Goto, Yuta Sakamoto, Koji Shimamura, Masahiko Takahashi, and Kensuke Takita for help with judgments. All remaining errors are mine. This material is based upon work supported by the National Science Foundation under grant BCS-0920888 (PI: Zeljko Boskovic).	Aihara Masahiko, 2007, P FORM APPR JAP LING, V4, P1; Boskovic Z, 2007, LINGUIST INQ, V38, P589, DOI 10.1162/ling.2007.38.4.589; Holmberg A, 2003, LINGUA, V113, P997, DOI 10.1016/S0024-3841(02)00162-6; Szabolcsi A, 2004, NAT LANG LINGUIST TH, V22, P409, DOI 10.1023/B:NALA.0000015791.00288.43; Han CH, 2007, LINGUIST INQ, V38, P1, DOI 10.1162/ling.2007.38.1.1; Saito M, 1998, LINGUIST INQ, V29, P439, DOI 10.1162/002438998553815; Miyagawa S, 1997, LINGUIST INQ, V28, P1; SELLS P, 1995, LINGUIST INQ, V26, P277; Giannakidou A, 2000, NAT LANG LINGUIST TH, V18, P457, DOI 10.1023/A:1006477315705; Szabolcsi A, 2002, APPROACH HUNG, V8, P217; Saito M, 2003, LINGUA, V113, P481, DOI 10.1016/S0024-3841(02)00083-9; [Anonymous], 1995, NAT LANG SEMANT, DOI 10.1007/BF01252885; [Anonymous], 2006, WH MOVEMENT MOVING; Watanabe A, 2006, NAT LANG LINGUIST TH, V24, P241, DOI 10.1007/s11049-005-3042-4; Aoyagi H., 1994, JAPANESE KOREAN LING, P295; Aoyagi Hiroshi, 1999, LINGUISTICS SEARCH H, P24; Aoyagi Hiroshi, 1998, THESIS U SO CALIFORN; Aoyagi Hiroshi, 2006, NIHONGO NO ZYOSI TO; Bobaljik JD, 2012, LINGUIST INQ, V43, P371; Boskovic Zeljko, 2008, SOUNDS SILENCE EMPTY, P195; Chierchia G., 2012, INT HDB NATURAL LANG, V33, P2297; Chomsky N, 1991, PRINCIPLES PARAMETER, P417; Chomsky N., 2000, STEP STEP ESSAYS MIN, P89; Chomsky N., 2001, K HALE LIFE LANGUAGE, P1; Chomsky Noam, 1995, MINIMALIST PROGRAM; Fox Danny, 1999, P W COAST C FORM LIN, V18, P132; Fox Danny, 2003, MINIMALIST SYNTAX, P82, DOI 10.1002/9780470758342.ch2; Fukui Naoki, 1986, THESIS MIT; Funakoshi Kenshi, 2013, P 4 ANN TAMP WORKSH, P11; Goro Takuya, 2007, THESIS U MARYLAND; Haegeman L., 2004, ZAS PAPERS LINGUISTI, V35, P157; Haegeman Liliane, 1995, CAMBRIDGE STUDIES LI, V75; Han Chung-Hye, 2004, P 30 ANN M BERK LING, P118; Hasegawa Nobuko, 1994, CURRENT TOPICS ENGLI, P1; Hasegawa Nobuko, 1991, INTERDISCIPLINARY AP, P271; Hayashishita J.-R., 2008, JAPANESE KOREAN LING, V13, P141; Hayashishita J.-R., 1999, P 23 ANN PENN LING C, P201; HAYASHISHITA JR, 2000, P WCCFL, V19, P204; Hoji H., 1985, THESIS U WASHINGTON; Hoji Hajime, 2006, THEORETICAL EMPIRICA, P126; Hoshi Koji, 2006, LANGUAGE CULTURE COM, V37, P47; Kamio Akira, 1983, NIHONGO NO KIHON KOO, P77; Kataoka Kiyoko, 2006, NIHONGO HITEIBUN NO; Kato Yasuhiko, 1985, NEGATIVE SENTENCES J; Kato Yasuhiko, 1997, SOPHIA LINGUISTICA, V41, P29; Kawamura Tomoko, 2008, NANZAN LINGUISTICS, V2, P103; Kayne R., 1994, ANTISYMMETRY SYNTAX; Kinsui Satoshi, 1993, NIHONGO KAKU MEGUTTE, P191; Kishimoto H, 2007, LINGUA, V117, P247, DOI 10.1016/j.lingua.2006.01.003; Kishimoto H, 2008, J LINGUIST, V44, P379, DOI 10.1017/S0022226708005161; KITAGAWA Y, 1994, P N E LINGUISTIC SOC, V24, P221; Kitagawa Yoshihisa, 1990, TILB U WORKSH SCRAMB; Kitahara Hisatsugu, 2000, CASE SCRAMBLING DERI; Koizumi M., 1995, THESIS MIT; Kondo Yasuhiro, 1980, KOKUGO TO KOKUBUNGAK, V57, P51; Kuno S, 1999, LANGUAGE, V75, P63, DOI 10.2307/417474; Kuno Susumu, 1980, 16 REG M CHIC LING S, P155; Kuno Susumu, 1983, SHIN NIHON BUNPOO KE; Kuroda Shige-Yuki, 1969, ANN B, V3, P111; Kuroda Shige-Yuki, 1993, SCOPE PRINCIPLE SCOP; Kuroda Shige-Yuki, 1969, ANN B, V4, P127; Kuroda S.-Y, 1988, 2 INT WORKSH JAP SYN, P103; Laka Itziar, 1990, THESIS MIT; Lebeaux David, 1988, THESIS U MASSACHUSET; Lechner W, 1998, STUD LINGUISTICA, V52, P276, DOI 10.1111/1467-9582.00037; Mahajan Anoop, 1990, THESIS MIT; McClosky J, 2000, LINGUIST INQ, V31, P57, DOI 10.1162/002438900554299; McNally L, 2008, LINGUIST INQ, V39, P161, DOI 10.1162/ling.2008.39.1.161; Miyagawa S., 2003, WORD ORDER SCRAMBLIN, P177, DOI 10.1002/9780470758403.ch8; Miyagawa S., 2010, WHY AGREE WHY MOVE U; Miyagawa S, 2005, STUD GENERAT GRAMM, V69, P181; Miyagawa Shigeru, 2001, K HALE LIFE LANGUAGE, P293; Miyagawa Shigeru, 1989, STRUCTURE CASE MARKI; Nemoto N., 1993, THESIS U CONNECTICUT; Nishiguchi Sumiyo, 2007, TBIL S LOG LANG COMP, P153; Nomura Masashi, 2005, THESIS U CONNECTICUT; POLLOCK JY, 1989, LINGUIST INQ, V20, P365; Reinhart T., 1976, THESIS MIT; Reinhart Tanya, 1983, ANAPHORA SEMANTIC IN; Richards Norvin, 2001, MOVEMENT IN LANGUAGE; Richards Norvin, 1997, THESIS MIT; Rizzi Luigi, 2007, COMPLEMENTIZER PHASE, P17; Rooth M., 1985, THESIS U MASSACHUSET; Rullmann Hotze, 1995, THESIS U MASSACHUSET; SAITO M, 1992, J EAST ASIAN LINGUIS, V1, P69, DOI 10.1007/BF00129574; Saito Mamoru, 2009, JAPANESE KOREAN LING, V16, P44; Saito Mamoru, 1983, P W COAST C FORM LIN, V2, P247; SAITO M, 1989, ALTERNATIVE CONCEPTIONS OF PHRASE STRUCTURE, P182; Saito Mamuro, 1985, THESIS MIT; Sakamoto Yuta, 2013, JAP KOR LING C MIT 1, V23; Sano M., 1985, DESCRIPTIVE APPL LIN, V18, P245; Shibata Yoshiyuki, 2012, FORM APPR JAP LING F, V6; Shibata Yoshiyuki, THESIS U CONNECTICUT; Shibata Yoshiyuki, JAPANESE KO IN PRESS, V22; Shimoyama J, 2011, J SEMANT, V28, P413, DOI 10.1093/jos/ffr004; Stepanov A., 2001, SYNTAX, V4, P94, DOI 10.1111/1467-9612.00038; Tada H., 1992, J JAPANESE LINGUISTI, V14, P91; Tada Hiroaki, 1993, THESIS MIT; Tada Hiroaki, 1990, SCRAMBLING S UNPUB; Takahashi D., 1994, THESIS U CONNECTICUT; Takezawa Koichi, 1987, THESIS U WASHINGTON; Takubo Yukinori, 1985, SEOUL PAPERS FORMAL, P35; Tomioka Satoshi, 2007, WORKING PAPERS SFB63, P97; Ueyama Ayumi, 1998, THESIS U SO CALIFORN; Ura H., 1994, MIT WORKING PAPERS L, V1, P211; Vallduvi Enric, 1994, PROBUS, V6, P263, DOI 10.1515/prbs.1994.6.2-3.263; Villa-Garcia Julio, 2012, THESIS U CONNECTICUT; Watanabe A, 2004, LINGUIST INQ, V35, P559, DOI 10.1162/0024389042350497; Yanagida Y, 2006, J EAST ASIAN LINGUIS, V15, P37, DOI 10.1007/s10831-005-2165-2; Yoon Erica, 2013, 14 TOK C PSYCH TCP 2; Zanuttini Raffaella, 1991, THESIS U PENNSYLVANI	111	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-8558	1572-8560		J EAST ASIAN LINGUIS	J. East Asian Linguist.	AUG	2015	24	3					217	269		10.1007/s10831-014-9131-9		53	Linguistics; Language & Linguistics	Linguistics	CN7ZT	WOS:000358656100001		
J	Pascual-Ezama, D; Fosgaard, TR; Cardenas, JC; Kujal, P; Veszteg, R; de Liano, BGG; Gunia, B; Weichselbaumer, D; Hilken, K; Antinyan, A; Delnoij, J; Proestakis, A; Tira, MD; Pratomo, Y; Jaber-Lopez, T; Branas-Garza, P				Pascual-Ezama, David; Fosgaard, Toke R.; Camilo Cardenas, Juan; Kujal, Praveen; Veszteg, Robert; Gil-Gomez de Liano, Beatriz; Gunia, Brian; Weichselbaumer, Doris; Hilken, Katharina; Antinyan, Armenak; Delnoij, Joyce; Proestakis, Antonios; Tira, Michael D.; Pratomo, Yulius; Jaber-Lopez, Tarek; Branas-Garza, Pablo			Context-dependent cheating: Experimental evidence from 16 countries	JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION			English	Article						Honesty; Corruption; Cultural differences	TAX COMPLIANCE; CONSEQUENCES; DISHONESTY; DECEPTION	Policy makers use several international indices that characterize countries according to the quality of their institutions. However, no effort has been made to study how the honesty of citizens varies across countries. This paper explores the honesty among citizens across 16 countries with 1440 participants. We employ a very simple task where participants face a trade-off between the joy of eating a fine chocolate and the disutility of having a threatened self-concept because of lying. Despite the incentives to cheat, we find that individuals are mostly honest. Further, international indices that are indicative of institutional honesty are completely uncorrelated with citizens' honesty for our sample countries. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Pascual-Ezama, David] Univ Complutense Madrid, Dept Financial Econ & Accounting, Madrid 28223, Spain; [Fosgaard, Toke R.] Univ Copenhagen, Dept Food & Resource Econ, DK-1958 Frederiksberg C, Denmark; [Camilo Cardenas, Juan] Univ Los Andes, CEDE, Fac Econ, Bogota, Colombia; [Kujal, Praveen; Branas-Garza, Pablo] Middlesex Univ London, Sch Business, Dept Econ, London NW4 4BT, England; [Veszteg, Robert] Waseda Univ, Sch Polit Sci & Econ, Shinjuku Ku, Tokyo 1698050, Japan; [Gil-Gomez de Liano, Beatriz] Univ Autonoma Madrid, Dept Social Psychol & Methodol, E-28049 Madrid, Spain; [Gunia, Brian] Johns Hopkins Carey Business Sch, Baltimore, MD 21202 USA; [Weichselbaumer, Doris] Univ Linz, Dept Econ, A-4040 Linz, Austria; [Weichselbaumer, Doris] Univ Linz, Dept Womens & Gender Studies, A-4040 Linz, Austria; [Hilken, Katharina] Vrije Univ Brussel, Dept Appl Econ, B-1050 Brussels, Belgium; [Antinyan, Armenak] Univ Erlangen Nurnberg, Chair Econ Theory, D-90403 Nurnberg, Germany; [Delnoij, Joyce] Univ Utrecht, Sch Econ, NL-3584 EC Utrecht, Netherlands; [Proestakis, Antonios] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21027 Ispra, VA, Italy; [Tira, Michael D.] Univ Padua, Dept Gen Psychol, I-35131 Padua, Italy; [Pratomo, Yulius] Satya Wacana Christian Univ, Fac Econ & Business, Dept Econ, Salatiga 50711, Indonesia; [Jaber-Lopez, Tarek] Univ Jaume 1, Dept Econ, Lab Econ Expt, Castellon de La Plana, Spain	Pascual-Ezama, D (reprint author), Univ Complutense Madrid, Dept Financial Econ & Accounting, Campus Somosaguas, Madrid 28223, Spain.	david.pascual@ccee.ucm.es; tf@ifro.ku.dk; jccarden@gmail.com; pkujal@gmail.com; rveszteg@gmail.com; bgil.gomezdelianno@uam.es; brian.gunia@jhu.edu; Doris.Weichselbaumer@jku.at; khilken@vub.ac.be; armenak.antinyan@fau.de; J.M.J.Delnoij@uu.nl; antonios.proestakis@ec.europa.eu; michael.d.tira@gmail.com; yulius.pratomo@staff.uksw.edu; tarekjaberlopez@gmail.com; branasgarza@gmail.com	Gunia, Brian/D-7887-2015	Gunia, Brian/0000-0001-8922-1747	Ministry of Science from Spain [ECO2013-44879-R]; Junta de Andalucia Excelllent Groups (Spain) [P12-SEJ-1436]	Financial support from the following: Ministry of Science from Spain: ECO2013-44879-R and Junta de Andalucia Excelllent Groups P12-SEJ-1436 (Spain).	Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Gino F, 2012, ORGAN BEHAV HUM DEC, V119, P15, DOI 10.1016/j.obhdp.2012.03.011; Dreber A, 2008, ECON LETT, V99, P197, DOI 10.1016/j.econlet.2007.06.027; Gelfand MJ, 2013, J APPL PSYCHOL, V98, P504, DOI 10.1037/a0031908; Shu LL, 2012, P NATL ACAD SCI USA, V109, P15197, DOI 10.1073/pnas.1209746109; ALM J, 1995, KYKLOS, V48, P3; Shalvi S, 2012, PSYCHOL SCI, V23, P1264, DOI 10.1177/0956797612443835; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Gneezy U, 2013, J ECON BEHAV ORGAN, V93, P293, DOI 10.1016/j.jebo.2013.03.025; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Bandura A, 1996, J PERS SOC PSYCHOL, V71, P364, DOI 10.1037/0022-3514.71.2.364; Abeler J, 2014, J PUBLIC ECON, V113, P96, DOI 10.1016/j.jpubeco.2014.01.005; Messerli FH, 2012, NEW ENGL J MED, V367, P1562, DOI 10.1056/NEJMon1211064; ARIELY D., 2012, HONEST TRUTH DISHONE; Ayal S., 2011, SOCIAL PSYCHOL MORAL; Bazerman MH, 2011, BLIND SPOTS: WHY WE FAIL TO DO WHATS RIGHT AND WHAT TO DO ABOUT IT, P1; Bucciol A, 2011, J ECON PSYCHOL, V32, P73, DOI 10.1016/j.joep.2010.12.001; Croson R., 2009, J ECON LIT, V47, P1, DOI DOI 10.1257/JEL.47.1.1; Cummings RG, 2009, J ECON BEHAV ORGAN, V70, P447, DOI 10.1016/j.jebo.2008.02.010; Exadaktylos F., 2013, SCI REP, V3; Fosgaard TR, 2013, J ECON BEHAV ORGAN, V93, P279, DOI 10.1016/j.jebo.2013.03.027; Kahneman D., 2011, THINKING FAST SLOW; Kountouris Y, 2013, J ECON BEHAV ORGAN, V96, P104, DOI 10.1016/j.jebo.2013.09.010; Kramer R.M., 1995, NEGOTIATION SOCIAL P; Magnus JR, 2002, J ECON EDUC, V33, P125; Pascual-Ezama D, 2013, J ECON BEHAV ORGAN, V93, P367, DOI 10.1016/j.jebo.2013.03.015; Rawwas M., 2004, J MARKETING ED, V26, P89, DOI [10.1177/0273475303262354, DOI 10.1177/0273475303262354]	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2681	1879-1751		J ECON BEHAV ORGAN	J. Econ. Behav. Organ.	AUG	2015	116						379	386		10.1016/j.jebo.2015.04.020		8	Economics	Business & Economics	CN4IE	WOS:000358393000026		
J	Rehdanz, K; Welsch, H; Narita, D; Okubo, T				Rehdanz, Katrin; Welsch, Heinz; Narita, Daiju; Okubo, Toshihiro			Well-being effects of a major natural disaster: The case of Fukushima	JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION			English	Article						Fukushima; Subjective well-being; Natural disaster; Nuclear accident; Difference-in-differences; Willingness to pay	LIFE SATISFACTION APPROACH; VALUING PUBLIC-GOODS; AIR-QUALITY; HAPPINESS; COSTS; ENVIRONMENT; PREFERENCES; VALUATION; POLLUTION; CLIMATE	Based on a quasi-experimental difference-in-differences approach, we use panel data for 5979 individuals interviewed in Japan before and after the tsunami and nuclear accident at Fukushima to analyze the effects of the combined disaster on people's subjective well-being. To conduct our analysis, we use Geographical Information Systems to merge the subjective well-being data with information on respondents' distance from the Fukushima Dai-ichi nuclear power plant, their proximity to nuclear power stations in general, and the spatial distribution of radioactive fallout after the accident. Our main findings are as follows: (1) After the disaster, people living in a place affected by the tsunami or close to the Fukushima Dai-ichi power plant experienced a drop in life happiness, while the effects declined with distance to the place of the disaster. (2) No change in subjective well-being is detectable in people living close to nuclear facilities in general. (3) In contrast to happiness with life after the disaster, no effect on people's happiness with their entire life can be found among those affected by the disaster. (4) The drop in life happiness in municipalities affected by the tsunami is equivalent to 72% of annual income and reaches 240% for those living in close distance to the Fukushima Dai-ichi power plant (<= 150 km). (C) 2015 Elsevier B.V. All rights reserved.	[Rehdanz, Katrin; Narita, Daiju] Kiel Inst World Econ, D-24105 Kiel, Germany; [Rehdanz, Katrin] Univ Kiel, Dept Econ, D-24118 Kiel, Germany; [Welsch, Heinz] Carl von Ossietzky Univ Oldenburg, Dept Econ, D-26111 Oldenburg, Germany; [Narita, Daiju] JICA Res Inst, Shinjuku Ku, Tokyo 1628433, Japan; [Okubo, Toshihiro] Keio Univ, Fac Econ, Minato Ku, Tokyo 1088345, Japan	Rehdanz, K (reprint author), Kiel Inst World Econ, Kiellinie 66, D-24105 Kiel, Germany.	katrin.rehdanz@ifw-kiel.de; heinz.welsch@uni-oldenburg.de; Narita.Daiju@jica.go.jp; okubo@econ.keio.ac.jp			Swiss Federal Office of Energy	We would like to thank Susana Ferreira, Arik Levinson, David Maddison, Uwe Jensen and two anonymous referees for helpful comments on an earlier version of the paper. The data analysis in this paper utilizes Keio Household Panel Survey (KHPS) data provided by the Panel Data Research Center at Keio University. For Heinz Welsch financial support by the Swiss Federal Office of Energy is acknowledged.	Almond D, 2009, Q J ECON, V124, P1729, DOI 10.1162/qjec.2009.124.4.1729; [Anonymous], 2014, INT REV ENV RESOUR E; Luechinger S, 2009, ECON J, V119, P482, DOI 10.1111/j.1468-0297.2008.02241.x; Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; Welsch H, 2008, APPL ECON, V40, P1839, DOI 10.1080/00036840600905225; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Welsch H, 2006, ECOL ECON, V58, P801, DOI 10.1016/j.ecolecon.2005.09.006; Luechinger S, 2009, J PUBLIC ECON, V93, P620, DOI 10.1016/j.jpubeco.2008.10.003; Ferreira S, 2010, ENVIRON RESOUR ECON, V46, P249, DOI 10.1007/s10640-009-9339-8; Maddison D, 2011, ECOL ECON, V70, P2437, DOI 10.1016/j.ecolecon.2011.07.027; Di Tella R, 2001, AM ECON REV, V91, P335, DOI 10.1257/aer.91.1.335; MacKerron G, 2012, J ECON SURV, V26, P705, DOI 10.1111/j.1467-6419.2010.00672.x; Frey BS, 2002, J ECON LIT, V40, P402, DOI 10.1257/002205102320161320; Carroll N, 2009, J POPUL ECON, V22, P445, DOI 10.1007/s00148-007-0174-3; Rehdanz K, 2005, ECOL ECON, V52, P111, DOI 10.1016/j.ecolecon.2004.06.015; Berger EM, 2010, KYKLOS, V63, P1; Welsch H, 2002, KYKLOS, V55, P473, DOI 10.1111/1467-6435.00198; MacKerron G, 2009, ECOL ECON, V68, P1441, DOI 10.1016/j.ecolecon.2008.10.004; Levinson A, 2012, J PUBLIC ECON, V96, P869, DOI 10.1016/j.jpubeco.2012.06.007; Atkinson A. B., 2000, HDB INCOME DISTRIBUT; Clark AE, 2008, J ECON LIT, V46, P95, DOI 10.1257/jel.46.1.95; Frey BS, 2000, ECON J, V110, P918, DOI 10.1111/1468-0297.00570; Frey BS, 2009, PUBLIC CHOICE, V138, P317, DOI 10.1007/s11127-008-9361-3; Goebel J., 2013, SOEP PAPERS MULTIDIS, P599; Helliwell J., 2012, WORLD HAPPINESS REPO; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Kimball M., 2006, 12062 NBER; Metcalfe R, 2011, ECON J, V121, pF81, DOI 10.1111/j.1468-0297.2010.02416.x; Murray T., 2013, CLIM CHANGE EC, V4; Ohtake F., 2013, 310 GCOE OS U GRAD S; Seko M., 2013, KAKEI PANERU DETA KA; Seko M., 2012, HIGASHI NIHON DAISHI; Toy W., 2007, HDB CULTURAL PSYCHOL, P691; Uchida Y., 2012, INT J WELLBEING, V2, P354, DOI DOI 10.5502/IJW.V2.I4.5; van Praag Bernard, 2008, HAPPINESS QUANTIFIED; Baarsma B., 2005, ECON J, V52, P111; Welsch H, 2008, KYKLOS, V61, P320, DOI 10.1111/j.1467-6435.2008.00404.x; Yamane F, 2013, RISK ANAL, V33, P2023, DOI 10.1111/risa.12045	38	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2681	1879-1751		J ECON BEHAV ORGAN	J. Econ. Behav. Organ.	AUG	2015	116						500	517		10.1016/j.jebo.2015.05.014		18	Economics	Business & Economics	CN4IE	WOS:000358393000035		
J	Shime, N				Shime, Nobuaki			A SURVEY OF THE COMPETENCY OF AMBULANCE SERVICE PERSONNEL IN THE DIAGNOSIS AND MANAGEMENT OF SEPSIS	JOURNAL OF EMERGENCY MEDICINE			English	Article						sepsis; medical education; ambulance service; emergency life-saving technician	EMERGENCY MEDICAL-SERVICES; PERCEPTION; KNOWLEDGE; CARE	Background: Few studies have evaluated the current status of knowledge of sepsis in ambulance service personnel. Objective: Our aim was to ascertain the levels of competency and proficiency of ambulance service personnel in the diagnosis and management of severe sepsis. Methods: A questionnaire was submitted to a sample of 208 participants in a professional ambulance service conference, and was recovered on site. The study probed eight areas of sepsis diagnosis and management based on modifications of a questionnaire used in a previous study. Results: The term sepsis in Japanese, Haiketsushou, was familiar to 99% of Japanese certified emergency life-saving technicians (ELST) (Group I) and to 92% of noncertified ambulance service personnel (Group II), although 15% of participants in Group I and 44% in Group II ignored the meaning of sepsis. The definition of sepsis as "body's response to infection,'' "blood poisoning,'' or "shock due to bacteria in blood'' were selected by 17%, 16%, and 37%, respectively, in Group I, and 4%, 6%, and 22%, respectively, in Group II. The mortality associated with sepsis was underestimated by 57% in Group I and 78% in Group II. Vital signs raising a suspicion for sepsis and their pertinent ranges were correctly chosen by only 50% of certified ELST. Hypothermia was prominently undervalued as a sign raising the suspicion of sepsis. Conclusions: Insufficient knowledge and perception for sepsis in Japanese ambulance services is revealed. A higher level of onsite or formal postgraduate education needs to be provided with a view to improve the prehospital management of sepsis. (C) 2015 Elsevier Inc.	[Shime, Nobuaki] Natl Hosp Org, Kyoto Med Ctr, Dept Emergency & Crit Care Med, Kyoto 6128555, Japan	Shime, N (reprint author), Natl Hosp Org, Kyoto Med Ctr, Dept Emergency & Crit Care Med, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.						Brice JH, 2008, PREHOSP EMERG CARE, V12, P366, DOI 10.1080/10903120802100100; Poeze M, 2004, CRIT CARE, V8, pR409, DOI 10.1186/cc2959; Rubulotta FM, 2009, CRIT CARE MED, V37, P167, DOI 10.1097/CCM.0b013e3181926883; Guerra WF, 2013, J EMERG MED, V44, P1116, DOI 10.1016/j.jemermed.2012.11.003; Kushimoto S, 2013, CRIT CARE, V17, DOI 10.1186/cc13106; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Seymour CW, 2012, J EMERG MED, V42, P666, DOI 10.1016/j.jemermed.2011.06.013; Seymour CW, 2010, PREHOSP EMERG CARE, V14, P145, DOI 10.3109/10903120903524997; Seymour CW, 2012, AM J RESP CRIT CARE, V186, P1264, DOI 10.1164/rccm.201204-0713OC; Shime N, 2012, ANAESTH INTENS CARE, V40, P737	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	AUG	2015	49	2					147	151		10.1016/j.jemermed.2014.12.066		5	Emergency Medicine	Emergency Medicine	CN7EV	WOS:000358597800013		
J	Ueoka, N; Hikasa, Y				Ueoka, Naotami; Hikasa, Yoshiaki			Effects in cats of atipamezole, flumazenil and 4-aminopyridine on stress-related neurohormonal and metabolic responses induced by medetomidine, midazolam and ketamine	JOURNAL OF FELINE MEDICINE AND SURGERY			English	Article							HEALTHY CATS; DOGS; XYLAZINE; COMBINATION; ANESTHESIA; YOHIMBINE; REVERSAL	This study aimed to investigate the antagonistic effects of a fixed dose of atipamezole (ATI), flumazenil (FLU) and 4-aminopyridine (4AP), both alone and in various combinations, on key stress-related neurohormonal and metabolic changes induced by medetomidine (MED), midazolam (MID) and ketamine (KET) in healthy cats. Seven cats were used consistently in eight investigation groups. Cats were administered a mixture of 0.05 mg/kg MED and 0.5 mg/kg MID followed 10 mins later by 10 mg/kg KET intramuscularly. Twenty minutes after KET injection, the cats were intravenously injected with either a physiological saline solution at 0.1 ml/kg (control) or one of the seven variations of experimental drugs, alone or in combination: ATI, FLU, 4AP, ATI + FLU, FLU + 4AP, ATI + 4AP and ATI + FLU + 4AP. Blood samples were collected 10 times during the 24 h test period. Plasma glucose, insulin, cortisol, epinephrine, norepinephrine and non-esterified fatty acid levels were measured. The administration of MED + MID + KET resulted in hyperglycaemia and decreases in epinephrine, norepinephrine, cortisol and non-esterified fatty acid levels. FLU or 4AP alone or FLU + 4AP did not effectively antagonise the effects induced by MED + MID + KET but enhanced the hyperglycaemia. ATI alone was effective in antagonising these effects. Compared with non-ATI regimens, combinations with ATI were more effective in antagonising the effects induced by MED + MID + KET; however, ATI + FLU + 4AP caused large increases in cortisol, epinephrine and norepinephrine concentrations. ATI, both alone and in combination, is effective in antagonising the neurohormonal and metabolic effects of MED + MID + KET in cats. However, ATI + FLU + 4AP is not suitable because of large stress-related hormonal responses.	[Ueoka, Naotami; Hikasa, Yoshiaki] Tottori Univ, Joint Dept Vet Med, Fac Agr, Lab Vet Internal Med, Tottori, Tottori 680, Japan; [Ueoka, Naotami] Ueoka Anim Hosp, Hiroshima, Japan	Hikasa, Y (reprint author), Tottori Univ, Joint Dept Vet Med, Fac Agr, 4-101 Koyama Minami, Tottori, Tottori 680, Japan.	hikasa@muses.tottori-u.ac.jp			Japan Society for the Promotion of Science	This work was supported, in part, by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to Yoshiaki Hikasa).	Adams HA, 1997, ANAESTHESIA, V46, P30; Ambrisko TD, 2002, CAN J VET RES, V66, P42; Ambrisko TD, 2003, CAN J VET RES, V67, P64; Ambrisko TD, 2005, AM J VET RES, V66, P406, DOI 10.2460/ajvr.2005.66.406; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Granholm M, 2006, VET ANAESTH ANALG, V33, P214, DOI 10.1111/j.1467-2995.2005.00259.x; Ko JCH, 2000, J AM VET MED ASSOC, V217, P509, DOI 10.2460/javma.2000.217.509; Fagerholm V, 2011, BASIC CLIN PHARMACOL, V108, P365, DOI 10.1111/j.1742-7843.2011.00699.x; Benson GJ, 2000, VET SURG, V29, P85, DOI 10.1111/j.1532-950X.2000.00085.x; DURANT NN, 1980, ANESTHESIOLOGY, V52, P381, DOI 10.1097/00000542-198005000-00001; Ebner J, 2007, J VET MED A, V54, P518, DOI 10.1111/j.1439-0442.2007.00971.x; Gaynor JS, 2002, HDB VET PAIN MANAGEM, P49; HATCH RC, 1983, AM J VET RES, V44, P417; Ilkiw JE, 2002, J VET PHARMACOL THER, V25, P181, DOI 10.1046/j.1365-2885.2002.00402.x; Kanda T, 2008, CAN J VET RES, V72, P278; Kanda T, 2008, CAN J VET RES, V72, P332; Kun A, 2002, VASC PHARMACOL, V39, P7, DOI 10.1016/S1537-1891(02)00278-1; Murahata Y, 2012, AM J VET RES, V73, P1871, DOI 10.2460/ajvr.73.12.1871; Savola JM, 1989, ACTA VET SCAND, V85, P38; Ueoka N, 2008, J FELINE MED SURG, V10, P47, DOI 10.1016/j.jfms.2007.06.013; Vaha-Vahe T., 1990, J SMALL ANIM PRACT, V31, P193; Zaki S, 2009, AUST VET J, V87, P82, DOI 10.1111/j.1751-0813.2009.00390.x	22	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1098-612X	1532-2750		J FELINE MED SURG	J. Feline Med. Surg.	AUG	2015	17	8					711	718		10.1177/1098612X14556557		8	Veterinary Sciences	Veterinary Sciences	CN5AZ	WOS:000358443100007		
J	Kotera, S; Yamaguchi, M				Kotera, Seigo; Yamaguchi, Masayuki			Flow property at capillary extrusion for ethylene-tetrafluoroethylene copolymer	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Ethylene-tetrafluoroethylene copolymer; Rheological properties; Extrusion; Melt fracture	LINEAR-POLYMERS; MOLECULAR-STRUCTURE; SHARKSKIN DEFECT; POLYETHYLENE; SHEAR; WEIGHT	The capillary extrusion property of ethylene-tetrafluoroethylene copolymer (ETFE) is evaluated. It is found that ETFE shows several types of flow instabilities. The shark-skin failure is observed over the first critical shear stress 7.9 x 10(4) Pa. Then, the slip-stick instability is detected at 1.8 x 10(5) Pa, which corresponds to the critical stress of the slippage at the die wall, evaluated by the Mooney method. Moreover, gross wavy melt fracture appears at high out-put rate condition. It is interesting to note that quasi-stable flow region; so-called "super-extrusion", is observed between slip-stick and wavy melt fracture regions. Because of the steady slippage, ETFE can be extruded at a high out-put rate condition without surface roughness and distortion of extrudates. (C) 2015 Elsevier B.V. All rights reserved.	[Kotera, Seigo; Yamaguchi, Masayuki] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Kotera, Seigo] Asahi Glass Co Ltd, Kanagawa Ku, Yokohama, Kanagawa 2210863, Japan	Yamaguchi, M (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	m_yama@jaist.ac.jp					Ajiroldi G., 1970, J APPL POLYM SCI, V14, P79; Allal A, 2006, J NON-NEWTON FLUID, V134, P127, DOI 10.1016/j.jnnfm.2005.12.010; Allal A, 2007, J NON-NEWTON FLUID, V146, P45, DOI 10.1016/j.jnnfm.2006.12.003; Ameduri B., 2004, PROPERTIES APPL; Yamaguchi M, 2002, POLYMER, V43, P5249, DOI 10.1016/S0032-3861(02)00373-7; Jordens K, 2000, POLYMER, V41, P7175, DOI 10.1016/S0032-3861(00)00073-2; KALIKA DS, 1987, J RHEOL, V31, P815, DOI 10.1122/1.549942; BROCHARD F, 1992, LANGMUIR, V8, P3033, DOI 10.1021/la00048a030; Yan D, 1999, POLYMER, V40, P1737, DOI 10.1016/S0032-3861(98)00318-8; Chen XY, 2012, J APPL POLYM SCI, V125, P2442, DOI 10.1002/app.36512; Chu B., 1993, J APPL POLYM SCI, V498, P97; Cogswell F. N., 1981, POLYM MELT RHEOLOGY; Drobny J. G., 2009, TECHNOLOGY FLUOROPOL; Ferry JD, 1980, VISCOELASTIC PROPERT; Hatzikiriakos SG, 2005, POLYM PROCESSING INS; Koopmans R, 2010, POLYM MELT FRACTURE; Kotera S, 2014, J FLUORINE CHEM, V166, P117, DOI 10.1016/j.jfluchem.2014.07.020; Linliu K., 1995, POLYMER, V36, P2265, DOI 10.1016/0032-3861(95)95306-L; Meller M, 2002, POLYM ENG SCI, V42, P611, DOI 10.1002/pen.10976; MILLS NJ, 1968, NATURE, V219, P1249, DOI 10.1038/2191249a0; Piau J.M., 1996, RHEOLOGY POLYM MELT; Rosenbaoum E., 1998, THESIS U BRIT COLUMB; Saito O., 1972, RAD CHEM MACROMOLECU; TOBOLSKY AV, 1963, J POLYM SCI PART A, V1, P483, DOI 10.1002/pol.1963.100010142; Tordella J.P., 1969, RHEOLOGY THEORY APPL, V5, P57; TUNG LH, 1960, J POLYM SCI, V46, P409, DOI 10.1002/pol.1960.1204614810; VINOGRAD.GV, 1972, POLYM ENG SCI, V12, P323, DOI 10.1002/pen.760120503; WU S, 1989, J POLYM SCI POL PHYS, V27, P723, DOI 10.1002/polb.1989.090270401	28	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	AUG	2015	176						20	25		10.1016/j.jfluchem.2015.05.002		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CN5GN	WOS:000358457900004		
J	Quan, HD; Zhang, N; Zhou, XM; Qian, H; Sekiya, A				Quan, Hengdao; Zhang, Ni; Zhou, Xiaomeng; Qian, Hua; Sekiya, Akira			Syntheses of isocyanates via amines and carbonyl fluoride	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Amines; Carbonyl fluoride; Isocyanates; Synthesis	THERMAL-DECOMPOSITION; DIMETHYL CARBONATE; CARBAMATE; CHEMISTRY; UREAS	Isocyanates are widely used in many different areas, but the most common synthesis route-phosgene route cannot fit the more and more rigorous restriction of safety and environment. Here, a facile synthesis method of isocyanates via amines and carbonyl fluoride is proven feasibly by expanding its applications to the syntheses of nine different isocyanates. And two differences with the phosgene route are proposed. The reaction could occur under milder conditions and afford isocyanates in good yields, especially for the isocyanates containing electron withdrawing groups. It is appealing for industrial application. (C) 2015 Elsevier B.V. All rights reserved.	[Quan, Hengdao; Zhang, Ni] Beijing Inst Technol, Sch Chem Engn & Environm, Beijing 100081, Peoples R China; [Quan, Hengdao; Zhou, Xiaomeng; Qian, Hua; Sekiya, Akira] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Quan, HD (reprint author), Beijing Inst Technol, Sch Chem Engn & Environm, 5 South Zhongguangcun St, Beijing 100081, Peoples R China.	hengdao-quan@aist.go.jp					SCRIVEN EFV, 1988, CHEM REV, V88, P297, DOI 10.1021/cr00084a001; FAWCETT FS, 1962, J AM CHEM SOC, V84, P4275, DOI 10.1021/ja00881a017; Deleon RG, 2002, APPL CATAL A-GEN, V225, P43, DOI 10.1016/S0926-860X(01)00692-5; Delebecq E, 2013, CHEM REV, V113, P80, DOI 10.1021/cr300195n; [Anonymous], 2012, SAF DAT SHEET; Tafesh AM, 1996, CHEM REV, V96, P2035, DOI 10.1021/cr950083f; Braverman S, 1999, TETRAHEDRON LETT, V40, P3235, DOI 10.1016/S0040-4039(99)00372-X; Aresta M, 1999, GREEN CHEM, V1, P237, DOI 10.1039/a904624k; AVATANEO M, 2005, J FLUORINE CHEM, V126, P631, DOI DOI 10.1016/J.JFLUCHEM.2005.01.014; BABAD H, 1973, CHEM REV, V73, P75, DOI 10.1021/cr60281a005; BAUMGARTEN HE, 1975, J ORG CHEM, V40, P3554, DOI 10.1021/jo00912a019; Bernd B, 1982, EP Patent, Patent No. [0052842 A2, 0052842]; Beyleveld W.M., 1974, U.S. Patent, Patent No. 3795689; Biskup K., 2010, U.S. Patent, Patent No. [2010/0152484 A1, 20100152484]; Bohmholdt G, 1992, US patent, Patent No. [5,087,739, 5087739]; BORDZILOVSKII VY, 1992, J APPL CHEM-USSR+, V65, P145; Charalambides YC, 2007, SYNTHETIC COMMUN, V37, P1037, DOI 10.1080/00397910601055156; Christmas M.J., 2006, W.O. Patent, Patent No. [2006/022763, 2006022763]; Curini M, 2002, TETRAHEDRON LETT, V43, P4895, DOI 10.1016/S0040-4039(02)00965-6; Denton W.I., 1966, U.S. Patent, Patent No. 3287387; FRANZ JE, 1964, J ORG CHEM, V29, P2592, DOI 10.1021/jo01032a025; Gemassmer A., 1958, U.S. Patent, Patent No. 2824117; HEYMANN H, 1945, J AM CHEM SOC, V67, P1979, DOI 10.1021/ja01227a035; IHS, 2002, 1F IHS; Islam SM, 1999, J MOL CATAL A-CHEM, V142, P169, DOI 10.1016/S1381-1169(98)00295-7; Lewandowski G, 2005, J HAZARD MATER, V119, P19, DOI 10.1016/j.jhazmat.2004.11.016; Lichty J.G., 1944, U.S. Patent, Patent No. 2362648; LOMBARDINO JF, 1964, J MED CHEM, V7, P97, DOI 10.1021/jm00331a021; Mayer H., 2005, U.S. Patent, Patent No. [6949672-132, 6949672132]; PATEL NR, 1992, INORG CHEM, V31, P2537, DOI 10.1021/ic00038a042; Paul F, 2000, COORDIN CHEM REV, V203, P269, DOI 10.1016/S0010-8545(99)00230-1; Perret N., 2011, U.S. Patent, Patent No. [2011/0306786 AA, 20110306786]; Pohls P., 1942, U.S. Patent, Patent No. 2297024; Quan H.D., 2013, J.P. Patent, Patent No. 5322183; Quan H.D., 2007, W.O. Patent, Patent No. [2007/037468, 2007037468]; Shi F, 2003, J CATAL, V219, P372, DOI 10.1016/S0021-9517(03)00198-2; THOMPSON JW, 1978, ISRAEL J CHEM, V17, P129; THRASHER JS, 1982, INORG CHEM, V21, P1616, DOI 10.1021/ic00134a068; Tremblay P, 2003, ANALYST, V128, P142, DOI 10.1039/b209779f; WALDMAN TE, 1994, J CHEM SOC CHEM COMM, P957, DOI 10.1039/c39940000957; Wicks DA, 1997, PROG ORG COAT, V30, P265, DOI 10.1016/S0300-9440(97)00002-7; Zengel H., 1980, U.S. Patent, Patent No. 4203916; Zhao X.Q, 2002, IND ENG CHEM RES, V41, P5139	43	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	AUG	2015	176						26	30		10.1016/j.jfluchem.2015.05.007		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CN5GN	WOS:000358457900005		
J	Sato, H; Hasegawa, G; Takeuchi, M; Takahashi, K; Sato, Y; Hashimoto, S; Mizuno, K; Kobayashi, M				Sato, H.; Hasegawa, G.; Takeuchi, M.; Takahashi, K.; Sato, Y.; Hashimoto, S.; Mizuno, K.; Kobayashi, M.			Gastroenterology: A unique endoscopic technique for full-layer histology of jackhammer esophagus	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Sato, H.; Takeuchi, M.; Takahashi, K.; Sato, Y.; Hashimoto, S.; Mizuno, K.] Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Niigata, Japan; [Kobayashi, M.] Niigata Univ, Med & Dent Hosp, Dept Endoscopy, Niigata, Japan; [Hasegawa, G.] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Dept Cellular Funct, Niigata, Japan	Sato, H (reprint author), Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Niigata, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	AUG	2015	30	8					1226	1226		10.1111/jgh.12914		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4YL	WOS:000358436400003		
J	Hori, Y; Naitoh, I; Ban, T; Narita, K; Nakazawa, T; Hayashi, K; Miyabe, K; Shimizu, S; Kondo, H; Nishi, Y; Yoshida, M; Umemura, S; Kato, A; Yamada, T; Ando, T; Joh, T				Hori, Yasuki; Naitoh, Itaru; Ban, Tesshin; Narita, Kei; Nakazawa, Takahiro; Hayashi, Kazuki; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Kato, Akihisa; Yamada, Tomonori; Ando, Tomoaki; Joh, Takashi			Stent under-expansion on the procedure day, a predictive factor for poor oral intake after metallic stenting for gastric outlet obstruction	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						gastric outlet obstruction scoring system; malignant gastric outlet obstruction; poor oral intake; self-expandable metallic stent	GASTRODUODENAL OBSTRUCTION; ENDOSCOPIC PALLIATION; MULTICENTER	Background and AimSelf-expandable metallic stents (SEMS) have been widely accepted as palliation therapy for malignant gastric outlet obstruction (GOO). However, the factors predictive of poor oral intake after SEMS placement have not been elucidated sufficiently. We aimed to clarify both the patient and stent-related predictive factors. MethodsWe retrospectively reviewed 126 consecutive patients who underwent uncovered SEMS placement for malignant GOO between April 2010 and March 2013 at a university hospital and two tertiary care referral centers. ResultsTechnical success of SEMS placement was achieved in all 126 (100%) patients. Improved oral intake was observed in 111 (88.1%) patients. A Karnofsky performance status 40 (odds ratio [OR], 1.19; 95% confidence interval [CI], 1.02-1.28; P=0.041), peritoneal dissemination (OR, 1.20; 95% CI, 1.01-1.26; P=0.038), and under-expansion of the SEMS on the procedure day (OR, 1.55; 95% CI, 1.26-1.62; P<0.001) were independent predictive factors for poor improvement on the GOO scoring system, according to multivariate analysis. ConclusionsSEMS under-expansion was a stent related, while poor performance status and peritoneal dissemination were patient related, predictive factors for poor oral intake after SEMS placement for malignant GOO.	[Hori, Yasuki; Naitoh, Itaru; Nakazawa, Takahiro; Hayashi, Kazuki; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Ban, Tesshin; Yamada, Tomonori] Nagoya Daini Red Cross Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Narita, Kei; Ando, Tomoaki] Gamagori City Hosp, Dept Gastroenterol, Gamagori, Japan	Naitoh, I (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	inaito@med.nagoya-cu.ac.jp					Wong YT, 2002, SURG ENDOSC, V16, P310, DOI 10.1007/s00464-001-9061-2; Adler DG, 2002, AM J GASTROENTEROL, V97, P72; Mendelsohn RB, 2011, GASTROINTEST ENDOSC, V73, P1135, DOI 10.1016/j.gie.2011.01.042; Ly J, 2010, SURG ENDOSC, V24, P290, DOI 10.1007/s00464-009-0577-1; Mittal A, 2004, BRIT J SURG, V91, P205, DOI 10.1002/bjs.4396; Gaidos JKJ, 2009, WORLD J GASTROENTERO, V15, P4365, DOI 10.3748/wjg.15.4365; Fukami N, 2011, GASTROINTEST ENDOSC, V74, P13, DOI 10.1016/j.gie.2010.12.003; Chandrasegaram MD, 2012, SURG ENDOSC, V26, P323, DOI 10.1007/s00464-011-1870-3; Tringali A, 2014, GASTROINTEST ENDOSC, V79, P66, DOI 10.1016/j.gie.2013.06.032; Sato T, 2015, DIGEST ENDOSC, V27, P121, DOI 10.1111/den.12300; Costamagna G, 2012, DIGEST LIVER DIS, V44, P37, DOI 10.1016/j.dld.2011.08.012; Yim HB, 2001, GASTROINTEST ENDOSC, V53, P329, DOI 10.1067/mge.2001.112842; Sasaki T, 2012, DIGEST ENDOSC, V24, P226, DOI 10.1111/j.1443-1661.2011.01208.x; Lee EYT, 2011, J GASTROEN HEPATOL, V26, P484, DOI 10.1111/j.1440-1746.2010.06523.x; Maetani I, 2009, GASTROINTEST ENDOSC, V69, P806, DOI 10.1016/j.gie.2008.06.009; Song GA, 2007, GASTROINTEST ENDOSC, V65, P782, DOI 10.1016/j.gie.2006.08.030; VANSHOOFT JE, 2011, ENDOSCOPY, V43, P671	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	AUG	2015	30	8					1246	1251		10.1111/jgh.12933		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4YL	WOS:000358436400009		
J	Nagata, N; Niikura, R; Aoki, T; Shimbo, T; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Yanase, M; Akiyama, J; Uemura, N				Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Shimbo, Takuro; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Uemura, Naomi			Association between colonic diverticulosis and bowel symptoms: A case-control study of 1629 Asian patients	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						colonic symptoms; sex differences; site of diverticulosis; symptomatic uncomplicated diverticular disease (SUDD)	FIBER DIET; DISEASE; RISK; SEX; QUESTIONNAIRE; POPULATION; VALIDATION; HEALTH; JAPAN; LIFE	Background: It remains unclear whether diverticulosis, absent inflammation, is responsible for chronic bowel symptoms. We examined the association between bowel symptoms and asymptomatic diverticulosis. Method: This case-control study included 543 patients with diverticulosis and 1086 age and sex-matched controls (1:2) without diverticulosis on screening colonoscopy. Eleven symptoms (abdominal discomfort, hunger discomfort, borborygmus, abdominal distension, flatus, constipation, diarrhea, loose stools, hard stools, fecal urgency, and incomplete evacuation) were evaluated using a gastrointestinal symptoms rating scale (GSRS) at baseline and second questionnaire. Associations between diverticulosis and symptoms were estimated using odds ratios (ORs) and 95 confidence interval (CI). Results: In multivariate analysis, constipation (OR, 0.85 [0.78-0.93]) and hard stools (OR, 0.86 [0.78-0.94]) were negatively associated with diverticulosis. The other nine symptoms showed no association with diverticulosis. Diverticulosis was negatively associated with constipation (OR, 0.93 [0.74-0.93]), hard stools (OR, 0.85 [0.76-0.96]), and incomplete evacuation (OR, 0.88 [0.79-0.99]) in males, and positively associated with diarrhea (OR, 1.39 [1.14-1.69]) and loose stools (OR, 1.28 [1.05-1.55]) in females. No bowel symptoms were positively associated with any of right-sided, left-sided, or bilateral diverticulosis. Test-retest reliability of GSRS (mean interval, 4.4 months) was moderate (Mean Kappa, 0.568) in males and good (Mean Kappa, 0.652) in females. Conclusions: This large, colonoscopy-based, case-control study demonstrated that neither constipation nor hard stools were associated with an increased risk of diverticulosis, regardless of diverticulum location. In females, but not males, diarrhea and loose stools were positively associated with diverticulosis. Long-term test-retest reliability suggested that these symptoms remain consistent over a given period.	[Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan; [Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Hepatol, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Clin Res & Informat, Int Clin Res Ctr, Res Inst, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	This study was supported in part by a grant from the National Center for Global Health and Medicine (26A-201). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Strate LL, 2012, AM J GASTROENTEROL, V107, P1486, DOI 10.1038/ajg.2012.194; Sim J, 2005, PHYS THER, V85, P257; Cohen E, 2013, CLIN GASTROENTEROL H, V11, P1614, DOI 10.1016/j.cgh.2013.03.007; Shiotani A, 2006, J GASTROENTEROL, V41, P562, DOI 10.1007/s00535-006-1805-2; Delvaux M, 2003, ALIMENT PHARM THERAP, V18, P71, DOI 10.1046/j.0953-0673.2003.01720.x; Wiklund IK, 2003, SCAND J GASTROENTERO, V38, P947, DOI 10.1080/00365520310004209; Peery AF, 2013, CLIN GASTROENTEROL H, V11, P1622, DOI 10.1016/j.cgh.2013.06.033; Engsbro AL, 2013, AM J GASTROENTEROL, V108, P972, DOI 10.1038/ajg.2013.15; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Jeyarajah S, 2008, INT J COLORECTAL DIS, V23, P619, DOI 10.1007/s00384-008-0446-8; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; Jung HK, 2010, AM J GASTROENTEROL, V105, P652, DOI 10.1038/ajg.2009.621; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; SADAHIRO S, 1992, SURG RADIOL ANAT, V14, P251, DOI 10.1007/BF01794949; Peery AF, 2013, CLIN GASTROENTEROL H, V11, P1532, DOI 10.1016/j.cgh.2013.04.048; Quan C, 2003, ALIMENT PHARM THERAP, V17, P1179, DOI 10.1046/j.0269-2813.2003.01553.x; Nagata N, 2014, GASTROINTEST ENDOSC, V80, P1124, DOI 10.1016/j.gie.2014.06.039; Chial Heather J, 2002, J Gend Specif Med, V5, P37; Hansen JM, 2009, AM J GASTROENTEROL, V104, P2394, DOI 10.1038/ajg.2009.391; Kang JY, 2011, ALIMENT PHARM THER, V33, P487, DOI 10.1111/j.1365-2036.2010.04540.x; Kubo M, 2011, NEUROGASTROENT MOTIL, V23, P249, DOI 10.1111/j.1365-2982.2010.01640.x; Nagata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081137; Nagata N, 2014, INT J COLORECTAL DIS, V29, P379, DOI 10.1007/s00384-013-1808-4; OTTE JJ, 1986, AM J GASTROENTEROL, V81, P529; PAINTER NS, 1969, LANCET, V2, P586; ROGERS J, 1989, GUT, V30, P634, DOI 10.1136/gut.30.5.634; Stürmer T, 2000, J Epidemiol Biostat, V5, P125; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; THOMPSON WG, 1982, DIGEST DIS SCI, V27, P605, DOI 10.1007/BF01297216; Yamada E, 2014, AM J GASTROENTEROL, V109, P1900, DOI 10.1038/ajg.2014.323	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	AUG	2015	30	8					1252	+		10.1111/jgh.12941		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4YL	WOS:000358436400001		
J	Shichijo, S; Hirata, Y; Sakitani, K; Yamamoto, S; Serizawa, T; Niikura, R; Watabe, H; Yoshida, S; Yamada, A; Yamaji, Y; Ushiku, T; Fukayama, M; Koike, K				Shichijo, Satoki; Hirata, Yoshihiro; Sakitani, Kosuke; Yamamoto, Shinzo; Serizawa, Takako; Niikura, Ryota; Watabe, Hirotsugu; Yoshida, Shuntaro; Yamada, Atsuo; Yamaji, Yutaka; Ushiku, Tetsuo; Fukayama, Masashi; Koike, Kazuhiko			Distribution of intestinal metaplasia as a predictor of gastric cancer development	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						intestinal metaplasia; gastric cancer; Helicobacter pylori	HELICOBACTER-PYLORI ERADICATION; RANDOMIZED CONTROLLED-TRIAL; RISK; CARCINOGENESIS; PEPSINOGEN; INFECTION; ATROPHY	Background and AimHelicobacter pylori, gastritis, and intestinal metaplasia (IM) are known risk factors for gastric cancer. In the present study, we conducted a cohort study to evaluate the predictive value of the distribution of IM for gastric cancer development. MethodsWe conducted a retrospective cohort study at a university hospital. From June 1998 to December 2000, we assessed histological gastritis using biopsy specimens, one from the antrum and one from the corpus, from 1450 patients, among whom 729 revisited for follow-up endoscopy. Patients were classified into three groups according to the distribution of IM at initial endoscopy. IM group A had no IM, IM group B had IM in the antrum only, and IM group C had IM in the corpus. The development of gastric cancer was assessed by endoscopic examination. ResultsThe mean duration of follow-up was 6.74.7 years. The cumulative incidence of gastric cancer at 5 years was 1.5% in total and 0.8%, 3.3%, and 2.7% in IM groups A, B, and C, respectively. The IM group was identified as an independent risk factor by multivariate analysis; compared with IM group A, hazard ratios were 3.6 (95% confidence interval [CI] 1.1-12.1) in IM group B and 3.8 (95% CI 1.01-14.1) in IM group C. In IM group C, the incidence of gastric cancer in patients who received eradication therapy was significantly lower than that in patients who did not receive (P=0.021, log-rank). ConclusionIM is a good predictive marker for the development of gastric cancer.	[Shichijo, Satoki; Hirata, Yoshihiro; Sakitani, Kosuke; Yamamoto, Shinzo; Serizawa, Takako; Niikura, Ryota; Watabe, Hirotsugu; Yoshida, Shuntaro; Yamada, Atsuo; Yamaji, Yutaka; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Ushiku, Tetsuo; Fukayama, Masashi] Univ Tokyo, Dept Pathol, Tokyo 1138655, Japan	Hirata, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	HIRATAY-INT@h.u-tokyo.ac.jp			Daiwa Securities Health Foundation	This work was supported in part by a grant from Daiwa Securities Health Foundation. The authors thank the endoscopists at the University of Tokyo Hospital who helped to perform EGD on the participants for the follow-up examinations over several years. We are also grateful to all the pathologists for performing histological examinations on the participants.	Shiotani A, 2005, INT J CANCER, V115, P463, DOI 10.1002/ijc.20852; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Tava F, 2006, HUM PATHOL, V37, P1489, DOI 10.1016/j.humpath.2006.05.012; Capelle LG, 2010, GASTROINTEST ENDOSC, V71, P1150, DOI 10.1016/j.gie.2009.12.029; Ogura K, 2008, J CLIN GASTROENTEROL, V42, P279, DOI 10.1097/01.mcg.0000248006.80699.7f; Sakitani K, 2011, J GASTROEN HEPATOL, V26, P1570, DOI 10.1111/j.1440-1746.2011.06767.x; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Yanaoka K, 2009, INT J CANCER, V125, P2697, DOI 10.1002/ijc.24591; Cassaro M, 2000, AM J GASTROENTEROL, V95, P1431, DOI 10.1111/j.1572-0241.2000.02074.x; CORREA P, 1995, AM J SURG PATHOL, V19, pS37; DENSHOED CM, 2013, ENDOSCOPY, V45, P249; desVries AC, 2009, GASTROINTEST ENDOSC, V70, P18; DESVRIES AC, 2008, GASTROENTEROLOGY, V134, P945; desVries AC, 2009, AM J GASTROENTEROL, V104, P1342; Hsu PI, 2007, AM J GASTROENTEROL, V102, P725, DOI 10.1111/j.1572-0241.2006.01109.x; Solcia E, 1996, AM J SURG PATHOL, V20, pS8; Wu CY, 2009, GASTROENTEROLOGY, V137, pe1; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470	21	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	AUG	2015	30	8					1260	1264		10.1111/jgh.12946		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4YL	WOS:000358436400010		
J	Ogawa, E; Furusyo, N; Kajiwara, E; Nomura, H; Kawano, A; Takahashi, K; Dohmen, K; Satoh, T; Azuma, K; Nakamuta, M; Koyanagi, T; Kotoh, K; Shimoda, S; Hayashi, J				Ogawa, Eiichi; Furusyo, Norihiro; Kajiwara, Eiji; Nomura, Hideyuki; Kawano, Akira; Takahashi, Kazuhiro; Dohmen, Kazufumi; Satoh, Takeaki; Azuma, Koichi; Nakamuta, Makoto; Koyanagi, Toshimasa; Kotoh, Kazuhiro; Shimoda, Shinji; Hayashi, Jun		Kyushu Univ Liver Dis Study KULDS	Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						anemia; hepatitis C virus; inosine triphosphatase; ribavirin; simeprevir	TREATMENT-EXPERIENCED PATIENTS; GENOTYPE 1; PEGYLATED INTERFERON-ALPHA-2B; HEPATOCELLULAR-CARCINOMA; VIROLOGICAL RESPONSE; RIBAVIRIN TREATMENT; RISK-FACTORS; INFECTION; FIBROSIS; PEGINTERFERON/RIBAVIRIN	Background and AimThe addition of hepatitis C virus (HCV) NS3/4A protease inhibitors to the pegylated interferon (PEG-IFN) and ribavirin combination regimen (triple therapy) has dramatically improved treatment outcome. Unfortunately, anemia remains a common adverse effect. This study was done to compare the development of severe anemia during simeprevir- or telaprevir-based triple therapy. MethodsThis retrospective multicenter study consisted of 837 consecutive Japanese HCV genotype 1 patients treated in a real-world clinical setting, 811 of whom were enrolled (simeprevir 281, telaprevir 530). The inosine triphosphate pyrophosphatase (ITPA) genotype at rs1127354 was determined for all studied patients. Logistic regression was done after propensity score matching to assess the risk of development of severe anemia. ResultsPropensity score matching of the entire study population yielded 266 matched pairs. Severe anemia (nadir hemoglobin <9.0g/dL) was developed during the treatment period by 81 (30.5%) and 144 (54.1%) patients treated with simeprevir and telaprevir, respectively. Treatment with simeprevir was independently associated with a lower risk of severe anemia (odds ratio 0.25, 95% confidence interval 0.16-0.38, P<0.0001). Moreover, ITPA genotype, age, hemoglobin level, and estimated glomerular filtration rate at baseline were also independent factors associated with the development of severe anemia. ConclusionsPatients treated with simeprevir-based triple therapy have a lower risk of the development of severe anemia than those treated with telaprevir. Moreover, ITPA genotype and age may be useful for individualizing treatment to reduce the risk of anemia-related adverse effects.	[Ogawa, Eiichi; Furusyo, Norihiro] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 8128582, Japan; [Takahashi, Kazuhiro] Hamanomachi Hosp, Dept Med, Fukuoka, Japan; [Dohmen, Kazufumi] Chihaya Hosp, Dept Internal Med, Fukuoka, Japan; [Azuma, Koichi] Kyushu Cent Hosp, Dept Med, Fukuoka, Japan; [Nakamuta, Makoto] Natl Hosp Org, Dept Gastroenterol, Kyushu Med Ctr, Fukuoka, Japan; [Koyanagi, Toshimasa] Fukuoka City Hosp, Dept Med, Fukuoka, Japan; [Kotoh, Kazuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Shimoda, Shinji] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Hayashi, Jun] Haradoi Hosp, Kyushu Gen Internal Med Ctr, Fukuoka, Japan; [Kajiwara, Eiji] Steel Mem Yawata Hosp, Dept Hepatol, Kitakyushu, Fukuoka, Japan; [Nomura, Hideyuki] Shin Kokura Hosp, Ctr Liver Dis, Kitakyushu, Fukuoka, Japan; [Kawano, Akira] Kitakyushu Municipal Med Ctr, Dept Med, Kitakyushu, Fukuoka, Japan; [Satoh, Takeaki] Natl Hosp Org Kokura Med Ctr, Ctr Liver Dis, Kitakyushu, Fukuoka, Japan	Hayashi, J (reprint author), Kyushu Univ Hosp, Dept Gen Internal Med, Higashi Ku, Fukuoka 8128582, Japan.	hayashij@gim.med.kyushu-u.ac.jp			MSD K.K.; Chugai Pharmaceutical Co.; Janssen Pharmaceutical K.K.	Norihiro Furusyo has received grants from MSD K.K., Chugai Pharmaceutical Co., and Janssen Pharmaceutical K.K. The other authors declare that they have no conflicts of interest. This study was funded by Janssen Pharmaceutical K.K.	Ramachandran P, 2012, ALIMENT PHARM THER, V35, P647, DOI 10.1111/j.1365-2036.2012.04992.x; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gast.2004.09.014; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Ogawa E, 2012, J GASTROEN HEPATOL, V27, P1233, DOI 10.1111/j.1440-1746.2011.06965.x; Furusyo N, 2013, J HEPATOL, V59, P205, DOI 10.1016/j.jhep.2013.03.020; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Ochi H, 2010, GASTROENTEROLOGY, V139, P1190, DOI 10.1053/j.gastro.2010.06.071; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; De Nicolo A, 2014, ANTIVIR RES, V109, P7, DOI 10.1016/j.antiviral.2014.06.005; Ogawa E, 2013, ALIMENT PHARM THER, V38, P1076, DOI 10.1111/apt.12494; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Ogawa E, 2013, J HEPATOL, V59, P667, DOI 10.1016/j.jhep.2013.05.017; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Wei L, 2014, GASTROENTEROLOGY, V146, P1145, DOI 10.1053/j.gastro.2014.03.008; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Furusyo N, 2014, J ANTIMICROB CHEMOTH, V69, P483, DOI 10.1093/jac/dkt371; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Hosmer DW, 2000, APPL LOGISTIC REGRES, P162; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI DOI 10.1002/HEP.1840200104.PUBMED:8020885; Zeuzem S, 2014, J HEPATOL, V60, P1112, DOI 10.1016/j.jhep.2014.01.013; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	AUG	2015	30	8					1309	1316		10.1111/jgh.12945		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4YL	WOS:000358436400017		
J	Sekine, K; Nagata, N; Sakamoto, K; Arai, T; Shimbo, T; Shinozaki, M; Okubo, H; Watanabe, K; Imbe, K; Mikami, S; Nozaki, Y; Sakurai, T; Yokoi, C; Kojima, Y; Kobayakawa, M; Yanase, M; Akiyama, J; Noda, M; Uemura, N				Sekine, Katsunori; Nagata, Naoyoshi; Sakamoto, Kayo; Arai, Tomohiro; Shimbo, Takuro; Shinozaki, Masafumi; Okubo, Hidetaka; Watanabe, Kazuhiro; Imbe, Koh; Mikami, Shintaro; Nozaki, Yuichi; Sakurai, Toshiyuki; Yokoi, Chizu; Kojima, Yasushi; Kobayakawa, Masao; Yanase, Mikio; Akiyama, Junichi; Noda, Mitsuhiko; Uemura, Naomi			Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						abdominal visceral obesity; Asian country; gallstone disease; visceral adipose tissue	BODY-MASS INDEX; HUMAN GALLBLADDER DYSMOTILITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CHOLESTEROL GALLSTONES; POPULATION; OBESITY; EPIDEMIOLOGY; PREVALENCE; WEIGHT	Background and AimVisceral adiposity is a strong determinant of insulin resistance, which decreases cholecystokinin response sensitivity, and increases cholesterol saturation in the gallbladder bile; thus, it potentially relates to gallstone disease development. We aimed to investigate whether visceral fat measured by computed tomography (CT) is a risk factor for gallstone disease. MethodsA cohort of 717 participants undergoing CT and ultrasonography was analyzed. The associations between body mass index (BMI), visceral adipose tissue (VAT) area, subcutaneous adipose tissue (SAT) area, and gallstone disease were analyzed adjusted for age, sex, hypertension, diabetes, and dyslipidemia. ResultsIn multivariate analysis, gallstone disease was significantly associated with VAT and SAT areas for both categorical data and trend (P for trend<0.001, 0.009), but not body mass index (BMI). Among patients with BMI<25, gallstone disease remained significantly associated with VAT area (P for trend 0.021) and SAT area (P for trend 0.005). Interactions between the obesity indices and being elderly on the risk of gallstone disease were found; specifically BMI (P=0.005), SAT (P<0.001), and VAT (P=0.154). A significant association between all obesity indices and gallstone disease was seen in patients aged <65 but not among those aged 65. However, no significant association was noted between the obesity indices and sex. ConclusionsCT-measured adipose tissue, rather than BMI, was a better predictor for risk of gallstone disease. This finding applies to younger people or even those with normal body weight, suggesting the importance of abdominal visceral fat accumulation in the development of gallstone disease.	[Sekine, Katsunori; Nagata, Naoyoshi; Okubo, Hidetaka; Watanabe, Kazuhiro; Imbe, Koh; Mikami, Shintaro; Nozaki, Yuichi; Sakurai, Toshiyuki; Yokoi, Chizu; Kojima, Yasushi; Kobayakawa, Masao; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Int Clin Res Ctr, Res Inst,Shinjuku Ku, Tokyo 1628655, Japan; [Sakamoto, Kayo; Arai, Tomohiro; Shinozaki, Masafumi] Natl Ctr Global Hlth & Med, Dept Diagnost Radiol, Int Clin Res Ctr, Res Inst,Shinjuku Ku, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Int Clin Res Ctr, Res Inst,Shinjuku Ku, Tokyo 1628655, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Uemura, Naomi] Kohnodai Hosp, Dept Gastroenterol & Hepatol, Natl Ctr Global Hlth & Med, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			Ministry of Health, Labour and Welfare of Japan [H25-016]	This work was funded by Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H25-016) from the Ministry of Health, Labour and Welfare of Japan. The funding body had no role in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Wells JCK, 2012, INT J OBESITY, V36, P148, DOI 10.1038/ijo.2011.51; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Tsai CJ, 2008, AM J GASTROENTEROL, V103, P2932, DOI 10.1111/j.1572-0241.2008.02189.x; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Stender S, 2013, HEPATOLOGY, V58, P2133, DOI 10.1002/hep.26563; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Nakeeb A, 2006, J GASTROINTEST SURG, V10, P940, DOI 10.1016/j.gassur.2006.04.005; Katsika D, 2007, J INTERN MED, V262, P581, DOI 10.1111/j.1365-2796.2007.01860.x; Goodpaster BH, 2002, CURR OPIN CLIN NUTR, V5, P481, DOI 10.1097/00075197-200209000-00005; GIOVANNUCCI E, 1994, AM J EPIDEMIOL, V140, P989; HARTZ AJ, 1984, AM J EPIDEMIOL, V119, P71; Yashima Y, 2011, J GASTROENTEROL, V46, P1213, DOI 10.1007/s00535-011-0430-x; Tsai CJ, 2004, AM J CLIN NUTR, V80, P38; Nervi F, 2006, J HEPATOL, V45, P299, DOI 10.1016/j.jhep.2006.01.026; Lee JG, 2009, NAT REV GASTRO HEPAT, V6, P533, DOI 10.1038/nrgastro.2009.126; Matsushita Y, 2008, INT J OBESITY, V32, P1861, DOI 10.1038/ijo.2008.188; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Syngal S, 1999, ANN INTERN MED, V130, P471; THAETE FL, 1995, INT J OBESITY, V19, P464; Ayaz T, 2014, J AGING RES, V2014, DOI [10.1155/2014/584315, DOI 10.1155/2014/584315]; BERR F, 1994, GASTROENTEROLOGY, V106, P215; EBERT EC, 1995, J IMMUNOL METHODS, V178, P219, DOI 10.1016/0022-1759(94)00259-Y; Greenberg AS, 2006, AM J CLIN NUTR, V83, p461S; Gullatte M M, 1990, Adv Clin Care, V5, P12; JORGENSEN T, 1988, GUT, V29, P433, DOI 10.1136/gut.29.4.433; KAMEDA H, 1984, JPN J MED, V23, P109; Kodama H, 1999, INT J OBESITY, V23, P211, DOI 10.1038/sj.ijo.0800781; Luzina E V, 2013, Klin Med (Mosk), V91, P63; Nagata N, 2014, INT J CANCER, V135, P2273, DOI 10.1002/ijc.28872; Svanvik BJ, 2006, J GASTROINTEST SURG, V10, P948; Panpimanmas S, 2009, J EPIDEMIOL, V19, P116, DOI 10.2188/jea.JE20080019; PORTINCASA P, 1994, J HEPATOL, V21, P430, DOI 10.1016/S0168-8278(05)80324-1; SEIDELL JC, 1998, AM J CLIN NUTR S, V67, P546; Tsunoda K, 2004, HEPATO-GASTROENTEROL, V51, P1271	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	AUG	2015	30	8					1325	1331		10.1111/jgh.12965		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CN4YL	WOS:000358436400019		
J	Khalil, MM; Tokunaga, T; Yousef, AF				Khalil, Mahmoud M.; Tokunaga, Tomochika; Yousef, Ahmed F.			Insights from stable isotopes and hydrochemistry to the Quaternary groundwater system, south of the Ismailia canal, Egypt	JOURNAL OF HYDROLOGY			English	Article						Quaternary aquifer; Ismailia canal; Hydrochemistry; Stable isotopes; Recharge sources	BASIN; RECHARGE; AQUIFER; FLOW; AUSTRALIA; WATERS; CHINA	Stable isotopic ratios of water (delta O-18 and delta H-2) and major dissolved ions were analyzed from samples collected from the area south of the Ismailia canal, Egypt. This region has recently experienced rapid growth that has increased both surface and groundwater use. The data from the samples were used to identify recharge sources, and mixing and salinization processes in the groundwater system in this region. On the basis of the isotopic data and geochemical data, four end-members were defined representing, groundwater in a Quaternary aquifer, groundwater in a Miocene aquifer, water in the Ismailia canal, and wastewater from the 10th of Ramadan city. Several different mixing trends were recognized in the study area. As a consequence of mixing with groundwater in the Miocene aquifer, groundwater in the Quaternary aquifer was found to have depleted isotopic signatures and increased total dissolved ions (TDI) toward the south of the study area, near subsurface Miocene structural highs. Another mixing trend, consisting of, enriched isotopic ratios and lower TDI values toward the north in the Quaternary aquifer, indicated mixing with surface water, i.e., the Ismailia canal and freshwater ponds. A third trend of locally high TDI values together with depleted stable isotopic data, i.e., the Ramsis area and the vicinity of the well field, were interpreted to be due to excessive pumping for irrigation and reclamation activities, which in turn resulted in upconing of the deeper saline groundwater from the Miocene aquifer. Lastly, leakage from the wastewater ponds into the recharge process was suggested by considering chemical and isotopic signature of the Quaternary groundwater sample No. 31. These results strongly indicate the urgent need for monitoring, protection and remediation of the Quaternary aquifer in order to guarantee the sustainability of water resources in the study area. This work also illustrates the efficiency of using stable isotopes and major ion chemistry to improve our understanding of a flow system. (C) 2015 Elsevier B.V. All rights reserved.	[Khalil, Mahmoud M.; Tokunaga, Tomochika] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, Kashiwa, Chiba 2778563, Japan; [Khalil, Mahmoud M.] Menia Univ, Dept Geol, Fac Sci, El Minia 61111, Egypt; [Yousef, Ahmed F.] Desert Res Ctr, Dept Geol, Cairo 11753, Egypt	Khalil, MM (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	mahmoud-khalil@geoenv.k.u-tokyo.ac.jp; tokunaga@k.u-tokyo.ac.jp; ahmedfawzy63@yahoo.com					Abd E1-Samie S.G., 2002, ARAB J NUCL SCI APPL, V35, P35; Abou E1-Magd M.H., 2011, THESIS MENOUFIA U SH, P234; Abou Heleika M.M., 2014, ARAB J GEOSCI, P1; Abu-Zeid M., 1983, LONG DISTANCE WATER, P15; African Water Facility, 2007, COMPR STUD PROJ PREP, P35; HORITA J, 1989, APPL RADIAT ISOTOPES, V40, P801; Carrera J, 2005, HYDROGEOL J, V13, P206, DOI 10.1007/s10040-004-0404-7; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Negrel P, 2011, J HYDROL, V397, P55, DOI 10.1016/j.jhydrol.2010.11.033; SHEPPARD SMF, 1986, REV MINERAL, V16, P165; Tweed S, 2011, J HYDROL, V408, P257, DOI 10.1016/j.jhydrol.2011.08.008; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Yuan RQ, 2011, J HYDROL, V405, P512, DOI 10.1016/j.jhydrol.2011.05.048; Macpherson GL, 2004, J HYDROL, V286, P271, DOI 10.1016/j.jhydrol.2003.09.016; FABRYKAMARTIN J, 1991, APPL GEOCHEM, V6, P447, DOI 10.1016/0883-2927(91)90044-P; Ma JZ, 2005, J ARID ENVIRON, V61, P277, DOI 10.1016/j.jaridenv.2004.07.014; Cartwright I, 2007, AUST J EARTH SCI, V54, P1103, DOI 10.1080/08120090701615741; Climate-Data.org, 2013, CLIM 10 RAM CIT CLIM; Cook P., 2000, ENV TRACERS SUBSURFA, P529; E1 Arabi N.E., 1997, GROUNDWATER URBAN EN, V1, P285; E1-Haddad I.M., 1996, THESIS MANSOURA U MA, P199; El Monayeri D.S., 2011, SECURITY IND WATER S, P209; El- Shazly E.M., 1975, GEOLOGICAL GROUNDWAT, P24; Eleraki M, 2010, Q J ENG GEOL HYDROGE, V43, P171, DOI 10.1144/1470-9236/08-079; El-Sayed M.H., 2012, J APPL SCI RES, V8, P1959; Fritz P., 1997, ENV ISOTOPES HYDROGE; Gat J.R., 1981, IAEA TECHNICAL REPOR, V210, P337; Hamed Y, 2014, J AFR EARTH SCI, V100, P418, DOI 10.1016/j.jafrearsci.2014.07.012; Hamza M.S., 1987, INT J WATER RESOUR D, V3, P228, DOI 10.1080/07900628708722354; Hefny K., 1980, GROUNDWATER ST UNPUB, P54; Hem JD, 1989, US GEOLOGICAL SURVEY, V2254, P263; Hounslow AW, 1995, WATER QUALITY DATA A, P397; Kinawy I. Z., 1977, Arid land irrigation in developing countries: environmental problems and effects [E. B. Worthington, editor]., P371; Morgan K, 2006, HYDROL PROCESS, V20, P2857, DOI 10.1002/hyp.6079; Ohsumi T., 1986, ANAL SCI, V2, P489, DOI DOI 10.2116/ANALSCI.2.489; Research Institute of Groundwater, 1994, EXTR GROUNDW E UNPUB; Research Institute of Groundwater, 2005, STUD GROUNDW R UNPUB; Said R., 1981, GEOLOGICAL EVOLUTION, P151; Shedid A.G., 2005, P 4 INT C GEOL AFR, V2, P145; Stahl R., 2008, FORSCHUNGSZENTRUM KA; TAHA AA, 2004, EMIRATES J ENG RES, V9, P35; US Environmental Protection Agency, 1997, 3001 USEPA	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	AUG	2015	527						555	564		10.1016/j.jhydrol.2015.05.024		10	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CN7QM	WOS:000358629100048		
J	Kikuchi, K; Nosaka, H; Yamazaki, H; Nagatani, M; Goh, T; Kurishima, K; Saida, T				Kikuchi, Kiyofumi; Nosaka, Hideyuki; Yamazaki, Hiroshi; Nagatani, Munehiko; Goh, Takashi; Kurishima, Kenji; Saida, Takashi			Design and Fabrication of Mixed Electronics-Optics Modulator for Dual-Carrier QPSK Generation	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Analog integrated circuits; heterojunction bipolar transistors; indium phosphide; integrated optoelectronics; multicarrier transmission; optical modulation; optical planar waveguides; phase shift keying (PSK); superchannel	TRANSMISSION; SYSTEMS; GBAUD	We discuss in detail the design and fabrication of a mixed electronics-optics (MEO) modulator and related key devices. Our proposed MEO modulator generates dual-carrier quadrature phase-shift keying (QPSK) signals utilizing both analog electrical and optical modulation with a simple optical circuit configuration. The key devices for the MEO modulator include a high-speed electrical-phase modulator and a complex optical modulator. We report the design and fabrication of a high-speed phase modulator IC with 0.5-mu m InP HBT technology, and a silica-LiNbO3 integrated optical amplitude and phase modulator. We performed proof-of-concept experiments for the MEO modulator, and confirmed the generation of 26-GHz spacing 14-GBaud dual-carrier QPSK signals.	[Kikuchi, Kiyofumi; Saida, Takashi] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan; [Nosaka, Hideyuki; Yamazaki, Hiroshi; Nagatani, Munehiko; Goh, Takashi; Kurishima, Kenji] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Kikuchi, K (reprint author), NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan.	kikuchi.kiyofumi@lab.ntt.co.jp; nosaka.hideyuki@lab.ntt.co.jp; ya-mazaki.hiroshi@lab.ntt.co.jp; nagatani.munehiko@lab.ntt.co.jp; goh.takashi@lab.ntt.co.jp; kurishima.kenji@lab.ntt.co.jp; saida.takashi@lab.ntt.co.jp					Kashio N, 2010, IEEE T ELECTRON DEV, V57, P373, DOI 10.1109/TED.2009.2037461; Chiba A, 2010, ELECTRON LETT, V46, P220, DOI 10.1049/el.2010.3141; Law D, 2013, IEEE COMMUN MAG, V51, P88, DOI 10.1109/MCOM.2013.6576344; Cole C, 2013, IEEE COMMUN MAG, V51, P50, DOI 10.1109/MCOM.2013.6476865; Yamazaki H, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2263120; Chung H., 2012, OPT FIB COMM C LOS A; Gnauck AH, 2012, J LIGHTWAVE TECHNOL, V30, P532, DOI 10.1109/JLT.2011.2175200; Isono H., 2014, P SOC PHOTO-OPT INS; Jansen SL, 2009, J LIGHTWAVE TECHNOL, V27, P177, DOI 10.1109/JLT.2008.2007972; Kikuchi K., 2013, EUR C OPT COMM LOND; Liu X., 2012, EUR C OPT COMM AMST; Mino S., 2013, OPT FIB COMM C AN CA; Nagatani M., 2011, COMP SEM INT CIRC S; Nakazawa M., 2010, OPT FIB COMM C SAN D; Olsson BE, 2011, OPT EXPRESS, V19, P784, DOI 10.1364/OE.19.00B784; Rahn J. T., 2012, OPT FIB COMM C LOS A; Raybon G, 2014, J LIGHTWAVE TECHNOL, V32, P824, DOI 10.1109/JLT.2013.2286963; Renaudier J., 2013, EUR C OPT COMM LOND; Sano A., 2012, OPT FIB COMM C LOS A; Tanaka T., 2014, OPT FIB COMM C SAN F; Tsuzuki K., 2012, OPT FIB COMM C LOS A; Xia T., 2012, OPT FIB COMM C LOS A; Yamada T., 2008, OPT FIB COMM C SAN D; Yamazaki H., 2012, EUR C OPT COMM AMST; Yamazaki Hiroshi, 2011, Opt Express, V19, pB69, DOI 10.1364/OE.19.000B69; Yamazaki H, 2011, J LIGHTWAVE TECHNOL, V29, P721, DOI 10.1109/JLT.2010.2101052; Yamazaki H., 2013, OPT FIB COMM C AN CA; Yamazaki H, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2256341; Zhuge QB, 2012, OPT EXPRESS, V20, P13841, DOI 10.1364/OE.20.013841	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	AUG 1	2015	33	15					3265	3270		10.1109/JLT.2015.2435056		6	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CN6WI	WOS:000358574700015		
J	Doi, Y; Oguma, M; Yoshimatsu, T; Ohno, T; Ogawa, I; Yoshida, E; Hashimoto, T; Sanjo, H				Doi, Yoshiyuki; Oguma, Manabu; Yoshimatsu, Toshihide; Ohno, Tetsuichiro; Ogawa, Ikuo; Yoshida, Eiji; Hashimoto, Toshikazu; Sanjo, Hiroaki			Compact High-Responsivity Receiver Optical Subassembly With a Multimode-Output-Arrayed Waveguide Grating for 100-Gb/s Ethernet	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Multimode-output arrayed waveguide grating; planar lightwave circuit; receiver optical sub-assembly; 100 Gigabit Ethernet	DEMULTIPLEXER	We developed a compact receiver optical subassembly (ROSA) for 100-Gigabit Ethernet (100 GbE) using multimode-output- arrayed waveguide grating (MM-AWG) and arrayed photodiodes (PDs). The four-channel silica-based MM-AWG has low insertion loss of less than 1 dB. The back-side-illumined PD with maximized-induced current structure provides high responsivity of 0.95 A/W. To avoid the distortion of the responsivity spectrum due to poor coupling between the multimode beam and PD, we employ a racetrack shape for the active region of the PD. The optical coupling between the MM-AWG and lens-coupled PD is optimized in terms of the flattening ratio of the racetrack shape. The fabricated ROSA has high responsivity of over 0.7 A/W with a flat-top spectrum and obtains high environmental stability thank to its large assembly tolerance of over +/- 4 mu m. For 4 x 25-Gb/s signals after 10-km transmission, the minimum receiver sensitivity of the ROSA has a margin of 4.8 dB for the Ethernet standard. The transmission performance with a 100-GbE transmitter optical subassembly was also confirmed.	[Doi, Yoshiyuki; Yoshimatsu, Toshihide; Ohno, Tetsuichiro; Sanjo, Hiroaki] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan; [Oguma, Manabu; Hashimoto, Toshikazu] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan; [Ogawa, Ikuo; Yoshida, Eiji] NTT Corp, NTT Photon Labs, Atsugi, Kanagawa 2430198, Japan	Doi, Y (reprint author), NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan.	doi.yoshiyuki@lab.ntt.co.jp; oguma.manabu@lab.ntt.co.jp; yoshimatsu.toshihide@lab.ntt.co.jp; ohno.tetsuichiro@lab.ntt.co.jp; ogawa-i@ntt-el.com; yoshida-eiji@ntt-el.com; hashimoto.toshikazu@lab.ntt.co.jp; sanjoh.hiroaki@lab.ntt.co.jp					AMERSFOORT MR, 1994, ELECTRON LETT, V30, P300, DOI 10.1049/el:19940249; [Anonymous], 2015, P8023BS IEEE; Fallahkhair AB, 2008, J LIGHTWAVE TECHNOL, V26, P1423, DOI 10.1109/JLT.2008.923643; Turkiewicz JP, 2012, IEEE PHOTONIC TECH L, V24, P942, DOI 10.1109/LPT.2012.2191278; [Anonymous], 2010, 8023BA2010 IEEE; Muramoto Y, 2003, ELECTRON LETT, V39, P1749, DOI 10.1049/el:20031116; ARUGA H, 2010, P ECOC, V2010, P1623; Baek Y., 2012, P 17 OECC JUL, P218; Cole CR, 2011, OPT FIBER TECHNOL, V17, P472, DOI 10.1016/j.yofte.2011.07.006; Doi Y., 2004, C LAS EL SAN FRANC C; Doi Y., 2013, OPT FIB COMM C NAT F; Doi Y, 2003, ELECTRON LETT, V39, P1603, DOI 10.1049/el:20031010; Gutierrez-Castrejon R., 2013, J LIGHTWAVE TECHNOL, V31, P2386, DOI DOI 10.1109/JLT.2013.2266271; Lee JK, 2014, OPT EXPRESS, V22, P4307, DOI 10.1364/OE.22.004307; Ohyama T, 2013, IEEE PHOTONIC TECH L, V25, P2416, DOI 10.1109/LPT.2013.2287350; Tangdiongga G. E., 2008, P SOC PHOTO-OPT INS, V6899, P68990; Tsunashima S., 2012, OPT EXP, V20, P1749; Yoshimatsu T., 2012, EUR C OPT COMM AMST	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	AUG 1	2015	33	15					3286	3292		10.1109/JLT.2015.2427367		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CN6WI	WOS:000358574700018		
J	Ogiso, H; Taniguchi, M; Okazaki, T				Ogiso, Hideo; Taniguchi, Makoto; Okazaki, Toshiro			Analysis of lipid-composition changes in plasma membrane microdomains	JOURNAL OF LIPID RESEARCH			English	Article						cationic colloidal silica beads; liquid chromatography-tandem mass spectrometry; lipid raft; lipidomics; diacylglycerol; phosphatidic acid; sphingomyelin; ceramide	SPHINGOMYELIN SYNTHASES; ENRICHED MICRODOMAINS; COLLOIDAL SILICA; GAUCHER-DISEASE; CELL-MEMBRANES; RAFTS; CERAMIDE; ACTIVATION; MIGRATION; DOMAINS	Sphingolipids accumulate in plasma membrane microdomain sites, such as caveolae or lipid rafts. Such microdomains are considered to be important nexuses for signal transduction, although changes in the microdomain lipid components brought about by signaling are poorly understood. Here, we applied a cationic colloidal silica bead method to analyze plasma membrane lipids from monolayer cells cultured in a 10 cm dish. The detergent-resistant fraction from the silica bead-coated membrane was analyzed by LC-MS/MS to evaluate the microdomain lipids. This method revealed that glycosphingolipids composed the microdomains as a substitute for sphingomyelin (SM) in mouse embryonic fibroblasts (tMEFs) from an SM synthase 1/2 double KO (DKO) mouse. The rate of formation of the detergent-resistant region was unchanged compared with that of WT-tMEFs. C2-ceramide (Cer) stimulation caused greater elevations in diacylglycerol and phosphatidic acid levels than in Cer levels within the microdomains of WT-tMEFs. We also found that lipid changes in the microdomains of SM-deficient DKO-tMEFs caused by serum stimulation occurred in the same manner as that of WT-tMEFs. This practical method for analyzing membrane lipids will facilitate future comprehensive analyses of membrane micro-domain-associated responses.	[Ogiso, Hideo; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol Immunol, Uchinada, Ishikawa 9200293, Japan; [Taniguchi, Makoto; Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 9200293, Japan	Okazaki, T (reprint author), Kanazawa Med Univ, Dept Hematol Immunol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	toshiroo@kanazawa-med.ac.jp			Takeda Science Foundation; Ministry of Education, Culture, Sport, Science, and Technology (MEXT) in Japan [S1201004, 25893269]; Kanazawa Medical University [H2012-15]	This work was partly supported by the Takeda Science Foundation and was performed as a joint research project with Shalom Co., Ltd. This study was also supported in part by grants from the Strategic Research Foundation Grant-Aided Project for Private Universities (grant number S1201004) and from the Application Procedures for Grant-in-Aid for Research Activity Start-up (grant number 25893269) from the Ministry of Education, Culture, Sport, Science, and Technology (MEXT) in Japan, and from Kanazawa Medical University (H2012-15; 2012-2016).	Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Hein LK, 2008, J LIPID RES, V49, P1725, DOI 10.1194/jlr.M800092-JLR200; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Matsushima T, 2012, J BIOL CHEM, V287, P19715, DOI 10.1074/jbc.M111.334847; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Hattersley KJ, 2013, BIOCHEM BIOPH RES CO, V442, P62, DOI 10.1016/j.bbrc.2013.11.009; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Jahn T, 2007, BLOOD, V110, P1739, DOI 10.1182/blood-2006-05-020925; Mollinedo F, 2010, FUTURE ONCOL, V6, P811, DOI [10.2217/fon.10.34, 10.2217/FON.10.34]; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Hajduch E, 2008, BIOCHEM J, V410, P369, DOI 10.1042/BJ20070936; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Duddempudi PK, 2013, FEBS J, V280, P2900, DOI 10.1111/febs.12293; Elschenbroich S, 2009, J PROTEOME RES, V8, P4860, DOI 10.1021/pr900318k; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Arjunan S, 2009, CELL BIOCHEM BIOPHYS, V53, P135, DOI 10.1007/s12013-009-9045-8; Bryant MR, 2009, GLIA, V57, P935, DOI 10.1002/glia.20818; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Gutierrez J, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-5; Ikenouchi J, 2012, J BIOL CHEM, V287, P9525, DOI 10.1074/jbc.M111.327064; Kajiwara K, 2014, BIOCHEM J, V458, P81, DOI 10.1042/BJ20130527; Kim Y, 2011, METHODS MOL BIOL, V748, P227, DOI 10.1007/978-1-61779-139-0_16; Mathias RA, 2011, PROTEOMICS, V11, P1238, DOI 10.1002/pmic.201000591; Nachbur U, 2006, BLOOD, V107, P2790, DOI 10.1182/blood-2005-07-2744; NAVAS P, 1989, CANCER RES, V49, P2147; Ogiso H, 2008, ANAL CHEM, V80, P9226, DOI 10.1021/ac801451p; Ogiso Hideo, 2014, Metabolites, V4, P98, DOI 10.3390/metabo4010098; Shikata K, 2003, BIOORGAN MED CHEM, V11, P2723, DOI 10.1016/S0968-0896(03)00228-1; Veldman RJ, 2001, BIOCHEM J, V355, P859	46	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	AUG	2015	56	8					1594	1605		10.1194/jlr.M059972		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN8CT	WOS:000358666000021		
J	Ishiguro, K; Washio, J; Sasaki, K; Takahashi, N				Ishiguro, Kazuko; Washio, Jumpei; Sasaki, Keiichi; Takahashi, Nobuhiro			Real-time monitoring of the metabolic activity of periodontopathic bacteria	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Antimicrobial substance; Bacterial metabolism; Fluorescent dye; Resazurin	PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; PREVOTELLA-INTERMEDIA; BIOCHEMICAL-MECHANISM; SUGAR METABOLISM; ACID; NIGRESCENS; INHIBITION; GLYCOLYSIS; FLUORIDE	Bacterial metabolic activity is associated with the onset and progression mechanisms of oral biofilm-mediated disease; however, at present no method to monitor bacterial metabolism exists, especially for periodontopathic bacteria. Therefore, we aimed to establish a novel method for monitoring the metabolic activity of periodontopathic bacteria, Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi) and Fusobacterium nucleatum (Fn), as well as Streptococcus mutans (Sm) for comparison. The method is based on the dye resazurin, which is converted to the fluorescent molecule resorufin by reducing molecules derived from bacterial metabolism. Additionally, the effects of antimicrobial substances on bacterial metabolic activity were evaluated using this method. When bacterial suspensions were incubated with tryptone, glutamate, aspartate or glucose in the presence of resazurin, the fluorescence intensity increased over time by these bacterial metabolic reactions, indicating that this method can be used to monitor the metabolic activity of periodontopathic bacteria. Chlorhexidine showed the 50% inhibitory concentration (IC50) of 15-49 mu g/ml for tryptone metabolism by Pg, Pi, and Fn, and 7.1-18 mu g/ml for glucose metabolism by Pi and Sm. The IC(50)s for cetylpyridinium chloride and sodium dodecyl sulfate were 0.8-2.1 and 28-44 mu g/ml, respectively for all bacteria examined. Fluoride had no effect except the IC50 of 640 mu g/ml for Sm, while minocycline hydrochloride had no effect on any of the bacteria. The present study established the method for real-time monitoring of the metabolic activity of periodontopathic bacteria, and the method might be useful for evaluating the effects of antimicrobial substances on the bacterial metabolic activity. (C) 2015 Elsevier B.V. All rights reserved.	[Ishiguro, Kazuko; Washio, Jumpei; Takahashi, Nobuhiro] Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Sendai, Miyagi 9808575, Japan; [Ishiguro, Kazuko; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 9808575, Japan	Takahashi, N (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Aoba Ku, 4-1 Sehyo Machi, Sendai, Miyagi 9808575, Japan.	nobu-t@dent.tohoku.ac.jp			KAKENHI grants from the JSPS [22390399, 23792498, 26293439, 26463154]	This study was supported by KAKENHI grants from the JSPS (nos. 22390399, 23792498, 26293439 and 26463154). The authors declare that no conflict of interest with respect to the authorship or publication of this article exists.	AMORIN CVG, 2004, BRAZ ORAL RES, V18, P242; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; Maehara H, 2005, CARIES RES, V39, P521, DOI 10.1159/000088190; Takahashi N, 2000, ORAL MICROBIOL IMMUN, V15, P188, DOI 10.1034/j.1399-302x.2000.150307.x; SHAH HN, 1987, CURR MICROBIOL, V15, P241, DOI 10.1007/BF01589374; Takahashi N, 1997, ORAL MICROBIOL IMMUN, V12, P323, DOI 10.1111/j.1399-302X.1997.tb00733.x; Takahashi N, 2000, ORAL MICROBIOL IMMUN, V15, P96, DOI 10.1034/j.1399-302x.2000.150205.x; Sreenivasan PK, 2013, LETT APPL MICROBIOL, V56, P14, DOI 10.1111/lam.12008; Takahashi N, 2001, J DENT RES, V80, P1425; TWIGG RS, 1945, NATURE, V155, P401, DOI 10.1038/155401a0; WEISBLUM B, 1968, BACTERIOL REV, V32, P493; Sbordone L, 2003, CLIN ORAL INVEST, V7, P181, DOI 10.1007/s00784-003-0236-1; GHARBIA SE, 1991, CURR MICROBIOL, V22, P159, DOI 10.1007/BF02092128; IWAMI Y, 1989, J DENT RES, V68, P16, DOI 10.1177/00220345890680010101; IWAMI Y, 1995, ORAL MICROBIOL IMMUN, V10, P360, DOI 10.1111/j.1399-302X.1995.tb00167.x; KANAPKA JA, 1971, ARCH BIOCHEM BIOPHYS, V146, P167, DOI 10.1016/S0003-9861(71)80053-X; Kawasaki T, 1985, Nihon Shishubyo Gakkai Kaishi, V27, P824; McBain AJ, 2004, J ANTIMICROB CHEMOTH, V53, P772, DOI 10.1093/jac/dkh168; Paster B., 1984, BERGEYS MANUAL SYSET, V2, P124; ROBRISH SA, 1991, INFECT IMMUN, V59, P4547; ROBRISH SA, 1987, J BACTERIOL, V169, P3891; Sakuma Y, 2013, DENT MATER J, V32, P585, DOI 10.4012/dmj.2013-060; Shimogishi M, 2014, DENT MATER J, V33, P70, DOI 10.4012/dmj.2013-158; Takahashi N, 2002, ORAL MICROBIOL IMMUN, V17, P50, DOI 10.1046/j.0902-0055.2001.00089.x; TAKAHASHI N, 1995, ORAL MICROBIOL IMMUN, V10, P349, DOI 10.1111/j.1399-302X.1995.tb00165.x; TAKAHASHI N, 1992, ORAL MICROBIOL IMMUN, V7, P165, DOI 10.1111/j.1399-302X.1992.tb00530.x	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	AUG	2015	115						22	26		10.1016/j.mimet.2015.05.015		5	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CN7PB	WOS:000358625400005		
J	Ishiwata, S; Umino, A; Balu, DT; Coyle, JT; Nishikawa, T				Ishiwata, Sayuri; Umino, Asami; Balu, Darrick T.; Coyle, Joseph T.; Nishikawa, Toru			Neuronal serine racemase regulates extracellular d-serine levels in the adult mouse hippocampus	JOURNAL OF NEURAL TRANSMISSION			English	Article						CaMKII alpha-expressing neurons; Hippocampus; In vivo microdialysis; N-methyl-D-aspartate type glutamate receptor; D-Serine; Serine racemase	IN-VIVO; TAURINE; RELEASE; MICRODIALYSIS; RECEPTORS; CYSTEINE; GLYCINE; CORTEX; SITE	In the hippocampus of mice lacking the gene for serine racemase (SR), a d-serine synthesizing enzyme, in the CaMKII alpha-expressing neurons, we observed a significant decrease in the extracellular concentration of d-serine, a coagonist for the N-methyl-d-aspartate type glutamate receptor (NMDAR), and NMDAR hypofunction as revealed by diminished extracellular taurine concentrations after an intra-hippocampal NMDA infusion when compared to the wild type controls. Therefore, the neuronal SR could regulate the extracellular d-serine signaling responsible for NMDAR activation in the hippocampus.	[Ishiwata, Sayuri; Umino, Asami; Nishikawa, Toru] Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Balu, Darrick T.; Coyle, Joseph T.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Balu, Darrick T.; Coyle, Joseph T.] McLean Hosp, Lab Psychiat & Mol Neurosci, Belmont, MA 02478 USA	Nishikawa, T (reprint author), Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	tnis.psyc@tmd.ac.jp			CREST (Core Research for Evolutional Science and Technology) program - Ministry of Education, Culture, Sports, Science and Technology of Japan; National Research Service Award [F32 MH090697, R01MH05190, P50MH0G0450]	This work was supported by the CREST (Core Research for Evolutional Science and Technology) program funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan to TN research team including SI and AU. A post-doctoral National Research Service Award F32 MH090697 to DTB and grants R01MH05190 and P50MH0G0450 to JTC also supported this study. We thank the International Technology Exchange Society (an English editing agency: 3398 Tyler Drive Brunswick, OH 44212-3726 USA, Tel: 1-330-273-5409, Fax: 1-330-225-3834, E-mail: editing@adelphia.net) for their assistance in English editing for preparing our present manuscript, and are entirely responsible for the scientific content of this paper.	Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Nishikawa T, 2011, J CHROMATOGR B, V879, P3169, DOI 10.1016/j.jchromb.2011.08.030; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Maucler C, 2013, ACS CHEM NEUROSCI, V4, P772, DOI 10.1021/cn4000549; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Balu DT, 2015, CURR OPIN PHARMACOL, V20, P109, DOI 10.1016/j.coph.2014.12.004; Ishiwata S, 2013, AMINO ACIDS, V44, P1391, DOI 10.1007/s00726-013-1464-6; Ishiwata S, 2013, INT J NEUROPSYCHOPH, V16, P1395, DOI 10.1017/S1461145712001484; LEHMANN A, 1985, J NEUROCHEM, V45, P1172, DOI 10.1111/j.1471-4159.1985.tb05538.x; MENENDEZ N, 1989, NEUROSCI LETT, V102, P64, DOI 10.1016/0304-3940(89)90308-X; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Rodriguez-Navarro JA, 2009, J NEUROSCI RES, V87, P208, DOI 10.1002/jnr.21818; SHIBANOKI S, 1993, J NEUROCHEM, V61, P1698, DOI 10.1111/j.1471-4159.1993.tb09806.x	15	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	AUG	2015	122	8					1099	1103		10.1007/s00702-015-1388-2		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN4FY	WOS:000358387200003		
J	Yamada, M; Saitoh, A; Ohashi, M; Suzuki, S; Oka, JI; Yamada, M				Yamada, Misa; Saitoh, Akiyoshi; Ohashi, Masanori; Suzuki, Satoshi; Oka, Jun-Ichiro; Yamada, Mitsuhiko			Induction of c-Fos immunoreactivity in the amygdala of mice expressing anxiety-like behavior after local perfusion of veratrine in the prelimbic medial prefrontal cortex	JOURNAL OF NEURAL TRANSMISSION			English	Article						Immunohistochemistry; Innate anxiety; Glutamate; Microdialysis; Open-field test	BASOLATERAL AMYGDALA; EXCITOTOXIC LESIONS; CONDITIONED FEAR; EXTINCTION; NUCLEUS; INNATE; MEMORY; RATS	Local perfusion of the sodium channel activator veratrine in mouse prelimbic medial prefrontal cortex (PL) induced c-Fos immunoreactivity in the sub-regions of amygdala. Co-perfusion of the NMDA receptor antagonist MK-801 diminished the c-Fos expression. Significant correlations were observed between c-Fos immunoreactivity and behavioral measures in the open-field test. The PL stimulation activates a neural network projecting to the amygdala via NMDA receptor-mediated glutamatergic neurotransmission. Anxiety-like behavior induced after the PL stimulation may be partly mediated through the activation of amygdala.	[Yamada, Misa; Saitoh, Akiyoshi; Ohashi, Masanori; Suzuki, Satoshi; Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, Kodaira, Tokyo 1878553, Japan; [Ohashi, Masanori; Suzuki, Satoshi; Oka, Jun-Ichiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, Chiba 2788510, Japan	Saitoh, A (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, 4-1-1 Ogawahigashimachi, Kodaira, Tokyo 1878553, Japan.	asaitoh@ncnp.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Japan [24-2]	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Intramural Research Grant (24-2) for Neurological and Psychiatric Disorders of NCNP, Japan.	Saitoh A, 2014, J NEUROSCI RES, V92, P1044, DOI 10.1002/jnr.23391; Lisboa SF, 2010, NEUROSCIENCE, V171, P760, DOI 10.1016/j.neuroscience.2010.09.048; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Shah AA, 2003, BRAIN RES, V969, P183, DOI 10.1016/S0006-8993(03)002299-6; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; BLANCHAR.DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Vazdarjanova A, 2001, EUR J NEUROSCI, V14, P709, DOI 10.1046/j.0953-816x.2001.01696.x; Ventura-Silva AP, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00032	12	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	AUG	2015	122	8					1203	1207		10.1007/s00702-015-1373-9		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN4FY	WOS:000358387200015		
J	Aimi, T; Suzuki, K; Hoshino, T; Mizushima, T				Aimi, Takahiro; Suzuki, Koichiro; Hoshino, Tatsuya; Mizushima, Tohru			Dextran sulfate sodium inhibits amyloid- oligomer binding to cellular prion protein	JOURNAL OF NEUROCHEMISTRY			English	Article						Alzheimer's disease; amyloid beta; cellular prion protein; dextran sulfate sodium	GLUTAMATE-RECEPTOR 5; A-BETA OLIGOMER; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; IN-VIVO; IMPAIRMENT; TOXICITY; MEMORY; PRPC	Amyloid- peptide (A), especially its oligomeric form, is believed to play an important role in the pathogenesis of Alzheimer's disease (AD). To this end, the binding of A oligomer to cellular prion protein (PrPC) plays an important role in synaptic dysfunction in a mouse model of AD. Here, we have screened for compounds that inhibit A oligomer binding to PrPC from medicines already used clinically (Mizushima Approved Medicine Library 1), and identified dextran sulfate sodium (DSS) as a candidate. In a cell-free assay, DSS inhibited A oligomer binding to PrPC but not to ephrin receptor B2, another endogenous receptor for A oligomers, suggesting that the drug's action is specific to the binding of A oligomer to PrPC. Dextran on the other hand did not affect this binding. DSS also suppressed A oligomer binding to cells expressing PrPC but not to control cells. Furthermore, while incubation of mouse hippocampal slices with A oligomers inhibited the induction of long-term potentiation, simultaneous treatment with DSS restored the long-term potentiation. As DSS has already been approved for use in patients with hypertriglyceridemia, and its safety in humans has been confirmed, we propose further analysis of this drug as a candidate for AD treatment.	[Aimi, Takahiro; Suzuki, Koichiro; Hoshino, Tatsuya; Mizushima, Tohru] Keio Univ, Fac Pharm, Tokyo 1058512, Japan	Mizushima, T (reprint author), Keio Univ, Dept Drug Discovery & Dev, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	mizushima-th@pha.keio.ac.jp			Center of Innovation Program from the Japan Science and Technology Agency; Scientific Technique Research Promotion Program for Agriculture, Forestry and Food Industry	This work was supported by the Center of Innovation Program from the Japan Science and Technology Agency, as well as Scientific Technique Research Promotion Program for Agriculture, Forestry and Food Industry. The authors have no conflicts of interest to declare.	Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Kitajima S, 1999, J VET MED SCI, V61, P67, DOI 10.1292/jvms.61.67; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Ostapchenko VG, 2013, J NEUROSCI, V33, P16552, DOI 10.1523/JNEUROSCI.3214-13.2013; Steidl EM, 2006, BRAIN RES, V1096, P70, DOI 10.1016/j.brainres.2006.04.034; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; BRAHMANK.DM, 1967, CIRC RES, V21, P817; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Dinamarca MC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00464; Farlow MR, 2005, NEUROLOGY, V65, pS25; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; LORENTSEN KJ, 1989, ANN INTERN MED, V111, P561; MATSUOKA N, 1986, TOHOKU J EXP MED, V149, P61, DOI 10.1620/tjem.149.61	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134	4					611	617		10.1111/jnc.13166		7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CN8KI	WOS:000358688700002		
J	Minatohara, K; Murata, Y; Fujiyoshi, Y; Doi, T				Minatohara, Keiichiro; Murata, Yasunobu; Fujiyoshi, Yoshinori; Doi, Tomoko			An intracellular domain with a novel sequence regulates cell surface expression and synaptic clustering of leucine-rich repeat transmembrane proteins in hippocampal neurons	JOURNAL OF NEUROCHEMISTRY			English	Article						membrane protein; post-synaptic density; protein targeting; synapse formation; synaptic adhesion molecules	ADHESION-LIKE MOLECULES; EXCITATORY SYNAPSES; LIGAND-BINDING; BETA-NEUREXINS; NMDA RECEPTOR; NEUROLIGIN; FAMILY; COMPLEX; PSD-95; GENE	Leucine-rich repeat transmembrane proteins (LRRTMs) are single-spanning transmembrane proteins that belong to the family of synaptically localized adhesion molecules that play various roles in the formation, maturation, and function of synapses. LRRTMs are highly localized in the post-synaptic density; however, the mechanisms and significance of LRRTM synaptic clustering remain unclear. Here, we focus on the intracellular domain of LRRTMs and investigate its role in cell surface expression and synaptic clustering. The deletion of 55-56 residues in the cytoplasmic tail caused significantly reduced synaptic clustering of LRRTM1-4 in rat hippocampal neurons, whereas it simultaneously resulted in augmented LRRTM1-2 cell surface expression. A series of deletions and further single amino acid substitutions in the intracellular domain of LRRTM2 demonstrated that a previously uncharacterized sequence at the region of -16 to -13 from the C-terminus was responsible for efficient synaptic clustering and proper cell surface trafficking of LRRTMs. Furthermore, the clustering-deficient LRRTM2 mutant lost the ability to promote the accumulation of post-synaptic density protein-95 (PSD-95). These results suggest that trafficking to the cell surface and synaptic clustering of LRRTMs are regulated by a specific mechanism through this novel sequence in the intracellular domain that underlies post-synaptic molecular assembly and maturation.	[Minatohara, Keiichiro; Murata, Yasunobu; Doi, Tomoko] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Fujiyoshi, Yoshinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan; [Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst, Nagoya, Aichi 4648601, Japan	Doi, T (reprint author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	doi@mb.biophys.kyoto-u.ac.jp			JSPS [19300128, 22227004]; New Energy and Industrial Technology Development Organization of Japan	This work was supported by JSPS Grants-in-Aid for scientific research 19300128 and 22227004, JSPS Research Fellowships for young scientists to K.M., and the New Energy and Industrial Technology Development Organization of Japan. We thank Dr H. Niwa and Dr M. Takeichi (RIKEN, Center for Developmental Biology, Japan) for the pCA-MCS expression vector and Dr M. Goda (CeSPI, Nagoya University, Japan) for technical advice on microscopy. The authors declare no conflicts of interest.	Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Soler-Llavina GJ, 2013, NEURON, V79, P439, DOI 10.1016/j.neuron.2013.06.007; Siddiqui TJ, 2013, NEURON, V79, P680, DOI 10.1016/j.neuron.2013.06.029; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Murata Y, 2005, BIOCHEM BIOPH RES CO, V327, P183, DOI 10.1016/j.bbrc.2004.11.154; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024; DESWIT J, 2009, NEURON, V64, P799; desWit J., 2013, NEURON, V79, P696; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Minatohara K, 2013, NEUROSCI LETT, V533, P44, DOI 10.1016/j.neulet.2012.11.019; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Nonaka M, 2006, J NEUROSCI, V26, P763, DOI 10.1523/JNEUROSCI.2489-05.2006; Seabold GK, 2012, J BIOL CHEM, V287, P4470, DOI 10.1074/jbc.M111.279661; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Sousa I, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-7; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Woo J, 2009, MOL CELL NEUROSCI, V42, P1, DOI 10.1016/j.mcn.2009.05.008	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134	4					618	628		10.1111/jnc.13159		11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CN8KI	WOS:000358688700003		
J	Tanabe, Y; Fujita-Jimbo, E; Momoi, MY; Momoi, T				Tanabe, Yuko; Fujita-Jimbo, Eriko; Momoi, Mariko Y.; Momoi, Takashi			CASPR2 forms a complex with GPR37 via MUPP1 but not with GPR37(R558Q), an autism spectrum disorder-related mutation	JOURNAL OF NEUROCHEMISTRY			English	Article						autism spectrum disorder; CASPR2; GPR37; MUPP1; PDZ	ENDOPLASMIC-RETICULUM STRESS; CELL-ADHESION MOLECULE; MYELINATED AXONS; NEUREXIN SUPERFAMILY; TIGHT JUNCTIONS; K+ CHANNELS; RECEPTOR; CNTNAP2; GENE; ASSOCIATION	Autism spectrum disorder (ASD) is a developmental brain disorder. Mutations in synaptic components including synaptic adhesion molecules have been found in ASD patients. Contactin-associated protein-like 2 (CASPR2) is one of the synaptic adhesion molecules associated with ASD. CASPR2 forms a complex with receptors via interaction with multiple PDZ domain protein 1 (MUPP1). Little is known about the relationship between impaired CASPR2-MUPP1-receptor complex and the pathogenesis of ASD. GPR37 is a receptor for survival factors. We recently identified mutations including R558Q in the G-protein-coupled receptor 37 (GPR37) gene in ASD patients. The mutated GPR37s accumulate in the endoplasmic reticulum. In this study, we show that GPR37 is a component of the CASPR2-MUPP1 receptor complex in the mouse brain. CASPR2 and GPR37 mainly interacted with the PDZ3 and PDZ11 domains of MUPP1, respectively. Compared to GPR37, GPR37(R558Q) slightly interacted with MUPP1 and caused dendritic alteration. GPR37, but not GPR37(R558Q) nor GPR37-deltaC which lacks its PDZ binding domain, was transported to the cell surface by MUPP1. In primary hippocampal neurons, GPR37 co-localized with MUPP1 and CASPR2 at the synapse, but not GPR37(R558Q). Thus, ASD-related mutation of GPR37 may cause the impaired CASPR2-MUPP1-GPR37 complex on the dendrites associated with one of the pathogenesis of ASD.	[Tanabe, Yuko; Fujita-Jimbo, Eriko; Momoi, Mariko Y.; Momoi, Takashi] Int Univ Hlth & Welf, Otawara, Tochigi 3278501, Japan; [Fujita-Jimbo, Eriko] Jichi Med Univ, Dept Pediat, Sch Med, Shimotsuke, Tochigi, Japan; [Momoi, Takashi] Tokyo Med Univ, Dept Pathophysiol, Shinjuku Ku, Tokyo 1608402, Japan	Momoi, T (reprint author), Int Univ Hlth & Welf, Ctr Med Sci, 2600-1 Kitakanamaru, Otawara, Tochigi 3278501, Japan.	momoi@iuhw.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24651223, 24500386, 15K06744, 15K06716]; Asahi Glass Foundation, Japan	We thank Momoko Arai, Miyoka Murashima, and Natsumi Muroi for supporting of experiments. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant numbers 24651223, 24500386, 15K06744, and 15K06716), and Asahi Glass Foundation, Japan. The authors have no conflicts of interest to declare.	Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Falivelli G, 2012, HUM MOL GENET, V21, P4761, DOI 10.1093/hmg/dds320; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Becamel C, 2001, J BIOL CHEM, V276, P12974, DOI 10.1074/jbc.M008089200; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Dutta P, 2014, J NEUROCHEM, V130, P360, DOI 10.1111/jnc.12741; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Balasubramanian S, 2007, J BIOL CHEM, V282, P4162, DOI 10.1074/jbc.M607695200; Lundius EG, 2014, J BIOL CHEM, V289, P4660, DOI 10.1074/jbc.M113.510883; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Marazziti D, 2011, FASEB J, V25, P2071, DOI 10.1096/fj.10-175737; Anderson GR, 2012, P NATL ACAD SCI USA, V109, P18120, DOI 10.1073/pnas.1216398109; Penagarikano O, 2012, TRENDS MOL MED, V18, P156, DOI 10.1016/j.molmed.2012.01.003; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Oiso S, 2009, J NEUROCHEM, V109, P158, DOI 10.1111/j.1471-4159.2009.05928.x; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Usiello A, 2000, NATURE, V408, P199; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Fujita E, 2012, J NEUROCHEM, V123, P886, DOI 10.1111/jnc.12022; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Fujita E., 2011, NEUROSCI LETT, V506, P277; Fujita-Jimbo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051155; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; MOMOI T, 2009, CELL BIOL INT, V34, P13	39	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134	4					783	793		10.1111/jnc.13168		11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CN8KI	WOS:000358688700017		
J	Hanakita, S; Koga, T; Shin, M; Igaki, H; Saito, N				Hanakita, Shunya; Koga, Tomoyuki; Shin, Masahiro; Igaki, Hiroshi; Saito, Nobuhito			The long-term outcomes of radiosurgery for arteriovenous malformations in pediatric and adolescent populations	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						arteriovenous malformation; children; Gamma Knife surgery; stereotactic radiosurgery	GAMMA-KNIFE SURGERY; FOLLOW-UP DATA; STEREOTACTIC RADIOSURGERY; CLINICAL ARTICLE; CORTICOSPINAL TRACTOGRAPHY; OBLITERATION RATES; NATURAL-HISTORY; DOSE-RESPONSE; GRADING SCALE; CHILDREN	OBJECT Although stereotactic radiosurgery (SRS) has been accepted as a therapeutic option for arteriovenous malformations (AVMs) in children and adolescents, substantial data are still lacking regarding the outcomes of SRS for AVMs in this age group, especially long-term complications. This study aimed to clarify the long-term outcomes of SRS for the treatment of AVM in pediatric patients aged <= 18 years. METHODS Outcomes of 116 patients who were aged 4-18 years when they underwent SRS between 1990 and 2009 at the study institute were analyzed retrospectively. RESULTS The median follow-up period after SRS was 100 months, with 6 patients followed up for more than 20 years. Actuarial obliteration rates at 3 and 5 years after SRS were 68% and 88%, respectively. Five hemorrhages occurred in 851 patient-years of follow-up. The annual bleeding rate after SRS before obliteration was calculated as 1.3%, which decreased to 0.2% after obliteration. Shorter maximum nidus diameter (p = 0.02) and higher margin dose (p = 0.03) were associated with a higher obliteration rate. Ten patients experienced adverse events after SRS. Of them, 4 patients presented with delayed complications years after SRS (range 9-20 years after SRS). CONCLUSIONS SRS can reduce the risk of hemorrhage in pediatric and adolescent AVMs, with an acceptable risk of complications in the long term. However, adverse events such as expanding hematoma and radiation necrosis that can occur after substantial follow-up should be taken into account at the time that treatment decisions are made and informed consent is obtained.	[Hanakita, Shunya; Koga, Tomoyuki; Shin, Masahiro; Saito, Nobuhito] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 1138655, Japan; [Igaki, Hiroshi] Tokyo Univ Hosp, Dept Radiol, Tokyo 1138655, Japan	Hanakita, S (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hanakita-s@umin.ac.jp					SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Smyth MD, 2002, J NEUROSURG, V97, P48, DOI 10.3171/jns.2002.97.1.0048; Lang SS, 2012, J NEUROSURG-PEDIATR, V9, P497, DOI 10.3171/2012.1.PEDS11453; Shin M, 2005, J NEUROSURG, V102, P842, DOI 10.3171/jns.2005.102.5.0842; Lawton MT, 2010, NEUROSURGERY, V66, P702, DOI 10.1227/01.NEU.0000367555.16733.E1; HEROS RC, 1990, NEUROSURGERY, V26, P570; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P388, DOI 10.3171/ped.2006.104.6.388; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; Tamura N, 2012, J NEUROSURG, V117, P150, DOI 10.3171/2012.7.GKS12998; Flickinger JC, 2002, RADIOTHER ONCOL, V63, P347, DOI 10.1016/S0167-8140(02)00103-2; Meyer-Heim AD, 2003, BRAIN DEV-JPN, V25, P416, DOI 10.1016/S0387-7604(03)00029-9; GRAF CJ, 1983, J NEUROSURG, V58, P331, DOI 10.3171/jns.1983.58.3.0331; Yen CP, 2010, J NEUROSURG-PEDIATR, V6, P426, DOI 10.3171/2010.8.PEDS10138; Kano H, 2012, J NEUROSURG, V116, P21, DOI 10.3171/2011.9.JNS101741; Shin M, 2004, J NEUROSURG, V101, P18, DOI 10.3171/jns.2004.101.1.0018; Steinberg GK, 1996, J NEUROSURG, V84, P920, DOI 10.3171/jns.1996.84.6.0920; Stapf C, 2003, STROKE, V34, P2664, DOI 10.1161/01.STR.0000094824.03372.9B; Koga T, 2011, ACTA NEUROCHIR, V153, P879, DOI 10.1007/s00701-011-0946-0; Koga T, 2012, INT J RADIAT ONCOL, V82, P799, DOI 10.1016/j.ijrobp.2010.11.046; Flickinger JC, 1996, INT J RADIAT ONCOL, V36, P873, DOI 10.1016/S0360-3016(96)00316-1; Hashimoto N, 2007, NEUROSURGERY, V61, P375, DOI 10.1227/01.NEU.0000255491.95944.EB; Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907; Shin M, 2002, J NEUROSURG, V97, P779, DOI 10.3171/jns.2002.97.4.0779; Foote KD, 2003, J NEUROSURG, V98, P337, DOI 10.3171/jns.2003.98.2.0337; Hanakita S, 2014, STROKE, V45, P3543, DOI 10.1161/STROKEAHA.114.007162; Wegner RE, 2011, INT J RADIAT ONCOL, V79, P1147, DOI 10.1016/j.ijrobp.2009.12.056; Yamada S, 2007, J NEUROSURG, V107, P965, DOI 10.3171/JNS-07/11/0965; Nicolato A, 2006, INT J RADIAT ONCOL, V64, P914, DOI 10.1016/j.ijrobp.2005.09.013; Hartmann A, 2000, STROKE, V31, P2361; Kano H, 2012, J NEUROSURG-PEDIATR, V9, P1, DOI 10.3171/2011.9.PEDS10458; Fullerton HJ, 2005, STROKE, V36, P2099, DOI 10.1161/01.STR.0000181746.77149.2b; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; da Costa L, 2009, STROKE, V40, P100, DOI 10.1161/STROKEAHA.108.524678; Yoshida K, 2014, J CLIN NEUROSCI, V21, P1453, DOI 10.1016/j.jocn.2013.10.039; Pan DHC, 2008, J NEUROSURG-PEDIATR, V1, P296, DOI 10.3171/PED/2008/1/4/296; Lindqvist M, 2000, NEUROSURGERY, V46, P803, DOI 10.1097/00006123-200004000-00006; Kurita H, 1996, J NEUROSURG, V84, P874, DOI 10.3171/jns.1996.84.5.0874; Sharma MS, 2008, NEUROSURGERY, V63, P728, DOI 10.1227/01.NEU.0000325726.72815.22; Bulsara KR, 2002, NEUROSURGERY, V50, P1137, DOI 10.1097/00006123-200205000-00036; CELLI P, 1984, SURG NEUROL, V22, P43, DOI 10.1016/0090-3019(84)90227-1; Kim H, 2010, AM J EPIDEMIOL, V171, P1317, DOI 10.1093/aje/kwq082; Koga T, 2010, NEUROSURGERY, V67, P398, DOI 10.1227/01.NEU.0000371989.90956.6F; Koga T, 2012, INT J RADIAT ONCOL, V83, P129, DOI 10.1016/j.ijrobp.2011.05.036; Koga T, 2011, NEUROSURGERY, V69, P45, DOI 10.1227/NEU.0b013e31821421d1; Maruyania K, 2007, J NEUROSURG, V107, P721, DOI 10.3171/JNS-07/10/0721; Maruyama K, 2005, J NEUROSURG, V102, P673, DOI 10.3171/jns.2005.102.4.0673; Nussbaum E S, 1995, Clin Neurosurg, V42, P348; Pollock BE, 1996, NEUROSURGERY, V38, P318, DOI 10.1097/00006123-199602000-00016	48	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2015	16	2					222	231		10.3171/2015.1.PEDS14407		10	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CN8PB	WOS:000358702000017		
J	Okawa, M; Amamoto, T; Abe, H; Yoshimura, S; Higashi, T; Inoue, T				Okawa, Masakazu; Amamoto, Takaaki; Abe, Hiroshi; Yoshimura, Sohei; Higashi, Toshio; Inoue, Tooru			Wake-up stroke in a young woman with rotational vertebral artery occlusion due to far-lateral cervical disc herniation	JOURNAL OF NEUROSURGERY-SPINE			English	Article						wake-up stroke; rotational vertebral artery occlusion; basilar occlusion; cervical disc herniation	BOW-HUNTERS STROKE; VERTEBROBASILAR INSUFFICIENCY; SURGICAL TREATMENT; COMPRESSION; SPONDYLOSIS	Wake-up stroke is most likely to be caused by small-vessel disease, and is related to snoring. The authors present a rare case of far-lateral cervical disc herniation with neck rotation, resulting in wake-up stroke in a young woman. The patient, a 31-year-old woman, was admitted to the hospital because of dysarthria and confusion when she awoke in the morning. Brain MRI showed acute infarction in the posterior fossa. Cerebral angiography showed thrombus in the distal top of the basilar artery and the bilateral posterior cerebral arteries. During angiography, the thrombus size decreased with heparinization. There was severe stenosis of the right vertebral artery (VA) at C5-6, and head rotation to the right resulted in complete occlusion of the right VA. Neck MRI showed far-lateral intervertebral disc herniation. Surgical decompression of the VA was performed via the anterior cervical approach. Histological examination showed a degenerative intervertebral disc. Postoperative angiography confirmed successful decompression of the VA.	[Okawa, Masakazu; Amamoto, Takaaki; Abe, Hiroshi; Higashi, Toshio; Inoue, Tooru] Fukuoka Univ, Dept Neurosurg, Fac Med, Fukuoka 8140180, Japan; [Yoshimura, Sohei] Fukuoka Red Cross Hosp, Dept Neurol, Fukuoka, Japan	Okawa, M (reprint author), Fukuoka Univ, Dept Neurosurg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	okawam@fukuoka-u.ac.jp					ABDULLAH AF, 1988, NEUROSURGERY, V22, P648; REULEN HJ, 1987, ACTA NEUROCHIR, V84, P64, DOI 10.1007/BF01456353; BAKAY L, 1965, J NEUROSURG, V23, P596, DOI 10.3171/jns.1965.23.6.0596; BUDWAY RJ, 1993, NEUROSURGERY, V33, P745; Kuether TA, 1997, NEUROSURGERY, V41, P427, DOI 10.1097/00006123-199708000-00019; Nemecek AN, 2003, J NEUROSURG, V98, P80, DOI 10.3171/spi.2003.98.1.0080; POWERS SR, 1961, SURGERY, V49, P257; RYAN G M, 1955, Lancet, V269, P1355; Saito K, 2010, J NEUROIMAGING, V20, P284, DOI 10.1111/j.1552-6569.2008.00309.x; SHIMIZU T, 1988, J NEUROSURG, V69, P127, DOI 10.3171/jns.1988.69.1.0127; SMITH DR, 1971, J NEUROL NEUROSUR PS, V34, P388, DOI 10.1136/jnnp.34.4.388; SORENSEN BF, 1978, NEUROSURGERY, V2, P259; Tanimoto A, 2013, J STROKE CEREBROVASC, V23, P1296; TATLOW WFT, 1957, NEUROLOGY, V7, P331; Tominaga T, 2002, J NEUROSURG, V97, P1456, DOI 10.3171/jns.2002.97.6.1456; Ujifuku K, 2009, J NEUROSURG-SPINE, V11, P326, DOI 10.3171/2009.4.SPINE08689; Vates GE, 2002, J NEUROSURG, V96, P90, DOI 10.3171/spi.2002.96.1.0090	17	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	AUG	2015	23	2					166	169		10.3171/2014.11.SPINE14393		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN8PO	WOS:000358703300005		
J	Nagamoto, Y; Iwasaki, M; Sakaura, H; Sugiura, T; Fujimori, T; Matsuo, Y; Kashii, M; Murase, T; Yoshikawa, H; Sugamoto, K				Nagamoto, Yukitaka; Iwasaki, Motoki; Sakaura, Hironobu; Sugiura, Tsuyoshi; Fujimori, Takahito; Matsuo, Yohei; Kashii, Masafumi; Murase, Tsuyoshi; Yoshikawa, Hideki; Sugamoto, Kazuomi			Sacroiliac joint motion in patients with degenerative lumbar spine disorders	JOURNAL OF NEUROSURGERY-SPINE			English	Article						sacroiliac joint; 3D kinematics; degenerative lumbar spine disorders; sacral	VIVO 3-DIMENSIONAL ANALYSIS; POSTERIOR LONGITUDINAL LIGAMENT; IN-VIVO; CERVICAL-SPINE; RADIOSTEREOMETRIC ANALYSIS; ILIAC SCREWS; KINEMATICS; MOVEMENTS; ROTATION; OSSIFICATION	OBJECT Usually additional anchors into the ilium are necessary in long fusion to the sacrum for degenerative lumbar spine disorders (DLSDs), especially for adult spine deformity. Although the use of anchors is becoming quite common, surgeons must always keep in mind that the sacroiliac (SI) joint is mobile and they should be aware of the kinematic properties of the SI joint in patients with DLSDs, including adult spinal deformity. No previous study has clarified in vivo kinematic changes in the SI joint with respect to patient age, sex, or parturition status or the presence of DLSDs. The authors conducted a study to clarify the mobility and kinematic characteristics of the SI joint in patients with DLSDs in comparison with healthy volunteers by using in vivo 3D motion analysis with voxel-based registration, a highly accurate, noninvasive method. METHODS Thirteen healthy volunteers (the control group) and 20 patients with DLSDs (the DLSD group) underwent low-dose 3D CT of the lumbar spine and pelvis in 3 positions (neutral, maximal trunk flexion, and maximal trunk extension). SI joint motion was calculated by computer processing of the CT images (voxel-based registration). 3D motion of the SI joint was expressed as both 6 df by Euler angles and translations on the coordinate system and a helical axis of rotation. The correlation between joint motion and the cross-sectional area of the trunk muscles was also investigated. RESULTS SI joint motion during trunk flexion-extension was minute in healthy volunteers. The mean rotation angles during trunk flexion were 0.07 degrees around the x axis, -0.02 degrees around the y axis, and 0.16 degrees around the z axis. The mean rotation angles during trunk extension were 0.38 degrees around the x axis, -0.08 degrees around the y axis, and 0.08 degrees around the z axis. During trunk flexion-extension, the largest amount of motion occurred around the x axis. In patients with DLSDs, the mean rotation angles during trunk flexion were 0.57 degrees around the x axis, 0.01 degrees around the y axis, and 0.19 around the z axis. The mean rotation angles during trunk extension were 0.68 degrees around the x axis, -0.11 degrees around the y axis, and 0.05 degrees around the z axis. Joint motion in patients with DLSDs was significantly greater, with greater individual difference, than in healthy volunteers. Among patients with DLSDs, women had significantly more motion than men did during trunk extension. SI joint motion was significantly negatively correlated with the cross-sectional area of the trunk muscles during both flexion and extension of the trunk. CONCLUSIONS The authors elucidated the mobility and kinematic characteristics of the SI joint in patients with DLSDs compared with healthy volunteers for the first time. This information is useful for spine surgeons because of the recent increase in spinopelvic fusion for the treatment of DLSDs.	[Nagamoto, Yukitaka; Sugiura, Tsuyoshi; Matsuo, Yohei; Kashii, Masafumi; Murase, Tsuyoshi; Yoshikawa, Hideki; Sugamoto, Kazuomi] Osaka Univ, Grad Sch Med, Dept Orthopaed, Osaka, Japan; [Iwasaki, Motoki] Osaka Rosai Hosp, Dept Orthopaed Surg, Osaka, Japan; [Sakaura, Hironobu] Kansai Rosai Hosp, Dept Orthopaed Surg, Amagasaki, Hyogo, Japan; [Fujimori, Takahito] Sumitomo Hosp, Dept Orthopaed Surg, Osaka, Japan	Nagamoto, Y (reprint author), Osaka Natl Hosp, Dept Orthopaed Surg, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	7gam0to@gmail.com			Ministry of Education, Culture, Sports and Technology, Japan [KAKENHI:22591632]	This work was supported by a grant-in-aid for Scientific Research C (KAKENHI:22591632) from the Ministry of Education, Culture, Sports and Technology, Japan.	van Wingerden JP, 2004, EUR SPINE J, V13, P199, DOI 10.1007/s00586-003-0575-2; Cohen SP, 2005, ANESTH ANALG, V101, P1440, DOI 10.1213/01.ANE.0000180831.60169.EA; Ishii T, 2006, SPINE, V31, P155, DOI 10.1097/01.brs.0000195173.47334.1f; Fujii R, 2007, EUR SPINE J, V16, P1867, DOI 10.1007/s00586-007-0373-3; Richardson CA, 2002, SPINE, V27, P399, DOI 10.1097/00007632-200202150-00015; Wilke HJ, 1997, Z ORTHOP GRENZGEB, V135, P550, DOI 10.1055/s-2008-1039744; VLEEMING A, 1990, SPINE, V15, P133, DOI 10.1097/00007632-199002000-00017; Nagamoto Y, 2011, SPINE, V36, P778, DOI 10.1097/BRS.0b013e3181e218cb; JACOB HAC, 1995, CLIN BIOMECH, V10, P352, DOI 10.1016/0268-0033(95)00003-4; VLEEMING A, 1992, CLIN BIOMECH, V7, P170, DOI 10.1016/0268-0033(92)90032-Y; Sturesson B, 2000, SPINE, V25, P214, DOI 10.1097/00007632-200001150-00012; Tsuchiya K, 2006, SPINE, V31, P303, DOI 10.1097/01.brs.0000197193.81296.f1; Ishii T, 2004, SPINE, V29, P2826, DOI 10.1097/01.brs.0000147806.31675.6b; Sturesson B, 2000, SPINE, V25, P364, DOI 10.1097/00007632-200002010-00018; Cibulka MT, 2001, SPINE, V26, P1404, DOI 10.1097/00007632-200106150-00033; Cunningham BW, 2010, SPINE, V35, pE198, DOI 10.1097/BRS.0b013e3181c142bf; EGUND N, 1978, ACTA RADIOL DIAGN, V19, P833; Fujimori T, 2012, J NEUROSURG-SPINE, V17, P74, DOI 10.3171/2012.3.SPINE111083; Fujimori T, 2014, SPINE J, V14, P1991, DOI 10.1016/j.spinee.2013.11.054; Fujimori T, 2012, J NEUROSURG-SPINE, V16, P289, DOI 10.3171/2011.11.SPINE11502; Gitelman A, 2008, ORTHOPEDICS, V31, P1; Ishii T, 2004, SPINE, V29, pE139, DOI 10.1097/01.BRS.0000116998.55056.3C; Lee CS, 2010, SPINE, V35, pE206, DOI 10.1097/BRS.0b013e3181bfa518; STURESSON B, 1989, SPINE, V14, P162, DOI 10.1097/00007632-198902000-00004; White A.A, 1990, CLIN BIOMECHANICS SP	25	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	AUG	2015	23	2					209	216		10.3171/2014.12.SPINE14590		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN8PO	WOS:000358703300012		
J	Morita, T; Takebayashi, T; Takashima, H; Yoshimoto, M; Ida, K; Tanimoto, K; Ohnishi, H; Fujiwara, H; Nagae, M; Yamashita, T				Morita, Tomonori; Takebayashi, Tsuneo; Takashima, Hiroyuki; Yoshimoto, Mitsunori; Ida, Kazunori; Tanimoto, Katsumasa; Ohnishi, Hirofumi; Fujiwara, Hiroyoshi; Nagae, Masateru; Yamashita, Toshihiko			Mapping occipital bone thickness using computed tomography for safe screw placement	JOURNAL OF NEUROSURGERY-SPINE			English	Article						morphological analysis; occipital bone; occipitocervical fusion; thickness; technique	OCCIPITOCERVICAL FUSION; RHEUMATOID-ARTHRITIS; INTERNAL-FIXATION; FOLLOW-UP; ROD; INSTRUMENTATION; RECONSTRUCTION; MORPHOLOGY; PLATE	OBJECT Safe and effective insertion of occipital bone screws requires morphological analysis of the occipital bone, which is poorly documented in the literature. The authors of this study present morphological data for determining the area of screw placement for optimal internal fixation. METHODS The subjects of this institutional review board approved retrospective study were 105 individuals without head and neck disease who underwent CT imaging at the authors' hospital. There were 55 males and 50 females, with a mean age of 57.1 years (range 20-91 years). Measurements using CT were taken according to a matrix of 55 points following a grid with 1-cm spacing based on the external occipital protuberance (EOP). RESULTS The maximum thickness of the occipital bone was at the level of the EOP at 16.4 mm. Areas with thicknesses > 8 mm were more frequent at the EOP and up to 2 cm in all directions, as well as up to 1 cm in all directions at a height of 1 cm inferiorly, and up to 3 cm from the EOP inferiorly. The male group tended to have a thicker occipital bone than the female group, and the differences were significant around the EOP. The ratio of the trabecular bone to the occipital bone thickness was > 30% in the central region. At positions more than 2 cm laterally, the ratio was < 15%, and the ratio gradually decreased further laterally. CONCLUSIONS Screws that are 8 mm long can be placed in the area extending 2 cm laterally from the EOP at the level of the superior nuchal line and approximately 3 cm inferior to the center. These results suggest that it may be possible to effectively insert a screw over a wider area than the conventional reference range.	[Morita, Tomonori; Takebayashi, Tsuneo; Takashima, Hiroyuki; Yoshimoto, Mitsunori; Ida, Kazunori; Tanimoto, Katsumasa; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido 0608556, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 0608556, Japan; [Fujiwara, Hiroyoshi; Nagae, Masateru] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthoped Surg, Kyoto, Japan	Takebayashi, T (reprint author), Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	takebaya@sapmed.ac.jp					Abumi K, 1999, SPINE, V24, P1425, DOI 10.1097/00007632-199907150-00007; FEHLINGS MG, 1993, NEUROSURGERY, V32, P198; Grob D, 1999, CLIN ORTHOP RELAT R, P46; Deutsch H, 2005, SPINE, V30, P530, DOI 10.1097/01.brs.0000154715.88911.ea; Zipnick RI, 1996, SPINE, V21, P1719, DOI 10.1097/00007632-199608010-00001; Matsunaga S, 2000, SPINE, V25, P1749, DOI 10.1097/00007632-200007150-00002; RANAWAT CS, 1979, J BONE JOINT SURG AM, V61, P1003; Nockels RP, 2007, J NEUROSURG-SPINE, V7, P117, DOI 10.3171/SPI-07/08/117; [Anonymous], 1996, SPINE; Ebraheim NA, 1996, SPINE, V21, P1725, DOI 10.1097/00007632-199608010-00002; FLINT GA, 1987, NEUROSURGERY, V21, P947; GROB D, 1991, SPINE, V16, pS17, DOI 10.1097/00007632-199103001-00005; Haher TR, 1999, SPINE, V24, P5, DOI 10.1097/00007632-199901010-00003; Hamblen D L, 1967, J Bone Joint Surg Br, V49, P33; Hertel G, 1999, EUR SPINE J, V8, P27, DOI 10.1007/s005860050123; HEYWOOD AWB, 1988, J BONE JOINT SURG BR, V70, P708; Hsu YH, 2009, J CHIN MED ASSOC, V72, P20, DOI 10.1016/S1726-4901(09)70015-2; Naderi S, 2001, J SPINAL DISORD, V14, P500, DOI 10.1097/00002517-200112000-00006; NEWMAN P, 1969, Journal of Bone and Joint Surgery British Volume, V51-B, P423; OLIVIER G, 1975, J ANAT, V120, P507; SASSO RC, 1994, SPINE, V19, P2364; Singh SK, 2003, J NEUROSURG, V98, P239, DOI 10.3171/spi.2003.98.3.0239; THOMPSON RC, 1985, SPINE, V10, P597, DOI 10.1097/00007632-198509000-00001; Vale FL, 1999, J NEUROSURG, V91, P144, DOI 10.3171/spi.1999.91.2.0144; ZYGMUNT SC, 1995, ACTA NEUROCHIR, V135, P25, DOI 10.1007/BF02307410	25	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	AUG	2015	23	2					254	258		10.3171/2014.11.SPINE14624		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CN8PO	WOS:000358703300018		
J	Kobayashi, M; Feng, Y; Xu, Y; Tabares, FL; Ida, K; Schmitz, O; Evans, TE; Frerichs, H; Liang, Y; Bader, A; Itoh, K; Yamada, H; Ghendrih, P; Ciraolo, G; Tafalla, D; Lopez-Fraguas, A; Guo, HY; Cui, ZY; Reiter, D; Asakura, N; Wenzel, U; Morita, S; Ohno, N; Peterson, BJ; Masuzaki, S				Kobayashi, M.; Feng, Y.; Xu, Y.; Tabares, F. L.; Ida, K.; Schmitz, O.; Evans, T. E.; Frerichs, H.; Liang, Y.; Bader, A.; Itoh, K.; Yamada, H.; Ghendrih, Ph.; Ciraolo, G.; Tafalla, D.; Lopez-Fraguas, A.; Guo, H. Y.; Cui, Z. Y.; Reiter, D.; Asakura, N.; Wenzel, U.; Morita, S.; Ohno, N.; Peterson, B. J.; Masuzaki, S.			Impact of 3D magnetic field structure on boundary and divertor plasmas in stellarator/heliotron devices	JOURNAL OF NUCLEAR MATERIALS			English	Article							DYNAMIC ERGODIC DIVERTOR; ALCATOR C-MOD; SCRAPE-OFF LAYER; LARGE HELICAL DEVICE; TORE-SUPRA; TOKAMAK PLASMAS; EDGE TURBULENCE; STOCHASTIC BOUNDARIES; IMPURITY TRANSPORT; W7-AS STELLARATOR	This paper overviews recent progress on the experimental identification and physics interpretation of 3D effects of magnetic field geometry on divertor transport. The 3D effects are elucidated as a consequence of competition between transports parallel (parallel to) and perpendicular (perpendicular to) to magnetic field, in open field lines cut by divertor plates, or in magnetic islands. The competition has strong impacts on divertor functions, such as determination of density regime, impurity screening, and detachment control. The effects of magnetic perturbation on the edge electric field and turbulent transport are also discussed. Based on the experiments and numerical simulations, key parameters governing the 3D transport physics for the individual divertor functions, e.g. pumping efficiency through divertor density regime, impurity screening and detachment control, are discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Kobayashi, M.; Ida, K.; Itoh, K.; Yamada, H.; Morita, S.; Peterson, B. J.; Masuzaki, S.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Feng, Y.; Wenzel, U.] Max Planck Inst Plasma Phys, D-17491 Greifswald, Germany; [Xu, Y.; Cui, Z. Y.] Southwestern Inst Phys, Chengdu 610041, Peoples R China; [Tabares, F. L.; Tafalla, D.; Lopez-Fraguas, A.] CIEMAT, Lab Nacl Fus, E-28040 Madrid, Spain; [Schmitz, O.; Frerichs, H.; Bader, A.] Univ Wisconsin, Madison, WI USA; [Evans, T. E.; Guo, H. Y.] Gen Atom, San Diego, CA 92186 USA; [Liang, Y.; Reiter, D.] Forschungszentrum Julich, Inst Energie & Klimaforsch Plasmaphys, D-52425 Julich, Germany; [Ghendrih, Ph.; Ciraolo, G.] CEA Cadarache, IRFM, St Paul Les Durance, France; [Guo, H. Y.] Chinese Acad Sci, Inst Plasma Phys, Hefei, Peoples R China; [Asakura, N.] Japan Atom Energy Agcy, Aomori 0393212, Japan; [Ohno, N.] Nagoya Univ, Nagoya, Aichi 4648603, Japan	Kobayashi, M (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.						Alejaldre C, 1999, PLASMA PHYS CONTR F, V41, pA539, DOI 10.1088/0741-3335/41/3A/047; Anderson DT, 2006, FUSION SCI TECHNOL, V50, P171; NEUHAUSER J, 1989, PLASMA PHYS CONTR F, V31, P1551, DOI 10.1088/0741-3335/31/10/006; LaBombard B, 1997, J NUCL MATER, V241, P149, DOI 10.1016/S0022-3115(97)80037-2; Lehnen M, 2005, J NUCL MATER, V337, P171, DOI 10.1016/j.jnucmat.2004.10.100; Tanaka H, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3496389; Xu Y, 2007, NUCL FUSION, V47, P1696, DOI 10.1088/0029-5515/47/12/008; Evans TE, 2006, NAT PHYS, V2, P419, DOI 10.1038/nphys312; SAMAIN A, 1984, J NUCL MATER, V128, P395, DOI 10.1016/0022-3115(84)90383-0; Grigull P, 2003, J NUCL MATER, V313, P1287, DOI 10.1016/S0022-3115(02)01499-X; Kobayashi M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3368681; Morita S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093017; Conway GD, 2015, PLASMA PHYS CONTR F, V57, DOI 10.1088/0741-3335/57/1/014035; STANGEBY PC, 1993, NUCL FUSION, V33, P1695, DOI 10.1088/0029-5515/33/11/I10; Kobayashi M, 2010, FUSION SCI TECHNOL, V58, P220; Feng Y, 2002, PLASMA PHYS CONTR F, V44, P611, DOI 10.1088/0741-3335/44/5/308; Xu Y, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/3/035005; Meslin B, 1999, J NUCL MATER, V266, P318, DOI 10.1016/S0022-3115(98)00875-7; Devynck P, 2002, NUCL FUSION, V42, P697, DOI 10.1088/0029-5515/42/6/308; Masuzaki S, 2003, J NUCL MATER, V313, P852, DOI 10.1016/S0022-3115(02)01461-7; Beyer P, 2002, PLASMA PHYS CONTR F, V44, P2167, DOI 10.1088/0741-3335/44/10/307; Stotler DP, 1999, J NUCL MATER, V266, P947, DOI 10.1016/S0022-3115(98)00555-8; Ahn JW, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/1/015005; EVANS TE, 1992, J NUCL MATER, V196, P421, DOI 10.1016/S0022-3115(06)80071-1; SHISHKIN AA, 1981, NUCL FUSION, V21, P603, DOI 10.1088/0029-5515/21/5/009; Hirsch M, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/5/053001; LIPPMANN S, 1991, NUCL FUSION, V31, P2131, DOI 10.1088/0029-5515/31/11/009; Frerichs H, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054008; Robinson JR, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/10/105007; Liang Y, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025013; Renner H, 2000, NUCL FUSION, V40, P1083, DOI 10.1088/0029-5515/40/6/306; Telesca G, 2009, J NUCL MATER, V390-91, P227, DOI 10.1016/j.jnucmat.2009.01.061; Leconte M, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/1/013004; Eich T, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093031; OHYABU N, 1994, NUCL FUSION, V34, P387, DOI 10.1088/0029-5515/34/3/I07; Ida K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013061; Finken KH, 1999, NUCL FUSION, V39, P637, DOI 10.1088/0029-5515/39/5/306; Feng Y, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095002; Evans TE, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093029; Feng Y, 2014, CONTRIB PLASM PHYS, V54, P426, DOI 10.1002/ctpp.201410092; SHIMOMURA Y, 1983, NUCL FUSION, V23, P869, DOI 10.1088/0029-5515/23/7/002; ASAKURA N, 1995, NUCL FUSION, V35, P381, DOI 10.1088/0029-5515/35/4/I02; Xu Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063020; Feng Y, 2004, CONTRIB PLASM PHYS, V44, P57, DOI 10.1002/ctpp.20041009; Kobayashi M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/3/033011; Tokar MZ, 2004, PHYS PLASMAS, V11, P4610, DOI 10.1063/1.1791232; Yamada H, 2010, FUSION SCI TECHNOL, V58, P12; Runov AM, 2001, PHYS PLASMAS, V8, P916, DOI 10.1063/1.1344921; Feng Y, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/024009; Kobayashi M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093032; Leconte M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694675; Suttrop W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225004; Ghendrih P, 1996, PLASMA PHYS CONTR F, V38, P1653, DOI 10.1088/0741-3335/38/10/002; Loarte A, 1998, NUCL FUSION, V38, P331, DOI 10.1088/0029-5515/38/3/303; Fischer R, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/11/115008; LOARTE A, 1992, CONTRIB PLASM PHYS, V32, P468, DOI 10.1002/ctpp.2150320344; Tokar MZ, 1997, PLASMA PHYS CONTR F, V39, P569, DOI 10.1088/0741-3335/39/4/005; TAKAMURA S, 1988, NUCL FUSION, V28, P183, DOI 10.1088/0029-5515/28/2/001; Feng Y, 2005, NUCL FUSION, V45, P89, DOI 10.1088/0029-5515/45/2/003; BRETON C, 1991, NUCL FUSION, V31, P1774, DOI 10.1088/0029-5515/31/9/017; Tamain P, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/7/075017; Liang Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.105003; Lasnier CJ, 1998, NUCL FUSION, V38, P1225, DOI 10.1088/0029-5515/38/8/209; Zagorski R, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024013; Schmitz O, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124029; LIPSCHULTZ B, 1995, J NUCL MATER, V220, P50, DOI 10.1016/0022-3115(94)00446-3; Lunt T, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054013; WOOTTON AJ, 1990, J NUCL MATER, V176, P77, DOI 10.1016/0022-3115(90)90030-Q; Garcia-Cortes I, 2006, FUSION SCI TECHNOL, V50, P307; Tamain P, 2010, J COMPUT PHYS, V229, P361, DOI 10.1016/j.jcp.2009.09.031; Bader A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113036; PAYAN J, 1995, NUCL FUSION, V35, P1357, DOI 10.1088/0029-5515/35/11/I03; LABOMBARD B, 1995, PHYS PLASMAS, V2, P2242, DOI 10.1063/1.871248; Corre Y, 2007, NUCL FUSION, V47, P119, DOI 10.1088/0029-5515/47/2/006; Drapiko EA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073005; Ciraolo G, 2014, CONTRIB PLASM PHYS, V54, P432, DOI 10.1002/ctpp.201410018; MIZUUCHI T, 1990, J NUCL MATER, V176, P1070, DOI 10.1016/0022-3115(90)90194-R; Schmitz O, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024009; MCCOOL SC, 1989, NUCL FUSION, V29, P547, DOI 10.1088/0029-5515/29/4/001; Feng Y, 2006, NUCL FUSION, V46, P807, DOI 10.1088/0029-5515/46/8/006; NICOLAI A, 1985, PLASMA PHYS CONTR F, V27, P1479, DOI 10.1088/0741-3335/27/12B/002; Reiser D, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2771133; Loarte A, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/3/033007; Clever M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054005; Ghendrih P, 2002, NUCL FUSION, V42, P1221, DOI 10.1088/0029-5515/42/10/308; Frerichs H, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/2/023001; Chowdhuri MB, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103784; Reiter D, 2005, FUSION SCI TECHNOL, V47, P172; Lehnen M, 2005, PLASMA PHYS CONTR F, V47, pB237, DOI 10.1088/0741-3335/47/12B/S18; Garcia OE, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2336422; SAMAIN A, 1982, J NUCL MATER, V111, P408, DOI 10.1016/0022-3115(82)90239-2; Loarte A, 1997, J NUCL MATER, V241, P118, DOI 10.1016/S0022-3115(96)00500-4; Boedo J.A., 2011, 38 EPS C PLASM PHYS, P201; Burhenn R, 2004, FUSION SCI TECHNOL, V46, P115; Colin C., PSI2014; Dei-cas R., 1975, PLASMA PHYS CONTROL, V1, P563; Ezumi N., 2009, J PLASMA FUSION RES, V8, P429; Feng Y, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024012; Grigull P, 2001, PLASMA PHYS CONTR F, V43, pA175, DOI 10.1088/0741-3335/43/12A/313; Groth M, 2011, J NUCL MATER, V415, pS530, DOI 10.1016/j.jnucmat.2010.10.024; Harrison J.R., PSI2014; Hoshino K, 2011, J NUCL MATER, V415, pS549, DOI 10.1016/j.jnucmat.2011.01.003; Ida K., 2010, 23 IAEA FEC DAEJ KOR; Kobayashi M., JOINT 19 ISHW 16 IEA; Kobayashi M., 2009, J PLASMA FUSION RES, V85, P393; Koenig R., 2002, PLASMA PHYS CONTROL, V44, P2365; Leconte M, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3610547; Lipschultz B, 2007, FUSION SCI TECHNOL, V51, P369; Loarte A, 2001, PLASMA PHYS CONTR F, V43, pR183, DOI 10.1088/0741-3335/43/6/201; Lunt T, 2013, J NUCL MATER, V438, pS254, DOI 10.1016/j.jnucmat.2013.01.040; Muller HW, 2013, J NUCL MATER, V438, pS64, DOI 10.1016/j.jnucmat.2013.01.010; Nguyen F, 1997, NUCL FUSION, V37, P743, DOI 10.1088/0029-5515/37/6/I03; Peterson B.J., 2013, PLASMA FUSION RES, V8; Scarin P., 2010, 23 IAEA FEC DAEJ KOR; Schmitz O, 2013, J NUCL MATER, V438, pS194, DOI 10.1016/j.jnucmat.2013.01.025; Schmitz O, 2011, J NUCL MATER, V415, pS886, DOI 10.1016/j.jnucmat.2011.01.136; Stangeby P., 2000, PLASMA BOUNDARY MAGN; Strumberger E, 1996, NUCL FUSION, V36, P891, DOI 10.1088/0029-5515/36/7/I06; Wischmeier M., PSI2014	119	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						2	10		10.1016/j.jnucmat.2015.01.011		9	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200002		
J	Tokitani, M; Kasahara, H; Masuzaki, S; Motojima, G; Shoji, M; Ueda, Y; Yoshida, N; Yoshimura, Y; Nagasaki, K; Ashikawa, N; Mutoh, T; Yamada, H; Nagata, S				Tokitani, M.; Kasahara, H.; Masuzaki, S.; Motojima, G.; Shoji, M.; Ueda, Y.; Yoshida, N.; Yoshimura, Y.; Nagasaki, K.; Ashikawa, N.; Mutoh, T.; Yamada, H.; Nagata, S.		LHD Expt Grp	Plasma wall interaction in long-pulse helium discharge in LHD - Microscopic modification of the wall surface and its impact on particle balance and impurity generation	JOURNAL OF NUCLEAR MATERIALS			English	Article							OPERATION; TRIAM-1M; ENERGY	Ultra-long-pulse helium discharge with ion and electron cyclotron heating (ICH + ECH) in the Large Helical Device (LHD) was achieved in a 48 min plasma (n(e) similar to 1.2 x 10(19) m(-3), T-i,T-e similar to 2 keV) with an average heating power of 1.2 MW. The temperature of the first-wall surface during discharges remained at nearly room temperature. However, even in ultra-long-pulse helium discharge, the discharge conditions cannot be said to be in a steady-state, because of two major issues interrupting the steady-state condition. One is the "dynamic change of the wall pumping rate" and the other is the "termination of the discharge with the exfoliation of the mixed-material deposition layers." Microscopic modifications, such as helium radiation damage and the formation of the mixed-material deposition layers composed of C (similar to 98%) and Fe (similar to 2%), on the plasma facing components (PFMs) were clarified to possibly influence the major issues. (C) 2014 Elsevier B.V. All rights reserved.	[Tokitani, M.; Kasahara, H.; Masuzaki, S.; Motojima, G.; Shoji, M.; Yoshimura, Y.; Ashikawa, N.; Mutoh, T.; Yamada, H.; LHD Expt Grp] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yoshida, N.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Nagasaki, K.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Nagata, S.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Tokitani, M (reprint author), Natl Inst Fus Sci, 322-6 Oroshi, Toki, Gifu 5095292, Japan.	tokitani.masayuki@LHD.nifs.ac.jp	Kyushu, RIAM/F-4018-2015		Japan Ministry of Education, Culture, Sports, Science and Technology; Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University; Institute for Materials Research, Tohoku University	This study was financially supported by the Japan Ministry of Education, Culture, Sports, Science and Technology. This work was partly supported by the Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University and the Institute for Materials Research, Tohoku University. The authors would like to thank Dr. Tosa and Dr. Kasahara of NIMS for nano-material testing.	Mutoh T, 2007, NUCL FUSION, V47, P1250, DOI 10.1088/0029-5515/47/9/023; Brezinsek S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083023; Tokitani M, 2009, J NUCL MATER, V386-88, P173, DOI 10.1016/j.jnucmat.2008.12.086; Tokitani M, 2004, J NUCL MATER, V329, P761, DOI 10.1016/j.jnucmat.2004.04.177; Ezumi N, 2003, J NUCL MATER, V313, P696, DOI 10.1016/S0022-3115(02)01364-8; Jacquinot J, 2003, NUCL FUSION, V43, P1583, DOI 10.1088/0029-5515/43/12/005; Kasahara H., 2014, 25 IAEA FUS EN C FEC; Masuzaki S, 2010, FUSION ENG DES, V85, P940, DOI 10.1016/j.fusengdes.2010.08.048; Miyamoto M., 2004, Journal of Nuclear Materials, DOI 10.1016/j.jnucmat.2004.04.181; Motojima G., J NUCL MAT; Mutoh T., 2013, NUCL FUSION, V53; Sagara A, 2003, J NUCL MATER, V313, P1, DOI 10.1016/S0022-3115(02)01326-0; Sakamoto M, 2002, NUCL FUSION, V42, P165, DOI 10.1088/0029-5515/42/2/307; Shoji M., 2014, 25 IAEA FUS EN C FEC; Tokitani M, 2005, NUCL FUSION, V45, P1544, DOI 10.1088/0029-5515/45/12/009; Tokitani M, 2007, J NUCL MATER, V367, P1487, DOI 10.1016/j.jnucmat.2007.04.010; Tokitani M, 2011, J NUCL MATER, V417, P668, DOI 10.1016/j.jnucmat.2010.12.185; Tokitani M, 2013, J NUCL MATER, V438, pS818, DOI 10.1016/j.jnucmat.2013.01.177; Tokitani M, 2010, FUSION SCI TECHNOL, V58, P305	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						91	98		10.1016/j.jnucmat.2014.12.062		8	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200014		
J	Ito, AM; Takayama, A; Oda, Y; Tamura, T; Kobayashi, R; Hattori, T; Ogata, S; Ohno, N; Kajita, S; Yajima, M; Noiri, Y; Yoshimoto, Y; Saito, S; Takamura, S; Murashima, T; Miyamoto, M; Nakamura, H				Ito, Atsushi M.; Takayama, Arimichi; Oda, Yasuhiro; Tamura, Tomoyuki; Kobayashi, Ryo; Hattori, Tatsunori; Ogata, Shuji; Ohno, Noriyasu; Kajita, Shin; Yajima, Miyuki; Noiri, Yasuyuki; Yoshimoto, Yoshihide; Saito, Seiki; Takamura, Shuichi; Murashima, Takahiro; Miyamoto, Mitsutaka; Nakamura, Hiroaki			Hybrid simulation research on formation mechanism of tungsten nanostructure induced by helium plasma irradiation	JOURNAL OF NUCLEAR MATERIALS			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BINARY-COLLISION-APPROXIMATION; INCIDENT ION ENERGY; BUBBLE FORMATION; HE; HYDROGEN; SURFACE; DEPENDENCE	The generation of tungsten fuzzy nanostructure by exposure to helium plasma is one of the important problems for the use of tungsten material as divertor plates in nuclear fusion reactors. In the present paper, the formation mechanisms of the helium bubble and the tungsten fuzzy nanostructure were investigated by using several simulation methods. We proposed the four-step process which is composed of penetration step, diffusion and agglomeration step, helium bubble growth step, and fuzzy nanostructure formation step. As the fourth step, the formation of the tungsten fuzzy nanostructure was successfully reproduced by newly developed hybrid simulation combining between molecular dynamics and Monte-Carlo method. The formation mechanism of tungsten fuzzy nanostructure observed by the hybrid simulation is that concavity and convexity of the surface are enhanced by the bursting of helium bubbles in the region around the concavity. (C) 2015 Elsevier B.V. All rights reserved.	[Ito, Atsushi M.; Takayama, Arimichi; Oda, Yasuhiro; Yajima, Miyuki; Nakamura, Hiroaki] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Tamura, Tomoyuki; Kobayashi, Ryo; Hattori, Tatsunori; Ogata, Shuji] Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan; [Ohno, Noriyasu; Kajita, Shin; Noiri, Yasuyuki; Nakamura, Hiroaki] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yoshimoto, Yoshihide] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan; [Saito, Seiki] Kushiro Natl Coll Technol, Kushiro, Hokkaido 0840916, Japan; [Takamura, Shuichi] Aichi Inst Technol, Toyota 4700392, Japan; [Murashima, Takahiro] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Miyamoto, Mitsutaka] Shimane Univ, Matsue, Shimane 6908504, Japan	Ito, AM (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	ito.atsushi@nifs.ac.jp	Kajita, Shin/Q-1020-2015		National Institute of Natural Science (NINS) Program for Cross-Disciplinary Study; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23710135, 25249132]; National Institute for Fusion Science (NIFS) Collaboration Research programs [NIFS14KNTS028, NIFS13KNSS037]	We would like thank to Dr. Naoaki Yoshida, Dr. Yoshio Ueda, Dr. Masayuki Tokitani and Dr. Heun Tae Lee for helpful discussions. Our work was supported by the National Institute of Natural Science (NINS) Program for Cross-Disciplinary Study, Grants-in-Aid for Scientific Research (Nos. 23710135 and 25249132) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the National Institute for Fusion Science (NIFS) Collaboration Research programs (NIFS14KNTS028 and NIFS13KNSS037). Numerical simulations were carried out by using the Plasma Simulator at the NIPS and the HELIOS supercomputer system at Computational Simulation Centre of International Fusion Energy Research Centre (IFERC-CSC), Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and JAEA.	Henriksson KOE, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103390; Becquart CS, 2009, J NUCL MATER, V386-88, P109, DOI 10.1016/j.jnucmat.2008.12.085; Ueda Y, 2009, J NUCL MATER, V386-88, P725, DOI 10.1016/j.jnucmat.2008.12.300; Becquart CS, 2007, NUCL INSTRUM METH B, V255, P23, DOI 10.1016/j.nimb.2006.11.006; Ohsawa K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184117; Henriksson KOE, 2006, NUCL INSTRUM METH B, V244, P377, DOI 10.1016/j.nimb.2005.10.020; Zhou YL, 2014, J NUCL MATER, V446, P49, DOI 10.1016/j.jnucmat.2013.11.034; Liu YL, 2009, NUCL INSTRUM METH B, V267, P3193, DOI 10.1016/j.nimb.2009.06.066; Nishijima D, 2004, J NUCL MATER, V329, P1029, DOI 10.1016/j.jnucmat.2004.04.129; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095005; Saito S, 2013, J NUCL MATER, V438, pS895, DOI 10.1016/j.jnucmat.2013.01.194; Henriksson KOE, 2006, FUSION SCI TECHNOL, V50, P43; Ito AM, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014062; Kajita S, 2011, J NUCL MATER, V418, P152, DOI 10.1016/j.jnucmat.2011.06.026; Hou M, 2010, J NUCL MATER, V403, P89, DOI 10.1016/j.jnucmat.2010.06.004; Yajima M, 2013, PLASMA SCI TECHNOL, V15, P282, DOI 10.1088/1009-0630/15/3/18; Tamura T, 2014, MODEL SIMUL MATER SC, V22, DOI 10.1088/0965-0393/22/1/015002; Nishijima D, 2003, J NUCL MATER, V313, P97, DOI 10.1016/S0022-3115(02)01368-5; Kajita S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.085204; Bond SD, 1999, J COMPUT PHYS, V151, P114, DOI 10.1006/jcph.1998.6171; Kato D., 2009, J PLASMA FUSION RES, V8, P404; Kobayashi R., J NUCL MAT IN PRESS; Lasa A., 2013, NUCL INSTRUM METH B, V244, P377; Lee HT, 2013, FUSION SCI TECHNOL, V63, P233; Nose S, 2001, J PHYS SOC JPN, V70, P75, DOI 10.1143/JPSJ.70.75; Oda Y., 2014, PLASMA FUSION RES, V9; Sefta F, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073015; Takamura S., 2006, PLASMA FUSION RES, V1, P51, DOI 10.1585/pfr.1.051; Takamura S., 2014, PLASMA FUSION RES, V9; Takayama A, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.01AL03; Takayama A., J NUCL MAT IN PRESS; Tamura T., P PSI2014 UNPUB	32	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						109	115		10.1016/j.jnucmat.2015.01.018		7	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200017		
J	Ibano, K; Tsutsui, T; Lang, TL; Togo, S; Ogawa, Y				Ibano, K.; Tsutsui, T.; Lang, T. L.; Togo, S.; Ogawa, Y.			Effects of impurity transport and melt layer motion to the tungsten wall erosion during anomaly events	JOURNAL OF NUCLEAR MATERIALS			English	Article							TRANSIENT; SAFETY; MODEL	Developing designs of future fusion devices, safety and soundness of the rector at anomaly events must be ensured. A computational approach is being taken by developing a homegrown integrated reactor simulation code and analyzing a loss-of-cooling-gas-puff accident (LCGA). This code currently includes simple plasma, edge, and wall models. In this study, models for the tungsten transport and melt layer motion was added and used for the analysis. It was found that this accident results significant erosion of the wall while impurities from the wall would contribute the radiation cooling for the intense heat flux. However, these effects strongly depend on an uncertain parameter of the tungsten transport as well as the tungsten melt layer motion. Thus, parametric survey for these uncertain quantities were taken and discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Ibano, K.; Tsutsui, T.; Lang, T. L.; Togo, S.; Ogawa, Y.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Ibano, K (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamada Oka, Suita, Osaka, Japan.	kibano@eei.eng.osaka-u.ac.jp			ZE Research Program [IAE ZE26B-32]	The authors thank Prof. Hiwatari at the University of Tokyo for providing information about the CSD model and advices on this work. This work is supported by the "ZE Research Program, IAE ZE26B-32."	Coenen JW, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/11/113020; Hiwatari R, 2005, J NUCL MATER, V337, P386, DOI 10.1016/j.jnucmat.2004.10.043; Honda T., 1997, J FUSION ENERG, V12, P175; Honda T, 1997, J NUCL SCI TECHNOL, V34, P538; Ibano K., 2014, PLASMA FUSION RES, V9; Loarte, 2007, NUCL FUSION, V47, pS203; Post D. E., 1977, Atomic Data and Nuclear Data Tables, V20, DOI 10.1016/0092-640X(77)90026-2; Rivas JC, 2011, FUSION SCI TECHNOL, V60, P825; Rivas JC, 2014, FUSION ENG DES, V89, P2043, DOI 10.1016/j.fusengdes.2014.04.010	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						185	188		10.1016/j.jnucmat.2014.09.082		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200030		
J	Kikuchi, Y; Sakuma, I; Kitagawa, Y; Asai, Y; Onishi, K; Fukumoto, N; Nagata, M; Ueda, Y; Kurishita, H				Kikuchi, Y.; Sakuma, I.; Kitagawa, Y.; Asai, Y.; Onishi, K.; Fukumoto, N.; Nagata, M.; Ueda, Y.; Kurishita, H.			Surface modifications on toughened, fine-grained, recrystallized tungsten with repetitive ELM-like pulsed plasma irradiation	JOURNAL OF NUCLEAR MATERIALS			English	Article								Surface modifications of toughened, fine-grained, recrystallized tungsten (TFGR W) materials with 1.1 wt.% TiC and 3.3 wt.% TaC dispersoids due to repetitive ELM-like pulsed (similar to 0.15 ms) helium plasma irradiation have been investigated by using a magnetized coaxial plasma gun. No surface cracking at the center part of the TFGR W samples exposed to 20 plasma pulses of similar to 0.3 MJ m(-2) was observed. The suppression of surface crack formation due to the increase of the grain boundary strength by addition of TiC and TaC dispersoids was confirmed in comparison with a pure W material. On the other hand, surface cracks and small pits appeared at the edge part of the TFGR W sample after the pulsed plasma irradiation. Erosion of the TiC and TaC dispersoids due to the pulsed plasma irradiation could cause the small pits on the surface, resulting in the surface crack formation. (C) 2014 Elsevier B.V. All rights reserved.	[Kikuchi, Y.; Sakuma, I.; Kitagawa, Y.; Asai, Y.; Onishi, K.; Fukumoto, N.; Nagata, M.] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Kurishita, H.] Tohoku Univ, Inst Mat Res, Ibaraki 3111313, Japan	Kikuchi, Y (reprint author), Univ Hyogo, Grad Sch Engn, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	ykikuchi@eng.u-hyogo.ac.jp			 [23760809]	This work was supported by Grant-in-Aid for Young Scientists (B) 23760809.	Nishijima D, 2013, J NUCL MATER, V434, P230, DOI 10.1016/j.jnucmat.2012.10.042; Federici G, 2003, PLASMA PHYS CONTR F, V45, P1523, DOI 10.1088/0741-3335/45/9/301; Philipps V, 2011, J NUCL MATER, V415, pS2, DOI 10.1016/j.jnucmat.2011.01.110; Kurishita H, 2013, MATER TRANS, V54, P456, DOI 10.2320/matertrans.MG201209; Eckstein W, 2002, 9132 IPP; Kajita S., 2009, PLASMA FUSION RES, V4; Kawai T., 2012, LIEGE BELGIUM, pP1; Kikuchi Y, 2013, J NUCL MATER, V438, pS715, DOI 10.1016/j.jnucmat.2013.01.151; Pintsuk G, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014060; Ueda Y, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014038	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						206	209		10.1016/j.jnucmat.2014.11.107		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200035		
J	Sakuma, I; Kikuchi, Y; Kitagawa, Y; Asai, Y; Onishi, K; Fukumoto, N; Nagata, M				Sakuma, I.; Kikuchi, Y.; Kitagawa, Y.; Asai, Y.; Onishi, K.; Fukumoto, N.; Nagata, M.			Experimental investigation of vapor shielding effects induced by ELM-like pulsed plasma loads using the double plasma gun device	JOURNAL OF NUCLEAR MATERIALS			English	Article							MATERIAL EROSION; PREDICTION	We have developed a unique experimental device of so-called double plasma gun, which consists of two magnetized coaxial plasma gun (MCPG) devices, in order to clarify effects of vapor shielding on material erosion due to transient events in magnetically confined fusion devices. Two ELM-like pulsed plasmas produced by the two MCPG devices were injected into a target chamber with a variable time difference. For generating ablated plasmas in front of a target material, an aluminum foil sample in the target chamber was exposed to a pulsed plasma produced by the 1st MCPG device. The 2nd pulsed plasma was produced with a time delay of 70 mu s. It was found that a surface absorbed energy measured by a calorimeter was reduced to similar to 66% of that without the Al foil sample. Thus, the reduction of the incoming plasma energy by the vapor shielding effect was successfully demonstrated in the present experiment. (C) 2014 Elsevier B.V. All rights reserved.	[Sakuma, I.; Kikuchi, Y.; Kitagawa, Y.; Asai, Y.; Onishi, K.; Fukumoto, N.; Nagata, M.] Univ Hyogo, Grad Sch Engn, Kobe, Hyogo 6500044, Japan	Sakuma, I (reprint author), 2167 Shosha, Himeji, Hyogo 6712280, Japan.	eu13z002@steng.u-hyogo.ac.jp			 [23760809]	This work was supported by Grant-in-Aid for Young Scientists (B) 23760809.	Federici G, 2003, PLASMA PHYS CONTR F, V45, P1523, DOI 10.1088/0741-3335/45/9/301; Al-Shboul KF, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4859136; Hassanein A, 2002, FUSION ENG DES, V60, P527, DOI 10.1016/S0920-3796(02)00008-X; Kikuchi Y., 2012, P 24 IAEA FUS EN C; Kono T., 2012, PLASMA FUSION RES, V7; Safronov V, 2001, J NUCL MATER, V290, P1052, DOI 10.1016/S0022-3115(00)00662-0; Sakuma I., 2011, P 24 S FUS ENG CHIC; Tanaka KA, 2011, FUSION SCI TECHNOL, V60, P329; Teresin V.I., 2008, P 21 IAEA FUS EN C; VANDERLAAN JG, 1991, FUSION ENG DES, V18, P135, DOI 10.1016/0920-3796(91)90119-B	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						233	236		10.1016/j.jnucmat.2014.10.020		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200041		
J	Sugiyama, K; Roth, J; Alimov, VK; Schmid, K; Balden, M; Elgeti, S; Koch, F; Hoschen, T; Baldwin, MJ; Doerner, RP; Maier, H; Jacob, W				Sugiyama, K.; Roth, J.; Alimov, V. Kh.; Schmid, K.; Balden, M.; Elgeti, S.; Koch, F.; Hoeschen, T.; Baldwin, M. J.; Doerner, R. P.; Maier, H.; Jacob, W.			Erosion study of Fe-W binary mixed layer prepared as model system for RAFM steel	JOURNAL OF NUCLEAR MATERIALS			English	Article							FUSION POWER-REACTORS	Fe-W binary mixed layers were prepared as a model system for reduced-activation ferritic-martensitic (RAFM) steel for studying their dynamic erosion behavior resulting from energetic deuterium (D) irradiation. This investigation aims toward an assessment of RAFM steels as plasma-facing material. The surface composition of the model layers is modified by D irradiation. W is enriched at the surface with D irradiation fluence due to the preferential sputtering of Fe. It depends on the D impinging energy as well as the initial W fraction of the Fe-W layer. No significant development of surface topography was observed within the examined conditions. The erosion yield of a Fe-W layer is comparable to that of pure Fe in the low-fluence range and decreases with increasing D fluence. These results indicate that the dynamic change of erosion yield is significantly correlated with the surface W enrichment. (C) 2014 Elsevier B.V. All rights reserved.	[Sugiyama, K.; Roth, J.; Alimov, V. Kh.; Schmid, K.; Balden, M.; Elgeti, S.; Koch, F.; Hoeschen, T.; Maier, H.; Jacob, W.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Alimov, V. Kh.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 930, Japan; [Baldwin, M. J.; Doerner, R. P.] Univ Calif San Diego, Energy Res Ctr, La Jolla, CA 92093 USA	Sugiyama, K (reprint author), Max Planck Inst Plasma Phys, Boltzmannstr 2, D-85748 Garching, Germany.	kazuyoshi.sugiyama@ipp.mpg.de			EFDA-Power Plant Physics Technology [WP12-PEX-03a-T03-01/IPP]; European Union's Horizon 2020 research and innovation programme [633053]	The authors greatfully acknowledge J. Dorner, C. Falsini, M. Fusseder, G. Matern and A. Weghorn for their technical assistance. This work was partially supported by EFDA-Power Plant Physics & Technology task agreement under contract of WP12-PEX-03a-T03-01/IPP, and has been carried out within the framework of the EUROfusion Consortium and received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 633053. The views and opinions expressed herein do not necessarily reflect those of the European Commission.	Alimov VK, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014049; Jitsukawa S, 2002, J NUCL MATER, V307, P179, DOI 10.1016/S0022-3115(02)01075-9; Maisonnier D, 2005, FUSION ENG DES, V75-79, P1173, DOI 10.1016/j.fusengdes.2005.06.095; Klueh RL, 2007, J NUCL MATER, V371, P37, DOI 10.1016/j.jnucmat.2007.05.005; Ehrlich K, 2001, FUSION ENG DES, V56-57, P71, DOI 10.1016/S0920-3796(01)00236-8; Baluc N, 2007, NUCL FUSION, V47, pS696, DOI 10.1088/0029-5515/47/10/S18; van der Schaaf B, 2003, FUSION ENG DES, V69, P197, DOI 10.1016/S0920-3796(03)00337-5; GOEBEL DM, 1984, J NUCL MATER, V121, P277, DOI 10.1016/0022-3115(84)90135-1; Chernov VM, 2007, NUCL FUSION, V47, P839, DOI 10.1088/0029-5515/47/8/015; Eckstein W., 1993, 982 IPP; Eckstein W., 1997, 123 IPP; Hollmann EM, 2002, PHYS PLASMAS, V9, P4330, DOI 10.1063/1.1503070; Roth J, 2014, J NUCL MATER, V454, P1, DOI 10.1016/j.jnucmat.2014.07.042	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						272	275		10.1016/j.jnucmat.2014.11.044		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200050		
J	Noiri, Y; Kajita, S; Ohno, N				Noiri, Y.; Kajita, S.; Ohno, N.			Nanostructure growth by helium plasma irradiation to tungsten in sputtering regime	JOURNAL OF NUCLEAR MATERIALS			English	Article								The formation of nanostructure on tungsten (W) surface due to Helium (He) plasma irradiation can be harmful for fusion reactors. Up to now, W nanostructure growth was investigated mainly without sputtering. Under sputtering regime, nanostructure growth competes with erosion due to sputtering. In this study, the nanostructure growth was investigated in the linear divertor simulator NAGDIS-II at incident ion energy range of 200-500 eV. The growth of nanostructures was investigated by experiments and calculations under the sputtering regime. With increasing incident ion energy, the thickness of nanostructured W layer saturated rapidly at a lower He fluence, resulting in thinner W nanostructured layer. The erosion rate of the top of the W nanostructured layer was obtained from the comparison with the numerical calculation. (C) 2015 Elsevier B.V. All rights reserved.	[Noiri, Y.; Ohno, N.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Kajita, S.] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Kajita, S (reprint author), Furo Cho,Chikusa Ku, Nagoya, Aichi 4648603, Japan.	noiri-yasuyuki13@ees.nagoya-u.ac.jp; kajita@ees.nagoya-u.ac.jp	Kajita, Shin/Q-1020-2015		Japan Society for the Promotion of Science (JSPS) [23686133]; NIFS/NINS	Authors thank Prof. Y. Ueda for giving us useful comments. This work was supported in part by a Grant-in-Aid for Young Scientists (A) 23686133 from the Japan Society for the Promotion of Science (JSPS). This work is supported by NIFS/NINS under the project of Formation of International Scientific Base and Network.	Doerner RP, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/043001; Baldwin MJ, 2009, J NUCL MATER, V390-91, P886, DOI 10.1016/j.jnucmat.2009.01.247; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095005; Nishijima D, 2011, J NUCL MATER, V415, pS96, DOI 10.1016/j.jnucmat.2010.12.017; Nishijima D, 2003, J NUCL MATER, V313, P97, DOI 10.1016/S0022-3115(02)01368-5; Baldwin MJ, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035001; Eckstein W, 2002, 9132 IPP; Takamura S., 2006, PLASMA FUSION RES, V1, P51, DOI 10.1585/pfr.1.051	8	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						285	288		10.1016/j.jnucmat.2015.01.036		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200053		
J	Bernard, E; Sakamoto, R; Yoshida, N; Yamada, H				Bernard, E.; Sakamoto, R.; Yoshida, N.; Yamada, H.			Temperature impact on W surface exposed to He plasma in LHD and its consequences for the material properties	JOURNAL OF NUCLEAR MATERIALS			English	Article							ION IRRADIATION	A new temperature controlled material probe was designed for the exposure of W samples to He plasma in the LHD (Large Helical Device). TEM (Transmission Electron Microscopy) analysis allowed the study of the impact of He irradiation under high temperatures (up to 600 degrees C) on W microstructure: bubbles and dislocation loops are formed at the surface. A heavily damaged layer rich in both damages is formed at the very surface layer whose thickness increases with the incident fluence; beyond this layer, bubbles are observed much deeper than expected, rising concerns about the consequences for the material properties conservation. Nano-indentation measurements showed that the hardness of exposed tungsten indeed increases as the dislocation loops are formed and large bubbles appear in the material. (C) 2014 Elsevier B.V. All rights reserved.	[Bernard, E.; Sakamoto, R.; Yamada, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Yoshida, N.] Kyushu Univ, Kasuga, Fukuoka 8168580, Japan	Bernard, E (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	elodie.bernard@nifs.ac.jp	Kyushu, RIAM/F-4018-2015		 [NIFS-ULPP032]	This work has been supported by NIFS-ULPP032. We gratefully acknowledge all members of the LHD team in NIFS, Kyushu University and Nagoya University for their fruitful help and support.	Tavassoli AAF, 2002, J NUCL MATER, V302, P73, DOI 10.1016/S0022-3115(02)00794-8; Baldwin MJ, 2009, J NUCL MATER, V390-91, P886, DOI 10.1016/j.jnucmat.2009.01.247; Philipps V, 2011, J NUCL MATER, V415, pS2, DOI 10.1016/j.jnucmat.2011.01.110; Hosemann P, 2012, J NUCL MATER, V425, P136, DOI 10.1016/j.jnucmat.2011.11.070; Bernard E., UNPUB; Iwakiri H, 1998, J NUCL MATER, V258, P873, DOI 10.1016/S0022-3115(98)00260-8; Iwakiri H, 2000, J NUCL MATER, V283, P1134, DOI 10.1016/S0022-3115(00)00289-0; Khripunov B, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014052; Kobayashi M., 2006, J PLASMA FUSION RES, V7, P85; Ueda Y., 2008, J NUCL MATER, V386-388, P725; Wright W., 2013, J NUCL MATER, V438, pS84; Yoshida N, 1999, RADIAT EFF DEFECT S, V148, P535, DOI 10.1080/10420159908229108; Ziegler J. F., 1985, STOPPING RANGE IONS	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						316	319		10.1016/j.jnucmat.2014.11.041		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200060		
J	Takamura, S				Takamura, Shuichi			Power transmission factor through the sheath in deuterium plasmas for virgin as well as nanostructured tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							HOT-ELECTRON COMPONENT	Power transmission factor (PTF) through the sheath of deuterium plasmas with hot electron component on virgin as well as nanostructured tungsten due to helium pre-irradiations are studied experimentally and compared with a PTF theory. PTF for nanostructured tungsten is larger than that for normal one, the reasons of which are discussed in terms of surface characteristics. (C) 2014 Elsevier B.V. All rights reserved.	Aichi Inst Technol, Fac Engn, Toyota 4700392, Japan	Takamura, S (reprint author), Aichi Inst Technol, Fac Engn, Yachikusa 1247,Yakusa Cho, Toyota 4700392, Japan.	takamura@aitech.ac.jp			JSPS [26420855, 23656578]	This research work was supported by Grant-in-Aid for Scientific Research (C) 26420855 and Grant-in-Aid for Challenging Exploratory Research 23656578 from JSPS. The authors would like to thank Prof. N. Ohno and Dr. S. Kajita of Nagoya University, and Prof. Y. Uesugi of Kanazawa University for discussions with them, and I. Ohta of AIT for his help on performing numerical analyses.	Takamura S, 2013, FUSION SCI TECHNOL, V63, P225; Takamura S, 2014, CONTRIB PLASM PHYS, V54, P474, DOI 10.1002/ctpp.201410016; Takamura S, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/12/123001; Eckstein W, 2002, 9132 IPP; Imai K., 2010, CONTRIB PLASM PHYS, V50, P458; Kawata J., 1994, J PLASMA FUSION RES, V70, P84; Lassner E., 1999, TUNGSTEN; MASUZAKI S, 1995, J NUCL MATER, V223, P286, DOI 10.1016/0022-3115(94)00685-7; PROPST FM, 1963, PHYS REV, V132, P1037, DOI 10.1103/PhysRev.132.1037; Takamura S, 2013, J NUCL MATER, V438, pS814, DOI 10.1016/j.jnucmat.2013.01.176; Takamura S, 2012, IEEJ T ELECTR ELECTR, V7, pS19, DOI 10.1002/tee.21801; Takamura S., 2014, PLASMA FUSION RES, V9; Takamura S., 2012, 24 FUS EN C SAN DIEG	13	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						325	328		10.1016/j.jnucmat.2014.09.060		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200062		
J	Miyamoto, M; Mikami, S; Nagashima, H; Iijima, N; Nishijima, D; Doerner, RP; Yoshida, N; Watanabe, H; Ueda, Y; Sagara, A				Miyamoto, M.; Mikami, S.; Nagashima, H.; Iijima, N.; Nishijima, D.; Doerner, R. P.; Yoshida, N.; Watanabe, H.; Ueda, Y.; Sagara, A.			Systematic investigation of the formation behavior of helium bubbles in tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							PLASMA; IRRADIATION	The formation of He bubbles in tungsten under exposure to a He plasma was systematically investigated using low energy (similar to 50 eV) He ions with a wide fluence range (similar to 10(23) to 10(26) m(-2)) in the linear divertor plasma simulator PISCES-A at several temperatures (523-973 K). TEM observations after thinning exposed W samples with FIB revealed that the layer thickness (>30 nm) of He bubbles largely exceeds the ion implantation range of a few nm. The size of He bubbles was found to increase with an increase in the sample temperature: it was around 10 nm at 973 K, while only small He bubbles of 1-2 nm were observed at <773 K. In addition, to obtain information on the initial formation behavior, in-situ TEM observations during He ion irradiation were also performed. (C) 2014 Elsevier B.V. All rights reserved.	[Miyamoto, M.; Mikami, S.; Nagashima, H.; Iijima, N.] Shimane Univ, Dept Mat Sci, Matsue, Shimane 6908504, Japan; [Nishijima, D.; Doerner, R. P.] Univ Calif San Diego, Energy Res Ctr, La Jolla, CA 92093 USA; [Yoshida, N.; Watanabe, H.] Kyushu Univ, RIAM, Kasuga, Fukuoka 8168580, Japan; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Sagara, A.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Miyamoto, M (reprint author), 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	miyamoto@riko.shimane-u.ac.jp	Kyushu, RIAM/F-4018-2015		Japan/U.S. Cooperation in Fusion Research and Development; Japan Society for the Promotion of Science (JSPS) [25709086, 25630420]	The authors wish to thank PISCES technical staff for their professional skill and dedicated support. This work was partly supported by Japan/U.S. Cooperation in Fusion Research and Development and a Grant-in-Aid for Young Scientists (A) 25709086 and for Challenging Exploratory Research 25630420 from the Japan Society for the Promotion of Science (JSPS).	Miyamoto M, 2011, J NUCL MATER, V415, pS657, DOI 10.1016/j.jnucmat.2011.01.008; Kajita S, 2007, NUCL FUSION, V47, P1358, DOI 10.1088/0029-5515/47/9/038; Nishijima D, 2013, J NUCL MATER, V434, P230, DOI 10.1016/j.jnucmat.2012.10.042; GOEBEL DM, 1984, J NUCL MATER, V121, P277, DOI 10.1016/0022-3115(84)90135-1; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095005; Nishijima D, 2011, J NUCL MATER, V415, pS96, DOI 10.1016/j.jnucmat.2010.12.017; Yoshida N, 2005, J NUCL MATER, V337, P946, DOI 10.1016/j.jnucmat.2004.10.162; Miyamoto M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065035; Ohno N, 2013, J NUCL MATER, V438, pS879, DOI 10.1016/j.jnucmat.2013.01.190; Eckstein W, 2002, 9132 IPP; Langley R.A., 1984, NUCL FUSION, V24, pS9, DOI 10.1088/0029-5515/24/S1/001; Nishijima D, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2786063; Takamura S., 2006, PLASMA FUSION RES, V1, P51, DOI 10.1585/pfr.1.051	13	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						333	336		10.1016/j.jnucmat.2014.10.098		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200064		
J	Kato, S; Tanaka, N; Sasao, M; Kisaki, M; Tsumori, K; Nishiura, M; Matsumoto, Y; Kenmotsu, T; Wada, M; Yamaoka, H				Kato, S.; Tanaka, N.; Sasao, M.; Kisaki, M.; Tsumori, K.; Nishiura, M.; Matsumoto, Y.; Kenmotsu, T.; Wada, M.; Yamaoka, H.			Angle-resolved intensity and energy distributions of positive and negative hydrogen ions released from tungsten surface by molecular hydrogen ion impact	JOURNAL OF NUCLEAR MATERIALS			English	Article							DISSOCIATIVE SCATTERING; METAL-SURFACES; LIGHT-IONS	Hydrogen ion reflection properties have been investigated following the injection of H+, H-2(+) and H-3(+) ions onto a polycrystalline W surface. Angle- and energy-resolved intensity distributions of both scattered H+ and H- ions are measured by a magnetic momentum analyzer. We have detected atomic hydrogen ions reflected from the surface, while molecular hydrogen ions are unobserved within our detection limit. The reflected hydrogen ion energy is approximately less than one-third of the incident beam energy for H-3(+) ion injection and less than a half of that for H-2(+) ion injection. Other reflection properties are very similar to those of monoatomic H+ ion injection. Experimental results are compared to the classical trajectory simulations using the ACAT code based on the binary collision approximation. (C) 2014 Elsevier B.V. All rights reserved.	[Kato, S.; Sasao, M.; Kenmotsu, T.; Wada, M.] Doshisha Univ, Kyotanabe, Kyoto 6100321, Japan; [Tanaka, N.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Nishiura, M.] Univ Tokyo, Kashiwa, Chiba 2778568, Japan; [Kisaki, M.; Tsumori, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Matsumoto, Y.] Tokushima Bunri Univ, Yamashiro, Tokushima 7708514, Japan; [Yamaoka, H.] RIICEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Kato, S (reprint author), Doshisha Univ, Kyotanabe, Kyoto 6100321, Japan.	eun1302@mail4.doshsha.ac.jp			NIFS [NIFS13KBAR005, NIFS14KBAR009]	We thank Dr. K. Shinto in Japan Atomic Energy Agency of his encouragement for the experiment. This work was performed under the collaboration program of NIFS (NIFS13KBAR005 & NIFS14KBAR009).	Hirai T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014006; NIEHUS H, 1993, SURF SCI REP, V17, P213, DOI 10.1016/0167-5729(93)90024-J; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095005; BUNGE AV, 1979, PHYS REV A, V19, P452, DOI 10.1103/PhysRevA.19.452; Fukui A, 2001, APPL SURF SCI, V169, P42, DOI 10.1016/S0169-4332(00)00641-3; HIRAYAMA H, 1993, PHYS REV B, V48, P8095, DOI 10.1103/PhysRevB.48.8095; Ohno N, 1998, PHYS REV LETT, V81, P818, DOI 10.1103/PhysRevLett.81.818; Tanaka N, 2009, J NUCL MATER, V390-91, P1035, DOI 10.1016/j.jnucmat.2009.01.281; Tanaka N, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4855455; Wada M, 2009, PLASMA DEVICES OPER, V17, P132, DOI 10.1080/10519990902884746; Wu C.H., 2000, NATO SCI SERIES; YAMAMURA Y, 1990, NUCL INSTRUM METH B, V51, P407, DOI 10.1016/0168-583X(90)90560-H; Yamaoka H, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2796173; Yamaoka H., 2006, REV SCI INSTRUM, V73; Yamaoka H, 2007, J NUCL MATER, V363, P1304, DOI 10.1016/j.jnucmat.2007.01.183; Yamaoka H, 2005, J NUCL MATER, V337, P942, DOI 10.1016/j.jnucmat.2004.08.020	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						351	354		10.1016/j.jnucmat.2014.12.026		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200068		
J	Takayama, A; Ito, AM; Oda, Y; Nakamura, H				Takayama, A.; Ito, A. M.; Oda, Y.; Nakamura, H.			First principles investigation of cluster consisting of hydrogen-helium atoms interstitially-trapped in tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							BEHAVIOR; IONS; HE	We evaluate the binding energies of mixed helium and hydrogen clusters consisted of interstitially trapped atoms in bcc tungsten by first-principles calculations based on density functional theories. It is shown that helium-rich interstitially-trapped clusters have the positive binding energies and the low electron-density region expand as the number of helium in the cluster increase. Thus, the helium-rich interstitially trapped clusters can act as a trapping site for hydrogen, and interstitially trapped helium interrupts or disturbs the hydrogen diffusion in tungsten. (C) 2014 Elsevier B.V. All rights reserved.	[Takayama, A.; Ito, A. M.; Oda, Y.; Nakamura, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Nakamura, H.] Nagoya Univ, Toki, Gifu 5095292, Japan	Takayama, A (reprint author), Oroshi Cho 322-6, Toki, Gifu 5095292, Japan.	takayama.arimichi@nifs.ac.jp			National Institute for Fusion Science Collaborative Research Programs; National Institutes of Natural Sciences (NINS) program	This work is partly supported by the National Institute for Fusion Science Collaborative Research Programs and the National Institutes of Natural Sciences (NINS) program for cross-disciplinary study.	Ueda Y, 2009, FUSION SCI TECHNOL, V56, P85; Henriksson KOE, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103390; Becquart CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.196402; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; Ozaki T, 2005, PHYS REV B, V72, DOI [10.1103/PhysRevB.72.045121, 10.1109/PhysRevB.72.045121]; Becquart CS, 2009, J NUCL MATER, V386-88, P109, DOI 10.1016/j.jnucmat.2008.12.085; Ueda Y, 2009, J NUCL MATER, V386-88, P725, DOI 10.1016/j.jnucmat.2008.12.300; GOLDFARB D, 1970, MATH COMPUT, V24, P23, DOI 10.2307/2004873; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Becquart CS, 2007, NUCL INSTRUM METH B, V255, P23, DOI 10.1016/j.nimb.2006.11.006; Ohsawa K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184117; Ozaki T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.195113; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Ohsawa K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094102; Jiang B, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134112; Zhou HB, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/11/115010; Ozaki T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155108; Tamura T, 2014, MODEL SIMUL MATER SC, V22, DOI 10.1088/0965-0393/22/1/015002; MORRISON I, 1993, PHYS REV B, V47, P6728, DOI 10.1103/PhysRevB.47.6728; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Broyden C., 1970, J I MATH ITS APPL, V6, P76, DOI DOI 10.1093/IMAMAT/6.1.76; Ehrhart P., 1991, NUMERICAL DATA FUNCT, V25, P115; Kato D., 2009, J PLASMA FUSION RES, V8, P404; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Oda Y., 2014, PLASMA FUSION RES, V9; Takayama A, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.01AL03	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						355	358		10.1016/j.jnucmat.2014.11.001		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200069		
J	Dai, SY; Liu, SG; Sun, JZ; Kirschner, A; Kawamura, G; Tskhakaya, D; Ding, R; Luo, GN; Wang, DZ				Dai, Shuyu; Liu, Shengguang; Sun, Jizhong; Kirschner, A.; Kawamura, G.; Tskhakaya, D.; Ding, Rui; Luo, Guangnan; Wang, Dezhen			Modelling of surface evolution of rough surface on divertor target in fusion devices	JOURNAL OF NUCLEAR MATERIALS			English	Article							TRANSPORT; EROSION	The 3D Monte-Carlo code SURO has been used to study the surface evolution of rough surface on the divertor target in fusion devices. The edge plasma at divertor region is modelled by the SDPIC code and used as input data for SURO. Coupled with SDPIC, SURO can perform more sophisticated simulations to calculate the local angle and surface evolution of rough surface. The simulation results show that the incident direction of magnetic field, gyration and E x B force has a significant impact on 3D angular distribution of background plasma and accordingly on the erosion of rough surface. The net eroded areal density of rough surface is studied by varying the magnetic field angle with surface normal. The evolution of the microscopic morphology of rough surface can lead to a significant change in the physical sputtering yield. (C) 2014 Published by Elsevier B.V.	[Dai, Shuyu; Liu, Shengguang; Sun, Jizhong; Wang, Dezhen] Dalian Univ Technol, Sch Phys & Optoelect Technol, Minist Educ, Key Lab Mat Modificat Laser Ion & Electron Beams, Dalian 116024, Peoples R China; [Kirschner, A.] Forschungszentrum Julich, Inst Energie & Klimaforsch Plasmaphys, D-52425 Julich, Germany; [Kawamura, G.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Tskhakaya, D.] TU Wien, Inst Appl Phys, Assoc EURATOM oAW, A-1040 Vienna, Austria; [Ding, Rui; Luo, Guangnan] Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Anhui, Peoples R China	Wang, DZ (reprint author), Dalian Univ Technol, Sch Phys & Optoelect Technol, 2 Linggong Rd, Dalian 116024, Peoples R China.	daishuyu@dlut.edu.cn; wangdez@dlut.edu.cn			National Magnetic Confinement Fusion Science Program [2013GB109001]; National Natural Science Foundation of China [11405021, 11275042, 11305025]; China Postdoctoral Science Foundation [2014M561217]; General project of scientific research of higher institutions in Liaoning province [L2014013]; Fundamental Research Funds for the Central Universities [DUT14RC(3)039]; EURATOM; EFDA	This work was supported by National Magnetic Confinement Fusion Science Program Nos. 2013GB109001, National Natural Science Foundation of China under Grant Nos. 11405021, 11275042 and 11305025, China Postdoctoral Science Foundation No. 2014M561217, General project of scientific research of higher institutions in Liaoning province No. L2014013 and the Fundamental Research Funds for the Central Universities No. DUT14RC(3)039. The contributions by A. Kirschner and D. Tskhakaya were supported by EURATOM and carried out within the framework of the EFDA. The views and opinions expressed herein do not necessarily reflect those of the European Commission.	Mayer M, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014039; Federici G, 2001, NUCL FUSION, V41, P1967, DOI 10.1088/0029-5515/41/12/218; Bizyukov I, 2006, J APPL PHYS, V100, DOI 10.1063/1.2400393; BROOKS JN, 1990, J NUCL MATER, V176, P278, DOI 10.1016/0022-3115(90)90060-Z; Dai S, 2011, CONTRIB PLASM PHYS, V51, P844, DOI 10.1002/ctpp.201000101; Dai SY, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/5/055004; Dai SY, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/12/123015; Droste S, 2006, CONTRIB PLASM PHYS, V46, P628, DOI 10.1002/ctpp.200610055; ISHITANI T, 1974, J MATER SCI, V9, P505, DOI 10.1007/BF00737856; Ohya K., 2000, J PLASMA FUSION RES, V3, P288; Rubel MJ, 2006, FUSION ENG DES, V81, P211, DOI 10.1016/j.fusengdes.2005.07.037; Schmid K, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/10/105004	12	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						372	376		10.1016/j.jnucmat.2014.11.081		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200073		
J	Onchi, T; Mahira, Y; Nagaoka, K; Tashima, S; Banerjee, S; Mishra, K; Idei, H; Hanada, K; Nakamura, K; Fujisawa, A; Nagashima, Y; Hasegawa, M; Matsuoka, K; Kuzmin, A; Watanabe, O; Kawasaki, S; Nakashima, H; Higashijima, A				Onchi, T.; Mahira, Y.; Nagaoka, K.; Tashima, S.; Banerjee, S.; Mishra, K.; Idei, H.; Hanada, K.; Nakamura, K.; Fujisawa, A.; Nagashima, Y.; Hasegawa, M.; Matsuoka, K.; Kuzmin, A.; Watanabe, O.; Kawasaki, S.; Nakashima, H.; Higashijima, A.			Observation of heat flux and plasma flow in scrape off layer in QUEST	JOURNAL OF NUCLEAR MATERIALS			English	Article							WEAKLY MAGNETIZED PLASMAS; PROBE	Thermal probe with double function of thermocouples and Langmuir probe has been developed, and the initial data observed in far-SOL in QUEST is obtained. Heat flux of megawatt per square meters related to energetic electrons and sonic plasma flow in far-SOL have been observed in the current rump-up phase although no high power inductive force like ohmic winding is applied. The heat flux and the flow are suppressed after the current is built up. In the quasi-steady state, plasma current starts and keeps sawtooth-like oscillation with 20 Hz frequency. The heat flux and the flow in far-SOL have clear responses to the oscillation. (C) 2014 Elsevier B.V. All rights reserved.	[Onchi, T.; Idei, H.; Hanada, K.; Nakamura, K.; Fujisawa, A.; Nagashima, Y.; Hasegawa, M.; Kuzmin, A.; Watanabe, O.; Kawasaki, S.; Nakashima, H.; Higashijima, A.] Kyushu Univ, RIAM, Kasuga, Fukuoka 8168580, Japan; [Mahira, Y.; Tashima, S.; Banerjee, S.; Mishra, K.] Kyushu Univ, IGSES, Kasuga, Fukuoka 8168580, Japan; [Nagaoka, K.; Matsuoka, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Onchi, T (reprint author), Kyushu Univ, RIAM, 6-1 Kasugakoen, Kasuga, Fukuoka 8168580, Japan.	onchi@triam.kyushu-u.ac.jp	Watanabe, Osamu/G-6207-2014; Kyushu, RIAM/F-4018-2015	Watanabe, Osamu/0000-0002-5034-5619; 	NIFS [NIFS12-KUTR081]; Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University;  [S24226020]	This work is supported by Grants-in-aid for Scientific Research (S24226020), NIFS Collaboration Research Program (NIFS12-KUTR081), and the Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University.	Smick N, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/2/023001; LaBombard B, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1876294; Tashima S, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/2/023010; FOREST CB, 1992, PHYS REV LETT, V68, P3559, DOI 10.1103/PhysRevLett.68.3559; Ishiguro M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4731700; Buttsworth DR, 2001, EXP THERM FLUID SCI, V25, P409, DOI 10.1016/S0894-1777(01)00093-0; Maekawa T, 2005, NUCL FUSION, V45, P1439, DOI 10.1088/0029-5515/45/11/026; Shikama T, 2006, CONTRIB PLASM PHYS, V46, P427, DOI 10.1002/ctpp.200610026; Shikama T, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1872895; Zushi H., 2012, P 24 IAEA FEC	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						428	431		10.1016/j.jnucmat.2014.11.136		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200086		
J	Hayashi, Y; Suzuki, Y; Ohno, N; Okamoto, M; Kikuchi, Y; Sakakibara, S; Watanabe, K; Takemura, Y				Hayashi, Y.; Suzuki, Y.; Ohno, N.; Okamoto, M.; Kikuchi, Y.; Sakakibara, S.; Watanabe, K.; Takemura, Y.			Influence of external resonant magnetic perturbation field on edge plasma of small tokamak HYBTOK-II	JOURNAL OF NUCLEAR MATERIALS			English	Article								Radial profile of externally applied resonant magnetic perturbation (RMP) field with mode numbers of m = 6 and n = 2 in a small tokamak device HYBTOK-II have been investigated using a magnetic probe array, which is able to measure the radial profile of magnetic field perturbation induced by applying RMP. Results of RMP penetration into the plasma show that the RMP decreased toward the plasma center, while they were amplified around the resonant surface with a safety factor q = 3 due to the formation of magnetic islands. This suggests that RMP fields for controlling edge plasmas may trigger some kind of MHD instabilities. In addition, simulation results, based on a linearized four-field model, which agrees with the experimental ones, indicates that the penetration and amplification process of RMP strongly depend on a Doppler-shifted frequency between the RMP and plasma rotation. (C) 2014 Elsevier B.V. All rights reserved.	[Hayashi, Y.; Suzuki, Y.; Ohno, N.] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Okamoto, M.] Ishikawa Natl Coll Technol, Tsubata Cho, Ishikawa 9290392, Japan; [Kikuchi, Y.] Univ Hyogo, Himeji, Hyogo 6712280, Japan; [Sakakibara, S.; Watanabe, K.; Takemura, Y.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Hayashi, Y (reprint author), Nagoya Univ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	hayashi-yuki13@ees.nagoya-u.ac.jp			NIFS Collaboration Research Program [NIFS14-KOAH031]; NIFS/NINS project of Formation of International Scientific Base and Network	This work is performed with the support and under the auspices of the NIFS Collaboration Research Program (NIFS14-KOAH031), and partially supported by NIFS/NINS under the project of Formation of International Scientific Base and Network.	Evans TE, 2006, NAT PHYS, V2, P419, DOI 10.1038/nphys312; Evans TE, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024002; Waelbroeck FL, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/7/074004; Kirk A, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/3/034008; Jeon YM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.035004; Kirk A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043007; Evans TE, 2005, NUCL FUSION, V45, P595, DOI 10.1088/0029-5515/45/7/007; Suttrop W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225004; Liang Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.265004; Schmitz O, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124029; Liu YQ, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124013; Becoulet M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054003; Evans TE, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.235003; Canik JM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.045001; Fielding S. J., 2001, EUR C ABSTR A, V25A, P1825; Kikuchi Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.085003; Kikuchi Y, 2004, NUCL FUSION, V44, pS28, DOI 10.1088/0029-5515/44/6/S03; Kikuchi Y, 2006, CONTRIB PLASM PHYS, V46, P539, DOI 10.1002/ctpp.200610041; Kobayashi M, 2000, NUCL FUSION, V40, P181, DOI 10.1088/0029-5515/40/2/304; Loarte A., 2010, P 23 IAEA FEC DAEG K; Mori M, 1996, PLASMA PHYS CONTR F, V38, P1189, DOI 10.1088/0741-3335/38/8/010; Okamoto M, 2007, NUCL FUSION, V47, P1106, DOI 10.1088/0029-5515/47/9/006; Schmitz O, 2013, J NUCL MATER, V438, pS194, DOI 10.1016/j.jnucmat.2013.01.025; SHOJI T, 1992, J NUCL MATER, V196, P296, DOI 10.1016/S0022-3115(06)80049-8; Takamura S, 2003, NUCL FUSION, V43, P393, DOI 10.1088/0029-5515/43/6/302; Ueda R, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4875340	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						463	466		10.1016/j.jnucmat.2014.12.018		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200094		
J	Togo, S; Takizuka, T; Nakamura, M; Hoshino, K; Ogawa, Y				Togo, S.; Takizuka, T.; Nakamura, M.; Hoshino, K.; Ogawa, Y.			SOL-divertor plasma simulations introducing anisotropic temperature with virtual divertor model	JOURNAL OF NUCLEAR MATERIALS			English	Article								A 1D SOL-divertor plasma simulation code by introducing the anisotropic ion temperature with virtual divertor model has been developed. By introducing the anisotropic ion temperature directly, the second-order derivative parallel ion viscosity term in the momentum transport equation can be excluded and the boundary condition at the divertor plate will not be required in the simulation. In order to express the effects of the divertor plate and accompanying sheath implicitly, a virtual divertor model which has artificial sinks for the particle, momentum and energy has been introduced. Periodic boundary condition becomes available by the use of the virtual divertor model. By using this model, SOL-divertor plasmas which satisfy the Bohm condition has been successfully obtained. The dependence of the ion temperature anisotropy on the normalized mean free path of ion and the validity of the parallel ion viscous flux for the Braginskii expression and the limited one are also investigated. (C) 2014 Elsevier B.V. All rights reserved.	[Togo, S.; Ogawa, Y.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778568, Japan; [Takizuka, T.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Nakamura, M.; Hoshino, K.] Japan Atom Energy Agcy, Aomori 0393212, Japan	Togo, S (reprint author), Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778568, Japan.	togo@ppl.k.u-tokyo.ac.jp	Hoshino, Kazuo/D-6931-2013	Hoshino, Kazuo/0000-0001-5672-9640	Japan Society for the Promotion of Science (JSPS)	We would like to thank Dr. K. Shimizu of Japan Atomic Energy Agency for his helpful advice on the numerical calculations. We are also grateful for Dr. K. Ibano of the University of Tokyo for the fruitful discussion in writing this manuscript. This work is partly supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS).	TAKIZUKA T, 1984, J NUCL MATER, V128, P104, DOI 10.1016/0022-3115(84)90334-9; Schneider R, 2006, CONTRIB PLASM PHYS, V46, P3, DOI 10.1002/ctpp.200610001; Braginskii S.I., 1965, Reviews of Plasma Physics; BRAVENEC RV, 1982, PHYS FLUIDS, V25, P608, DOI 10.1063/1.863806; Chankin AV, 2009, J NUCL MATER, V390-91, P319, DOI 10.1016/j.jnucmat.2009.01.307; Froese Aaron, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.026; Fundamenski W, 2005, PLASMA PHYS CONTR F, V47, pR163, DOI 10.1088/0741-3335/47/11/R01; Stambaugh R, 1999, NUCL FUSION, V39, P2391, DOI 10.1088/0029-5515/39/12/304; Kawashima H., 2006, PLASMA FUSION RES, V1, DOI 10.1585/pfr.1.031; Nakamura M, 2011, J NUCL MATER, V415, pS553, DOI 10.1016/j.jnucmat.2011.01.026; Stangeby P.C, 1999, PLASMA BOUNDARY MAGN; Togo S., 2013, PLASMA FUSION RES, V8; Wischmeier M, 2011, J NUCL MATER, V415, pS523, DOI 10.1016/j.jnucmat.2011.02.020; ZAWAIDEH E, 1986, PHYS FLUIDS, V29, P463, DOI 10.1063/1.865731	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						502	505		10.1016/j.jnucmat.2014.09.081		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200103		
J	Nakashima, Y; Takeda, H; Ichimura, K; Hosoi, K; Oki, K; Sakamoto, M; Hirata, M; Ichimura, M; Ikezoe, R; Imai, T; Iwamoto, M; Hosoda, Y; Katanuma, I; Kariya, T; Kigure, S; Kohagura, J; Minami, R; Numakura, T; Takahashi, S; Yoshikawa, M; Asakura, N; Fukumoto, M; Hatayama, A; Hirooka, Y; Kado, S; Kubo, H; Masuzaki, S; Matsuura, H; Nagata, S; Nishino, N; Ohno, N; Sagara, A; Shikama, T; Shoji, M; Tonegawa, A; Ueda, Y				Nakashima, Y.; Takeda, H.; Ichimura, K.; Hosoi, K.; Oki, K.; Sakamoto, M.; Hirata, M.; Ichimura, M.; Ikezoe, R.; Imai, T.; Iwamoto, M.; Hosoda, Y.; Katanuma, I.; Kariya, T.; Kigure, S.; Kohagura, J.; Minami, R.; Numakura, T.; Takahashi, S.; Yoshikawa, M.; Asakura, N.; Fukumoto, M.; Hatayama, A.; Hirooka, Y.; Kado, S.; Kubo, H.; Masuzaki, S.; Matsuura, H.; Nagata, S.; Nishino, N.; Ohno, N.; Sagara, A.; Shikama, T.; Shoji, M.; Tonegawa, A.; Ueda, Y.			Progress of divertor simulation research toward the realization of detached plasma using a large tandem mirror device	JOURNAL OF NUCLEAR MATERIALS			English	Article							END-CELL; GAMMA-10	This paper describes the results of the experiments performed on Tandem Mirror device GAMMA 10/PDX mainly using a new "divertor simulation experimental module (D-module)" installed on one of the end mirror exits which is specially designed to investigate the physics of plasma detachment. The additional ICRF heating in the anchor-cells, connected to both ends of the central-cell, significantly increases the density in the both cells, which attained the generation of the highest particle flux up to 10(23) particles/s m(2) at the end-mirror exit. H-2 and noble gas injection to enhance the radiation cooling in D-module was performed and a remarkable reduction of the electron temperature (from few tens eV to <3 eV) on the target plate were successfully achieved associated with the strong reduction of particle and heat flux. A significant effect of simultaneous injection with hydrogen and noble gases for detached plasma formation was recognized for the first time. (C) 2014 Elsevier B.V. All rights reserved.	[Nakashima, Y.; Takeda, H.; Ichimura, K.; Hosoi, K.; Oki, K.; Sakamoto, M.; Hirata, M.; Ichimura, M.; Ikezoe, R.; Imai, T.; Iwamoto, M.; Hosoda, Y.; Katanuma, I.; Kariya, T.; Kigure, S.; Kohagura, J.; Minami, R.; Numakura, T.; Takahashi, S.; Yoshikawa, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Asakura, N.; Fukumoto, M.; Kubo, H.] Japan Atom Energy Agcy, Naka Fus Inst, Ibaraki 3110193, Japan; [Hatayama, A.] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2208522, Japan; [Hirooka, Y.; Masuzaki, S.; Sagara, A.; Shoji, M.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kado, S.] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Matsuura, H.] Osaka Prefecture Univ, Ctr Radiat Res, Osaka 5998570, Japan; [Nagata, S.; Shikama, T.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Nishino, N.] Hiroshima Univ, Grad Sch Engn, Hiroshima 7398527, Japan; [Ohno, N.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Tonegawa, A.] Tokai Univ, Grad Sch Sci, Yokohama, Kanagawa 2591292, Japan; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Osaka 5650871, Japan	Nakashima, Y (reprint author), 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	nakashma@prc.tsukuba.ac.jp			bi-directional Collaboration Research Programs [NIFS12KUGM037, NIFS14KUGM086]; Ministry of Education, Science, Sports and Culture of Japan [24360378]	The authors would like to acknowledge the members of the GAMMA 10 group, University of Tsukuba for their collaboration in the experiments. This work was performed with the support by the bi-directional Collaboration Research Programs (NIFS12KUGM037 and NIFS14KUGM086) and grant-in-aid for Scientific Research from Ministry of Education, Science, Sports and Culture of Japan (24360378).	TAMANO T, 1995, PHYS PLASMAS, V2, P2321, DOI 10.1063/1.871256; INUTAKE M, 1985, PHYS REV LETT, V55, P939, DOI 10.1103/PhysRevLett.55.939; Ichimura K., 2012, PLASMA FUSION RES, V7; Nakashima Y, 2013, J NUCL MATER, V438, pS738, DOI 10.1016/j.jnucmat.2013.01.157; Nakashima Y, 2010, FUSION ENG DES, V85, P956, DOI 10.1016/j.fusengdes.2010.09.015; Nakashima Y, 2013, FUSION SCI TECHNOL, V63, P100; Nakashima Y, 2011, J NUCL MATER, V415, pS996, DOI 10.1016/j.jnucmat.2010.11.081; Ohno N., 2001, CONTRIB PLASM PHYS, V41, P407; Pigarov AY, 1996, PHYS LETT A, V222, P251, DOI 10.1016/0375-9601(96)00629-9	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						537	540		10.1016/j.jnucmat.2014.12.063		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200111		
J	Pandya, SN; Peterson, BJ; Kobayashi, M; Mukai, K; Sano, R; Tanaka, H; Masuzaki, S; Miyazawa, J; Akiyama, T; Motojima, G; Ohno, N				Pandya, Shwetang N.; Peterson, Byron J.; Kobayashi, Masahiro; Mukai, Kiyofumi; Sano, Ryuichi; Tanaka, Hirohiko; Masuzaki, Suguru; Miyazawa, Junichi; Akiyama, Tsuyoshi; Motojima, Gen; Ohno, Noriyasu			Evolution of radiation profiles during detached plasmas and radiative collapse in LHD	JOURNAL OF NUCLEAR MATERIALS			English	Article							PARTICLE CONTROL	The divertor heat loads can be efficiently controlled by plasma detachment, hence it is foreseen as a suitable operational regime for divertor operation of future machines. Detachment regime is normally approached by raising the plasma density to a point where plasma detaches from the divertor. If such an approach is adapted to detach the Large Helical Device (LHD) plasma, the plasma goes to radiative collapse due to thermal instabilities. Another approach to detach LHD plasma is by intrinsic impurity seeding using Ne. The discharges detach but ultimately collapse at comparatively lower densities. The detachment is achieved and sustained at high densities by the induction of an m/n = 1/1 resonant magnetic perturbation (RMP) in the stochastic edge of the LHD plasma. First quantitative measurements of the two-dimensional (2D) impurity radiation profiles from the three-dimensional (3D) plasma edge of LHD showing the time evolution of radiative collapse and RMP assisted detachment measured by recently upgraded and calibrated Infrared imaging Video Bolometer (IRVB) are presented in this article. (C) 2014 Elsevier B.V. All rights reserved.	[Pandya, Shwetang N.; Sano, Ryuichi] Grad Univ Adv Studies, Toki, Gifu 5095292, Japan; [Peterson, Byron J.; Kobayashi, Masahiro; Mukai, Kiyofumi; Tanaka, Hirohiko; Masuzaki, Suguru; Miyazawa, Junichi; Akiyama, Tsuyoshi; Motojima, Gen] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ohno, Noriyasu] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Pandya, SN (reprint author), Grad Univ Adv Studies, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	pandya.shwetang@LHD.nifs.ac.jp			NIFS [NIFS13ULHH026, NIFS13GGHH001]	This research was supported by NIFS Grants NIFS13ULHH026 and NIFS13GGHH001. The authors are also grateful to the LHD experiment and technical team for their excellent support during the 17th LHD experimental campaign.	SUDO S, 1990, NUCL FUSION, V30, P11, DOI 10.1088/0029-5515/30/1/002; Feng Y, 2004, CONTRIB PLASM PHYS, V44, P57, DOI 10.1002/ctpp.20041009; Kobayashi M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093032; Drapiko EA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073005; Chowdhuri MB, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103784; Reiter D, 2005, FUSION SCI TECHNOL, V47, P172; Greenwald M, 2002, PLASMA PHYS CONTR F, V44, pR27, DOI 10.1088/0741-3335/44/8/201; Stambaugh R, 1999, NUCL FUSION, V39, P2391, DOI 10.1088/0029-5515/39/12/304; Masuzaki S, 2013, J NUCL MATER, V438, pS133, DOI 10.1016/j.jnucmat.2013.01.021; Miyazawa J., 2014, 21 PSI C KAN; Pandya SN, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4891317; Pandya SN, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4873713; Peterson BJ, 2011, J NUCL MATER, V415, pS1147, DOI 10.1016/j.jnucmat.2011.01.047; Peterson B. J., 2006, PLASMA FUSION RES, V1, P045, DOI 10.1585/pfr.1.045; Peterson BJ, 2000, REV SCI INSTRUM, V71, P3696, DOI 10.1063/1.1290044; Sano R., 2012, PLASMA FUSION RES, V7	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						551	554		10.1016/j.jnucmat.2014.09.047		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200114		
J	Nakano, T				Nakano, T.		JT-60 Team	Comparison of Ne and Ar seeded radiative divertor plasmas in JT-60U	JOURNAL OF NUCLEAR MATERIALS			English	Article							HIGH-PERFORMANCE; HIGH-DENSITY; IONS; BEHAVIOR	In H-mode plasmas with Ne, Ar and a mixture of Ne and Ar injection, the divertor radiation power fractions amongst these impurities in addition to an intrinsic impurity, C, are investigated. In plasmas with the inner divertor plasma attached, carbon is the biggest radiator, whichever impurity, Ne, Ar or a mixture of Ar and Ne is injected. In contrast, in plasmas with the inner divertor plasma detached, Ne is the biggest radiator due to a significantly high recombination radiation from Ne VIII. Ar is always a minor contributor in plasmas with the inner divertor both attached and detached. (C) 2014 Elsevier B.V. All rights reserved.	[Nakano, T.; JT-60 Team] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan	Nakano, T (reprint author), Mukoyama 801-1, Naka, Ibaraki 3110193, Japan.	nakano.tomohide@jaea.go.jp			JPSP [24760707]	This work was partly supported by JPSP, Grant-in-Aid for Scientific Research for Young Scientist (24760707).	Gu MF, 2003, ASTROPHYS J, V582, P1241, DOI 10.1086/344745; Nakano T, 2013, J NUCL MATER, V438, pS291, DOI 10.1016/j.jnucmat.2013.01.049; Asakura N, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115010; Giroud C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113025; Kallenbach A, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/5/055002; Kallenbach A, 2011, J NUCL MATER, V415, pS19, DOI 10.1016/j.jnucmat.2010.11.105; Reinke ML, 2011, J NUCL MATER, V415, pS340, DOI 10.1016/j.jnucmat.2010.10.055; Fujimoto K., 2009, PLASMA FUSION RES, V4; Higashijima S, 2003, J NUCL MATER, V313, P1123, DOI 10.1016/S0022-3115(02)01502-7; Itami K, 1997, PHYS REV LETT, V78, P1267, DOI 10.1103/PhysRevLett.78.1267; KAWACHI T, 1995, PHYS REV E, V51, P1428, DOI 10.1103/PhysRevE.51.1428; Kubo H, 2005, J NUCL MATER, V337, P161, DOI 10.1016/j.jnucmat.2004.09.039; Kubo H, 2001, NUCL FUSION, V41, P227, DOI 10.1088/0029-5515/41/2/310; KUBO H, 1988, REV SCI INSTRUM, V59, P1515, DOI 10.1063/1.1140181; Nakano T, 2009, J NUCL MATER, V390-91, P255, DOI 10.1016/j.jnucmat.2009.01.085; Sakurai S, 2001, J NUCL MATER, V290, P1002, DOI 10.1016/S0022-3115(00)00475-X; Takenaga H, 2005, NUCL FUSION, V45, P1618, DOI 10.1088/0029-5515/45/12/017; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						555	560		10.1016/j.jnucmat.2014.11.127		6	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200115		
J	Suzuki, C; Murakami, I; Akiyama, T; Masuzaki, S; Funaba, H; Yoshinuma, M				Suzuki, C.; Murakami, I.; Akiyama, T.; Masuzaki, S.; Funaba, H.; Yoshinuma, M.		LHD Expt Grp	Vacuum ultraviolet spectroscopy in detached plasmas with impurity gas seeding in LHD	JOURNAL OF NUCLEAR MATERIALS			English	Article							RADIATION; JT-60U	We have carried out vacuum ultraviolet (VUV) spectroscopy of impurity ions in detached plasmas with impurity gas seeding in the Large Helical Device (LHD). In neon (Ne) gas seeding experiments, temporal evolutions of VUV spectral lines from Ne IV-VIII were recorded by a grazing incidence spectrometer. In addition, spatial profiles of fully ionized Ne density were measured by charge exchange spectroscopy. An electron temperature range where each ion emits is inferred based on the comparisons of the measured line intensity ratios with the calculations using collisional-radiative models. (C) 2014 Elsevier B.V. All rights reserved.	[Suzuki, C.; Murakami, I.; Akiyama, T.; Masuzaki, S.; Funaba, H.; Yoshinuma, M.; LHD Expt Grp] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Suzuki, C (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	csuzuki@nifs.ac.jp			National Institute for Fusion Science [NIFS10ULHH007]	This work has been performed with the support and under the auspices of the budget NIFS10ULHH007 from the National Institute for Fusion Science.	Akiyama T, 2010, FUSION SCI TECHNOL, V58, P352; Nakano T, 2013, J NUCL MATER, V438, pS291, DOI 10.1016/j.jnucmat.2013.01.049; Yoshinuma M, 2010, FUSION SCI TECHNOL, V58, P375; SCHWOB JL, 1987, REV SCI INSTRUM, V58, P1601, DOI 10.1063/1.1139408; Asakura N, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115010; Giroud C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113025; Kallenbach A, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/5/055002; Narihara K, 2001, REV SCI INSTRUM, V72, P1122, DOI 10.1063/1.1319368; Reinke ML, 2011, J NUCL MATER, V415, pS340, DOI 10.1016/j.jnucmat.2010.10.055; Ishijima T, 1999, PLASMA PHYS CONTR F, V41, P1155, DOI 10.1088/0741-3335/41/9/307; Masuzaki S, 2013, J NUCL MATER, V438, pS133, DOI 10.1016/j.jnucmat.2013.01.021; Summers H., 2004, ADAS USER MANUAL VER	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						561	564		10.1016/j.jnucmat.2014.12.085		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200116		
J	Hoshino, K; Shimizu, K; Takizuka, T; Asakura, N; Nakano, T				Hoshino, K.; Shimizu, K.; Takizuka, T.; Asakura, N.; Nakano, T.			The influence of the radial particle transport on the divertor plasma detachment	JOURNAL OF NUCLEAR MATERIALS			English	Article							JT-60U; SOL	Divertor plasma detachment is the most promising candidate to reduce the divertor heat load in fusion reactors. Present understanding of detachment physics is not sufficient to adequately reproduce experimental observations. Understanding and control of detachment physics is indispensable to design the divertor in future machines. To improve the quality of divertor modeling and reveal limitations of the detachment physics built into state-of-the-art codes, an integrated divertor code SONIC has been applied to modeling of the JT-60U detached divertor plasma. In this study, the radial diffusion coefficient in the private region or the far SOL region is increased to investigate the influence of radial plasma transport on detachment characteristics. Saturation of the reduction in ion flux after roll-over is improved by the radial transport enhancement, while the radial profile at the mid-plane agreed with the experimental data. (C) 2014 Elsevier B.V. All rights reserved.	[Hoshino, K.; Asakura, N.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan; [Shimizu, K.; Nakano, T.] Japan Atom Energy Agcy, Mukoyama, Ibaraki 3110193, Japan; [Takizuka, T.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Hoshino, K (reprint author), 2-166 Oaza Obuchi Aza Omotedate, Rokkasho, Aomori 0393212, Japan.	hoshino.kazuo@jaea.go.jp	Hoshino, Kazuo/D-6931-2013	Hoshino, Kazuo/0000-0001-5672-9640	Japan Society for the Promotion of Science	SONIC simulations were carried out using the HELIOS super-computer system at International Fusion Energy Research Centre, Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and Japan Atomic Energy Agency. This work is partially supported by Grant-in-Aid for Young Scientists (B) and Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (B).	Asakura N, 1997, J NUCL MATER, V241, P559, DOI 10.1016/S0022-3115(96)00564-8; Hatae T, 1999, REV SCI INSTRUM, V70, P772, DOI 10.1063/1.1149392; Wischmeier M, 2009, J NUCL MATER, V390-91, P250, DOI 10.1016/j.jnucmat.2009.01.081; Asakura N, 1999, NUCL FUSION, V39, P1983, DOI 10.1088/0029-5515/39/11Y/344; Canik JM, 2011, J NUCL MATER, V415, pS409, DOI 10.1016/j.jnucmat.2010.11.084; Coster DP, 2011, J NUCL MATER, V415, pS545, DOI 10.1016/j.jnucmat.2010.12.223; Groth M, 2011, J NUCL MATER, V415, pS530, DOI 10.1016/j.jnucmat.2010.10.024; Hoshino K., 2010, J PLASMA FUSION RES, V9, P592; Hoshino K., 2014, PLASMA FUSION RES, V9; Hoshino K, 2011, J NUCL MATER, V415, pS549, DOI 10.1016/j.jnucmat.2011.01.003; Kawashima H., 2006, PLASMA FUSION RES, V1, DOI 10.1585/pfr.1.031; Kotov V, 2013, J NUCL MATER, V438, pS449, DOI 10.1016/j.jnucmat.2013.01.091; Shimizu K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065028; Wiesen S, 2011, J NUCL MATER, V415, pS535, DOI 10.1016/j.jnucmat.2010.12.010	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						573	576		10.1016/j.jnucmat.2014.11.133		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200119		
J	Yamoto, S; Homma, Y; Hoshino, K; Sawada, Y; Bonnin, X; Coster, D; Schneider, R; Hatayama, A				Yamoto, S.; Homma, Y.; Hoshino, K.; Sawada, Y.; Bonnin, X.; Coster, D.; Schneider, R.; Hatayama, A.			Effects of background plasma characteristics on tungsten impurity transport in the SOL/divertor region using IMPGYRO code	JOURNAL OF NUCLEAR MATERIALS			English	Article							BINARY COLLISION MODEL; THERMAL FORCE; SIMULATION	The difference of tungsten impurity transport characteristics between a high recycling regime and a partially detached regime has been studied with the IMPGYRO code. Background plasma profiles from a JT-60U model geometry, computed from SOLPS, have been used. To obtain such characteristic regimes, we have changed electron (Q(e)) and ion (Q(i)) input powers at the core boundary. In the high-recycling regime, the tungsten impurities are transported toward the upstream of the SOL. On the other hand, in the partially detached regime, most tungsten impurities are localized near the inner and outer divertors. These features are mainly related to the background plasma temperature and ion flow. (C) 2014 Elsevier B.V. All rights reserved.	[Yamoto, S.; Homma, Y.; Sawada, Y.; Hatayama, A.] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Hoshino, K.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan; [Bonnin, X.] Univ Paris 13, CNRS, LSPM, Sorbonne Paris Cite, F-93430 Villetaneuse, France; [Coster, D.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Schneider, R.] Ernst Moritz Arndt Univ Greifswald, D-17487 Greifswald, Germany	Yamoto, S (reprint author), Keio Univ, 3-14-1 Hiyoshi Kouhoku, Yokohama, Kanagawa 2238522, Japan.	yamoto@ppl.appi.keio.ac.jp	Hoshino, Kazuo/D-6931-2013	Hoshino, Kazuo/0000-0001-5672-9640			TAKIZUKA T, 1977, J COMPUT PHYS, V25, P205, DOI 10.1016/0021-9991(77)90099-7; Schneider R, 2006, CONTRIB PLASM PHYS, V46, P3, DOI 10.1002/ctpp.200610001; Bonnin X, 2011, J NUCL MATER, V415, pS488, DOI 10.1016/j.jnucmat.2010.10.041; Braginskii S.I., 1965, REV PLASMA PHYS, V1; Coster D., 2014, 21 INT C PLASM SURF; Coster D., 2013, P 40 BPS C PLASM PHY; Fukano A, 2007, J NUCL MATER, V363, P211, DOI 10.1016/j.jnucmat.2007.01.037; Hatayama A, 2000, NUCL FUSION, V40, P2009, DOI 10.1088/0029-5515/40/12/305; Homma Y, 2012, J COMPUT PHYS, V231, P3211, DOI 10.1016/j.jcp.2011.12.037; Homma Y, 2013, J COMPUT PHYS, V250, P206, DOI 10.1016/j.jcp.2013.04.039; Sawada Y., 2012, T FUSION SCI TECHNOL, V63, P352; Schmid K, 2007, J NUCL MATER, V363, P674, DOI 10.1016/j.jnucmat.2007.01.045; Shimizu K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065028; Toma M, 2013, J NUCL MATER, V438, pS620, DOI 10.1016/j.jnucmat.2013.01.130; Trubnikov B. A., 1965, REV PLASMA PHYS, V1; Ueda Y, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065027; Yamoto S, 2014, CONTRIB PLASM PHYS, V54, P421, DOI 10.1002/ctpp.201410031	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						615	619		10.1016/j.jnucmat.2014.10.013		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200128		
J	Morisaki, T; Oyama, K; Tamura, N; Masuzaki, S; Akiyama, T; Motojima, G; Miyazawa, J; Peterson, BJ; Ohno, N; Yamada, H				Morisaki, T.; Oyama, K.; Tamura, N.; Masuzaki, S.; Akiyama, T.; Motojima, G.; Miyazawa, J.; Peterson, B. J.; Ohno, N.; Yamada, H.		LHD Expt Grp	Radiated power distributions in impurity-seeded plasmas in LHD	JOURNAL OF NUCLEAR MATERIALS			English	Article							LARGE HELICAL DEVICE	In LHD, impurity seeding has been performed to enhance the radiative cooling in the edge region. Neon, nitrogen and argon were seeded by gas puffing, and the behaviour of those impurities in the plasma was investigated with the innovative diagnostic method. Two bolometer arrays were used to measure the two-dimensional radiated power distribution. Using the tomographic technique, radiated power distributions on a poloidal plane can be obtained with the high time resolution. During the discharge with neon puff, considerable radiation from the core region was observed, in addition to the strong edge radiation. In spite of the highly radiated power, plasma did not result in the radiation collapse. On the other hand, in the nitrogen-seeded discharge, the strong radiation only from the peripheral region was observed. Different time evolutions of the total radiated power between neon and nitrogen seeded discharges were observed after stopping each impurity puff. (C) 2015 Elsevier B.V. All rights reserved.	[Morisaki, T.; Tamura, N.; Masuzaki, S.; Akiyama, T.; Motojima, G.; Miyazawa, J.; Peterson, B. J.; Yamada, H.; LHD Expt Grp] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Morisaki, T.; Oyama, K.; Ohno, N.] Nagoya Univ, Nagoya, Aichi 4648602, Japan	Morisaki, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	morisaki@nifs.ac.jp			JSPS of the Japanese government;  [NIFS13ULPP019]	The authors would like to thank all members of the device engineering group for their support and operation of the machine. This work is funded by NIFS13ULPP019 and partially supported by the Grant-Aid for Scientific Research from JSPS of the Japanese government.	Kallenbach A, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124041; Giroud C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113025; Asakura N., 2011, NUCL MAT, V415, pS318; Gray DS, 2004, REV SCI INSTRUM, V75, P376, DOI 10.1063/1.1642745; Iwama N., 2009, J PLASMA FUSION RES, V8, P691; Liu Y., 2006, REV SCI INSTRUM, V79; Masuzaki S., 2013, NUCL MAT, V438, pS133; Morisaki T, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2718530; Motojima O, 1999, PHYS PLASMAS, V6, P1843, DOI 10.1063/1.873443; Nakano T., 2013, NUCL MAT, V438, pS291; Peterson BJ, 2003, PLASMA PHYS CONTR F, V45, P1167, DOI 10.1088/0741-3335/45/7/309; Suzuki C, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/014016	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						640	643		10.1016/j.jnucmat.2015.01.016		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200133		
J	Morita, S; Kobayashi, M; Oishi, T; Zhang, HM; Goto, M; Cui, ZY; Dong, CF; Hu, LQ; Huang, XL; Kawamura, G; Masuzaki, S; Murakami, I; Wang, EH				Morita, S.; Kobayashi, M.; Oishi, T.; Zhang, H. M.; Goto, M.; Cui, Z. Y.; Dong, C. F.; Hu, L. Q.; Huang, X. L.; Kawamura, G.; Masuzaki, S.; Murakami, I.; Wang, E. H.			Effect of neutral hydrogen on edge impurity behavior in stochastic magnetic field layer of Large Helical Device	JOURNAL OF NUCLEAR MATERIALS			English	Article							DIVERTOR PHYSICS; LHD	Two-dimensional (2-D) distribution of impurity line emissions has been measured with 2-D extreme ultraviolet (EUV) spectroscopy in Large Helical Device (LHD) for studying the edge impurity transport in stochastic magnetic field layer with three-dimensional (3-D) structure. The impurity behavior in the vicinity of two X-points at inboard and outboard sides of the toroidal plasma can be separately examined with the 2-D measurement. As a result, it is found that the carbon location changes from inboard to outboard X-points when the plasma axis is shifted from R-ax = 3.6 m to 3.75 m. A 3-D simulation with EMC3-EIRENE code agrees with the result at R-ax = 3.75 m but disagreed with the result at R-ax = 3.60 m. The discrepancy between the measurement and simulation at Rax = 3.60 m is considerably reduced when an effect of neutral hydrogen localized in the inboard side is taken into account, which can modify the density gradient and friction force along the magnetic field. (C) 2014 Elsevier B.V. All rights reserved.	[Morita, S.; Kobayashi, M.; Oishi, T.; Goto, M.; Kawamura, G.; Masuzaki, S.; Murakami, I.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Morita, S.; Kobayashi, M.; Oishi, T.; Zhang, H. M.; Goto, M.; Huang, X. L.; Murakami, I.] Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan; [Cui, Z. Y.; Dong, C. F.] Southwestern Inst Phys, Chengdu 610041, Sichuan, Peoples R China; [Hu, L. Q.; Wang, E. H.] Acad Sinica, Inst Plasma Phys, Hefei 230031, Anhui, Peoples R China	Morita, S (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	morita@nifs.ac.jp			LHD project [NIF-S13ULPP010]; JSPS-NRF-NSFC A3 Foresight Program (NSFC) [11261140328]; JSPS-NRF-NSFC A3 Foresight Program (NRF) [2012K2A6000443]	The authors thank all the members of the LHD team for their cooperation through the LHD experiment. This work was partially carried out under the LHD project financial support (NIF-S13ULPP010) and partly supported by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No.11261140328, NRF: No. 2012K2A6000443).	Kobayashi M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3368681; Morita S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093017; Kobayashi M, 2010, FUSION SCI TECHNOL, V58, P220; Feng Y, 2004, CONTRIB PLASM PHYS, V44, P57, DOI 10.1002/ctpp.20041009; Kobayashi M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/3/033011; Morita S, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/9/094007; Zhou HY, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.106103; Giroud C, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/063022; Chowdhuri MB, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103784; Reiter D, 2005, FUSION SCI TECHNOL, V47, P172; Dong CF, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3658050; Feng Y, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024012; Kawamura G, 2014, CONTRIB PLASM PHYS, V54, P437, DOI 10.1002/ctpp.201410027; Morita S, 2014, IEEE T PLASMA SCI, V42, P2542, DOI 10.1109/TPS.2014.2342231; Wang EH, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4705290	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						644	648		10.1016/j.jnucmat.2014.12.055		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200134		
J	Iida, K; Notani, M; Uesugi, Y; Tanaka, Y; Ishijima, T				Iida, K.; Notani, M.; Uesugi, Y.; Tanaka, Y.; Ishijima, T.			Suppression of hydrogenated carbon film deposition and hydrogen isotope retention by nitrogen addition into cold remote H/D and CH4 mixture plasmas	JOURNAL OF NUCLEAR MATERIALS			English	Article							CNX THIN-FILMS; GROWTH	Control of tritium retention and its removal from the first wall of future fusion devices are one of the most crucial issues for safety and effective use for fuel. Nitrogen addition into remote edge plasmas has been considered and tested as an effective method for suppression of carbon film deposition and reduction of hydrogen isotope absorption in the deposited films. In this paper we have investigated the scavenger effects of nitrogen injected into low temperature D-2/CH4 plasmas on hydrogenated carbon film growth using a small helical device. The result of the deposition shows that the key reactive particles with CN and ND(H) bonds to suppression of hydrogenated carbon film growth and hydrogen isotope absorption are much slowly generated compared with hydrocarbon particles such as CD(H)(x) and C2D(H)(x). This may be due to the slow atomic nitrogen diffusion into hydrogenated carbon layer and the chemical equilibrium between nitrogen absorption. (C) 2015 Published by Elsevier B.V.	[Iida, K.; Notani, M.; Uesugi, Y.; Tanaka, Y.; Ishijima, T.] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Uesugi, Y.; Tanaka, Y.; Ishijima, T.] Kanazawa Univ, Res Ctr Sustainable Energy & Technol, Kanazawa, Ishikawa 9201192, Japan	Iida, K (reprint author), Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan.	me131004@ec.t.kanazawa-u.ac.jp; uesugi@ec.t.kanazawa-u.ac.jp	Tanaka, Yasunori/E-6609-2015	Tanaka, Yasunori/0000-0002-0796-2507	 [25289336]	This work was supported by Grants-in-Aid for Scientific Research Number 25289336.	Tabares FL, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/3/033001; Roth J, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/10/103001; Bohmeyer W, 2009, J NUCL MATER, V390-91, P560, DOI 10.1016/j.jnucmat.2009.01.098; Federici G, 2001, J NUCL MATER, V290, P260, DOI 10.1016/S0022-3115(00)00627-9; Hammer P, 2000, DIAM RELAT MATER, V9, P577, DOI 10.1016/S0925-9635(99)00300-3; Hellgren N, 2001, THIN SOLID FILMS, V382, P146, DOI 10.1016/S0040-6090(00)01690-4; Lazar G, 2008, J APPL PHYS, V104, DOI 10.1063/1.2951622; Matthews GF, 2013, J NUCL MATER, V438, pS2, DOI 10.1016/j.jnucmat.2013.01.282; Sasaki A., 2013, J NUCL MATER, P1092; Tabares FL, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.175006; Vlcek J, 1999, J APPL PHYS, V86, P3646, DOI 10.1063/1.371273; Voevodin AA, 2002, J APPL PHYS, V92, P4980, DOI 10.1063/1.1509106	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						693	696		10.1016/j.jnucmat.2015.01.017		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200145		
J	Tanaka, H; Masuzaki, S; Ohno, N; Morisaki, T; Tsuji, Y				Tanaka, H.; Masuzaki, S.; Ohno, N.; Morisaki, T.; Tsuji, Y.		LHD Expt Grp	Multi-pin Langmuir probe measurement for identification of blob propagation characteristics in the Large Helical Device	JOURNAL OF NUCLEAR MATERIALS			English	Article							PLASMA; TRANSPORT; LHD; DIVERTOR; TOKAMAK	In order to investigate the blobby plasma transport in the Large Helical Device, we have measured electrostatic fluctuations around the divertor leg by using a newly-designed multi-pin reciprocating Langmuir probe. Near the low-field side edge of the divertor leg, positive spikes of ion saturation current fluctuation were observed. In addition, the electric field which correlates with the ion saturation current fluctuation was firstly evaluated with the neighboring floating potential measurement. Considering the positional relationship with the magnetic geometry, the identified direction of the electric field inside the blobs is consistent with the theoretically predicted E x B motion. By applying the conditional averaging method, a quantitative speed of the blobs was preliminary estimated. (C) 2014 Elsevier B.V. All rights reserved.	[Tanaka, H.; Masuzaki, S.; Morisaki, T.; LHD Expt Grp] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ohno, N.; Tsuji, Y.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4548603, Japan	Tanaka, H (reprint author), Natl Inst Fus Sci, Toki, Gifu 5095292, Japan.	tanaka.hirohiko@lhd.nifs.ac.jp			KAKENHI [23860064, 25820440]; NIFS budget [NIFS12ULPP029, NIFS13KLPP028]; NIFS/NINS under the project of Formation of International Network for Scientific Collaborations	This work was supported by KAKENHI (23860064 and 25820440). This research was also performed under the auspices of NIFS budget (NIFS12ULPP029 and NIFS13KLPP028) and NIFS/NINS under the project of Formation of International Network for Scientific Collaborations.	D'Ippolito DA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3594609; Krasheninnikov SI, 2001, PHYS LETT A, V283, P368, DOI 10.1016/S0375-9601(01)00252-3; OHYABU N, 1994, NUCL FUSION, V34, P387, DOI 10.1088/0029-5515/34/3/I07; Boedo JA, 2001, PHYS PLASMAS, V8, P4826, DOI 10.1063/1.1406940; Ezumi N, 2003, J NUCL MATER, V313, P696, DOI 10.1016/S0022-3115(02)01364-8; Kirnev GS, 2005, NUCL FUSION, V45, P459, DOI [10.1088/0029-5515/45/6/007, 10.1088/0029-5515/.45/6/007]; Nakamura Y., 1993, J PLASMA FUSION RES, V69, P41; Ohno N, 2006, CONTRIB PLASM PHYS, V46, P692, DOI 10.1002/ctpp.200610065; Pigarov AY, 2008, CONTRIB PLASM PHYS, V48, P82, DOI 10.1002/ctpp.200810014; Tanaka H, 2013, J NUCL MATER, V438, pS563, DOI 10.1016/j.jnucmat.2013.01.117; Tanaka H., 2012, PLASMA FUSION RES, V7; Tanaka H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065017; Tsuchiya H., 2010, PLASMA FUSION RES, V5, pS2078	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						761	764		10.1016/j.jnucmat.2014.10.059		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200161		
J	Shoji, M; Masuzaki, S; Tanaka, Y; Pigarov, AY; Smirnov, RD; Kawamura, G; Uesugi, Y; Yamada, H				Shoji, M.; Masuzaki, S.; Tanaka, Y.; Pigarov, A. Yu.; Smirnov, R. D.; Kawamura, G.; Uesugi, Y.; Yamada, H.		LHD Expt Grp	Analysis of the three-dimensional trajectories of dusts observed with a stereoscopic fast framing camera in the Large Helical Device	JOURNAL OF NUCLEAR MATERIALS			English	Article							TRANSPORT; PARTICLES; DYNAMICS; LHD	The three-dimensional trajectories of dusts have been observed with two stereoscopic fast framing cameras installed in upper and outer viewports in the Large Helical Device (LHD). It shows that the dust trajectories locate in divertor legs and an ergodic layer around the main plasma confinement region. While it is found that most of the dusts approximately move along the magnetic field lines with acceleration, there are some dusts which have sharply curved trajectories crossing over the magnetic field lines. A dust transport simulation code was modified to investigate the dust trajectories in fully three dimensional geometries such as LHD plasmas. It can explain the general trend of most of observed dust trajectories by the effect of the plasma flow in the peripheral plasma. However, the behavior of the some dusts with sharply curved trajectories is not consistent with the simulations. (C) 2014 Elsevier B.V. All rights reserved.	[Shoji, M.; Masuzaki, S.; Kawamura, G.; Uesugi, Y.; Yamada, H.; LHD Expt Grp] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Tanaka, Y.] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Pigarov, A. Yu.; Smirnov, R. D.] Univ Calif San Diego, La Jolla, CA 92093 USA	Shoji, M (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	shoji@LHD.nifs.ac.jp	Smirnov, Roman/B-9916-2011; Uesugi, Yoshihiko/C-3311-2015	Smirnov, Roman/0000-0002-9114-5330; Uesugi, Yoshihiko/0000-0001-6039-6842	NIFS [NIFS12KNVN236]; NIFS/NINS under the project of Formation of International Scientific Base and Network; NIFS Collaboration Research program [NIFS13KLPP026];  [NIFSULPP015]	The authors would like to thank all the members of the LHD, and they are grateful for the support for the computational resources of the LHD numerical analysis server, which is supported by the NIFS budget code NIFS12KNVN236. This work is financially supported by NIFSULPP015 and by NIFS/NINS under the project of Formation of International Scientific Base and Network. It is performed with the support and under the auspices of the NIFS Collaboration Research program NIFS13KLPP026.	Pigarov AY, 2007, J NUCL MATER, V363, P216, DOI 10.1016/j.jnucmat.2007.01.053; Feng Y, 2002, PLASMA PHYS CONTR F, V44, P611, DOI 10.1088/0741-3335/44/5/308; Pigarov AY, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2145157; Krasheninnikov SI, 2004, PHYS PLASMAS, V11, P3141, DOI 10.1063/1.1724834; Smirnov RD, 2007, PLASMA PHYS CONTR F, V49, P347, DOI 10.1088/0741-3335/49/4/001; Reiter D, 2005, FUSION SCI TECHNOL, V47, P172; Kawamura G, 2014, CONTRIB PLASM PHYS, V54, P437, DOI 10.1002/ctpp.201410027; Koga K., 2012, P 24 IAEA FUS EN C S; Komori A, 2010, FUSION SCI TECHNOL, V58, P1; Krasheninnikov SI, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/8/083001; Ratynskaia S, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/7/074009; Tanaka Y, 2011, J NUCL MATER, V415, pS1106, DOI 10.1016/j.jnucmat.2010.12.237; Tokitani M, 2013, J NUCL MATER, V438, pS818, DOI 10.1016/j.jnucmat.2013.01.177	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						861	864		10.1016/j.jnucmat.2014.10.060		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200183		
J	Tateishi, M; Koga, K; Katayama, R; Yamashita, D; Kamataki, K; Seo, H; Itagaki, N; Shiratani, M; Ashikawa, N; Masuzaki, S; Nishimura, K; Sagara, A				Tateishi, Mizuki; Koga, Kazunori; Katayama, Ryu; Yamashita, Daisuke; Kamataki, Kunihiro; Seo, Hyunwoong; Itagaki, Naho; Shiratani, Masaharu; Ashikawa, Naoko; Masuzaki, Suguru; Nishimura, Kiyohiko; Sagara, Akio		LHD Expt Grp	Real-time mass measurement of dust particles deposited on vessel wall in a divertor simulator using quartz crystal microbalances	JOURNAL OF NUCLEAR MATERIALS			English	Article							PLASMA; RADICALS; FILMS; FLUX; ITER	We are developing a dust monitoring method using quartz crystal microbalances (QCMs) equipped with a dust eliminating filter. Here we report a dust eliminating ratio of the filter and first measurement results of the QCMs in a divertor simulator. The volume of spherical dust in unit area on the filter and QCM under the filter were 2.09 x 10(-9) and 1.22 x 10(-19) m(3) m(-2), respectively. Thus, the dust eliminating ratio of the filter is 94.2%. The QCM without the filter gives deposition rate due to radicals and dust particles, whereas the QCM with the filter gives deposition rate predominantly due to radicals. From the results, we deduce information of mass fraction of dust particles in deposits. (C) 2014 Elsevier B.V. All rights reserved.	[Tateishi, Mizuki; Koga, Kazunori; Katayama, Ryu; Yamashita, Daisuke; Seo, Hyunwoong; Itagaki, Naho; Shiratani, Masaharu] Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, Fukuoka 8190395, Japan; [Kamataki, Kunihiro] Kyushu Univ, Fac Arts & Sci, Nishi Ku, Fukuoka 8190395, Japan; [Itagaki, Naho] PRESTO JST, Chiyoda Ku, Tokyo 1020075, Japan; [Ashikawa, Naoko; Masuzaki, Suguru; Nishimura, Kiyohiko; Sagara, Akio; LHD Expt Grp] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Koga, K (reprint author), Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	koga@ed.kyushu-u.ac.jp			National Institute for Fusion Science [NIFS12KLPF020, NIFS14KLPF033]; JSPS KAKENHI [26600126]	This research was supported by General Coordinated Research Grant from the National Institute for Fusion Science Grant Nos. NIFS12KLPF020 and NIFS14KLPF033, and JSPS KAKENHI Grant No. 26600126.	Girard JP, 2007, FUSION ENG DES, V82, P506, DOI 10.1016/j.fusengdes.2007.03.017; Roth J, 2009, J NUCL MATER, V390-91, P1, DOI 10.1016/j.jnucmat.2009.01.037; Winter J, 2000, PHYS PLASMAS, V7, P3862, DOI 10.1063/1.1288911; Hopf C, 2000, J APPL PHYS, V87, P2719, DOI 10.1063/1.372246; Bourgoin D, 1997, J NUCL MATER, V241, P765, DOI 10.1016/S0022-3115(97)80137-7; Denkevits A, 2010, FUSION ENG DES, V85, P1059, DOI 10.1016/j.fusengdes.2010.01.009; Federici G, 2000, J NUCL MATER, V283, P110, DOI 10.1016/S0022-3115(00)00158-6; Iwashita S, 2013, FUSION ENG DES, V88, P28, DOI 10.1016/j.fusengdes.2012.10.002; Iwashita S., 2009, J PLASMA FUSION RES, V8, P308; Kim Y., 2012, MRS P, V1426, P307; Kim YH, 2013, DISCRETE DYN NAT SOC, V2013, P1; Koga K, 2004, IEEE T PLASMA SCI, V32, P405, DOI 10.1109/TPS.2004.828129; Koga K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NA08; Koga K, 2013, J NUCL MATER, V438, pS727, DOI 10.1016/j.jnucmat.2013.01.154; Koga K., 2009, PLASMA FUSION RES, V4, P34; Koga K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2126572; Krasheninnikov SI, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/8/083001; Kreter A, 2009, J NUCL MATER, V390-91, P38, DOI 10.1016/j.jnucmat.2009.01.041; Nishiyama K, 2013, J NUCL MATER, V438, pS788, DOI 10.1016/j.jnucmat.2013.01.169; von Keudell A, 2000, APPL PHYS LETT, V76, P676, DOI 10.1063/1.125858	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						865	868		10.1016/j.jnucmat.2014.10.049		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200184		
J	Tomita, Y; Huang, ZH; Pan, YD; Kawamura, G; Yan, LW				Tomita, Y.; Huang, Z. H.; Pan, Y. D.; Kawamura, G.; Yan, L. W.			Secondary electron emission from a charged spherical dust particle due to electron incidence according to OML model	JOURNAL OF NUCLEAR MATERIALS			English	Article							DYNAMICS	Effect of secondary electron emission (SEE) current to dust charging and influence to forces on a dust particle are studied according to the orbital motion limited (OML) model. As higher electron temperature increases the SEE current, the negative dust charge decreases. As a result, the ion friction force on the dust particle decreases. The critical electron temperatures without the dust charge are 75.1, 70.3 and 55.9 eV for graphite and are 31.3, 30.4 and 27.1 eV for tungsten to the temperature ratio T-i/T-e= 0.1, 1.0 and 10.0, respectively. At the critical electron temperature, there is no ion scattering force but the ion absorption force remains finite. (C) 2014 Elsevier B.V. All rights reserved.	[Tomita, Y.; Huang, Z. H.; Pan, Y. D.; Yan, L. W.] Southwestern Inst Phys, Chengdu 610041, Sichuan, Peoples R China; [Kawamura, G.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Tomita, Y (reprint author), 1-228 Ohata Cho, Tajimi, Gifu 5070818, Japan.	tomita@swip.ac.cn			National Magnetic Confinement Fusion Science Program of China [2014GB107000, 2013GB112008]; National Science Foundation of China [11320101005, 11175060, 11375054, 11075046]; China-Korean joint foundation [2012DFG02230]	This work is partially supported by the National Magnetic Confinement Fusion Science Program of China under Grant Nos. 2014GB107000 and 2013GB112008; the National Science Foundation of China under Grant Nos. 11320101005, 11175060, 11375054 and 11075046; the China-Korean joint foundation under the Grant No. 2012DFG02230.	ALLEN JE, 1992, PHYS SCRIPTA, V45, P497, DOI 10.1088/0031-8949/45/5/013; Pigarov AY, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2145157; Krasheninnikov SI, 2004, PHYS PLASMAS, V11, P3141, DOI 10.1063/1.1724834; Smirnov RD, 2007, PLASMA PHYS CONTR F, V49, P347, DOI 10.1088/0741-3335/49/4/001; PEDGLEY JM, 1993, PLASMA PHYS CONTR F, V35, P397, DOI 10.1088/0741-3335/35/3/009; Sagara A, 2003, J NUCL MATER, V313, P1, DOI 10.1016/S0022-3115(02)01326-0; Thomas E.W., DATA COMPENDIUM PLAS, P94; Tomita Y., 2013, PLASMA FUSION RES, V8; Tomita Y., 2009, J PLASMA FUSION RES, V8, P273; Winter J, 2004, PLASMA PHYS CONTR F, V46, pB583, DOI 10.1088/0741-3335/46/12B/047	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						881	884		10.1016/j.jnucmat.2014.12.009		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200188		
J	Kado, S				Kado, S.			Thermal equilibrium/disequilibrium features in the excited-state temperature of atomic helium in MAP-II divertor simulator	JOURNAL OF NUCLEAR MATERIALS			English	Article							COLLISIONAL-RADIATIVE MODEL	Doppler-Stark spectrometry and laser Thomson scattering diagnostics for helium plasmas were applied to the MAP-II (material and plasma) steady-state linear divertor simulator at the University of Tokyo. In recombining plasmas, as the volumetric recombination proceeded, atomic, ionic and electron temperatures converged to the same values, which indicated the achievement of thermal equilibrium. On the other hand, in ionizing plasmas, in addition to the collisional heating of bulk atoms, excess heating of atoms in the high principal quantum number states (above Griem's boundary) was observed. This disequilibrium feature can be attributed to the presence of two prevailing conditions: that the characteristic time of the charge-exchange process of the atoms with ions in the system became shorter than the lifetime of the excited atoms spent above Griem's boundary, and that the population influx from above Griem's boundary is considerably larger than that from below the boundary. (C) 2014 Elsevier B.V. All rights reserved.	Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6100011, Japan	Kado, S (reprint author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6100011, Japan.	kado@iae.kyoto-u.ac.jp			Ministry of Education, Science, Sports and Culture [21540507]	The experiments in this work were conducted as part of the master's thesis of K. Suzuki supervised by the author (Univ. Tokyo, 2008-2010). This work was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research(C), 21540507, 2009.	Tolstikhina IY, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.032707; Fujimoto T., 2004, PLASMA SPECTROSCOPY; Goto M, 2003, J QUANT SPECTROSC RA, V76, P331, DOI 10.1016/S0022-4073(02)00060-2; Iida Y., 2006, J PLASMA FUSION RES, V7, P123; Iida Y, 2013, J NUCL MATER, V438, pS1237, DOI 10.1016/j.jnucmat.2013.01.274; Janev R. K., 1987, ELEMENTARY PROCESSES; Kado S, 2011, J NUCL MATER, V415, pS1174, DOI 10.1016/j.jnucmat.2011.01.048; Kado S, 2004, CONTRIB PLASM PHYS, V44, P656, DOI 10.1002/ctpp.200410097; Kado S., 2005, J PLASMA FUSION RES, V81, P810, DOI 10.1585/jspf.81.810; Sakaue H.A., 2006, J PLASMA FUSION RES, V7, P195; Scotti F, 2009, J NUCL MATER, V390-91, P303, DOI 10.1016/j.jnucmat.2009.01.134; Scotti F., 2006, PLASMA FUSION RES, V1, P54, DOI 10.1585/pfr.1.054; Scotti F., 2007, PLASMA FUSION RES, V2, pS1110, DOI 10.1585/pfr.2.S1110	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						902	906		10.1016/j.jnucmat.2014.12.089		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200193		
J	Kajita, S; Veshchev, E; Lisgo, S; Barnsley, R; Morgan, P; Walsh, M; Ogawa, H; Sugie, T; Itami, K				Kajita, Shin; Veshchev, Evgeny; Lisgo, Steve; Barnsley, Robin; Morgan, Philip; Walsh, Michael; Ogawa, Hiroaki; Sugie, Tatsuo; Itami, Kiyoshi			Influence of stray light for divertor spectroscopy in ITER	JOURNAL OF NUCLEAR MATERIALS			English	Article							REFLECTIONS; TOKAMAK	The influence of stray light in the divertor spectroscopy system in ITER is quantitatively investigated using a ray tracing simulation. Simulation results show that the stray light is negligible at positions in the divertor where the plasma emission is strong. However, it is also shown that the stray light can be significantly greater than the real signal if the plasma intensity is low. Deuterium and beryllium emissions are used for the assessment; for beryllium cases in particular, since the emission profile may be non-uniform in the divertor region, the influence of stray light can be non-negligible at some positions, e.g., above the divertor dome. (C) 2014 Elsevier B.V. All rights reserved.	[Kajita, Shin] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan; [Veshchev, Evgeny; Lisgo, Steve; Barnsley, Robin; Morgan, Philip; Walsh, Michael] ITER Org, F-13115 St Paul Les Durance, France; [Ogawa, Hiroaki; Sugie, Tatsuo; Itami, Kiyoshi] Japan Atom Energy Agcy, Naka, Ibaraki 8011, Japan	Kajita, S (reprint author), Nagoya Univ, EcoTopia Sci Inst, Furo Cho, Nagoya, Aichi 4648603, Japan.	kajita.shin@nagoya-u.jp	Kajita, Shin/Q-1020-2015				Kukushkin AS, 2011, FUSION ENG DES, V86, P2865, DOI 10.1016/j.fusengdes.2011.06.009; Arakawa E., 1997, HDB OPT CONSTANTS SO, VII, P421; Banerjee S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075032; Guillemaut C, 2011, FUSION ENG DES, V86, P2954, DOI 10.1016/j.fusengdes.2011.07.008; Harhausen J, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/025002; Hollmann EM, 2003, REV SCI INSTRUM, V74, P3984, DOI 10.1063/1.1602941; Hollmann EM, 2004, CONTRIB PLASM PHYS, V44, P301, DOI 10.1002/ctpp.200410046; Iwamae A., 2011, 2011045 JAEA; Kajita S, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/8/085020; Kukushkin A., 2013, EFDAJETCP130405; Palik E. D., 1985, HDB OPTICAL CONSTANT; Reichle R, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014029; Schunke B, 2005, REV SCI INSTRUM, V76, DOI [10.1063/1.1988315, 10.1063/1.988315]; Sugie T, 1999, REV SCI INSTRUM, V70, P351, DOI 10.1063/1.1149340; Veshchev E., 2013, DIVERTOR IMPURITY MO; Zastrow K.-D., 2008, REV SCI INSTRUM, V79	16	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						936	939		10.1016/j.jnucmat.2014.11.057		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200201		
J	Ono, K; Miyamoto, M; Hasuike, S; Nakano, T; Kurata, H				Ono, K.; Miyamoto, M.; Hasuike, S.; Nakano, T.; Kurata, H.			Ellipsometric and electron spectroscopic study of degradation of optical properties in Mo mirror irradiated with deuterium and/or helium ions	JOURNAL OF NUCLEAR MATERIALS			English	Article							LOW-ENERGY; FUSION-REACTOR; REFLECTIVITY; MECHANISMS; CHOICE; ITER	Degradation of optical properties in Mo mirrors irradiated with helium and/or deuterium ions has been studied by ellipsometric spectroscopy, electron energy loss spectroscopy, and electron microscopy. It was found that values of the optical constants (reflectivity, refractive index, and extinction coefficient) of the specimens decreased in the order of deuterium, deuterium and helium dual-beam, and helium irradiations. The penetration depth of the laser light in the specimen, estimated from the observed extinction coefficient, increased in the same order. Electron energy loss spectroscopic study on an individual helium bubble formed in a specimen without surface roughness clearly revealed that the reflectivity decreased owing to a change in the di-electric constants caused by the formation of the bubble, and it was associated with a decrease in the optical constants. These results and the microstructure observation indicate that the degradation of reflectivity originating from the helium bubble is the primary issue affecting a diagnostic mirror irradiated with charge-exchange neutral particles. (C) 2014 Elsevier B.V. All rights reserved.	[Ono, K.; Miyamoto, M.; Hasuike, S.; Nakano, T.] Shimane Univ, Dept Mat Sci, Matsue, Shimane 6908504, Japan; [Kurata, H.] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Ono, K (reprint author), Shimane Univ, Dept Mat Sci, 1060 Nishi Kawatsu, Matsue, Shimane 6908504, Japan.	k-ono@riko.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20026007]; Collaborative Research Program of Institute for Chemical Research, Kyoto University [2011-65]	A part of this work was supported by Grants-in-Aid for Scientific Research of Ministry of Education, Culture, Sports, Science and Technology, Japan, (Grant No: 20026007), and Collaborative Research Program of Institute for Chemical Research, Kyoto University (Grant No: 2011-65).	Miyamoto M, 2011, J NUCL MATER, V415, pS657, DOI 10.1016/j.jnucmat.2011.01.008; Morishita K, 2003, J NUCL MATER, V323, P243, DOI 10.1016/j.jnucmat.2003.08.019; Ebihara A, 2007, J NUCL MATER, V363, P1195, DOI 10.1016/j.jnucmat.2007.01.153; De Temmerman G, 2007, J NUCL MATER, V363, P259, DOI 10.1016/j.jnucmat.2007.01.024; BENNETT HE, 1963, J OPT SOC AM, V53, P1389, DOI 10.1364/JOSA.53.001389; Belyaeva AI, 2011, J NUCL MATER, V413, P5, DOI 10.1016/j.jnucmat.2011.03.026; Bondarenko V.N., 2006, PROB ATOM SCI TECH P, V12, P80; Egerton RF, 2011, ELECT ENERGY LOSS SP; Fujiwara H, 2007, SPECTROSCOPIC ELLIPS; Haruta M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3610526; Kajita S, 2011, J NUCL MATER, V417, P838, DOI 10.1016/j.jnucmat.2010.12.205; Lintnovsky A., 2007, J NUCL MATER, V363-365, P1395; Miyamoto M., 2009, PLASMA PHYS OPERAT, V17, P128; Nakano T, 2011, J NUCL MATER, V417, P834, DOI 10.1016/j.jnucmat.2010.12.143; Ono K, 2011, J NUCL MATER, V415, pS1214, DOI 10.1016/j.jnucmat.2010.11.003; Ono K, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014065; Rubel M, 2009, J NUCL MATER, V390-91, P1066, DOI 10.1016/j.jnucmat.2009.01.257; Sugie T, 2004, J NUCL MATER, V329, P1481, DOI 10.1016/j.jnucmat.2004.04.248; Ueda Y, 2013, J NUCL MATER, V442, pS267, DOI 10.1016/j.jnucmat.2012.10.023; Urabe H, 2009, J NUCL MATER, V386-88, P1038, DOI 10.1016/j.jnucmat.2008.12.243; Voitsenya VS, 1998, J NUCL MATER, V258, P1919, DOI 10.1016/S0022-3115(98)00129-9; Voitsenya VS, 2001, J NUCL MATER, V290, P336, DOI 10.1016/S0022-3115(00)00634-6	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						952	955		10.1016/j.jnucmat.2014.12.003		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200205		
J	Hatano, Y; Widdowson, A; Bekris, N; Ayres, C; Baron-Wiechec, A; Likonen, J; Koivuranta, S; Ikonen, J; Yumizura, K				Hatano, Y.; Widdowson, A.; Bekris, N.; Ayres, C.; Baron-Wiechec, A.; Likonen, J.; Koivuranta, S.; Ikonen, J.; Yumizura, K.		JET-EFDA Contributors	2D tritium distribution on tungsten tiles used in JET ITER-like wall project	JOURNAL OF NUCLEAR MATERIALS			English	Article							RETENTION; DIVERTOR	Post-mortem measurements of 2-dimensional tritium (T) distribution using an imaging plate (IP) technique were performed for tungsten (W) divertor tiles (W-coated CFC) used in JET-ITER like wall (ILW) project. The observed T distributions were clearly inhomogeneous, and there were band-like regions with high T concentrations that extended in the toroidal direction on tiles 1, 3, 4 and 6. The concentrations of T in the band-like regions were higher by an order of magnitude than the concentrations in other parts. The inhomogeneous T distributions were explained by non-uniform co-deposition with other elements such as beryllium. The concentrations of T on the outboard vertical tiles (tiles 7 and 8) were low and relatively uniform in comparison with other tiles. (C) 2015 EURATOM. Published by Elsevier B.V. All rights reserved.	[Hatano, Y.; Yumizura, K.] Toyama Univ, Toyama 9308555, Japan; [Widdowson, A.; Bekris, N.; Ayres, C.; Baron-Wiechec, A.] Culham Sci Ctr, EURATOM CCFE Fus Assoc, Abingdon OX14 3DB, Oxon, England; [Likonen, J.; Koivuranta, S.] VTT Tech Res Ctr Finland, Assoc EURATOM Tekes, FIN-02044 Espoo, Finland; [Ikonen, J.] Univ Helsinki, Assoc EURATOM Tekes, FI-00014 Helsinki, Finland; [JET-EFDA Contributors] Culham Sci Ctr, JET EFDA, Abingdon OX14 3DB, Oxon, England	Hatano, Y (reprint author), Toyama Univ, Hydrogen Isotope Res Ctr, Gofuku 3190, Toyama 9308555, Japan.	hatano@ctg.u-toyama.ac.jp			EURATOM; JSPS KAKENHI [26289353]; Japan Atomic Energy Agency (JAEA), Broader Approach activities [26K276]; National Institute for Fusion Research (NIFS), TEXTOR Collaboration	This work was supported by EURATOM and carried out within the framework of the European Fusion Development Agreement. The views and opinions expressed herein do not necessarily reflect those of the European Commission. This work was also supported by JSPS KAKENHI Grant Number 26289353, the Japan Atomic Energy Agency (JAEA) under the Joint Work contract 26K276, as a part of Broader Approach activities, and the National Institute for Fusion Research (NIFS) as a part of TEXTOR Collaboration. The authors would like to express their sincere thanks to Dr. Margarida Ruas (University of Oxford) for the use of the image scanner, and to Professors Y. Nakamura and S. Masuzaki (NIFS), Dr. N. Asakura (JAEA) and Dr. P. Coad (Association EURATOM-Tekes) for their kind advice and encouragement.	KATZ L, 1952, REV MOD PHYS, V24, P28, DOI 10.1103/RevModPhys.24.28; Batistoni P, 2013, FUSION ENG DES, V88, P733, DOI 10.1016/j.fusengdes.2012.12.023; Widdowson A, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014010; Ruset C, 2009, FUSION ENG DES, V84, P1662, DOI 10.1016/j.fusengdes.2008.11.053; Matthews GF, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014001; Brezinsek S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083023; Petersson P, 2015, J NUCL MATER, V463, P814, DOI 10.1016/j.jnucmat.2014.12.077; Likonen J, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014016; Coad JP, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014012; Hirai T, 2007, FUSION ENG DES, V82, P1839, DOI 10.1016/j.fusengdes.2007.02.024; Matthews GF, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014015; Saitoh H, 1998, J NUCL MATER, V258, P1404, DOI 10.1016/S0022-3115(98)00144-5; Sugiyama K, 2003, J NUCL MATER, V313, P507, DOI 10.1016/S0022-3115(02)01387-9; Tanabe T, 2005, J NUCL MATER, V345, P89, DOI 10.1016/j.jnucmat.2005.05.004; Tanabe T, 2007, J NUCL MATER, V363, P960, DOI 10.1016/j.jnucmat.2007.01.191; Tanabe T, 2003, J NUCL MATER, V313, P478, DOI 10.1016/S0022-3115(02)01377-6	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						966	969		10.1016/j.jnucmat.2014.12.041		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200208		
J	Lee, HT; De Temmerman, G; Gao, L; Schwarz-Selinger, T; Meisl, G; Hoschen, T; Ueda, Y				Lee, H. T.; De Temmerman, G.; Gao, L.; Schwarz-Selinger, T.; Meisl, G.; Hoeschen, T.; Ueda, Y.			Deuterium retention in tungsten exposed to mixed D plus N plasma at divertor relevant fluxes in Magnum-PSI	JOURNAL OF NUCLEAR MATERIALS			English	Article							NITRIDE	Nitrogen (N) has been proposed as an extrinsic impurity species in the divertor to reduce the local power load onto tungsten (W) plasma-facing components. Laboratory studies at low incident fluxes have indicated N increases deuterium (D) retention in tungsten. Here we show that W exposed to D + N Magnum-PSI plasmas under divertor relevant particle fluxes (similar to 10(24) D/m(2) s), also results in an increase in D retention by enhanced near surface trapping up to 1100 K due either to N or Mo impurities, and increased retention in the bulk at T > 700 K. These results demonstrate that N or Mo surface impurities have the potential to alter the tritium inventory in tungsten plasma-facing components under diverter relevant particle fluxes by affecting surface and bulk retention processes. (C) 2014 Elsevier B.V. All rights reserved.	[Lee, H. T.; Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [De Temmerman, G.] Dutch Inst Fundamental Energy Res, NL-3439 MN Nieuwegein, Netherlands; [Gao, L.; Schwarz-Selinger, T.; Meisl, G.; Hoeschen, T.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany	Lee, HT (reprint author), 2-1 Yamada Oka, Suita, Osaka, Japan.	heunlee@wakate.frc.eng.osaka-u.ac.jp			TEXTOR-Japan international collaboration	This work was supported in part by TEXTOR-Japan international collaboration. Magnum-PSI operation by J. Scholten and technical assistance of M.A. van den Berg with temperature measurements are gratefully acknowledged. The technical support of M. Fuesseder and J. Dorner with NRA measurements are also gratefully acknowledged.	Schmid K, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025006; Schmid K, 2012, NUCL INSTRUM METH B, V281, P64, DOI 10.1016/j.nimb.2012.03.024; Gao L, 2014, J NUCL MATER, V451, P352, DOI 10.1016/j.jnucmat.2014.04.029; De Temmerman G, 2013, FUSION ENG DES, V88, P483, DOI 10.1016/j.fusengdes.2013.05.047; Giroud C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113025; Lindig S, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014040; Buzi L, 2014, J NUCL MATER, V455, P316, DOI 10.1016/j.jnucmat.2014.06.059; Gao L, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014023; Kallenbach A, 2011, J NUCL MATER, V415, pS19, DOI 10.1016/j.jnucmat.2010.11.105; Meisl G, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/9/093018; Pitts RA, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014001; Lee HT, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014021; Loarte A, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3567547; Mayer M, 2009, NUCL INSTRUM METH B, V267, P506, DOI 10.1016/j.nimb.2008.11.033; Oberkofler M, 2013, J NUCL MATER, V438, pS258, DOI 10.1016/j.jnucmat.2013.01.041; Ogorodnikova OV, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014034; Scholten J, 2013, FUSION ENG DES, V88, P1785, DOI 10.1016/j.fusengdes.2013.05.063; van der Meiden HJ, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/11/C11011; Wei ZB, 1997, J CATAL, V168, P176, DOI 10.1006/jcat.1997.1641	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						974	978		10.1016/j.jnucmat.2014.11.043		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200210		
J	Iijima, N; Miyamoto, M; Nishijima, D; Baldwin, MJ; Doerner, RP; Ueda, Y; Sagara, A; Hoschen, T				Iijima, N.; Miyamoto, M.; Nishijima, D.; Baldwin, M. J.; Doerner, R. P.; Ueda, Y.; Sagara, A.; Hoeschen, T.			Effect of temperature on microstructures and retention properties in tungsten exposed to D plus He plus Be mixture plasmas in PISCES	JOURNAL OF NUCLEAR MATERIALS			English	Article							SURFACE	The influence of temperature on microstructures and D retention properties in tungsten exposed to D + He + Be mixture plasmas is investigated. For the low temperature exposure case at 573 K, the Be seeding to D + He mixture plasmas results in the suppression of high density He nano-bubbles, which are distinctive internal defects observed in He irradiated/exposed metals. In contrast, fine and high-density He bubbles appear for W exposed to D + He + Be mixture plasmas at higher temperatures of >773 K. TDS measurements also show that the influence of Be seeding to D + He mixture plasmas, which counteracts the significant reduction in D retention, becomes weak with increasing temperature. From XPS analyses, it is considered that Be2W is formed by interdiffusion and solid-state-reaction at the high temperature exposure case, and the influence of the metallic Be on surface properties gradually disappears with increasing temperature. (C) 2014 Elsevier B.V. All rights reserved.	[Iijima, N.; Miyamoto, M.] Shimane Univ, Dept Mat Sci, Matsue, Shimane 6908504, Japan; [Nishijima, D.; Baldwin, M. J.; Doerner, R. P.] Univ Calif San Diego, Energy Res Ctr, La Jolla, CA 92093 USA; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Sagara, A.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Hoeschen, T.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany	Miyamoto, M (reprint author), 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	s139101@matsu.shimane-u.ac.p; miyamoto@riko.shimane-u.ac.jp			Japan/U.S. Cooperation in Fusion Research and Development; Japan Society for the Promotion of Science (JSPS) [25709086]	The authors wish to thank PISCES technical staff for their professional skill and dedicated support. This work was partly supported by Japan/U.S. Cooperation in Fusion Research and Development and a Grant-in-Aid for Young Scientists (A) 25709086 from the Japan Society for the Promotion of Science (JSPS).	Allouche A, 2008, J PHYS CONF SER, V117, P12002, DOI 10.1088/1742-6596/117/1/012002; Miyamoto M, 2011, J NUCL MATER, V415, pS657, DOI 10.1016/j.jnucmat.2011.01.008; Baldwin MJ, 2009, J NUCL MATER, V390-91, P886, DOI 10.1016/j.jnucmat.2009.01.247; Iwakiri H, 2002, J NUCL MATER, V307, P135, DOI 10.1016/S0022-3115(02)01178-9; Loarte A, 2007, NUCL FUSION, V47, pS203, DOI 10.1088/0029-5515/47/6/S04; Miyamoto M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065035; Lee HT, 2007, J NUCL MATER, V363, P898, DOI 10.1016/j.jnucmat.2007.01.111; Nishijima D, 2005, NUCL FUSION, V45, P669, DOI 10.1088/0029-5515/45/7/016; Baldwin MJ, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103021; Doemer R.P., 2004, J APPL PHYS, V95, P4471; Doerner RP, 2004, PHYS SCRIPTA, VT111, P75, DOI 10.1238/Physica.Topical.111a00075; Hamrin K., 1970, Physica Scripta, V1, DOI 10.1088/0031-8949/1/5-6/018; Miyamoto M, 2013, J NUCL MATER, V438, pS216, DOI 10.1016/j.jnucmat.2013.01.030; Nishijima D, 2013, J NUCL MATER, V438, pS1245, DOI 10.1016/j.jnucmat.2013.01.276; Nishijima D, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2786063; Ueda Y., 2008, J NUCL MATER, V386-388, P725	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						979	982		10.1016/j.jnucmat.2014.10.099		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200211		
J	Nobuta, Y; Hatano, Y; Matsuyama, M; Abe, S; Yamauchi, Y; Hino, T				Nobuta, Y.; Hatano, Y.; Matsuyama, M.; Abe, S.; Yamauchi, Y.; Hino, T.			Helium irradiation effects on tritium retention and long-term tritium release properties in polycrystalline tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							HYDROGEN RETENTION; GRAPHITE; HE	DT+ ion irradiation with energy of 0.5 and 1.0 key was performed on helium pre-irradiated tungsten and the amount of retained tritium and the long-term release of retained tritium in vacuum was investigated using an IF technique and BIXS. Tritium retention and long-term tritium release were significantly influenced by helium pre-irradiation. The amount of retained tritium increased until it reached 1 x 10(17) He/cm(2), and at 1 x 10(18) He/cm(2) it became smaller compared to 1 x 10(17) He/cm(2). The amount of retained tritium in tungsten without helium pre-irradiation largely decreased after several weeks preservation in vacuum, and the long-term release rate during vacuum preservation was retarded by helium pre-irradiation. The results indicate that the long-term tritium release and the helium irradiation effect on it should be taken into account for more precise estimation of tritium retention in the long-term use of tungsten in fusion devices. (C) 2014 Elsevier B.V. All rights reserved.	[Nobuta, Y.; Yamauchi, Y.; Hino, T.] Hokkaido Univ, Lab Plasma Phys & Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Hatano, Y.; Matsuyama, M.; Abe, S.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan	Nobuta, Y (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	y-nobuta@eng.hokudai.ac.jp			Collaboration Research Program for Large Helical Device in National Institute for Fusion Science [NIFS14KUHR029]	This work was supported by the Collaboration Research Program for Large Helical Device (NIFS14KUHR029) in National Institute for Fusion Science.	Lee HT, 2007, J NUCL MATER, V360, P196, DOI 10.1016/j.jnucmat.2006.09.013; Ogorodnikova OV, 2011, J NUCL MATER, V415, pS661, DOI 10.1016/j.jnucmat.2010.12.012; EVANS JH, 1978, J NUCL MATER, V76-7, P228, DOI 10.1016/0022-3115(78)90145-9; Iwakiri H, 2002, J NUCL MATER, V307, P135, DOI 10.1016/S0022-3115(02)01178-9; MIYAHARA J, 1986, NUCL INSTRUM METH A, V246, P572, DOI 10.1016/0168-9002(86)90156-7; Franzen P, 1997, J NUCL MATER, V241, P1082, DOI 10.1016/S0022-3115(96)00664-2; Yoshida N, 2005, J NUCL MATER, V337, P946, DOI 10.1016/j.jnucmat.2004.10.162; Haasz AA, 1997, J NUCL MATER, V241, P1076, DOI 10.1016/S0022-3115(97)80197-3; Hino T, 1998, FUSION ENG DES, V39-40, P227, DOI 10.1016/S0920-3796(98)00157-4; JAGER W, 1980, J NUCL MATER, V93-4, P756, DOI 10.1016/0022-3115(80)90204-4; LIFSHITZ Y, 1986, J NUCL MATER, V137, P139, DOI 10.1016/0022-3115(86)90043-7; Matsuyama M, 2002, FUSION SCI TECHNOL, V41, P505; Nobuta Y, 2014, FUSION ENG DES, V89, P1516, DOI 10.1016/j.fusengdes.2014.04.004; Shimada M, 2005, J NUCL MATER, V337, P808, DOI 10.1016/j.jnucmat.2004.09.063; YAMAUCHI Y, 1995, J NUCL MATER, V220, P851, DOI 10.1016/0022-3115(94)00596-6	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						993	996		10.1016/j.jnucmat.2014.12.047		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200214		
J	Shinoda, N; Yamauchi, Y; Nobuta, Y				Shinoda, N.; Yamauchi, Y.; Nobuta, Y.			Deuterium retention on He-irradiated F82H with surface impurity layer	JOURNAL OF NUCLEAR MATERIALS			English	Article							FERRITIC STEEL; DESORPTION BEHAVIOR; STAINLESS-STEEL; DAMAGE; WATER	The deuterium retention/desorption behavior of F82H has been studied to clarify the effect of radiation damage with respect to the impurity layer. To evaluate the effects of oxygen impurities, non-oxidized and thermally oxidized samples were prepared with the introduction of radiation damage through He irradiation. The amount of deuterium retained in the thermally oxidized samples was less than that of the non-oxidized samples. The amount of deuterium retained in the oxidized sample increased after He irradiation. The retention/desorption behaviors were discussed in the surface chemical state. (C) 2015 Elsevier B.V. All rights reserved.	[Shinoda, N.; Yamauchi, Y.; Nobuta, Y.] Hokkaido Univ, Lab Plasma Phys & Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Shinoda, N (reprint author), Hokkaido Univ, Lab Plasma Phys & Engn, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	na-shinoda04@frontier.hokudai.ac.jp			"Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	A part of this work was conducted at Hokkaido University, supported by "Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Serra E, 1998, J NUCL MATER, V255, P105, DOI 10.1016/S0022-3115(98)00038-5; ROCHESTER CH, 1979, J CHEM SOC FARAD T 1, V75, P1073, DOI 10.1039/f19797501073; Serra E, 1997, J NUCL MATER, V245, P108, DOI 10.1016/S0022-3115(97)00021-4; Hamaguchi D, 2009, J NUCL MATER, V386-88, P375, DOI 10.1016/j.jnucmat.2008.12.124; Hirohata Y, 1998, FUSION ENG DES, V39-40, P485, DOI 10.1016/S0920-3796(97)00170-1; Ito T, 2011, J NUCL MATER, V417, P1147, DOI 10.1016/j.jnucmat.2010.12.206; Joly JP, 2000, VACUUM, V59, P854, DOI 10.1016/S0042-207X(00)00393-6; Kohyama A., 1995, J NUCL MATER, V220-222, P851; Nakamura H, 2012, FUSION ENG DES, V87, P916, DOI 10.1016/j.fusengdes.2012.02.044; Oya Y, 2012, FUSION ENG DES, V87, P580, DOI 10.1016/j.fusengdes.2012.01.025; Shinoda N, 2014, FUSION ENG DES, V89, P921, DOI 10.1016/j.fusengdes.2014.05.019; Takagi I., 2013, NUCL MAT, V442, pS33; WOLFF H, 1987, J NUCL MATER, V145, P671, DOI 10.1016/0022-3115(87)90421-1; Yamauchi Y, 1999, J NUCL MATER, V266, P1257, DOI 10.1016/S0022-3115(98)00519-4; Yamauchi Y, 2007, J NUCL MATER, V363, P984, DOI 10.1016/j.jnucmat.2007.01.136; Yamauchi Y, 2009, J NUCL MATER, V390-91, P1048, DOI 10.1016/j.jnucmat.2009.01.285; Yamauchi Y, 2010, FUSION ENG DES, V85, P1838, DOI 10.1016/j.fusengdes.2010.06.007	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1001	1004		10.1016/j.jnucmat.2015.01.037		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200216		
J	Shimada, M; Hara, M; Otsuka, T; Oya, Y; Hatano, Y				Shimada, Masashi; Hara, Masanori; Otsuka, Teppei; Oya, Yasuhisa; Hatano, Yuji			Defect annealing and thermal desorption of deuterium in low dose HFIR neutron-irradiated tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							HYDROGEN ISOTOPES; DIFFUSION; SAFETY; ITER	Three tungsten samples irradiated at High Flux Isotope Reactor at Oak Ridge National Laboratory were exposed to deuterium plasma (ion thence of 1 x 10(26) m(-2)) at three different temperatures (100, 200, and 500 degrees C) in Tritium Plasma Experiment at Idaho National Laboratory. Subsequently, thermal desorption spectroscopy was performed with a ramp rate of 10 degrees C min(-1) up to 900 degrees C, and the samples were annealed at 900 degrees C for 0.5 h. These procedures were repeated three times to uncover defect-annealing effects on deuterium retention. The results show that deuterium retention decreases approximately 70% for at 500 degrees C after each annealing, and radiation damages were not annealed out completely even after the 3rd annealing. TMAP modeling revealed the trap concentration decreases approximately 80% after each annealing at 900 degrees C for 0.5 h. (C) 2014 Elsevier B.V. All rights reserved.	[Shimada, Masashi] Idaho Natl Lab, Fus Safety Program, Idaho Falls, ID USA; [Hara, Masanori; Hatano, Yuji] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 930, Japan; [Otsuka, Teppei] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Higashi Ku, Fukuoka 812, Japan; [Oya, Yasuhisa] Shizuoka Univ, Fac Sci, Radiosci Res Lab, Shizuoka 4228017, Japan	Shimada, M (reprint author), POB 1625,MS 7113, Idaho Falls, ID 83415 USA.	Masashi.Shimada@inl.gov			U.S. Department of Energy Office of Science, Office of Fusion Energy Sciences, under the DOE Idaho Operations Office [DE-AC07-05ID14517]	This material is based upon work supported by the U.S. Department of Energy Office of Science, Office of Fusion Energy Sciences, under the DOE Idaho Operations Office contract number DE-AC07-05ID14517.	Causey R, 1999, J NUCL MATER, V266, P467, DOI 10.1016/S0022-3115(98)00538-8; ANDERL RA, 1992, FUSION TECHNOL, V21, P745; Hatano Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073006; Taylor N, 2012, FUSION ENG DES, V87, P476, DOI 10.1016/j.fusengdes.2012.01.001; Taylor N, 2011, FUSION ENG DES, V86, P619, DOI 10.1016/j.fusengdes.2010.11.037; Venhaus T, 2001, J NUCL MATER, V290, P505, DOI 10.1016/S0022-3115(00)00443-8; Shimada M, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014051; ORIANI RA, 1970, ACTA METALL MATER, V18, P147, DOI 10.1016/0001-6160(70)90078-7; FRAUENFE.R, 1969, J VAC SCI TECHNOL, V6, P388, DOI 10.1116/1.1492699; Hatano Y, 2013, J NUCL MATER, V438, pS114, DOI 10.1016/j.jnucmat.2013.01.018; Lipschultz B., 2010, PSFCRR104 MIT; Longhurst G.R., 1992, EGGFSP10315 ID NAT L; Longhurst G.R., 2008, INEELEXT0402352, P2; Merrill B. J., 2013, J PLASMA FUSION RES, V10, P71; Schultz H., 1991, ATOMIC DEFECTS METAL, VIII; Shimada M., NUCL FUSION IN PRESS; Shimada M, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3627609; Taylor N, 2013, FUSION SCI TECHNOL, V64, P111; Venhaus TJ, 2001, FUSION TECHNOL, V39, P868; Ziegler J. F., STOPPING RANGE IONS	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1005	1008		10.1016/j.jnucmat.2014.10.054		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200217		
J	Taylor, CN; Shimada, M; Merrill, BJ; Akers, DW; Hatano, Y				Taylor, C. N.; Shimada, M.; Merrill, B. J.; Akers, D. W.; Hatano, Y.			Development of positron annihilation spectroscopy for investigating deuterium decorated voids in neutron-irradiated tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article								The present work is a continuation of a recent research to develop and optimize positron annihilation spectroscopy (PAS) for characterizing neutron-irradiated tungsten. Tungsten samples were exposed to neutrons in the High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory and damaged to 0.025 and 0.3 dpa. Subsequently, they were exposed to deuterium plasmas in the Tritium Plasma Experiment (TPE) at Idaho National Laboratory. The implanted deuterium was desorbed through sample heating to 900 degrees C, and Doppler broadening (DB)-PAS was performed both before and after heating. Results show that deuterium impregnated tungsten is identified as having a smaller S-parameter. The S-parameter increases after deuterium desorption. Microstructural changes also occur during sample heating. These effects can be isolated from deuterium desorption by comparing the S-parameters from the deuterium-free back face with the deuterium-implanted front face. The application of using DB-PAS to examine deuterium retention in tungsten is examined. (C) 2014 Elsevier B.V. All rights reserved.	[Taylor, C. N.; Shimada, M.; Merrill, B. J.] Idaho Natl Lab, Fus Safety Program, Idaho Falls, ID 83415 USA; [Akers, D. W.] Idaho Natl Lab, Expt Programs, Idaho Falls, ID 83415 USA; [Hatano, Y.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan	Taylor, CN (reprint author), POB 1625, Idaho Falls, ID 83415 USA.	chase.taylor@inl.gov			US Department of Energy, Office of Fusion Energy Sciences, under the DOE Idaho Field Office [DE-AC07-05ID14517]	We would like to thank M. Drigert for help in PAS data collection. This work was prepared for the US Department of Energy, Office of Fusion Energy Sciences, under the DOE Idaho Field Office contract number DE-AC07-05ID14517. Samples for this work came from the collaborative Japan/USA TITAN project.	[Anonymous], E706ID ASTM INT; Tuomisto F, 2013, REV MOD PHYS, V85, P1583, DOI 10.1103/RevModPhys.85.1583; Shimada M, 2012, FUSION ENG DES, V87, P1166, DOI 10.1016/j.fusengdes.2012.02.103; SIEGEL RW, 1980, ANNU REV MATER SCI, V10, P393, DOI 10.1146/annurev.ms.10.080180.002141; Oya Y, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014050; MOURINO M, 1979, PHYS LETT A, V71, P106, DOI 10.1016/0375-9601(79)90890-9; Brusa RS, 1999, J APPL PHYS, V85, P2390, DOI 10.1063/1.369555; GREENWOOD LR, 1994, J NUCL MATER, V212, P635, DOI 10.1016/0022-3115(94)90136-8; Haaks M, 2005, PHYS STATUS SOLIDI A, V202, pR38, DOI 10.1002/pssa.200510004; Mayer M., 1997, 9113 IPP; Nambissan P.M.G., 1989, J NUCL MATER, V71, P1165; Schultz H., 1991, ATOMIC DEFECTS METAL, P179; Smmada M., 2015, NUCL FUSION, V55; SUBRAHMANYAM VS, 1994, SOLID STATE COMMUN, V89, P523, DOI 10.1016/0038-1098(94)90749-8; Taylor CN, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014055; Wampler WR, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115023	16	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1009	1012		10.1016/j.jnucmat.2014.11.033		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200218		
J	Hamaji, Y; Lee, HT; Torikai, Y; Sugiyama, K; Ueda, Y				Hamaji, Y.; Lee, H. T.; Torikai, Y.; Sugiyama, K.; Ueda, Y.			Gaseous tritium uptake by C deposition layer on tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							AMORPHOUS-CARBON FILMS; REDEPOSITION; RETENTION; DEUTERIUM	Tritium (T) uptake by exposure to gaseous T on deuterated C deposition layer on W was investigated. The C deposition layer were prepared by mixed D and C ion irradiation. The specimens were exposed to D an T mixed gas at 423 and 573 K. The additional T retention by gas exposure at 573 K was about 4 times higher than that by gas exposure at 423 K. Further heating from 573 to 673 K in vacuum after the gas exposure, resulted in more than 70% of retained T stayed after heating at 673 K. That should be due to changing of nature of trap sites in C deposition layer during experiments. These results suggest that additional T trapped in such trap sites require higher temperature to remove retained T in such trap sites. (C) 2014 Elsevier B.V. All rights reserved.	[Hamaji, Y.; Lee, H. T.; Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Torikai, Y.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Sugiyama, K.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany	Hamaji, Y (reprint author), Osaka Univ, Grad Sch Engn, AR G2-301, Suita, Osaka 5650871, Japan.	yukinori_h@st.eie.eng.osaka-u.ac.jp		hamaji, yukinori/0000-0002-9230-2334			Salancon E, 2008, J NUCL MATER, V376, P160, DOI 10.1016/j.jnucmat.2008.02.070; BESOCKE K, 1987, J NUCL MATER, V145, P651, DOI 10.1016/0022-3115(87)90417-X; BOUNOUH Y, 1995, PHYS REV B, V51, P9597, DOI 10.1103/PhysRevB.51.9597; CAUSEY RA, 1986, J VAC SCI TECHNOL A, V4, P1189, DOI 10.1116/1.573392; Di Pietro E., 2014, FUSION ENG DES, P4; Finlay TJ, 2013, J NUCL MATER, V443, P145, DOI 10.1016/j.jnucmat.2013.06.053; Ivanova D, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014006; Jacob W., 2007, TOP APPL PHYS, P329; Jacob W, 2005, J NUCL MATER, V337, P839, DOI 10.1016/j.jnucmat.2004.10.035; Kanaya K., 1972, J PHYS D, V43; Rohde V, 2001, J NUCL MATER, V290, P317, DOI 10.1016/S0022-3115(00)00574-2; Tanabe T, 2003, J NUCL MATER, V313, P478, DOI 10.1016/S0022-3115(02)01377-6; Torikai Y., 2013, J NUCL MATER, P1; Ueda Y, 2002, FUSION ENG DES, V61-62, P255, DOI 10.1016/S0920-3796(02)00169-2; WILD C, 1987, APPL PHYS LETT, V51, P1506, DOI 10.1063/1.98617; Yamawaki A, 2009, FUSION SCI TECHNOL, V56, P1038	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1017	1020		10.1016/j.jnucmat.2014.11.052		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200220		
J	Otsuka, T; Ogawa, Y; Higaki, M; Ishitani, Y				Otsuka, T.; Ogawa, Y.; Higaki, M.; Ishitani, Y.			Retention behaviors of tritium loaded near the surface region of metals by gas absorption and plasma implantation	JOURNAL OF NUCLEAR MATERIALS			English	Article							FACING COMPONENTS; HYDROGEN; STEELS; COPPER	Retention behaviors of hydrogen loaded by gas absorption and plasma implantation to pure copper, pure tungsten and the F82H steels at various temperatures have been examined by the tritium imaging plate technique. Three components are distinguished in hydrogen retained near the surface region; one is an endothermic trapping component in the bulk or near the surface region, second is an exothermic trapping component induced by plasma implantation and third is a trapping component in oxide layers. The relative amount of each component in depth near the surface region of the metals can alter retention behaviors of hydrogen with respect to the loading temperatures. (C) 2014 Elsevier B.V. All rights reserved.	[Otsuka, T.; Ogawa, Y.; Higaki, M.; Ishitani, Y.] Kyushu Univ, Interdisciplinary Grad Sch Engn & Sci, Kasuga, Fukuoka 8168581, Japan	Otsuka, T (reprint author), 6-1 Kasuga Kouen, Kasuga, Fukuoka 8168580, Japan.	t-otsuka@nucl.kyushu-u.ac.jp			KAKENHI [26289364]	The corresponding author (T.O.) is financially supported by KAKENHI No. 26289364.	Causey RA, 2002, J NUCL MATER, V300, P91, DOI 10.1016/S0022-3115(01)00732-2; Roth J, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014031; ORIANI RA, 1970, ACTA METALL MATER, V18, P147, DOI 10.1016/0001-6160(70)90078-7; Perevezentsev AN, 2008, J NUCL MATER, V372, P263, DOI 10.1016/j.jnucmat.2007.03.215; BEGEAL DR, 1978, J VAC SCI TECHNOL, V15, P1146, DOI 10.1116/1.569527; CASKEY GR, 1976, CORROSION, V32, P370; Ogolodnikova O.V., 2008, J APPL PHYS, V103; Otsuka T, 2011, J NUCL MATER, V415, pS769, DOI 10.1016/j.jnucmat.2010.11.046; Otsuka T, 2013, J ALLOY COMPD, V580, pS44, DOI 10.1016/j.jallcom.2013.02.001; Otsuka T, 2010, FUSION ENG DES, V85, P1437, DOI 10.1016/j.fusengdes.2010.03.063; Sugiyama K, 2004, J NUCL MATER, V329, P874, DOI 10.1016/j.jnucmat.2004.04.345; TAMURA M, 1986, J NUCL MATER, V141, P1067, DOI 10.1016/0022-3115(86)90144-3	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1029	1032		10.1016/j.jnucmat.2014.11.038		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200223		
J	Katayama, K; Uehara, K; Date, H; Fukada, S; Watanabe, H				Katayama, K.; Uehara, K.; Date, H.; Fukada, S.; Watanabe, H.			Temperature dependence of deuterium retention in tungsten deposits by deuterium ion irradiation	JOURNAL OF NUCLEAR MATERIALS			English	Article							LAYERS; HELIUM; MICROSTRUCTURE; RELEASE	Tungsten (W) deposits were formed by hydrogen plasma sputtering and blisters were observed on the surface. The W deposits and W foils were exposed to deuterium ions with 2 keV-D2+ to doses of 1.0 x 10(21) D2+/m(2) at 294 and 773 K in addition to 573 K in the present authors' previous work. Hydrogen isotopes release behaviors from the W deposits and W foils were observed by the thermal desorption spectroscopy method. The amount of deuterium released from the W deposit was considerably larger than that from W foil. The obtained deuterium retention in D/m(2) was in the range of deuterium retention in polycrystalline tungsten. Not only implanted deuterium but also hydrogen, which was incorporated during the sputtering-deposition process, were released from the W deposits. A hydrogen release peak at around 1100 K was observed for the W deposits. This is considered to be due to the rupture of the blisters. (C) 2014 Elsevier B.V. All rights reserved.	[Katayama, K.; Uehara, K.; Date, H.; Fukada, S.] Kyushu Univ, Interdisciplinaly Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Watanabe, H.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Katayama, K (reprint author), Kyushu Univ, Interdisciplinaly Grad Sch Engn Sci, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	kadzu@nucl.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University	This work was supported in part by the Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University.	Alimov VK, 2011, J NUCL MATER, V414, P479, DOI 10.1016/j.jnucmat.2011.05.041; Katayama K, 2007, FUSION ENG DES, V82, P1645, DOI 10.1016/j.fusengdes.2007.04.026; Katayama K, 2008, FUSION SCI TECHNOL, V54, P549; Tian Z, 2010, J NUCL MATER, V399, P101, DOI 10.1016/j.jnucmat.2010.01.007; Haasz AA, 1998, J NUCL MATER, V258, P889, DOI 10.1016/S0022-3115(98)00072-5; Alimov VK, 2010, J NUCL MATER, V399, P225, DOI 10.1016/j.jnucmat.2010.01.024; De Temmerman G, 2009, J NUCL MATER, V389, P479, DOI 10.1016/j.jnucmat.2009.03.028; Doyle B.L., 1985, DADIAT EFF, V89, P21; Ishikawa S, 2012, FUSION ENG DES, V87, P1390, DOI 10.1016/j.fusengdes.2012.03.021; Iwakiri H, 2000, J NUCL MATER, V283, P1134, DOI 10.1016/S0022-3115(00)00289-0; Katayama K, 2009, J NUCL MATER, V390-91, P689, DOI 10.1016/j.jnucmat.2009.01.190; Katayama K., 2013, J NUCL MATER, V438, P1010; Katayama K., 2012, J APPL NUCL SCI TECH, V5, P102; Uchida Y, 2008, FUSION SCI TECHNOL, V54, P545	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1033	1036		10.1016/j.jnucmat.2014.11.103		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200224		
J	Oya, M; Lee, HT; Ueda, Y; Kurishita, H; Oyaidzu, M; Hayashi, T; Yoshida, N; Morgan, TW; De Temmerman, G				Oya, M.; Lee, H. T.; Ueda, Y.; Kurishita, H.; Oyaidzu, M.; Hayashi, T.; Yoshida, N.; Morgan, T. W.; De Temmerman, G.			Surface morphology changes and deuterium retention in Toughened, Fine-grained Recrystallized Tungsten under high-flux irradiation conditions	JOURNAL OF NUCLEAR MATERIALS			English	Article								Surface morphology changes and deuterium (D) retention in Toughened, Fine-Grained Recrystallized Tungsten (TFGR W) with TaC dispersoids (W-TaC) and pure tungsten exposed to D plasmas to a fluence of 10(26) D/m(2) s were studied as a function of the D ion flux (10(22)-10(24) D/m(2) s). As the flux increased from 10(22) D/m(2) s to 10(24) D/m(2) s, the numbers of blisters increased for both materials. However, smaller blisters were observed on W-TaC compared to pure W. In W-TaC, cracks beneath the surface along grain boundaries were observed, which were comparable to the blister sizes. The reason for the smaller blister sizes may arise from smaller grain sizes of W-TaC. In addition, reduction of the D retention in W-TaC was observed for higher flux exposures. D depth profiles indicate this reduction arises due to decrease in trapping in the bulk. (C) 2014 Elsevier B.V. All rights reserved.	[Oya, M.; Lee, H. T.; Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Kurishita, H.] Tohoku Univ, Inst Mat Res, Oarai, Ibaraki 3111313, Japan; [Oyaidzu, M.; Hayashi, T.] Japan Atom Energy Agcy, Int Fus Energy Res Ctr, Fus Res & Dev Directorate, Aomori 0393212, Japan; [Yoshida, N.] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan; [Morgan, T. W.; De Temmerman, G.] FOM Inst DIFFER, Dutch Inst Fundamental Energy Res, NL-3439 MN Nieuwegein, Netherlands	Oya, M (reprint author), Osaka Univ, Grad Sch Engn, AR-G2-301,2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ohya@st.eie.eng.osaka-u.ac.jp	Kyushu, RIAM/F-4018-2015		Broader Approach Activities in Rokkasho, Japan	This work was partly supported by Broader Approach Activities in Rokkasho, Japan. The author would like to thank K. Sugiyama for technical assistance with NRA analysis.	Alimov VK, 2011, J NUCL MATER, V414, P479, DOI 10.1016/j.jnucmat.2011.05.041; Lee HT, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014045; Oya M, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014048; De Temmerman G, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073008; Philipps V, 2011, J NUCL MATER, V415, pS2, DOI 10.1016/j.jnucmat.2011.01.110; Oya M, 2013, J NUCL MATER, V438, pS1052, DOI 10.1016/j.jnucmat.2013.01.230; Hoshihira T, 2009, J NUCL MATER, V386-88, P776, DOI 10.1016/j.jnucmat.2008.12.215; Lindig S, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014040; Kurishita H, 2010, J NUCL MATER, V398, P87, DOI 10.1016/j.jnucmat.2009.10.015; Tanabe T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014044; Kurishita H, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014032; Miyamoto M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065035; Luo G.-N., 2004, REV SCI INSTRUM, V75, P4347; Mayer M, 2009, NUCL INSTRUM METH B, V267, P506, DOI 10.1016/j.nimb.2008.11.033; Mayer M., 1997, 9113 IPP; Ueda Y., 2005, Journal of Nuclear Materials, V337-339, DOI 10.1016/j.jnucmat.2004.10.077	16	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1037	1040		10.1016/j.jnucmat.2014.11.124		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200225		
J	Zibrov, M; Mayer, M; Gao, L; Elgeti, S; Kurishita, H; Gasparyan, Y; Pisarev, A				Zibrov, M.; Mayer, M.; Gao, L.; Elgeti, S.; Kurishita, H.; Gasparyan, Yu.; Pisarev, A.			Deuterium retention in TiC and TaC doped tungsten at high temperatures	JOURNAL OF NUCLEAR MATERIALS			English	Article							NUCLEAR-REACTION; HYDROGEN; FILMS	Samples made of tungsten doped either with titanium carbide (W-1.1TiC) or tantalum carbide (W-3.3TaC) were either exposed to D-2 gas at a pressure of 100 kPa at 800-963 K or irradiated by 38 eV/D ions at 800 K. The deuterium (D) inventory in the samples was examined by nuclear reaction analysis and thermal desorption spectroscopy. The D bulk concentration and total retention in W-3.3TaC were comparable in all cases to that in pure polycrystalline W. The D bulk concentration in W-1.1TiC was more than one order of magnitude higher than that in pure W after exposure to D-2 gas, and was also several times higher than that in W-1.1TiC after irradiation at 800 K. It is suggested that D trapping inside the carbide precipitates in W-1.1TiC becomes essential at high temperatures. (C) 2014 Elsevier B.V. All rights reserved.	[Zibrov, M.; Gasparyan, Yu.; Pisarev, A.] Natl Res Nucl Univ, MEPhI Moscow Engn Phys Inst, Moscow 115409, Russia; [Zibrov, M.; Mayer, M.; Gao, L.; Elgeti, S.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Kurishita, H.] Tohoku Univ, IMR, Int Res Ctr Nucl Mat Sci, Oarai, Ibaraki 3111313, Japan	Zibrov, M (reprint author), Kashirskoe Shosse 31, Moscow 115409, Russia.	mzibrov@gmail.com	Gasparyan, Yury/C-4694-2012; 	Gasparyan, Yury/0000-0003-0003-0579; Mayer, Matej/0000-0002-5337-6963; Zibrov, Mikhail/0000-0002-5131-7329	Impuls- und Vernetzungsfond of the Helmholtz Society; Russian Ministry of Education and Science [14.Y26.31.0008]; Euratom research and training programme	The technical assistance of J. Dorner, M. Fusseder, T. Durbeck, G. Matern, and T. Hoschen is gratefully acknowledged. This work was supported by the Impuls- und Vernetzungsfond of the Helmholtz Society and by the Russian Ministry of Education and Science (Contract 14.Y26.31.0008). This project has also received funding from the Euratom research and training programme 2014-2018.	Alimov VK, 2013, J NUCL MATER, V438, pS959, DOI 10.1016/j.jnucmat.2013.01.208; Ogorodnikova OV, 2008, J APPL PHYS, V103, DOI 10.1063/1.2828139; Federici G, 2001, NUCL FUSION, V41, P1967, DOI 10.1088/0029-5515/41/12/218; Schmid K, 2012, NUCL INSTRUM METH B, V281, P64, DOI 10.1016/j.nimb.2012.03.024; Manhard A, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/1/015010; Wang P, 2013, NUCL INSTRUM METH B, V300, P54, DOI 10.1016/j.nimb.2013.01.057; Schmid K, 2012, J NUCL MATER, V426, P247, DOI 10.1016/j.jnucmat.2012.04.003; Oya M, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014048; Wei FG, 2006, METALL MATER TRANS A, V37A, P331, DOI 10.1007/s11661-006-0004-3; Salancon E, 2008, J NUCL MATER, V376, P160, DOI 10.1016/j.jnucmat.2008.02.070; Oya M, 2013, J NUCL MATER, V438, pS1052, DOI 10.1016/j.jnucmat.2013.01.230; Kurishita H, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014032; Roth J, 2009, J NUCL MATER, V390-91, P1, DOI 10.1016/j.jnucmat.2009.01.037; Ding HM, 2013, J ALLOY COMPD, V551, P67, DOI 10.1016/j.jallcom.2012.10.067; Eckstein W, 2002, 9132 IPP; FRAUENFE.R, 1969, J VAC SCI TECHNOL, V6, P388, DOI 10.1116/1.1492699; Manhard A, 2013, PRAKT METALLOGR-PR M, V50, P5; Alimov VK, 2005, NUCL INSTRUM METH B, V234, P169, DOI 10.1016/j.nimb.2005.01.009; Mayer M., 1997, 9113 IPP; NAGATA S, 1990, NUCL INSTRUM METH B, V48, P231, DOI 10.1016/0168-583X(90)90110-G; Nozaki T, 2011, MATER TRANS, V52, P526, DOI 10.2320/matertrans.M2010307; Pierson H. O., 1996, HDB REFRACTORY CARBI; Pintsuk G, 2012, COMPREHENSIVE NUCLEAR MATERIALS, VOL 4: RADIATION EFFECTS IN STRUCTURAL AND FUNCTIONAL MATERIALS FOR FISSION AND FUSION REACTORS, P551; SATO K, 1985, J NUCL MATER, V133, P714, DOI 10.1016/0022-3115(85)90242-9; Zibrov M, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014050	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1045	1048		10.1016/j.jnucmat.2014.11.112		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200227		
J	Watanabe, T; Kaneko, T; Matsunami, N; Ohno, N; Kajita, S; Kuwabara, T				Watanabe, T.; Kaneko, T.; Matsunami, N.; Ohno, N.; Kajita, S.; Kuwabara, T.			In-situ measurement of deuterium retention in W under plasma exposure	JOURNAL OF NUCLEAR MATERIALS			English	Article							TUNGSTEN	The time dependence of the deuterium (D) retention in tungsten (W) was investigated by conducting successive D and hydrogen (H) plasma exposure using the plasma surface dynamics with ion beam analysis (PS-DIBA) which can conduct in-situ D retention measurement. At the sample temperature of 450 K, D retention rapidly dropped after the termination of D plasma exposure. On the other hand, at the sample temperature of 350 K, a slow decay of D retention after termination of D plasma was observed. The results indicate that the sample temperature has a strong influence on the dynamic behavior of D retention in W. Furthermore, by successive H plasma exposure to D retained W, D retention in W decreased exponentially in time. The result suggests that successive H plasma exposure is one of effective methods to remove tritium in W. (C) 2014 Elsevier B.V. All rights reserved.	[Watanabe, T.; Kaneko, T.; Ohno, N.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Matsunami, N.] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4680073, Japan; [Kajita, S.; Kuwabara, T.] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Watanabe, T (reprint author), Furo Cho,Chikusa Ku, Nagoya, Aichi 4648603, Japan.	watanabe-takashi13@ees.nagoya-u.ac.jp	Kajita, Shin/Q-1020-2015		JSPS KAKENHI [23656573]; NIFS/NINS	This work was supported by JSPS KAKENHI Grant Number 23656573, and partially supported by NIFS/NINS under the project of Formation of International Scientific Base and Network. One of co-authors (N. O) would like to thank Dr. Oya in Shizuoka Univ. for providing tungsten samples.	Alimov V.Kh., 2009, 14 INT C FUS REACT M; MOLLER W, 1980, NUCL INSTRUM METHODS, V168, P111, DOI 10.1016/0029-554X(80)91239-2; Ohno N, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014053; ANDERL RA, 1992, FUSION TECHNOL, V21, P745; Tian Z, 2010, J NUCL MATER, V399, P101, DOI 10.1016/j.jnucmat.2010.01.007; Haasz AA, 1998, J NUCL MATER, V258, P889, DOI 10.1016/S0022-3115(98)00072-5; Loarte A, 2007, NUCL FUSION, V47, pS203, DOI 10.1088/0029-5515/47/6/S04; Tanabe T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014044; Doerner R.P., 2008, COMMUNICATION; FRAUENFE.R, 1968, J CHEM PHYS, V48, P3955, DOI 10.1063/1.1669720; Ishikawa J., 1999, CHARGED PARTICLE BEA; Nakamura Y., 2013, J NUCL MATER, V438, P540; Roszell JP, 2011, J NUCL MATER, V415, pS641, DOI 10.1016/j.jnucmat.2010.12.013; Rusinov A., 2012, ENG SCI REP KYUSHU U, V34, P1; Tanabe T, 2011, J NUCL MATER, V417, P545, DOI 10.1016/j.jnucmat.2010.12.112; 't Hoen MHJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.225001; THOMAS EW, 1992, NUCL INSTRUM METH B, V69, P427, DOI 10.1016/0168-583X(92)95298-6; Yamagiwa M, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014032	18	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1049	1052		10.1016/j.jnucmat.2014.12.011		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200228		
J	Ishida, M; Lee, HT; Ueda, Y				Ishida, M.; Lee, H. T.; Ueda, Y.			The influence of neon or argon impurities on deuterium permeation in tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article								Nitrogen (N) or neon (Ne) in the divertor and argon (Ar) puffing in the first wall have been proposed to reduce the local power loads on tungsten (W) plasma facing components. The impurities sputter and modify the W surface, which can affect hydrogen (H, D, T) transport in W. In this study, mixed D + Ne or D + Ar ion driven permeation experiments were performed to investigate the influence of Ne or Ar impurities on D transport. The D permeation flux for mixed irradiation was lower in comparison to D-only irradiation at T> 500 K, opposite to trends observed for N. The reason for the observed decrease in permeation flux was interpreted to arise from combined effects of sputtering and possible precipitation. The lag times for D + Ne case was slower than D-only case, while D + Ar was faster. This indicates Ne precipitation effects may influence the H transport in W similar to helium. (C) 2014 Elsevier B.V. All rights reserved.	[Ishida, M.; Lee, H. T.; Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Ishida, M (reprint author), Osaka Univ, Grad Sch Engn, AR-G2-301,2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ishida@st.eie.eng.osaka-u.ac.jp					Nakano T, 2013, J NUCL MATER, V438, pS291, DOI 10.1016/j.jnucmat.2013.01.049; Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208; Kallenbach A, 2011, J NUCL MATER, V415, pS19, DOI 10.1016/j.jnucmat.2010.11.105; Federici G, 1996, J NUCL MATER, V233, P741, DOI 10.1016/S0022-3115(96)00186-9; Lee HT, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014021; Lee HT, 2011, J NUCL MATER, V415, pS696, DOI 10.1016/j.jnucmat.2010.12.023; Peng HY, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014046	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1062	1065		10.1016/j.jnucmat.2014.11.123		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200231		
J	Zhou, H; Hirooka, Y; Zushi, H; Kuzmin, A; Ashikawa, N; Muroga, T; Sagara, A				Zhou, H.; Hirooka, Y.; Zushi, H.; Kuzmin, A.; Ashikawa, N.; Muroga, T.; Sagara, A.		QUEST Grp	Effects of surface conditions on the plasma-driven permeation behavior through a ferritic steel alloy observed in VEHICLE-1 and QUEST	JOURNAL OF NUCLEAR MATERIALS			English	Article							1ST WALL; HYDROGEN; REACTOR; F82H	Effects of surface conditions on the plasma-driven permeation of hydrogen through a ferritic steel alloy F82H have been studied in a laboratory-scale plasma device: VEHICLE-1 and the medium-sized spherical tokamak: QUEST. Both of the surface contamination and area effects have been examined and discussed. Thick surface impurity film has been found to act as a second layer for diffusion and affect the permeation behavior in laboratory-scale and tokamak experiments. Hydrogen diffusion coefficient in the impurity layer has been estimated using the multi-layer diffusion model. A decrease in steady state permeation flux has been measured when increasing the plasma-facing surface area, which is in agreement with theoretical prediction. (C) 2014 Elsevier B.V. All rights reserved.	[Zhou, H.] Grad Univ Adv Studies, Toki, Gifu 5095292, Japan; [Hirooka, Y.; Ashikawa, N.; Muroga, T.; Sagara, A.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Zushi, H.; Kuzmin, A.; QUEST Grp] Kyushu Univ, RIAM, Kasuga, Fukuoka 8168580, Japan	Zhou, H (reprint author), 322-6 Oroshi, Toki, Gifu 5095292, Japan.	zhou.haishan@LHD.nifs.ac.jp	Kyushu, RIAM/F-4018-2015				Causey RA, 2002, J NUCL MATER, V300, P91, DOI 10.1016/S0022-3115(01)00732-2; CAUSEY R., 1984, J NUCL MATER, V122-123, P1547; Crank J., 1975, MATH DIFFUSION; DOYLE BL, 1982, J NUCL MATER, V111, P628, DOI 10.1016/0022-3115(82)90277-X; Hanada Kazuaki, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S1007; HATANO Y., 1998, VAC SCI TECHNOL A, VA16, P2078; Hirooka Y, 2013, FUSION SCI TECHNOL, V64, P345; Hirooka Y, 2005, J NUCL MATER, V337, P585, DOI [10.1016/j.jnucmat.2004.09.065, 10.1016/j.jnucmat.2004.03.065]; HIROOKA Y, 1987, NUCL INSTRUM METH B, V23, P458, DOI 10.1016/0168-583X(87)90471-X; Hirooka Y, 2014, FUSION SCI TECHNOL, V66, P63; Hollmann EM, 2002, PHYS PLASMAS, V9, P4330, DOI 10.1063/1.1503070; Livshits AI, 1998, J APPL PHYS, V84, P2558, DOI 10.1063/1.368418; Ogorodnikova OV, 2000, FUSION ENG DES, V49-50, P921, DOI 10.1016/S0920-3796(00)00339-2; Otsuka T., 2010, PHYS SCRIPTA, V138; Takizawa M, 1997, J NUCL MATER, V248, P15, DOI 10.1016/S0022-3115(97)00111-6; Tonegawa A, 2003, J NUCL MATER, V313, P1046, DOI 10.1016/S0022-3115(02)01535-0; Zhou H., 2013, PLASMA FUSION RES, V8; Zhou H, 2013, FUSION SCI TECHNOL, V63, P361; Zhou H., 2014, PLASMA FUSION RES, V9; Zhou HS, 2014, J NUCL MATER, V455, P470, DOI 10.1016/j.jnucmat.2014.07.061; Ziegler J.F., 2010, NUCL INSTRUM METH B, V12, P1818	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1066	1070		10.1016/j.jnucmat.2014.10.092		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200232		
J	Kobayashi, R; Hattori, T; Tamura, T; Ogata, S				Kobayashi, Ryo; Hattori, Tatsunori; Tamura, Tomoyuki; Ogata, Shuji			A molecular dynamics study on bubble growth in tungsten under helium irradiation	JOURNAL OF NUCLEAR MATERIALS			English	Article							TRANSITION-METALS; SIMULATIONS; DEFECTS; HE	Molecular dynamics simulation has been performed to investigate the effects of irradiated helium atoms in tungsten on the bubble nucleation and the dislocation loop formation. Simulation results clearly show that helium atoms in tungsten tend to migrate as isolated interstitials at high temperatures and to be absorbed to existing tungsten-vacancies or defects such as bubbles or dislocations. Tungsten self-interstitial atoms pushed out from the helium bubble tend to stay in the vicinity of the bubble and, then form a dislocation loop when the number of the atoms exceed the threshold. Since the bubbles and dislocation loops cause further nucleation of bubbles, there appears a helium bubble array along (1 1 1) direction. The bubble growth rate within this self induced bubble growth mechanism will be much faster than that of existing growth model. The growth model needs to be reformulated by taking the self-induced effects into account. (C) 2014 Elsevier B.V. All rights reserved.	[Kobayashi, Ryo; Hattori, Tatsunori; Ogata, Shuji] Nagoya Inst Technol, Dept Sci & Engn Simulat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tamura, Tomoyuki] Nagoya Inst Technol, Ctr Fostering Young & Innovat Researchers, Showa Ku, Nagoya, Aichi 4668555, Japan	Kobayashi, R (reprint author), Nagoya Inst Technol, Dept Sci & Engn Simulat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	kobayashi.ryo@nitech.ac.jp			NIMS Program for Cross-disciplinary Study, JSPS KAKENHI [B 24740201]; IFERC-CSC	Authors thank Dr. A. Ito for motivating us to do this work and providing us the interatomic potential he made. This research was supported by NIMS Program for Cross-disciplinary Study, JSPS KAKENHI Grant-in-Aid for Young Scientists B 24740201, and IFERC-CSC.	FEATHERSTON FH, 1963, PHYS REV, V130, P1324, DOI 10.1103/PhysRev.130.1324; Derlet PM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054107; Becquart CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.196402; Sefta F, 2013, J APPL PHYS, V114, DOI 10.1063/1.4860315; Becquart CS, 2007, NUCL INSTRUM METH B, V255, P23, DOI 10.1016/j.nimb.2006.11.006; Krasheninnikov SI, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014040; Li XC, 2012, J NUCL MATER, V426, P31, DOI 10.1016/j.jnucmat.2012.03.039; Kajita S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798597; Henriksson KOE, 2006, NUCL INSTRUM METH B, V244, P377, DOI 10.1016/j.nimb.2005.10.020; Zhou YL, 2014, J NUCL MATER, V446, P49, DOI 10.1016/j.jnucmat.2013.11.034; Ventelon L, 2012, J NUCL MATER, V425, P16, DOI 10.1016/j.jnucmat.2011.08.024; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095005; Lu GH, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/086001; WILSON WD, 1981, PHYS REV B, V24, P5616, DOI 10.1103/PhysRevB.24.5616; Saito S, 2013, J NUCL MATER, V438, pS895, DOI 10.1016/j.jnucmat.2013.01.194; Ito AM, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014062; Zhou HB, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/11/115010; ACKLAND GJ, 1987, PHILOS MAG A, V56, P15; Tamura T, 2014, MODEL SIMUL MATER SC, V22, DOI 10.1088/0965-0393/22/1/015002; FINNIS MW, 1984, PHILOS MAG A, V50, P45; Chen LB, 2012, SCI CHINA PHYS MECH, V55, P55, DOI 10.1007/s11433-011-4577-5; Baldwin MJ, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035001; Berendsen C., 1984, J CHEM PHYS, V81, P3684; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Hou Q, 2010, J APPL PHYS, V107, DOI 10.1063/1.3354088; Iwakiri H, 2000, J NUCL MATER, V283, P1134, DOI 10.1016/S0022-3115(00)00289-0; Li YG, 2012, J NUCL MATER, V431, P26, DOI 10.1016/j.jnucmat.2011.12.015; Morishita K., 2001, EFFECTS HELIUM RAD D; Ono K, 2009, PHILOS MAG, V89, P513, DOI 10.1080/14786430802629493; Takamura S., 2006, PLASMA FUSION RES, V1, P51, DOI 10.1585/pfr.1.051; Takamura S., 2014, PLASMA FUSION RES, V9	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1071	1074		10.1016/j.jnucmat.2014.12.049		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200233		
J	Motojima, G; Masuzaki, S; Tokitani, M; Kasahara, H; Yoshimura, Y; Kobayashi, M; Sakamoto, R; Morisaki, T; Miyazawa, J; Akiyama, T; Ohno, N; Mutoh, T; Yamada, H				Motojima, G.; Masuzaki, S.; Tokitani, M.; Kasahara, H.; Yoshimura, Y.; Kobayashi, M.; Sakamoto, R.; Morisaki, T.; Miyazawa, J.; Akiyama, T.; Ohno, N.; Mutoh, T.; Yamada, H.		LHD Expt Grp	Global helium particle balance in LHD	JOURNAL OF NUCLEAR MATERIALS			English	Article							FUEL RETENTION; DISCHARGES; EXHAUST	Global helium particle balance in long-pulse discharges is analyzed for the first time in the Large Helical Device (LHD) with the plasma-facing components of the first wall and the divertor tiles composed of stainless steel and carbon, respectively. During the 2-min discharge sustained by ion cyclotron resonance heating (ICRH) and electron cyclotron heating (ECH), helium is observed to be highly retained in the wall (regarded as both the first wall and the divertor tiles). Almost all (about 96%) puffed helium particles (1.3 x 10(22) He) are absorbed in the wall near the end of the discharge. Even though a dynamic retention is eliminated, 56% is still absorbed. The analysis is also applied to longer pulse discharges over 40 min by ICRH and ECH, indicating that the helium wall retention is dynamically changed in time. At the initial phase of the discharge, a mechanism for adsorbing helium other than dynamical retention is invoked. (C) 2014 Elsevier B.V. All rights reserved.	[Motojima, G.; Masuzaki, S.; Tokitani, M.; Kasahara, H.; Yoshimura, Y.; Kobayashi, M.; Sakamoto, R.; Morisaki, T.; Miyazawa, J.; Akiyama, T.; Mutoh, T.; Yamada, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ohno, N.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Motojima, G (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	motojima.gen@lhd.nifs.ac.jp					Douai D, 2011, J NUCL MATER, V415, pS1021, DOI 10.1016/j.jnucmat.2010.11.083; WADE MR, 1995, PHYS PLASMAS, V2, P2357, DOI 10.1063/1.871489; Campbell D.J., 2012, P 24 FUS EN C SAN DI; Day C., 2006, CERN ACC SCH P VAC A; Kasahara H., 2014, 25 IAEA FUS EN C FEC; Komori A, 2010, FUSION SCI TECHNOL, V58, P1; Loarer T, 2007, NUCL FUSION, V47, P1112, DOI 10.1088/0029-5515/47/9/007; Masuzaki S, 2010, FUSION SCI TECHNOL, V58, P321; Nakamura Y, 2001, J NUCL MATER, V290, P1040, DOI 10.1016/S0022-3115(00)00463-3; Sakamoto M, 2004, NUCL FUSION, V44, P693, DOI 10.1088/0029-5515/44/7/001; Schmid K, 2007, NUCL FUSION, V47, P984, DOI 10.1088/0029-5515/47/8/032; Tokitani M., 21 PSI C 2014 KAN JA; Tokitani M, 2013, J NUCL MATER, V438, pS818, DOI 10.1016/j.jnucmat.2013.01.177; Wade M.R., 1995, PHYS REV LETT, V74, P1995; Zastrow KD, 2005, NUCL FUSION, V45, P163, DOI 10.1088/0029-5515/45/3/002	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1080	1083		10.1016/j.jnucmat.2014.10.081		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200235		
J	Hanada, K; Zushi, H; Yoshida, N; Yugami, N; Honda, T; Hasegawa, M; Mishra, K; Kuzmin, A; Nakamura, K; Fujisawa, A; Idei, H; Nagashima, Y; Watanabe, O; Onchi, T; Watanabe, H; Tokunaga, K; Higashijima, A; Kawasaki, S; Nakashima, H; Takase, Y; Fukuyama, A; Mitarai, O; Peng, YKM				Hanada, K.; Zushi, H.; Yoshida, N.; Yugami, N.; Honda, T.; Hasegawa, M.; Mishra, K.; Kuzmin, A.; Nakamura, K.; Fujisawa, A.; Idei, H.; Nagashima, Y.; Watanabe, O.; Onchi, T.; Watanabe, H.; Tokunaga, K.; Higashijima, A.; Kawasaki, S.; Nakashima, H.; Takase, Y.; Fukuyama, A.; Mitarai, O.; Peng, Y. K. M.			Particle balance in long duration RF driven plasmas on QUEST	JOURNAL OF NUCLEAR MATERIALS			English	Article							POWER BALANCE; TRIAM-1M	Global particle balance in non-inductive long-duration plasma on QUEST has been investigated. Approximately 70% of the fuel hydrogen (H) was retained in the wall and then was almost exhausted just after the discharge. The global recycling ratio (R-g), defined as the ratio of the evacuated H-2 flux to that injected, was found to gradually increase during discharges and subsequently rose rapidly. To study the growth of R-g, the thermal desorption spectra after deuterium implantation in a specimen exposed to QUEST plasma was analyzed with a model which includes reflection, diffusion, solution, recombination, trapping, and plasma-induced desorption in the re-deposition layer. The model reconstructs the growth of R-g during a long-duration plasma and indicates solution plays a dominant role in the growth. (C) 2015 Elsevier B.V. All rights reserved.	[Hanada, K.; Zushi, H.; Yoshida, N.; Hasegawa, M.; Kuzmin, A.; Nakamura, K.; Fujisawa, A.; Idei, H.; Nagashima, Y.; Watanabe, O.; Onchi, T.; Watanabe, H.; Tokunaga, K.; Higashijima, A.; Kawasaki, S.; Nakashima, H.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8128580, Japan; [Yugami, N.; Honda, T.; Mishra, K.] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Takase, Y.] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Fukuyama, A.] Kyoto Univ, Grad Sch Technol, Kyoto 6068501, Japan; [Mitarai, O.] Tokai Univ, Sch Ind Engn, Hiratsuka, Kanagawa 25912, Japan; [Peng, Y. K. M.] UT Battelle, Oak Ridge Natl Lab, Columbus, OH USA	Hanada, K (reprint author), Kyushu Univ, Appl Mech Res Inst, 6-1 Kasuga Koen, Kasuga, Fukuoka 8128580, Japan.	hanada@triam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015; Watanabe, Osamu/G-6207-2014	Watanabe, Osamu/0000-0002-5034-5619	NIFS Collaboration Research Program [NIFS13KUTR085, NIFS13KUTR093]; Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC) [11261140328]; ITER-BA;  [24226020];  [24656559]	This work was supported by Grant-in-Aid for JSPS Fellows (KAKENHI Grant Nos. 24226020 and 24656559) and performed with the support and under the auspices of the NIFS Collaboration Research Program (NIFS13KUTR085 and NIFS13KUTR093). This work was also supported in part by the Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University and by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328) and ITER-BA.	Tashima S, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/2/023010; Hanada K, 2006, FUSION ENG DES, V81, P2257, DOI 10.1016/j.fusengdes.2006.03.004; Valanju PM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3110984; Mayer M, 2001, J NUCL MATER, V290, P381, DOI 10.1016/S0022-3115(00)00486-4; Tanabe T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014044; Ryutov DD, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2738399; Ishiguro M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4731700; Banerjee S, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4890359; Hanada K., 2012, IEEJ A, V132, P490; Hanada K, 2007, J NUCL MATER, V363, P1425, DOI 10.1016/j.jnucmat.2007.01.255; Hanada K, 2011, PLASMA SCI TECHNOL, V13, P307, DOI 10.1088/1009-0630/13/3/08; Idei H., 2007, P 32 INT C INFR MILL, P789; Idei H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4891710; Kirk A, 2004, PLASMA PHYS CONTR F, V46, P551, DOI 10.1088/0741-3335/46/3/009; Kuzmin A., J NUCL MAT IN PRESS; Mishra K, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4889903; Paul SF, 2005, J NUCL MATER, V337, P251, DOI 10.1016/j.jnucmat.2004.10.153; Sakamoto M., 2004, NUCL FUSION, V44, pP693; Sharma S.K., 2010, J PLASMA FUSION RES, V9, P142; Yugami N., 2014, PSI 2014 M MAY 2014, pP3; Zushi H, 2005, NUCL FUSION, V45, pS142, DOI 10.1088/0029-5515/45/10/S12	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1084	1086		10.1016/j.jnucmat.2015.01.013		3	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200236		
J	Kuzmin, A; Zushi, H; Takagi, I; Sharma, SK; Rusinov, A; Inoue, Y; Hirooka, Y; Zhou, H; Kobayashi, M; Sakamoto, M; Hanada, K; Yoshida, N; Nakamura, K; Fujisawa, A; Matsuoka, K; Idei, H; Nagashima, Y; Hasegawa, M; Onchi, T; Banerjee, S; Mishra, K				Kuzmin, A.; Zushi, H.; Takagi, I.; Sharma, S. K.; Rusinov, A.; Inoue, Y.; Hirooka, Y.; Zhou, H.; Kobayashi, M.; Sakamoto, M.; Hanada, K.; Yoshida, N.; Nakamura, K.; Fujisawa, A.; Matsuoka, K.; Idei, H.; Nagashima, Y.; Hasegawa, M.; Onchi, T.; Banerjee, S.; Mishra, K.			Global gas balance and influence of atomic hydrogen irradiation on the wall inventory in steady-state operation of QUEST tokamak	JOURNAL OF NUCLEAR MATERIALS			English	Article							FUEL RETENTION	Hydrogen wall pumping is studied in steady state tokamak operation (SSTO) of QUEST with all metal plasma facing materials PFMs at 100 degrees C. The duration of SSTO is up to 820 sinfully non-inductive plasma. Global gas balance analysis shows that wall pumping at the apparent (retention-release) rate of 1-6 x 10(18) H/s is dominant and 70-80% of injected H-2 can be retained in PFMs. However, immediately after plasma termination the H-2 release rate enhances to 1018 H/s. In order to understand a true retention process the direct measurement of retention flux has been carried out by permeation probes. The comparison between the evaluated wall retention and results from global analysis is discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Kuzmin, A.; Zushi, H.; Rusinov, A.; Hanada, K.; Yoshida, N.; Nakamura, K.; Fujisawa, A.; Matsuoka, K.; Idei, H.; Nagashima, Y.; Hasegawa, M.; Onchi, T.] Kyushu Univ, RIAM, Kasuga, Fukuoka 8168580, Japan; [Takagi, I.] Kyoto Univ, Grad Sch Engn, Kyoto 6068501, Japan; [Sharma, S. K.] Inst Plasma Res, Ahmadabad, Gujarat, India; [Inoue, Y.; Banerjee, S.; Mishra, K.] Kyushu Univ, IGSES, Kasuga, Fukuoka 8168580, Japan; [Hirooka, Y.; Kobayashi, M.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Zhou, H.] Grad Sch Adv Studies, Toki, Gifu 5095292, Japan; [Sakamoto, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan	Kuzmin, A (reprint author), Kyushu Univ, RIAM, 6-1 Kasugakoen, Kasuga, Fukuoka 8168580, Japan.	kuzmin@triam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		Scientific Research [S24226020]; NIFS collaboration Research Program [NIFS11KUTR063]	This work is supported by Grants-in-aid for Scientific Research (S24226020). This work is also performed with the support and under the auspices of the NIFS collaboration Research Program (NIFS11KUTR063).	Brezinsek S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083023; Roth J, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/10/103001; Hong SH, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103027; Haas G, 1998, VACUUM, V51, P39, DOI 10.1016/S0042-207X(98)00131-6; Hanada K., 2008, P 22 INT C FUS EN 20; Hartl T, 2013, FUSION ENG DES, V88, P2194, DOI 10.1016/j.fusengdes.2013.05.068; Loarer T, 2013, J NUCL MATER, V438, pS108, DOI 10.1016/j.jnucmat.2013.01.017; Longhurst G.R., INEELEXT0401657 ID N; Pegourie B, 2004, PHYS SCRIPTA, VT111, P23; Rohde V, 2009, J NUCL MATER, V390-91, P474, DOI 10.1016/j.jnucmat.2009.01.047; Sharma SK, 2012, J NUCL MATER, V420, P83, DOI 10.1016/j.jnucmat.2011.09.026	11	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1087	1090		10.1016/j.jnucmat.2014.12.092		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200237		
J	Takahashi, H; Osakabe, M; Nagaoka, K; Nakano, H; Tokitani, M; Fujii, K; Murakami, S; Takeiri, Y; Seki, T; Saito, K; Kasahara, H; Seki, R; Kamio, S; Masuzaki, S; Mutoh, T				Takahashi, H.; Osakabe, M.; Nagaoka, K.; Nakano, H.; Tokitani, M.; Fujii, K.; Murakami, S.; Takeiri, Y.; Seki, T.; Saito, K.; Kasahara, H.; Seki, R.; Kamio, S.; Masuzaki, S.; Mutoh, T.		LHD Expt Grp	Effect of the RF wall conditioning on the high performance plasmas in the Large Helical Device	JOURNAL OF NUCLEAR MATERIALS			English	Article							LHD	The wall conditioning using radio frequency (RF) plasma was carried out using Ion Cyclotron Range of Frequency (ICRF) heating and/or Electron Cyclotron Resonance Heating (ECRH) with the working gas of helium under the established confinement magnetic field. After sufficient numbers of repetitive wall discharge conditioning (DC, ICDC for ICRF and ECDC for ECRH), the formation of the parabolic electron density profile and the increase of the central ion temperature T-i were observed. There was no difference in the attained central T-i of the NBI discharge just after the conditioning using a similar value of input energy regardless of the applied RF source. Thus, it is concluded that both ICDC and the ECDC are effective for the higher T-i plasma production under the established magnetic field in the Large Helical Device. The effective RF wall conditioning scenarios are also investigated for high T-i plasma production. (C) 2014 Elsevier B.V. All rights reserved.	[Takahashi, H.; Osakabe, M.; Nagaoka, K.; Nakano, H.; Tokitani, M.; Takeiri, Y.; Seki, T.; Saito, K.; Kasahara, H.; Seki, R.; Kamio, S.; Masuzaki, S.; Mutoh, T.; LHD Expt Grp] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Fujii, K.] Kyoto Univ, Dept Mech Engn & Sci, Kyoto 6158540, Japan; [Murakami, S.] Kyoto Univ, Dept Nucl Engn, Kyoto 6068501, Japan	Takahashi, H (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	takahashi.hiromi@LHD.nifs.ac.jp			NIFS [ULRR701, ULRR702, ULRR703]	This work was supported by the NIFS grants, ULRR701, 702, and 703.	Ohyabu N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.055002; Nagaoka K, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083022; Douai D, 2011, J NUCL MATER, V415, pS1021, DOI 10.1016/j.jnucmat.2010.11.083; Takahashi H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073034; de la Cal E, 2005, PLASMA PHYS CONTR F, V47, P197, DOI 10.1088/0741-3335/47/2/001; Douai D., 2014, 21 INT C PSI KAN JAP, V120; IIYOSHI A, 1990, FUSION TECHNOL, V17, P169; Kaneko O, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104015; Komori A, 2009, J NUCL MATER, V390-91, P232, DOI 10.1016/j.jnucmat.2009.01.064; Li J, 2011, J NUCL MATER, V415, pS35, DOI 10.1016/j.jnucmat.2010.10.048; Masuzaki S, 2010, FUSION SCI TECHNOL, V58, P297; Nishimura K, 2005, J NUCL MATER, V337, P431, DOI 10.1016/j.jnucmat.2004.10.152; Sagara A., 1999, J PLASMA FUSION RES, V75, P263, DOI 10.1585/jspf.75.263; Takahashi H., 2014, PLASMA FUSION RES, V9, DOI DOI 10.1585/PFR.9.1402050; Takeiri Y., 2015, PLASMA FUSION RES, V10; Tokitani M, 2010, FUSION SCI TECHNOL, V58, P305	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1100	1103		10.1016/j.jnucmat.2014.11.131		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200240		
J	Bobyr, NP; Alimov, VK; Khripunov, BI; Spitsyn, AV; Mayer, M; Hatano, Y; Golubeva, AV; Petrov, VB				Bobyr, N. P.; Alimov, V. Kh.; Khripunov, B. I.; Spitsyn, A. V.; Mayer, M.; Hatano, Y.; Golubeva, A. V.; Petrov, V. B.			Influence of helium on hydrogen isotope exchange in tungsten at sequential exposures to deuterium and helium-protium plasmas	JOURNAL OF NUCLEAR MATERIALS			English	Article							LOW-ENERGY; RETENTION; IRRADIATIONS	Hydrogen isotopes exchange in tungsten was investigated after sequential exposures to low energy deuterium (D) and helium-seeded protium (He-seeded H) plasmas at sample temperatures of 403 and 533 K. Deuterium depth profiles were measured by the D(He-3, p)He-4 nuclear reaction with 3He energies between 0.69 and 4.5 MeV allowing determination of the D concentration up to a depth of 8 mu m. It was found that a significant part of the deuterium initially retained in tungsten after D plasma exposure was released during sequential exposure to a protium plasma. However, exposure of the D-plasma-exposed W samples to the He-seeded H plasma reduces the amount of released deuterium as compared to pure H plasma exposure. (C) 2014 Elsevier B.V. All rights reserved.	[Bobyr, N. P.; Khripunov, B. I.; Spitsyn, A. V.; Golubeva, A. V.; Petrov, V. B.] NRC Kurcharov Inst, Moscow 123182, Russia; [Alimov, V. Kh.; Mayer, M.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Alimov, V. Kh.; Hatano, Y.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan	Bobyr, NP (reprint author), NRC Kurcharov Inst, Ac Kurcharov Sq 1-1, Moscow 123182, Russia.	NPBobyr@gmail.com	Spitsyn, Alexander/A-2989-2014; 	Mayer, Matej/0000-0002-5337-6963			Alimov VK, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014037; Alimov VK, 2011, J NUCL MATER, V417, P572, DOI 10.1016/j.jnucmat.2011.01.088; Alimov VK, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014048; Skinner CH, 2008, FUSION SCI TECHNOL, V54, P891; Federici G, 2001, NUCL FUSION, V41, P1967, DOI 10.1088/0029-5515/41/12/218; Schmid K, 2012, NUCL INSTRUM METH B, V281, P64, DOI 10.1016/j.nimb.2012.03.024; Ueda Y, 2009, J NUCL MATER, V386-88, P725, DOI 10.1016/j.jnucmat.2008.12.300; Alimov VK, 2012, J NUCL MATER, V420, P519, DOI 10.1016/j.jnucmat.2011.11.003; Alimov VK, 2012, J NUCL MATER, V420, P370, DOI 10.1016/j.jnucmat.2011.10.025; Lee HT, 2007, J NUCL MATER, V363, P898, DOI 10.1016/j.jnucmat.2007.01.111; Baldwin MJ, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103021; Hatano Y, 2013, J NUCL MATER, V438, pS114, DOI 10.1016/j.jnucmat.2013.01.018; Iwakiri H, 2000, J NUCL MATER, V283, P1134, DOI 10.1016/S0022-3115(00)00289-0; Khripunov B.I., 1995, FUSION TECHNOL, V1994, P243; Mayer M., 1997, 9113 IPP; Roth J, 2013, J NUCL MATER, V432, P341, DOI 10.1016/j.jnucmat.2012.08.004; Tobita K, 2006, FUSION ENG DES, V81, P1151, DOI 10.1016/j.fusengdes.2005.08.058	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1122	1124		10.1016/j.jnucmat.2014.12.022		3	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200245		
J	Takagi, I; Nomura, S; Minamimoto, T; Akiyoshi, M; Kobayashi, T; Sasaki, T				Takagi, Ikuji; Nomura, Shinji; Minamimoto, Toshihiro; Akiyoshi, Masafumi; Kobayashi, Taishi; Sasaki, Takayuki			Hydrogen-deuterium exchange on plasma-exposed W and SS surface	JOURNAL OF NUCLEAR MATERIALS			English	Article							STAINLESS-STEEL; ISOTOPE-EXCHANGE; GLOW-DISCHARGES; ENERGY HYDROGEN; TUNGSTEN; TRITIUM; REPLACEMENT; REFLECTION; REMOVAL	The desorption cross section for hydrogen isotopes adsorbed on stainless steel (SS) and tungsten (W) has been evaluated experimentally to provide basic information on tritium exchange. One side of a sample sheet was alternately exposed to H and D plasma, and deuterium density on the surface was repeatedly observed using nuclear reaction analysis (NRA) under continuous plasma exposure. From the time dependent change in the deuterium density, the desorption cross sections for SS and W were estimated to be 6.9 +/- 2.3 x 10(-23) m(2) and 4.6 +/- 1.0 x 10(-23) m(2), respectively. No significant differences in the cross section between H and D plasma were observed. Recombinative desorption was found to dominate the desorption process owing to the low incident energy of hydrogen atoms. (C) 2014 Elsevier B.V. All rights reserved.	[Takagi, Ikuji; Nomura, Shinji; Minamimoto, Toshihiro; Akiyoshi, Masafumi; Kobayashi, Taishi; Sasaki, Takayuki] Kyoto Univ, Dept Nucl Engn, Kyoto 6068501, Japan	Takagi, I (reprint author), Kyoto Daigaku Katsura, Nishikyo Ku, Kyoto 6158540, Japan.	takagi@nucleng.kyoto-u.ac.jp					AKAISHI K, 1987, J NUCL MATER, V145, P275, DOI 10.1016/0022-3115(87)90342-4; Akiyoshi M, 2005, NUCL INSTRUM METH B, V232, P173, DOI 10.1016/j.nimb.2005.03.041; Alimov VK, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014037; Hino T, 2012, FUSION ENG DES, V87, P876, DOI 10.1016/j.fusengdes.2012.02.051; Roth J, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/10/103001; Bastasz R., 1981, J NUCL MATER, V103 & 104, P499, DOI 10.1016/0022-3115(82)90647-X; BASTASZ R, 1982, J NUCL MATER, V111, P805, DOI 10.1016/0022-3115(82)90310-5; BLEWER RS, 1978, J NUCL MATER, V76-7, P305, DOI 10.1016/0022-3115(78)90162-9; ECKSTEIN W, 1985, APPL PHYS A-MATER, V38, P123, DOI 10.1007/BF00620463; ESTRUP PJ, 1966, J CHEM PHYS, V45, P2254, DOI 10.1063/1.1727919; HORTON LD, 1992, J NUCL MATER, V196, P139, DOI 10.1016/S0022-3115(06)80020-6; Nakamura H, 2004, FUSION ENG DES, V70, P163, DOI 10.1016/j.fusengdes.2003.11.001; Roth J, 2013, J NUCL MATER, V432, P341, DOI 10.1016/j.jnucmat.2012.08.004; Takagi I, 2011, J NUCL MATER, V417, P564, DOI 10.1016/j.jnucmat.2010.12.115; Takagi I., 2002, FUSION SCI TECHNOL, V31, P902; Takagi I, 2001, J NUCL MATER, V290, P501, DOI 10.1016/S0022-3115(00)00442-6; Takagi I, 1998, FUSION ENG DES, V41, P73, DOI 10.1016/S0920-3796(97)00179-8; Tanabe T, 2009, J NUCL MATER, V390-91, P705, DOI 10.1016/j.jnucmat.2009.01.194	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1125	1128		10.1016/j.jnucmat.2014.11.037		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200246		
J	Takizuka, T; Tokunaga, S; Hoshino, K; Shimizu, K; Asakura, N				Takizuka, T.; Tokunaga, S.; Hoshino, K.; Shimizu, K.; Asakura, N.			Combination of helical ferritic-steel inserts and flux-tube-expansion divertor for the heat control in tokamak DEMO reactor	JOURNAL OF NUCLEAR MATERIALS			English	Article								Edge localized modes (ELMS) in the H-mode operation of tokamak reactors may be suppressed/mitigated by the resonant magnetic perturbation (RMP), but RMP coils are considered incompatible with DEMO reactors under the strong neutron flux. We propose an innovative concept of the RMP without installing coils but inserting ferritic steels of the helical configuration. Helically perturbed field is naturally formed in the axisymmetric toroidal field through the helical ferritic steel inserts (FSIs). When ELMs are avoided, large stationary heat load on divertor plates can be reduced by adopting a flux-tube-expansion (FEE) divertor like an X divertor. Separatrix shape and divertor-plate inclination are similar to those of a simple long-leg divertor configuration. Combination of the helical FSIs and the FTE divertor is a suitable method for the heat control to avoid transient ELM heat pulse and to reduce stationary divertor heat load in a tokamak DEMO reactor. (C) 2014 Elsevier B.V. All rights reserved.	[Takizuka, T.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Tokunaga, S.; Hoshino, K.; Asakura, N.] Japan Atom Energy Agcy, Aomori 0393212, Japan; [Shimizu, K.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan	Takizuka, T (reprint author), 1284-21 Muramatsu, Tokai, Ibaraki 3191112, Japan.	takizuka.tomonori@gmail.com	Hoshino, Kazuo/D-6931-2013	Hoshino, Kazuo/0000-0001-5672-9640	Japan Society for the Promotion of Science [24360382]	This work was supported by the Grant-in-Aid for Scientific Research (B) 24360382 from Japan Society for the Promotion of Science. The authors acknowledge the collaborators on this research program, Prof. A. Fukuyama of Kyoto University, Prof. T. Fukuda of Osaka University, and Dr. N. Hayashi, Dr. M. Honda and Dr. N. Oyama of Japan Atomic Energy Agency (JAEA). They thank Dr. K. Tobita, Dr. M. Kikuchi and Dr. M. Yagi of JAEA for fruitful discussion about reactor designs. One of authors, TT, is grateful to Prof. Y. Ueda of Osaka University for his continuous encouragement.	Herrmann A, 2002, PLASMA PHYS CONTR F, V44, P883, DOI 10.1088/0741-3335/44/6/318; Valanju PM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3110984; Kotschenreuther M, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2739422; Evans TE, 2013, J NUCL MATER, V438, pS11, DOI 10.1016/j.jnucmat.2013.01.283; Loarte A, 2007, NUCL FUSION, V47, pS203, DOI 10.1088/0029-5515/47/6/S04; Ryutov DD, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2738399; Hishinuma A, 1998, J NUCL MATER, V258, P193, DOI 10.1016/S0022-3115(98)00395-X; Hoshino K, 2012, CONTRIB PLASM PHYS, V52, P550, DOI 10.1002/ctpp.201210048; Takizuka T, 2013, FUSION SCI TECHNOL, V63, P64	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1229	1232		10.1016/j.jnucmat.2014.12.065		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200269		
J	Asakura, N; Hoshino, K; Shimizu, K; Shinya, K; Utoh, H; Tokunaga, S; Tobita, K; Ohno, N				Asakura, N.; Hoshino, K.; Shimizu, K.; Shinya, K.; Utoh, H.; Tokunaga, S.; Tobita, K.; Ohno, N.			Simulation study of power load with impurity seeding in advanced divertor "short super-X divertor" for a tokamak reactor	JOURNAL OF NUCLEAR MATERIALS			English	Article							CONFIGURATION; DEMO	A short super-X divertor (SXD) is proposed as an option for the Demo divertor, where the field line length from the divertor null to the outer target was largely increased compared to a similar-size conventional divertor. Physics and engineering design studies for a 3 GW-level fusion power Demo reactor (SlimCS) (Tobita et al., 2009) have recently progressed. Minimal number of the divertor coils were installed inside the toroidal field coil, i.e. interlink-winding. Arrangement of the poloidal field coils and their currents were determined, taking into account of the engineering design such as vacuum vessel and the neutron shield structures, and the divertor maintenance scenario. Divertor plasma simulation showed that significant radiation region is produced between the super-X null and the target. Radiation loss in the divertor was increased, producing fully detached plasmas efficiently. Advantages of the short SXD were demonstrated, but the total peak heat load was a marginal level (10 MW m(-2)) for the engineering design. (C) 2015 Elsevier B.V. All rights reserved.	[Asakura, N.; Hoshino, K.; Utoh, H.; Tokunaga, S.; Tobita, K.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan; [Shimizu, K.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Shinya, K.] Toshiba Nucl Engn Serv Co, Isogo Ku, Yokohama, Kanagawa 258523, Japan; [Ohno, N.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Asakura, N (reprint author), Japan Atom Energy Agcy, 2-166 Omotedate, Rokkasho, Aomori 0393212, Japan.	asakura.nobuyuki@jaea.go.jp	Hoshino, Kazuo/D-6931-2013	Hoshino, Kazuo/0000-0001-5672-9640	MEXT [25420899]	This work was carried out within the framework of the Broader Approach DEMO Design Activity, was partly supported by Grant-in-Aid No. 25420899 from MEXT.	Pitcher CS, 1997, PLASMA PHYS CONTR F, V39, P779, DOI 10.1088/0741-3335/39/6/001; Umansky MV, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075005; Soukhanovskii VA, 2013, J NUCL MATER, V438, pS96, DOI 10.1016/j.jnucmat.2013.01.015; Piras F, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/5/055009; Kotschenreuther M, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2739422; Ryutov DD, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2738399; Ryutov DD, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2967900; Asakura N, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123013; Asakura N, 2013, FUSION SCI TECHNOL, V63, P70; Kukushkin AS, 2013, J NUCL MATER, V438, pS203, DOI 10.1016/j.jnucmat.2013.01.027; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029; Utoh H, 2014, FUSION ENG DES, V89, P2456, DOI 10.1016/j.fusengdes.2014.03.011; Valanju P.M., 2009, FUSION ENG DES, V51	13	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1238	1242		10.1016/j.jnucmat.2015.01.068		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200271		
J	Hirai, T; Escourbiac, F; Barabash, V; Durocher, A; Fedosov, A; Ferrand, L; Jokinen, T; Komarov, V; Merola, M; Carpentier-Chouchana, S; Arkhipov, N; Kuznetcov, V; Volodin, A; Suzuki, S; Ezato, K; Seki, Y; Riccardi, B; Bednarek, M; Gavila, P				Hirai, T.; Escourbiac, F.; Barabash, V.; Durocher, A.; Fedosov, A.; Ferrand, L.; Jokinen, T.; Komarov, V.; Merola, M.; Carpentier-Chouchana, S.; Arkhipov, N.; Kuznetcov, V.; Volodin, A.; Suzuki, S.; Ezato, K.; Seki, Y.; Riccardi, B.; Bednarek, M.; Gavila, P.			Status of technology R&D for the ITER tungsten divertor monoblock	JOURNAL OF NUCLEAR MATERIALS			English	Article								In order to develop and validate the high performance tungsten monoblock technology, the full-tungsten divertor qualification program was defined. As the first step, small-scale mock-ups were manufactured and successfully tested under the required high heat flux loads. The test results demonstrated that the technology is available in Japan and Europe. Post-tests observation of the loaded W monoblocks showed generation of self-castellation - a crack along coolant tube axis. The cause of the self-castellation was discussed and a tungsten material characterization program is being developed with the objective to understand mechanical properties that influence the occurrence of the self-castellation. (C) 2015 ITER Organization. Published by Elsevier B.V. All rights reserved.	[Hirai, T.; Escourbiac, F.; Barabash, V.; Durocher, A.; Fedosov, A.; Ferrand, L.; Jokinen, T.; Komarov, V.; Merola, M.; Carpentier-Chouchana, S.] ITER Org, F-13067 St Paul Les Durance, France; [Arkhipov, N.] Project Ctr ITER, Moscow 123182, Russia; [Kuznetcov, V.; Volodin, A.] DV Efremov Sci Res Inst Electrophys Apparatus, St Petersburg 196641, Russia; [Suzuki, S.; Ezato, K.; Seki, Y.] Fus Res & Dev Directorate JAEA, JAEA, Naka, Ibaraki 3110193, Japan; [Riccardi, B.; Bednarek, M.; Gavila, P.] F4E, E-08019 Barcelona, Spain	Hirai, T (reprint author), ITER Org, Route Vinon Sur Verdon,CS 90 046, F-13067 St Paul Les Durance, France.	takeshi.hirai@iter.org					Akiba M., 1991, PLASMA DEVICES OPER, V1, P205, DOI 10.1080/10519999108225538; Pintsuk G, 2013, FUSION ENG DES, V88, P1858, DOI 10.1016/j.fusengdes.2013.05.091; Hirai T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014006; Hirai T, 2013, FUSION ENG DES, V88, P1798, DOI 10.1016/j.fusengdes.2013.05.010; Hirai T, 2009, J NUCL MATER, V390-91, P751, DOI 10.1016/j.jnucmat.2009.01.313; Campbell D., 2012, 24 IAEA FUS EN C SAN; Carpentier-Chouchana S, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014002; Davis JW, 1998, J NUCL MATER, V258, P308, DOI 10.1016/S0022-3115(98)00285-2; Dieter G. E., 1988, MECH METALLURGY SI M; ESCOURBIAC F., 2012, 24 IAEA FUS EN C SAN; Ezato K., 2014, PROGR ITER FULL TUNG; Gavila P., 2014, HIGH HEAT FLUX TESTI; Kuznetsov V, 2014, FUSION ENG DES, V89, P955, DOI 10.1016/j.fusengdes.2014.04.064; Mertens P, 2013, J NUCL MATER, V438, pS401, DOI 10.1016/j.jnucmat.2013.01.080; Pintsuk G., 2014, CHARACTERIZATION ITE; Pitts RA, 2013, J NUCL MATER, V438, pS48, DOI 10.1016/j.jnucmat.2013.01.008; Seki Y., 2014, IAEA 25 FUS EN C ST; Suzuki S., 2013, R D PROCUREMENT STAT	18	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	AUG	2015	463						1248	1251		10.1016/j.jnucmat.2014.12.027		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CN5KC	WOS:000358467200273		
J	Kubota, Y; Higashiyama, A; Imano, H; Sugiyama, D; Kawamura, K; Kadota, A; Nishimura, K; Miyamatsu, N; Miyamoto, Y; Okamura, T				Kubota, Y.; Higashiyama, A.; Imano, H.; Sugiyama, D.; Kawamura, K.; Kadota, A.; Nishimura, K.; Miyamatsu, N.; Miyamoto, Y.; Okamura, T.			Serum polyunsaturated fatty acid composition and serum high-sensitivity C-reactive protein levels in healthy Japanese residents: The KOBE study	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						n-3 polyunsaturated fatty acid; long chain n-3 polyunsaturated fatty acid; n-6 polyunsaturated fatty acid; hs-CRP	CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; DIETARY-INTAKE; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; LINOLENIC ACID; N-3; RISK; MEN; ASSOCIATION	Serum polyunsaturated fatty acid (PUFA) composition reflects dietary intake and is related to risks for cardiovascular diseases. We hypothesized that serum n-3 PUFA composition, especially including long-chain n-3 PUFA such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), is associated with inflammatory status, which is related to increased risk for cardiovascular diseases. We investigated the relationship between serum PUFA composition and high-sensitivity C-reactive protein (hs-CRP) levels in a cross-sectional study among 1,102 healthy men and women aged 40-74 years who reside in Kobe City. Multiple linear regression models that predict hs-CRP level were prepared to confirm the contribution of serum total n-3 PUFA, long-chain n-3 PUFA, EPA and DHA compositions after adjusting for other PUFAs and atherosclerotic risk factors. The serum n-3 PUFA, particularly long-chain n-3 PUFA, compositions were inversely associated with the hs-CRP levels. The standardized regression coefficient was -0.089 (p < 0.01) for total n-3 PUFA, -0.091 (p < 0.01) for long-chain n-3 PUFA, -0.071 (p = 0.03) for EPA, and -0.068 (p = 0.04) for DHA. The n-6 PUFA compositions were also inversely associated with the hs-CRP levels (-0.169 [p < 0.01] for total n-6 PUFA and -0.159 [p < 0.01] for linoleic acid). The serum n-3 PUFA compositions were inversely related with the hs-CRP levels, similar associations were also observed in n-6 PUFA compositions. Our results suggest that dietary PUFA intake was inversely associated with attenuated inflammation in healthy Japanese population.	[Kubota, Y.; Higashiyama, A.; Imano, H.; Sugiyama, D.; Kadota, A.; Nishimura, K.; Miyamatsu, N.; Miyamoto, Y.; Okamura, T.] Fdn Biomed Res & Innovat, Inst Biomed Res & Innovat, Dept Res & Dev Preempt & Prevent Med, Cohort Study Team, Kobe, Hyogo, Japan; [Kubota, Y.; Higashiyama, A.] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan; [Higashiyama, A.; Nishimura, K.; Miyamoto, Y.] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan; [Sugiyama, D.; Okamura, T.] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Kawamura, K.] Fdn Biomed Res & Innovat, Procluster Kobe, Kobe, Hyogo, Japan; [Kadota, A.] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Shiga, Japan; [Miyamatsu, N.] Shiga Univ Med Sci, Dept Clin Nursing, Shiga, Japan	Kubota, Y (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	yo-kubota@hyo-med.ac.jp			Regional Innovation Cluster Program, Global Type, Ministry of Education, Culture, Sports, Science and Technology; Japan society for the promotion of science [24590844, 25460824, 23390178]	This study was supported by grants from Regional Innovation Cluster Program, Global Type, Ministry of Education, Culture, Sports, Science and Technology and by a grant-in-aid for scientific research (C) 24590844, (C) 25460824 and (B) 23390178 from the Japan society for the promotion of science. The authors thank all the volunteers participated in the KOBE study, research staff members and the KOBE municipal government for supporting to conduct the survey.	Blaha MJ, 2011, ARTERIOSCL THROM VAS, V31, P1430, DOI 10.1161/ATVBAHA.111.223768; Czernichow S, 2010, BRIT J NUTR, V104, P788, DOI 10.1017/S0007114510002096; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Iso H, 2002, STROKE, V33, P2086, DOI 10.1161/01.STR.0000023890.25066.50; Sekikawa A, 2011, STROKE, V42, P2538, DOI 10.1161/STROKEAHA.110.613042; Pischon T, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.CIR.0000079224.46084.C2; Calder PC, 2004, CLIN SCI, V107, P1; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Kalogeropoulos N, 2010, CLIN CHIM ACTA, V411, P584, DOI 10.1016/j.cca.2010.01.023; Niu KJ, 2006, AM J CLIN NUTR, V84, P223; Micallef MA, 2009, EUR J CLIN NUTR, V63, P1154, DOI 10.1038/ejcn.2009.20; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ohsawa M, 2008, ATHEROSCLEROSIS, V201, P184, DOI 10.1016/j.atherosclerosis.2008.01.008; Tomiyama H, 2011, ATHEROSCLEROSIS, V217, P433, DOI 10.1016/j.atherosclerosis.2011.04.004; Hu FB, 2001, J AM COLL NUTR, V20, P5; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Poudel-Tandukar K, 2009, NUTR RES, V29, P363, DOI 10.1016/j.nutres.2009.05.012; ISO H, 1989, INT J EPIDEMIOL, V18, P374, DOI 10.1093/ije/18.2.374; Dacks PA, 2013, J NUTR HEALTH AGING, V17, P240, DOI 10.1007/s12603-012-0431-3; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Jung UJ, 2012, ARTERIOSCL THROM VAS, V32, P2929, DOI 10.1161/ATVBAHA.112.300188; SARKKINEN ES, 1994, AM J CLIN NUTR, V59, P364; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atheroselerosis.2007.11.008; Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Harris WS, 1997, AM J CLIN NUTR, V65, P1645; Higashiyama A, 2012, J ATHEROSCLER THROMB, V19, P1027; Hingorani AD, 2012, EUR HEART J, V33, P2258, DOI 10.1093/eurheartj/ehs168; Iso H, 2012, J ATHEROSCLER THROMB, V19, P756; James MJ, 2000, AM J CLIN NUTR, V71, p343S; Kaikkonen JE, 2014, FREE RADICAL RES, V48, P420, DOI 10.3109/10715762.2014.883071; OZAWA A, 1982, BUNSEKI KAGAKU, V31, P87; Poudel-Tandukar K, 2012, ATHEROSCLEROSIS, V220, P520, DOI 10.1016/j.atherosclerosis.2011.11.012; Rangel-Huerta OD, 2012, BRIT J NUTR, V107, pS159, DOI 10.1017/S0007114512001559; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Wang XP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-25; Yoneyama S, 2007, J EPIDEMIOL, V17, P86, DOI 10.2188/jea.17.86	41	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	AUG	2015	19	7					719	728		10.1007/s12603-015-0497-9		10	Geriatrics & Gerontology; Nutrition & Dietetics	Geriatrics & Gerontology; Nutrition & Dietetics	CN5CQ	WOS:000358447600002		
J	Wada, A				Wada, Akiyoshi			Verification of tropical cyclone heat potential for tropical cyclone intensity forecasting in the Western North Pacific	JOURNAL OF OCEANOGRAPHY			English	Article						Tropical cyclone intensity forecast; Tropical cyclone deepening; Tropical cyclone heat potential; 26 degrees C isothermal depth; Ocean data assimilation; Profiling float	OCEAN THERMAL STRUCTURE; MONSOON; INTENSIFICATION; CYCLOGENESIS; VARIABILITY; ALTIMETRY; DYNAMICS	Tropical cyclone heat potential (TCHP) is a measurable metric calculated by the summation of ocean heat content from the surface down to the depth of the 26 A degrees C isotherm. TCHP calculated by the Meteorological Research Institute multivariate ocean variational estimation (MOVE) system is verified by using TCHP based on in situ observations by profiling floats during 2002-2012. After the verification, the threshold of MOVE-based TCHP before the passage of a tropical cyclone (TC) favorable for triggering TC deepening is determined by best-track central pressure drops for the nearest 6 hours from 1985 to 2012. The threshold is specified as the minimum range of TCHP when the ratio of the number of records for TC deepening to the total best-track number of records in a TCHP bin is significantly greater than the reference ratio determined for each domain at a significance level of 0.05. The threshold is relatively low (40-60 kJ cm(-2)) around 5-10A degrees N, west of 120A degrees E and east of 140A degrees E, whereas it is relatively high (80-100 kJ cm(-2)) around 15-20A degrees N. Around 5-10A degrees N, the ratio for each moving speed shows two peaks: with moving speeds of 3-5 and 7-9 m s(-1). The former case is exemplified by Typhoon Mike (1990) under relatively low TCHP (< 80 kJ cm(-2)), whereas the latter case is exemplified by Typhoon Haiyan (2013), which is more rapidly intensified and reaches a lower minimum central pressure under relatively high TCHP (> 120 kJ cm(-2)).	Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan	Wada, A (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	awada@mri-jma.go.jp			JSPS KAKENHI [15K05292]	The author is grateful to Mr. M. Higaki, S. Matsumoto, and S. Ishizaki for providing the data sets used in this study. This study was supported by N. Koide and colleagues in the Japan Meteorological Agency and Meteorological Research Institute. The author thanks two anonymous reviewers for providing useful comments on improving the original version of this manuscript. This work was supported by JSPS KAKENHI Grant Number 15K05292.	Ali M. M., 2007, EOS T AM GEOPHYS UN, V88, P93, DOI [10.1029/2007EO080001, DOI 10.1029/2007EO080001]; Ali MM, 2012, IEEE GEOSCI REMOTE S, V9, P1114, DOI 10.1109/LGRS.2012.2190491; Ritchie EA, 1999, MON WEATHER REV, V127, P2027, DOI 10.1175/1520-0493(1999)127<2027:LSPAWT>2.0.CO;2; Wang Y, 2004, METEOROL ATMOS PHYS, V87, P257, DOI 10.1007/s00703-003-0055-6; Wada A, 2007, J OCEANOGR, V63, P427, DOI 10.1007/s10872-007-0039-0; Wang B, 2008, METEOROL ATMOS PHYS, V99, P1, DOI 10.1007/s00703-006-0238-z; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; [Anonymous], 2005, TECHNICAL REPORTS ME; Pun IF, 2013, GEOPHYS RES LETT, V40, P4680, DOI 10.1002/grl.50548; Lin II, 2009, MON WEATHER REV, V137, P3744, DOI 10.1175/2009MWR2713.1; Shay LK, 2010, MON WEATHER REV, V138, P2110, DOI 10.1175/2010MWR3189.1; Usui N, 2006, ADV SPACE RES, V37, P806, DOI 10.1016/j.asr.2005.09.022; HOLLAND GJ, 1995, METEOROL ATMOS PHYS, V56, P57, DOI 10.1007/BF01022521; Wada A, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017583; [Anonymous], 2005, ADV METEOROL, DOI DOI 10.1155/2010/756071; Gjorgjievska S, 2014, ATMOS CHEM PHYS, V14, P3065, DOI 10.5194/acp-14-3065-2014; Rogers R, 2013, MON WEATHER REV, V141, P2970, DOI 10.1175/MWR-D-12-00357.1; Wada A, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011993; Wada A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035129; Shay LK, 2000, MON WEATHER REV, V128, P1366, DOI 10.1175/1520-0493(2000)128<1366:EOAWOF>2.0.CO;2; Mainelli M, 2008, WEATHER FORECAST, V23, P3, DOI 10.1175/2007WAF2006111.1; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Smith RK, 2009, Q J ROY METEOR SOC, V135, P1321, DOI 10.1002/qj.428; Gill A.E., 1982, ATMOSPHERE OCEAN DYN, V30; Goni G., 2003, EOS T AM GEOPHYS UN, V84, P573, DOI DOI 10.1029/2003EO510001; Goni G, 1996, J GEOPHYS RES-OCEANS, V101, P16273, DOI 10.1029/96JC01146; Goni G., 2009, OCEANOGRAPHY, V22, P176; Gray WM, 1979, METEOROLOGY TROPICAL, P155; Knaff JA, 2013, J CLIMATE, V26, P2631, DOI 10.1175/JCLI-D-12-00038.1; Kumar B, 2011, NAT HAZARDS, V59, P1671, DOI 10.1007/s11069-011-9858-9; LANDER MA, 1994, WEATHER FORECAST, V9, P640, DOI 10.1175/1520-0434(1994)009<0640:DOAMGA>2.0.CO;2; Law K, 2011, IMPACT OCEANIC HEAT, DOI [10.5772/13799, DOI 10.5772/13799]; Leipper D. F., 1972, Journal of Physical Oceanography, V2, DOI 10.1175/1520-0485(1972)002<0218:HHPOTG>2.0.CO;2; Lin I-I, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2008GL035815, DOI 10.1029/2008GL035815]; Lin II, 2005, MON WEATHER REV, V133, P2635, DOI 10.1175/MWR3005.1; Malan N, 2013, J GEOPHYS RES-OCEANS, V118, P6734, DOI 10.1002/2013JC008958; Pun IF, 2007, IEEE T GEOSCI REMOTE, V45, P1616, DOI 10.1109/TGRS.2007.895950; Pun IF, 2014, PROG OCEANOGR, V121, P109, DOI 10.1016/j.pocean.2013.10.004; Shay L. K., 2010, GLOBAL PERSPECTIVES, V4, P93, DOI DOI 10.1142/9789814293488_0003; UNESCO, 1981, UNESCO TECHN PAP MAR, V36; Vissa NK, 2013, NAT HAZARDS, V68, P351, DOI 10.1007/s11069-013-0625-y; Wada A, 2010, IMPACTS OCEANIC PREE; Wada A, 2013, ADV METEOROL, DOI 10.1155/2013/859810	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	AUG	2015	71	4					373	387		10.1007/s10872-015-0298-0		15	Oceanography	Oceanography	CN7OH	WOS:000358623400004		
J	Oka, E; Qiu, B; Takatani, Y; Enyo, K; Sasano, D; Kosugi, N; Ishii, M; Nakano, T; Suga, T				Oka, Eitarou; Qiu, Bo; Takatani, Yusuke; Enyo, Kazutaka; Sasano, Daisuke; Kosugi, Naohiro; Ishii, Masao; Nakano, Toshiya; Suga, Toshio			Decadal variability of Subtropical Mode Water subduction and its impact on biogeochemistry	JOURNAL OF OCEANOGRAPHY			English	Article						North Pacific Subtropical Mode Water; Subduction; Decadal variability; Kuroshio Extension; Biogeochemistry	WESTERN NORTH PACIFIC; KUROSHIO EXTENSION SYSTEM; WINTER MIXED-LAYER; 137-DEGREES-E SECTION; MESOSCALE EDDIES; OCEAN; CLIMATOLOGY; GYRE; REGION	Temperature and salinity data from Argo profiling floats during 2005-2014 were analyzed to examine the decadal variability of the North Pacific Subtropical Mode Water (STMW) in relation to that of the Kuroshio Extension (KE) system. The formation volume of STMW in the southern recirculation gyre of KE in the cooling season was larger during the stable KE period after 2010 than the unstable KE period of 2006-2009 by 50 %. As a result, the volume and spatial extent of STMW increased (decreased) in the formation region during the stable (unstable) KE period, as well as in the southern, downstream region with a time lag of 1-2 years. The decadal expansion and contraction of STMW were also detected by shipboard observations conducted routinely in the most downstream region near the western boundary, in terms of not only physical, but also biogeochemical parameters. After 2010, enhanced subduction of STMW consistently increased dissolved oxygen, pH, and aragonite saturation state and decreased potential vorticity, apparent oxygen utilization, nitrate, and dissolved inorganic carbon, among which changes of dissolved inorganic carbon, pH, and aragonite saturation state were against their long-term trends. These results indicate a new mechanism consisting of westward sea surface height anomaly propagation, the KE state transition, and the STMW formation and subduction, by which the climate variability affects physical and biogeochemical structures in the ocean's interior and potentially impacts the surface ocean acidification trend and biological production.	[Oka, Eitarou] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Qiu, Bo] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Takatani, Yusuke; Enyo, Kazutaka; Sasano, Daisuke; Ishii, Masao; Nakano, Toshiya] Japan Meteorol Agcy, Global Environm & Marine Dept, Tokyo 1008122, Japan; [Takatani, Yusuke; Sasano, Daisuke; Kosugi, Naohiro; Ishii, Masao; Nakano, Toshiya] Meteorol Res Inst, Oceanog & Geochem Res Dept, Tsukuba, Ibaraki 3050052, Japan; [Suga, Toshio] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 9808578, Japan; [Suga, Toshio] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokosuka, Kanagawa 2370061, Japan	Oka, E (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan.	eoka@aori.u-tokyo.ac.jp			JSPS [21340133, 25287118, 24241010]; MEXT [22106007, 25121502, 24121003]; NASA [NNX13AE51G]; NSF [OCE-0926594]; MRI's key research fund [C3]	The authors are grateful to the captain, crew, and scientists of R/V Chofu-maru, R/V Keifu-maru, and R/V Ryofumaru of JMA for their efforts in long-term observations. They also thank Kanako Sato and Kana Nakamoto for their assistance in preparing the Argo float data and Yosuke Iida, Atsushi Kojima, Tomoyuki Kitamura, participants at the 2014 HYARC symposium on air-sea interaction, and two anonymous reviewers for helpful comments on the manuscript. E.O. and T.S. acknowledge support by JSPS through Grant 21340133 and 25287118 and MEXT through 22106007. E.O. is also supported by MEXT through 25121502. B.Q. acknowledges support by NASA through Grant NNX13AE51G and NSF through OCE-0926594. D.S. acknowledges support by JSPS through 24241010. M.I. acknowledges support by MRI's key research fund C3 and MEXT through 24121003.	Oka E, 2007, J OCEANOGR, V63, P293, DOI 10.1007/s10872-007-0029-2; Qiu B, 2007, J PHYS OCEANOGR, V37, P982, DOI 10.1175/JPO3097.1; Rainville L, 2014, J CLIMATE, V27, P2842, DOI 10.1175/JCLI-D-13-00227.1; Ishii M, 2001, MAR CHEM, V75, P17, DOI 10.1016/S0304-4203(01)00023-8; Kobashi F, 2012, J OCEANOGR, V68, P21, DOI 10.1007/s10872-011-0083-7; Uchida H, 2008, J ATMOS OCEAN TECH, V25, P2271, DOI 10.1175/2008JTECHO549.1; SUGA T, 1989, J PHYS OCEANOGR, V19, P1605, DOI 10.1175/1520-0485(1989)019<1605:SMWITS>2.0.CO;2; Suga T, 2008, PROG OCEANOGR, V77, P285, DOI 10.1016/j.pocean.2006.12.005; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; TALLEY LD, 1988, J PHYS OCEANOGR, V18, P89, DOI 10.1175/1520-0485(1988)018<0089:PVDITN>2.0.CO;2; SUGA T, 1990, J MAR RES, V48, P543; Midorikawa T, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003095; Oka E, 2009, J OCEANOGR, V65, P151, DOI 10.1007/s10872-009-0015-y; Sugimoto S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021410; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; SUGA T, 1995, J PHYS OCEANOGR, V25, P958, DOI 10.1175/1520-0485(1995)025<0958:TSMWCI>2.0.CO;2; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; Miyazawa Y, 2009, J OCEANOGR, V65, P737; Oka E, 2012, J OCEANOGR, V68, P5, DOI 10.1007/s10872-011-0032-5; Xie SP, 2011, J CLIMATE, V24, P1212, DOI 10.1175/2010JCLI3896.1; Kremeur AS, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005161; Oka E, 2011, J PHYS OCEANOGR, V41, P666, DOI 10.1175/2011JPO4501.1; Midorikawa T, 2010, TELLUS B, V62, P649, DOI 10.1111/j.1600-0889.2010.00474.x; Qiu B, 2014, J CLIMATE, V27, P1751, DOI 10.1175/JCLI-D-13-00318.1; Rainville L, 2007, OCEAN MODEL, V17, P338, DOI 10.1016/j.ocemod.2007.03.002; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Ishii M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006831; Oka E, 2012, J OCEANOGR, V68, P355, DOI 10.1007/s10872-011-0098-0; Takatani Y, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004227; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Bates NR, 2002, NATURE, V420, P489, DOI 10.1038/nature01253; Hanawa K., 2001, OCEAN CIRCULATION CL, P373, DOI DOI 10.1016/S0074-6142(01)80129-7; Kobashi F, 2013, B COAST OCEANOGR, V50, P119; Kouketsu S, 2015, J OCEANOGR IN PRESS; Levitus S., 1982, 13 NOAA; Lozier SM, 1995, PROG OCEANOGR, V36, P1; Macdonald AM, 2001, J ATMOS OCEAN TECH, V18, P394, DOI 10.1175/1520-0426(2001)018<0394:AIANPC>2.0.CO;2; Nishikawa S, 2010, J PHYS OCEANOGR, V40, P1748, DOI 10.1175/2010JPO4261.1; Oka E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018581; Qiu B, 2006, J PHYS OCEANOGR, V36, P1365, DOI 10.1175/JPO2918.1; Roemmich D., 2001, OBSERVING OCEANS 21, P248; Sasaki YN, 2015, J OCEANOGR IN PRESS; SUGA T, 1995, J PHYS OCEANOGR, V25, P1012, DOI 10.1175/1520-0485(1995)025<1012:IVONPS>2.0.CO;2; Sugimoto S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041795; Takikawa T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023842; Xu LX, 2014, J GEOPHYS RES-OCEANS, V119, P4867, DOI 10.1002/2014JC009861	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	AUG	2015	71	4					389	400		10.1007/s10872-015-0300-x		12	Oceanography	Oceanography	CN7OH	WOS:000358623400005		
J	Kimizuka, M; Kobashi, F; Kubokawa, A; Iwasaka, N				Kimizuka, Masafumi; Kobashi, Fumiaki; Kubokawa, Atsushi; Iwasaka, Naoto			Vertical and horizontal structures of the North Pacific subtropical gyre axis	JOURNAL OF OCEANOGRAPHY			English	Article						North Pacific subtropical gyre; Wind-driven circulation; Gyre axis; Sverdrup balance; Ventilated thermocline theory	CENTRAL MODE WATER; WIND-DRIVEN CIRCULATION; VENTILATED THERMOCLINE; KUROSHIO EXTENSION; MIXED-LAYER; OCEAN; REANALYSIS; TRANSPORT; COUNTERCURRENT; VARIABILITY	Mean structures of the North Pacific subtropical gyre are investigated using Argo float observations and several wind stress products, with a particular focus on the gyre axis, which is defined as a large-scale boundary between eastward motions on the northern part of the subtropical gyre and westward motions on the southern part. Structures of the gyre axis are different between the regions east and west of about 180A degrees. In the west, the gyre axis is affected by the strong Kuroshio Extension jet, showing discrepancy with features expected from the Sverdrup balance and ventilated thermocline theory. In the east, depth-integrated geostrophic circulation displays the two gyre axes at about 25A degrees N and 30A degrees N in association with a local cyclonic wind stress curl anomaly. It is expected from the Sverdrup balance that the two gyre axes would extend to the west across the subtropical gyre, but the actual geostrophic circulation exhibits only one gyre axis around 30A degrees N to the west. The vertical structure of the subtropical gyre exhibits a remarkable northward shift of the gyre axis with depth in the east, consistent with the southward decrease in the thickness of density layers around the gyre axis, while the northward shift is less obvious in the west, where the gyre axis lies along the southern flank of the Kuroshio Extension. The gyre shift is relatively smaller in the central mode water (CMW) layer due to the horizontal uniformity of the CMW, suggesting a dynamic effect of the CMW on large-scale circulations of the subtropical gyre.	[Kimizuka, Masafumi; Kobashi, Fumiaki; Iwasaka, Naoto] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Koto Ku, Tokyo 1358533, Japan; [Kobashi, Fumiaki] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan; [Kubokawa, Atsushi] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Kimizuka, M (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Koto Ku, Etchujima 2-1-6, Tokyo 1358533, Japan.	d122006@kaiyodai.ac.jp	Iwasaka, Naoto/O-1883-2014		Ministry of Education, Culture, Sports, Science and Technology, Japan [22106007, 23340139]	Comments and suggestions from the editor and anonymous reviewers helped to greatly improve the manuscript. This study is partially supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology, Japan (22106007, 23340139). The MOAA GPV was obtained from the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) website. The JRA25 wind stress data was obtained from the Japan Meteorological Agency website, the J-OFURO from the J-OFURO website of Tokai University, the NCEP/NCAR and NCEP/DOE data from the NOAA website, and the MERRA from the NASA website. The authors would like to acknowledge these data providers.	Ladd C, 2002, J PHYS OCEANOGR, V32, P2870, DOI 10.1175/1520-0485(2002)032<2870:DVONPC>2.0.CO;2; STOMMEL H, 1977, DEEP-SEA RES, V24, P325, DOI 10.1016/0146-6291(77)93000-4; Kubota M, 2002, J OCEANOGR, V58, P213, DOI 10.1023/A:1015845321836; Qiu B, 1997, J PHYS OCEANOGR, V27, P431, DOI 10.1175/1520-0485(1997)027<0431:EAFMOT>2.0.CO;2; Kobashi F, 2012, J OCEANOGR, V68, P21, DOI 10.1007/s10872-011-0083-7; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Qu TD, 2002, J OCEANOGR, V58, P525, DOI 10.1023/A:1021221500837; Giglio D, 2012, J PHYS OCEANOGR, V42, P2089, DOI 10.1175/JPO-D-12-029.1; Kobashi F, 2008, J CLIMATE, V21, P5960, DOI 10.1175/2008JCLI2311.1; SVERDRUP HU, 1947, P NATL ACAD SCI USA, V33, P318, DOI 10.1073/pnas.33.11.318; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Qiu B, 2013, GEOPHYS RES LETT, V40, P2183, DOI 10.1002/grl.50394; Kubokawa A, 1999, J PHYS OCEANOGR, V29, P1314, DOI 10.1175/1520-0485(1999)029<1314:VTSABA>2.0.CO;2; Kobashi F, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003479; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; Qiu B, 2006, J PHYS OCEANOGR, V36, P457, DOI 10.1175/JPO2849.1; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; Xie SP, 2001, SCIENCE, V292, P2057, DOI 10.1126/science.1059781; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Xie SP, 2011, J CLIMATE, V24, P1212, DOI 10.1175/2010JCLI3896.1; Hanawa K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019904; HELLERMAN S, 1983, J PHYS OCEANOGR, V13, P1093, DOI 10.1175/1520-0485(1983)013<1093:NMWSOT>2.0.CO;2; SEKINE Y, 1994, J PHYS OCEANOGR, V24, P261, DOI 10.1175/1520-0485(1994)024<0261:SVIVTO>2.0.CO;2; Suga T, 1997, J PHYS OCEANOGR, V27, P140, DOI 10.1175/1520-0485(1997)027<0140:TDITNP>2.0.CO;2; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Kubokawa A, 1999, J PHYS OCEANOGR, V29, P1303, DOI 10.1175/1520-0485(1999)029<1303:SCIAIO>2.0.CO;2; Aoki K, 2008, J OCEANOGR, V64, P49, DOI 10.1007/s10872-008-0004-6; Chelton DB, 1996, INT WOCE NEWSLETT, V25, P3; Chen SM, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004005; Flament P, 1998, ATLAS HAWAII, P82; HAUTALA SL, 1994, J GEOPHYS RES-OCEANS, V99, P16041, DOI 10.1029/94JC01084; Hosoda S, 2004, J OCEANOGR, V60, P865, DOI 10.1007/s10872-005-5779-0; Hosoda S., 2008, JAMSTEC REP RES DEV, V8, P47, DOI DOI 10.5918/JAMSTECR.8.47; HUANG RX, 1994, J PHYS OCEANOGR, V24, P1608, DOI 10.1175/1520-0485(1994)024<1608:TDSOTW>2.0.CO;2; Kubota M, 1995, J OCEANOGR, V51, P441, DOI 10.1007/BF02286391; Masuzawa J, 1969, DEEP-SEA RES, V16, P436; MUNK WH, 1950, J METEOROL, V7, P79; Nakamura H, 1996, J OCEANOGR, V52, P171, DOI 10.1007/BF02235668; Nakano H, 2002, J PHYS OCEANOGR, V32, P161, DOI 10.1175/1520-0485(2002)032<0161:ASOMZF>2.0.CO;2; Oka E, 2005, J PHYS OCEANOGR, V35, P1997, DOI 10.1175/JPO2811.1; Press WH, 1992, NUMERICAL RECIPES FO, P963; REID JL, 1975, J MAR RES, V33, P37; Rhines PB, 1982, J MAR RES, V40, P559; Uda M, 1969, J OCEANOGR SOC JAPAN, V25, P201; Yoshikawa Y, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020068; YOUNG WR, 1982, J MAR RES, V40, P849	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	AUG	2015	71	4					409	425		10.1007/s10872-015-0301-9		17	Oceanography	Oceanography	CN7OH	WOS:000358623400007		
J	Yamamoto-Kawai, M; Kawamura, N; Ono, T; Kosugi, N; Kubo, A; Ishii, M; Kanda, J				Yamamoto-Kawai, Michiyo; Kawamura, Natsuko; Ono, Tsuneo; Kosugi, Naohiro; Kubo, Atsushi; Ishii, Masao; Kanda, Jota			Calcium carbonate saturation and ocean acidification in Tokyo Bay, Japan	JOURNAL OF OCEANOGRAPHY			English	Article						Ocean acidification; Eutrophication; Calcium carbonate saturation; Tokyo Bay; Anthoropgenic CO2	DISSOLVED ORGANIC-MATTER; COASTAL ECOSYSTEMS; ALKALINITY; SEA; SEAWATER; GAS; PH; CALCIFICATION; ARAGONITE; IMPACTS	From April 2011 to January 2012, seasonal variation of the aragonite saturation state (Omega ar) was observed for the first time in Tokyo Bay, in order to understand the current state of ocean acidification in a highly eutrophicated bay in Japan. Omega ar in the bay ranged between 1.55 and 5.12, much greater than observed in offshore waters. At the surface, Omega ar was high during summer as a result of photosynthesis with some conflicting effect of freshwater input. At the bottom, Omega ar was low during summer due to remineralization of organic matter. Based on an assumption that our observations represent current conditions in Tokyo Bay, it is estimated that the emission of anthropogenic CO2 has already decreased Omega ar by 0.6 since the preindustrial period and will further decrease by 1.0-1.6 by the end of this century if emission of CO2 is continued at a high level [representative concentration pathway (RCP) 8.5 scenario]. With other conditions remaining the same, bottom waters of the bay will reach seasonal aragonite undersaturation by 2060-2070. However, because coastal regions have a large interannual variability, we need further observations to evaluate our estimations and future predictions presented here. Nevertheless, it should be safe to say that the larger seasonal variation in Omega causes the Tokyo Bay to reach aragonite undersaturation earlier than offshore regions and such conditions have negative consequences on the variety of calcifying organisms living in Tokyo Bay. Ocean acidification could thus give an additional stress to the ecosystem of the bay, which is now suffering from eutrophication and hypoxia.	[Yamamoto-Kawai, Michiyo] Tokyo Univ Marine Sci & Technol, Ctr Adv Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Kawamura, Natsuko; Kubo, Atsushi; Kanda, Jota] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Tokyo 1088477, Japan; [Ono, Tsuneo] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Kosugi, Naohiro; Ishii, Masao] Meteorol Res Inst, Ibaraki, Japan	Yamamoto-Kawai, M (reprint author), Tokyo Univ Marine Sci & Technol, Ctr Adv Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	michiyo@kaiyodai.ac.jp			Kurita Water and Environment Foundation	We thank all participants, officers and crewmembers for their help in sampling during the cruise of R/V Seiyo-maru. We are grateful for the support of the Oceanographic Observation Center at the Tokyo University of Marine Science and Technology for assistance with coordination of observation, maintenance of equipment, and data processing. We also thank the two anonymous reviewers for their careful and helpful comments. This work was partly supported by a grant from Kurita Water and Environment Foundation. Some figures in this paper were illustrated using Ocean Data View software (R. Schlitzer 2008, available at http://odv.awi.de/).	Ando H., 2003, OCEANOGRAPHY JAPAN, V12, P407; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Green MA, 2004, LIMNOL OCEANOGR, V49, P727; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Fraga F, 1998, SCI MAR, V62, P161; Yamamoto-Kawai M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045501; Kulinski K, 2014, J MARINE SYST, V132, P106, DOI 10.1016/j.jmarsys.2014.01.011; Sabine CL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001639; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Cloern JE, 2014, BIOGEOSCIENCES, V11, P2477, DOI 10.5194/bg-11-2477-2014; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Yamamoto-Kawai M, 2013, J GEOPHYS RES-OCEANS, V118, P6274, DOI 10.1002/2013JC009157; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Yara Y, 2012, BIOGEOSCIENCES, V9, P4955, DOI 10.5194/bg-9-4955-2012; Cai WJ, 1998, GEOCHIM COSMOCHIM AC, V62, P473, DOI 10.1016/S0016-7037(97)00363-3; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Hernandez-Ayon JM, 2007, LIMNOL OCEANOGR-METH, V5, P225; Yao WS, 1998, DEEP-SEA RES PT I, V45, P1383, DOI 10.1016/S0967-0637(98)00018-1; Ishii Mitsuhiro, 2008, Bulletin of the Japanese Society of Fisheries Oceanography, V72, P189; Ishii M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006831; BREWER PG, 1976, LIMNOL OCEANOGR, V21, P108; Koeve W, 2012, BIOGEOSCIENCES, V9, P3787, DOI 10.5194/bg-9-3787-2012; Branch TA, 2013, TRENDS ECOL EVOL, V28, P178, DOI 10.1016/j.tree.2012.10.001; Narita D, 2012, CLIMATIC CHANGE, V113, P1049, DOI 10.1007/s10584-011-0383-3; Bouman HA, 2010, ESTUAR COAST SHELF S, V87, P63, DOI 10.1016/j.ecss.2009.12.014; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Duarte MD, 2013, ESTUAR COAST, V36, P221; Frommel A. Y., 2011, NAT CLIM CHANGE, V2, P42, DOI DOI 10.1038/NCLIMATE1324; Furukawa K, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P15, DOI 10.1007/1-4020-3655-8_2; Gattuso JP, 2011, OCEAN ACIDIFICATION, P311; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Joint Global Ocean Flux Study (JGOFS), 1996, 19 JGOFS CTR STUD EN; Kanda J, 2008, J JAPAN SOC WATER EN, V31, P559; Kawabe M, 1997, J OCEANOGR, V53, P19, DOI 10.1007/BF02700745; Kim HC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040271; Kobayashi J, 1960, STUD AGR, V48, P63; Kodama K, 2011, MAR POLLUT BULL, V63, P215, DOI 10.1016/j.marpolbul.2011.04.022; Kodama K, 2010, PROG OCEANOGR, V87, P157, DOI 10.1016/j.pocean.2010.09.003; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/nclimate1680, 10.1038/NCLIMATE1680]; Kubo A, 2015, BIOGEOSCIENCES, V12, P269, DOI 10.5194/bg-12-269-2015; Lewis E., 1998, ORNLCDIAC105 US DEP; Matsumura T, 2001, LA MER, V39, P19; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; MUCCI A, 1983, AM J SCI, V283, P780; Murata A, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002615; Nomura H, 1998, OCEANOGR JAPAN, V7, P159; Nomura H, 1997, LA MER, V35, P107; Okada T., 2007, J HYDRAUL COASTAL EN, V63, P67; Salisbury J., 2008, EOS T AGU, V89, P513, DOI DOI 10.1029/2008E0500001; Shibata Y, 1982, LA MER, V20, P75; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Taguchi F, 2009, B COASTAL OCEANOGRAP, V47, P71; Unoki S, 1977, TECH REP PHYS OCEANO, P89; Wakita M, 2013, BIOGEOSCIENCES, V10, P7817, DOI 10.5194/bg-10-7817-2013; Wootton Timothy J., 2008, P NATL ACAD SCI USA, V105, P18848; Yamada Y, 1997, B KANAGAWA PREF FISH, V2, P65; Yasunaka S, 2013, J GEOPHYS RES-OCEANS, V118, P3843, DOI 10.1002/jgrc.20279	66	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	AUG	2015	71	4					427	439		10.1007/s10872-015-0302-8		13	Oceanography	Oceanography	CN7OH	WOS:000358623400008		
J	Matsuno, T; Endoh, T; Hibiya, T; Senjyu, T; Watanabe, M				Matsuno, Takeshi; Endoh, Takahiro; Hibiya, Toshiyuki; Senjyu, Tomoharu; Watanabe, Michio			Formation of the well-mixed homogeneous layer in the bottom water of the Japan Sea	JOURNAL OF OCEANOGRAPHY			English	Article						Japan Sea bottom water (JSBW); Turbulence measurements; Geothermal heat; Well-mixed bottom layer	EAST/JAPAN SEA	The deep and bottom waters of the Japan Sea (depth a parts per thousand(3) 1000 m) are characterized by low temperature and weak stratification. In the Japan Basin, especially, the bottom water (depth a parts per thousand(3) 2500 m), called the Japan Sea bottom water (JSBW), with a thickness of over 1000 m, is mostly homogeneous. Several studies in recent decades have suggested that the potential temperature of the JSBW is gradually increasing, even though the thick homogeneous vertical structure is being maintained. Although downward mixing of heat from the upper layer was believed to be responsible for this characteristic feature, our microstructure measurements found that the intensity of turbulence in the JSBW is too weak to explain the formation of the gradually warming thick homogeneous layer. By use of a one-dimensional numerical model we demonstrated that this characteristic feature of the JSBW can be reasonably explained on the basis of a combination of geothermal heating from the seabed and an appropriate horizontal supply of cold water to the bottom layer.	[Matsuno, Takeshi; Senjyu, Tomoharu] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Endoh, Takahiro] Univ Tokyo, Ocean Alliance, Tokyo, Japan; [Hibiya, Toshiyuki] Univ Tokyo, Grad Sch Sci, Tokyo 113, Japan; [Watanabe, Michio] Japan Agcy Marine Earth Sci & Technol, Yokohama Inst Earth Sci, Yokohama, Kanagawa, Japan	Matsuno, T (reprint author), Kyushu Univ, Appl Mech Res Inst, 6-1 Kasuga Kohen, Kasuga, Fukuoka 8168580, Japan.	matsuno@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		JSPS KAKENHI [22340139]	The data used in this study were obtained during the research cruises of R/V Tansei-Maru, KT-10-27, KT-11-19 and R/V Hakuho-Maru, KH-10-2. We would like to express our appreciation to the captain, officers, and crew for their dedication and cooperation. We would like to extend our gratitude to Seiji Nishimura and all the participants in the cruises. This work was supported by JSPS KAKENHI grant number 22340139.	Senjyu T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014093; Senjyu T, 2005, DEEP-SEA RES PT II, V52, P1726, DOI 10.1016/j.dsr2.2003.10.013; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Chandrasekhar S, 1961, HYDRODYNAMIC HYDROMA, P654; Gamo T, 2014, PROG OCEANOGR, V121, P94, DOI 10.1016/j.pocean.2013.10.012; GAMO T, 1986, J MAR RES, V44, P781; Gamo T, 2011, TRAC-TREND ANAL CHEM, V30, P1308, DOI 10.1016/j.trac.2011.06.005; Horibe Y., 1983, J OCEANOGR SOC JAPAN, V39, P220, DOI 10.1007/BF02070392; Kim K, 2001, GEOPHYS RES LETT, V28, P3293, DOI 10.1029/2001GL013078; Kim KR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014498; Kim K-R, 2002, OCEANOGR JPN, V11, P419; Kim YG, 2010, GEO-MAR LETT, V30, P595, DOI 10.1007/s00367-010-0207-x; Matsuno T, 2005, DEEP-SEA RES PT II, V52, P1564, DOI 10.1016/j.dsr2.2004.06.037; Minami H., 1999, J OCEANOGR, V55, P197, DOI 10.1023/A:1007889929187; Mori K, 2005, J OCEANOGR, V61, P761, DOI 10.1007/s10872-005-0082-7; Park YG, 2013, J GEOPHYS RES-OCEANS, V118, P1893, DOI 10.1002/jgrc.20161; UNESCO, 1983, UNESCO TECH PAP MAR, V44, P53; Yamano M, 1988, B EARTHQ RES I TOKYO, V62, P417	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	AUG	2015	71	4					441	447		10.1007/s10872-015-0303-7		7	Oceanography	Oceanography	CN7OH	WOS:000358623400009		
J	Aramaki, K; Kimura, M; Masuda, K				Aramaki, Kenji; Kimura, Minami; Masuda, Kazuki			Preparation of O/I-1-type Emulsions and S/I-1-type Dispersions Encapsulating UV-Absorbing Agents	JOURNAL OF OLEO SCIENCE			English	Article						O/I-1-type emulsion; S/I-1-type dispersion; UV absorbing agent; UV absorbability; gel emulsion	CUBIC-PHASE; HEXAGONAL PHASE; LIQUID-CRYSTAL; GEL-EMULSION; CONCENTRATED EMULSIONS; NONIONIC SURFACTANT; OIL SYSTEMS; RHEOLOGY; SOLUBILIZATION; BEHAVIOR	Oil-in-cubic phase (O/I-1) emulsions encapsulating the cosmetic UV absorbing agents 2-ethylhexyl 4-methoxycinnamate (EHMC), 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (octocrylene, OCR) and 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)-1,3-propanedione (Avobenzone,TBMP) were prepared by vortex mixing accompanied by a heating-cooling process. A ternary phase diagram in a water/C12EO25/EHMC system at 25 degrees C was constructed and the two-phase equilibrium of an oil phase and an I-1 phase, which is necessary to prepare the O/I-1-type emulsions, was confirmed. Also, the melting of the I-1 phase into a fluid micellar solution phase was confirmed, allowing emulsification by a heating-cooling process. The O/I-1-type emulsions were formulated in the ternary system as well as a quaternary system. The four-component system contained an additional cosolvent, isopropyl myristate (IPM). The use of the cosolvent allows the use of reduced amounts of EHMC, which is desirable because EHMC can cause temporary skin irritation. Formulation of the O/I-1-type emulsions with other UV absorbing agents (OCR and TBMP) was also possible using the same emulsification method. When IPM was changed to tripalmitin, which has a melting point greater than room temperature, a solid-oil dispersion in I-1 phase was formed. We have termed this a "solidin-cubic phase (S/I-1) type dispersion". These novel emulsions have not been reported previously. The UV absorbability of the O/I-1-type emulsions and S/I-1-type dispersions that encapsulate the UV absorbing agents was confirmed by measurement of UV absorption spectra.	[Aramaki, Kenji; Kimura, Minami; Masuda, Kazuki] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Aramaki, K (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Tokiwadai 79-7, Yokohama, Kanagawa 2408501, Japan.	aramakik@ynu.ac.jp			Cosmetology Research Foundation	The authors thank for the financial support from the Cosmetology Research Foundation.	Adam M. M., 2009, J COLLOID INTERF SCI, V329, P366; Adam M. M., 2013, J DISPER SCI TECHNOL, V34, P1629; Adam Md. M, 2014, J OLEO SCI, V63, P97; Alam MM, 2008, LANGMUIR, V24, P12253, DOI 10.1021/la8021547; Alam M. M., 2014, Food Structure, V1, P137; Alam MM, 2014, J SURFACTANTS DETERG, V17, P19, DOI 10.1007/s11743-013-1465-1; Alam MM, 2008, J COLLOID INTERF SCI, V325, P243, DOI 10.1016/j.jcis.2008.05.066; Alam MM, 2009, J COLLOID INTERF SCI, V329, P366, DOI 10.1016/j.jcis.2008.09.074; Alam MM, 2010, J COLLOID INTERF SCI, V341, P267, DOI 10.1016/j.jcis.2009.09.047; Alam MM, 2009, J COLLOID INTERF SCI, V336, P329, DOI 10.1016/j.jcis.2009.03.054; May A, 2011, LANGMUIR, V27, P2286, DOI 10.1021/la104539q; Esquena J, 2012, LANGMUIR, V28, P12334, DOI 10.1021/la302120f; Kawada H, 2010, LANGMUIR, V26, P2430, DOI 10.1021/la902905b; Alam MM, 2009, J OLEO SCI, V58, P361, DOI 10.5650/jos.58.361; STREY R, 1994, COLLOID POLYM SCI, V272, P1005, DOI 10.1007/BF00658900; Pal R, 2006, FOOD HYDROCOLLOID, V20, P997, DOI 10.1016/j.foodhyd.2005.12.001; [Anonymous], 2005, Japan Pat, Patent No. 2248162; [Anonymous], 2008, Japan Pat, Patent No. [546848A, 546848]; Matsumoto Y, 2009, COLLOID SURFACE A, V341, P27, DOI 10.1016/j.colsurfa.2009.03.032; Aramaki K, 2013, J OLEO SCI, V62, P803, DOI 10.5650/jos.62.803; Aramaki K., 2004, J OLEO SCI, V53, P557; Aramaki K, 2001, COLLOID SURFACE A, V183, P371, DOI 10.1016/S0927-7757(01)00524-6; Aramaki K, 1999, COLLOID POLYM SCI, V277, P34, DOI 10.1007/s003960050364; Kunieda H, 2001, J COLLOID INTERF SCI, V236, P78, DOI 10.1006/jcis.2000.7393; KUNIEDA H, 1990, COLLOID SURFACE, V47, P35, DOI 10.1016/0166-6622(90)80060-H; Kunieda H., 2001, J OLEO SCI, V50, P633; Kunieda H, 2000, J PHYS CHEM B, V104, P2005, DOI 10.1021/jp992957y; Nakama Y., 1998, J JPN OIL CHEM SOC, V47, P585; Rodriguez C, 2000, J COLLOID INTERF SCI, V223, P197, DOI 10.1006/jcis.1999.6646; Rodriguez-Abreu C, 2004, LANGMUIR, V20, P5235, DOI 10.1021/la0498962; Rodriguez-Abreu C, 2007, LANGMUIR, V23, P11007, DOI 10.1021/la701722f; Rodriguez-Abreu C, 2005, COLLOID SURFACE A, V269, P59, DOI 10.1016/j.colsurfa.2005.06.061; SUZUKI T, 1989, J COLLOID INTERF SCI, V129, P491, DOI 10.1016/0021-9797(89)90463-3; Uddin MH, 2001, LANGMUIR, V17, P5169, DOI 10.1021/la010289d	34	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					801	807		10.5650/jos.ess15052		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500002		
J	Sagitani, H; Komoriya, M				Sagitani, Hiromichi; Komoriya, Masumi			Stability Conditions and Mechanism of Cream Soaps: Effect of Polyols	JOURNAL OF OLEO SCIENCE			English	Article						cream soaps; potassium acid soaps; polyols; phase diagram; SAXS; DSC; lamellar gel phase	PHASE-TRANSITIONS; ACID SOAPS; WATER	Fatty acids, fatty acid potassium soaps, polyols and water are essential ingredients for producing stable cream soaps. The solution behavior of the above four components system has been studied to elucidate the effect of four sorts of polyols (glycerol, 1,3-butylene glycol, polyethylene glycol 400 and dipropylene glycol) on the stability of cream soaps. It has been revealed that the lamellar liquid crystalline one-phase converted to a two-phase of a lamellar phase and an isotropic aqueous solution by the addition of a few percent of 1,3-butylene glycol, polyethylene glycol 400 and dipropylene glycol, whereas the lamellar one-phase was remained by about 50 wt% of glycerol in the aqueous solution. The X-ray data at room temperature showed that the existence of 1:1 acid soap (1:1 mole ratio of potassium soap/fatty acid) crystals in the 1,3-butylene glycol, polyethylene glycol 400 and dipropylene glycol systems, whereas that the coexistence of 1:1 acid soap crystal and a lamellar gel phase (swelled lamellar gel structure) in the glycerol system. The phase transition peaks from coagel to gel (T-gel) and from gel to liquid state (T-c) were appeared in the above four polyol systems by DSC measurements. It was confirmed from the combined data of SAXS and DSC that the existence of anhydrous 1:1 acid soap gels (or with small amount of bound water) in the all polyol systems, whereas the coexistence of the anhydrate gel and the swelled gel with a lot of intermediate water in the only glycerol system. This swelled gel structure would be contributed to stabilize the dispersed anhydrate acid soap crystals in cream soaps.	[Sagitani, Hiromichi; Komoriya, Masumi] POLA CHEM IND INC, Totsuka Ku, Yokohama, Kanagawa 2440812, Japan	Komoriya, M (reprint author), POLA CHEM IND INC, Totsuka Ku, 560 Kashio Cho, Yokohama, Kanagawa 2440812, Japan.	m-komoriya@pola.co.jp					Tandon P, 2000, J MOL STRUCT, V524, P201, DOI 10.1016/S0022-2860(00)00378-1; Ambrosi M, 2004, PHYS CHEM CHEM PHYS, V6, P1401, DOI 10.1039/b314061j; Boneva MP, 2010, COLLOID SURFACE A, V354, P172, DOI 10.1016/j.colsurfa.2009.06.031; CISTOLA DP, 1986, BIOCHEMISTRY-US, V25, P2804, DOI 10.1021/bi00358a011; de Walle D. V., 2008, FOOD RES INT, V41, P1020; Fujiyama M., 2002, Patent No. [JP2002-154946 (A), 2002154946]; Kamiya M., 2012, Patent No. [JP2012-144488 (A), 2012144488]; KODAMA M, 1991, ADV COLLOID INTERFAC, V35, P1, DOI 10.1016/0001-8686(91)80019-G; Komorisono M., 2011, Patent No. [JP2011-213693 (A), 2011213693]; Kralchevsky PA, 2008, J COLLOID INTERF SCI, V327, P169, DOI 10.1016/j.jcis.2008.08.006; Noguchi Y., 2002, Patent No. [JP2002-226359 (A), 2002226359]; Sagitani H, 2014, J OLEO SCI, V63, P365, DOI 10.5650/jos.ess13174; Sagitani H., 1984, J JPN OIL CHEM SOC, V33, P156; Tamura T., 2010, Patent No. [JP2010-209220 (A), 2010209220]; Tomomasa S., 1987, J JPN OIL CHEM SOC Y, V36, P938; Zhu S, 2007, J PHYS CHEM B, V111, P1016, DOI 10.1021/jp0659047	16	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					809	816		10.5650/jos.ess14292		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500003		
J	Gotoh, K; Kanasaki, Y; Uchinomaru, H				Gotoh, Keiko; Kanasaki, Yu; Uchinomaru, Haruka			Introduction of Atmospheric Pressure Plasma to Aqueous Detergent Processes	JOURNAL OF OLEO SCIENCE			English	Editorial Material						atmospheric pressure plasma; PET substrate; stearic acid; detergency; quartz crystal microbalance	QUARTZ-CRYSTAL MICROBALANCE; FABRICS; SURFACE; JET	The effects of exposure of polymer surfaces to atmospheric pressure plasma (APP) on detergency were investigated from the viewpoint of pretreatment to cleaning in aqueous systems using three PET substrates: film, mesh, and fabric. The PET substrates were soiled with stearic acid as a model oily contaminant, and were treated with the APP jet immediately before cleaning. Stir washing in aqueous solutions with and without alkali or anionic surfactant was performed, and then the detergency was evaluated from the microscopic image analysis or surface reflectance measurement. For all PET samples and detergent solutions, APP exposure was found to promote the removal of stearic acid. Contact angle measurements showed that APP exposure enhanced the hydrophilicity of PET and stearic acid. The increase in the surface oxygen concentration on PET and stearic acid due to the APP exposure was also observed by XPS analysis. The simultaneous oxidation of the PET substrate and stearic acid soil by the APP pretreatment resulted in detergency improvement via surface hydrophilization. Furthermore, microscopic observations suggested that the collapse of crystallized stearic acid deposited on the PET substrate by APP heating facilitated its removal. In situ detergency evaluation by a quartz crystal microbalance technique confirmed that the removal of stearic acid from the PET substrate was promoted by the APP exposure. The experimental findings of this study demonstrate the effectiveness of the APP exposure before cleaning in aqueous solutions.	[Gotoh, Keiko; Uchinomaru, Haruka] Nara Womens Univ, Fac Human Life & Environm, Nara 6308506, Japan; [Kanasaki, Yu] Nara Womens Univ, Sch Nat Sci & Ecol Awareness, Nara 6308506, Japan	Gotoh, K (reprint author), Nara Womens Univ, Fac Human Life & Environm, Kita Uoya Nishi Machi, Nara 6308506, Japan.	k-gotoh@cc.nara-wu.ac.jp					Sun D, 2004, TEXT RES J, V74, P751, DOI 10.1177/004051750407400901; Feng T., 2013, CHINESE PHYS LETT, V30; Fridman A., 2010, PLASMA PHYS ENG; Gard N, 1980, CRYST RES TECHNOL, V15, P1303; Gotoh K, 2013, J OLEO SCI, V62, P73, DOI 10.5650/jos.62.73; Gotoh K, 2005, J SURFACTANTS DETERG, V8, P305, DOI 10.1007/s11743-005-0360-4; Gotoh K, 2013, ULTRASON SONOCHEM, V20, P747, DOI 10.1016/j.ultsonch.2012.10.001; Gotoh K, 2013, SEN-I GAKKAISHI, V69, P169; Gotoh K, 2012, SEN-I GAKKAISHI, V68, P19; Gotoh K, 2008, J OLEO SCI, V57, P495, DOI 10.5650/jos.57.495; Gotoh K, 2013, TEXT RES J, V83, P1606, DOI 10.1177/0040517513478454; Gotoh K., 2006, COLLOID SURFACES A, V272, P17; Gotoh K., 2011, J HOME EC JAPAN, V62, P173; Gotoh K., 2013, J HOME EC JAPAN, V64, P705; Gotoh K, 2011, J ADHES SCI TECHNOL, V25, P307, DOI 10.1163/016942410X511114; Gotoh K, 2012, COLLOID POLYM SCI, V290, P1005, DOI 10.1007/s00396-012-2600-7; John MJ, 2009, WOODHEAD PUBL TEXT, V97, P1; Kanasaki Y., DYNAMIC ANAL F UNPUB; Lieberman MA, 2005, PRINCIPLES OF PLASMA DISCHARGES AND MATERIALS PROCESSING, 2ND EDITION, P1; Lommatzsch U, 2007, POLYMER SURFACE MODIFICATION: RELEVANCE TO ADHESION, VOL 4, P25; Lommatzsch U, 2007, PLASMA PROCESS POLYM, V4, pS1041, DOI 10.1002/ppap.200732402; Nagai Y, 2014, TENSIDE SURFACT DET, V51, P113, DOI 10.3139/113.110290; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schiitze A., 1998, IEEE T PLASMA SCI, V26, P1685; Schram DC, 2002, PURE APPL CHEM, V74, P369, DOI 10.1351/pac200274030369; Selwyn GS, 2001, CONTRIB PLASM PHYS, V41, P610, DOI 10.1002/1521-3986(200111)41:6<610::AID-CTPP610>3.0.CO;2-L; Voinova MV, 2004, SPECTROSC-INT J, V18, P537	27	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					817	824		10.5650/jos.ess15033		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500004		
J	Iwasa, M; Nakaya, S; Maki, Y; Marumoto, S; Usami, A; Miyazawa, M				Iwasa, Megumi; Nakaya, Satoshi; Maki, Yusuke; Marumoto, Shinsuke; Usami, Atsushi; Miyazawa, Mitsuo			Identification of Aroma-active Compounds in Essential Oil from Uncaria Hook by Gas Chromatography-Mass Spectrometry and Gas Chromatography-Olfactometry	JOURNAL OF OLEO SCIENCE			English	Article						Uncaria Hook; Uncaria rhynchophylla; crude drug; essential oil; GC-O; AEDA; GC-MS	VOLATILE FLAVOR COMPONENTS; CHARACTER IMPACT ODORANTS; CRUDE DRUGS; KAMPO MEDICINE; CHOTO-SAN; CONSTITUENTS; SATIVA; LEAVES	The chemical composition of essential oil extracted from Uncaria Hook ("Chotoko" in Japanese), the branch with curved hook of the herbal medicine Uncaria rhynchophylla has been investigated by GC and GC-MS analyses. Eighty-four compounds, representing 90.8% of the total content was identified in oil obtained from Uncaria Hook. The main components i were (E)-cinnamaldehyde (13.4%), alpha-copaene (8.0%), methyl eugenol (6.8%), delta-cadinene (5.3%), and curcumene (3.6%). The important key aroma-active compounds in the oil were detected by gas chromatography-olfactometry (GC-O) and aroma extract dilution analysis (AEDA), using the flavor dilution (FD) factor to express the odor potency of each compounds. Furthermore, the odor activity value (OAV) has been used as a measure of the relative contribution of each compound to the aroma of the Uncaria Hook oil. The GC-O and AEDA results showed that alpha-copaene (FD = 4, OAV = 4376), (E)-linalool oxide (FD = 64, OAV = 9.1), and methyl eugenol (FD = 64, OAV = 29) contributed to the woody and spicy odor of Uncaria Hook oil, whereas furfural (FD = 8, OAV = 4808) contributed to its sweet odor. These results warrant further investigations of the application of essential oil from Uncaria Hook in the phytochemical and medicinal fields.	[Iwasa, Megumi; Nakaya, Satoshi; Maki, Yusuke; Usami, Atsushi; Miyazawa, Mitsuo] Kinki Univ, Kindai Univ, Dept Appl Chem, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Marumoto, Shinsuke] Kinki Univ, Kindai Univ, Joint Res Ctr, Higashiosaka, Osaka 5778502, Japan	Miyazawa, M (reprint author), Kinki Univ, Kindai Univ, Dept Appl Chem, Fac Sci & Engn, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Adams RP, 2001, IDENTIFICATION ESSEN; Takahashi T, 2010, PHYTOCHEM ANALYSIS, V21, P489, DOI 10.1002/pca.1224; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; MIYAZAWA M, 1984, AGR BIOL CHEM TOKYO, V48, P2847; Kawata J, 2008, J NAT MED, V62, P239, DOI 10.1007/s11418-007-0221-0; Kawakami Z, 2011, J ETHNOPHARMACOL, V134, P74, DOI 10.1016/j.jep.2010.11.063; Miyazawa M, 2013, J OLEO SCI, V62, P51, DOI 10.5650/jos.62.51; Yuzurihara M, 2002, EUR J PHARMACOL, V444, P183, DOI 10.1016/S0014-2999(02)01623-0; Qian MC, 2005, J FOOD SCI, V70, pC13; Watanabe H, 2003, PHARMACOL BIOCHEM BE, V75, P635, DOI 10.1016/S0091-3057(03)00109-6; Yuan D, 2008, J NAT PROD, V71, P1271, DOI 10.1021/np8000305; Zeller A, 2006, J AGR FOOD CHEM, V54, P3686, DOI 10.1021/jf052944j; Yang C, 2010, J SCI FOOD AGR, V90, P1268, DOI 10.1002/jsfa.3969; Kang TH, 2004, LIFE SCI, V76, P331, DOI 10.1016/j.lfs.2004.08.012; Du XF, 2010, FOOD CHEM, V119, P1127, DOI 10.1016/j.foodchem.2009.08.024; Miyazawa M, 2006, J NAT MED, V60, P89, DOI 10.1007/s11418-005-009-z; MIYAZAWA M, 1988, AGR BIOL CHEM TOKYO, V52, P2961; Heitzman ME, 2005, PHYTOCHEMISTRY, V66, P5, DOI 10.1016/j.phytochem.2004.10.022; Miyazawa M, 2008, J ESSENT OIL RES, V20, P420; Laus G, 2004, PHYTOTHER RES, V18, P259, DOI 10.1002/ptr.1469; Cui L, 2010, AGR SCI CHINA, V9, P1689, DOI 10.1016/S1671-2927(09)60267-4; Guth H, 1999, FLAVOR CHEMISTRY, P377; Kashima Y, 2011, J AGR FOOD CHEM, V59, P7114, DOI 10.1021/jf201401j; Kawata Jyunichi, 2007, J Oleo Sci, V56, P59; Mimaki Y, 1997, YAKUGAKU ZASSHI, V117, P1011; Ministry of Health Labour and Welfare, 2010, JAP PHARM, P166; Miyazawa M, 2008, J OLEO SCI, V57, P139, DOI 10.5650/jos.57.139; MIYAZAWA M, 1988, AGR BIOL CHEM TOKYO, V52, P1053; Miyazawa M, 2003, FLAVOUR FRAG J, V18, P15, DOI 10.1002/ffj.1135; Miyazawa M, 2003, FLAVOUR FRAG J, V18, P231, DOI 10.1002/ffj.1203; MIYAZAWA M, 1989, AGR BIOL CHEM TOKYO, V53, P3337; Miyazawa M., 2004, J OLEO SCI, V53, P511; Miyazawa M, 2009, J OLEO SCI, V58, P163, DOI 10.5650/jos.58.163; Miyazawa M, 2010, J OLEO SCI, V59, P527, DOI 10.5650/jos.59.527; Miyazawa M, 2002, FLAVOUR FRAG J, V17, P187, DOI 10.1002/ffj.1079; Miyazawa M, 2001, FLAVOUR FRAG J, V16, P215, DOI 10.1002/ffj.982; MIYAZAWA M, 1987, AGR BIOL CHEM TOKYO, V51, P3153; MIYAZAWA M, 1983, AGR BIOL CHEM TOKYO, V47, P2925; Miyazawa Mitsuo, 2007, J Oleo Sci, V56, P457; Utsunomiya H., 2005, J OLEO SCI, V54, P609; Zhao Q, 2005, BIOL PHARM BULL, V28, P1873, DOI 10.1248/bpb.28.1873	41	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					825	833		10.5650/jos.ess15048		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500005		
J	Hadrich, F; Bouallagui, Z; Junkyu, H; Isoda, H; Sayadi, S				Hadrich, Fatma; Bouallagui, Zouhaier; Junkyu, Han; Isoda, Hiroko; Sayadi, Sami			The alpha-Glucosidase and alpha-Amylase Enzyme Inhibitory of Hydroxytyrosol and Oleuropein	JOURNAL OF OLEO SCIENCE			English	Article						alpha-amylase; alpha-glucosidase; diabetes; hydroxytyrosol; oleuropein	PHENOLIC-COMPOUNDS; HYPERTENSION; EXTRACTS; FLAVONOIDS; MODE; HERB	To date, numerous studies have reported on the antidiabetic properties of various plant extracts through inhibition of carbohydrate-hydrolysing enzymes. The objective of this research was to evaluate the inhibitory effect of the hydroxytyrosol and the oleuropein against alpha-amylase and alpha-glucosidase. The hydroxytyrosol was purified from olive leaves. The result shows that the hydroxytyrosol had the strongest alpha-glucosidase inhibitory effect with IC50 values of 150 mu M with mild inhibition against alpha-amylase. The enzyme kinetic studies, using Lineweaver-Burk indicated that, in the presence of the hydroxytyrosol, the Michaelis-Menton constant (K-m) remained constant but the maximal velocity (V-max) decreased, revealing a non-competitive type of inhibition with inhibition constants; K-i for the formation of the inhibitor-enzyme complex and K-is for the formation of the inhibitor-enzyme-substrate complex of 104.3 and 150.1 mu M, respectively. On the other hand, oleuropein showedan uncompetitive inhibition. The concentrations used in this work were below cytotoxic levels observed at 400 mu M. However, at 600 mu M, the hydroxytyrosol significantly decreased viability of the Caco-2 cells (p < 0.05) and in the case of the oleuropein, there's an increase in cell number compared to control (p < 0.05). These results suggest that the hydroxytyrosol and oleuropein are two potential effective alpha-glucosidase inhibitors for management of postprandial hyperglycemia.	[Hadrich, Fatma; Bouallagui, Zouhaier; Sayadi, Sami] Sfax Biotechnol Ctr, Lab Mixte Int LMI ECOS MED, Environm Bioproc Lab, Sfax 3038, Tunisia; [Junkyu, Han; Isoda, Hiroko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Junkyu, Han; Isoda, Hiroko] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058572, Japan	Sayadi, S (reprint author), Sfax Biotechnol Ctr, Lab Mixte Int LMI ECOS MED, Environm Bioproc Lab, POB 1177, Sfax 3038, Tunisia.	Sami.sayadi@cbs.rnrt.tn					Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149; Shobana S, 2009, FOOD CHEM, V115, P1268, DOI 10.1016/j.foodchem.2009.01.042; Kruger CL, 2003, FOOD CHEM TOXICOL, V41, P793, DOI 10.1016/S0278-6915(03)00018-8; Hung HY, 2012, NAT PROD REP, V29, P580, DOI 10.1039/c2np00074a; Song YQ, 2005, J AM COLL NUTR, V24, P376; Manaharan T, 2011, FOOD CHEM, V129, P1355, DOI 10.1016/j.foodchem.2011.05.041; Etxeberria U, 2012, EXPERT OPIN THER TAR, V16, P269, DOI 10.1517/14728222.2012.664134; Ryan D, 2002, SCI HORTIC-AMSTERDAM, V92, P147, DOI 10.1016/S0304-4238(01)00287-4; Chethan S, 2008, FOOD CHEM, V111, P187, DOI 10.1016/j.foodchem.2008.03.063; Mateos R, 2011, FOOD CHEM, V125, P865, DOI 10.1016/j.foodchem.2010.09.054; Loizzo MR, 2011, J FOOD BIOCHEM, V35, P381, DOI 10.1111/j.1745-4514.2010.00390.x; Hano C, 2013, BIOORG MED CHEM LETT, V23, P3007, DOI 10.1016/j.bmcl.2013.03.029; Burlingham BT, 2003, J CHEM EDUC, V80, P214; Palanisamy UD, 2011, FOOD CHEM, V127, P21, DOI 10.1016/j.foodchem.2010.12.070; Bhandari MR, 2008, FOOD CHEM, V106, P247, DOI 10.1016/j.foodchem.2007.05.077; Kwon YI, 2008, BIORESOURCE TECHNOL, V99, P2981, DOI 10.1016/j.biortech.2007.06.035; Apostolidis E, 2007, INNOV FOOD SCI EMERG, V8, P46, DOI 10.1016/j.ifset.2006.06.001; Hsieh SH, 2011, ACTA DIABETOL, V48, P71, DOI 10.1007/s00592-010-0220-6; Isik S, 2012, FOOD CHEM, V134, P29, DOI 10.1016/j.foodchem.2012.02.020; Komaki E, 2003, FOOD SCI TECHNOL RES, V9, P35, DOI 10.3136/fstr.9.35; Liu J.P., 2004, J ETHNOPHARMACOL, V115, P173; Melo EBD, 2006, TETRAHEDRON, V62, P10277; Ratner R. E., 2001, AM J CARDIOL, V88, P26, DOI 10.1016/S0002-9149(01)01834-3; Rietjens SJ, 2007, AM J PHYSIOL-HEART C, V292, P1931; Ryu H.W., 2009, J AGR FOOD CHEM, V58, P202; Santiago-Mora R., 2010, OSTEOPOROSIS INT, V22, P657; Worthington V., 1993, WORTHINGTON ENZYME M, P36	27	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					835	843		10.5650/jos.ess15026		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500006		
J	Yawata, M; Satoh, T; Iwahashi, M; Hori, R; Takeuchi, S; Shiramasa, H; Totani, N				Yawata, Miho; Satoh, Tohru; Iwahashi, Maiko; Hori, Ryuji; Takeuchi, Shigeo; Shiramasa, Hiroshi; Totani, Nagao			The Antioxidation Mechanism of Polydimethylsiloxane in Oil	JOURNAL OF OLEO SCIENCE			English	Article						polydimethylsiloxane; tocopherol; antioxidation mechanism; suspension	DEGRADATION COMPOUNDS; OXYGEN-CONTENT; FRYING OILS; OLIVE OIL; TOCOPHEROLS; OXIDATION	Strong and stable antioxidation effects of polydimethylsiloxane (PDMS) are widely accepted and utilized in commercial frying oil; however, the mechanism is not fully established. On the other hand, canola oil contains about 700 ppm (mg/kg-oil) of the natural antioxidant, tocopherol. Canola oil containing 0, 1 and 10 ppm added PDMS was heated at 180 degrees C for 1 h under stirring, then left for 2-3 days at room temperature; this treatment was repeated 5 times. Compared to pure canola oil, PDMS-containing canola oil exhibited remarkably lower peroxide, p-anisidine and acid values, a lower decrease in tocopherol content but a higher oxygen content during the heating experiments, implicating low oxygen consumption for the oxidation. While PDMS has not been known to exhibit antioxidative effects at ambient temperatures, the present results show that PDMS prevents autoxidation as well as thermal oxidation. In addition, PDMS, not tocopherols, provided the major antioxidative effect during intermittent heating, and the decrease of tocopherols was significantly inhibited by PDMS. Phase contrast microscopy confirmed that PDMS contained in canola oil was suspended as particles. Also, the oxygen content in standing PDMS-containing canola oil decreased as the depth of oil increased, corresponding to the PDMS distribution, which also decreased as the depth of oil increased. Moreover, PDMS had a higher affinity for oxygen than canola oil in a mixture of canola oil/PDMS, 1:1 v/v. Thus, it is suggested that PDMS restricted the behavior of oxygen dissolved in canola oil by attracting oxygen in and around the PDMS particles, which is wholly different from the radical scavenging antioxidation of tocopherol.	[Yawata, Miho; Satoh, Tohru; Totani, Nagao] Kobe Gakuin Univ, Fac Nutr, Nishi Ku, Kobe, Hyogo 6512180, Japan; [Iwahashi, Maiko; Hori, Ryuji; Takeuchi, Shigeo; Shiramasa, Hiroshi] J Oil Mills Inc, R&D Div, Tsurumi Ku, Yokohama, Kanagawa 2300053, Japan	Totani, N (reprint author), Kobe Gakuin Univ, Fac Nutr, Nishi Ku, 518 Arise, Kobe, Hyogo 6512180, Japan.	totani@nutr.kobegakuin.ac.jp					Barrera-Arellano D, 2002, J SCI FOOD AGR, V82, P1696, DOI 10.1002/jsfa.1245; FREEMAN IP, 1973, J AM OIL CHEM SOC, V50, P101, DOI 10.1007/BF02633557; Totani N, 2013, J OLEO SCI, V62, P989, DOI 10.5650/jos.62.989; Barrera-Arellano D, 1999, J SCI FOOD AGR, V79, P1923, DOI 10.1002/(SICI)1097-0010(199910)79:13<1923::AID-JSFA457>3.0.CO;2-8; Franco MN, 2014, J OLEO SCI, V63, P115, DOI 10.5650/jos.ess13098; Gerde J. A., 2011, J AM OIL CHEM SOC, P1573; Hara S., 2006, J FAC SCI TECH SEIKE, V43, P95; Martin J. B., 1953, U. S. Pat, V2, P213, Patent No. 2634213; Messina V, 2009, INT J FOOD SCI TECH, V44, P552, DOI 10.1111/j.1365-2621.2008.01844.x; NIKI E, 1989, J SYN ORG CHEM JPN, V47, P902; Ogata F, 2014, J OLEO SCI, V63, P187, DOI 10.5650/jos.ess13096; Przybylski R, 2013, J AM OIL CHEM SOC, V90, P1271, DOI 10.1007/s11746-013-2278-0; Standard Method for the Analysis of Fats, 2013, OILS REL MAT; Totani N, 2012, J OLEO SCI, V61, P601, DOI 10.5650/jos.61.601; Totani N., 2006, Journal of Oleo Science, V55, P135; Yasuda K., 1992, EDIBLE OIL OIL IND, P201; Yawata M, 2014, J OLEO SCI, V63, P987, DOI 10.5650/jos.ess14085	17	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					853	859		10.5650/jos.ess15064		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500008		
J	Yamazaki, I; Kimura, F; Nakagawa, K; Nakai, K; Arima, T; Kawabata, T; Kagawa, Y; Saitoh, S; Mizuno, S; Yaegashi, N; Miyazawa, T				Yamazaki, Isao; Kimura, Fumiko; Nakagawa, Kiyotaka; Nakai, Kunihiko; Arima, Takahiro; Kawabata, Terue; Kagawa, Yasuo; Saitoh, Shoji; Mizuno, Satoshi; Yaegashi, Nobuo; Miyazawa, Teruo			Heterogeneity of the Fatty Acid Composition of Japanese Placentae for Determining the Perinatal Fatty Acid Status: a Methodological Study	JOURNAL OF OLEO SCIENCE			English	Article						placenta; human; pregnant; fatty acid compositions; GC-FID	DIETARY-INTAKE; DOCOSAHEXAENOIC ACIDS; GROWTH-RETARDATION; ARACHIDONIC-ACID; FOOD SOURCES; PREGNANCY; TISSUE; EXPRESSION; MEMBRANES; PROTEINS	Analysis of the placenta can be a useful way to determine the fatty acid (FA) status of pregnant women and neonates since this large organ can be obtained easily and non-invasively. Although several studies have been conducted on using placental tissue for FA analysis, the sampling methods have not been thoroughly examined. The aim of the present study was to determine a suitable method of sampling human placentae by focusing on their heterogeneity. Twenty-four placentae were collected from healthy pregnant Japanese women in the Miyagi Prefecture of Japan. Five of them were used to compare the FA composition between the peripheral area and the central area of the placentae. The other 19 were examined to determine differences in the FA composition between the fetal and maternal side. Placental tissue crude lipid was saponified, and methyl was esterified with 14% sodium boron trifluoride methanol for gas chromatography with flame ionization detector analysis. Fifty-six peaks were detected from the methyl esters of the placental total lipid, and 33 of those were identified as FA methyl esters. There were considerable variations in the FA composition, as the variation was low in the central parts and high in the peripheral parts of the placentae. The 18:1n-9 and 18:2n-6 levels were higher in the fetal side, whereas the 20:3n-6, 20:4n-6, and 22:6n-3 levels were higher in the maternal side. These findings indicate the presence of heterogeneity in the FA composition of human placenta, and they suggest the necessity for standardizing the sampling method so that the placental tissue can be used to determine the FA status.	[Yamazaki, Isao; Kimura, Fumiko; Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 980, Japan; [Nakai, Kunihiko] Tohoku Univ, Grad Sch Med, Dept Dev & Environm Med, Environm & Genome Res Ctr, Sendai, Miyagi 980, Japan; [Arima, Takahiro] Tohoku Univ, Grad Sch Med, Environm & Genome Res Ctr, Dept Informat Genet, Sendai, Miyagi 980, Japan; [Kawabata, Terue; Kagawa, Yasuo] Kagawa Nutr Univ, Fac Nutr, Kagawa, Japan; [Saitoh, Shoji; Mizuno, Satoshi; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Gynecol & Obstet, Sendai, Miyagi 980, Japan; [Miyazawa, Teruo] New Ind Creat Hatchery Ctr NICHe, Sendai, Miyagi, Japan	Kimura, F (reprint author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 980, Japan.	f_kimura@biochem.tohoku.ac.jp			Environment Research and Technology Development Fund [5C-1153]; Ministry of the Environment, Japan; JSPS KAKENHI Grant [24580171]	This study was partly supported by a grant from the Environment Research and Technology Development Fund (5C-1153) of the Ministry of the Environment, Japan, and by a JSPS KAKENHI Grant (Number 24580171). This study was conducted under the approval of the Japan Environment and Children' s Study (JECS) as an adjunct study. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the Japanese government. We thank the staffs of this JECS adjunct study for the collection of biological materials.	Rahmawaty S, 2013, LIPIDS, V48, P869, DOI 10.1007/s11745-013-3812-4; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Huppertz B, 2008, J CLIN PATHOL, V61, P1296, DOI 10.1136/jcp.2008.055277; Lands B, 2012, NUTRIENTS, V4, P1338, DOI 10.3390/nu4091338; Bitsanis D, 2006, LIPIDS, V41, P341, DOI 10.1007/s11745-006-5104-8; Judge MP, 2007, LIPIDS, V42, P117, DOI 10.1007/s11745-006-3007-3; CHAMBAZ J, 1985, BIOL NEONATE, V47, P136; Cruz-Hernandez C, 2004, J AOAC INT, V87, P545; Salem N, 1996, P NATL ACAD SCI USA, V93, P49, DOI 10.1073/pnas.93.1.49; AL MDM, 1990, EARLY HUM DEV, V24, P239, DOI 10.1016/0378-3782(90)90031-D; Wang YP, 2005, HYPERTENS PREGNANCY, V24, P235, DOI 10.1080/10641950500281118; Kulkarni AV, 2011, PROSTAG LEUKOTR ESS, V84, P51, DOI 10.1016/j.plefa.2010.09.005; PERCY P, 1991, BIOCHIM BIOPHYS ACTA, V1084, P173, DOI 10.1016/0005-2760(91)90217-6; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Uauy R, 2000, P NUTR SOC, V59, P3, DOI 10.1017/S0029665100000021; Takkunen M, 2013, LIPIDS, V48, P1093, DOI 10.1007/s11745-013-3832-0; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; Dhobale MV, 2011, PROSTAG LEUKOTR ESS, V85, P149, DOI 10.1016/j.plefa.2011.06.003; Haggarty P, 2010, ANNU REV NUTR, V30, P237, DOI 10.1146/annurev.nutr.012809.104742; Lakin V, 1998, PROSTAG LEUKOTR ESS, V59, P209, DOI 10.1016/S0952-3278(98)90065-5; Bitsanis D, 2005, J NUTR, V135, P2566; Haggarty P, 2004, EUR J CLIN NUTR, V58, P1559, DOI 10.1038/sj.ejcn.1602016; Campbell FM, 1996, MOL CELL BIOCHEM, V155, P77, DOI 10.1007/BF00714336; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Larque E, 2006, AM J CLIN NUTR, V84, P853; Araya J, 1995, Rev Med Chil, V122, P503; BAYON Y, 1993, LIPIDS, V28, P631, DOI 10.1007/BF02536058; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haeussner E, 2013, PLACENTA, V34, P574, DOI 10.1016/j.placenta.2013.04.011; Huang MC, 2011, FOOD CHEM TOXICOL, V49, P1711, DOI 10.1016/j.fct.2011.04.013; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Klingler M, 2003, LIPIDS, V38, P561, DOI 10.1007/s11745-003-1496-8; Knipp GT, 2000, PLACENTA, V21, P367, DOI 10.1053/plac.1999.0484; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Matorras R, 2001, ACTA OBSTET GYN SCAN, V80, P807, DOI 10.1034/j.1600-0412.2001.080009807.x; Otsuka R, 2013, LIPIDS, V48, P719, DOI 10.1007/s11745-013-3763-9; Powell TL, 1999, BBA-BIOMEMBRANES, V1420, P86, DOI 10.1016/S0005-2736(99)00096-6; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Sioen I, 2013, LIPIDS, V48, P729, DOI 10.1007/s11745-013-3788-0	40	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					905	914		10.5650/jos.ess15071		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500013		
J	Shibata, O				Shibata, Osamu			To Reinforce Oleo Science Research Preface	JOURNAL OF OLEO SCIENCE			English	Editorial Material									Nagasaki Int Univ, Nagasaki, Japan	Shibata, O (reprint author), Nagasaki Int Univ, Nagasaki, Japan.							0	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	AUG	2015	64	8					P1	P1				1	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CO1EL	WOS:000358896500001		
J	Yagyuu, T; Obayashi, C; Ueyama, Y; Takano, M; Tanaka, Y; Kawaguchi, M; Takeda, M; Kasai, T; Kirita, T				Yagyuu, Takahiro; Obayashi, Chiho; Ueyama, Yoshihiro; Takano, Masato; Tanaka, Yuu; Kawaguchi, Masahiko; Takeda, Maiko; Kasai, Takahiko; Kirita, Tadaaki			Multivariate analyses of Ki-67, cytokeratin 13 and cytokeratin 17 in diagnosis and prognosis of oral precancerous lesions	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						cytokeratin 13; Ki-67; multivariate analysis; oral precancerous lesions; reactive atypical epithelium	SQUAMOUS-CELL CARCINOMA; MALIGNANT-TRANSFORMATION; EPITHELIAL DYSPLASIA; ORTHOKERATOTIC DYSPLASIA; LEUKOPLAKIA; EXPRESSION; P53; PROGRESSION; IMMUNOHISTOCHEMISTRY; CANCER	BackgroundKi-67, cytokeratin 13, and/or cytokeratin 17 detection by immunohistochemistry has been reported to be useful for the diagnosis of oral precancerous lesions. However, the use of these markers remains controversial because of the lack of appropriately designed statistical studies. We assessed the hypothesis that Ki-67, cytokeratin 13, or cytokeratin 17 immunohistochemistry could facilitate the diagnosis of oral precancerous lesions and/or predict prognosis. MethodsEpithelial dysplasia was classified as low grade (none or mild dysplasia) or high grade (moderate dysplasia, severe dysplasia, or carcinoma in situ). This study included 58 low-grade and 36 high-grade dysplasia cases. We used logistic regression to assess the diagnostic values of Ki-67, cytokeratin 13, and cytokeratin 17 for high-grade dysplasia. Correlations between these markers and the prognosis of oral atypical epithelium were assessed using the Cox proportional hazards model. ResultsKi-67 overexpression and cytokeratin 13 loss were independent diagnostic markers for high-grade dysplasia (odds ratios, 1.92 and 2.53; 95% confidence intervals, 1.03-3.58, and 1.19-5.38, respectively). The area under the curve of Ki-67 was 0.73 and that of cytokeratin 13 was 0.72. However, the combination of Ki-67 and cytokeratin 13 yielded the area under the curve of 0.78. Ki-67 overexpression was significantly associated with recurrence and/or malignant transformation of oral atypical epithelium (hazard ratio, 7.25; 95% confidence interval, 1.07-48.92). ConclusionsKi-67 overexpression and cytokeratin 13 loss may be useful for distinguishing oral precancerous lesions from reactive atypical epithelium. Moreover, Ki-67 overexpression may be a risk factor for recurrence and/or malignant transformation of oral atypical epithelium.	[Yagyuu, Takahiro; Ueyama, Yoshihiro; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 6348521, Japan; [Yagyuu, Takahiro; Obayashi, Chiho; Takano, Masato; Takeda, Maiko] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 6348521, Japan; [Tanaka, Yuu; Kawaguchi, Masahiko] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 6348521, Japan; [Kasai, Takahiko] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Kitakyushu, Fukuoka 807, Japan	Yagyuu, T (reprint author), Nara Med Univ, Dept Oral & Maxillofacial Surg, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	t-yagyuu@naramed-u.ac.jp					Menendez ST, 2012, MODERN PATHOL, V25, P1069, DOI 10.1038/modpathol.2012.63; Kujan O, 2006, ORAL ONCOL, V42, P987, DOI 10.1016/j.oraloncology.2005.12.014; Sakamoto K, 2011, HISTOPATHOLOGY, V58, P531, DOI 10.1111/j.1365-2559.2011.03759.x; Chang KW, 2000, J ORAL PATHOL MED, V29, P56, DOI 10.1034/j.1600-0714.2000.290202.x; Shah NG, 2007, INT J BIOL MARKER, V22, P132; Lin CY, 2010, HEAD NECK-J SCI SPEC, V32, P1028, DOI 10.1002/hed.21287; Matsubara R, 2011, INT J ONCOL, V39, P1391, DOI 10.3892/ijo.2011.1151; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Nasser W, 2011, J ORAL PATHOL MED, V40, P629, DOI 10.1111/j.1600-0714.2011.01026.x; WARNAKULASURIYA KAAS, 1995, J ORAL PATHOL MED, V24, P165, DOI 10.1111/j.1600-0714.1995.tb01159.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P127, DOI 10.1111/j.1600-0714.2007.00584.x; Cruz I, 2002, J CLIN PATHOL, V55, P98; Takeda T, 2006, J ORAL PATHOL MED, V35, P369, DOI 10.1111/j.1600-0714.2006.00444.x; Arsenic R, 2013, VIRCHOWS ARCH, V462, P609, DOI 10.1007/s00428-013-1412-6; Carrilho C, 2004, HUM PATHOL, V35, P546, DOI 10.1016/j.humpath.2004.01.021; Collett D, 1994, MODELLING SURVIVAL D, P150; Gale N, 2005, WHO CLASSIFICATION T, P177; Gires O, 2006, BIOCHEM BIOPH RES CO, V343, P252, DOI 10.1016/j.bbrc.2006.02.139; Girod SC, 1998, BRIT J ORAL MAX SURG, V36, P252, DOI 10.1016/S0266-4356(98)90708-2; Griner P F, 1981, Ann Intern Med, V94, P557; Izumo T, 2011, INT J CLIN ONCOL, V16, P15, DOI 10.1007/s10147-010-0169-z; Izumo T, 2012, JPN J CLIN ONCOL, V42, P1099, DOI 10.1093/jjco/hys141; Kitamura R, 2012, J CANCER RES CLIN, V138, P1299, DOI 10.1007/s00432-012-1202-6; Klein JP, 1997, SURVIVAL ANAL TECHNI, P83; Kobayashi T, 2012, HISTOPATHOLOGY, V61, P910, DOI 10.1111/j.1365-2559.2012.04283.x; Kobayashi T, 2010, PATHOL INT, V60, P156, DOI 10.1111/j.1440-1827.2009.02499.x; Kovesi G, 2003, ONCOLOGY-BASEL, V65, P331, DOI 10.1159/000074646; Kreppel M, 2012, ORAL DIS, V18, P692, DOI 10.1111/j.1601-0825.2012.01927.x; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034773; Mikami T, 2011, ORAL ONCOL, V47, P497, DOI 10.1016/j.oraloncology.2011.03.015; Nobusawa A, 2014, PATHOL INT, V64, P20, DOI 10.1111/pin.12125; Ohta K, 2010, ONCOL REP, V24, P9, DOI 10.3892/or_00000822; Okada Y, 2010, J HARD TISSUE BIOL, V19, P123; TAYLOR CR, 1994, HUM PATHOL, V25, P2, DOI 10.1016/0046-8177(94)90164-3; The Working Committee for New Histopathological Criteria for Borderline Malignancies of the Oral Mucosa the Japanese Society of Oral Pathology, 2014, J ORAL MAXILLOFAC SU, V26, P397; Whipple ME, 2004, LARYNGOSCOPE, V114, P1346, DOI 10.1097/00005537-200408000-00006; Zlobec I, 2006, MODERN PATHOL, V19, P1236, DOI 10.1038/modpathol.3800642	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	AUG	2015	44	7					523	531		10.1111/jop.12262		9	Dentistry, Oral Surgery & Medicine; Pathology	Dentistry, Oral Surgery & Medicine; Pathology	CN8MR	WOS:000358695700007		
J	Hosono, S; Mugishima, H; Takahashi, S; Masaoka, N; Yamamoto, T; Tamura, M				Hosono, S.; Mugishima, H.; Takahashi, S.; Masaoka, N.; Yamamoto, T.; Tamura, M.			One-time umbilical cord milking after cord cutting has same effectiveness as multiple-time umbilical cord milking in infants born at < 29 weeks of gestation: a retrospective study	JOURNAL OF PERINATOLOGY			English	Article							RANDOMIZED-CONTROLLED-TRIAL; PLACENTAL TRANSFUSION; CELL TRANSFUSIONS; PRETERM INFANTS; ADAPTATION; GRAVITY; VOLUME; NEED	OBJECTIVE: To compare two strategies to potentiate the effects of placental transfusion in infants born at <29 weeks of gestation. STUDY DESIGN: Twenty infants who received one-time umbilical cord milking after umbilical cord cutting were compared with 20 infants from a previous study group who received multiple-time umbilical cord milking. The primary outcome measurements were the probability of not needing a red blood cell (RBC) transfusion during the hospital stay and the total number of RBC transfusions within 21 days after birth. RESULT: There was no significant difference in the probability of not needing a transfusion during the hospital stay (P = 0.75) and the mean number of RBC transfusions given within the first 21 days of life (1.1 +/- 1.8 for the one-time umbilical cord-milking group vs 0.7 +/- 1.2 for the multiple-time umbilical cord-milking group, P = 0.48). CONCLUSION: One-time umbilical cord milking after umbilical cord cutting had similar beneficial effects to multiple-time umbilical cord milking before umbilical cord cutting in very premature infants.	[Hosono, S.; Mugishima, H.; Takahashi, S.; Masaoka, N.] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Div Neonatol, Tokyo 1738610, Japan; [Yamamoto, T.] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Obstet & Gynecol, Chiba, Japan; [Masaoka, N.; Yamamoto, T.] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1738610, Japan; [Tamura, M.] Saitama Med Univ, Kawagoe Med Ctr, Ctr Maternal Fetal & Neonatal Med, Div Neonatal Med, Saitama, Japan	Hosono, S (reprint author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Div Neonatol, 30-1 Oyaguchi Itabashi, Tokyo 1738610, Japan.	hosono.shigeharu@nihon-u.ac.jp			MEXT KAKENHI [26461649]	This work was supported by MEXT KAKENHI (Grant-in-Aid for Scientific Research (C) Grant Number 26461649.	Alan S, 2014, J PEDIAT HEMATOL ONC, V36, pE493, DOI 10.1097/MPH.0000000000000143; Hosono S, 2008, ARCH DIS CHILD-FETAL, V93, pF14, DOI 10.1136/adc.2006.108902; Rabe H, 2011, OBSTET GYNECOL, V117, P205, DOI 10.1097/AOG.0b013e3181fe46ff; Vain NE, 2014, LANCET, V384, P235, DOI 10.1016/S0140-6736(14)60197-5; Erickson-Owens DA, 2012, J PERINATOL, V32, P580, DOI 10.1038/jp.2011.159; Katheria AC, 2014, J PEDIATR-US, V164, P1045, DOI 10.1016/j.jpeds.2014.01.024; March MI, 2013, J PERINATOL, V33, P763, DOI 10.1038/jp.2013.70; Boere I, 2015, ARCH DIS CHILD-FETAL, V100, pF121, DOI 10.1136/archdischild-2014-307144; Hosono S, 2009, ARCH DIS CHILD-FETAL, V94, pF328, DOI 10.1136/adc.2008.142935; Hosono S, 2015, PEDIATR INT, V57, P68, DOI 10.1111/ped.12464; Jelin AC, 2013, J MATERN-FETAL NEO M, V27, P1457; Katheria A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094085; Mercer JS, 2010, J PERINATOL, V30, P11, DOI 10.1038/jp.2009.170; Patel S, 2014, AM J OBSTET GYNECOL, V211; Rabe H, 2012, COCHRANE DB SYST REV, V8; Raju TNK, 2014, LANCET, V384, P213, DOI 10.1016/S0140-6736(14)60411-6; Takami T, 2012, J PEDIATR-US, V161, P742, DOI 10.1016/j.jpeds.2012.03.053; Upadhyay A, 2013, AM J OBSTET GYNECOL, V208, p[120, e1]	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0743-8346	1476-5543		J PERINATOL	J. Perinatol.	AUG	2015	35	8					590	594		10.1038/jp.2015.15		5	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CN8IQ	WOS:000358684100012		
J	Takeshima, H; Venturi, E; Sitsapesan, R				Takeshima, Hiroshi; Venturi, Elisa; Sitsapesan, Rebecca			New and notable ion-channels in the sarcoplasmic/endoplasmic reticulum: do they support the process of intracellular Ca2+ release?	JOURNAL OF PHYSIOLOGY-LONDON			English	Review							RECESSIVE OSTEOGENESIS IMPERFECTA; PROTEIN KINASE-A; ENDOPLASMIC-RETICULUM; K+-CHANNEL; CHLORIDE CHANNEL; POTASSIUM CHANNEL; SKELETAL-MUSCLE; CALCIUM-RELEASE; SELECTIVE CHANNEL; ANION CHANNEL	Intracellular Ca2+ release through ryanodine receptor (RyR) and inositol trisphosphate receptor (IP3R) channels is supported by a complex network of additional proteins that are located in or near the Ca2+ release sites. In this review, we focus, not on RyR/IP3R, but on other ion-channels that are known to be present in the sarcoplasmic/endoplasmic reticulum (ER/SR) membranes. We review their putative physiological roles and the evidence suggesting that they may support the process of intracellular Ca2+ release, either indirectly by manipulating ionic fluxes across the ER/SR membrane or by directly interacting with a Ca2+-release channel. These channels rarely receive scientific attention because of the general lack of information regarding their biochemical and/or electrophysiological characteristics makes it difficult to predict their physiological roles and their impact on SR Ca2+ fluxes. We discuss the possible role of SR K+ channels and, in parallel, detail the known biochemical and biophysical properties of the trimeric intracellular cation (TRIC) proteins and their possible biological and pathophysiological roles in ER/SR Ca2+ release. We summarise what is known regarding Cl- channels in the ER/SR and the non-selective cation channels or putative Ca2+ leak channels', including mitsugumin23 (MG23), pannexins, presenilins and the transient receptor potential (TRP) channels that are distributed across ER/SR membranes but which have not yet been fully characterised functionally.	[Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Venturi, Elisa; Sitsapesan, Rebecca] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	Sitsapesan, R (reprint author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	rebecca.sitsapesan@pharm.ox.ac.uk			British Heart Foundation; JSPS	Our collaborative work was supported in part by the British Heart Foundation and JSPS Core-to-core program grants.	Ahern GP, 1998, BIOPHYS J, V74, P2335; Rubinato E, 2014, GENE, V545, P290, DOI 10.1016/j.gene.2014.05.028; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/M503544200; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Yamazaki D, 2009, DEVELOPMENT, V136, P2355, DOI 10.1242/dev.036798; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Inesi G, 2014, J CELL COMMUN SIGNAL, V8, P5, DOI 10.1007/s12079-013-0213-7; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P643, DOI 10.1016/j.bbamem.2013.05.025; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; MILLER C, 1978, J MEMBRANE BIOL, V40, P1, DOI 10.1007/BF01909736; Shilling D, 2012, J BIOL CHEM, V287, P10933, DOI 10.1074/jbc.M111.300491; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Ashrafpour M, 2012, PFLUG ARCH EUR J PHY, V464, P175, DOI 10.1007/s00424-012-1121-z; BELL J, 1985, BIOPHYS J, V48, P349; BELL JE, 1984, BIOPHYS J, V45, P279; Cai Yiqiang, 1999, Journal of Biological Chemistry, V274, P28557, DOI 10.1074/jbc.274.40.28557; Divangahi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000586; FOX JA, 1985, BIOPHYS J, V47, P573; Gillespie D, 2008, BIOPHYS J, V95, P3706, DOI 10.1529/biophysj.108.131987; Giunti R, 2007, ARCH BIOCHEM BIOPHYS, V462, P115, DOI 10.1016/j.abb.2007.03.039; GRAY MA, 1985, J PHYSIOL-LONDON, V369, pP183; Guo T, 2013, BIOPHYS J, V105, P1151, DOI 10.1016/j.bpj.2013.07.042; HILL JA, 1990, AM J PHYSIOL, V258, pH159; HILL JA, 1989, BIOPHYS J, V55, P35; Kamp F, 1998, BIOPHYS J, V74, P290; KAWANO S, 1992, CIRC RES, V71, P585; Kawano S, 1999, J BIOL CHEM, V274, P2085, DOI 10.1074/jbc.274.4.2085; KAWANO S, 1993, CIRC RES, V73, P751; Kuum M, 2012, J CELL SCI, V125, P625, DOI 10.1242/jcs.090126; LABARCA P, 1980, J GEN PHYSIOL, V76, P397, DOI 10.1085/jgp.76.4.397; LABARCA PP, 1981, J MEMBRANE BIOL, V61, P31, DOI 10.1007/BF01870750; Lamhonwah AM, 2010, ANN NEUROL, V67, P802, DOI 10.1002/ana.21982; LIU QY, 1991, BIOPHYS J, V60, P198; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Lotteau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058673; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; Nishi M, 1998, FEBS LETT, V432, P191, DOI 10.1016/S0014-5793(98)00864-3; Picher M, 1996, BBA-BIOMEMBRANES, V1279, P93, DOI 10.1016/0005-2736(95)00239-1; Pitt SJ, 2010, BIOPHYS J, V99, P417, DOI 10.1016/j.bpj.2010.04.051; ROUSSEAU E, 1992, MOL CELL BIOCHEM, V114, P109; ROUSSEAU E, 1988, EUR BIOPHYS J BIOPHY, V16, P143; SHEN WK, 1993, BIOPHYS J, V65, P747; Stauber T, 2012, COMPREHENSIVE PHYSL; TANIFUJI M, 1987, J MEMBRANE BIOL, V99, P103, DOI 10.1007/BF01871230; Taylor CW, 2012, MOL CELL ENDOCRINOL, V353, P21, DOI 10.1016/j.mce.2011.08.028; TOMLINS B, 1986, PFLUG ARCH EUR J PHY, V407, P341, DOI 10.1007/BF00585312; TOMLINS B, 1984, J MEMBRANE BIOL, V80, P191, DOI 10.1007/BF01868775; TOWNSEND C, 1995, J MEMBRANE BIOL, V147, P121; UEHARA A, 1994, J MOL CELL CARDIOL, V26, P195, DOI 10.1006/jmcc.1994.1022; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Venturi E, 2013, PFLUGERS ARCH, V465, P1; Venturi E, 2011, BIOCHEMISTRY-US, V50, P2623, DOI 10.1021/bi1019447; Veronesi B, 2006, TOXICOL SCI, V89, P1, DOI 10.1093/toxsci/kfj034; WANG JX, 1994, J PHYSIOL-LONDON, V477, P279; Wicki-Stordeur LE, 2013, CELL COMMUN ADHES, V20, P73, DOI 10.3109/15419061.2013.791681; Xin H, 2005, BIOCHEM BIOPH RES CO, V332, P756, DOI 10.1016/j.bbrc.2005.05.016; Yamashita A, 2013, FEBS LETT, V587, P1299, DOI 10.1016/j.febslet.2013.03.024; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x; Yamazaki T, 2010, BIOCHEM BIOPH RES CO, V392, P196, DOI 10.1016/j.bbrc.2010.01.013; Zhou M, 2005, J HISTOCHEM CYTOCHEM, V53, P1491, DOI 10.1369/jhc.5A6736.2005; Zhou XY, 2014, CIRC RES, V114, P706, DOI 10.1161/CIRCRESAHA.114.301816	86	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	AUG 1	2015	593	15					3241	3251		10.1113/jphysiol.2014.281881		11	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CN9SR	WOS:000358789800007		
J	Jamnongkan, T; Sukumaran, SK; Sugimoto, M; Hara, T; Takatsuka, Y; Koyama, K				Jamnongkan, Tongsai; Sukumaran, Sathish K.; Sugimoto, Masataka; Hara, Tomijiro; Takatsuka, Yumiko; Koyama, Kiyohito			Towards novel wound dressings: antibacterial properties of zinc oxide nanoparticles and electrospun fiber mats of zinc oxide nanoparticle/poly(vinyl alcohol) hybrids	JOURNAL OF POLYMER ENGINEERING			English	Article						antibacterial activity; electrospinning; poly(vinyl alcohol); wound dressing; ZnO nanoparticles	ZNO NANOPARTICLES; SILVER NANOPARTICLES; ESCHERICHIA-COLI; OXIDATIVE STRESS; STAPHYLOCOCCUS-AUREUS; LIPID-PEROXIDATION; COMPOSITE FIBERS; PARTICLE-SIZE; NANOFIBERS; BACTERIA	Zinc oxide (ZnO) nanoparticles possess antibacterial properties. Being less toxic to humans than silver, they are attractive as antibacterial agents in biomedical applications. In this study, we focus on the influence of the size of ZnO nanoparticles on their antibacterial action against strains of three bacteria: one Gram-negative, Escherichia coli and two Gram-positive, Bacillus subtilis and Staphylococcus aureus. The antibacterial efficacy of the nanoparticles increases with decreasing particle size. A major contributor to antibacterial action is the oxidative stress induced by the ZnO. To understand the relationship between antibacterial action and induced oxidative stress, we measured the dependence of the nanoparticle diameter on H2O2 concentration. Even at a fixed nanoparticle concentration, the H2O2 concentration increased with decreasing nanoparticle diameter. This is qualitatively similar to the dependence of the antibacterial activity on the nanoparticle diameter. In addition, in the presence of ZnO nanoparticles, we detected increased quantities of endogenous H2O2 in the E. coli. For use as antibacterial wound dressings, we fabricated nonwoven fiber mats from poly(vinyl alcohol) (PVA)/ZnO nanoparticle suspensions. The antibacterial efficacy of the PVA/ZnO electrospun fiber mats also increased with a decrease in the diameter and an increase in the concentration of the ZnO nanoparticles.	[Jamnongkan, Tongsai; Sukumaran, Sathish K.; Sugimoto, Masataka; Hara, Tomijiro; Takatsuka, Yumiko; Koyama, Kiyohito] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Sukumaran, SK (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan.	sa.k.sukumaran@gmail.com; sugimoto@yz.yamagata-u.ac.jp			JSPS KAKENHI [23655209]; Sagawa International Student Scholarship Foundation; Dissemination of Tenure Tracking System Program of Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by JSPS KAKENHI Grant no. 23655209. TJ would like to acknowledge the support from the Sagawa International Student Scholarship Foundation. Part of this work was undertaken when SKS was supported by the Dissemination of Tenure Tracking System Program of Ministry of Education, Culture, Sports, Science and Technology, Japan. We gratefully acknowledge Dr. Yuji Aoki and Dr. Toshinori Makuta of Yamagata University for helpful discussions and the latter for the use of instrumental facilities. We are also especially grateful to an anonymous referee for insightful comments that led to improvements in the manuscript.	Kong YX, 2012, POLYM COMPOSITE, V33, P1613, DOI 10.1002/pc.22298; Sawai J, 1996, J CHEM ENG JPN, V29, P251, DOI 10.1252/jcej.29.251; Hong KH, 2006, J POLYM SCI POL PHYS, V44, P2468, DOI 10.1002/polb.20913; Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081; Sharma D, 2010, THIN SOLID FILMS, V519, P1224, DOI [10.1016/j.tsf.2010.08.073, 10.1016/j.tsf2010.08.073]; Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332; Dutta RK, 2012, COLLOID SURFACE B, V94, P143, DOI 10.1016/j.colsurfb.2012.01.046; Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1; Ann LC, 2014, CERAM INT, V40, P2993, DOI 10.1016/j.ceratnint.2013.10.008; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Shalumon KT, 2011, INT J BIOL MACROMOL, V49, P247, DOI 10.1016/j.ijbiomac.2011.04.005; Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7; Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Sarkar K, 2010, MATER TODAY, V13, P12, DOI 10.1016/S1369-7021(10)70199-1; Huang JX, 2004, J AM CHEM SOC, V126, P851, DOI 10.1021/ja0371754; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0; Rujitanaroj PO, 2008, POLYMER, V49, P4723, DOI 10.1016/j.polymer.2008.08.021; Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Koski A, 2004, MATER LETT, V58, P493, DOI 10.1016/S0167-577X(03)00532-9; Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5; Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Ding B, 2002, J POLYM SCI POL PHYS, V40, P1261, DOI 10.1002/polb.10191; Dryden MS., 2010, J ANTIMICROB CHEM S3, V65, piii35; Gunalan S, 2012, PROG NAT SCI-MATER, V22, P695, DOI 10.1016/j.pnsc.2012.11.015; Jamnongkan T, 2014, POLYM ENG SCI, V54, P1969, DOI 10.1002/pen.23730; Padron S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4769886; Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611; Aghdam EM, 2012, GENE, V511, P455, DOI 10.1016/j.gene.2012.09.014; Siddique S, 2013, ACTA CHIM SLOV, V60, P660; Sun T, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-98; Wang C., 2012, AFR J BIOTECHNOL, V11, P10248; Xin SF, 2012, IND ENG CHEM RES, V51, P10621, DOI 10.1021/ie300861p	42	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-6447	2191-0340		J POLYM ENG	J. Polym. Eng.	AUG	2015	35	6					575	586		10.1515/polyeng-2014-0319		12	Polymer Science	Polymer Science	CN7JG	WOS:000358609900007		
J	Demircan, O; Yilmaz, C; Kocaman, ES; Tang, S; Hamada, H; Yildiz, M				Demircan, O.; Yilmaz, C.; Kocaman, E. S.; Tang, S.; Hamada, H.; Yildiz, M.			Effect of fiber densities on impact properties of biaxial warp-knitted textile composites	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						Textile composites; impact behavior; knitting	REINFORCED POLYPROPYLENE COMPOSITES; MECHANICAL-PROPERTIES; STACKING-SEQUENCE; DAMAGE RESISTANCE; COMPRESSION; STRENGTH; PERFORMANCE; TENSILE	In this study, an appropriate fabric weight content controlled by the density of the warp and weft fibers is determined for biaxial warp-knitted composites referring to mechanical test results. Six different types of composite panel with two different fabric weights (813 and 1187 gr/m(2)) and with three different stacking sequences [90(we)/0(wa)/90(we)/0(wa)](s), [90(wa)/ 0(we)/90(wa)/0(we)](s), and [90(wa)/0(we)/90(we)/0(wa)](s) are fabricated by using Resin Transfer Molding method. Having produced composite panels, drop weight impact tests are conducted on specimens. Microstructural characterization of impact tested materials is performed using optical microscope. The results of this study reveal that composites with biaxial warp-knitted preforms with lower weft and warp fiber densities (thin-ply) could absorb higher impact energies compared to those with higher weft and warp fiber densities (thick-ply).	[Demircan, O.; Yilmaz, C.; Kocaman, E. S.; Yildiz, M.] Sabanci Univ, Fac Engn & Nat Sci, AC2PL, TR-34196 Istanbul, Turkey; [Demircan, O.] Ondokuz Mayis Univ, Mat Sci & Engn Dept, Fac Engn, Samsun, Turkey; [Tang, S.; Hamada, H.] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Adv Fibrosci, Kyoto 606, Japan	Yildiz, M (reprint author), Sabanci Univ, Fac Engn & Nat Sci, AC2PL, TR-34196 Istanbul, Turkey.	meyildiz@sabanciuniv.edu			Scientific and Technical Research Council of Turkey (TUBITAK) [113C009, 112M357]	The authors gratefully acknowledge financial support from the Scientific and Technical Research Council of Turkey (TUBITAK) with the project numbers of 113C009 and 112M357.	Amacher R, 2013, 19 INT C COMP MAT MO, P1; Walker L, 2002, COMPOS PART A-APPL S, V33, P893, DOI 10.1016/S1359-835X(02)00010-6; Khondker OA, 2006, COMPOS PART A-APPL S, V37, P2285, DOI 10.1016/j.compositesa.2005.12.032; Amacher R, 2014, COMPOS SCI TECHNOL, V101, P121, DOI 10.1016/j.compscitech.2014.06.027; Guillamet G, 2014, COMPOS SCI TECHNOL, V98, P44, DOI 10.1016/j.compscitech.2014.04.014; Aktas A, 2003, COMPOS STRUCT, V62, P107, DOI 10.1016/S0263-8223(03)00096-5; Tan KT, 2012, COMPOS SCI TECHNOL, V72, P587, DOI 10.1016/j.compscitech.2012.01.003; Cheng KB, 2002, COMPOS PART A-APPL S, V33, P1219, DOI 10.1016/S1359-835X(02)00076-3; Yokozeki T, 2008, COMPOS STRUCT, V82, P382, DOI 10.1016/j.compstruct.2007.01.015; Khashaba UA, 2013, COMPOS PART B-ENG, V45, P1694, DOI 10.1016/j.compositesb.2012.09.066; Sihn S, 2007, COMPOS SCI TECHNOL, V67, P996, DOI 10.1016/j.compscitech.2006.06.008; Tan KT, 2010, COMPOS PART A-APPL S, V41, P1857, DOI 10.1016/j.compositesa.2010.09.007; Hufenbach W, 2009, COMPOS SCI TECHNOL, V69, P1422, DOI 10.1016/j.compscitech.2008.09.033; Demircan O, 2014, 1 JOINT TURK JAP WOR, P1; Demircan O, 2013, SCI ENG COMPOS MATER, V20, P255, DOI 10.1515/secm-2012-0046; Gao SL, 2001, COMPOS PART A-APPL S, V32, P775, DOI 10.1016/S1359-835X(00)00189-5; Hamada H, 2000, J REINF PLAST COMP, V19, P364, DOI 10.1106/FQTH-LFTG-UKLR-D55M; Karger-Kocsis J, 1996, PLAST RUBB COMPOS PR, V25, P109; Khondker OA, 2005, COMPOS PART A-APPL S, V36, P638, DOI 10.1016/j.compositesa.2004.07.006; Khondker OA, 2004, COMPOS PART A-APPL S, V35, P1185, DOI 10.1016/j.compositesa.2004.03.003; Kim JK, 1998, IMPACT RESPONSE DY 1; Kocsis JK, 1997, J THERMOPLAST COMPOS, V10, P163; Kocsis JK, 1998, COMPOS PART A-APPL S, V29A, P1319; Lee NJ, 1999, COMPOS PART A-APPL S, V30, P815, DOI 10.1016/S1359-835X(98)00185-7; LI JJ, 2010, J TEXT I, V101, P33; Mattsson D, 2008, ENG FRACT MECH, V75, P2666, DOI 10.1016/j.engfracmech.2007.03.014; Pandita SD, 2002, COMPOS SCI TECHNOL, V62, P1113, DOI 10.1016/S0266-3538(02)00057-X; RAMAKRISHNA S, 1995, SCI ENG COMPOS MATER, V4, P61; Ramakrishna S, 1995, 10 INT C COMP MAT, P245; Rodini JB, 1978, P 4 C FIBR COMP SAN; Tsai SW, 2005, 46 AIAA ASME ASCE AH, P1; Xue P, 2002, COMPOS PART A-APPL S, V33, P113, DOI 10.1016/S1359-835X(01)00067-7; Yao L, 2007, J MATER SCI, V42, P6494, DOI 10.1007/s10853-007-1534-9	33	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	AUG	2015	34	16					1287	1297		10.1177/0731684415577985		11	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	CN8YV	WOS:000358733000002		
J	Kumar, V; Yokozeki, T; Goto, T; Takahashi, T				Kumar, V.; Yokozeki, T.; Goto, T.; Takahashi, T.			Mechanical and electrical properties of PANI-based conductive thermosetting composites	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						Conductive composites; polyaniline; mechanical properties; electrical conductivity	IN-SITU POLYMERIZATION; EPOXY-RESIN; POLYANILINE; POLYMERS; BLENDS; SURFACTANT	Polyaniline (PANI) is one of the most studied intrinsic electrically conductive polymer in recent years. In the present work, PANI-based conductive composites have been prepared using dodecylbenzenesulphonic acid (DBSA) as a dopant and divinylbenzene (DVB) as a cross-linking polymer to enhance the rigidity. In this mixture, DBSA acts as the dopant of PANI as well as the curing agent of DVB, and this means that doping and curing of the composite occur simultaneously. PANI-DBSA mixture has been prepared by physical mixing using centrifugal mixer. The ratio of PANI and DBSA has been kept constant in weight ratio 30:70. Furthermore, DVB content has been varied to prepare the different samples. It has been found that with the increase in DVB content, a good dispersion of PANI-DBSA/DVB solution is achieved. However, significant improvement in the electrical conductivity of the samples is observed with the increase in PANI content. Mechanical flexural test has been performed on the prepared samples using a three-point bending configuration. It has been found that the flexural modulus and brittleness of the prepared samples increase with the increase in the content of DVB in the composite. Morphology of the composite surfaces has been also studied and it has been found that low concentration of DVB results into a poor dispersion and hence agglomeration of PANI-DBSA in composite can be seen clearly in the images.	[Kumar, V.; Yokozeki, T.] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo, Japan; [Goto, T.; Takahashi, T.] Yamagata Univ, Dept Organ Device Engn, Yonezawa, Yamagata, Japan	Yokozeki, T (reprint author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yokozeki@aastr.t.u-tokyo.ac.jp					Jeon BH, 1999, SYNTHETIC MET, V104, P95, DOI 10.1016/S0379-6779(99)00053-3; HEEGER AJ, 1993, SYNTHETIC MET, V57, P3471; Shirshova N, 2013, COMPOS PART A-APPL S, V46, P96, DOI 10.1016/j.compositesa.2012.10.007; Haba Y, 2000, SYNTHETIC MET, V110, P189, DOI 10.1016/S0379-6779(99)00280-5; Jia W, 2003, SYNTHETIC MET, V132, P269, DOI 10.1016/S0379-6779(02)00460-5; Schettini ARA, 2011, MACROMOL SYMP, V299-300, P164, DOI 10.1002/masy.200900106; Dumitrescu I, 2009, U POLITEH BUCH SER A, V71, P63; ZHENG WY, 1995, MACROMOL CHEM PHYSIC, V196, P2443, DOI 10.1002/macp.1995.021960803; Roichman Y, 1999, SYNTHETIC MET, V98, P201, DOI 10.1016/S0379-6779(98)00190-8; Long YZ, 2004, PHYSICA B, V344, P82, DOI 10.1016/j.physb.2003.09.245; [Anonymous], 2007, D79010 ASTM INT, DOI [10.1520/D0790-10, DOI 10.1520/D0790-10]; Malinauskas A, 2001, POLYMER, V42, P3957, DOI 10.1016/S0032-3861(00)00800-4; CAO Y, 1993, SYNTHETIC MET, V57, P3514, DOI 10.1016/0379-6779(93)90468-C; YANG CY, 1994, POLYMER, V35, P1142, DOI 10.1016/0032-3861(94)90004-3; Castillo-Ortega MM, 2001, J APPL POLYM SCI, V81, P1498, DOI 10.1002/app.1578; Deborah DLC, 2010, COMPOSITE MAT SCI AP, V4th, P162; Del Castillo-Castro T, 2009, COMPOS PART A-APPL S, V40, P1573, DOI 10.1016/j.compositesa.2009.07.001; Faez R, 2001, EUR POLYM J, V37, P1139, DOI 10.1016/S0014-3057(00)00235-4; Goethals EJ, 1998, TELECHELIC POLYM, P100; Goto T, 2011, POLYM ADVAN TECHNOL, V22, P1286, DOI 10.1002/pat.1972; Kondawar S. B., 2011, ADV MAT LETT, V2, P362; Michael JDS, 2014, MAT RES, V17, P59; Ramamurthy PC, 2004, MAT RES SOC S P, V791; Bal S, 2007, B MATER SCI, V30, P379, DOI 10.1007/s12034-007-0061-2; Soares BG, 2010, SYNTHETIC MET, V160, P1981, DOI 10.1016/j.synthmet.2010.07.021; Zilberman M, 1997, J APPL POLYM SCI, V66, P243, DOI 10.1002/(SICI)1097-4628(19971010)66:2<243::AID-APP5>3.0.CO;2-W	26	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	AUG	2015	34	16					1298	1305		10.1177/0731684415588551		8	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	CN8YV	WOS:000358733000003		
J	Kawamoto, T; Endo, T				Kawamoto, Tetsuya; Endo, Toshihiko			Personality change in adolescence: Results from a Japanese sample	JOURNAL OF RESEARCH IN PERSONALITY			English	Article						Personality change; Adolescence; Japanese; Neuroticism; Extraversion; Gender; Birth cohort	LINEAR MODELING ANALYSES; RANK-ORDER STABILITY; MULTIPLE-RATER TWIN; MEAN-LEVEL CHANGE; BIG 5; GENDER-DIFFERENCES; MIDDLE ADULTHOOD; YOUNG ADULTHOOD; SEX-DIFFERENCES; LIFE EVENTS	We examined developmental trends in personality traits during adolescence by using data from the secondary school affiliated with the University of Tokyo (N = 3656; range 12-18; 1832 female), collected from 1981 to 2010. Hierarchical linear modeling analyses revealed cumulative mean-level changes in personality averaging approximately 1 SD across adolescence. Scales related to Neuroticism showed linear increases, and those related to Extraversion showed distinct developmental patterns: General Activity and Rhathymia did not change, while Ascendance and Social Extroversion declined. Additionally, we found significant gender and birth cohort effects on personality. Although the intercepts differed according to both factors, the trajectories were different only for the birth cohort. These findings suggest that personality development trajectories differ according to the sociocultural context. (C) 2015 Elsevier Inc. All rights reserved.	[Kawamoto, Tetsuya; Endo, Toshihiko] Univ Tokyo, Grad Sch Educ, Tokyo 1130033, Japan; [Kawamoto, Tetsuya] Japan Soc Promot Sci, Tokyo, Japan	Kawamoto, T (reprint author), Univ Tokyo, Grad Sch Educ 201, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tk5049@p.u-tokyo.ac.jp			JSPS KAKENHI [26.12061]	Preparation of this manuscript was supported by JSPS KAKENHI Grant Number 26.12061. The author would like to thank Enago (www.enago.jp) for the English language review.	Abe S, 2009, J PAEDIATR CHILD H, V45, P636, DOI 10.1111/j.1440-1754.2009.01586.x; Aizawa N, 2002, JPN J EDUC PSYCHOL, V50, P215; Andrich D., 1994, J EARLY ADOLESC, V14, P328, DOI 10.1177/0272431694014003002; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Canals J, 2005, PERS INDIV DIFFER, V39, P179, DOI 10.1016/j.paid.2004.12.012; Bleidorn W, 2012, PERS SOC PSYCHOL B, V38, P1594, DOI 10.1177/0146167212456707; Pullmann H, 2006, EUR J PERSONALITY, V20, P447, DOI 10.1002/per.611; Walvoord EC, 2010, J ADOLESCENT HEALTH, V47, P433, DOI 10.1016/j.jadohealth.2010.05.018; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Twenge JM, 2000, J PERS SOC PSYCHOL, V79, P1007, DOI 10.1037//0022-3514.79.6.1007; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Kandler C, 2013, DEV PSYCHOL, V49, P1739, DOI 10.1037/a0030744; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Klimstra TA, 2009, J PERS SOC PSYCHOL, V96, P898, DOI 10.1037/a0014746; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Neyer FJ, 2007, J PERS, V75, P535, DOI 10.1111/j.1467-6494.2007.00448.x; HOFSTEE WKB, 1994, EUR J PERSONALITY, V8, P149, DOI 10.1002/per.2410080302; Smits IAM, 2011, J PERS SOC PSYCHOL, V100, P1124, DOI 10.1037/a0022874; Kandler C, 2010, J PERS, V78, P1565, DOI 10.1111/j.1467-6494.2010.00661.x; Wortman J, 2012, PSYCHOL AGING, V27, P867, DOI 10.1037/a0029322; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Terracciano A, 2005, PSYCHOL AGING, V20, P493, DOI 10.1037/0882-7974.20.3.493; Helson R, 2002, J PERS SOC PSYCHOL, V83, P752, DOI 10.1037//0022-3514.83.3.752; Lamb ME, 2002, CHILD DEV, V73, P1517, DOI 10.1111/1467-8624.00487; Twenge JM, 2001, PERS INDIV DIFFER, V30, P735, DOI 10.1016/S0191-8869(00)00066-0; Bleidorn W, 2012, J PERS, V80, P1029, DOI 10.1111/j.1467-6494.2011.00758.x; Roberts BW, 2001, J PERS SOC PSYCHOL, V81, P670, DOI 10.1037//0022-3514.81.4.670; Branje SJT, 2007, EUR J PERSONALITY, V21, P45, DOI 10.1002/per.596; Lehmann R, 2013, DEV PSYCHOL, V49, P365, DOI 10.1037/a0028277; Kandler C, 2010, J PERS SOC PSYCHOL, V98, P995, DOI 10.1037/a0019558; Mensah FK, 2013, J ADOLESCENT HEALTH, V53, P118, DOI 10.1016/j.jadohealth.2012.12.018; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Casey BJ, 2008, DEV REV, V28, P62, DOI 10.1016/j.dr.2007.08.003; Parker PD, 2012, J PERS, V80, P1061, DOI 10.1111/j.1467-6494.2012.00766.x; De Fruyt F, 2006, J PERS SOC PSYCHOL, V91, P538, DOI 10.1037/0022-3514.91.3.538; Josefsson K, 2013, DEV PSYCHOPATHOL, V25, P713, DOI 10.1017/S0954579413000126; Lockenhoff CE, 2009, J TRAUMA STRESS, V22, P53, DOI 10.1002/jts.20385; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Van den Akker AL, 2014, J PERS SOC PSYCHOL, V107, P736, DOI 10.1037/a0037248; Colom R, 2004, PERS INDIV DIFFER, V36, P75, DOI 10.1016/S0191-8869(03)00053-9; Tachibanaki T, 2006, JPN ECON REV, V57, P1, DOI 10.1111/j.1468-5876.2006.00355.x; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Casey BJ, 2010, NEURON, V67, P749, DOI 10.1016/j.neuron.2010.08.033; Billstedt E, 2013, INT J GERIATR PSYCH, V28, P298, DOI 10.1002/gps.3825; Bryk A. S., 1992, HIERARCHICAL LINEAR; Costa Jr P. T., 1994, CAN PERSONALITY CHAN, P21, DOI DOI 10.1037/10143-002; Costa P., 1992, REVISED NEO PERSONAL; Denda K, 2006, INT J PSYCHIAT MED, V36, P231, DOI 10.2190/3YCX-H0MT-49DK-C61Q; Donnellan AB, 2008, PSYCHOL AGING, V23, P558, DOI 10.1037/a0012897; Eagly A. H., 1987, SEX DIFFERENCES SOCI; Guilford J. P., 1943, GUILFORDMARTIN INVEN; Guilford J. P, 1940, INVENTORY FACTORS ST; Guilford J. P., 1943, GUILFORDMARTIN PERSO; Guilford J. S., 1976, GUILFORDZIMMERMAN TE; Hasegawa K., 1990, JAPANESE J ED PSYCHO, V38, P306; Hein L, 2008, THIRD WORLD Q, V29, P447, DOI 10.1080/01436590801931439; Ishige M, 2005, JPN J EDUC PSYCHOL, V53, P356; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Jones CJ, 2003, J PERS ASSESS, V80, P294, DOI 10.1207/S15327752JPA8003_07; Klimstra TA, 2013, J RES PERS, V47, P768, DOI 10.1016/j.jrp.2013.08.004; Kotaka M., 1994, JAPANESE J PERSONALI, V2, P47; McCrae R. R., 2008, HDB PERSONALITY THEO, V3, P159; McCrae RR, 2002, J PERS SOC PSYCHOL, V83, P1456, DOI 10.1037//0022-3514.83.6.1456; Mervielde I., 1999, PERSONALITY PSYCHOL, V7, P107; MORINAGA Y, 1993, SEX ROLES, V29, P317, DOI 10.1007/BF00289426; Mottus R, 2012, PSYCHOL AGING, V27, P243, DOI 10.1037/a0023690; Muthen L. K., 2012, MPLUS USERS GUIDE; Natsuno R., 1998, THEORY PRACTICE 5 FA, P156; Okada T., 1993, JAPANESE J DEV PSYCH, V4, P162; Porteous M. A., 1985, CHILD PSYCHOL PSYCHI, V26, P465; R Core Team, 2013, R LANG ENV STAT COMP; Raudenbush S. W., 2002, HIERARCHICAL LINEAR; Revelle W., 2014, PSYCH PROCEDURES PER; Robins RW, 2001, J PERS, V69, P617, DOI 10.1111/1467-6494.694157; Sato Y., 2009, HUMAN WELFARE STUDIE, V12, P153; Shimonaka Y., 1996, 06610148 MIN ED SCI; SHIRAKAWA Y, 1992, PSYCHOLOGIA, V35, P193; SILBERMAN MA, 1993, CURR PSYCHOL, V12, P163, DOI 10.1007/BF02686821; Singer JD, 2003, APPL LONGITUDINAL DA; Sneed JR, 2012, J AM PSYCHOANAL ASS, V60, P1057, DOI 10.1177/0003065112459954; Steunenberg B, 2005, J GERONTOL B-PSYCHOL, V60, pP27; Suzuki H, 2011, PSYCHIAT RES, V188, P138, DOI 10.1016/j.psychres.2010.10.025; Terracciano A, 2006, J GERONTOL B-PSYCHOL, V61, pP108; Tsujioka Y, 2000, NEW METHOD PERSONALI; Van Aken MAG, 2006, EUR J PERSONALITY, V20, P497, DOI 10.1002/per.603; Yatabe J., 1975, PSYCHOL ASSESSMENT B, P269	89	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0092-6566	1095-7251		J RES PERS	J. Res. Pers.	AUG	2015	57						32	42		10.1016/jjrp.2015.03.002		11	Psychology, Social	Psychology	CN5JQ	WOS:000358466000004		
J	Rang, Y; Zeng, HL; Nakajima, H; Kato, S; Uchiyama, K				Rang, Ying; Zeng, Hulie; Nakajima, Hizuru; Kato, Shungo; Uchiyama, Katsumi			Quantitative on-line concentration for capillary electrophoresis with inkjet sample introduction technique	JOURNAL OF SEPARATION SCIENCE			English	Article						Capillary electrophoresis; Inkjet technique; On-line concentration; Quantitative analysis; Volume-control injection	INJECTION SYSTEM; CAFFEINE; ACCURATE; DROPLETS; SULFATE; COFFEE; TEA	A quantitative sample introduction method based upon inkjet injection was applied to capillary electrophoresis coupled with stacking and sweeping on-line concentration techniques. Methylxanthines were used as model compounds for the proof-of-concept of the method. The volume of injected sample could be easily manipulated by controlling the number of ejected droplets in the injection procedure. Under optimized conditions, a linear relationship between the ejected droplet number and peak area was obtained when the droplet number introduced into the capillary was less than 100. Under optimized quantitative on-line concentration conditions, the limits of detection for theobromine, caffeine, and theophylline were 1.0, 2.0, and 1.0 mu M, respectively. The inkjet injection system was evaluated by comparing it with conventional injection methods. The electropherogram of the inkjet injection mode was the same as that for hydrodynamic injection mode, and no sample discrimination was observed compared with the electrokinetic injection mode. The established method was applied to the determination of methylxanthines in bottled green tea. The recoveries of theobromine, caffeine, and theophylline were 94.1, 110.6, and 86.8%, respectively. We conclude that proposed method can be used for quantitative concentration for capillary electrophoresis, thus resulting in an improved accuracy.	[Rang, Ying; Zeng, Hulie; Nakajima, Hizuru; Kato, Shungo; Uchiyama, Katsumi] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Hachioji, Tokyo 1920364, Japan	Uchiyama, K (reprint author), Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Hachioji, Tokyo 1920364, Japan.	uchiyama-katsumi@tmu.ac.jp			Japan Society for the promotion of Science [2255079]; Tokyo Metropolitan Government (TMG)	This work was supported by Japan Society for the promotion of Science (no. 2255079) and High Technology Research Funding from Tokyo Metropolitan Government (TMG).	Altria KD, 2002, LC GC EUR, V15, P588; Volpi N, 2009, ANAL BIOCHEM, V388, P140, DOI 10.1016/j.ab.2009.02.012; Chen FM, 2012, ANAL CHIM ACTA, V739, P77, DOI 10.1016/j.aca.2012.06.022; Lin CE, 2004, J CHROMATOGR A, V1051, P85, DOI 10.1016/j.chroma.2004.08.038; Mayer BX, 2001, J CHROMATOGR A, V907, P21, DOI 10.1016/S0021-9673(00)01057-8; Horie H, 1997, J CHROMATOGR A, V758, P332, DOI 10.1016/S0021-9673(96)00764-9; Meinhart AD, 2010, FOOD CHEM, V120, P1155, DOI 10.1016/j.foodchem.2009.11.048; Verkouteren RM, 2009, ANAL CHEM, V81, P8577, DOI 10.1021/ac901563j; Chem F. M., 2013, ANAL CHEM, V85, P7413; Chen BY, 2014, BIOMED CHROMATOGR, V28, P320, DOI 10.1002/bmc.3036; Chen FM, 2013, TALANTA, V107, P111, DOI 10.1016/j.talanta.2012.12.058; KLEPARNIK K, 1995, J CHROMATOGR A, V698, P375, DOI 10.1016/0021-9673(94)00845-Z; Li MJ, 2009, J SEP SCI, V32, P267, DOI 10.1002/jssc.200800529; Luo C, 2013, J MASS SPECTROM, V48, P321, DOI 10.1002/jms.3159; Palmer C. P., 2005, J SEP SCI, V15, P756; Petersson M, 1998, J CHROMATOGR B, V714, P39, DOI 10.1016/S0378-4347(98)00092-9; Shrivas K, 2007, J CHROMATOGR A, V1170, P9, DOI 10.1016/j.chroma.2007.09.020; Talik P, 2012, SEP PURIF REV, V41, P1, DOI 10.1080/15422119.2011.569047; Weng Y., 2013, CHROMATOGRAPHIA, V34, P33; Yasui T, 2012, ANAL CHEM, V84, P9282, DOI 10.1021/ac3020565; Zeng HL, 2012, SENSOR ACTUAT B-CHEM, V168, P446, DOI 10.1016/j.snb.2012.04.007; Zeng HL, 2009, J CHROMATOGR A, V1216, P3337, DOI 10.1016/j.chroma.2009.02.051; Zeng HL, 2012, ANAL CHEM, V84, P10537, DOI 10.1021/ac302353q; Zhao YP, 1997, J CHROMATOGR B, V688, P265, DOI 10.1016/S0378-4347(96)00278-2	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	AUG	2015	38	15					2722	2728		10.1002/jssc.201500201		7	Chemistry, Analytical	Chemistry	CN5BE	WOS:000358443600020		
J	Wylie, K				Wylie, Kevan			A TALE OF TWO MINDS	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract									[Wylie, Kevan] WAS, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		294	294				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600003		
J	Namiki, M; Shigehara, K				Namiki, Mikio; Shigehara, Kazuyoshi			HPV INFECTION IN MEN	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						HPV infection; STIs; impacts in men			[Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Shigehara, Kazuyoshi] Ishikawa Prefectural Hosp, Kanazawa, Ishikawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI	PL-04	296	296				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600012		
J	Higashi, Y; Wong, J				Higashi, Yuko; Wong, Joe			ASIA-PACIFIC TRANS HEALTH BLUEPRINT	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						sexual rights; transgender health; discrimination			[Higashi, Yuko] Osaka Prefecture Univ, Dept Humanities & Social Sci, Habikino, Osaka, Japan; [Wong, Joe] Asia Pacific Trans Network, Bangkok, Thailand								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		312	312				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600077		
J	Higashi, Y; Paalanen, T				Higashi, Yuko; Paalanen, Tommi			ROUND TABLE SESSION BY WAS SEXUAL RIGHTS COMMITTEE	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						sexual rights; WAS declaration; advocacy			[Higashi, Yuko] Osaka Prefecture Univ, Dept Humanities & Social Sci, Sakai, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI	RT-02	320	320				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600113		
J	Dale, SPF				Dale, Sonja P. F.			IDENTITY AND SEXUALITY - STORIES FROM INDIVIDUALS WHO IDENTIFY THEMSELVES AS X-GENDER IN JAPAN	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						identity; x-gender; Japan			[Dale, Sonja P. F.] Sophia Univ, Tokai Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		324	324				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600127		
J	Skowronski, D; Waszynska, K				Skowronski, Dariusz; Waszynska, Katarzyna			ARE YOUNG JAPANESE HAVING LESS SEX? THE CELIBACY SYNDROME IN JAPAN - A CLINICAL AND CULTURAL PHENOMENON IN SEXUALITY COUNSELLING OR MEDIA THEORY? THE IMPLICATIONS FOR THE SEXUAL HEALTH PROFESSIONALS BASED ON THE QUANTITATIVE STUDY	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						celibacy syndrome; sexual avoidance; sexuality in Japan			[Skowronski, Dariusz] Temple Univ Japan Campus, Tokyo, Japan; [Waszynska, Katarzyna] Adam Mickiewicz Univ, Fac Educ Studies, Poznan, Poland								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		326	326				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600133		
J	Tromovitch, P				Tromovitch, Philip			THE PREVALENCE AND PROBABLE IMPACT OF CHILDHOOD AND ADOLESCENT SEXUAL EXPERIENCES IN JAPAN: SEPARATELY ANALYZING WANTED, UNWANTED, AND COERCED INCIDENTS	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						child sexual abuse; sexual experience in youth; adult functioning			[Tromovitch, Philip] Doshisha Univ, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		327	327				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600135		
J	Ohkawa, R				Ohkawa, Reiko			FEMALE SEXUAL DYSFUNCTION AS A CAUSE OF INFERTILITY	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						female sexual dysfunction; infertility; vaginismus			[Ohkawa, Reiko] Natl Hosp Org, Chiba Med Ctr, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		334	334				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600157		
J	Saotome, T; Yonezawa, K; Suganuma, N				Saotome, Tomoko; Yonezawa, Keiko; Suganuma, Nobuhiko			SEXUAL FUNCTIONS FROM PREGNANCY TO ONE YEAR POST DELIVERY IN JAPANESE COUPLES	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						delivery; sexual function; partnership			[Saotome, Tomoko; Yonezawa, Keiko; Suganuma, Nobuhiko] Kyoto Univ, Dept Gynecol Nursing, Grad Sch Med, Kyoto 6068501, Japan; [Saotome, Tomoko] Kanagawa Prefectural Shiomidai Hosp, Dept OB Gyn, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		335	335				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600160		
J	Skowronski, D; Andrews, J; Kobayashi, M				Skowronski, Dariusz; Andrews, John; Kobayashi, Maaya			THE SEXUAL AND MARITAL SATISFACTION IN INTERCULTURAL WESTERN-JAPANESE COMMITTED TO ROMANTIC RELATIONSHIPS. THE IMPLICATIONS FOR SEX THERAPY AND COUPLE COUNSELLING BASED ON THE QUALITATIVE STUDY	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						intercultural sexual satisfaction; risk factors; sex therapy			[Skowronski, Dariusz] Temple Univ Japan Campus, Tokyo, Japan; [Andrews, John; Kobayashi, Maaya] Temple Univ Japan Campus, Psychol Studies, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		336	336				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600162		
J	Yamanaka, K				Yamanaka, Kyoko			THE ANALYSIS OF PSYCHO-SOCIAL PROBLEMS THAT PEOPLE WITH HIV/AIDS EXPERIENCED AFTER HAART IN JAPAN	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						HIV/AIDS; People with HIV/AIDS; psycho-social problems			[Yamanaka, Kyoko] Osaka Prefecture Univ, Coll Hlth & Human Sci, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		337	337				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600166		
J	Yamamoto, B				Yamamoto, Beverley			A COMPARATIVE ANALYSIS OF UNDERSTANDINGS OF SEXUAL BEHAVIOUR AMONG KEY STAKEHOLDERS IN UK SECONDARY SCHOOLS	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						youth sexuality; sexual risk-taking; sexual health			[Yamamoto, Beverley] Osaka Univ, Suita, Osaka 565, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		341	341				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600178		
J	Nakahara, Y				Nakahara, Yumiko			DOES SEX STRENGTHEN THE COUPLE'S INTIMATE RELATIONSHIP? INTERVIEWS WITH AGED MALES IN JAPAN	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						sexless; intimate relationship; interviews			[Nakahara, Yumiko] Hyogo Univ Teachers Educ, Kato, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		347	348				2	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600200		
J	Pacher, A				Pacher, Alice			TRANSFORMATION OF SEXUAL BEHAVIOR IN YOUNG ADULTS IN MODERN JAPAN	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						couple relationship; Japan; sexual education			[Pacher, Alice] Meiji Univ, Tokyo 101, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		348	348				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600201		
J	Yonezawa, K; Saotome, T; Suganuma, N				Yonezawa, Keiko; Saotome, Tomoko; Suganuma, Nobuhiko			SYSTEMATIC REVIEW OF THE LITERATURE ABOUT HERBAL MEDICINE AND MALE SEXUAL FUNCTION	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						systematic review; Kampo traditional medicine; sexual dysfunction			[Yonezawa, Keiko; Saotome, Tomoko; Suganuma, Nobuhiko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		350	351				2	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600210		
J	Hayashi, K; Fukagai, T; Sasaki, H; Koshikiya, A; Igarashi, A; Morita, M; Tanifuji, S; Imamura, Y; Yamagishi, M; Shimoyama, H; Yamamoto, K; Ota, M; Ishikawa, K				Hayashi, Keiichiro; Fukagai, Takashi; Sasaki, Haruaki; Koshikiya, Atsushi; Igarashi, Atsushi; Morita, Masashi; Tanifuji, Satoru; Imamura, Yuichiro; Yamagishi, Motoki; Shimoyama, Hideaki; Yamamoto, Kenro; Ota, Michiya; Ishikawa, Kimiyasu			EFFECT OF TADALAFIL THAT WAS ADDITIONALLY ADMINISTERED TO PATIENTS RECEIVING AN ALPA-1 BLOCKER IN JAPANESE MEN WITH LOWER URINARY TRACT SYMPTOMS SUGGESTIVE OF BENIGN PROSTATIC HYPERPLASIA	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						tadalafil; BPH/LUTS; add-on therapy			[Hayashi, Keiichiro] Showa Univ, Koto Toyosu Hosp, Shinagawa, Japan; [Fukagai, Takashi; Koshikiya, Atsushi; Igarashi, Atsushi; Morita, Masashi] Showa Univ, Koto Toyosu Hosp, Dept Urol, Tokyo, Japan; [Sasaki, Haruaki; Tanifuji, Satoru; Imamura, Yuichiro; Yamagishi, Motoki; Shimoyama, Hideaki; Yamamoto, Kenro; Ota, Michiya] Showa Univ, Fujigaoka Hosp, Dept Urol, Yokohama, Kanagawa 227, Japan; [Ishikawa, Kimiyasu] Yokohama Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		352	352				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600215		
J	Amano, T; Imao, T; Yamamoto, T; Fukuda, M; Takemae, K				Amano, Toshiyasu; Imao, Tetsuya; Yamamoto, Teppei; Fukuda, Mamoru; Takemae, Katsuro			REPORT OF OUR 12 YEARS' EXPERIENCE OF MALE ADOLESCENCE SEXUAL EDUCATION IN NAGANO, JAPAN	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						male adolescence sexual education; sexually-transmitted infections; sexual dysfunctions			[Amano, Toshiyasu; Imao, Tetsuya; Yamamoto, Teppei; Fukuda, Mamoru; Takemae, Katsuro] Nagano Red Cross Hosp, Dept Urol, Nagano, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		357	357				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600230		
J	Kagiura, F; Kinoshita, K; Ootsuka, W; Miyashita, M; Wakabayashi, C; Ikushima, Y				Kagiura, Fumiko; Kinoshita, Kazue; Ootsuka, Wakako; Miyashita, Mika; Wakabayashi, Chihiro; Ikushima, Yuzuru			EXPLORED FACTORS OF ASSOCIATED RESTRICTION WITH SEXUAL LIFE IN PEOPLE LIVING WITH HIV/AIDS IN JAPAN	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						people living with HIV/AIDS; dicrimination; sexual life			[Kagiura, Fumiko] Hiroshima Univ, Hiroshima, Japan; [Kinoshita, Kazue; Ootsuka, Wakako] Hiroshima Univ Hosp, Dept Nursing, Hiroshima, Japan; [Miyashita, Mika] Hiroshima Univ, Div Nursing Sci, Hiroshima, Japan; [Wakabayashi, Chihiro] Saitama Prefectural Univ, Dept Hlth Sci, Saitama, Japan; [Ikushima, Yuzuru] Posit Living & Community Empowerment Tokyo, Dept Res Projects, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		363	363				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600250		
J	Uchiyama, A				Uchiyama, Ayako			THE REASONS OF SEX OFFENDERS' CHOICE FOR THEIR VICTIMS	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						sex crimes; sex offenders; victims			[Uchiyama, Ayako] Mejiro Univ, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		364	364				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600255		
J	Hayashi, I; Yoshidome, A				Hayashi, Itoko; Yoshidome, Atsuko			THE ATTITUDE OF JAPANESE FEMALE NURSING UNIVERSITY STUDENTS REGARDING CONTRACEPTION	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						contraception; Japanese students; attitudes; sexual risk			[Hayashi, Itoko] Oita Univ Nursing & Hlth Sci, Oita, Japan; [Yoshidome, Atsuko] Kagoshima Univ, Kagoshima 890, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		376	376				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600292		
J	Takamura, H; Esumi, S				Takamura, Hisako; Esumi, Shingo			THE GREAT EAST JAPAN EARTHQUAKE RECONSTRUCTION ASSISTANCE PROJECT 'THE EFFECTS OF THE PEER CARAVAN PROJECT "MENTAL HEALTH AND DREAMS IN LIFE - REBUILDING HOPES IN LIFE" FOR YOUNG PEOPLE IN PUBERTY	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						peer counselling; adolescents; post-disaster			[Takamura, Hisako; Esumi, Shingo] Jichi Med Univ, Sch Med, Shimotsuke, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		377	377				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600295		
J	Yamada, F; Takeda, K; Watanabe, M; Meguro, K				Yamada, Fujiko; Takeda, Kazue; Watanabe, Michi; Meguro, Keiko			INCORPORATING DATING VIOLENCE INTO THE HIGH SCHOOL SEX EDUCATION CURRICULUM	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						high school sex education; dating violence; teaching methods; midwives; school nurses			[Yamada, Fujiko] Yamagata Univ Hosp, Yamagata, Japan; [Yamada, Fujiko] Yamagata Chuo High Sch, Yamagata, Japan; [Takeda, Kazue; Watanabe, Michi; Meguro, Keiko] Yamagata Univ Hosp, Dept Obstet & Gynecol, Yamagata, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		378	378				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600298		
J	Imamura, K; Kayashima, K				Imamura, Kumiko; Kayashima, Kimiko			FACTORS INFLUENCING WOMEN'S RESUMPTION OF SEXUAL INTERCOURSE FROM 4 TO 5 MONTHS, POSTPARTUM	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						postpartum; sexual intercourse resumption; female sexual function			[Imamura, Kumiko] Saitama Med Univ, Moroyama, Saitama, Japan; [Kayashima, Kimiko] Jikei Univ, Sch Nursing, Chofu, Tokyo 1828570, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		379	379				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600302		
J	Murata, A; Kawasaki, H; Suganuma, N				Murata, Ai; Kawasaki, Hikari; Suganuma, Nobuhiko			CONSCIOUSNESS INVESTIGATION FOR ASSISTED REPRODUCTIVE TECHNOLOGY AMONG SEXUAL MINORITIES	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						sexual minority; assisted reproductive technology; sexual orientation			[Murata, Ai] Kyoto Univ, Sch Human Hlth Sci, Fac Med, Seibo Hosp, Kyoto 6068501, Japan; [Kawasaki, Hikari; Suganuma, Nobuhiko] Kyoto Univ, Sch Human Hlth Sci, Fac Med, Kyoto 6068501, Japan; [Kawasaki, Hikari] Kyoto Univ Hosp, Kyoto 606, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		379	379				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600303		
J	Nishi, K; Kayashima, K				Nishi, Keiko; Kayashima, Kimiko			THE USE OF PESSARY AMONG PELVIC ORGAN PROLAPSE PATIENTS AND ITS IMPACT ON DAILY LIFE AND SEX LIFE	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract						pelvic organ prolapse; pessary; symptoms; sexual life; daily life			[Nishi, Keiko] Jikei Daisan Nursing Sch, Tokyo, Japan; [Kayashima, Kimiko] Jikei Univ, Sch Nursing, Chofu, Tokyo 1828570, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	AUG	2015	12			5	SI		380	380				1	Urology & Nephrology	Urology & Nephrology	CN5SA	WOS:000358488600304		
J	Liu, Y; Iijima, J				Liu, Y.; Iijima, J.			Business process simulation in the context of enterprise engineering	JOURNAL OF SIMULATION			English	Article						enterprise ontology; DEMO; conceptual modelling; business process simulation; enterprise engineering; BPR	DISCRETE-EVENT SIMULATION; FRAMEWORK; SYSTEMS; DEMO	Traditional business process-based discrete event simulation is not sufficiently powerful to support change-related business process reengineering (BPR). The simulation methods are inadequate for describing large, complex systems and are difficult to change so as to simulate new BPR designs. The limitations are caused by (1) focusing on workflow; (2) low-abstraction conceptual models; and (3) a lack of separate opinions on design and implementation. Our research is based on enterprise engineering, a construction-based approach, rather than workflow. By clarifying the differences between and dependencies of the ontological and implementation models, this research proposes a generic framework for generating a modularized and component-based simulation model with increased reusability as well as with the capacity to make controllable changes in enterprise simulation. The method is assumed to assist BPR by reducing complexity and through its focus on enterprise engineering-based design thinking and human-centered interactions.	[Liu, Y.; Iijima, J.] Tokyo Inst Technol, Tokyo 1528552, Japan	Liu, Y (reprint author), Tokyo Inst Technol, Dept Ind Engn & Management, Meguro Ku, Ookayama 2-12-1-W9-66, Tokyo 1528552, Japan.						Vergidis K, 2008, IEEE T SYST MAN CY C, V38, P69, DOI 10.1109/TSMCC.2007.905812; Chwif L, 2013, J SIMUL, V7, P50, DOI 10.1057/jos.2012.18; Barjis J, 2007, ENTERP INFORM SYST, V1, P365, DOI 10.1080/17517570701646590; Turnitsa C, 2010, WINT SIMUL C PROC, P643, DOI 10.1109/WSC.2010.5679124; DAVENPORT TH, 1994, MIS QUART, V18, P121, DOI 10.2307/249760; Barber K. D., 2003, Business Process Management Journal, V9, DOI 10.1108/14637150310484544; Jahangirian M, 2010, EUR J OPER RES, V203, P1, DOI 10.1016/j.ejor.2009.06.004; Greasley A, 1998, INT J OPER PROD MAN, V18, P978, DOI 10.1108/01443579810225568; Siebers P, 2010, J SIMUL, V4, P204, DOI 10.1057/jos.2010.14; Aguilar-Saven RS, 2004, INT J PROD ECON, V90, P129, DOI 10.1016/S0925-5273(03)00102-6; Barjis J, 2002, P 7 CAISE IFIP WG8 1, P1671; Barjis J, 2001, INFO ORG DESIGN SER, V1, P213; Barjis J, 2008, SCI COMPUT PROGRAM, V71, P73, DOI 10.1016/j.scico.2008.01.002; Barjis J, 2010, P SPRING SIM MULT 20, P119; Cetinkaya D, 2012, P TMS DEVS 12 P 2012; Cetinkaya D, 2011, P 2011 SUMM COMP SIM; Chen PP-S., 1976, ACM T DATABASE SYST, V1, P9, DOI DOI 10.1145/320434.320440; Dietz J., 2006, ENTERPRISE ONTOLOGY; Dietz JLG, 2012, EEWC 2012 LNBIP 110, P15; Dietz JLG, 2000, ICEIS 2000, P267; Dietz JLG, 2014, THEORIES ENTERPRISE; Dietz Jan L. G., 2013, International Journal of Organisational Design and Engineering, V3; Greasley A., 2003, Business Process Management Journal, V9, DOI 10.1108/14637150310484481; Guizzardi G, 2012, P 2012 WINT SIM C IE; Hammer M., 1993, REENGINEERING CORPOR; Hoogervorst JA, 2009, ENTERP ENG SER, P1, DOI 10.1007/978-3-540-92671-9; Hopcroft J. E., 2006, INTRO AUTOMATA THEOR; Reijiers HA, 2005, OMEGA-INT J MANAGE S, V33, P283, DOI 10.1016/j.omega.2004.04.012; Liu Y, 2014, EEWC 2014; Martin J, 1995, USING 7 PRINCIPLES E; Netjes M, 2006, WORKSH TUT PRACT USE; Paolucci E, 1997, P EUR C INF SYST IEE; Perinforma A.P.C., 2012, ESSENCE ORG; Robinson S, 2006, Proceedings of the 2006 Winter Simulation Conference, Vols 1-5, P792, DOI 10.1109/WSC.2006.323160; Salimifard K, 2001, EUR J OPER RES, V134, P664, DOI 10.1016/S0377-2217(00)00292-7; Scholz-Reiter B., 1999, PROCESS MODELLING; Tumay K, 1996, 1996 WINTER SIMULATION CONFERENCE PROCEEDINGS, P93; Valiris G, 2004, BUSINESS PROCESS MAN, V10, P445, DOI 10.1108/14637150410548100; Wang W, 2007, P 2007 WINT SIM C, P762; Zeigler B. P., 2000, THEORY MODELING SIMU	40	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1747-7778	1747-7786		J SIMUL	J. Simul.	AUG	2015	9	3					206	222		10.1057/jos.2014.35		17	Computer Science, Interdisciplinary Applications; Operations Research & Management Science	Computer Science; Operations Research & Management Science	CN5JX	WOS:000358466700002		
J	Duan, ZG; Arjmand, F; Zhang, LF; Meng, FJ; Abe, H				Duan, Zhengang; Arjmand, Farzin; Zhang, Lefu; Meng, Fanjiang; Abe, Hiroaki			Electrochemical and XPS investigation of the corrosion behavior of Alloy 690 at high-temperature water	JOURNAL OF SOLID STATE ELECTROCHEMISTRY			English	Article						Alloy 690; Potentiodynamic polarization; XPS; Passive film; High-temperature corrosion	SIMULATED PRIMARY WATER; SURFACE OXIDE-FILMS; PWR PRIMARY WATER; DISSOLVED-OXYGEN; STAINLESS-STEEL; PH; MECHANISM; HYDROGEN; NICKEL; ZN	The effects of solution temperature, pH, and dissolved oxygen concentration on the electrochemical behavior of Alloy 690 in high-temperature water were investigated by electrochemical potentiodynamic polarization, and the oxide films developed on the specimens were characterized by X-ray photoelectron spectroscopy (XPS). The results revealed that in deaerated water + ETA solution decreasing the temperature and the pH of the environment improves the passivity of the oxide film on Alloy 690. The XPS analysis of the oxide film formed on Alloy 690 specimens after exposing to high-temperature water showed that the outer layer of the film consists of Ni hydroxides, Cr hydroxides, and NiFe2O4, while Cr2O3 and (Ni (x) , Fe1 -aEuro parts per thousand x ) Cr2O4 form the major part of the inner layer of the film.	[Duan, Zhengang; Arjmand, Farzin; Zhang, Lefu] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200240, Peoples R China; [Meng, Fanjiang] Shanghai Nucl Engn Res & Design Inst, Shanghai 200233, Peoples R China; [Abe, Hiroaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Zhang, LF (reprint author), Shanghai Jiao Tong Univ, Sch Mech Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	lfzhang@sjtu.edu.cn			Large-scale Advanced PWR Nuclear Power Plant Major Project - Shanghai Nuclear Engineering Research and Design Institute (SNERDI) [2011ZX06002001]	This study was supported by the Large-scale Advanced PWR Nuclear Power Plant Major Project (No. 2011ZX06002001) sponsored by the Shanghai Nuclear Engineering Research and Design Institute (SNERDI).	Wildgoose GG, 2004, ELECTROANAL, V16, P421, DOI 10.1002/elan.200302875; Zhang ZM, 2015, CORROS SCI, V94, P245, DOI 10.1016/j.corsci.2015.02.003; Terachi T, 2008, J NUCL SCI TECHNOL, V45, P975, DOI 10.3327/jnst.45.975; LISTER DH, 1987, CORROS SCI, V27, P113, DOI 10.1016/0010-938X(87)90068-0; Li XH, 2013, CORROS SCI, V67, P169, DOI 10.1016/j.corsci.2012.10.018; MCINTYRE NS, 1975, ANAL CHEM, V47, P2208, DOI 10.1021/ac60363a034; Huang F, 2013, CORROS SCI, V76, P52, DOI 10.1016/j.corsci.2013.06.023; Sun H, 2009, CORROS SCI, V51, P2565, DOI 10.1016/j.corsci.2009.06.043; Liu XH, 2012, CORROS SCI, V65, P136, DOI 10.1016/j.corsci.2012.08.022; Seo MJ, 2014, NUCL ENG DES, V280, P62, DOI 10.1016/j.nucengdes.2014.08.023; Abraham GJ, 2012, NUCL ENG DES, V243, P69, DOI 10.1016/j.nucengdes.2011.11.018; Ziemniak SE, 2006, CORROS SCI, V48, P498, DOI 10.1016/j.corsci.2005.01.006; GREELEY RS, 1960, J PHYS CHEM-US, V64, P652, DOI 10.1021/j100834a031; Sun H, 2009, CORROS SCI, V51, P2840, DOI 10.1016/j.corsci.2009.08.006; Huang JB, 2009, CORROS SCI, V51, P2976, DOI 10.1016/j.corsci.2009.08.002; ROBERTSON J, 1989, CORROS SCI, V29, P1275, DOI 10.1016/0010-938X(89)90120-0; Cook WG, 2012, CORROS SCI, V58, P284, DOI 10.1016/j.corsci.2012.02.007; Harrod DL, 2001, JOM-J MIN MET MAT S, V53, P14, DOI 10.1007/s11837-001-0080-1; Zhang ZM, 2011, CORROS SCI, V53, P3623, DOI 10.1016/j.corsci.2011.07.012; Machet A, 2002, SURF INTERFACE ANAL, V34, P197, DOI 10.1002/sia.1282; Huang JB, 2010, CORROS SCI, V52, P3444, DOI 10.1016/j.corsci.2010.06.016; Chen YY, 2005, MAT SCI ENG A-STRUCT, V396, P129, DOI 10.1016/j.msea.2005.01.026; [Anonymous], 2008, SAFETY RAD PROTECTIO; Kim DJ, 2008, CORROS SCI, V50, P1221, DOI 10.1016/j.corsci.2008.01.008; Ashassi-Sorkhabi H, 2009, CORROS SCI, V51, P1828, DOI 10.1016/j.corsci.2009.05.010; Feron D, 2012, WOODHEAD PUBL SER EN, P1, DOI 10.1533/9780857095343; Hermas AA, 2014, PROG ORG COAT, V77, P403, DOI 10.1016/j.porgcoat.2013.11.002; Huang JB, 2011, CORROS SCI, V53, P3254, DOI 10.1016/j.corsci.2011.06.001; Kuang WJ, 2013, CORROS SCI, V69, P197, DOI 10.1016/j.corsci.2012.12.003; Kuang WJ, 2011, CORROS SCI, V53, P3853, DOI 10.1016/j.corsci.2011.07.038; Le Calvar M, 2010, WORKSH COMM PRACT SA; Oldfield JW, 1988, GALVANIC CORROSION; Sun H, 2012, CORROS SCI, V59, P334, DOI 10.1016/j.corsci.2012.03.022	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-8488	1433-0768		J SOLID STATE ELECTR	J. Solid State Electrochem.	AUG	2015	19	8					2265	2273		10.1007/s10008-015-2856-1		9	Electrochemistry	Electrochemistry	CN6LQ	WOS:000358546700008		
J	Sasadai, J; Urabe, Y; Maeda, N; Shinohara, H; Fujii, E				Sasadai, Junpei; Urabe, Yukio; Maeda, Noriaki; Shinohara, Hiroshi; Fujii, Eri			The Effect of Ankle Taping to Restrict Plantar Flexion on Ball and Foot Velocity During an Instep Kick in Soccer	JOURNAL OF SPORT REHABILITATION			English	Article						sports performance; motion analysis; posterior ankle impingement syndrome	IMPINGEMENT; SUPPORT; JOINT	Context: Posterior ankle impingement syndrome is a common disorder in soccer players and ballet dancers. In soccer players, it is caused by the repetitive stress of ankle plantar flexion due to instep kicking. Protective ankle dorsiflexion taping is recommended with the belief that it prevents posterior ankle impingement. However, the relationship between ankle taping and ball-kicking performance remains unclear. Objective: To demonstrate the relationship between the restrictions of ankle taping and performance of an instep kick in soccer. Design: Laboratory-based repeated-measures. Setting: University laboratory. Participants: 11 male university soccer players. Intervention: The subjects' ankle plantar flexion was limited by taping. Four angles of planter flexion (0 degrees, 15 degrees, 30 degrees, and without taping) were formed by gradation limitation. The subjects performed maximal instep kicks at each angle. Main Outcome Measures: The movements of the kicking legs and the ball were captured using 3 high-speed cameras at 200 Hz. The direct linear-transformation method was used to obtain 3-dimensional coordinates using a digitizing system. Passive ankle plantar-flexion angle, maximal plantar-flexion angle at ball impact, ball velocity, and foot velocity were measured. The data were compared among 4 conditions using repeated-measures ANOVA, and the correlations between ball velocity and foot velocity and between ball velocity and toe velocity were calculated. Results: Ankle dorsiflexion taping could gradually limit both passive plantar flexion and plantar flexion at the impact. Furthermore, limitation of 0 and 15 degrees reduced the ball velocity generated by instep kicks. Conclusion: Plantar-flexion-limiting taping at 30 degrees has a potential to prevent posterior ankle impingement without decreasing the ball velocity generated by soccer instep kicks.	[Sasadai, Junpei; Urabe, Yukio; Maeda, Noriaki; Shinohara, Hiroshi; Fujii, Eri] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Sasadai, J (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	j-sasadai@hiroshima-u.ac.jp					Nunome H, 2002, MED SCI SPORT EXER, V34, P2028, DOI 10.1249/01.MSS.0000039076.43492.EF; Calder JD, 2010, AM J SPORT MED, V38, P120, DOI 10.1177/0363546509346390; MCDOUGALL A, 1955, J BONE JOINT SURG BR, V37, P257; Krause DA, 2011, J SPORT REHABIL, V20, P333; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Tol JL, 2002, AM J SPORT MED, V30, P45; Dorge HC, 2002, J SPORT SCI, V20, P293; Levanon J, 1998, MED SCI SPORT EXER, V30, P917, DOI 10.1097/00005768-199806000-00022; Lees A, 1998, J SPORT SCI, V16, P211, DOI 10.1080/026404198366740; van Dijk CN, 2009, J BONE JOINT SURG AM, V91A, P287, DOI 10.2106/JBJS.I.00445; Metcalfe RC, 1997, J ATHL TRAINING, V32, P136; van Dijk CN, 2000, ARTHROSCOPY, V16, P871, DOI 10.1053/jars.2000.19430; Wilkerson GB, 2002, J ATHL TRAINING, V37, P436; Asami T., 1983, BIOMECHANICS B, P695; Forbes H, 2013, J SPORT REHABIL, V22, P170; Giannini S, 2013, FOOT ANKLE INT, V34, P459, DOI 10.1177/1071100713477609; Ishii H, 2009, J BIOMECH, V42, P2712, DOI 10.1016/j.jbiomech.2009.08.025; Japan Football Association, 2013, JAP FOOTB ASS PROF; Lees A, 2009, CONT SPORT LEISURE E, P149; Quackenbush Katherine E, 2008, N Am J Sports Phys Ther, V3, P25; RARICK GL, 1962, J BONE JOINT SURG AM, V44, P1183; Rathur Sharik, 2009, Am J Orthop (Belle Mead NJ), V38, P252; Robinson Philip, 2006, AJR Am J Roentgenol, V187, pW53, DOI 10.2214/AJR.05.0614; Rodano R, 1993, SCI FOOTBALL, P357; Shinkai H, 2009, MED SCI SPORT EXER, V41, P889, DOI 10.1249/MSS.0b013e31818e8044	26	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2015	24	3					261	267		10.1123/jsr.2014-0156		7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO0BW	WOS:000358816100004		
J	Nakamura, M; Ikezoe, T; Tokugawa, T; Ichihashi, N				Nakamura, Masatoshi; Ikezoe, Tome; Tokugawa, Takahiro; Ichihashi, Noriaki			Acute Effects of Stretching on Passive Properties of Human Gastrocnemius Muscle-Tendon Unit: Analysis of Differences Between Hold-Relax and Static Stretching	JOURNAL OF SPORT REHABILITATION			English	Article						muscle stiffness; ultrasonography; proprioceptive neuromuscular facilitation stretching; passive torque; stretch tolerance	PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION; PLANTAR FLEXOR MOMENT; HAMSTRING FLEXIBILITY; IN-VIVO; STIFFNESS; LENGTH; CONTRACTION; DURATION; PERFORMANCE; RESPONSES	Context: Hold relax stretching (HRS) and static stretching (SS) are commonly used to increase joint range of motion (ROM) and decrease muscle stiffness. However, whether there are differences between acute effects of HRS and SS on end ROM, passive torque, and muscle stiffness is unclear. In addition, any differences between the mechanisms by which HRS and SS lead to an increase in end ROM are unclear. Objective: To compare the acute effects of HRS and SS on the passive properties of the gastrocnemius muscle tendon unit (MTU), end ROM, passive torque, and muscle stiffness in vivo and to investigate the factors involved in increasing end ROM. Design: Crossover experimental design. Participants: 30 healthy men (21.7 +/- 1.2 y) with no history of neuromuscular disease or musculoskeletal injury involving the lower limbs. Intervention: Both HRS and SS of 30 s were repeated 4 times, lasting a total of 2 min. Main Outcome Measures: End ROM, passive torque, and muscle stiffness were measured during passive ankle dorsiflexion using a dynamometer and ultrasonography before and immediately after HRS and SS. Results: The results showed that end ROM and passive torque at end ROM significantly increased immediately after both HRS and SS, whereas muscle stiffness significantly decreased. In addition, the percentage change in passive torque at end ROM on use of the HRS technique was significantly higher than that after use of the SS technique. However, the percentage change in muscle stiffness after SS was significantly higher than that with HRS. Conclusion: These results suggest that both HRS and SS can effectively decrease muscle stiffness of the gastrocnemius MTU and that HRS induces a change in the passive torque at end ROM-ie, sensory perception-rather than changing muscle stiffness.	[Nakamura, Masatoshi; Ikezoe, Tome; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Tokugawa, Takahiro] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Nakamura, M (reprint author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.	manakamu@mail.doshisha.ac.jp			Japan Society for the Promotion of Science (JSPS)	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows.	Feland JB, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.010967; O'Hora J, 2011, J STRENGTH COND RES, V25, P1586, DOI 10.1519/JSC.0b013e3181df7f98; Weppler CH, 2010, PHYS THER, V90, P438, DOI 10.2522/ptj.20090012; Mitchell UH, 2007, J SPORT REHABIL, V16, P85; Magnusson SP, 1996, ARCH PHYS MED REHAB, V77, P373, DOI 10.1016/S0003-9993(96)90087-8; Puentedura EJ, 2011, PHYS THER SPORT, V12, P122, DOI 10.1016/j.ptsp.2011.02.006; Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008; Spernoga SG, 2001, J ATHL TRAINING, V36, P44; Miyahara Y, 2013, J STRENGTH COND RES, V27, P195, DOI 10.1519/JSC.0b013e3182510856; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Nakamura M, 2013, MANUAL THER, V18, P211, DOI 10.1016/j.math.2012.09.010; Kay AD, 2009, J APPL PHYSIOL, V107, P1181, DOI 10.1152/japplphysiol.00281.2009; SALE D, 1982, J APPL PHYSIOL, V52, P1636; SHELLOCK FG, 1985, SPORTS MED, V2, P267, DOI 10.2165/00007256-198502040-00004; Youdas James W., 2010, Physiotherapy Theory and Practice, V26, P240, DOI 10.3109/09593980903015292; Nakamura M, 2012, EUR J APPL PHYSIOL, V112, P2749, DOI 10.1007/s00421-011-2250-3; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Magnusson SP, 1996, AM J SPORT MED, V24, P622, DOI 10.1177/036354659602400510; Kay AD, 2008, EUR J SPORT SCI, V8, P41, DOI 10.1080/17461390701855505; Azevedo DC, 2011, PHYS THER SPORT, V12, P117, DOI 10.1016/j.ptsp.2011.04.003; Bixler B, 1992, Fam Pract Res J, V12, P131; CONDON SM, 1987, PHYS THER, V67, P24; Gajdosik RL, 2007, EUR J APPL PHYSIOL, V99, P449, DOI 10.1007/s00421-006-0366-7; Haff GG, 2006, STRENGTH COND J, V28, P64, DOI 10.1519/1533-4295(2006)028[0064:RDFT]2.0.CO;2; Halbertsma JPK, 1996, ARCH PHYS MED REHAB, V77, P688, DOI 10.1016/S0003-9993(96)90009-X; Hubley C L, 1984, J Orthop Sports Phys Ther, V6, P104; Kubo K, 2001, EUR J APPL PHYSIOL, V84, P162; MacIntosh BR, 2005, J APPL PHYSIOL, V98, P1666, DOI 10.1152/japplphysiol.01045.2004; Maddigan ME, 2012, J STRENGTH COND RES, V26, P1238, DOI 10.1519/JSC.0b013e3182510611; Mizuno T, 2013, SCAND J MED SCI SPOR, V23, P23, DOI 10.1111/j.1600-0838.2011.01329.x; Ryan ED, 2008, MED SCI SPORT EXER, V40, P1529, DOI 10.1249/MSS.0b013e31817242eb; O'Sullivan K, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-37; Voss DE, 1985, PROPRIOCEPTIVE NEURO; WORRELL TW, 1994, J ORTHOP SPORT PHYS, V20, P154	34	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2015	24	3					286	292		10.1123/jsr.2014-0164		7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO0BW	WOS:000358816100007		
